PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, Q; Swaminathan, S; Yang, D; Dai, L; Sui, HY; Yang, J; Hornung, RL; Wang, YM; Huang, DW; Hu, XJ; Lempicki, RA; Imamichi, T				Chen, Qian; Swaminathan, Sanjay; Yang, De; Dai, Lue; Sui, Hongyan; Yang, Jun; Hornung, Ronald L.; Wang, Yanmei; Huang, Da Wei; Hu, Xiaojun; Lempicki, Richard A.; Imamichi, Tomozumi			Interleukin-27 Is a Potent Inhibitor of cis HIV-1 Replication in Monocyte-Derived Dendritic Cells via a Type I Interferon-Independent Pathway	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; GASTROINTESTINAL-TRACT; TRANS-INFECTION; CUTTING EDGE; IL-27; INDUCTION; DEPLETION; CYTOKINE; IMMATURE	IL-27, a member of the IL-12 family of cytokines, plays an important and diverse role in the function of the immune system. Whilst generally recognized as an anti-inflammatory cytokine, in addition IL-27 has been found to have broad anti-viral effects. Recently, IL-27 has been shown to be a potent inhibitor of HIV-1 infection in CD4+ T cells and macrophages. The main objective of this study was to see whether IL-27 has a similar inhibitory effect on HIV-1 replication in dendritic cells (DCs). Monocytes were differentiated into immature DCs (iDCs) and mature DCs (mDCs) with standard techniques using a combination of GM-CSF, IL-4 and LPS. Following differentiation, iDCs were infected with HIV-1 and co-cultured in the presence or absence of IL-27. IL-27 treated DCs were shown to be highly potent inhibitors of cis HIV-1, particularly of CCR5 tropic strains. Of note, other IL-12 family members (IL-12, IL-23 and IL-35) had no effect on HIV-1 replication. Microarray studies of IL-27 treated DCs showed no up-regulation of Type I (IFN) gene expression. Neutralization of the Type-I IFN receptor had no impact on the HIV inhibition. Lastly, IL-27 mediated inhibition was shown to act post-viral entry and prior to completion of reverse transcription. These results show for the first time that IL-27 is a potent inhibitor of cis HIV-1 infection in DCs by a Type I IFN independent mechanism. IL-27 has previously been reported to inhibit HIV-1 replication in CD4+ T cells and macrophages, thus taken together, this cytokine is a potent anti-HIV agent against all major cell types targeted by the HIV-1 virus and may have a therapeutic role in the future.	[Chen, Qian; Swaminathan, Sanjay; Dai, Lue; Sui, Hongyan; Imamichi, Tomozumi] Sci Applicat Int Corp SAIC Frederick Inc, Appl & Dev Res Directorate ADD, Lab Human Retrovirol, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Yang, De] SAIC Frederick Inc, Basic Res Program Directorate, Mol Immunoregulat Lab, Frederick Natl Lab Canc Res, Frederick, MD USA; [Yang, Jun; Huang, Da Wei; Hu, Xiaojun; Lempicki, Richard A.] SAIC Frederick Inc, Lab Immunopathogenesis & Bioinformat, ADD, Frederick Natl Lab Canc Res, Frederick, MD USA; [Hornung, Ronald L.; Wang, Yanmei] SAIC Frederick Inc, Immunol Monitoring Lab, ADD, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Imamichi, T (corresponding author), Sci Applicat Int Corp SAIC Frederick Inc, Appl & Dev Res Directorate ADD, Lab Human Retrovirol, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.	timamichi@mail.nih.gov	Sui, Hongyan/M-1305-2013; Lempicki, Richard A/E-1844-2012	Lempicki, Richard A/0000-0002-7059-409X; Imamichi, Tomozumi/0000-0002-1474-1796; Swaminathan, Sanjay/0000-0001-5315-6445	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institute of Allergy and Infectious Disease	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported [in part] by the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guzzo C, 2010, AIDS, V24, P1371, DOI 10.1097/QAD.0b013e3283391d2b; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; He L, 2011, J AIDS HIV RES, V3, P6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imamichi T, 2003, J VIROL, V77, P1011, DOI 10.1128/JVI.77.2.1011-1020.2003; Imamichi T, 2000, J VIROL, V74, P10958, DOI 10.1128/JVI.74.23.10958-10964.2000; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Karakhanova S, 2011, J LEUKOCYTE BIOL, V89, P837, DOI 10.1189/jlb.1209788; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yang D, 1999, J IMMUNOL, V163, P1737; Yang D, 2012, J EXP MED, V209, P157, DOI 10.1084/jem.20101354; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213	39	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59194	10.1371/journal.pone.0059194	http://dx.doi.org/10.1371/journal.pone.0059194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527130	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600063
J	Funston, PJ; Groom, RJ; Lindsey, PA				Funston, Paul J.; Groom, Rosemary J.; Lindsey, Peter A.			Insights into the Management of Large Carnivores for Profitable Wildlife-Based Land Uses in African Savannas	PLOS ONE			English	Article							POPULATION-DYNAMICS; LION POPULATION; LYCAON-PICTUS; PREY; PREDATION; CONSERVATION; CHEETAHS; DENSITY; RESERVE; ZEBRA	Large African predators, especially lions (Panthera leo) and leopards (Panthera pardus), are financially valuable for ecotourism and trophy hunting operations on land also utilized for the production of other wildlife species for the same purpose. Predation of ungulates used for trophy hunting can create conflict with landholders and trade off thus exists between the value of lions and leopards and their impact on ungulate populations. Therefore productionist and conservation trade-offs are complexly graded and difficult to resolve. We investigated this with a risk-benefit analysis on a large private wildlife production area in Zimbabwe. Our model showed that lions result in substantial financial costs through predation on wild ungulates that may not be offset by profits from hunting them, whereas the returns from trophy hunting of leopards are projected to exceed the costs due to leopard predation. In the absence of additional income derived from photo-tourism the number of lions may need to be managed to minimize their impact. Lions drive important ecological processes, but there is a need to balance ecological and financial imperatives on wildlife ranches, community wildlife lands and other categories of multiple use land used for wildlife production. This will ensure the competitiveness of wildlife based land uses relative to alternatives. Our findings may thus be limited to conservancies, community land-use areas and commercial game ranches, which are expansive in Africa, and should not necessarily applied to areas where biodiversity conservation is the primary objective, even if hunting is allowed there.	[Funston, Paul J.] Tshwane Univ Technol, Nat Conservat Dept, Pretoria, South Africa; [Groom, Rosemary J.] Univ Johannesburg, Dept Zool, Auckland Pk, South Africa; [Groom, Rosemary J.] African Wildlife Conservat Fund, Doral, FL USA; [Lindsey, Peter A.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Lindsey, Peter A.] Panthera Fdn, New York, NY USA	Tshwane University of Technology; University of Johannesburg; University of Pretoria	Funston, PJ (corresponding author), Tshwane Univ Technol, Nat Conservat Dept, Pretoria, South Africa.	funstonpj@tut.ac.za			National Geographic Conservation Trust; Columbus Zoo; Chicago Zoological Society; Rufford Foundation; Conservation Force	National Geographic Conservation Trust(National Geographic Society); Columbus Zoo; Chicago Zoological Society; Rufford Foundation; Conservation Force	Funding for the fieldwork was provided by National Geographic Conservation Trust, Columbus Zoo, Chicago Zoological Society, the Rufford Foundation, and Conservation Force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archabald K, 2001, ENVIRON CONSERV, V28, P135, DOI 10.1017/S0376892901000145; Bailey, 1993, AFRICAN LEOPARD ECOL; Biggs Harry C., 2008, P537; Booth V, 2004, AFRICAN HUNTER, V10, P31; BOTHMA JD, 1990, S AFR J WILDL RES, V20, P26; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; Child B, 1996, BIODIVERS CONSERV, V5, P369, DOI 10.1007/BF00051780; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; Creel S., 2002, AFRICAN WILD DOG BEH; du Toit R. F., 1994, LOWVELD CONSERVANCIE, P28; Durant SM, 2000, BEHAV ECOL, V11, P624, DOI 10.1093/beheco/11.6.624; Ericsson G, 2004, WILDLIFE BIOL, V10, P269, DOI 10.2981/wlb.2004.032; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Frame G, 1999, ENCY MAMMALS, P58; Funston PJ, 2006, S AFR J WILDL RES, V36, P9; Funston PJ, 2010, J ZOOL, V281, P56, DOI 10.1111/j.1469-7998.2009.00682.x; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Grange S, 2004, OECOLOGIA, V140, P523, DOI 10.1007/s00442-004-1567-6; Grange S, 2006, ECOGRAPHY, V29, P899, DOI 10.1111/j.2006.0906-7590.04684.x; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; HENSCHEL JR, 1990, AFR J ECOL, V28, P69, DOI 10.1111/j.1365-2028.1990.tb01138.x; HENSCHEL JR, 1988, AFR J ECOL, V26, P247, DOI 10.1111/j.1365-2028.1988.tb00977.x; Joubert CJ, 2010, AERIAL SURVEY LARGER; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; Lindsey P, 2004, S AFR J WILDL RES, V34, P143; Lindsey P., 2008, EVOLUTION INNOVATION, P163; Lindsey PA, 2013, ORYX, V47, P41, DOI 10.1017/S0030605311001049; Lindsey PA, 2011, ORYX, V45, P96, DOI 10.1017/S0030605310000153; Lindsey PA, 2005, BIOL CONSERV, V123, P339, DOI 10.1016/j.biocon.2004.12.002; Lindsey PA, 2005, CONSERV BIOL, V19, P1205, DOI 10.1111/j.1523-1739.2005.00088.x; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Mbizah MM, 2009, THESIS U ZIMBABWE HA; MILLS MGL, 1995, WILDLIFE RES, V22, P75, DOI 10.1071/WR9950075; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Peel MJS, 1999, S AFR J WILDL RES, V29, P31; Pellew R.A., 1983, P93; POLE AJ, 1999, THESIS U ABERDEEN AB; Power R. J., 2002, Koedoe, V45, P67; Power RJ, 2003, S AFR J WILDL RES, V33, P3; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Schaller G. B., 1972, SERENGETI LION STUDY; Skinner J. D., 1990, MAMMALS SO AFRICAN S; Starfield A.M., 1991, BUILDING MODELS CONS; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Wilkie DS, 1999, ORYX, V33	51	20	20	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59044	10.1371/journal.pone.0059044	http://dx.doi.org/10.1371/journal.pone.0059044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527083	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600053
J	Ali, S; Chopra, R; Manvati, S; Singh, YP; Kaul, N; Behura, A; Mahajan, A; Sehajpal, P; Gupta, S; Dhar, MK; Chainy, GBN; Bhanwer, AS; Sharma, S; Bamezai, RNK				Ali, Shafat; Chopra, Rupali; Manvati, Siddharth; Singh, Yoginder Pal; Kaul, Nabodita; Behura, Anita; Mahajan, Ankit; Sehajpal, Prabodh; Gupta, Subash; Dhar, Manoj K.; Chainy, Gagan B. N.; Bhanwer, Amarjit S.; Sharma, Swarkar; Bamezai, Rameshwar N. K.			Replication of Type 2 Diabetes Candidate Genes Variations in Three Geographically Unrelated Indian Population Groups	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-DEGRADING ENZYME; LARGE-SCALE ASSOCIATION; SUSCEPTIBILITY LOCI; RISK LOCI; JAPANESE POPULATION; ADULT OBESITY; VARIANTS; MELLITUS; METAANALYSIS	Type 2 diabetes (T2D) is a syndrome of multiple metabolic disorders and is genetically heterogeneous. India comprises one of the largest global populations with highest number of reported type 2 diabetes cases. However, limited information about T2D associated loci is available for Indian populations. It is, therefore, pertinent to evaluate the previously associated candidates as well as identify novel genetic variations in Indian populations to understand the extent of genetic heterogeneity. We chose to do a cost effective high-throughput mass-array genotyping and studied the candidate gene variations associated with T2D in literature. In this case-control candidate genes association study, 91 SNPs from 55 candidate genes have been analyzed in three geographically independent population groups from India. We report the genetic variants in five candidate genes: TCF7L2, HHEX, ENPP1, IDE and FTO, are significantly associated (after Bonferroni correction, p<5.5E204) with T2D susceptibility in combined population. Interestingly, SNP rs7903146 of the TCF7L2 gene passed the genome wide significance threshold (combined P value = 2.05E208) in the studied populations. We also observed the association of rs7903146 with blood glucose (fasting and postprandial) levels, supporting the role of TCF7L2 gene in blood glucose homeostasis. Further, we noted that the moderate risk provided by the independently associated loci in combined population with Odds Ratio (OR)<1.38 increased to OR = 2.44, (95% CI = 1.67-3.59) when the risk providing genotypes of TCF7L2, HHEX, ENPP1 and FTO genes were combined, suggesting the importance of gene-gene interactions evaluation in complex disorders like T2D.	[Ali, Shafat; Chopra, Rupali; Manvati, Siddharth; Singh, Yoginder Pal; Kaul, Nabodita; Behura, Anita; Mahajan, Ankit; Sharma, Swarkar; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Chopra, Rupali; Manvati, Siddharth; Bamezai, Rameshwar N. K.] Shri Mata Vaishno Devi Univ, Katra, Jammu & Kashmir, India; [Singh, Yoginder Pal; Kaul, Nabodita; Sehajpal, Prabodh; Bhanwer, Amarjit S.] Guru Nanak Dev Univ, Amritsar, Punjab, India; [Behura, Anita; Chainy, Gagan B. N.] Utkal Univ, Dept Biotechnol, Bhubaneswar, Odisha, India; [Mahajan, Ankit; Gupta, Subash; Dhar, Manoj K.] Univ Jammu, Jammu 180004, Jammu & Kashmir, India; [Sharma, Swarkar] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Sharma, Swarkar] Shri Mata Vaishno Devi Univ, Sch Biol & Chem, Katra, Jammu & Kashmir, India	Jawaharlal Nehru University, New Delhi; Shri Mata Vaishno Devi University; Guru Nanak Dev University; Utkal University; University of Jammu; Texas Scottish Rite Hospital for Children; Shri Mata Vaishno Devi University	Sharma, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	sawerkar@hotmail.com; bamezai@hotmail.com	Chainy, Gagan B.N./G-7020-2012; ALI, SHAFAT/Q-6269-2017; Kaul, Nabodita/AAR-8832-2020; SHARMA, SWARKAR/B-8096-2008	SHARMA, SWARKAR/0000-0001-8857-5906; Bhanwer, AJS/0000-0001-5181-9268; Chainy, Gagan/0000-0002-6418-0480; Bamezai, R.N.K/0000-0002-5128-2859	Department of Biotechnology (DBT) [BT/PR/8846/MED/12/327/2007]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	Authors acknowledge the support provided by the Department of Biotechnology (DBT) through a multi-centric research project BT/PR/8846/MED/12/327/2007, sanctioned under the supervision of RNKB to ASB, PS and SG. RNKB also acknowledges the infrastructure support provided to NCAHG by UGC and DBT for its high-throughput project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhary S, 2009, DIABETES, V58, P2137, DOI 10.2337/db09-0059; Ali S, 2012, HUM GENET, V131, P703, DOI 10.1007/s00439-011-1114-6; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gamboa-Melendez MA, 2012, DIABETES; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gu HF, 2004, DIABETES, V53, P2137, DOI 10.2337/diabetes.53.8.2137; Gupta V, 2012, DIABETOLOGIA, V55, P349, DOI 10.1007/s00125-011-2355-6; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Meyre D, 2012, DIABETOLOGIA, V55, P873, DOI 10.1007/s00125-012-2478-4; Mtiraoui N, 2012, DIABETES METAB; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Rai E, 2007, HUM GENET, V122, P535, DOI 10.1007/s00439-007-0421-4; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schulze MB, 2007, DIABETOLOGIA, V50, P2405, DOI 10.1007/s00125-007-0766-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shetty P, 2012, NATURE, V485, pS14, DOI 10.1038/485S14a; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabara Y, 2009, DIABETES, V58, P493, DOI 10.2337/db07-1785; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	57	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58881	10.1371/journal.pone.0058881	http://dx.doi.org/10.1371/journal.pone.0058881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527042	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100053
J	Apicella, A; Soncini, M; Deriu, MA; Natalello, A; Bonanomi, M; Dellasega, D; Tortora, P; Regonesi, ME; Casari, CS				Apicella, Alessandra; Soncini, Monica; Deriu, Marco Agostino; Natalello, Antonino; Bonanomi, Marcella; Dellasega, David; Tortora, Paolo; Regonesi, Maria Elena; Casari, Carlo Spartaco			A Hydrophobic Gold Surface Triggers Misfolding and Aggregation of the Amyloidogenic Josephin Domain in Monomeric Form, While Leaving the Oligomers Unaffected	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; ATAXIN-3; MEMBRANE; PROTEINS; DYNAMICS; FIBRILLOGENESIS; ADSORPTION; MICROSCOPY; FIELD	Protein misfolding and aggregation in intracellular and extracellular spaces is regarded as a main marker of the presence of degenerative disorders such as amyloidoses. To elucidate the mechanisms of protein misfolding, the interaction of proteins with inorganic surfaces is of particular relevance, since surfaces displaying different wettability properties may represent model systems of the cell membrane. Here, we unveil the role of surface hydrophobicity/hydrophilicity in the misfolding of the Josephin domain (JD), a globular-shaped domain of ataxin-3, the protein responsible for the spinocerebellar ataxia type 3. By means of a combined experimental and theoretical approach based on atomic force microscopy, Fourier transform infrared spectroscopy and molecular dynamics simulations, we reveal changes in JD morphology and secondary structure elicited by the interaction with the hydrophobic gold substrate, but not by the hydrophilic mica. Our results demonstrate that the interaction with the gold surface triggers misfolding of the JD when it is in native-like configuration, while no structural modification is observed after the protein has undergone oligomerization. This raises the possibility that biological membranes would be unable to affect amyloid oligomeric structures and toxicity.	[Apicella, Alessandra; Dellasega, David; Casari, Carlo Spartaco] Politecn Milan, Dept Energy, I-20133 Milan, Italy; [Apicella, Alessandra] Politecn Milan, NEMAS Ctr NanoEngn Mat & Surfaces, I-20133 Milan, Italy; [Apicella, Alessandra] Ecole Polytech Fed Lausanne, Dept Sci & Genie Mat, Lab Technol Composites & Polymeres LTC, Lausanne, Switzerland; [Soncini, Monica] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Deriu, Marco Agostino] Politecn Torino, Dept Aerosp & Mech Engn DIMEAS, Turin, Italy; [Natalello, Antonino; Bonanomi, Marcella; Tortora, Paolo] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Regonesi, Maria Elena] Univ Milano Bicocca, Dept Stat & Quantitat Methods DiSMeQ, Milan, Italy; [Casari, Carlo Spartaco] Italian Inst Technol, Ctr Nano Sci & Technol Polimi, Milan, Italy	Polytechnic University of Milan; Polytechnic University of Milan; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Polytechnic University of Milan; Polytechnic University of Turin; University of Milano-Bicocca; University of Milano-Bicocca; Istituto Italiano di Tecnologia - IIT	Soncini, M (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy.	monica.soncini@polimi.it; mariaelena.regonesi@unimib.it	Dellasega, David/G-4371-2011; Deriu, Marco Agostino Agostino/GPW-8179-2022; Deriu, Marco Agostino/M-5161-2016; Casari, Carlo S./C-6189-2008; Natalello, Antonino/B-9659-2012; Soncini, Monica/E-9609-2018	Dellasega, David/0000-0002-7389-9307; Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Deriu, Marco Agostino/0000-0003-1918-1772; Casari, Carlo S./0000-0001-9144-6822; Natalello, Antonino/0000-0002-1489-272X; Tortora, Paolo/0000-0001-5234-601X; Soncini, Monica/0000-0001-8607-7196	Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research (PRIN); Regione Lombardia (N.E.D.D. project)	Fondazione Cariplo (N.O.B.E.L. project)(Fondazione Cariplo); Italian Ministry for Instruction, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia (N.E.D.D. project)	This work was funded by the Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research (PRIN 2007); Regione Lombardia (N.E.D.D. project). The funders had a role in the data collection and analysis and for the payment of the publication.	Ahmad S, 2010, J R SOC INTERFACE, V7, pS423, DOI 10.1098/rsif.2010.0190.focus; Apicella A, 2012, BIOCHIMIE, V94, P1026, DOI 10.1016/j.biochi.2012.01.002; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Artali R, 2008, J R SOC INTERFACE, V5, P273, DOI 10.1098/rsif.2007.1137; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Deriu MA, 2007, J MATER SCI, V42, P8864, DOI 10.1007/s10853-007-1784-6; Deriu MA, 2010, BIOPHYS J, V99, P2190, DOI 10.1016/j.bpj.2010.06.070; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Evangelisti E, 2012, J CELL SCI, V125, P2416, DOI 10.1242/jcs.098434; Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8; HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4; Heinz H, 2005, CHEM MATER, V17, P5658, DOI 10.1021/cm0509328; Heinz H, 2010, J COMPUT CHEM, V31, P1564, DOI 10.1002/jcc.21421; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Iori F, 2009, J COMPUT CHEM, V30, P1465, DOI 10.1002/jcc.21165; Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863; KARPLUS M, 1995, CURR OPIN STRUC BIOL, V5, P58, DOI 10.1016/0959-440X(95)80010-X; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2011, BIOPHYS J, V100, P2033, DOI 10.1016/j.bpj.2011.02.056; Masino L, 2011, FASEB J, V25, P45, DOI 10.1096/fj.10-161208; Morozova-Roche LA, 2004, BIOCHEMISTRY-US, V43, P9610, DOI 10.1021/bi0494121; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183; ODIN C, 1994, SURF SCI, V317, P321, DOI 10.1016/0039-6028(94)90288-7; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Sethuraman A, 2005, BIOPHYS J, V88, P1322, DOI 10.1529/biophysj.104.051797; Soncini M, 2007, BIOMECH MODEL MECHAN, V6, P399, DOI 10.1007/s10237-006-0060-z; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Stefani M, 2008, INT J MOL SCI, V9, P2515, DOI 10.3390/ijms9122515; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	41	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58794	10.1371/journal.pone.0058794	http://dx.doi.org/10.1371/journal.pone.0058794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527026	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100043
J	Shaler, CR; Horvath, CN; McCormick, S; Jeyanathan, M; Khera, A; Zganiacz, A; Kasinska, J; Stampfli, MR; Xing, Z				Shaler, Christopher R.; Horvath, Carly N.; McCormick, Sarah; Jeyanathan, Mangalakumari; Khera, Amandeep; Zganiacz, Anna; Kasinska, Joanna; Stampfli, Martin R.; Xing, Zhou			Continuous and Discontinuous Cigarette Smoke Exposure Differentially Affects Protective Th1 Immunity against Pulmonary Tuberculosis	PLOS ONE			English	Article							CALMETTE-GUERIN; EXPRESSION; INFECTION; ACTIVATION; CYTOKINES; MUCOSAL; CELLS	Pulmonary tuberculosis (TB), caused by Mycobacterium tuberculosis, is the leading cause of death due to a bacterial pathogen. Emerging epidemiologic evidence suggests that the leading risk factor associated with TB mortality is cigarette smoke exposure. Despite this, it remains poorly understood what is the effect of cigarette smoke exposure on anti-TB immunity and whether its potential detrimental effect can be reversed by cigarette smoking cessation. In our current study, we have investigated the impact of both continuous and discontinuous cigarette smoke exposure on the development of anti-mycobacterial type 1 immunity in murine models. We find that while continuous cigarette smoke exposure severely impairs type 1 immunity in the lung, a short-term smoking cessation allows rapid restoration of anti-mycobacterial immunity. The ability of continuous cigarette smoke exposure to dampen type 1 protective immunity is attributed locally to its affects on innate immune cells in the lung. Continuous cigarette smoke exposure locally, by not systemically, impairs APC accumulation and their production of TNF, IL-12, and RANTES, blunts the recruitment of CD4+IFN-gamma+T cells to the lung, and weakens the formation of granuloma. On the other hand, smoking cessation was found to help restore type 1 immunity by rapidly improving the functionality of lung APCs, enhancing the recruitment of CD4+IFN-gamma+T cells to the lung, and promoting the formation of granuloma. Our study for the first time demonstrates that continuous, but not discontinuous, cigarette smoke exposure severely impedes the lung expression of anti-TB Th1 immunity via inhibiting innate immune activation and lung T cell recruitment. Our findings thus suggest cigarette smoking cessation to be beneficial to the control of pulmonary TB.	[Stampfli, Martin R.] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University	Stampfli, MR (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada.	stampfli@mcmaster.ca; xingz@mcmaster.ca		McCormick, Sarah/0000-0001-7718-6438; Stampfli, Martin/0000-0003-4918-5889	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study is supported by funds from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer CMT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013251; Bloss E, 2011, PUBLIC HEALTH REP, V126, P677, DOI 10.1177/003335491112600510; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Caschler GJ, 2008, AM J RESP CELL MOL, V38, P218, DOI 10.1165/rcmb.2007-0053OC; Chiang YC, 2012, INT J INFECT DIS, V16, pE130, DOI 10.1016/j.ijid.2011.10.007; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Garcia I, 2000, LAB INVEST, V80, P1385, DOI 10.1038/labinvest.3780146; Goetsch U, 2012, INFECTION, V40, P389, DOI 10.1007/s15010-011-0238-x; Horvath CN, 2012, MUCOSAL IMMUNOL, V5, P420, DOI 10.1038/mi.2012.19; Leung CC, 2010, ARCH INTERN MED, V170, P287, DOI 10.1001/archinternmed.2009.506; Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005; Phaybouth V, 2006, AM J PHYSIOL-LUNG C, V290, pL222, DOI 10.1152/ajplung.00148.2005; Ramachandran Reshmi, 2011, Indian J Tuberc, V58, P204; Rocha-Ramirez LM, 2008, TUBERCULOSIS, V88, P212, DOI 10.1016/j.tube.2007.10.003; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Shaler CR, 2011, AM J PATHOL, V178, P1622, DOI 10.1016/j.ajpath.2010.12.022; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Small CL, 2008, J IMMUNOL, V180, P5558, DOI 10.4049/jimmunol.180.8.5558; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; Vesosky B, 2010, J LEUKOCYTE BIOL, V87, P1153, DOI 10.1189/jlb.1109742; Wakeham J, 1998, J IMMUNOL, V160, P6101; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wang J, 2004, J IMMUNOL, V173, P4590, DOI 10.4049/jimmunol.173.7.4590; Wang J, 2000, BLOOD, V95, P2337, DOI 10.1182/blood.V95.7.2337.007k22_2337_2345; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156; World Health Organization, 2019, WHO REPORT GLOBAL TO	30	35	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59185	10.1371/journal.pone.0059185	http://dx.doi.org/10.1371/journal.pone.0059185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527127	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100088
J	Zhou, SB; Salisbury, J; Preedy, VR; Emery, PW				Zhou, Shaobo; Salisbury, Jonathan; Preedy, Victor R.; Emery, Peter W.			Increased Collagen Synthesis Rate during Wound Healing in Muscle	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; IN-VIVO; DEGRADATION; TISSUES; PROLINE	Wound healing in muscle involves the deposition of collagen, but it is not known whether this is achieved by changes in the synthesis or the degradation of collagen. We have used a reliable flooding dose method to measure collagen synthesis rate in vivo in rat abdominal muscle following a surgical incision. Collagen synthesis rate was increased by 480% and 860% on days 2 and 7 respectively after surgery in the wounded muscle compared with an undamaged area of the same muscle. Collagen content was increased by approximately 100% at both day 2 and day 7. These results demonstrate that collagen deposition during wound healing in muscle is achieved entirely by an increase in the rate of collagen synthesis.	[Zhou, Shaobo; Preedy, Victor R.; Emery, Peter W.] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England; [Salisbury, Jonathan] Kings Coll Hosp, Dept Histopathol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Emery, PW (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England.	peter.emery@kcl.ac.uk	Salisbury, Jonathan/N-1356-2019; Zhou, Shaobo/I-1536-2019	Zhou, Shaobo/0000-0001-5214-2973; Salisbury, Jonathan/0000-0002-5889-4276	BBSRC - Biotechnology and Biological Sciences Research Council [S16409]	BBSRC - Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by BBSRC - Biotechnology and Biological Sciences Research Council Grant no S16409 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrione P, 2010, AM J PHYS MED REHAB, V89, P854, DOI 10.1097/PHM.0b013e3181f1c1c7; Bucci L. R., 1995, NUTR APPL INJURY REH; EMERY PW, 1994, BRIT J SURG, V81, P539, DOI 10.1002/bjs.1800810417; EMERY PW, 1995, CLIN SCI, V89, P383, DOI 10.1042/cs0890383; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HUSZAR G, 1980, ANAL BIOCHEM, V105, P424, DOI 10.1016/0003-2697(80)90481-9; Kiernan J.A, 1990, HISTOLOGICAL HISTOCH; LAURENT GJ, 1982, BIOCHEM J, V206, P535, DOI 10.1042/bj2060535; LAURENT GJ, 1982, ANAL BIOCHEM, V123, P223, DOI 10.1016/0003-2697(82)90438-9; LAURENT GJ, 1987, AM J PHYSIOL, V252, P1; MAYS PK, 1991, BIOCHEM J, V276, P307, DOI 10.1042/bj2760307; MCANULTY RJ, 1987, COLLAGEN REL RES, V7, P93; McAnulty RJ, 2005, METH MOLEC MED, V117, P189; Zhou SB, 2006, ELECTROPHORESIS, V27, P1147, DOI 10.1002/elps.200500684	15	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58324	10.1371/journal.pone.0058324	http://dx.doi.org/10.1371/journal.pone.0058324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526975	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100022
J	Prates, ET; Stankovic, I; Silveira, RL; Liberato, MV; Henrique-Silva, F; Pereira, N; Polikarpov, I; Skaf, MS				Prates, Erica T.; Stankovic, Ivana; Silveira, Rodrigo L.; Liberato, Marcelo V.; Henrique-Silva, Flavio; Pereira, Nei, Jr.; Polikarpov, Igor; Skaf, Munir S.			X-ray Structure and Molecular Dynamics Simulations of Endoglucanase 3 from Trichoderma harzianum: Structural Organization and Substrate Recognition by Endoglucanases That Lack Cellulose Binding Module	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INITIAL CONFIGURATIONS; ENZYMATIC-HYDROLYSIS; CELLOBIOHYDROLASE-I; CATALYTIC CORE; REESEI; MODEL; CEL12A; DEGRADATION; CELLULASES	Plant biomass holds a promise for the production of second-generation ethanol via enzymatic hydrolysis, but its utilization as a biofuel resource is currently limited to a large extent by the cost and low efficiency of the cellulolytic enzymes. Considerable efforts have been dedicated to elucidate the mechanisms of the enzymatic process. It is well known that most cellulases possess a catalytic core domain and a carbohydrate binding module (CBM), without which the enzymatic activity can be drastically reduced. However, Cel12A members of the glycosyl hydrolases family 12 (GHF12) do not bear a CBM and yet are able to hydrolyze amorphous cellulose quite efficiently. Here, we use X-ray crystallography and molecular dynamics simulations to unravel the molecular basis underlying the catalytic capability of endoglucanase 3 from Trichoderma harzianum (ThEG3), a member of the GHF12 enzymes that lacks a CBM. A comparative analysis with the Cellulomonas fimi CBM identifies important residues mediating interactions of EG3s with amorphous regions of the cellulose. For instance, three aromatic residues constitute a harboring wall of hydrophobic contacts with the substrate in both ThEG3 and CfCBM structures. Moreover, residues at the entrance of the active site cleft of ThEG3 are identified, which might hydrogen bond to the substrate. We advocate that the ThEG3 residues Asn152 and Glu201 interact with the substrate similarly to the corresponding CfCBM residues Asn81 and Arg75. Altogether, these results show that CBM motifs are incorporated within the ThEG3 catalytic domain and suggest that the enzymatic efficiency is associated with the length and position of the substrate chain, being higher when the substrate interact with the aromatic residues at the entrance of the cleft and the catalytic triad. Our results provide guidelines for rational protein engineering aiming to improve interactions of GHF12 enzymes with cellulosic substrates.	[Prates, Erica T.; Stankovic, Ivana; Silveira, Rodrigo L.; Skaf, Munir S.] State Univ Campinas UNICAMP, Inst Chem, Campinas, SP, Brazil; [Liberato, Marcelo V.; Polikarpov, Igor] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil; [Henrique-Silva, Flavio] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [Pereira, Nei, Jr.] Univ Fed Rio de Janeiro, Ctr Tecnol, Escola Quim, Lab Desenvolvimento Bioproc LaDeBio, Rio De Janeiro, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Federal do Rio de Janeiro	Polikarpov, I (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil.	ipolikarpov@ifsc.usp.br; skaf@iqm.unicamp.br	Prates, Erica/E-3858-2016; Henrique-Silva, Flavio/A-1937-2013; Teixeira Prates, Erica/GLU-6833-2022; UNICAMP, CCES -/J-7787-2015; Liberato, Marcelo V/J-3606-2014; Polikarpov, Igor/D-2575-2012; Skaf, Munir S/B-1614-2013; Pereira, Nei/H-2471-2016; Silveira, Rodrigo L/I-3961-2014	Liberato, Marcelo V/0000-0002-7609-7844; Skaf, Munir S/0000-0001-7485-1228; Silveira, Rodrigo L/0000-0001-9515-3082; Polikarpov, Igor/0000-0001-9496-4174	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/56255-9, 09/54035-4, 10/08680-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [490022/2009-0, 550985/2010-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge the support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) via grants 08/56255-9, 09/54035-4 and 10/08680-2; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) via grants 490022/2009-0, 550985/2010-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Berner RA, 2003, NATURE, V426, P323, DOI 10.1038/nature02131; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cheng YS, 2011, PROTEINS, V79, P1193, DOI 10.1002/prot.22953; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Generoso WC, 2012, GENET MOL RES, V11, P1544, DOI 10.4238/2012.May.21.11; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hatcher ER, 2009, J CHEM THEORY COMPUT, V5, P1315, DOI 10.1021/ct9000608; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Kuzmanic A, 2010, BIOPHYS J, V98, P861, DOI 10.1016/j.bpj.2009.11.011; Laughrey ZR, 2008, J AM CHEM SOC, V130, P14625, DOI 10.1021/ja803960x; Liberato MV, 2012, ACTA CRYSTALLOGR F, V68, P306, DOI 10.1107/S1744309112000838; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez JM, 2003, J COMPUT CHEM, V24, P819, DOI 10.1002/jcc.10216; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; MARTYNA GJ, 1994, PHYS REV E, V50, P3234, DOI 10.1103/PhysRevE.50.3234; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakazawa H, 2009, APPL MICROBIOL BIOT, V83, P649, DOI 10.1007/s00253-009-1901-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; PHILLIPS GN, 1990, BIOPHYS J, V57, P381, DOI 10.1016/S0006-3495(90)82540-6; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sandgren M, 2005, PROG BIOPHYS MOL BIO, V89, P246, DOI 10.1016/j.pbiomolbio.2004.11.002; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sims R, 2008, 1 2 GENERATION BIOFU; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Sulzenbacher G, 1999, BIOCHEMISTRY-US, V38, P4826, DOI 10.1021/bi982648i; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Wilson DB, 2012, APPL MICROBIOL BIOT, V93, P497, DOI 10.1007/s00253-011-3701-9; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Xiao ZZ, 2001, BIOTECHNOL LETT, V23, P711, DOI 10.1023/A:1010325122851; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	58	29	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59069	10.1371/journal.pone.0059069	http://dx.doi.org/10.1371/journal.pone.0059069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516599	gold, Green Submitted, Green Published			2022-12-27	WOS:000316407400089
J	Herbst, A; Johnson, CJ; Hynes, K; McKenzie, D; Aiken, JM				Herbst, Allen; Johnson, Chad J.; Hynes, Kayla; McKenzie, Debbie; Aiken, Judd M.			Mitochondrial Biogenesis Drives a Vicious Cycle of Metabolic Insufficiency and Mitochondrial DNA Deletion Mutation Accumulation in Aged Rat Skeletal Muscle Fibers	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; CREATINE-KINASE; GENE-EXPRESSION; HUMAN-CELLS; WILD-TYPE; SARCOPENIA; ALPHA; RESPIRATION; DISEASE; NUMBER	Aged muscles possess dysfunctional fibers that contain intracellular expansions of somatically derived mitochondrial DNA deletion mutations. At high abundance, these mutations disrupt the expression of mitochondrially-encoded protein subunits of the electron transport chain resulting in aerobic respiration deficient muscle fiber segments. These fiber segments atrophy and break contributing to the loss of muscle mass and function that occurs with age. By combining micro-dissection of individual muscle fibers with microarray analysis, we observed the response induced within these abnormal muscle fibers and detected an increase in many genes affecting metabolism and metabolic regulation. The transcriptional profile and subsequent protein validation suggested that a non-compensatory program of mitochondrial biogenesis was initiated. We hypothesized that this non-adaptive program of mitochondrial biogenesis was driving mtDNA deletion mutation accumulation. We tested this hypothesis by treating aged rats with beta-Guanidinopropionic acid, a compound that stimulates mitochondrial biogenesis. beta-Guanidinopropionic acid treatment increased muscle mitochondrial genome copy number and resulted in a 3.7 fold increase in the abundance of electron transport chain negative muscle fiber segments. We conclude that in electron transport system abnormal muscle fiber segments, a vicious cycle of metabolic insufficiency and non-compensatory mitochondrial biogenesis drive mtDNA deletion mutation accumulation.	[Herbst, Allen; Aiken, Judd M.] Univ Alberta, Ctr Prions & Prot Folding Dis Agr Food & Nutr Sci, Edmonton, AB, Canada; [Johnson, Chad J.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Hynes, Kayla; McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada	University of Alberta; University of Wisconsin System; University of Wisconsin Madison; University of Alberta	Aiken, JM (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis Agr Food & Nutr Sci, Edmonton, AB, Canada.	Judd.Aiken@ualberta.ca	McKenzie, Debbie/G-4459-2015	McKenzie, Debbie/0000-0002-9291-6977; Herbst, Allen/0000-0001-6601-1245; Aiken, Judd/0000-0001-6119-4521	Senior Scholar Grant from the Ellison Medical Foundation; National Institutes of Health NIA [5R01AG030423-04]; NATIONAL INSTITUTE ON AGING [R01AG030423] Funding Source: NIH RePORTER	Senior Scholar Grant from the Ellison Medical Foundation; National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by a Senior Scholar Grant from the Ellison Medical Foundation and by the National Institutes of Health NIA 5R01AG030423-04 (http://www.ellisonfoundation.org, http://www.nia.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken J, 2002, ANN NY ACAD SCI, V959, P412, DOI 10.1111/j.1749-6632.2002.tb02111.x; Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cortopassi G, 2006, MITOCHONDRION, V6, P161, DOI 10.1016/j.mito.2006.05.002; Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje; EINSIEDEL LJ, 1992, J NEUROL SCI, V112, P170, DOI 10.1016/0022-510X(92)90147-D; Evans W, 1997, J NUTR, V127, pS998; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Lushaj EB, 2008, J GERONTOL A-BIOL, V63, P921, DOI 10.1093/gerona/63.9.921; Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006; Mueller-Hoecker J., 1993, Virchows Archiv A Pathological Anatomy and Histopathology, V422, P7; OGorman E, 1997, FEBS LETT, V414, P253, DOI 10.1016/S0014-5793(97)01045-4; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rosenberg IH, 1997, J NUTR, V127, P990, DOI DOI 10.1016/J.CGER.2011.03.003; ROWLEY GL, 1971, J AM CHEM SOC, V93, P5542, DOI 10.1021/ja00750a038; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; STADHOUDERS AM, 1994, P NATL ACAD SCI USA, V91, P5089, DOI 10.1073/pnas.91.11.5089; Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015; Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230; Tien ES, 2003, CANCER RES, V63, P5767; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	43	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59006	10.1371/journal.pone.0059006	http://dx.doi.org/10.1371/journal.pone.0059006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516592	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200126
J	Mitnick, CD; Franke, MF; Rich, ML; Viru, FAA; Appleton, SC; Atwood, SS; Bayona, JN; Bonilla, CA; Chalco, K; Fraser, HSF; Furin, JJ; Guerra, D; Hurtado, RM; Joseph, K; Llaro, K; Mestanza, L; Mukherjee, JS; Munoz, M; Palacios, E; Sanchez, E; Seung, KJ; Shin, SS; Sloutsky, A; Tolman, AW; Becerra, MC				Mitnick, Carole D.; Franke, Molly F.; Rich, Michael L.; Alcantara Viru, Felix A.; Appleton, Sasha C.; Atwood, Sidney S.; Bayona, Jaime N.; Bonilla, Cesar A.; Chalco, Katiuska; Fraser, Hamish S. F.; Furin, Jennifer J.; Guerra, Dalia; Hurtado, Rocio M.; Joseph, Keith; Llaro, Karim; Mestanza, Lorena; Mukherjee, Joia S.; Munoz, Maribel; Palacios, Eda; Sanchez, Epifanio; Seung, Kwonjune J.; Shin, Sonya S.; Sloutsky, Alexander; Tolman, Arielle W.; Becerra, Mercedes C.			Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality	PLOS ONE			English	Article							MDR-TB; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT OUTCOMES; STANDARDIZED TREATMENT; THERAPY; PERU; TIME; LIMA; FLUOROQUINOLONES; METAANALYSIS	Rationale: A better understanding of the composition of optimal treatment regimens for multidrug-resistant tuberculosis (MDR-TB) is essential for expanding universal access to effective treatment and for developing new therapies for MDR-TB. Analysis of observational data may inform the definition of an optimized regimen. Objectives: This study assessed the impact of an aggressive regimen-one containing at least five likely effective drugs, including a fluoroquinolone and injectable-on treatment outcomes in a large MDR-TB patient cohort. Methods: This was a retrospective cohort study of patients treated in a national outpatient program in Peru between 1999 and 2002. We examined the association between receiving an aggressive regimen and the rate of death. Measurements and Main Results: In total, 669 patients were treated with individualized regimens for laboratory-confirmed MDR-TB. Isolates were resistant to a mean of 5.4 (SD 1.7) drugs. Cure or completion was achieved in 66.1% (442) of patients; death occurred in 20.8% (139). Patients who received an aggressive regimen were less likely to die (crude hazard ratio [HR]: 0.62; 95% CI: 0.44,0.89), compared to those who did not receive such a regimen. This association held in analyses adjusted for comorbidities and indicators of severity (adjusted HR: 0.63; 95% CI: 0.43,0.93). Conclusions: The aggressive regimen is a robust predictor of MDR-TB treatment outcome. TB policy makers and program directors should consider this standard as they design and implement regimens for patients with drug-resistant disease. Furthermore, the aggressive regimen should be considered the standard background regimen when designing randomized trials of treatment for drug-resistant TB.	[Mitnick, Carole D.; Franke, Molly F.; Mukherjee, Joia S.; Tolman, Arielle W.; Becerra, Mercedes C.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02215 USA; [Mitnick, Carole D.; Franke, Molly F.; Rich, Michael L.; Appleton, Sasha C.; Bayona, Jaime N.; Fraser, Hamish S. F.; Joseph, Keith; Mukherjee, Joia S.; Seung, Kwonjune J.; Shin, Sonya S.; Becerra, Mercedes C.] Partners Hlth, Boston, MA USA; [Mitnick, Carole D.; Rich, Michael L.; Atwood, Sidney S.; Fraser, Hamish S. F.; Joseph, Keith; Mukherjee, Joia S.; Seung, Kwonjune J.; Shin, Sonya S.; Becerra, Mercedes C.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Alcantara Viru, Felix A.; Bayona, Jaime N.; Chalco, Katiuska; Guerra, Dalia; Llaro, Karim; Mestanza, Lorena; Munoz, Maribel; Palacios, Eda] Socios Salud Sucursal Peru, Lima, Peru; [Bonilla, Cesar A.] Minist Hlth, Lima, Peru; [Furin, Jennifer J.] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA; [Hurtado, Rocio M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hurtado, Rocio M.] Global Hlth Comm, Boston, MA USA; [Sanchez, Epifanio] Hosp Nacl Sergio E Bernales, Lima, Peru; [Sloutsky, Alexander] Ctr Hlth Policy & Res, Massachusetts Supranat TB Reference Lab, Boston, MA USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; Harvard University; Massachusetts General Hospital	Mitnick, CD (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02215 USA.	carole_mitnick@hms.harvard.edu	Akram, Nudrat Aisha/F-6882-2010; BONILLA-ASALDE, CÉSAR ANTONIO/AHH-6777-2022; Franke, Molly/AAK-7559-2020; AlQurainy, Fahd/GZA-7225-2022; Mitnick, Carole/GRO-1991-2022; Fraser, Hamish HS/E-3773-2013; Akram, Nudrat Aisha/I-1512-2015; Ashraf, Muhammad/I-6800-2015; Fraser, Hamish/AGP-6129-2022	Akram, Nudrat Aisha/0000-0001-9140-8252; BONILLA-ASALDE, CÉSAR ANTONIO/0000-0002-4470-1939; Franke, Molly/0000-0002-4890-5728; Mitnick, Carole/0000-0002-3455-658X; Fraser, Hamish/0000-0003-4383-2854	National Institute of Allergy and Infectious Diseases [1 K01 AI065836-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI065836] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx) (1 K01 AI065836-01 to CDM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Becerra MC, 2010, CLIN INFECT DIS, V51, P709, DOI 10.1086/655892; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Chalco K, 2006, INT NURS REV, V53, P253, DOI 10.1111/j.1466-7657.2006.00490.x; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; Devasia RA, 2009, J ANTIMICROB CHEMOTH, V63, P1173, DOI 10.1093/jac/dkp096; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Flament-Saillour M, 1999, AM J RESP CRIT CARE, V160, P587, DOI 10.1164/ajrccm.160.2.9901012; Franke MF, 2013, CLIN INFECT DIS; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Fraser HSF, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P270; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Joseph P, 2011, INDIAN J MED RES, V133, P529; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leung EC, 2012, EUR RESP J; Matrat S, 2006, ANTIMICROB AGENTS CH, V50, P4170, DOI 10.1128/AAC.00944-06; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; Ministerio de Salud, 2006, NORM TECN SAL CONTR; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick C, 2010, AM J RESP CRIT CARE, V182, P1337, DOI 10.1164/rccm.201007-1126ED; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pachas AMC, 2004, INT J TUBERC LUNG D, V8, P52; Palacios E, 2012, INT J TUBERC LUNG D, V16, P348, DOI 10.5588/ijtld.11.0473; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; *PARTN HLTH, 2003, PIH GUID MED MAN MUL; Partners In Health Harvard Medical School Bill & Melinda Gates Foundation, 2002, DOTS PLUS HDB GUID C; Partners In Health World Health Organization, 2010, MAN MDR TB FIELD GUI; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Rich ML, 2006, INT J TUBERC LUNG D, V10, P290; Shah NS, 2011, EMERG INFECT DIS, V17, P510, DOI 10.3201/eid1703.101363; Shin SS, 2010, AM J RESP CRIT CARE, V182, P426, DOI 10.1164/rccm.200911-1768OC; Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961; Stricker BHC, 2010, EUR J EPIDEMIOL, V25, P245, DOI 10.1007/s10654-010-9451-7; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Sweetland A, 2002, WORLD MENTAL HLTH CA; Toczek A, 2012, INT J TUBERC LUNG DI; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; van Walraven C, 2004, J CLIN EPIDEMIOL, V57, P672, DOI 10.1016/j.jclinepi.2003.12.008; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; Waisman JL, 2001, MEDICINA-BUENOS AIRE, V61, P810; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2006, GUID PROGR MAN DRUG; World Health Organization, 2006, GUID MAN DRUG RES TU; World Health Organization, 2012, GLOB TUB REP P2012; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	59	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58664	10.1371/journal.pone.0058664	http://dx.doi.org/10.1371/journal.pone.0058664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516529	Green Published, gold			2022-12-27	WOS:000316849200103
J	Miyata, Y; Watanabe, S; Sagara, Y; Mitsunari, K; Matsuo, T; Ohba, K; Sakai, H				Miyata, Yasuyoshi; Watanabe, Shin-ichi; Sagara, Yuji; Mitsunari, Kensuke; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki			High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-A; RENAL-CELL CARCINOMA; BINDING PROTEIN HUR; FACTOR-C; ANGIOGENESIS; RNA; LYMPHANGIOGENESIS; CYCLOOXYGENASE-2; ROLES	Introduction: Human antigen R (HuR) regulates the stability of mRNA and is associated with cell proliferation, angiogenesis, and lymphangiogenesis. However, the clinical significance and pathological role of HuR in bladder cancer remains unclear. The main objective of this investigation was to clarify the relationships between HuR expression and clinical significance and cancer cell proliferation, angiogenesis, lymphangiogenesis, and expressions of cyclooxygenase (COX)-2 and vascular endothelial growth factor (VEGF)-A, -C, and -D. Methods: All expressions were examined by immunohistochemical techniques in 122 formalin-fixed specimens of bladder cancer patients. HuR expression was evaluated separately with cytoplasmic and nuclear staining. Cell proliferation, angiogenesis and lymphangiogenesis were measured as the percentage of Ki-67-positive cell (proliferation index, PI), CD34-stained vessels (microvessel density, MVD), and D2-40-stained vessels (lymph vessel density, LVD). Relationships between each HuR expression and clinicopathological features, prognosis, and expressions of COX-2 and VEGFs were analyzed by multi-variate analyses. HuR expression was also investigated in 10 mice of N-Butyl-N-[4-hydroxybutil] nitrosamine (BBN) induced bladder cancer model. Results: In human tissues, high cytoplasmic expression was seen in 5% and 25.4% of normal and cancer cells, respectively. Nuclear HuR expression bore no significant relationship to any pathological features. However, cytoplasmic HuR expression appeared positively associated with pT stage and grade (P<0.001). In mouse tissues, similar trends were confirmed. Cytoplasmic expression correlated with PI, MVD, and LVD, as well as expression of VEGF-A and -C, but not VEGF-D. High cytoplasmic expression of HuR was a significant predictor of metastasis and cause-specific survival, and was identified as a prognostic correlative factor for metastasis (hazard ratio, 4.75; P = 0.028) in a multivariate analysis model that included pathological features. Conclusions: Cytoplasmic HuR appears to play important roles in cell proliferation, progression, and survival of bladder cancer patients. Its expression was associated with angiogenesis, lymphangiogenesis, and expressions of VEGF-A and -C.	[Miyata, Yasuyoshi; Watanabe, Shin-ichi; Sagara, Yuji; Mitsunari, Kensuke; Matsuo, Tomohiro; Ohba, Kojiro; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nephrourol, Nagasaki 852, Japan	Nagasaki University	Miyata, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Nephrourol, Nagasaki 852, Japan.	int.doc.miya@m3.dion.ne.jp	mitsunari, kensuke/ABI-1916-2020	Matsuo, Tomohiro/0000-0002-9508-0319	Japan Society for the Promotion of Science [22591771]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (No. 22591771). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Afonso J, 2009, HISTOPATHOLOGY, V55, P514, DOI 10.1111/j.1365-2559.2009.03425.x; Ajili F, 2012, ULTRASTRUCT IN PRESS; Atasoy U, 1998, J CELL SCI, V111, P3145; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; Brennan CM, 2011, CELL MIL LIFE SCI, V58, P341; Cho SJ, 2012, J BIOL CHEM, V287, P14535, DOI 10.1074/jbc.M111.326827; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Iwata T, 2008, UROLOGY, V71, P749, DOI 10.1016/j.urology.2007.10.063; Kadota K, 2008, EUR J CANCER, V44, P1057, DOI 10.1016/j.ejca.2008.03.012; Kim I, 2012, NUCLEIC ACIDS RES, V40, P6863, DOI 10.1093/nar/gks331; Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125; Lim SJ, 2009, CANCER RES TREAT, V13, P6959; Miyata Y, 2003, CLIN CANCER RES, V9, P1741; Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284; Ronkainen H, 2011, TUMOR BIOL, V32, P481, DOI 10.1007/s13277-010-0141-6; Sagara Y, 2010, CANCER EPIDEMIOL, V34, P350, DOI 10.1016/j.canep.2010.03.001; Sakuma T, 2008, J NEURO-ONCOL, V88, P143, DOI 10.1007/s11060-008-9559-8; Shariat SF, 2003, J UROLOGY, V170, P985, DOI 10.1097/01.ju.0000080401.85145.ee; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Wang J, 2011, MED ONCOL, V28, pS577, DOI 10.1007/s12032-010-9734-6; Wang J, 2009, ONCOLOGY-BASEL, V76, P420, DOI 10.1159/000216837; Yuan Z, 2011, ANTICANCER RES, V31, P303	25	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59095	10.1371/journal.pone.0059095	http://dx.doi.org/10.1371/journal.pone.0059095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516604	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200133
J	Van Acker, H; Sass, A; Bazzini, S; De Roy, K; Udine, C; Messiaen, T; Riccardi, G; Boon, N; Nelis, HJ; Mahenthiralingam, E; Coenye, T				Van Acker, Heleen; Sass, Andrea; Bazzini, Silvia; De Roy, Karen; Udine, Claudia; Messiaen, Thomas; Riccardi, Giovanna; Boon, Nico; Nelis, Hans J.; Mahenthiralingam, Eshwar; Coenye, Tom			Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; PERSISTER CELLS; CENOCEPACIA; MECHANISMS; RESISTANCE; PLASMID	The presence of persister cells has been proposed as a factor in biofilm resilience. In the present study we investigated whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. After treatment of Bcc biofilms with high concentrations of various antibiotics often a small subpopulation survived. To investigate the molecular mechanism of tolerance in this subpopulation, Burkholderia cenocepacia biofilms were treated with 1024 mu g/ml of tobramycin. Using ROS-specific staining and flow cytometry, we showed that tobramycin increased ROS production in treated sessile cells. However, approximately 0.1% of all sessile cells survived the treatment. A transcriptome analysis showed that several genes from the tricarboxylic acid cycle and genes involved in the electron transport chain were downregulated. In contrast, genes from the glyoxylate shunt were upregulated. These data indicate that protection against ROS is important for the survival of persisters. To confirm this, we determined the number of persisters in biofilms formed by catalase mutants. The persister fraction in Delta katA and Delta katB biofilms was significantly reduced, confirming the role of ROS detoxification in persister survival. Pretreatment of B. cenocepacia biofilms with itaconate, an inhibitor of isocitrate lyase (ICL), the first enzyme in the glyoxylate shunt, reduced the persister fraction approx. 10-fold when the biofilms were subsequently treated with tobramycin. In conclusion, most Bcc biofilms contain a significant fraction of persisters that survive treatment with high doses of tobramycin. The surviving persister cells downregulate the TCA cycle to avoid production of ROS and at the same time activate an alternative pathway, the glyoxylate shunt. This pathway may present a novel target for combination therapy.	[Van Acker, Heleen; Sass, Andrea; Messiaen, Thomas; Nelis, Hans J.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Bazzini, Silvia; Udine, Claudia; Riccardi, Giovanna] Univ Pavia, Dipartimento Biol & Biotecnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Mahenthiralingam, Eshwar] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [De Roy, Karen; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium	Ghent University; University of Pavia; Cardiff University; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	Tom.Coenye@UGent.be	Sass, Andrea Michaela/G-6537-2014; Mahenthiralingam, Eshwar/D-3333-2009; Coenye, Tom/A-6291-2014; De Roy, Karen/A-7624-2011; Coenye, Tom/Z-1928-2019; Boon, Nico/B-4083-2011	Sass, Andrea Michaela/0000-0001-9396-7648; Mahenthiralingam, Eshwar/0000-0001-9014-3790; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Boon, Nico/0000-0002-7734-3103; RICCARDI, Giovanna/0000-0003-3295-0070	The Research Foundation - Flanders FWO-Vlaanderen; Special Research Fund of Ghent University; Cystic Fibrosis Foundation Therapeutics Inc; Interuniversity Attraction Poles Programme	The Research Foundation - Flanders FWO-Vlaanderen(FWO); Special Research Fund of Ghent University(Ghent University); Cystic Fibrosis Foundation Therapeutics Inc; Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office)	This work was financially supported by The Research Foundation - Flanders FWO-Vlaanderen, Special Research Fund of Ghent University, Cystic Fibrosis Foundation Therapeutics Inc and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. EM and TC acknowledge the European Cooperation in Science and Technology (COST) action BM1003 for facilitating collaborative networking that assisted with these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Miguel Valvano for providing us with B. cenocepacia C524 and the B. cenocepacia MDL1 and MDL2 mutant strains and Pam Sokol, James Zlosnik and John LiPuma for the early and late clonal pairs. TC acknowledges the support of the Special Research Fund of Ghent University and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. EM and TC acknowledge the European Cooperation in Science and Technology ( COST) action BM1003 for facilitating collaborative networking that assisted with these studies.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Caraher E, 2007, EUR J CLIN MICROBIOL, V26, P213, DOI 10.1007/s10096-007-0256-x; Cardona ST, 2006, APPL ENVIRON MICROB, V72, P2547, DOI 10.1128/AEM.72.4.2547-2555.2006; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; De Soyza A, 2004, THORAX, V59, P526, DOI 10.1136/thx.2003.010801; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x; Hagins JM, 2010, MICROBIOL-SGM, V156, P1201, DOI 10.1099/mic.0.033381-0; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lefebre MD, 2005, MICROBIOL-SGM, V151, P1975, DOI 10.1099/mic.0.27704-0; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; LiPuma JJ, 2002, LANCET, V359, P2002, DOI 10.1016/S0140-6736(02)08836-0; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Singh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007344; Van Acker E, 2010, J CYST FIBROS, V9, P450, DOI 10.1016/j.jcf.2010.08.015; van Schaik EJ, 2009, INFECT IMMUN, V77, P4275, DOI 10.1128/IAI.00609-09; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	34	90	90	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58943	10.1371/journal.pone.0058943	http://dx.doi.org/10.1371/journal.pone.0058943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516582	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000316849200123
J	Nurul-Fadhilah, A; Teo, PS; Huybrechts, I; Foo, LH				Nurul-Fadhilah, Abdullah; Teo, Pey Sze; Huybrechts, Inge; Foo, Leng Huat			Infrequent Breakfast Consumption Is Associated with Higher Body Adiposity and Abdominal Obesity in Malaysian School-Aged Adolescents	PLOS ONE			English	Article							MASS INDEX; LONGITUDINAL ASSOCIATIONS; WEIGHT-GAIN; HONG-KONG; CHILDREN; OVERWEIGHT; BEHAVIORS; FREQUENCY; HEALTH; ENERGY	Unhealthy dietary pattern increases the risk of obesity and metabolic disorders in growing children and adolescents. However, the way the habitual pattern of breakfast consumption influences body composition and risk of obesity in adolescents is not well defined. Thus, the aim of the present study was to assess any associations between breakfast consumption practices and body composition profiles in 236 apparently healthy adolescents aged 12 to 19 years. A self-administered questionnaire on dietary behaviour and lifestyle practices and a dietary food frequency questionnaire were used. Body composition and adiposity indices were determined using standard anthropometric measurement protocols and dual energy x-ray absorptiometry (DXA). Mean age of the participants was 15.3 +/- 1.9 years. The majority of participants (71.2%) fell in the normal body mass index (BMI) ranges. Breakfast consumption patterns showed that only half of the participants (50%) were consuming breakfast daily. Gender-specific multivariate analyses (ANCOVA) showed that in both boys and girls, those eating breakfast at least 5 times a week had significantly lower body weight, body mass index (BMI), BMI z-scores, waist circumference, body fat mass and percent body fat (%BF) compared to infrequent breakfast eaters, after adjustment for age, household income, pubertal status, eating-out and snacking practices, daily energy intakes, and daily physical activity levels. The present findings indicate that infrequent breakfast consumption is associated with higher body adiposity and abdominal obesity. Therefore, daily breakfast consumption with healthy food choices should be encouraged in growing children and adolescents to prevent adiposity during these critical years of growth.	[Nurul-Fadhilah, Abdullah; Teo, Pey Sze; Foo, Leng Huat] Univ Sains Malaysia, Sch Hlth Sci, Program Nutr, Kubang Kerian, Kelantan, Malaysia; [Huybrechts, Inge] IARC, Dietary Exposure Assessment Grp, Lyon, France; [Huybrechts, Inge] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Universiti Sains Malaysia; World Health Organization; International Agency for Research on Cancer (IARC); Ghent University	Foo, LH (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Program Nutr, Hlth Campus, Kubang Kerian, Kelantan, Malaysia.	lhfoo@kb.usm.my	Teo, Pey Sze/I-8571-2019; Foo, Leng Huat/I-1127-2012; Abdullah, Nurul Fadhilah/X-2401-2019	Teo, Pey Sze/0000-0002-7325-9959; Abdullah, Nurul Fadhilah/0000-0002-9816-629X	Universiti Sains Malaysia (USM) Research University Grant [1001/PPSK/812015]	Universiti Sains Malaysia (USM) Research University Grant(Universiti Sains Malaysia)	The present research work was funded by the Universiti Sains Malaysia (USM) Research University Grant (1001/PPSK/812015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalkhail B, 2002, INT J FOOD SCI NUTR, V53, P519, DOI 10.1080/09637480220164370; Astbury NM, 2011, J NUTR, V141, P1381, DOI 10.3945/jn.110.128645; Barker M, 2000, APPETITE, V35, P161, DOI 10.1006/appe.2000.0345; Cheung Patrick C. H., 2007, Hong Kong Medical Journal, V13, P16; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dialektakou KD, 2008, J AM DIET ASSOC, V108, P1517, DOI 10.1016/j.jada.2008.06.435; Dubois L, 2009, PUBLIC HEALTH NUTR, V12, P19, DOI 10.1017/S1368980008001894; Harding S, 2008, INT J EPIDEMIOL, V37, P162, DOI 10.1093/ije/dym252; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Laska MN, 2012, OBESITY, V20, P118, DOI 10.1038/oby.2011.179; Mota J, 2008, ANN HUM BIOL, V35, P1, DOI 10.1080/03014460701779617; Moy F. M., 2006, MALAYSIAN J NUTR, V12, P1; Nicklas Theresa A., 2004, Nutr Today, V39, P30, DOI 10.1097/00017285-200401000-00009; Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001; Nurul-Fadhilah A, 2012, ASIA PAC J CLIN NUTR, V21, P97; Phillips SM, 2004, OBES RES, V12, P461, DOI 10.1038/oby.2004.52; Pietrobelli A, 2005, INT J OBESITY, V29, pS97, DOI 10.1038/sj.ijo.0803079; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Shaw ME, 1998, ADOLESCENCE, V33, P851; Siega-Riz AM, 1998, AM J CLIN NUTR, V67, p748S, DOI 10.1093/ajcn/67.4.748S; Smith KJ, 2010, AM J CLIN NUTR, V92, P1316, DOI 10.3945/ajcn.2010.30101; So HK, 2011, BRIT J NUTR, V106, P742, DOI 10.1017/S0007114511000754; Sugiyama Shinichi, 2012, Environmental Health and Preventive Medicine, V17, P408, DOI 10.1007/s12199-012-0270-1; TANNER JM, 1986, CLIN ENDOCRINOL META, V15, P411, DOI 10.1016/S0300-595X(86)80005-6; Teo PS, 2012, J SCI MED S IN PRESS; Tin SPP, 2011, INT J OBESITY, V35, P899, DOI 10.1038/ijo.2011.58; Utter J, 2007, J AM DIET ASSOC, V107, P570, DOI 10.1016/j.jada.2007.01.010; Williams P, 2007, INT J FOOD SCI NUTR, V58, P201, DOI 10.1080/09637480701198075; World Health Organization, 1995, WHO TECHN REP SER	34	40	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59297	10.1371/journal.pone.0059297	http://dx.doi.org/10.1371/journal.pone.0059297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520556	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000318679900116
J	Yamamoto, H; Maeda, K; Uji, Y; Tsuchihashi, H; Mori, T; Shimizu, T; Endo, Y; Kadota, A; Miura, K; Koga, Y; Ito, T; Tani, T				Yamamoto, Hiroshi; Maeda, Kazuhisa; Uji, Yoshitaka; Tsuchihashi, Hiroshi; Mori, Tsuyoshi; Shimizu, Tomoharu; Endo, Yoshihiro; Kadota, Aya; Miura, Katsuyuki; Koga, Yusuke; Ito, Toshinori; Tani, Tohru			Association between Reduction of Plasma Adiponectin Levels and Risk of Bacterial Infection after Gastric Cancer Surgery	PLOS ONE			English	Article							SURGICAL SITE INFECTION; C-REACTIVE PROTEIN; MULTIVARIATE-ANALYSIS; EXPRESSION; ADIPOSE; HYPOADIPONECTINEMIA; COMPLICATIONS	Background and Purpose: Infections are important causes of postoperative morbidity after gastric surgery; currently, no factors have been identified that can predict postoperative infection. Adiponectin (ADN) mediates energy metabolism and functions as an immunomodulator. Perioperative ADN levels and perioperative immune functioning could be mutually related. Here we evaluated a potential biological marker to reliably predict the incidence of postoperative infections to prevent such comorbidities. Methods: We analyzed 150 consecutive patients who underwent elective gastric cancer surgery at the Shiga University of Medical Science Hospital (Shiga, Japan) from 1997 to 2009; of these, most surgeries (n = 100) were performed 2008 onwards. The patient characteristics and surgery-related factors between two groups (with and without infection) were compared by the paired t-test and chi(2) test, including preoperative ADN levels, postoperative day 1 ADN levels, and ADN ratio (postoperative ADN levels/preoperative ADN levels) as baseline factors. Logistic regression analysis was performed to access the independent association between ADN ratio and postoperative infection. Finally, receiver operating curves (ROCs) were constructed to examine its clinical utility. Results: Sixty patients (40%) experienced postoperative infections. The baseline values of age, American Society of Anesthesiologists physical status, total operating time, blood loss, surgical procedure, C-reactive protein (CRP) levels, preoperative ADN levels, and ADN ratio were significantly different between groups. Logistic regression analysis using these factors indicated that type 2 diabetes mellitus (T2DM) and ADN ratio were significantly independent variables (*p<0.05, ** p<0.01, respectively). ROC analysis revealed that the useful cutoff values (sensitivity/specificity) for preoperative ADN levels, ADN ratio, blood loss, operating time, and CRP levels were 8.81(0.567/0.568), 0.76 (0.767/0.761), 405 g (0.717/0.693), 342 min (0.617/0.614), and 8.94 mg/dl (0.583/0.591), respectively. Conclusion: T2DM and ADN ratio were independent predictors of postoperative infection and ADN ratio was the most useful predictor for postoperative infection.	[Yamamoto, Hiroshi; Uji, Yoshitaka; Tsuchihashi, Hiroshi; Mori, Tsuyoshi; Shimizu, Tomoharu; Endo, Yoshihiro; Tani, Tohru] Shiga Univ Med Sci, Dept Surg, Shiga, Japan; [Maeda, Kazuhisa; Koga, Yusuke; Ito, Toshinori] Osaka Univ, Grad Sch Med, Dept Complementary & Alternat Med, Osaka, Japan; [Kadota, Aya; Miura, Katsuyuki] Shiga Univ Med Sci, Dept Hlth Sci, Shiga, Japan	Shiga University of Medical Science; Osaka University; Shiga University of Medical Science	Maeda, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Complementary & Alternat Med, Osaka, Japan.	maedakazu@aol.com			Knowledge Cluster Initiative; Otsuka Pharmaceutical Co. Ltd.	Knowledge Cluster Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical)	This work was supported by Grant-in Aid for Scientific Research (C)(http://www.jsps.go.jp/english/e-grants/index.html), a grant of the Knowledge Cluster Initiative implemented by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)(http://www.mext.go.jp/english/whitepaper/1302746.htm), and also in part by a grant from Otsuka Pharmaceutical Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; Fasshauer M, 2001, FEBS LETT, V507, P142, DOI 10.1016/S0014-5793(01)02960-X; Fernandez-Real JM, 2003, J CLIN ENDOCR METAB, V88, P2714, DOI 10.1210/jc.2002-021583; Hadigan C, 2004, ANN INTERN MED, V140, P786, DOI 10.7326/0003-4819-140-10-200405180-00008; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Imai E, 2008, AM J INFECT CONTROL, V36, P727, DOI 10.1016/j.ajic.2007.12.011; Imai Eiko, 2005, Journal of Infection and Chemotherapy, V11, P141, DOI 10.1007/s10156-005-0379-x; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lin E, 2000, SURGERY, V127, P117, DOI 10.1067/msy.2000.101584; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; Matsuda A, 2009, J SURG RES, V157, P227, DOI 10.1016/j.jss.2008.09.007; Nishimura A, 2006, CLIN CHIM ACTA, V371, P163, DOI 10.1016/j.cca.2006.03.008; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ozalp N, 2009, SURG TODAY, V39, P1013, DOI 10.1007/s00595-008-3984-3; Peake PW, 2006, BIOCHEM BIOPH RES CO, V341, P108, DOI 10.1016/j.bbrc.2005.12.162; Pessaux P, 2003, ARCH SURG-CHICAGO, V138, P314, DOI 10.1001/archsurg.138.3.314; SCHENTAG JJ, 1984, ARCH SURG-CHICAGO, V119, P300; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Soares AF, 2005, FREE RADICAL BIO MED, V38, P882, DOI 10.1016/j.freeradbiomed.2004.12.010; Sorensen LT, 2005, ANN SURG, V241, P654, DOI 10.1097/01.sla.0000157131.84130.12; Sumiyama Y, 2001, Nihon Geka Gakkai Zasshi, V102, P856; Tang GJ, 1996, CRIT CARE MED, V24, P423, DOI 10.1097/00003246-199603000-00010; Tsuchihashi H, 2006, J SURG RES, V134, P348, DOI 10.1016/j.jss.2006.01.001; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Xydakis AM, 2004, J CLIN ENDOCR METAB, V89, P2697, DOI 10.1210/jc.2003-031826	34	11	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56129	10.1371/journal.pone.0056129	http://dx.doi.org/10.1371/journal.pone.0056129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520452	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900011
J	Banas, M; Zabieglo, K; Kasetty, G; Kapinska-Mrowiecka, M; Borowczyk, J; Drukala, J; Murzyn, K; Zabel, BA; Butcher, EC; Schroeder, JM; Schmidtchen, A; Cichy, J				Banas, Magdalena; Zabieglo, Katarzyna; Kasetty, Gopinath; Kapinska-Mrowiecka, Monika; Borowczyk, Julia; Drukala, Justyna; Murzyn, Krzysztof; Zabel, Brian A.; Butcher, Eugene C.; Schroeder, Jens M.; Schmidtchen, Artur; Cichy, Joanna			Chemerin Is an Antimicrobial Agent in Human Epidermis	PLOS ONE			English	Article							ANTIBIOTIC PEPTIDE; STRATUM-CORNEUM; DENDRITIC CELLS; DISEASED SKIN; PH GRADIENT; IN-VIVO; RECRUITMENT; ACTIVATION; RECEPTOR; PROTEIN	Chemerin, a chemoattractant ligand for chemokine-like receptor 1 (CMKLR1) is predicted to share similar tertiary structure with antibacterial cathelicidins. Recombinant chemerin has antimicrobial activity. Here we show that endogenous chemerin is abundant in human epidermis, and that inhibition of bacteria growth by exudates from organ cultures of primary human skin keratinocytes is largely chemerin-dependent. Using a panel of overlapping chemerin-derived synthetic peptides, we demonstrate that the antibacterial activity of chemerin is primarily mediated by Val 66 -Pro 85, which causes direct bacterial lysis. Therefore, chemerin is an antimicrobial agent in human skin.	[Banas, Magdalena; Zabieglo, Katarzyna; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Borowczyk, Julia; Drukala, Justyna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Krakow, Poland; [Murzyn, Krzysztof] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Computat Biophys & Bioinformat, Krakow, Poland; [Kasetty, Gopinath; Schmidtchen, Artur] Lund Univ, Div Dermatol & Venerol, Dept Clin Sci, Lund, Sweden; [Kapinska-Mrowiecka, Monika] Zeromski Hosp, Dept Dermatol, Krakow, Poland; [Zabel, Brian A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Inst Res & Educ, Palo Alto, CA USA; [Butcher, Eugene C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Schroeder, Jens M.] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany	Jagiellonian University; Jagiellonian University; Jagiellonian University; Lund University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Kiel; Schleswig Holstein University Hospital	Cichy, J (corresponding author), Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	Joanna.Cichy@uj.edu.pl	Schmidtchen, Artur/F-9507-2015; Murzyn, Krzysztof/A-4744-2014	Drukala, Justyna/0000-0001-5573-2979; Cichy, Joanna/0000-0002-0552-8344; Borowczyk, Julia/0000-0002-4638-1596	Team Award; Polish National Science Center [2011/02/A/NZ5/00337]; European Union [POIG.02.01.00-12-064/08]; National Institutes of Health (NIH); NIH [AI-079320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079320] Funding Source: NIH RePORTER	Team Award; Polish National Science Center; European Union(European Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Team Award and Polish National Science Center grant 2011/02/A/NZ5/00337 (to JC). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08). ECB is supported by grants from the National Institutes of Health (NIH) and by an endowed chair in Experimental Pathology. BAZ is supported by NIH grant AI-079320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Allen SJ, 2007, BIOMOL NMR ASSIGM, V1, P171, DOI 10.1007/s12104-007-9047-7; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Cichy J, 2011, PROTEINASE REGULATOR, P137; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Gesell J, 1997, J BIOMOL NMR, V9, P127, DOI 10.1023/A:1018698002314; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Mak P, 2007, AM J REPROD IMMUNOL, V57, P81, DOI 10.1111/j.1600-0897.2006.00456.x; Malmsten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016400; Mani R, 2007, CHEMBIOCHEM, V8, P1877, DOI 10.1002/cbic.200700335; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Ohman H, 1998, J INVEST DERMATOL, V111, P674, DOI 10.1046/j.1523-1747.1998.00356.x; OHMAN H, 1994, ACTA DERM-VENEREOL, V74, P375; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; RADETSKY M, 1986, J CLIN MICROBIOL, V24, P600, DOI 10.1128/JCM.24.4.600-606.1986; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Skrzeczynska-Moncznik J, 2009, BIOCHEM BIOPH RES CO, V380, P323, DOI 10.1016/j.bbrc.2009.01.071; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamaguchi Y, 2011, J BIOL CHEM, V286, P39510, DOI 10.1074/jbc.M111.258921; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954	37	55	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58709	10.1371/journal.pone.0058709	http://dx.doi.org/10.1371/journal.pone.0058709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527010	Green Published, gold			2022-12-27	WOS:000317562600033
J	Miranda, LN; Hutchison, K; Grossman, AR; Brawley, SH				Miranda, Lilibeth N.; Hutchison, Keith; Grossman, Arthur R.; Brawley, Susan H.			Diversity and Abundance of the Bacterial Community of the Red Macroalga Porphyra umbilicalis: Did Bacterial Farmers Produce Macroalgae?	PLOS ONE			English	Article							AGARILYTICA SP NOV.; MARINE BACTERIUM; MICROBIAL DIVERSITY; ALGA; DISEASE; MORPHOGENESIS; VARIABILITY; RHODOPHYTA; BANGIALES; L.	Macroalgae harbor microbial communities whose bacterial biodiversity remains largely uncharacterized. The goals of this study were 1) to examine the composition of the bacterial community associated with Porphyra umbilicalis Kutzing from Schoodic Point, ME, 2) determine whether there are seasonal trends in species diversity but a core group of bacteria that are always present, and 3) to determine how the microbial community associated with a laboratory strain (P.um.1) established in the presence of antibiotics has changed. P. umbilicalis blades (n = 5, fall 2010; n = 5, winter 2011; n = 2, clonal P.um.1) were analyzed by pyrosequencing over two variable regions of the 16 S rDNA (V5-V6 and V8; 147,880 total reads). The bacterial taxa present were classified at an 80% confidence threshold into eight phyla (Bacteroidetes, Proteobacteria, Planctomycetes, Chloroflexi, Actinobacteria, Deinococcus-Thermus, Firmicutes, and the candidate division TM7). The Bacteroidetes comprised the majority of bacterial sequences on both field and lab blades, but the Proteobacteria (Alphaproteobacteria, Gammaproteobacteria) were also abundant. Sphingobacteria (Bacteroidetes) and Flavobacteria (Bacteroidetes) had inverse abundances on natural versus P.um.1 blades. Bacterial communities were richer and more diverse on blades sampled in fall compared to winter. Significant differences were observed between microbial communities among all three groups of blades examined. Only two OTUs were found on all 12 blades, and only one of these, belonging to the Saprospiraceae (Bacteroidetes), was abundant. Lewinella (as 66 OTUs) was found on all field blades and was the most abundant genus. Bacteria from the Bacteroidetes, Proteobacteria and Planctomycetes that are known to digest the galactan sulfates of red algal cell walls were well-represented. Some of these taxa likely provide essential morphogenetic and beneficial nutritive factors to P. umbilicalis and may have had unexpected effects upon evolution of macroalgal form as well as function.	[Miranda, Lilibeth N.; Brawley, Susan H.] Univ Maine, Sch Marine Sci, Orono, ME USA; [Hutchison, Keith] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA; [Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Carnegie Institution for Science	Miranda, LN (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore.	lilibethnmiranda@gmail.com			National Science Foundation [IOS 0929558, IOS 0929758]; National Oceanic and Atmospheric Administration [NA060AR4170108]; Division Of Integrative Organismal Systems [0741907] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by National Science Foundation IOS 0929558 to SHB and IOS 0929758 to ARG, and National Oceanic and Atmospheric Administration NA060AR4170108 to SHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegado RA, 2012, ELIFE, V1, DOI 10.7554/eLife.00013; Andersen R. A., 2005, ALGAL CULTURING TECH; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Blouin N, 2007, AQUACULTURE, V270, P77, DOI 10.1016/j.aquaculture.2007.03.002; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Brodie J, 2008, TAXON, V57, P1328, DOI 10.1002/tax.574022; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Caro-Quintero A, 2011, ISME J, V5, P131, DOI 10.1038/ismej.2010.93; Case RJ, 2011, ENVIRON MICROBIOL, V13, P529, DOI 10.1111/j.1462-2920.2010.02356.x; Cayrou C, 2010, J ANTIMICROB CHEMOTH, V65, P2119, DOI 10.1093/jac/dkq290; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chan CX, 2012, J PHYCOL, V48, P1328, DOI 10.1111/j.1529-8817.2012.01229.x; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Correc G, 2011, CARBOHYD POLYM, V83, P277, DOI 10.1016/j.carbpol.2010.07.060; DUAN D, 1995, WORLD J MICROB BIOT, V11, P351, DOI 10.1007/BF00367118; Egan S, 2001, FEMS MICROBIOL ECOL, V35, P67, DOI 10.1111/j.1574-6941.2001.tb00789.x; FRIES L, 1978, Z PFLANZENPHYSIOL, V88, P383, DOI 10.1016/S0044-328X(78)80253-0; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gantt E, 2010, RED ALGAE GENOMIC AG; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kazamia E, 2012, ENVIRON MICROBIOL, V14, P1466, DOI 10.1111/j.1462-2920.2012.02733.x; Kim Jeong-Hee, 1992, Bulletin of the Korean Fisheries Society, V25, P314; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee SD, 2007, INT J SYST EVOL MICR, V57, P2814, DOI 10.1099/ijs.0.65254-0; Lin BK, 2012, INT J SYST EVOL MICR, V62, P869, DOI 10.1099/ijs.0.027136-0; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x; Marshall K, 2006, MICROB ECOL, V52, P302, DOI 10.1007/s00248-006-9060-x; Matsuo Y, 2005, SCIENCE, V307, P1598, DOI 10.1126/science.1105486; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; Namba A, 2010, FISHERIES SCI, V76, P873, DOI 10.1007/s12562-010-0273-z; Nasrolahi A, 2012, FEMS MICROBIOL ECOL, V81, P583, DOI 10.1111/j.1574-6941.2012.01384.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Park CS, 2006, J APPL PHYCOL, V18, P295, DOI 10.1007/s10811-006-9031-0; PROVASOLI L, 1972, Journal of Phycology, V8, P10; PROVASOLI L, 1958, BIOL BULL, V114, P375, DOI 10.2307/1538992; PROVASOLI L, 1980, J PHYCOL, V16, P196, DOI 10.1111/j.1529-8817.1980.tb03019.x; PROVASOLI L, 1964, AM J BOT, V51, P681; R Core Team, 2012, R LANG ENV STAT COMP; Sakai T, 2003, MAR BIOTECHNOL, V5, P409, DOI 10.1007/s10126-002-0118-6; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042872; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Steinberg PD, 1997, BIODEGRADATION, V8, P211, DOI 10.1023/A:1008236901790; SUNAIRI M, 1995, J APPL BACTERIOL, V79, P225, DOI 10.1111/j.1365-2672.1995.tb00939.x; Sutherland JE, 2011, J PHYCOL, V47, P1131, DOI 10.1111/j.1529-8817.2011.01052.x; SUTO SHUNZO, 1954, BULL JAPANESE SOC SCI FISH, V19, P1176; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Thomas F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021475; TSUKIDATE J-I, 1971, BULL JAP SOC SCI FISH, V37, P376; Tujula NA, 2010, ISME J, V4, P301, DOI 10.1038/ismej.2009.107; Vairappan CS, 2010, J APPL PHYCOL, V22, P305, DOI 10.1007/s10811-009-9460-7; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weinberger F, 1999, J PHYCOL, V35, P747, DOI 10.1046/j.1529-8817.1999.3540747.x; White RE, 2011, ELDRIDGE TIDE PILOT; Yamanoi H, 2008, NIPPON SUISAN GAKK, V74, P1024, DOI 10.2331/suisan.74.1024; Yamazaki A, 1998, J PHYCOL, V34, P1082, DOI 10.1046/j.1529-8817.1998.341082.x; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Yung PY, 2011, APPL ENVIRON MICROB, V77, P1512, DOI 10.1128/AEM.02038-10	75	81	82	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58269	10.1371/journal.pone.0058269	http://dx.doi.org/10.1371/journal.pone.0058269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526971	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600016
J	Francis, RM; Nielsen, SL; Kryger, P				Francis, Roy M.; Nielsen, Steen L.; Kryger, Per			Varroa-Virus Interaction in Collapsing Honey Bee Colonies	PLOS ONE			English	Article							DEFORMED WING VIRUS; APIS-MELLIFERA L.; NOSEMA-CERANAE; DESTRUCTOR ACARI; PARALYSIS VIRUS; PREVALENCE; JACOBSONI; TRANSMISSION; INFECTIONS; PESTICIDES	Varroa mites and viruses are the currently the high-profile suspects in collapsing bee colonies. Therefore, seasonal variation in varroa load and viruses (Acute-Kashmir-Israeli complex (AKI) and Deformed Wing Virus (DWV)) were monitored in a yearlong study. We investigated the viral titres in honey bees and varroa mites from 23 colonies (15 apiaries) under three treatment conditions: Organic acids (11 colonies), pyrethroid (9 colonies) and untreated (3 colonies). Approximately 200 bees were sampled every month from April 2011 to October 2011, and April 2012. The 200 bees were split to 10 sub-samples of 20 bees and analysed separately, which allows us to determine the prevalence of virus-infected bees. The treatment efficacy was often low for both treatments. In colonies where varroa treatment reduced the mite load, colonies overwintered successfully, allowing the mites and viruses to be carried over with the bees into the next season. In general, AKI and DWV titres did not show any notable response to the treatment and steadily increased over the season from April to October. In the untreated control group, titres increased most dramatically. Viral copies were correlated to number of varroa mites. Most colonies that collapsed over the winter had significantly higher AKI and DWV titres in October compared to survivors. Only treated colonies survived the winter. We discuss our results in relation to the varroa-virus model developed by Stephen Martin.	[Francis, Roy M.; Nielsen, Steen L.; Kryger, Per] Aarhus Univ, Dept Agroecol Sci & Technol, Slagelse, Denmark	Aarhus University	Francis, RM (corresponding author), Aarhus Univ, Dept Agroecol Sci & Technol, Slagelse, Denmark.	royfrancis.mathew@agrsci.dk	Kryger, Per/C-1773-2013; Kryger, Per/H-4600-2019	Kryger, Per/0000-0001-5306-3230; Kryger, Per/0000-0001-5306-3230	Promilleafgiftsfonden	Promilleafgiftsfonden	The authors wish to thank Promilleafgiftsfonden for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL B V, 1983, EXPT APPL ACAROLOGY, V19, P607; BALL BV, 1988, ANN APPL BIOL, V113, P237, DOI 10.1111/j.1744-7348.1988.tb03300.x; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Branco MR, 2006, APIDOLOGIE, V37, P452, DOI 10.1051/apido:2006010; Buchler R, 2010, APIDOLOGIE, V41, P393, DOI 10.1051/apido/2010011; Carreck NL, 2010, J APICULT RES, V49, P93, DOI 10.3896/IBRA.1.49.1.13; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Cowling DW, 1999, PREV VET MED, V39, P211, DOI 10.1016/S0167-5877(98)00131-7; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Duay Pedro, 2002, Genetics and Molecular Research, V1, P227; EU, 2011, GUID PIL SURV PROJ H, P1; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Francis RM, 2012, J APIC SCI, V56, P137, DOI 10.2478/v10289-012-0014-x; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gross M, 2008, CURR BIOL, V18, pR684, DOI 10.1016/j.cub.2008.08.004; Hauck Walter W., 1991, Annals of Epidemiology, V1, P277; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; IFANTIDIS MD, 1983, J APICULT RES, V22, P200, DOI 10.1080/00218839.1983.11100588; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; LE CONTE Y, 1987, APIDOLOGIE, V18, P305, DOI 10.1051/apido:19870402; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lee KV, 2010, J ECON ENTOMOL, V103, P1039, DOI 10.1603/EC10037; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Martin S, 2001, EUROPE-REV LIT MENS, V79, P321; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martin SJ, 2010, J APICULT RES, V49, P72, DOI 10.3896/IBRA.1.49.1.10; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nordstrom S, 1999, APIDOLOGIE, V30, P475, DOI 10.1051/apido:19990602; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; PIOTROWSKI F, 1982, Angewandte Parasitologie, V23, P49; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sergeant ESG, 2012, EPITOOLS EPIDEMIOLOG; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vejsnaes F, 2010, J APICULT RES, V49, P109, DOI 10.3896/IBRA.1.49.1.20; Vetharaniam I, 2012, ECOL MODEL, V224, P11, DOI 10.1016/j.ecolmodel.2011.10.016; Yang X, 2007, PARASITOLOGY, V134, P405, DOI 10.1017/S0031182006000710; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	57	204	213	2	277	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57540	10.1371/journal.pone.0057540	http://dx.doi.org/10.1371/journal.pone.0057540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526946	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100014
J	Im, SK; Jeong, H; Jeong, HW; Kim, KT; Hwang, D; Ikegami, M; Kong, YY				Im, Sun-Kyoung; Jeong, HyoBin; Jeong, Hyun-Woo; Kim, Kyong-Tai; Hwang, Daehee; Ikegami, Machiko; Kong, Young-Yun			Disruption of Sorting Nexin 5 Causes Respiratory Failure Associated with Undifferentiated Alveolar Epithelial Type I Cells in Mice	PLOS ONE			English	Article							MOUSE LUNG DEVELOPMENT; PULMONARY SURFACTANT; MAMMALIAN RETROMER; GENETIC-DISORDERS; EGF RECEPTOR; MIND BOMB-1; PROTEIN; NOTCH; SNX5; DIFFERENTIATION	Sorting nexin 5 (Snx5) has been posited to regulate the degradation of epidermal growth factor receptor and the retrograde trafficking of cation-independent mannose 6-phosphate receptor/insulin-like growth factor II receptor. Snx5 has also been suggested to interact with Mind bomb-1, an E3 ubiquitin ligase that regulates the activation of Notch signaling. However, the in vivo functions of Snx5 are largely unknown. Here, we report that disruption of the Snx5 gene in mice (Snx5(-/-) mice) resulted in partial perinatal lethality; 40% of Snx5(-/-) mice died shortly after birth due to cyanosis, reduced air space in the lungs, and respiratory failure. Histological analysis revealed that Snx5(-/-) mice exhibited thickened alveolar walls associated with undifferentiated alveolar epithelial type I cells. In contrast, alveolar epithelial type II cells were intact, exhibiting normal surfactant synthesis and secretion. Although the expression levels of surfactant proteins and saturated phosphatidylcholine in the lungs of Snx5(-/-) mice were comparable to those of Snx5(+/+) mice, the expression levels of T1 alpha, Aqp5, and Rage, markers for distal alveolar epithelial type I cells, were significantly decreased in Snx5(-/-) mice. These results demonstrate that Snx5 is necessary for the differentiation of alveolar epithelial type I cells, which may underlie the adaptation to air breathing at birth.	[Im, Sun-Kyoung; Jeong, Hyun-Woo; Kong, Young-Yun] Seoul Natl Univ, Sch Biol Sci, Coll Nat Sci, Seoul, South Korea; [Im, Sun-Kyoung; Kim, Kyong-Tai] POSTECH, Div Mol & Life Sci, Dept Life Sci, Pohang, South Korea; [Jeong, HyoBin; Hwang, Daehee] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Ikegami, Machiko] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Ikegami, Machiko] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Cincinnati Children's Hospital Medical Center; University of Cincinnati	Kong, YY (corresponding author), Seoul Natl Univ, Sch Biol Sci, Coll Nat Sci, Seoul, South Korea.	ykong@snu.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627; Jeong, Hyun-Woo/0000-0002-6976-6739	Basic Science Research Program through the National Research Foundation of Korea [2012-0000121]; National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea [0920310]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) [2011-0019269]; Global Frontier Project grant of the National Research Foundation [2011-0028413]; Ministry of Education, Science and Technology of Korea	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea; Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Global Frontier Project grant of the National Research Foundation(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (RND no. 2012-0000121), National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea (RND no. 0920310), Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST; RND no. 2011-0019269), and Global Frontier Project grant (RND no. 2011-0028413) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cavet ME, 2008, FASEB J, V22, P3607, DOI 10.1096/fj.07-094086; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cole FS, 2001, PEDIATR RES, V50, P157, DOI 10.1203/00006450-200108000-00001; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; DEMELLO DE, 1994, AM J RESP CELL MOL, V11, P230, DOI 10.1165/ajrcmb.11.2.8049084; Galambos C, 2002, AM J RESP CELL MOL, V27, P194, DOI 10.1165/ajrcmb.27.2.4703; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Glasser SW, 2006, SEMIN PERINATOL, V30, P341, DOI 10.1053/j.semperi.2006.09.001; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Hara S, 2008, MOL BIOL CELL, V19, P3823, DOI 10.1091/mbc.E08-03-0314; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17302, DOI 10.1073/pnas.0508649102; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Jin N, 2009, DEVELOPMENT, V136, P3347, DOI 10.1242/dev.032979; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kumar VH, 2005, ADV CLIN CHEM, V40, P261, DOI 10.1016/S0065-2423(05)40007-4; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Liu H, 2006, BIOCHEM BIOPH RES CO, V342, P537, DOI 10.1016/j.bbrc.2006.01.179; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; MASON RJ, 1976, J LIPID RES, V17, P281; Matsui R, 1999, CELL SIGNAL, V11, P221, DOI 10.1016/S0898-6568(98)00070-9; Matzke A, 2007, MOL CELL BIOL, V27, P8797, DOI 10.1128/MCB.01355-07; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; O'Brien KB, 2010, DEVELOPMENT, V137, P2147, DOI 10.1242/dev.037150; Panaro NJ, 2000, CLIN CHEM, V46, P1851; Pei LM, 2011, NAT MED, V17, P1466, DOI 10.1038/nm.2450; Rawlins EL, 2011, DEV DYNAM, V240, P463, DOI 10.1002/dvdy.22482; Lyra PPR, 2007, CLINICS, V62, P181, DOI 10.1590/S1807-59322007000200014; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Verges M, 2007, FRONT BIOSCI-LANDMRK, V12, P3825, DOI 10.2741/2355; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Warburton D, 1998, BIOCHEM CELL BIOL, V76, P971, DOI 10.1139/bcb-76-6-971; Warshamana GS, 2001, EXP MOL PATHOL, V71, P13, DOI 10.1006/exmp.2001.2376; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Wert SE, 2009, PEDIATR DEVEL PATHOL, V12, P253, DOI 10.2350/09-01-0586.1; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Yoon MJ, 2008, MOL CELL BIOL, V28, P4794, DOI 10.1128/MCB.00436-08	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58511	10.1371/journal.pone.0058511	http://dx.doi.org/10.1371/journal.pone.0058511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526992	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100028
J	Krog, A; Heggeset, TMB; Muller, JEN; Kupper, CE; Schneider, O; Vorholt, JA; Ellingsen, TE; Brautaset, T				Krog, Anne; Heggeset, Tonje M. B.; Mueller, Jonas E. N.; Kupper, Christiane E.; Schneider, Olha; Vorholt, Julia A.; Ellingsen, Trond E.; Brautaset, Trygve			Methylotrophic Bacillus methanolicus Encodes Two Chromosomal and One Plasmid Born NAD(+) Dependent Methanol Dehydrogenase Paralogs with Different Catalytic and Biochemical Properties	PLOS ONE			English	Article							ELECTRON-MICROSCOPIC ANALYSIS; SWISS-MODEL; L-LYSINE; ACTIVATOR PROTEIN; NUDIX HYDROLASES; PATHWAY GENES; PSI-BLAST; THERMOTOLERANT; IDENTIFICATION; SEQUENCE	Bacillus methanolicus can utilize methanol as the sole carbon source for growth and it encodes an NAD+-dependent methanol dehydrogenase *(Mdh), catalyzing the oxidation of methanol to formaldehyde. Recently, the genomes of the B. methanolicus strains MGA3 *(ATCC53907) and PB1 *(NCIMB13113) were sequenced and found to harbor three different putative Mdh encoding genes, each belonging to the type III Fe-NAD(+)-dependent alcohol dehydrogenases. In each strain, two of these genes are encoded on the chromosome and one on a plasmid; only one chromosomal act gene encoding the previously described activator protein ACT was found. The six Mdhs and the ACT proteins were produced recombinantly in Escherichia coli, purified, and characterized. All Mdhs required NAD+ as cosubstrate, were catalytically stimulated by ACT, exhibited a broad and different substrate specificity range and displayed both dehydrogenase and reductase activities. All Mdhs catalyzed the oxidation of methanol; however the catalytic activity for methanol was considerably lower than for most other alcohols tested, suggesting that these enzymes represent a novel class of alcohol dehydrogenases. The kinetic constants for the Mdhs were comparable when acting as pure enzymes, but together with ACT the differences were more pronounced. Quantitative PCR experiments revealed major differences with respect to transcriptional regulation of the paralogous genes. Taken together our data indicate that the repertoire of methanol oxidizing enzymes in thermotolerant bacilli is larger than expected with complex mechanisms involved in their regulation.	[Krog, Anne; Heggeset, Tonje M. B.; Kupper, Christiane E.; Schneider, Olha; Ellingsen, Trond E.; Brautaset, Trygve] SINTEF Mat & Chem, Dept Biotechnol, Trondheim, Norway; [Krog, Anne] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Mueller, Jonas E. N.; Vorholt, Julia A.] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	SINTEF; Norwegian University of Science & Technology (NTNU); Swiss Federal Institutes of Technology Domain; ETH Zurich	Brautaset, T (corresponding author), SINTEF Mat & Chem, Dept Biotechnol, Trondheim, Norway.	trygve.brautaset@sintef.no	Heggeset, Tonje Marita Bjerkan/I-9077-2019; Vorholt, Julia/K-3514-2016; Müller, Jonas/GQA-3371-2022	Vorholt, Julia/0000-0002-6011-4910; Heggeset, Tonje/0000-0002-1221-8598	Research Council of Norway; Swiss National Foundation; European Science Foundation	Research Council of Norway(Research Council of Norway); Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by a grant from the Research Council of Norway, the Swiss National Foundation and the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anthony C, 2004, ARCH BIOCHEM BIOPHYS, V428, P2, DOI 10.1016/j.abb.2004.03.038; Anthony C, 1991, Biotechnology, V18, P79; Anthony C., 1982, BIOCH METHYLOTROPHS; Arfman N, 1997, EUR J BIOCHEM, V244, P426, DOI 10.1111/j.1432-1033.1997.00426.x; ARFMAN N, 1992, INT J SYST BACTERIOL, V42, P439, DOI 10.1099/00207713-42-3-439; ARFMAN N, 1991, J BIOL CHEM, V266, P3955; ARFMAN N, 1989, ARCH MICROBIOL, V152, P280, DOI 10.1007/BF00409664; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Brautaset T, 2004, J BACTERIOL, V186, P1229, DOI 10.1128/JB.186.5.1229-1238.2004; Brautaset T, 2007, APPL MICROBIOL BIOT, V74, P22, DOI 10.1007/s00253-006-0757-z; Brautaset T, 2010, APPL MICROBIOL BIOT, V87, P951, DOI 10.1007/s00253-010-2559-6; BYSTRYKH LV, 1993, J BACTERIOL, V175, P1814, DOI 10.1128/JB.175.6.1814-1822.1993; Chistoserdova L, 2011, ENVIRON MICROBIOL, V13, P2603, DOI 10.1111/j.1462-2920.2011.02464.x; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; DEVRIES GE, 1992, J BACTERIOL, V174, P5346, DOI 10.1128/JB.174.16.5346-5353.1992; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heggeset TMB, 2012, APPL ENVIRON MICROB, V78, P5170, DOI 10.1128/AEM.00703-12; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hektor HJ, 2002, J BIOL CHEM, V277, P46966, DOI 10.1074/jbc.M207547200; Jakobsen OM, 2006, J BACTERIOL, V188, P3063, DOI 10.1128/JB.188.8.3063-3072.2006; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kloosterman H, 2002, J BIOL CHEM, V277, P34785, DOI 10.1074/jbc.M205617200; Marcal D, 2009, J BACTERIOL, V191, P1143, DOI 10.1128/JB.01077-08; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Naerdal I, 2011, APPL ENVIRON MICROB, V77, P6020, DOI 10.1128/AEM.05093-11; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Sambrook J., 2001, MOL CLONING LAB MANU; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; SCHENDEL FJ, 1990, APPL ENVIRON MICROB, V56, P963, DOI 10.1128/AEM.56.4.963-970.1990; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; VONCK J, 1991, J BIOL CHEM, V266, P3949; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07	38	55	60	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59188	10.1371/journal.pone.0059188	http://dx.doi.org/10.1371/journal.pone.0059188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527128	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100089
J	Meng, FD; Ren, YD; Suo, SQGW; Sun, XJ; Li, XL; Li, PC; Yang, W; Li, GX; Li, L; Schwegmann-Wessels, C; Herrler, G; Ren, XF				Meng, Fandan; Ren, Yudong; Suo, Siqingaowa; Sun, Xuejiao; Li, Xunliang; Li, Pengchong; Yang, Wei; Li, Guangxing; Li, Lu; Schwegmann-Wessels, Christel; Herrler, Georg; Ren, Xiaofeng			Evaluation on the Efficacy and Immunogenicity of Recombinant DNA Plasmids Expressing Spike Genes from Porcine Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus	PLOS ONE			English	Article							ANTIGENIC STRUCTURE; PROTEIN; CORONAVIRUS; VACCINATION; PROTECTION; ANTIBODIES; INFLUENZA; EPITOPES; SEQUENCE; CELLS	Porcine transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PDEV) can cause severe diarrhea in pigs. Development of effective vaccines against TGEV and PEDV is one of important prevention measures. The spike (S) protein is the surface glycoprotein of TGEV and PEDV, which can induce specific neutralization antibodies and is a candidate antigen for vaccination attempts. In this study, the open reading frames of the TGEV S1 protein and in addition of the S or S1 proteins of PEDV were inserted into the eukaryotic expression vector, pIRES, resulting in recombinant plasmids, pIRES-(TGEV-S1-PEDV-S1) and pIRES-(TGEV-S1-PEDV-S). Subsequently, 6-8 weeks old Kunming mice were inoculated with both DNA plasmids. Lymphocyte proliferation assay, virus neutralization assay, IFN-gamma assay and CTL activity assay were performed. TGEV/PEDV specific antibody responses as well as kinetic changes of T lymphocyte subgroups of the immunized mice were analyzed. The results showed that the recombinant DNA plasmids increased the proliferation of T lymphocytes and the number of CD4+ and CD8+ T lymphocyte subgroups. In addition, the DNA vaccines induced a high level of IFN-gamma in the immunized mice. The specific CTL activity in the pIRES-(TGEV-S1-PEDV-S) group became significant at 42 days post-immunization. At 35 days post-immunization, the recombinant DNA plasmids bearing full-length S genes of TGEV and PEDV stimulated higher levels of specific antibodies and neutralizing antibodies in immunized mice.	[Meng, Fandan; Ren, Yudong; Suo, Siqingaowa; Sun, Xuejiao; Li, Xunliang; Li, Pengchong; Yang, Wei; Li, Guangxing; Ren, Xiaofeng] Northeast Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Li, Lu] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Schwegmann-Wessels, Christel; Herrler, Georg] Univ Vet Med, Inst Virol, Hannover, Germany	Northeast Agricultural University - China; Northeast Agricultural University - China; University of Veterinary Medicine Hannover, Foundation	Ren, XF (corresponding author), Northeast Agr Univ, Coll Vet Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn			National Natural Science Foundation of China [31270187]; Program for New Century Excellent Talents in University of Ministry of Education of P.R. China [NCET-10-0144]; Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang; Research Team Program on Scientific and Technological Innovation in Heilongjiang Provincial University [2011TD001]; Innovation Talent Project (Excellent discipline leader) of the Harbin Science and Technology Bureau [RC2012XK002003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of P.R. China(Program for New Century Excellent Talents in University (NCET)); Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang; Research Team Program on Scientific and Technological Innovation in Heilongjiang Provincial University; Innovation Talent Project (Excellent discipline leader) of the Harbin Science and Technology Bureau	The authors acknowledge National Natural Science Foundation of China (31270187), The Program for New Century Excellent Talents in University of Ministry of Education of P.R. China (NCET-10-0144), Sponsored by Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang, Research Team Program on Scientific and Technological Innovation in Heilongjiang Provincial University (2011TD001), Innovation Talent Project (Excellent discipline leader) of the Harbin Science and Technology Bureau (RC2012XK002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIDGEN A, 1993, J GEN VIROL, V74, P1795, DOI 10.1099/0022-1317-74-9-1795; CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1; Claerebout E, 2005, PARASITE IMMUNOL, V27, P325, DOI 10.1111/j.1365-3024.2005.00780.x; Cruz DJM, 2008, VIRUS RES, V132, P192, DOI 10.1016/j.virusres.2007.10.015; DEBOUCK P, 1982, P INT PIG VET SOC C, V7, P53; DELMAS B, 1986, J GEN VIROL, V67, P1405, DOI 10.1099/0022-1317-67-7-1405; DOYLE LP, 1946, J AM VET MED ASSOC, V108, P257; DUARTE M, 1994, J GEN VIROL, V75, P1195, DOI 10.1099/0022-1317-75-5-1195; DUARTE M, 1994, VIROLOGY, V198, P466, DOI 10.1006/viro.1994.1058; GARWES DJ, 1979, VET MICROBIOL, V3, P179, DOI 10.1016/0378-1135(79)90034-8; GOODWIN R. F. W., 1958, Veterinary Record, V70, P271; Isabel C, 1990, J GEN VIROL, V71, P271; JIMENEZ G, 1986, J VIROL, V60, P131; Jimenez G, 1985, P INT PIG VET SOC C, V9, P186; JOHNSON MW, 1992, VET MED-US, V87, P382; Jung-Eun P, 2010, ARCH VIROL, V155, P595; Kweon CH, 1993, KOREAN J VET RES, V33, P249; LAUDE H, 1986, J GEN VIROL, V67, P119, DOI 10.1099/0022-1317-67-1-119; LAVIADA MD, 1990, VIRUS RES, V16, P247, DOI 10.1016/0168-1702(90)90051-C; Lekutis C, 1997, J IMMUNOL, V158, P4471; Li GX, 2012, IMMUNOL INVEST, V41, P231, DOI 10.3109/08820139.2011.614306; Liu BQ, 2009, J BIOTECHNOL, V141, P91, DOI 10.1016/j.jbiotec.2009.02.005; Liu MA, 2003, J INTERN MED, V253, P402, DOI 10.1046/j.1365-2796.2003.01140.x; Margaret AL, 2011, IMMUNOL REV, V239, P62; Meng FD, 2010, HYBRIDOMA, V29, P345, DOI 10.1089/hyb.2010.0009; MOXLEY RA, 1989, AM J VET RES, V50, P111; Niu XY, 1992, VET, V22, P22; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; ROBINSON HL, 1993, VACCINE, V11, P957, DOI 10.1016/0264-410X(93)90385-B; Sasahara J, 1958, VET SCI, V20, P1; Sestak K, 1996, AM J VET RES, V57, P664; Shuojie L, 2007, MED SCI, V27, P625; Spaan W, 1988, GEN VIROL, V69, P29; Straw BE, 2000, DIS SWINE, P181; STURMAN LS, 1985, J VIROL, V56, P904, DOI 10.1128/JVI.56.3.904-911.1985; Sui XW, 2010, ANTIVIR RES, V85, P346, DOI 10.1016/j.antiviral.2009.10.014; Sumi T, 2007, IMMUNOL LETT, V108, P62, DOI 10.1016/j.imlet.2006.10.003; Sun DB, 2007, ACTA VIROL, V51, P149; Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022; Sun-Hwa C., 2002, MOL CELLS, V14, P295; Tsuda T, 1997, VET SOC, V31, P21; Ulmer J B, 1997, Behring Inst Mitt, P79; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Yin J.C., 2006, VET SCI CHINA, V3, P203	47	33	42	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57468	10.1371/journal.pone.0057468	http://dx.doi.org/10.1371/journal.pone.0057468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526943	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100012
J	Pan, HS; Lu, YH; Wyckhuys, KAG				Pan, Hongsheng; Lu, Yanhui; Wyckhuys, Kris A. G.			Early-Season Host Switching in Adelphocoris spp. (Hemiptera: Miridae) of Differing Host Breadth	PLOS ONE			English	Article							TARNISHED PLANT BUG; PHYTOPHAGOUS INSECTS; NORTHERN CHINA; BT COTTON; HETEROPTERA; PREFERENCE; MISSISSIPPI; PERFORMANCE; GENERALIST; LOUISIANA	The mirid bugs Adelphocoris suturalis (Jakovlev), Adelphocoris lineolatus (Goeze) and Adelphocoris fasciaticollis (Reuter) (Hemiptera: Miridae) are common pests of several agricultural crops. These three species have vastly different geographical distributions, phenologies and abundances, all of which are linked to their reliance on local plants. Previous work has shown notable differences in Adelphocoris spp. host use for overwintering. In this study, we assessed the extent to which each of the Adelphocoris spp. relies on some of its major overwinter hosts for spring development. Over the course of four consecutive years (2009-2012), we conducted population surveys on 77 different plant species from 39 families. During the spring, A. fasciaticollis used the broadest range of hosts, as it was found on 35 plant species, followed by A. suturalis (15 species) and A. lineolatus (7 species). Abundances of the species greatly differed between host plants, with A. fasciaticollis reaching the highest abundance on Chinese date (Ziziphus jujuba Mill.), whereas both A. suturalis and A. lineolatus preferred alfalfa (Medicago sativa L.). The host breadths of the three Adelphocoris spp. differed greatly between subsequent spring and winter seasons. The generalist species exhibited the least host fidelity, with A. suturalis and A. lineolatus using 8 of 22 and 4 of 12 overwinter host species for spring development, respectively. By contrast, the comparative specialist A. fasciaticollis relied on 9 of its 11 overwinter plants as early-season hosts. We highlight important seasonal changes in host breadth and interspecific differences in the extent of host switching behavior between the winter and spring seasons. These findings benefit our understanding of the evolutionary interactions between mirid bugs and their host plants and can be used to guide early-season population management.	[Pan, Hongsheng; Lu, Yanhui] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Wyckhuys, Kris A. G.] Int Ctr Trop Agr CIAT Asia, Hanoi, Vietnam	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lu, YH (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	yhlu@ippcaas.cn	Wyckhuys, Kris/AAJ-4352-2020	Wyckhuys, Kris/0000-0003-0922-488X; Lu, Yanhui/0000-0002-6552-0248	National Basic Research Program of China [2012CB114104]; National Natural Science Funds [31222046]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (number 2012CB114104) and the National Natural Science Funds (number 31222046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Cao C. Y., 1983, MANAGEMENT COTTON MI; CHU H. F., 1958, ACTA ENT SINICA, V8, P97; Coyle DR, 2011, ENTOMOL EXP APPL, V138, P137, DOI 10.1111/j.1570-7458.2010.01083.x; Esquivel JF, 2007, ENVIRON ENTOMOL, V36, P725, DOI 10.1603/0046-225X(2007)36[725:HPOTTP]2.0.CO;2; Gao Zongren, 1992, Scientia Agricultura Sinica, V25, P15; Gao Zongren, 1998, Acta Phytophylacica Sinica, V25, P330; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; HOLOPAINEN JK, 1991, J APPL ENTOMOL, V111, P484, DOI 10.1111/j.1439-0418.1991.tb00351.x; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Li YF, 2011, ANN C CHIN SOC PLANT, P210; Liu HM, 1991, ACTA PHYTOPHYL SIN, V18, P147; Liu M, 2008, CHINA JUJUBE DEV REP; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2012, J ECON ENTOMOL, V105, P1603, DOI 10.1603/EC12003; Lu YH, 2011, CROP PROT, V30, P1455, DOI 10.1016/j.cropro.2011.07.010; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Muller J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025986; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Robbins JT, 2000, SOUTHWEST ENTOMOL, P21; Rossi AM, 1996, J CHEM ECOL, V22, P653, DOI 10.1007/BF02033576; SAS Institute, 2005, SAS STAT US GUID VER; Scott D.R., 1977, Bulletin Ent Soc Amer, V23, P19; SINGER MC, 1983, EVOLUTION, V37, P389, DOI 10.1111/j.1558-5646.1983.tb05547.x; Snodgrass CL, 2005, ENVIRON ENTOMOL, V34, P705, DOI 10.1603/0046-225X-34.3.705; Snodgrass GL, 2006, ENVIRON ENTOMOL, V35, P1417, DOI 10.1603/0046-225X(2006)35[1417:SOTPBH]2.0.CO;2; SNODGRASS GL, 1984, J GEORGIA ENTOMOL SO, V19, P93; SNODGRASS GL, 1984, ENVIRON ENTOMOL, V13, P110, DOI 10.1093/ee/13.1.110; STOYENOFF JL, 1994, OECOLOGIA, V97, P143, DOI 10.1007/BF00323144; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; VELASCO LRI, 1993, ENVIRON ENTOMOL, V22, P326, DOI 10.1093/ee/22.2.326; Wang ZR., 1990, FARMLAND WEEDS CHINA; Welsman JA, 2007, ENVIRON ENTOMOL, V36, P541, DOI 10.1603/0046-225X(2007)36[541:DOSAHA]2.0.CO;2; Wheeler Jr A. G., 2001, BIOL PLANT BUGS; Zhang SM., 1996, GEOGRAPHICAL DISTRIB; Zheng L. Y., 2004, FAUNA SINICA INSECTA, V33	40	26	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59000	10.1371/journal.pone.0059000	http://dx.doi.org/10.1371/journal.pone.0059000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527069	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100064
J	Pittaway, JK; Ahuja, KDK; Beckett, JM; Bird, ML; Robertson, IK; Ball, MJ				Pittaway, Jane K.; Ahuja, Kiran D. K.; Beckett, Jeffrey M.; Bird, Marie-Louise; Robertson, Iain K.; Ball, Madeleine J.			Make Vitamin D While the Sun Shines, Take Supplements When t Doesn't: A Longitudinal, Observational Study of Older Adults in Tasmania, Australia	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; GEELONG OSTEOPOROSIS; SUBTROPICAL CLIMATE; POSITION STATEMENT; SUNLIGHT EXPOSURE; BONE HEALTH; DETERMINANTS; DIET; INSUFFICIENCY; PERSPECTIVES	Low vitamin D status has been associated with a number of chronic conditions, particularly in older adults. The aim of this study was to identify how best to maintain optimum vitamin D status throughout the year in this high-risk population. The main objectives of the study were to assess seasonal vitamin D status; identify the main determinants of vitamin D status; determine if taking part in the study led to alterations in participant behaviour and vitamin D status. A longitudinal design across four consecutive seasons observed ninety-one 60-85 year old community-dwelling adults in Tasmania (41 pi S) over 13 consecutive months, with a follow-up assessment at next winter's end. Associations between solar UVB exposure, sun protection behaviours, dietary and supplemental vitamin D with serum 25(OH) D concentrations were assessed. Variation in serum 25(OH) D demonstrated an identical pattern to solar UVB, lagging 8-10 weeks. Serum 25(OH) D was positively associated with summer UVB (mean 15.9 nmol/L; 95%CI 11.8-19.9 nmol/L, p<0.001) and vitamin D supplementation (100-600 IU/day: 95%CI 10.2 nmol/L; 0.8-19.6 nmol/L; p = 0.03; 800 IU/day: 21.0 nmol/L; 95%CI 8.1-34.0 nmol/L; p = 0.001). Seasonal variation in serum 25(OH) D was greatly diminished in supplement users. The most common alteration in participant behaviour after the study was ingesting vitamin D supplements. Post-study vitamin D supplementation 2800 IU/day was seven times more likely than during the study resulting in mean difference in serum 25(OH) D between supplement and non-supplement users of 30.1 nmol/L (95%CI 19.4-40.8 nmol/L; p<0.001). The main limitation was homogeneity of participant ethnicity. Solar exposure in summer and ingestion of vitamin D supplements in other seasons are the most effective ways of achieving and maintaining year-round vitamin D sufficiency in older adults in the Southern hemisphere. Vitamin D supplementation has greatest effect on vitamin D status if ingested during and after winter, i.e. between the autumn and spring equinoxes.	[Pittaway, Jane K.; Ahuja, Kiran D. K.; Beckett, Jeffrey M.; Bird, Marie-Louise; Robertson, Iain K.; Ball, Madeleine J.] Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia	University of Tasmania	Pittaway, JK (corresponding author), Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia.	Jane.Pittaway@utas.edu.au	Pittaway, Jane/I-7886-2013; Ahuja, Kiran/AAI-4026-2021; Ahuja, Kiran DK/A-3147-2012	Pittaway, Jane/0000-0001-9095-901X; Ahuja, Kiran/0000-0002-0323-4692; Ahuja, Kiran DK/0000-0002-0323-4692; Bird, Marie-Louise/0000-0001-9642-7196; Beckett, Jeffrey/0000-0002-2911-0313	Clifford Craig Medical Trust; University of Tasmania New Academic Research Grant	Clifford Craig Medical Trust; University of Tasmania New Academic Research Grant	The study was partially funded by a grant from the Clifford Craig Medical Trust (http://cliffordcraig.org.au/84-balance-in-older-tasmanians/) and a University of Tasmania New Academic Research Grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AIHW, 2010, AUSTR HLTH SER, V12; Andersen R, 2005, EUR J CLIN NUTR, V59, P533, DOI 10.1038/sj.ejcn.1602108; [Anonymous], NUTR REF VAL AUSTR N; Ashwell M, 2010, BRIT J NUTR, V104, P603, DOI 10.1017/S0007114510002138; Barake R, 2010, J AM COLL NUTR, V29, P25, DOI 10.1080/07315724.2010.10719813; Bird ML, 2013, AGE AGEING, V42, P181, DOI 10.1093/ageing/afs067; Bolland MJ, 2006, OSTEOPOROSIS INT, V17, P1742, DOI 10.1007/s00198-006-0190-2; British Association of Dermatologists Cancer Research UK Diabetes UK Multiple Sclerosis Society National Heart Forum, 2010, CONS VIT D POS STAT; Burgaz A, 2007, AM J CLIN NUTR, V86, P1399, DOI 10.1093/ajcn/86.5.1399; Chen TC, 2007, ARCH BIOCHEM BIOPHYS, V460, P213, DOI 10.1016/j.abb.2006.12.017; Dalgard C, 2010, BRIT J NUTR, V104, P914, DOI 10.1017/S0007114510001509; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; FSANZ, 2009, FOOD STAND AUSTR NZ; Gannage-Yared MH, 2009, BRIT J NUTR, V101, P487, DOI 10.1017/S0007114508023404; Heaney RP, 2011, J BONE MINER RES, V26, P455, DOI 10.1002/jbmr.328; Heaney RP, 2006, J NUTR, V136, P1123, DOI 10.1093/jn/136.4.1123; Hill T, 2005, EUR J CLIN NUTR, V59, P404, DOI 10.1038/sj.ejcn.1602088; Hill TR, 2006, PUBLIC HEALTH NUTR, V9, P225, DOI 10.1079/PHN2005837; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Laird E, 2010, NUTRIENTS, V2, P693, DOI 10.3390/nu2070693; Lucas JA, 2005, OSTEOPOROSIS INT, V16, P1641, DOI 10.1007/s00198-005-1888-2; Macdonald HM, 2011, OSTEOPOROSIS INT, V22, P2461, DOI 10.1007/s00198-010-1467-z; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; Marks R, 1999, Australas J Dermatol, V40, P1, DOI 10.1046/j.1440-0960.1999.00307.x; Ministry of Health and Cancer Society of New Zealand, 2012, COMPANION STATEMENT; Nowson CA, 2012, MED J AUSTRALIA, V196, P686, DOI 10.5694/mja11.10301; Pasco JA, 2004, J BONE MINER RES, V19, P752, DOI 10.1359/JBMR.040125; Pasco JA, 2001, MED J AUSTRALIA, V175, P401, DOI 10.5694/j.1326-5377.2001.tb143643.x; Perez-Lopez FR, 2012, MATURITAS, V71, P83, DOI 10.1016/j.maturitas.2011.11.002; Peterlik M, 2009, INT J ENV RES PUB HE, V6, P2585, DOI 10.3390/ijerph6102585; Romero-Ortuno R, 2011, AGE AGEING, V40, P168, DOI 10.1093/ageing/afq138; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Stalgis-Bilinski KL, 2011, MED J AUSTRALIA, V194, P345, DOI 10.5694/j.1326-5377.2011.tb03003.x; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; van Dam RM, 2007, AM J CLIN NUTR, V85, P755, DOI 10.1093/ajcn/85.3.755; van der Mei IAF, 2007, ENVIRON HEALTH PERSP, V115, P1132, DOI 10.1289/ehp.9937; Webb AR, 2010, BRIT J DERMATOL, V163, P1050, DOI 10.1111/j.1365-2133.2010.09975.x; Yee, 1996, ADVANTAGES DISADVANT; Zhang R, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-65	40	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59063	10.1371/journal.pone.0059063	http://dx.doi.org/10.1371/journal.pone.0059063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527088	Green Published, gold			2022-12-27	WOS:000316411600032
J	Qin, LX; Rao, Y; Li, L; Huang, JF; Xu, WL; Li, XB				Qin, Li-Xia; Rao, Yue; Li, Long; Huang, Jun-Feng; Xu, Wen-Liang; Li, Xue-Bao			Cotton GalT1 Encoding a Putative Glycosyltransferase Is Involved in Regulation of Cell Wall Pectin Biosynthesis during Plant Development	PLOS ONE			English	Article							CLASSICAL ARABINOGALACTAN PROTEIN; ARABIDOPSIS; IDENTIFICATION; GENES; EXPRESSION; TOBACCO; FIBER; ROOT; GLYCOSYLATION; GALACTOSE	Arabinogalactan proteins (AGPs), are a group of highly glycosylated proteins that are found throughout the plant kingdom. To date, glycosyltransferases that glycosylate AGP backbone have remained largely unknown. In this study, a gene (GhGalT1) encoding a putative beta-1,3-galactosyltransferase (GalT) was identified in cotton. GhGalT1, belonging to CAZy GT31 family, is the type II membrane protein that contains an N-terminal transmembrane domain and a C-terminal galactosyltransferase functional domain. A subcellular localization assay demonstrated that GhGalT1 was localized in the Golgi apparatus. RT-PCR analysis revealed that GhGalT1 was expressed at relatively high levels in hypocotyls, roots, fibers and ovules. Overexpression of GhGalT1 in Arabidopsis promoted plant growth and metabolism. The transgenic seedlings had much longer primary roots, higher chlorophyll content, higher photosynthetic efficiency, the increased biomass, and the enhanced tolerance to exogenous D-arabinose and D-galactose. In addition, gas chromatography (GC) analysis of monosaccharide composition of cell wall fractions showed that pectin was changed in the transgenic plants, compared with that of wild type. Three genes (GAUT8, GAUT9 and xgd1) involved in pectin biosynthesis were dramatically up-regulated in the transgenic lines. These data suggested that GhGalT1 may be involved in regulation of pectin biosynthesis required for plant development.	[Qin, Li-Xia; Rao, Yue; Li, Long; Huang, Jun-Feng; Xu, Wen-Liang; Li, Xue-Bao] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University	Xu, WL (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	wenliangxu@yahoo.com.cn; xbli@mail.ccnu.edu.cn			National Natural Sciences Foundation of China [30870142]; 1 Ministry of Agriculture of China for transgenic research [2009ZX08009-117B, 2011ZX08009-003]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); 1 Ministry of Agriculture of China for transgenic research	This work was supported by National Natural Sciences Foundation of China (grant no. 30870142) and the project from the 1 Ministry of Agriculture of China for transgenic research (grant No. 2009ZX08009-117B, 2011ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the menuscript.	Acosta-Garcia G, 2004, PLANT CELL, V16, P2614, DOI 10.1105/tpc.104.024588; Bowling AJ, 2011, PROTOPLASMA, V248, P579, DOI 10.1007/s00709-010-0212-y; Brown D, 2011, PLANT J, V66, P401, DOI 10.1111/j.1365-313X.2011.04501.x; Egelund J, 2011, ANNU PLANT REV, V41, P213, DOI 10.1002/9781444391015.ch7; Egert A, 2012, PLANT CELL PHYSIOL, V53, P921, DOI 10.1093/pcp/pcs036; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Gaspar YM, 2004, PLANT PHYSIOL, V135, P2162, DOI 10.1104/pp.104.045542; Gong SY, 2012, PLANT BIOLOGY, V14, P447, DOI 10.1111/j.1438-8677.2011.00518.x; Hijazi M, 2012, J BIOL CHEM, V287, P9623, DOI 10.1074/jbc.M111.247874; Huang GQ, 2008, PHYSIOL PLANTARUM, V134, P348, DOI 10.1111/j.1399-3054.2008.01139.x; Huang GQ, 2013, PLANT PHYSIOL, V161, P1278, DOI 10.1104/pp.112.203760; Jensen JK, 2011, PLANT J, V66, P387, DOI 10.1111/j.1365-313X.2010.04475.x; Johnson KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025154; KEEGSTRA K, 1973, PLANT PHYSIOL, V51, P188, DOI 10.1104/pp.51.1.188; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Nguema-Ona E, 2012, ANN BOT-LONDON, V110, P383, DOI 10.1093/aob/mcs143; Oka T, 2010, PLANT PHYSIOL, V152, P332, DOI 10.1104/pp.109.146266; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Rosti J, 2007, PLANT CELL, V19, P1565, DOI 10.1105/tpc.106.049619; Sandhu APS, 2009, MOL PLANT, V2, P840, DOI 10.1093/mp/ssp056; Schultz C, 1998, TRENDS PLANT SCI, V3, P426, DOI 10.1016/S1360-1385(98)01328-4; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; van Hengel AJ, 2002, PLANT J, V32, P105, DOI 10.1046/j.1365-313X.2002.01406.x; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x; Wu YF, 2009, ACTA BIOCH BIOPH SIN, V41, P495, DOI 10.1093/abbs/gmp037; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Yang J, 2007, PLANT J, V49, P629, DOI 10.1111/j.1365-313X.2006.02985.x; Yokoyama R, 2004, PLANT CELL PHYSIOL, V45, P1111, DOI 10.1093/pcp/pch151; Yuan DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022758; Zabotina OA, 2012, PLANT PHYSIOL, V159, P1367, DOI 10.1104/pp.112.198119	46	27	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59115	10.1371/journal.pone.0059115	http://dx.doi.org/10.1371/journal.pone.0059115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527103	gold, Green Published, Green Submitted			2022-12-27	WOS:000316411600038
J	Sanchez-Perez, LA; Choi, BD; Archer, GE; Cui, XY; Flores, C; Johnson, LA; Schmittling, RJ; Snyder, D; Herndon, JE; Bigner, DD; Mitchell, DA; Sampson, JH				Sanchez-Perez, Luis A.; Choi, Bryan D.; Archer, Gary E.; Cui, Xiuyu; Flores, Catherine; Johnson, Laura A.; Schmittling, Robert J.; Snyder, David; Herndon, James E., II; Bigner, Darell D.; Mitchell, Duane A.; Sampson, John H.			Myeloablative Temozolomide Enhances CD8(+) T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice	PLOS ONE			English	Article							ANTITUMOR IMMUNE-RESPONSE; LOCAL IMMUNOTHERAPY; METASTATIC MELANOMA; MALIGNANT-MELANOMA; PLUS CONCOMITANT; DENDRITIC CELLS; PHASE-II; IN-VIVO; CANCER; LYMPHODEPLETION	Temozolomide (TMZ) is an alkylating agent shown to prolong survival in patients with high grade glioma and is routinely used to treat melanoma brain metastases. A prominent side effect of TMZ is induction of profound lymphopenia, which some suggest may be incompatible with immunotherapy. Conversely, it has been proposed that recovery from chemotherapy-induced lymphopenia may actually be exploited to potentiate T-cell responses. Here, we report the first demonstration of TMZ as an immune host-conditioning regimen in an experimental model of brain tumor and examine its impact on antitumor efficacy of a well-characterized peptide vaccine. Our results show that high-dose, myeloablative (MA) TMZ resulted in markedly reduced CD4(+), CD8(+) T-cell and CD4(+) Foxp3(+) T-Reg counts. Adoptive transfer of nai " ve CD8(+) T cells and vaccination in this setting led to an approximately 70-fold expansion of antigen-specific CD8(+) T cells over controls. Ex vivo analysis of effector functions revealed significantly enhanced levels of pro-inflammatory cytokine secretion from mice receiving MA TMZ when compared to those treated with a lower lymphodepletive, non-myeloablative (NMA) dose. Importantly, MA TMZ, but not NMA TMZ was uniquely associated with an elevation of endogenous IL-2 serum levels, which we also show was required for optimal T-cell expansion. Accordingly, in a murine model of established intracerebral tumor, vaccination-induced immunity in the setting of MA TMZ-but not lymphodepletive, NMA TMZ-led to significantly prolonged survival. Overall, these results may be used to leverage the side-effects of a clinically-approved chemotherapy and should be considered in future study design of immune-based treatments for brain tumors.	[Sanchez-Perez, Luis A.; Choi, Bryan D.; Archer, Gary E.; Cui, Xiuyu; Flores, Catherine; Schmittling, Robert J.; Snyder, David; Bigner, Darell D.; Mitchell, Duane A.; Sampson, John H.] Duke Univ, Med Ctr, Dept Surg, Duke Brain Tumor Immunotherapy Program,Div Neuros, Durham, NC 27710 USA; [Archer, Gary E.; Flores, Catherine; Bigner, Darell D.; Mitchell, Duane A.; Sampson, John H.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC 27710 USA; [Choi, Bryan D.; Bigner, Darell D.; Mitchell, Duane A.; Sampson, John H.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Johnson, Laura A.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Translat Res Program, Philadelphia, PA 19104 USA; [Sampson, John H.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; [Sampson, John H.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Herndon, James E., II] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA	Duke University; Duke University; Duke University; University of Pennsylvania; Pennsylvania Medicine; Duke University; Duke University; Duke University	Sampson, JH (corresponding author), Duke Univ, Med Ctr, Dept Surg, Duke Brain Tumor Immunotherapy Program,Div Neuros, Durham, NC 27710 USA.	john.sampson@duke.edu	Johnson, Laura/H-4861-2013	Sampson, John/0000-0002-0104-7658	National Institutes of Health: SRC on Primary Tumors of the Central Nervous System [P50 NS020023-28, 3R01-CA-135272-02S1];  [5P50-NS020023-29];  [5R01-CA135272-02S1];  [5R01-CA134844-03];  [5UL1-RR024128-05];  [5R21-NS067980-02];  [5R21-NS068057-02]; NATIONAL CANCER INSTITUTE [DP2CA174502, R01CA135272, R01CA134844] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023, R21NS068057, R21NS067980] Funding Source: NIH RePORTER	National Institutes of Health: SRC on Primary Tumors of the Central Nervous System; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health: SRC on Primary Tumors of the Central Nervous System P50 NS020023-28 and 3R01-CA-135272-02S1 supplement for Brain Tumor Stem Cell R01. Additional support was provided by 5P50-NS020023-29, 5R01-CA135272-02S1, 5R01-CA134844-03, 5UL1-RR024128-05, 5R21-NS067980-02, and 5R21-NS068057-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrey LE, 2001, SEMIN ONCOL, V28, P34, DOI 10.1053/sonc.2001.26653; Asavaroengchai W, 2002, P NATL ACAD SCI USA, V99, P931, DOI 10.1073/pnas.022634999; Biasco G, 2001, NEW ENGL J MED, V345, P621, DOI 10.1056/NEJM200108233450817; BLANCHER A, 1993, EUR CYTOKINE NETW, V4, P331; Brode S, 2008, CRIT REV IMMUNOL, V28, P109, DOI 10.1615/CritRevImmunol.v28.i2.20; Chua D, 2010, CLIN LUNG CANCER, V11, P176, DOI 10.3816/CLC.2010.n.022; Daniels GA, 2004, NAT BIOTECHNOL, V22, P1125, DOI 10.1038/nbt1007; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gress RE, 2007, BIOL BLOOD MARROW TR, V13, P17, DOI 10.1016/j.bbmt.2006.10.012; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu HM, 2002, CANCER RES, V62, P3914; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kochenderfer JN, 2007, BLOOD, V110, P450, DOI 10.1182/blood-2006-11-057935; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Mitchell DA, BLOOD, V118, P3003; Mitchell DA, 2011, BLOOD, V118, P3003, DOI 10.1182/blood-2011-02-334565; Muranski P, 2006, NAT CLIN PRACT ONCOL, V3, P668, DOI 10.1038/ncponc0666; Neyns B, 2010, CANCER-AM CANCER SOC, V116, P2868, DOI 10.1002/cncr.25035; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Salem ML, 2009, J IMMUNOL, V182, P2030, DOI 10.4049/jimmunol.0801829; Sampson JH, 2011, NEURO-ONCOLOGY, V13, P324, DOI 10.1093/neuonc/noq157; Sanchez-Perez L, 2005, CANCER RES, V65, P2009, DOI 10.1158/0008-5472.CAN-04-3216; SARIS SC, 1989, J NEUROSURG, V71, P169, DOI 10.3171/jns.1989.71.2.0169; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Su YB, 2004, J CLIN ONCOL, V22, P610, DOI 10.1200/JCO.2004.07.060; Trudeau ME, 2006, ANN ONCOL, V17, P952, DOI 10.1093/annonc/mdl056; Velicu S, 2006, J NEUROIMMUNOL, V174, P74, DOI 10.1016/j.jneuroim.2006.01.016; Wick W, 2005, J CLIN ONCOL, V23, P4235, DOI 10.1200/JCO.2004.00.8417; Wrzesinski C, 2005, CURR OPIN IMMUNOL, V17, P195, DOI 10.1016/j.coi.2005.02.002; Wrzesinski C, 2007, J CLIN INVEST, V117, P492, DOI 10.1172/JCI30414	38	48	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59082	10.1371/journal.pone.0059082	http://dx.doi.org/10.1371/journal.pone.0059082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527092	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600035
J	Tolppanen, AM; Lavikainen, P; Soininen, H; Hartikainen, S				Tolppanen, Anna-Maija; Lavikainen, Piia; Soininen, Hilkka; Hartikainen, Sirpa			Incident Hip Fractures among Community Dwelling Persons with Alzheimer's Disease in a Finnish Nationwide Register-Based Cohort	PLOS ONE			English	Article							RISK-FACTORS; ELDERLY-PATIENTS; FALLS; DEMENTIA; IMPACT	Background: Previous cohort studies have shown that persons with Alzheimer's disease (AD) have a higher risk of hip fractures but recent data from large representative cohorts is scarce. Methods: We investigated the association between AD and prevalent and incident hip fractures in an exposure-matched cohort study conducted in Finland 2002-2009 (the Medication and Alzheimer's disease in 2005 study; MEDALZ-2005). The study population included all community-dwelling persons with verified AD diagnosis in Finland on December 31, 2005 and one matched comparison person per AD case (N = 56,186, mean age 79.9 (SD 6.8) years, range 42-101 years). The diagnosis of AD was extracted from a special reimbursement register. Data on hip fractures during 2002-2009 was extracted from the Finnish National hospital discharge register. Analyses of incident hip fractures (n = 2,861) were restricted to years 2006-2009. Results: Persons with AD were twice as likely to have previous hip fracture in 2005 (odds ratio, 95% confidence interval 2.00, 1.82-2.20) than matched aged population without AD. They were also more likely to experience incident hip fracture during the four-year follow-up (hazard ratio, 95% confidence interval 2.57, 2.32-2.84, adjusted for health status, psychotropic drug and bisphosphonate use). The AD-associated risk increase decreased linearly across age groups. Although people with AD had higher risk of hip fractures regardless of sex, the risk increase was larger in men than women. Conclusion: Findings from our nationwide study are in line with previous studies showing that persons with AD, regardless of sex or age, have higher risk of hip fracture in comparison to general population. Although there was some suggestion of effect modification by age or sex, AD was consistently associated with doubling of the risk of incident hip fracture.	[Tolppanen, Anna-Maija; Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Lavikainen, Piia; Hartikainen, Sirpa] Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Hartikainen, Sirpa] Univ Eastern Finland, Pharmacol & Geriatr Pharmacotherapy Unit, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Tolppanen, AM (corresponding author), Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland.	anna-maija.tolppanen@uef.fi		Lavikainen, Piia/0000-0003-3560-8860	University of Eastern Finland	University of Eastern Finland	The research was funded by University of Eastern Finland strategic funding (AMT, PL, HS, SH). The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Baker NL, 2011, AGE AGEING, V40, P49, DOI 10.1093/ageing/afq146; BUCHNER DM, 1987, JAMA-J AM MED ASSOC, V257, P1492, DOI 10.1001/jama.257.11.1492; Cauley JA, 1999, J BONE MINER RES, V14, P1175, DOI 10.1359/jbmr.1999.14.7.1175; CUMMING RG, 1994, J AM GERIATR SOC, V42, P774, DOI 10.1111/j.1532-5415.1994.tb06540.x; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; CUMMINGS SR, 1994, OSTEOPOROSIS INT, V4, P67; Formiga F, 2008, BONE, V43, P941, DOI 10.1016/j.bone.2008.06.014; Formiga F, 2008, AGING CLIN EXP RES, V20, P434; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Harboun M, 2008, INT J GERIATR PSYCH, V23, P1245, DOI 10.1002/gps.2058; Holmes J, 2000, PSYCHOL MED, V30, P921, DOI 10.1017/S0033291799002548; Johnston JM, 1999, J AM GERIATR SOC, V47, P1342, DOI 10.1111/j.1532-5415.1999.tb07436.x; Laitinen ML, 2011, INT PSYCHOGERIATR, V23, P1623, DOI 10.1017/S1041610211001621; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MELTON LJ, 1994, J AM GERIATR SOC, V42, P614, DOI 10.1111/j.1532-5415.1994.tb06859.x; Mitani S, 2010, J ORTHOP SCI, V15, P192, DOI 10.1007/s00776-009-1440-x; Norton R, 1997, J AM GERIATR SOC, V45, P1108, DOI 10.1111/j.1532-5415.1997.tb05975.x; Oliveria SA, 2006, PHARMACOEPIDEM DR S, V15, P763, DOI 10.1002/pds.1274; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Pettersson AF, 2005, DEMENT GERIATR COGN, V19, P299, DOI 10.1159/000084555; Rapp Kilian, 2011, Evid Based Nurs, V14, P78, DOI 10.1136/ebn1160; Sato Y, 2004, J NEUROL SCI, V223, P107, DOI 10.1016/j.jns.2004.03.033; Saxena P, 2000, INJURY, V31, P421, DOI 10.1016/S0020-1383(00)00012-7; Sloan FA, 2002, ALZ DIS ASSOC DIS, V16, P137, DOI 10.1097/00002093-200207000-00002; Sund R, 2011, ANN MED, V43, pS39, DOI 10.3109/07853890.2011.586360; Tamimi I, 2012, J BONE MINERAL RES O; Tanaka S, 2010, BONE, V47, P1064, DOI 10.1016/j.bone.2010.08.019; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Trimpou P, 2010, OSTEOPOROSIS INT, V21, P409, DOI 10.1007/s00198-009-0961-7; van Iersel MB, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.084418; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005; Weller I, 2000, Ann Epidemiol, V10, P461, DOI 10.1016/S1047-2797(00)00085-5; Zhao Y, 2012, SCI WORLD J, DOI 10.1100/2012/872173; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108	37	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59124	10.1371/journal.pone.0059124	http://dx.doi.org/10.1371/journal.pone.0059124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZS	23527106	gold, Green Published, Green Submitted			2022-12-27	WOS:000316411600040
J	Yang, XM; Sarvestani, SK; Moeinzadeh, S; He, XZ; Jabbari, E				Yang, Xiaoming; Sarvestani, Samaneh K.; Moeinzadeh, Seyedsina; He, Xuezhong; Jabbari, Esmaiel			Effect of CD44 Binding Peptide Conjugated to an Engineered Inert Matrix on Maintenance of Breast Cancer Stem Cells and Tumorsphere Formation	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; OSTEOGENIC DIFFERENTIATION; ADHESION; IDENTIFICATION; RECEPTOR; GROWTH; DOMAIN; INVOLVEMENT; EXPRESSION; OSTEOPONTIN	Introduction: As cancer cells are affected by many factors in their microenvironment, a major challenge is to isolate the effect of a specific factor on cancer stem cells (CSCs) while keeping other factors unchanged. We have developed a synthetic inert 3D polyethylene glycol diacrylate (PEGDA) gel culture system as a unique tool to study the effect of microenvironmental factors on CSCs response. We have reported that CSCs formed in the inert PEGDA gel by encapsulation of breast cancer cells maintain their stemness within a certain range of gel stiffness. The objective was to investigate the effect of CD44 binding peptide (CD44BP) conjugated to the gel on the maintenance of breast CSCs. Methods: 4T1 or MCF7 breast cancer cells were encapsulated in PEGDA gel with CD44BP conjugation. Control groups included dissolved CD44BP and the gel with mutant CD44BP conjugation. Tumorsphere size and density, and expression of CSC markers were determined after 9 days. For in vivo, cell encapsulated gels were inoculated in syngeneic Balb/C mice and tumor formation was determined after 4 weeks. Effect of CD44BP conjugation on breast CSC maintenance was compared with integrin binding RGD peptide (IBP) and fibronectin-derived heparin binding peptide (FHBP). Results: Conjugation of CD44BP to the gel inhibited breast tumorsphere formation in vitro and in vivo. The ability of the encapsulated cells to form tumorspheres in the peptide-conjugated gels correlated with the expression of CSC markers. Tumorsphere formation in vitro was enhanced by FHBP while it was abolished by IBP. Conclusion: CD44BP and IBP conjugated to the gel abolished tumorsphere formation by encapsulated 4T1 cells while FHBP enhanced tumorsphere formation compared to cells in the gel without peptide. The PEGDA hydrogel culture system provides a novel tool to investigate the individual effect of factors in the microenvironment on CSC maintenance without interference of other factors.	[Yang, Xiaoming; Sarvestani, Samaneh K.; Moeinzadeh, Seyedsina; He, Xuezhong; Jabbari, Esmaiel] Univ S Carolina, Dept Chem Engn, Biomimet Mat & Tissue Engn Lab, Columbia, SC 29208 USA; [Yang, Xiaoming] Dorn Res Inst, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Jabbari, E (corresponding author), Univ S Carolina, Dept Chem Engn, Biomimet Mat & Tissue Engn Lab, Columbia, SC 29208 USA.	jabbari@engr.sc.edu	Jabbari, Esmaiel/AAJ-2369-2020	Jabbari, Esmaiel/0000-0001-6548-5422	National Science Foundation [CBET0756394, CBET0931998, DMR1049381]; National Institutes of Health [DE19180]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019180] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by research grants to E. Jabbari from the National Science Foundation under grant Nos. CBET0756394, CBET0931998, and DMR1049381, and the National Institutes of Health under Grant No. DE19180. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhold EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032459; AKIYAMA SK, 1990, BIOCHIM BIOPHYS ACTA, V1031, P91, DOI 10.1016/0304-4157(90)90004-V; Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; *AM CANC SOC, 2010, BREAST CANC FACTS FI; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Biddle A, 2012, CANC METASTASIS REV; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Calvo A, 2008, ONCOGENE, V27, P5373, DOI 10.1038/onc.2008.155; Cox RD, 2011, DIS MODEL MECH, V4, P155, DOI 10.1242/dmm.000414; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Del Vecchio CA, 2012, CANCER RES, V72, P2657, DOI 10.1158/0008-5472.CAN-11-2656; Ercan C, 2011, CURR MOL MED, V11, P270, DOI 10.2174/156652411795678007; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v; He XZ, 2012, LANGMUIR, V28, P5387, DOI 10.1021/la205005h; Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129; Hurt EM, 2010, STEM CELLS, V28, P390, DOI 10.1002/stem.271; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Krohn A, 2009, CANCER LETT, V280, P65, DOI 10.1016/j.canlet.2009.02.005; Kruger JA, 2006, BLOOD, V108, P3906, DOI 10.1182/blood-2006-05-024687; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595; Majeti R, 2011, ONCOGENE, V30, P1009, DOI 10.1038/onc.2010.511; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149; Masuko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029728; Moeinzadeh S, 2012, BIOMACROMOLECULES, V13, P2073, DOI 10.1021/bm300453k; Monferran S, 2008, INT J CANCER, V123, P357, DOI 10.1002/ijc.23498; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; OWENS LV, 1995, CANCER RES, V55, P2752; Piotrowicz RS, 2011, MOL CANCER THER, V10, P2072, DOI 10.1158/1535-7163.MCT-11-0351; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pulaski BA, 2000, CANCER IMMUNOL IMMUN, V49, P34, DOI 10.1007/s002620050024; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Rennstam K, 2010, BREAST CANCER RES TR, V122, P315, DOI 10.1007/s10549-009-0568-x; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rizzo S, 2005, CELL PROLIFERAT, V38, P363, DOI 10.1111/j.1365-2184.2005.00356.x; Saha S, 2012, INTEGR BIOL-UK, V4, P897, DOI 10.1039/c2ib20034a; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SHEPHERD R, 1982, BRIT J CANCER, V45, P413, DOI 10.1038/bjc.1982.69; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Weber GF, 1997, P ASSOC AM PHYSICIAN, V109, P1; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Yang XM, 2013, TISSUE ENG PT A, V19, P669, DOI [10.1089/ten.TEA.2012.0333, 10.1089/ten.tea.2012.0333]; You SJ, 2005, BREAST CANCER RES TR, V91, P47, DOI 10.1007/s10549-004-6603-z; Yu CH, 2011, P NATL ACAD SCI USA, V108, P20585, DOI 10.1073/pnas.1109485108; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591	69	25	31	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59147	10.1371/journal.pone.0059147	http://dx.doi.org/10.1371/journal.pone.0059147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527117	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600043
J	Zachariou, M; Alexander, SPH; Coombes, S; Christodoulou, C				Zachariou, Margarita; Alexander, Stephen P. H.; Coombes, Stephen; Christodoulou, Chris			A Biophysical Model of Endocannabinoid- Mediated Short Term Depression in Hippocampal Inhibition	PLOS ONE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; PHOSPHOLIPASE-C-BETA; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; SYNAPTIC PLASTICITY; CA2+ CHANNELS; SUBCELLULAR-DISTRIBUTION; RETROGRADE SUPPRESSION; DIACYLGLYCEROL LIPASE; CALCIUM-CHANNELS	Memories are believed to be represented in the synaptic pathways of vastly interconnected networks of neurons. The plasticity of synapses, that is, their strengthening and weakening depending on neuronal activity, is believed to be the basis of learning and establishing memories. An increasing number of studies indicate that endocannabinoids have a widespread action on brain function through modulation of synap-tic transmission and plasticity. Recent experimental studies have characterised the role of endocannabinoids in mediating both short-and long-term synaptic plasticity in various brain regions including the hippocampus, a brain region strongly associated with cognitive functions, such as learning and memory. Here, we present a biophysically plausible model of cannabinoid retrograde signalling at the synaptic level and investigate how this signalling mediates depolarisation induced suppression of inhibition ( DSI), a prominent form of short-term synaptic depression in inhibitory transmission in hippocampus. The model successfully captures many of the key characteristics of DSI in the hippocampus, as observed experimentally, with a minimal yet sufficient mathematical description of the major signalling molecules and cascades involved. More specifically, this model serves as a framework to test hypotheses on the factors determining the variability of DSI and investigate under which conditions it can be evoked. The model reveals the frequency and duration bands in which the post-synaptic cell can be sufficiently stimulated to elicit DSI. Moreover, the model provides key insights on how the state of the inhibitory cell modulates DSI according to its firing rate and relative timing to the post-synaptic activation. Thus, it provides concrete suggestions to further investigate experimentally how DSI modulates and is modulated by neuronal activity in the brain. Importantly, this model serves as a stepping stone for future deciphering of the role of endocannabinoids in synaptic transmission as a feedback mechanism both at synaptic and network level.	[Zachariou, Margarita; Christodoulou, Chris] Univ Cyprus, Dept Comp Sci, Nicosia, Cyprus; [Alexander, Stephen P. H.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England; [Coombes, Stephen] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England	University of Cyprus; University of Nottingham; University of Nottingham	Zachariou, M (corresponding author), Univ Cyprus, Dept Comp Sci, Nicosia, Cyprus.	mzachariou@cs.ucy.ac.cy	Coombes, Stephen/O-2321-2019; Christodoulou, Chris/AAC-4140-2020; Christodoulou, Chris/I-6666-2016; Coombes, Stephen/J-1859-2012; Alexander, Steve P/B-8105-2009	Coombes, Stephen/0000-0003-1610-7665; Christodoulou, Chris/0000-0001-9398-5256; Christodoulou, Chris/0000-0001-9398-5256; Coombes, Stephen/0000-0003-1610-7665; Alexander, Steve P/0000-0003-4417-497X; Zachariou, Margarita/0000-0001-8950-4077	European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation [DIDAKTOR/0609/12]	European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation	This work was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (project DIDAKTOR/0609/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Alger BE, 2002, PROG NEUROBIOL, V68, P247; Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; Alger BE, 2010, DEVELOPMENTAL PLASTICITY OF INHIBITORY CIRCUITRY, P137, DOI 10.1007/978-1-4419-1243-5_8; [Anonymous], 1994, ELECTROPHYSIOLOGY NE; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bertram R, 2003, J NEUROPHYSIOL, V90, P1643, DOI 10.1152/jn.00190.2003; Bertram R, 2002, J NEUROPHYSIOL, V87, P2612, DOI 10.1152/jn.2002.87.5.2612; Bertram R, 2001, NEURAL COMPUT, V13, P69, DOI 10.1162/089976601300014637; Best AR, 2010, NEURON, V65, P291, DOI 10.1016/j.neuron.2010.01.030; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Brager DH, 2003, J NEUROSCI, V23, P10475; Carter E, 2007, CEREB CORTEX, V17, pI16, DOI 10.1093/cercor/bhm103; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Christie BR, 1996, HIPPOCAMPUS, V6, P17, DOI 10.1002/(SICI)1098-1063(1996)6:1<17::AID-HIPO4>3.0.CO;2-4; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; Dayan P, 2001, COMPUTATIONAL NEUROS; Deadwyler SA, 2004, NEURON, V42, P465, DOI 10.1016/S0896-6273(04)00195-3; Diana MA, 2004, BRIT J PHARMACOL, V142, P9, DOI 10.1038/sj.bjp.0705726; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Ermentrout B., 2002, SIMULATION ANAL ANIM; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2003, BRIT J PHARMACOL, V140, P781, DOI 10.1038/sj.bjp.0705466; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Goonawardena AV, 2011, HIPPOCAMPUS, V21, P520, DOI 10.1002/hipo.20769; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Guo J, 2004, MOL PHARMACOL, V65, P665, DOI 10.1124/mol.65.3.665; Hampson RE, 2003, J NEUROPHYSIOL, V90, P55, DOI 10.1152/jn.01161.2002; Hampson RE, 2000, J NEUROSCI, V20, P8932; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Hashimotodani Y, 2008, NEUROPHARMACOLOGY, V54, P58, DOI 10.1016/j.neuropharm.2007.06.002; Hashimotodani Y, 2007, J PHYSIOL-LONDON, V584, P373, DOI 10.1113/jphysiol.2007.137497; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hemond P, 2008, HIPPOCAMPUS, V18, P411, DOI 10.1002/hipo.20404; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffman AF, 2000, J NEUROSCI, V20, P2470; HUGHES JR, 1958, PHYSIOL REV, V38, P91, DOI 10.1152/physrev.1958.38.1.91; Isokawa M, 2006, J NEUROPHYSIOL, V95, P3001, DOI 10.1152/jn.00975.2005; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Katona I, 2009, CURR TOP BEHAV NEURO, V1, P65, DOI 10.1007/978-3-540-88955-7_3; Keener J., 2009, MATH PHYSL, V1; Kim J, 2002, J NEUROSCI, V22, P10182; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Lenz RA, 1999, J PHYSIOL-LONDON, V521, P147, DOI 10.1111/j.1469-7793.1999.00147.x; Lenz RA, 1998, J PHYSIOL-LONDON, V512, P61, DOI 10.1111/j.1469-7793.1998.061bf.x; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Morishita W, 1999, J NEUROPHYSIOL, V82, P2556, DOI 10.1152/jn.1999.82.5.2556; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 1998, PFLUG ARCH EUR J PHY, V435, P273; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Ohno-Shosaku T, 2007, J PHYSIOL-LONDON, V584, P407, DOI 10.1113/jphysiol.2007.137505; Pan B, 2011, J NEUROSCI, V31, P13420, DOI 10.1523/JNEUROSCI.2075-11.2011; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; PITLER TA, 1992, J NEUROSCI, V12, P4122; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Rachmuth G, 2011, P NATL ACAD SCI USA, V108, pE1266, DOI 10.1073/pnas.1106161108; Ranganathan M, 2006, PSYCHOPHARMACOLOGY, V188, P425, DOI 10.1007/s00213-006-0508-y; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; Straiker A, 2006, AAPS J, V8, pE272; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Traub R.D., 1991, NEURONAL NETWORKS HI; Wang J, 2001, J PHYSIOL-LONDON, V533, P757, DOI 10.1111/j.1469-7793.2001.t01-1-00757.x; Wang XJ, 1996, J NEUROSCI, V16, P6402; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Woodin MA, 2011, PLASTICITY INHIBITOR; Zachariou M, 2007, NEUROCOMPUTING, V70, P1902, DOI 10.1016/j.neucom.2006.10.065; Zachariou M, 2008, COGN NEURODYNAMICS, V2, P159, DOI 10.1007/s11571-008-9050-4; Zhang L, 2011, PLOS ONE, V6; Zhuang S, 2005, BEHAV PHARMACOL, V16, P463, DOI 10.1097/00008877-200509000-00020	100	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58926	10.1371/journal.pone.0058926	http://dx.doi.org/10.1371/journal.pone.0058926			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527052	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000316411600018
J	Chen, LQ; Qu, GB; Sun, X; Zhang, SP; Wang, L; Sang, NG; Du, YG; Liu, J; Liu, SJ				Chen, Liqun; Qu, Guangbo; Sun, Xue; Zhang, Shuping; Wang, Lei; Sang, Nan; Du, Yuguo; Liu, Jun; Liu, Sijin			Characterization of the Interaction between Cadmium and Chlorpyrifos with Integrative Techniques in Incurring Synergistic Hepatoxicity	PLOS ONE			English	Article							LIPID-PEROXIDATION; METABOLIZING ENZYMES; RAT HEPATOCYTES; METHYL MERCURY; HEAVY-METALS; HEPG2 CELLS; EXPOSURE; TOXICITY; ZINC; EXPRESSION	Mixture toxicity is an important issue for the risk assessment of environmental pollutants, for which an extensive amount of data are necessary in evaluating their potential adverse health effects. However, it is very hard to decipher the interaction between compounds due to limited techniques. Contamination of heavy metals and organophosphoric insecticides under the environmental and biological settings poses substantial health risk to humans. Although previous studies demonstrated the co-occurrence of cadmium (Cd) and chlorpyrifos (CPF) in environmental medium and food chains, their interaction and potentially synergistic toxicity remain elusive thus far. Here we integrated the approaches of thin-layer chromatography and H-1 NMR to study the interaction between Cd2+ and CPF in inducing hepatoxicity. A novel interaction was identified between Cd2+ and CPF, which might be the bonding between Cd2+ and nitrogen atom in the pyridine ring of CPF, or the chelation formation between one Cd2+ and two CPF molecules. The Cd-CPF complex was conferred with distinct biological fate and toxicological performances from its parental components. We further demonstrated that the joint hepatoxicity of Cd ion and CPF was chiefly due to the Cd-CPF complex-facilitated intracellular transport associated with oxidative stress.	[Chen, Liqun; Qu, Guangbo; Sun, Xue; Zhang, Shuping; Wang, Lei; Du, Yuguo; Liu, Jun; Liu, Sijin] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Chen, Liqun; Sang, Nan] Shanxi Univ, Coll Environm & Resource, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Shanxi University	Liu, J (corresponding author), Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	junliu@rcees.ac.cn; sjliu@rcees.ac.cn	Wang, Lei/D-7812-2019; Qu, Guangbo/R-6605-2016	Wang, Lei/0000-0001-7103-9402; Sang, Nan/0000-0002-2433-3200; Qu, Guangbo/0000-0002-5220-7009	Chinese Academy of Sciences [KZCX2-EW-404]; National Natural Science Foundation of China [21077128, 20921063, 21177151]; program of "Hundreds Talents'' of from Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program of "Hundreds Talents'' of from Chinese Academy of Sciences	This work was supported by grants from the Chinese Academy of Sciences (KZCX2-EW-404), National Natural Science Foundation of China (grant numbers: 21077128, 20921063, 21177151), and from the program of "Hundreds Talents'' of from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenard G, 2010, ENVIRON HEALTH PERSP, V118, P331, DOI 10.1289/ehp.0900975; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Babczynska A, 2002, B ENVIRON CONTAM TOX, V69, P586, DOI 10.1007/s00128-002-0101-y; Baran CP, 2004, CURR PHARM DESIGN, V10, P855, DOI 10.2174/1381612043452866; Boobis A, 2011, CRIT REV TOXICOL, V41, P369, DOI 10.3109/10408444.2010.543655; BUCIO L, 1995, TOXICOLOGY, V102, P285, DOI 10.1016/0300-483X(95)03095-W; DelRaso NJ, 2003, TOXICOL SCI, V72, P19, DOI 10.1093/toxsci/kfg009; DIETER MP, 1975, B ENVIRON CONTAM TOX, V13, P257, DOI 10.1007/BF01685332; Dondero F, 2005, GENE, V345, P259, DOI 10.1016/j.gene.2004.11.031; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Ediz L, 2011, INT J MED SCI, V8, P139, DOI 10.7150/ijms.8.139; Fatta D, 2007, J HAZARD MATER, V145, P169, DOI 10.1016/j.jhazmat.2006.11.009; Goel A, 2006, TOXICOL LETT, V163, P235, DOI 10.1016/j.toxlet.2005.11.002; Goel A, 2005, CHEM-BIOL INTERACT, V156, P131, DOI 10.1016/j.cbi.2005.08.004; Goel A, 2000, BIOL TRACE ELEM RES, V74, P171, DOI 10.1385/BTER:74:2:171; Hass U, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9360; Hsieh Chia-Jung, 2011, BMC Res Notes, V4, P291, DOI 10.1186/1756-0500-4-291; Jayalakshmi K, 2005, BRAIN RES, V1046, P97, DOI 10.1016/j.brainres.2005.03.054; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P106, DOI 10.1289/ehp.9358; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Liu SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011272; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Lowe ER, 2009, TOXICOL SCI, V108, P258, DOI 10.1093/toxsci/kfp034; Mansour SA, 2009, CHEMOSPHERE, V75, P601, DOI 10.1016/j.chemosphere.2009.01.058; Markovic M, 2010, ARCH ENVIRON CON TOX, V58, P341, DOI 10.1007/s00244-009-9359-y; MOHR FC, 1995, MOL PHARMACOL, V48, P512; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Padilla S, 2005, TOXICOL SCI, V88, P161, DOI 10.1093/toxsci/kfi274; Pehkonen SO, 2005, ENVIRON SCI TECHNOL, V39, P2586, DOI 10.1021/es0486869; Ragunathan N, 2010, ENVIRON HEALTH PERSP, V118, P1685, DOI 10.1289/ehp.1002334; Rai A, 2010, TOXICOL SCI, V118, P586, DOI 10.1093/toxsci/kfq266; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Rusyniak DE, 2004, SEMIN NEUROL, V24, P197, DOI 10.1055/s-2004-830907; SHAIKH ZA, 1995, ENVIRON HEALTH PERSP, V103, P73, DOI 10.2307/3432017; Smith E, 2012, J HAZARD MATER, V199, P453, DOI 10.1016/j.jhazmat.2011.11.016; Steevens JA, 1999, TOXICOL SCI, V52, P168, DOI 10.1093/toxsci/52.2.168; Tully DB, 2000, TOXICOL APPL PHARM, V168, P79, DOI 10.1006/taap.2000.9014; Tuzmen N, 2008, CELL BIOCHEM FUNCT, V26, P119, DOI 10.1002/cbf.1411; Yang RH, 2007, ENVIRON HEALTH PERSP, V115, P1339, DOI 10.1289/ehp.10290	41	21	24	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059553	10.1371/journal.pone.0059553	http://dx.doi.org/10.1371/journal.pone.0059553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516638	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400114
J	Ohkouchi, S; Shibata, M; Sasaki, M; Koike, M; Safig, P; Peters, C; Nagata, S; Uchiyama, Y				Ohkouchi, Susumu; Shibata, Masahiro; Sasaki, Mitsuho; Koike, Masato; Safig, Paul; Peters, Christoph; Nagata, Shigekazu; Uchiyama, Yasuo			Biogenesis and Proteolytic Processing of Lysosomal DNase II	PLOS ONE			English	Article							PORCINE SPLEEN DEOXYRIBONUCLEASE; PROGRAMMED CELL-DEATH; MOUSE EYE LENS; CATHEPSIN-D; IMMUNOAFFINITY PURIFICATION; MOLECULAR-CLONING; RAT MACROPHAGES; GENE-EXPRESSION; MAMMALIAN DNA; BODY-FLUIDS	Deoxyribonuclease II (DNase II) is a key enzyme in the phagocytic digestion of DNA from apoptotic nuclei. To understand the molecular properties of DNase II, particularly the processing, we prepared a polyclonal antibody against carboxyl-terminal sequences of mouse DNase II. In the present study, partial purification of DNase II using Con A Sepharose enabled the detection of endogenous DNase II by Western blotting. It was interesting that two forms of endogenous DNase II were detected - a 30 kDa form and a 23 kDa form. Neither of those forms carried the expected molecular weight of 45 kDa. Subcellular fractionation showed that the 23 kDa and 30 kDa proteins were localized in lysosomes. The processing of DNase II in vivo was also greatly altered in the liver of mice lacking cathepsin L. DNase II that was extracellularly secreted from cells overexpressing DNase II was detected as a pro-form, which was activated under acidic conditions. These results indicate that DNase II is processed and activated in lysosomes, while cathepsin L is involved in the processing of the enzyme.	[Ohkouchi, Susumu; Sasaki, Mitsuho; Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo 113, Japan; [Shibata, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Gross Anat & Morphogenesis, Niigata, Japan; [Safig, Paul] Univ Kiel, Inst Biochem, Unit Mol Cell Biol & Transgen Res, Kiel, Germany; [Peters, Christoph] Univ Freiburg, Inst Mol Med & Zellforsch, D-79106 Freiburg, Germany; [Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan	Juntendo University; Niigata University; University of Kiel; University of Freiburg; Kyoto University	Uchiyama, Y (corresponding author), Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo 113, Japan.	y-uchi@juntendo.ac.jp	Koike, Masato/F-9584-2010; Nagata, Shigekazu/AAG-3203-2019	Koike, Masato/0000-0002-3174-5684; Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science [16GS0315, 23111004, 23110517, 23659102, 23390041]; Ministry of Education, Science, Sports and Culture, Japan (MEXT); MEXT; Grants-in-Aid for Scientific Research [24590249] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Creative Scientific Research (16GS0315), for Scientific Research on Innovative Areas (23111004 and 23110517 for YU), for Challenging Exploratory Research (23659102) and for Scientific Research (B) (23390041) from the Japan Society for the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan (MEXT), MEXT-supported Program for the Strategic Research Foundation at Private Universities (YU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KP, 1998, GENE, V215, P281, DOI 10.1016/S0378-1119(98)00280-7; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; Chou SF, 2002, BIOCHEM BIOPH RES CO, V296, P48, DOI 10.1016/S0006-291X(02)00835-5; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; DULANEY JT, 1972, J BIOL CHEM, V247, P1424; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; GIESELMANN V, 1985, J BIOL CHEM, V260, P3215; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARA K, 1988, FEBS LETT, V231, P229, DOI 10.1016/0014-5793(88)80737-3; Huang RT, 2009, FEBS J, V276, P1891, DOI 10.1111/j.1742-4658.2009.06915.x; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2008, METHOD ENZYMOL, V442, P271, DOI 10.1016/S0076-6879(08)01414-6; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; KOIZUMI T, 1995, EXP ANIM TOKYO, V44, P169, DOI 10.1538/expanim.44.169; KOMINAMI E, 1988, FEBS LETT, V231, P225, DOI 10.1016/0014-5793(88)80736-1; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; LIAO TH, 1989, BIOCHIM BIOPHYS ACTA, V1007, P15, DOI 10.1016/0167-4781(89)90124-3; LIAO TH, 1985, J BIOL CHEM, V260, P708; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; MacLea KS, 2003, BIOCHEM J, V371, P867, DOI 10.1042/BJ20021875; MacLea KS, 2002, BIOCHEM BIOPH RES CO, V292, P415, DOI 10.1006/bbrc.2002.6687; McIlroy D, 2000, GENE DEV, V14, P549; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nakajima T, 2002, BBA-GEN SUBJECTS, V1570, P160, DOI 10.1016/S0304-4165(02)00191-5; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; PARWARESCH MR, 1986, AM J PATHOL, V125, P141; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; Uchiyama Y, 2009, METHOD ENZYMOL, V453, P33, DOI 10.1016/S0076-6879(08)04003-2; Wang CC, 1998, J BIOL CHEM, V273, P17192, DOI 10.1074/jbc.273.27.17192; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; YASUDA T, 1992, BIOCHIM BIOPHYS ACTA, V1119, P185, DOI 10.1016/0167-4838(92)90390-Y; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	40	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59148	10.1371/journal.pone.0059148	http://dx.doi.org/10.1371/journal.pone.0059148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516607	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200134
J	Tiwari, S; Hudson, S; Gattone, VH; Miller, C; Chernoff, EAG; Belecky-Adams, TL				Tiwari, Sarika; Hudson, Scott; Gattone, Vincent H., II; Miller, Caroline; Chernoff, Ellen A. G.; Belecky-Adams, Teri L.			Meckelin 3 Is Necessary for Photoreceptor Outer Segment Development in Rat Meckel Syndrome	PLOS ONE			English	Article							INHERITED RETINAL DEGENERATION; LEBER CONGENITAL AMAUROSIS; POLYCYSTIC KIDNEY-DISEASE; RETINITIS-PIGMENTOSA; CELL-DEATH; GRUBER-SYNDROME; INTRAFLAGELLAR TRANSPORT; KNOCKOUT MICE; PRIMARY CILIA; MEDIATES CILIOGENESIS	Ciliopathies lead to multiorgan pathologies that include renal cysts, deafness, obesity and retinal degeneration. Retinal photoreceptors have connecting cilia joining the inner and outer segment that are responsible for transport of molecules to develop and maintain the outer segment process. The present study evaluated meckelin (MKS3) expression during outer segment genesis and determined the consequences of mutant meckelin on photoreceptor development and survival in Wistar polycystic kidney disease Wpk/Wpk rat using immunohistochemistry, analysis of cell death and electron microscopy. MKS3 was ubiquitously expressed throughout the retina at postnatal day 10 (P10) and P21. However, in the mature retina, MKS3 expression was restricted to photoreceptors and the retinal ganglion cell layer. At P10, both the wild type and homozygous Wpk mutant retina had all retinal cell types. In contrast, by P21, cells expressing rod- and cone-specific markers were fewer in number and expression of opsins appeared to be abnormally localized to the cell body. Cell death analyses were consistent with the disappearance of photoreceptor-specific markers and showed that the cells were undergoing caspase-dependent cell death. By electron microscopy, P10 photoreceptors showed rudimentary outer segments with an axoneme, but did not develop outer segment discs that were clearly present in the wild type counterpart. At p21 the mutant outer segments appeared much the same as the P10 mutant outer segments with only a short axoneme, while the wild-type controls had developed outer segments with many well-organized discs. We conclude that MKS3 is not important for formation of connecting cilium and rudimentary outer segments, but is critical for the maturation of outer segment processes.	[Tiwari, Sarika; Hudson, Scott; Chernoff, Ellen A. G.; Belecky-Adams, Teri L.] Indiana Univ Purdue Univ Indianapolis, Dept Biol, Indianapolis, IN 46202 USA; [Gattone, Vincent H., II; Miller, Caroline] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Tiwari, Sarika; Hudson, Scott; Chernoff, Ellen A. G.; Belecky-Adams, Teri L.] Indiana Univ Purdue Univ Indianapolis, Ctr Regenerat Biol & Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Belecky-Adams, TL (corresponding author), Indiana Univ Purdue Univ Indianapolis, Dept Biol, Indianapolis, IN 46202 USA.	tbadams@iupui.edu		Belecky-Adams, Teri/0000-0003-1299-8448	National Eye Institute [5RO1EY019525-02, 1R15EY020816-01]; American Health Assistance Foundation [G2008-113]; National Institutes of Health [R01DK68581]; NATIONAL EYE INSTITUTE [R15EY020816, R01EY019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068581] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Eye Institute (5RO1EY019525-02 and 1R15EY020816-01 to TBA), American Health Assistance Foundation (G2008-113 to TBA), and National Institutes of Health (R01DK68581 to VG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2012, HUM MOL GENET, V21, P1272, DOI 10.1093/hmg/ddr557; Alexiev BA, 2006, ARCH PATHOL LAB MED, V130, P1236; Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Collin GB, 2012, INVEST OPHTH VIS SCI, V53, P967, DOI 10.1167/iovs.11-8766; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; DE ROBERTIS E., 1960, JOUR GEN PHYSIOL, V43, P1; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Guo CR, 2012, EXP EYE RES, V104, P39, DOI 10.1016/j.exer.2012.08.013; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Ikeda S, 2000, HUM MOL GENET, V9, P155, DOI 10.1093/hmg/9.2.155; Jozwick C, 2006, EXP EYE RES, V83, P1074, DOI 10.1016/j.exer.2006.05.012; Keady BT, 2011, MOL BIOL CELL, V22, P921, DOI 10.1091/mbc.E10-09-0792; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; KUWABARA T, 1976, ARCH OPHTHALMOL-CHIC, V94, P1369; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Liu CD, 1999, J NEUROSCI, V19, P4778; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Lopes VS, 2010, MOL BIOL CELL, V21, P4076, DOI 10.1091/mbc.E10-08-0715; MESSER A, 1995, AM J MED GENET, V57, P361, DOI 10.1002/ajmg.1320570251; Morgan NV, 2002, HUM GENET, V111, P456, DOI 10.1007/s00439-002-0817-0; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Nakanishi T, 2012, J NEUROCHEM; Nauta J, 2000, J AM SOC NEPHROL, V11, P2272, DOI 10.1681/ASN.V11122272; NILSSON SEG, 1964, J ULTRA MOL STRUCT R, V11, P581, DOI 10.1016/S0022-5320(64)80084-8; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Organisciak DT, 2003, INVEST OPHTH VIS SCI, V44, P486, DOI 10.1167/iovs.02-0708; PAGHROEHL K, 1991, CELL MOL NEUROBIOL, V11, P593, DOI 10.1007/BF00741448; Papermaster DS, 2002, INVEST OPHTH VIS SCI, V43, P1300; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Pretorius PR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000884; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Ramamurthy V, 2009, CLIN GENET, V76, P137, DOI 10.1111/j.1399-0004.2009.01240.x; Rascher K, 2004, VISION RES, V44, P2091, DOI 10.1016/j.visres.2004.03.027; Rattner A, 2006, AM J OPHTHALMOL, V141, P558, DOI 10.1016/j.ajo.2005.10.045; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SANYAL S, 1986, J EMBRYOL EXP MORPH, V98, P111; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; SMITH SB, 1994, EXP EYE RES, V58, P77, DOI 10.1006/exer.1994.1196; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Szymanska K, 2012, CILIA, V1, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1186; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Tammachote R, 2009, HUM MOL GENET, V18, P3311, DOI 10.1093/hmg/ddp272; Thompson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035865; TREISMAN JE, 1988, MOL CELL BIOL, V8, P1570, DOI 10.1128/MCB.8.4.1570; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Valter K, 2009, EXP EYE RES, V89, P1003, DOI 10.1016/j.exer.2009.08.009; Warburton-Pitt SR, 2012, J CELL SCI; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Won J, 2011, HUM MOL GENET, V20, P482, DOI 10.1093/hmg/ddq494; Won JY, 2009, HUM MOL GENET, V18, P4329, DOI 10.1093/hmg/ddp385; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yamashita T, 2009, J NEUROSCI, V29, P9748, DOI 10.1523/JNEUROSCI.5854-08.2009; Zhang QH, 2011, P NATL ACAD SCI USA, V108, P20678, DOI 10.1073/pnas.1113220108; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P3965, DOI 10.1073/pnas.0637349100	91	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59306	10.1371/journal.pone.0059306	http://dx.doi.org/10.1371/journal.pone.0059306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516626	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200143
J	Yang, Y; Li, Y; Wang, KB; Wang, Y; Yin, WQ; Li, L				Yang, Ye; Li, Yuan; Wang, Kebo; Wang, Yu; Yin, Wenqin; Li, Lei			P38/NF-kappa B/Snail Pathway Is Involved in Caffeic Acid-Induced Inhibition of Cancer Stem Cells-Like Properties and Migratory Capacity in Malignant Human Keratinocyte	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; UP-REGULATES SNAIL; NF-KAPPA-B; E-CADHERIN; SKIN-CANCER; EXPRESSION; ACTIVATION; REPRESSION; KINASES; BREAST	Background: Skin cancer is the most common cancer throughout the world. The epithelial-mesenchymal transition (EMT) and the acquisition of cancer stem cells (CSCs)-like properties emerge as critical steps in the metastasis of human skin cancers. Caffeic acid (CaA) exerts anticarcinogenic effects. However, the effects of CaA on the migratory capability and on the CSCs-like properties of skin cancer cells, and the molecular mechanisms underlying it are not fully understood. Methods: Malignant HaCaT cells were treated by CaA. Transwell assay was performed to determine that CaA attenuated the migratory capability; Spheroid formation assay was performed to confirm that CaA decreased the CSCs-like phenotype; Treated malignant HaCaT cells were molecularly characterized by RT-PCR, Western blots, Southwestern blot, and immunoprecipitation. Results: In CaA-treated malignant human keratinocyte (malignant HaCaT cells), inhibition of the migratory capability and CSCs-like phenotype were observed. CaA up-regulated the phosphorylation of p38, and down-regulated the activation of nuclear factor kappa B (NF-kappa B)/snail signal pathway. Indeed, p38 decreased the DNA-binding activity of NF-kappa B to the promoter of snail gene, which resulted in the transcriptional inactivation of snail. Blockage of p38 attenuated the CaA-induced inhibition of migratory capability and CSCs-like phenotype in malignant HaCaT cells. Conclusions: CaA attenuates the migratory capability and CSCs-like Properties of malignant human keratinocyte, in which, p38-mediated down-regulation of NF-kappa B/snail signal pathway is involved.	[Yang, Ye; Wang, Kebo; Wang, Yu; Yin, Wenqin; Li, Lei] Nanjing Med Univ, Sch Publ Hlth, Dept Hyg Anal & Detect, Nanjing, Jiangsu, Peoples R China; [Li, Yuan; Li, Lei] Nanjing Med Univ, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Li, L (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Hyg Anal & Detect, Nanjing, Jiangsu, Peoples R China.	drleili@hotmail.com			Natural Science Foundations of China [81072338]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Natural Science Foundations of China (81072338) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Benitah SA, 2011, NATURE, V478, P329, DOI 10.1038/478329a; Borden EC, 2007, SEMIN ONCOL, V34, P449, DOI 10.1053/j.seminoncol.2007.09.001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dong R, 2007, BRAZ J MED BIOL RES, V40, P1071, DOI 10.1590/S0100-879X2007000800007; Eaves CJ, 2008, NATURE, V456, P581, DOI 10.1038/456581a; HUANG MT, 1988, CANCER RES, V48, P5941; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Jung JE, 2007, CARCINOGENESIS, V28, P1780, DOI 10.1093/carcin/bgm130; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Kim HM, 2012, ANN SURG ONCOL, V19, pS539, DOI 10.1245/s10434-011-2040-5; Lencinas A, 2010, TOXICOL SCI, V116, P273, DOI 10.1093/toxsci/kfq086; Li YA, 2010, TOXICOL SCI, V116, P174, DOI 10.1093/toxsci/kfq109; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Montserrat N, 2011, HUM PATHOL, V42, P103, DOI 10.1016/j.humpath.2010.05.019; Nagasaka R, 2007, BIOCHEM BIOPH RES CO, V358, P615, DOI 10.1016/j.bbrc.2007.04.178; Nakamura M, 2011, J DERMATOL SCI, V61, P7, DOI 10.1016/j.jdermsci.2010.11.015; Nemoto Y, 2011, VET PATHOL, V48, P1029, DOI 10.1177/0300985810396106; Shaikh WR, 2012, J CANCER EDUC, V27, P709, DOI 10.1007/s13187-012-0378-4; Staniforth V, 2006, CARCINOGENESIS, V27, P1803, DOI 10.1093/carcin/bgl006; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Szliszka E, 2012, INT J ONCOL, V41, P818, DOI 10.3892/ijo.2012.1527; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Tokar EJ, 2010, JNCI-J NATL CANCER I, V102, P638, DOI 10.1093/jnci/djq093; Tokar EJ, 2010, ENVIRON HEALTH PERSP, V118, P108, DOI 10.1289/ehp.0901059; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang ZS, 2012, ENVIRON HEALTH PERSP, V120, P92, DOI 10.1289/ehp.1104061; Wu Y, 2012, CELL ADHES MIGR, V4, P199; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang KJ, 2011, HEPATO-GASTROENTEROL, V58, P1; Zhu LF, 2012, LAB INVEST, V92, P744, DOI 10.1038/labinvest.2012.8	36	58	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58915	10.1371/journal.pone.0058915	http://dx.doi.org/10.1371/journal.pone.0058915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516577	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200122
J	Badiola, N; Alcalde, V; Pujol, A; Munter, LM; Multhaup, G; Lleo, A; Coma, M; Soler-Lopez, M; Aloy, P				Badiola, Nahuai; Alcalde, Victor; Pujol, Albert; Muenter, Lisa-Marie; Multhaup, Gerd; Lleo, Alberto; Coma, Mireia; Soler-Lopez, Montserrat; Aloy, Patrick			The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; NEURONAL LOSS; A-BETA-42; OLIGOMERS; NEURODEGENERATION; FLURBIPROFEN; TANGLES	A key event in the pathogenesis of Alzheimer's disease (AD) is the accumulation of amyloid-beta (A beta) species in the brain, derived from the sequential cleavage of the amyloid precursor protein (APP) by beta- and gamma-secretases. Based on a systems biology study to repurpose drugs for AD, we explore the effect of lansoprazole, and other proton-pump inhibitors (PPIs), on Ab production in AD cellular and animal models. We found that lansoprazole enhances A beta 37, A beta 40 and A beta 42 production and lowers A beta 38 levels on amyloid cell models. Interestingly, acute lansoprazole treatment in wild type and AD transgenic mice promoted higher A beta 40 levels in brain, indicating that lansoprazole may also exacerbate Ab production in vivo. Overall, our data presents for the first time that PPIs can affect amyloid metabolism, both in vitro and in vivo.	[Badiola, Nahuai; Alcalde, Victor; Pujol, Albert; Soler-Lopez, Montserrat; Aloy, Patrick] Inst Res Biomed, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Pujol, Albert; Coma, Mireia] Anax Biotech, Barcelona, Spain; [Muenter, Lisa-Marie; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Lleo, Alberto] Hosp Santa Creu & Sant Pau, Dept Neurol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Aloy, Patrick] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Free University of Berlin; CIBERNED; Hospital of Santa Creu i Sant Pau; ICREA	Aloy, P (corresponding author), Inst Res Biomed, Joint IRB BSC Program Computat Biol, Barcelona, Spain.	patrick.aloy@irbbarcelona.org	Lleó, Alberto/K-5783-2019; Aloy, Patrick/AAB-3538-2019; Badiola, Nahuai/C-6526-2011	Badiola, Nahuai/0000-0001-9488-5628; Munter, Lisa/0000-0001-5736-1462; Aloy, Patrick/0000-0002-3557-0236; Alcalde Adell, Victor/0000-0002-7868-2983	Spanish Ministerio de Ciencia e Innovacion [PSE-010000-2009-1, BIO2010-22073]; ICREA Funding Source: Custom	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ICREA(ICREA)	The present work has been supported by the Spanish Ministerio de Ciencia e Innovacion (PSE-010000-2009-1; BIO2010-22073) and by the own fund of each institute, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hay SO, 2009, J NEUROCHEM, V111, P683, DOI 10.1111/j.1471-4159.2009.06355.x; ARNOLD R, 1994, ALIMENT PHARM THER, V8, P65; Bien J, 2012, J BIOL CHEM; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DaRocha-Souto B, 2011, J NEUROPATH EXP NEUR, V70, P360, DOI 10.1097/NEN.0b013e318217a118; Dias LM, 2009, CLIN DRUG INVEST, V29, P3, DOI 10.2165/1153121-S0-000000000-00000; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Geerts H, 2007, IDRUGS, V10, P121; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lai KC, 2005, AM J MED, V118, P1271, DOI 10.1016/j.amjmed.2005.04.031; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazzaroni M, 2009, DRUGS, V69, P51, DOI 10.2165/00003495-200969010-00004; Li Y, 2006, FASEB J, V20, P285, DOI 10.1096/fj.05-4986com; Lleo A, 2007, CELL MOL LIFE SCI, V64, P1403, DOI 10.1007/s00018-007-6516-1; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; LONDONG W, 1991, ALIMENT PHARM THERAP, V5, P245; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Morihara T, 2002, J NEUROCHEM, V83, P1009, DOI 10.1046/j.1471-4159.2002.01195.x; Nakagawa S, 2012, INFLAMMATION, V35, P1062, DOI 10.1007/s10753-011-9412-7; Narlawar R, 2007, BIOORG MED CHEM LETT, V17, P176, DOI 10.1016/j.bmcl.2006.09.061; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Parsons C, 2012, DRUG AGING, V29, P143, DOI 10.2165/11598560-000000000-00000; Pilotto A, 2010, SURG ONCOL, V19, P167, DOI 10.1016/j.suronc.2009.11.014; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Pospai D, 1998, GASTROEN CLIN BIOL, V22, P801; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Rojo LE, 2010, J ALZHEIMERS DIS, V19, P573, DOI 10.3233/JAD-2010-1262; SATOH H, 1989, J PHARMACOL EXP THER, V248, P806; Schulz-Geske S, 2009, WORLD J GASTROENTERO, V15, P4392, DOI 10.3748/wjg.15.4392; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheen E, 2011, DIGEST DIS SCI, V56, P931, DOI 10.1007/s10620-010-1560-3; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Spires-Jones TL, 2007, AM J PATHOL, V171, P1304, DOI 10.2353/ajpath.2007.070055; Takagi T, 2009, J PHARMACOL EXP THER, V331, P255, DOI 10.1124/jpet.109.152702; Tanigawa T, 2009, J CLIN BIOCHEM NUTR, V45, P86, DOI 10.3164/jcbn.08-267; Vonkeman HE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2207; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang-Dietrich L, 2013, J ALZHEIMERS DIS; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	54	100	104	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58837	10.1371/journal.pone.0058837	http://dx.doi.org/10.1371/journal.pone.0058837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520537	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900097
J	Fiorito, F; Irace, C; Di Pascale, A; Colonna, A; Iovane, G; Pagnini, U; Santamaria, R; De Martino, L				Fiorito, Filomena; Irace, Carlo; Di Pascale, Antonio; Colonna, Alfredo; Iovane, Giuseppe; Pagnini, Ugo; Santamaria, Rita; De Martino, Luisa			2,3,7,8-Tetrachlorodibenzo-p-Dioxin Promotes BHV-1 Infection in Mammalian Cells by Interfering with Iron Homeostasis Regulation	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; BOVINE HERPESVIRUS-1 BHV-1; ARYL-HYDROCARBON RECEPTOR; RIBONUCLEOTIDE REDUCTASE; FERRITIN BIOSYNTHESIS; INDUCED APOPTOSIS; OXIDATIVE STRESS; METABOLISM; EXPRESSION; TYPE-1	Mammalian cells require iron to satisfy metabolic needs or to accomplish specialized functions, and DNA viruses, like bovine herpesvirus 1 (BHV-1), require an iron-replete host to efficiently replicate, so that iron bioavailability is an important component of viral virulence. Cellular iron metabolism is coordinately controlled by the Iron Regulatory Proteins (IRP1 and IRP2), whose activity is affected by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a current and persistent environmental contaminant. Considering that TCDD enhances BHV-1 replication, herein we analyzed the effects of TCDD on iron metabolism during BHV-1 infection in MDBK cells, and presented evidences of a divergent modulation of IRP1 and IRP2 RNA-binding capacity. Moreover, an up-regulation of transferrin receptor 1 (TfR1) and a concomitant down-regulation of ferritin were observed. This scenario led to an expansion of the labile iron pool (LIP) and induces a significant enhance of viral titer, as confirmed by increased levels of BHV-1 infected cell protein 0 (blCP0), the major transcriptional regulatory protein of BHV-1. Taken together, our data suggest that TCDD increases the free intracellular iron availability thereby promoting the onset of BHV-1 infection and rendering bovine cells more vulnerable to the virus.	[Fiorito, Filomena; Iovane, Giuseppe; Pagnini, Ugo; De Martino, Luisa] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Naples, Italy; [Irace, Carlo; Di Pascale, Antonio; Colonna, Alfredo; Santamaria, Rita] Univ Naples Federico II, Dipartimento Farm, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Pagnini, U (corresponding author), Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Naples, Italy.	upagnini@unina.it; rsantama@unina.it	Fiorito, Filomena/O-2175-2016	Fiorito, Filomena/0000-0002-6658-7807	Polo delle Scienze e delle Tecnologie per la Vita dell'Universita di Napoli "Federico II'' [2012-4/STV-Progetto FORGIARE]; Compagnia San Paolo di Torino, Italy	Polo delle Scienze e delle Tecnologie per la Vita dell'Universita di Napoli "Federico II''; Compagnia San Paolo di Torino, Italy	Filomena Fiorito was supported by a fellowship from Polo delle Scienze e delle Tecnologie per la Vita dell'Universita di Napoli "Federico II'' (2012-4/STV-Progetto FORGIARE) co-funded by Compagnia San Paolo di Torino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Ackermann M, 2006, VET MICROBIOL, V113, P293, DOI 10.1016/j.vetmic.2005.11.043; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Burleson GR, 1996, FUND APPL TOXICOL, V29, P40, DOI 10.1006/faat.1996.0004; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; De Martino L, 2003, J CELL BIOCHEM, V89, P373, DOI 10.1002/jcb.10518; Devireddy LR, 1999, J VIROL, V73, P3778, DOI 10.1128/JVI.73.5.3778-3788.1999; Diletti G., 2003, ORGANOHALOGEN COMPOU, V64, P1; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Esposito M, 2010, CHEMOSPHERE, V79, P341, DOI 10.1016/j.chemosphere.2010.01.025; Fiorito F, 2008, J CELL BIOCHEM, V103, P221, DOI 10.1002/jcb.21398; Fiorito F, 2008, APOPTOSIS, V13, P1243, DOI 10.1007/s10495-008-0249-y; Fiorito F, 2011, TOXICOLOGY, V290, P258, DOI 10.1016/j.tox.2011.10.004; Fiorito F, 2010, J CELL BIOCHEM, V111, P333, DOI 10.1002/jcb.22700; FRAEFEL C, 1994, J VIROL, V68, P3154, DOI 10.1128/JVI.68.5.3154-3162.1994; Gollapudi S, 1996, BIOCHEM BIOPH RES CO, V226, P889, DOI 10.1006/bbrc.1996.1445; HANSON N, 1994, VIRUS RES, V34, P265, DOI 10.1016/0168-1702(94)90127-9; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; IARC Social Inequalities and Cancer, 1997, IARC MON; Irace C, 2005, J NEUROCHEM, V95, P1321, DOI 10.1111/j.1471-4159.2005.03449.x; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jones C, 2003, CLIN MICROBIOL REV, V16, P79, DOI 10.1128/CMR.16.1.79-95.2003; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Lamarche N, 1996, BIOCHEM J, V320, P129, DOI 10.1042/bj3200129; LAMBERT DM, 1973, LAB INVEST, V29, P737; Maffettone C, 2008, J CELL BIOCHEM, V104, P213, DOI 10.1002/jcb.21618; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Murayama T, 2002, BIOCHEM BIOPH RES CO, V296, P651, DOI 10.1016/S0006-291X(02)00921-X; Ohata H, 2003, MICROBIOL IMMUNOL, V47, P363, DOI 10.1111/j.1348-0421.2003.tb03408.x; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Rashed MN, 2011, J TRACE ELEM MED BIO, V25, P181, DOI 10.1016/j.jtemb.2011.07.001; Raso GM, 2009, BIOCHEM PHARMACOL, V78, P1001, DOI 10.1016/j.bcp.2009.05.034; Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983; REED L. J., 1938, AMER JOUR HYG, V27, P493; Romeo AM, 2001, J BIOL CHEM, V276, P24301, DOI 10.1074/jbc.M010806200; Santamaria R, 2004, BBA-MOL CELL RES, V1691, P151, DOI 10.1016/j.bbamcr.2004.01.004; Santamaria R, 2006, BBA-MOL CELL RES, V1763, P815, DOI 10.1016/j.bbamcr.2006.03.010; Santamaria R, 2011, BBA-MOL CELL RES, V1813, P704, DOI 10.1016/j.bbamcr.2011.02.003; Santelli F, 2006, EUR FOOD RES TECHNOL, V223, P51, DOI 10.1007/s00217-005-0112-0; Smith AG, 1998, MOL PHARMACOL, V53, P52, DOI 10.1124/mol.53.1.52; TIKOO SK, 1995, ADV VIRUS RES, V45, P191, DOI 10.1016/S0065-3527(08)60061-5; van Asbeck BS, 2001, J CLIN VIROL, V20, P141, DOI 10.1016/S1386-6532(00)00122-0; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200	55	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58845	10.1371/journal.pone.0058845	http://dx.doi.org/10.1371/journal.pone.0058845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520538	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900098
J	Brum, DG; Luizon, MR; Santos, AC; Lana-Peixoto, MA; Rocha, CF; Brito, ML; de Oliveira, EML; Bichuetti, DB; Gabbai, AA; Diniz, DS; Kaimen-Maciel, DR; Comini-Frota, ER; Wiezel, CEV; Muniz, YCN; Costa, RMD; Mendes, CT; Donadi, EA; Barreira, AA; Simoes, AL				Brum, Doralina Guimaraes; Luizon, Marcelo Rizzatti; Santos, Antonio Carlos; Lana-Peixoto, Marco Aurelio; Rocha, Cristiane Franklin; Brito, Maria Lucia; Lobato de Oliveira, Enedina Maria; Bichuetti, Denis Bernardi; Gabbai, Alberto Alan; Diniz, Denise Sisterolli; Kaimen-Maciel, Damacio Ramon; Comini-Frota, Elizabeth Regina; Vieira Wiezel, Claudia E.; Netto Muniz, Yara Costa; da Silva Costa, Roberta Martins; Mendes-Junior, Celso Teixeira; Donadi, Eduardo Antonio; Barreira, Amilton Antunes; Simoes, Aguinaldo Luiz			European Ancestry Predominates in Neuromyelitis Optica and Multiple Sclerosis Patients from Brazil	PLOS ONE			English	Article								Background: Neuromyelitis optica (NMO) is considered relatively more common in non-Whites, whereas multiple sclerosis (MS) presents a high prevalence rate, particularly in Whites from Western countries populations. However, no study has used ancestry informative markers (AIMs) to estimate the genetic ancestry contribution to NMO patients. Methods: Twelve AIMs were selected based on the large allele frequency differences among European, African, and Amerindian populations, in order to investigate the genetic contribution of each ancestral group in 236 patients with MS and NMO, diagnosed using the McDonald and Wingerchuck criteria, respectively. All 128 MS patients were recruited at the Faculty of Medicine of Ribeirao Preto (MS-RP), Southeastern Brazil, as well as 108 healthy bone marrow donors considered as healthy controls. A total of 108 NMO patients were recruited from five Neurology centers from different Brazilian regions, including Ribeirao Preto (NMO-RP). Principal Findings: European ancestry contribution was higher in MS-RP than in NMO-RP (78.5% vs. 68.7%) patients. In contrast, African ancestry estimates were higher in NMO-RP than in MS-RP (20.5% vs. 12.5%) patients. Moreover, principal component analyses showed that groups of NMO patients from different Brazilian regions were clustered close to the European ancestral population. Conclusions: Our findings demonstrate that European genetic contribution predominates in NMO and MS patients from Brazil.	[Brum, Doralina Guimaraes; Santos, Antonio Carlos; Barreira, Amilton Antunes] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Sao Paulo, Brazil; [Brum, Doralina Guimaraes] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Neurol Psicol & Psiquiatria, Botucatu, SP, Brazil; [Luizon, Marcelo Rizzatti; Vieira Wiezel, Claudia E.; Simoes, Aguinaldo Luiz] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo, Brazil; [Lana-Peixoto, Marco Aurelio; Rocha, Cristiane Franklin] Univ Fed Minas Gerais, Fac Med, Dept Oftalmol & Otorrinolaringol, Belo Horizonte, MG, Brazil; [Brito, Maria Lucia] Hosp Restauracao, Secretaria Saude Estado Pernambuco, Recife, PE, Brazil; [Lobato de Oliveira, Enedina Maria; Bichuetti, Denis Bernardi; Gabbai, Alberto Alan] Univ Fed Sao Paulo, Dept Neurol & Neurocirurgia, Sao Paulo, Brazil; [Bichuetti, Denis Bernardi] Univ Fed Goias, Fac Med, Dept Clin Med, Goiania, Go, Brazil; [Kaimen-Maciel, Damacio Ramon] Univ Estadual Londrina, Dept Clin Med, Ctr Ciencias Saude, Londrina, Parana, Brazil; [Comini-Frota, Elizabeth Regina] Univ Fed Minas Gerais, Fac Med, Dept Neurol, Belo Horizonte, MG, Brazil; [Netto Muniz, Yara Costa; Donadi, Eduardo Antonio] Univ Sao Paulo, Div Imunol Clin, Fac Med Ribeirao Preto, Dept Clin Med, Sao Paulo, Brazil; [da Silva Costa, Roberta Martins] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Oftalmol & Otorrinolaringol & Cirurgia Cabec, Sao Paulo, Brazil; [Mendes-Junior, Celso Teixeira] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Goias; Universidade Estadual de Londrina; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Barreira, AA (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Sao Paulo, Brazil.	aabarrei@fmrp.usp.br	Bichuetti, Denis B/F-7240-2012; donadi, eduardo A/H-7080-2013; Mendes-Junior, Celso Teixeira/B-1994-2010; Luizon, Marcelo R/G-1400-2014; Luizon, Marcelo/AAC-5910-2019; Brum, Doralina G/A-1225-2015; Lana-Peixoto, Marco Aurelio/AAD-2580-2019; Simoes, Aguinaldo L/E-7508-2011; Comini-Frota, Elizabeth R./F-8461-2012; Vieira Wiezel, Cláudia/P-7748-2017; Oliveira, Enedina M.L/B-2720-2016; Muniz, Yara Costa Netto/C-6456-2016	Bichuetti, Denis B/0000-0002-4011-3734; donadi, eduardo A/0000-0002-9457-9601; Mendes-Junior, Celso Teixeira/0000-0002-7337-1203; Luizon, Marcelo R/0000-0002-8331-3525; Luizon, Marcelo/0000-0002-8331-3525; Brum, Doralina G/0000-0002-9050-3319; Lana-Peixoto, Marco Aurelio/0000-0003-2454-681X; Comini-Frota, Elizabeth R./0000-0002-2702-0402; Vieira Wiezel, Cláudia/0000-0002-4381-0834; Oliveira, Enedina M.L/0000-0002-4939-7200; Muniz, Yara Costa Netto/0000-0001-9526-8306; Simoes, Aguinaldo Luiz/0000-0001-5950-894X; Barreira, Amilton/0000-0002-4791-223X	Coordencao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil); Fundacao de Apoio ao Ensino, Pesquisa e Assisteancia do HCFMRP-USP (FAEPA-Brazil)	Coordencao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino, Pesquisa e Assisteancia do HCFMRP-USP (FAEPA-Brazil)	This study was funded by the Coordencao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-Brazil), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Brazil), and Fundacao de Apoio ao Ensino, Pesquisa e Assisteancia do HCFMRP-USP (FAEPA-Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; Brum DG, 2010, MULT SCLER J, V16, P21, DOI 10.1177/1352458509350741; Cabre P, 2001, NEUROLOGY, V56, P507, DOI 10.1212/WNL.56.4.507; Cabrera-Gomez JA, 2009, J NEUROL, V256, P35, DOI 10.1007/s00415-009-0009-0; Enoch Mary-Anne, 2006, J Psychopharmacol, V20, P19, DOI 10.1177/1359786806066041; Kira J, 1996, ANN NEUROL, V40, P569; KURTZKE JF, 1977, J NEUROL, V215, P1, DOI 10.1007/BF00312546; Luizon MR, 2008, AM J HUM BIOL, V20, P86, DOI 10.1002/ajhb.20681; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	14	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58925	10.1371/journal.pone.0058925	http://dx.doi.org/10.1371/journal.pone.0058925			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527051	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600045
J	Giudice, FS; Pinto, DS; Nor, JE; Squarize, CH; Castilho, RM				Giudice, Fernanda S.; Pinto, Decio S., Jr.; Noer, Jacques E.; Squarize, Cristiane H.; Castilho, Rogerio M.			Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; LINKING NUMBER CHANGE; GENE-EXPRESSION; EMERGING MECHANISMS; PANCREATIC-CANCER; TUMOR PROGRESSION; PROSTATE-CANCER; CARCINOMA-CELLS; GASTRIC-CANCER; TRICHOSTATIN-A	The genome is organized and packed into the nucleus through interactions with core histone proteins. Emerging evidence suggests that tumors are highly responsive to epigenetic alterations that induce chromatin-based events and dynamically influence tumor behavior. We examined chromatin organization in head and neck squamous cell carcinoma (HNSCC) using acetylation levels of histone 3 as a marker of chromatin compaction. Compared to control oral keratinocytes, we found that HNSCC cells are hypoacetylated and that microenvironmental cues (e. g., microvasculature endothelial cells) induce tumor acetylation. Furthermore, we found that chemical inhibition of histone deacetylases (HDAC) reduces the number of cancer stem cells (CSC) and inhibits clonogenic sphere formation. Paradoxically, inhibition of HDAC also induced epithelial-mesenchymal transition (EMT) in HNSCC cells, accumulation of BMI-1, an oncogene associated with tumor aggressiveness, and expression of the vimentin mesenchymal marker. Importantly, we observed co-expression of vimentin and acetylated histone 3 at the invasion front of human HNSCC tumor tissues. Collectively, these findings suggest that environmental cues, such as endothelial cell-secreted factors, modulate tumor plasticity by limiting the population of CSC and inducing EMT. Therefore, inhibition of HDAC may constitute a novel strategy to disrupt the population of CSC in head and neck tumors to create a homogeneous population of cancer cells with biologically defined signatures and predictable behavior.	[Giudice, Fernanda S.; Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Lab Epithelial Biol, Ann Arbor, MI 48109 USA; [Giudice, Fernanda S.; Pinto, Decio S., Jr.] Univ Sao Paulo, Sch Dent, Dept Oral Pathol, Sao Paulo, Brazil; [Noer, Jacques E.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Universidade de Sao Paulo; University of Michigan System; University of Michigan	Castilho, RM (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Lab Epithelial Biol, Ann Arbor, MI 48109 USA.	rcastilh@umich.edu	Nor, Jacques/AAJ-6139-2021; Pinto, Décio/B-6041-2011; Castilho, Rogerio M/E-4987-2010	Nor, Jacques/0000-0002-4056-0235; Pinto, Décio/0000-0001-6198-5155; Castilho, Rogerio M/0000-0001-5358-612X; Squarize, Cristiane/0000-0002-6782-3429	National Institutes of Health (NIH/NCI) [P50-CA97248]; NIH/NIDCR [R01-DE21139]; NATIONAL CANCER INSTITUTE [P50CA097248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021139] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by the National Institutes of Health (NIH/NCI) P50-CA97248 (University of Michigan Head and Neck SPORE); and by grant R01-DE21139 from the NIH/NIDCR (JEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1989, P NATL ACAD SCI USA, V86, P4102, DOI 10.1073/pnas.86.11.4102; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Birchmeier C, 1996, ACTA ANAT, V156, P217; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Castilho RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010503; Chen C, 2011, CANCER INVEST, V29, P548, DOI 10.3109/07357907.2011.597810; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Er O, 2009, ONKOLOGIE, V32, P605, DOI 10.1159/000232375; Fantin VR, 2007, CLIN CANCER RES, V13, P7237, DOI 10.1158/1078-0432.CCR-07-2114; Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hu YF, 1999, GENE DEV, V13, P637, DOI 10.1101/gad.13.6.637; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Izumiya M, 2012, ANTICANCER RES, V32, P3847; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jayani RS, 2010, METHOD CELL BIOL, V98, P35, DOI 10.1016/S0091-679X(10)98002-3; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kaneko T, 2007, CANCER RES, V67, P9685, DOI 10.1158/0008-5472.CAN-07-1497; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; La Fleur L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044071; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251; Li W, 2010, J GASTROEN HEPATOL, V25, P568, DOI 10.1111/j.1440-1746.2009.06045.x; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Lydall D, 2005, DNA REPAIR, V4, P1195, DOI 10.1016/j.dnarep.2005.06.007; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Qin ZK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-61; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Robey RW, 2011, MOL PHARMACEUT, V8, P2021, DOI 10.1021/mp200329f; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Salnikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046391; Sampieri K, 2012, SEMIN CANCER BIOL, V22, P187, DOI 10.1016/j.semcancer.2012.03.002; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Song SH, 2011, DRUGS, V71, P2391, DOI 10.2165/11596690-000000000-00000; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spotswood HT, 2002, J CLIN INVEST, V110, P577, DOI 10.1172/JCI200216547; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SUGITA K, 1992, CANCER RES, V52, P168; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Wang H, 2008, J CANCER RES CLIN, V134, P535, DOI 10.1007/s00432-007-0316-8; Warner KA, 2008, NEOPLASIA, V10, P131, DOI 10.1593/neo.07815; WATT FM, 1988, J CELL SCI, P85; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; YOSHIDA M, 1987, CANCER RES, V47, P3688; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40; Zhang ZC, 2012, ORAL ONCOL, V48, P1, DOI 10.1016/j.oraloncology.2011.10.004; Zhou JL, 2010, PLANT MOL BIOL, V72, P585, DOI 10.1007/s11103-009-9594-7	100	97	105	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58672	10.1371/journal.pone.0058672	http://dx.doi.org/10.1371/journal.pone.0058672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527004	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600030
J	Jin, YL; Turaev, D; Weinmaier, T; Rattei, T; Makse, HA				Jin, Yuliang; Turaev, Dmitrij; Weinmaier, Thomas; Rattei, Thomas; Makse, Hernan A.			The Evolutionary Dynamics of Protein-Protein Interaction Networks Inferred from the Reconstruction of Ancient Networks	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; SMALL-WORLD; ORTHOLOGOUS GROUPS; MAP; DIVERGENCE; DUPLICATION; MODULARITY; MODULES; EGGNOG; GENES	Cellular functions are based on the complex interplay of proteins, therefore the structure and dynamics of these protein-protein interaction (PPI) networks are the key to the functional understanding of cells. In the last years, large-scale PPI networks of several model organisms were investigated. A number of theoretical models have been developed to explain both the network formation and the current structure. Favored are models based on duplication and divergence of genes, as they most closely represent the biological foundation of network evolution. However, studies are often based on simulated instead of empirical data or they cover only single organisms. Methodological improvements now allow the analysis of PPI networks of multiple organisms simultaneously as well as the direct modeling of ancestral networks. This provides the opportunity to challenge existing assumptions on network evolution. We utilized present-day PPI networks from integrated datasets of seven model organisms and developed a theoretical and bioinformatic framework for studying the evolutionary dynamics of PPI networks. A novel filtering approach using percolation analysis was developed to remove low confidence interactions based on topological constraints. We then reconstructed the ancient PPI networks of different ancestors, for which the ancestral proteomes, as well as the ancestral interactions, were inferred. Ancestral proteins were reconstructed using orthologous groups on different evolutionary levels. A stochastic approach, using the duplication-divergence model, was developed for estimating the probabilities of ancient interactions from today's PPI networks. The growth rates for nodes, edges, sizes and modularities of the networks indicate multiplicative growth and are consistent with the results from independent static analysis. Our results support the duplication-divergence model of evolution and indicate fractality and multiplicative growth as general properties of the PPI network structure and dynamics.	[Jin, Yuliang; Makse, Hernan A.] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Jin, Yuliang; Makse, Hernan A.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Turaev, Dmitrij; Weinmaier, Thomas; Rattei, Thomas] Univ Vienna, Dept Computat Syst Biol, Vienna, Austria	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); University of Vienna	Rattei, T (corresponding author), Univ Vienna, Dept Computat Syst Biol, Vienna, Austria.	thomas.rattei@univie.ac.at; hmakse@lev.ccny.cuny.edu	Weinmaier, Thomas/K-5780-2013; Rattei, Thomas/F-1366-2011	Weinmaier, Thomas/0000-0002-9552-3220; Rattei, Thomas/0000-0002-0592-7791	National Science Foundation [NSF-0827508]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant NSF-0827508 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bizhani G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036110; Bollobas B., 1985, RANDOM GRAPHS; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Bunde A., 1996, FRACTALS DISORDERED; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dutkowski J, 2007, BIOINFORMATICS, V23, pI149, DOI 10.1093/bioinformatics/btm194; Evlampiev K, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-49; Evlampiev K, 2008, P NATL ACAD SCI USA, V105, P9863, DOI 10.1073/pnas.0804119105; Fields S, 2005, FEBS J, V272, P5391, DOI 10.1111/j.1742-4658.2005.04973.x; Gallos LK, 2007, P NATL ACAD SCI USA, V104, P7746, DOI 10.1073/pnas.0700250104; Gallos LK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00454; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Galvao V, 2010, P NATL ACAD SCI USA, V107, P5750, DOI 10.1073/pnas.0914748107; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gibson TA, 2011, BIOINFORMATICS, V27, P376, DOI 10.1093/bioinformatics/btq623; Gibson TA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000252; Gibson TA, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P190; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018701; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055101; Koegl Manfred, 2007, Briefings in Functional Genomics & Proteomics, V6, P302, DOI 10.1093/bfgp/elm035; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kunin V, 2004, MOL BIOL EVOL, V21, P1171, DOI 10.1093/molbev/msh085; Lei Yang, 2008, 2008 International Conference on Neural Networks and Signal Processing, P53, DOI 10.1109/ICNNSP.2008.4590308; Li W. H, 1997, MOL EVOLUTION; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Navlakha S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001119; Ohno S., 1970, EVOLUTION GENE DUPLI; Patro R, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-25; Patthy Laszlo, 1999, PROTEIN EVOLUTION; Pinney JW, 2007, P NATL ACAD SCI USA, V104, P20449, DOI 10.1073/pnas.0706339104; Presser A, 2008, P NATL ACAD SCI USA, V105, P950, DOI 10.1073/pnas.0707293105; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; Rajagopala SV, 2009, PROTEOMICS, V9, P5296, DOI 10.1002/pmic.200900282; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rozenfeld HD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.025701; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Song CM, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/03/P03006; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Suter B, 2008, CURR OPIN BIOTECH, V19, P316, DOI 10.1016/j.copbio.2008.06.005; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wodak SJ, 2009, MOL CELL PROTEOMICS, V8, P3, DOI 10.1074/mcp.R800014-MCP200; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang XC, 2010, INTRODUCTION TO THZ WAVE PHOTONICS, P1, DOI 10.1007/978-1-4419-0978-7_1; Zinman GE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-134	74	38	38	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58134	10.1371/journal.pone.0058134	http://dx.doi.org/10.1371/journal.pone.0058134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526967	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600013
J	Cai, T; Wang, Q; Zhou, QY; Wang, CK; Hou, SP; Qi, J; Kijlstra, A; Yang, PZ				Cai, Tao; Wang, Qian; Zhou, Qingyun; Wang, Chaokui; Hou, Shengping; Qi, Jian; Kijlstra, Aize; Yang, Peizeng			Increased Expression of IL-22 Is Associated with Disease Activity in Behcet's Disease	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; CROHNS-DISEASE; HOST-DEFENSE; SERUM-LEVELS; CELLS; INTERLEUKIN-22; TH17; HEPATOCYTES; IL-10	Objective: Interleukin (IL)-22 has been reported to be involved in the development of autoimmune diseases. This study aimed to analyze the expression and potential role of IL-22 in the pathogenesis of Behcet's disease (BD). Methods: The levels of IL-22 in patient sera or supernatants of cultured peripheral blood mononuclear cells (PBMCs) and CD4(+)T cells were detected by enzyme-linked immunosorbent assay (ELISA). Flow cytometry was used to evaluate the frequency of IL-22-producing CD4(+) T cells. IL-22 mRNA from erythema nodosum skin lesions was examined using real time quantitative RT-PCR. Results: BD patients with active uveitis showed a significantly higher expression of IL-22 in the supernatants of stimulated PBMCs and CD4(+)T cells compared with BD patients without active uveitis and normal controls. An increased frequency of IL-22-producing CD4(+)T cells was also found in BD patients with active uveitis. IL-22 mRNA expression was elevated in erythema nodosum skin lesions. In BD patients, a high IL-22 level in the supernatant of stimulated PBMCs correlated with the presence of retinal vasculitis and erythema nodosum. Conclusions: IL-22 was associated with disease activity in BD and correlated with the presence of small vessel inflammation, suggesting that it may be involved in its pathogenesis.	[Cai, Tao; Wang, Qian; Zhou, Qingyun; Wang, Chaokui; Hou, Shengping; Qi, Jian; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Cai, Tao; Wang, Qian; Zhou, Qingyun; Wang, Chaokui; Hou, Shengping; Qi, Jian; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Cai, Tao; Wang, Qian; Zhou, Qingyun; Wang, Chaokui; Hou, Shengping; Qi, Jian; Yang, Peizeng] Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Netherlands	Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China.	peizengycmu@126.com	Hou, Shengping/E-5250-2013	Wang, Qian/0000-0003-3820-9494	National Natural Science Foundation [30973242]; Natural Science Foundation of Chongqing (CSTC) [2010BB5391]; Key Project of Natural Science Foundation [81130019]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Key Project of Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Key Project of Natural Science Foundation; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Key Project of Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation Project of CQ CSTC); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality	National Natural Science Foundation Project (30973242, http://159.226.244.22/portal/Proj_List.asp), Natural Science Foundation of Chongqing (CSTC,2010BB5391, http://www.ctin.ac.cn/Index.aspx), Key Project of Natural Science Foundation (81130019, http://159.226.244.22/portal/Proj_List.asp), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003, http://www.ctin.ac.cn/View.aspx?id = 14380), Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037, http://www.ctin.ac.cn/Index.aspx), and Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality (http://cqkjdj.cstc.gov.cn/View.aspx?id = 1000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018139; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Ciccia F, 2012, ANN RHEUM DIS, V71, P295, DOI 10.1136/ard.2011.154013; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Ke Y, 2011, J IMMUNOL, V187, P2130, DOI 10.4049/jimmunol.1100482; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kim B, 2000, AM J DERMATOPATH, V22, P12; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Li ZQ, 2008, J IMMUNOL, V181, P5147, DOI 10.4049/jimmunol.181.7.5147; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Pan HF, 2009, CLIN CHIM ACTA, V401, P179, DOI 10.1016/j.cca.2008.11.009; Qin WZ, 2011, CLIN EXP MED, V11, P245, DOI 10.1007/s10238-011-0134-9; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; SILMAN AJ, 1990, LANCET, V335, P1078; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Yang PZ, 2008, OPHTHALMOLOGY, V115, P312, DOI 10.1016/j.ophtha.2007.04.056; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	28	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59009	10.1371/journal.pone.0059009	http://dx.doi.org/10.1371/journal.pone.0059009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527071	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100065
J	Elamin, E; Masclee, A; Juuti-Uusitalo, K; van IJzendoorn, S; Troost, F; Pieters, HJ; Dekker, J; Jonkers, D				Elamin, Elhaseen; Masclee, Ad; Juuti-Uusitalo, Kati; van IJzendoorn, Sven; Troost, Freddy; Pieters, Harm-Jan; Dekker, Jan; Jonkers, Daisy			Fatty Acid Ethyl Esters Induce Intestinal Epithelial Barrier Dysfunction via a Reactive Oxygen Species-Dependent Mechanism in a Three-Dimensional Cell Culture Model	PLOS ONE			English	Article							ACETALDEHYDE-INDUCED INCREASE; KAPPA-B ACTIVATION; PARACELLULAR PERMEABILITY; NONOXIDATIVE METABOLITES; TYROSINE PHOSPHORYLATION; ETHANOL-METABOLISM; INDUCED DISRUPTION; HYDROGEN-PEROXIDE; HEAVY DRINKERS; FACTOR-ALPHA	Background & Aims: Evidence is accumulating that ethanol and its oxidative metabolite, acetaldehyde, can disrupt intestinal epithelial integrity, an important factor contributing to ethanol-induced liver injury. However, ethanol can also be metabolized non-oxidatively generating phosphatidylethanol and fatty acid ethyl esters (FAEEs). This study aims to investigate the effects of FAEEs on barrier function, and to explore the role of oxidative stress as possible mechanism. Methods: Epithelial permeability was assessed by paracellular flux of fluorescein isothiocyanate-conjugated dextran using live cell imaging. Cell integrity was evaluated by lactate dehydrogenase release. Localization and protein levels of ZO-1 and occludin were analyzed by immunofluorescence and cell-based ELISA, respectively. Intracellular oxidative stress and cellular ATP levels were measured by dichlorofluorescein and luciferase driven bioluminescence, respectively. Results: In vitro, ethyl oleate and ethyl palmitate dose dependently increased permeability associated with disruption and decreased ZO-1 and occludin protein levels, respectively, and increased intracellular oxidative stress without compromising cell viability. These effects could partially be attenuated by pretreatment with the antioxidant, resveratrol, pointing to the role of oxidative stress in the FAEEs-induced intestinal barrier dysfunction. Conclusions: These findings show that FAEEs can induce intestinal barrier dysfunction by disrupting the tight junctions, most likely via reactive oxygen species-dependent mechanism.	[Elamin, Elhaseen; Masclee, Ad; Juuti-Uusitalo, Kati; van IJzendoorn, Sven; Troost, Freddy; Dekker, Jan; Jonkers, Daisy] TIFN, Wageningen, Netherlands; [Elamin, Elhaseen; Masclee, Ad; Troost, Freddy; Pieters, Harm-Jan; Jonkers, Daisy] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [van IJzendoorn, Sven] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Juuti-Uusitalo, Kati] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Dekker, Jan] Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; University of Groningen; Tampere University; Wageningen University & Research	Jonkers, D (corresponding author), TIFN, Wageningen, Netherlands.	d.jonkers@maastrichtuniversity.nl	Troost, Freddy/B-2782-2015	Juuti-Uusitalo, Kati/0000-0003-2275-5562	Top Institute Food and Nutrition Wageningen, The Netherlands	Top Institute Food and Nutrition Wageningen, The Netherlands(Netherlands Government)	This study was supported by Top Institute Food and Nutrition (http://www.tifn.nl), Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Aydin HH, 2005, FOOD CHEM TOXICOL, V43, P139, DOI 10.1016/j.fct.2004.09.003; Banan A, 2000, GUT, V46, P830, DOI 10.1136/gut.46.6.830; Banan A, 2004, AM J PHYSIOL-CELL PH, V287, pC1139, DOI 10.1152/ajpcell.00146.2004; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; Banan A, 2000, J PHARMACOL EXP THER, V294, P997; Basuroy S, 2005, AM J PHYSIOL-GASTR L, V289, pG367, DOI 10.1152/ajpgi.00464.2004; Belguendouz L, 1998, BIOCHEM PHARMACOL, V55, P811, DOI 10.1016/S0006-2952(97)00544-3; Borucki K, 2007, ALCOHOL CLIN EXP RES, V31, P423, DOI 10.1111/j.1530-0277.2006.00323.x; Borucki K, 2004, ALCOHOL CLIN EXP RES, V28, P1102, DOI 10.1097/01.ALC.0000130791.20186.4D; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Carrasco-Pozo C, 2012, CHEM-BIOL INTERACT, V195, P199, DOI 10.1016/j.cbi.2011.12.007; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Doyle KM, 1996, JAMA-J AM MED ASSOC, V276, P1152, DOI 10.1001/jama.276.14.1152; DOYLE KM, 1994, J LIPID RES, V35, P428; Elamin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035008; GubitosiKlug RA, 1996, J BIOL CHEM, V271, P32519, DOI 10.1074/jbc.271.51.32519; HABER PS, 1993, J LAB CLIN MED, V121, P759; Kaldas MI, 2003, J PHARM PHARMACOL, V55, P307, DOI 10.1211/002235702612; Kaphalia B.S., 2001, CELL MOL BIOL, V47, P173; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; LANGE LG, 1983, J CLIN INVEST, V72, P724, DOI 10.1172/JCI111022; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; LAPOSATA M, 1995, PROSTAG LEUKOTR ESS, V52, P87, DOI 10.1016/0952-3278(95)90003-9; Lewis K, 2009, ANN NY ACAD SCI, V1165, P327, DOI 10.1111/j.1749-6632.2009.04036.x; Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0; Liu Y, 2000, J CELL SCI, V113, P2363; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Martin AR, 2004, BIOCHEM PHARMACOL, V67, P1399, DOI 10.1016/j.bcp.2003.12.024; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Panaro MA, 2012, BRIT J NUTR, V108, P1623, DOI 10.1017/S0007114511007227; Poritz LS, 2004, J SURG RES, V116, P14, DOI 10.1016/S0022-4804(03)00311-1; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Rao R. K., 2008, V447, P171, DOI 10.1007/978-1-59745-242-7_13; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Rao RK, 1997, AM J PHYSIOL-GASTR L, V273, pG812, DOI 10.1152/ajpgi.1997.273.4.G812; Rao RK, 1998, ALCOHOL CLIN EXP RES, V22, P1724, DOI 10.1097/00000374-199811000-00015; Rao RK, 2000, AM J PHYSIOL-GASTR L, V279, pG332, DOI 10.1152/ajpgi.2000.279.2.G332; Reilly ME, 2000, J NUTR, V130, P3045, DOI 10.1093/jn/130.12.3045; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Soderberg Britt L, 2003, Am J Clin Pathol, V119 Suppl, pS94; SZCZEPIORKOWSKI ZM, 1995, GASTROENTEROLOGY, V108, P515, DOI 10.1016/0016-5085(95)90081-0; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Tyulina OV, 2002, ALCOHOL ALCOHOLISM, V37, P179, DOI 10.1093/alcalc/37.2.179; Unno N, 1996, AM J PHYSIOL-GASTR L, V270, pG1010, DOI 10.1152/ajpgi.1996.270.6.G1010; Vespa A, 2003, J BIOL CHEM, V278, P11528, DOI 10.1074/jbc.M208337200; Waszkiewicz N, 2012, FOLIA HISTOCHEM CYTO, V50, P1, DOI [10.5603/FHC.2012.0001, 10.2478/18690]; Werner J, 2001, SURGERY, V129, P736, DOI 10.1067/msy.2001.113891; Wu H, 2006, TOXICOL APPL PHARM, V216, P238, DOI 10.1016/j.taap.2006.05.003	56	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58561	10.1371/journal.pone.0058561	http://dx.doi.org/10.1371/journal.pone.0058561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526996	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100030
J	Petherick, ES; Cullum, NA; Pickett, KE				Petherick, Emily S.; Cullum, Nicky A.; Pickett, Kate E.			Investigation of the Effect of Deprivation on the Burden and Management of Venous Leg Ulcers: A Cohort Study Using the THIN Database	PLOS ONE			English	Article							ARTERIAL-DISEASE; PRIMARY-CARE; PREVALENCE; ULCERATION; POPULATION; SMOKING; OBESITY	Background: There has been limited examination of the contribution of socio-economic factors to the development of leg ulcers, despite the social patterning of many underlying risk factors. No previous studies were found that examined social patterns in the quality of treatment received by patients with leg ulcers. Methods: Using The Health Improvement Network (THIN) database we identified a cohort of over 14000 patients with a diagnosis of venous leg ulceration, prospectively recorded between the years 2001 and 2006, with linked area-level socioeconomic information (Townsend deprivation quintile). We assessed socio-economic differences in the incidence and prevalence of leg ulcers using negative binomial regression. Socio-economic differences in two key areas of guideline recommended leg ulcer management, arterial Doppler assessment and compression bandaging, were assessed using multilevel regression. Results: The risk of incident venous leg ulceration increased for patients living in areas of higher deprivation, even after adjustment for known risk factors age and gender. Overall reported rates of Doppler assessment and provision of compression therapy were low, with less than sixteen per cent of patients having a database record of receiving these recommended diagnostic and treatment options. Patients diagnosed with incident venous leg ulcers living in the most deprived areas were less likely to receive the recommended Doppler-aided assessment for peripheral vascular disease than patients living in the least deprived areas (odds ratio 0.43, 95% confidence interval 0.24-0.78). Documented provision of compression therapy did not vary with deprivation. Conclusions: A socio-economic gradient in venous leg ulcer disease was observed. The overall rates of people with venous leg ulcers who were documented as receiving guideline recommended care (2001-2006) were low. Reported use of Doppler ultrasound assessment was negatively associated with socio-economic status. These findings suggest that the inequalities experienced by leg ulcer patients may be exacerbated by reduced access to guideline-based management.	[Petherick, Emily S.] Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Cullum, Nicky A.] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Pickett, Kate E.] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Pickett, Kate E.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of Manchester; University of York - UK; University of Hull; University of York - UK	Petherick, ES (corresponding author), Bradford Inst Hlth Res, Bradford, W Yorkshire, England.	Emily.Petherick@bthft.nhs.uk	Cullum, Nicky/AAT-5888-2020; Cullum, Nicky A/F-2438-2011; Petherick, Emily s/J-9755-2012	Cullum, Nicky/0000-0003-2631-123X; Cullum, Nicky A/0000-0003-2631-123X; Petherick, Emily s/0000-0001-6778-8128	NIHR researcher development award; NIHR career scientist award; Personal Awards Scheme (Researcher Development Award); MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: researchfish; National Institute for Health Research [RDA/02/06/84, CSA/03/07/014, NF-SI-0512-10028] Funding Source: researchfish	NIHR researcher development award; NIHR career scientist award; Personal Awards Scheme (Researcher Development Award); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	At the time this research was conducted EP was funded by an NIHR researcher development award. KP is supported by an NIHR career scientist award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article presents independent research commissioned by the National Institute for Health Research (NIHR) when ESP was funded by the Personal Awards Scheme (Researcher Development Award). Professor N Cullum is an NIHR Senior Investigator. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Blak B, 2006, 9 ANN C UK FED PRIM; Bourke Alison, 2004, Inform Prim Care, V12, P171; Byers AL, 2003, J CLIN EPIDEMIOL, V56, P559, DOI 10.1016/S0895-4356(03)00028-3; CALLAM MJ, 1988, SCOT MED J, V33, P358, DOI 10.1177/003693308803300603; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Clarke P, 2008, J EPIDEMIOL COMMUN H, V62, P752, DOI 10.1136/jech.2007.060798; Clinical Resource Efficiency Support Team, 1998, GUID ASS MAN LEG ULC; CORNWALL JV, 1986, BRIT J SURG, V73, P693, DOI 10.1002/bjs.1800730905; Finlayson K, 2009, INT J NURS STUD, V46, P1071, DOI 10.1016/j.ijnurstu.2008.12.012; FOWKES FGR, 1994, PHLEBOLOGY, V9, P87, DOI 10.1177/026835559400900210; Gourgou S, 2002, AM J EPIDEMIOL, V155, P1007, DOI 10.1093/aje/155.11.1007; Graham Ian D, 2003, Adv Skin Wound Care, V16, P305, DOI 10.1097/00129334-200311000-00013; Graham ID, 2003, CAN FAM PHYSICIAN, V49, P896; Hickie S, 1998, J CLIN NURS, V7, P45, DOI 10.1046/j.1365-2702.1998.00124.x; Hippisley-Cox J, 2004, BRIT MED J, V329, P1267, DOI 10.1136/bmj.38279.588125.7C; Husband LL, 1996, J ADV NURS, V24, P53, DOI 10.1046/j.1365-2648.1996.01617.x; Hussain S., 2008, 083 U LEEDS SCH GEOG; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lorimer Karen R, 2003, J Wound Ostomy Continence Nurs, V30, P132, DOI 10.1067/mjw.2003.122; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Moffatt CJ, 2006, BRIT J DERMATOL, V155, P307, DOI 10.1111/j.1365-2133.2006.07265.x; Moffatt CJ, 2004, QJM-INT J MED, V97, P431, DOI 10.1093/qjmed/hch075; O'Meara S, 2010, COCHRANE DATABASE SY; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Royal College of Nursing, 2006, NURS MAN PAT LEG ULC; Schofield J, 2000, Nurs Stand, V14, P54; Schofield J, 2000, NURSING STANDARD, V14, P58; Schofield J, 2000, NURS STAND, V14, P60; *SCOTT INT GUID NE, 1998, CAR PAT CHRON LEG UL; Simon DA, 2004, BMJ-BRIT MED J, V328, P1358, DOI 10.1136/bmj.328.7452.1358; Simon DA., 2004, J WOUND CARE, V3, P179; The Health Improvement Network, 2007, THIN DAT EPIC GUID R; The information centre, QUAL OUTC FRAM; Townsend PP., 1988, HLTH DEPRIVATION INE; van Rij AM, 2008, EUR J VASC ENDOVASC, V35, P739, DOI 10.1016/j.ejvs.2008.01.006; Vowden Kathryn R, 2009, J Tissue Viability, V18, P13, DOI 10.1016/j.jtv.2008.11.002; Willigendael EM, 2004, J VASC SURG, V40, P1158, DOI 10.1016/j.jvs.2004.08.049	38	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58948	10.1371/journal.pone.0058948	http://dx.doi.org/10.1371/journal.pone.0058948			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527054	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100057
J	Ailes, E; Budge, P; Shankar, M; Collier, S; Brinton, W; Cronquist, A; Chen, M; Thornton, A; Beach, MJ; Brunkard, JM				Ailes, Elizabeth; Budge, Philip; Shankar, Manjunath; Collier, Sarah; Brinton, William; Cronquist, Alicia; Chen, Melissa; Thornton, Andrew; Beach, Michael J.; Brunkard, Joan M.			Economic and Health Impacts Associated with a Salmonella Typhimurium Drinking Water Outbreak-Alamosa, CO, 2008	PLOS ONE			English	Article							REACTIVE ARTHRITIS; INFECTION; MILWAUKEE; ILLNESS; LOSSES	In 2008, a large Salmonella outbreak caused by contamination of the municipal drinking water supply occurred in Alamosa, Colorado. The objectives of this assessment were to determine the full economic costs associated with the outbreak and the long-term health impacts on the community of Alamosa. We conducted a postal survey of City of Alamosa (2008 population: 8,746) households and businesses, and conducted in-depth interviews with local, state, and nongovernmental agencies, and City of Alamosa healthcare facilities and schools to assess the economic and long-term health impacts of the outbreak. Twenty-one percent of household survey respondents (n = 369/1,732) reported diarrheal illness during the outbreak. Of those, 29% (n = 108) reported experiencing potential long-term health consequences. Most households (n = 699/771, 91%) reported municipal water as their main drinking water source at home before the outbreak; afterwards, only 30% (n = 233) drank unfiltered municipal tap water. The outbreak's estimated total cost to residents and businesses of Alamosa using a Monte Carlo simulation model (10,000 iterations) was approximately $1.5 million dollars (range: $196,677-$6,002,879), and rose to $2.6 million dollars (range: $1,123,471-$7,792,973) with the inclusion of outbreak response costs to local, state and nongovernmental agencies and City of Alamosa healthcare facilities and schools. This investigation documents the significant economic and health impacts associated with waterborne disease outbreaks and highlights the potential for loss of trust in public water systems following such outbreaks.	[Ailes, Elizabeth; Collier, Sarah] Int Hlth Resources Consulting, Atlanta, GA USA; [Ailes, Elizabeth; Budge, Philip; Shankar, Manjunath; Collier, Sarah; Chen, Melissa; Thornton, Andrew; Beach, Michael J.; Brunkard, Joan M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Brinton, William] San Luis Valley Publ Hlth Emergency Preparedness, Alamosa, CO USA; [Cronquist, Alicia] Colorado Dept Publ Hlth & Environm, Dis Control & Environm Epidemiol Div, Denver, CO USA	Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment	Brunkard, JM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	jbrunkard@cdc.gov	Budge, Philip/ABE-6458-2020	Chen, Melissa/0000-0002-4569-5614; Budge, Philip/0000-0002-0069-2372; Brunkard, Joan/0000-0001-5270-2627	Environmental Protection Agency Office of Science and Technology	Environmental Protection Agency Office of Science and Technology	The Environmental Protection Agency Office of Science and Technology provided funding for this project but had no role in project design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US CENS BUR 2005 200; [Anonymous], US CENS BUR 2008 POP; Bureau of Labor Statistics, MAY 2009 METR NONM A; Buxton JA, 2002, J RHEUMATOL, V29, P2154; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; Corso PS, 2003, EMERG INFECT DIS, V9, P426, DOI 10.3201/eid0904.020417; Craun GF, 2010, CLIN MICROBIOL REV, V23, P507, DOI 10.1128/CMR.00077-09; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; Environmental Protection Agency, 1975, FED REG, P59566; Falco R., 2009, WATERBORNE SALMONELL; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; HARRINGTON W, 1989, J URBAN ECON, V25, P116, DOI 10.1016/0094-1190(89)90048-X; Link MW, 2006, AM J EPIDEMIOL, V164, P1019, DOI 10.1093/aje/kwj310; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Pontius F, 1994, J AM WATER WORKS ASS, V86, P63; Pontius FW, 1997, J AM WATER WORKS ASS, V89, P18; SAMUEL MP, 1995, J RHEUMATOL, V22, P1947; Townes JM, 2008, ANN RHEUM DIS, V67, P1689, DOI 10.1136/ard.2007.083451; Yelin E, 2007, ARTHRITIS RHEUM-US, V56, P1397, DOI 10.1002/art.22565	19	26	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e57439	10.1371/journal.pone.0057439	http://dx.doi.org/10.1371/journal.pone.0057439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526942	Green Published, gold			2022-12-27	WOS:000316411600003
J	Zhang, XY; Shen, BR; Zhang, YC; Wan, XJ; Yao, QP; Wu, GL; Wang, JY; Chen, SG; Yan, ZQ; Jiang, ZL				Zhang, Xing-Yi; Shen, Bao-Rong; Zhang, Yu-Cheng; Wan, Xue-Jiao; Yao, Qing-Ping; Wu, Guang-Liang; Wang, Ji-Yao; Chen, Si-Guo; Yan, Zhi-Qiang; Jiang, Zong-Lai			Induction of Thoracic Aortic Remodeling by Endothelial-Specific Deletion of MicroRNA-21 in Mice	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; BLOOD-PRESSURE; SHEAR-STRESS; MOUSE MODEL; EXPRESSION; ELASTIN; MIGRATION; COLLAGEN	MicroRNAs (miRs) are known to have an important role in modulating vascular biology. MiR21 was found to be involved in the pathogenesis of proliferative vascular disease. The role of miR21 in endothelial cells (ECs) has well studied in vitro, but the study in vivo remains to be elucidated. In this study, miR21 endothelial-specific knockout mice were generated by Cre/ LoxP system. Compared with wild-type mice, the miR21 deletion in ECs resulted in structural and functional remodeling of aorta significantly, such as diastolic pressure dropping, maximal tension depression, endothelium-dependent relaxation impairment, an increase of opening angles and wall-thickness/inner diameter ratio, and compliance decrease, in the miR21 endothelial-specific knockout mice. Furthermore, the miR21 deletion in ECs induced down-regulation of collagen I, collagen III and elastin mRNA and proteins, as well as up-regulation of Smad7 and down-regulation of Smad2/5 in the aorta of miR21 endothelial-specific knockout mice. CTGF and downstream MMP/TIMP changes were also identified to mediate vascular remodeling. The results showed that miR21 is identified as a critical molecule to modulate vascular remodeling, which will help to understand the role of miR21 in vascular biology and the pathogenesis of vascular diseases.	[Zhang, Xing-Yi; Shen, Bao-Rong; Zhang, Yu-Cheng; Wan, Xue-Jiao; Yao, Qing-Ping; Wu, Guang-Liang; Wang, Ji-Yao; Chen, Si-Guo; Yan, Zhi-Qiang; Jiang, Zong-Lai] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yan, ZQ (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Inst Mechanobiol & Med Engn, Shanghai 200030, Peoples R China.	zqyan@sjtu.edu.cn	CHEN, SI/GZL-4800-2022		National Natural Science Foundation of China [11232010, 11172176, 30970703]; Ministry of Science & Technology of China [2006BAI23B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science & Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 11232010, 11172176, 30970703, www.nsfc.gov.cn) and National Key Project of Scientific and Technical Supporting Programs funded by Ministry of Science & Technology of China (NO. 2006BAI23B02, www.most.gov. cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Au CG, 2011, INT J EXP PATHOL, V92, P57, DOI 10.1111/j.1365-2613.2010.00750.x; BENDECK MP, 1991, CIRC RES, V69, P1165, DOI 10.1161/01.RES.69.4.1165; Benetos A, 2000, J AM COLL CARDIOL, V35, P673, DOI 10.1016/S0735-1097(99)00586-0; Benko R, 2004, LIFE SCI, V75, P1255, DOI 10.1016/j.lfs.2004.04.007; Briones AM, 2003, J PHYSIOL-LONDON, V552, P185, DOI 10.1113/jphysiol.2003.046904; Cavarretta E, 2012, ARTERIOSCL THROM VAS, V32, P165, DOI 10.1161/ATVBAHA.111.242008; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Dab H, 2012, J RENIN-ANGIO-ALDO S, V13, P19, DOI 10.1177/1470320311414752; Fan WH, 2002, J BIOL CHEM, V277, P9800, DOI 10.1074/jbc.M111213200; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; Guo XM, 2003, AM J PHYSIOL-HEART C, V285, pH2614, DOI 10.1152/ajpheart.00567.2003; Hishikawa K, 1999, CIRCULATION, V100, P2108, DOI 10.1161/01.CIR.100.20.2108; Horita HN, 2011, ARTERIOSCL THROM VAS, V31, P2909, DOI 10.1161/ATVBAHA.111.233585; Huang W, 2002, P NATL ACAD SCI USA, V99, P2603, DOI 10.1073/pnas.042684399; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jiang Z, 2000, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V17, P66; Jones JA, 2009, AM J PATHOL, V175, P1746, DOI 10.2353/ajpath.2009.081141; Kang H, 2012, CURR OPIN HEMATOL, V19, P224, DOI 10.1097/MOH.0b013e3283523e57; Kassab GS, 2006, J R SOC INTERFACE, V3, P719, DOI 10.1098/rsif.2006.0138; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; LAGE SG, 1993, AM J PHYSIOL, V265, pH232, DOI 10.1152/ajpheart.1993.265.1.H232; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Lu J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp482; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nigro P, 2011, ANTIOXID REDOX SIGN, V15, P1405, DOI 10.1089/ars.2010.3679; Qi W, 2007, NEPHROLOGY, V12, P267, DOI 10.1111/j.1440-1797.2007.00788.x; Reinke CA, 2008, DEV CELL, V15, P174, DOI 10.1016/j.devcel.2008.07.015; Rippe C, 2012, EXP GERONTOL, V47, P45, DOI 10.1016/j.exger.2011.10.004; Ritt M, 2009, HYPERTENSION, V54, P384, DOI 10.1161/HYPERTENSIONAHA.109.133025; Rodrigues Paula, 2008, Open Respir Med J, V2, P46, DOI 10.2174/1874306400802010046; Rodriguez-Vita J, 2005, CIRCULATION, V111, P2509, DOI 10.1161/01.CIR.0000165133.84978.E2; Safar ME, 2005, HYPERTENSION, V46, P205, DOI 10.1161/01.HYP.0000167992.80876.26; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Schober A, 2012, THROMB HAEMOSTASIS, V8, P107; Shifren A, 2008, J APPL PHYSIOL, V105, P1610, DOI 10.1152/japplphysiol.90563.2008; Silver FH, 2001, CRIT REV BIOMED ENG, V29, P279, DOI 10.1615/CritRevBiomedEng.v29.i3.10; Tan TW, 2009, J CELL BIOCHEM, V107, P345, DOI 10.1002/jcb.22132; Uchinaka A, 2012, MOL CELL BIOCHEM, V368, P203, DOI 10.1007/s11010-012-1361-4; VanLandingham LG, 2009, AM J PHYSIOL-REG I, V297, pR723, DOI 10.1152/ajpregu.00212.2009; Wang CJ, 2009, APPL IMMUNOHISTO M M, V17, P530, DOI 10.1097/PAI.0b013e3181a13bf2; Wang HQ, 2006, ENDOTHELIUM-J ENDOTH, V13, P171, DOI 10.1080/10623320600760282; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wei PC, 2011, INT J PARASITOL, V41, P1175, DOI 10.1016/j.ijpara.2011.07.002; Whaley-Connell A, 2008, AM J PHYSIOL-ENDOC M, V295, pE103, DOI 10.1152/ajpendo.00752.2007; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68	50	18	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59002	10.1371/journal.pone.0059002	http://dx.doi.org/10.1371/journal.pone.0059002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527070	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600024
J	Zou, W; Chen, HC; Hise, KB; Tang, HL; Foley, SL; Meehan, J; Lin, WJ; Nayak, R; Xu, JS; Fang, H; Chen, JJ				Zou, Wen; Chen, Hung-Chia; Hise, Kelley B.; Tang, Hailin; Foley, Steven L.; Meehan, Joe; Lin, Wei-Jiun; Nayak, Rajesh; Xu, Joshua; Fang, Hong; Chen, James J.			Meta-Analysis of Pulsed-Field Gel Electrophoresis Fingerprints Based on a Constructed Salmonella Database	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; DRAFT GENOME SEQUENCES; TANDEM REPEAT ANALYSIS; MICROARRAY ANALYSIS; UNITED-STATES; SEROTYPES; IDENTIFICATION; TYPHIMURIUM; STRAINS; DISCRIMINATION	A database was constructed consisting of 45,923 Salmonella pulsed-field gel electrophoresis (PFGE) patterns. The patterns, randomly selected from all submissions to CDC PulseNet during 2005 to 2010, included the 20 most frequent serotypes and 12 less frequent serotypes. Meta-analysis was applied to all of the PFGE patterns in the database. In the range of 20 to 1100 kb, serotype Enteritidis averaged the fewest bands at 12 bands and Paratyphi A the most with 19, with most serotypes in the 13215 range among the 32 serptypes. The 10 most frequent bands for each of the 32 serotypes were sorted and distinguished, and the results were in concordance with those from distance matrix and two-way hierarchical cluster analyses of the patterns in the database. The hierarchical cluster analysis divided the 32 serotypes into three major groups according to dissimilarity measures, and revealed for the first time the similarities among the PFGE patterns of serotype Saintpaul to serotypes Typhimurium, Typhimurium var. 5-, and I 4,[5], 12:i:-; of serotype Hadar to serotype Infantis; and of serotype Muenchen to serotype Newport. The results of the meta-analysis indicated that the pattern similarities/dissimilarities determined the serotype discrimination of PFGE method, and that the possible PFGE markers may have utility for serotype identification. The presence of distinct, serotype specific patterns may provide useful information to aid in the distribution of serotypes in the population and potentially reduce the need for laborious analyses, such as traditional serotyping.	[Zou, Wen; Chen, Hung-Chia; Meehan, Joe; Xu, Joshua; Chen, James J.] US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA; [Chen, Hung-Chia] China Med Univ, Granduate Inst Biostat, Taichung, Taiwan; [Chen, Hung-Chia] China Med Univ, Ctr Biostat, Taichung, Taiwan; [Hise, Kelley B.] Ctr Dis Control & Prevent CDC, PulseNet Database Unit, Enter Dis Lab Branch, Div Foodborne Waterborne & Environm Dis,Natl Ctr, Atlanta, GA USA; [Foley, Steven L.; Nayak, Rajesh] US FDA, Natl Ctr Toxicol Res, Div Microbiol, Jefferson, AR 72079 USA; [Lin, Wei-Jiun] Feng Chia Univ, Dept Appl Math, Taichung 40724, Taiwan; [Fang, Hong] US FDA, Natl Ctr Toxicol Res, Off Sci Coordinat, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA); China Medical University Taiwan; China Medical University Taiwan; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); Feng Chia University; US Food & Drug Administration (FDA)	Zou, W (corresponding author), US FDA, Natl Ctr Toxicol Res, Div Bioinformat & Biostat, Jefferson, AR 72079 USA.	wen.zou@fda.hhs.gov		Zou, Wen/0000-0002-3735-1133; Meehan, Joe/0000-0001-9602-3394; Foley, Steven/0000-0003-3146-4548	Food Protection Plan of FDA	Food Protection Plan of FDA	This work was funded by Food Protection Plan of FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20; Beranek A, 2009, INT J MED MICROBIOL, V299, P43, DOI 10.1016/j.ijmm.2008.06.002; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465, DOI 10.1128/JCM.38.7.2465-2467.2000; Cao GJ, 2012, J BACTERIOL, V194, P5146, DOI 10.1128/JB.01171-12; CDC Division of Foodborne Bacterial and Mycotic Diseases Atlanta GA, 2009, CDC 2009 SALM ANN SU; CDC Division of Foodborne Bacterial and Mycotic Diseases Atlanta GA, 2006, CDC SALM 2006 ANN SU; Chiou CS, 2010, INT J FOOD MICROBIOL, V142, P67, DOI 10.1016/j.ijfoodmicro.2010.06.001; de Boer P, 2000, J CLIN MICROBIOL, V38, P1940, DOI 10.1128/JCM.38.5.1940-1946.2000; Deza M.M., 2009, ENCY DISTANCES; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Foley SL, 2007, FOODBORNE PATHOG DIS, V4, P253, DOI 10.1089/fpd.2007.0085; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Frye JG, 2011, FOODBORNE PATHOG DIS, V8, P663, DOI 10.1089/fpd.2010.0695; Gaul SB, 2007, J CLIN MICROBIOL, V45, P472, DOI 10.1128/JCM.00962-06; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Gerner-Smidt P, 2010, FOODBORNE PATHOG DIS, V7, P609, DOI 10.1089/fpd.2010.9998; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hoffmann M, 2012, J BACTERIOL, V194, P3274, DOI 10.1128/JB.00419-12; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Janssen P, 1996, MICROBIOL-UK, V142, P1881, DOI 10.1099/13500872-142-7-1881; Janssen P, 1997, INT J SYST BACTERIOL, V47, P1179, DOI 10.1099/00207713-47-4-1179; Kerouanton A, 2007, FOODBORNE PATHOG DIS, V4, P293, DOI 10.1089/fpd.2007.0090; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kuehni-Boghenbor K, 2006, APPL ENVIRON MICROB, V72, P4061, DOI 10.1128/AEM.01996-05; Liebana E, 2001, J CLIN MICROBIOL, V39, P3609, DOI 10.1128/JCM.39.10.3609-3616.2001; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Lindstedt BA, 2000, J CLIN MICROBIOL, V38, P1623, DOI 10.1128/JCM.38.4.1623-1627.2000; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Stepan RM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-153; Timme RE, 2012, J BACTERIOL, V194, P5994, DOI 10.1128/JB.01289-12; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1; Zou W, 2009, J APPL MICROBIOL, V107, P906, DOI 10.1111/j.1365-2672.2009.04270.x; Zou W, 2012, J CLIN MICROBIOL, V50, P1524, DOI 10.1128/JCM.00111-12; Zou W, 2011, J INFECT DEV COUNTR, V5, P94, DOI 10.3855/jidc.1396; Zou W, 2010, J CLIN MICROBIOL, V48, P3122, DOI 10.1128/JCM.00645-10	39	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59224	10.1371/journal.pone.0059224	http://dx.doi.org/10.1371/journal.pone.0059224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516614	gold, Green Submitted, Green Published			2022-12-27	WOS:000316407400099
J	Chagnot, C; Agus, A; Renier, S; Peyrin, F; Talon, R; Astruc, T; Desvaux, M				Chagnot, Caroline; Agus, Allison; Renier, Sandra; Peyrin, Frederic; Talon, Regine; Astruc, Thierry; Desvaux, Mickael			In Vitro Colonization of the Muscle Extracellular Matrix Components by Escherichia coli O157:H7: The Influence of Growth Medium, Temperature and pH on Initial Adhesion and Induction of Biofilm Formation by Collagens I and III	PLOS ONE			English	Article							CLOSTRIDIUM-CELLULOLYTICUM; AUTOTRANSPORTER PROTEIN; CONNECTIVE-TISSUE; SECRETION SYSTEM; BEEF; ATTACHMENT; O157-H7; BINDING; EXPRESSION; VIRULENCE	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 are responsible for repeated food-poisoning cases often caused by contaminated burgers. EHEC infection is predominantly a pediatric illness, which can lead to life-threatening diseases. Ruminants are the main natural reservoir for EHEC and food contamination almost always originates from faecal contamination. In beef meat products, primary bacterial contamination occurs at the dehiding stage of slaughtering. The extracellular matrix (ECM) is the most exposed part of the skeletal muscles in beef carcasses. Investigating the adhesion to the main muscle fibrous ECM proteins, insoluble fibronectin, collagen I, III and IV, laminin-alpha 2 and elastin, results demonstrated that the preceding growth conditions had a great influence on subsequent bacterial attachment. In the tested experimental conditions, maximal adhesion to fibril-forming collagens I or III occurred at 25 degrees C and pH 7. Once initially adhered, exposure to lower temperatures, as applied to meat during cutting and storage, or acidification, as in the course of post-mortem physiological modifications of muscle, had no effect on detachment, except at pH(u). In addition, dense biofilm formation occurred on immobilized collagen I or III and was induced in growth medium supplemented with collagen I in solution. From this first comprehensive investigation of EHEC adhesion to ECM proteins with respect to muscle biology and meat processing, new research directions for the development of innovative practices to minimize the risk of meat contamination are further discussed.	[Chagnot, Caroline; Agus, Allison; Renier, Sandra; Talon, Regine; Desvaux, Mickael] INRA, Microbiol UR454, Clermont Ferrand, France; [Chagnot, Caroline; Peyrin, Frederic; Astruc, Thierry] INRA, Qual Prod Anim UR370, Clermont Ferrand, France	INRAE; INRAE	Desvaux, M (corresponding author), INRA, Microbiol UR454, Clermont Ferrand, France.	mickael.desvaux@clermont.inra.fr	DESVAUX, Mickael/A-8333-2008; Peyrin, Francoise/G-2823-2013; TALON, Régine/A-2427-2011; TALON, Régine/AAZ-4941-2020	DESVAUX, Mickael/0000-0003-2986-6417; Peyrin, Francoise/0000-0002-1988-3435; TALON, Régine/0000-0003-3122-4376; TALON, Régine/0000-0003-3122-4376	INRA (French National Institute for Agronomical Research) in part with the MICEL project; inter-departement CEPIA/MICA (Science and Process Engineering of Agricultural Products/Microbiology and Food Chain) AIP (Action Incitative Programmee)	INRA (French National Institute for Agronomical Research) in part with the MICEL project; inter-departement CEPIA/MICA (Science and Process Engineering of Agricultural Products/Microbiology and Food Chain) AIP (Action Incitative Programmee)	This work was supported by INRA (French National Institute for Agronomical Research) in part with the MICEL project funded by the inter-departement CEPIA/MICA (Science and Process Engineering of Agricultural Products/Microbiology and Food Chain) AIP (Action Incitative Programmee) 2010-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, MICROBIOL-SGM, V156, P408, DOI 10.1099/mic.0.033126-0; Anand SK, 2003, INT J FOOD MICROBIOL, V85, P1, DOI 10.1016/S0168-1605(02)00482-8; Ando H, 2007, MICROBIOL-SGM, V153, P464, DOI 10.1099/mic.0.2006/000893-0; Auty M, 2005, J FOOD PROTECT, V68, P482, DOI 10.4315/0362-028X-68.3.482; Bavaro Mary F, 2012, Curr Gastroenterol Rep, V14, P317, DOI 10.1007/s11894-012-0264-6; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; Bonifait L, 2008, APPL ENVIRON MICROB, V74, P4969, DOI 10.1128/AEM.00558-08; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Brady MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00226; Cabedo L, 1997, J FOOD PROTECT, V60, P102, DOI 10.4315/0362-028X-60.2.102; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chen JR, 2007, LWT-FOOD SCI TECHNOL, V40, P249, DOI 10.1016/j.lwt.2005.10.011; Chingcuanco F, 2012, MICROBIOL-SGM, V158, P2399, DOI 10.1099/mic.0.056374-0; Collington GK, 1998, GUT, V42, P200, DOI 10.1136/gut.42.2.200; Desvaux M, 2004, J MICROBIOL BIOTECHN, V14, P1200; Desvaux M, 2002, MICROB ECOL, V43, P271, DOI 10.1007/s00248-001-0043-7; Desvaux M, 2001, APPL ENVIRON MICROB, V67, P3846, DOI 10.1128/AEM.67.9.3846-3851.2001; Desvaux M, 2003, BIOFUTUR, V237, P34; Desvaux M, 2006, FEMS MICROBIOL LETT, V264, P22, DOI 10.1111/j.1574-6968.2006.00425.x; Desvaux M, 2006, BIOTECHNOL PROGR, V22, P1229, DOI 10.1021/bp060016e; Duffy G, 2006, MEAT SCI, V74, P76, DOI 10.1016/j.meatsci.2006.04.011; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Farfan MJ, 2011, INFECT IMMUN, V79, P3744, DOI 10.1128/IAI.05317-11; Frank J F, 2001, Adv Food Nutr Res, V43, P319, DOI 10.1016/S1043-4526(01)43008-7; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fratamico PM, 1996, J FOOD PROTECT, V59, P453, DOI 10.4315/0362-028X-59.5.453; Gobert AP, 2007, J IMMUNOL, V178, P8168, DOI 10.4049/jimmunol.178.12.8168; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Guedon E, 2000, BIOTECHNOL BIOENG, V67, P327, DOI 10.1002/(SICI)1097-0290(20000205)67:3<327::AID-BIT9>3.3.CO;2-L; GUINEE PAM, 1977, INFECT IMMUN, V15, P676; Hasman H, 1999, J BACTERIOL, V181, P4834, DOI 10.1128/JB.181.16.4834-4841.1999; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Henderson IR, 2004, DRUG DISCOV TODAY, V9, P241; Hennequin C, 2007, RES MICROBIOL, V158, P339, DOI 10.1016/j.resmic.2007.02.005; Hermos CR, 2011, J CLIN MICROBIOL, V49, P955, DOI 10.1128/JCM.02119-10; Hirakawa H, 2009, MICROBIOL-SGM, V155, P541, DOI 10.1099/mic.0.020420-0; House B, 2009, MICROBIOL-SGM, V155, P2907, DOI 10.1099/mic.0.025171-0; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Karch H, 2009, BERL MUNCH TIERARZTL, V122, P417, DOI 10.2376/0005-9366-122-417; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; LEEDLE JAZ, 1980, APPL ENVIRON MICROB, V39, P709, DOI 10.1128/AEM.39.4.709-719.1980; Li J, 1999, INT J FOOD MICROBIOL, V53, P185, DOI 10.1016/S0168-1605(99)00159-2; Lonergan EH, 2010, MEAT SCI, V86, P184, DOI 10.1016/j.meatsci.2010.05.004; Medina MB, 2002, BIOTECHNOL LETT, V24, P77, DOI 10.1023/A:1013871329099; Medina MB, 1998, BIOTECHNOL TECH, V12, P235, DOI 10.1023/A:1008829609813; Medina MB, 2001, INT J FOOD MICROBIOL, V69, P199, DOI 10.1016/S0168-1605(01)00497-4; Meng J, 1997, ANNU REV NUTR, V17, P255, DOI 10.1146/annurev.nutr.17.1.255; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; PARDEE AB, 1959, J MOL BIOL, V1, P165, DOI 10.1016/S0022-2836(59)80045-0; Payot S, 1999, APPL MICROBIOL BIOT, V52, P670, DOI 10.1007/s002530051577; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Purslow PP, 2010, J BODYW MOV THER, V14, P411, DOI 10.1016/j.jbmt.2010.01.005; Purslow PP, 2005, MEAT SCI, V70, P435, DOI 10.1016/j.meatsci.2004.06.028; Purslow PP, 2002, COMP BIOCHEM PHYS A, V133, P947, DOI 10.1016/S1095-6433(02)00141-1; Rhoades JR, 2009, FOOD MICROBIOL, V26, P357, DOI 10.1016/j.fm.2008.10.012; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rivas L, 2006, J FOOD PROTECT, V69, P999, DOI 10.4315/0362-028X-69.5.999; Tarr PI, 2009, KIDNEY INT, V75, pS29, DOI 10.1038/ki.2008.615; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; Torres AG, 2002, MOL MICROBIOL, V45, P951, DOI 10.1046/j.1365-2958.2002.03094.x; Totsika M, 2012, APPL ENVIRON MICROB, V78, P2179, DOI 10.1128/AEM.06680-11; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; Voermans NC, 2008, NEUROMUSCULAR DISORD, V18, P843, DOI 10.1016/j.nmd.2008.05.017; Wells TJ, 2008, ENVIRON MICROBIOL, V10, P589, DOI 10.1111/j.1462-2920.2007.01479.x; Wells TJ, 2009, ENVIRON MICROBIOL, V11, P1803, DOI 10.1111/j.1462-2920.2009.01905.x; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2009, J BACTERIOL, V191, P411, DOI 10.1128/JB.01306-08; Zulfakar SS, 2012, INT J FOOD MICROBIOL, V157, P210, DOI 10.1016/j.ijfoodmicro.2012.05.007	76	21	21	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59386	10.1371/journal.pone.0059386	http://dx.doi.org/10.1371/journal.pone.0059386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516631	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200146
J	Ketuly, KA; Hadi, AHA; Golbabapour, S; Hajrezaie, M; Hassandarvish, P; Ali, HM; Majid, NA; Abdulla, MA				Ketuly, Kamal A.; Hadi, A. Hamid A.; Golbabapour, Shahram; Hajrezaie, Maryam; Hassandarvish, Pouya; Ali, Hapipah Mohd; Majid, Nazia Abdul; Abdulla, Mahmood A.			Acute Toxicity and Gastroprotection Studies with a Newly Synthesized Steroid	PLOS ONE			English	Article							GASTRIC-MUCOSAL INJURY; ANTIULCEROGENIC ACTIVITY; LEAF EXTRACT; LESIONS; ULCER; DIPROPIONATE; PANTOPRAZOLE; ANTIOXIDANT; OMEPRAZOLE; APOPTOSIS	Background: Synthetic steroids, such as 9 alpha-bromobeclomethasonedipropionate, have shown gastroprotective activity. For example, the potent glucocorticoid steroid, beclomethasone dipropionate, has been used for treatment of bowel ulcerations. The purpose of the present study was to evaluate the effect of a synthetic steroid, (20S)-22-acetoxymethyl-6 beta-methoxy-3 alpha,5-dihydro-3'H-cyclopropa[3 alpha,5]-5 alpha-pregnane (AMDCP), on ethanol-induced gastric mucosa injuries in rats. Methodology/Principal Finding: Rats were divided into 8 groups. The negative control and ethanol control groups were administered Tween 20 (10%v/v) orally. The reference control group, 20 mg/kg omeprazole (10% Tween 20, 5 mL/kg), was administrated orally. The experimental groups received 1, 5, 10, 15 or 20 mg/kg of the AMDCP compound (10% Tween 20, 5 mL/kg). After 60 min, Tween 20 and absolute ethanol was given orally (5 mL/kg) to the negative control group and to the rest of the groups, and the rats were sacrificed an hour later. The acidity of gastric content, gastric wall mucus and areas of mucosal lesions were assessed. In addition, histology and immunohistochemistry of the gastric wall were assessed. Prostaglandin E2 (PGE(2)) and malondialdehyde (MDA) content were also measured. The ethanol control group exhibited severe mucosal lesion compared with the experimental groups with fewer mucosal lesions along with a reduction of edema and leukocyte infiltration. Immunohistochemical staining of Hsp70 and Bax proteins showed over-expression and under-expression, respectively, in the experimental groups. The experimental groups also exhibited high levels of PGE(2) as well as a reduced amount of MDA. AMDCP decreased the acidity and lipid peroxidation and increased the levels of antioxidant enzymes. Conclusion/Significance: The current investigation evaluated the gastroprotective effects of AMDCP on ethanol-induced gastric mucosal lesions in rats. This study also suggests that AMDCP might be useful as a gastroprotective agent.	[Ketuly, Kamal A.; Hadi, A. Hamid A.; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Golbabapour, Shahram; Hajrezaie, Maryam; Hassandarvish, Pouya; Abdulla, Mahmood A.] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Golbabapour, Shahram; Hajrezaie, Maryam; Majid, Nazia Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	Hassandarvish, Pouya/K-8112-2012; MAJID, NAZIA ABDUL/B-9215-2010	Hassandarvish, Pouya/0000-0003-0364-5587; MAJID, NAZIA ABDUL/0000-0002-6817-8046	University of Malaya HIR-MOHE [HIR-MOHE] [F000009-21001]; UMRG [RG035/10, RG0373/11]	University of Malaya HIR-MOHE [HIR-MOHE]; UMRG	This study was funded by the University of Malaya HIR-MOHE [HIR-MOHE (F000009-21001)] and UMRG grants (RG035/10 BIO and RG0373/11 HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Al-Attar A. M., 2011, Research Journal of Medicinal Plant, V5, P477, DOI 10.3923/rjmp.2011.477.490; AlRashdi AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786426; Bandyopadhyay Debashis, 2001, Current Molecular Medicine (Hilversum), V1, P501, DOI 10.2174/1566524013363483; Bandyopadhyay Debashis, 2002, Indian Journal of Experimental Biology, V40, P693; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Blandizzi C, 2000, FUNDAM CLIN PHARM, V14, P89, DOI 10.1111/j.1472-8206.2000.tb00396.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzozowski T, 2005, WORLD J GASTROENTERO, V11, P6450, DOI 10.3748/wjg.v11.i41.6450; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Demir Suleyman, 2003, Turk J Gastroenterol, V14, P39; Dursun H, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-36; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Huang JQ, 2001, BEST PRACT RES CL GA, V15, P355, DOI 10.1053/bega.2001.0184; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Jelski W, 2009, DIGEST DIS SCI, V54, P725, DOI 10.1007/s10620-008-0422-8; Ketuly KA, 1997, ACTA CRYSTALLOGR C, V53, P981, DOI 10.1107/S0108270197003570; Ketuly KA, 2011, J MED PLANTS RES, V5, P514; Ketuly KA, 2009, ACTA CRYSTALLOGR E, V65, pO1822, DOI 10.1107/S1600536809025987; Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P211; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Liang P, 1997, J CELL SCI, V110, P1431; Mahmood AA, 2010, J MED PLANTS RES, V4, P685; Mahmood AA, 2011, J MED PLANTS RES, V5, P2562; Maity P, 2003, MOL CELL BIOCHEM, V253, P329, DOI 10.1023/A:1026040723669; MARHUENDA E, 1993, PHYTOTHER RES, V7, P13, DOI 10.1002/ptr.2650070105; MILLER TA, 1985, AM J PHYSIOL, V249, pG137, DOI 10.1152/ajpgi.1985.249.1.G137; MORON F, 1983, ARCH INT PHARMACOD T, V265, P309; OECD Guideline for testing of chemicals, 2005, OECD GUID TEST CHEM; Rizzello F, 2002, ALIMENT PHARM THERAP, V16, P1109, DOI 10.1046/j.1365-2036.2002.01298.x; Sannomiya M, 2005, J ETHNOPHARMACOL, V97, P1, DOI 10.1016/j.jep.2004.09.053; Schubert ML, 2005, CURR OPIN GASTROEN, V21, P636, DOI 10.1097/01.mog.0000181713.89281.14; Silen W, 1981, World J Surg, V5, P165; Takeuchi K., 2002, GASTROINTESTINAL MUC, P227; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Targosz A, 2012, INFLAMM RES, V61, P955, DOI 10.1007/s00011-012-0487-x; Toma W, 2002, BIOL PHARM BULL, V25, P1151, DOI 10.1248/bpb.25.1151; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Yildirim A, 2007, J PHYSIOL PHARMACOL, V58, P105; Zhao W, 2009, ACTA BIOCH BIOPH SIN, V41, P301, DOI 10.1093/abbs/gmp014	42	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59296	10.1371/journal.pone.0059296	http://dx.doi.org/10.1371/journal.pone.0059296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516624	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200141
J	Robins, KJ; Hooks, DO; Rehm, BHA; Ackerley, DF				Robins, Katherine J.; Hooks, David O.; Rehm, Bernd H. A.; Ackerley, David F.			Escherichia coli NemA Is an Efficient Chromate Reductase That Can Be Biologically Immobilized to Provide a Cell Free System for Remediation of Hexavalent Chromium	PLOS ONE			English	Article							POLYHYDROXYALKANOATE SYNTHASE; RALSTONIA-EUTROPHA; CLASS-I; ENZYME; NITROREDUCTASE; DEHYDROGENASE; REGENERATION; TOLERANCE; POLYESTER; PROTEIN	Hexavalent chromium is a serious and widespread environmental pollutant. Although many bacteria have been identified that can transform highly water-soluble and toxic Cr(VI) to insoluble and relatively non-toxic Cr(III), bacterial bioremediation of Cr(VI) pollution is limited by a number of issues, in particular chromium toxicity to the remediating cells. To address this we sought to develop an immobilized enzymatic system for Cr(VI) remediation. To identify novel Cr(VI) reductase enzymes we first screened cell extracts from an Escherichia coli library of soluble oxidoreductases derived from a range of bacteria, but found that a number of these enzymes can reduce Cr(VI) indirectly, via redox intermediates present in the crude extracts. Instead, activity assays for 15 candidate enzymes purified as His6-tagged proteins identified E. coli NemA as a highly efficient Cr(VI) reductase (k(cat)/K-M = 1.1 x 10(5) M-1 s(-1) with NADH as cofactor). Fusion of nemA to the polyhydroxyalkanoate synthase gene phaC from Ralstonia eutropha enabled high-level biosynthesis of functionalized polyhydroxyalkanoate granules displaying stable and active NemA on their surface. When these granules were combined with either Bacillus subtilis glucose dehydrogenase or Candida boidinii formate dehydrogenase as a cofactor regenerating partner, high levels of chromate transformation were observed with only low initial concentrations of expensive NADH cofactor being required, the overall reaction being powered by consumption of the cheap sacrificial substrates glucose or formic acid, respectively. This system therefore offers promise as an economic solution for ex situ Cr(VI) remediation.	[Robins, Katherine J.; Ackerley, David F.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Hooks, David O.; Rehm, Bernd H. A.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Hooks, David O.; Rehm, Bernd H. A.] Victoria Univ Wellington, MacDiarmid Inst Adv Mat & Nanotechnol, Wellington, New Zealand; [Ackerley, David F.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand	Victoria University Wellington; Massey University; Victoria University Wellington; Victoria University Wellington	Ackerley, DF (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	david.ackerley@vuw.ac.nz	Ackerley, David F/B-6325-2015	Rehm, Bernd/0000-0003-3908-8903; Robins, Katherine/0000-0001-5049-4246; Hooks, David/0000-0002-7660-5706; Ackerley, David/0000-0002-6188-9902	Royal Society of New Zealand Marsden Fund [VUW0704]; Cancer Society of New Zealand [07/01]; Massey University; Victoria University of Wellington	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Cancer Society of New Zealand; Massey University; Victoria University of Wellington	Development of the oxidoreductase over-expression library was supported by the Royal Society of New Zealand Marsden Fund (Contract VUW0704; http://www.royalsociety.org.nz/programmes/funds/marsden/awards/award-2007-2/) and the Cancer Society of New Zealand (Contract 07/01; http://www.cancernz.org.nz/research/). The PHA bead isolation and characterization was funded by Massey University (www.massey.ac.nz). The remaining research was funded by Victoria University of Wellington (www.vuw.ac.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley DF, 2006, J BACTERIOL, V188, P3371, DOI 10.1128/JB.188.9.3371-3381.2006; Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004; Amara AA, 2003, BIOCHEM J, V374, P413, DOI 10.1042/BJ20030431; Barak Y, 2006, APPL ENVIRON MICROB, V72, P7074, DOI 10.1128/AEM.01334-06; Blatchford PA, 2012, BIOTECHNOL BIOENG, V109, P1101, DOI 10.1002/bit.24402; Brodie EL, 2011, CHEMOSPHERE, V85, P660, DOI 10.1016/j.chemosphere.2011.07.021; Brown SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/mcp.M500394-MCP200; Cheng YJ, 2012, ELEMENTS, V8, P107, DOI 10.2113/gselements.8.2.107; Gonzalez CF, 2003, ACTA BIOTECHNOL, V23, P233, DOI 10.1002/abio.200390030; Greenberg AD., 1981, STANDARD METHODS EXA, V15, P187; Jahns AC, 2008, BIOCONJUGATE CHEM, V19, P2072, DOI 10.1021/bc8001979; Jahns AC, 2009, APPL ENVIRON MICROB, V75, P5461, DOI 10.1128/AEM.01072-09; Kwak YH, 2003, APPL ENVIRON MICROB, V69, P4390, DOI 10.1128/AEM.69.8.4390-4395.2003; Lee SY, 1996, TRENDS BIOTECHNOL, V14, P98, DOI 10.1016/0167-7799(96)80930-9; Liu GF, 2009, BIORESOURCE TECHNOL, V100, P2791, DOI 10.1016/j.biortech.2008.12.040; Liu KJ, 2001, MOL CELL BIOCHEM, V222, P41, DOI 10.1023/A:1017994720562; Liu WF, 2007, BIOTECHNOL ADV, V25, P369, DOI 10.1016/j.biotechadv.2007.03.002; LOFROTH G, 1978, MUTAT RES, V53, P65; McCarty P. L., 1994, Handbook of bioremediation., P87; Miura K, 1997, BIOL PHARM BULL, V20, P110; OKRENT D, 1993, J HAZARD MATER, V34, P363, DOI 10.1016/0304-3894(93)85099-Z; Opperman DJ, 2008, J BACTERIOL, V190, P3076, DOI 10.1128/JB.01766-07; Opperman DJ, 2008, FEMS MICROBIOL LETT, V280, P210, DOI 10.1111/j.1574-6968.2007.01063.x; Peters V, 2006, APPL ENVIRON MICROB, V72, P1777, DOI 10.1128/AEM.72.3.1777-1783.2006; Peters V, 2005, FEMS MICROBIOL LETT, V248, P93, DOI 10.1016/j.femsle.2005.05.027; Prosser GA, 2010, J BIOTECHNOL, V150, P190, DOI 10.1016/j.jbiotec.2010.08.007; Prosser GA, 2010, BIOCHEM PHARMACOL, V79, P678, DOI 10.1016/j.bcp.2009.10.008; Prosser GA, 2013, BIOCHEM PHARMACOL, V85, P1091, DOI 10.1016/j.bcp.2013.01.029; Race PR, 2007, J MOL BIOL, V368, P481, DOI 10.1016/j.jmb.2007.02.012; Ramirez-Diaz MI, 2008, BIOMETALS, V21, P321, DOI 10.1007/s10534-007-9121-8; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; RICHARD FC, 1991, WATER RES, V25, P807, DOI 10.1016/0043-1354(91)90160-R; Riley RG, 1992, DOEER0547T; Schirwitz K, 2007, PROTEIN SCI, V16, P1146, DOI 10.1110/ps.062741707; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Sedlacek V, 2010, ARCH MICROBIOL, V192, P919, DOI 10.1007/s00203-010-0622-4; STEARNS DM, 1994, CHEM RES TOXICOL, V7, P219, DOI 10.1021/tx00038a016; van der Donk WA, 2003, CURR OPIN BIOTECH, V14, P421, DOI 10.1016/S0958-1669(03)00094-6; Viti C., 2007, ENV BIOREMEDIATION T, P57; Weckbecker A, 2005, METH BIOTEC, V17, P225; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Yang CP, 2007, LANGMUIR, V23, P4480, DOI 10.1021/la062925j; Yuan W, 2001, ARCH BIOCHEM BIOPHYS, V394, P87, DOI 10.1006/abbi.2001.2522; Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t	44	58	62	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59200	10.1371/journal.pone.0059200	http://dx.doi.org/10.1371/journal.pone.0059200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23527133	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200136
J	Wyrebek, M; Bidochka, MJ				Wyrebek, Michael; Bidochka, Michael J.			Variability in the Insect and Plant Adhesins, Mad1 and Mad2, within the Fungal Genus Metarhizium Suggest Plant Adaptation as an Evolutionary Force	PLOS ONE			English	Article							M-FLAVOVIRIDE; ANISOPLIAE; RHIZOSPHERE; ELEMENT; TRANSCRIPTION; EXPRESSION; DESTRUXINS; ROBERTSII; VIRULENCE; PATHOGEN	Several species of the insect pathogenic fungus Metarhizium are associated with certain plant types and genome analyses suggested a bifunctional lifestyle; as an insect pathogen and as a plant symbiont. Here we wanted to explore whether there was more variation in genes devoted to plant association (Mad2) or to insect association (Mad1) overall in the genus Metarhizium. Greater divergence within the genus Metarhizium in one of these genes may provide evidence for whether host insect or plant is a driving force in adaptation and evolution in the genus Metarhizium. We compared differences in variation in the insect adhesin gene, Mad1, which enables attachment to insect cuticle, and the plant adhesin gene, Mad2, which enables attachment to plants. Overall variation for the Mad1 promoter region (7.1%), Mad1 open reading frame (6.7%), and Mad2 open reading frame (7.4%) were similar, while it was higher in the Mad2 promoter region (9.9%). Analysis of the transcriptional elements within the Mad2 promoter region revealed variable STRE, PDS, degenerative TATA box, and TATA box-like regions, while this level of variation was not found for Mad1. Sequences were also phylogenetically compared to EF-1 alpha, which is used for species identification, in 14 isolates representing 7 different species in the genus Metarhizium. Phylogenetic analysis demonstrated that the Mad2 phylogeny is more congruent with 5' EF-1 alpha than Mad1. This would suggest that Mad2 has diverged among Metarhizium lineages, contributing to clade- and species-specific variation, while it appears that Mad1 has been largely conserved. While other abiotic and biotic factors cannot be excluded in contributing to divergence, these results suggest that plant relationships, rather than insect host, have been a major driving factor in the divergence of the genus Metarhizium.	[Wyrebek, Michael; Bidochka, Michael J.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada	Brock University	Bidochka, MJ (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	bidochka@brocku.ca		Bidochka, Michael/0000-0002-2544-9977	NSERC (Natural Sciences and Engineering Research Council) of Canada	NSERC (Natural Sciences and Engineering Research Council) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The sole source of funding was NSERC (Natural Sciences and Engineering Research Council) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barelli L, 2011, FUNGAL BIOL-UK, V115, P1174, DOI 10.1016/j.funbio.2011.08.003; Berry V, 2006, IEEE ACM T COMPUT BI, V3, P289, DOI 10.1109/TCBB.2006.39; Bidochka MJ, 2001, APPL ENVIRON MICROB, V67, P1335, DOI 10.1128/AEM.67.3.1335-1342.2001; Bischoff JF, 2006, MYCOLOGIA, V98, P737, DOI 10.3852/mycologia.98.5.737; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; BOORSTEIN WR, 1990, EMBO J, V9, P2543, DOI 10.1002/j.1460-2075.1990.tb07435.x; BRIDGE PD, 1993, J GEN MICROBIOL, V139, P1163, DOI 10.1099/00221287-139-6-1163; Bridge PD, 1997, BIODIVERS CONSERV, V6, P177, DOI 10.1023/A:1018387918686; Bruck DJ, 2010, BIOCONTROL, V55, P103, DOI 10.1007/s10526-009-9236-7; Bruck DJ, 2005, BIOL CONTROL, V32, P155, DOI 10.1016/j.biocontrol.2004.09.003; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; FEGAN M, 1993, J GEN MICROBIOL, V139, P2075, DOI 10.1099/00221287-139-9-2075; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hu G, 2002, APPL ENVIRON MICROB, V68, P6383, DOI 10.1128/AEM.68.12.6383-6387.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal SCM, 1997, MYCOL RES, V101, P257, DOI 10.1017/S0953756296002560; LEAL SCM, 1994, MYCOL RES, V98, P1077, DOI 10.1016/S0953-7562(09)80436-X; LIN KJ, 1986, J INVERTEBR PATHOL, V47, P120, DOI 10.1016/0022-2011(86)90170-9; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; Nakazato L, 2006, APPL MICROBIOL BIOT, V72, P521, DOI 10.1007/s00253-005-0292-3; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nishi O, 2011, APPL ENTOMOL ZOOL, V46, P301, DOI 10.1007/s13355-011-0045-y; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; RIBA G, 1986, MYCOPATHOLOGIA, V96, P161, DOI 10.1007/BF00437383; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; Small CLN, 2004, CURR MICROBIOL, V48, P428, DOI 10.1007/s00284-003-4228-9; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; TIGANOMILANI MS, 1995, J INVERTEBR PATHOL, V65, P206, DOI 10.1006/jipa.1995.1031; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06; Wang SB, 2011, P NATL ACAD SCI USA, V108, P20449, DOI 10.1073/pnas.1113824108; Wang SB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002097; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0	40	17	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59357	10.1371/journal.pone.0059357	http://dx.doi.org/10.1371/journal.pone.0059357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516629	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200145
J	Blair, YI; McMahon, AD; Macpherson, LMD				Blair, Yvonne I.; McMahon, Alex D.; Macpherson, Lorna M. D.			Comparison and Relative Utility of Inequality Measurements: As Applied to Scotland's Child Dental Health	PLOS ONE			English	Article							ORAL-HEALTH; CARIES; DEPRIVATION; IMPROVEMENT; PROGRAM; INDEX	This study compared and assessed the utility of tests of inequality on a series of very large population caries datasets. National cross-sectional caries datasets for Scotland's 5-year-olds in 1993/94 (n = 5,078); 1995/96 (n = 6,240); 1997/98 (n = 6,584); 1999/00 (n = 6,781); 2002/03 (n = 9,747); 2003/04 (n = 10,956); 2005/06 (n = 10,945) and 2007/08 (n = 12,067) were obtained. Outcomes were based on the d(3)mft metric (i.e. the number of decayed, missing and filled teeth). An area-based deprivation category (DepCat) measured the subjects' socioeconomic status (SES). Simple absolute and relative inequality, Odds Ratios and the Significant Caries Index (SIC) as advocated by the World Health Organization were calculated. The measures of complex inequality applied to data were: the Slope Index of Inequality (absolute) and a variety of relative inequality tests i.e. Gini coefficient; Relative Index of Inequality; concentration curve; Koolman & Doorslaer's transformed Concentration Index; Receiver Operator Curve and Population Attributable Risk (PAR). Additional tests used were plots of SIC deciles (SIC10) and a Scottish Caries Inequality Metric (SCIM10). Over the period, mean d(3)mft improved from 3.1(95% CI 3.0-3.2) to 1.9(95% CI 1.8-1.9) and d(3)mft = 0% from 41.1(95% CI 39.8-42.3) to 58.3(95% CI 57.8-59.7). Absolute simple and complex inequality decreased. Relative simple and complex inequality remained comparatively stable. Our results support the use of the SII and RII to measure complex absolute and relative SES inequalities alongside additional tests of complex relative inequality such as PAR and Koolman and Doorslaer's transformed CI. The latter two have clear interpretations which may influence policy makers. Specialised dental metrics (i.e. SIC, SIC10 and SCIM10) permit the exploration of other important inequalities not determined by SES, and could be applied to many other types of disease where ranking of morbidity is possible e.g. obesity. More generally, the approaches described may be applied to study patterns of health inequality affecting worldwide populations.	[Blair, Yvonne I.] Oral Hlth Directorate, Glasgow, Lanark, Scotland; [McMahon, Alex D.; Macpherson, Lorna M. D.] Univ Glasgow, Sch Dent, Community Oral Hlth Sect, Glasgow, Lanark, Scotland	University of Glasgow	Blair, YI (corresponding author), Oral Hlth Directorate, Clutha House, Glasgow, Lanark, Scotland.	y.blair@dental.gla.ac.uk			SDECC	SDECC	The Scottish Dental Epidemiology Co-ordinating Committee (SDECC) performs the function of Data Controller for the caries datasets used for this study, within the terms of the Data Protection Act, 1998. The authors acknowledge the support of the SDECC in granting release of these data for this study.	Acheson D, 1998, INDEPENDENT INQUIRY; Antunes JLF, 2005, COMMUNITY DENT HLTH, V22, P94; Antunes JLF, 2004, COMMUNITY DENT ORAL, V32, P41, DOI 10.1111/j.1600-0528.2004.00125.x; Armfield JM, 2009, J PUBLIC HEALTH DENT, V69, P125, DOI 10.1111/j.1752-7325.2008.00110.x; Bagramian RA, 2009, AM J DENT, V22, P3; Blair YI, 2012, 199394200708 U GLASG; Bratthall D, 2000, INT DENT J, V50, P378, DOI 10.1111/j.1875-595X.2000.tb00572.x; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Cheng NF, 2008, AM J EPIDEMIOL, V168, P906, DOI 10.1093/aje/kwn207; Child Poverty Action Group, 2012, CHILD POV FACTS FIG; Do LG, 2010, J DENT RES, V89, P959, DOI 10.1177/0022034510371280; EDELSTEIN BL, 1995, PUBLIC HEALTH REP, V110, P522; Gakidou E, 2001, GPE DISCUSSION PAPER, V18; Harper S, 2005, NCI CANC SURVEILLANC, V6; Harper S, 2008, AM J EPIDEMIOL, V167, P889, DOI 10.1093/aje/kwn016; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Koolman X, 2004, HEALTH ECON, V13, P649, DOI 10.1002/hec.884; Levin KA, 2009, EUR J PUBLIC HEALTH, V19, P337, DOI 10.1093/eurpub/ckp035; Low A, 2004, J PUBLIC HEALTH-UK, V26, P388, DOI 10.1093/pubmed/fdh175; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Macpherson LMD, 2012, REPORT 2012 DETAILED; Marmot M, 2010, FAIR SOC HLTH LIVES; Marmot MC, 2008, CLOS GAP GEN HLTH EQ; Maxwell S, 1999, OVERSEAS DEV I POVER; McLoone P., 2004, CARSTAIRS SCORES SCO; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mitropoulos CM, 1992, BASCD TRAINERS PACK; Morgan MZ, 2005, COMMUNITY DENT HLTH, V22, P246; Nugent Z, 1996, CARIES RES, V30, P294; Nugent Zoann Jane, 2002, Community Dent Health, V19, P43; Pattussi MP, 2001, SOC SCI MED, V53, P915, DOI 10.1016/S0277-9536(00)00391-9; Perera I, 2008, CARIES RES, V42, P105, DOI 10.1159/000116874; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; PETERSEN PE, 1990, COMMUNITY DENT ORAL, V18, P153, DOI 10.1111/j.1600-0528.1990.tb00042.x; Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P900, DOI 10.1136/jech.2004.023036; Regidor E, 2004, J EPIDEMIOL COMMUN H, V58, P858, DOI 10.1136/jech.2003.015347; Schou L, 1994, Community Dent Health, V11, P97; Scottish Executive, 2003, WORK TOG HLTH CAR SC; Scottish Executive, 2003, IMPR HLTH SCOTL CHAL; Scottish Executive, 2005, ACT PLAN IMPR OR HLT; Scottish Government, 2008, EQ WELL REP MIN TASK, V2; Shaw D, 2009, BIOETHICS, V23, P131, DOI 10.1111/j.1467-8519.2008.00715.x; Shaw M, 2007, HDB INEQUALITY SOCIO; The Scottish Government, 2012, SOC WELF INC POV STA; The Scottish Government, 2012, STAT PUBL NAT STAT P; The Scottish Office, 1999, HLTH SCOTLAND WHIT P; The Scottish Office, 1995, SCOTL HLTH CHALL ALL; Turner S, 2010, BRIT DENT J, V209, P79, DOI 10.1038/sj.bdj.2010.629; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Watt R, 1999, BRIT DENT J, V187, P6, DOI 10.1038/sj.bdj.4800191a; Williams Ruth F G, 2006, Int J Equity Health, V5, P5	52	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58593	10.1371/journal.pone.0058593	http://dx.doi.org/10.1371/journal.pone.0058593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520524	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000318679900084
J	Diomede, L; Rigacci, S; Romeo, M; Stefani, M; Salmona, M				Diomede, Luisa; Rigacci, Stefania; Romeo, Margherita; Stefani, Massimo; Salmona, Mario			Oleuropein Aglycone Protects Transgenic C. elegans Strains Expressing A beta 42 by Reducing Plaque Load and Motor Deficit	PLOS ONE			English	Article							INCLUSION-BODY MYOSITIS; AMYLOID-INDUCED TOXICITY; BILOBA EXTRACT EGB-761; VIRGIN OLIVE OIL; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; MEDITERRANEAN DIET; COGNITIVE IMPAIRMENT; MOLECULAR PATHOLOGY; MASS-SPECTROMETRY	The presence of amyloid aggregates of the 42 amino acid peptide of amyloid beta (A beta 42) in the brain is the characteristic feature of Alzheimer's disease (AD). Amyloid beta (A beta deposition is also found in muscle fibers of individuals affected by inclusion body myositis (sIBM), a rare muscular degenerative disease affecting people over 50. Both conditions are presently lacking an effective therapeutic treatment. There is increasing evidence to suggest that natural polyphenols may prevent the formation of toxic amyloid aggregates; this applies also to oleuropein aglycone (OLE), the most abundant polyphenol in extra virgin olive oil, previously shown to hinder amylin and A beta aggregation. Here we evaluated the ability of OLE to interfere with A beta proteotoxicity in vivo by using the transgenic CL2006 and CL4176 strains of Caenorhabditis elegans, simplified models of AD and of sIBM, which express human A beta in the cytoplasm of body wall muscle cells. OLE-fed CL2006 worms displayed reduced A beta plaque deposition, less abundant toxic A beta oligomers, remarkably decreased paralysis and increased lifespan with respect to untreated animals. A protective effect was also observed in CL4176 worms but only when OLE was administered before the induction of the A beta transgene expression. These effects were specific, dose-related, and not mediated by the known polyphenolic anti-oxidant activity, suggesting that, in this model organism, OLE interferes with the A beta aggregation skipping the appearance of toxic species, as already shown in vitro for A beta 42.	[Diomede, Luisa; Romeo, Margherita; Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Rigacci, Stefania; Stefani, Massimo] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Rigacci, Stefania; Stefani, Massimo] Res Ctr Mol Basis Neurodegenerat CIMN, Florence, Italy; [Stefani, Massimo] Natl Inst Biostruct & Biosyst, Rome, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Florence	Diomede, L (corresponding author), Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy.	luisa.diomede@marionegri.it	salmona, mario/ABI-4066-2020; salmona, mario/AAA-7116-2020; Diomede, Luisa/P-3417-2014	salmona, mario/0000-0002-9098-9873; Diomede, Luisa/0000-0002-2258-0531; STEFANI, MASSIMO/0000-0002-4490-1922; Romeo, Margherita/0000-0002-3020-8545	Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute''; Banca Intesa San Paolo [2009-2012]; NIH Office of Research Infrastructure Program [P40 OD010440]; Cariplo Foundation [2009-2543]	Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute''(Regione Toscana); Banca Intesa San Paolo; NIH Office of Research Infrastructure Program; Cariplo Foundation(Fondazione Cariplo)	This work was partly supported by grants from the Regione Toscana: "Programma per la Ricerca Regionale in Materia di Salute 2009,'' from the Cariplo Foundation, Project n. 2009-2543 and from the Banca Intesa San Paolo, Grant 2009-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ada De Luigi for X-34 synthesis. C. elegans strains and E. coli OP50 were provided by CGC, which is funded by NIH Office of Research Infrastructure Program (P40 OD010440).	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Bazoti FN, 2006, J AM SOC MASS SPECTR, V17, P568, DOI 10.1016/j.jasms.2005.11.016; Bazoti FN, 2008, J AM SOC MASS SPECTR, V19, P1078, DOI 10.1016/j.jasms.2008.03.011; Beauchamp GK, 2005, NATURE, V437, P45, DOI 10.1038/437045a; Berr C, 2009, DEMENT GERIATR COGN, V28, P357, DOI 10.1159/000253483; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; D'Agostino C, 2011, ACTA NEUROPATHOL, V122, P627, DOI 10.1007/s00401-011-0874-3; Daccache A, 2011, NEUROCHEM INT, V58, P700, DOI 10.1016/j.neuint.2011.02.010; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Engel WK, 2006, NEUROLOGY, V66, pS20, DOI 10.1212/01.wnl.0000192260.33106.bb; Farr SA, 2012, J ALZHEIMERS DIS, V28, P81, DOI 10.3233/JAD-2011-110662; Feart C, 2010, CURR OPIN CLIN NUTR, V13, P14, DOI 10.1097/MCO.0b013e3283331fe4; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Kitazawa M, 2006, AM J PATHOL, V168, P1986, DOI 10.2353/ajpath.2006.051232; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Ling Y, 2003, INT J BIOCHEM CELL B, V35, P1505, DOI 10.1016/S1357-2725(03)00133-X; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Morita M, 2009, BRAIN RES, V1295, P186, DOI 10.1016/j.brainres.2009.08.002; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Omar Syed Haris, 2010, Sci Pharm, V78, P133, DOI 10.3797/scipharm.0912-18; Papandreou MA, 2009, BEHAV BRAIN RES, V198, P352, DOI 10.1016/j.bbr.2008.11.013; Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Rigacci S, 2011, CURR ALZHEIMER RES, V8, P841, DOI 10.2174/156720511798192682; Rigacci S, 2010, J NUTR BIOCHEM, V21, P726, DOI 10.1016/j.jnutbio.2009.04.010; Scarmeas N, 2011, ANN NEUROL, V69, P257, DOI 10.1002/ana.22317; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Soler-Rivas C, 2000, J SCI FOOD AGR, V80, P1013, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1013::AID-JSFA571>3.0.CO;2-C, 10.1002/(SICI)1097-0010(20000515)80:7&lt;1013::AID-JSFA571&gt;3.0.CO;2-C]; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Zhu JTT, 2009, NEUROSCI LETT, V461, P172, DOI 10.1016/j.neulet.2009.06.010	53	98	101	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58893	10.1371/journal.pone.0058893	http://dx.doi.org/10.1371/journal.pone.0058893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520540	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900100
J	Koshiba, M; Shirakawa, Y; Mimura, K; Senoo, A; Karino, G; Nakamura, S				Koshiba, Mamiko; Shirakawa, Yuka; Mimura, Koki; Senoo, Aya; Karino, Genta; Nakamura, Shun			Familiarity Perception Call Elicited under Restricted Sensory Cues in Peer-Social Interactions of the Domestic Chick	PLOS ONE			English	Article							BIOLOGICAL MOTION; GALLUS-GALLUS; STIMULATION; RECOGNITION; BEHAVIOR; STRESS; HEN	Social cognitive mechanisms are central to understanding developmental abnormalities, such as autistic spectrum disorder. Peer relations besides parent-infant or pair-bonding interactions are pivotal social relationships that are especially well developed in humans. Cognition of familiarity forms the basis of peer socialization. Domestic chick (Gallus gallus) studies have contributed to our understanding of the developmental process in sensory-motor cognition but many processes remain unknown. In this report, we used chicks, as they are precocial birds, and we could therefore focus on peer interaction without having to consider parenting. The subject chick behavior towards familiar and unfamiliar reference peers was video-recorded, where the subject and the reference were separated by either an opaque or transparent wall. Spectrogram and behavior correlation analyses based on principal component analysis, revealed that chicks elicited an intermediate contact call and a morphologically different distress call, more frequently towards familiar versus unfamiliar chicks in acoustic only conditions. When both visual and acoustic cues were present, subject chicks exhibited approaching and floor pecking behavior, while eliciting joyful (pleasant) calls, irrespective of whether reference peers were familiar or unfamiliar. Our result showed that chicks recognized familiarity using acoustic cues and expressed cognition through modified distress calls. These finding suggests that peer affiliation may be established by acoustic recognition, independent of visual face recognition, and that eventually, both forms of recognition are integrated, with modulation of acoustic recognition.	[Koshiba, Mamiko; Shirakawa, Yuka; Mimura, Koki; Senoo, Aya; Karino, Genta; Nakamura, Shun] Tokyo Univ Agr & Technol, Tokyo, Japan; [Koshiba, Mamiko; Nakamura, Shun] NCNP, Tokyo, Japan	Tokyo University of Agriculture & Technology; National Center for Neurology & Psychiatry - Japan	Koshiba, M (corresponding author), Tokyo Univ Agr & Technol, Tokyo, Japan.	koshiba@cc.tuat.ac.jp	Nakamura, Shun/GVN-8593-2022; Koshiba, Mamiko/AAV-4841-2021		MEXT [21200017]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [22-6]; Comprehensive study on making practical guideline for developmental disorders based on the neuroscientific findings	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Comprehensive study on making practical guideline for developmental disorders based on the neuroscientific findings	This study was supported by MEXT, Grant-in-Aid for Scientific Research on Innovative Areas (21200017), Comprehensive study on making practical guideline for developmental disorders based on the neuroscientific findings, and by the Intramural Research Grant (22-6) for Neurological and Psychiatric Disorders of NCNP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW RJ, 1969, ANN NY ACAD SCI, V159, P625, DOI 10.1111/j.1749-6632.1969.tb12967.x; Bolhuis JJ, 1999, BEHAV BRAIN RES, V98, P245, DOI 10.1016/S0166-4328(98)00090-4; BOLHUIS JJ, 1999, DEV ANIMAL BEHAV REA, P176; Bouchet H, 2012, J COMP PSYCHOL, V126, P45, DOI 10.1037/a0025018; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Brown J, 2010, ANIM COGN, V13, P555, DOI 10.1007/s10071-009-0306-0; COLLIAS N, 1953, BEHAVIOUR, V5, P175, DOI 10.1163/156853953X00104; Ellis JMS, 2012, BRAIN BEHAV EVOLUT, V79, P128, DOI 10.1159/000334078; Feltenstein MW, 2005, PSYCHOPHARMACOLOGY, V181, P153, DOI 10.1007/s00213-005-2227-1; Field SE, 2007, NEUROBIOL LEARN MEM, V88, P321, DOI 10.1016/j.nlm.2007.04.001; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; KENT JP, 1989, BEHAVIOUR, V108, P1, DOI 10.1163/156853989X00015; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kondo N, 2012, P ROY SOC B-BIOL SCI, V279, P1937, DOI 10.1098/rspb.2011.2419; Kondo N, 2009, JPN PSYCHOL RES, V51, P197, DOI 10.1111/j.1468-5884.2009.00399.x; Konishi M., 1963, Z TIERPSYCHOL, V20, P349, DOI DOI 10.1111/J.1439-0310.1963.TB01156.X; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Koshiba M, 2011, PROG NEURO-PSYCHOPH, V35, P1499, DOI 10.1016/j.pnpbp.2011.01.021; Lemasson A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-362; MacKay D. M., 1972, NONVERBAL COMMUNICAT, P3; Marx G, 2001, APPL ANIM BEHAV SCI, V75, P61, DOI 10.1016/S0168-1591(01)00180-0; Mascalzoni E, 2010, P NATL ACAD SCI USA, V107, P4483, DOI 10.1073/pnas.0908792107; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; MUIR D, 1979, CAN J PSYCHOL, V33, P320, DOI 10.1037/h0081729; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Salva OR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018802; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; VALLORTIGARA G, 1994, NEUROPSYCHOLOGIA, V32, P417, DOI 10.1016/0028-3932(94)90087-6; Vallortigara G., 1988, ETHOLOGY, V78, P241; Yazaki Y, 1999, J COMP PHYSIOL A, V184, P13, DOI 10.1007/s003590050302	35	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58847	10.1371/journal.pone.0058847	http://dx.doi.org/10.1371/journal.pone.0058847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520539	gold, Green Submitted, Green Published			2022-12-27	WOS:000318679900099
J	Hossein-nezhad, A; Spira, A; Holick, MF				Hossein-nezhad, Arash; Spira, Avrum; Holick, Michael F.			Influence of Vitamin D Status and Vitamin D-3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial	PLOS ONE			English	Article							GENE-EXPRESSION; TARGET GENES; D DEFICIENCY; MICROARRAY; PROLIFERATION; PREVENTION; GROWTH; EGR-1; CHIP	Background: Although there have been numerous observations of vitamin D deficiency and its links to chronic diseases, no studies have reported on how vitamin D status and vitamin D-3 supplementation affects broad gene expression in humans. The objective of this study was to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in healthy adults. (Trial registration: ClinicalTrials.gov NCT01696409). Methods and Findings: A randomized, double-blind, single center pilot trial was conducted for comparing vitamin D supplementation with either 400 IUs (n = 3) or 2000 IUs (n = 5) vitamin D-3 daily for 2 months on broad gene expression in the white blood cells collected from 8 healthy adults in the winter. Microarrays of the 16 buffy coats from eight subjects passed the quality control filters and normalized with the RMA method. Vitamin D-3 supplementation that improved serum 25-hydroxyvitamin D concentrations was associated with at least a 1.5 fold alteration in the expression of 291 genes. There was a significant difference in the expression of 66 genes between subjects at baseline with vitamin D deficiency (25(OH)D<20 ng/ml) and subjects with a 25(OH)D>20 ng/ml. After vitamin D-3 supplementation gene expression of these 66 genes was similar for both groups. Seventeen vitamin D-regulated genes with new candidate vitamin D response elements including TRIM27, CD83, COPB2, YRNA and CETN3 which have been shown to be important for transcriptional regulation, immune function, response to stress and DNA repair were identified. Conclusion/Significance: Our data suggest that any improvement in vitamin D status will significantly affect expression of genes that have a wide variety of biologic functions of more than 160 pathways linked to cancer, autoimmune disorders and cardiovascular disease with have been associated with vitamin D deficiency. This study reveals for the first time molecular finger prints that help explain the nonskeletal health benefits of vitamin D.	[Hossein-nezhad, Arash; Holick, Michael F.] Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Nutr & Diabet,Vitamin Skin & Bone, Boston, MA 02215 USA; [Spira, Avrum] Boston Univ, Med Ctr, Dept Med, Sect Computat Biomed, Boston, MA USA	Boston University; Boston University	Holick, MF (corresponding author), Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Nutr & Diabet,Vitamin Skin & Bone, Boston, MA 02215 USA.	mfholick@bu.edu	Shirvani, Arash/AAD-6246-2020; Shirvani, Arash H/A-2847-2010	Shirvani, Arash H/0000-0003-2847-4737; Holick, Michael/0000-0001-6023-9062; Spira, Avrum/0000-0003-1467-0489	National Institutes of Health Clinical Translational Science Institute [UL-1-RR-25711]	National Institutes of Health Clinical Translational Science Institute	This work was supported by a pilot grant from the National Institutes of Health Clinical Translational Science Institute Grant UL-1-RR-25711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Arora S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r166; Bartosik-Psujek H, 2010, MULT SCLER, V16, P1513, DOI 10.1177/1352458510379611; Berry DM, 2002, EXP CELL RES, V272, P176, DOI 10.1006/excr.2001.5410; Ferraresso S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-354; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Giovannucci E, 2009, J CLIN ENDOCR METAB, V94, P418, DOI 10.1210/jc.2008-2695; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; Holick MF, 2008, J CLIN ENDOCR METAB, V93, P677, DOI 10.1210/jc.2007-2308; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2008, MOL ASPECTS MED, V29, P361, DOI 10.1016/j.mam.2008.08.008; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Kristl J, 2008, PHARM RES, V25, P521, DOI 10.1007/s11095-007-9388-z; Maxwell JR, 2012, RHEUMATOLOGY, V51, P1514, DOI 10.1093/rheumatology/kes134; Montecino M, 2008, CRIT REV EUKAR GENE, V18, P163, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.50; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Rosenblatt J, 2010, BONE MARROW TRANSPL, V45, P1463, DOI 10.1038/bmt.2009.366; Srivastava S, 2012, MOL CELL BIOL, V32, P3132, DOI 10.1128/MCB.00019-12; Sudo H, 2010, GENOMICS, V95, P210, DOI 10.1016/j.ygeno.2010.02.002; Tarroni P, 2012, J CELL BIOCHEM, V113, P640, DOI 10.1002/jcb.23392; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wada Y, 2003, J SURG RES, V115, P294, DOI 10.1016/S0022-4804(03)00213-0; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Yu SH, 2011, J IMMUNOL, V186, P1384, DOI 10.4049/jimmunol.1002545; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	31	169	177	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58725	10.1371/journal.pone.0058725	http://dx.doi.org/10.1371/journal.pone.0058725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527013	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600035
J	Moore, MS; Reichard, JD; Murtha, TD; Nabhan, ML; Pian, RE; Ferreira, JS; Kunz, TH				Moore, Marianne S.; Reichard, Jonathan D.; Murtha, Timothy D.; Nabhan, Morgan L.; Pian, Rachel E.; Ferreira, Jennifer S.; Kunz, Thomas H.			Hibernating Little Brown Myotis (Myotis lucifugus) Show Variable Immunological Responses to White-Nose Syndrome	PLOS ONE			English	Article							OXIDATIVE STRESS; IMMUNE-RESPONSE; EXPERIMENTAL-INFECTION; SUPEROXIDE-DISMUTASE; ANTIOXIDANT DEFENSES; BATS; DISEASE; MECHANISMS; PREVENTION; CHIROPTERA	White-nose syndrome (WNS) is an emerging infectious disease devastating hibernating North American bat populations that is caused by the psychrophilic fungus Geomyces destructans. Previous histopathological analysis demonstrated little evidence of inflammatory responses in infected bats, however few studies have compared other aspects of immune function between WNS-affected and unaffected bats. We collected bats from confirmed WNS-affected and unaffected sites during the winter of 2008-2009 and compared estimates of their circulating levels of total leukocytes, total immunoglobulins, cytokines and total antioxidants. Bats from affected and unaffected sites did not differ in their total circulating immunoglobulin levels, but significantly higher leukocyte counts were observed in bats from affected sites and particularly in affected bats with elevated body temperatures (above 20 degrees C). Bats from WNS-affected sites exhibited significantly lower antioxidant activity and levels of interleukin-4 (IL-4), a cytokine that induces T cell differentiation. Within affected sites only, bats exhibiting visible fungal infections had significantly lower antioxidant activity and levels of IL-4 compared to bats without visible fungal infections. Overall, bats hibernating in WNS-affected sites showed immunological changes that may be evident of attempted defense against G. destructans. Observed changes, specifically elevated circulating leukocytes, may also be related to the documented changes in thermoregulatory behaviors of affected bats (i.e. increased frequencies in arousal from torpor). Alterations in immune function may reflect expensive energetic costs associated with these processes and intrinsic qualities of the immunocapability of hibernating bats to clear fungal infections. Additionally, lowered antioxidant activity indicates a possible imbalance in the pro-versus antioxidant system, may reflect oxidative tissue damage, and should be investigated as a contributor to WNS-associated morbidity and mortality.	[Moore, Marianne S.; Reichard, Jonathan D.; Murtha, Timothy D.; Nabhan, Morgan L.; Pian, Rachel E.; Ferreira, Jennifer S.; Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	Boston University	Moore, MS (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	msm035@bucknell.edu		Murtha, Timothy/0000-0001-5427-9340	National Speleological Society; Bat Conservation International; New York Department of Environmental Conservation; U.S. Fish and Wildlife Service	National Speleological Society; Bat Conservation International; New York Department of Environmental Conservation; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	This study was made possible by funding through the National Speleological Society, Bat Conservation International, New York Department of Environmental Conservation and the U.S. Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Apak R, 2004, J AGR FOOD CHEM, V52, P7970, DOI 10.1021/jf048741x; ASHMAN RB, 1993, J INFECT DIS, V168, P511, DOI 10.1093/infdis/168.2.511-a; Barbour R.W., 1969, BATS AM; Bertrand S, 2006, FUNCT ECOL, V20, P1022, DOI 10.1111/j.1365-2435.2006.01191.x; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bouma HR, 2010, VET IMMUNOL IMMUNOP, V136, P319, DOI 10.1016/j.vetimm.2010.03.016; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; BRACK V, 1985, CAN J ZOOL, V63, P2952, DOI 10.1139/z85-442; Bratsch S, 2011, DEV COMP IMMUNOL, V35, P421, DOI 10.1016/j.dci.2010.06.004; Butler JE, 2011, DEV COMP IMMUNOL, V35, P273, DOI 10.1016/j.dci.2010.08.011; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; CASADEVALL A, 1995, INFECT IMMUN, V63, P4211, DOI 10.1128/IAI.63.11.4211-4218.1995; Courtin F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fuller NW, 2011, ECOHEALTH, V8, P154, DOI 10.1007/s10393-011-0705-y; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F., 2004, LIFE COLD EVOLUTION, P209; Gharib B, 1999, J HEPATOL, V30, P594, DOI 10.1016/S0168-8278(99)80189-5; GREER DL, 1981, AM J TROP MED HYG, V30, P653, DOI 10.4269/ajtmh.1981.30.653; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; HATTEN BA, 1968, J IMMUNOL, V101, P141; HATTEN BA, 1970, J IMMUNOL, V105, P872; Ihara Y, 1999, J NEUROL SCI, V170, P90, DOI 10.1016/S0022-510X(99)00192-6; JAEGER R, 1963, EXPERIENTIA, V19, P596, DOI 10.1007/BF02151011; Jain NC, 1993, ESSENTIALS VET HEMAT; Kelly SA, 1998, ENVIRON HEALTH PERSP, V106, P375, DOI 10.2307/3434064; Kepler TB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-444; Kindt T.J., 2007, KUBY IMMUNOLOGY; KOTTS CE, 1987, J ANIM SCI, V64, P615, DOI 10.2527/jas1987.642615x; KRUTZSCH PHILIP H., 1959, JOUR MAMMAL, V40, P547, DOI 10.2307/1376274; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; LOPEZTORRES M, 1991, MECH AGEING DEV, V59, P129, DOI 10.1016/0047-6374(91)90079-F; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Lyman C. P., 1970, P301; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; MCMURRAY DN, 1979, AM J TROP MED HYG, V28, P1036, DOI 10.4269/ajtmh.1979.28.1036; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Metnitz PGH, 1999, INTENS CARE MED, V25, P180, DOI 10.1007/s001340050813; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Moore MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027430; Ono J, 2008, CLIN CHIM ACTA, V390, P115, DOI 10.1016/j.cca.2008.01.008; Peterhans E, 1997, J NUTR, V127, pS962, DOI 10.1093/jn/127.5.962S; Pikula J, 2012, J WILDLIFE DIS, V48, P207, DOI 10.7589/0090-3558-48.1.207; Polonelli L, 2000, MED MYCOL, V38, P281, DOI 10.1080/mmy.38.s1.281.292; Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Speth C, 2008, MYCOSES, V51, P477, DOI 10.1111/j.1439-0507.2008.01597.x; Sulkin S E, 1974, Monogr Virol, V8, P1; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TESH RB, 1966, AM J TROP MED HYG, V15, P544, DOI 10.4269/ajtmh.1966.15.544; Toien O, 2001, AM J PHYSIOL-REG I, V281, pR572; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Turmelle AS, 2010, J COMP PHYSIOL B, V180, P1155, DOI 10.1007/s00360-010-0486-6; Turner Gregory G., 2011, Bat Research News, V52, P13; Turner Gregory G., 2009, Bat Research News, V50, P47; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002	68	44	45	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58976	10.1371/journal.pone.0058976	http://dx.doi.org/10.1371/journal.pone.0058976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527062	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600047
J	Torregrosa, A; Taylor, MD; Flint, LE; Flint, AL				Torregrosa, Alicia; Taylor, Maxwell D.; Flint, Lorraine E.; Flint, Alan L.			Present, Future, and Novel Bioclimates of the San Francisco, California Region	PLOS ONE			English	Article							CLIMATE-CHANGE; VEGETATION	Bioclimates are syntheses of climatic variables into biologically relevant categories that facilitate comparative studies of biotic responses to climate conditions. Isobioclimates, unique combinations of bioclimatic indices (continentality, ombrotype, and thermotype), were constructed for northern California coastal ranges based on the Rivas-Martinez worldwide bioclimatic classification system for the end of the 20th century climatology (1971-2000) and end of the 21st century climatology (2070-2099) using two models, Geophysical Fluid Dynamics Laboratory (GFDL) model and the Parallel Climate Model (PCM), under the medium-high A2 emission scenario. The digitally mapped results were used to 1) assess the relative redistribution of isobioclimates and their magnitude of change, 2) quantify the loss of isobioclimates into the future, 3) identify and locate novel isobioclimates projected to appear, and 4) explore compositional change in vegetation types among analog isobioclimate patches. This study used downscaled climate variables to map the isobioclimates at a fine spatial resolution -270 m grid cells. Common to both models of future climate was a large change in thermotype. Changes in ombrotype differed among the two models. The end of 20th century climatology has 83 isobioclimates covering the 63,000 km(2) study area. In both future projections 51 of those isobioclimates disappear over 40,000 km(2). The ordination of vegetation-bioclimate relationships shows very strong correlation of Rivas-Martinez indices with vegetation distribution and composition. Comparisons of vegetation composition among analog patches suggest that vegetation change will be a local rearrangement of species already in place rather than one requiring long distance dispersal. The digitally mapped results facilitate comparison with other Mediterranean regions. Major remaining challenges include predicting vegetation composition of novel isobioclimates and developing metrics to compare differences in climate space.	[Torregrosa, Alicia; Taylor, Maxwell D.] US Geol Survey, Western Geog Sci Ctr, Menlo Pk, CA 94025 USA; [Flint, Lorraine E.; Flint, Alan L.] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Torregrosa, A (corresponding author), US Geol Survey, Western Geog Sci Ctr, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	atorregrosa@usgs.gov		Torregrosa, Alicia/0000-0001-7361-2241	US Geological Survey Land Change Science Program	US Geological Survey Land Change Science Program(United States Geological Survey)	This work was supported by the US Geological Survey Land Change Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; [Anonymous], 2010, 2010 FOR RANG ASS SA; Barbour MG, 2007, TERRESTRIAL VEGETATI, Vxvii; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Boeye J, 2013, EVOL APPL, V6, P353, DOI 10.1111/eva.12004; Briles CE, 2008, PALAEOGEOGR PALAEOCL, V265, P159, DOI 10.1016/j.palaeo.2008.05.007; Brunsfeld S., 2001, INTEGRATING ECOLOGY, V14, P319; California Climate and Agricultural Network, 2021, INV CAL AGR CLIM SOL; Castri F., 1973, MEDITERRANEAN TYPE E; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; CODY ML, 1978, ANNU REV ECOL SYST, V9, P265, DOI 10.1146/annurev.es.09.110178.001405; Cress JJ, 2009, TERRESTRIAL ECOSYSTE, P1; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Eklof A, 2012, PHIL T R SOC B, VB367; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2011, ARCGIS DESKT REL 10; Fischer DT, 2009, J BIOGEOGR, V36, P783, DOI 10.1111/j.1365-2699.2008.02025.x; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Franco G, 2009, CALIFORNIA ENERGY CO; Franco G, 2003, CLIMATE CHANGE RES D; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Koeppen W., 1900, GEOGR Z, V6, P593, DOI DOI 10.2307/27803939; Ku┬ppen, 1900, GEOGR Z, V6, P657, DOI DOI 10.2307/27803939; Lancaster LT, 2013, ORIGIN DIVERSIFICATI, DOI [10.1111/evo.12016, DOI 10.1111/EVO.12016]; Latch EK, 2009, MOL ECOL, V18, P1730, DOI 10.1111/j.1365-294X.2009.04153.x; Leakey ADB, 2012, ADV PHOTOSYNTH RESP, V34, P733, DOI 10.1007/978-94-007-1579-0_29; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; Nalder IA, 1998, AGR FOREST METEOROL, V92, P211, DOI 10.1016/S0168-1923(98)00102-6; Notaro M, 2012, ECOL APPL, V22, P1365, DOI 10.1890/11-1269.1; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Rivas-Martinez S., 1997, Itinera Geobotanica, V10, P5; Rivas-Martinez S., 1995, FOLIA BOTANICA MATRI, V16, P1; Rivas-Martinez S, 2003, CD SERIES PHYTOSOCIO; RIVASMARTINEZ S, 1996, GEOBOTANICA CLIMATOL; RUNDEL PW, 1982, OECOLOGIA, V55, P409, DOI 10.1007/BF00376930; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanderson M, 1999, B AM METEOROLOGICAL, V80; Sawyer J. O., 2008, MANUAL CALIFORNIA VE; Sayre R, 2009, NEW MAP STANDARDIZED, P17; Stein BA, 2000, PRECIOUS HERITAGE ST; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; ter Braak, 1996, UNIMODAL MODELS RELA; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thompson RS, 1998, STRATEGY ASSESSING P; Thorne J. H., 2012, DEV APPL DOWNSCALED; Torregrosa A, 1999, THESIS SAN FRANCISCO; Vallis G. K, 2011, CLIMATE OCEANS; Van de Ven CM, 2007, EARTH INTERACT, V11, DOI 10.1175/EI205.1; Westerling AL, 2008, CLIMATIC CHANGE, V87, pS231, DOI 10.1007/s10584-007-9363-z; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wisz MS, 2012, BIOL REV CAMBRIDGE P	56	14	14	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58450	10.1371/journal.pone.0058450	http://dx.doi.org/10.1371/journal.pone.0058450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526985	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600023
J	Williams, M; Villarreal, A; Bozhilov, K; Lin, S; Talbot, P				Williams, Monique; Villarreal, Amanda; Bozhilov, Krassimir; Lin, Sabrina; Talbot, Prue			Metal and Silicate Particles Including Nanoparticles Are Present in Electronic Cigarette Cartomizer Fluid and Aerosol	PLOS ONE			English	Article							TRACE-ELEMENTS; TOXICITY; TOBACCO; NICOTINE; SMOKE	Background: Electronic cigarettes (EC) deliver aerosol by heating fluid containing nicotine. Cartomizer EC combine the fluid chamber and heating element in a single unit. Because EC do not burn tobacco, they may be safer than conventional cigarettes. Their use is rapidly increasing worldwide with little prior testing of their aerosol. Objectives: We tested the hypothesis that EC aerosol contains metals derived from various components in EC. Methods: Cartomizer contents and aerosols were analyzed using light and electron microscopy, cytotoxicity testing, x-ray microanalysis, particle counting, and inductively coupled plasma optical emission spectrometry. Results: The filament, a nickel-chromium wire, was coupled to a thicker copper wire coated with silver. The silver coating was sometimes missing. Four tin solder joints attached the wires to each other and coupled the copper/silver wire to the air tube and mouthpiece. All cartomizers had evidence of use before packaging (burn spots on the fibers and electrophoretic movement of fluid in the fibers). Fibers in two cartomizers had green deposits that contained copper. Centrifugation of the fibers produced large pellets containing tin. Tin particles and tin whiskers were identified in cartridge fluid and outer fibers. Cartomizer fluid with tin particles was cytotoxic in assays using human pulmonary fibroblasts. The aerosol contained particles > 1 mu m comprised of tin, silver, iron, nickel, aluminum, and silicate and nanoparticles (<100 nm) of tin, chromium and nickel. The concentrations of nine of eleven elements in EC aerosol were higher than or equal to the corresponding concentrations in conventional cigarette smoke. Many of the elements identified in EC aerosol are known to cause respiratory distress and disease. Conclusions: The presence of metal and silicate particles in cartomizer aerosol demonstrates the need for improved quality control in EC design and manufacture and studies on how EC aerosol impacts the health of users and bystanders.	[Williams, Monique; Villarreal, Amanda; Lin, Sabrina; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Bozhilov, Krassimir] Univ Calif Riverside, Cent Facil Adv Microscopy & Microanal, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021		Tobacco-Related Disease Research Program (TRDRP); MARC National Institutes of Health (NIH); TRDRP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM062756] Funding Source: NIH RePORTER	Tobacco-Related Disease Research Program (TRDRP)(University of California System); MARC National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Tobacco-Related Disease Research Program (TRDRP) to PT, a Cornelius Hopper Award to MW, a MARC National Institutes of Health (NIH) fellowship to AV, and a TRDRP Postdoctoral Fellowship to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Administration FaD Services DoHaP], 2012, HAMF POT HARMF CONST; Agency for Toxic Substances and Disease Registry (ATSDR), 2007, TOX PROF LEAD; Agency for Toxic Substances and Disease Registry ATSDR, 2010, TOX PROF BOR; Agency for Toxic Substances and Disease Registry (ATSDR), 2004, INT PROF BENZ TOL ET; [ATSDR Services DoHaH], 2008, TOX PROF MAN; ATSDR, 2004, TOX PROF STRONT; ATSDR, 2005, TOXICOLOGICAL PROFIL; ATSDR, 2004, TOX PROF COPP; [ATSDR Agency for Toxic Substances & Disease Registry CfDCaP], 2005, TOX PROF ZINC; ATSDR, 2017, TOX PROF AL; ATSDR, 2007, TOX PROF BAR BAR COM; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF CHROM; ATSDR (Agency for Toxic Substances and Disease Registry), 2005, TOX PROF NICK; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Bakand S, 2012, INHAL TOXICOL, V24, P125, DOI 10.3109/08958378.2010.642021; Behar RZ, 2012, J PHARMACOL TOX MET, V66, P238, DOI 10.1016/j.vascn.2012.07.003; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bhabra G, 2009, NAT NANOTECHNOL, V4, P876, DOI [10.1038/NNANO.2009.313, 10.1038/nnano.2009.313]; Bian L, 2011, MED ONCOL, V28, pS560, DOI 10.1007/s12032-010-9655-4; Caponnetto Pasquale, 2011, J Med Case Rep, V5, P585, DOI 10.1186/1752-1947-5-585; Caponnetto P, 2012, EXPERT REV RESP MED, V6, P63, DOI [10.1586/ers.11.92, 10.1586/ERS.11.92]; Chen IL, 2013, NICOTINE TOB RES, V15, P615, DOI 10.1093/ntr/nts145; Chen Wei-hong, 2005, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V23, P366; CHIBA M, 1992, B WORLD HEALTH ORGAN, V70, P269; Etter JF, 2011, EUR RESPIR J, V38, P1219, DOI 10.1183/09031936.00066011; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Flouris AD, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c311; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Horie M., 2011, ENVIRON TOXICOL, V28, P61, DOI [10.1002/tox.20695, DOI 10.1002/TOX.20695]; Hua M, 2011, TOBACCO CONTROL; Kang GS, 2011, ENVIRON HEALTH PERSP, V119, P176, DOI 10.1289/ehp.1002508; Laugesen M., 2008, SAFETY REPORT RUYAN, P1; Lee NC, 2009, LEAD FREE SOLDERING; Liu SH, 2004, J APPL PHYS, V95, P7742, DOI 10.1063/1.1712019; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; [NJDHSS Services NJDoHS], 2007, HAZ SUBST FACT SHEET; Noel JK, 2011, TOB CONTROL, V20, P81, DOI 10.1136/tc.2010.038562; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Odum Lauren E, 2012, J Pharm Pract, V25, P611, DOI 10.1177/0897190012451909; [RTKHS Services NJDoHS], 2009, RIGHT KNOW HAZ SUBST; [RTKHS Services NJDoHS], 2010, RIGHT KNOW HAZ SUBST; [RTKHS Services NJDoHS], 2008, RIGHT KNOW HAZ SUBST; [RTKHS Services NJDoHS], 2011, RIGHT KNOW HAZ SUBST; Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103; SCHULER P, 1958, Ind Med Surg, V27, P432; Smith CJ, 1997, FOOD CHEM TOXICOL, V35, P1107, DOI 10.1016/S0278-6915(97)00063-X; SMITH RA, 1986, J NON-CRYST SOLIDS, V84, P421, DOI 10.1016/0022-3093(86)90805-7; Stohs SJ, 1997, INHAL TOXICOL, V9, P867; Takenaka S, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3454667; Terzano C, 2010, EUR REV MED PHARMACO, V14, P809; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; U.S. Food and Drug Administration, 2012, HARMF POT HARMF CONS; van Dijk WD, 2011, ANAL BIOANAL CHEM, V399, P3573, DOI 10.1007/s00216-011-4701-4; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; Westenberger B., 2009, EVALUATION E CIGARET, P1; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164; Yang W, 2008, INT J PHARMACEUT, V356, P239, DOI 10.1016/j.ijpharm.2008.02.011; Young JA, 2008, J CHEM EDUC, V85, P193; Young JA, 2004, J CHEM EDUC, V81, P1562	61	418	437	11	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57987	10.1371/journal.pone.0057987	http://dx.doi.org/10.1371/journal.pone.0057987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526962	gold, Green Published			2022-12-27	WOS:000317562600011
J	Blake, JA; Ziman, MR				Blake, Judith A.; Ziman, Melanie R.			The Characterisation of Pax3 Expressant Cells in Adult Peripheral Nerve	PLOS ONE			English	Article							NONMYELINATING SCHWANN-CELLS; MUSCLE PROGENITOR CELLS; NEURAL CREST; STEM-CELLS; WALLERIAN DEGENERATION; MOLECULAR CHARACTERIZATION; NEUROFIBROMATOSIS TYPE-1; EPIDERMAL MELANOCYTES; GENE-EXPRESSION; SATELLITE CELLS	Pax3 has numerous integral functions in embryonic tissue morphogenesis and knowledge of its complex function in cells of adult tissue continues to unfold. Across a variety of adult tissue lineages, the role of Pax3 is principally linked to maintenance of the tissue's resident stem/progenitor cell population. In adult peripheral nerves, Pax3 is reported to be expressed in nonmyelinating Schwann cells, however, little is known about the purpose of this expression. Based on the evidence of the role of Pax3 in other adult tissue stem and progenitor cells, it was hypothesised that the cells in adult peripheral nerve that express Pax3 may be peripheral glioblasts. Here, methods have been developed for identification and visualisation of Pax3 expressant cells in normal 60 day old mouse peripheral nerve that allowed morphological and phenotypic distinctions to be made between Pax3 expressing cells and other nonmyelinating Schwann cells. The distinctions described provide compelling support for a resident glioblast population in adult mouse peripheral nerve.	[Blake, Judith A.; Ziman, Melanie R.] Edith Cowan Univ, Sch Med Sci, Joondalup, WA, Australia; [Ziman, Melanie R.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia	Edith Cowan University; University of Western Australia	Ziman, MR (corresponding author), Edith Cowan Univ, Sch Med Sci, Joondalup, WA, Australia.	m.ziman@ecu.edu.au		Ziman, Mel/0000-0001-7527-3538	University, State and Federal Government	University, State and Federal Government	The author would like to gratefully acknowledge Dr Paul Rigby for expert guidance and instruction using the scanning laser confocal microscope, Tammy Esmaili and Andrew Wilson for assistance with animal work, Dr Mark Brown and Rebecca Slattery for assistance with RT-PCR investigations, Dr Jennifer Thompson for insightful immunohistochemical advice and Dr Angus Stewart for instruments necessary for quality nerve fibre preparations. The Pax3 monoclonal antibody, developed by C. P. Ordahl, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA, USA. BioRad microscopy was carried out using facilities at the Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, which is supported by University, State and Federal Government funding.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Ara J, 2005, J NEUROSCI RES, V79, P468, DOI 10.1002/jnr.20370; BAICHWAL RR, 1989, BIOCHEM BIOPH RES CO, V164, P883, DOI 10.1016/0006-291X(89)91541-6; Barber TD, 1999, GENE, V237, P311, DOI 10.1016/S0378-1119(99)00339-X; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Botchkarev VA, 1997, J COMP NEUROL, V386, P379, DOI 10.1002/(SICI)1096-9861(19970929)386:3<379::AID-CNE4>3.0.CO;2-Z; CARLSEN F, 1980, J ANAT, V130, P545; Chen SZ, 2003, NAT NEUROSCI, V6, P1186, DOI 10.1038/nn1139; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cramer SF, 2009, AM J DERMATOPATH, V31, P331, DOI 10.1097/DAD.0b013e31819cd0cb; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Davids LM, 2009, CLIN EXP DERMATOL, V34, P246, DOI 10.1111/j.1365-2230.2008.02793.x; Djian-Zaouche J, 2012, PIGM CELL MELANOMA R, V25, P545, DOI 10.1111/j.1755-148X.2012.01024.x; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Dong ZP, 1999, J NEUROSCI RES, V56, P334, DOI 10.1002/(SICI)1097-4547(19990515)56:4<334::AID-JNR2>3.0.CO;2-#; EPSTEIN DJ, 1991, GENOMICS, V10, P89, DOI 10.1016/0888-7543(91)90488-Z; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; FERNANDEZVALLE C, 1995, J NEUROCYTOL, V24, P667, DOI 10.1007/BF01179817; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; GRIFFIN JW, 1987, J NEUROSCI, V7, P682; Grinspan JB, 1996, J NEUROSCI, V16, P6107; Guenard V, 1996, GLIA, V18, P27, DOI 10.1002/(SICI)1098-1136(199609)18:1<27::AID-GLIA3>3.0.CO;2-0; GUPTA SK, 1990, DEV NEUROSCI-BASEL, V12, P22, DOI 10.1159/000111832; Gutmann DH, 2001, HUM MOL GENET, V10, P1519, DOI 10.1093/hmg/10.14.1519; IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1; Jessen K R, 1992, Curr Opin Neurobiol, V2, P575, DOI 10.1016/0959-4388(92)90021-C; JESSEN KR, 1994, CURR BIOL, V4, P824, DOI 10.1016/S0960-9822(00)00183-4; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; KIOUSSI C, 1995, NEURON, V15, P553, DOI 10.1016/0896-6273(95)90144-2; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kury P, 2002, J NEUROSCI, V22, P7586; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LEBLANC AC, 1990, J NEUROSCI RES, V26, P317, DOI 10.1002/jnr.490260308; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Li L, 2010, J CELL SCI, V123, P853, DOI 10.1242/jcs.061598; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Medic S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009977; Meier C, 1999, J NEUROSCI, V19, P3847; Murinson BB, 2005, J COMP NEUROL, V484, P392, DOI 10.1002/cne.20506; Murphy P, 1996, DEVELOPMENT, V122, P2847; Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Padilla F, 1999, J NEUROSCI RES, V58, P270; PELLEGRINO RG, 1986, J NEUROCYTOL, V15, P17, DOI 10.1007/BF02057901; PERRY VH, 1992, BIOESSAYS, V14, P401, DOI 10.1002/bies.950140610; Pongpudpunth M, 2010, AM J DERMATOPATH, V32, P574, DOI 10.1097/DAD.0b013e3181cc8c7c; Pritchard C, 2003, GENE, V305, P61, DOI 10.1016/S0378-1119(02)01186-1; Reeves FC, 1999, J CELL SCI, V112, P253; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Riccardi VM, 2000, TERATOLOGY, V62, P4, DOI 10.1002/1096-9926(200007)62:1<4::AID-TERA2>3.0.CO;2-Q; Rutkowski JL, 2000, HUM MOL GENET, V9, P1059, DOI 10.1093/hmg/9.7.1059; SALONEN V, 1987, J NEUROCYTOL, V16, P713, DOI 10.1007/BF01637662; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; SHEELA S, 1990, J CELL BIOL, V111, P645, DOI 10.1083/jcb.111.2.645; Sobue G, 1990, Rinsho Shinkeigaku, V30, P1358; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; Stoll G, 1999, BRAIN PATHOL, V9, P313; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Syroid DE, 1996, P NATL ACAD SCI USA, V93, P9229, DOI 10.1073/pnas.93.17.9229; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; Theos A, 2006, ANN INTERN MED, V144, P842, DOI 10.7326/0003-4819-144-11-200606060-00010; TONA A, 1993, J HISTOCHEM CYTOCHEM, V41, P593, DOI 10.1177/41.4.8450198; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; TSUKAMOTO K, 1994, HUM GENET, V93, P270, DOI 10.1007/BF00212021; Venters SJ, 2004, DEV DYNAM, V229, P591, DOI 10.1002/dvdy.20016; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; WEINBERG HJ, 1978, J NEUROCYTOL, V7, P555, DOI 10.1007/BF01260889; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Xia SJJ, 2004, ONCOGENE, V23, P6864, DOI 10.1038/sj.onc.1207850; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	81	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59184	10.1371/journal.pone.0059184	http://dx.doi.org/10.1371/journal.pone.0059184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527126	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100087
J	Epa, VC; Dolezal, O; Doughty, L; Xiao, XW; Jost, C; Pluckthun, A; Adams, TE				Epa, V. Chandana; Dolezal, Olan; Doughty, Larissa; Xiao, Xiaowen; Jost, Christian; Plueckthun, Andreas; Adams, Timothy E.			Structural Model for the Interaction of a Designed Ankyrin Repeat Protein with the Human Epidermal Growth Factor Receptor 2	PLOS ONE			English	Article							AFFINITY; DOCKING; COMPLEMENTARITY; PREDICTIONS; HERCEPTIN; KINETICS; DARPINS; COMPLEX; HER2	Designed Ankyrin Repeat Proteins are a class of novel binding proteins that can be selected and evolved to bind to targets with high affinity and specificity. We are interested in the DARPin H10-2-G3, which has been evolved to bind with very high affinity to the human epidermal growth factor receptor 2 (HER2). HER2 is found to be over-expressed in 30% of breast cancers, and is the target for the FDA-approved therapeutic monoclonal antibodies trastuzumab and pertuzumab and small molecule tyrosine kinase inhibitors. Here, we use computational macromolecular docking, coupled with several interface metrics such as shape complementarity, interaction energy, and electrostatic complementarity, to model the structure of the complex between the DARPin H10-2-G3 and HER2. We analyzed the interface between the two proteins and then validated the structural model by showing that selected HER2 point mutations at the putative interface with H10-2-G3 reduce the affinity of binding up to 100-fold without affecting the binding of trastuzumab. Comparisons made with a subsequently solved X-ray crystal structure of the complex yielded a backbone atom root mean square deviation of 0.84-1.14 Angstroms. The study presented here demonstrates the capability of the computational techniques of structural bioinformatics in generating useful structural models of protein-protein interactions.	[Epa, V. Chandana; Dolezal, Olan; Doughty, Larissa; Xiao, Xiaowen; Adams, Timothy E.] Commonwealth Sci & Ind Res Org Mat Sci & Engn, Parkville, Vic, Australia; [Jost, Christian; Plueckthun, Andreas] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Zurich	Epa, VC (corresponding author), Commonwealth Sci & Ind Res Org Mat Sci & Engn, Parkville, Vic, Australia.	Vidana.Epa@csiro.au	Adams, Timothy E/I-6231-2012; Epa, Vidana C./D-2320-2013; Dolezal, Olan/E-1691-2015; Doughty, Larissa/AAP-7952-2021; Plückthun, Andreas/C-2746-2009	Adams, Timothy E/0000-0003-3436-0066; Plückthun, Andreas/0000-0003-4191-5306; Jost, Christian/0000-0002-4169-5879; DOLEZAL, OLAN/0000-0002-5823-6978; Doughty, Larissa/0000-0002-4929-528X	Commonwealth Scientific and Industrial Research Organization	Commonwealth Scientific and Industrial Research Organization	This work was funded by the Commonwealth Scientific and Industrial Research Organization. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2009, GROWTH FACTORS, V27, P141, DOI 10.1080/08977190902843565; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Choi Y, 2010, PROTEINS, V78, P1431, DOI 10.1002/prot.22658; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kruger DM, 2010, NUCLEIC ACIDS RES, V38, pW480, DOI 10.1093/nar/gkq471; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Nahshol O, 2008, ANAL BIOCHEM, V383, P52, DOI 10.1016/j.ab.2008.08.017; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Theurillat JP, 2010, MODERN PATHOL, V23, P1289, DOI 10.1038/modpathol.2010.103; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederstein M, 2005, J MOL BIOL, V345, P1199, DOI 10.1016/j.jmb.2004.11.012; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	35	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59163	10.1371/journal.pone.0059163	http://dx.doi.org/10.1371/journal.pone.0059163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527120	gold, Green Published, Green Accepted			2022-12-27	WOS:000317562100086
J	Feng, S; Chen, Y; Gao, YG				Feng, Shu; Chen, Yun; Gao, Yong-Gui			Crystal Structure of 70S Ribosome with Both Cognate tRNAs in the E and P Sites Representing an Authentic Elongation Complex	PLOS ONE			English	Article							ALLOSTERIC 3-SITE MODEL; ESCHERICHIA-COLI; MESSENGER-RNA; BACTERIAL RIBOSOME; READING FRAME; L1 STALK; ANGSTROM RESOLUTION; PROTEIN-SYNTHESIS; PEPTIDE-BOND; FUSIDIC ACID	During the translation cycle, a cognate deacylated tRNA can only move together with the codon into the E site. We here present the first structure of a cognate tRNA bound to the ribosomal E site resulting from translocation by EF-G, in which an entire L1 stalk (L1 protein and L1 rRNA) interacts with E-site tRNA (E-tRNA), representing an authentic ribosome elongation complex. Our results revealed that the Watson-Crick base pairing is formed at the first and second codon-anticodon positions in the E site in the ribosome elongation complex, whereas the codon-anticodon interaction in the third position is indirect. Analysis of the observed conformations of mRNA and E-tRNA suggests that the ribosome intrinsically has the potential to form codon-anticodon interaction in the E site, independently of the mRNA configuration. We also present a detailed description of the biologically relevant position of the entire L1 stalk and its interacting cognate E-tRNA, which provides a better understanding of the structural basis for translation elongation. Furthermore, to gain insight into translocation, we report the positioning of protein L6 contacting EF-G, as well as the conformational change of the C-terminal tail of protein S13 in the decoding center.	[Feng, Shu; Chen, Yun; Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Gao, Yong-Gui] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Gao, Yong-Gui] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; MRC Laboratory Molecular Biology	Gao, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	ygao@ntu.edu.sg	Gao, Yonggui/A-9473-2015; Gao, Yong Gui/A-2187-2011	Gao, Yonggui/0000-0001-7298-0835; 	Singapore National Research Foundation [NRF-RF2009-RF001-267]; Medical Research Council (UK) [U105184332]	Singapore National Research Foundation(National Research Foundation, Singapore); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Singapore National Research Foundation (NRF-RF2009-RF001-267) and the Medical Research Council (UK) grant U105184332. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blaha G, 2001, COLD SPRING HARB SYM, V66, P135, DOI 10.1101/sqb.2001.66.135; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; BODLEY JW, 1970, J BIOL CHEM, V245, P5656; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Cukras AR, 2005, J MOL BIOL, V349, P47, DOI 10.1016/j.jmb.2005.03.075; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Davies C, 1998, J MOL BIOL, V279, P873, DOI 10.1006/jmbi.1998.1780; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Du X, 2003, NUCLEIC ACIDS RES, V31, P2865, DOI 10.1093/nar/gkg382; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fukai S, 2003, RNA, V9, P100, DOI 10.1261/rna.2760703; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; JORGENSEN F, 1990, J MOL BIOL, V215, P511, DOI 10.1016/S0022-2836(05)80164-0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KUHBERGER R, 1979, BIOCHEMISTRY-US, V18, P187; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Nechifor R, 2007, J MOL BIOL, V368, P1412, DOI 10.1016/j.jmb.2007.03.009; Nierhaus KH, 2006, BIOCHIMIE, V88, P1013, DOI 10.1016/j.biochi.2006.02.009; Nierhaus KH, 2012, J BIOL CHEM, V287, P27049, DOI 10.1074/jbc.L112.381848; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan DL, 2006, NAT STRUCT MOL BIOL, V13, P354, DOI 10.1038/nsmb1074; Petropoulos AD, 2012, J BIOL CHEM, V287, P11642, DOI 10.1074/jbc.C111.330068; RHEINBERGER HJ, 1981, P NATL ACAD SCI-BIOL, V78, P5310, DOI 10.1073/pnas.78.9.5310; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Selmer M, 2012, ACTA CRYSTALLOGR D, V68, P578, DOI 10.1107/S0907444912006348; Trabuco LG, 2010, J MOL BIOL, V402, P741, DOI 10.1016/j.jmb.2010.07.056; Walker SE, 2008, P NATL ACAD SCI USA, V105, P9192, DOI 10.1073/pnas.0710146105; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	49	23	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58829	10.1371/journal.pone.0058829	http://dx.doi.org/10.1371/journal.pone.0058829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527033	Green Published, gold			2022-12-27	WOS:000317562100048
J	Wubshet, M; Berhane, Y; Worku, A; Kebede, Y				Wubshet, Mamo; Berhane, Yemane; Worku, Alemayehu; Kebede, Yigzaw			Death and Seeking Alternative Therapy Largely Accounted for Lost to Follow-up of Patients on ART in Northwest Ethiopia: A Community Tracking Survey	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; RESOURCE-LIMITED SETTINGS; SAMPLING-BASED APPROACH; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; MEDICINE USE; PROGRAMS; OUTCOMES; MORTALITY; RETENTION	Background: Antiretroviral treatment programs in sub-Saharan African countries are highly affected by LTF. Tracking patients lost to follow-up and understanding their status is essential to maintain program quality and to develop targeted interventions to prevent LTF. We aimed to determine the outcome and factors associated with LTF. Method: A lost to follow-up community tracking survey was conducted to determine the reasons, outcomes and factors associated with LTF at the University of Gondar Hospital, northwest Ethiopia. All patients were tracked at home to ascertain outcome status for lost to follow-up (death and non-death losses). Result: Out of the 551 patients LTF, 486 (88.20%) were successfully tracked. Death was the most common reason accounted for 233 (47.94%) of the lost to follow-up. Reasons for non-deaths losses include: stopped antiretroviral treatment due to different reasons, 135(53.36%), and relocation to another antiretroviral treatment program by self-transfer, 118(46.64%). The rate of mortality in the first six months was 72.12 per 100 person-years (95% CI: 61.80-84.24) but this sharply decreased after 12 months to 7.92 per 100 person-years (95% CI: 4.44-14.41). Baseline clinical characteristics were strongly associated with mortality. Conclusion: Death accounts for about half of the loss to follow up. Most deaths occur in the first six months of loss. Seeking alternative therapy is another major reason for loss to follow up. Early tracking mechanisms are necessary to prevent death.	[Wubshet, Mamo; Kebede, Yigzaw] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Wubshet, Mamo; Berhane, Yemane; Worku, Alemayehu] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia	University of Gondar; Addis Continental Institute of Public Health; Addis Ababa University	Wubshet, M (corresponding author), Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.	mamo_wubshet@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	University of Gondar and North Gondar, Amhara regional HIV/AIDS Prevention and Control Office, Ethiopia	University of Gondar and North Gondar, Amhara regional HIV/AIDS Prevention and Control Office, Ethiopia	Financial support for this paper was obtained from the by the University of Gondar and North Gondar, Amhara regional HIV/AIDS Prevention and Control Office, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababa Addis, 2007, ANT TREATM PROGR IMP; Abeysekera WWM, 2009, J NATL SCI FOUND SRI, V37, P41, DOI 10.4038/jnsfsr.v37i1.456; Assefa Y, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-81; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MW, PLOS ONE, V5; Central Statistical Agency AA Ethiopia, 2011, ETH DMOGR HLTH SURV; Conley NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043138; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; FMOH, 2007, IMPL GUID TB HIV COL; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Hsiao AF, 2003, JAIDS-J ACQ IMM DEF, V33, P157, DOI 10.1097/00126334-200306010-00007; I-TECH, 2011, PAT LOST FOLL UP RES; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Namuddu B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-855; Nansera D, 2012, INT J TUBERC LUNG DI; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; WHO/UNAIDS, 2006, PAT MON GUID HIV CAR; Wubshet M, 2012, ISRN AIDS 2012; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	30	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59197	10.1371/journal.pone.0059197	http://dx.doi.org/10.1371/journal.pone.0059197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527132	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600048
J	Yan, JH; Du, T; Zhao, W; Hartmann, T; Lu, H; Lu, Y; Ouyang, HM; Jiang, XJ; Sun, L; Jin, C				Yan, Jianghong; Du, Ting; Zhao, Wan; Hartmann, Thomas; Lu, Hua; Lu, Yang; Ouyang, Haomiao; Jiang, Xuejun; Sun, Lei; Jin, Cheng			Transcriptome and Biochemical Analysis Reveals That Suppression of GPI-Anchor Synthesis Leads to Autophagy and Possible Necroptosis in Aspergillus fumigatus	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CELL-DEATH; FK506-BINDING PROTEIN; PROGRAMMED NECROSIS; NIDULANS; GENE; BIOSYNTHESIS; EXPRESSION; PATHWAYS; YEAST	Previously, it has been shown that GPI proteins are required for cell wall synthesis and organization in Aspergillus fumigatus, a human opportunistic pathogen causing life-threatening invasive aspergillosis (IA) in immunocompromised patients. Blocking GPI anchor synthesis leads to severe phenotypes such as cell wall defects, increased cell death, and attenuated virulence. However, the mechanism by which these phenotypes are induced is unclear. To gain insight into global effects of GPI anchoring in A. fumigatus, in this study a conditional expression mutant was constructed and a genome wide transcriptome analysis was carried out. Our results suggested that suppression of GPI anchor synthesis mainly led to activation of phosphatidylinositol (PtdIns) signaling and ER stress. Biochemical and morphological evidence showed that autophagy was induced in response to suppression of the GPI anchor synthesis, and also an increased necroptosis was observed. Based on our results, we propose that activation of PtdIns3K and increased cytosolic Ca2+, which was induced by both ER stress and PtdIns signaling, acted as the main effectors to induce autophagy and possible necroptosis.	[Yan, Jianghong; Du, Ting; Zhao, Wan; Hartmann, Thomas; Lu, Hua; Lu, Yang; Ouyang, Haomiao; Jiang, Xuejun; Jin, Cheng] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Sun, Lei] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Jin, C (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	jinc@im.ac.cn	lu, hua/AIC-3655-2022	jin, cheng/0000-0002-1514-6374	National Natural Science Foundation of China [31030025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (31030025) to CJ (http://nsfc.gov.cn/Porta10/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; BODEY GP, 1989, EUR J CLIN MICROBIOL, V8, P413, DOI 10.1007/BF01964057; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruneau JM, 2001, ELECTROPHORESIS, V22, P2812, DOI 10.1002/1522-2683(200108)22:13&lt;2812::AID-ELPS2812&gt;3.0.CO;2-Q; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Chabane S, 2006, APPL ENVIRON MICROB, V72, P3259, DOI 10.1128/AEM.72.5.3259-3267.2006; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Dargan SL, 2002, BIOCHEM J, V361, P401, DOI 10.1042/0264-6021:3610401; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; Dichtl K, 2012, MOL MICROBIOLOGY; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; ELORZA MV, 1985, J GEN MICROBIOL, V131, P2209; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; Golstein P, 2007, EMBO REP, V8, P829, DOI 10.1038/sj.embor.7401042; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; HEARN VM, 1994, MICROBIOL-UK, V140, P789, DOI 10.1099/00221287-140-4-789; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jain R, 2011, MOL MICROBIOLOGY; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Langfelder K, 2002, CURR GENET, V41, P268, DOI 10.1007/s00294-002-0313-z; Lat A, 2010, EMERG INFECT DIS, V16, P971, DOI 10.3201/eid1606.100165; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; Lee JI, 2005, FEMS MICROBIOL LETT, V249, P121, DOI 10.1016/j.femsle.2005.06.006; LEIDICH SD, 1995, J BIOL CHEM, V270, P13029, DOI 10.1074/jbc.270.22.13029; Li H, 2007, MOL MICROBIOL, V64, P1014, DOI 10.1111/j.1365-2958.2007.05709.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacMillan D, 2005, J CELL SCI, V118, P5443, DOI 10.1242/jcs.02657; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Mousavi SAA, 2003, FUNGAL GENET BIOL, V39, P221, DOI 10.1016/S1087-1845(03)00047-1; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Ohishi K, 2000, MOL BIOL CELL, V11, P1523, DOI 10.1091/mbc.11.5.1523; Richie DL, 2007, MOL MICROBIOL, V63, P591, DOI 10.1111/j.1365-2958.2006.05534.x; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Romano J, 2006, MICROBIOL-SGM, V152, P1919, DOI 10.1099/mic.0.28936-0; Romero B, 2003, FUNGAL GENET BIOL, V40, P103, DOI 10.1016/S1087-1845(03)00090-2; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Upadhyay S, 2006, FUNGAL GENET BIOL, V43, P739, DOI 10.1016/j.fgb.2006.05.002; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Weidner G, 1998, CURR GENET, V33, P378, DOI 10.1007/s002940050350; Xia GQ, 2001, EUR J BIOCHEM, V268, P4079, DOI 10.1046/j.1432-1327.2001.02323.x; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang L, 2009, MICROBIOL-SGM, V155, P2157, DOI 10.1099/mic.0.027490-0; Zmeili OS, 2007, QJM-INT J MED, V100, P317, DOI 10.1093/qjmed/hcm035	64	23	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59013	10.1371/journal.pone.0059013	http://dx.doi.org/10.1371/journal.pone.0059013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527074	gold, Green Published			2022-12-27	WOS:000316411600026
J	Crespo, JA; Li, YR; Ruiz-Castillo, J				Crespo, Juan A.; Li, Yungrong; Ruiz-Castillo, Javier			The Measurement of the Effect on Citation Inequality of Differences in Citation Practices across Scientific Fields	PLOS ONE			English	Article							RESEARCH PERFORMANCE; SCIENTOMETRIC INDICATORS; IMPACT; PUBLICATIONS; SCORES; SCALES	This paper has two aims: (i) to introduce a novel method for measuring which part of overall citation inequality can be attributed to differences in citation practices across scientific fields, and (ii) to implement an empirical strategy for making meaningful comparisons between the number of citations received by articles in 22 broad fields. The number of citations received by any article is seen as a function of the article's scientific influence, and the field to which it belongs. A key assumption is that articles in the same quantile of any field citation distribution have the same degree of citation impact in their respective field. Using a dataset of 4.4 million articles published in 1998-2003 with a five-year citation window, we estimate that differences in citation practices between the 22 fields account for 14% of overall citation inequality. Our empirical strategy is based on the strong similarities found in the behavior of citation distributions. We obtain three main results. Firstly, we estimate a set of average-based indicators, called exchange rates, to express the citations received by any article in a large interval in terms of the citations received in a reference situation. Secondly, using our exchange rates as normalization factors of the raw citation data reduces the effect of differences in citation practices to, approximately, 2% of overall citation inequality in the normalized citation distributions. Thirdly, we provide an empirical explanation of why the usual normalization procedure based on the fields' mean citation rates is found to be equally successful.	[Crespo, Juan A.] Univ Autonoma Madrid, Dept Econ Cuantitat, Madrid, Spain; [Li, Yungrong; Ruiz-Castillo, Javier] Univ Carlos III Madrid, Dept Econ, Madrid, Spain	Autonomous University of Madrid; Universidad Carlos III de Madrid	Crespo, JA (corresponding author), Univ Autonoma Madrid, Dept Econ Cuantitat, Madrid, Spain.	juan.crespo@uam.es	Crespo, Juan/A-2444-2011; Ruiz-Castillo, Javier/O-8180-2019	Li, Yunrong/0000-0002-3491-3401; CRESPO FERNANDEZ, JUAN ALFONSO/0000-0001-6696-621X	Santander Universities Global Division of Banco Santander; Spanish MEC [SEJ2007-67436, ECO2010-19596]	Santander Universities Global Division of Banco Santander; Spanish MEC(Spanish Government)	The authors acknowledge financial support by Santander Universities Global Division of Banco Santander. Crespo and Ruiz-Castillo also acknowledge financial help from the Spanish MEC through grants SEJ2007-67436 and ECO2010-19596. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarran P, 2011, SCIENTOMETRICS, V88, P385, DOI 10.1007/s11192-011-0407-9; Albarran P, 2011, J AM SOC INF SCI TEC, V62, P40, DOI 10.1002/asi.21448; Bornmann L, 2011, J INFORMETR, V5, P228, DOI 10.1016/j.joi.2010.10.009; BOURGUIGNON F, 1979, ECONOMETRICA, V47, P901, DOI 10.2307/1914138; Crespo JA, 2012, FIELD NORMALIZ UNPUB; Crespo JA, 2012, COMP CITATION UNPUB; Garfiled W, 1979, CITATION INDEXING IT; Glanzel W, 2011, SCIENTOMETRICS, V87, P415, DOI 10.1007/s11192-011-0345-6; Glanzel W, 2011, J INF SCI, V37, P40, DOI 10.1177/0165551510392316; Glanzel W., 1985, SCIENTOMETRICS INDIC; Glanzel W., 1983, P 1 NAT C INT PART S; Herranz N, J AM SOC IN IN PRESS; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P2133, DOI 10.1002/asi.21609; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P1370, DOI 10.1002/asi.21534; Leydesdorff L, 2010, J INFORMETR, V4, P644, DOI 10.1016/j.joi.2010.05.003; Moed HF, 2010, J INFORMETR, V4, P265, DOI 10.1016/j.joi.2010.01.002; MOED HF, 1985, RES POLICY, V14, P131, DOI 10.1016/0048-7333(85)90012-5; MOED HF, 1995, SCIENTOMETRICS, V33, P381, DOI 10.1007/BF02017338; MOED HF, 1988, HDB QUANTITATIVE STU, P177; Moravcsik M. J., 1978, J AM SOC INFORM SCI, V105, P17268; PINSKI G, 1976, INFORM PROCESS MANAG, V12, P297, DOI 10.1016/0306-4573(76)90048-0; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033833; Radicchi F, 2012, J INFORMETR, V6, P121, DOI 10.1016/j.joi.2011.09.002; Roemer JE., 1998, EQUALITY OPPORTUNITI; Ruiz-Castillo J, 2003, RES EC INEQ, V9, P1; SCHUBERT A, 1987, SCIENTOMETRICS, V12, P267, DOI 10.1007/BF02016664; SCHUBERT A, 1986, SCIENTOMETRICS, V9, P281, DOI 10.1007/BF02017249; Schubert A, 1996, SCIENTOMETRICS, V36, P311, DOI 10.1007/BF02129597; Schubert A, 1998, HDB QUANTITATIVE STU, P137; SHORROCKS AF, 1980, ECONOMETRICA, V48, P613, DOI 10.2307/1913126; SHORROCKS AF, 1984, ECONOMETRICA, V52, P1369, DOI 10.2307/1913511; Small H, 1985, SCIENTOMETRICS, V7, P393; Vinkler P, 2003, SCIENTOMETRICS, V58, P687, DOI 10.1023/B:SCIE.0000006888.69146.24; VINKLER P, 1986, SCIENTOMETRICS, V10, P157, DOI 10.1007/BF02026039; Waltman L, 2012, J INFORM IN PRESS; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2378, DOI 10.1002/asi.22748; Zitt M, 2008, J AM SOC INF SCI TEC, V59, P1856, DOI 10.1002/asi.20880; Zitt M, 2010, J INFORMETR, V4, P392, DOI 10.1016/j.joi.2010.03.004	39	41	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58727	10.1371/journal.pone.0058727	http://dx.doi.org/10.1371/journal.pone.0058727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516542	Green Published, gold			2022-12-27	WOS:000316407400054
J	Li, B; Baylink, DJ; Deb, C; Zannetti, C; Rajaallah, F; Xing, WR; Walter, MH; Lau, KHW; Qin, XZ				Li, Bo; Baylink, David J.; Deb, Chandra; Zannetti, Claudia; Rajaallah, Fatima; Xing, Weirong; Walter, Michael H.; Lau, K. -H. William; Qin, Xuezhong			1,25-Dihydroxyvitamin D3 Suppresses TLR8 Expression and TLR8-Mediated Inflammatory Responses in Monocytes In Vitro and Experimental Autoimmune Encephalomyelitis In Vivo	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MULTIPLE-SCLEROSIS; D-3; ACTIVATION; VITAMIN-D3; DISEASE; BRAIN; CELLS	1,25-Dihydroxyvitamin D3 (1,25(OH)(2)D-3) suppresses autoimmunity and inflammation; however, the mechanism of its action has not been fully understood. We sought in this study to determine whether the anti-immune/anti-inflammatory action of 1,25(OH)(2)D-3 is in part mediated through an interplay between 1,25(OH)(2)D-3 and toll-like receptor (TLR)7/8 signaling. 1,25(OH)(2)D-3 treatment prior to and/or following experimental autoimmune encephalomyelitis (EAE) induction effectively reduced inflammatory cytokine expression in the spinal cord and ameliorated EAE. These effects were accompanied with a reduction in expression of several TLRs with the most profound effect observed for TLR8. The expression of TLR8 adaptor protein MyD88 was also significantly reduced by 1,25(OH)(2)D-3. To determine the molecular mechanism by which 1,25(OH)(2)D-3 suppresses EAE induction of TLR8 and inflammatory cytokine expression, we evaluated whether 1,25(OH)(2)D-3 can directly inhibit TLR8 signaling and the resulting inflammatory responses in human THP-1 monocytes. 1,25(OH)(2)D-3 treatment not only significantly reduced TLR8 expression but also the expression or activity of MyD88, IRF-4, IRF-7 and NF-kB in monocytes challenged with TLR8 ligands. TLR8 promoter-luciferase reporter assays indicated that 1,25(OH)(2)D-3 decreases TLR8 mRNA level in part via inhibiting TLR8 gene transcription activity. As a result of inhibition on TLR8 signaling cascade at various stages, 1,25(OH)(2)D-3 significantly diminished the TLR8 target gene expression (TNF-alpha and IL-1 beta). In summary, our novel findings suggest that TLR8 is a new target of 1,25(OH)(2)D-3 and may mediate the anti-inflammatory action of 1,25(OH)(2)D-3. Our findings also point to a destructive role of TLR8 in EAE and shed lights on pathogenesis of multiple sclerosis.	[Li, Bo; Baylink, David J.; Deb, Chandra; Rajaallah, Fatima; Walter, Michael H.; Lau, K. -H. William; Qin, Xuezhong] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; [Zannetti, Claudia] Int Agcy Res Canc, F-69372 Lyon, France; [Xing, Weirong; Lau, K. -H. William; Qin, Xuezhong] Jerry L Pettis Mem Vet Affairs Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA	Loma Linda University; World Health Organization; International Agency for Research on Cancer (IARC)	Qin, XZ (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA.	xqin@llu.edu		Lau, Kin-Hing/0000-0003-1109-5052	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-11-2-0052]; GI Foundation of Loma Linda University; Department of Medicine, Loma Linda University School of Medicine	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); GI Foundation of Loma Linda University; Department of Medicine, Loma Linda University School of Medicine	This study was supported by funding from the Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) under Grant No. W81XWH-11-2-0052 (to David J. Baylink), GI Foundation of Loma Linda University (to Michael Walter) and Department of Medicine, Loma Linda University School of Medicine, (to Xuezhong Qin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becklund BR, 2009, P NATL ACAD SCI USA, V106, P5276, DOI 10.1073/pnas.0813312106; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Butchi NB, 2008, J IMMUNOL, V180, P7604, DOI 10.4049/jimmunol.180.11.7604; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Dickie LJ, 2010, RHEUMATOLOGY, V49, P1466, DOI 10.1093/rheumatology/keq124; Do JE, 2008, RHEUMATOLOGY, V47, P840, DOI 10.1093/rheumatology/ken109; Gambhir V, 2011, IMMUNOBIOLOGY, V216, P988, DOI 10.1016/j.imbio.2011.03.011; Gao Z, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/383087; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Katrych O, 2009, CNS NEUROL DISORD-DR, V8, P512, DOI 10.2174/187152709789824598; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Mayne CG, 2011, EUR J IMMUNOL, V41, P822, DOI 10.1002/eji.201040632; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Sloka S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-56; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Spach KM, 2004, PHYSIOL GENOMICS, V18, P141, DOI 10.1152/physiolgenomics.00003.2004; Trudler D, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/497987; Ulzheimer JC, 2010, BIODRUGS, V24, P249, DOI 10.2165/11537160-000000000-00000; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Wingerchuk DM, 2005, J NEUROL NEUROSUR PS, V76, P1294, DOI 10.1136/jnnp.2004.056499; Zannetti C, 2010, J BIOL CHEM, V285, P34773, DOI 10.1074/jbc.M110.133884	34	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58808	10.1371/journal.pone.0058808	http://dx.doi.org/10.1371/journal.pone.0058808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516559	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400064
J	Song, LJ; Li, XM; Jayandharan, GR; Wang, Y; Aslanidi, GV; Ling, C; Zhong, L; Gao, GP; Yoder, MC; Ling, CQ; Tan, MQ; Srivastava, A				Song, Liujiang; Li, Xiaomiao; Jayandharan, Giridhara R.; Wang, Yuan; Aslanidi, George V.; Ling, Chen; Zhong, Li; Gao, Guangping; Yoder, Mervin C.; Ling, Changquan; Tan, Mengqun; Srivastava, Arun			High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; HUMAN BETA-GLOBIN; LEBERS CONGENITAL AMAUROSIS; GROWTH-FACTOR RECEPTOR; HUMAN GENE-THERAPY; HUMAN GAMMA-GLOBIN; HUMAN BONE-MARROW; 2-MEDIATED TRANSDUCTION; PROGENITOR CELLS; TRANSGENE EXPRESSION	We have observed that of the 10 AAV serotypes, AAV6 is the most efficient in transducing primary human hematopoietic stem cells (HSCs), and that the transduction efficiency can be further increased by specifically mutating single surface-exposed tyrosine (Y) residues on AAV6 capsids. In the present studies, we combined the two mutations to generate a tyrosine double-mutant (Y705+731F) AAV6 vector, with which >70% of CD34(+) cells could be transduced. With the long-term objective of developing recombinant AAV vectors for the potential gene therapy of human hemoglobinopathies, we generated the wild-type (WT) and tyrosine-mutant AAV6 vectors containing the following erythroid cell-specific promoters: beta-globin promoter (beta p) with the upstream hyper-sensitive site 2 (HS2) enhancer from the beta-globin locus control region (HS2-beta bp), and the human parvovirus B19 promoter at map unit 6 (B19p6). Transgene expression from the B19p6 was significantly higher than that from the HS2-beta p, and increased up to 30-fold and up to 20-fold, respectively, following erythropoietin (Epo)-induced differentiation of CD34(+) cells in vitro. Transgene expression from the B19p6 or the HS2-beta p was also evaluated in an immuno-deficient xenograft mouse model in vivo. Whereas low levels of expression were detected from the B19p6 in the WT AAV6 capsid, and that from the HS2-beta p in the Y705+ 731F AAV6 capsid, transgene expression from the B19p6 promoter in the Y705+ 731F AAV6 capsid was significantly higher than that from the HS2-beta p, and was detectable up to 12 weeks post-transplantation in primary recipients, and up to 6 additional weeks in secondary transplanted animals. These data demonstrate the feasibility of the use of the novel Y705+ 731F AAV6-B19p6 vectors for high-efficiency transduction of HSCs as well as expression of the b-globin gene in erythroid progenitor cells for the potential gene therapy of human hemoglobinopathies such as beta-thalassemia and sickle cell disease.	[Song, Liujiang; Tan, Mengqun] Cent S Univ, Sch Basic Med Sci, Dept Physiol, Expt Hematol Lab, Changsha, Hunan, Peoples R China; [Song, Liujiang; Tan, Mengqun] Shenzhen Inst Xiangya Biomed, Shenzhen, Peoples R China; [Song, Liujiang; Li, Xiaomiao; Jayandharan, Giridhara R.; Aslanidi, George V.; Ling, Chen; Zhong, Li; Srivastava, Arun] Univ Florida, Coll Med, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL USA; [Song, Liujiang; Li, Xiaomiao; Jayandharan, Giridhara R.; Aslanidi, George V.; Ling, Chen; Zhong, Li; Srivastava, Arun] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL USA; [Song, Liujiang; Li, Xiaomiao; Jayandharan, Giridhara R.; Aslanidi, George V.; Ling, Chen; Zhong, Li; Srivastava, Arun] Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA; [Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India; [Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India; [Wang, Yuan; Ling, Changquan] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Wang, Yuan; Ling, Changquan] Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China; [Zhong, Li; Gao, Guangping] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA; [Zhong, Li] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Yoder, Mervin C.] Indiana Univ Sch Med, Herman B Well Ctr Pediat Res, Indianapolis, IN USA; [Yoder, Mervin C.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Srivastava, Arun] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Srivastava, Arun] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL USA	Central South University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Naval Medical University; Shanghai University of Traditional Chinese Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tan, MQ (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Physiol, Expt Hematol Lab, Changsha, Hunan, Peoples R China.	mqtan26@163.com; aruns@peds.ufl.edu	Zhong, Li/GZM-4358-2022; Ling, Changquan/J-2108-2016; Aslanidi, George/C-5680-2019	Zhong, Li/0000-0003-1611-5171; Ling, Changquan/0000-0003-3476-6445; Yoder, Mervin/0000-0003-4354-7631; Ling, Changquan/0000-0002-0037-4059; Ling, Chen/0000-0003-1527-1471; Aslanidi, George/0000-0002-2726-8627	Fanconi Anemia Research Fund, Inc.; Natural Science Foundation of China (NSFC) [30971299]; Public Health Service [R01 HL-065770, HL-076901, P01 DK-058327, R01 HL-097088]; National Institutes of Health; Department of Biotechnology, Government of India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076901, R01HL097088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER	Fanconi Anemia Research Fund, Inc.; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by a grant from the Fanconi Anemia Research Fund, Inc. (to LZ), a Natural Science Foundation of China (NSFC) grant 30971299 (to MT), and Public Health Service grants R01 HL-065770, HL-076901, P01 DK-058327 (Project 1), and R01 HL-097088 from the National Institutes of Health (to AS). GRJ was supported in part by an Overseas Associate Fellowship-2006 from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN H, 1990, BIOCHEM J, V271, P785, DOI 10.1042/bj2710785; Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Aslanidi GV, 2013, PLOS ONE IN PRESS; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cheng B, 2012, GENE THER, V19, P375, DOI 10.1038/gt.2011.105; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dalkara D, 2012, GENE THER, V19, P176, DOI 10.1038/gt.2011.163; Denard J, 2012, J VIROL, V86, P6620, DOI 10.1128/JVI.00297-12; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fisher KJ, 1996, J VIROL, V70, P520, DOI 10.1128/JVI.70.1.520-532.1996; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Han ZC, 2008, HUM GENE THER, V19, P267, DOI 10.1089/hum.2007.161; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Imren S, 2004, J CLIN INVEST, V114, P953, DOI 10.1172/JCI200421838; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; Kauss MA, 2010, HUM GENE THER, V21, P1129, DOI 10.1089/hum.2010.016; Kurpad C, 1999, J HEMATOTH STEM CELL, V8, P585, DOI 10.1089/152581699319740; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maina N, 2008, HUM GENE THER, V19, P365, DOI 10.1089/hum.2007.173; Maina N, 2008, HUM GENE THER, V19, P376, DOI 10.1089/hum.2007.143; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; MILLER JL, 1993, BLOOD, V82, P1900; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Miyachi T, 1999, BRIT J CANCER, V79, P1018, DOI 10.1038/sj.bjc.6690163; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Myklebust JH, 2000, BLOOD, V95, P510, DOI 10.1182/blood.V95.2.510; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Oh IH, 2004, EXP HEMATOL, V32, P461, DOI 10.1016/j.exphem.2004.02.001; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Pawliuk R, 1998, ANN NY ACAD SCI, V850, P151, DOI 10.1111/j.1749-6632.1998.tb10472.x; Ponnazhagan S, 1997, J VIROL, V71, P3098, DOI 10.1128/JVI.71.4.3098-3104.1997; Ponnazhagan S, 1997, J VIROL, V71, P8262, DOI 10.1128/JVI.71.11.8262-8267.1997; PONNAZHAGAN S, 1995, J VIROL, V69, P8096, DOI 10.1128/JVI.69.12.8096-8101.1995; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Qiao CP, 2010, HUM GENE THER, V21, P1343, DOI 10.1089/hum.2010.003; Schuhmann NK, 2010, EXP HEMATOL, V38, P707, DOI 10.1016/j.exphem.2010.04.016; SHADE RO, 1986, J VIROL, V58, P921, DOI 10.1128/JVI.58.3.921-936.1986; Song L, 2013, CYTOTHERAPY IN PRESS; Song SH, 2004, P NATL ACAD SCI USA, V101, P2112, DOI 10.1073/pnas.0307833100; Tan MQ, 2001, MOL THER, V3, P940, DOI 10.1006/mthe.2001.0346; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; Ussher JE, 2010, HUM GENE THER, V21, P1675, DOI 10.1089/hum.2010.087; Veldwijk MR, 2010, CYTOTHERAPY, V12, P107, DOI 10.3109/14653240903348293; WALSH CE, 1992, P NATL ACAD SCI USA, V89, P7257, DOI 10.1073/pnas.89.15.7257; Wang XS, 1995, P NATL ACAD SCI USA, V92, P12416, DOI 10.1073/pnas.92.26.12416; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Weltner J, 2012, J VIROL, V86, P4463, DOI 10.1128/JVI.06302-11; Wilber A, 2011, BLOOD, V117, P2817, DOI 10.1182/blood-2010-08-300723; Witt O, 2000, BLOOD, V95, P2391, DOI 10.1182/blood.V95.7.2391.007k21_2391_2396; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; YAKOBSON B, 1987, J VIROL, V61, P972, DOI 10.1128/JVI.61.4.972-981.1987; Zhong L, 2006, HUM GENE THER, V17, P321, DOI 10.1089/hum.2006.17.321; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zhou SZ, 1996, GENE THER, V3, P223	64	25	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58757	10.1371/journal.pone.0058757	http://dx.doi.org/10.1371/journal.pone.0058757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516552	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400061
J	Zocevic, A; Vorimore, F; Vicari, N; Gasparini, J; Jacquin, L; Sachse, K; Magnino, S; Laroucau, K				Zocevic, Aleksandar; Vorimore, Fabien; Vicari, Nadia; Gasparini, Julien; Jacquin, Lisa; Sachse, Konrad; Magnino, Simone; Laroucau, Karine			A Real-Time PCR Assay for the Detection of Atypical Strains of Chlamydiaceae from Pigeons	PLOS ONE			English	Article							PSITTACI INFECTIONS; POULTRY	Recent evidence of the occurrence of atypical Chlamydiaceae strains in pigeons, different from the established Chlamydiaceae, requires the development of a specific and rapid detection tool to investigate their prevalence and significance. Here is described a new real-time PCR assay that allows specific detection of atypical Chlamydiaceae from pigeons. The assay has been used to assess the dissemination of these strains in field samples collected from Parisian pigeon populations in 2009. The results suggest a limited dissemination compared to the usually higher prevalence of Chlamydia psittaci that is the main species associated with avian chlamydiosis.	[Zocevic, Aleksandar; Vorimore, Fabien; Laroucau, Karine] Univ Paris Est, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France; [Vicari, Nadia; Magnino, Simone] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Pavia, Italy; [Gasparini, Julien; Jacquin, Lisa] UPMC, CNRS, Lab Ecol & Evolut, ENS,UMR 7625, Paris, France; [Sachse, Konrad] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany	Ecole Nationale Veterinaire d'Alfort (ENVA); IZS Lombardia e Emilia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Laroucau, K (corresponding author), Univ Paris Est, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France.	karine.laroucau@anses.fr	Gasparini, Julien/J-9263-2012; Vicari, Nadia/HCH-8694-2022; Laroucau, Karine/GSO-1980-2022; Sachse, Konrad/GWC-4999-2022; Jacquin, Lisa/H-6878-2019	Laroucau, Karine/0000-0001-7605-8602; Sachse, Konrad/0000-0003-1230-1786; Jacquin, Lisa/0000-0002-0521-6113; Vicari, Nadia/0000-0001-8156-0138	Region Ile-de-France [2008-07]	Region Ile-de-France(Region Ile-de-France)	This work was supported by grants from Region Ile-de-France (post-doctoral fellowship and Sustainable Development 145 Network R2DS, No. 2008-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AA, 1997, J VET DIAGN INVEST, V9, P159, DOI 10.1177/104063879700900209; Deschuyffeleer TPG, 2012, ANN OCCUP HYG, V56, P340, DOI 10.1093/annhyg/mer102; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Gasparini J, 2011, ENVIRON MICROBIOL, V13, P3186, DOI 10.1111/j.1462-2920.2011.02575.x; Greub Gilbert, 2010, Int J Syst Evol Microbiol, V60, P2694, DOI 10.1099/ijs.0.028233-0; Herrmann B, 2000, APPL ENVIRON MICROB, V66, P3654, DOI 10.1128/AEM.66.8.3654-3656.2000; Laroucau K, 2009, INFECT GENET EVOL, V9, P1240, DOI 10.1016/j.meegid.2009.08.005; Lemus JA, 2010, PLOS ONE; Menard A, 2006, J MED MICROBIOL, V55, P471, DOI 10.1099/jmm.0.46335-0; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Robertson T, 2009, J APPL MICROBIOL, V107, P2017, DOI 10.1111/j.1365-2672.2009.04388.x; Sachse K, 2012, VET MICROBIOL, V157, P476, DOI 10.1016/j.vetmic.2012.01.002; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Vicari N., 2009, 1 EUR M AN CHLAM ZOO; Zocevic A, 2012, ENVIRON MICROBIOL, V14, P2212, DOI 10.1111/j.1462-2920.2012.02800.x	18	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58741	10.1371/journal.pone.0058741	http://dx.doi.org/10.1371/journal.pone.0058741			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516548	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400059
J	Nakamura, T; Takumi, T; Takano, A; Hatanaka, F; Yamamoto, Y				Nakamura, Toru; Takumi, Toru; Takano, Atsuko; Hatanaka, Fumiyuki; Yamamoto, Yoshiharu			Characterization and Modeling of Intermittent Locomotor Dynamics in Clock Gene-Deficient Mice	PLOS ONE			English	Article							D-ASPARTATE ANTAGONIST; MICROTUS-ARVALIS; CIRCADIAN GENES; HEAVY TAILS; COMMON VOLE; RHYTHMS; LESIONS; DEPRESSION; DISORDERS; COMPONENT	The scale-invariant and intermittent dynamics of animal behavior are attracting scientific interest. Recent findings concerning the statistical laws of behavioral organization shared between healthy humans and wild-type mice (WT) and their alterations in human depression patients and circadian clock gene (Period 2; Per2) mutant mice indicate that clock genes play functional roles in intermittent, ultradian locomotor dynamics. They also claim the clinical and biological importance of the laws as objective biobehavioral measures or endophenotypes for psychiatric disorders. In this study, to elucidate the roles of breakdown of the broader circadian regulatory circuit in intermittent behavioral dynamics, we studied the statistical properties and rhythmicity of locomotor activity in Per2 mutants and mice deficient in other clock genes (Bmal1, Clock). We performed wavelet analysis to examine circadian and ultradian rhythms and estimated the cumulative distributions of resting period durations during which locomotor activity levels are continuously lower than a predefined threshold value. The wavelet analysis revealed significant amplification of ultradian rhythms in the BMAL1-deficient mice, and instability in the Per2 mutants. The resting period distributions followed a power-law form in all mice. While the distributions for the BMAL1-deficient and Clock mutant mice were almost identical to those for the WT mice, with no significant differences in their parameter (power-law scaling exponent), only the Per2 mutant mice showed consistently and significantly lower values of the scaling exponent, indicating the increased intermittency in ultradian locomotor dynamics. Furthermore, based on a stochastic priority queuing model, we explained the power-law nature of resting period distributions, as well as its alterations shared with human depressive patients and Per2 mutant mice. Our findings lead to the development of a novel mathematical model for abnormal behaviors in psychiatric disorders.	[Nakamura, Toru; Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Takumi, Toru; Hatanaka, Fumiyuki] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan; [Takano, Atsuko] Osaka Univ, Res Ctr Child Mental Dev, Osaka, Japan	University of Tokyo; Hiroshima University; Osaka University	Yamamoto, Y (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	yamamoto@p.u-tokyo.ac.jp		Yamamoto, Yoshiharu/0000-0002-1132-0355; nakamura, toru/0000-0002-5340-6333	Ministry of Education, Culture, Sports, Science and Technology [23240094, 23700795]; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23240094, 23700795] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (A) [23240094] (to YY) and Grant-in-Aid for Young Scientists (B) [23700795] (to TN) from the Ministry of Education, Culture, Sports, Science and Technology and by Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (to TT and YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; GERKEMA MP, 1993, J BIOL RHYTHM, V8, P151, DOI 10.1177/074873049300800205; GERKEMA MP, 1990, J BIOL RHYTHM, V5, P81, DOI 10.1177/074873049000500201; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; IBUKA N, 1977, BRAIN RES, V122, P33, DOI 10.1016/0006-8993(77)90660-6; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; NAKAMURA T, 2007, PHYS REV LETT, V99, DOI DOI 10.1103/PHYSREVLETT.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Sano W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043539; SCHWARTZ WJ, 1991, PHYSIOL BEHAV, V49, P1283, DOI 10.1016/0031-9384(91)90364-T; Sorribes A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002075; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58884	10.1371/journal.pone.0058884	http://dx.doi.org/10.1371/journal.pone.0058884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516567	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849200118
J	Sookoian, S; Pirola, CJ				Sookoian, Silvia; Pirola, Carlos J.			Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease	PLOS ONE			English	Article							GENE PRIORITIZATION; SUSCEPTIBILITY; MICRORNAS; VARIANT; PNPLA3; RISK; TOOL	The abnormal accumulation of fat in the liver is often related either to metabolic risk factors associated with metabolic syndrome in the absence of alcohol consumption (nonalcoholic fatty liver disease, NAFLD) or to chronic alcohol consumption (alcoholic fatty liver disease, AFLD). Clinical and histological studies suggest that NAFLD and AFLD share pathogenic mechanisms. Nevertheless, current data are still inconclusive as to whether the underlying biological process and disease pathways of NAFLD and AFLD are alike. Our primary aim was to integrate omics and physiological data to answer the question of whether NAFLD and AFLD share molecular processes that lead to disease development. We also explored the extent to which insulin resistance (IR) is a distinctive feature of NAFLD. To answer these questions, we used systems biology approaches, such as gene enrichment analysis, protein-protein interaction networks, and gene prioritization, based on multi-level data extracted by computational data mining. We observed that the leading disease pathways associated with NAFLD did not significantly differ from those of AFLD. However, systems biology revealed the importance of each molecular process behind each of the two diseases, and dissected distinctive molecular NAFLD and AFLD-signatures. Comparative co-analysis of NAFLD and AFLD clarified the participation of NAFLD, but not AFLD, in cardiovascular disease, and showed that insulin signaling is impaired in fatty liver regardless of the noxa, but the putative regulatory mechanisms associated with NAFLD seem to encompass a complex network of genes and proteins, plausible of epigenetic modifications. Gene prioritization showed a cancer-related functional map that suggests that the fatty transformation of the liver tissue is regardless of the cause, an emerging mechanism of ubiquitous oncogenic activation. In conclusion, similar underlying disease mechanisms lead to NAFLD and AFLD, but specific ones depict a particular disease signature that has a different impact on the systemic context.	[Sookoian, Silvia] Univ Buenos Aires, Natl Council Sci & Technol Res CONICET, Inst Med Res IDIM, Dept Clin & Mol Hepatol, Buenos Aires, DF, Argentina; [Pirola, Carlos J.] Univ Buenos Aires, Natl Council Sci & Technol Res CONICET, Inst Med Res IDIM, Dept Mol Genet & Biol Complex Dis, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Sookoian, S (corresponding author), Univ Buenos Aires, Natl Council Sci & Technol Res CONICET, Inst Med Res IDIM, Dept Clin & Mol Hepatol, Buenos Aires, DF, Argentina.	sookoian.silvia@lanari.fmed.uba.ar; pirola.carlos@lanari.fmed.uba.ar	Pirola, Carlos Jose/H-2720-2019	Pirola, Carlos Jose/0000-0001-8234-4058	Agencia Nacional de Promocion Cienti-fica y Tecnologica [PICT 2008-1521, PICT 2010-0441]; Universidad de Buenos Aires [UBACYT CM04]	Agencia Nacional de Promocion Cienti-fica y Tecnologica(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This study was partially supported by grants PICT 2008-1521 and PICT 2010-0441 (Agencia Nacional de Promocion Cienti-fica y Tecnologica) and UBACYT CM04 (Universidad de Buenos Aires). SS and CJP belong to Consejo Nacional de Investigaciones Cienti-ficas (CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Barbosa-Silva A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-435; Barbosa-Silva A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-70; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; de Alwis NMW, 2007, SEMIN LIVER DIS, V27, P44, DOI 10.1055/s-2006-960170; Guzman G, 2008, ARCH PATHOL LAB MED, V132, P1761, DOI 10.1043/1543-2165-132.11.1761; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Hwang ST, 2010, J GASTROEN HEPATOL, V25, P562, DOI 10.1111/j.1440-1746.2009.06117.x; Pirola CJ, 2013, GUT, V62, P1356, DOI 10.1136/gutjnl-2012-302962; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Kukreja RC, 2011, MOL PHARMACOL, V80, P558, DOI 10.1124/mol.111.073528; Lefkowitch Jay H, 2005, Clin Liver Dis, V9, P37, DOI 10.1016/j.cld.2004.11.001; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Pavlopoulos Georgios A, 2011, BMC Res Notes, V4, P384, DOI 10.1186/1756-0500-4-384; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sookoian S, 2007, WORLD J GASTROENTERO, V13, P4242, DOI 10.3748/wjg.v13.i31.4242; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Sookoian S, 2010, HEPATOLOGY, V52, P1992, DOI 10.1002/hep.23927; Sookoian S, 2010, J HYPERTENS, V28, P1194, DOI 10.1097/HJH.0b013e328337f6d5; Sookoian S, 2010, MOL GENET METAB, V99, P80, DOI 10.1016/j.ymgme.2009.08.004; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Sorensen HT, 2003, J CLIN GASTROENTEROL, V36, P356, DOI 10.1097/00004836-200304000-00015; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Syn WK, 2009, SEMIN LIVER DIS, V29, P200, DOI 10.1055/s-0029-1214375; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Trepo E, 2011, J HEPATOL, V55, P906, DOI 10.1016/j.jhep.2011.01.028; Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974	33	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58895	10.1371/journal.pone.0058895	http://dx.doi.org/10.1371/journal.pone.0058895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516571	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200119
J	Zhang, B; Liu, JY				Zhang, Bing; Liu, Jin-Yuan			Mass Spectrometric Identification of In Vivo Phosphorylation Sites of Differentially Expressed Proteins in Elongating Cotton Fiber Cells	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; LARGE-SCALE; SACCHAROMYCES-CEREVISIAE; PHOSPHOPROTEOME ANALYSIS; ARABIDOPSIS-THALIANA; PROTEOMICS; DATABASE; REVEALS; LEAVES	Two-dimensional gel electrophoresis (2-DE)-based proteomics approach was applied to extensively explore the molecular basis of plant development and environmental adaptation. These proteomics analyses revealed thousands of differentially expressed proteins (DEPs) closely related to different biological processes. However, little attention has been paid to how peptide mass fingerprinting (PMF) data generated by the approach can be directly utilized for the determination of protein phosphorylation. Here, we used the software tool FindMod to predict the peptides that might carry the phosphorylation modification by examining their PMF data for mass differences between the empirical and theoretical peptides and then identified phosphorylation sites using MALDI TOF/TOF according to predicted peptide data from these DEP spots in the 2-D gels. As a result, a total of 48 phosphorylation sites of 40 DEPs were successfully identified among 235 known DEPs previously revealed in the 2-D gels of elongating cotton fiber cells. The 40 phosphorylated DEPs, including important enzymes such as enolase, transketolase and UDP-L-rhamnose synthase, are presumed to participate in the functional regulation of numerous metabolic pathways, suggesting the reverse phosphorylation of these proteins might play important roles in elongating cotton fibers. The results also indicated that some different isoforms of the identical DEP revealed in our 2-DE-based proteomics analysis could be annotated by phosphorylation events. Taken together, as the first report of large-scale identification of phosphorylation sites in elongating cotton fiber cells, our study provides not only an excellent example of directly identifying phosphorylation sites from known DEPs on 2-D gels but also provides a valuable resource for future functional studies of phosphorylated proteins in this field.	[Liu, Jin-Yuan] Tsinghua Univ, Sch Life Sci, Mol Biol Lab, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Liu, JY (corresponding author), Tsinghua Univ, Sch Life Sci, Mol Biol Lab, Beijing 100084, Peoples R China.	liujy@mail.tsinghua.edu.cn	Zhang, Bing/Z-3337-2019	Zhang, Bing/0000-0001-9774-517X	State Key Basic Research and Development Plan [2010CB126003]; National Natural Science Foundation of China [90608016]; National Transgenic Animals and Plants Research Project [2011ZX08005-003, 2011ZX08009-003]	State Key Basic Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Animals and Plants Research Project	This work was supported by grants from the State Key Basic Research and Development Plan (2010CB126003), the National Natural Science Foundation of China (90608016) and the National Transgenic Animals and Plants Research Project (2011ZX08005-003 and 2011ZX08009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; CLAUSER KR, 1995, P NATL ACAD SCI USA, V92, P5072, DOI 10.1073/pnas.92.11.5072; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gao JJ, 2009, NUCLEIC ACIDS RES, V37, pD960, DOI 10.1093/nar/gkn733; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; Gerhardt S, 2003, PLANT PHYSIOL, V132, P1941, DOI 10.1104/pp.103.020982; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Larsen MR, 2001, ELECTROPHORESIS, V22, P566, DOI 10.1002/1522-2683(200102)22:3<566::AID-ELPS566>3.0.CO;2-T; Lemeer S, 2012, ANAL BIOANAL CHEM, V402, P249, DOI 10.1007/s00216-011-5469-2; Luo R, 2012, J PROTEOMICS, V75, P868, DOI 10.1016/j.jprot.2011.10.003; Mujer CV, 1995, PLANT CELL PHYSIOL, V36, P1459; Munoz J, 2011, METHODS MOL BIOL, V767, P297, DOI 10.1007/978-1-61779-201-4_22; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Paradela A, 2008, J PROTEOME RES, V7, P1809, DOI 10.1021/pr7006544; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Sundstrom JM, 2009, J PROTEOME RES, V8, P798, DOI 10.1021/pr8005556; Thaker VS, 1999, ACTA PHYSIOL PLANT, V21, P57, DOI 10.1007/s11738-999-0027-7; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; Tichy A, 2011, J PROTEOMICS, V74, P2786, DOI 10.1016/j.jprot.2011.07.018; Torres MP, 2005, J PROTEOME RES, V4, P1628, DOI 10.1021/pr050129d; Tress ML, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r162; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wilkins MR, 1999, J MOL BIOL, V289, P645, DOI 10.1006/jmbi.1999.2794; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Zhang B, 2013, PROTEOMICS, V13, P1159, DOI 10.1002/pmic.201200176; Zhou L, 2011, PLOS ONE, V6; Zolnierowicz Stanislaw, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P483, DOI 10.1093/emboj/19.4.483	35	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58758	10.1371/journal.pone.0058758	http://dx.doi.org/10.1371/journal.pone.0058758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516553	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200111
J	El-Zaatari, M; Kao, JY; Tessier, A; Bai, LC; Hayes, MM; Fontaine, C; Eaton, KA; Merchant, JL				El-Zaatari, Mohamad; Kao, John Y.; Tessier, Art; Bai, Longchuan; Hayes, Michael M.; Fontaine, Clinton; Eaton, Kathryn A.; Merchant, Juanita L.			Gli1 Deletion Prevents Helicobacter-Induced Gastric Metaplasia and Expansion of Myeloid Cell Subsets	PLOS ONE			English	Article							SONIC HEDGEHOG; KAPPA-B; TUMOR MICROENVIRONMENT; ATROPHIC GASTRITIS; SIGNALING PATHWAY; SUPPRESSOR-CELLS; IL-6 PRODUCTION; ACTIVATION; CANCER; INTERLEUKIN-1-BETA	Chronic inflammation in the stomach induces metaplasia, the pre-cancerous lesion that precedes inflammation-driven neoplastic transformation. While Hedgehog signaling contributes to the initiation of some cancers, its role in gastric transformation remains poorly defined. We found that Helicobacter-infected C57BL/6 mice develop extensive mucous cell metaplasia at 6 month but not at 2 months post-infection. Gastric metaplasia coincided with the appearance of CD45(+)MHCII(+)CD11b(+)CD11c(+) myeloid cells that were normally not present in the chronic gastritis at 2 months. The myeloid regulatory gene Schlafen-4 was identified in a microarray analysis comparing infected WT versus Gli1 null mice and was expressed in the CD11b(+)CD11c(+) myeloid population. Moreover this same population expressed IL-1 beta and TNF alpha pro-inflammatory cytokines. By 6 months, the mucous neck cell metaplasia (SPEM) expressed IL-6, phosphorylated STAT3 and the proliferative marker Ki67. Expression was not observed in Gli1 mutant mice consistent with the requirement of Gli1 to induce this pre-neoplastic phenotype. Ectopic Shh ligand expression alone was not sufficient to induce SPEM, but with Helicobacter infection synergistically increased the histologic severity observed with the inflammation. Therefore Hedgehog signaling is required, but is not sufficient to generate pre-neoplastic changes during chronic gastritis. Gli1-dependent myeloid cell differentiation plays a pivotal role in the appearance of myeloid cell subtypes ostensibly required for SPEM development. Moreover, it suggests that therapies capable of targeting this phenotypic switch might prevent progression to metaplasia, the pre-neoplastic change that develops prior to dysplasia and gastric cancer, which also occurs in other epithelial-derived neoplasias initiated by chronic inflammation.	[El-Zaatari, Mohamad; Kao, John Y.; Tessier, Art; Bai, Longchuan; Hayes, Michael M.; Merchant, Juanita L.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Fontaine, Clinton; Eaton, Kathryn A.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Merchant, JL (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	merchanj@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184	Public Health Service [P01-DK62041, R01 DK087708-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK062041, R01DK087708] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Public Health Service Grants P01-DK62041 (JLM) and R01 DK087708-01 (JYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; CORREA P, 1975, LANCET, V2, P58; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Zaatari M, 2010, GASTROENTEROLOGY, V139, P2061, DOI 10.1053/j.gastro.2010.08.047; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Goldenring JR, 2011, EXP CELL RES, V317, P2759, DOI 10.1016/j.yexcr.2011.08.017; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Howlett M, 2012, GUT, V61, P1398, DOI 10.1136/gutjnl-2011-300539; Ihrig M, 2005, INFECT IMMUN, V73, P1664, DOI 10.1128/IAI.73.3.1664-1670.2005; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; KAUMA SW, 1994, ENDOCRINOLOGY, V134, P457, DOI 10.1210/en.134.1.457; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Lamb A, 2012, J CELL BIOCH; Lauth M, 2011, ADV CANCER RES, V110, P1, DOI 10.1016/B978-0-12-386469-7.00001-3; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Mohammadi M, 1996, J IMMUNOL, V156, P4729; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Obonyo M, 2011, HELICOBACTER, V16, P398, DOI 10.1111/j.1523-5378.2011.00861.x; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Schmidt PH, 1999, LAB INVEST, V79, P639; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Shiotani A, 2006, ALIMENT PHARM THER, V24, P71, DOI 10.1111/j.1365-2036.2006.00028.x; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Syu LJ, 2012, AM J PATHOL, V181, P2114, DOI 10.1016/j.ajpath.2012.08.017; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Tsukihara S, 2004, AM J REPROD IMMUNOL, V52, P218, DOI 10.1111/j.1600-0897.2004.00209.x; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; van Zuylen WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015723; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; Zavros Y, 2007, J BIOL CHEM, V282, P33265, DOI 10.1074/jbc.M707090200	40	53	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58935	10.1371/journal.pone.0058935	http://dx.doi.org/10.1371/journal.pone.0058935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520544	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900104
J	Kondor, D; Vattay, G				Kondor, Daniel; Vattay, Gabor			Dynamics and Structure in Cell Signaling Networks: Off-State Stability and Dynamically Positive Cycles	PLOS ONE			English	Article							TRANSDUCTION; SYSTEMS; PATHWAYS; DATABASE; MODELS	The signaling system is a fundamental part of the cell, as it regulates essential functions including growth, differentiation, protein synthesis, and apoptosis. A malfunction in this subsystem can disrupt the cell significantly, and is believed to be involved in certain diseases, with cancer being a very important example. While the information available about intracellular signaling networks is constantly growing, and the network topology is actively being analyzed, the modeling of the dynamics of such a system faces difficulties due to the vast number of parameters, which can prove hard to estimate correctly. As the functioning of the signaling system depends on the parameters in a complex way, being able to make general statements based solely on the network topology could be especially appealing. We study a general kinetic model of the signaling system, giving results for the asymptotic behavior of the system in the case of a network with only activatory interactions. We also investigate the possible generalization of our results for the case of a more general model including inhibitory interactions too. We find that feedback cycles made up entirely of activatory interactions (which we call dynamically positive) are especially important, as their properties determine whether the system has a stable signal-off state, which is desirable in many situations to avoid autoactivation due to a noisy environment. To test our results, we investigate the network topology in the Signalink database, and find that the human signaling network indeed has only significantly few dynamically positive cycles, which agrees well with our theoretical arguments.	[Kondor, Daniel; Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary	Eotvos Lorand University	Kondor, D (corresponding author), Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary.	kdani88@elte.hu	Vattay, Gabor/Q-4266-2019; Vattay, Gabor/G-9638-2017; Kondor, Daniel/AAD-9871-2019	Vattay, Gabor/0000-0002-0919-9429; Kondor, Daniel/0000-0003-3720-7462	Hungarian National Development Agency [TAMOP 4.2.1/B-09/1/KMR-2010-0003, TECH08:3dhist08]; Hungarian National Science Foundation [OTKA 7779]	Hungarian National Development Agency; Hungarian National Science Foundation	Hungarian National Development Agency (TAMOP 4.2.1/B-09/1/KMR-2010-0003 and TECH08:3dhist08) and the Hungarian National Science Foundation (OTKA 7779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Binder Bernd, 2004, Genome Inform, V15, P13; Choi C, 2004, COMP FUNCT GENOM, V5, P163, DOI 10.1002/cfg.386; Copeland NG, 2009, TRENDS GENET, V25, P455, DOI 10.1016/j.tig.2009.08.004; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Fazekas D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-7; Gough NR, 2002, ANN NY ACAD SCI, V971, P585, DOI 10.1111/j.1749-6632.2002.tb04532.x; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Kartal O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008001; Korcsmaros T, 2010, BIOINFORMATICS, V26, P2042, DOI 10.1093/bioinformatics/btq310; Levitzki A, 1995, ANN NY ACAD SCI, V766, P363, DOI 10.1111/j.1749-6632.1995.tb26686.x; Meye C.D., 2000, MATRIX ANAL APPL LIN, P661; Mitkowski W, 2008, BULL POL ACAD SCI-TE, V56, P309; Sontag Eduardo D, 2007, Syst Synth Biol, V1, P59, DOI 10.1007/s11693-007-9005-9; Sprott JC, 2008, AM J PHYS, V76, P474, DOI 10.1119/1.2830540; Szabo A., 2012, NANO COMMUN NETW, V3, P57; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	19	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57653	10.1371/journal.pone.0057653	http://dx.doi.org/10.1371/journal.pone.0057653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520476	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900035
J	Kreahling, JM; Foroutan, P; Reed, D; Martinez, G; Razabdouski, T; Bui, MM; Raghavan, M; Letson, D; Gillies, RJ; Altiok, S				Kreahling, Jenny M.; Foroutan, Parastou; Reed, Damon; Martinez, Gary; Razabdouski, Tiffany; Bui, Marilyn M.; Raghavan, Meera; Letson, Douglas; Gillies, Robert J.; Altiok, Soner			Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas	PLOS ONE			English	Article							DNA-DAMAGING AGENTS; CELL LUNG-CANCER; CHECKPOINT ABROGATION; RETINOIC ACID; P53; KINASE; PHOSPHORYLATION; DIFFERENTIATION; IMMUNOCYTOCHEMISTRY; TRANSFORMATION	Sarcomas are rare and heterogeneous mesenchymal tumors affecting both pediatric and adult populations with more than 70 recognized histologies. Doxorubicin and ifosfamide have been the main course of therapy for treatment of sarcomas; however, the response rate to these therapies is about 10-20% in metastatic setting. Toxicity with the drug combination is high, response rates remain low, and improvement in overall survival, especially in the metastatic disease, remains negligible and new agents are needed. Wee1 is a critical component of the G2/M cell cycle checkpoint control and mediates cell cycle arrest by regulating the phosphorylation of CDC2. Inhibition of Wee1 by MK1775 has been reported to enhance the cytotoxic effect of DNA damaging agents in different types of carcinomas. In this study we investigated the therapeutic efficacy of MK1775 in various sarcoma cell lines, patient-derived tumor explants ex vivo and in vivo both alone and in combination with gemcitabine, which is frequently used in the treatment of sarcomas. Our data demonstrate that MK1775 treatment as a single agent at clinically relevant concentrations leads to unscheduled entry into mitosis and initiation of apoptotic cell death in all sarcomas tested. Additionally, MK1775 significantly enhances the cytotoxic effect of gemcitabine in sarcoma cells lines with different p53 mutational status. In patient-derived bone and soft tissue sarcoma samples we showed that MK1775 alone and in combination with gemcitabine causes significant apoptotic cell death. Magnetic resonance imaging (MRI) and histopathologic studies showed that MK1775 induces significant cell death and terminal differentiation in a patient-derived xenograft mouse model of osteosarcoma in vivo. Our results together with the high safety profile of MK1775 strongly suggest that this drug can be used as a potential therapeutic agent in the treatment of both adult as well as pediatric sarcoma patients.	[Kreahling, Jenny M.; Reed, Damon; Bui, Marilyn M.; Altiok, Soner] H Lee Moffitt Canc Ctr & Res Inst, Expt Therapeut Program, Tampa, FL USA; [Foroutan, Parastou; Martinez, Gary; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging Res, Tampa, FL USA; [Raghavan, Meera] H Lee Moffitt Canc Ctr & Res Inst, Dept Diagnost Imaging & Sarcoma, Tampa, FL USA; [Reed, Damon; Bui, Marilyn M.; Letson, Douglas; Altiok, Soner] H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Program, Tampa, FL USA; [Razabdouski, Tiffany] Univ S Florida, Dept Comparat Med, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Altiok, S (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Expt Therapeut Program, Tampa, FL USA.	soner.altiok@moffitt.org	Reed, Damon/R-8179-2019	Reed, Damon/0000-0002-8238-2465; Gillies, Robert/0000-0002-8888-7747	Moffitt Cancer Center Department of Sarcoma Research Grant; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA125627] Funding Source: NIH RePORTER	Moffitt Cancer Center Department of Sarcoma Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Moffitt Cancer Center Department of Sarcoma Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Bodine PVN, 1996, J BONE MINER RES, V11, P806; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Crescenzi E, 2006, MOL CANCER THER, V5, P776, DOI 10.1158/1535-7163.MCT-05-0425; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Fenaux P, 2001, SEMIN HEMATOL, V38, P13, DOI 10.1053/shem.2001.20862; Feuerbach D, 1997, J BONE MINER RES, V12, P179, DOI 10.1359/jbmr.1997.12.2.179; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; Fletcher CDM, 2002, WHO CLASSIFICATION T; HALL PA, 1994, J PATHOL, V172, P1, DOI 10.1002/path.1711720103; Hallstrom TMKA, 2007, P NATL ACAD SCI USA, V104, P7211, DOI 10.1073/pnas.0609299104; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hirai H, 2010, CANCER BIOL THER, V9, P514, DOI 10.4161/cbt.9.7.11115; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; HOUSSET M, 1982, BRIT J HAEMATOL, V51, P125, DOI 10.1111/j.1365-2141.1982.tb07297.x; Indovina P, 2010, CANCER BIOL THER, V9, P523, DOI 10.4161/cbt.9.7.11276; Jenster G, 1999, SEMIN ONCOL, V26, P407; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; KRAISS S, 1991, EXP CELL RES, V192, P157, DOI 10.1016/0014-4827(91)90170-Y; Kreahling JM, 2012, MOL CANCER THER, V11, P174, DOI 10.1158/1535-7163.MCT-11-0529; LEPELLEY P, 1994, LEUKEMIA, V8, P1342; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Ludwig J, 2008, CURR CLIN ONCOL, P317, DOI 10.1007/978-1-60327-424-1_16; MARKS JR, 1991, CANCER RES, V51, P2979; Martin Y, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-21; Merck Sharp & Dohme Corp, INV BROCH; Mizuarai S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-34; Murrow LM, 2010, BREAST CANCER RES TR, V122, P347, DOI 10.1007/s10549-009-0571-2; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Pauwels B, 2003, INT J RADIAT ONCOL, V57, P1075, DOI 10.1016/S0360-3016(03)01443-3; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; PosthumaDeBoer J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-156; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Rubio-Viqueira B, 2007, MOL CANCER THER, V6, P515, DOI 10.1158/1535-7163.MCT-06-0388; Schellens JH, 2009, ASCO ANN M; STANFORD JL, 1986, EPIDEMIOL REV, V8, P42, DOI 10.1093/oxfordjournals.epirev.a036295; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; WYNFORDTHOMAS D, 1992, J PATHOL, V166, P329, DOI 10.1002/path.1711660402; Yoshida T, 2004, ANN ONCOL, V15, P252, DOI 10.1093/annonc/mdh073	43	67	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57523	10.1371/journal.pone.0057523	http://dx.doi.org/10.1371/journal.pone.0057523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520471	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900030
J	Smits, G; Mollema, L; Hahne, S; de Melker, H; Tcherniaeva, I; Waaijenborg, S; van Binnendijk, R; van der Klis, F; Berbers, G				Smits, Gaby; Mollema, Liesbeth; Hahne, Susan; de Melker, Hester; Tcherniaeva, Irina; Waaijenborg, Sandra; van Binnendijk, Rob; van der Klis, Fiona; Berbers, Guy			Seroprevalence of Mumps in The Netherlands: Dynamics over a Decade with High Vaccination Coverage and Recent Outbreaks	PLOS ONE			English	Article							LONG-TERM PERSISTENCE; RUBELLA ANTIBODIES; YOUNG-ADULTS; CELLULAR-IMMUNITY; SEX-DIFFERENCES; MMR-VACCINE; FOLLOW-UP; MEASLES; POPULATION; VIRUS	Here we present mumps virus specific antibody levels in a large cross-sectional population-based serosurveillance study performed in the Netherlands in 2006/2007 (n = 7900). Results were compared with a similar study (1995/1996) and discussed in the light of recent outbreaks. Mumps antibodies were tested using a fluorescent bead-based multiplex immunoassay. Overall seroprevalence was 90.9% with higher levels in the naturally infected cohorts compared with vaccinated cohorts. Mumps virus vaccinations at 14 months and 9 years resulted in an increased seroprevalence and antibody concentration. The second vaccination seemed to be important in acquiring stable mumps antibody levels in the long term. In conclusion, the Dutch population is well protected against mumps virus infection. However, we identified specific age- and population groups at increased risk of mumps infection. Indeed, in 2007/2008 an outbreak has occurred in the low vaccination coverage groups emphasizing the predictive value of serosurveillance studies.	[Smits, Gaby; Tcherniaeva, Irina; van Binnendijk, Rob; van der Klis, Fiona; Berbers, Guy] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Mollema, Liesbeth; Hahne, Susan; de Melker, Hester; Waaijenborg, Sandra] Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Smits, G (corresponding author), Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands.	Gaby.Smits@rivm.nl						ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Andrews N, 2000, EPIDEMIOL INFECT, V125, P127, DOI 10.1017/S0950268899004173; [Anonymous], EURO SURVEILL; Baum SG, 2000, PRINCIPLES PRACTICE, V2, P1708; Brockhoff HJ, 2010, VACCINE, V28, P2932, DOI 10.1016/j.vaccine.2010.02.020; Burgmeijer R, 2007, HDB VACCINATIES THEO; CHRISTENSON B, 1994, VACCINE, V12, P41, DOI 10.1016/0264-410X(94)90009-4; Cohen C, 2007, EMERG INFECT DIS, V13, P12; Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054; Date AA, 2008, J INFECT DIS, V197, P1662, DOI 10.1086/588197; Davidkin I, 2008, J INFECT DIS, V197, P950, DOI 10.1086/528993; Dayan GH, 2008, NEW ENGL J MED, V358, P1580, DOI 10.1056/NEJMoa0706589; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; Dittrich S, 2011, VACCINE, V29, P9271, DOI 10.1016/j.vaccine.2011.09.072; Dominguez A, 2010, VACCINE, V28, P3567, DOI 10.1016/j.vaccine.2010.02.107; Fanoy EB, 2011, VACCINE, V29, P9551, DOI 10.1016/j.vaccine.2011.09.100; GREEN MS, 1994, INT J EPIDEMIOL, V23, P1078, DOI 10.1093/ije/23.5.1078; Greenland K, 2012, VACCINE, V30, P4676, DOI 10.1016/j.vaccine.2012.04.083; Harling R, 2005, VACCINE, V23, P4070, DOI 10.1016/j.vaccine.2004.10.020; HORSTMANN DM, 1985, REV INFECT DIS, V7, pS80; Jokinen S, 2007, J INFECT DIS, V196, P861, DOI 10.1086/521029; Kay D, 2011, MUMPS OUTBREAKS 4 U; LeBaron CW, 2009, J INFECT DIS, V199, P552, DOI 10.1086/596207; Mitchell LA, 1999, J MED MICROBIOL, V48, P1075, DOI 10.1099/00222615-48-12-1075; Mossong J, 2004, EPIDEMIOL INFECT, V132, P11, DOI 10.1017/S0950268803001584; Plotkin SA, 2013, VACCINES; Rubin SA, 2012, J VIROL, V86, P615, DOI 10.1128/JVI.06125-11; Sandra Waaijenborg SH, WANING MATERNA UNPUB; Smits GP, 2012, CLIN VACCINE IMMUNOL; van Binnendijk RS, 2011, EURO SURVEILL, V16; Van den Hof S, 2003, EPIDEMIOL INFECT, V131, P703, DOI 10.1017/S0950268803008641; van den Hof S, 1999, VACCINE, V18, P931, DOI 10.1016/S0264-410X(99)00348-5; van der Klis FRM, 2009, NETH J MED, V67, P301; Vandermeulen C, 2007, VACCINE, V25, P6672, DOI 10.1016/j.vaccine.2007.07.008; Vandermeulen C, 2009, J INFECT DIS, V199, P1457, DOI 10.1086/598482; VANLIER EA, 2012, 2010010012012 RIVM; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Whelan J, 2010, EURO SURVEILL, V15	38	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58234	10.1371/journal.pone.0058234	http://dx.doi.org/10.1371/journal.pone.0058234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520497	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900056
J	Voorhees, JL; Tarr, AJ; Wohleb, ES; Godbout, JP; Mo, XK; Sheridan, JF; Eubank, TD; Marsh, CB				Voorhees, Jeffrey L.; Tarr, Andrew J.; Wohleb, Eric S.; Godbout, Jonathan P.; Mo, Xiaokui; Sheridan, John F.; Eubank, Timothy D.; Marsh, Clay B.			Prolonged Restraint Stress Increases IL-6, Reduces IL-10, and Causes Persistent Depressive-Like Behavior That Is Reversed by Recombinant IL-10	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; PITUITARY-ADRENAL AXIS; FORCED SWIM TEST; MAJOR DEPRESSION; PROTEIN EXPRESSION; IMMUNE-RESPONSES; GENE-EXPRESSION; VIRUS-INFECTION; TNF-ALPHA; HPA AXIS	Altered inflammatory cytokine profiles are often observed in individuals suffering from major depression. Recent clinical work reports on elevated IL-6 and decreased IL-10 in depression. Elevated IL-6 has served as a consistent biomarker of depression and IL-10 is proposed to influence depressive behavior through its ability to counterbalance pro-inflammatory cytokine expression. Clinical and animal studies suggest a role for IL-10 in modifying depressive behavior. Murine restraint stress (RST) is regularly employed in the study of behavioral and biological symptoms associated with depressive disorders. While responses to acute RST exposure have been widely characterized, few studies have examined the ongoing and longitudinal effects of extended RST and fewer still have examined the lasting impact during the post-stress period. Consistent with clinical data, we report that a protocol of prolonged murine RST produced altered cytokine profiles similar to those observed in major depressive disorder. Parallel to these changes in circulating cytokines, IL-10 mRNA expression was diminished in the cortex and hippocampus throughout the stress period and following cessation of RST. Moreover, chronic RST promoted depressive-like behavior throughout the 28-day stress period and these depressive-like complications were maintained weeks after cessation of RST. Because of the correlation between IL-10 suppression and depressive behavior and because many successful antidepressant therapies yield increases in IL-10, we examined the effects of IL-10 treatment on RST-induced behavioral changes. Behavioral deficits induced by RST were reversed by exogenous administration of recombinant IL-10. This work provides one of the first reports describing the biological and behavioral impact following prolonged RST and, taken together, this study provides details on the correlation between responses to chronic RST and those seen in depressive disorders.	[Voorhees, Jeffrey L.; Eubank, Timothy D.; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Voorhees, Jeffrey L.; Eubank, Timothy D.; Marsh, Clay B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Tarr, Andrew J.; Wohleb, Eric S.; Sheridan, John F.] Ohio State Univ, Div Oral Biol, Columbus, OH 43210 USA; [Tarr, Andrew J.; Godbout, Jonathan P.; Sheridan, John F.] Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA; [Wohleb, Eric S.; Sheridan, John F.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Godbout, Jonathan P.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Godbout, Jonathan P.] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Eubank, TD (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	Tim.Eubank@osumc.edu; Clay.Marsh@osumc.edu	Sheridan, John F/E-4081-2011; Wohleb, Eric/AAQ-6895-2021; Eubank, Tim/E-3043-2011	Eubank, Tim/0000-0002-8225-7824; Sheridan, John/0000-0002-6927-0266	National Institutes of Health (NIH) [T32 HL07946, NIH R01 HL067176, NIH R01 HL102464]; TDE; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067176, T32HL007946, R01HL102464] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TDE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) T32 HL07946, NIH R01 HL067176, NIH R01 HL102464, and startup funds from TDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Anisman H, 1998, BRAIN RES, V779, P177, DOI 10.1016/S0006-8993(97)01114-1; Bartolomucci A, 2003, BRAIN RES BULL, V62, P173, DOI 10.1016/j.brainresbull.2003.09.009; Blume J, 2011, BRAIN BEHAV IMMUN, V25, P221, DOI 10.1016/j.bbi.2010.10.008; Bluthe RM, 1999, PSYCHONEUROENDOCRINO, V24, P301, DOI 10.1016/S0306-4530(98)00077-8; Bowers SL, 2008, BRAIN BEHAV IMMUN, V22, P105, DOI 10.1016/j.bbi.2007.07.012; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Campbell T, 2001, BRAIN BEHAV IMMUN, V15, P235, DOI 10.1006/brbi.2000.0598; Carlezon WA, 2002, BIOL PSYCHIAT, V51, P882, DOI 10.1016/S0006-3223(01)01344-0; Connor TJ, 2005, J NEUROIMMUNOL, V159, P119, DOI 10.1016/j.jneuroim.2004.10.016; Curtin NM, 2009, BRAIN BEHAV IMMUN, V23, P371, DOI 10.1016/j.bbi.2008.12.010; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Delgado-Morales R, 2012, PHYSIOL BEHAV, V105, P669, DOI 10.1016/j.physbeh.2011.10.008; Dhabhar FS, 2009, J PSYCHIATR RES, V43, P962, DOI 10.1016/j.jpsychires.2009.05.010; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; El Bouhassani M, 2011, J BIOL CHEM, V286, P17227, DOI 10.1074/jbc.M111.220483; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Harris RBS, 2002, AM J PHYSIOL-REG I, V282, pR77, DOI 10.1152/ajpregu.2002.282.1.R77; Harvey D, 2006, PHYSIOL BEHAV, V87, P842, DOI 10.1016/j.physbeh.2006.03.002; HOLM S, 1979, SCAND J STAT, V6, P65; Houshyar H, 2001, J NEUROENDOCRINOL, V13, P862, DOI 10.1046/j.1365-2826.2001.00713.x; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; KEIM KL, 1977, PHARMACOL BIOCHEM BE, V6, P79, DOI 10.1016/0091-3057(77)90162-9; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; Khairova RA, 2009, INT J NEUROPSYCHOPH, V12, P561, DOI 10.1017/S1461145709009924; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042054; Klinsey SG, 2007, BRAIN BEHAV IMMUN, V21, P458, DOI 10.1016/j.bbi.2006.11.001; Koldzic-Zivanovic N, 2006, BRAIN BEHAV IMMUN, V20, P460, DOI 10.1016/j.bbi.2005.09.003; Krzyszton CP, 2008, AM J PHYSIOL-REG I, V295, pR1109, DOI 10.1152/ajpregu.90302.2008; Kubera M, 2001, J AFFECT DISORDERS, V63, P171, DOI 10.1016/S0165-0327(00)00182-8; Kubera N, 2001, J CLIN PSYCHOPHARM, V21, P199, DOI 10.1097/00004714-200104000-00012; Lamkin DM, 2012, BRAIN BEHAV IMMUN, V26, P635, DOI 10.1016/j.bbi.2012.01.013; Lanquillon S, 2000, NEUROPSYCHOPHARMACOL, V22, P370, DOI 10.1016/S0893-133X(99)00134-7; Lawson MA, 2011, BRAIN BEHAV IMMUN, V25, P1569, DOI 10.1016/j.bbi.2011.05.006; Leitch MM, 2003, NEUROPSYCHOPHARMACOL, V28, P119, DOI 10.1038/sj.npp.1300016; Lenczowski MJP, 1999, AM J PHYSIOL-REG I, V276, pR652, DOI 10.1152/ajpregu.1999.276.3.R652; Liu J, 2012, P NATL ACAD SCI USA, V109, P10018, DOI 10.1073/pnas.1200941109; Loftis JM, 2010, NEUROBIOL DIS, V37, P519, DOI 10.1016/j.nbd.2009.11.015; Lundh SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051168; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Maes M, 1999, NEUROPSYCHOPHARMACOL, V20, P370, DOI 10.1016/S0893-133X(98)00088-8; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mesquita AR, 2008, J PSYCHIATR RES, V43, P89, DOI 10.1016/j.jpsychires.2008.02.004; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Mohawk JA, 2005, J BIOL RHYTHM, V20, P245, DOI 10.1177/0748730405276323; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; O'Brien SM, 2007, J PSYCHIAT RES, V41, P326, DOI 10.1016/j.jpsychires.2006.05.013; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Raedler TJ, 2011, CURR OPIN PSYCHIATR, V24, P519, DOI 10.1097/YCO.0b013e32834b9db6; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Roque S, 2009, CARDIOVASC PSYCHIAT, V2009; Sakic B, 2001, BRAIN BEHAV IMMUN, V15, P25, DOI 10.1006/brbi.1999.0576; Sakic B, 1997, BRAIN RES BULL, V44, P155, DOI 10.1016/S0361-9230(97)00107-X; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Selye H., 1936, CAN MED ASSOC J, V34, P704; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; SHERIDAN JF, 1991, J NEUROIMMUNOL, V31, P245, DOI 10.1016/0165-5728(91)90046-A; Smith EM, 1999, J NEUROIMMUNOL, V100, P140, DOI 10.1016/S0165-5728(99)00206-4; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Solomon MB, 2011, NEUROSCIENCE; Swiergiel AH, 1999, BRAIN BEHAV IMMUN, V13, P252, DOI 10.1006/brbi.1999.0565; Swiergiel AH, 2008, BEHAV BRAIN RES, V186, P32, DOI 10.1016/j.bbr.2007.07.018; Swiergiel AH, 2006, BEHAV BRAIN RES, V171, P94, DOI 10.1016/j.bbr.2006.03.024; Tu HL, 2007, CELL MOL NEUROBIOL, V27, P161, DOI 10.1007/s10571-006-9137-6; Walker TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044371; Wang JP, 1998, NEUROCHEM INT, V33, P143, DOI 10.1016/S0197-0186(98)00016-3; Wang Y, 2008, J IMMUNOL, V181, P3441, DOI 10.4049/jimmunol.181.5.3441; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; ZALCMAN S, 1994, BRAIN RES, V643, P40, DOI 10.1016/0006-8993(94)90006-X; Zalcman S, 1998, BRAIN RES, V811, P111, DOI 10.1016/S0006-8993(98)00904-4; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zhou QD, 2011, P NATL ACAD SCI USA, V108, P2867, DOI 10.1073/pnas.1019270108; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	87	154	158	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58488	10.1371/journal.pone.0058488	http://dx.doi.org/10.1371/journal.pone.0058488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520517	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900076
J	Fenichel, EP; Kuminoff, NV; Chowell, G				Fenichel, Eli P.; Kuminoff, Nicolai V.; Chowell, Gerardo			Skip the Trip: Air Travelers' Behavioral Responses to Pandemic Influenza	PLOS ONE			English	Article							INFECTIOUS-DISEASES; TRANSMISSION; SPREAD; IMPACT; STRAIN; UK	Theory suggests that human behavior has implications for disease spread. We examine the hypothesis that individuals engage in voluntary defensive behavior during an epidemic. We estimate the number of passengers missing previously purchased flights as a function of concern for swine flu or A/H1N1 influenza using 1.7 million detailed flight records, Google Trends, and the World Health Organization's FluNet data. We estimate that concern over "swine flu," as measured by Google Trends, accounted for 0.34% of missed flights during the epidemic. The Google Trends data correlates strongly with media attention, but poorly (at times negatively) with reported cases in FluNet. Passengers show no response to reported cases. Passengers skipping their purchased trips forwent at least $50 M in travel related benefits. Responding to actual cases would have cut this estimate in half. Thus, people appear to respond to an epidemic by voluntarily engaging in self-protection behavior, but this behavior may not be responsive to objective measures of risk. Clearer risk communication could substantially reduce epidemic costs. People undertaking costly risk reduction behavior, for example, forgoing nonrefundable flights, suggests they may also make less costly behavior adjustments to avoid infection. Accounting for defensive behaviors may be important for forecasting epidemics, but linking behavior with epidemics likely requires consideration of risk communication.	[Fenichel, Eli P.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Kuminoff, Nicolai V.] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA; [Chowell, Gerardo] Arizona State Univ, Sch Human Evolut, Tempe, AZ USA; [Chowell, Gerardo] Arizona State Univ, Sch Change, Tempe, AZ USA; [Chowell, Gerardo] NIH, Div Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD 20892 USA	Yale University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Fenichel, EP (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	eli.fenichel@yale.edu	Chowell, Gerardo/F-5038-2012	Chowell, Gerardo/0000-0003-2194-2251; Fenichel, Eli/0000-0002-7649-8250	National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health [1R01GM100471-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100471] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	U.S. Airways Corporation generously provided data and background information on the airline industry. This publication was made possible by grant number 1R01GM100471-01 from the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health. Its contents are solely the responsibility of the authors and do not represent the official views of NIGMS or US Airways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bitar D, 2009, EUROSURVEILLANCE, V14; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Cameron A. C., 2010, MICROECONOMETRICS US; Cameron C., 2005, MICROECONOMETRICS US, P1056; Chen FH, 2009, MATH BIOSCI, V217, P125, DOI 10.1016/j.mbs.2008.11.005; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; d'Onofrio A, 2009, J THEOR BIOL, V256, P473, DOI 10.1016/j.jtbi.2008.10.005; DeHart RL, 2003, ANNU REV PUBL HEALTH, V24, P133, DOI 10.1146/annurev.publhealth.24.100901.140853; Dell'Omodarme M, 2005, STAT MED, V24, P2669, DOI 10.1002/sim.2131; Dickmann P, 2011, INFLUENZA OTHER RESP, V5, P39, DOI 10.1111/j.1750-2659.2010.00168.x; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Fenichel E. P., 2013, MODELING INTERPLAY H, P153; Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Gelman A., 2007, DATA ANAL USING REGR; GEOFFARD PY, 1995, BIOMETRIKA, V82, P101; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022151; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Keogh-Brown MR, 2010, HEALTH ECON, V19, P1345, DOI 10.1002/hec.1554; Lau JTF, 2004, EPIDEMIOL INFECT, V132, P727, DOI 10.1017/S0950268804002225; Leggat PA, 2010, J TRAVEL MED, V17, P291, DOI 10.1111/j.1708-8305.2010.00445.x; Mao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024706; Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062; Mesnard A, 2009, J PUBLIC ECON, V93, P931, DOI 10.1016/j.jpubeco.2009.05.001; Nguyen AV, 2010, EMERG INFECT DIS, V16, P1710, DOI 10.3201/eid1611.100703; Nishiura H, 2009, EUROSURVEILLANCE, V14, P1; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Stern AM, 2009, JAMA-J AM MED ASSOC, V302, P1221, DOI 10.1001/jama.2009.1367; Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503; Vosen S, 2011, J FORECASTING, V30, P565, DOI 10.1002/for.1213; Wagner BG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-81	47	74	74	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58249	10.1371/journal.pone.0058249	http://dx.doi.org/10.1371/journal.pone.0058249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23526970	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600015
J	O'Reilly-Wapstra, JM; Miller, AM; Hamilton, MG; Williams, D; Glancy-Dean, N; Potts, BM				O'Reilly-Wapstra, Julianne M.; Miller, Alison M.; Hamilton, Matthew G.; Williams, Dean; Glancy-Dean, Naomi; Potts, Brad M.			Chemical Variation in a Dominant Tree Species: Population Divergence, Selection and Genetic Stability across Environments	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; PLANT DEFENSIVE CHEMISTRY; QUANTITATIVE TRAIT LOCI; GLOBULUS SSP GLOBULUS; EUCALYPTUS-GLOBULUS; MAMMALIAN HERBIVORE; WOOD DENSITY; PULP YIELD; RESISTANCE; NITENS	Understanding among and within population genetic variation of ecologically important plant traits provides insight into the potential evolutionary processes affecting those traits. The strength and consistency of selection driving variability in traits would be affected by plasticity in differences among genotypes across environments (GxE). We investigated population divergence, selection and environmental plasticity of foliar plant secondary metabolites (PSMs) in a dominant tree species, Eucalyptus globulus. Using two common garden trials we examined variation in PSMs at multiple genetic scales; among 12 populations covering the full geographic range of the species and among up to 60 families within populations. Significant genetic variation in the expression of many PSMs resides both among and within populations of E. globulus with moderate (e. g., sideroxylonal A h(2)op = 0.24) to high (e. g., macrocarpal G h(2)op = 0.48) narrow sense heritabilities and high coefficients of additive genetic variation estimated for some compounds. A comparison of Qst and Fst estimates suggest that variability in some of these traits may be due to selection. Importantly, there was no genetic by environment interaction in the expression of any of the quantitative chemical traits despite often significant site effects. These results provide evidence that natural selection has contributed to population divergence in PSMs in E. globulus, and identifies the formylated phloroglucinol compounds (particularly sideroxylonal) and a dominant oil, 1,8-cineole, as candidates for traits whose genetic architecture has been shaped by divergent selection. Additionally, as the genetic differences in these PSMs that influence community phenotypes is stable across environments, the role of plant genotype in structuring communities is strengthened and these genotypic differences may be relatively stable under global environmental changes.	[O'Reilly-Wapstra, Julianne M.; Miller, Alison M.; Hamilton, Matthew G.; Glancy-Dean, Naomi; Potts, Brad M.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Williams, Dean] Forestry Tasmania, Hobart, Tas, Australia; [O'Reilly-Wapstra, Julianne M.; Miller, Alison M.; Hamilton, Matthew G.; Potts, Brad M.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	O'Reilly-Wapstra, JM (corresponding author), Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia.	joreilly@utas.edu.au	Potts, Brad M/C-6489-2013; O'Reilly-Wapstra, Julianne M/J-7275-2014; Hamilton, Matthew/C-6556-2008	Potts, Brad M/0000-0001-6244-289X; O'Reilly-Wapstra, Julianne M/0000-0003-4801-4412; Hamilton, Matthew/0000-0001-8098-8845	Australian Research Council [DP1094084, DP120102889]; UTAS Rising Stars Programme	Australian Research Council(Australian Research Council); UTAS Rising Stars Programme	This work was funded by the Australian Research Council (DP1094084, DP120102889) and the UTAS Rising Stars Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Ramirez-Valiente JA, 2011, TREE GENET GENOMES, V7, P285, DOI 10.1007/s11295-010-0331-9; Andrew RL, 2007, OECOLOGIA, V153, P891, DOI 10.1007/s00442-007-0784-1; Andrew RL, 2010, ANN BOT-LONDON, V105, P707, DOI 10.1093/aob/mcq034; [Anonymous], 2002, TANNIN CHEM; ARMBRUSTER WS, 1991, EVOLUTION, V45, P1229, DOI 10.1111/j.1558-5646.1991.tb04389.x; Barbour RC, 2009, ECOLOGY, V90, P1762, DOI 10.1890/08-0951.1; Bulinski J, 1999, FOREST ECOL MANAG, V113, P241, DOI 10.1016/S0378-1127(98)00430-7; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Silva JCE, 2009, TREE GENET GENOMES, V5, P291, DOI 10.1007/s11295-008-0174-9; Downes GM, 2010, J NEAR INFRARED SPEC, V18, P147, DOI 10.1255/jnirs.875; Dungey HS, 1997, CAN J FOREST RES, V27, P750, DOI 10.1139/cjfr-27-5-750; Dutkowski GW, 1999, AUST J BOT, V47, P237, DOI 10.1071/BT97114; Dutkowski GW, 2012, TREE GENET GENOMES, P1; Edelaar P, 2011, MOL ECOL, V20, P1805, DOI 10.1111/j.1365-294X.2011.05051.x; Falconer D. S., 1996, INTRO QUANTITATIVE G; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Freeman JS, 2008, NEW PHYTOL, V178, P846, DOI 10.1111/j.1469-8137.2008.02417.x; Freeman JS, 2001, AUST J BOT, V49, P585, DOI 10.1071/BT00094; Frei ES, 2012, J ECOL, V100, P297, DOI 10.1111/j.1365-2745.2011.01909.x; Fritz RS, 1999, ECOLOGY, V80, P382, DOI 10.1890/0012-9658(1999)080[0382:ROHPTH]2.0.CO;2; Garcia-Gonzalez F, 2012, EVOLUTION, V66, P2341, DOI 10.1111/j.1558-5646.2011.01565.x; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gilmour AR, 2009, ASREML USER GUIDE RE; GRAHAM HD, 1992, J AGR FOOD CHEM, V40, P801, DOI 10.1021/jf00017a018; GRIFFIN AR, 1988, SILVAE GENET, V37, P124; Hallsson LR, 2012, J EVOLUTION BIOL, V25, P1275, DOI 10.1111/j.1420-9101.2012.02512.x; Hamilton M. G., 2008, New Zealand Journal of Forestry Science, V38, P102; HOULE D, 1992, GENETICS, V130, P195; Humphreys JR, 2008, SILVAE GENET, V57, P262, DOI 10.1515/sg-2008-0040; Jimenez-Ambriz G, 2007, NEW PHYTOL, V173, P199, DOI 10.1111/j.1469-8137.2006.01923.x; Johnson GR, 2007, TREE GENET GENOMES, V3, P25, DOI 10.1007/s11295-006-0054-0; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Latta RG, 1998, AM NAT, V151, P283, DOI 10.1086/286119; Lopez GA, 2003, CAN J FOREST RES, V33, P2108, DOI [10.1139/x03-132, 10.1139/X03-132]; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; McKiernan AB, 2012, J CHEM ECOL, V38, P204, DOI 10.1007/s10886-012-0071-4; McKinnon GE, 2005, AUST J BOT, V53, P827, DOI 10.1071/BT04195; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Miller AM, 2009, FOREST ECOL MANAG, V259, P45, DOI 10.1016/j.foreco.2009.09.040; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; Moore BD, 2010, ECOLOGY, V91, P3165, DOI 10.1890/09-1714.1; O'Reilly-Wapstra JM, 2004, FUNCT ECOL, V18, P677, DOI 10.1111/j.0269-8463.2004.00887.x; O'Reilly-Wapstra JM, 2005, OECOLOGIA, V142, P597, DOI 10.1007/s00442-004-1769-y; O'Reilly-Wapstra JM, 2005, J CHEM ECOL, V31, P357, DOI 10.1007/s10886-005-1346-9; O'Reilly-Wapstra JM, 2007, J CHEM ECOL, V33, P1876, DOI 10.1007/s10886-007-9366-2; O'Reilly-Wapstra JM, 2012, ECOL REV, P10; O'Reilly-Wapstra JM, 2010, EVOL ECOL RES, V12, P491; Orians CM, 2010, OECOLOGIA, V163, P283, DOI 10.1007/s00442-009-1521-8; Poelman EH, 2008, TRENDS PLANT SCI, V13, P534, DOI 10.1016/j.tplants.2008.08.003; POTTS BM, 1994, AUST J BOT, V42, P471, DOI 10.1071/BT9940471; Potts BM, 2004, P IUFRO C, P4661; Rasmann S, 2011, ECOL LETT, V14, P476, DOI 10.1111/j.1461-0248.2011.01609.x; SAS Institute Inc, 2009, STATISTICS-ABINGDON, V2; Stackpole DJ, 2010, TREE GENET GENOMES, V6, P179, DOI 10.1007/s11295-009-0239-4; Steane DA, 2006, TREE GENET GENOMES, V2, P30, DOI 10.1007/s11295-005-0028-7; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Steinbauer MJ, 2010, AUSTRAL ECOL, V35, P205, DOI 10.1111/j.1442-9993.2009.02028.x; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Thompson J. N., 2005, INTERSPEC INTERACT; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; Vannette RL, 2011, GLOBAL CHANGE BIOL, V17, P1277, DOI 10.1111/j.1365-2486.2010.02316.x; VOLKER PW, 1994, SILVAE GENET, V43, P366; Wallis IR, 2011, PERSPECT PLANT ECOL, V13, P305, DOI 10.1016/j.ppees.2011.05.005; Wallis IR, 2005, PHYTOCHEM ANALYSIS, V16, P49, DOI 10.1002/pca.810; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Williams E.R., 2002, EXPT DESIGN ANAL TRE; WOODS EC, 2011, ECOLOGICAL MONOGRAPH, V0082; Yeoh SH, 2012, TREE GENET GENOMES, V8, P695, DOI 10.1007/s11295-011-0457-4	74	27	28	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58416	10.1371/journal.pone.0058416	http://dx.doi.org/10.1371/journal.pone.0058416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526981	gold, Green Published, Green Accepted			2022-12-27	WOS:000317562600020
J	Wei, ZY; Chen, MJ; Zhang, YT; Wang, XF; Jiang, SS; Wang, Y; Wu, X; Qin, SY; He, L; Zhang, LR; Xing, QH				Wei, Zhiyun; Chen, Mingjie; Zhang, Yiting; Wang, Xiaofei; Jiang, Songshan; Wang, Yang; Wu, Xi; Qin, Shengying; He, Lin; Zhang, Lirong; Xing, Qinghe			No Correlation of hsa-miR-148a with Expression of PXR or CYP3A4 in Human Livers from Chinese Han Population	PLOS ONE			English	Article							CYTOCHROME-P450 3A4; METABOLISM; RECEPTOR	There is a huge variability of hepatic CYP3A4 level in human populations, which was believed to contribute to different responses to drugs among individuals. Transcription of CYP3A4 was regulated by transcription factors such as pregnane X receptor (PXR). MiRNA hsa-miR-148a was previously reported to influence PXR expression in HepG2 cells and in Japanese populations. In this study, we conducted a similar correlation study in Chinese Han population (N = 24). No significant correlation of hsa-miR-148a was found with PXR expression or CYP3A4 expression. Our results suggest that hsa-miR-148a does not play a major role in the regulation of PXR or CYP3A4 expression in human livers from Chinese Han population.	[Wei, Zhiyun; Chen, Mingjie; Zhang, Yiting; He, Lin; Xing, Qinghe] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Wei, Zhiyun; Chen, Mingjie; Zhang, Yiting; He, Lin; Xing, Qinghe] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wei, Zhiyun; Chen, Mingjie; Zhang, Yiting; Wang, Yang; Wu, Xi; Qin, Shengying; He, Lin; Xing, Qinghe] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Wang, Xiaofei; Zhang, Lirong] Zhengzhou Univ, Sch Med, Dept Pharmacol, Zhengzhou, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, MOE Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Zhengzhou University; Sun Yat Sen University; Sun Yat Sen University	Zhang, LR (corresponding author), Zhengzhou Univ, Sch Med, Dept Pharmacol, Zhengzhou, Peoples R China.	lrzhang@zzu.edu.cn; qhxing@fudan.edu.cn	Wang, Yang/HCG-9543-2022; Wei, Zhiyun/E-2008-2016; Zhang, Li/GWM-7501-2022	Wei, Zhiyun/0000-0002-3554-4142; 	National Natural Science Foundation of China [30971582, 90919049, 81173127]; 973 Program [2010CB529600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China [grant 30971582; 90919049; 81173127], and the 973 Program [2010CB529600]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dresser GK, 2000, CLIN PHARMACOKINET, V38, P41, DOI 10.2165/00003088-200038010-00003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Martinez-Jimenez CP, 2007, CURR DRUG METAB, V8, P185, DOI 10.2174/138920007779815986; Nakajima M, 2011, PHARMACOL THERAPEUT, V131, P330, DOI 10.1016/j.pharmthera.2011.04.009; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Stevens JC, 2003, J PHARMACOL EXP THER, V307, P573, DOI 10.1124/jpet.103.054841; Takada Tomonari, 2004, Drug Metab Pharmacokinet, V19, P103, DOI 10.2133/dmpk.19.103; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200	11	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59141	10.1371/journal.pone.0059141	http://dx.doi.org/10.1371/journal.pone.0059141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527115	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600059
J	Basu, A; Jaisankar, P; Kumar, GS				Basu, Anirban; Jaisankar, Parasuraman; Kumar, Gopinatha Suresh			Binding of the 9-O-N-aryl/arylalkyl Amino Carbonyl Methyl Substituted Berberine Analogs to tRNA(phe)	PLOS ONE			English	Article							PLANT ALKALOID PALMATINE; ENHANCED DNA-BINDING; ALKYL ETHER ANALOGS; TRANSFER-RNA; SMALL MOLECULES; SELF-STRUCTURE; STRANDED POLY(A); DRUG TARGET; PROTOBERBERINE; RECOGNITION	Background: Three new analogs of berberine with aryl/arylalkyl amino carbonyl methyl substituent at the 9-position of the isoquinoline chromophore along with berberrubine were studied for their binding to tRNA(phe) by wide variety of biophysical techniques like spectrophotometry, spectrofluorimetry, circular dichroism, thermal melting, viscosity and isothermal titration calorimetry. Methodology/Principal Findings: Scatchard binding isotherms revealed that the cooperative binding mode of berberine was propagated in the analogs also. Thermal melting studies showed that all the 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs stabilized the tRNA(phe) more in comparison to berberine. Circular dichroism studies showed that these analogs perturbed the structure of tRNA(phe) more in comparison to berberine. Ferrocyanide quenching studies and viscosity results proved the intercalative binding mode of these analogs into the helical organization of tRNA(phe). The binding was entropy driven for the analogs in sharp contrast to the enthalpy driven binding of berberine. The introduction of the aryl/arylalkyl amino carbonyl methyl substituent at the 9-position thus switched the enthalpy driven binding of berberine to entropy dominated binding. Salt and temperature dependent calorimetric studies established the involvement of multiple weak noncovalent interactions in the binding process. Conclusions/Significance: The results showed that 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs exhibited almost ten folds higher binding affinity to tRNA(phe) compared to berberine whereas the binding of berberrubine was dramatically reduced by about twenty fold in comparison to berberine. The spacer length of the substitution at the 9-position of the isoquinoline chromophore appears to be critical in modulating the binding affinities towards tRNA(phe).	[Basu, Anirban; Jaisankar, Parasuraman; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Div Chem, Kolkata, India; [Basu, Anirban; Kumar, Gopinatha Suresh] CSIR Indian Inst Chem Biol, Biophys Chem Lab, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Kumar, GS (corresponding author), CSIR Indian Inst Chem Biol, Div Chem, Kolkata, India.	gskumar@csiriicb.in	Kumar, Gopinatha Suresh/W-1461-2019; Jaisankar, Parasuraman/C-1553-2009; KUMAR, P. SURESH/AAT-8951-2020; Kumar, Dr Suresh/HHZ-2615-2022	Jaisankar, Parasuraman/0000-0003-0583-4920; KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553	CSIR, Government of India; UGC Senior research fellowship	CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC Senior research fellowship	This work was supported by grants from the network project GenCODE of CSIR, Government of India and UGC Senior research fellowship to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baird AW, 1997, ADV DRUG DELIVER REV, V23, P111, DOI 10.1016/S0169-409X(96)00429-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu A, 2012, RSC ADV, V2, P7714, DOI 10.1039/c2ra20841e; Basu A, 2012, BIOORGAN MED CHEM, V20, P2498, DOI 10.1016/j.bmc.2012.03.006; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; Bhadra K, 2007, BBA-GEN SUBJECTS, V1770, P1071, DOI 10.1016/j.bbagen.2007.03.001; Bhadra K, 2008, DNA CELL BIOL, V27, P675, DOI 10.1089/dna.2008.0779; Bhadra K, 2008, BBA-GEN SUBJECTS, V1780, P1054, DOI 10.1016/j.bbagen.2008.05.005; Bhowmik D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037939; Bodiwala HS, 2011, EUR J MED CHEM, V46, P1045, DOI 10.1016/j.ejmech.2011.01.016; Buchmueller KL, 2006, BIOCHEMISTRY-US, V45, P13551, DOI 10.1021/bi061245c; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; CHAIRES JB, 1982, BIOCHEMISTRY-US, V21, P3933, DOI 10.1021/bi00260a005; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; Chen WH, 2005, BIOORG MED CHEM LETT, V15, P2689, DOI 10.1016/j.bmcl.2004.10.098; Cheong HK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh081; Chueh WH, 2012, FOOD CHEM, V131, P1263, DOI 10.1016/j.foodchem.2011.09.116; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023186; DEBNATH D, 1989, INDIAN J BIOCHEM BIO, V26, P201; Foloppe N, 2006, DRUG DISCOV TODAY, V11, P1019, DOI 10.1016/j.drudis.2006.09.001; Fulle S, 2010, J MOL RECOGNIT, V23, P220, DOI 10.1002/jmr.1000; GAIT MJ, 1995, TRENDS BIOTECHNOL, V13, P430, DOI 10.1016/S0167-7799(00)88998-2; Gallego J, 2001, ACCOUNTS CHEM RES, V34, P836, DOI 10.1021/ar000118k; Garbett NC, 2004, BIOPHYS J, V87, P3974, DOI 10.1529/biophysj.104.047415; Gesteland R., 2006, RNA WORLD, V3rd edn. Cold Spring Harbor; Giri P, 2006, BIOORG MED CHEM LETT, V16, P2364, DOI 10.1016/j.bmcl.2006.01.124; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Giri P, 2008, J PHOTOCH PHOTOBIO A, V194, P111, DOI 10.1016/j.jphotochem.2007.07.022; Giri P, 2006, INT J BIOL MACROMOL, V39, P210, DOI 10.1016/j.ijbiomac.2006.03.026; Giri P, 2010, MINI-REV MED CHEM, V10, P568, DOI 10.2174/138955710791384009; Giri P, 2009, CURR MED CHEM, V16, P965, DOI 10.2174/092986709787581932; Guthrie KM, 2007, BIOPHYS CHEM, V126, P117, DOI 10.1016/j.bpc.2006.05.006; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; Hermann T, 1998, CURR OPIN BIOTECH, V9, P66, DOI 10.1016/S0958-1669(98)80086-4; HILL ZD, 1986, J CHEM EDUC, V63, P162, DOI 10.1021/ed063p162; Hoenigman SM, 1996, ANAL CHEM, V68, P3274, DOI 10.1021/ac960336k; Hossain M, 2012, J BIOMOL STRUCT DYN, V30, P223, DOI 10.1080/07391102.2012.677774; Hossain M, 2009, MOL BIOSYST, V5, P1311, DOI 10.1039/b909563b; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; Islam M, 2007, BIOPHYS CHEM, V125, P508, DOI 10.1016/j.bpc.2006.11.001; Islam MM, 2011, MEDCHEMCOMM, V2, P631, DOI 10.1039/c0md00209g; Islam MM, 2011, DNA CELL BIOL, V30, P123, DOI 10.1089/dna.2010.1109; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Islam MM, 2008, J MOL STRUCT, V891, P498, DOI 10.1016/j.molstruc.2008.04.043; Islam MM, 2009, MOL BIOSYST, V5, P244, DOI 10.1039/b816480k; Iwasa K, 1998, EUR J MED CHEM, V33, P65, DOI 10.1016/S0223-5234(99)80077-4; Janbaz KH, 2000, FITOTERAPIA, V71, P25, DOI 10.1016/S0367-326X(99)00098-2; Jen-Jacobson L, 2000, STRUCTURE, V8, P1015, DOI 10.1016/S0969-2126(00)00501-3; Job P, 1928, ANN CHIM FRANCE, V9, P113; Kanakis CD, 2009, SPECTROSC-INT J, V23, P29, DOI 10.1155/2009/154321; Krishnan P, 2000, ANTI-CANCER DRUG DES, V15, P255; Kumar GS, 2012, J BIOSCIENCES, V37, P539, DOI 10.1007/s12038-012-9217-3; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE; Liu JC, 1999, PHARMACOLOGY, V59, P283, DOI 10.1159/000028331; Lo CY, 2013, BIOORG MED CHEM LETT, V23, P305, DOI 10.1016/j.bmcl.2012.10.098; Long YH, 2006, BIOORGAN MED CHEM, V14, P4670, DOI 10.1016/j.bmc.2006.03.004; Ma Y, 2008, BIOORGAN MED CHEM, V16, P7582, DOI 10.1016/j.bmc.2008.07.029; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Murphy FV, 2000, STRUCT FOLD DES, V8, pR83, DOI 10.1016/S0969-2126(00)00126-X; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; N'soukpoe-Kossi CN, 2009, BIOCHEM CELL BIOL, V87, P621, DOI [10.1139/O09-036, 10.1139/o09-036]; NANDI R, 1990, BIOCHIM BIOPHYS ACTA, V1049, P339, DOI 10.1016/0167-4781(90)90107-D; Ouameur AA, 2010, RNA, V16, P1968, DOI 10.1261/rna.1994310; Pang JY, 2005, BIOORGAN MED CHEM, V13, P5835, DOI 10.1016/j.bmc.2005.05.048; Peng WH, 2007, LIFE SCI, V81, P933, DOI 10.1016/j.lfs.2007.08.003; Qin Y, 2006, BIOORGAN MED CHEM, V14, P25, DOI 10.1016/j.bmc.2005.07.069; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Ren JS, 2000, BIOCHEMISTRY-US, V39, P8439, DOI 10.1021/bi000474a; Shirwaikar A, 2006, BIOL PHARM BULL, V29, P1906, DOI 10.1248/bpb.29.1906; Sinha R, 2009, J PHYS CHEM B, V113, P13410, DOI 10.1021/jp9069515; Sun T, 2008, NUCLEIC ACIDS RES, V36, P1654, DOI 10.1093/nar/gkm1180; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Xavier KA, 2000, TRENDS BIOTECHNOL, V18, P349, DOI 10.1016/S0167-7799(00)01464-5; Yadav RC, 2005, BIOORGAN MED CHEM, V13, P165, DOI 10.1016/j.bmc.2004.09.045; Yan D, 2008, J BIOCHEM BIOPH METH, V70, P845, DOI 10.1016/j.jbbm.2007.07.009; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050	79	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58279	10.1371/journal.pone.0058279	http://dx.doi.org/10.1371/journal.pone.0058279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526972	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100020
J	Durante-Rodriguez, G; Mancheno, JM; Rivas, G; Alfonso, C; Garcia, JL; Diaz, E; Carmona, M				Durante-Rodriguez, Gonzalo; Miguel Mancheno, Jose; Rivas, German; Alfonso, Carlos; Luis Garcia, Jose; Diaz, Eduardo; Carmona, Manuel			Identification of a Missing Link in the Evolution of an Enzyme into a Transcriptional Regulator	PLOS ONE			English	Article							ANAEROBIC CATABOLISM; PHENYLACETIC ACID; ESCHERICHIA-COLI; GENE; REPRESSOR; SEQUENCE; BZDR	The evolution of transcriptional regulators through the recruitment of DNA-binding domains by enzymes is a widely held notion. However, few experimental approaches have directly addressed this hypothesis. Here we report the reconstruction of a plausible pathway for the evolution of an enzyme into a transcriptional regulator. The BzdR protein is the prototype of a subfamily of prokaryotic transcriptional regulators that controls the expression of genes involved in the anaerobic degradation of benzoate. We have shown that BzdR consists of an N-terminal DNA-binding domain connected through a linker to a C-terminal effector-binding domain that shows significant identity to the shikimate kinase (SK). The construction of active synthetic BzdR-like regulators by fusing the DNA-binding domain of BzdR to the Escherichia coli SKI protein strongly supports the notion that an ancestral SK domain could have been involved in the evolutionary origin of BzdR. The loss of the enzymatic activity of the ancestral SK domain was essential for it to evolve as a regulatory domain in the current BzdR protein. This work also supports the view that enzymes precede the emergence of the regulatory systems that may control their expression.	[Durante-Rodriguez, Gonzalo; Luis Garcia, Jose; Diaz, Eduardo; Carmona, Manuel] Ctr Invest Biol CSIC, Dept Environm Biol, Madrid, Spain; [Miguel Mancheno, Jose] CSIC, Inst Phys Chem Rocasolano, Grp Crystallog & Struct Biol, Madrid, Spain; [Rivas, German; Alfonso, Carlos] Ctr Invest Biol CSIC, Dept Chem & Phys Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Carmona, M (corresponding author), Ctr Invest Biol CSIC, Dept Environm Biol, Madrid, Spain.	mcarmona@cib.csic.es	Durante-Rodríguez, Gonzalo/H-3000-2013; Rivas, German/AAG-7458-2022; Mancheno, Jose/K-4984-2014; Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Garcia Lopez, Jose Luis/G-9139-2015; Diaz, Eduardo/F-8605-2016	Durante-Rodríguez, Gonzalo/0000-0003-3113-9868; Rivas, German/0000-0003-3450-7478; Mancheno, Jose/0000-0001-6943-3291; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Carmona, Manuel/0000-0002-1591-7618; Diaz, Eduardo/0000-0002-9731-6524	Ministry of Economy and Competitiveness of Spain [BIO2009-10438, CSD2007-00005, BIO2008-04478-C03-03, BFU2010-17929, CSD-2006-00015]	Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was supported by the Ministry of Economy and Competitiveness of Spain [BIO2009-10438, CSD2007-00005, BIO2008-04478-C03-03, BFU2010-17929, CSD-2006-00015]. GD-R was the recipient of a FPI fellowship from the Ministry of Economy and Competitiveness of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; ALLISON SL, 1990, J BACTERIOL, V172, P5470, DOI 10.1128/jb.172.9.5470-5476.1990; Aravind L, 1998, CURR BIOL, V8, pR111, DOI 10.1016/S0960-9822(98)70982-0; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; COGGINS JR, 1987, METHOD ENZYMOL, V142, P325; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; DEFEYTER R, 1987, METHOD ENZYMOL, V142, P355; Durante-Rodriguez G, 2006, J BACTERIOL, V188, P2343, DOI 10.1128/JB.188.7.2343-2354.2006; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Ferrandez A, 2000, J BIOL CHEM, V275, P12214, DOI 10.1074/jbc.275.16.12214; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fucile G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000292; Galvao TC, 2007, MOL MICROBIOL, V65, P907, DOI 10.1111/j.1365-2958.2007.05832.x; Hartmann MD, 2006, J MOL BIOL, V364, P411, DOI 10.1016/j.jmb.2006.09.001; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Krell T, 1998, J MOL BIOL, V278, P983, DOI 10.1006/jmbi.1998.1755; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOBNEROLESEN A, 1992, J BACTERIOL, V174, P525, DOI 10.1128/jb.174.2.525-529.1992; LOHR D, 1995, J BIOL CHEM, V270, P27671, DOI 10.1074/jbc.270.46.27671; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; MILLAR G, 1986, BIOCHEM J, V237, P427, DOI 10.1042/bj2370427; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; QUAIL MA, 1994, FEBS LETT, V356, P183, DOI 10.1016/0014-5793(94)01264-4; Sambrook J., 2001, MOL CLONING LAB MANU; Silhavy T.J., 1984, EXPT GENE FUSIONS; Vinella D, 1996, J BACTERIOL, V178, P3818, DOI 10.1128/jb.178.13.3818-3828.1996; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; WHIPP MJ, 1995, J BACTERIOL, V177, P1627, DOI 10.1128/jb.177.6.1627-1629.1995	33	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57518	10.1371/journal.pone.0057518	http://dx.doi.org/10.1371/journal.pone.0057518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526945	Green Published, gold			2022-12-27	WOS:000317562100013
J	Huang, CF; Dai, CY; Yeh, ML; Huang, JF; Huang, CI; Hsieh, MY; Lin, ZY; Chen, SC; Wang, LY; Juo, SHH; Chuang, WL; Lin, YC; Yu, ML				Huang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Jee-Fu; Huang, Ching-I; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Lin, Yi-Ching; Yu, Ming-Lung			Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients	PLOS ONE			English	Article							INTERLEUKIN-28B GENETIC-VARIANTS; PEGINTERFERON ALPHA-2B; ANTIVIRAL THERAPY; RIBAVIRIN; INTERFERON; MULTICENTER; IDENTIFICATION; POLYMORPHISMS; METAANALYSIS	Background/Aims: The impact of virological factors and interleukin-28B (IL-28B) genetic variants on retreatment of hepatitis C virus genotype 2 (HCV-2) treatment-experienced patients remains unknown. Methods: On-treatment virological responses and IL-28B rs8099917 genotype were determined in 46 HCV-2 treatment-experienced patients (42 previous relapsers; four previous non-responders) retreated with 24-week peginterferon/ribavirin. Results: Forty (87.0%) patients carried the rs8099917 TT genotype and 6 patients (13.0%) carried the TG/GG genotype. The sustained virological response (SVR; seronegativity of HCV RNA throughout 24 weeks of the post-treatment follow-up period) rate was 71.7%. Compared with previous non-responders, previous relapsers had a significantly higher SVR rate (78.6% vs. 0%, P = 0.004) and a lower relapse rate (17.5% vs. 100%, P = 0.04). All the previous non-responders were with the rs8099917 TT genotype. As for those who relapsed, treatment responses, including the rates of rapid virological response (RVR, 80.6% vs. 66.7%, P = 0.59), early virological response (EVR, 97.2% vs. 83.3%, P = 0.27), end-of-treatment virological response (97.2% vs. 83.3%, P = 0.27) and SVR (80.6% vs. 66.7%, P = 0.59) and relapse rate (17.1% vs. 20.0%, P = 1) did not differ significantly between patients with the rs8099917 TT and those with the non-TT genotype. Multivariate analysis revealed that the most important factor predictive of an SVR in the retreatment of HCV-2 was previous relapse; the only factor predictive of an SVR for previous relapsers was the achievement of an EVR. Compared with the achievement of a RVR, the attainment of an EVR was more accurate in predicting an SVR (88% vs. 74%). Conclusions: Peginterferon/ribavirin is effective in the retreatment of HCV-2 relapsers, especially among those who achieved an EVR.	[Huang, Chung-Feng; Lin, Yi-Ching] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung, Taiwan; [Huang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Jee-Fu; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Dai, Chia-Yen] Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan; [Dai, Chia-Yen; Huang, Jee-Fu; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Kaohsiung, Taiwan; [Huang, Jee-Fu] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Ching-I; Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Lin, Yi-Ching] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Dai, CY (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan.	fish6069@gmail.com	Juo, Suh-Hang/C-9545-2009; Huang, Jee-Fu/AAX-4622-2020; Chuang, Wan-Long/ABF-7427-2021; Yu, Ming-Lung/AAZ-4306-2020	Huang, Jee-Fu/0000-0002-2752-7051; Chuang, Wan-Long/0000-0002-2376-421X; Yu, Ming-Lung/0000-0001-8145-1900; Lin, Yi-Ching/0000-0002-0849-6149	Kaohsiung Medical University Hospital [KMUH100-9I02]; National Science Council, Taiwan [NSC 100-2314-B-037-014-MY2]	Kaohsiung Medical University Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Kaohsiung Medical University Hospital (KMUH100-9I02) and a grant from the National Science Council, Taiwan (NSC 100-2314-B-037-014-MY2). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso M, 2007, DIGEST LIVER DIS, V39, P47, DOI 10.1016/j.dld.2006.08.007; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Huang JF, 2007, ALIMENT PHARM THER, V25, P1029, DOI 10.1111/j.1365-2036.2007.03297.x; Jacobson IM, 2005, AM J GASTROENTEROL, V100, P2453, DOI 10.1111/j.1572-0241.2005.00282.x; Jensen DM, 2009, ANN INTERN MED, V150, P528, DOI 10.7326/0003-4819-150-8-200904210-00007; Kozuka R, 2012, HEPATOL RES IN PRESS; Krawitt EL, 2005, J HEPATOL, V43, P243, DOI 10.1016/j.jhep.2005.03.015; Liu CH, 2012, ANTIVIR THE IN PRESS; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2012, LIVER INT, V32, P135, DOI 10.1111/j.1478-3231.2011.02710.x; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Omata M, 2012, HEPATOL INT IN PRESS; Oze T, 2011, J GASTROENTEROL, V46, P1031, DOI 10.1007/s00535-011-0409-7; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Schreiber J, 2012, ALIMENT PHARM THER, V36, P353, DOI 10.1111/j.1365-2036.2012.05197.x; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Singal AG, 2010, ALIMENT PHARM THER, V32, P969, DOI 10.1111/j.1365-2036.2010.04427.x; Thompson AJ, 2012, HEPATOLOGY, V56, P373, DOI 10.1002/hep.25792; Vermehren J, 2011, J CLIN VIROL, V52, P133, DOI 10.1016/j.jcv.2011.07.007; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5; Yu ML, 2007, ONCOLOGY-BASEL, V72, P16, DOI 10.1159/000111703; Yu ML, 2006, ANTIVIR THER, V11, P985; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58882	10.1371/journal.pone.0058882	http://dx.doi.org/10.1371/journal.pone.0058882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527043	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100054
J	Wang, X; Dong, Y; Han, X; Qi, XQ; Huang, CG; Hou, LJ				Wang, Xiang; Dong, Yan; Han, Xi; Qi, Xiang-Qian; Huang, Cheng-Guang; Hou, Li-Jun			Nutritional Support for Patients Sustaining Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							TOTAL PARENTERAL-NUTRITION; EARLY ENTERAL NUTRITION; CONTROLLED-TRIAL; HEAD; HYPERALIMENTATION; SUPPLEMENTATION; GLUTAMINE; BENEFITS; MODERATE	Background: In traumatic brain injury (TBI), the appropriate timing and route of feeding, and the efficacy of immune-enhancing formulae have not been well established. We performed this meta-analysis aiming to compare the effects of different nutritional support modalities on clinical outcomes of TBI patients. Methods: We systematically searched Pubmed, Embase, and the Cochrane Library until October, 2012. All randomized controlled trials (RCTs) and non-randomized prospective studies (NPSs) that compared the effects of different routes, timings, or formulae of feeding on outcomes in TBI patients were selected. The primary outcomes included mortality and poor outcome. The secondary outcomes included the length of hospital stay, the length of ventilation days, and the rate of infectious or feeding-related complications. Findings: 13 RCTs and 3 NPSs were included. The pooled data demonstrated that, compared with delayed feeding, early feeding was associated with a significant reduction in the rate of mortality (relative risk [RR] = 0.35; 95% CI, 0.24-0.50), poor outcome (RR = 0.70; 95% CI, 0.54-0.91), and infectious complications (RR = 0.77; 95% CI, 0.59-0.99). Compared with enteral nutrition, parenteral nutrition showed a slight trend of reduction in the rate of mortality (RR = 0.61; 95% CI, 0.34-1.09), poor outcome (RR = 0.73; 95% CI, 0.51-1.04), and infectious complications (RR = 0.89; 95% CI, 0.66-1.22), whereas without statistical significances. The immune-enhancing formula was associated with a significant reduction in infection rate compared with the standard formula (RR = 0.54; 95% CI, 0.35-0.82). Small-bowel feeding was found to be with a decreasing rate of pneumonia compared with nasogastric feeding (RR = 0.41; 95% CI, 0.22-0.76). Conclusion: After TBI, early initiation of nutrition is recommended. It appears that parenteral nutrition is superior to enteral nutrition in improving outcomes. Our results lend support to the use of small-bowel feeding and immune-enhancing formulae in reducing infectious complications.	[Wang, Xiang; Dong, Yan; Qi, Xiang-Qian; Huang, Cheng-Guang; Hou, Li-Jun] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Dong, Yan] Second Mil Med Univ, Changzheng Hosp, Ctr Neurosci, Shanghai, Peoples R China; [Han, Xi] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Fudan University	Huang, CG (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	huang64@163.com; lj_hou@hotmail.com		Wang, Xiang/0000-0001-7465-606X	Natural Science Foundation of China [81171130/H0908]; Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [11ZR1448700]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation from Science and Technology Commission of Shanghai Municipality	This study was supported by Natural Science Foundation of China (81171130/H0908) and Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (11ZR1448700). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Berg A, 2008, CLIN NUTR, V27, P816, DOI 10.1016/j.clnu.2008.06.006; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Boselli M, 2012, NUTR CLIN PRACT, V27, P99, DOI 10.1177/0884533611431068; Bratton S.L., 2007, J NEUROTRAUMA S, V24, pS37, DOI DOI 10.1089/NEU.2007.9999; Briassoulis G, 2006, PEDIATR CRIT CARE ME, V7, P56, DOI 10.1097/01.PCC.0000192339.44871.26; CALON B, 1990, INFUSIONSTHERAPIE, V17, P246; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; Dhandapani Sivashanmugam, 2012, Surg Neurol Int, V3, P31, DOI 10.4103/2152-7806.93858; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; GADISSEUX P, 1984, J NEUROSURG, V60, P219, DOI 10.3171/jns.1984.60.2.0219; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Griffiths RD, 2006, LANCET, V368, P1868, DOI 10.1016/S0140-6736(06)69771-7; HADLEY MN, 1986, NEUROSURGERY, V19, P367, DOI 10.1097/00006123-198609000-00006; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; HAUSMANN D, 1985, INTENS CARE MED, V11, P80; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Meirelles CMJ, 2011, NUTR HOSP, V26, P1120, DOI [10.1590/S0212-16112011000500030, 10.3305/nh.2011.26.5.5133]; Khorana Jiraporn, 2009, Journal of the Medical Association of Thailand, V92, P188; Kostadima E, 2005, EUR RESPIR J, V26, P106, DOI 10.1183/09031936.05.00096104; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Maurya I, 2011, SAUDI J ANAESTH, V5, P195, DOI 10.4103/1658-354X.82800; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nataloni S, 1999, CLIN NUTR, V18, P247, DOI 10.1016/S0261-5614(99)80077-6; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Suchner U, 1996, NUTRITION, V12, P13, DOI 10.1016/0899-9007(95)00016-X; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TWYMAN D, 1985, JPEN-PARENTER ENTER, V9, P679, DOI 10.1177/0148607185009006679; Vincent JL, 2013, LANCET, V381, P354, DOI 10.1016/S0140-6736(12)61893-5; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; Wells G.A., 2000, VIS COMMUN Q; Worthington ML, 2011, NUTR CLIN PRACT, V26, P650, DOI 10.1177/0884533611425799; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zaloga GP, 2006, LANCET, V367, P1101, DOI 10.1016/S0140-6736(06)68307-4; Ziegler TR, 2009, NEW ENGL J MED, V361, P1088, DOI 10.1056/NEJMct0806956	51	54	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58838	10.1371/journal.pone.0058838	http://dx.doi.org/10.1371/journal.pone.0058838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527035	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100050
J	Zou, JY; Yang, H; Cui, HJ; Shu, YL; Xu, PP; Xu, CL; Chen, T				Zou, Jingyang; Yang, Hua; Cui, Hengjian; Shu, Yuelong; Xu, Peipei; Xu, Cuiling; Chen, Tao			Geographic Divisions and Modeling of Virological Data on Seasonal Influenza in the Chinese Mainland during the 2006-2009 Monitoring Years	PLOS ONE			English	Article								Background: Seasonal influenza epidemics occur annually with bimodality in southern China and unimodality in northern China. Regional differences exist in surveillance data collected by the National Influenza Surveillance Network of the Chinese mainland. Qualitative and quantitative analyses on the spatiotemporal rules of the influenza virus's activities are needed to lay the foundation for the surveillance, prevention and control of seasonal influenza. Methods: The peak performance analysis and Fourier harmonic extraction methods were used to explore the spatiotemporal characteristics of the seasonal influenza virus activity and to obtain geographic divisions. In the first method, the concept of quality control was introduced and robust estimators were chosen to make the results more convincing. The dominant Fourier harmonics of the provincial time series were extracted in the second method, and the VARiable CLUSter (VARCLUS) procedure was used to variably cluster the extracted results. On the basis of the above geographic division results, three typical districts were selected and corresponding sinusoidal models were applied to fit the time series of the virological data. Results: The predominant virus during every peak is visible from the bar charts of the virological data. The results of the two methods that were used to obtain the geographic divisions have some consistencies with each other and with the virus activity mechanism. Quantitative models were established for three typical districts: the south1 district, including Guangdong, Guangxi, Jiangxi and Fujian; the south2 district, including Hunan, Hubei, Shanghai, Jiangsu and Zhejiang; and the north district, including the 14 northern provinces except Qinghai. The sinusoidal fitting models showed that the south1 district had strong annual periodicity with strong winter peaks and weak summer peaks. The south2 district had strong semi-annual periodicity with similarly strong summer and winter peaks, and the north district had strong annual periodicity with only winter peaks.	[Zou, Jingyang] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Yang, Hua; Xu, Peipei] Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Yang, Hua] Beijing Normal Univ, Inst Remote Sensing Applicat CAS, Sch Geog & Remote Sensing Sci, Beijing 100875, Peoples R China; [Cui, Hengjian] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Shu, Yuelong; Xu, Cuiling; Chen, Tao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Capital Normal University; Chinese Center for Disease Control & Prevention	Yang, H (corresponding author), Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.	yh_crs@bnu.edu.cn			"Special Program for Prevention and Control of Infectious Diseases'' from the Ministry of Science and Technology of China [2008ZX10004-012]	"Special Program for Prevention and Control of Infectious Diseases'' from the Ministry of Science and Technology of China	This work is supported by the "Special Program for Prevention and Control of Infectious Diseases'' (No. 2008ZX10004-012) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdesmaki M, 2012, PACKAGE GENECYCLE; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; [Anonymous], 2002, SAS HELP DOC; Arkema JM, 2008, EURO SURVEILL, V13; Brockwell PJ, 1988, TIME SERIES THEORY M; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Gao Yan, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1097; Huang W, 2008, DIS SURVEILLANCE, V23, P469; Huang W, 2008, DIS SURVEILLANCE, V23, P463; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Maronna RA, 2006, ROUST STAT THEORY ME; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Mei YuFa, 2008, Disease Surveillance, V23, P682; Meijer A, 2007, EURO SURVEILL, V12; Meijer A, 2006, EURO SURVEILL, V11, P623; Montgomery D.C., 2004, INTRO STAT QUALITY C; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WHO, 2012, WHO INT GLOB EP SURV; [闫磊 Yan Lei], 2010, 地球信息科学学报, V12, P410; Zhu H, 2006, MODERN PREVENTIVE ME, V33, P913	23	13	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58434	10.1371/journal.pone.0058434	http://dx.doi.org/10.1371/journal.pone.0058434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526984	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100026
J	Huang, TC; Wang, YC				Huang, Tzung-Chi; Wang, Yao-Ching			Deformation Effect on SUVmax Changes in Thoracic Tumors Using 4-D PET/CT Scan	PLOS ONE			English	Article							FDG-PET; CT; MOTION; THERAPY; IMAGES; 3D	Respiratory motion blurs the standardized uptake value (SUV) and leads to a further signal reduction and changes in the SUV maxima. 4D PET can provide accurate tumor localization as a function of the respiratory phase in PET/CT imaging. We investigated thoracic tumor motion by respiratory 4D CT and assessed its deformation effect on the SUV changes in 4D PET imaging using clinical patient data. Twelve radiation oncology patients with thoracic cancer, including five lung cancer patients and seven esophageal cancer patients, were recruited to the present study. The 4D CT and PET image sets were acquired and reconstructed for 10 respiratory phases across the whole respiratory cycle. The optical flow method was applied to the 4D CT data to calculate the maximum displacements of the tumor motion in respiration. Our results show that increased tumor motion has a significant degree of association with the SUVmax loss for lung cancer. The results also show that the SUVmax loss has a higher correlation with tumors located at lower lobe of lung or at lower regions of esophagus.	[Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Wang, Yao-Ching] China Med Univ Hosp, Div Radiat Oncol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		school project of China Medical University, Taiwan [CMU99-S-46]	school project of China Medical University, Taiwan	This study was financially supported by the school project of China Medical University, Taiwan (CMU99-S-46), and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramyuk A, 2009, RADIOTHER ONCOL, V91, P399, DOI 10.1016/j.radonc.2009.01.003; Aristophanous M, 2012, INT J RADIAT ONCOL, V82, P99, DOI DOI 10.1016/J.IJR0BP.2010.12.060; Bradley J, 2004, INT J RADIAT ONCOL, V59, P78, DOI 10.1016/j.ijrobp.2003.10.044; Callahan J, 2011, AUSTRALAS PHYS ENG S, V34, P489, DOI 10.1007/s13246-011-0109-x; Cerfolio RJ, 2004, ANN THORAC SURG, V78, P1903, DOI 10.1016/j.athoracsur.2004.06.102; Guerrero T, 2004, PHYS MED BIOL, V49, P4147, DOI 10.1088/0031-9155/49/17/022; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huang TC, 2011, PHYS MED BIOL, V56, P2559, DOI 10.1088/0031-9155/56/8/014; Huang TC, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-45; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; MacManus M, 2009, RADIOTHER ONCOL, V91, P85, DOI 10.1016/j.radonc.2008.11.008; Nehmeh SA, 2004, MED PHYS, V31, P3179, DOI 10.1118/1.1809778; Park SJ, 2008, PHYS MED BIOL, V53, P3661, DOI 10.1088/0031-9155/53/13/018; Pevsner A, 2005, MED PHYS, V32, P2358, DOI 10.1118/1.1943809; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Wang SZ, 2012, KOREAN J RADIOL, V13, P417, DOI 10.3348/kjr.2012.13.4.417; Wolthaus JWH, 2005, PHYS MED BIOL, V50, P1569, DOI 10.1088/0031-9155/50/7/017	17	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58886	10.1371/journal.pone.0058886	http://dx.doi.org/10.1371/journal.pone.0058886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516568	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400071
J	Zhao, Y; Tao, LJ; Jiang, DP; Chen, XY; Li, P; Ning, YL; Xiong, RP; Liu, P; Peng, YZ; Zhou, YG				Zhao, Yan; Tao, Liju; Jiang, Dongpo; Chen, Xingyun; Li, Ping; Ning, Yalei; Xiong, Renping; Liu, Ping; Peng, Yizhi; Zhou, Yuan-Guo			The-144C/A Polymorphism in the Promoter of HSP90beta Is Associated with Multiple Organ Dysfunction Scores	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; POSTISCHEMIC VENTRICULAR RECOVERY; NITRIC-OXIDE SYNTHASE; SEPTIC SHOCK; RECEPTOR; GENE; ACTIVATION; EXPRESSION; SEPSIS; TRAUMA	Introduction: Variations in genetic background are the leading cause of differential susceptibility to traumatic infection. Heat shock protein 90 (HSP90), a broadly distributed and conserved molecule, regulates inflammation under stressful and traumatic conditions. However, the relationships between HSP90 genetic polymorphisms, post-traumatic inflammatory responses and organ function remain unknown. Methods: A total of 286 healthy volunteers and patients with severe trauma took part in a single nucleotide polymorphism (SNP)-based analysis of the HSP90beta gene and a clinical association analysis. HSP90beta and TNF-alpha levels were determined using quantitative PCR and western blot. The transcriptional activity of the HSP90beta promoter was assayed using the Dual-Luciferase Reporter Assay System. Results: The minor allele frequencies for the SNP located at -144 bp relative to the HSP90beta transcriptional start site were 28.47% and 28.52% in the normal and trauma populations, respectively; no significant differences were found between these two distributions. However, the results showed that a promoter containing the -144A allele had a higher transcriptional activity than did a promoter containing the wild-type -144C allele. Furthermore, the -144A promoter induced high expression of HSP90beta and low expression of the inflammatory factor TNF-alpha in a lipopolysaccharide-induced inflammatory model. A clinical association analysis showed that the multiple organ dysfunction scores for -144AA genotype carriers were significantly lower than those of -144CC carriers following trauma. No significant correlations were found between the presence of the two alleles and the incidence of sepsis. Conclusions: These results indicate that differences in expression caused by the -144 polymorphism in the HSP90beta promoter are associated with cellular inflammatory responses and the severity of organ injury. These findings will aid in risk assessment and early prevention of complications for patients with severe trauma.	[Zhao, Yan; Chen, Xingyun; Li, Ping; Ning, Yalei; Xiong, Renping; Liu, Ping; Zhou, Yuan-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, Chongqing, Peoples R China; [Zhao, Yan; Chen, Xingyun; Li, Ping; Ning, Yalei; Xiong, Renping; Liu, Ping; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Tao, Liju; Peng, Yizhi] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Jiang, Dongpo] Third Mil Med Univ, Daping Hosp, Intens Care Unit, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Peng, YZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	yizhipen@sina.com; yuanguo.zhou@gmail.com	Li, ping/J-6507-2019	Li, Ping/0000-0002-4926-3835	Foundation for the Author of National Excellent Doctoral Dissertation of China [200156]; National Natural Science Foundation of China [81000832]; National Basic Research Program of China [2005CB522602]; Innovation Grants of the Third Military Medical University [2010XQN32]	Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Innovation Grants of the Third Military Medical University	This work was supported by the Foundation for the Author of National Excellent Doctoral Dissertation of China [grant 200156], the National Natural Science Foundation of China [grant 81000832], National Basic Research Program of China [grant 2005CB522602] and Innovation Grants of the Third Military Medical University [grant 2010XQN32]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani M, 1998, J THORAC CARDIOV SUR, V115, P200, DOI 10.1016/S0022-5223(98)70458-1; Bhattacharyya S, 2010, BLOOD, V115, P1921, DOI 10.1182/blood-2009-06-224782; BOHEN SP, 1995, J BIOL CHEM, V270, P29433, DOI 10.1074/jbc.270.49.29433; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen KH, 2011, BRIT J SURG, V98, P1252, DOI 10.1002/bjs.7532; Chen KH, 2011, SHOCK, V35, P35, DOI 10.1097/SHK.0b013e3181eb45b3; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; CURRIE RW, 1988, CIRC RES, V63, P543, DOI 10.1161/01.RES.63.3.543; Duan ZX, 2011, J TRAUMA, V70, P954, DOI 10.1097/TA.0b013e3181e88adf; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Ekambaram P, 2012, TOXICOL MECH METHOD, V22, P367, DOI 10.3109/15376516.2012.673091; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Garcia-Segarra G, 2007, INTENS CARE MED, V33, P1354, DOI 10.1007/s00134-007-0695-y; Glushkova OV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P702, DOI 10.1134/S0006297910060040; Gu W, 2011, J TRAUMA; Hsu HY, 2007, MOL PHARMACOL, V71, P344, DOI 10.1124/mol.106.024240; Kainuma E, 2009, PSYCHONEUROENDOCRINO, V34, P1459, DOI 10.1016/j.psyneuen.2009.04.021; KARMAZYN M, 1990, AM J PHYSIOL, V259, pH424, DOI 10.1152/ajpheart.1990.259.2.H424; Lannan EA, 2012, ENDOCRINOLOGY; Latchman DS, 2001, CARDIOVASC RES, V51, P637, DOI 10.1016/S0008-6363(01)00354-6; Latchman DS, 2004, CURR NEUROVASC RES, V1, P21, DOI 10.2174/1567202043480206; MacLean MJ, 2005, BIOCHEM BIOPH RES CO, V337, P133, DOI 10.1016/j.bbrc.2005.09.025; Madach K, 2010, CRIT CARE, V14, DOI 10.1186/cc8992; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Millson SH, 2007, FEBS J, V274, P4453, DOI 10.1111/j.1742-4658.2007.05974.x; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Nielsen ER, 2006, ANN NY ACAD SCI, V1067, P343, DOI 10.1196/annals.1354.048; Padmini E, 2012, CELL BIOCH BIOPHYS; Passarino G, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9141; Pribenszky C, 2010, BIOL REPROD, V83, P690, DOI 10.1095/biolreprod.110.083386; Scale TAI, 2005, SCAL TAI; Shen HY, 2010, J NEUROTRAUM, V27, P373, DOI 10.1089/neu.2009.0926; Sonna LA, 2002, J APPL PHYSIOL, V92, P2208, DOI 10.1152/japplphysiol.01002.2001; Taiyab A, 2010, BIOCH BIOPHYS ACTA; Tominaga M, 2009, J GASTROEN HEPATOL, V24, P1136, DOI 10.1111/j.1440-1746.2008.05763.x; Tsantes AE, 2010, BLOOD COAGUL FIBRIN, V21, P175, DOI 10.1097/MBC.0b013e32833678a1; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Voss AK, 2000, DEVELOPMENT, V127, P1; Waterer Grant W, 2010, Expert Rev Respir Med, V4, P229, DOI 10.1586/ers.10.13; Wong HR, 2012, CRIT CARE MED, V40, P1618, DOI 10.1097/CCM.0b013e318246b546; Yang C, 2011, CYTOKINE, V54, P29, DOI 10.1016/j.cyto.2010.12.011; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Zhao Y, 2010, CELL PHYSIOL BIOCHEM, V25, P359, DOI 10.1159/000303039	47	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58646	10.1371/journal.pone.0058646	http://dx.doi.org/10.1371/journal.pone.0058646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516526	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200100
J	Ali, M; Broadhurst, RW				Ali, Muzaffar; Broadhurst, R. William			Solution Structure of the QUA1 Dimerization Domain of pXqua, the Xenopus Ortholog of Quaking	PLOS ONE			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNA; SIGNAL-TRANSDUCTION; QKI PROTEINS; SAM68; STAR; EXPRESSION; GLD-1; HOMODIMERIZATION; FAMILY	The STAR protein family member Quaking is essential for early development in vertebrates. For example, in oligodendrocyte cells it regulates the splicing, localization, translation and lifetime of a set of mRNAs that code for crucial components of myelin. The Quaking protein contains three contiguous conserved regions: a QUA1 oligomerization element, followed by a single-stranded RNA binding motif comprising the KH and QUA2 domains. An embryonic lethal point mutation in the QUA1 domain, E48G, is known to affect both the aggregation state and RNA-binding properties of the murine Quaking ortholog (QKI). Here we report the NMR solution structure of the QUA1 domain from the Xenopus laevis Quaking ortholog (pXqua), which forms a dimer composed of two perpendicularly docked a-helical hairpin motifs. Size exclusion chromatography studies of a range of mutants demonstrate that the dimeric state of the pXqua QUA1 domain is stabilized by a network of interactions between side-chains, with significant roles played by an intra-molecular hydrogen bond between Y41 and E72 (the counterpart to QKI E48) and an inter-protomer salt bridge between E72 and R67. These results are compared with recent structural and mutagenesis studies of QUA1 domains from the STAR family members QKI, GLD-1 and Sam68.	[Ali, Muzaffar; Broadhurst, R. William] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Broadhurst, RW (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	rwb1002@cam.ac.uk	Broadhurst, Bill William/J-6710-2017	Broadhurst, Bill William/0000-0002-0264-4593	Slater Fund, University of Cambridge; Wellcome Trust [094252/Z/10/Z]	Slater Fund, University of Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Slater Fund, University of Cambridge, and a project grant from the Wellcome Trust, http://www.wellcome.ac.uk/(R. William Broadhurst; 094252/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Backx L, 2010, AM J MED GENET A, V152A, P319, DOI 10.1002/ajmg.a.33202; Bardiaux B, 2009, PROTEINS, V75, P569, DOI 10.1002/prot.22268; Beuck C, 2012, J MOL BIOL, V423, P766, DOI 10.1016/j.jmb.2012.08.027; Beuck C, 2010, STRUCTURE, V18, P377, DOI 10.1016/j.str.2009.12.016; Biedermann B, 2010, CELL CYCLE, V9, P1929, DOI 10.4161/cc.9.10.11533; Bockbrader K, 2008, FUTUR NEUROL, V3, P655, DOI 10.2217/14796708.3.6.655; Bohnsack BL, 2006, GENESIS, V44, P93, DOI 10.1002/gene.20189; Carmel AB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-48; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Corioni M, 2011, NUCLEIC ACIDS RES, V39, P1868, DOI 10.1093/nar/gkq1042; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; EBERSOLE T, 1992, GENETICS, V131, P183; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Galarneau A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-47; Guo WG, 2011, CELL PHYSIOL BIOCHEM, V28, P593, DOI 10.1159/000335755; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hocine S, 2010, COLD SPRING HARB PER; Itoh M, 2002, NUCLEIC ACIDS RES, V30, P5452, DOI 10.1093/nar/gkf673; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; Klempan TA, 2009, BIOL PSYCHIAT, V66, P824, DOI 10.1016/j.biopsych.2009.05.010; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Li ZZ, 2002, JPN J CANCER RES, V93, P167, DOI 10.1111/j.1349-7006.2002.tb01255.x; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lobbardi R, 2011, DEVELOPMENT, V138, P1783, DOI 10.1242/dev.059121; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mackereth CD, 2012, CURR OPIN STRUC BIOL, V22, P287, DOI 10.1016/j.sbi.2012.03.013; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Nir R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002632; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Ryder SP, 2004, RNA, V10, P1449, DOI 10.1261/rna.7780504; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Sun H, 2012, IEEE ACM T COMPUT BI, V9, P249, DOI 10.1109/TCBB.2011.67; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wang YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012824; Winzor DJ, 2003, J BIOCHEM BIOPH METH, V56, P15, DOI 10.1016/S0165-022X(03)00071-X; Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334; Wu HY, 2001, MOL CELL NEUROSCI, V17, P292, DOI 10.1006/mcne.2000.0941; Yang GD, 2010, GASTROENTEROLOGY, V138, P231, DOI 10.1053/j.gastro.2009.08.001; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006; Zhao LX, 2010, P NATL ACAD SCI USA, V107, P19061, DOI 10.1073/pnas.1007487107; Zorn AM, 1997, GENE DEV, V11, P2176, DOI 10.1101/gad.11.17.2176; Zorn AM, 1997, GENE, V188, P199, DOI 10.1016/S0378-1119(96)00795-0; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	67	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57345	10.1371/journal.pone.0057345	http://dx.doi.org/10.1371/journal.pone.0057345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520467	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900026
J	Franci, C; Zhou, J; Jiang, ZS; Modrusan, Z; Good, Z; Jackson, E; Kouros-Mehr, H				Franci, Christian; Zhou, Jenny; Jiang, Zhaoshi; Modrusan, Zora; Good, Zinaida; Jackson, Erica; Kouros-Mehr, Hosein			Biomarkers of Residual Disease, Disseminated Tumor Cells, and Metastases in the MMTV-PyMT Breast Cancer Model	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MOLECULAR PORTRAITS; TRANSCRIPTION FACTORS; TARGETING NOTCH; STAT FAMILY; RESISTANCE; DISTINCT; INTERLEUKIN-6; SIGNATURE; PATHWAY	Cancer metastases arise in part from disseminated tumor cells originating from the primary tumor and from residual disease persisting after therapy. The identification of biomarkers on micro-metastases, disseminated tumors, and residual disease may yield novel tools for early detection and treatment of these disease states prior to their development into metastases and recurrent tumors. Here we describe the molecular profiling of disseminated tumor cells in lungs, lung metastases, and residual tumor cells in the MMTV-PyMT breast cancer model. MMTV-PyMT mice were bred with actin-GFP mice, and focal hyperplastic lesions from pubertal MMTV-PyMT;actin-GFP mice were orthotopically transplanted into FVB/n mice to track single tumor foci. Tumor-bearing mice were treated with TAC chemotherapy (docetaxel, doxorubicin, cyclophosphamide), and residual and relapsed tumor cells were sorted and profiled by mRNA microarray analysis. Data analysis revealed enrichment of the Jak/Stat pathway, Notch pathway, and epigenetic regulators in residual tumors. Stat1 was significantly up-regulated in a DNA-damage-resistant population of residual tumor cells, and a pre-existing Stat1 sub-population was identified in untreated tumors. Tumor cells from adenomas, carcinomas, lung disseminated tumor cells, and lung metastases were also sorted from MMTV-PyMT transplant mice and profiled by mRNA microarray. Whereas disseminated tumors cells appeared similar to carcinoma cells at the mRNA level, lung metastases were genotypically very different from disseminated cells and primary tumors. Lung metastases were enriched for a number of chromatin-modifying genes and stem cell-associated genes. Histone analysis of H3K4 and H3K9 suggested that lung metastases had been reprogrammed during malignant progression. These data identify novel biomarkers of residual tumor cells and disseminated tumor cells and implicate pathways that may mediate metastasis formation and tumor relapse after therapy.	[Franci, Christian; Zhou, Jenny; Jiang, Zhaoshi; Modrusan, Zora; Good, Zinaida; Jackson, Erica; Kouros-Mehr, Hosein] Genentech Inc, Res Oncol Dept, San Francisco, CA 94080 USA	Roche Holding; Genentech	Kouros-Mehr, H (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	kouros.mehr@gmail.com		Good, Zinaida/0000-0003-2343-5771	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Funding was provided by Genentech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carmo CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019861; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Duan ZF, 2006, CANCER CHEMOTH PHARM, V57, P25, DOI 10.1007/s00280-005-0026-3; Ezponda T, 2012, ONCOGENE; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fryknas M, 2007, INT J CANCER, V120, P189, DOI 10.1002/ijc.22291; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hall C, 2012, CANCER-AM CANCER SOC, V118, P342, DOI 10.1002/cncr.26202; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Martin M, 2006, ANN ONCOL, V17, P1205, DOI 10.1093/annonc/mdl135; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Montel V, 2005, AM J PATHOL, V166, P1565, DOI 10.1016/S0002-9440(10)62372-3; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Popovic R, 2012, CANCER DISCOV, V2, P405, DOI 10.1158/2159-8290.CD-12-0076; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Rickardson L, 2005, BRIT J CANCER, V93, P483, DOI 10.1038/sj.bjc.6602699; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Rodriguez-Viciana P, 2006, P NATL ACAD SCI USA, V103, P19290, DOI 10.1073/pnas.0609343103; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sheen-Chen SM, 2007, ANTICANCER RES, V27, P2481; Slade MJ, 2007, NAT CLIN PRACT ONCOL, V4, P30, DOI 10.1038/ncponc0685; Sorlie T, 2004, EUR J CANCER, V40, P2667, DOI 10.1016/j.ejca.2004.08.021; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; Tsai MH, 2007, CANCER RES, V67, P3845, DOI 10.1158/0008-5472.CAN-06-4250; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vecchi M, 2008, ONCOGENE, V27, P2148, DOI 10.1038/sj.onc.1210858; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zhang GJ, 1999, ANTICANCER RES, V19, P1427; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020965	73	27	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58183	10.1371/journal.pone.0058183	http://dx.doi.org/10.1371/journal.pone.0058183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520493	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900052
J	Li, ZM; Tian, T; Lv, F; Chang, Y; Wang, XH; Zhang, L; Li, X; Li, L; Ma, W; Wu, JJ; Zhang, MZ				Li, Zhaoming; Tian, Tian; Lv, Feng; Chang, Yu; Wang, Xinhua; Zhang, Lei; Li, Xin; Li, Ling; Ma, Wang; Wu, Jingjing; Zhang, Mingzhi			Six1 Promotes Proliferation of Pancreatic Cancer Cells via Upregulation of Cyclin D1 Expression	PLOS ONE			English	Article							GENE-EXPRESSION; HOMEOPROTEIN SIX1; OVEREXPRESSION; CARCINOMA; METASTASIS; EZRIN; TUMORIGENESIS; MECHANISM; APOPTOSIS; SURVIVAL	Six1 is one of the transcription factors that act as master regulators of development and are frequently dysregulated in cancers. However, the role of Six1 in pancreatic cancer is not clear. Here we show that the relative expression of Six1 mRNA is increased in pancreatic cancer and correlated with advanced tumor stage. In vitro functional assays demonstrate that forced overexpression of Six1 significantly enhances the growth rate and proliferation ability of pancreatic cancer cells. Knockdown of endogenous Six1 decreases the proliferation of these cells dramatically. Furthermore, Six1 promotes the growth of pancreatic cancer cells in a xenograft assay. We also show that the gene encoding cyclin D1 is a direct transcriptional target of Six1 in pancreatic cancer cells. Overexpression of Six1 upregulates cyclin D1 mRNA and protein, and significantly enhances the activity of the cyclin D1 promoter in PANC-1 cells. We demonstrate that Six1 promotes cell cycle progression and proliferation by upregulation of cyclin D1. These data suggest that Six1 is overexpressed in pancreatic cancer and may contribute to the increased cell proliferation through upregulation of cyclin D1.	[Li, Zhaoming; Chang, Yu; Wang, Xinhua; Zhang, Lei; Li, Xin; Li, Ling; Ma, Wang; Wu, Jingjing; Zhang, Mingzhi] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Tian, Tian] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Lv, Feng] Peoples Hosp Henan Prov, Dept Surg, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Tian, T (corresponding author), Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China.	t0013153@gmail.com; mingzhi.zhang@126.com	li, li/AAT-2097-2020; Wang, Xin/AAN-8435-2021; li, li/GPX-3938-2022; li, li/HII-4157-2022; LI, LI/GVS-5344-2022; LI, LI QING/GRR-8855-2022; Li, Li/AEM-3636-2022	Wang, Xin/0000-0002-4457-7376; Li, Zhaoming/0000-0002-2876-5182	national Natural Science Foundation of China (NSFC) [81172118]; China Postdoctoral Science Foundation	national Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funds from national Natural Science Foundation of China (NSFC, NO 81172118) and by grants from China Postdoctoral Science Foundation (to LZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; Donahue TR, 2012, CLIN CANCER RES, V18, P1352, DOI 10.1158/1078-0432.CCR-11-1539; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Konishi Y, 2006, BRAIN RES, V1116, P93, DOI 10.1016/j.brainres.2006.07.103; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Laurance ME, 2001, NUCLEIC ACIDS RES, V29, P652, DOI 10.1093/nar/29.3.652; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Liu Y, 2012, NUCL ACIDS RES; Luo XL, 2011, INT J MOL MED, V28, P349, DOI 10.3892/ijmm.2011.692; Luo XL, 2009, INT J MOL MED, V23, P357, DOI 10.3892/ijmm_00000139; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ng KT, 2006, BRIT J CANCER, V95, P1050, DOI 10.1038/sj.bjc.6603399; Ng KTP, 2010, INT J CANCER, V127, P859, DOI 10.1002/ijc.25105; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Reichenberger KJ, 2005, CANCER RES, V65, P2668, DOI 10.1158/0008-5472.CAN-04-4286; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tan J, 2011, TUMOR BIOL, V32, P1241, DOI 10.1007/s13277-011-0228-8; Tempero MA, 2011, ANN ONCOL, V22, P1500, DOI 10.1093/annonc/mdq545; Wang CA, 2012, J CLIN INVEST, V122, P1895, DOI 10.1172/JCI59858; Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031507; Zheng XH, 2010, INT J GYNECOL CANCER, V20, P1587, DOI 10.1111/IGC.0b013e3181f9defb; Zou D, 2004, DEVELOPMENT, V131, P5561, DOI 10.1242/dev.01437	39	65	72	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59203	10.1371/journal.pone.0059203	http://dx.doi.org/10.1371/journal.pone.0059203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527134	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600064
J	Behrendt, JM; Nagel, D; Chundoo, E; Alexander, LM; Dupin, D; Hine, AV; Bradley, M; Sutherland, AJ				Behrendt, Jonathan M.; Nagel, David; Chundoo, Evita; Alexander, Lois M.; Dupin, Damien; Hine, Anna V.; Bradley, Mark; Sutherland, Andrew J.			Synthesis and Characterization of Dual-Functionalized Core-Shell Fluorescent Microspheres for Bioconjugation and Cellular Delivery	PLOS ONE			English	Article							NANOPARTICLES; IMMOBILIZATION; SURFACE; SIRNA; QUANTITATION; CELLS; BEADS; SIZE	The efficient transport of micron-sized beads into cells, via a non-endocytosis mediated mechanism, has only recently been described. As such there is considerable scope for optimization and exploitation of this procedure to enable imaging and sensing applications to be realized. Herein, we report the design, synthesis and characterization of fluorescent microsphere-based cellular delivery agents that can also carry biological cargoes. These core-shell polymer microspheres possess two distinct chemical environments; the core is hydrophobic and can be labeled with fluorescent dye, to permit visual tracking of the microsphere during and after cellular delivery, whilst the outer shell renders the external surfaces of the microspheres hydrophilic, thus facilitating both bioconjugation and cellular compatibility. Cross-linked core particles were prepared in a dispersion polymerization reaction employing styrene, divinylbenzene and a thiol-functionalized co-monomer. These core particles were then shelled in a seeded emulsion polymerization reaction, employing styrene, divinylbenzene and methacrylic acid, to generate orthogonally functionalized core-shell microspheres which were internally labeled via the core thiol moieties through reaction with a thiol reactive dye (DY630-maleimide). Following internal labeling, bioconjugation of green fluorescent protein (GFP) to their carboxyl-functionalized surfaces was successfully accomplished using standard coupling protocols. The resultant dual-labeled microspheres were visualized by both of the fully resolvable fluorescence emissions of their cores (DY630) and shells (GFP). In vitro cellular uptake of these microspheres by HeLa cells was demonstrated conventionally by fluorescence-based flow cytometry, whilst MTT assays demonstrated that 92% of HeLa cells remained viable after uptake. Due to their size and surface functionalities, these far-red-labeled microspheres are ideal candidates for in vitro, cellular delivery of proteins.	[Behrendt, Jonathan M.; Chundoo, Evita; Sutherland, Andrew J.] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England; [Nagel, David; Hine, Anna V.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Alexander, Lois M.; Bradley, Mark] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland; [Dupin, Damien] Univ Sheffield, Dept Chem, Sheffield, S Yorkshire, England	Aston University; Aston University; University of Edinburgh; University of Sheffield	Sutherland, AJ (corresponding author), Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England.	a.j.sutherland@aston.ac.uk	Dupin, Damien/ABE-5635-2020; Behrendt, Jonathan/L-2885-2013	Dupin, Damien/0000-0003-0868-9028; Behrendt, Jonathan/0000-0002-9246-4667; Hine, Anna/0000-0003-4065-831X; Sutherland, Andrew/0000-0003-3651-1809	Engineering and Physical Sciences Research Council of the United Kingdom [EP/D038197/1, EP/D038057/1]; Advantage West Midlands; European Regional Development Fund; EPSRC [EP/D038057/1, EP/J501724/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D038057/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Advantage West Midlands(General Electric); European Regional Development Fund(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council of the United Kingdom through the provision of grants EP/D038197/1 and EP/D038057/1. The Beckmann Coulter Delta Nano C Particle Analyzer used in this research was obtained, through Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials Project 2), with support from Advantage West Midlands and part funded by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami RC, 2011, MOL THER, V19, P1141, DOI 10.1038/mt.2011.56; Alexander LM, 2010, MOL BIOSYST, V6, P399, DOI 10.1039/b914428e; Alexander LM, 2009, BIOCONJUGATE CHEM, V20, P422, DOI 10.1021/bc800529r; Algar WR, 2011, BIOCONJUGATE CHEM, V22, P825, DOI 10.1021/bc200065z; Behrendt JM, 2009, J MATER CHEM, V19, P215, DOI 10.1039/b814261k; Bousalem S, 2005, J MATER CHEM, V15, P3109, DOI 10.1039/b500982k; Bradley M, 2008, BIOORG MED CHEM LETT, V18, P313, DOI 10.1016/j.bmcl.2007.10.075; Braeckmans K, 2010, J CONTROL RELEASE, V148, P69, DOI 10.1016/j.jconrel.2010.08.029; Dhar S, 2009, J AM CHEM SOC, V131, P14652, DOI 10.1021/ja9071282; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Fubini B, 2011, NANOMEDICINE-UK, V6, P899, DOI [10.2217/nnm.11.80, 10.2217/NNM.11.80]; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gennet N, 2009, NEW BIOTECHNOL, V25, P442, DOI 10.1016/j.nbt.2009.05.006; Gude M, 2002, LETT PEPT SCI, V9, P203, DOI 10.1007/BF02538384; Higuchi Y, 2011, BIOMATERIALS, V32, P6676, DOI 10.1016/j.biomaterials.2011.05.076; Jose AJ, 2005, POLYMER, V46, P2880, DOI 10.1016/j.polymer.2005.02.001; KOBAYASHI K, 1992, J APPL POLYM SCI, V46, P27, DOI 10.1002/app.1992.070460104; Kutschera U, 2005, THEOR BIOSCI, V124, P1, DOI 10.1016/j.thbio.2005.04.001; Li X, 2011, BIOMATERIALS, V32, P9546, DOI 10.1016/j.biomaterials.2011.08.068; Nelson Jr SJ, 1966, United States Patent, Patent No. 3260748; PAINE AJ, 1990, MACROMOLECULES, V23, P3104, DOI 10.1021/ma00214a012; Pallen MJ, 2011, TRENDS MICROBIOL, V19, P58, DOI 10.1016/j.tim.2010.11.001; Petkau K, 2011, J AM CHEM SOC, V133, P17063, DOI 10.1021/ja2075345; Reetz MT, 2002, TETRAHEDRON, V58, P8465, DOI 10.1016/S0040-4020(02)01052-9; Sanchez-Martin RM, 2005, CHEMBIOCHEM, V6, P1341, DOI 10.1002/cbic.200500059; Sanchez-Martin RM, 2006, ANGEW CHEM INT EDIT, V45, P5472, DOI 10.1002/anie.200601242; Sanchez-Martin RM, 2009, CHEMBIOCHEM, V10, P1453, DOI 10.1002/cbic.200900136; Scutaru AM, 2010, BIOCONJUGATE CHEM, V21, P2222, DOI 10.1021/bc1001906; Slomkowski S, 2002, POLYM ADVAN TECHNOL, V13, P906, DOI 10.1002/pat.283; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Tantra R, 2011, NANOTOXICOLOGY, V5, P381, DOI 10.3109/17435390.2010.512987; Tsakiridis A, 2009, BIOMATERIALS, V30, P5853, DOI 10.1016/j.biomaterials.2009.06.024; Vagner J, 1996, P NATL ACAD SCI USA, V93, P8194, DOI 10.1073/pnas.93.16.8194; Wang JT, 2011, SMALL, V7, P1728, DOI 10.1002/smll.201001913; Wang SH, 2011, J NANOBIOTECHNOL, V8; Zhao EY, 2012, NANOSCALE, V4, P5102, DOI 10.1039/c2nr31290e	36	11	11	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e50713	10.1371/journal.pone.0050713	http://dx.doi.org/10.1371/journal.pone.0050713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526923	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000317562100001
J	Welaga, P; Moyer, CA; Aborigo, R; Adongo, P; Williams, J; Hodgson, A; Oduro, A; Engmann, C				Welaga, Paul; Moyer, Cheryl A.; Aborigo, Raymond; Adongo, Philip; Williams, John; Hodgson, Abraham; Oduro, Abraham; Engmann, Cyril			Why Are Babies Dying in the First Month after Birth? A 7-Year Study of Neonatal Mortality in Northern Ghana	PLOS ONE			English	Article							VERBAL AUTOPSY; NAVRONGO EXPERIMENT; CHILD-MORTALITY; NATIONAL CAUSES; RISK-FACTORS; STILLBIRTHS; DEATHS; HEALTH; COMMUNITY; SURVIVAL	Objectives: To determine the neonatal mortality rate in the Kassena-Nankana District (KND) of northern Ghana, and to identify the leading causes and timing of neonatal deaths. Methods: The KND falls within the Navrongo Health Research Centre's Health and Demographic Surveillance System (HDSS), which uses trained field workers to gather and update health and demographic information from community members every four months. We utilized HDSS data from 2003-2009 to examine patterns of neonatal mortality. Results: A total of 17,751 live births between January 2003 and December 2009 were recorded, including 424 neonatal deaths 64.8%(275) of neonatal deaths occurred in the first week of life. The overall neonatal mortality rate was 24 per 1000 live births (95% CI 22 to 26) and early neonatal mortality rate was 16 per 1000 live births (95% CI 14 to 17). Neonatal mortality rates decreased over the period from 26 per 1000 live births in 2003 to 19 per 1000 live births in 2009. In all, 32%(137) of the neonatal deaths were from infections, 21%(88) from birth injury and asphyxia and 18%(76) from prematurity, making these three the leading causes of neonatal deaths in the area. Birth injury and asphyxia (31%) and prematurity (26%) were the leading causes of early neonatal deaths, while infection accounted for 59% of late neonatal deaths. Nearly 46% of all neonatal deaths occurred during the first three postnatal days. In multivariate analysis, multiple births, gestational age <32 weeks and first pregnancies conferred the highest odds of neonatal deaths. Conclusions: Neonatal mortality rates are declining in rural northern Ghana, with majority of deaths occurring within the first week of life. This has major policy, programmatic and research implications. Further research is needed to better understand the social, cultural, and logistical factors that drive high mortality in the early days following delivery.	[Welaga, Paul; Aborigo, Raymond; Williams, John; Hodgson, Abraham; Oduro, Abraham] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana; [Moyer, Cheryl A.] Univ Michigan, Sch Med, Global REACH, Ann Arbor, MI USA; [Moyer, Cheryl A.] Univ Michigan, Sch Med, Dept Med Educ, Ann Arbor, MI USA; [Adongo, Philip] Univ Ghana, Sch Publ Hlth, Legon, Ghana; [Engmann, Cyril] Univ N Carolina, Sch Med, Dept Paediat & Maternal Child Hlth, Chapel Hill, NC USA; [Engmann, Cyril] Univ N Carolina, Sch Publ Hlth, Dept Paediat & Maternal Child Hlth, Chapel Hill, NC USA; [Aborigo, Raymond] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Sunway Campus, Malaysia	Ghana Health Service; Navrongo Health Research Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Ghana; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Monash University; Monash University Sunway	Welaga, P (corresponding author), Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana.	pwelaga@yahoo.com		ODURO, ABRAHAM/0000-0002-4191-7419; Adongo, Philip Baba/0000-0002-0614-4756; Moyer, Cheryl/0000-0002-5796-157X	Navrongo Health Research Center; University of North Carolina; University of Michigan	Navrongo Health Research Center; University of North Carolina; University of Michigan(University of Michigan System)	Funding was provided by grants and in-kind contributions from the Navrongo Health Research Center and the Universities of North Carolina and Michigan. The data used for the analysis is part of an ongoing project activities of the Navrongo Health and Demographic Surveillance System which monitors the population dynamics of the study area. The universities of North Carolina and Michigan supported the travel expenses of Cyril Engmann and Cheryl Moyer respectively in this collaborative work. The funders had no role in study design, and analysis, decision to publish, or preparation of the manuscript.	Aborigo RA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-76; [Anonymous], 2005, LANCET, V365, P1983; Baiden F, 2006, TROP MED INT HEALTH, V11, P532, DOI 10.1111/j.1365-3156.2006.01582.x; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; BINKA FN, 1995, STUD FAMILY PLANN, V26, P121, DOI 10.2307/2137832; Binka FN, 2007, TROP MED INT HEALTH, V12, P578, DOI 10.1111/j.1365-3156.2007.01826.x; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chandramohan D, 2008, PLOS MED, V5, P169, DOI 10.1371/journal.pmed.0050057; de Almeida MF, 2011, CAD SAUDE PUBLICA, V27, P1088, DOI 10.1590/S0102-311X2011000600006; Denham AR, 2010, SOC SCI MED, V71, P608, DOI 10.1016/j.socscimed.2010.04.022; Diallo AH, 2011, J PERINATOL, V31, P656, DOI 10.1038/jp.2011.6; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Engmann C, 2012, J PERINATOL, V32, P585, DOI 10.1038/jp.2011.154; Engmann C, 2009, TROP MED INT HEALTH, V14, P1496, DOI 10.1111/j.1365-3156.2009.02395.x; Engmann C, 2012, TROP MED INT HEALTH, V17, P272, DOI 10.1111/j.1365-3156.2011.02931.x; Engmann C, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-42; Engmann C, 2009, INT J GYNECOL OBSTET, V105, P112, DOI 10.1016/j.ijgo.2008.12.012; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Garenne M, 2006, B WORLD HEALTH ORGAN, V84, P248; Ghana Statistical Service Research, 2008, GHAN DEM HLTH SURV 2; Jehan I, 2009, B WORLD HEALTH ORGAN, V87, P130, DOI 10.2471/BLT.08.050963; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2008, PAEDIATR PERINAT EP, V22, P410, DOI 10.1111/j.1365-3016.2008.00960.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McClure EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.07.004; Moyer C. A., 2012, BMC Pregnancy and Childbirth, V12; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Petterson B, 1998, BAILLIERE CLIN OB GY, V12, P1, DOI 10.1016/S0950-3552(98)80036-9; Phillips JF, 2006, B WORLD HEALTH ORGAN, V84, P949, DOI 10.2471/BLT.06.030064; Rahman S, 2010, INT J WOMENS HEALTH, V2, P311, DOI 10.2147/IJWH.S12426; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Setel PW, 2005, B WORLD HEALTH ORGAN, V83, P611; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Upadhyay RP, 2012, INDIAN PEDIATR, V49, P291, DOI 10.1007/s13312-012-0044-2; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2005, WHO INT STAT CLASS D; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	41	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58924	10.1371/journal.pone.0058924	http://dx.doi.org/10.1371/journal.pone.0058924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527050	Green Published, gold			2022-12-27	WOS:000317562100056
J	Cherng, YG; Liao, CC; Chen, TH; Xiao, D; Wu, CH; Chen, TL				Cherng, Yih-Giun; Liao, Chien-Chang; Chen, Tso-Hsiao; Xiao, Duan; Wu, Chih-Hsiung; Chen, Ta-Liang			Are Non-cardiac Surgeries Safe for Dialysis Patients? - A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							STAGE RENAL-FAILURE; PERITONEAL-DIALYSIS; FLUID MANAGEMENT; MEDICAL PROGRESS; CARDIAC-SURGERY; MORTALITY; RISK; HEMODIALYSIS; SURVIVAL; DISEASE	Background: End-stage renal disease represents a risk complex that complicates surgical results. The surgical outcomes of dialysis patients have been studied in specific fields, but the global features of postoperative adverse outcomes in dialysis patients receiving non-cardiac surgeries have not been examined. Methods: Taiwan's National Health Insurance Research Database was used to study 8,937 patients under regular dialysis with 8,937 propensity-score matched-pair controls receiving non-cardiac surgery between 2004 and 2007. We investigated the influence of hemodialysis and peritoneal dialysis, effects of hypertension and diabetes, and impact of additional comorbidities on postoperative adverse outcomes. Results: Postoperative mortality in dialysis patients was higher than in controls (odds ratio [OR] 3.33, 95% confidence interval [CI] 2.56 to 4.33) when receiving non-cardiac surgeries. Complications such as acute myocardial infarction, pneumonia, bleeding, and septicemia were significantly increased. Postoperative mortality was significantly increased among peritoneal dialysis patients (OR 2.71, 95% CI 1.70 to 4.31) and hemodialysis patients (OR 3.42, 95% CI 2.62 to 4.47) than in controls. Dialysis patients with both hypertension and diabetes had the highest risk of postoperative complications; these risks increased with number of preoperative medical conditions. Patients under dialysis also showed significantly increased length of hospitalization, more ICU stays and higher medical expenditures. Conclusion: Surgical patients under dialysis encountered significantly higher postoperative complications and mortality than controls when receiving non-cardiac surgeries. Different dialysis techniques, pre-existing hypertension/diabetes, and various comorbidities had complication-specific impacts on surgical adverse outcomes. These findings can help surgical teams provide better risk assessment and postoperative care for dialysis patients.	[Cherng, Yih-Giun] Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, New Taipei City, Taiwan; [Cherng, Yih-Giun; Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang; Chen, Ta-Liang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, Tso-Hsiao] Taipei Med Univ, Dept Nephrol, Dept Internal Med, Coll Med,Wan Fang Med Ctr, Taipei, Taiwan; [Xiao, Duan] Second Peoples Hosp Shi Fang City, Dept Coloproctol, Shi Fang City, Sichuan Provinc, Peoples R China; [Wu, Chih-Hsiung] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, New Taipei City, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chen, TL (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan.	tlc@tmu.edu.tw		Cherng, Yih-Giun/0000-0002-0201-4380	Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital	Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital	This research was supported by a Foundation for Anesthesia Education and Research fellowship grant through Taipei Medical University Hospital without conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Bechtel JFM, 2008, ANN THORAC SURG, V85, P147, DOI 10.1016/j.athoracsur.2007.08.048; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; de Peppo AP, 2002, ANN THORAC SURG, V74, P378, DOI 10.1016/S0003-4975(02)03711-6; Drolet S, 2010, DIS COLON RECTUM, V53, P1508, DOI 10.1007/DCR.0b013e3181e8fc8e; Guh JY, 2007, AM J KIDNEY DIS, V49, P626, DOI 10.1053/j.ajkd.2007.02.259; Herzog CA, 2002, CIRCULATION, V106, P2207, DOI 10.1161/01.CIR.0000035248.71165.EB; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; Huang CC, 2008, ACTA NEPHROLOGICA, V22, P215; Ifudu O, 1998, NEW ENGL J MED, V339, P1054, DOI 10.1056/NEJM199810083391507; Jaar BG, 2005, ANN INTERN MED, V143, P174, DOI 10.7326/0003-4819-143-3-200508020-00003; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Kuo HW, 2010, PHARMACOEPIDEM DR S, V19, P743, DOI 10.1002/pds.1962; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Lin HF, 2012, NEPHROL DIAL TRANSPL, V27, P1585, DOI 10.1093/ndt/gfr464; Lin JL, 2003, NEW ENGL J MED, V348, P277, DOI 10.1056/NEJMoa021672; Lin JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026977; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Miller RD, 2009, ANESTHETIC IMPLICATI, P1067; Murphy SW, 2000, KIDNEY INT, V57, P1720, DOI 10.1046/j.1523-1755.2000.00017.x; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Noordzij M, 2006, NEPHROL DIAL TRANSPL, V21, P2513, DOI 10.1093/ndt/gfl257; Parquin F, 1996, EUR J CARDIO-THORAC, V10, P929, DOI 10.1016/S1010-7940(96)80392-7; Pastan S, 1998, NEW ENGL J MED, V338, P1428, DOI 10.1056/NEJM199805143382006; Perrinet M, 2010, J CLIN PHARM THER, V35, P395, DOI 10.1111/j.1365-2710.2009.01106.x; Prichard SS, 2000, KIDNEY INT, V57, pS100, DOI 10.1046/j.1523-1755.2000.07417.x; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; SLINGER PD, 1995, J CARDIOTHOR VASC AN, V9, P442, DOI 10.1016/S1053-0770(05)80103-X; Tsai SY, 2009, J EPIDEMIOL, V19, P169, DOI 10.2188/jea.JE20080099; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Winkelmayer WC, 2002, J AM SOC NEPHROL, V13, P2353, DOI 10.1097/01.ASN.0000025785.41314.76; Yu YH, 2011, SPINE, V36, P660, DOI 10.1097/BRS.0b013e3181dc9a33	39	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58942	10.1371/journal.pone.0058942	http://dx.doi.org/10.1371/journal.pone.0058942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516581	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400080
J	McQuade, KJ; Nakajima, A; Ilacqua, AN; Shimada, N; Sawai, S				McQuade, Kyle J.; Nakajima, Akihiko; Ilacqua, April N.; Shimada, Nao; Sawai, Satoshi			The Green Tea Catechin Epigallocatechin Gallate (EGCG) Blocks Cell Motility, Chemotaxis and Development in Dictyostelium discoideum	PLOS ONE			English	Article							DENSITY WAVE-PROPAGATION; GALLOYL MOIETY; ADENYLYL-CYCLASE; MOUND FORMATION; PRESTALK CELLS; DIFFERENTIATION; AGGREGATION; EXPRESSION; POLYPHENOLS; MECHANISMS	Catechins, flavanols found at high levels in green tea, have received significant attention due to their potential health benefits related to cancer, autoimmunity and metabolic disease, but little is known about the mechanisms by which these compounds affect cellular behavior. Here, we assess whether the model organism Dictyostelium discoideum is a useful tool with which to characterize the effects of catechins. Epigallocatechin gallate (EGCG), the most abundant and potent catechin in green tea, has significant effects on the Dictyostelium life cycle. In the presence of EGCG aggregation is delayed, cells do not stream and development is typically stalled at the loose aggregate stage. The developmental effects very likely result from defects in motility, as EGCG reduces both random movement and chemotaxis of Dictyostelium amoebae. These results suggest that catechins and their derivatives may be useful tools with which to better understand cell motility and development in Dictyostelium and that this organism is a useful model to further characterize the activities of catechins.	[McQuade, Kyle J.; Ilacqua, April N.] Colorado Mesa Univ, Dept Biol Sci, Grand Junction, CO USA; [Nakajima, Akihiko; Shimada, Nao; Sawai, Satoshi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Sawai, Satoshi] Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo, Japan; [Sawai, Satoshi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	McQuade, KJ (corresponding author), Colorado Mesa Univ, Dept Biol Sci, Grand Junction, CO USA.	kmcquade@coloradomesa.edu	Nakajima, Akihiko/U-1973-2019; Sawai, Satoshi/AAX-8536-2020	Nakajima, Akihiko/0000-0002-2690-6973; Sawai, Satoshi/0000-0003-3764-219X	JSPS [22680024, 23870006]; JST PRESTO program; Human Frontier Science Program [RGY 70/2008]; Platform for Dynamic Approaches to Living Systems from MEXT, Japan; Colorado Mesa University (CMU) Biology Department; Faculty Development Awards from CMU; Beta Beta Beta Honor Society;  [23111506]; Grants-in-Aid for Scientific Research [22680024] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST PRESTO program; Human Frontier Science Program(Human Frontier Science Program); Platform for Dynamic Approaches to Living Systems from MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Colorado Mesa University (CMU) Biology Department; Faculty Development Awards from CMU; Beta Beta Beta Honor Society; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work in the Sawai Lab was supported by JSPS Grant-in-Aid for Young Scientists (A) (22680024), Grant-in-Aid for Scientific Research on Innovative Areas (23111506), JST PRESTO program and in part by Human Frontier Science Program (RGY 70/2008) and Platform for Dynamic Approaches to Living Systems from MEXT, Japan. AN was supported by JSPS Grant-in-Aid for Research Activity Start-up (23870006). KJM was supported by the Colorado Mesa University (CMU) Biology Department and by Faculty Development Awards from CMU. ANI was supported by an undergraduate research award from Beta Beta Beta Honor Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007; BERKS M, 1990, DEVELOPMENT, V110, P977; Clow PA, 2000, DEVELOPMENT, V127, P2715; Comer FI, 2006, MOL BIOL CELL, V17, P357, DOI 10.1091/mbc.E05-08-0781; Dannat K, 2003, PHARMAZIE, V58, P204; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; EARLY A, 1995, CELL, V83, P91, DOI 10.1016/0092-8674(95)90237-6; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; GROSS JD, 1976, J CELL SCI, V22, P645; Haque AM, 2008, J NUTR BIOCHEM, V19, P619, DOI 10.1016/j.jnutbio.2007.08.008; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Jackson JK, 2010, J MATER SCI-MATER M, V21, P1435, DOI 10.1007/s10856-010-4019-3; Jaeger S, 2009, BIOINFORMATICS, V25, P2383, DOI 10.1093/bioinformatics/btp405; Jiang F, 2010, CLIN IMMUNOL, V137, P347, DOI 10.1016/j.clim.2010.08.007; Jiang Y, 1998, BIOPHYS J, V75, P2615, DOI 10.1016/S0006-3495(98)77707-0; Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161; King JS, 2009, DIS MODEL MECH, V2, P306, DOI 10.1242/dmm.001271; Kotsifas M, 2002, J MUSCLE RES CELL M, V23, P839, DOI 10.1023/A:1024444215766; Kurahashi N, 2008, AM J EPIDEMIOL, V167, P71, DOI 10.1093/aje/kwm249; Kuzuhara Takashi, 2009, PLoS Curr, V1, pRRN1052; Lang M, 2009, LIVER INT, V29, P670, DOI 10.1111/j.1478-3231.2009.01984.x; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; Loomis WF, 2011, DEV GROWTH DIFFER, V53, P567, DOI 10.1111/j.1440-169X.2010.01241.x; MATSUKUMA S, 1979, J EMBRYOL EXP MORPH, V50, P243; Myre MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002052; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; NELLEN W, 1984, MOL CELL BIOL, V4, P2890, DOI 10.1128/MCB.4.12.2890; Ogunleye AA, 2010, BREAST CANCER RES TR, V119, P477, DOI 10.1007/s10549-009-0415-0; Patel H, 2000, EMBO J, V19, P2247, DOI 10.1093/emboj/19.10.2247; Rietdorf J, 1996, DEV BIOL, V177, P427, DOI 10.1006/dbio.1996.0175; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Sawai S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r144; SCHNITZLER GR, 1994, GENE DEV, V8, P502, DOI 10.1101/gad.8.4.502; SIEGERT F, 1991, PHYSICA D, V49, P224, DOI 10.1016/0167-2789(91)90210-Z; SIEGERT F, 1989, J CELL SCI, V93, P325; SIEGERT F, 1992, P NATL ACAD SCI USA, V89, P6433, DOI 10.1073/pnas.89.14.6433; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; SOLL DR, 1988, J CELL BIOCHEM, V37, P177, DOI 10.1002/jcb.240370205; Suganuma M, 2011, CANCER SCI, V102, P317, DOI 10.1111/j.1349-7006.2010.01805.x; Sugatani J, 2004, INT ARCH ALLERGY IMM, V134, P17, DOI 10.1159/000077529; Szabo CM, 2002, J MED CHEM, V45, P2894, DOI 10.1021/jm010279+; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; Tillner J, 1998, TOXICOL IN VITRO, V12, P463, DOI 10.1016/S0887-2333(98)00016-2; TRAYNOR D, 1992, P NATL ACAD SCI USA, V89, P8303, DOI 10.1073/pnas.89.17.8303; Van Aller GS, 2011, BIOCHEM BIOPH RES CO, V406, P194, DOI 10.1016/j.bbrc.2011.02.010; Van Driessche N, 2007, P NATL ACAD SCI USA, V104, P15406, DOI 10.1073/pnas.0705996104; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Wang X, 2003, BIOCHEM PHARMACOL, V66, P2039, DOI 10.1016/S0006-2952(03)00585-9; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297; YAMAMOTO A, 1983, DIFFERENTIATION, V24, P83, DOI 10.1111/j.1432-0436.1983.tb01307.x; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	57	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59275	10.1371/journal.pone.0059275	http://dx.doi.org/10.1371/journal.pone.0059275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516620	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400104
J	Meredith, JM; Underhill, A; McArthur, CC; Eggleston, P				Meredith, Janet M.; Underhill, Ann; McArthur, Clare C.; Eggleston, Paul			Next-Generation Site-Directed Transgenesis in the Malaria Vector Mosquito Anopheles gambiae: Self-Docking Strains Expressing Germline-Specific phiC31 Integrase	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; GENETIC-TRANSFORMATION; LINE TRANSFORMATION; TRANSPOSON VECTOR; REGULATORY REGION; HIGH-EFFICIENCY; AEDES-AEGYPTI; DROSOPHILA; PIGGYBAC; DNA	Diseases transmitted by mosquitoes have a devastating impact on global health and the situation is complicated due to difficulties with both existing control measures and the impact of climate change. Genetically modified mosquitoes that are refractory to disease transmission are seen as having great potential in the delivery of novel control strategies. The Streptomyces phage phiC31 integrase system has been successfully adapted for site-directed transgene integration in a range of insects, thus overcoming many limitations due to size constraints and random integration associated with transposon-mediated transformation. Using this technology, we previously published the first site-directed transformation of Anopheles gambiae, the principal vector of human malaria. Mosquitoes were initially engineered to incorporate the phiC31 docking site at a defined genomic location. A second phase of genetic modification then achieved site-directed integration of an anti-malarial effector gene. In the current publication we report improved efficiency and utility of the phiC31 integrase system following the generation of Anopheles gambiae self-docking strains. Four independent strains, with docking sites at known locations on three different chromosome arms, were engineered to express integrase under control of the regulatory regions of the nanos gene from Anopheles gambiae. The resulting protein accumulates in the posterior oocyte to provide integrase activity at the site of germline development. Two self-docking strains, exhibiting significantly different levels of integrase expression, were assessed for site-directed transgene integration and found to demonstrate greatly improved survival and efficiency of transformation. In the fight against malaria, it is imperative to establish a broad repertoire of both anti-malarial effector genes and tissue-specific promoters to regulate their expression, enabling those offering maximum effect with minimum fitness cost to be identified. The improved technology we describe here will facilitate comparative studies of effector transgenes, allowing informed choices to be made that potentially lead to transmission blockade.	[Meredith, Janet M.; Underhill, Ann; McArthur, Clare C.; Eggleston, Paul] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England	Keele University	Eggleston, P (corresponding author), Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England.	p.eggleston@keele.ac.uk			Wellcome Trust [084582]; European Union through FP7 Infrastructures Award [228421]	Wellcome Trust(Wellcome TrustEuropean Commission); European Union through FP7 Infrastructures Award	The authors are grateful for financial support from the Wellcome Trust (http://www.wellcome.ac.uk/) through Programme Grant 084582 to PE and to the European Union (http://cordis.europa.eu/fp7/home_en.html) through FP7 Infrastructures Award 228421 to PE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, INSECT MOL BIOL, V14, P271, DOI 10.1111/j.1365-2583.2004.00557.x; Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2; Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000402; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Besansky N.J., 1993, Insect Molecular Biology, V1, P171, DOI 10.1111/j.1365-2583.1993.tb00089.x; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; CHATER KF, 1981, GENE, V15, P249, DOI 10.1016/0378-1119(81)90134-7; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Jahan N, 1997, ANN TROP MED PARASIT, V91, P365, DOI 10.1080/00034989760987; Jasinskiene N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng148; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Keravala A, 2009, MOL THER, V17, P112, DOI 10.1038/mt.2008.241; Labbe GMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000788; Lombardo Fabrizio, 2009, BMC Res Notes, V2, P24, DOI 10.1186/1756-0500-2-24; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Lorenzen MD, 2002, INSECT MOL BIOL, V11, P399, DOI 10.1046/j.1365-2583.2002.00349.x; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Nolan T, 2011, GENETICA, V139, P33, DOI 10.1007/s10709-010-9482-8; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Papathanos PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-65; Perera OP, 2002, INSECT MOL BIOL, V11, P291, DOI 10.1046/j.1365-2583.2002.00336.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Rodrigues FG, 2006, MEM I OSWALDO CRUZ, V101, P755, DOI 10.1590/S0074-02762006000700008; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Sethuraman N, 2007, INSECT BIOCHEM MOLEC, V37, P941, DOI 10.1016/j.ibmb.2007.05.004; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192	51	27	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59264	10.1371/journal.pone.0059264	http://dx.doi.org/10.1371/journal.pone.0059264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516619	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000316849200139
J	Fernandez, MV; Heras, S; Vinas, J; Maltagliati, F; Roldan, MI				Victoria Fernandez, Maria; Heras, Sandra; Vinas, Jordi; Maltagliati, Ferruccio; Ines Roldan, Maria			Multilocus Comparative Phylogeography of Two Aristeid Shrimps of High Commercial Interest (Aristeus antennatus and Aristaeomorpha foliacea) Reveals Different Responses to Past Environmental Changes	PLOS ONE			English	Article							GENETIC-STRUCTURE; NUCLEAR GENE; HAPLOTYPE RECONSTRUCTION; MEDITERRANEAN SEA; DNA; DECAPODA; CRUSTACEA; HISTORY; RISSO; SUBSTITUTIONS	Phylogeographical studies can reveal hidden patterns in the evolutionary history of species. Comparative analyses of closely related species can further help disentangle the relative contributions of processes responsible for such patterns. In this work, the phylogeography of two aristeid species, Aristeus antennatus and Aristaeomorpha foliacea, was compared through multiple genetic markers. These marine shrimp species are of high commercial importance, and are exploited in the Mediterranean Sea (MED) and in Mozambique Channel (MOZ) where they occur in partial sympatry. Aristeus antennatus (N = 50) from Western and Eastern Mediterranean (WM and EM, respectively), Atlantic Ocean (AO) and MOZ, and Aristaeomorpha foliacea (N = 40) from WM, EM, MOZ North-Western Australia (AUS) were analyzed with two nuclear genes (PEPCK and NaK) and one mitochondrial (COI) gene. Within the study area differences were found between the two species in their phylogeographical patterns, suggesting distinct responses to environmental changes. Monophyly of Aristeus antennatus was found across its distributional range. This pattern contrasted by a deep evolutionary split within Aristaeomorpha foliacea where genetic diversity followed geography distinguishing MED-MOZ and AUS. We propose that the AUS lineage of A. foliacea warrants consideration as a distinct species, with consequent implications in systematics and resource management.	[Victoria Fernandez, Maria; Heras, Sandra; Vinas, Jordi; Ines Roldan, Maria] Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain; [Maltagliati, Ferruccio] Univ Pisa, Dipartimento Biol, Pisa, Italy	Universitat de Girona; University of Pisa	Roldan, MI (corresponding author), Univ Girona, Dept Biol, Lab Ictiol Genet, Campus Montilivi, Girona, Spain.	marina.roldan@udg.edu	Viñas, Jordi/A-5397-2010; Roldan, Maria Ines/L-2144-2014; Heras, Sandra/F-6658-2010; Heras, Sandra/Q-2108-2019	Viñas, Jordi/0000-0003-0193-1141; Roldan, Maria Ines/0000-0003-3936-3522; Heras, Sandra/0000-0002-9142-8760; Heras, Sandra/0000-0002-9142-8760	Ministerio de Educacion y Ciencia, Spain [CTM2006-00785, BES-2007-15865]; Ministerio de Ciencia e Innovacion, Spain [AGL2009-09228]	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by a grant from Ministerio de Educacion y Ciencia, Spain (CTM2006-00785) and a grant from Ministerio de Ciencia e Innovacion, Spain (AGL2009-09228) to MIR. MVF benefited from a predoctoral fellowship from Ministerio de Educacion y Ciencia, Spain (BES-2007-15865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J, 2004, MOL MARKERS NATURAL; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bensch A, 2008, WORLDWIDE REV BOTTOM; Bermingham E, 1998, MOL ECOL, V7, P367, DOI 10.1046/j.1365-294x.1998.00424.x; Bianchini M.L, 1994, ITTP SPECIAL PUBLICA, V3, P63; Calman W. T., 1925, Report Fisheries and Marine Biological Survey Cape Town, V4, P1; Campillo A., 1994, NTR ITPP SPECIAL PUB, V3, P25; Cannas R, 2012, MAR ECOL-EVOL PERSP, V33, P350, DOI 10.1111/j.1439-0485.2011.00504.x; Cartes JE, 2011, J MARINE SYST, V88, P516, DOI 10.1016/j.jmarsys.2011.07.001; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez MV, 2013, J SEA RES, V76, P146, DOI 10.1016/j.seares.2012.08.004; Figueiredo MJ, 2001, FISH RES, V51, P321, DOI 10.1016/S0165-7836(01)00255-7; Friedlander TP, 1996, MOL BIOL EVOL, V13, P594, DOI 10.1093/oxfordjournals.molbev.a025619; FRIEDLANDER TP, 1992, SYST BIOL, V41, P483, DOI 10.2307/2992589; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holthuis L.B., 1980, FAO SPECIES CATALOGU, V125, P1; Kapiris K., 2009, INT J ZOOLOGY, DOI [10.1155/2009/979512, DOI 10.1155/2009/979512]; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lavery S, 2004, MOL PHYLOGENET EVOL, V31, P39, DOI 10.1016/j.ympev.2003.07.015; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Ma KY, 2009, MOL PHYLOGENET EVOL, V53, P45, DOI 10.1016/j.ympev.2009.05.019; Maggio T, 2009, MAR ECOL-EVOL PERSP, V30, P354, DOI 10.1111/j.1439-0485.2008.00277.x; Mallet James, 2001, P523; Marlow JR, 2000, SCIENCE, V290, P2288; Mayr E, 1970, POPULATIONS SPECIES; McMillen-Jackson AL, 2003, MOL ECOL, V12, P2895, DOI 10.1046/j.1365-294X.2003.01955.x; Millot C, 2005, SCI MAR, V69, P5, DOI 10.3989/scimar.2005.69s15; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander JAA., 2004, BIOINFORMATICS; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Politou CY, 2004, SCI MAR, V68, P129; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roldan MI, 2009, GENETICA, V136, P1, DOI 10.1007/s10709-008-9330-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarda F, 1998, J EXP MAR BIOL ECOL, V221, P131, DOI 10.1016/S0022-0981(97)00119-6; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Sobrino I, 2009, W INDIAN OCEAN J MAR, V8; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavares C, 2010, TREATISE ON ZOOLOGY-ANATOMY, TAXONOMY, BIOLOGY: THE CRUSTACEA, VOL 9, PT A, P99; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; Tsang LM, 2008, MOL PHYLOGENET EVOL, V48, P359, DOI 10.1016/j.ympev.2008.04.009; Tsoi KH, 2005, MAR BIOL, V147, P367, DOI 10.1007/s00227-005-1585-x; Vargas-Yanez M., 2010, CAMBIO CLIMATICO MED; Fernandez MV, 2011, CR BIOL, V334, P705, DOI 10.1016/j.crvi.2011.07.005; Fernandez MV, 2011, MAR ECOL PROG SER, V421, P163, DOI 10.3354/meps08881; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	65	10	11	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59033	10.1371/journal.pone.0059033	http://dx.doi.org/10.1371/journal.pone.0059033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516594	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200127
J	Xin, HP; Zhu, W; Wang, LN; Xiang, Y; Fang, LC; Li, JT; Sun, XM; Wang, NA; Londo, JP; Li, SH				Xin, Haiping; Zhu, Wei; Wang, Lina; Xiang, Yue; Fang, Linchuan; Li, Jitao; Sun, Xiaoming; Wang, Nian; Londo, Jason P.; Li, Shaohua			Genome Wide Transcriptional Profile Analysis of Vitis amurensis and Vitis vinifera in Response to Cold Stress	PLOS ONE			English	Article							LOW-TEMPERATURE; FREEZING TOLERANCE; ABSCISIC-ACID; GENE-EXPRESSION; PROTEIN-KINASE; ABIOTIC STRESS; ARABIDOPSIS; DROUGHT; GRAPEVINE; ACCLIMATION	Grape is one of the most important fruit crops worldwide. The suitable geographical locations and productivity of grapes are largely limited by temperature. Vitis amurensis is a wild grapevine species with remarkable cold-tolerance, exceeding that of Vitis vinifera, the dominant cultivated species of grapevine. However, the molecular mechanisms that contribute to the enhanced freezing tolerance of V. amurensis remain unknown. Here we used deep sequencing data from restriction endonuclease-generated cDNA fragments to evaluate the whole genome wide modification of transcriptome of V. amurensis under cold treatment. Vitis vinifera cv. Muscat of Hamburg was used as control to help investigate the distinctive features of V. amruensis in responding to cold stress. Approximately 9 million tags were sequenced from non-cold treatment (NCT) and cold treatment (CT) cDNA libraries in each species of grapevine sampled from shoot apices. Alignment of tags into V. vinifera cv. Pinot noir (PN40024) annotated genome identified over 15,000 transcripts in each library in V. amruensis and more than 16,000 in Muscat of Hamburg. Comparative analysis between NCT and CT libraries indicate that V. amurensis has fewer differential expressed genes (DEGs, 1314 transcripts) than Muscat of Hamburg (2307 transcripts) when exposed to cold stress. Common DEGs (408 transcripts) suggest that some genes provide fundamental roles during cold stress in grapes. The most robust DEGs (more than 20-fold change) also demonstrated significant differences between two kinds of grapevine, indicating that cold stress may trigger species specific pathways in V. amurensis. Functional categories of DEGs indicated that the proportion of up-regulated transcripts related to metabolism, transport, signal transduction and transcription were more abundant in V. amurensis. Several highly expressed transcripts that were found uniquely accumulated in V. amurensis are discussed in detail. This subset of unique candidate transcripts may contribute to the excellent cold-hardiness of V. amurensis.	[Xin, Haiping; Zhu, Wei; Wang, Lina; Xiang, Yue; Fang, Linchuan; Li, Jitao; Sun, Xiaoming; Wang, Nian; Li, Shaohua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Xin, Haiping; Wang, Nian; Li, Shaohua] Chinese Acad Sci, Inst Bot, Lab Plant Resources, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Zhu, Wei; Wang, Lina; Xiang, Yue; Fang, Linchuan; Li, Jitao; Sun, Xiaoming] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Londo, Jason P.] ARS, USDA, Grape Genet Res Unit, Geneva, NY USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of Agriculture (USDA)	Li, SH (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China.	shhli@wbgcas.cn	Sun, Xiaoming/AHA-6034-2022; Zhu, Wei/HGA-4471-2022; fang, lin chuan/K-4923-2013	Sun, Xiaoming/0000-0002-0788-3382; Zhu, Wei/0000-0003-1459-6733; Wang, lina/0000-0001-5526-5979; Londo, Jason/0000-0003-0535-4820; /0000-0001-9185-4199; fang, lin chuan/0000-0003-1923-7908	National Natural Science Foundation of China (NSFC) [31130047, 31000902, 31171931]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC Accession No.: 31130047, 31000902 and 31171931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Cheung AY, 2002, PLANT CELL, V14, P945, DOI 10.1105/tpc.000836; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2006, METHOD MOL BIOL, V639, P39; Cho SK, 2006, FEBS LETT, V580, P3136, DOI 10.1016/j.febslet.2006.04.062; Delvalle D, 2005, PLANT J, V43, P398, DOI 10.1111/j.1365-313X.2005.02462.x; Fennell A., 2004, J CROP IMPROV, V10, P201, DOI DOI 10.1300/J411v10n01_09; Fuller MP, 1999, ANN APPL BIOL, V135, P589, DOI 10.1111/j.1744-7348.1999.tb00891.x; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; GOSTI F, 1995, MOL GEN GENET, V246, P10, DOI 10.1007/BF00290128; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; Hofmann NR, 2008, PLANT CELL, V20, P1732, DOI 10.1105/tpc.108.200711; Hong SW, 1997, PLANT PHYSIOL, V113, P1203, DOI 10.1104/pp.113.4.1203; Huang Y, 2011, EUPHYTICA, V177, P25, DOI 10.1007/s10681-010-0243-7; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jan N, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue3-fulltext-3; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee HE, 2007, BIOCHEM BIOPH RES CO, V353, P863, DOI 10.1016/j.bbrc.2006.12.095; Lissarre M, 2010, PLANT SIGNAL BEHAV, V5, P948, DOI 10.4161/psb.5.8.12135; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Miura K, 2008, PLANT SIGNAL BEHAV, V3, P52, DOI 10.4161/psb.3.1.4865; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nemoto Y, 2000, PLANT SCI, V158, P53, DOI 10.1016/S0168-9452(00)00305-8; Orvar BL, 2000, PLANT J, V23, P785, DOI 10.1046/j.1365-313x.2000.00845.x; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takuhara Y, 2011, J PLANT PHYSIOL, V168, P967, DOI 10.1016/j.jplph.2010.11.008; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tillett RL, 2012, PLANT BIOTECHNOL J, V10, P105, DOI 10.1111/j.1467-7652.2011.00648.x; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Vannozzi A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-130; Wagstaff C, 2010, J EXP BOT, V61, P2905, DOI 10.1093/jxb/erq113; Whitham S, 1996, P NATL ACAD SCI USA, V93, P8776, DOI 10.1073/pnas.93.16.8776; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Xiao H, 2008, PLANT CELL ENVIRON, V31, P1, DOI 10.1111/j.1365-3040.2007.01741.x; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Xu WR, 2010, PLANTA, V231, P475, DOI 10.1007/s00425-009-1062-8; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; Zhou MQ, 2011, CRIT REV BIOTECHNOL, V31, P186, DOI 10.3109/07388551.2010.505910; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102	66	77	86	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58740	10.1371/journal.pone.0058740	http://dx.doi.org/10.1371/journal.pone.0058740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516547	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200108
J	Glasgow, SD; Chapman, CA				Glasgow, Stephen D.; Chapman, C. Andrew			Muscarinic Depolarization of Layer II Neurons of the Parasubiculum	PLOS ONE			English	Article							MEDIAL ENTORHINAL CORTEX; HIPPOCAMPAL PYRAMIDAL CELLS; MEMBRANE-POTENTIAL OSCILLATIONS; CHOLINERGIC MODULATION; RAT-BRAIN; STELLATE CELLS; AFTER-HYPERPOLARIZATION; RETROHIPPOCAMPAL REGION; DENDRITIC EXCITABILITY; SYNAPTIC-TRANSMISSION	The parasubiculum (PaS) is a component of the hippocampal formation that sends its major output to layer II of the entorhinal cortex. The PaS receives strong cholinergic innervation from the basal forebrain that is likely to modulate neuronal excitability and contribute to theta-frequency network activity. The present study used whole cell current- and voltage-clamp recordings to determine the effects of cholinergic receptor activation on layer II PaS neurons. Bath application of carbachol (CCh; 10-50 mu M) resulted in a dose-dependent depolarization of morphologically-identified layer II stellate and pyramidal cells that was not prevented by blockade of excitatory and inhibitory synaptic inputs. Bath application of the M-1 receptor antagonist pirenzepine (1 mu M), but not the M-2-preferring antagonist methoctramine (1 mu M), blocked the depolarization, suggesting that it is dependent on M1 receptors. Voltage-clamp experiments using ramped voltage commands showed that CCh resulted in the gradual development of an inward current that was partially blocked by concurrent application of the selective Kv7.2/3 channel antagonist XE-991, which inhibits the muscarine-dependent K+ current I-M. The remaining inward current also reversed near E-K and was inhibited by the K+ channel blocker Ba2+, suggesting that M-1 receptor activation attenuates both I-M as well as an additional K+ current. The additional K+ current showed rectification at depolarized voltages, similar to K+ conductances mediated by Kir 2.3 channels. The cholinergic depolarization of layer II PaS neurons therefore appears to occur through M-1-mediated effects on I-M as well as an additional K+ conductance.	[Glasgow, Stephen D.; Chapman, C. Andrew] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Chapman, CA (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada.	andrew.chapman@concordia.ca		Glasgow, Stephen/0000-0002-9809-4812	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Doctoral Postgraduate Scholarship; Fonds de Recherche du Quebec-Sante (FRQS)	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Doctoral Postgraduate Scholarship; Fonds de Recherche du Quebec-Sante (FRQS)	This work was supported by grants to C.A.C. from the Natural Sciences and Engineering Research Council (NSERC) of Canada (www.nserc-crsng.gc.ca). S.D.G. was funded by an NSERC Doctoral Postgraduate Scholarship. C.A.C. is a member of the Center for Studies in Behavioral Neurobiology, funded by the Fonds de Recherche du Quebec-Sante (FRQS; www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1984, J COMP NEUROL, V225, P327, DOI 10.1002/cne.902250303; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BENSON DM, 1988, J PHYSIOL-LONDON, V404, P479, DOI 10.1113/jphysiol.1988.sp017301; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Bland BH, 2002, J NEUROPHYSIOL, V88, P3046, DOI 10.1152/jn.00315.2002; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; BULATKO AK, 1995, J PHYSIOL-LONDON, V484, P307, DOI 10.1113/jphysiol.1995.sp020666; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CABALLEROBLEDA M, 1993, J COMP NEUROL, V328, P115, DOI 10.1002/cne.903280109; CABALLEROBLEDA M, 1994, EXP BRAIN RES, V101, P93; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; Caruana DA, 2004, J NEUROPHYSIOL, V92, P1226, DOI 10.1152/jn.00038.2004; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chapman CA, 1999, J NEUROSCI, V19, P8637; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; DUTAR P, 1988, J NEUROSCI, V8, P4214; Elmedyb P, 2007, BASIC CLIN PHARMACOL, V100, P316, DOI 10.1111/j.1742-7843.2007.00048.x; Figenschou A, 1996, EUR J NEUROSCI, V8, P211, DOI 10.1111/j.1460-9568.1996.tb01182.x; Funahashi M, 1997, HIPPOCAMPUS, V7, P117, DOI 10.1002/(SICI)1098-1063(1997)7:2<117::AID-HIPO1>3.0.CO;2-K; Funahashi M, 1997, J PHYSIOL-LONDON, V501, P387, DOI 10.1111/j.1469-7793.1997.387bn.x; GAHWILER BH, 1987, NEUROSCI LETT, V76, P301, DOI 10.1016/0304-3940(87)90419-8; Glasgow SD, 2012, NEUROSCIENCE, V201, P1, DOI 10.1016/j.neuroscience.2011.11.039; Glasgow SD, 2008, J NEUROPHYSIOL, V100, P2746, DOI 10.1152/jn.90351.2008; Glasgow SD, 2007, J NEUROPHYSIOL, V97, P3868, DOI 10.1152/jn.01306.2006; HajDahmane S, 1996, J NEUROSCI, V16, P3848; Hamam BN, 2003, J NEUROSCI METH, V123, P61, DOI 10.1016/S0165-0270(02)00341-2; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Heys JG, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00032; Heys JG, 2012, J NEUROSCI, V32, P9066, DOI 10.1523/JNEUROSCI.0868-12.2012; Heys JG, 2010, J NEUROPHYSIOL, V104, P258, DOI 10.1152/jn.00492.2009; HOWE AR, 1995, J NEUROSCI, V15, P458; Hsu KS, 1996, NEUROSCIENCE, V73, P751, DOI 10.1016/0306-4522(96)00066-8; Karschin C, 1996, J NEUROSCI, V16, P3559; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Klink R, 1997, J NEUROPHYSIOL, V77, P1829, DOI 10.1152/jn.1997.77.4.1829; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Linley JE, 2012, J PHYSIOL-LONDON, V590, P793, DOI 10.1113/jphysiol.2011.223404; Liu LW, 2008, J CELL PHYSIOL, V216, P91, DOI 10.1002/jcp.21378; Ma L, 2007, HIPPOCAMPUS, V17, P114, DOI 10.1002/hipo.20250; MADISON DV, 1987, J NEUROSCI, V7, P733; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; MASH DC, 1986, NEUROSCIENCE, V19, P551, DOI 10.1016/0306-4522(86)90280-0; Mittmann T, 1998, J NEUROPHYSIOL, V79, P1579, DOI 10.1152/jn.1998.79.3.1579; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Qian J, 1997, BRIT J PHARMACOL, V122, P511, DOI 10.1038/sj.bjp.0701400; Reboreda A, 2007, J NEUROPHYSIOL, V97, P3937, DOI 10.1152/jn.01233.2006; Saganich MJ, 2001, J NEUROSCI, V21, P4609, DOI 10.1523/JNEUROSCI.21-13-04609.2001; Shalinsky MH, 2002, J NEUROPHYSIOL, V88, P1197, DOI 10.1152/jn.2002.88.3.1197; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; SHIBATA H, 1993, J COMP NEUROL, V337, P431, DOI 10.1002/cne.903370307; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; Tu B, 2009, J NEUROSCI, V29, P10436, DOI 10.1523/JNEUROSCI.2580-09.2009; UCHIMURA N, 1990, J PHYSIOL-LONDON, V422, P369, DOI 10.1113/jphysiol.1990.sp017989; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Yoshida M, 2007, J NEUROPHYSIOL, V98, P2779, DOI 10.1152/jn.00033.2007; Zaczek R, 1998, J PHARMACOL EXP THER, V285, P724; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	74	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58901	10.1371/journal.pone.0058901	http://dx.doi.org/10.1371/journal.pone.0058901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520542	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000318679900102
J	Kawano, Y; Higgins, C; Yamamoto, Y; Nyhus, J; Bernard, A; Dong, HW; Karten, HJ; Schilling, T				Kawano, Yoshihiro; Higgins, Christopher; Yamamoto, Yasuhito; Nyhus, Julie; Bernard, Amy; Dong, Hong-Wei; Karten, Harvey J.; Schilling, Tobias			Darkfield Adapter for Whole Slide Imaging: Adapting a Darkfield Internal Reflection Illumination System to Extend WSI Applications	PLOS ONE			English	Article							STRIA TERMINALIS; BED NUCLEI; RAT-BRAIN; PROJECTIONS; PATHOLOGY; EXPRESSION	We present a new method for whole slide darkfield imaging. Whole Slide Imaging (WSI), also sometimes called virtual slide or virtual microscopy technology, produces images that simultaneously provide high resolution and a wide field of observation that can encompass the entire section, extending far beyond any single field of view. For example, a brain slice can be imaged so that both overall morphology and individual neuronal detail can be seen. We extended the capabilities of traditional whole slide systems and developed a prototype system for darkfield internal reflection illumination (DIRI). Our darkfield system uses an ultra-thin light-emitting diode (LED) light source to illuminate slide specimens from the edge of the slide. We used a new type of side illumination, a variation on the internal reflection method, to illuminate the specimen and create a darkfield image. This system has four main advantages over traditional darkfield: (1) no oil condenser is required for high resolution imaging (2) there is less scatter from dust and dirt on the slide specimen (3) there is less halo, providing a more natural darkfield contrast image, and (4) the motorized system produces darkfield, brightfield and fluorescence images. The WSI method sometimes allows us to image using fewer stains. For instance, diaminobenzidine (DAB) and fluorescent staining are helpful tools for observing protein localization and volume in tissues. However, these methods usually require counter-staining in order to visualize tissue structure, limiting the accuracy of localization of labeled cells within the complex multiple regions of typical neurohistological preparations. Darkfield imaging works on the basis of light scattering from refractive index mismatches in the sample. It is a label-free method of producing contrast in a sample. We propose that adapting darkfield imaging to WSI is very useful, particularly when researchers require additional structural information without the use of further staining.	[Kawano, Yoshihiro; Higgins, Christopher] Olympus Amer, Center Valley, PA USA; [Yamamoto, Yasuhito] Olympus Corp, Hachioji, Tokyo, Japan; [Nyhus, Julie; Bernard, Amy] Allen Inst Brain Sci, Seattle, WA USA; [Dong, Hong-Wei] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Karten, Harvey J.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Schilling, Tobias] Olympus Soft Imaging Solut GmbH, Munster, Germany	Olympus Corporation; Olympus Corporation; Allen Institute for Brain Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; Olympus Corporation	Kawano, Y (corresponding author), Olympus Amer, Center Valley, PA USA.	yoshihiro.kawano@olympus.com	; Kawano, Yoshihiro/B-6208-2016	Bernard, Amy/0000-0003-2540-1153; Kawano, Yoshihiro/0000-0001-6442-8733				Abramowitz M, 1987, CONTRAST METHODS MIC, V2; Abramowitz M, 1990, REFLECTED LIGHT MICR, V3; Abramowitz M, 1987, MICROSCOPE BASICS, V1; Bass M, 1995, HDB OPTICS 2, P171; Blake Charles A., 2003, Anatomical Record, V275B, P196, DOI 10.1002/ar.b.10037; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Costello SSP, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.2.e11; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2003, J COMP NEUROL, V463, P434, DOI 10.1002/cne.10758; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Hecht E, 2002, OPTICS, V4th, P86; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leong FJWM, 2001, J PATHOL, V195, P508, DOI 10.1002/path.972; Long RE, 2013, TOXICOL PATHOL, V41, P115, DOI 10.1177/0192623312451162; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Murphy DB, 2001, FUNDAMENTALS LIGHT M, P112; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Pantanowitz Liron, 2011, J Pathol Inform, V2, P36, DOI 10.4103/2153-3539.83746; Pluta M., 1989, ADV LIGHT MICROSCOPY, V2, P102; Reyes-Irisarri E, 2005, NEUROSCIENCE, V132, P1173, DOI 10.1016/j.neuroscience.2005.01.050; Weinstein RS, 2009, HUM PATHOL, V40, P1057, DOI 10.1016/j.humpath.2009.04.006; Yagi Y, 2005, J TELEMED TELECARE, V11, P109, DOI 10.1258/1357633053688705	23	8	8	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58344	10.1371/journal.pone.0058344	http://dx.doi.org/10.1371/journal.pone.0058344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520500	Green Submitted, gold, Green Published			2022-12-27	WOS:000318679900059
J	Moita, E; Gil-Izquierdo, A; Sousa, C; Ferreres, F; Silva, LR; Valentao, P; Dominguez-Perles, R; Baenas, N; Andrade, PB				Moita, Eduarda; Gil-Izquierdo, Angel; Sousa, Carla; Ferreres, Federico; Silva, Luis R.; Valentao, Patricia; Dominguez-Perles, Raul; Baenas, Nieves; Andrade, Paula B.			Integrated Analysis of COX-2 and iNOS Derived Inflammatory Mediators in LPS-Stimulated RAW Macrophages Pre-Exposed to Echium plantagineum L. Bee Pollen Extract	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; BIOACTIVE COMPOUNDS; PROSTAGLANDIN E(2); FLAVONOIDS; CYCLOOXYGENASE; EXPRESSION; PRODUCTS; BIOSYNTHESIS; EICOSANOIDS	Oxidative stress and inflammation play important roles in disease development. This study intended to evaluate the anti-inflammatory and antioxidant potential of Echium plantagineum L. bee pollen to support its claimed health beneficial effects. The hydromethanol extract efficiently scavenged nitric oxide ((NO)-N-center dot) although against superoxide (O-2(center dot-)) it behaved as antioxidant at lower concentrations and as pro-oxidant at higher concentrations. The anti-inflammatory potential was evaluated in LPS-stimulated macrophages. The levels of (NO)-N-center dot and L-citrulline decreased for all extract concentrations tested, while the levels of prostaglandins, their metabolites and isoprostanes, evaluated by UPLC-MS, decreased with low extract concentrations. So, E. plantagineum bee pollen extract can exert anti-inflammatory activity by reducing (NO)-N-center dot and prostaglandins. The extract is able to scavenge the reactive species (NO)-N-center dot and O-2(center dot-) and reduce markers of oxidative stress in cells at low concentrations.	[Moita, Eduarda; Sousa, Carla; Silva, Luis R.; Valentao, Patricia; Andrade, Paula B.] Univ Porto, Fac Farm, Dept Quim, Rede Quim & Tecnol REQUIMTE,Lab Farmacognosia, P-4100 Oporto, Portugal; [Gil-Izquierdo, Angel; Ferreres, Federico; Dominguez-Perles, Raul; Baenas, Nieves] CSIC, CEBAS, Dept Food Sci & Technol, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain	Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Gil-Izquierdo, A (corresponding author), CSIC, CEBAS, Dept Food Sci & Technol, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain.	angelgil@cebas.csic.es; pandrade@ff.up.pt	BAENAS, NIEVES/M-2171-2014; REQUIMTE, PHYTO/M-4633-2013; Valentão, Patrícia/D-4818-2013; Silva, Luís R./D-5485-2013; Sousa, Carla/D-4989-2013; Gil-Izquierdo, Angel/B-5563-2008; Dominguez-Perles, Raul/AAK-4212-2021; Andrade, Paula B/A-5900-2008; Baenas, Nieves/AAG-8215-2019; Ferreres, Federico/H-5028-2011; Domínguez-Perles, Raul/J-7456-2013	Valentão, Patrícia/0000-0002-0740-4396; Silva, Luís R./0000-0001-5264-3516; Sousa, Carla/0000-0003-2734-7461; Gil-Izquierdo, Angel/0000-0001-7646-0386; Dominguez-Perles, Raul/0000-0001-6232-712X; Andrade, Paula B/0000-0002-9764-3920; Ferreres, Federico/0000-0002-8682-0004; Domínguez-Perles, Raul/0000-0001-6232-712X; BAENAS, NIEVES/0000-0001-7404-2623	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-C/EQB/LA0006/2011]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) for grant PEst-C/EQB/LA0006/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Basu S, 2007, MED RES REV, V27, P435, DOI 10.1002/med.20098; Boppre M, 2005, J AGR FOOD CHEM, V53, P594, DOI 10.1021/jf0484531; Bruneton J, 1999, PHYTOCHIMIE PLANTES; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chen YC, 2001, J CELL BIOCHEM, V82, P537, DOI 10.1002/jcb.1184; Clancy R, 2000, J IMMUNOL, V165, P1582, DOI 10.4049/jimmunol.165.3.1582; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; Di Paola-Naranjo RD, 2004, J CHROMATOGR A, V1054, P205, DOI 10.1016/j.chroma.2004.05.023; Escuredo O, 2012, FOOD CHEM, V130, P671, DOI 10.1016/j.foodchem.2011.07.107; Fernandes F, 2012, MOLECULES, V17, P5269, DOI 10.3390/molecules17055269; Ferreres F, 2010, RAPID COMMUN MASS SP, V24, P801, DOI 10.1002/rcm.4454; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Harada Y, 1996, PROSTAG OTH LIPID M, V51, P19, DOI 10.1016/0090-6980(95)00168-9; Hodek P, 2002, CHEM-BIOL INTERACT, V139, P1, DOI 10.1016/S0009-2797(01)00285-X; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Kim JH, 2012, MOL NUTR FOOD RES, V56, P454, DOI 10.1002/mnfr.201100270; Kim JY, 2008, EUR J PHARMACOL, V584, P175, DOI 10.1016/j.ejphar.2008.01.032; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; Lopes G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031145; Luthria DL, 2006, J SCI FOOD AGR, V86, P2266, DOI 10.1002/jsfa.2666; Marnett LJ, 2000, J BIOL CHEM, V275, P13427, DOI 10.1074/jbc.275.18.13427; MAROTTA P, 1992, BRIT J PHARMACOL, V107, P640, DOI 10.1111/j.1476-5381.1992.tb14499.x; Marzinzig M, 1997, NITRIC OXIDE-BIOL CH, V1, P177, DOI 10.1006/niox.1997.0116; Matsumoto H, 1997, BIOCHEM BIOPH RES CO, V230, P110, DOI 10.1006/bbrc.1996.5894; Medina S, 2012, RAPID COMMUN MASS SP, V26, P1249, DOI 10.1002/rcm.6224; Medina S, 2012, PROSTAG OTH LIPID M, V99, P79, DOI 10.1016/j.prostaglandins.2012.07.002; MOORE KP, 1995, CIRC RES, V77, P335, DOI 10.1161/01.RES.77.2.335; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Okoli CO, 2004, PHARMACOL BIOCHEM BE, V79, P473, DOI 10.1016/j.pbb.2004.08.012; Oliveira AP, 2009, FOOD CHEM TOXICOL, V47, P2841, DOI 10.1016/j.fct.2009.09.004; Ozdol NC, 2004, EUR J PHARMACOL, V506, P189, DOI 10.1016/j.ejphar.2004.10.050; Paramas AMG, 2006, FOOD CHEM, V95, P148, DOI 10.1016/j.foodchem.2005.02.008; Pinho BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024098; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Roberts LJ, 2002, CELL MOL LIFE SCI, V59, P808, DOI 10.1007/s00018-002-8469-8; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; SENSHU T, 1992, ANAL BIOCHEM, V203, P94, DOI 10.1016/0003-2697(92)90047-B; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Song WL, 2008, J BIOL CHEM, V283, P1179, DOI 10.1074/jbc.M706839200; SWIERKOSZ TA, 1995, BRIT J PHARMACOL, V114, P1335, DOI 10.1111/j.1476-5381.1995.tb13353.x; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Trottein F, 2009, GLYCOCONJUGATE J, V26, P1259, DOI 10.1007/s10719-009-9244-y; VATSIS KP, 1982, J BIOL CHEM, V257, P1221; Wadsworth TL, 1999, BIOCHEM PHARMACOL, V57, P941, DOI 10.1016/S0006-2952(99)00002-7; Yan Z, 2010, ANAL BIOCHEM, V403, P126, DOI 10.1016/j.ab.2010.04.016	48	69	69	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59131	10.1371/journal.pone.0059131	http://dx.doi.org/10.1371/journal.pone.0059131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520554	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900114
J	Qiu, WJ; Wee, KN; Takeda, K; Lim, XM; Sugii, S; Radda, GK; Han, WP				Qiu, Wenjie; Wee, Kenneth; Takeda, Kosuke; Lim, Xuemei; Sugii, Shigeki; Radda, George K.; Han, Weiping			Suppression of Adipogenesis by Pathogenic Seipin Mutant Is Associated with Inflammatory Response	PLOS ONE			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; NECROSIS-FACTOR-ALPHA; ENDOPLASMIC-RETICULUM STRESS; LIPID DROPLET FORMATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; ADJUVANT ARTHRITIS; METABOLIC DISEASE; 3T3-L1 ADIPOCYTES	Background: While pathogenic mutations in BSCL2/Seipin cause congenital generalized lipodystrophy, the underlying mechanism is largely unknown. In this study, we investigated whether and how the pathogenic missense A212P mutation of Seipin (Seipin-A212P) inhibits adipogenesis. Methodology/Results: We analyzed gene expression and lipid accumulation in stable 3T3-L1 cell lines expressing wild type (3T3-WT), non-lipodystrophic mutants N88S (3T3-N88S) and S90L (3T3-S90L), or lipodystrophic mutant A212P Seipin (3T3-A212P). When treated with adipogenic cocktail, 3T3-WT, 3T3-N88S and 3T3-S90L cells exhibited proper differentiation into mature adipocytes, indistinguishable from control 3T3-L1 cells. In contrast, adipogenesis was significantly impaired in 3T3-A212P cells. The defective adipogenesis in 3T3-A212P cells could be partially rescued by either PPAR gamma agonist or PPAR gamma overexpression. Gene expression profiling by microarray revealed that inhibition of adipogenesis was associated with activation of inflammatory genes including IL-6 and iNOS. We further demonstrated that Seipin-A212P expression at pre-differentiation stages significantly activated inflammatory responses by using an inducible expression system. The inflammation-associated inhibition of adipogenesis could be rescued by treatment with anti-inflammatory agents. Conclusions: These results suggest that pathogenic Seipin-A212P inhibits adipogenesis and the inhibition is associated with activation of inflammatory pathways at pre-differentiation stages. Use of anti-inflammatory drugs may be a potential strategy for the treatment of lipodystrophy.	[Qiu, Wenjie; Wee, Kenneth; Takeda, Kosuke; Lim, Xuemei; Sugii, Shigeki; Radda, George K.; Han, Weiping] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Sugii, Shigeki; Han, Weiping] Duke Natl Univ Singapore, Grad Sch Med, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Han, Weiping] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Sugii, S (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore.	shigeki_sugii@sbic.a-star.edu.sg; weiping_han@sbic.a-star.edu.sg		Sugii, Shigeki/0000-0002-2537-9534	Agency for Science, Technology and Research, Singapore Biomedical Research Council	Agency for Science, Technology and Research, Singapore Biomedical Research Council	This study was supported by an intramural funding from Agency for Science, Technology and Research, Singapore Biomedical Research Council (WH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Bonne S, 2003, J CELL BIOL, V161, P403, DOI 10.1083/jcb.200303036; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Capeau J, 2005, BIOCHEM SOC T, V33, P1073, DOI 10.1042/BST0331073; Cardoso I, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-74; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; DANESCH U, 1992, J BIOL CHEM, V267, P7185; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jc.84.9.3390; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; GWYNN B, 1990, MOL CELL BIOL, V10, P5244, DOI 10.1128/MCB.10.10.5244; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Lee SJ, 2010, CELL METAB, V12, P65, DOI 10.1016/j.cmet.2010.05.003; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; MacDougald OA, 2007, CELL METAB, V6, P159, DOI 10.1016/j.cmet.2007.08.010; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Maussion G, 2008, HUM MOL GENET, V17, P2541, DOI 10.1093/hmg/ddn154; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; Nunes AF, 2012, MOL NEUROBIOL, V45, P440, DOI 10.1007/s12035-012-8256-y; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Perrey S, 2001, METABOLISM, V50, P36, DOI 10.1053/meta.2001.19505; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Rosenbaum SE, 1998, MOL ENDOCRINOL, V12, P1150, DOI 10.1210/me.12.8.1150; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; THEISENPOPP P, 1992, INT J IMMUNOPHARMACO, V14, P565, DOI 10.1016/0192-0561(92)90117-4; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; TSUBOI I, 1995, CYTOKINE, V7, P372, DOI 10.1006/cyto.1995.0047; Victoria B, 2010, DIABETIC MED, V27, P1178, DOI 10.1111/j.1464-5491.2010.03052.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Woo SJ, 2010, J OCUL PHARMACOL TH, V26, P223, DOI 10.1089/jop.2010.0012; Yang G, 2009, J BIOL CHEM, V284, P3719, DOI 10.1074/jbc.M804965200; Yang W, 2012, BIOCH J; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	62	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57874	10.1371/journal.pone.0057874	http://dx.doi.org/10.1371/journal.pone.0057874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520483	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900042
J	Yan, J; Zhang, Y; Zhang, JP; Liang, J; Li, L; Zheng, LM				Yan, Jing; Zhang, Yi; Zhang, Jing-Ping; Liang, Jing; Li, Lian; Zheng, Limin			Tim-3 Expression Defines Regulatory T Cells in Human Tumors	PLOS ONE			English	Article							INTERFERON-GAMMA PRODUCTION; ACTIVATED MONOCYTES; PERITUMORAL STROMA; POOR-PROGNOSIS; UP-REGULATION; PATHWAY; GALECTIN-9; IMMUNITY; CANCER; EXHAUSTION	Tim-3, a member of the novel Tim (T cell immunoglobulin and mucin domain) family, has been reported to negatively regulate the immune responses against viral infection and had implications for autoimmune disease. However, the nature and role of Tim-3(+) CD4 T cells in human tumors remain largely unknown. In the present study, we characterized Tim-3(+) CD4 T cells in 100 specimens from human hepatocellular, cervical, colorectal and ovarian carcinoma patients. Compared with peripheral blood and nontumor-infiltrating lymphocytes, the lymphocytes isolated from the corresponding tumor tissues of hepatocellular, cervical, colorectal and ovarian carcinoma patients contained significantly greater proportion of Tim-3(+) CD4 T cells. The majority of tumor-derived Tim-3(+) CD4 T cells exhibited an impaired capacity to produce IFN-gamma and IL-2, but expressed higher levels of CD25, Foxp3, CTLA-4 and GITR than their Tim-3 2 CD4 T cell counterparts. In contrast, most Tim-3(+) CD4 T cells isolated from the paired nontumor tissues and peripheral blood did not express these molecules. Moreover, tumor-derived Tim-3(+) CD4 T cells, but not tumor-derived Tim-3(+) CD4 T cells, significantly suppressed the proliferation of autologous CD8(+) T cells in vitro. Notably, multi-color immunofluorescence and confocal microscopy demonstrated that Tim-3(+) Foxp3(+) CD4(+) cells were preferentially distributed in the tumor nest rather than the peritumoral stroma of hepatocellular carcinoma. Together, our data indicate that Tim-3-expressing CD4 T cells in human tumors could represent the functional regulatory T cells which contribute to the formation of the immune-suppressive tumor micromilieu.	[Yan, Jing; Zhang, Jing-Ping; Zheng, Limin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yi; Liang, Jing; Li, Lian; Zheng, Limin] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zheng, LM (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	zhenglm@mail.sysu.edu.cn	zhang, jingping/AAM-2751-2021; zheng, limin/HGB-2510-2022; ZHANG, JINGPING/AAT-8229-2021	zhang, jingping/0000-0003-0090-6710; Zheng, Limin/0000-0002-8281-1450	National Basic Research Program of China [2010CB529904, 2011CB811305]; National Natural Science Foundation of China [81230073, 91029737]; Ministry of Health of China [2012ZX10002-011]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of China	This work was supported by project grants from the National Basic Research Program of China (2010CB529904 and 2011CB811305; http://www.973.gov.cn/Default_3.aspx), the National Natural Science Foundation of China (81230073 and 91029737; http://www.nsfc.gov.cn/Portal0/default152.htm), and the Ministry of Health of China (2012ZX10002-011; http://www.moh.gov.cn/publicfiles//business/htmlfiles/wsb/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, CANCER RES, V72, P2159, DOI 10.1158/0008-5472.CAN-11-3538; Anderson AC, 2012, CURR OPIN IMMUNOL, V24, P213, DOI 10.1016/j.coi.2011.12.005; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Blank C, 2007, CANCER IMMUNOL IMMUN, V56, P739, DOI 10.1007/s00262-006-0272-1; Chen MG, 2012, CELL MOL IMMUNOL, V9, P375, DOI 10.1038/cmi.2012.18; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Gao Q, 2011, CANCER SCI, V102, P1522, DOI 10.1111/j.1349-7006.2011.01981.x; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030676; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Gleason MK, 2012, BLOOD, V119, P3064, DOI 10.1182/blood-2011-06-360321; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Gupta S, 2012, J CLIN INVEST, V122, P2395, DOI 10.1172/JCI45138; He J, 2012, CHIN J CANCER, V31, P287, DOI 10.5732/cjc.011.10376; Hu GZ, 2010, CELL MOL IMMUNOL, V7, P414, DOI 10.1038/cmi.2010.39; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2009, CELL MOL IMMUNOL, V6, P35, DOI 10.1038/cmi.2009.5; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Li LQ, 2005, BLOOD, V106, P3068, DOI 10.1182/blood-2005-04-1531; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moorman JP, 2012, J IMMUNOL, V189, P755, DOI 10.4049/jimmunol.1200162; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Ngiow SF, 2011, CANCER RES, V71, P6567, DOI 10.1158/0008-5472.CAN-11-1487; Piersma SJ, 2008, HUM IMMUNOL, V69, P241, DOI 10.1016/j.humimm.2008.02.005; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Simmons WJ, 2005, J IMMUNOL, V174, P1405, DOI 10.4049/jimmunol.174.3.1405; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Wiersma V. R., 2011, MED RES REV; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhou J, 2009, INT J CANCER, V125, P1640, DOI 10.1002/ijc.24556; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	56	119	135	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58006	10.1371/journal.pone.0058006	http://dx.doi.org/10.1371/journal.pone.0058006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526963	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900072
J	Hill, EJ; Nagel, DA; O'Neil, JD; Torr, E; Woehrling, EK; Devitt, A; Coleman, MD				Hill, Eric J.; Nagel, David A.; O'Neil, John D.; Torr, Elizabeth; Woehrling, Elizabeth K.; Devitt, Andrew; Coleman, Michael D.			Effects of Lithium and Valproic Acid on Gene Expression and Phenotypic Markers in an NT2 Neurosphere Model of Neural Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NEURONAL DIFFERENTIATION; HISTONE DEACETYLASE; PROGENITOR CELLS; PROTEIN BINDING; RETINOIC ACID; INHIBITION; INDUCTION; SYSTEM; TARGET	Mood stabilising drugs such as lithium (LiCl) and valproic acid (VPA) are the first line agents for treating conditions such as Bipolar disorder and Epilepsy. However, these drugs have potential developmental effects that are not fully understood. This study explores the use of a simple human neurosphere-based in vitro model to characterise the pharmacological and toxicological effects of LiCl and VPA using gene expression changes linked to phenotypic alterations in cells. Treatment with VPA and LiCl resulted in the differential expression of 331 and 164 genes respectively. In the subset of VPA targeted genes, 114 were downregulated whilst 217 genes were upregulated. In the subset of LiCl targeted genes, 73 were downregulated and 91 were upregulated. Gene ontology (GO) term enrichment analysis was used to highlight the most relevant GO terms associated with a given gene list following toxin exposure. In addition, in order to phenotypically anchor the gene expression data, changes in the heterogeneity of cell subtype populations and cell cycle phase were monitored using flow cytometry. Whilst LiCl exposure did not significantly alter the proportion of cells expressing markers for stem cells/undifferentiated cells (Oct4, SSEA4), neurons (Neurofilament M), astrocytes (GFAP) or cell cycle phase, the drug caused a 1.4-fold increase in total cell number. In contrast, exposure to VPA resulted in significant upregulation of Oct4, SSEA, Neurofilament M and GFAP with significant decreases in both G2/M phase cells and cell number. This neurosphere model might provide the basis of a human-based cellular approach for the regulatory exploration of developmental impact of potential toxic chemicals.	[Hill, Eric J.; Nagel, David A.; O'Neil, John D.; Torr, Elizabeth; Woehrling, Elizabeth K.; Devitt, Andrew; Coleman, Michael D.] Aston Univ, Sch Life & Hlth Sci, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England	Aston University	Hill, EJ (corresponding author), Aston Univ, Sch Life & Hlth Sci, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England.	hillej@aston.ac.uk	Coleman, Michael Damian/AAD-5503-2019	Devitt, Andrew/0000-0002-4651-6761; Coleman, MIchael D/0000-0002-5510-6852; Hill, Eric/0000-0002-9419-1500	Humane Research Trust (Stockport, UK)	Humane Research Trust (Stockport, UK)	This study was funded by the Humane Research Trust (Stockport, UK). The authors declare that the sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Breier JM, 2010, NEUROTOXICOL TERATOL, V32, P4, DOI 10.1016/j.ntt.2009.06.005; Brodie MJ, 1996, NEW ENGL J MED, V334, P168, DOI 10.1056/NEJM199601183340308; Bug G, 2005, CANCER, V104, P2717, DOI 10.1002/cncr.21589; Currie RA, 2005, REPROD TOXICOL, V20, P433, DOI 10.1016/j.reprotox.2005.03.014; Daston GP, 2008, TOXICOL SCI, V105, P233, DOI 10.1093/toxsci/kfn138; Fielden MR, 2001, TOXICOL SCI, V60, P6, DOI 10.1093/toxsci/60.1.6; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; Hill EJ, 2008, TOXICOLOGY, V249, P243, DOI 10.1016/j.tox.2008.05.014; Hill EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036098; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hogberg HT, 2009, TOXICOL APPL PHARM, V235, P268, DOI 10.1016/j.taap.2008.12.014; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Johnson G, 1998, NEUROPSYCHOPHARMACOL, V19, P200, DOI 10.1016/S0893-133X(98)00019-0; Jung GA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-66; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kultima K, 2004, ENVIRON HEALTH PERSP, V112, P1225, DOI 10.1289/txg.7034; Kumar S, 2000, DRUG METAB DISPOS, V28, P845; Lee T, 2008, BMC BIOINFORM S9, V9, pS20; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; NAU H, 1984, J PEDIATR-US, V104, P627, DOI 10.1016/S0022-3476(84)80567-3; Newport DJ, 2005, AM J PSYCHIAT, V162, P2162, DOI 10.1176/appi.ajp.162.11.2162; Nguyen HTT, 2009, ADV THER, V26, P281, DOI 10.1007/s12325-009-0011-z; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; PRICE LH, 1994, NEW ENGL J MED, V331, P591; ROBERT E, 1982, LANCET, V2, P937, DOI 10.1016/s0140-6736(82)90908-4; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; Scholz G, 1998, ALTEX-ALTERN TIEREXP, V15, P3; Seiler A, 2002, ALTEX-ALTERN TIEREXP, V19, P55; Teng HF, 2010, J CELL BIOCHEM, V110, P995, DOI 10.1002/jcb.22613; Turner CE, 2000, J CELL SCI, V113, P4139; Walmod PS, 1999, CELL MOTIL CYTOSKEL, V42, P241, DOI 10.1002/(SICI)1097-0169(1999)42:3<241::AID-CM7>3.0.CO;2-3; Werling U, 2001, MOL PHARMACOL, V59, P1269, DOI 10.1124/mol.59.5.1269; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003	39	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58822	10.1371/journal.pone.0058822	http://dx.doi.org/10.1371/journal.pone.0058822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527032	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000317562100047
J	Shanmugham, B; Pan, A				Shanmugham, Buvaneswari; Pan, Archana			Identification and Characterization of Potential Therapeutic Candidates in Emerging Human Pathogen Mycobacterium abscessus: A Novel Hierarchical In Silico Approach	PLOS ONE			English	Article							DRUG TARGETS; SIGNAL-TRANSDUCTION; METABOLIC PATHWAYS; NETWORK ANALYSIS; CYSTIC-FIBROSIS; TUBERCULOSIS; DATABASE; SAFETY; BIOSYNTHESIS; PROTEINS	Mycobacterium abscessus, a non-tuberculous rapidly growing mycobacterium, is recognized as an emerging human pathogen causing a variety of infections ranging from skin and soft tissue infections to severe pulmonary infections. Lack of an optimal treatment regimen and emergence of multi-drug resistance in clinical isolates necessitate the development of better/new drugs against this pathogen. The present study aims at identification and qualitative characterization of promising drug targets in M. abscessus using a novel hierarchical in silico approach, encompassing three phases of analyses. In phase I, five sets of proteins were mined through chokepoint, plasmid, pathway, virulence factors, and resistance genes and protein network analysis. These were filtered in phase II, in order to find out promising drug target candidates through subtractive channel of analysis. The analysis resulted in 40 therapeutic candidates which are likely to be essential for the survival of the pathogen and non-homologous to host, human anti-targets, and gut flora. Many of the identified targets were found to be involved in different metabolisms (viz., amino acid, energy, carbohydrate, fatty acid, and nucleotide), xenobiotics degradation, and bacterial pathogenicity. Finally, in phase III, the candidate targets were qualitatively characterized through cellular localization, broad spectrum, interactome, functionality, and druggability analysis. The study explained their subcellular location identifying drug/vaccine targets, possibility of being broad spectrum target candidate, functional association with metabolically interacting proteins, cellular function (if hypothetical), and finally, druggable property. Outcome of the present study could facilitate the identification of novel antibacterial agents for better treatment of M. abscesses infections.	[Shanmugham, Buvaneswari; Pan, Archana] Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Pondicherry, India	Pondicherry University	Pan, A (corresponding author), Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Pondicherry, India.	archana@bicpu.edu.in	Pan, Archana/ABC-5701-2021	Pan, Archana/0000-0002-3568-7047				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade RJ, 2011, J ANTIMICROB CHEMOTH, V66, P1431, DOI 10.1093/jac/dkr159; Andrade RJ, 1999, J HEPATOL, V31, P641, DOI 10.1016/S0168-8278(99)80343-2; Anishetty S, 2005, COMPUT BIOL CHEM, V29, P368, DOI 10.1016/j.compbiolchem.2005.07.001; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Asif SM, 2009, BIOINFORMATION, V4, P245, DOI 10.6026/97320630004245; BAKKE OM, 1995, CLIN PHARMACOL THER, V58, P108, DOI 10.1016/0009-9236(95)90078-0; Barh D, 2011, DRUG DEVELOP RES, V72, P162, DOI 10.1002/ddr.20413; Barh Debmalya, 2009, In Silico Biology, V9, P225, DOI 10.3233/ISB-2009-0399; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Barrett JF, 1998, ANTIMICROB AGENTS CH, V42, P1529, DOI 10.1128/AAC.42.7.1529; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Briken V, 2008, CURR DRUG TARGETS, V9, P150, DOI 10.2174/138945008783502449; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brown BM, 2004, BIOCHEMISTRY-US, V43, P13541, DOI 10.1021/bi048469k; Brown ED, 2005, CHEM REV, V105, P759, DOI 10.1021/cr030116o; Butt AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043080; Butt AM, 2012, INFECT GENET EVOL, V12, P53, DOI 10.1016/j.meegid.2011.10.017; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chopra S, 2011, J ANTIMICROB CHEMOTH, V66, P1533, DOI 10.1093/jac/dkr154; Clement A, 2006, THORAX, V61, P895, DOI 10.1136/thx.2005.057950; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; Cui T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-118; Cullen AR, 2000, AM J RESP CRIT CARE, V161, P641, DOI 10.1164/ajrccm.161.2.9903062; Cunningham FX, 2000, J BACTERIOL, V182, P5841, DOI 10.1128/JB.182.20.5841-5848.2000; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Dutta Anirban, 2006, In Silico Biology, V6, P43; Eisenreich W, 1996, P NATL ACAD SCI USA, V93, P6431, DOI 10.1073/pnas.93.13.6431; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Fenner H, 1989, Scand J Rheumatol Suppl, V80, P32; Friedman MA, 1999, JAMA-J AM MED ASSOC, V281, P1728, DOI 10.1001/jama.281.18.1728; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Fung M, 2001, DRUG INF J, V35, P293, DOI 10.1177/009286150103500134; Galperin MY, 1999, CURR OPIN BIOTECH, V10, P571, DOI 10.1016/S0958-1669(99)00035-X; Gayathri R, 2010, J POSTGRAD MED, V56, P19, DOI 10.4103/0022-3859.65278; Goulding CW, 2005, J MOL BIOL, V349, P61, DOI 10.1016/j.jmb.2005.03.023; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Henann NE, 2001, PHARMACOTHERAPY, V21, P1579, DOI 10.1592/phco.21.20.1579.34479; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jeon K, 2009, AM J RESP CRIT CARE, V180, P896, DOI 10.1164/rccm.200905-0704OC; JOB ML, 1990, DICP ANN PHARMAC, V24, P467, DOI 10.1177/106002809002400504; KAGER L, 1982, INFECTION, V10, P338, DOI 10.1007/BF01642294; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kovatcheva-Datchary Petia, 2009, Therap Adv Gastroenterol, V2, P9, DOI 10.1177/1756283X09337646; Kushwaha SK, 2010, J THEOR BIOL, V262, P284, DOI 10.1016/j.jtbi.2009.09.029; Lazarczyk DA, 2001, DIGEST DIS SCI, V46, P925, DOI 10.1023/A:1010741510046; Leao SC, 2009, J CLIN MICROBIOL, V47, P2691, DOI 10.1128/JCM.00808-09; Lu JZQ, 2005, COMB CHEM HIGH T SCR, V8, P15, DOI 10.2174/1386207053328192; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; Mathema VB, 2011, ARCH MICROBIOL, V193, P837, DOI 10.1007/s00203-011-0751-4; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Miravitlles Marc, 2007, Int J Chron Obstruct Pulmon Dis, V2, P191; Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752; Moses PL, 1999, AM J GASTROENTEROL, V94, P1393, DOI 10.1016/S0002-9270(99)00149-5; Mulder Nicola, 2007, V396, P59; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Nord CE, 2006, ANTIMICROB AGENTS CH, V50, P3375, DOI 10.1128/AAC.00373-06; NORRBY SR, 1995, J ANTIMICROB CHEMOTH, V36, P207, DOI 10.1093/jac/36.suppl_A.207; Park S, 2008, J KOREAN MED SCI, V23, P49, DOI 10.3346/jkms.2008.23.1.49; Paterson GK, 2006, J MED MICROBIOL, V55, P355, DOI 10.1099/jmm.0.46423-0; Pearson MA, 1997, BIOCHEMISTRY-US, V36, P8164, DOI 10.1021/bi970514j; Peterson J.W., 1996, MED MICROBIOLOGY; Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x; Prayle A, 2010, THORAX, V65, P654, DOI 10.1136/thx.2009.131532; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rabizadeh Shervin, 2008, Curr Infect Dis Rep, V10, P92, DOI 10.1007/s11908-008-0017-8; Rafii Fatemeh, 2008, Ther Clin Risk Manag, V4, P1343; Raman Karthik, 2008, BMC Microbiol, V8, P234, DOI 10.1186/1471-2180-8-234; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Recanatini Maurizio, 2004, Drug Discov Today Technol, V1, P209, DOI 10.1016/j.ddtec.2004.10.004; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Said MR, 2004, P NATL ACAD SCI USA, V101, P18006, DOI 10.1073/pnas.0405996101; Sakharkar Kishore R, 2004, In Silico Biol, V4, P355; Samonis G, 2005, ANTIMICROB AGENTS CH, V49, P5189, DOI 10.1128/AAC.49.12.5189.2005; Sarkar M, 2012, J MOL MODEL, V18, P1855, DOI 10.1007/s00894-011-1204-3; SAVAGE DC, 1986, ANNU REV NUTR, V6, P155, DOI 10.1146/annurev.nu.06.070186.001103; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Shanmugam A, 2010, BIOINFORMATION, V4, P392, DOI 10.6026/97320630004392; Sharma A, 2012, EUR J MED CHEM, V57, P185, DOI 10.1016/j.ejmech.2012.09.018; Shenai S, 2009, INT J INFECT DIS, V13, P46, DOI 10.1016/j.ijid.2008.03.025; SHIGI Y, 1989, J ANTIMICROB CHEMOTH, V24, P131, DOI 10.1093/jac/24.2.131; Singh Shailza, 2007, J Bioinform Comput Biol, V5, P135, DOI 10.1142/S0219720007002564; Singh S, 2007, BIOINFORMATION, V2, P68, DOI 10.6026/97320630002068; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stephenson K, 2002, CURR OPIN PHARMACOL, V2, P507, DOI 10.1016/S1471-4892(02)00194-7; Suzuki A, 2010, DRUG SAFETY, V33, P503, DOI 10.2165/11535340-000000000-00000; Swarbrick J., 2008, OPEN ENZYM INHIB J, V1, P12, DOI [10.2174/1874940200801010012, DOI 10.2174/1874940200801010012]; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tanaka Eisaku, 2002, Journal of Infection and Chemotherapy, V8, P252, DOI 10.1007/s10156-002-0176-8; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; Thornhill M, 2000, BRIT J DERMATOL, V143, P117, DOI 10.1046/j.1365-2133.2000.03600.x; Vetrivel Umashankar, 2011, Hugo J, V5, P25, DOI 10.1007/s11568-011-9152-7; Wang FY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004027; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhanel G G, 1998, Can J Infect Dis, V9, P215; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	117	58	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59126	10.1371/journal.pone.0059126	http://dx.doi.org/10.1371/journal.pone.0059126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527108	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100079
J	Winterfeld, S; Ernst, S; Borsch, M; Gerken, U; Kuhn, A				Winterfeld, Sophie; Ernst, Stefan; Boersch, Michael; Gerken, Uwe; Kuhn, Andreas			Real Time Observation of Single Membrane Protein Insertion Events by the Escherichia coli Insertase YidC	PLOS ONE			English	Article							PF3 COAT PROTEIN; ENERGY-TRANSFER; SUBSTRATE	Membrane protein translocation and insertion is a central issue in biology. Here we focus on a minimal system, the membrane insertase YidC of Escherichia coli that inserts small proteins into the cytoplasmic membrane. In a reconstituted system individual insertion processes were followed by single-pair fluorescence resonance energy transfer (FRET), with a pair of fluorophores on YidC and the substrate Pf3 coat protein. After addition of N-terminally labeled Pf3 coat protein a close contact to YidC at its cytoplasmic label was observed. This allowed to monitor the translocation of the N-terminal domain of Pf3 coat protein across the membrane in real time. Translocation occurred within milliseconds as the label on the N-terminal domain rapidly approached the fluorophore on the periplasmic domain of YidC at the trans side of the membrane. After the close contact, the two fluorophores separated, reflecting the release of the translocated Pf3 coat protein from YidC into the membrane bilayer. When the Pf3 coat protein was labeled C-terminally, no translocation of the label was observed although efficient binding to the cytoplasmic positions of YidC occurred.	[Winterfeld, Sophie; Ernst, Stefan; Boersch, Michael; Gerken, Uwe; Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, Stuttgart, Germany; [Ernst, Stefan; Boersch, Michael] Univ Stuttgart, Inst Phys 23, D-70174 Stuttgart, Germany	University Hohenheim; University of Stuttgart	Kuhn, A (corresponding author), Univ Hohenheim, Inst Microbiol & Mol Biol, Stuttgart, Germany.	Andreas.Kuhn@uni-hohenheim.de		Borsch, Michael/0000-0002-0634-2963	Deutsche Forschungsgemeinschaft (DFG) [Ku749/6-1, Bo1891/10-2]; Methoden fur die Lebenswissenschaften of the Baden-Wurttemberg Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Methoden fur die Lebenswissenschaften of the Baden-Wurttemberg Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG grants Ku749/6-1 and Bo1891/10-2), and by contract research Methoden fur die Lebenswissenschaften of the Baden-Wurttemberg Stiftung with MB and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1960, J BIOL CHEM, V235, P769; Benz M, 2009, MOL PLANT, V2, P1410, DOI 10.1093/mp/ssp095; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Darkes MJM, 2000, ACTA CRYSTALLOGR D, V56, P48, DOI 10.1107/S090744499901375X; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Eisenhawer M, 2001, BIOCHEMISTRY-US, V40, P12321, DOI 10.1021/bi0107694; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Ernst S, 2011, J MOL BIOL, V412, P165, DOI 10.1016/j.jmb.2011.07.023; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gaisne M, 2006, FEMS YEAST RES, V6, P869, DOI 10.1111/j.1567-1364.2006.00083.x; Gerken U, 2008, BIOCHEMISTRY-US, V47, P6052, DOI 10.1021/bi800116t; Imhof N, 2011, BIOCHEMISTRY-US, V50, P3229, DOI 10.1021/bi1020293; Kiefer D, 1999, EMBO J, V18, P6299, DOI 10.1093/emboj/18.22.6299; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Klenner C, 2008, FEBS LETT, V582, P3967, DOI 10.1016/j.febslet.2008.10.044; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; KUHN H, 1970, J CHEM PHYS, V53, P101, DOI 10.1063/1.1673749; LESSL M, 1992, J BACTERIOL, V174, P2493, DOI 10.1128/jb.174.8.2493-2500.1992; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Winterfeld S, 2009, BIOCHEMISTRY-US, V48, P6684, DOI 10.1021/bi9003809; Xie K, 2007, BIOCHEMISTRY-US, V46, P15153, DOI 10.1021/bi701398y	27	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59023	10.1371/journal.pone.0059023	http://dx.doi.org/10.1371/journal.pone.0059023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527078	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100067
J	Chung, JY; Kim, MW; Bang, MS; Kim, M				Chung, Jin-Young; Kim, Min-Wook; Bang, Moon-Suk; Kim, Manho			Increased Expression of Neurotrophin 4 Following Focal Cerebral Ischemia in Adult Rat Brain with Treadmill Exercise	PLOS ONE			English	Article							ARTERY OCCLUSION; GENE-EXPRESSION; ENVIRONMENTAL ENRICHMENT; HIPPOCAMPUS; PLASTICITY; INJURY; BDNF; TRKB; DAMAGE	Neurotrophin 4 (NT-4) belongs to the family of neurotrophic factors, and it interacts with the tyrosine kinase B (trkB) receptor. NT-4 has neuroprotective effects following cerebral ischemia. Its role might be similar to brain-derived neurotrophic factor (BDNF), because both interact with trkB. Exercise also improves neural function by increasing neurotrophic factors. However, expression profiles of NT-4 in the brain during exercise are unknown. Here, we assessed the expressions of NT-4 and its receptor, trkB, following cerebral ischemia and hypothesized that exercise changes the expressions of NT-4 and trkB. Results showed that in a permanent middle cerebral artery occlusion rat model, ischemia decreased NT-4 and trkB expression. Immunohistochemistry showed their immunoreactivities around the region of the ischemic area. Treadmill exercise changed the expression of NT-4, which increased in the contralateral hemisphere in rats with ischemic injury. TrkB also showed similar patterns to its neurotophins. The change in NT-4 suggested that exercise might have primed NT4 production so that further injury causes slightly greater increases in NT4 compared with non-exercise controls.	[Chung, Jin-Young; Kim, Manho] Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea; [Kim, Min-Wook] Catholic Univ Korea, Coll Med, Dept Rehabil Med, Seoul, South Korea; [Kim, Min-Wook] Incheon St Marys Hosp, ICIM, Inchon, South Korea; [Bang, Moon-Suk] Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Seoul National University (SNU); Seoul National University Hospital	Kim, M (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul 110744, South Korea.	kimmanho@snu.ac.kr			Korea Health 21 RD Project; Ministry of Health and Welfare [A092058]; WCU-Neurocytomics program; 21C Frontier Functional Proteomics Project [FPR08K1301-02210]	Korea Health 21 RD Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); WCU-Neurocytomics program; 21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Korea Health 21 R&D Project, Ministry of Health and Welfare (A092058) and WCU-Neurocytomics program and by grants from 21C Frontier Functional Proteomics Project (FPR08K1301-02210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001; Bang OY, 2009, J CLIN NEUROL, V5, P107, DOI 10.3988/jcn.2009.5.3.107; Burette A, 1997, BRAIN RES, V776, P10, DOI 10.1016/S0006-8993(97)00934-7; Chan KM, 1996, NEUROCHEM RES, V21, P763, DOI 10.1007/BF02532298; Chang HC, 2009, BEHAV BRAIN RES, V205, P450, DOI 10.1016/j.bbr.2009.07.033; Chung JY, 2010, BRAIN RES, V1353, P187, DOI 10.1016/j.brainres.2010.06.057; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Ding Y, 2004, NEUROSCIENCE, V124, P583, DOI 10.1016/j.neuroscience.2003.12.029; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Goutan E, 1998, MOL BRAIN RES, V59, P154, DOI 10.1016/S0169-328X(98)00156-9; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Johansson BB, 1999, ACT NEUR S, V73, P51; Keyvani K, 2004, J NEUROPATH EXP NEUR, V63, P598, DOI 10.1093/jnen/63.6.598; Kim MW, 2005, BRAIN RES, V1052, P16, DOI 10.1016/j.brainres.2005.05.070; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; PERSSON H, 1993, CURR OPIN NEUROL NEU, V6, P11; Ploughman M, 2007, EUR J NEUROSCI, V25, P3453, DOI 10.1111/j.1460-9568.2007.05591.x; Russo-Neustadt A, 2001, BEHAV BRAIN RES, V120, P87, DOI 10.1016/S0166-4328(00)00364-8; Semkova I, 1999, BRAIN RES REV, V30, P176, DOI 10.1016/S0165-0173(99)00013-2; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; Widenfalk J, 1999, NEUROSCI RES, V34, P125, DOI 10.1016/S0168-0102(99)00051-6; Zhang WR, 1999, NEUROSCI LETT, V276, P161, DOI 10.1016/S0304-3940(99)00848-4	27	32	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e52461	10.1371/journal.pone.0052461	http://dx.doi.org/10.1371/journal.pone.0052461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526925	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600001
J	Tesfaye, M; Silverstein, KAT; Nallu, S; Wang, L; Botanga, CJ; Gomez, SK; Costa, LM; Harrison, MJ; Samac, DA; Glazebrook, J; Katagiri, F; Gutierrez-Marcos, JF; VandenBosch, KA				Tesfaye, Mesfin; Silverstein, Kevin A. T.; Nallu, Sumitha; Wang, Lin; Botanga, Christopher J.; Gomez, S. Karen; Costa, Liliana M.; Harrison, Maria J.; Samac, Deborah A.; Glazebrook, Jane; Katagiri, Fumiaki; Gutierrez-Marcos, Jose F.; VandenBosch, Kathryn A.			Spatio-Temporal Expression Patterns of Arabidopsis thaliana and Medicago truncatula Defensin-Like Genes	PLOS ONE			English	Article							SELF-INCOMPATIBILITY; NORMALIZATION METHODS; PLANT DEFENSINS; POLLEN; MICROARRAY; JASMONATE; PEPTIDES; FAMILIES; IDENTIFICATION; ORGANIZATION	Plant genomes contain several hundred defensin-like (DEFL) genes that encode short cysteine-rich proteins resembling defensins, which are well known antimicrobial polypeptides. Little is known about the expression patterns or functions of many DEFLs because most were discovered recently and hence are not well represented on standard microarrays. We designed a custom Affymetrix chip consisting of probe sets for 317 and 684 DEFLs from Arabidopsis thaliana and Medicago truncatula, respectively for cataloging DEFL expression in a variety of plant organs at different developmental stages and during symbiotic and pathogenic associations. The microarray analysis provided evidence for the transcription of 71% and 90% of the DEFLs identified in Arabidopsis and Medicago, respectively, including many of the recently annotated DEFL genes that previously lacked expression information. Both model plants contain a subset of DEFLs specifically expressed in seeds or fruits. A few DEFLs, including some plant defensins, were significantly up-regulated in Arabidopsis leaves inoculated with Alternaria brassicicola or Pseudomonas syringae pathogens. Among these, some were dependent on jasmonic acid signaling or were associated with specific types of immune responses. There were notable differences in DEFL gene expression patterns between Arabidopsis and Medicago, as the majority of Arabidopsis DEFLs were expressed in inflorescences, while only a few exhibited root-enhanced expression. By contrast, Medicago DEFLs were most prominently expressed in nitrogen-fixing root nodules. Thus, our data document salient differences in DEFL temporal and spatial expression between Arabidopsis and Medicago, suggesting distinct signaling routes and distinct roles for these proteins in the two plant species.	[Tesfaye, Mesfin; Silverstein, Kevin A. T.; Nallu, Sumitha; Wang, Lin; Glazebrook, Jane; Katagiri, Fumiaki; VandenBosch, Kathryn A.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Botanga, Christopher J.] Chicago State Univ, Dept Biol Sci, Chicago, IL USA; [Gomez, S. Karen; Harrison, Maria J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Costa, Liliana M.] Univ Oxford, Dept Plant Sci, Oxford, England; [Costa, Liliana M.; Gutierrez-Marcos, Jose F.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Samac, Deborah A.] ARS, USDA, Plant Sci Res Unit, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Chicago State University; Cornell University; Boyce Thompson Institute for Plant Research; University of Oxford; University of Warwick; United States Department of Agriculture (USDA)	Samac, DA (corresponding author), ARS, USDA, Plant Sci Res Unit, St Paul, MN USA.	dasamac@umn.edu	Gutierrez-Marcos, Jose/AAE-2229-2020; Samac, Deborah/ABC-8744-2021; Nallu, Sumitha/D-5382-2017	Gutierrez-Marcos, Jose/0000-0002-5441-9080; Samac, Deborah/0000-0002-1847-0508; Katagiri, Fumiaki/0000-0001-6893-3788; Harrison, Maria J/0000-0001-8716-1875; Glazebrook, Jane/0000-0001-5167-736X	National Science Foundation [IOB-0516811, IOB-0419648]; University of Minnesota, College of Biological Sciences; Royal Society; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-05ER15670]; Biotechnology and Biological Sciences Research Council [BBS/E/H/00JG0371] Funding Source: researchfish; BBSRC [BBS/E/H/00JG0371] Funding Source: UKRI	National Science Foundation(National Science Foundation (NSF)); University of Minnesota, College of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Science Foundation award IOB-0516811 to K.A.T.S. and K.A.V., by funds from the University of Minnesota, College of Biological Sciences to K.A.V., and by funds from The Royal Society to J.F.G.-M. Preparation of A. brassicicola- and P. syringae-inoculated samples was supported by grants from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (DE-FG02-05ER15670) and National Science Foundation (IOB-0419648), respectively, to J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Allen A, 2008, PLANTA, V227, P331, DOI 10.1007/s00425-007-0620-1; Alunni B, 2007, MOL PLANT MICROBE IN, V20, P1138, DOI 10.1094/MPMI-20-9-1138; Alvarez-Buylla E. R, 2010, ARABIDOPSIS BOOK, V8, pe0127, DOI [DOI 10.1199/TAB.0127, 10.1199/tab.0127]; Ameline-Torregrosa C, 2008, MOL PLANT MICROBE IN, V21, P61, DOI 10.1094/MPMI-21-1-0061; Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Costa LM, 2012, CURR BIOL, V22, P160, DOI 10.1016/j.cub.2011.11.059; Dresselhaus T, 2009, CURR OPIN PLANT BIOL, V12, P773, DOI 10.1016/j.pbi.2009.09.015; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Gutierrez-Marcos JF, 2004, PLANT CELL, V16, P1288, DOI 10.1105/tpc.019778; Hanks JN, 2005, PLANT MOL BIOL, V58, P385, DOI 10.1007/s11103-005-5567-7; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kaur J, 2012, MOL PLANT PATHOL, V13, P1032, DOI 10.1111/j.1364-3703.2012.00813.x; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Lamblin AFJ, 2003, NUCLEIC ACIDS RES, V31, P196, DOI 10.1093/nar/gkg119; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Manners JM, 1998, PLANT MOL BIOL, V38, P1071, DOI 10.1023/A:1006070413843; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Meyers BC, 2004, PLANT PHYSIOL, V135, P801, DOI 10.1104/pp.104.039495; Moore I, 1998, P NATL ACAD SCI USA, V95, P376, DOI 10.1073/pnas.95.1.376; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Rutherford S, 2005, PLANT J, V43, P769, DOI 10.1111/j.1365-313X.2005.02486.x; Samac DA, 2011, MOL PLANT PATHOL, V12, P786, DOI [10.1111/j.1364-3703.2011.00712.x, 10.1111/J.1364-3703.2011.00712.X]; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2002, PLANT CELL, V14, P491, DOI 10.1105/tpc.010378; SHIRZADEGAN M, 1991, NUCLEIC ACIDS RES, V19, P6055, DOI 10.1093/nar/19.21.6055; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; Stotz HU, 2009, PLANT MOL BIOL, V71, P131, DOI 10.1007/s11103-009-9512-z; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Tesfaye M, 2006, MOL PLANT MICROBE IN, V19, P330, DOI 10.1094/MPMI-19-0330; Tesfaye M, 2009, BIOENERG RES, V2, P59, DOI 10.1007/s12155-009-9034-1; Thomma BPHJ, 1998, PLANT PHYSIOL BIOCH, V36, P533, DOI 10.1016/S0981-9428(98)80179-4; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Vanoosthuyse V, 2001, PLANT MOL BIOL, V46, P17, DOI 10.1023/A:1010664704926; von Malek B, 2002, PLANTA, V216, P187, DOI 10.1007/s00425-002-0906-2; Wang HL, 2005, ANN BOT-LONDON, V95, P737, DOI 10.1093/aob/mci080; Wang L, 2009, PLOS PATHOG, V5; Wang L, 2008, MOL PLANT MICROBE IN, V21, P1408, DOI 10.1094/MPMI-21-11-1408; Watanabe M, 2000, FEBS LETT, V473, P139, DOI 10.1016/S0014-5793(00)01514-3; Wilson DL, 2003, BIOINFORMATICS, V19, P1325, DOI 10.1093/bioinformatics/btg146; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhu YL, 2003, GENETICS, V163, P1123	79	46	48	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58992	10.1371/journal.pone.0058992	http://dx.doi.org/10.1371/journal.pone.0058992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527067	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600022
J	Danielsen, L; Lohaus, G; Sirrenberg, A; Karlovsky, P; Bastien, C; Pilate, G; Polle, A				Danielsen, Lara; Lohaus, Gertrud; Sirrenberg, Anke; Karlovsky, Petr; Bastien, Catherine; Pilate, Gilles; Polle, Andrea			Ectomycorrhizal Colonization and Diversity in Relation to Tree Biomass and Nutrition in a Plantation of Transgenic Poplars with Modified Lignin Biosynthesis	PLOS ONE			English	Article							CINNAMYL ALCOHOL-DEHYDROGENASE; NITROGEN-USE EFFICIENCY; MYCORRHIZAL COLONIZATION; COMMUNITY COMPOSITION; MOLECULAR PHYSIOLOGY; POPULUS-TREMULOIDES; DOWN-REGULATION; GROWTH; FIELD; LIGNIFICATION	Wood from biomass plantations with fast growing tree species such as poplars can be used as an alternative feedstock for production of biofuels. To facilitate utilization of lignocellulose for saccharification, transgenic poplars with modified or reduced lignin contents may be useful. However, the potential impact of poplars modified in the lignification pathway on ectomycorrhizal (EM) fungi, which play important roles for plant nutrition, is not known. The goal of this study was to investigate EM colonization and community composition in relation to biomass and nutrient status in wildtype (WT, Populus tremula x Populus alba) and transgenic poplar lines with suppressed activities of cinnamyl alcohol dehydrogenase, caffeate/5-hydroxyferulate O-methyltransferase, and cinnamoyl-CoA reductase in a biomass plantation. In different one-year-old poplar lines EM colonization varied from 58% to 86%, but the EM community composition of WT and transgenic poplars were indistinguishable. After two years, the colonization rate of all lines was increased to about 100%, but separation of EM communities between distinct transgenic poplar genotypes was observed. The differentiation of the EM assemblages was similar to that found between different genotypes of commercial clones of Populus x euramericana. The transgenic poplars exhibited significant growth and nutrient element differences in wood, with generally higher nutrient accumulation in stems of genotypes with lower than in those with higher biomass. A general linear mixed model simulated biomass of one-year-old poplar stems with high accuracy (adjusted R-2 = 97%) by two factors: EM colonization and inverse wood N concentration. These results imply a link between N allocation and EM colonization, which may be crucial for wood production in the establishment phase of poplar biomass plantations. Our data further support that multiple poplar genotypes regardless whether generated by transgenic approaches or conventional breeding increase the variation in EM community composition in biomass plantations.	[Danielsen, Lara; Lohaus, Gertrud; Polle, Andrea] Univ Gottingen, Busgen Inst, Dept Forest Bot & Tree Physiol, D-37073 Gottingen, Germany; [Sirrenberg, Anke; Karlovsky, Petr] Univ Gottingen, Dept Mol Phytopathol & Mycotoxin Res, D-37073 Gottingen, Germany; [Bastien, Catherine; Pilate, Gilles] INRA, Ameliorat Genet & Physiol Forestieres UR0588, CS Ardon 40001, Orleans, France	University of Gottingen; University of Gottingen; INRAE	Polle, A (corresponding author), Univ Gottingen, Busgen Inst, Dept Forest Bot & Tree Physiol, D-37073 Gottingen, Germany.	apolle@gwdg.de	BASTIEN, Catherine/GWQ-2951-2022; Pilate, Gilles/E-8784-2017	Pilate, Gilles/0000-0003-4802-8849; Polle, Andrea/0000-0001-8697-6394; Karlovsky, Petr/0000-0002-6532-5856	European Commission within the Seventh Framework Program for the Research, Project Energypoplar [FP7-211917]	European Commission within the Seventh Framework Program for the Research, Project Energypoplar	The authors gratefully acknowledge financial support by the European Commission within the Seventh Framework Program for the Research, Project Energypoplar (FP7-211917). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R., 1987, COLOUR ATLAS ECTOMYC; [Anonymous], 2009, LANG ENV STAT COMP; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Baucher M, 2003, CRIT REV BIOCHEM MOL, V38, P305, DOI 10.1080/10409230390242443; Baucher M, 1996, PLANT PHYSIOL, V112, P1479, DOI 10.1104/pp.112.4.1479; Baum C, 2002, FOREST ECOL MANAG, V163, P1, DOI 10.1016/S0378-1127(01)00534-5; Beniwal RS, 2010, ENVIRON EXP BOT, V69, P189, DOI 10.1016/j.envexpbot.2010.02.005; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bradley KL, 2007, PLANT SOIL, V294, P185, DOI 10.1007/s11104-007-9246-0; Calfapietra C, 2007, TREE PHYSIOL, V27, P1153, DOI 10.1093/treephys/27.8.1153; Chen F, 2003, PHYTOCHEMISTRY, V64, P1013, DOI 10.1016/S0031-9422(03)00463-1; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Coleman HD, 2008, PLANT PHYSIOL, V148, P1229, DOI 10.1104/pp.108.125500; Cooke JEK, 2005, NEW PHYTOL, V167, P19, DOI 10.1111/j.1469-8137.2005.01451.x; Courty PE, 2011, J EXP BOT, V62, P249, DOI 10.1093/jxb/erq274; Danielsen L, 2012, ECOL EVOL, V2, P1935, DOI 10.1002/ece3.305; Druebert C, 2009, PLANT CELL ENVIRON, V32, P992, DOI 10.1111/j.1365-3040.2009.01983.x; Ducic T, 2009, SOIL BIOL BIOCHEM, V41, P742, DOI 10.1016/j.soilbio.2009.01.013; Euring D, 2012, TREES-STRUCT FUNCT, V26, P1933, DOI 10.1007/s00468-012-0761-0; Finzi AC, 2007, P NATL ACAD SCI USA, V104, P14014, DOI 10.1073/pnas.0706518104; Gehring CA, 2006, OECOLOGIA, V149, P158, DOI 10.1007/s00442-006-0437-9; Glynn C, 2004, ENTOMOL EXP APPL, V113, P1, DOI 10.1111/j.0013-8703.2004.00199.x; Gotelli N.J., 2005, ECOSIM NULL MODELS S; Halupa Dimitri, 2006, ENZYKLOPADIE LAUBBAU, P367; HEINRICHS H, 1986, Z PFLANZ BODENKUNDE, V149, P350, DOI 10.1002/jpln.19861490313; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Holeski LM, 2009, BIOCHEM SYST ECOL, V37, P139, DOI 10.1016/j.bse.2009.02.003; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jones MD, 2004, CAN J BOT, V82, P1089, DOI [10.1139/B04-110, 10.1139/b04-110]; Joshi CP, 2004, NEW PHYTOL, V164, P53, DOI 10.1111/j.1469-8137.2004.01155.x; Jouanin L, 2000, PLANT PHYSIOL, V123, P1363, DOI 10.1104/pp.123.4.1363; Jug A, 1999, FOREST ECOL MANAG, V121, P85, DOI 10.1016/S0378-1127(98)00558-1; Kaldorf M, 2002, PLANTA, V214, P653, DOI 10.1007/s004250100658; Karp A, 2011, J EXP BOT, V62, P3263, DOI 10.1093/jxb/err099; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Khasa PD, 2002, BIOMASS BIOENERG, V22, P99, DOI 10.1016/S0961-9534(01)00072-1; Kleemann F, 2011, EUR J FOREST RES, V130, P707, DOI 10.1007/s10342-010-0460-6; Komsta L, 2010, OUTLIERS TEST OUTLIE; Labbe J, 2011, TREE GENET GENOMES, V7, P617, DOI 10.1007/s11295-010-0361-3; Langenfeld-Heyser R, 2007, MYCORRHIZA, V17, P121, DOI 10.1007/s00572-006-0084-3; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; LEPLE JC, 1992, PLANT CELL REP, V11, P137, DOI 10.1007/BF00232166; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Li H, 2012, J EXP BOT, V63, P6173, DOI 10.1093/jxb/ers271; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Luo ZB, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest:2008073; Millard P, 2010, TREE PHYSIOL, V30, P1083, DOI 10.1093/treephys/tpq042; Muhsin TM, 2002, NEW PHYTOL, V153, P153, DOI 10.1046/j.0028-646X.2001.00297.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neville J, 2002, APPL SOIL ECOL, V19, P209, DOI 10.1016/S0929-1393(01)00193-7; Oksanen J, 2010, R PACKAGE VERSION 1; Orians CM, 1997, ENTOMOL EXP APPL, V83, P285, DOI 10.1046/j.1570-7458.1997.00183.x; Parrent JL, 2006, ECOLOGY, V87, P2278, DOI 10.1890/0012-9658(2006)87[2278:CANAAE]2.0.CO;2; Pena R, 2010, APPL ENVIRON MICROB, V76, P1831, DOI 10.1128/AEM.01703-09; Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607; Polle A, 2010, PLANT BIOLOGY, V12, P239, DOI 10.1111/j.1438-8677.2009.00318.x; PREGITZER KS, 1990, TREE PHYSIOL, V7, P79, DOI 10.1093/treephys/7.1-2-3-4.79; Quoreshi AM, 2008, BIOMASS BIOENERG, V32, P381, DOI 10.1016/j.biombioe.2007.10.010; Rennenberg H, 2010, PLANT BIOLOGY, V12, P275, DOI 10.1111/j.1438-8677.2009.00309.x; Rooney DC, 2011, BIOMASS BIOENERG, V35, P4605, DOI 10.1016/j.biombioe.2011.08.015; Rooney DC, 2009, TRENDS PLANT SCI, V14, P542, DOI 10.1016/j.tplants.2009.08.004; Sims REH, 2006, GLOBAL CHANGE BIOL, V12, P2054, DOI 10.1111/j.1365-2486.2006.01163.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Stanton BJ, 2009, FAO IPC POPLARS WILL, V86, P26; Stettler RF, 2012, BOLOGY POPULUS ITS I, P87; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Swaty RL, 2004, ECOLOGY, V85, P1072, DOI 10.1890/03-0224; Tagu D, 2001, MYCORRHIZA, V10, P237, DOI 10.1007/PL00009997; Tamm S, 2006, ENZYKLOPADIE LAUBBAU, P405; Tilsner J, 2005, PLANTA, V221, P328, DOI 10.1007/s00425-004-1446-8; VanDoorsselaere J, 1995, PLANT J, V8, P855, DOI 10.1046/j.1365-313X.1995.8060855.x; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	74	36	40	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59207	10.1371/journal.pone.0059207	http://dx.doi.org/10.1371/journal.pone.0059207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516610	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200137
J	Shao, XT; Qian, Y; Xu, CH; Hong, B; Xu, WH; Shen, L; Jin, CZ; Wu, ZG; Tong, XM; Yao, HP				Shao, Xueting; Qian, Yun; Xu, Chenhuai; Hong, Bo; Xu, Wanhong; Shen, Ling; Jin, Changzhong; Wu, Zhigang; Tong, Xiangmin; Yao, Hangping			The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-Induced Hepatitis in Mice	PLOS ONE			English	Article							A-INDUCED HEPATITIS; NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; INDUCED LIVER-INJURY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INFLAMMATORY-BOWEL-DISEASE; IL-18 BINDING-PROTEIN; TUMOR-NECROSIS-FACTOR; CONCANAVALIN-A; IN-VIVO	Background: Concanavalin A (ConA)-induced hepatitis is an experimental murine model mirroring the pathology of human autoimmune hepatitis. Aim: To investigate the effects of intrasplenically transplanted fetal hepatocytes (BNL.CL2) transfected with recombinant adenovirus vector expressing the IL-18 binding protein (IL-18BP) and IL-4 fusion protein on ConA-induced hepatitis in mice. Methods: Ad-IL-18BP/IL-4 was used to infect BNL.CL2 cells. IL-4 and IL-18BP fusion protein expression were detected by ELISA and Western blotting. BNL.CL2 cells infected with Ad-IL-18BP/IL-4 were intrasplenically transplanted into mice. After 10 days, mice were injected with ConA (15 mg/kg), and sacrificed 18 hours later. Liver injury was assessed by serum transaminase and liver histology. TNF-alpha, IL-18, IL-4, IL-10, IL-12p70 and monocyte-chemoattracting protein (MCP)-1 levels in serum and liver homogenates were detected by ELISA. Signaling molecules in liver homogenates were analyzed by Western blotting. Results: Ad-IL-18BP/IL-4 effectively expressed the IL-18BP/IL-4 fusion protein for more than 14 days in BNL.CL12 cells. Treatment of mice with Ad-IL-18BP/IL-4-BNL.CL2 before ConA injection significantly reduced the elevated plasma levels of transaminases compared with ConA control groups. TNF-alpha, IL-18, IL-12p70 and MCP-1 levels in serum and liver homogenates from mice transplanted with Ad-IL-18BP/IL-4-BNL.CL2 were lower and IL-4 and IL-10 levels were higher than control groups. Phosphorylation levels of NF-kappa B p65, AKT, p38 and JNK1/2 in liver homogenates were markedly suppressed by Ad-IL-18BP/IL-4. Conclusions: Ad-IL-18BP/IL-4 was effectively transfected into mouse BNL.CL2 cells. Intrasplenic transplantation of Ad-IL-18BP/IL-4-BNL.CL12 cells alleviated the severity of inflammation in ConA-induced experimental hepatitis and provides a useful basis for the targeted gene therapy of liver disease.	[Shao, Xueting; Qian, Yun; Xu, Chenhuai; Shen, Ling; Jin, Changzhong; Wu, Zhigang; Tong, Xiangmin; Yao, Hangping] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Hong, Bo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Wanhong] ACEA Bio, Hangzhou High Throughput Drug Screening Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yao, HP (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yaohangping@zju.edu.cn			National Natural Science Foundation of China [30972777]; Zhejiang Province Natural Science Foundation [Y207521]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was partially supported by National Natural Science Foundation of China (No. 30972777) and Zhejiang Province Natural Science Foundation (No.Y207521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, EUR J IMMUNOL, V36, P37, DOI 10.1002/eji.200535138; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Brown MA, 1997, CRIT REV IMMUNOL, V17, P1; Bulau AM, 2011, THESCIENTIFICWORLDJO, V11, P2480, DOI 10.1100/2011/968479; Cao X, 1996, NATL MED J CHINA, V76, P646; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fujino M, 2003, GENE THER, V10, P1781, DOI 10.1038/sj.gt.3302067; Grimm MC, 1996, J LEUKOCYTE BIOL, V59, P804, DOI 10.1002/jlb.59.6.804; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; GUPTA S, 1991, HEPATOLOGY, V14, P144, DOI 10.1002/hep.1840140124; Hamalainen M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45673; Hu XD, 2010, ACTA PHARMACOL SIN, V31, P703, DOI 10.1038/aps.2010.53; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Kawayama T, 2012, J INTERF CYTOK RES, V32, P443, DOI 10.1089/jir.2012.0029; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; Kremer L, 1999, J IMMUNOL, V163, P3226; Kucharzik T, 1998, CLIN EXP IMMUNOL, V111, P152; Lamacchia C, 2012, EUR J IMMUNOL, V42, P1294, DOI 10.1002/eji.201142204; Lavon I, 2003, MOL PHARMACOL, V64, P1334, DOI 10.1124/mol.64.6.1334; Leng JH, 2008, ACTA BIOCH BIOPH SIN, V40, P116, DOI 10.1111/j.1745-7270.2008.00384.x; LEONARD EJ, 1990, IMMUNOL TODAY, V11, P97, DOI 10.1016/0167-5699(90)90035-8; Li CY, 2011, J CELL PHYSIOL, V226, P2338, DOI 10.1002/jcp.22576; Li Y, 2012, CELL PHYSIOL BIOCHEM, V29, P31, DOI 10.1159/000337584; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Mase A, 2010, J ETHNOPHARMACOL, V127, P742, DOI 10.1016/j.jep.2009.11.029; Massaguer A, 2002, J LEUKOCYTE BIOL, V72, P262; Navarro-Alvarez N, 2010, J HEPATOL, V52, P211, DOI 10.1016/j.jhep.2009.11.019; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; Qian Y, 2011, EUR J MED RES, V16, P295, DOI 10.1186/2047-783X-16-7-295; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sarra GM, 2002, VISION RES, V42, P541, DOI 10.1016/S0042-6989(01)00230-9; Schumann J, 1998, J IMMUNOL, V161, P5745; Smeets RL, 2003, GENE THER, V10, P1004, DOI 10.1038/sj.gt.3301986; TEVELDE AA, 1990, BLOOD, V76, P1392; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Toyabe S, 1997, J IMMUNOL, V159, P1537; van Holten J, 2004, ARTHRITIS RES THER, V6, pR239, DOI 10.1186/ar1165; WONG HL, 1993, J EXP MED, V177, P775, DOI 10.1084/jem.177.3.775; Yao HP, 2010, INFLAMM RES, V59, P97, DOI 10.1007/s00011-009-0072-0; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324; Yin H, 2010, LIVER INT, V30, P623, DOI 10.1111/j.1478-3231.2009.02199.x; Zhang LH, 2001, GENE THER, V8, P1333, DOI 10.1038/sj.gt.3301524; Zhang LH, 2001, PARASITE IMMUNOL, V23, P11, DOI 10.1046/j.1365-3024.2001.00349.x; Zhang WP, 1997, SCI CHINA SER C, V40, P554, DOI 10.1007/BF03183596; Zhou YC, 2012, DIGEST LIVER DIS, V44, P398, DOI 10.1016/j.dld.2011.11.013	47	19	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58836	10.1371/journal.pone.0058836	http://dx.doi.org/10.1371/journal.pone.0058836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516562	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200117
J	Berzigotti, A; De Gottardi, A; Vukotic, R; Siramolpiwat, S; Abraldes, JG; Garcia-Pagan, JC; Bosch, J				Berzigotti, Annalisa; De Gottardi, Andrea; Vukotic, Ranka; Siramolpiwat, Sith; Abraldes, Juan G.; Carlos Garcia-Pagan, Juan; Bosch, Jaime			Effect of Meal Ingestion on Liver Stiffness in Patients with Cirrhosis and Portal Hypertension	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY FIBROSCAN; INTEREQUIPMENT VARIABILITY; POSTPRANDIAL INCREASE; ESOPHAGEAL-VARICES; BLOOD-FLOW; PRESSURE; DISEASE; INTEROBSERVER; HEMODYNAMICS	Background and Aims: Liver stiffness is increasingly used in the non-invasive evaluation of chronic liver diseases. Liver stiffness correlates with hepatic venous pressure gradient (HVPG) in patients with cirrhosis and holds prognostic value in this population. Hence, accuracy in its measurement is needed. Several factors independent of fibrosis influence liver stiffness, but there is insufficient information on whether meal ingestion modifies liver stiffness in cirrhosis. We investigated the changes in liver stiffness occurring after the ingestion of a liquid standard test meal in this population. Methods: In 19 patients with cirrhosis and esophageal varices (9 alcoholic, 9 HCV-related, 1 NASH; Child score 6.961.8), liver stiffness (transient elastography), portal blood flow (PBF) and hepatic artery blood flow (HABF) (Doppler-Ultrasound) were measured before and 30 minutes after receiving a standard mixed liquid meal. In 10 the HVPG changes were also measured. Results: Post-prandial hyperemia was accompanied by a marked increase in liver stiffness (+27 +/- 33%; p<0.0001). Changes in liver stiffness did not correlate with PBF changes, but directly correlated with HABF changes (r = 0.658; p = 0.002). After the meal, those patients showing a decrease in HABF (n = 13) had a less marked increase of liver stiffness as compared to patients in whom HABF increased (n = 6; +12 +/- 21% vs. +62 +/- 29%, p<0.0001). As expected, post-prandial hyperemia was associated with an increase in HVPG (n = 10; +26 +/- 13%, p = 0.003), but changes in liver stiffness did not correlate with HVPG changes. Conclusions: Liver stiffness increases markedly after a liquid test meal in patients with cirrhosis, suggesting that its measurement should be performed in standardized fasting conditions. The hepatic artery buffer response appears an important factor modulating postprandial changes of liver stiffness. The post-prandial increase in HVPG cannot be predicted by changes in liver stiffness.	[Berzigotti, Annalisa; De Gottardi, Andrea; Vukotic, Ranka; Siramolpiwat, Sith; Abraldes, Juan G.; Carlos Garcia-Pagan, Juan; Bosch, Jaime] Hosp Clin Barcelona, Liver Unit, Hepat Hemodynam Lab, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Berzigotti, Annalisa; Abraldes, Juan G.; Carlos Garcia-Pagan, Juan; Bosch, Jaime] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona	Bosch, J (corresponding author), Hosp Clin Barcelona, Liver Unit, Hepat Hemodynam Lab, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	jbosch@clinic.ub.es	Garcia-Pagan, Juan-Carlos/P-6291-2015; De Gottardi, Andrea/AAN-7512-2020; Berzigotti, Annalisa/AAB-8999-2019; Berzigotti, Annalisa/AGJ-9475-2022	Garcia-Pagan, Juan-Carlos/0000-0001-9032-4954; De Gottardi, Andrea/0000-0002-4401-2340; Berzigotti, Annalisa/0000-0003-4562-9016; Siramolpiwat, Sith/0000-0001-9842-3025; Gonzalez-Abraldes, Juan/0000-0003-3421-937X	Instituto de Salud Carlos III [FIS 09/1261]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work is supported in part by grants from Instituto de Salud Carlos III (FIS 09/1261). CIBERehd is funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 2007, GUT, V56, P259, DOI 10.1136/gut.2006.095240; Arena U, 2008, GUT, V57, P1288, DOI 10.1136/gut.2008.149708; Bellis L, 2003, HEPATOLOGY, V37, P378, DOI 10.1053/jhep.2003.50053; Berzigotti A, 2006, J HEPATOL, V44, P310, DOI 10.1016/j.jhep.2005.10.015; Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; Berzigottil A, 2012, ULTRASCHALL MED, V33, P8, DOI 10.1055/s-0031-1299145; Bosch J, 2006, SEMIN LIVER DIS, V26, P348, DOI 10.1055/s-2006-951603; BRANDT JL, 1955, J CLIN INVEST, V34, P1017, DOI 10.1172/JCI103151; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Castera L, 2012, J HEPATOL, V56, P696, DOI 10.1016/j.jhep.2011.07.005; Colli A, 2010, RADIOLOGY, V257, P872, DOI 10.1148/radiol.10100013; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; GAIANI S, 1989, HEPATOLOGY, V9, P815, DOI 10.1002/hep.1840090604; Kazemi F, 2006, J HEPATOL, V45, P230, DOI 10.1016/j.jhep.2006.04.006; LEE SS, 1988, HEPATOLOGY, V8, P647, DOI 10.1002/hep.1840080335; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; Mederacke I, 2009, LIVER INT, V29, P1500, DOI 10.1111/j.1478-3231.2009.02100.x; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Millonig G, 2010, J HEPATOL, V52, P206, DOI 10.1016/j.jhep.2009.11.018; Robic MA, 2011, J HEPATOL, V55, P1017, DOI 10.1016/j.jhep.2011.01.051; SABBA C, 1992, GASTROENTEROLOGY, V102, P1009, DOI 10.1016/0016-5085(92)90190-A; SABBA C, 1995, HEPATOLOGY, V21, P428, DOI 10.1016/0270-9139(95)90103-5; Sacerdoti D, 1997, J HEPATOL, V27, P986, DOI 10.1016/S0168-8278(97)80141-9; Schiedermaier P, 2006, SCAND J GASTROENTERO, V41, P826, DOI 10.1080/00365520500463290	26	87	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58742	10.1371/journal.pone.0058742	http://dx.doi.org/10.1371/journal.pone.0058742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520531	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900091
J	Bradshaw-Pierce, EL; Pitts, TM; Kulikowski, G; Selby, H; Merz, AL; Gustafson, DL; Serkova, NJ; Eckhardt, SG; Weekes, CD				Bradshaw-Pierce, Erica L.; Pitts, Todd M.; Kulikowski, Gillian; Selby, Heather; Merz, Andrea L.; Gustafson, Daniel L.; Serkova, Natalie J.; Eckhardt, S. Gail; Weekes, Colin D.			Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; ADVANCED SOLID TUMORS; RAD001 EVEROLIMUS; PHASE-I; MAMMALIAN TARGET; PIK3CA MUTATION; MTOR INHIBITORS; COLON-CANCER; RAT-BRAIN; PHARMACOKINETICS	Purpose: The PI3K/AKT/mTOR pathway is frequently dysregulated in cancers and inhibition of mTOR has demonstrated the ability to modulate pro-survival pathways. As such, we sought to determine the ability of the mTOR inhibitor everolimus to potentiate the antitumor effects of irinotecan in colorectal cancer (CRC). Experimental Design: The combinatorial effects of everolimus and irinotecan were evaluated in vitro and in vivo in CRC cell lines harboring commonly found mutations in PIK3CA, KRAS and/or BRAF. Pharmacokinetically-directed dosing protocols of everolimus and irinotecan were established and used to assess the in vivo antitumor effects of the agents. At the end of treatment, 3-6 tumors per treatment arm were harvested for biomarker analysis by NMR metabolomics. Results: Everolimus and irinotecan/SN38 demonstrated synergistic anti-proliferative effects in multiple CRC cell lines in vitro. Combination effects of everolimus and irinotecan were determined in CRC xenograft models using clinically-relevant dosing protocols. Everolimus demonstrated significant tumor growth inhibition alone and when combined with irinotecan in HT29 and HCT116 tumor xenografts. Metabolomic analysis showed that HT29 tumors were more metabolically responsive than HCT116 tumors. Everolimus caused a decrease in glycolysis in both tumor types whilst irinotecan treatment resulted in a profound accumulation of lipids in HT29 tumors indicating a cytotoxic effect. Conclusions: Quantitative analysis of tumor growth and metabolomic data showed that the combination of everolimus and irinotecan was more beneficial in the BRAF/PIK3CA mutant HT29 tumor xenografts, which had an additive effect, than the KRAS/PIK3CA mutant HCT116 tumor xenografts, which had a less than additive effect.	[Bradshaw-Pierce, Erica L.; Pitts, Todd M.; Kulikowski, Gillian; Selby, Heather; Eckhardt, S. Gail; Weekes, Colin D.] Univ Colorado Anschutz Med Campus, Div Med Oncol, Aurora, CO USA; [Bradshaw-Pierce, Erica L.; Merz, Andrea L.; Serkova, Natalie J.] Univ Colorado Anschutz Med Campus, Dept Anesthesiol, Aurora, CO USA; [Bradshaw-Pierce, Erica L.; Pitts, Todd M.; Gustafson, Daniel L.; Serkova, Natalie J.; Eckhardt, S. Gail; Weekes, Colin D.] Univ Colorado Anschutz Med Campus, Univ Colorado, Ctr Canc, Aurora, CO USA; [Gustafson, Daniel L.] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; [Gustafson, Daniel L.] Colorado State Univ, Anim Canc Ctr, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; Colorado State University	Bradshaw-Pierce, EL (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	Erica.Pierce@ucdenver.edu			Novartis International AG; University of Colorado Cancer Center [P30 CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Novartis International AG(Novartis); University of Colorado Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Novartis International AG and University of Colorado Cancer Center Grant P30 CA046934. Novartis had some input in the study design, but did not play a role in data collection analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, CANC FACTS FIG, P5; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Boros L G, 2007, Ernst Schering Found Symp Proc, P189; Calvo E, 2012, EUR J CANCER, V48, P333, DOI 10.1016/j.ejca.2011.11.027; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Delbaldo C, 2005, EUR J CANCER, V41, P1739, DOI 10.1016/j.ejca.2005.04.029; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Gabrielsson J, 2009, J PHARMACOL EXP THER, V331, P767, DOI 10.1124/jpet.109.157172; Gabrielsson J, 2010, J PHARMACOL TOXICOL, V61, P146, DOI 10.1016/j.vascn.2010.02.002; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Guichard S, 1998, CANCER CHEMOTH PHARM, V42, P165, DOI 10.1007/s002800050801; Houghton PJ, 2010, CLIN CANCER RES, V16, P1368, DOI 10.1158/1078-0432.CCR-09-1314; JOSHI SS, 1989, TUMOR BIOL, V10, P117, DOI 10.1159/000217607; KANEDA N, 1990, CANCER RES, V50, P1715; Klawitter J, 2010, CHEM RES TOXICOL, V23, P608, DOI 10.1021/tx900351q; Koch G, 2009, J PHARMACOKINET PHAR, V36, P179, DOI 10.1007/s10928-009-9117-9; Lane HA, 2009, CLIN CANCER RES, V15, P1612, DOI 10.1158/1078-0432.CCR-08-2057; Laplanche R, 2007, J PHARMACOKINET PHAR, V34, P373, DOI 10.1007/s10928-007-9051-7; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Manegold PC, 2008, CLIN CANCER RES, V14, P892, DOI 10.1158/1078-0432.CCR-07-0955; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Messersmith WA, 2004, CLIN CANCER RES, V10, P6522, DOI 10.1158/1078-0432.CCR-04-0746; Mohseni M, 2010, J CLIN INVEST, V120, P2655, DOI 10.1172/JCI44026; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mordant P, 2010, MOL CANCER THER, V9, P358, DOI 10.1158/1535-7163.MCT-09-1014; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; O'Reilly T, 2011, ANTI-CANCER DRUG, V22, P58, DOI 10.1097/CAD.0b013e3283400a20; Ocvirk J, 2010, WORLD J GASTROENTERO, V16, P3133, DOI 10.3748/wjg.v16.i25.3133; Okamoto I, 2010, JPN J CLIN ONCOL, V40, P17, DOI 10.1093/jjco/hyp120; Pfizer I, 2010, IRINOTECAN FULL PRES; Phan A, 2012, CANC TREAT REV; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Saunders MP, 2009, CANCER CHEMOTH PHARM, V64, P665, DOI 10.1007/s00280-008-0914-4; Serkova N, 2001, BRIT J PHARMACOL, V133, P875, DOI 10.1038/sj.bjp.0704142; Serkova NJ, 2007, CURR OPIN MOL THER, V9, P572; Serkova NJ, 2006, EXPERT REV MOL DIAGN, V6, P717, DOI 10.1586/14737159.6.5.717; Serkova Natalie J., 2009, V520, P273, DOI 10.1007/978-1-60327-811-9_20; Slatter JG, 2000, DRUG METAB DISPOS, V28, P423; Stewart CF, 1997, CANCER CHEMOTH PHARM, V40, P259, DOI 10.1007/s002800050656; Suntharalingam M, 2012, INT J RADIAT ONCOL, V82, P1845, DOI 10.1016/j.ijrobp.2011.02.062; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669; Yao K, 2005, BRIT J CANCER, V93, P1356, DOI 10.1038/sj.bjc.6602864; Zamboni WC, 1998, CLIN CANCER RES, V4, P743; Zamboni WC, 1998, CLIN CANCER RES, V4, P455	50	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58089	10.1371/journal.pone.0058089	http://dx.doi.org/10.1371/journal.pone.0058089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520486	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900045
J	Padler-Karavani, V; Tremoulet, AH; Yu, H; Chen, X; Burns, JC; Varki, A				Padler-Karavani, Vered; Tremoulet, Adriana H.; Yu, Hai; Chen, Xi; Burns, Jane C.; Varki, Ajit			A Simple Method for Assessment of Human Anti-Neu5Gc Antibodies Applied to Kawasaki Disease	PLOS ONE			English	Article							N-GLYCOLYLNEURAMINIC ACID; NONHUMAN SIALIC-ACID; HANGANUTZIU-DEICHER ANTIBODIES; HUMAN XENO-AUTOANTIBODIES; VERTEBRATE AMINO-SUGARS; SENSITIVE DETERMINATION; MAACKIA-AMURENSIS; HEALTHY-CHILDREN; HUMAN-SERUM; CELLS	N-Glycolylneuraminic acid (Neu5Gc) is an immunogenic sugar of dietary origin that metabolically incorporates into diverse native glycoconjugates in humans. Anti-Neu5Gc antibodies are detected in all human sera, though with variable levels and epitope-recognition profiles. These antibodies likely play a role in several inflammation-mediated pathologies including cardiovascular diseases and cancer. In cancer, they have dualistic and opposing roles, either stimulating or repressing disease, as a function of their dose, and some of these antibodies serve as carcinoma biomarkers. Thus, anti-Neu5Gc antibodies may signify risk of inflammation-mediated diseases, and changes in their levels could potentially be used to monitor disease progression and/or response to therapy. Currently, it is difficult to determine levels of anti-Neu5Gc antibodies in individual human samples because these antibodies recognize multiple Neu5Gc-epitopes. Here we describe a simple and specific method for detection and overall estimation of human anti-Neu5Gc antibodies. We exploit the difference between two mouse models that differ only by Neu5Gc-presence (wild-type) or Neu5Gc-absence (Cmah(-/-) knockout). We characterize mouse serum from both strains by HPLC, lectin and mass-spectrometry analysis and show the target Neu5Gc-epitopes. We then use Cmah(-/-) knockout sera to inhibit all non-Neu5Gc-reactivity followed by binding to wild-type sera to detect overall anti-Neu5Gc response in a single assay. We applied this methodology to characterize and quantify anti-Neu5Gc IgG and IgA in sera of patients with Kawasaki disease (KD) at various stages compared to controls. KD is an acute childhood febrile disease characterized by inflammation of coronary arteries that untreated may lead to coronary artery aneurysms with risk of thrombosis and myocardial infarction. This estimated response is comparable to the average of detailed anti-Neu5Gc IgG profile analyzed by a sialoglycan microarray. Both assays revealed an elevated response in acute KD patients with normal coronaries compared to patients with aneurysm or dilated coronaries. Implications of these findings are discussed.	[Padler-Karavani, Vered; Varki, Ajit] Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Padler-Karavani, Vered; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, Rady Childrens Hosp, Dept Pediat, San Diego, CA 92103 USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California Davis	Varki, A (corresponding author), Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	PADLER-KARAVANI, VERED/AAC-6055-2022; Chen, Xi/H-1811-2018	PADLER-KARAVANI, VERED/0000-0002-4761-3571; Chen, Xi/0000-0002-3160-614X	National Institutes of Health [R01GM32373, R01CA38701]; ISEF Fellowship; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISEF Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM32373 and R01CA38701 to A.V. and ISEF Fellowship to V.P-K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; ARITA K, 1982, BIKEN J, V25, P157; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Brinkman-Van der Linden ECM, 2002, ANAL BIOCHEM, V303, P98, DOI 10.1006/abio.2001.5539; Burns JC, 2007, NEW ENGL J MED, V356, P659, DOI 10.1056/NEJMp068268; Burns JC, 2009, INDIAN J PEDIATR, V76, P71, DOI 10.1007/s12098-009-0031-3; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; CHERESH DA, 1984, SCIENCE, V225, P844, DOI 10.1126/science.6206564; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; Giordani L, 2011, CLIN EXP IMMUNOL, V163, P346, DOI 10.1111/j.1365-2249.2010.04297.x; Goodarzi MT, 1998, GLYCOCONJUGATE J, V15, P469, DOI 10.1023/A:1006930902625; HARA S, 1986, J CHROMATOGR, V377, P111, DOI 10.1016/S0378-4347(00)80766-5; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Irie A, 1998, BIOCHEM BIOPH RES CO, V248, P330, DOI 10.1006/bbrc.1998.8946; KAWAMORI J, 1989, Acta Paediatrica Japonica, V31, P537; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; Kotani N, 1997, ANAL BIOCHEM, V252, P40, DOI 10.1006/abio.1997.2300; Lee HH, 2009, YONSEI MED J, V50, P493, DOI 10.3349/ymj.2009.50.4.493; Lu QZ, 2012, ANAL CHEM, V84, P2761, DOI 10.1021/ac2030893; Luca NJC, 2012, DRUGS, V72, P1029, DOI 10.2165/11631440-000000000-00000; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Matsubara T, 2005, CLIN EXP IMMUNOL, V141, P381, DOI 10.1111/j.1365-2249.2005.02821.x; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; NORGARD KE, 1993, P NATL ACAD SCI USA, V90, P1068, DOI 10.1073/pnas.90.3.1068; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2012, J BIOL CHEM, V287, P22593, DOI 10.1074/jbc.M112.359323; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Padler-Karavani V, 2011, XENOTRANSPLANTATION, V18, P1, DOI 10.1111/j.1399-3089.2011.00622.x; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; STOOP JW, 1969, CLIN EXP IMMUNOL, V4, P101; TAKIGUCHI M, 1984, CLIN EXP IMMUNOL, V56, P345; TAMURA T, 1984, DIAGN CLIN IMMUNOL, V2, P101; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Yellen ES, 2010, PEDIATRICS, V125, pE234, DOI 10.1542/peds.2009-0606; ZEGERS BJM, 1975, CLIN CHIM ACTA, V65, P319, DOI 10.1016/0009-8981(75)90257-0; Zhu A, 2002, XENOTRANSPLANTATION, V9, P376, DOI 10.1034/j.1399-3089.2002.02138.x	50	52	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58443	10.1371/journal.pone.0058443	http://dx.doi.org/10.1371/journal.pone.0058443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520510	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900069
J	Tarrataca, L; Wichert, A				Tarrataca, Luis; Wichert, Andreas			Quantum Iterative Deepening with an Application to the Halting Problem	PLOS ONE			English	Article							UNIVERSAL QUANTUM; TURING-MACHINES; COMPUTER	Classical models of computation traditionally resort to halting schemes in order to enquire about the state of a computation. In such schemes, a computational process is responsible for signaling an end of a calculation by setting a halt bit, which needs to be systematically checked by an observer. The capacity of quantum computational models to operate on a superposition of states requires an alternative approach. From a quantum perspective, any measurement of an equivalent halt qubit would have the potential to inherently interfere with the computation by provoking a random collapse amongst the states. This issue is exacerbated by undecidable problems such as the Entscheidungsproblem which require universal computational models, e.g. the classical Turing machine, to be able to proceed indefinitely. In this work we present an alternative view of quantum computation based on production system theory in conjunction with Grover's amplitude amplification scheme that allows for (1) a detection of halt states without interfering with the final result of a computation; (2) the possibility of non-terminating computation and (3) an inherent speedup to occur during computations susceptible of parallelization. We discuss how such a strategy can be employed in order to simulate classical Turing machines.	[Tarrataca, Luis; Wichert, Andreas] INESC ID Inst Super Tecn, Dept Informat, Lisbon, Portugal	INESC-ID; Universidade de Lisboa	Tarrataca, L (corresponding author), INESC ID Inst Super Tecn, Dept Informat, Lisbon, Portugal.	luis.tarrataca@ist.utl.pt	Wichert, Andreas/E-2494-2012	Wichert, Andreas/0000-0002-2179-4378	FCT - Fundacao para a Ciencia e a Tecnologia [PEst-OE/EEI/LA0021/2011, DFRH - SFRH/BD/61846/2009]; FCT/Portuguese ministry of education and science	FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FCT/Portuguese ministry of education and science	This work was supported by national funds through FCT - Fundacao para a Ciencia e a Tecnologia, under project PEst-OE/EEI/LA0021/2011 and FCT grant DFRH - SFRH/BD/61846/2009. The grant in question is a PhD grant attributed by the FCT/Portuguese ministry of education and science. Funder's website: http://www.fct.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky S S A, 1999, HDB COMPUTABILITY TH; Bernstein E, 1993, STOC 93, P11, DOI DOI 10.1145/167088.167097; Brassard G, 2000, ARXIVQUANTPH0005055; Browne D, 2011, LECT NOTES COMPUT SC, V6519, P35, DOI 10.1007/978-3-642-18073-6_4; Chuang IL, 1998, PHYS REV LETT, V80, P3408, DOI 10.1103/PhysRevLett.80.3408; Church Alonzo, 1936, J SYMBOLIC LOGIC, V1, P40, DOI DOI 10.2307/2269326; Cormen Thomas H., 2009, INTRO ALGORITHMS; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Duncan R, 2010, LECT NOTES COMPUT SC, V6199, P285, DOI 10.1007/978-3-642-14162-1_24; Ekert A, 1996, REV MOD PHYS, V68, P733, DOI 10.1103/RevModPhys.68.733; Franklin S. P., 1997, ARTIFICIAL MINDS, VNew; Grover LK, 2004, ARXIVQUANTPH0407122; Grover LK, 1996, STOC, P212, DOI [10.1145/237814.237866, DOI 10.1145/237814.237866]; Hilbert D, 1900, P INT C MATH PAR, P253; Hirvensalo M., 2004, QUANTUM COMPUTING; Iriyama S, 2004, ARXIVQUANTPH0405191; Kaye P., 2007, INTRO QUANTUM COMPUT; KORF RE, 1985, ARTIF INTELL, V27, P97, DOI 10.1016/0004-3702(85)90084-0; Lewis HR, 1981, ELEMENTS THEORY COMP; Linden N, 1998, ARXIVQUANTPH9806054; Mhalla M, 2012, ARXIV E PRINTS; Miyadera T, 2003, ARXIVQUANTPH0302051; Muller M, 2008, IEEE T INFORM THEORY, V54, P763, DOI 10.1109/TIT.2007.913263; Muller Markus, 2007, QUANTUM KOLMOGOROV C; Myers JM, 1997, PHYS REV LETT, V78, P1823, DOI 10.1103/PhysRevLett.78.1823; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Ozawa M, 2002, LECT NOTES COMPUT SC, V2509, P58; Ozawa M, 1998, PHYS REV LETT, V80, P631, DOI 10.1103/PhysRevLett.80.631; Ozawa M, 1998, TECHNICAL REPORT; Perdrix S, 2004, ARXIVQUANTPH0402156; Perdrix S, 2004, ARXIVQUANTPH0404146; Perdrix S, 2011, ELECTRON NOTES THEOR, V270, P99, DOI 10.1016/j.entcs.2011.01.009; Perdrix S, 2006, ELECTRON NOTES THEOR, V135, P119, DOI 10.1016/j.entcs.2005.09.026; Post EL, 1943, AM J MATH, V65, P197, DOI 10.2307/2371809; Raussendorf R, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022312; Raussendorf R, 2001, PHYS REV LETT, V86, P5188, DOI 10.1103/PhysRevLett.86.5188; Russell S.J., 2016, ARTIF INTELL; Sharma A, 2006, THEORY AUTOMATA FORM; Slate D. J., 1977, Chess skill in man and machine, P82; Stuart T, 2004, TECHNICAL REPORT; Tarrataca L, 2012, QUANTUM INF PROCESS, V11, P189, DOI 10.1007/s11128-011-0241-2; Tarrataca L, 2011, COGN COMPUT, V3, P510, DOI 10.1007/s12559-011-9103-6; Tarrataca L, 2011, QUANTUM INF PROCESS, V10, P475, DOI 10.1007/s11128-010-0212-z; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57309	10.1371/journal.pone.0057309	http://dx.doi.org/10.1371/journal.pone.0057309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520465	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900024
J	Schmid, BV; Over, EAB; van den Broek, IVF; de Coul, ELMO; van Bergen, JEAM; Fennema, JSA; Gotz, HM; Hoebe, CJPA; de Wit, GA; van der Sande, MAB; Kretzschmar, MEE				Schmid, Boris V.; Over, Eelco A. B.; van den Broek, Ingrid V. F.; de Coul, Eline L. M. Op; van Bergen, Jan E. A. M.; Fennema, Johan S. A.; Gotz, Hannelore M.; Hoebe, Christian J. P. A.; de Wit, G. Ardine; van der Sande, Marianne A. B.; Kretzschmar, Mirjam E. E.			Effects of Population Based Screening for Chlamydia Infections in The Netherlands Limited by Declining Participation Rates	PLOS ONE			English	Article							COST-EFFECTIVENESS; DISEASE-CONTROL; TRACHOMATIS; PROGRAM; GONORRHEA; IMPLEMENTATION; AZITHROMYCIN; PARTNERSHIPS; PREVALENCE; PREDICTION	Background: A large trial to investigate the effectiveness of population based screening for chlamydia infections was conducted in the Netherlands in 2008-2012. The trial was register based and consisted of four rounds of screening of women and men in the age groups 16-29 years in three regions in the Netherlands. Data were collected on participation rates and positivity rates per round. A modeling study was conducted to project screening effects for various screening strategies into the future. Methods and Findings: We used a stochastic network simulation model incorporating partnership formation and dissolution, aging and a sexual life course perspective. Trends in baseline rates of chlamydia testing and treatment were used to describe the epidemiological situation before the start of the screening program. Data on participation rates was used to describe screening uptake in rural and urban areas. Simulations were used to project the effectiveness of screening on chlamydia prevalence for a time period of 10 years. In addition, we tested alternative screening strategies, such as including only women, targeting different age groups, and biennial screening. Screening reduced prevalence by about 1% in the first two screening rounds and leveled off after that. Extrapolating observed participation rates into the future indicated very low participation in the long run. Alternative strategies only marginally changed the effectiveness of screening. Higher participation rates as originally foreseen in the program would have succeeded in reducing chlamydia prevalence to very low levels in the long run. Conclusions: Decreasing participation rates over time profoundly impact the effectiveness of population based screening for chlamydia infections. Using data from several consecutive rounds of screening in a simulation model enabled us to assess the future effectiveness of screening on prevalence. If participation rates cannot be kept at a sufficient level, the effectiveness of screening on prevalence will remain limited.	[Schmid, Boris V.; van den Broek, Ingrid V. F.; de Coul, Eline L. M. Op; van Bergen, Jan E. A. M.; van der Sande, Marianne A. B.; Kretzschmar, Mirjam E. E.] RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Over, Eelco A. B.; de Wit, G. Ardine] RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [van Bergen, Jan E. A. M.] STI AIDS Netherlands, Amsterdam, Netherlands; [van Bergen, Jan E. A. M.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Fennema, Johan S. A.] Publ Hlth Serv Amsterdam, Amsterdam, Netherlands; [Gotz, Hannelore M.] Publ Hlth Serv Rotterdam Rijnmond, Rotterdam, Netherlands; [Gotz, Hannelore M.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Hoebe, Christian J. P. A.] Publ Hlth Serv Southern Limburg, Bilthoven, Netherlands; [Hoebe, Christian J. P. A.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands; [de Wit, G. Ardine; van der Sande, Marianne A. B.; Kretzschmar, Mirjam E. E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Utrecht University; Utrecht University Medical Center	Kretzschmar, MEE (corresponding author), RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	mirjam.kretzschmar@rivm.nl	Schmid, Boris V./P-9013-2016	Schmid, Boris V./0000-0003-0452-623X; Hoebe, Christian/0000-0003-1815-0974; de Wit, G. Ardine/0000-0002-1375-7657; Gotz, Hannelore Martha/0000-0002-1236-6224; van der Sande, Marianne AB/0000-0002-4778-6739; Kretzschmar, Mirjam/0000-0002-4394-7697	Strategic Research Programme of the RIVM; Dutch organisation for Health Research and Development (ZonMW) [12.400.001]	Strategic Research Programme of the RIVM; Dutch organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The project was funded by a grant of the Strategic Research Programme of the RIVM and a grant from the Dutch organisation for Health Research and Development (ZonMW, project number 12.400.001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CL, 2012, J R SOC INTERFACE, V9, P136, DOI 10.1098/rsif.2011.0131; Althaus CL, 2010, EPIDEMICS-NETH, V2, P123, DOI 10.1016/j.epidem.2010.04.002; Andersen B, 2006, SEX TRANSM DIS, V33, P407, DOI 10.1097/01.olq.0000200609.77577.3f; Bakker F, 2009, SEKSUELE GEZONDHEID; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; de Vries R, 2006, VALUE HEALTH, V9, P1, DOI 10.1111/j.1524-4733.2006.00075.x; Dokkum NFB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-176; Dutch College of General Practitioners (NHG), 2004, GUID STD CONS; van Bergen J, 2007, INT J STD AIDS, V18, P374, DOI 10.1258/095646207781024883; Geisler WM, 2011, CLIN INFECT DIS, V53, pS92, DOI 10.1093/cid/cir698; Gillespie P, 2012, SEX TRANSM INFECT, V88, P222, DOI 10.1136/sextrans-2011-050067; Gotz HM, 2005, SEX TRANSM INFECT, V81, P24, DOI 10.1136/sti.2004.010181; Greenland KE, 2011, SEX TRANSM DIS, V38, P467, DOI 10.1097/OLQ.0b013e318204546e; Handsfield HH, 2011, SEX TRANSM DIS, V38, P1028, DOI 10.1097/OLQ.0b013e318227a366; Health Council of the Netherlands, 2004, SCREEN CHLAM; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson RE, 2010, STAT BIOL HEALTH, P357, DOI 10.1007/978-0-387-93835-6_20; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; Kretzschmar M, 2012, SEX TRANSM DIS, V39, P325, DOI 10.1097/OLQ.0b013e31824e52c2; LaMontagne DS, 2004, SEX TRANSM INFECT, V80, P335, DOI 10.1136/sti.2004.012856; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; National Institute of Public Health and the Environment, 2010, 21026100820102010 RI; Op de Coul ELM, 2012, SEX TRANSM DIS, V39, P97, DOI 10.1097/OLQ.0b013e3182383097; Schmid BV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002470; Suijkerbuijk AWM, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-72; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173; van Bergen JEAM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-293; van Bergen JEAM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-42; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; van den Broek IVF, 2012, SEX TRANSM INFECT, V88, P205, DOI 10.1136/sextrans-2011-050219; van den Broek IVF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-39; van den Broek IVF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-89; van den Hoek J A, 1999, Ned Tijdschr Geneeskd, V143, P668; VandeLaar MJW, 1997, SEX TRANSM DIS, V24, P334, DOI 10.1097/00007435-199707000-00005; Welte R, 2000, SEX TRANSM DIS, V27, P518, DOI 10.1097/00007435-200010000-00005; Welte R, 2003, SEX TRANSM INFECT, V79, P426, DOI 10.1136/sti.79.5.426	40	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58674	10.1371/journal.pone.0058674	http://dx.doi.org/10.1371/journal.pone.0058674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527005	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600031
J	Baker, P; Muthumayandi, K; Gerrand, C; Kleim, B; Bettinson, K; Deehan, D				Baker, Paul; Muthumayandi, Karthikeyan; Gerrand, Craig; Kleim, Benjamin; Bettinson, Karen; Deehan, David			Influence of Body Mass Index (BMI) on Functional Improvements at 3 Years Following Total Knee Replacement: A Retrospective Cohort Study	PLOS ONE			English	Article							OBESE-PATIENTS; MORBIDLY OBESE; OSTEOARTHRITIS; OUTCOMES; HIP; WEIGHT; ASSOCIATION; POPULATION; HEIGHT; SF-36	Background: The number of patients presenting for total knee replacement who are classified as obese is increasing. The functional benefits of performing TKR in these patients are unclear. Aim: To assess the influence pre-operative body mass index has upon knee specific function, general health status and patient satisfaction at 3 years following total knee replacement. Design: Retrospective comparative cohort study using prospectively collected data from an institutional arthroplasty register. Methods: 1367 patients were assessed using the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and Medical Outcomes Trust Short Form-36 (SF-36) scores supplemented by a validated measure of satisfaction pre-operatively and subsequently at 1,2 and 3 year post-operatively. Comparisons were made by dividing the cohort into 4 groups based on body mass index (BMI) 18.5-25.0 kg/m(2) (n = 253); >25.0-30.0 kg/m(2) (n = 559); >30.0235.0 kg/m(2) (n = 373); >35.0 kg/m(2) (n = 182). Results: Despite lower pre-operative, 1 and 3 year WOMAC and SF-36 scores patients with the highest BMIs >35.0 kg/m(2) experienced similar improvements to patients with a 'normal' BMI (18.5-25.0 kg/m(2)) at 1 year (Difference in WOMAC improvement = 0.0 (95% CI -5.2 to 5.2), p = 1.00) and this improvement was sustained at up to 3 years (Difference in 1 year to 3 year improvement = 2.2 (95% CI: -2.1 to 6.5), p = 1.00). This effect was also observed for the SF-36 mental and physical component scores. Despite equivalent functional improvements levels of satisfaction in the >35.0 kg/m(2) group were lower than for any other BMI group (>35.0 kg/m(2) = 84.6% satisfied versus 18.5-5.0 kg/m(2) = 93.3% satisfied, p = 0.01) as was the proportion of patients who stated they would have the operation again (>35.0 kg/m(2) = 69.6% versus 18.5-25.0 kg/m(2) = 82.2%, p = 0.01). Conclusion: Obese and morbidly obese patients gain as much functional benefit from total knee replacement as patients with lesser body mass indexes. This benefit is maintained for up to 3 years following surgery. However, these patients are less satisfied with their knee replacement and almost a third would not have the operation again.	[Baker, Paul] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Muthumayandi, Karthikeyan; Bettinson, Karen] Freeman Rd Hosp, Dept Orthopaed Res, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Gerrand, Craig; Kleim, Benjamin] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Deehan, David] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK	Baker, P (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	drpnbaker@hotmail.com		Deehan, David/0000-0001-5780-8818; Muthumayandi, Karthikeyan/0000-0001-8090-0452	Depuy Orthopaedics Inc (Marwah, Indiana, USA)	Depuy Orthopaedics Inc (Marwah, Indiana, USA)	This work was supported by a research grant from Depuy Orthopaedics Inc (Marwah, Indiana, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AK, 2006, J BONE JOINT SURG BR, V88B, P1321, DOI 10.1302/0301-620X.88B10.17697; Anderson JG, 1996, J ARTHROPLASTY, V11, P831, DOI 10.1016/S0883-5403(96)80183-5; Baker P, 2012, J BONE JOINT SURG AM, V94A, P1501, DOI 10.2106/JBJS.K.01180; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; Dalury DF, 2012, CLIN ORTHOP RELAT R, V470, P117, DOI 10.1007/s11999-011-1964-1; Dekkers JC, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-69; Dowsey MM, 2008, ANZ J SURG, V78, P439, DOI 10.1111/j.1445-2197.2008.04554.x; Escobar A, 2007, OSTEOARTHR CARTILAGE, V15, P273, DOI 10.1016/j.joca.2006.09.001; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; Haverkort EB, 2012, AM J SURG, V203, P700, DOI 10.1016/j.amjsurg.2011.06.053; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; HOCHBERG MC, 1995, J RHEUMATOL, V22, P488; Kulkarni A, 2011, SURG-J R COLL SURG E, V9, P18, DOI 10.1016/j.surge.2010.08.004; Lohmander LS, 2009, ANN RHEUM DIS, V68, P490, DOI 10.1136/ard.2008.089748; Mahomed N, 2011, ARTHRITIS, DOI 10.1155/2011/591253; Samson AJ, 2010, ANZ J SURG, V80, P595, DOI 10.1111/j.1445-2197.2010.05396.x; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Scott CEH, 2010, J BONE JOINT SURG BR, V92B, P1253, DOI 10.1302/0301-620X.92B9.24394; SPECTOR TD, 1994, ANN RHEUM DIS, V53, P565, DOI 10.1136/ard.53.9.565; Stickles B, 2001, OBES RES, V9, P219, DOI 10.1038/oby.2001.24; Suleiman LI, 2012, J SURG RES, V174, P7, DOI 10.1016/j.jss.2011.05.057; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; World Health Organisation global infobase, 2012, GLOB COMP EST PREV O; Yeung E, 2011, INT ORTHOP, V35, P929, DOI 10.1007/s00264-010-1051-3; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	26	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59079	10.1371/journal.pone.0059079	http://dx.doi.org/10.1371/journal.pone.0059079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527090	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000317562100072
J	Fortugno, F; Katsakou, C; Bremner, S; Kiejna, A; Kjellin, L; Nawka, P; Raboch, J; Kallert, T; Priebe, S				Fortugno, Federico; Katsakou, Christina; Bremner, Stephen; Kiejna, Andrzej; Kjellin, Lars; Nawka, Petr; Raboch, Jiri; Kallert, Thomas; Priebe, Stefan			Symptoms Associated with Victimization in Patients with Schizophrenia and Related Disorders	PLOS ONE			English	Article							SEVERE MENTAL-ILLNESS; INVOLUNTARY HOSPITAL ADMISSION; PSYCHIATRIC RATING-SCALE; VIOLENT VICTIMIZATION; PATIENTS VIEWS; BEHAVIOR; INDIVIDUALS; PSYCHOSIS; OUTCOMES; PEOPLE	Background: Patients with psychoses have an increased risk of becoming victims of violence. Previous studies have suggested that higher symptom levels are associated with a raised risk of becoming a victim of physical violence. There has been, however, no evidence on the type of symptoms that are linked with an increased risk of recent victimization. Methods: Data was taken from two studies on involuntarily admitted patients, one national study in England and an international one in six other European countries. In the week following admission, trained interviewers asked patients whether they had been victims of physical violence in the year prior to admission, and assessed symptoms on the Brief Psychiatric Rating Scale (BPRS). Only patients with a diagnosis of schizophrenia or related disorders (ICD-10 F20-29) were included in the analysis which was conducted separately for the two samples. Symptom levels assessed on the BPRS subscales were tested as predictors of victimization. Univariable and multivariable logistic regression models were fitted to estimate adjusted odds ratios. Results: Data from 383 patients in the English sample and 543 patients in the European sample was analysed. Rates of victimization were 37.8% and 28.0% respectively. In multivariable models, the BPRS manic subscale was significantly associated with victimization in both samples. Conclusions: Higher levels of manic symptoms indicate a raised risk of being a victim of violence in involuntary patients with schizophrenia and related disorders. This might be explained by higher activity levels, impaired judgement or poorer self-control in patients with manic symptoms. Such symptoms should be specifically considered in risk assessments.	[Fortugno, Federico] Univ Roma La Sapienza, Neurosci Mental Hlth & Sensory Funct Dept, Sch Med & Psychol, St Andrea Hosp, Rome, Italy; [Katsakou, Christina; Priebe, Stefan] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England; [Bremner, Stephen] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England; [Kiejna, Andrzej] Wroclaw Med Univ, Dept Psychiat, Wroclaw, Poland; [Kjellin, Lars] Univ Orebro, Sch Hlth & Med Sci, Psychiat Res Ctr, Orebro, Sweden; [Nawka, Petr] Psychiat Outpatient Klin, Dresden, Germany; [Raboch, Jiri] Charles Univ Prague, Med Sch 1, Dept Psychiat, Prague, Czech Republic; [Kallert, Thomas] Pk Hosp Leipzig, Dept Psychiat Psychosomat Med & Psychotherapy, Leipzig, Germany; [Kallert, Thomas] Soteria Hosp Leipzig, Leipzig, Germany	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of London; Queen Mary University London; University of London; Queen Mary University London; Wroclaw Medical University; Orebro University; Technische Universitat Dresden; Charles University Prague	Priebe, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England.	s.priebe@qmul.ac.uk	raboch, jiri/N-7445-2017; Bremner, Stephen/R-4038-2016	raboch, jiri/0000-0001-6667-1497; Bremner, Stephen/0000-0003-0790-7070; Priebe, Stefan/0000-0001-9864-3394				Andermeyer MC, 1998, SOC PSYCH PSYCH EPID, V33, pS1, DOI 10.1007/s001270050203; Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Arboleda-Florez J, 1998, SOC PSYCH PSYCH EPID, V33, pS38, DOI 10.1007/s001270050208; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; BARTELS SJ, 1991, SCHIZOPHRENIA BULL, V17, P163, DOI 10.1093/schbul/17.1.163; Brekke JS, 2001, PSYCHIATR SERV, V52, P1358, DOI 10.1176/appi.ps.52.10.1358; Choe JY, 2008, PSYCHIAT SERV, V59, P153, DOI 10.1176/ps.2008.59.2.153; Corrigan PW, 2005, PSYCHIAT RES, V136, P153, DOI 10.1016/j.psychres.2005.06.005; Fazel S, 2011, SCHIZOPHRENIA BULL, V37, P800, DOI 10.1093/schbul/sbp135; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Hiday VA, 2002, AM J PSYCHIAT, V159, P1403, DOI 10.1176/appi.ajp.159.8.1403; Hodgins S, 2007, BRIT J PSYCHIAT, V191, P343, DOI 10.1192/bjp.bp.106.06.029587; Junginger J, 1996, SCHIZOPHRENIA BULL, V22, P91, DOI 10.1093/schbul/22.1.91; Kallert Thomas W, 2005, World Psychiatry, V4, P168; Kallert TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028191; Katsakou C, 2006, ACTA PSYCHIAT SCAND, V114, P232, DOI 10.1111/j.1600-0447.2006.00823.x; Kruse M, 2010, SCAND J PUBLIC HEALT, V38, P611, DOI 10.1177/1403494810377682; Lam JA, 1998, PSYCHIATR SERV, V49, P678, DOI 10.1176/ps.49.5.678; Link B.G., 1994, VIOLENCE MENTAL DISO, P137; Maniglio R, 2009, ACTA PSYCHIAT SCAND, V119, P180, DOI 10.1111/j.1600-0447.2008.01300.x; Naudts K, 2006, SCHIZOPHRENIA BULL, V32, P562, DOI 10.1093/schbul/sbj036; Nielssen OB, 2012, J CLIN PSYCHIAT, V73, pE580, DOI 10.4088/JCP.11r07036; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Priebe S, 2011, EUR ARCH PSY CLIN N, V261, P77; Priebe S, 2010, BRIT J PSYCHIAT, V196, P179, DOI 10.1192/bjp.bp.109.068916; Priebe S, 2009, BRIT J PSYCHIAT, V194, P49, DOI 10.1192/bjp.bp.108.052266; Sells DJ, 2003, PSYCHIAT SERV, V54, P1253, DOI 10.1176/appi.ps.54.9.1253; Silver E, 2002, CRIMINOLOGY, V40, P191, DOI 10.1111/j.1745-9125.2002.tb00954.x; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Swanson JW, 2002, AM J PUBLIC HEALTH, V92, P1523, DOI 10.2105/AJPH.92.9.1523; Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490; Swartz MS, 1998, AM J PSYCHIAT, V155, P226; Taylor PJ, 2008, CAN J PSYCHIAT, V53, P647, DOI 10.1177/070674370805301004; Teplin LA, 2005, ARCH GEN PSYCHIAT, V62, P911, DOI 10.1001/archpsyc.62.8.911; Torrey EF, 2008, PSYCHIAT SERV, V59, P147, DOI 10.1176/ps.2008.59.2.147; Vaughn MG, 2010, ANN EPIDEMIOL, V20, P281, DOI 10.1016/j.annepidem.2009.11.011; VENTURA J, 1993, INT J METH PSYCH RES, V3, P221; Ventura J, 2000, PSYCHIAT RES, V97, P129, DOI 10.1016/S0165-1781(00)00228-6; Walsh E, 2003, BRIT J PSYCHIAT, V183, P233, DOI 10.1192/bjp.183.3.233; Walsh E, 2002, BRIT J PSYCHIAT, V180, P490, DOI 10.1192/bjp.180.6.490; Watson AC, 2004, PSYCHIAT SERV, V55, P49, DOI 10.1176/appi.ps.55.1.49; World Health Organization, 1992, ICD 10 CLASSIFICATIO	42	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58142	10.1371/journal.pone.0058142	http://dx.doi.org/10.1371/journal.pone.0058142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23526968	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000317562100019
J	Wang, XJ; Wang, XJ; Duan, YH; Yin, SN; Zhang, HC; Huang, L; Kang, ZS				Wang, Xiaojing; Wang, Xiaojie; Duan, Yinghui; Yin, Shuining; Zhang, Hongchang; Huang, Li; Kang, Zhensheng			TaAbc1, a Member of Abc1-Like Family Involved in Hypersensitive Response against the Stripe Rust Fungal Pathogen in Wheat	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; PUCCINIA-STRIIFORMIS; COMPATIBLE INTERACTION; CELL-DEATH; RESISTANCE; IDENTIFICATION; PROTEIN; CDNA; CADMIUM; ENCODES	To search for genes involved in wheat (Triticum aestivum L.) defense response to the infection of stripe rust pathogen Puccinia striiformis f. sp. tritici (Pst), we identified and cloned a new wheat gene similar to the genes in the Abc1-like gene family. The new gene, designated as TaAbc1, encodes a 717-amino acid, 80.35 kD protein. The TaAbc1 protein contains two conserved domains shared by Abc1-like proteins, two trans-membrane domains at the C-terminal, and a 36-amino acid chloroplast targeting presequence at the N-terminal. Characterization of TaAbc1 expression revealed that gene expression was tissue-specific and could be up-regulated by biotic agents (e. g., stripe rust pathogen) and/or by an abiotic stress like wounding. High-fold induction was associated with the hypersensitive response (HR) triggered only by avirulent stripe rust pathotypes, suggesting that TaAbc1 is a rust-pathotype specific HR-mediator. Down-regulating TaAbc1 reduced HR but not the overall resistance level in Suwon11 to CYR23, suggesting TaAbc1 was involved in HR against stripe rust, but overall host resistance is not HR-dependent.	[Wang, Xiaojing; Wang, Xiaojie; Duan, Yinghui; Yin, Shuining; Zhang, Hongchang; Kang, Zhensheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wang, Xiaojing; Duan, Yinghui; Zhang, Hongchang] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Wang, Xiaojing; Huang, Li] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Wang, Xiaojie; Yin, Shuining; Kang, Zhensheng] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Montana State University System; Montana State University Bozeman; Northwest A&F University - China	Kang, ZS (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	Kangzs@nwsuaf.edu.cn		Wang, Xiaojie/0000-0001-9968-0373; Kang, Zhensheng/0000-0001-5575-0122	National Basic Research Program of China [2013CB127700]; National Natural Science Foundation of China [30930064]; 111 Project from the Ministry of Education of China [B07049]; Basic Research to Enable Agricultural Development Program from the National Science Foundation of the USA [IOS-0965429]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from the Ministry of Education of China(Ministry of Education, China - 111 Project); Basic Research to Enable Agricultural Development Program from the National Science Foundation of the USA(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by National Basic Research Program of China (No. 2013CB127700), National Natural Science Foundation of China (No. 30930064), the 111 Project from the Ministry of Education of China (No. B07049) and, Basic Research to Enable Agricultural Development Program from the National Science Foundation of the USA (IOS-0965429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Brasseur G, 1997, EUR J BIOCHEM, V246, P103, DOI 10.1111/j.1432-1033.1997.t01-1-00103.x; Cardazzo B, 1998, GENE, V221, P117, DOI 10.1016/S0378-1119(98)00417-X; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Geske FJ, 2001, HUM PATHOL, V32, P1029, DOI 10.1053/hupa.2001.28250; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hsieh EJ, 2004, BIOCHEM BIOPH RES CO, V317, P648, DOI 10.1016/j.bbrc.2004.03.096; Iiizumi M, 2002, CANCER RES, V62, P1246; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; Jasinski M, 2008, PLANT PHYSIOL, V147, P719, DOI 10.1104/pp.107.110247; Kang Z, 1984, ACTA CLLEGII SEPTENT, V4, P18; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; KLEMENT Z, 1963, NATURE, V199, P299, DOI 10.1038/199299b0; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lacy G. H., 1982, PHYTOPATHOGENIC PROK, V2, P149; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-586; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; Pogue G. P., 1998, PLANT MOL BIOL MAN L, P1; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Stakman EC, 1915, J AGRIC RES, V4, P193; Stakman EC., 1962, IDENTIFICATION PHYSL, P1; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-289; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010; Xia N, 2010, MOL BIOL REP, V37, P3703, DOI 10.1007/s11033-010-0023-4; Zhang G, 2009, J PHYTOPATHOL, V157, P722, DOI 10.1111/j.1439-0434.2009.01556.x; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3	36	8	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58969	10.1371/journal.pone.0058969	http://dx.doi.org/10.1371/journal.pone.0058969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527058	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100059
J	Zhang, RY; Zhao, Y; Chu, MJ; Mehta, A; Wei, YY; Liu, Y; Xun, PC; Bai, JL; Yu, H; Su, L; Zhang, HX; Hu, ZB; Shen, HB; Chen, F; Christiani, DC				Zhang, Ruyang; Zhao, Yang; Chu, Minjie; Mehta, Amar; Wei, Yongyue; Liu, Yao; Xun, Pengcheng; Bai, Jianling; Yu, Hao; Su, Li; Zhang, Hongxi; Hu, Zhibin; Shen, Hongbing; Chen, Feng; Christiani, David C.			A Large Scale Gene-Centric Association Study of Lung Function in Newly-Hired Female Cotton Textile Workers with Endotoxin Exposure	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY; POLYMORPHISMS; POPULATION; PROTEIN; HEALTH; LOCI	Background: Occupational exposure to endotoxin is associated with decrements in pulmonary function, but how much variation in this association is explained by genetic variants is not well understood. Objective: We aimed to identify single nucleotide polymorphisms (SNPs) that are associated with the rate of forced expiratory volume in one second (FEV1) decline by a large scale genetic association study in newly-hired healthy young female cotton textile workers. Methods: DNA samples were genotyped using the Illumina Human CVD BeadChip. Change rate in FEV1 was modeled as a function of each SNP genotype in linear regression model with covariate adjustment. We controlled the type 1 error in study-wide level by permutation method. The false discovery rate (FDR) and the family-wise error rate (FWER) were set to be 0.10 and 0.15 respectively. Results: Two SNPs were found to be significant (P<6.29x10(-5)), including rs1910047 (P = 3.07x10(-5), FDR = 0.0778) and rs9469089 (P = 6.19x10(-5), FDR = 0.0967), as well as other eight suggestive (P<5x10(-4)) associated SNPs. Gene-gene and gene-environment interactions were also observed, such as rs1910047 and rs1049970 (P = 0.0418, FDR = 0.0895); rs9469089 and age (P = 0.0161, FDR = 0.0264). Genetic risk score analysis showed that the more risk loci the subjects carried, the larger the rate of FEV1 decline occurred (P-trend = 3.01x10(-18)). However, the association was different among age subgroups (P = 7.11x10(-6)) and endotoxin subgroups (P = 1.08x10(-2)). Functional network analysis illustrates potential biological connections of all interacted genes. Conclusions: Genetic variants together with environmental factors interact to affect the rate of FEV1 decline in cotton textile workers.	[Zhang, Ruyang; Zhao, Yang; Chu, Minjie; Wei, Yongyue; Liu, Yao; Bai, Jianling; Yu, Hao; Hu, Zhibin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Zhang, Ruyang; Zhao, Yang; Chu, Minjie; Wei, Yongyue; Liu, Yao; Bai, Jianling; Yu, Hao; Hu, Zhibin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Minist Educ MOE, Key Lab Modern Toxicol, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Zhang, Ruyang; Chu, Minjie; Liu, Yao; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Zhao, Yang; Mehta, Amar; Wei, Yongyue; Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Mehta, Amar] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mehta, Amar] Univ Basel, Basel, Switzerland; [Xun, Pengcheng] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Zhang, Hongxi] Shanghai Med Univ 2, Putuo Dist Peoples Hosp, Shanghai, Peoples R China; [Christiani, David C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Pulm & Crit Care Unit,Dept Med, Boston, MA USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Harvard University; Harvard T.H. Chan School of Public Health; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Indiana University System; Indiana University Bloomington; Shanghai Jiao Tong University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chen, F (corresponding author), Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn; dchris@hsph.harvard.edu	zhao, yang/GXF-4424-2022; pengcheng, xun/D-3411-2013; Wei, Yongyue/GYV-5660-2022	pengcheng, xun/0000-0002-6245-4505; Wei, Yongyue/0000-0002-1132-1796; Chen, Feng/0000-0002-2699-7190; Zhang, Ruyang/0000-0003-3861-4297	USA: The National Institute for Occupational Safety and Health [RO104241]; USA: National Institute of Environmental Health Sciences [ES00002]; China: National Natural Science Foundation of China [81072389, 30901232]; China: Natural Science Foundation of the Jiangsu Higher Education Institutions of China [10KJA33034]; China: Research Fund for the Doctoral Program of Higher Education of China [20113234110002]; China: Research and Innovation Project for College Graduates of Jiangsu Province [CXZZ11_0733]; China: Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH002421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	USA: The National Institute for Occupational Safety and Health; USA: National Institute of Environmental Health Sciences; China: National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China: Natural Science Foundation of the Jiangsu Higher Education Institutions of China; China: Research Fund for the Doctoral Program of Higher Education of China; China: Research and Innovation Project for College Graduates of Jiangsu Province; China: Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grants from USA: The National Institute for Occupational Safety and Health (RO104241), National Institute of Environmental Health Sciences (ES00002) and China: National Natural Science Foundation of China (81072389, 30901232), Natural Science Foundation of the Jiangsu Higher Education Institutions of China (10KJA33034), the Research Fund for the Doctoral Program of Higher Education of China (20113234110002), the Research and Innovation Project for College Graduates of Jiangsu Province (CXZZ11_0733), and the grant from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Arora R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002866; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; BECK GJ, 1982, ANN INTERN MED, V97, P645, DOI 10.7326/0003-4819-97-5-645; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carpe N, 2010, AM J RESP CELL MOL, V43, P720, DOI 10.1165/rcmb.2009-0412OC; CASTELLAN RM, 1987, NEW ENGL J MED, V317, P605, DOI 10.1056/NEJM198709033171005; Cebra-Thomas JA, 2003, DEV DYNAM, V226, P82, DOI 10.1002/dvdy.10208; Dai JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021120; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Ekins S, 2007, METH MOL B, V356, P319; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; German Z, 2000, J BIOL CHEM, V275, P8183, DOI 10.1074/jbc.275.11.8183; Guan XJ, 2013, J CELL BIOCHEM, V114, P323, DOI 10.1002/jcb.24377; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hang JQ, 2005, AM J RESP CRIT CARE, V171, P165, DOI 10.1164/rccm.200407-888OC; HARKEMA JR, 1993, TOXICOL LETT, V68, P251, DOI 10.1016/0378-4274(93)90136-L; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Imboden M, 2009, ENVIRON HEALTH PERSP, V117, P1420, DOI 10.1289/ehp.0800430; Ishiguro H, 2011, SYNAPSE, V65, P103, DOI 10.1002/syn.20821; JANUS ED, 1985, LANCET, V1, P152; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; KENNEDY SM, 1987, AM REV RESPIR DIS, V135, P194; KOHNO T, 1993, ONCOGENE, V8, P1825; Korman BD, 2009, ARTHRITIS RHEUM-US, V60, P47, DOI 10.1002/art.24180; Korthagen NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030442; Kuang E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003007; Lee SH, 2011, CLIN EXP ALLERGY, V41, P1533, DOI 10.1111/j.1365-2222.2011.03801.x; Liebers V, 2006, AM J IND MED, V49, P474, DOI 10.1002/ajim.20310; Lu JA, 2010, BBA-REV CANCER, V1806, P268, DOI 10.1016/j.bbcan.2010.07.001; OLENCHOCK S A, 1990, Biomedical and Environmental Sciences, V3, P443; Pegorier S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-85; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2011, CIRCULATION, V123, P374, DOI 10.1161/CIRCULATIONAHA.110.976613; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Roeckel N, 2009, CANCER RES, V69, P292, DOI 10.1158/0008-5472.CAN-08-3314; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Stark JR, 2009, CANCER EPIDEM BIOMAR, V18, P1859, DOI 10.1158/1055-9965.EPI-08-0981; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Tang HF, 2011, FASEB J, V25, P4292, DOI 10.1096/fj.11-187955; Wang XR, 2003, ARCH ENVIRON HEALTH, V58, P6, DOI 10.3200/AEOH.58.1.6-13; Wang XR, 2003, OCCUP ENVIRON MED, V60, P115, DOI 10.1136/oem.60.2.115; Wang XR, 2002, AM J IND MED, V41, P111, DOI 10.1002/ajim.10042; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yin XJ, 2004, BIOMED ENVIRON SCI, V17, P432; Zhang HX, 2007, OCCUP ENVIRON MED, V64, P409, DOI 10.1136/oem.2006.029025; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zuniga J, 2012, EUR RESPIR J, V39, P604, DOI 10.1183/09031936.00020611	56	3	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59035	10.1371/journal.pone.0059035	http://dx.doi.org/10.1371/journal.pone.0059035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527081	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100068
J	Matsunaga, E; Nambu, S; Oka, M; Okanoya, K; Iriki, A				Matsunaga, Eiji; Nambu, Sanae; Oka, Mariko; Okanoya, Kazuo; Iriki, Atsushi			Comparative Analysis of Protocadherin-11 X-Linked Expression among Postnatal Rodents, Non-Human Primates, and Songbirds Suggests Its Possible Involvement in Brain Evolution	PLOS ONE			English	Article							DEVELOPING MOUSE-BRAIN; CENTRAL-NERVOUS-SYSTEM; CADHERIN EXPRESSION; N-CADHERIN; DELTA-PROTOCADHERINS; CLASSIC CADHERINS; II CADHERINS; DIFFERENTIAL EXPRESSION; RESTRICTED EXPRESSION; OL-PROTOCADHERIN	Background: Protocadherin-11 is a cell adhesion molecule of the cadherin superfamily. Since, only in humans, its paralog is found on the Y chromosome, it is expected that protocadherin-11X/Y plays some role in human brain evolution or sex differences. Recently, a genetic mutation of protocadherin-11X/Y was reported to be associated with a language development disorder. Here, we compared the expression of protocadherin-11 X-linked in developing postnatal brains of mouse (rodent) and common marmoset (non-human primate) to explore its possible involvement in mammalian brain evolution. We also investigated its expression in the Bengalese finch (songbird) to explore a possible function in animal vocalization and human language faculties. Methodology/Principal Findings: Protocadherin-11 X-linked was strongly expressed in the cerebral cortex, hippocampus, amygdala and brainstem. Comparative analysis between mice and marmosets revealed that in certain areas of marmoset brain, the expression was clearly enriched. In Bengalese finches, protocadherin-11 X-linked was expressed not only in nuclei of regions of the vocal production pathway and the tracheosyringeal hypoglossal nucleus, but also in areas homologous to the mammalian amygdala and hippocampus. In both marmosets and Bengalese finches, its expression in pallial vocal control areas was developmentally regulated, and no clear expression was seen in the dorsal striatum, indicating a similarity between songbirds and non-human primates. Conclusions/Significance: Our results suggest that the enriched expression of protocadherin-11 X-linked is involved in primate brain evolution and that some similarity exists between songbirds and primates regarding the neural basis for vocalization.	[Matsunaga, Eiji; Nambu, Sanae; Oka, Mariko; Iriki, Atsushi] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Okanoya, Kazuo] JST ERATO, ERATO Okanoya Emot Informat Project, Saitama, Japan; [Okanoya, Kazuo] RIKEN Brain Sci Inst, Emot Informat Joint Res Lab, Wako, Saitama, Japan	RIKEN; University of Tokyo; RIKEN	Matsunaga, E (corresponding author), RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan.	Eiji.Matsunaga@brain.riken.jp			Takeda Science Foundation; Funding Program for World-leading Innovative R&D on Science and Technology (FIRST), at RIKEN, Japan	Takeda Science Foundation(Takeda Science Foundation (TSF)); Funding Program for World-leading Innovative R&D on Science and Technology (FIRST), at RIKEN, Japan	Funding was received from the Takeda Science Foundation (to EM), Funding Program for World-leading Innovative R&D on Science and Technology (FIRST), at RIKEN, Japan (to AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2010, AM J MED GENET B, V153B, P736, DOI 10.1002/ajmg.b.31041; Arndt K, 1998, J COMP NEUROL, V401, P367; Arndt K, 1996, J COMP NEUROL, V373, P373, DOI 10.1002/(SICI)1096-9861(19960923)373:3<373::AID-CNE5>3.0.CO;2-#; Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; Barnes SH, 2010, DEVELOPMENT, V137, P805, DOI 10.1242/dev.042457; Bekirov IH, 2002, NEUROSCIENCE, V115, P213, DOI 10.1016/S0306-4522(02)00375-5; Blanco P, 2000, MAMM GENOME, V11, P906, DOI 10.1007/s003350010177; Blanco-Arias P, 2004, MAMM GENOME, V15, P41, DOI 10.1007/s00335-003-3028-7; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Bourne JA, 2005, CEREB CORTEX, V15, P740, DOI 10.1093/cercor/bhh175; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheng MF, 1999, BRAIN BEHAV EVOLUT, V53, P243, DOI 10.1159/000006597; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Durand CM, 2006, AM J MED GENET B, V141B, P67, DOI 10.1002/ajmg.b.30229; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; Etzrodt J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-153; Fitch W Tecumseh, 2011, Front Evol Neurosci, V3, P9, DOI 10.3389/fnevo.2011.00009; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fushimi D, 1997, DEV DYNAM, V209, P269, DOI 10.1002/(SICI)1097-0177(199707)209:3<269::AID-AJA3>3.0.CO;2-G; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hertel N, 2008, J COMP NEUROL, V508, P511, DOI 10.1002/cne.21696; Hertel N, 2012, J COMP NEUROL, V520, P3982, DOI 10.1002/cne.23140; Hirano S, 1999, J NEUROSCI, V19, P995; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Hulpiau P, 2011, MOL BIOL EVOL, V28, P647, DOI 10.1093/molbev/msq233; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.3.CO;2-R; Inoue T, 2001, DEVELOPMENT, V128, P561; Ju MJ, 2004, NEUROSCIENCE, V128, P785, DOI 10.1016/j.neuroscience.2004.06.063; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Kim SY, 2010, NEUROSCIENCE, V170, P189, DOI 10.1016/j.neuroscience.2010.05.027; Korematsu K, 1997, DEV DYNAM, V208, P178, DOI 10.1002/(SICI)1097-0177(199702)208:2<178::AID-AJA5>3.0.CO;2-F; Krishna-K, 2009, CEREB CORTEX, V19, P388, DOI 10.1093/cercor/bhn090; Krishna-K K, 2011, NEUROSCIENCE, V175, P37, DOI 10.1016/j.neuroscience.2010.11.056; Lefkovics K, 2012, J COMP NEUROL, V520, P1387, DOI 10.1002/cne.22801; Leung LC, 2013, NAT NEUROSCI, V16, P166, DOI 10.1038/nn.3290; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; Matsunaga E, 2008, J COMP NEUROL, V508, P329, DOI 10.1002/cne.21676; Matsunaga E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025272; Matsunaga E, 2011, NEUROREPORT, V22, P629, DOI 10.1097/WNR.0b013e3283491665; Matsunaga E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00028; Matsunaga E, 2011, J COMP NEUROL, V519, P1736, DOI 10.1002/cne.22598; Mayer M, 2010, GENE EXPR PATTERNS, V10, P351, DOI 10.1016/j.gep.2010.08.002; Miller CT, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00128; Miyake K, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-81; Nakagawa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049233; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Neudert F, 2008, J COMP NEUROL, V511, P736, DOI 10.1002/cne.21865; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Paxinos G., 2012, MARMOSET BRAIN STERE; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; Pistorio AL, 2006, J ACOUST SOC AM, V120, P1655, DOI 10.1121/1.2225899; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Priddle TH, 2012, CEREB CORTEX; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Redies C, 2005, CELL MOL LIFE SCI, V62, P2840, DOI 10.1007/s00018-005-5320-z; Redies C, 2000, J COMP NEUROL, V421, P481, DOI 10.1002/(SICI)1096-9861(20000612)421:4<481::AID-CNE3>3.0.CO;2-H; Redies C, 2001, J COMP NEUROL, V438, P253; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Saarimaki-Vire J, 2011, DEV DYNAM, V240, P1989, DOI 10.1002/dvdy.22686; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Scharff C, 2013, CURR OPIN NEUROBIOL, V23, P29, DOI 10.1016/j.conb.2012.10.001; Simoes CS, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00123; Speevak MD, 2011, AM J MED GENET B, V156B, P484, DOI 10.1002/ajmg.b.31186; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Suzuki SC, 2007, J NEUROSCI, V27, P3466, DOI 10.1523/JNEUROSCI.0243-07.2007; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takahashi M, 2005, DEV DYNAM, V232, P200, DOI 10.1002/dvdy.20209; Takahashi M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-87; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Treubert-Zimmermann U, 2002, J NEUROSCI, V22, P7617; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Vanhalst K, 2005, CELL MOL LIFE SCI, V62, P1247, DOI 10.1007/s00018-005-5021-7; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Williams NA, 2006, AM J MED GENET B, V141B, P623, DOI 10.1002/ajmg.b.30357; Wilson ND, 2006, CYTOGENET GENOME RES, V114, P137, DOI 10.1159/000093329; Wohrn JCP, 1999, NEUROSCIENCE, V90, P985, DOI 10.1016/S0306-4522(98)00526-0; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; Yamazaki Y, 2011, EXP BRAIN RES, V213, P63, DOI 10.1007/s00221-011-2778-9; Yoon MS, 2000, J COMP NEUROL, V421, P461, DOI 10.1002/(SICI)1096-9861(20000612)421:4<461::AID-CNE2>3.0.CO;2-M	90	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58840	10.1371/journal.pone.0058840	http://dx.doi.org/10.1371/journal.pone.0058840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527036	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600012
J	Dejean, A; Orivel, J; Rossi, V; Roux, O; Lauth, J; Male, PJG; Cereghino, R; Leroy, C				Dejean, Alain; Orivel, Jerome; Rossi, Vivien; Roux, Olivier; Lauth, Jeremie; Male, Pierre-Jean G.; Cereghino, Regis; Leroy, Celine			Predation Success by a Plant-Ant Indirectly Favours the Growth and Fitness of Its Host Myrmecophyte	PLOS ONE			English	Article							MUTUALISM; EVOLUTION; CONFLICT; CASTRATION; SANCTIONS; BEHAVIOR; BENEFITS; RATIOS; SEX	Mutualisms, or interactions between species that lead to net fitness benefits for each species involved, are stable and ubiquitous in nature mostly due to "byproduct benefits'' stemming from the intrinsic traits of one partner that generate an indirect and positive outcome for the other. Here we verify if myrmecotrophy (where plants obtain nutrients from the refuse of their associated ants) can explain the stability of the tripartite association between the myrmecophyte Hirtella physophora, the ant Allomerus decemarticulatus and an Ascomycota fungus. The plant shelters and provides the ants with extrafloral nectar. The ants protect the plant from herbivores and integrate the fungus into the construction of a trap that they use to capture prey; they also provide the fungus and their host plant with nutrients. During a 9-month field study, we over-provisioned experimental ant colonies with insects, enhancing colony fitness (i.e., more winged females were produced). The rate of partial castration of the host plant, previously demonstrated, was not influenced by the experiment. Experimental plants showed higher delta N-15 values (confirming myrmecotrophy), plus enhanced vegetative growth (e. g., more leaves produced increased the possibility of lodging ants in leaf pouches) and fitness (i.e., more fruits produced and more flowers that matured into fruit). This study highlights the importance of myrmecotrophy on host plant fitness and the stability of ant-myrmecophyte mutualisms.	[Dejean, Alain; Cereghino, Regis] Univ Toulouse, UPS, Ecolab, Toulouse, France; [Dejean, Alain; Orivel, Jerome; Lauth, Jeremie] CNRS, Ecol Forets Guyane UMR CNRS 8172, Kourou, France; [Rossi, Vivien] CIRAD, Ecofog UMR CIRAD 93, Kourou, France; [Roux, Olivier] IRD, Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Bobo Dioulasso, Burkina Faso; [Male, Pierre-Jean G.] CNRS, EDB UMR CNRS 5174, Toulouse, France; [Cereghino, Regis] CNRS, Lab Ecol Fonct UMR CNRS 5245, Toulouse, France; [Leroy, Celine] IRD, AMAP BotAn & BioinforMat Architecture Plantes, UMR IRD 123, Montpellier, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CIRAD; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Dejean, A (corresponding author), Univ Toulouse, UPS, Ecolab, Toulouse, France.	alain.dejean@wanadoo.fr	Rossi, Vivien/C-9721-2009; Leroy, Celine/I-4857-2016; Roux, Olivier/A-1181-2011; Male, Pierre-Jean G./A-7618-2010; Roux, Olivier/I-5675-2016	Rossi, Vivien/0000-0001-5458-1523; Leroy, Celine/0000-0003-4859-8040; Male, Pierre-Jean G./0000-0003-0896-726X; Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248; Cereghino, Regis/0000-0003-3981-3159; Roux, Olivier/0000-0001-5440-0219	French Labex CEBA(The laboratory of Excellence Centre for Studies of Amazonian Biodiversity), Tripartite associations and Plant Nutrition (Tri-Nutri)	French Labex CEBA(The laboratory of Excellence Centre for Studies of Amazonian Biodiversity), Tripartite associations and Plant Nutrition (Tri-Nutri)	This work was supported by the French Labex CEBA 2012 (The laboratory of Excellence Centre for Studies of Amazonian Biodiversity), Tripartite associations and Plant Nutrition (Tri-Nutri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Aron S, 2001, J ANIM ECOL, V70, P831, DOI 10.1046/j.0021-8790.2001.00545.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bono JM, 2003, P ROY SOC B-BIOL SCI, V270, P811, DOI 10.1098/rspb.2002.2287; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; CONNOR RC, 1995, BIOL REV, V70, P427, DOI 10.1111/j.1469-185X.1995.tb01196.x; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Dejean A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037683; Dejean A, 2012, NATURWISSENSCHAFTEN, V99, P265, DOI 10.1007/s00114-012-0895-3; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Douglas A.E., 2010, SYMBIOTIC HABIT; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Edwards DP, 2006, P ROY SOC B-BIOL SCI, V273, P595, DOI 10.1098/rspb.2005.3273; Frederickson ME, 2009, AM NAT, V173, P675, DOI 10.1086/597608; Gaume L, 2005, EVOL ECOL RES, V7, P435; Grangier J, 2008, NATURWISSENSCHAFTEN, V95, P909, DOI 10.1007/s00114-008-0398-4; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Holland J. Nathaniel, 2005, P17; Izzo TJ, 2002, OECOLOGIA, V133, P200, DOI 10.1007/s00442-002-1027-0; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Leimar O, 2003, DAHL WS ENV, P203; Leimar O, 2010, PHILOS T R SOC B, V365, P2619, DOI 10.1098/rstb.2010.0116; Leroy C, 2011, J ECOL, V99, P583, DOI 10.1111/j.1365-2745.2010.01763.x; Male PJG, 2012, EVOL ECOL, V26, P55, DOI 10.1007/s10682-011-9485-7; O'Keefe KJ, 2002, AM NAT, V159, P597, DOI 10.1086/339990; Orivel J, 2011, OECOLOGIA, V165, P369, DOI 10.1007/s00442-010-1739-5; Raine NE, 2002, ECOLOGY, V83, P3086, DOI 10.1890/0012-9658(2002)083[3086:SSAFAB]2.0.CO;2; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Ruiz-Gonzalez MX, 2011, BIOL LETTERS, V7, P475, DOI 10.1098/rsbl.2010.0920; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Szilagyi A, 2009, ECOL LETT, V12, P1306, DOI 10.1111/j.1461-0248.2009.01382.x; Thornham DG, 2012, FUNCT ECOL, V26, P11, DOI 10.1111/j.1365-2435.2011.01937.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Wilkinson DM, 2001, OIKOS, V92, P377, DOI 10.1034/j.1600-0706.2001.920222.x; Willmer PG, 2009, FUNCT ECOL, V23, P888, DOI 10.1111/j.1365-2435.2009.01632.x; Young TP, 1997, OECOLOGIA, V109, P98, DOI 10.1007/s004420050063; Yu DW, 1998, P ROY SOC B-BIOL SCI, V265, P375, DOI 10.1098/rspb.1998.0305	39	8	8	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59405	10.1371/journal.pone.0059405	http://dx.doi.org/10.1371/journal.pone.0059405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516632	gold, Green Submitted, Green Published			2022-12-27	WOS:000316407400109
J	Hansen, JT; Lyngso, C; Speerschneider, T; Hansen, PBL; Gales, C; Weiner, DM; Sheikh, SP; Burstein, ES; Hansen, JL				Hansen, Jonas Tind; Lyngso, Christina; Speerschneider, Tobias; Hansen, Pernille B. L.; Gales, Celine; Weiner, David M.; Sheikh, Soren P.; Burstein, Ethan S.; Hansen, Jakob Lerche			Functional Enhancement of AT1R Potency in the Presence of the TP alpha R Is Revealed by a Comprehensive 7TM Receptor Co-Expression Screen	PLOS ONE			English	Article							ANGIOTENSIN-II TYPE-1; THROMBOXANE RECEPTORS; DOPAMINE-RECEPTORS; AT(1); ACTIVATION; PHARMACOLOGY; HETERODIMERS; INHIBITION; FORM; MAS	Background: Functional cross-talk between seven transmembrane (7TM) receptors can dramatically alter their pharmacological properties, both in vitro and in vivo. This represents an opportunity for the development of novel therapeutics that potentially target more specific biological effects while causing fewer adverse events. Although several studies convincingly have established the existence of 7TM receptor cross-talk, little is known about the frequencey and biological significance of this phenomenon. Methodology/Principal Findings: To evaluate the extent of synergism in 7TM receptor signaling, we took a comprehensive approach and co-expressed 123 different 7TM receptors together with the angiotensin II type 1 receptor (AT1R) and analyzed how each receptor affected the angiotensin II (AngII) response. To monitor the effect we used integrative receptor activation/signaling assay called Receptor Selection and Amplification Technology (R-SAT). In this screen the thromboxane A2 alpha receptor (TP alpha R) was the only receptor which significantly enhanced the AngII-mediated response. The TP alpha R-mediated enhancement of AngII signaling was significantly reduced when a signaling deficient receptor mutant (TP alpha R R130V) was co-expressed instead of the wild-type TP alpha R, and was completely blocked both by TP alpha R antagonists and COX inhibitors inhibiting formation of thromboxane A(2) (TXA(2)). Conclusions/Significance: We found a functional enhancement of AT1R only when co-expressed with TP alpha R, but not with 122 other 7TM receptors. In addition, the TP alpha R must be functionally active, indicating the AT1R enhancement is mediated by a paracrine mechanism. Since we only found one receptor enhancing AT1R potency, our results suggest that functional augmentation through 7TM receptor cross-talk is a rare event that may require specific conditions to occur.	[Hansen, Jonas Tind; Lyngso, Christina; Speerschneider, Tobias; Hansen, Jakob Lerche] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Mol Cardiol Lab, Copenhagen, Denmark; [Hansen, Jonas Tind; Lyngso, Christina; Speerschneider, Tobias; Hansen, Jakob Lerche] Univ Copenhagen, Fac Hlth Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Hansen, Jonas Tind; Lyngso, Christina] Glostrup Cty Hosp, Dept Clin Biochem, Glostrup, Denmark; [Hansen, Pernille B. L.] Univ Southern Denmark, Odense C, Denmark; [Gales, Celine] Univ Toulouse III Paul Sabatier, Inst Natl Sante & Rech Med, Inst Malad Metabol & Cardiovasc I2MC, Toulouse, France; [Weiner, David M.] Proteostasis Therapeut Inc, Cambridge, MA USA; [Sheikh, Soren P.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Lab Mol & Cellular Cardiol, DK-5000 Odense, Denmark; [Burstein, Ethan S.] ACADIA Pharmaceut Inc, San Diego, CA USA; [Hansen, Jakob Lerche] Diabet NBEs & Obes Biol, Novo Nordisk, Maolov, Denmark	University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Southern Denmark; Odense University Hospital	Hansen, JL (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Mol Cardiol Lab, Copenhagen, Denmark.	JLHH@novonordisk.com		Hansen, Pernille B. Laerkegaard/0000-0003-0661-1665; GALES, Celine/0000-0002-4938-1583	Danish Council for Independent Research \ Medical Sciences; Danish National Research Foundation; Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat; Novo Nordisk Foundation	Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by The Danish Council for Independent Research vertical bar Medical Sciences, the Danish National Research Foundation, The Kobmand i Odense Johan og Hanne Weimann f. Seedorffs legat, and The Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Bachschmid M, 2003, FASEB J, V17, P914, DOI 10.1096/fj.02-0530fje; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Brauner-Osborne H, 1996, EUR J PHARMACOL, V295, P93, DOI 10.1016/0014-2999(95)00639-7; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Burstein ES, 2006, CURR PHARM DESIGN, V12, P1717, DOI 10.2174/138161206776873662; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Capra V, 2004, MOL PHARMACOL, V66, P880, DOI 10.1124/mol.104.001487; Castillo-Hernandez JR, 2004, VASC PHARMACOL, V41, P147, DOI 10.1016/j.vph.2004.08.002; Chien CC, 2009, J CELL PHYSIOL, V218, P405, DOI 10.1002/jcp.21613; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; de Lourdes Gonzalez-Hernandez M., 2010, Autonomic & Autacoid Pharmacology, V30, P167, DOI 10.1111/j.1474-8673.2009.00446.x; Espanol AJ, 2010, INFLAMM RES, V59, P227, DOI 10.1007/s00011-009-0097-4; Francois H, 2004, HYPERTENSION, V43, P364, DOI 10.1161/01.HYP.0000112225.27560.24; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hansen JL, 2009, J BIOL CHEM, V284, P1831, DOI 10.1074/jbc.M804607200; Hansen JL, 2008, EUR J PHARMACOL, V590, P255, DOI 10.1016/j.ejphar.2008.05.010; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Karip E, 2007, NEUROCHEM INT, V51, P261, DOI 10.1016/j.neuint.2007.05.018; Kawada N, 2004, AM J PHYSIOL-RENAL, V287, pF753, DOI 10.1152/ajprenal.00423.2003; KELNER MJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P240, DOI 10.1006/abbi.1994.1305; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Lyngso C, 2009, MOL CELL ENDOCRINOL, V302, P203, DOI 10.1016/j.mce.2008.09.018; Miggin SM, 1998, BBA-GEN SUBJECTS, V1425, P543, DOI 10.1016/S0304-4165(98)00109-3; Milligan G, 2006, DRUG DISCOV TODAY, V11, P541, DOI 10.1016/j.drudis.2006.04.007; Oro C, 2007, PHARMACOL THERAPEUT, V113, P210, DOI 10.1016/j.pharmthera.2006.10.001; Pedersen SF, 2006, AM J PHYSIOL-CELL PH, V291, pC1286, DOI 10.1152/ajpcell.00325.2005; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Santos EL, 2007, REGUL PEPTIDES, V141, P159, DOI 10.1016/j.regpep.2006.12.030; Sauliere A, 2012, NAT CHEM BIOL; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; SMITH EF, 1981, J CARDIOVASC PHARM, V3, P791, DOI 10.1097/00005344-198107000-00012; Sparks MA, 2013, HYPERTENSION, V61, P166, DOI 10.1161/HYPERTENSIONAHA.112.193250; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Turu G, 2009, J BIOL CHEM, V284, P16914, DOI 10.1074/jbc.M109.003681; Weiner DM, 2001, J PHARMACOL EXP THER, V299, P268; Wilcox CS, 1996, AM J PHYSIOL-REG I, V271, pR891, DOI 10.1152/ajpregu.1996.271.4.R891; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zeng CY, 2005, HYPERTENSION, V45, P804, DOI 10.1161/01.HYP.0000155212.33212.99; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E; Zeng CY, 2003, HYPERTENSION, V41, P724, DOI 10.1161/01.HYP.0000047880.78462.0E	51	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58890	10.1371/journal.pone.0058890	http://dx.doi.org/10.1371/journal.pone.0058890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516570	Green Submitted, gold, Green Published			2022-12-27	WOS:000316407400073
J	Bisseleua, HBD; Fotio, D; Yede; Missoup, AD; Vidal, S				Bisseleua, Herve Bertin Daghela; Fotio, Daniel; Yede; Missoup, Alain Didier; Vidal, Stefan			Shade Tree Diversity, Cocoa Pest Damage, Yield Compensating Inputs and Farmers' Net Returns in West Africa	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; BIODIVERSITY CONSERVATION; AGROFORESTRY SYSTEMS; CACAO AGROFORESTS; SPECIES RICHNESS; THEOBROMA-CACAO; BIRDS; ANTS; HYMENOPTERA; CULTIVATION	Cocoa agroforests can significantly support biodiversity, yet intensification of farming practices is degrading agroforestry habitats and compromising ecosystem services such as biological pest control. Effective conservation strategies depend on the type of relationship between agricultural matrix, biodiversity and ecosystem services, but to date the shape of this relationship is unknown. We linked shade index calculated from eight vegetation variables, with insect pests and beneficial insects (ants, wasps and spiders) in 20 cocoa agroforests differing in woody and herbaceous vegetation diversity. We measured herbivory and predatory rates, and quantified resulting increases in cocoa yield and net returns. We found that number of spider webs and wasp nests significantly decreased with increasing density of exotic shade tree species. Greater species richness of native shade tree species was associated with a higher number of wasp nests and spider webs while species richness of understory plants did not have a strong impact on these beneficial species. Species richness of ants, wasp nests and spider webs peaked at higher levels of plant species richness. The number of herbivore species (mirid bugs and cocoa pod borers) and the rate of herbivory on cocoa pods decreased with increasing shade index. Shade index was negatively related to yield, with yield significantly higher at shade and herb covers < 50%. However, higher inputs in the cocoa farms do not necessarily result in a higher net return. In conclusion, our study shows the importance of a diverse shade canopy in reducing damage caused by cocoa pests. It also highlights the importance of conservation initiatives in tropical agroforestry landscapes.	[Bisseleua, Herve Bertin Daghela] MDG Ctr West & Cent Afr, Dakar, Senegal; [Bisseleua, Herve Bertin Daghela; Fotio, Daniel; Yede; Missoup, Alain Didier] IRAD, Entomol Lab, Yaounde, Cameroon; [Bisseleua, Herve Bertin Daghela; Vidal, Stefan] Univ Gottingen, Dept Crop Sci, Entomol Sect, D-37073 Gottingen, Germany; [Bisseleua, Herve Bertin Daghela] Columbia Univ, Earth Inst, Ctr Environm Res & Conservat, New York, NY USA	University of Gottingen; Columbia University	Bisseleua, HBD (corresponding author), MDG Ctr West & Cent Afr, Dakar, Senegal.	herve.bisseleua@mdgwca.org	Vidal, Stefan/AAC-3130-2020	Vidal, Stefan/0000-0002-1673-4055	Georg-August University of Goettingen (Dept of Crop Sciences, Entomological section)	Georg-August University of Goettingen (Dept of Crop Sciences, Entomological section)	Financial support was provided by Georg-August University of Goettingen (Dept of Crop Sciences, Entomological section). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisseleua DHB, 2011, ENVIRON ENTOMOL, V40, P111, DOI 10.1603/EN09101; Bisseleua DHB, 2009, CONSERV BIOL, V23, P1176, DOI 10.1111/j.1523-1739.2009.01220.x; Bobo KS, 2006, BIODIVERS CONSERV, V15, P4097, DOI 10.1007/s10531-005-3368-6; Bos MM, 2008, BIOL INVASIONS, V10, P1399, DOI 10.1007/s10530-008-9215-4; Bos MM, 2007, BIODIVERS CONSERV, V16, P2429, DOI 10.1007/s10531-007-9196-0; Cassano CR, 2009, BIODIVERS CONSERV, V18, P577, DOI 10.1007/s10531-008-9526-x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Cicuzza D, 2011, BIOTROPICA, P1, DOI [10.1111/j.1744-7429.2010.00741x, DOI 10.1111/J.1744-7429.2010.00741X]; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Clough Y, 2009, CONSERV LETT, V2, P197, DOI 10.1111/j.1755-263X.2009.00072.x; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; COLWELL RK, 2006, ESTIMATES S STAT EST; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Duguma B, 2001, AGROFOREST SYST, V51, P177, DOI 10.1023/A:1010747224249; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Greenberg R, 2000, ANIM CONSERV, V3, P105, DOI 10.1111/j.1469-1795.2000.tb00235.x; Herve BD, 2008, BIODIVERS CONSERV, V17, P1821, DOI 10.1007/s10531-007-9276-1; Jagoret P, 2009, BIOTECH AGRO SOC ENV, V12, P367; Klein AM, 2006, J ANIM ECOL, V75, P315, DOI 10.1111/j.1365-2656.2006.01042.x; Laird SA, 2007, BIODIVERS CONSERV, V16, P2401, DOI 10.1007/s10531-007-9188-0; Laube I, 2008, J ORNITHOL, V149, P181, DOI 10.1007/s10336-007-0258-6; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Ndoye O, 2000, J MOD AFR STUD, V38, P225, DOI 10.1017/S0022278X00003347; Norgrove L, 2009, TROP ECOL, V50, P71; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Philpott SM, 2005, BIOTROPICA, V37, P468, DOI 10.1111/j.1744-7429.2005.00063.x; Philpott SM, 2004, OECOLOGIA, V140, P140, DOI 10.1007/s00442-004-1561-z; Philpott SM, 2008, BIODIVERS CONSERV, V17, P1805, DOI 10.1007/s10531-007-9267-2; Philpott SM, 2006, ECOL ENTOMOL, V31, P369, DOI 10.1111/j.1365-2311.2006.00793.x; Rice RA, 2000, AMBIO, V29, P167, DOI 10.1579/0044-7447-29.3.167; Schroth G, 2004, AGROFORESTRY BIODIVE; See YA, 1996, B ENTOMOL RES, V86, P467, DOI 10.1017/S0007485300035045; Snoeck D, 2010, AGROFOREST SYST, V78, P323, DOI 10.1007/s10457-009-9254-6; Sonwa DJ, 2007, BIODIVERS CONSERV, V16, P2385, DOI 10.1007/s10531-007-9187-1; Sperber CF, 2004, BASIC APPL ECOL, V5, P241, DOI 10.1016/j.baae.2004.04.001; SPSS Inc, 2000, SYST 11 WIND; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Sunderlin WD, 2000, ENVIRON CONSERV, V27, P284, DOI 10.1017/S0376892900000321; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Wielgoss A, 2010, AGR ECOSYST ENVIRON, V135, P253, DOI 10.1016/j.agee.2009.10.003; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zapfack L, 2002, BIODIVERS CONSERV, V11, P2047, DOI 10.1023/A:1020861925294	45	42	43	3	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56115	10.1371/journal.pone.0056115	http://dx.doi.org/10.1371/journal.pone.0056115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520451	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900010
J	Casolaro, A; Golay, J; Albanese, C; Ceruti, R; Patton, V; Cribioli, S; Pezzoni, A; Losa, M; Texido, G; Giussani, U; Marchesi, F; Amboldi, N; Valsasina, B; Bungaro, S; Cazzaniga, G; Rambaldi, A; Introna, M; Pesenti, E; Alzani, R				Casolaro, Alessia; Golay, Josee; Albanese, Clara; Ceruti, Roberta; Patton, Veronica; Cribioli, Sabrina; Pezzoni, Alice; Losa, Marco; Texido, Gemma; Giussani, Ursula; Marchesi, Francesco; Amboldi, Nadia; Valsasina, Barbara; Bungaro, Silvia; Cazzaniga, Gianni; Rambaldi, Alessandro; Introna, Martino; Pesenti, Enrico; Alzani, Rachele			The Polo-Like Kinase 1 (PLK1) Inhibitor NMS-P937 Is Effective in a New Model of Disseminated Primary CD56(+) Acute Monoblastic Leukaemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; COPY-NUMBER ALTERATIONS; IN-VIVO; XENOGRAFT MODELS; SCID MICE; EXPRESSION; MOUSE; CELLS; AML	CD56 is expressed in 15-20% of acute myeloid leukaemias (AML) and is associated with extramedullary diffusion, multidrug resistance and poor prognosis. We describe the establishment and characterisation of a novel disseminated model of AML (AML-NS8), generated by injection into mice of leukaemic blasts freshly isolated from a patient with an aggressive CD56(+) monoblastic AML (M5a). The model reproduced typical manifestations of this leukaemia, including presence of extramedullary masses and central nervous system involvement, and the original phenotype, karyotype and genotype of leukaemic cells were retained in vivo. Recently Polo-Like Kinase 1 (PLK1) has emerged as a new candidate drug target in AML. We therefore tested our PLK1 inhibitor NMS-P937 in this model either in the engraftment or in the established disease settings. Both schedules showed good efficacy compared to standard therapies, with a significant increase in median survival time (MST) expecially in the established disease setting (MST = 28, 36, 62 days for vehicle, cytarabine and NMS-P937, respectively). Importantly, we could also demonstrate that NMS-P937 induced specific biomarker modulation in extramedullary tissues. This new in vivo model of CD56(+) AML that recapitulates the human tumour lends support for the therapeutic use of PLK1 inhibitors in AML.	[Casolaro, Alessia; Albanese, Clara; Ceruti, Roberta; Patton, Veronica; Cribioli, Sabrina; Texido, Gemma; Amboldi, Nadia; Valsasina, Barbara; Pesenti, Enrico; Alzani, Rachele] Nerviano Med Sci, Milan, Italy; [Golay, Josee; Rambaldi, Alessandro; Introna, Martino] Osped Riuniti Bergamo, Lab Cellular Therapy G Lanzani, USC Haematol, I-24100 Bergamo, Italy; [Pezzoni, Alice] Ist Clin Humanitas, Dept Haematol & Oncol, Milan, Italy; [Losa, Marco] Fdn Filarete, Milan, Italy; [Giussani, Ursula] Osped Riuniti Bergamo, Dept Med Genet, I-24100 Bergamo, Italy; [Marchesi, Francesco] Accelera Srl, Milan, Italy; [Bungaro, Silvia; Cazzaniga, Gianni] Univ Milano Bicocca, Pediat Clin, Tettamanti Res Ctr, Monza, Italy	Nerviano Medical Sciences S.r.l; Ospedali Riuniti di Bergamo; IRCCS Humanitas Research Hospital; Ospedali Riuniti di Bergamo; University of Milano-Bicocca	Alzani, R (corresponding author), Nerviano Med Sci, Milan, Italy.	rachele.alzani@nervianoms.com	Rambaldi, Alessandro/P-2603-2018; Golay, Josee/AAA-4085-2022; Rambaldi, Alessandro/M-6172-2019; Marchesi, Francesco/ABF-9255-2021; Introna, Martino/AAA-5823-2019; Cazzaniga, Giovanni/K-6338-2016	Rambaldi, Alessandro/0000-0002-3739-7502; Golay, Josee/0000-0002-7932-909X; Rambaldi, Alessandro/0000-0002-3739-7502; Marchesi, Francesco/0000-0003-1179-5788; Introna, Martino/0000-0001-6216-0892; Cazzaniga, Giovanni/0000-0003-2955-4528				Appelbaum FR, 2007, BLOOD, V109, P1810, DOI 10.1182/blood-2006-08-041152; Baer MR, 1997, BLOOD, V90, P1643, DOI 10.1182/blood.V90.4.1643.1643_1643_1648; Bardini M, 2011, LEUKEMIA, V25, P175, DOI 10.1038/leu.2010.232; Berg T, 2012, EXPERT OPIN INV DRUG, V21, P1069, DOI 10.1517/13543784.2012.691163; Beria I, 2011, BIOORG MED CHEM LETT, V21, P2969, DOI 10.1016/j.bmcl.2011.03.054; Blair A, 1997, BLOOD, V89, P3104, DOI 10.1182/blood.V89.9.3104; CESANO A, 1992, ONCOGENE, V7, P827; Chang H, 2004, LEUKEMIA RES, V28, P1007, DOI 10.1016/j.leukres.2004.01.006; Cucchi U, 2010, ANTICANCER RES, V30, P4973; Delgado J, 2002, AM J HEMATOL, V69, P28, DOI 10.1002/ajh.10012; Di Bona E, 2002, HAEMATOLOGICA, V87, P250; Dohner H, 2011, HEMATOL-AM SOC HEMAT, P36, DOI 10.1182/asheducation-2011.1.36; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gattenloehner S, 2007, BLOOD, V110, P2027, DOI 10.1182/blood-2007-02-074203; GIAVAZZI R, 1995, INT J CANCER, V61, P280, DOI 10.1002/ijc.2910610223; Golay J, 2005, BRIT J HAEMATOL, V128, P310, DOI 10.1111/j.1365-2141.2004.05322.x; Greif PA, 2011, LEUKEMIA, V25, P821, DOI 10.1038/leu.2011.19; Ikezoe T, 2009, LEUKEMIA, V23, P1564, DOI 10.1038/leu.2009.94; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee EM, 2007, LEUKEMIA LYMPHOMA, V48, P659, DOI 10.1080/10428190601113584; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li ZJ, 2006, EUR J HAEMATOL, V77, P128, DOI 10.1111/j.1600-0609.2006.00686.x; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; McInnes C, 2011, DRUG DISCOV TODAY, V16, P619, DOI 10.1016/j.drudis.2011.05.002; Novotny JR, 2006, EUR J HAEMATOL, V76, P299, DOI 10.1111/j.1600-0609.2005.00607.x; Radaelli E, 2009, HISTOL HISTOPATHOL, V24, P879, DOI 10.14670/HH-24.879; Raspadori D, 2001, LEUKEMIA, V15, P1161, DOI 10.1038/sj.leu.2402174; Ravandi F, 2002, LEUKEMIA RES, V26, P643, DOI 10.1016/S0145-2126(01)00188-6; Renner AG, 2009, BLOOD, V114, P659, DOI 10.1182/blood-2008-12-195867; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Suela J, 2007, LEUKEMIA, V21, P1224, DOI 10.1038/sj.leu.2404653; Swerdlow SH, 2008, WHO CLASSIFICATION T, V2, P91; Tsykunova G, 2012, EXPERT OPIN INV DRUG, V21, P587, DOI 10.1517/13543784.2012.668525; Valsasina B, 2012, MOL CANCER THER, V11, P1006, DOI 10.1158/1535-7163.MCT-11-0765; Vilas-Zornoza A, 2012, LEUKEMIA, V26, P1517, DOI 10.1038/leu.2012.31; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	38	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58424	10.1371/journal.pone.0058424	http://dx.doi.org/10.1371/journal.pone.0058424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520509	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000318679900068
J	Ishikawa, Y; Fukui, S; Saito, T; Fujita, J; Watanabe, M; Yoshiuchi, K				Ishikawa, Yoshiki; Fukui, Sakiko; Saito, Toshiya; Fujita, Junko; Watanabe, Minako; Yoshiuchi, Kazuhiro			Family Preference for Place of Death Mediates the Relationship between Patient Preference and Actual Place of Death: A Nationwide Retrospective Cross-Sectional Study	PLOS ONE			English	Article							ILL CANCER-PATIENTS; QUALITY-OF-LIFE; PREFERRED PLACE; HOME; PREDICTORS; CONGRUENCE; CAREGIVERS; AGREEMENT; KAPPA	Background: Discrepancy between preferred and actual place of death is common in cancer patients. While previous research has elucidated the factors associated with congruence between patients' preferred and actual place of death, it is not known how the perspective of the family influences the place of death. This study examined whether family preference for place of death mediates the relationship between patient preference and actual place of death. Methods: A total of 258 cancer patients (home death, n = 142; hospital death, n = 116) who had received terminal care in Japan were analyzed. Measures included patients' demographic variables, patient and family preferences for place for death, actual place of death, patients' functional status, use and intensity of home care, availability of inpatient bed, living arrangement, and amount of extended family support. Results: Patient-family congruence on preferred place of death was 66% in patients who died at home and 47% in patients who died at other places (kappa coefficient: 0.20 and 0.25, respectively). In a multiple logistic regression model, patients were more likely to die at home when patients were male (odds ratio [OR], 95% confidence interval [CI]: 2.53, 1.06-6.05) and when their family preferred death at home (OR, 95% CI: 37.37, 13.82-101.03). A Sobel test revealed that family preference mediated the relationship between patient preference and place of death (p<0.05). Conclusions: This study is, to our knowledge, the first to unveil the role of the family in the relationship between patient preference and place of death in Japan. In order to honor patients' wishes to die at home, supporting caregivers in the family may be an essential component of terminal care.	[Ishikawa, Yoshiki] Jichi Med Univ, Dept Publ Hlth, Shimotuke, Tochigi, Japan; [Ishikawa, Yoshiki; Saito, Toshiya] Canc Scan, Shibuya Ku, Tokyo, Japan; [Fukui, Sakiko; Fujita, Junko] Japanese Red Cross Univ, Grad Sch Nursing, Dept Community Hlth Nursing, Shibuya Ku, Tokyo, Japan; [Watanabe, Minako] Ibaraki Christian Univ, Dept Nursing, Hitachi, Ibaraki, Japan; [Yoshiuchi, Kazuhiro] Univ Tokyo, Grad Sch Med, Dept Stress Sci & Psychosomat Med, Bunkyo Ku, Tokyo, Japan	Jichi Medical University; University of Tokyo	Fukui, S (corresponding author), Japanese Red Cross Univ, Grad Sch Nursing, Dept Community Hlth Nursing, Shibuya Ku, Tokyo, Japan.	sfukui@redcross.ac.jp			Japanese Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [24660061] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Special Research Grant from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bell CL, 2009, PALLIATIVE MED, V23, P482, DOI 10.1177/0269216309106318; Bell CL, 2010, J PAIN SYMPTOM MANAG, V39, P591, DOI 10.1016/j.jpainsymman.2009.07.007; Costantini M, 2008, PALLIATIVE MED, V22, P785, DOI 10.1177/0269216308096424; Dilworth-Anderson P, 2002, GERONTOLOGIST, V42, P237, DOI 10.1093/geront/42.2.237; Donovan R, 2011, SOC SCI MED, V72, P338, DOI 10.1016/j.socscimed.2010.10.010; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Foreman LM, 2006, PALLIATIVE MED, V20, P447, DOI 10.1191/0269216306pm1149oa; Fukui S, 2004, CANCER-AM CANCER SOC, V101, P421, DOI 10.1002/cncr.20383; Fukui S., 2012, SOCIAL SECURITY REV, V2488, P16; Fukui S, 2011, INT J NURS STUD, V48, P1393, DOI 10.1016/j.ijnurstu.2011.05.001; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lebra TS., 1976, JAPANESE PATTERNS BE, DOI [10.1515/9780824846404, DOI 10.1515/9780824846404]; Munday D, 2007, J ROY SOC MED, V100, P211, DOI 10.1258/jrsm.100.5.211; Murray MA, 2009, ONCOL NURS FORUM, V36, P69, DOI 10.1188/09.ONF.69-77; Nakamura S, 2010, GERIATR GERONTOL INT, V10, P154, DOI 10.1111/j.1447-0594.2009.00570.x; Tang ST, 2008, PSYCHO-ONCOLOGY, V17, P1202, DOI 10.1002/pon.1343; Tang ST, 2005, SOC SCI MED, V61, P1560, DOI 10.1016/j.socscimed.2005.02.006; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	22	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56848	10.1371/journal.pone.0056848	http://dx.doi.org/10.1371/journal.pone.0056848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520458	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900017
J	Wang, L; Fan, J; Chen, SQ; Zhang, Y; Curiel, TJ; Zhang, B				Wang, Long; Fan, Jie; Chen, Siqi; Zhang, Yi; Curiel, Tyler J.; Zhang, Bin			Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ECTO-5'-NUCLEOTIDASE CD73; ADENOSINE GENERATION; TARGETED DISRUPTION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; TUMOR-GROWTH; TRANSPLANTATION; LYMPHOCYTES; EXPRESSION	CD73 functions as an ecto-5-nucleotidase to produce extracellular adenosine that has anti-inflammatory and immunosuppressive activity. We here demonstrate that CD73 helps control graft-versus-host disease (GVHD) in mouse models. Survival of wild-type (WT) recipients of either allogeneic donor naive CD73 knock-out (KO) or WT T cells was similar suggesting that donor naive T cell CD73 did not contribute to GVHD. By contrast, donor CD73 KO CD4(+)CD25(+) regulatory T cells (Treg) had significantly impaired ability to mitigate GVHD mortality compared to WT Treg, suggesting that CD73 on Treg is critical for GVHD protection. However, compared to donor CD73, recipient CD73 is more effective in limiting GVHD. Pharmacological blockade of A2A receptor exacerbated GVHD in WT recipients, but not in CD73 KO recipients, suggesting that A2 receptor signaling is primarily implicated in CD73-mediated GVHD protection. Moreover, pharmacological blockade of CD73 enzymatic activity induced stronger alloreactive T cell activity, worsened GVHD and enhanced the graft-versusleukemia (GVL) effect. These findings suggest that both donor and recipient CD73 protects against GVHD but also limits GVL effects. Thus, either enhancing or blocking CD73 activity has great potential clinical application in allogeneic bone marrow transplants.	[Wang, Long; Curiel, Tyler J.; Zhang, Bin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Fan, Jie; Chen, Siqi; Zhang, Bin] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med,Div Hematol Oncol, Chicago, IL 60611 USA; [Zhang, Yi; Zhang, Bin] Zhengzhou Univ, Affiliated Hosp 1, Ctr Cell Biotherapy, Dept Bioengn, Zhengzhou, Henan Province, Peoples R China	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Zhengzhou University	Zhang, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA.	bin.zhang@northwestern.edu	Chen, Siqi/AAJ-1568-2020	Chen, Siqi/0000-0002-9498-3823; Zhang, Yi/0000-0001-9861-4681	National Institutes of Health [CA149669]; Liz Tilberis Scholar Award, CTSA [UL1RR025767]; National Natural Science Foundation of China [81171985, 81171986]; Cancer Therapy and Research Center [2P30 CA054174-17]; Hayes and Voelcker Endowments; Holly Beach Public Library Association; Texas STARS Award; Hogg Foundation; Owens Foundation; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA149669] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Liz Tilberis Scholar Award, CTSA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Therapy and Research Center; Hayes and Voelcker Endowments; Holly Beach Public Library Association; Texas STARS Award; Hogg Foundation; Owens Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was in part supported by National Institutes of Health grant CA149669, Liz Tilberis Scholar Award, CTSA grant (UL1RR025767), the National Natural Science Foundation of China (No. 81171985) (BZ), and the Cancer Therapy and Research Center (2P30 CA054174-17) (BZ, TJC); the Hayes and Voelcker Endowments, the Holly Beach Public Library Association, Texas STARS Award, The Hogg Foundation and the Owens Foundation (TJC); the National Natural Science Foundation of China (No. 81171986) (YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas L, 1996, BLOOD, V88, P1755, DOI 10.1182/blood.V88.5.1755.bloodjournal8851755; Airas L, 2000, J IMMUNOL, V165, P5411, DOI 10.4049/jimmunol.165.10.5411; Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Alam MS, 2009, J INFECT DIS, V199, P494, DOI 10.1086/596205; Algars A, 2011, BLOOD, V117, P4387, DOI 10.1182/blood-2010-11-321646; Antonioli L, 2011, EUR J PHARMACOL, V650, P639, DOI 10.1016/j.ejphar.2010.10.041; Chen BJ, 2004, BLOOD, V103, P1534, DOI 10.1182/blood-2003-08-2987; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Ferrara J L, 1999, Biol Blood Marrow Transplant, V5, P347, DOI 10.1016/S1083-8791(99)70011-X; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; Holler E, 2002, CURR OPIN HEMATOL, V9, P479, DOI 10.1097/00062752-200211000-00002; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Lappas CM, 2010, J LEUKOCYTE BIOL, V87, P345, DOI 10.1189/jlb.0609388; Liang Y, 2008, BLOOD, V111, P954, DOI 10.1182/blood-2007-05-089573; Louis NA, 2008, J IMMUNOL, V180, P4246, DOI 10.4049/jimmunol.180.6.4246; Mikhailov A, 2008, J IMMUNOL, V181, P464, DOI 10.4049/jimmunol.181.1.464; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Ohtsuka T, 2010, J IMMUNOL, V185, P1321, DOI 10.4049/jimmunol.0901847; Regateiro FS, 2011, EUR J IMMUNOL; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Robson SC, 2005, SEMIN THROMB HEMOST, V31, P217, DOI 10.1055/s-2005-869527; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Salcido-Ochoa F, 2010, TRANSPLANT REV-ORLAN, V24, P52, DOI 10.1016/j.trre.2010.01.002; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; THOMSON LF, 1990, TISSUE ANTIGENS, V35, P9, DOI 10.1111/j.1399-0039.1990.tb01750.x; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Tsukamoto H, 2012, BLOOD, V119, P4554, DOI 10.1182/blood-2011-09-375899; van den Brink MRM, 2002, NAT REV IMMUNOL, V2, P273, DOI 10.1038/nri775; Wang L, 2011, J CLIN INVEST, V121, P2371, DOI 10.1172/JCI45559; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yamashita Y, 1998, EUR J IMMUNOL, V28, P2981, DOI 10.1002/(SICI)1521-4141(199810)28:10<2981::AID-IMMU2981>3.0.CO;2-D; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2011, EUR J IMMUNOL, V41, P1231, DOI 10.1002/eji.201041292; Zhang B, 2010, CANCER RES, V70, P6407, DOI 10.1158/0008-5472.CAN-10-1544	53	32	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58397	10.1371/journal.pone.0058397	http://dx.doi.org/10.1371/journal.pone.0058397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520507	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900066
J	Wang, SY; Peng, LB; Li, JH; Zeng, XH; Ouyang, LH; Tan, CQ; Lu, Q				Wang, Siying; Peng, Liubao; Li, Jianhe; Zeng, Xiaohui; Ouyang, Lihui; Tan, Chongqing; Lu, Qiong			A Trial-Based Cost-Effectiveness Analysis of Erlotinib Alone versus Platinum-Based Doublet Chemotherapy as First-Line Therapy for Eastern Asian Nonsquamous Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-III TRIAL; 2ND-LINE TREATMENT; ECONOMIC-EVALUATION; CLINICAL-TRIALS; GENE-MUTATIONS; OPEN-LABEL; GEFITINIB; EGFR; COMBINATION	Introduction: Lung cancer, the most prevalent malignant cancer in the world, remains a serious threat to public health. Recently, a large number of studies have shown that an epidermoid growth factor receptor-tyrosine kinase inhibitor (EGFR TKI), Erlotinib, has significantly better efficacy and is better tolerated in advanced non-small cell lung cancer (NSCLC) patients with a positive EGFR gene mutation. However, access to this drug is severely limited in China due to its high acquisition cost. Therefore, we decided to conduct a study to compare cost-effectiveness between erlotinib monotherapy and carboplatin-gemcitabine (CG) combination therapy in patients with advanced EGFR mutation-positive NSCLC. Methods: A Markov model was developed from the perspective of the Chinese health care system to evaluate the cost-effectiveness of the two treatment strategies; this model was based on data from the OPTIMAL trial, which was undertaken at 22 centres in China. The 10-year quality-adjusted life years (QALYs), direct costs, and incremental cost-effectiveness ratio (ICER) were estimated. To allow for uncertainties within the parameters and to estimate the model robustness, one-way sensitivity analysis and probabilistic sensitivity analysis were performed. Results: The median progression-free survival (PFS) obtained from Markov model was 13.2 months (13.1 months was reported in the trial) in the erlotinib group while and 4.64 months (4.6 months was reported in the trial) in the CG group. The QALYs were 1.4 years in the erlotinib group and 1.96 years in the CG group, indicating difference of 0.56 years. The ICER was most sensitive to the health utility of DP ranged from $58,584.57 to $336,404.2. At a threshold of $96,884, erlotinib had a 50% probability of being cost-effective. Conclusions: Erlotinib monotherapy is more cost-effective compared with platinum-based doublets chemotherapy as a first-line therapy for advanced EGFR mutation-positive NSCLC patients from within the Chinese health care system.	[Wang, Siying; Peng, Liubao; Li, Jianhe; Zeng, Xiaohui; Ouyang, Lihui; Tan, Chongqing; Lu, Qiong] Cent S Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China; [Wang, Siying; Li, Jianhe; Zeng, Xiaohui; Ouyang, Lihui; Tan, Chongqing] Cent S Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China	Central South University; Central South University	Peng, LB (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China.	pengliubao@126.com			China National Natural Science Funds [81176028]	China National Natural Science Funds(National Natural Science Foundation of China (NSFC))	China National Natural Science Funds, Grant No. 81176028, supported the authors' data collection and analysis, and decision to publish.	Bongers ML, 2012, PHARMACOECONOMICS, V30, P17, DOI 10.2165/11595000-000000000-00000; Borget I, 2012, EUR RESPIR J, V39, P172, DOI 10.1183/09031936.00201210; Bradbury PA, 2010, JNCI-J NATL CANCER I, V102, P298, DOI 10.1093/jnci/djp518; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Carlson JJ, 2008, LUNG CANCER, V61, P405, DOI 10.1016/j.lungcan.2007.12.023; Carlson Josh J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P409, DOI 10.1586/erp.09.49; Carlson JJ, 2009, VALUE HEALTH, V12, P20, DOI 10.1111/j.1524-4733.2008.00415.x; Chan SK, 2006, EUR J CANCER, V42, P17, DOI 10.1016/j.ejca.2005.07.031; CHEN YM, 2011, J EXP CLIN MED, V3, P116; China Center for Health Economic Research, CHIN GUID PHARM EV V; Chouaid C, 2012, 0505 GFPC, DOI DOI 10.1016/J.CLLC.2012.04.006; Chouaid C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-301; Cromwell I, 2012, LUNG CANCER, V76, P472, DOI 10.1016/j.lungcan.2011.12.003; Cromwell I, 2011, J THORAC ONCOL, V6, P2097, DOI 10.1097/JTO.0b013e31822f657a; Doral Stefani Stephen, 2008, J Med Econ, V11, P383, DOI 10.3111/13696990802208186; Doyle S, 2008, LUNG CANCER, V62, P374, DOI 10.1016/j.lungcan.2008.03.019; Dragnev KH, 2011, CANCER PREV RES, V4, P818, DOI 10.1158/1940-6207.CAPR-10-0376; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fragoulakis VF, 2012, LUNG CANCER-TARGETS, V3, P43, DOI 10.2147/LCTT.S33608; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Giaccone G, 2005, J CLIN ONCOL, V23, P7073; Goffin J, 2010, J THORAC ONCOL, V5, P260, DOI 10.1097/JTO.0b013e3181c6f035; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Lewis G, 2010, J INT MED RES, V38, P9, DOI 10.1177/147323001003800102; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Lyseng-Williamson KA, 2010, PHARMACOECONOMICS, V28, P75, DOI 10.2165/10482880-000000000-00000; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Nafees B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-84; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paz-Ares L, 2006, J CLIN ONCOL, V24, P7020, DOI DOI 10.1200/jco.2006.24.18_suppl.7020; Peasgood T, 2009, OSTEOPOROSIS INT, V20, P853, DOI 10.1007/s00198-009-0844-y; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Scagliotti G, 2011, J THORAC ONCOL, V6, P64, DOI 10.1097/JTO.0b013e3181f7c6d4; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller J, 2004, LUNG CANCER, V43, P101, DOI 10.1016/j.lungcan.2003.06.003; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Vergnenegre A, 2012, CLINICOECONOMIC OUTC, V4, P31, DOI 10.2147/CEOR.S25923; Walleser S, 2012, CLINICOECONOMIC OUTC, V4, P269, DOI 10.2147/CEOR.S31794; Wu B, 2012, CLIN THER, V34, P468, DOI 10.1016/j.clinthera.2012.01.012; Wu B, 2011, CLIN THER, V33, P1446, DOI 10.1016/j.clinthera.2011.09.016; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Zeng XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048323; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	55	35	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e55917	10.1371/journal.pone.0055917	http://dx.doi.org/10.1371/journal.pone.0055917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520448	gold, Green Submitted, Green Published			2022-12-27	WOS:000318679900007
J	Wozniak, MB; Le Calvez-Kelm, F; Abedi-Ardekani, B; Byrnes, G; Durand, G; Carreira, C; Michelon, J; Janout, V; Holcatova, I; Foretova, L; Brisuda, A; Lesueur, F; McKay, J; Brennan, P; Scelo, G				Wozniak, Magdalena B.; Le Calvez-Kelm, Florence; Abedi-Ardekani, Behnoush; Byrnes, Graham; Durand, Geoffroy; Carreira, Christine; Michelon, Jocelyne; Janout, Vladimir; Holcatova, Ivana; Foretova, Lenka; Brisuda, Antonin; Lesueur, Fabienne; McKay, James; Brennan, Paul; Scelo, Ghislaine			Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States	PLOS ONE			English	Article							KIDNEY CANCER; DIFFERENTIAL EXPRESSION; BETA-CATENIN; RNA-SEQ; IDENTIFICATION; SURVIVAL; TUMOR; MICROARRAY; SIGNATURES; VHL	Gene expression microarray and next generation sequencing efforts on conventional, clear cell renal cell carcinoma (ccRCC) have been mostly performed in North American and Western European populations, while the highest incidence rates are found in Central/Eastern Europe. We conducted whole-genome expression profiling on 101 pairs of ccRCC tumours and adjacent non-tumour renal tissue from Czech patients recruited within the "K2 Study'', using the Illumina HumanHT-12 v4 Expression BeadChips to explore the molecular variations underlying the biological and clinical heterogeneity of this cancer. Differential expression analysis identified 1650 significant probes (fold change >= 2 and false discovery rate <0.05) mapping to 630 up- and 720 down-regulated unique genes. We performed similar statistical analysis on the RNA sequencing data of 65 ccRCC cases from the Cancer Genome Atlas (TCGA) project and identified 60% (402) of the downregulated and 74% (469) of the upregulated genes found in the K2 series. The biological characterization of the significantly deregulated genes demonstrated involvement of downregulated genes in metabolic and catabolic processes, excretion, oxidation reduction, ion transport and response to chemical stimulus, while simultaneously upregulated genes were associated with immune and inflammatory responses, response to hypoxia, stress, wounding, vasculature development and cell activation. Furthermore, genome-wide DNA methylation analysis of 317 TCGA ccRCC/adjacent non-tumour renal tissue pairs indicated that deregulation of approximately 7% of genes could be explained by epigenetic changes. Finally, survival analysis conducted on 89 K2 and 464 TCGA cases identified 8 genes associated with differential prognostic outcomes. In conclusion, a large proportion of ccRCC molecular characteristics were common to the two populations and several may have clinical implications when validated further through large clinical cohorts.	[Wozniak, Magdalena B.; Le Calvez-Kelm, Florence; Abedi-Ardekani, Behnoush; Byrnes, Graham; Durand, Geoffroy; Carreira, Christine; Michelon, Jocelyne; Lesueur, Fabienne; McKay, James; Brennan, Paul; Scelo, Ghislaine] Int Agcy Res Canc, F-69372 Lyon, France; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Holcatova, Ivana] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Brisuda, Antonin] Univ Hosp Motol, Fac Med 2, Dept Urol, Prague, Czech Republic	World Health Organization; International Agency for Research on Cancer (IARC); Palacky University Olomouc; Charles University Prague; Masaryk Memorial Cancer Institute; Charles University Prague; Motol University Hospital	Scelo, G (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	SceloG@iarc.fr	Abedi-Ardekani, Behnoush/O-7829-2016; Scelo, Ghislaine/CAF-8077-2022; Lesueur, Fabienne/R-2178-2017; Holcatova, Ivana/C-8327-2017; Janout, Vladimir/M-5133-2014	Abedi-Ardekani, Behnoush/0000-0002-0980-0587; Lesueur, Fabienne/0000-0001-7404-4549; Holcatova, Ivana/0000-0002-1366-0337; Foretova, Lenka/0000-0003-0494-2620; Byrnes, Graham/0000-0003-3893-7539; Brisuda, Antonin/0000-0001-5103-1358; Le Calvez-Kelm, Florence/0000-0003-0063-5068	US NCI U01 [CA155309]; EC [241669]; European Regional Development Fund; State Budget of the Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; NATIONAL CANCER INSTITUTE [U01CA155309] Funding Source: NIH RePORTER	US NCI U01; EC(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fund(European Commission); State Budget of the Czech Republic (RECAMO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US NCI U01 grant # CA155309. Additional support for the Czech Republic sample collection and follow-up was provided by the EC FP7 CAGEKID project # 241669, and the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Beleut M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-310; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Boer JM, 2001, GENOME RES, V11, P1861, DOI 10.1101/gr.184501; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brannon AR, 2012, EUR UROL, V61, P258, DOI 10.1016/j.eururo.2011.10.007; Brannon A Rose, 2010, Genes Cancer, V1, P152; Cho M, 2001, BRIT J CANCER, V85, P563, DOI 10.1054/bjoc.2001.1951; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Davidson B, 2012, HUM PATHOL, V43, P684, DOI 10.1016/j.humpath.2011.06.015; Delahunt B, 2009, MODERN PATHOL, V22, pS24, DOI 10.1038/modpathol.2008.183; Diaz-Uriarte R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-30; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Eble JN, 2004, PATHOLOGY GENETICS T; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ficarra V, 2005, CANCER, V103, P68, DOI 10.1002/cncr.20749; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gieseg MA, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-26; Girgis AH, 2012, CANC RES; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kearsey J, 2004, EUR J BIOCHEM, V271, P2584, DOI 10.1111/j.1432-1033.2004.04186.x; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Klatte T, 2007, CLIN CANCER RES, V13, P7388, DOI 10.1158/1078-0432.CCR-07-0411; Lane BR, 2009, J UROLOGY, V181, P849, DOI 10.1016/j.juro.2008.10.069; Lin F, 2006, ANN CLIN LAB SCI, V36, P283; Monga SPS, 2002, CANCER RES, V62, P2064; Morikawa T, 2007, CLIN CANCER RES, V13, P5703, DOI 10.1158/1078-0432.CCR-07-0603; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Pantuck AJ, 2003, CLIN CANCER RES, V9, P4641; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Peruzzi B, 2006, P NATL ACAD SCI USA, V103, P14531, DOI 10.1073/pnas.0606850103; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sanjmyatav J, 2011, J UROLOGY, V186, P289, DOI 10.1016/j.juro.2011.03.033; Shay JES, 2012, SEMIN CELL DEV BIOL, V23, P389, DOI 10.1016/j.semcdb.2012.04.004; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Tan WQ, 2011, J UROLOGY, V186, P2071, DOI 10.1016/j.juro.2011.06.049; Tang XX, 2000, P NATL ACAD SCI USA, V97, P10936, DOI 10.1073/pnas.190123297; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vasselli JR, 2003, P NATL ACAD SCI USA, V100, P6958, DOI 10.1073/pnas.1131754100; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Wuttig D, 2012, INT J CANCER, V131, pE693, DOI 10.1002/ijc.27419; Wuttig D, 2009, INT J CANCER, V125, P474, DOI 10.1002/ijc.24353; Yoshida Y, 2010, J NEURO-ONCOL, V98, P41, DOI 10.1007/s11060-009-0064-5; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	64	81	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57886	10.1371/journal.pone.0057886	http://dx.doi.org/10.1371/journal.pone.0057886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526956	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900059
J	Ariefiandy, A; Purwandana, D; Seno, A; Ciofi, C; Jessop, TS				Ariefiandy, Achmad; Purwandana, Deni; Seno, Aganto; Ciofi, Claudio; Jessop, Tim S.			Can Camera Traps Monitor Komodo Dragons a Large Ectothermic Predator?	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; CONSERVATION; POPULATIONS; DENSITIES; ABUNDANCE; CONFLICT; WINBUGS; PACKAGE; TIGERS; PREY	Camera trapping has greatly enhanced population monitoring of often cryptic and low abundance apex carnivores. Effectiveness of passive infrared camera trapping, and ultimately population monitoring, relies on temperature mediated differences between the animal and its ambient environment to ensure good camera detection. In ectothermic predators such as large varanid lizards, this criterion is presumed less certain. Here we evaluated the effectiveness of camera trapping to potentially monitor the population status of the Komodo dragon (Varanus komodoensis), an apex predator, using site occupancy approaches. We compared site-specific estimates of site occupancy and detection derived using camera traps and cage traps at 181 trapping locations established across six sites on four islands within Komodo National Park, Eastern Indonesia. Detection and site occupancy at each site were estimated using eight competing models that considered site-specific variation in occupancy (psi) and varied detection probabilities (p) according to detection method, site and survey number using a single season site occupancy modelling approach. The most parsimonious model [psi (site), p (site*survey); omega = 0.74] suggested that site occupancy estimates differed among sites. Detection probability varied as an interaction between site and survey number. Our results indicate that overall camera traps produced similar estimates of detection and site occupancy to cage traps, irrespective of being paired, or unpaired, with cage traps. Whilst one site showed some evidence detection was affected by trapping method detection was too low to produce an accurate occupancy estimate. Overall, as camera trapping is logistically more feasible it may provide, with further validation, an alternative method for evaluating long-term site occupancy patterns in Komodo dragons, and potentially other large reptiles, aiding conservation of this species.	[Ariefiandy, Achmad; Purwandana, Deni] Komodo Survival Program, Denpasar, Bali, Indonesia; [Seno, Aganto] Komodo Natl Pk, Labuan Bajo, Flores, Indonesia; [Ciofi, Claudio] Univ Florence, Dept Anim Biol & Genet, Florence, Italy; [Jessop, Tim S.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Florence; University of Melbourne	Jessop, TS (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	tjessop@unimelb.edu.au	Jessop, Tim/Q-2473-2019; Ciofi, Claudio/AAH-9461-2019	CIOFI, CLAUDIO/0000-0001-8537-8659; Jessop, Tim S./0000-0002-7712-4373; Ariefiandy, Achmad/0000-0003-4085-8354	American Zoological Association	American Zoological Association	Funding was provided through members of the American Zoological Association contributing to the Komodo Species Survival Plan (to AA, DP, TSJ, CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffenberg W, 1981, THE BEHAVIOURAL ECOL; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Ciofi C, 2004, HERPETOL J, V14, P99; Ciofi C, 2002, ZOO AND AQUARIUM BIO, P129; Ciofi C, 2007, COPEIA, P462; Doody JS, 2009, ANIM CONSERV, V12, P46, DOI 10.1111/j.1469-1795.2008.00219.x; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Enge KM, 2004, SOUTHEAST NAT, V3, P571, DOI 10.1656/1528-7092(2004)003[0571:SOTNMV]2.0.CO;2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Green B, 1993, GOANNA THE BIOLOGY O; Griffiths AD, 2007, WILDLIFE RES, V34, P609, DOI 10.1071/WR07024; Harlow Henry J., 2010, International Journal of Zoology, V2010, P1, DOI 10.1155/2010/921371; Hines JE, 2006, PRESENCE 2 4 SOFTWAR; Huey R.B., 1982, Biology of Reptilia, V12, P25; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; IUCN, 2012, THE IUCN RED LIST OF; Jenkins M, 1994, INT TRADE REPTILE SK; Jessop TS, 2007, BIOL CONSERV, V135, P247, DOI 10.1016/j.biocon.2006.10.025; Jessop TS, 2013, BIOL INVASIONS, V15, P1653, DOI 10.1007/s10530-012-0398-3; Jessop TS, 2006, OIKOS, V112, P422, DOI 10.1111/j.0030-1299.2006.14371.x; Jessop TS, 2004, BIOL CONSERV, V117, P463, DOI 10.1016/j.biocon.2003.08.005; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Karanth KU, 1998, ECOLOGY, V79, P2852; Kery M., 2010, INTRO WINBUGS ECOLOG, P302; Khatiwada J.R, 2009, BIAWAK, V3, P100; Laver RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045398; Linkie M, 2010, INTEGR ZOOL, V5, P342, DOI 10.1111/j.1749-4877.2010.00215.x; Luiselli L, 2006, J TROP ECOL, V22, P555, DOI 10.1017/S0266467406003397; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Luxmoore R, 1990, REPORT TO THE CITES; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin J, 2009, BIOL CONSERV, V142, P2726, DOI 10.1016/j.biocon.2009.06.027; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; O'Connell AF, 2010, CAMERA TRAPS IN ANIM; Pernetta Angelo P., 2009, Biawak, V3, P37; Ray J. C., 2005, LARGE CARNIVORES CON; Rosellini S, 2008, WILDLIFE RES, V35, P434, DOI 10.1071/WR07030; Roughton CM, 2006, WILDLIFE RES, V33, P193, DOI 10.1071/WR05045; Shine R, 1998, WILDLIFE RES, V25, P437, DOI 10.1071/WR97118; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Sutherland DR, 2011, P ROY SOC B-BIOL SCI, V278, P641, DOI 10.1098/rspb.2010.2103; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thorn M, 2011, BIOL CONSERV, V144, P1799, DOI 10.1016/j.biocon.2011.03.009; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Vanak AT, 2007, WILDLIFE BIOL, V13, P219, DOI 10.2981/0909-6396(2007)13[219:EONTFS]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM	57	28	34	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58800	10.1371/journal.pone.0058800	http://dx.doi.org/10.1371/journal.pone.0058800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527027	Green Published, gold			2022-12-27	WOS:000317562600040
J	Cao, CW; Wang, ZY; Niu, CY; Desneux, N; Gao, XW				Cao, Chuanwang; Wang, Zhiying; Niu, Changying; Desneux, Nicolas; Gao, Xiwu			Transcriptome Profiling of Chironomus kiinensis under Phenol Stress Using Solexa Sequencing Technology	PLOS ONE			English	Article							HYDROCARBON RECEPTOR; TOXICITY; PESTICIDES; QSAR; ANNOTATION; HERBICIDES; BLAST2GO; METAL; TOOL	Phenol is a major pollutant in aquatic ecosystems due to its chemical stability, water solubility and environmental mobility. To date, little is known about the molecular modifications of invertebrates under phenol stress. In the present study, we used Solexa sequencing technology to investigate the transcriptome and differentially expressed genes (DEGs) of midges (Chironomus kiinensis) in response to phenol stress. A total of 51,518,972 and 51,150,832 clean reads in the phenol-treated and control libraries, respectively, were obtained and assembled into 51,014 non-redundant (Nr) consensus sequences. A total of 6,032 unigenes were classified by Gene Ontology (GO), and 18,366 unigenes were categorized into 238 Kyoto Encyclopedia of Genes and Genomes (KEGG) categories. These genes included representatives from almost all functional categories. A total of 10,724 differentially expressed genes (P value <0.05) were detected in a comparative analysis of the expression profiles between phenol-treated and control C. kiinensis including 8,390 upregulated and 2,334 downregulated genes. The expression levels of 20 differentially expressed genes were confirmed by real-time RT-PCR, and the trends in gene expression that were observed matched the Solexa expression profiles, although the magnitude of the variations was different. Through pathway enrichment analysis, significantly enriched pathways were identified for the DEGs, including metabolic pathways, aryl hydrocarbon receptor (AhR), pancreatic secretion and neuroactive ligand-receptor interaction pathways, which may be associated with the phenol responses of C. kiinensis. Using Solexa sequencing technology, we identified several groups of key candidate genes as well as important biological pathways involved in the molecular modifications of chironomids under phenol stress.	[Cao, Chuanwang; Wang, Zhiying] NE Forestry Univ, Dept Forest Protect, Harbin, Peoples R China; [Niu, Changying] Huazhong Agr Univ, Hubei Key Lab Utilizat Insect Resources & Sustain, Wuhan, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France; [Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	Northeast Forestry University - China; Huazhong Agricultural University; INRAE; China Agricultural University	Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	gaoxiwu@263.net.cn	Desneux, Nicolas/J-6262-2013		Natural Science Foundation of China [31101676]; Harbin Science and Technology Innovation Talents Special Foundation [2010RFQXS055]; State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences [KF-2008-23]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Science and Technology Innovation Talents Special Foundation; State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was partly supported by Natural Science Foundation of China (31101676); Harbin Science and Technology Innovation Talents Special Foundation (2010RFQXS055) and State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences (KF-2008-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; AWRC, 1984, 82 AWRC, P224; BARBER JT, 1995, CHEMOSPHERE, V31, P3567, DOI 10.1016/0045-6535(95)00205-M; Budavari S., 1996, MERCK INDEX ENCY CHE; Carstanjen D, 2005, J IMMUNOL, V174, P4613, DOI 10.4049/jimmunol.174.8.4613; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crane M, 2002, ECOTOX ENVIRON SAFE, V53, P361, DOI 10.1016/S0147-6513(02)00038-6; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devillers J, 2004, SAR QSAR ENVIRON RES, V15, P237, DOI 10.1080/10629360410001724905; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Eullaffroy P, 2003, WATER RES, V37, P1983, DOI 10.1016/S0043-1354(02)00621-8; Faria MS, 2007, ECOTOX ENVIRON SAFE, V67, P218, DOI 10.1016/j.ecoenv.2006.11.018; Ge Shi-lin, 2011, Yingyong Shengtai Xuebao, V22, P1900; Ge ShiLin, 2011, Journal of Northeast Forestry University, V39, P108; Goh S.H., 1986, CRITERIA STANDARDS O, V4, P224; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Ibrahim H, 1998, B ENVIRON CONTAM TOX, V60, P448, DOI 10.1007/s001289900646; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kar S, 2010, SAR QSAR ENVIRON RES, V21, P149, DOI 10.1080/10629360903568697; Kumar K. S., 2010, TOXICOL ENV HEALTH, V2, P39; Kuncewicz T, 2001, AM J PHYSIOL-RENAL, V281, pF326, DOI 10.1152/ajprenal.2001.281.2.F326; Lauss M, 2007, PHARMACOGENOMICS, V8, P1063, DOI 10.2217/14622416.8.8.1063; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032288; Maleki A, 2005, AL HAITHAM J SCI TEC, V1, P73; Maleki S, 2008, Pak J Biol Sci, V11, P1286, DOI 10.3923/pjbs.2008.1286.1289; Michalowicz J, 2007, POL J ENVIRON STUD, V16, P347; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1989, CRIT REV TOXICOL, V20, P153, DOI 10.3109/10408448909017908; Park JS, 2012, AQUAT TOXICOL, V106, P182, DOI 10.1016/j.aquatox.2011.10.004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Rice-Evans C. A., 1998, FLAVONOIDS HLTH DIS; Schuler LJ, 2005, ARCH ENVIRON CON TOX, V49, P173, DOI 10.1007/s00244-004-0224-8; STOM DI, 1981, B ENVIRON CONTAM TOX, V27, P332, DOI 10.1007/BF01611028; Su SY, 2009, J ETHNOPHARMACOL, V123, P68, DOI 10.1016/j.jep.2009.02.027; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; *USEPA, 2000, EPA600R99064 OFF RES; USEPA, 2006, ENERGY STAR OV 2006; VERNIER P, 1995, TRENDS PHARMACOL SCI, V16, P375, DOI 10.1016/S0165-6147(00)89078-1; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XD, 2001, CHEMOSPHERE, V44, P447, DOI 10.1016/S0045-6535(00)00198-3; WARNER MA, 1985, ANESTHESIOLOGY, V62, P366, DOI 10.1097/00000542-198503000-00030; Wilczek G, 2003, COMP BIOCHEM PHYS C, V134, P501, DOI 10.1016/S1532-0456(03)00039-5; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhu H, 2008, J CHEM INF MODEL, V48, P766, DOI 10.1021/ci700443v	58	11	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58914	10.1371/journal.pone.0058914	http://dx.doi.org/10.1371/journal.pone.0058914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527048	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562600044
J	Howick, J; Bishop, FL; Heneghan, C; Wolstenholme, J; Stevens, S; Hobbs, FDR; Lewith, G				Howick, Jeremy; Bishop, Felicity L.; Heneghan, Carl; Wolstenholme, Jane; Stevens, Sarah; Hobbs, F. D. Richard; Lewith, George			Placebo Use in the United Kingdom: Results from a National Survey of Primary Care Practitioners	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CLINICAL-PRACTICE; QUESTIONNAIRE SURVEY; GENERAL-PRACTICE; RESPONSE BIAS; INTERVENTIONS; MEDICINE	Objectives: Surveys in various countries suggest 17% to 80% of doctors prescribe 'placebos' in routine practice, but prevalence of placebo use in UK primary care is unknown. Methods: We administered a web-based questionnaire to a representative sample of UK general practitioners. Following surveys conducted in other countries we divided placebos into 'pure' and 'impure'. 'Impure' placebos are interventions with clear efficacy for certain conditions but are prescribed for ailments where their efficacy is unknown, such as antibiotics for suspected viral infections. 'Pure' placebos are interventions such as sugar pills or saline injections without direct pharmacologically active ingredients for the condition being treated. We initiated the survey in April 2012. Two reminders were sent and electronic data collection closed after 4 weeks. Results: We surveyed 1715 general practitioners and 783 (46%) completed our questionnaire. Our respondents were similar to those of all registered UK doctors suggesting our results are generalizable. 12% (95% CI 10 to 15) of respondents used pure placebos while 97% (95% CI 96 to 98) used impure placebos at least once in their career. 1% of respondents used pure placebos, and 77% (95% CI 74 to 79) used impure placebos at least once per week. Most (66% for pure, 84% for impure) respondents stated placebos were ethical in some circumstances. Conclusion and implications: Placebo use is common in primary care but questions remain about their benefits, harms, costs, and whether they can be delivered ethically. Further research is required to investigate ethically acceptable and cost-effective placebo interventions.	[Howick, Jeremy; Heneghan, Carl; Stevens, Sarah; Hobbs, F. D. Richard] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Bishop, Felicity L.] Univ Southampton, Fac Social & Human Sci, Ctr Applicat Hlth Psychol, Southampton, Hants, England; [Wolstenholme, Jane] Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Oxford, England; [Lewith, George] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of Oxford; University of Southampton; University of Oxford; University of Southampton	Howick, J (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	Jeremy.howick@phc.ox.ac.uk	Howick, Jeremy/ADP-7644-2022	Wolstenholme, Jane/0000-0001-7493-1850; Howick, Jeremy/0000-0003-0280-7206; Lay-Flurrie, Sarah/0000-0003-1094-8455; Lewith, George/0000-0002-2364-3960; hobbs, richard/0000-0001-7976-7172; Bishop, Felicity/0000-0002-8737-6662	University of Oxford Department of Primary Care Health Sciences; Southampton Complementary Medical Research Trust [1094802]	University of Oxford Department of Primary Care Health Sciences; Southampton Complementary Medical Research Trust	Jeremy Howick is an NSPCR-NIHR Fellow. The University of Oxford Department of Primary Care Health Sciences and The Southampton Complementary Medical Research Trust (Registered Charity No: 1094802) funded part of the research. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti F, 2007, Handb Exp Pharmacol, P393; Benedetti F, 1998, PAIN, V75, P313, DOI 10.1016/S0304-3959(98)00010-4; Benedetti F., 2020, PLACEBO EFFECTS, DOI [10.1093/oso/9780198843177.001.0001, DOI 10.1093/OSO/9780198843177.001.0001]; Benedetti F, 2011, PSYCHOPHARMACOLOGY, V213, P791, DOI 10.1007/s00213-010-2037-y; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; Berger JT, 1999, WESTERN J MED, V170, P93; Bostick NA, 2008, J CLIN ETHIC, V19, P58; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; COMAROFF J, 1976, SOCIOL REV, V24, P79, DOI 10.1111/j.1467-954X.1976.tb00574.x; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Cunha BA, 2001, MED CLIN N AM, V85, P149, DOI 10.1016/S0025-7125(05)70309-6; de Craen AJM, 1999, J ROY SOC MED, V92, P511, DOI 10.1177/014107689909201005; de Jong V, 2011, J MIND BODY REGULATI, P1; Department of Health, 2011, 2010 11 REF COSTS PU; ELLIS J, 1995, LANCET, V346, P407, DOI 10.1016/S0140-6736(95)92781-6; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Ernst E, 2000, BMJ-BRIT MED J, V321, P1133, DOI 10.1136/bmj.321.7269.1133; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Foddy B, 2009, AM J BIOETHICS, V9, P4, DOI 10.1080/15265160903318350; Gill P, 1996, BRIT MED J, V312, P819; GMC, 2012, LIST REG MED PRACT S; Golomb B, 2002, JAMA; GOODWIN JS, 1979, ANN INTERN MED, V91, P106, DOI 10.7326/0003-4819-91-1-106; GOTZSCHE PC, 1994, LANCET, V344, P925; GRUNBAUM A, 1986, PSYCHOL MED, V16, P19, DOI 10.1017/S0033291700002506; Health and Social Care Information Centre, 2012, PRESCR COST AN ENGL; Heneghan C, 2007, BRIT J GEN PRACT, V57, P948, DOI 10.3399/096016407782604965; Howick J, 2008, PHILOS ISSUES EVIDEN; Howick J, 2009, AM J BIOETHICS, V9, P34, DOI 10.1080/15265160903090041; Howick JH., 2011, PHILOS EVIDENCE BASE; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Imrie R, 2000, COMPLEMENT THER MED, V8, P123, DOI 10.1054/ctim.2000.0370; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Makris UE, 2010, J RHEUMATOL, V37, P1236, DOI 10.3899/jrheum.090935; Mayr A, 2012, J CLIN EPIDEMIOL, V65, P970, DOI 10.1016/j.jclinepi.2012.03.005; Meissner K, 2012, FAM PRACT, V29, P79, DOI 10.1093/fampra/cmr045; Moerman Daniel E., 2002, CAMBRIDGE STUDIES ME; Murray E, 2007, BRIT J GEN PRACT, V57, P939, DOI 10.3399/096016407782605045; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; Nunn R., 2009, BMJ-BRIT MED J, V338, P1015; Reame NK, 2005, MENOPAUSE, V12, P4, DOI 10.1097/00042192-200512010-00003; Roelofs PDDM, 2008, SPINE, V33, P1766, DOI 10.1097/BRS.0b013e31817e69d3; Shapiro AK, 1978, HDB PSYCHOTHERAPY BE, P369; Shermon R, 2008, J GEN INTERN MED, V23, P7, DOI 10.1007/s11606-007-0332-z; SMITH R, 1991, BRIT MED J, V303, P798, DOI 10.1136/bmj.303.6806.798; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Ward KE, 2010, AM J HEALTH-SYST PH, V67, P206, DOI 10.2146/ajhp080603; World Medical Association (WMA), 2008, DECL HELS; WORSLEY A, 1984, HUM NUTR-APPL NUTR, V38A, P29	53	96	96	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58247	10.1371/journal.pone.0058247	http://dx.doi.org/10.1371/journal.pone.0058247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23526969	Green Published, gold, Green Accepted			2022-12-27	WOS:000317562600014
J	Quemere, E; Hibert, F; Miquel, C; Lhuillier, E; Rasolondraibe, E; Champeau, J; Rabarivola, C; Nusbaumer, L; Chatelain, C; Gautier, L; Ranirison, P; Crouau-Roy, B; Taberlet, P; Chikhi, L				Quemere, Erwan; Hibert, Fabrice; Miquel, Christian; Lhuillier, Emeline; Rasolondraibe, Emmanuel; Champeau, Julie; Rabarivola, Clement; Nusbaumer, Louis; Chatelain, Cyrille; Gautier, Laurent; Ranirison, Patrick; Crouau-Roy, Brigitte; Taberlet, Pierre; Chikhi, Lounes			A DNA Metabarcoding Study of a Primate Dietary Diversity and Plasticity across Its Entire Fragmented Range	PLOS ONE			English	Article							KIBALE-NATIONAL-PARK; PROPITHECUS-TATTERSALLI; VARECIA-VARIEGATA; FOREST; CONSERVATION; DENSITY; COLOBUS	In tropical regions, most primary ecosystems have been replaced by mosaic landscapes in which species must cope with a large shift in the distribution of their habitat and associated food resources. Primates are particularly vulnerable to habitat modifications. Most species persist in small fragments surrounded by complex human-mediated matrices whose structure and connectivity may strongly influence their dispersal and feeding behavior. Behavioral plasticity appears to be a crucial parameter governing the ability of organisms to exploit the resources offered by new matrix habitats and thus to persist in fragmented habitats. In this study, we were interested in the dietary plasticity of the golden-crowned sifaka (Propithecus tattersalli), an endangered species of lemur, found only in the Daraina region in north-eastern Madagascar. We used a DNA-based approach combining the barcoding concept and Illumina next-generation sequencing to (i) describe the species diet across its entire range and (ii) evaluate the influence of landscape heterogeneity on diet diversity and composition. Faeces from 96 individuals were sampled across the entire species range and their contents were analyzed using the trnL metabarcoding approach. In parallel, we built a large DNA reference database based on a checklist of the plant species of the Daraina region. Our results suggest that golden-crowned sifakas exhibit remarkable dietary diversity with at least 130 plant species belonging to 80 genera and 49 different families. We highlighted an influence of both habitat type and openness on diet composition suggesting a high flexibility of foraging strategies. Moreover, we observed the presence of numerous cultivated and naturalized plants in the faeces of groups living in forest edge areas. Overall, our findings support our initial expectation that P. tattersalli is able to cope with the current level of alteration of the landscape and confirm our previous results on the distribution and the dispersal ability of this species.	[Quemere, Erwan; Champeau, Julie; Crouau-Roy, Brigitte; Chikhi, Lounes] Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, ENFA, F-31062 Toulouse, France; [Quemere, Erwan; Lhuillier, Emeline] INRA, Lab Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France; [Hibert, Fabrice; Chikhi, Lounes] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Miquel, Christian; Taberlet, Pierre] Univ Grenoble 1, CNRS, Lab Ecol Alpine, Grenoble, France; [Rasolondraibe, Emmanuel; Rabarivola, Clement] Univ Mahajanga, Fac Sci, Mahajanga, Madagascar; [Nusbaumer, Louis; Chatelain, Cyrille; Gautier, Laurent] Conservatoire & Jardin Bot Ville Geneve, Lab Bot Systemat & Biodivers, Chambesy, Switzerland; [Nusbaumer, Louis; Chatelain, Cyrille; Gautier, Laurent] Univ Geneva, Chambesy, Switzerland; [Ranirison, Patrick] Univ Antananarivo, Dept Biol & Ecol Vegetale, Antananarivo, Madagascar	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Ecole Nationale Formation Agronomique (ENSFEA); INRAE; Instituto Gulbenkian de Ciencia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Geneva; University Antananarivo	Quemere, E (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, ENFA, F-31062 Toulouse, France.	erwan@quemere.fr	Quemere, Erwan/I-2018-2014; Taberlet, Pierre/D-1178-2010	Taberlet, Pierre/0000-0002-3554-5954; Chikhi, Lounes/0000-0002-1140-0718; Quemere, Erwan/0000-0002-3880-1933; Chatelain, Cyrille/0000-0001-6929-0008; Lhuillier, Emeline/0000-0003-2629-7773	Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien [CD-AOO1-07-003]; Laboratoire d'Excellence (LABEX) [ANR-10-LABX-41]; FCT [PTDC/BIA-BEC/100176/2008]; Conservatoire et Jardin botaniques de la Ville de Geneve; Conservation International (CBC fund); Fondation Jean-Marcel Aubert; Vontobel Stiftung; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BEC/100176/2008] Funding Source: FCT	Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien; Laboratoire d'Excellence (LABEX); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Conservatoire et Jardin botaniques de la Ville de Geneve; Conservation International (CBC fund); Fondation Jean-Marcel Aubert; Vontobel Stiftung; Fundação para a Ciência e a Tecnologia	The lab work was partly funded by the Institut Francais de la Biodiversite, Programme Biodiversite de l'Ocean Indien (reference no. CD-AOO1-07-003) and by Laboratoire d'Excellence (LABEX) entitled TULIP (ANR-10-LABX-41). LC was also partly funded by the FCT grant PTDC/BIA-BEC/100176/2008. PR, LG, LN, and CC were supported by the Conservatoire et Jardin botaniques de la Ville de Geneve, Conservation International (CBC fund), the Fondation Jean-Marcel Aubert and the Vontobel Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2007, BIOL CONSERV, V135, P212, DOI 10.1016/j.biocon.2006.10.022; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Balko EA, 2005, AM J PRIMATOL, V66, P45, DOI 10.1002/ajp.20127; Cameron J L, 1996, Rev Reprod, V1, P117; Campbell JL, 2000, AM J PRIMATOL, V52, P133, DOI 10.1002/1098-2345(200011)52:3<133::AID-AJP2>3.0.CO;2-#; Campbell Smith G, 2011, PLOS ONE, V6; Chapman C, 1987, FLEXIBILITY DIETS 3; Chapman C, 2010, COMPLEX RESPONSES CL; Chapman CA, 2002, AM J PHYS ANTHROPOL, V117, P349, DOI 10.1002/ajpa.10053; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Chase J, 2010, COMMUNITY ECOLOGY; Colwell R, 1999, USERS GUIDE ESTIMATE, P22; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cowlishaw G, 1999, BEHAV ECOL SOCIOBIOL, V45, P67, DOI 10.1007/s002650050540; Dehgan A, 2003, BEHAV EXTINCTION PRE; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Dunham N, 2011, COPING FOREST FRAGME; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Ganzhorn J, 2003, NATURAL HIST MADAGAS, P193; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Goodman SM, 2006, INVENTAIRES FAUNE FL; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Harris TR, 2007, PRIMATES, V48, P208, DOI 10.1007/s10329-006-0036-8; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibert F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025850; Irwin MT, 2008, INT J PRIMATOL, V29, P95, DOI 10.1007/s10764-007-9222-9; Isabirye-Basuta GM, 2008, INT J PRIMATOL, V29, P35, DOI 10.1007/s10764-008-9239-8; Lehman SM, 2006, AM J PHYS ANTHROPOL, V129, P232, DOI 10.1002/ajpa.20241; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Marsh LK, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P1; Matthews LJ, 2011, P ROY SOC B-BIOL SCI, V278, P1256, DOI 10.1098/rspb.2010.1489; Meyers D, 1993, EFFECTS RESOURCE SEA; Mittermeier R, 1987, CONSERVATION PRIMATE; Mittermeier RA, 2010, LEMURS MADAGASCAR CO; Mittermeier Russell A., 2009, Primate Conservation, V24, P1; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nusbaumer L., 2010, Systematics and conservation of African plants. Proceedings of the 18th AETFAT Congress, Yaounde, Cameroun, 26 February to 2 March 2007, P253; Onderdonk DA, 2000, INT J PRIMATOL, V21, P587, DOI 10.1023/A:1005509119693; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Quemere E, 2012, P NATL ACAD SCI; Quemere E, 2010, MOL ECOL, V19, P1606, DOI 10.1111/j.1365-294X.2010.04581.x; Quemere E, 2010, AM J PRIMATOL, V72, P72, DOI 10.1002/ajp.20754; Quemere E, 2010, CONSERV GENET, V11, P675, DOI 10.1007/s10592-009-9837-9; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds V, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P309; Rothman MJ, 2012, METHODS PRIMATE NUTR; Silver SC, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P251; Sodhi NS, 2010, CONSERVATION BIOLOGY FOR ALL, P1; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tscharntke T, 2012, BIOL REV CAMB PHILOS; Umapathy G, 2003, PRIMATE REPORT, V58, P67; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vallet D, 2008, CONSERV GENET, V9, P677, DOI 10.1007/s10592-007-9361-8; Vargas A, 2002, BIOL CONSERV, V108, P325, DOI 10.1016/S0006-3207(02)00117-9; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wieczkowski J, 2003, ASPECTS ECOLOGICAL F	59	70	78	1	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58971	10.1371/journal.pone.0058971	http://dx.doi.org/10.1371/journal.pone.0058971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527060	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100061
J	Jiang, YH; Lin, VCH; Liao, CH; Kuo, HC				Jiang, Yuan-Hong; Lin, Victor Chia-Hsiang; Liao, Chun-Hou; Kuo, Hann-Chorng			International Prostatic Symptom Score - Voiding/Storage Subscore Ratio in Association with Total Prostatic Volume and Maximum Flow Rate Is Diagnostic of Bladder Outlet-Related Lower Urinary Tract Dysfunction in Men with Lower Urinary Tract Symptoms	PLOS ONE			English	Article							DETRUSOR WALL THICKNESS; OVERACTIVE BLADDER; CONTINENCE SOCIETY; ICS-BPH; OBSTRUCTION; HYPERPLASIA; UROFLOWMETRY; PATHOPHYSIOLOGY; TERMINOLOGY; MANAGEMENT	Objectives: The aim of this study was to investigate the predictive values of the total International Prostate Symptom Score (IPSS-T) and voiding to storage subscore ratio (IPSS-V/S) in association with total prostate volume (TPV) and maximum urinary flow rate (Qmax) in the diagnosis of bladder outlet-related lower urinary tract dysfunction (LUTD) in men with lower urinary tract symptoms (LUTS). Methods: A total of 298 men with LUTS were enrolled. Video-urodynamic studies were used to determine the causes of LUTS. Differences in IPSS-T, IPSS-V/S ratio, TPV and Qmax between patients with bladder outlet-related LUTD and bladder-related LUTD were analyzed. The positive and negative predictive values (PPV and NPV) for bladder outlet-related LUTD were calculated using these parameters. Results: Of the 298 men, bladder outlet-related LUTD was diagnosed in 167 (56%). We found that IPSS-V/S ratio was significantly higher among those patients with bladder outlet-related LUTD than patients with bladder-related LUTD (2.28 +/- 2.25 vs. 0.90 +/- 0.88, p<0.001). TPV was similar between the two groups; however, in contrast to patients with bladder-related LUTD, patients with bladder outlet-related LUTD had higher detrusor voiding pressure, lower Qmax values, and greater postvoid residual volumes. The combination of TPV >= 30 ml and Qmax <= 10 ml/sec had a PPV of 68.8% and a NPV of 53.5% for bladder outlet-related LUTD. When IPSS-T >= 12 or IPSS-T >= 15 was considered as an additional criterion, PPV increased to 75.0% and 78.5%, respectively, and the NPV decreased to 50.9% and 50.2%, respectively. When IPSS-V/S>1 or >2 was factored into the equation instead of IPSS-T, PPV were 91.4% and 97.3%, respectively, and NPV were 54.8% and 49.8%, respectively. Conclusions: Combination of IPSS-T with TPV and Qmax increases the PPV of bladder outlet-related LUTD. Furthermore, including IPSS-V/S>1 or >2 into the equation results in a higher PPV than IPSS-T. IPSS-V/S>1 is a stronger predictor of bladder outlet-related LUTD than IPSS-T.	[Jiang, Yuan-Hong; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Jiang, Yuan-Hong; Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan; [Lin, Victor Chia-Hsiang] E Da Univ, Dept Urol, Kaohsiung, Taiwan; [Liao, Chun-Hou] Cardinal Tien Hosp, Dept Urol, New Taipei, Taiwan; [Liao, Chun-Hou] Fu Jen Catholic Univ, New Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; E-Da Hospital; Fu Jen Catholic University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw		Liao, Chun-Hou/0000-0002-7340-110X				Abrams P, 2013, J UROLOGY, V189, pS93, DOI 10.1016/j.juro.2012.11.021; Abrams P, 2001, BRIT MED J, V322, P106, DOI 10.1136/bmj.322.7278.106; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Apostolidis A, 2009, EUR UROL, V56, P937, DOI 10.1016/j.eururo.2009.07.050; Botker-Rasmussen I, 1999, NEUROUROL URODYNAM, V18, P545, DOI 10.1002/(SICI)1520-6777(1999)18:6<545::AID-NAU2>3.0.CO;2-1; CHANCELLOR MB, 1991, J UROLOGY, V145, P810, DOI 10.1016/S0022-5347(17)38458-6; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Chung SD, 2010, BJU INT, V105, P668, DOI 10.1111/j.1464-410X.2009.08927.x; de la Rosette JJMCH, 1998, NEUROUROL URODYNAM, V17, P99, DOI 10.1002/(SICI)1520-6777(1998)17:2<99::AID-NAU3>3.3.CO;2-5; Djavan B, 2011, CURR OPIN UROL, V21, P5, DOI 10.1097/MOU.0b013e32834100ef; Eckhardt MD, 2001, UROLOGY, V58, P966, DOI 10.1016/S0090-4295(01)01413-3; Fujimura T, 2012, BJU INT, V109, P1512, DOI 10.1111/j.1464-410X.2011.10445.x; Griffiths DJ, 1996, UROL CLIN N AM, V23, P279, DOI 10.1016/S0094-0143(05)70311-6; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Ignjatovic Ivan, 2001, International Urology and Nephrology, V32, P655, DOI 10.1023/A:1014457808748; Kaplan SA, 2011, INT J CLIN PRACT, V65, P487, DOI 10.1111/j.1742-1241.2010.02611.x; Kuo HC, 2007, UROLOGY, V70, P272, DOI 10.1016/j.urology.2007.03.063; Kuo HC, 1999, UROLOGY, V54, P90, DOI 10.1016/S0090-4295(99)00092-8; Kuo HC, 2000, UROL INT, V64, P86, DOI 10.1159/000030497; Lee JY, 2004, BJU INT, V94, P817, DOI 10.1111/j.1464-410X.2004.05039.x; Liao CH, 2011, INT J CLIN PRACT, V65, P552, DOI 10.1111/j.1742-1241.2011.02638.x; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Nitti Victor W, 2005, Rev Urol, V7 Suppl 6, pS14; Oelke M, 2007, EUR UROL, V52, P827, DOI 10.1016/j.eururo.2006.12.023; Reynard JM, 1998, BRIT J UROL, V82, P619; Steele GS, 2000, J UROLOGY, V164, P344, DOI 10.1016/S0022-5347(05)67356-9; Ziada A, 1999, UROLOGY, V53, P1, DOI 10.1016/S0090-4295(98)00532-9	27	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59176	10.1371/journal.pone.0059176	http://dx.doi.org/10.1371/journal.pone.0059176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527124	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600045
J	Naish, D; Simpson, M; Dyke, G				Naish, Darren; Simpson, Martin; Dyke, Gareth			A New Small-Bodied Azhdarchoid Pterosaur from the Lower Cretaceous of England and Its Implications for Pterosaur Anatomy, Diversity and Phylogeny	PLOS ONE			English	Article							ISLE-OF-WIGHT; NORTHEASTERN CHINA; LIAONING PROVINCE; PTERODACTYLOID PTEROSAUR; FEATHERED DINOSAURS; YIXIAN FORMATION; GERMANY; TAPEJARIDAE; EVOLUTION; LIMESTONE	Background: Pterosaurs have been known from the Cretaceous sediments of the Isle of Wight (southern England, United Kingdom) since 1870. We describe the three-dimensional pelvic girdle and associated vertebrae of a small near-adult pterodactyloid from the Atherfield Clay Formation (lower Aptian, Lower Cretaceous). Despite acknowledged variation in the pterosaur pelvis, previous studies have not adequately sampled or incorporated pelvic characters into phylogenetic analyses. Methodology/Principal Findings: The new specimen represents the new taxon Vectidraco daisymorrisae gen. et sp. nov., diagnosed by the presence of a concavity posterodorsal to the acetabulum and the form of its postacetabular process on the ilium. Several characters suggest that Vectidraco belongs to Azhdarchoidea. We constructed a pelvis-only phylogenetic analysis to test whether the pterosaur pelvis carries a useful phylogenetic signal. Resolution in recovered trees was poor, but they approximately matched trees recovered from analyses of total evidence. We also added Vectidraco and our pelvic characters to an existing total-evidence matrix for pterosaurs. Both analyses recovered Vectidraco within Azhdarchoidea. Conclusions/Significance: The Lower Cretaceous strata of western Europe have yielded members of several pterosaur lineages, but Aptian pterosaurs from western Europe are rare. With a pelvis length of 40 mm, the new animal would have had a total length of c. 350 mm, and a wingspan of c. 750 mm. Barremian and Aptian pterodactyloids from western Europe show that small-bodied azhdarchoids lived alongside ornithocheirids and istiodactylids. This assemblage is similar in terms of which lineages are represented to the coeval beds of Liaoning, China; however, the number of species and specimens present at Liaoning is much higher. While the general phylogenetic composition of western European and Chinese communities appear to have been approximately similar, the differences may be due to different palaeoenvironmental and depositional settings. The western Europe pterodactyloid record may therefore be artificially low in diversity due to preservational factors.	[Naish, Darren; Simpson, Martin; Dyke, Gareth] Univ Southampton, Southampton, Hants, England; [Dyke, Gareth] Univ Southampton, Inst Life Sci, Southampton, Hants, England	University of Southampton; University of Southampton	Naish, D (corresponding author), Univ Southampton, Southampton, Hants, England.	eotyrannus@gmail.com	Dyke, Gareth/AAJ-9320-2020	Dyke, Gareth/0000-0002-8390-7817				Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Andres B, 2010, J VERTEBR PALEONTOL, V30, P163, DOI 10.1080/02724630903409220; Averianov A. O., 2010, P ZOOLOGICAL I RUSSI, V314, P246; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Bennett S.C., 1990, Journal of Vertebrate Paleontology, V10, P80; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; Bennett SC, 1996, J VERTEBR PALEONTOL, V16, P432, DOI 10.1080/02724634.1996.10011332; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Eck Kristina, 2011, Swiss Journal of Palaeontology, V130, P277, DOI 10.1007/s13358-011-0024-5; Elgin R, 2012, TAPEJARA WELLNHOFERI; Elgin Ross A., 2011, Swiss Journal of Palaeontology, V130, P259, DOI 10.1007/s13358-011-0017-4; Fastnacht M, 2005, ACTA PALAEONTOL POL, V50, P273; Frey Eberhard, 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V194, P379; Vidarte CF, 2010, BOL GEOL MIN, V121, P311; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Guo ZF, 2003, SCI CHINA SER D, V46, P1261, DOI 10.1360/03yd0071; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019790; Hooley R. W., 1913, Quarterly Journal of the Geological Society of London, V69; Hooley R. W., 1925, Quarterly Journal of the Geological Society of London, V81, P1; Hooley R. W., 1907, Quarterly Journal of the Geological Society of London, V63; Howse S.C.B., 2001, DINOSAURS ISLE WIGHT, P324; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hyder ES, 2012, ACTA PALAEONTOLOGICA; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jiang Shun-Xing, 2011, Vertebrata Palasiatica, V49, P172; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P683; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Lu JC, 2010, ACTA GEOL SIN-ENGL, V84, P241; Lue Junchang, 2008, Zitteliana Reihe B, V28, P229; Maisch MW, 2004, CRETACEOUS RES, V25, P625, DOI 10.1016/j.cretres.2004.06.002; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Martill David M., 2008, Zitteliana Reihe B, V28, P209; Martill DM., 2001, DINOSAURS ISLE WIGHT; Martill DM, 2011, ENGLISH WEALDEN FOSS, P370; Martill DM, 2001, DINOSAURS ISLE WIGHT, P49; Naish D., 2011, ENGLISH WEALDEN FOSS, P526; Naish D, 2011, CRETACEOUS RES, V32, P464, DOI 10.1016/j.cretres.2011.03.001; Norman D., 2011, ENGLISH WEALDEN FOSS, P407; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Owen R., 1861, PALAEONTOGRAPHICAL 1, P1; OWEN R, 1870, PALAEONTOGRAPHICAL S, P41; Owen R, 1874, PALAEONTOGRAPHICAL S, P1; Romer A, 1956, OSTEOLOGY REPTILES; Salisbury S.W., 2011, ENGLISH WEALDEN FOSS, P305; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Sayao J.M., 2006, ESTUDOS GEOL GICOS, V16, P16; Seeley H. G., 1901, DRAGONS AIR ACCOUNT; SIMPSON M I, 1985, Proceedings of the Geologists' Association, V96, P23; Steel L, 2005, CRETACEOUS RES, V26, P686, DOI 10.1016/j.cretres.2005.03.005; Sweetman SC, 2010, J IBER GEOL, V36, P225, DOI 10.5209/rev_JIGE.2010.v36.n2.9; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Unwin D., 2007, CRATO FOSSIL BEDS BR, P475, DOI 10.1017/CBO9780511535512.018; UNWIN D M, 1992, Journal of Vertebrate Paleontology, V12, p57A; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2004, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V22, P39; Unwin David M., 2000, P420; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Unwin David M., 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P189; Veldmeijer Andre J., 2003, Scripta Geologica, V125, P35; Vullo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038900; Vullo R, 2009, GEOL MAG, V146, P931, DOI 10.1017/S0016756809990525; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wang XL, 2010, AN ACAD BRAS CIENC, V82, P1045, DOI 10.1590/S0001-37652010000400024; Wang XL, 2009, AN ACAD BRAS CIENC, V81, P793, DOI 10.1590/S0001-37652009000400016; Wellnhofer P., 1988, Historical Biology, V1, P3; WELLNHOFER P, 1974, Annals of Carnegie Museum, V45, P5; Wellnhofer P., 1978, TEIL 19 PTEROSAURIA, P82; WELLNHOFER P, 1970, BAYERISCHE AKAD WISS, V141, P1; Wellnhofer P., 1975, ALLGEMEINE SKELETTMO, VA148, P1; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176; Williston SW, 1903, FIELD COLUMBIAN MUSE, V78, P125; Witton MP, 2009, CRETACEOUS RES, V30, P676, DOI 10.1016/j.cretres.2008.12.004; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Xiaolin W, 2012, NATURWISSENSCHAFTEN, V99, P249; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Young C.C, 1964, VERTEBRATA PALA SIAT, V8, P221	84	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58451	10.1371/journal.pone.0058451	http://dx.doi.org/10.1371/journal.pone.0058451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526986	Green Published, Green Accepted, gold			2022-12-27	WOS:000316411600007
J	Wang, YB; Kahane, S; Cutcliffe, LT; Skilton, RJ; Lambden, PR; Persson, K; Bjartling, C; Clarke, IN				Wang, Yibing; Kahane, Simona; Cutcliffe, Lesley T.; Skilton, Rachel J.; Lambden, Paul R.; Persson, Kenneth; Bjartling, Carina; Clarke, Ian N.			Genetic Transformation of a Clinical (Genital Tract), Plasmid-Free Isolate of Chlamydia trachomatis: Engineering the Plasmid as a Cloning Vector	PLOS ONE			English	Article							CRYPTIC PLASMID; COMMON PLASMID; NUCLEOTIDE-SEQUENCE; BIOVAR TRACHOMA; STRAIN; REPLICATION; INFECTIVITY; DIVERSITY; DISEASE; GROWTH	Our study had three objectives: to extend the plasmid-based transformation protocol to a clinical isolate of C. trachomatis belonging to the trachoma biovar, to provide "proof of principle'' that it is possible to "knock out'' selected plasmid genes (retaining a replication competent plasmid) and to investigate the plasticity of the plasmid. A recently developed, plasmid-based transformation protocol for LGV isolates of C. trachomatis was modified and a plasmid-free, genital tract C. trachomatis isolate from Sweden (SWFP-) was genetically transformed. Transformation of this non-LGV C. trachomatis host required a centrifugation step, but the absence of the natural plasmid removed the need for plaque purification of transformants. Transformants expressed GFP, were penicillin resistant and iodine stain positive for accumulated glycogen. The transforming plasmid did not recombine with the host chromosome. A derivative of pGFP::SW2 carrying a deletion of the plasmid CDS5 gene was engineered. CDS5 encodes pgp3, a protein secreted from the inclusion into the cell cytoplasm. This plasmid (pCDS5KO) was used to transform C. trachomatis SWFP-, and established that pgp3 is dispensable for plasmid function. The work shows it is possible to selectively delete segments of the chlamydial plasmid, and this is the first step towards a detailed molecular dissection of the role of the plasmid. The 3.6 kb beta-galactosidase cassette was inserted into the deletion site of CDS5 to produce plasmid placZ-CDS5KO. Transformants were penicillin resistant, expressed GFP and stained for glycogen. In addition, they expressed b-galactosidase showing that the lacZ cassette was functional in C. trachomatis. An assay was developed that allowed the visualisation of individual inclusions by X-gal staining. The ability to express active beta-galactosidase within chlamydial inclusions is an important advance as it allows simple, rapid assays to measure directly chlamydial infectivity without the need for plaquing, fluorescence or antibody staining.	[Wang, Yibing; Cutcliffe, Lesley T.; Skilton, Rachel J.; Lambden, Paul R.; Clarke, Ian N.] Univ Southampton, Mol Microbiol Grp, Southampton, Hants, England; [Kahane, Simona] Ben Gurion Univ Negev, Dept Virol, IL-84105 Beer Sheva, Israel; [Persson, Kenneth] Malmo Univ Hosp, Dept Lab Med, Malmo, Sweden; [Bjartling, Carina] Malmo Univ Hosp, Dept Obstet & Gynaecol, Malmo, Sweden	University of Southampton; Ben Gurion University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Clarke, IN (corresponding author), Univ Southampton, Mol Microbiol Grp, Southampton, Hants, England.	inc@soton.ac.uk		Clarke, Ian/0000-0002-4938-1620	Wellcome Trust [091296]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, grant number 091296 entitled Extrachromosomal elements of Chlamydia: Development of an efficient transformation system for Chlamydia trachomatis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN Q, 1992, J CLIN MICROBIOL, V30, P2814, DOI 10.1128/JCM.30.11.2814-2821.1992; BLACK CM, 1989, CURR MICROBIOL, V19, P67, DOI 10.1007/BF01568906; Burstein GR, 1999, CLIN INFECT DIS, V28, pS66, DOI 10.1086/514728; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; Chen DJ, 2010, WIRELESSHART: REAL-TIME MESH NETWORK FOR INDUSTRIAL AUTOMATION, P3, DOI 10.1007/978-1-4419-6047-4_1; COMANDUCCI M, 1988, MOL MICROBIOL, V2, P531, DOI 10.1111/j.1365-2958.1988.tb00060.x; COMANDUCCI M, 1990, PLASMID, V23, P149, DOI 10.1016/0147-619X(90)90034-A; Farencena A, 1997, INFECT IMMUN, V65, P2965, DOI 10.1128/IAI.65.7.2965-2969.1997; Frazer LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030747; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; HATT C, 1988, NUCLEIC ACIDS RES, V16, P4053, DOI 10.1093/nar/16.9.4053; Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Matsumoto A, 1998, J CLIN MICROBIOL, V36, P3013, DOI 10.1128/JCM.36.10.3013-3019.1998; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; O'Connell CM, 2006, MICROBIOL-SGM, V152, P1601, DOI 10.1099/mic.0.28658-0; O'Connell CM, 2011, INFECT IMMUN, V79, P1044, DOI 10.1128/IAI.01118-10; Paavonen J, 1998, DERMATOL CLIN, V16, P747, DOI 10.1016/S0733-8635(05)70041-3; PEELING RW, 1991, INFECT IMMUN, V59, P2624, DOI 10.1128/IAI.59.8.2624-2630.1991; Persson K, 1996, P 3 M EUR SOC CHLAM, V3, P33; PETERSON EM, 1990, PLASMID, V23, P144, DOI 10.1016/0147-619X(90)90033-9; Pickett MA, 2005, MICROBIOL-SGM, V151, P893, DOI 10.1099/mic.0.27625-0; Ripa T, 2007, SEX TRANSM DIS, V34, P255, DOI 10.1097/OLQ.0b013e31805ce2b9; Rockey DD, 2011, J EXP MED, V208, P2159, DOI 10.1084/jem.20112088; Rockey DD, 2000, PROKARYOTIC DEVELOPMENT, P403; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; Skilton RJ, 2007, J BACTERIOL, V189, P4957, DOI 10.1128/JB.00235-07; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; SRIPRAKASH KS, 1987, PLASMID, V18, P205, DOI 10.1016/0147-619X(87)90063-1; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stothard DR, 1999, INFECT IMMUN, V67, P2051; Stothard DR, 1998, INFECT IMMUN, V66, P6010, DOI 10.1128/IAI.66.12.6010-6013.1998; TAM JE, 1992, PLASMID, V27, P231, DOI 10.1016/0147-619X(92)90025-6; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; THOMAS NS, 1992, P 2 EUR SOC CHLAM RE, P42; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; WARD ME, 1983, BRIT MED BULL, V39, P109, DOI 10.1093/oxfordjournals.bmb.a071800	39	26	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59195	10.1371/journal.pone.0059195	http://dx.doi.org/10.1371/journal.pone.0059195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527131	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000316411600047
J	Yoshimura, T; Howard, OMZ; Ito, T; Kuwabara, M; Matsukawa, A; Chen, KQ; Liu, Y; Liu, MY; Oppenheim, JJ; Wang, JM				Yoshimura, Teizo; Howard, O. M. Zack; Ito, Toshihiro; Kuwabara, Masaki; Matsukawa, Akihiro; Chen, Keqiang; Liu, Ying; Liu, Mingyong; Oppenheim, Joost J.; Wang, Ji Ming			Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells	PLOS ONE			English	Article							MACROPHAGE INFILTRATION; TUMOR MICROENVIRONMENT; INFLAMMATORY MONOCYTES; SUPPRESSOR-CELLS; MAMMARY-TUMORS; RECRUITMENT; MCP-1; PURIFICATION; ANGIOGENESIS; EXPRESSION	MCP-1/CCL2 plays an important role in the initiation and progression of cancer. Since tumor cells produce MCP-1, they are considered to be the main source of this chemokine. Here, we examined whether MCP-1 produced by non-tumor cells affects the growth and lung metastasis of 4T1 breast cancer cells by transplanting them into the mammary pad of WT or MCP-1(-/-) mice. Primary tumors at the injected site grew similarly in both mice; however, lung metastases were markedly reduced in MCP-1(-/-) mice, with significantly longer mouse survival. High levels of MCP-1 mRNA were detected in tumors growing in WT, but not MCP-1(-/-) mice. Serum MCP-1 levels were increased in tumor-bearing WT, but not MCP-1(-/-) mice. Transplantation of MCP-1(-/-) bone marrow cells into WT mice did not alter the incidence of lung metastasis, whereas transplantation of WT bone marrow cells into MCP-1(-/-) mice increased lung metastasis. The primary tumors of MCP-1(-/-) mice consistently developed necrosis earlier than those of WT mice and showed decreased infiltration by macrophages and reduced angiogenesis. Interestingly, 4T1 cells that metastasized to the lung constitutively expressed elevated levels of MCP-1, and intravenous injection of 4T1 cells producing a high level of MCP-1 resulted in increased tumor foci in the lung of WT and MCP-1(-/-) mice. Thus, stromal cell-derived MCP-1 in the primary tumors promotes lung metastasis of 4T1 cells, but tumor cell-derived MCP-1 can also contribute once tumor cells enter the circulation. A greater understanding of the source and role of this chemokine may lead to novel strategies for cancer treatment.	[Yoshimura, Teizo; Howard, O. M. Zack; Chen, Keqiang; Liu, Ying; Liu, Mingyong; Oppenheim, Joost J.; Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Ito, Toshihiro; Kuwabara, Masaki; Matsukawa, Akihiro] Okayama Univ, Dept Pathol & Expt Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Okayama University	Yoshimura, T (corresponding author), NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA.	yoshimut@mail.nih.gov	Howard, O M Zack/B-6117-2012	Howard, O M Zack/0000-0002-0505-7052; Yoshimura, Teizo/0000-0002-3853-2075; Matsukawa, Akihiro/0000-0002-5081-6089	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010725, ZIABC010015] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Arderiu G, 2011, ARTERIOSCL THROM VAS, V31, P2607, DOI 10.1161/ATVBAHA.111.233536; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; BOTTAZZI B, 1990, INT J CANCER, V45, P795, DOI 10.1002/ijc.2910450436; BOTTAZZI B, 1992, J IMMUNOL, V148, P1280; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Davidson B, 2008, BREAST J, V14, P476, DOI 10.1111/j.1524-4741.2008.00625.x; FRANCI C, 1995, J IMMUNOL, V154, P6511; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Garber K, 2009, J NATL CANCER I, V101, P1110, DOI 10.1093/jnci/djp266; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Heppner GH, 2000, BREAST CANCER RES, V2, P331; HIROSE K, 1995, BRIT J CANCER, V72, P708, DOI 10.1038/bjc.1995.398; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; ROLLINS BJ, 1991, MOL CELL BIOL, V11, P3125, DOI 10.1128/MCB.11.6.3125; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Stathopoulos GT, 2008, JNCI-J NATL CANCER I, V100, P1464, DOI 10.1093/jnci/djn325; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Wang JM, 1998, INT J CANCER, V75, P900, DOI 10.1002/(SICI)1097-0215(19980316)75:6<900::AID-IJC13>3.0.CO;2-6; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; YAMASHIRO S, 1994, AM J PATHOL, V145, P856; YOSHIMURA T, 1993, J IMMUNOL, V151, P6225; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449	49	74	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58791	10.1371/journal.pone.0058791	http://dx.doi.org/10.1371/journal.pone.0058791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527025	Green Submitted, gold, Green Published			2022-12-27	WOS:000316411600011
J	Zhuang, PY; Shen, J; Zhu, XD; Zhang, JB; Tang, ZY; Qin, LX; Sun, HC				Zhuang, Peng-Yuan; Shen, Jun; Zhu, Xiao-Dong; Zhang, Ju-Bo; Tang, Zhao-You; Qin, Lun-Xiu; Sun, Hui-Chuan			Direct Transformation of Lung Microenvironment by Interferon- a Treatment Counteracts Growth of Lung Metastasis of Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-C VIRUS; IN-VIVO SELECTION; COMBINATION THERAPY; CURATIVE RESECTION; NUDE-MICE; EXTRAHEPATIC METASTASES; INTRAHEPATIC RECURRENCE; PULMONARY METASTASIS; TUMOR ANGIOGENESIS; CONTROLLED-TRIAL	Background: Interferon (IFN)-alpha is effective in inhibiting tumor growth and metastasis of hepatocellular carcinoma (HCC). However, the biologic mechanisms of IFN-alpha treatment in lung metastasis are not yet clear. Methods: The effect of IFN-alpha treatment was studied by using an orthotopic xenograft model and measuring tumor size and lung metastasis. Pretreatment with IFN-alpha before implantation of tumor was done to explore the effect of IFN-alpha on lung tissues. Cytokines and macrophages were measured by immunohistochemistry and/or PCR assay, using human origin or mouse origin primers to differentiate the sources. Circulating tumor cells (CTCs) were also assayed by flow cytometry. Results: IFN-alpha treatment did not decrease the number of CTCs (0.075%+/- 0.020% versus 0.063%+/- 0.018%, P = 0.574, IFN-alpha-treated versus control groups), but did decrease the number and size of lung metastasis (number: 1.75 +/- 1.0 versus 28.0 +/- 6.3, P = 0.008; size [pixels]: 116.8 +/- 72.2 versus 5226.4 +/- 1355.7, P = 0.020), and inhibited macrophage infiltration (0.20% +/- 0.04% versus 1.36%+/- 0.21%, P = 0.0058) and alteration of matrix metalloproteinase (MMP)-9 expression (mean integrated optical density (IOD): 5.1 +/- 1.7 versus 21.9 +/- 0.4, P<0.000) in the lung, which was independent of the primary tumor. Conclusion: IFN-alpha inhibited lung metastasis by directly modulating the lung microenvironment.	[Zhuang, Peng-Yuan; Shen, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China; [Zhuang, Peng-Yuan; Zhu, Xiao-Dong; Zhang, Ju-Bo; Tang, Zhao-You; Qin, Lun-Xiu; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; [Zhuang, Peng-Yuan; Zhu, Xiao-Dong; Zhang, Ju-Bo; Tang, Zhao-You; Qin, Lun-Xiu; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China.	toxoy@163.com	Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [81101851]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant support, National Natural Science Foundation of China (No. 81101851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arii S, 1998, J Hepatobiliary Pancreat Surg, V5, P86, DOI 10.1007/PL00009956; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kubo S, 2001, ANN INTERN MED, V134, P963, DOI 10.7326/0003-4819-134-10-200105150-00010; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Lin SM, 2004, CANCER-AM CANCER SOC, V100, P376, DOI 10.1002/cncr.20004; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lo CM, 2007, ANN SURG, V245, P831, DOI 10.1097/01.sla.0000245829.00977.45; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Nagano H, 2007, CANCER-AM CANCER SOC, V110, P2493, DOI 10.1002/cncr.23033; Nakamura M, 2008, CANCER, V112, P1765, DOI 10.1002/cncr.23356; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poon RTP, 2002, J AM COLL SURGEONS, V195, P311, DOI 10.1016/S1072-7515(02)01226-7; Poon RTP, 2000, CANCER, V89, P500, DOI 10.1002/1097-0142(20000801)89:3<500::AID-CNCR4>3.3.CO;2-F; Shiratori Y, 2003, ANN INTERN MED, V138, P299, DOI 10.7326/0003-4819-138-4-200302180-00008; Sun HC, 2006, J CANCER RES CLIN, V132, P458, DOI 10.1007/s00432-006-0091-y; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Titus B, 2005, CANCER RES, V65, P7320, DOI 10.1158/0008-5472.CAN-05-1403; Tomimaru Y, 2006, AM J SURG, V192, P46, DOI 10.1016/j.amjsurg.2005.12.006; Uka K, 2008, ONCOLOGY-BASEL, V75, P8, DOI 10.1159/000151614; van Deventer HW, 2005, CANCER RES, V65, P3374, DOI 10.1158/0008-5472.CAN-04-2616; von Marschall Z, 2003, J NATL CANCER I, V95, P437, DOI 10.1093/jnci/95.6.437; Wada H, 2007, ONCOL REP, V18, P801; Wang L, 2003, J GASTROINTEST SURG, V7, P587, DOI 10.1016/S1091-255X(03)00072-6; Wang L, 2000, HEPATOLOGY, V32, P43, DOI 10.1053/jhep.2000.8525; Yang BW, 2008, EUR J GASTROEN HEPAT, V20, P1077, DOI 10.1097/MEG.0b013e3283050a67; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521; Zhuang PY, 2010, J CANCER RES CLIN, V136, P1891, DOI 10.1007/s00432-010-0848-1	39	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58913	10.1371/journal.pone.0058913	http://dx.doi.org/10.1371/journal.pone.0058913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527047	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600017
J	Orimoto, A; Suzuki, T; Ueno, A; Kawai, T; Nakamura, H; Kanamori, T				Orimoto, Ai; Suzuki, Takahiro; Ueno, Atsuko; Kawai, Tatsushi; Nakamura, Hiroshi; Kanamori, Takao			Effect of 2-Hydroxyethyl Methacrylate on Antioxidant Responsive Element-Mediated Transcription: A Possible Indication of Its Cytotoxicity	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; REGULATORY MECHANISMS; DENTAL ADHESIVES; PHASE-2 RESPONSE; EPITHELIAL-CELLS; RESIN MONOMERS; IN-VITRO; KEAP1; NRF2	Background: The resin monomer 2-hydroxyethyl methacrylate (HEMA) is known to be more cytotoxic than methyl methacrylate (MMA). Using a luciferase reporter assay system, we previously showed that MMA activates the glutathione S-transferase alpha 1 gene (Gsta1) promoter through the anti-oxidant responsive element (ARE). However, it is not known whether HEMA induces ARE-mediated transcription. Methodology/Principal Findings: We further developed the reporter system and studied the concentration-dependent effect of HEMA on ARE enhancer activity. The revised system employed HepG2 cells stably transfected with a destabilized luciferase reporter vector carrying 2 copies of the 41-bp ARE region of Gsta1. In this system, MMA increased ARE activity by 244-fold at 30 mM; HEMA augmented ARE activity at 3 mM more intensely than MMA (36-fold versus 11-fold) and was equipotent as MMA at 10 mM (56-fold activation); however, HEMA failed to increase ARE activity at 30 mM. In HepG2 cells, HEMA detectably lowered the cellular glutathione levels at 10 mM and cell viability at 30 mM, but MMA did not. Conclusions: These results suggest that the low-concentration effect of HEMA on ARE activity reflects its cytotoxicity. Our reporter system used to examine ARE activity may be useful for evaluating cytotoxicities of resin monomers at concentrations lower than those for which cell viabilities are reduced.	[Orimoto, Ai; Nakamura, Hiroshi] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 464, Japan; [Suzuki, Takahiro; Kanamori, Takao] Aichi Gakuin Univ, Sch Dent, Dept Biochem, Nagoya, Aichi 464, Japan; [Ueno, Atsuko] Aichi Gakuin Univ, Sch Dent, Dept Gerodontol, Nagoya, Aichi 464, Japan; [Kawai, Tatsushi] Aichi Gakuin Univ, Sch Dent, Dept Dent Mat Sci, Nagoya, Aichi 464, Japan	Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University	Orimoto, A (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Endodont, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	orimoto@dpc.agu.ac.jp; tsuzuki@dpc.agu.ac.jp			Strategic Research AGU-Platform Formation; Japan Society for the Promotion of Science (JSPS)	Strategic Research AGU-Platform Formation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Strategic Research AGU-Platform Formation (2008 "2012") and by Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS, to T. Kawai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakopoulou A, 2009, INT J MOL SCI, V10, P3861, DOI 10.3390/ijms10093861; Bouillaguet S, 1996, J ENDODONT, V22, P244, DOI 10.1016/S0099-2399(06)80141-X; Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021; Demirci M, 2008, DENT MATER, V24, P362, DOI 10.1016/j.dental.2007.06.009; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430; Filing RS, 1992, P NATL ACAD SCI USA, V89, P668; Fujisawa S, 2009, DENT MATER J, V28, P722, DOI 10.4012/dmj.28.722; Geurtsen W, 1998, J DENT RES, V77, P2012, DOI 10.1177/00220345980770121001; Geurtsen W, 1999, J BIOMED MATER RES, V48, P772, DOI 10.1002/(SICI)1097-4636(1999)48:6<772::AID-JBM2>3.0.CO;2-X; HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201; Hara H, 2006, J NEUROSCI RES, V84, P860, DOI 10.1002/jnr.20974; Hattori N, 2008, J DENT RES, V87, P1117, DOI 10.1177/154405910808701214; Ishikawa A, 2006, DENT MATER J, V25, P205, DOI 10.4012/dmj.25.205; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Kaspar JW, 2012, J CELL SCI, V125, P1027, DOI 10.1242/jcs.097295; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; NAKABAYASHI N, 1992, DENT MATER, V8, P125, DOI 10.1016/0109-5641(92)90067-M; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nyberg SL, 2005, LIVER TRANSPLANT, V11, P901, DOI 10.1002/lt.20446; Paranjpe A, 2005, J DENT RES, V84, P172, DOI 10.1177/154405910508400212; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001; Schweikl H, 2001, J DENT RES, V80, P1615, DOI 10.1177/00220345010800070401; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Van Landuyt KL, 2008, DENT MATER, V24, P1412, DOI 10.1016/j.dental.2008.02.018; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58907	10.1371/journal.pone.0058907	http://dx.doi.org/10.1371/journal.pone.0058907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516576	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400076
J	Dressaire, C; Picard, F; Redon, E; Loubiere, P; Queinnec, I; Girbal, L; Cocaign-Bousquet, M				Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Queinnec, Isabelle; Girbal, Laurence; Cocaign-Bousquet, Muriel			Role of mRNA Stability during Bacterial Adaptation	PLOS ONE			English	Article							RATE REGULATED GENES; CODON USAGE BIAS; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; DECAY; TRANSCRIPTOME; DEGRADATION; EXPRESSION; EFFICIENCY; CLEAVAGE	Bacterial adaptation involves extensive cellular reorganization. In particular, growth rate adjustments are associated with substantial modifications of gene expression and mRNA abundance. In this work we aimed to assess the role of mRNA degradation during such variations. A genome-wide transcriptomic-based method was used to determine mRNA half-lives. The model bacterium Lactococcus lactis was used and different growth rates were studied in continuous cultures under isoleucine-limitation and in batch cultures during the adaptation to the isoleucine starvation. During continuous isoleucine-limited growth, the mRNAs of different genes had different half-lives. The stability of most of the transcripts was not constant, and increased as the growth rate decreased. This half-life diversity was analyzed to investigate determinants of mRNA stability. The concentration, length, codon adaptation index and secondary structures of mRNAs were found to contribute to the determination of mRNA stability in these conditions. However, the growth rate was, by far, the most influential determinant. The respective influences of mRNA degradation and transcription on the regulation of intra-cellular transcript concentration were estimated. The role of degradation on mRNA homeostasis was clearly evidenced: for more than 90% of the mRNAs studied during continuous isoleucine-limited growth of L. lactis, degradation was antagonistic to transcription. Although both transcription and degradation had, opposite effects, the mRNA changes in response to growth rate were driven by transcription. Interestingly, degradation control increased during the dynamic adaptation of bacteria as the growth rate reduced due to progressive isoleucine starvation in batch cultures. This work shows that mRNA decay differs between gene transcripts and according to the growth rate. It demonstrates that mRNA degradation is an important regulatory process involved in bacterial adaptation. However, its impact on the regulation of mRNA levels is smaller than that of transcription in the conditions studied.	[Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Queinnec, Isabelle; Girbal, Laurence; Cocaign-Bousquet, Muriel] Univ Toulouse, Toulouse, France; [Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Girbal, Laurence; Cocaign-Bousquet, Muriel] Inst Natl Sci Appl, UPS, INP, LISBP, F-31077 Toulouse, France; [Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Girbal, Laurence; Cocaign-Bousquet, Muriel] INRA, Ing Syst Biol & Proc UMR792, F-31931 Toulouse, France; [Dressaire, Clementine; Picard, Flora; Redon, Emma; Loubiere, Pascal; Girbal, Laurence; Cocaign-Bousquet, Muriel] CNRS, UMR5504, Toulouse, France; [Queinnec, Isabelle] CNRS, LAAS, F-31077 Toulouse, France	Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Dressaire, C (corresponding author), Univ Toulouse, Toulouse, France.	clementine.dressaire@insa-toulouse.fr		GIRBAL, Laurence/0000-0002-8773-4829	Institut National de la Recherche Agronomique Integrative Biology Program (agroBI)	Institut National de la Recherche Agronomique Integrative Biology Program (agroBI)	This work was supported by the Institut National de la Recherche Agronomique Integrative Biology Program (agroBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Babu MMG, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-49; BECHHOFER DH, 1989, J BACTERIOL, V171, P5803, DOI 10.1128/jb.171.11.5803-5811.1989; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Condon C, 2011, CURR OPIN MICROBIOL, V14, P148, DOI 10.1016/j.mib.2011.01.010; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Dressaire C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S18; Dressaire C, 2010, MOL BIOSYST, V6, P1255, DOI 10.1039/c001702g; Dressaire C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000606; Dressaire C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-343; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; Feng HH, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/617509; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; FISHOV I, 1995, MOL MICROBIOL, V15, P789, DOI 10.1111/j.1365-2958.1995.tb02349.x; Hambraeus G, 2003, MOL GENET GENOMICS, V269, P706, DOI 10.1007/s00438-003-0883-6; Lackner DH, 2008, INT REV CEL MOL BIO, V271, P199, DOI 10.1016/S1937-6448(08)01205-7; Lahtvee PJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-12; Lenz G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028544; Mackie GA, 1997, J BIOL CHEM, V272, P609; Picard F, 2012, BMC GENOMIC IN PRESS; Redon E, 2005, J BIOL CHEM, V280, P36380, DOI 10.1074/jbc.M506006200; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Regnier P, 2009, PROG MOL BIOL TRANSL, V85, P137, DOI 10.1016/S0079-6603(08)00804-0; Russell JB, 2007, J MOL MICROB BIOTECH, V13, P1, DOI 10.1159/000103591; SANDLER P, 1989, J BACTERIOL, V171, P6680, DOI 10.1128/jb.171.12.6680-6688.1989; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Silva IJ, 2011, WIRES RNA, V2, P818, DOI 10.1002/wrna.94; Takayama K, 2000, ENVIRON MICROBIOL, V2, P355, DOI 10.1046/j.1462-2920.2000.00119.x; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410	43	36	37	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59059	10.1371/journal.pone.0059059	http://dx.doi.org/10.1371/journal.pone.0059059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516597	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200130
J	Mayer, G; Kauschke, S; Rudiger, J; Stevenson, PA				Mayer, Georg; Kauschke, Susann; Ruediger, Jan; Stevenson, Paul A.			Neural Markers Reveal a One-Segmented Head in Tardigrades (Water Bears)	PLOS ONE			English	Article							HOX GENE-EXPRESSION; NERVOUS-SYSTEM; 3-DIMENSIONAL RECONSTRUCTION; PHYLOGENETIC POSITION; VELVET WORMS; EVOLUTION; ONYCHOPHORA; ARTHROPODS; FMRFAMIDE; BRAIN	Background: While recent neuroanatomical and gene expression studies have clarified the alignment of cephalic segments in arthropods and onychophorans, the identity of head segments in tardigrades remains controversial. In particular, it is unclear whether the tardigrade head and its enclosed brain comprises one, or several segments, or a non-segmental structure. To clarify this, we applied a variety of histochemical and immunocytochemical markers to specimens of the tardigrade Macrobiotus cf. harmsworthi and the onychophoran Euperipatoides rowelli. Methodology/Principal Findings: Our immunolabelling against serotonin, FMRFamide and alpha-tubulin reveals that the tardigrade brain is a dorsal, bilaterally symmetric structure that resembles the brain of onychophorans and arthropods rather than a circumoesophageal ring typical of cycloneuralians (nematodes and allies). A suboesophageal ganglion is clearly lacking. Our data further reveal a hitherto unknown, unpaired stomatogastric ganglion in Macrobiotus cf. harmsworthi, which innervates the ectodermal oesophagus and the endodermal midgut and is associated with the second leg-bearing segment. In contrast, the oesophagus of the onychophoran E. rowelli possesses no immunoreactive neurons, whereas scattered bipolar, serotonin-like immunoreactive cell bodies are found in the midgut wall. Furthermore, our results show that the onychophoran pharynx is innervated by a medullary loop nerve accompanied by monopolar, serotonin-like immunoreactive cell bodies. Conclusions/Significance: A comparison of the nervous system innervating the foregut and midgut structures in tardigrades and onychophorans to that of arthropods indicates that the stomatogastric ganglion is a potential synapomorphy of Tardigrada and Arthropoda. Its association with the second leg-bearing segment in tardigrades suggests that the second trunk ganglion is a homologue of the arthropod tritocerebrum, whereas the first ganglion corresponds to the deutocerebrum. We therefore conclude that the tardigrade brain consists of a single segmental region corresponding to the arthropod protocerebrum and, accordingly, that the tardigrade head is a non-composite, one-segmented structure.	[Mayer, Georg; Kauschke, Susann; Ruediger, Jan; Stevenson, Paul A.] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany	Leipzig University	Mayer, G (corresponding author), Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany.	gmayer@onychophora.com	Stevenson, Paul A/A-2048-2010; Mayer, Georg/Y-9581-2018	Mayer, Georg/0000-0003-0737-2440	German Research Foundation (DFG) [Ma 4147/3-1]; Emmy Noether Programme of the DFG	German Research Foundation (DFG)(German Research Foundation (DFG)); Emmy Noether Programme of the DFG(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG, http://www.dfg.de/index.jsp) to GM (Ma 4147/3-1). GM is a Research Group Leader supported by the Emmy Noether Programme of the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenhakker MP, 2004, J NEUROPHYSIOL, V91, P78, DOI 10.1152/jn.00741.2003; Bitsch J, 2007, ACTA ZOOL-STOCKHOLM, V88, P317, DOI 10.1111/j.1463-6395.2007.00284.x; Bitsch J, 2010, ACTA ZOOL-STOCKHOLM, V91, P249, DOI 10.1111/j.1463-6395.2009.00402.x; Brenneis G, 2010, J MORPHOL, V271, P169, DOI 10.1002/jmor.10789; Budd GE, 2001, ZOOL ANZ, V240, P265, DOI 10.1078/0044-5231-00034; Bullock T. H., 1965, STRUCTURE FUNCTION N, VI; BULLOCK TH, 1965, STRUCTURE FUNCTION N, V2, P802; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Dearden PK, 2002, DEVELOPMENT, V129, P5461, DOI 10.1242/dev.00099; Dewel RA, 1999, ZOOL ANZ, V238, P191; Dewel RA, 1996, ZOOL J LINN SOC-LOND, V116, P35; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; Eriksson BJ, 2010, DEV GENES EVOL, V220, P117, DOI 10.1007/s00427-010-0329-1; Gabriel WN, 2007, DEV GENES EVOL, V217, P421, DOI 10.1007/s00427-007-0152-5; Girosi L, 2005, CELL TISSUE RES, V320, P331, DOI 10.1007/s00441-004-1072-6; Halberg KA, 2009, J MORPHOL, V270, P996, DOI 10.1002/jmor.10734; Hanstrom B., 1935, BEMERKUNGEN GEHIRN S, V31, P1; Hartenstein V, 1997, TRENDS NEUROSCI, V20, P421, DOI 10.1016/S0166-2236(97)01066-7; Hejnol A, 2005, DEVELOPMENT, V132, P1349, DOI 10.1242/dev.01701; Hejnol A, 2008, NATURE, V456, P382, DOI 10.1038/nature07309; HENRY LAURA M., 1948, MICROENTOMOLOGY, V13, P27; HENRY LAURA M., 1953, MICROENTOMOLOGY, V18, P16; Ishida Y, 1998, BRAIN RES, V788, P207, DOI 10.1016/S0006-8993(97)01541-2; Jager M, 2006, NATURE, V441, P506, DOI 10.1038/nature04591; Jellies J, 1996, J COMP NEUROL, V373, P1, DOI 10.1002/(SICI)1096-9861(19960909)373:1<1::AID-CNE1>3.0.CO;2-8; Kotikova EA, 2005, HYDROBIOLOGIA, V546, P239, DOI 10.1007/s10750-005-4203-5; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; KRISTENSEN R M, 1984, Smithsonian Contributions to Zoology, V391, P1; KRISTENSEN RM, 1984, T AM MICROSC SOC, V103, P295, DOI 10.2307/3226191; Lartillot N, 2008, PHILOS T R SOC B, V363, P1463, DOI 10.1098/rstb.2007.2236; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Ma XY, 2009, ARTHROPOD STRUCT DEV, V38, P271, DOI 10.1016/j.asd.2009.03.001; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Mallatt J, 2010, MOL PHYLOGENET EVOL, V55, P1, DOI 10.1016/j.ympev.2009.09.028; Marcus E, 1929, TARDIGRADA HG BRONNS, P1; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Matsuda R., 1965, MEM AM ENTOMOL I, V4, P1; Mayer G, 2005, ARTHROPOD STRUCT DEV, V34, P471, DOI 10.1016/j.asd.2005.03.004; Mayer G, 2005, J MORPHOL, V263, P60, DOI 10.1002/jmor.10289; Mayer G, 2008, J COMP NEUROL, V507, P1196, DOI 10.1002/cne.21603; Mayer G, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-118; Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-255; Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011; Mayer G, 2009, P ROY SOC B-BIOL SCI, V276, P3571, DOI 10.1098/rspb.2009.0950; Michel S, 2000, J COMP NEUROL, V425, P244, DOI 10.1002/1096-9861(20000918)425:2<244::AID-CNE7>3.0.CO;2-A; Mittmann B, 2003, DEV GENES EVOL, V213, P9, DOI 10.1007/s00427-002-0285-5; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; MOROZ L, 1994, CELL TISSUE RES, V275, P277, DOI 10.1007/BF00319425; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Oliveira IS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019973; Ou Q, 2012, NATURE COMM IN PRESS; Persson DK, 2012, J MORPHOL, V273, P1227, DOI 10.1002/jmor.20054; Plate L., 1888, ZOOLOGISCHE JB, V3, P487, DOI DOI 10.5962/BHL.PART.1265; Poprawa I, 2005, TISSUE CELL, V37, P385, DOI 10.1016/j.tice.2005.06.003; PROSS ARMIN, 1966, Z MORPHOL OKDL TIERE, V58, P38, DOI 10.1007/BF00409640; Raikova OI, 2000, TISSUE CELL, V32, P358, DOI 10.1054/tice.2000.0121; Reglodi D, 1997, CELL TISSUE RES, V288, P575, DOI 10.1007/s004410050843; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Rieger V, 2010, INVERTEBR BIOL, V129, P77, DOI 10.1111/j.1744-7410.2010.00189.x; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; SCHOLL G, 1977, ZOOMORPHOLOGIE, V86, P99; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; SIDDIQUI SS, 1989, J NEUROSCI, V9, P2963; Sivasubramanian P, 2004, COMP BIOCH PHYS A, V99, P507; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; Thomas M.B., 1991, P91; TIEGS OW, 1947, Q J MICROSC SCI, V88, P165; Tiegs OW, 1940, Q J MICROSC SCI, V82, P1; WEYGOLDT P, 1975, ZOOMORPHOLOGIE, V82, P137, DOI 10.1007/BF00993587; Whitington PM, 2011, ARTHROPOD STRUCT DEV, V40, P193, DOI 10.1016/j.asd.2011.01.006; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Wiederhoft H, 1996, ZOOL J LINN SOC-LOND, V116, P71; Zantke J, 2008, ZOOMORPHOLOGY, V127, P21, DOI 10.1007/s00435-007-0045-1	79	51	52	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59090	10.1371/journal.pone.0059090	http://dx.doi.org/10.1371/journal.pone.0059090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516602	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200132
J	Todd, J; Riedner, G; Maboko, L; Hoelscher, M; Weiss, HA; Lyamuya, E; Mabey, D; Rusizoka, M; Belec, L; Hayes, R				Todd, Jim; Riedner, Gabriele; Maboko, Leonard; Hoelscher, Michael; Weiss, Helen A.; Lyamuya, Eligius; Mabey, David; Rusizoka, Mary; Belec, Laurent; Hayes, Richard			Effect of Genital Herpes on Cervicovaginal HIV Shedding in Women Co-Infected with HIV AND HSV-2 in Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLACEBO-CONTROLLED TRIAL; FEMALE BAR WORKERS; SIMPLEX-VIRUS; SEX WORKERS; SUPPRESSIVE THERAPY; TYPE-2 INFECTION; AFRICAN WOMEN; SOUTH-AFRICA; ACYCLOVIR	Objectives: To compare the presence and quantity of cervicovaginal HIV among HIV seropositive women with clinical herpes, subclinical HSV-2 infection and without HSV-2 infection respectively; to evaluate the association between cervicovaginal HIV and HSV shedding; and identify factors associated with quantity of cervicovaginal HIV. Design: Four groups of HIV seropositive adult female barworkers were identified and examined at three-monthly intervals between October 2000 and March 2003 in Mbeya, Tanzania: (1) 57 women at 70 clinic visits with clinical genital herpes; (2) 39 of the same women at 46 clinic visits when asymptomatic; (3) 55 HSV-2 seropositive women at 60 clinic visits who were never observed with herpetic lesions; (4) 18 HSV-2 seronegative women at 45 clinic visits. Associations of genital HIV shedding with HIV plasma viral load (PVL), herpetic lesions, HSV shedding and other factors were examined. Results: Prevalence of detectable genital HIV RNA varied from 73% in HSV-2 seronegative women to 94% in women with herpetic lesions (geometric means 1634 vs 3339 copies/ml, p = 0.03). In paired specimens from HSV-2 positive women, genital HIV viral shedding was similar during symptomatic and asymptomatic visits. On multivariate regression, genital HIV RNA (log(10) copies/mL) was closely associated with HIV PVL (beta = 0.51 per log(10) copies/ml increase, 95%CI:0.41-0.60, p<0.001) and HSV shedding (beta = 0.24 per log(10) copies/ml increase, 95% CI:0.16-0.32, p<0.001) but not the presence of herpetic lesions (beta = -0.10, 95%CI:-0.28-0.08, p = 0.27). Conclusions: HIV PVL and HSV shedding were more important determinants of genital HIV than the presence of herpetic lesions. These data support a role of HSV-2 infection in enhancing HIV transmissibility.	[Todd, Jim; Riedner, Gabriele; Weiss, Helen A.; Mabey, David; Hayes, Richard] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Riedner, Gabriele; Maboko, Leonard; Rusizoka, Mary] Natl Inst Med Res, Mbeya Med Res Programme, Mbeya, Tanzania; [Hoelscher, Michael] Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany; [Lyamuya, Eligius] Muhimbili Univ Coll Hlth Sci, Dar Es Salaam, Tanzania; [Belec, Laurent] Hop Europeen Georges Pompidou, Microbiol Lab, Paris, France; [Belec, Laurent] Univ Paris 05, Fac Med Paris Descartes, Paris, France	University of London; London School of Hygiene & Tropical Medicine; University of Munich; Muhimbili University of Health & Allied Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Todd, J (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England.	jim.todd@lshtm.ac.uk	Hoelscher, Michael/D-3436-2012; weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Mabey, David/0000-0002-0031-8276; Todd, Jim/0000-0001-5918-4914; Hayes, Richard/0000-0002-1729-9892	European Commission, DGXII, INCO-DC [ICA-CT-1998-10007]; Wellcome Trust [060145/Z/00/A]; Department for International Development [RD638]; Tanzanian Minister of Health and Social Welfare; Medical Research Council [MR/K012126/1] Funding Source: researchfish	European Commission, DGXII, INCO-DC; Wellcome Trust(Wellcome TrustEuropean Commission); Department for International Development; Tanzanian Minister of Health and Social Welfare; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by: European Commission, DGXII, INCO-DC, Grant nummber: ICA-CT-1998-10007; Wellcome Trust, Grant number: 060145/Z/00/A; and Department for International Development, Grant number: RD638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the women who participated in the study and the research team of the NIMR-Mbeya Medical Research Programme, and the Director and personnel in Mbeya Referral Hospital clinics and laboratories for making this study possible. We acknowledge the Medical officer in charge of Mbeya municipality, and the Tanzanian Minister of Health and Social Welfare for their support. We thank Oliver Hoffmann, Karl-Heinz Herbinger, Britta Dechamps, Gudrun Schoen and Frowin Nichombe for their active support in Mbeya, and Heiner Grosskurth and Mar Pujades-Rodrigues for their support in London. We acknowledge the help of Dr Jerome Legoff in quantifying the HSV DNA in this study.	ALBRECHT MA, 1989, J VIROL, V63, P1861, DOI 10.1128/JVI.63.5.1861-1868.1989; Ashley RL, 1999, CLIN MICROBIOL REV, V12, P1; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Behets FMT, 1999, J INFECT DIS, V180, P1382, DOI 10.1086/315005; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C.L., 2004, HERPES, V11, p36A; Chen CY, 2000, SEX TRANSM DIS, V27, P21, DOI 10.1097/00007435-200001000-00005; Chu K, 2006, INT J STD AIDS, V17, P681, DOI 10.1258/095646206780071108; CLEMETSON DBA, 1993, JAMA-J AM MED ASSOC, V269, P2860, DOI 10.1001/jama.269.22.2860; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cowan FM, 2008, SEX TRANSM INFECT, V84, P548, DOI 10.1136/sti.2008.031153; Cowan FF, 2006, AIDS, V20, P261, DOI 10.1097/01.aids.0000198086.39831.4a; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Espy MJ, 2000, J CLIN MICROBIOL, V38, P795, DOI 10.1128/JCM.38.2.795-799.2000; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Keou FXM, 1999, AIDS, V13, P536, DOI 10.1097/00002030-199903110-00021; LeGoff J, 2007, AIDS, V21, P1569, DOI 10.1097/QAD.0b013e32825a69bd; Limpakarnjanarat K, 1999, THAILAND SEX TRANSM, V75, P30; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; McClelland RS, 2002, AIDS, V16, P2425, DOI 10.1097/00002030-200212060-00007; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; MOSCA JD, 1987, P NATL ACAD SCI USA, V84, P7408, DOI 10.1073/pnas.84.21.7408; MOSS GB, 1995, J INFECT DIS, V172, P1469, DOI 10.1093/infdis/172.6.1469; Nagot N, 2005, JAIDS-J ACQ IMM DEF, V39, P632; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; Riedner G, 2007, SEX TRANSM INFECT, V83, P91, DOI 10.1136/sti.2006.021287; Rodriguez MDM, 2002, AIDS, V16, P451; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Tanton C, 2010, J INFECT DIS, V201, P1285, DOI 10.1086/651696; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	42	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59037	10.1371/journal.pone.0059037	http://dx.doi.org/10.1371/journal.pone.0059037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516595	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000316849200128
J	Gumenyuk, V; Korzyukov, O; Roth, T; Bowyer, SM; Drake, CL				Gumenyuk, Valentina; Korzyukov, Oleg; Roth, Thomas; Bowyer, Susan M.; Drake, Christopher L.			Sleep Extension Normalizes ERP of Waking Auditory Sensory Gating in Healthy Habitually Short Sleeping Individuals	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; EVOKED-RESPONSES; NEUROPHYSIOLOGICAL EVIDENCE; P50 SUPPRESSION; LONG SLEEPERS; NEURAL BASIS; SCHIZOPHRENIA; ATTENTION; DEPRIVATION; PERFORMANCE	Chronic sleep loss has been associated with increased daytime sleepiness, as well as impairments in memory and attentional processes. In the present study, we evaluated the neuronal changes of a pre-attentive process of wake auditory sensory gating, measured by brain event-related potential (ERP) - P50 in eight normal sleepers (NS) (habitual total sleep time (TST) 7 h 32 m) vs. eight chronic short sleeping individuals (SS) (habitual TST <= 6 h). To evaluate the effect of sleep extension on sensory gating, the extended sleep condition was performed in chronic short sleeping individuals. Thus, one week of time in bed (6 h 11 m) corresponding to habitual short sleep (hSS), and one week of extended time (similar to 8 h 25 m) in bed corresponding to extended sleep (eSS), were counterbalanced in the SS group. The gating ERP assessment was performed on the last day after each sleep condition week (normal sleep and habitual short and extended sleep), and was separated by one week with habitual total sleep time and monitored by a sleep diary. We found that amplitude of gating was lower in SS group compared to that in NS group (0.3 mu V vs. 1.2 mu V, at Cz electrode respectively). The results of the group x laterality interaction showed that the reduction of gating amplitude in the SS group was due to lower amplitude over the left hemisphere and central-midline sites relative to that in the NS group. After sleep extension the amplitude of gating increased in chronic short sleeping individuals relative to their habitual short sleep condition. The sleep condition 6 frontality interaction analysis confirmed that sleep extension significantly increased the amplitude of gating over frontal and central brain areas compared to parietal brain areas.	[Gumenyuk, Valentina; Roth, Thomas; Drake, Christopher L.] Henry Ford Hosp, Sleep Disorders & Res Ctr, Detroit, MI 48202 USA; [Korzyukov, Oleg] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Bowyer, Susan M.] Henry Ford Hosp, Dept Neurol, Neuromagnetism Lab, Detroit, MI 48202 USA; [Bowyer, Susan M.] Wayne State Univ, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Northwestern University; Henry Ford Health System; Henry Ford Hospital; Wayne State University	Gumenyuk, V (corresponding author), Henry Ford Hosp, Sleep Disorders & Res Ctr, Detroit, MI 48202 USA.	vgumeny1@hfhs.org	Drake, Christopher/L-6274-2017	Drake, Christopher/0000-0002-5486-3587				ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; Aeschbach D, 2001, NEUROSCIENCE, V102, P493, DOI 10.1016/S0306-4522(00)00518-2; Aeschbach D, 1996, AM J PHYSIOL-REG I, V270, pR41, DOI 10.1152/ajpregu.1996.270.1.R41; Balkin TJ, 2011, J CLIN SLEEP MED, V7, pS12, DOI 10.5664/JCSM.1344; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Boutros NN, 1999, BIOL PSYCHIAT, V45, P917, DOI 10.1016/S0006-3223(98)00253-4; BUCHWALD JS, 1991, ELECTROEN CLIN NEURO, V80, P303, DOI 10.1016/0168-5597(91)90114-D; BUCHWALD JS, 1992, ELECTROEN CLIN NEURO, V84, P164, DOI 10.1016/0168-5597(92)90021-3; Cajochen C, 2000, BIOL PSYCHIAT, V47, P610, DOI 10.1016/S0006-3223(99)00242-5; Clementz BA, 1997, BIOL PSYCHIAT, V41, P1035, DOI 10.1016/S0006-3223(96)00208-9; Cohen J, 1988, STAT POWER ANAL BEHA, Vxxi; Cote KA, 2008, PHYSIOL BEHAV, V95, P353, DOI 10.1016/j.physbeh.2008.06.016; Dinges DF, 1997, SLEEP, V20, P267; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2005, SLEEP, V28, P1059; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; ERWIN R, 1986, ELECTROEN CLIN NEURO, V65, P383, DOI 10.1016/0168-5597(86)90017-1; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; GarciaRill E, 1997, MED HYPOTHESES, V49, P379, DOI 10.1016/S0306-9877(97)90083-9; Ghisolfi ES, 2006, EUR NEUROPSYCHOPHARM, V16, P204, DOI 10.1016/j.euroneuro.2005.09.001; Ghisolfi ES, 2002, NEUROPSYCHOPHARMACOL, V27, P629; Gosselin A, 2005, CLIN NEUROPHYSIOL, V116, P211, DOI 10.1016/j.clinph.2004.07.033; Gumenyuk V, 2011, SLEEP, V34, P1659, DOI 10.5665/sleep.1430; Hairston IS, 2010, EUR J NEUROSCI, V31, P2112, DOI 10.1111/j.1460-9568.2010.07237.x; Hanlon FM, 2005, PSYCHOPHYSIOLOGY, V42, P417, DOI 10.1111/j.1469-8986.2005.00299.x; HANSOTIA P, 1985, NEUROLOGY, V35, P1672, DOI 10.1212/WNL.35.11.1672; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kamdar BB, 2004, SLEEP MED, V5, P441, DOI 10.1016/j.sleep.2004.05.003; Kisley MA, 2001, CLIN NEUROPHYSIOL, V112, P1154, DOI 10.1016/S1388-2457(01)00578-8; Knutson KL, 2010, SLEEP, V33, P37, DOI 10.1093/sleep/33.1.37; Korzyukov O, 2007, NEUROIMAGE, V35, P814, DOI 10.1016/j.neuroimage.2006.12.011; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Mayer AR, 2009, NEUROIMAGE, V44, P182, DOI 10.1016/j.neuroimage.2008.08.025; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; McNair D. M, 1992, PROFILE MOOD STATES; Milner CE, 2009, NEUROREPORT, V20, P331, DOI 10.1097/WNR.0b013e328323284e; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; ROEHRS T, 1989, SLEEP, V12, P449, DOI 10.1093/sleep/12.5.449; Roehrs T, 1996, SLEEP, V19, P576; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Shambroom JR, 2012, J SLEEP RES, V21, P221, DOI 10.1111/j.1365-2869.2011.00944.x; STERIADE M, 1990, J NEUROSCI, V10, P2541; Teo C, 1998, Sleep Res Online, V1, P62; Thoma RJ, 2005, SCHIZOPHR RES, V73, P311, DOI 10.1016/j.schres.2004.07.001; Thoma RJ, 2003, AM J PSYCHIAT, V160, P1595, DOI 10.1176/appi.ajp.160.9.1595; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Uc EY, 2003, J NEUROL SCI, V212, P1, DOI 10.1016/S0022-510X(03)00082-0; Ucar E, 2012, J PSYCHOPHARMACOL, V26, P1113, DOI 10.1177/0269881111430752; WIEGAND M, 1991, J NEUROL, V238, P203, DOI 10.1007/BF00314781; ZOURIDAKIS G, 1992, BIOL PSYCHIAT, V32, P839, DOI 10.1016/0006-3223(92)90088-H	52	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59007	10.1371/journal.pone.0059007	http://dx.doi.org/10.1371/journal.pone.0059007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520548	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900108
J	Lin, F; Lasry, A; Sansom, SL; Wolitski, RJ				Lin, Feng; Lasry, Arielle; Sansom, Stephanie L.; Wolitski, Richard J.			Estimating the Impact of State Budget Cuts and Redirection of Prevention Resources on the HIV Epidemic in 59 California Local Health Departments	PLOS ONE			English	Article							BEHAVIORAL SURVEILLANCE SYSTEM; UNITED-STATES; SEXUAL-BEHAVIOR; CONDOM USE; ANTIRETROVIRAL THERAPY; TESTING BEHAVIORS; PERCEIVED HEALTH; AGES 14; TRANSMISSION; RISK	Background: In the wake of a national economic downturn, the state of California, in 2009-2010, implemented budget cuts that eliminated state funding of HIV prevention and testing. To mitigate the effect of these cuts remaining federal funds were redirected. This analysis estimates the impact of these budget cuts and reallocation of resources on HIV transmission and associated HIV treatment costs. Methods and Findings: We estimated the effect of the budget cuts and reallocation for California county health departments (excluding Los Angeles and San Francisco) on the number of individuals living with or at-risk for HIV who received HIV prevention services. We used a Bernoulli model to estimate the number of new infections that would occur each year as a result of the changes, and assigned lifetime treatment costs to those new infections. We explored the effect of redirecting federal funds to more cost-effective programs, as well as the potential effect of allocating funds proportionately by transmission category. We estimated that cutting HIV prevention resulted in 55 new infections that were associated with $20 million in lifetime treatment costs. The redirection of federal funds to more cost-effective programs averted 15 HIV infections. If HIV prevention funding were allocated proportionately to transmission categories, we estimated that HIV infections could be reduced below the number that occurred annually before the state budget cuts. Conclusions: Reducing funding for HIV prevention may result in short-term savings at the expense of additional HIV infections and increased HIV treatment costs. Existing HIV prevention funds would likely have a greater impact on the epidemic if they were allocated to the more cost-effective programs and the populations most likely to acquire and transmit the infection.	[Lin, Feng; Lasry, Arielle; Sansom, Stephanie L.; Wolitski, Richard J.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Sansom, SL (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	sos9@cdc.gov						[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Arnold EA, 2010, EXAMINING IMPACT HIV; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Camoni L, 2011, ANN I SUPER SANITA, V47, P214, DOI 10.4415/ANN_11_02_14; Centers for Disease Control and Prevention, 2012, DIV HIV AIDS PREV PR; Centers for Disease Control and Prevention, 2010, HIV SURV REP; Centers for Disease Control and Prevention, 2011, HIV TEST CDC FUND SI; Chandra Anjani, 2011, Natl Health Stat Report, P1; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Crosby R, 2009, INT J SEX HEALTH, V21, P183, DOI 10.1080/19317610903205627; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Fortenberry JD, 2010, J SEX MED, V7, P305, DOI 10.1111/j.1743-6109.2010.02018.x; Friedman SR, 2005, J URBAN HEALTH, V82, P434, DOI 10.1093/jurban/jti088; Grigoryan A, 2010, JAMA-J AM MED ASSOC, V303, P126; Herbenick D, 2010, J SEX MED, V7, P277, DOI 10.1111/j.1743-6109.2010.02010.x; Holtgrave DR, 2010, JAIDS-J ACQ IMM DEF, V55, P139, DOI 10.1097/QAI.0b013e3181f4107a; Holtgrave DR, 2006, ANNU REV PUBL HEALTH, V27, P261, DOI 10.1146/annurev.publhealth.26.021304.144454; Holtgrave DR, 2004, INT J STD AIDS, V15, P789, DOI 10.1258/0956462042563639; Jemmott LS, 2007, AM J PUBLIC HEALTH, V97, P1034, DOI 10.2105/AJPH.2003.020271; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; Lansky A., 2009, Morbidity and Mortality Weekly Report, V58, P329; Lasry A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037545; Leibowitz AA, 2011, JAIDS-J ACQ IMM DEF, V58, pE11, DOI 10.1097/QAI.0b013e31822101c8; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; Metsch L, 2007, 2007 NAT HIV PREV C; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; National Association of State and Territorial Apprenticeship Directors (NASTAD) National Coalition of STD Directors (NCSD), 2011, 2010 STAT GEN REV HI; Office of National AIDS Policy, 2010, NATL HIV AIDS STRAT; Pinkerton SD, 1998, HDB EC EVALUATION HI; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Reece M, 2010, J SEX MED, V7, P266, DOI 10.1111/j.1743-6109.2010.02017.x; Reece M, 2010, J SEX MED, V7, P291, DOI 10.1111/j.1743-6109.2010.02009.x; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scholes D, 2003, AIDS, V17, P1547, DOI 10.1097/00002030-200307040-00016; The California State Office of AIDS, 2009, OFF AIDS FY2009 10 B; The Kaiser Family Foundation, 2011, US FED FUND HIV AIDS; The Kaiser Family Foundation National Association of State and Territorial Apprenticeship Directors (NASTAD), 2009, NAT HIV PREV INV; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Viall Abigail H., 2011, Morbidity and Mortality Weekly Report, V60, P805; Wingood GM, 2004, JAIDS-J ACQ IMM DEF, V37, pS58, DOI 10.1097/01.qai.0000140603.57478.a9; Xia Q, 2006, JAIDS-J ACQ IMM DEF, V41, P238, DOI 10.1097/01.qai.0000185574.98472.36; [No title captured]	55	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e55713	10.1371/journal.pone.0055713	http://dx.doi.org/10.1371/journal.pone.0055713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520447	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900006
J	Sudo, H; Yamada, K; Iwasaki, K; Higashi, H; Ito, M; Minami, A; Iwasaki, N				Sudo, Hideki; Yamada, Katsuhisa; Iwasaki, Koji; Higashi, Hideaki; Ito, Manabu; Minami, Akio; Iwasaki, Norimasa			Global Identification of Genes Related to Nutrient Deficiency in Intervertebral Disc Cells in an Experimental Nutrient Deprivation Model	PLOS ONE			English	Article							NUCLEUS PULPOSUS CELLS; MICROARRAY ANALYSIS; CASPASE 3; DEGENERATION; EXPRESSION; APOPTOSIS; P21(CIP1/WAF1); PATHOGENESIS; INHIBITION; ACTIVATION	Background: Intervertebral disc degeneration is a significant cause of degenerative spinal diseases. Nucleus pulposus (NP) cells reportedly fail to survive in large degenerated discs with limited nutrient availability. Therefore, understanding the regulatory mechanism of the molecular response of NP cells to nutrient deprivation may reveal a new strategy to treat disc degeneration. This study aimed to identify genes related to nutrient deprivation in NP cells on a global scale in an experimental nutrient deprivation model. Methodology/Principal Findings: Rat NP cells were subjected to serum starvation. Global gene expression was profiled by microarray analysis. Confirmation of the selected genes was obtained by real-time polymerase chain reaction array analysis. Western blotting was used to confirm the expression of selected genes. Functional interactions between p21(Cip1) and caspase 3 were examined. Finally, flow cytometric analyses of NP cells were performed. Microarray analysis revealed 2922 differentially expressed probe sets with >= 1.5-fold changes in expression. Serum starvation of NP cells significantly affected the expression of several genes involved in DNA damage checkpoints of the cell cycle, including Atm, Brca1, Cdc25, Gadd45, Hus1, Ppm1D, Rad 9, Tp53, and Cyclin D1. Both p27(Kip1) and p53 protein expression was upregulated in serum-starved cells. p21(Cip1) expression remained in NP cells transfected with short interfering RNA targeting caspase 3 (caspase 3 siRNA). Both G1 arrest and apoptosis induced by serum starvation were inhibited in cells transfected with caspase 3 siRNA. Conclusions/Significance: Nutrient deprivation in NP cells results in the activation of a signaling response including DNA damage checkpoint genes regulating the cell cycle. These results provide novel possibilities to improve the success of intervertebral disc regenerative techniques.	[Sudo, Hideki; Ito, Manabu] Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan; [Yamada, Katsuhisa; Iwasaki, Koji; Minami, Akio; Iwasaki, Norimasa] Hokkaido Univ, Dept Orthopaed Surg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Higashi, Hideaki] Hokkaido Univ, Div Infect & Immun, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Sudo, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan.	hidekisudo@yahoo.co.jp	Higashi, Hideaki/F-6872-2012; Sudo, Hideki/G-2748-2012	Iwasaki, Koji/0000-0002-4525-9150	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20591733]; Japan Orthopaedics and Traumatology Foundation (JOTF); Takeda Science Foundation; Suzuken Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Orthopaedics and Traumatology Foundation (JOTF); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (20591733), the Japan Orthopaedics and Traumatology Foundation (JOTF), the Takeda Science Foundation, and the Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladin DMK, 2007, SPINE, V32, P2820, DOI 10.1097/BRS.0b013e31815b75c5; Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cheung KMC, 2010, SPINE J, V10, P958, DOI 10.1016/j.spinee.2010.09.011; Chung SA, 2007, SPINE, V32, P1188, DOI 10.1097/BRS.0b013e31805471a3; Dai SM, 2006, ARTHRITIS RHEUM-US, V54, P818, DOI 10.1002/art.21639; Evans C, 2006, J BONE JOINT SURG AM, V88A, P95, DOI 10.2106/JBJS.E.01328; Feng Z, 2007, BRAIN RES, V1177, P103, DOI 10.1016/j.brainres.2007.07.047; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; Gruber HE, 2007, SPINE, V32, P1181, DOI 10.1097/BRS.0b013e318053ec89; Gruber HE, 2011, SPINE J, V11, P782, DOI 10.1016/j.spinee.2011.06.012; Guehring T, 2009, ARTHRITIS RHEUM-US, V60, P1026, DOI 10.1002/art.24407; Hristova GI, 2011, J ORTHOP RES, V29, P1888, DOI 10.1002/jor.21456; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Kanno T, 2012, ONCOGENE, V31, P3098, DOI 10.1038/onc.2011.475; Kokkonen SM, 2002, SPINE, V27, P2274, DOI 10.1097/00007632-200210150-00017; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lin JY, 1996, MOL CELL BIOL, V16, P1786; Mavrogonatou E, 2010, J ORTHOP RES, V28, P1276, DOI 10.1002/jor.21140; Moskalev AA, 2012, AGEING RES REV, V11, P51, DOI 10.1016/j.arr.2011.09.003; Nakai T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2567; Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3; Reddi AH, 2011, ARTHRITIS RHEUM-US, V63, P1477, DOI 10.1002/art.30252; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sudo H, 2011, ARTHRITIS RHEUM-US, V63, P1648, DOI 10.1002/art.30251; Sudo H, 2010, J ORTHOP RES, V28, P1608, DOI 10.1002/jor.21185; Tang JJ, 2006, MOL CELL BIOCHEM, V291, P139, DOI 10.1007/s11010-006-9206-7; Uchida K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-84; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005	33	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58806	10.1371/journal.pone.0058806	http://dx.doi.org/10.1371/journal.pone.0058806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520533	gold, Green Submitted, Green Published			2022-12-27	WOS:000318679900093
J	Perrini, S; Ficarella, R; Picardi, E; Cignarelli, A; Barbaro, M; Nigro, P; Peschechera, A; Palumbo, O; Carella, M; De Fazio, M; Natalicchio, A; Laviola, L; Pesole, G; Giorgino, F				Perrini, Sebastio; Ficarella, Romina; Picardi, Ernesto; Cignarelli, Angelo; Barbaro, Maria; Nigro, Pasquale; Peschechera, Alessandro; Palumbo, Orazio; Carella, Massimo; De Fazio, Michele; Natalicchio, Annalisa; Laviola, Luigi; Pesole, Graziano; Giorgino, Francesco			Differences in Gene Expression and Cytokine Release Profiles Highlight the Heterogeneity of Distinct Subsets of Adipose Tissue-Derived Stem Cells in the Subcutaneous and Visceral Adipose Tissue in Humans	PLOS ONE			English	Article							GLUCOSE-UPTAKE; BONE-MARROW; CORD BLOOD; FAT-CELLS; IN-VITRO; ADIPOCYTES; POPULATIONS; SIGNATURES; OBESITY; MASS	Differences in the inherent properties of adipose tissue-derived stem cells (ASC) may contribute to the biological specificity of the subcutaneous (Sc) and visceral (V) adipose tissue depots. In this study, three distinct subpopulations of ASC, i.e. ASC(SVF), ASC(Bottom), and ASC(Ceiling), were isolated from Sc and V fat biopsies of non-obese subjects, and their gene expression and functional characteristics were investigated. Genome-wide mRNA expression profiles of ASC(SVF), ASC(Bottom) and ASC(Ceiling) from Sc fat were significantly different as compared to their homologous subsets of V-ASCs. Furthermore, ASC(SVF), ASC(Ceiling) and ASC(Bottom) from the same fat depot were also distinct from each other. In this respect, both principal component analysis and hierarchical clusters analysis showed that ASC(Ceiling) and ASC(SVF) shared a similar pattern of closely related genes, which was highly different when compared to that of ASC(Bottom). However, larger variations in gene expression were found in inter-depot than in intra-depot comparisons. The analysis of connectivity of genes differently expressed in each ASC subset demonstrated that, although there was some overlap, there was also a clear distinction between each Sc-ASC and their corresponding V-ASC subsets, and among ASC(SVF), ASC(Bottom), and ASC(Ceiling) of Sc or V fat depots in regard to networks associated with regulation of cell cycle, cell organization and development, inflammation and metabolic responses. Finally, the release of several cytokines and growth factors in the ASC cultured medium also showed both inter-and intra-depot differences. Thus, ASC(Ceiling) and ASC(Bottom) can be identified as two genetically and functionally heterogeneous ASC populations in addition to the ASC(SVF), with ASC(Bottom) showing the highest degree of unmatched gene expression. On the other hand, inter-depot seem to prevail over intra-depot differences in the ASC gene expression assets and network functions, contributing to the high degree of specificity of Sc and V adipose tissue in humans.	[Perrini, Sebastio; Ficarella, Romina; Cignarelli, Angelo; Barbaro, Maria; Nigro, Pasquale; Peschechera, Alessandro; Natalicchio, Annalisa; Laviola, Luigi; Giorgino, Francesco] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Internal Med Endocrinol Androl & Metab Dis, Bari, Italy; [De Fazio, Michele] Univ Bari Aldo Moro, Sect Gen Surg & Liver Transplantat, Bari, Italy; [Picardi, Ernesto; Pesole, Graziano] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Pharmacol Sci, Bari, Italy; [Pesole, Graziano] CNR, Inst Biomembranes & Bioenerget, Bari, Italy; [Palumbo, Orazio; Carella, Massimo] Ist Ricovero & Cura Carattere Sci Casa Sollievo S, San Giovanni Rotondo, FG, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Giorgino, F (corresponding author), Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Internal Med Endocrinol Androl & Metab Dis, Bari, Italy.	francesco.giorgino@uniba.it	Picardi, Ernesto/A-5863-2015; PALUMBO, ORAZIO/C-1133-2014; Laviola, Luigi/AAC-2237-2022; Pesole, Graziano/E-9051-2014; Giorgino, Francesco/K-7262-2016; Cignarelli, Angelo/I-6353-2013; Pesole, Graziano/K-5283-2019; Carella, Massimo/A-2804-2014	Picardi, Ernesto/0000-0002-6549-0114; PALUMBO, ORAZIO/0000-0001-6583-3482; Pesole, Graziano/0000-0003-3663-0859; Giorgino, Francesco/0000-0001-7372-2678; Cignarelli, Angelo/0000-0001-6477-9031; FOSCHINO BARBARO, MARIA PIA/0000-0001-9939-2697; Carella, Massimo/0000-0002-6830-6829; Perrini, Sebastio/0000-0002-2728-7721	Ministero dell'Universita e Ricerca (Italy); COST Action BM0602; Fondazione della Societa Italiana di Diabetologia per la Ricerca in Diabetologia e Malattie Metaboliche (Fo.Ri.SID); NovoNordisk	Ministero dell'Universita e Ricerca (Italy)(Ministry of Education, Universities and Research (MIUR)); COST Action BM0602(European Cooperation in Science and Technology (COST)); Fondazione della Societa Italiana di Diabetologia per la Ricerca in Diabetologia e Malattie Metaboliche (Fo.Ri.SID); NovoNordisk(Novo Nordisk)	This work was supported in part by grants from the Ministero dell'Universita e Ricerca (Italy), the COST Action BM0602, the Fondazione della Societa Italiana di Diabetologia per la Ricerca in Diabetologia e Malattie Metaboliche (Fo.Ri.SID), and NovoNordisk to F. Giorgino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Bluher M, 2007, DIABETES CARE, V30, P3110, DOI 10.2337/dc07-1257; Bombelli M, 2011, HYPERTENSION, V58, P1029, DOI 10.1161/HYPERTENSIONAHA.111.175125; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Despres JP, 2001, ANN MED, V33, P534, DOI 10.3109/07853890108995963; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Fain JN, 2008, INT J OBESITY, V32, P429, DOI 10.1038/sj.ijo.0803745; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hausman GJ, 2006, J CLIN INVEST, V116, P3103, DOI 10.1172/JCI30666; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Hwang JH, 2009, J KOREAN MED SCI, V24, P547, DOI 10.3346/jkms.2009.24.4.547; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892; Kovsan J, 2009, AM J PHYSIOL-ENDOC M, V296, pE315, DOI 10.1152/ajpendo.90486.2008; Laviola L, 2006, DIABETES, V55, P952, DOI 10.2337/diabetes.55.04.06.db05-1414; Lundgren M, 2004, J CLIN ENDOCR METAB, V89, P2989, DOI 10.1210/jc.2003-031157; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Miyazaki T, 2005, DIFFERENTIATION, V73, P69, DOI 10.1111/j.1432-0436.2005.07302004.x; Peinado JR, 2012, PROTEOMICS, V12, P607, DOI 10.1002/pmic.201100355; Peng LY, 2008, STEM CELLS DEV, V17, P761, DOI 10.1089/scd.2007.0217; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Perrini S, 2008, ENDOCRINOLOGY, V149, P1302, DOI 10.1210/en.2007-1349; Perrini Sebastio, 2009, Archives of Physiology and Biochemistry, V115, P218, DOI 10.1080/13813450903260864; Perrini Sebastio, 2008, Archives of Physiology and Biochemistry, V114, P277, DOI [10.1080/13813450802334752, 10.1080/13813450802334752 ]; Piantoni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-331; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Tam CS, 2011, INT J PEDIATR OBES, V6, pE360, DOI 10.3109/17477166.2011.575152; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Nora CCV, 2012, STEM CELLS DEV, V21, P1761, DOI 10.1089/scd.2011.0030; Virtanen KA, 2002, J CLIN ENDOCR METAB, V87, P3902, DOI 10.1210/jc.87.8.3902	41	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57892	10.1371/journal.pone.0057892	http://dx.doi.org/10.1371/journal.pone.0057892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526958	Green Published, gold, Green Submitted			2022-12-27	WOS:000315637900060
J	Li, Y; Zhang, Q; Carreira-Rosario, A; Maines, JZ; McKearin, DM; Buszczak, M				Li, Yun; Zhang, Qiao; Carreira-Rosario, Arnaldo; Maines, Jean Z.; McKearin, Dennis M.; Buszczak, Michael			Mei-P26 Cooperates with Bam, Bgcn and Sxl to Promote Early Germline Development in the Drosophila Ovary	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; SEX-LETHAL; OF-MARBLES; PROTEIN-LEVELS; SELF-RENEWAL; GENE; NANOS; PROLIFERATION; TRANSCRIPTION; MAINTENANCE	In the Drosophila female germline, spatially and temporally specific translation of mRNAs governs both stem cell maintenance and the differentiation of their progeny. However, the mechanisms that control and coordinate different modes of translational repression within this lineage remain incompletely understood. Here we present data showing that Mei-P26 associates with Bam, Bgcn and Sxl and nanos mRNA during early cyst development, suggesting that this protein helps to repress the translation of nanos mRNA. Together with recently published studies, these data suggest that Mei-P26 mediates both GSC self-renewal and germline differentiation through distinct modes of translational repression depending on the presence of Bam.	[Li, Yun; Zhang, Qiao; Carreira-Rosario, Arnaldo; Maines, Jean Z.; Buszczak, Michael] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [McKearin, Dennis M.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Buszczak, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	michael.buszczak@utsouthwestern.edu		Buszczak, Michael/0000-0001-6361-3654; Carreira-Rosario, Arnlado/0000-0003-0202-3858	E.E. and Greer Garson Fogelson endowment for scholars program (UTSW Medical Center); National Institutes of Health [GM045820]; National Institutes of Health, National Research Service Award from the National Institute of General Medical Sciences [T32GM083831]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083831, R01GM045820] Funding Source: NIH RePORTER	E.E. and Greer Garson Fogelson endowment for scholars program (UTSW Medical Center); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Research Service Award from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by the E.E. and Greer Garson Fogelson endowment for scholars program (UTSW Medical Center), the National Institutes of Health (GM045820) (MB) and by the National Institutes of Health, National Research Service Award T32GM083831 from the National Institute of General Medical Sciences (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casper A, 2006, DEVELOPMENT, V133, P2783, DOI 10.1242/dev.02415; Chau J, 2012, P NATL ACAD SCI USA, V109, P9465, DOI 10.1073/pnas.1120473109; Chau J, 2009, GENETICS, V182, P121, DOI 10.1534/genetics.109.100693; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Forbes A, 1998, DEVELOPMENT, V125, P679; Glasscock E, 2005, GENETICS, V170, P1677, DOI 10.1534/genetics.105.043174; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Herranz H, 2010, EMBO J, V29, P1688, DOI 10.1038/emboj.2010.69; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; Liu NK, 2009, GENE DEV, V23, P2742, DOI 10.1101/gad.1820709; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Ohlstein B, 2000, GENETICS, V155, P1809; Page SL, 2000, GENETICS, V155, P1757; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; SALZ HK, 1992, GENETICS, V130, P547; SCHUPBACH T, 1985, GENETICS, V109, P529; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Staab S, 1996, DEVELOPMENT, V122, P4065; Tastan OY, 2010, DEVELOPMENT, V137, P3167, DOI 10.1242/dev.050575; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; WEI G, 1994, DEV BIOL, V161, P318, DOI 10.1006/dbio.1994.1032; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yang LL, 2007, DEVELOPMENT, V134, P4265, DOI 10.1242/dev.009159	31	41	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58301	10.1371/journal.pone.0058301	http://dx.doi.org/10.1371/journal.pone.0058301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526974	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600017
J	Pan, YX; Trojan, J; Guo, YJ; Anthony, DD				Pan, Yuexin; Trojan, Jerzy; Guo, Yajun; Anthony, Donald D.			Rescue of MHC-1 Antigen Processing Machinery by Down-Regulation in Expression of IGF-1 in Human Glioblastoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR-I; GLIOMA-CELLS; RAT GLIOBLASTOMA; INTERFERON-GAMMA; GENE-THERAPY; IFN-GAMMA; TRANSPORTER; INSULIN; MELANOMA; CANCER	Escape from immune recognition has been hypothesized to be a factor in carcinogenesis. It may be mediated for many cancers through down-regulation in the MHC class 1 antigen processing and presentation pathway. TAP-1, TAP-2, tightly linked to LMP-2 and LMP-7 are multiple components of the endogenous, antigen presentation pathway machinery. We addressed the question of alterations in this pathway in human Glioblastoma (HGB) and of its relationship to modulation in expression of IGF-1 that is highly expressed in this cancer. Deficiencies in expression of TAP-1 were demonstrated by RT-PCR and/or by immuno-flow cytometry in the HGB cell line T98G obtained from ATCC, and in 3 of 4 human cell lines established from patients with Glioblastoma Multiforme. Deficiencies in expression of TAP-2 were observed in 3 of 4, deficiencies in expression of LMP-2 in 4 of 4 and deficiencies in LMP-7 in 3 of 4 HGB cell lines examined by RT-PCR and Western blot. Following down-regulation of IGF-1 by transfection with the pAnti IGF-1 vector that expresses IGF-1 RNA in antisense orientation, or by the exogenous addition of IGF-1 receptor monoclonal antibody to cell culture media, the deficiencies in components of the MHC-1 antigen presentation pathway were up-regulated and/or rescued in all HGB cell lines tested. Moreover, this up-regulation in expression was aborted by addition of 100 ng/ml of IGF-1 to the culture media. Unlike in the case of IFN-gamma, the restoration of TAP-1 and LMP-2 by down-regulation of IGF-1 in Glioblastoma cells was not correlated to the tyrosine phosphorylation of STAT 1. In summary, the simultaneous reversion in expression of the multiple constituents of MHC-1 antigen processing path and up-regulation in expression of MHC-1 occurring with down-regulation in IGF-1 may have a role in reinforcement of immunity against tumor antigen(s) in some animal cancers and in humans with Glioblastoma Multiforme.	[Pan, Yuexin; Anthony, Donald D.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci, Cleveland, OH 44106 USA; [Pan, Yuexin; Anthony, Donald D.] Univ Hosp Cleveland, Dept Med, Cleveland, OH 44106 USA; [Trojan, Jerzy] Univ Paris 11, Paul Brousse Hosp, INSERM, U542, Villejuif, France; [Trojan, Jerzy] Univ Paris 11, Paul Brousse Hosp, U602, Villejuif, France; [Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China	Case Western Reserve University; University Hospitals of Cleveland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Naval Medical University	Anthony, DD (corresponding author), Case Western Reserve Univ, Sch Med, Div Gen Med Sci, Cleveland, OH 44106 USA.	dda2@case.edu	Trojan, Jerzy/AAL-5183-2020		American Cancer Society [CN-8 A]; Ohio Board of Regents	American Cancer Society(American Cancer Society); Ohio Board of Regents	The work was supported by American Cancer Society grant CN-8 A, a grant from the Ohio Board of Regents and by gifts from the following benefactors: Marcia & Robert Williams, Regina & David Letterman, the Paul Newman Foundation, Mrs. Helen Wright, Mr. & Mrs. Edward Yoman, Mrs. Elizabeth Becker, Kimberly Birn & family, Mrs. Verna Warpula, Herbert Braverman, John D. Proctor, Harold & Clare Minoff, James & Rosemary Koehler, Wm. Gustaferro & family, Edward & Mary Lasko, and other unnamed donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Alyssa J, 1998, CANCER RES, V58, P3600; [Anonymous], J BIOL CHEM, V273, P16177; Anthony DD, 1998, ADV EXP MED BIOL, V451, P27; Baik I, 2005, CANCER RES, V65, P358; Beck S, 1996, J MOL BIOL, V255, P1, DOI 10.1006/jmbi.1996.0001; Brucet M, 2004, GENES IMMUN, V5, P26, DOI 10.1038/sj.gene.6364035; Cramer LA, 2000, J IMMUNOL, V165, P3190, DOI 10.4049/jimmunol.165.6.3190; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Flutter B, 2004, CELL MOL IMMUNOL, V1, P22; Gibson JM, 2001, MOL HUM REPROD, V7, P79, DOI 10.1093/molehr/7.1.79; Giuliani C, 2006, J ENDOCRINOL, V189, P605, DOI 10.1677/joe.1.06486; Groettrup M, 2001, CRIT REV IMMUNOL, V21, P339; Guo Y, 2002, INT IMMUNOL, V14, P189, DOI 10.1093/intimm/14.2.189; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hofmann Matthias, 2001, Expert Opin Ther Targets, V5, P379, DOI 10.1517/14728222.5.3.379; Inoue M, 2012, ONCOIMMUNOLOGY, V1, P1104, DOI 10.4161/onci.21056; Kamarashev J, 2001, INT J CANCER, V95, P23, DOI 10.1002/1097-0215(20010120)95:1<23::AID-IJC1004>3.0.CO;2-4; LafargeFrayssinet C, 1997, CANCER GENE THER, V4, P276; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lankat-Buttgereit B, 1999, FEBS LETT, V464, P108, DOI 10.1016/S0014-5793(99)01676-2; Li P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011859; Liu YJ, 2000, CANCER GENE THER, V7, P456, DOI 10.1038/sj.cgt.7700137; Ly A, 2001, J CLIN PATHOL-MOL PA, V54, P230, DOI 10.1136/mp.54.4.230; Ly A, 2000, NEUROSCI LETT, V281, P13, DOI 10.1016/S0304-3940(00)00758-8; Ma XM, 2012, MOL MED REP, V6, P1433, DOI 10.3892/mmr.2012.1110; Matsui M, 2002, J GASTROEN HEPATOL, V17, P897, DOI 10.1046/j.1440-1746.2002.02837.x; MONACO JJ, 1995, J LEUKOCYTE BIOL, V57, P543, DOI 10.1002/jlb.57.4.543; Murray JL, 2000, J IMMUNOTHER, V23, P28, DOI 10.1097/00002371-200001000-00005; Niedermann G, 2002, CURR TOP MICROBIOL, V268, P91; Pan YX, 2000, METH MOLEC MED, V35, P189, DOI 10.1385/1-59259-086-1:189; Petersson M, 1998, J IMMUNOL, V161, P2099; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Seliger B, 2001, CANCER RES, V61, P8647; Straten PT, 1997, INT J CANCER, V70, P582; TROJAN J, 1993, SCIENCE, V259, P94, DOI 10.1126/science.8418502; TROJAN J, 1994, P NATL ACAD SCI USA, V91, P6088, DOI 10.1073/pnas.91.13.6088; Trojan J, 1996, NEUROSCI LETT, V212, P9, DOI 10.1016/0304-3940(96)12770-1; TROJAN J, 1992, P NATL ACAD SCI USA, V89, P4874, DOI 10.1073/pnas.89.11.4874; Upegui-Gonzalez LC, 2001, HEPATO-GASTROENTEROL, V48, P660; Vitale M, 1998, CANCER RES, V58, P737; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58428	10.1371/journal.pone.0058428	http://dx.doi.org/10.1371/journal.pone.0058428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526983	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600022
J	Feng, HJ; Tian, XH; Liu, YC; Li, YJ; Zhang, XY; Jones, BJ; Sun, YQ; Sun, J				Feng, Hongjie; Tian, Xinhui; Liu, Yongchang; Li, Yanjun; Zhang, Xinyu; Jones, Brian Joseph; Sun, Yuqiang; Sun, Jie			Analysis of Flavonoids and the Flavonoid Structural Genes in Brown Fiber of Upland Cotton	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; FRUIT-DEVELOPMENT; COLORFUL MODEL; GRAPE BERRIES; HUMAN HEALTH; EXPRESSION; PROANTHOCYANIDIN; IDENTIFICATION; BIOTECHNOLOGY; BIOCHEMISTRY	Backgroud: As a result of changing consumer preferences, cotton (Gossypium Hirsutum L.) from varieties with naturally colored fibers is becoming increasingly sought after in the textile industry. The molecular mechanisms leading to colored fiber development are still largely unknown, although it is expected that the color is derived from flavanoids. Experimental Design: Firstly, four key genes of the flavonoid biosynthetic pathway in cotton (GhC4H, GhCHS, GhF3'H, and GhF3'5'H) were cloned and studied their expression profiles during the development of brown-and white cotton fibers by QRT-PCR. And then, the concentrations of four components of the flavonoid biosynthetic pathway, naringenin, quercetin, kaempferol and myricetin in brown-and white fibers were analyzed at different developmental stages by HPLC. Result: The predicted proteins of the four flavonoid structural genes corresponding to these genes exhibit strong sequence similarity to their counterparts in various plant species. Transcript levels for all four genes were considerably higher in developing brown fibers than in white fibers from a near isogenic line (NIL). The contents of four flavonoids (naringenin, quercetin, kaempferol and myricetin) were significantly higher in brown than in white fibers and corresponding to the biosynthetic gene expression levels. Conclusions: Flavonoid structural gene expression and flavonoid metabolism are important in the development of pigmentation in brown cotton fibers.	[Feng, Hongjie; Tian, Xinhui; Liu, Yongchang; Li, Yanjun; Zhang, Xinyu; Sun, Jie] Shihezi Univ, Coll Agr, Key Lab Oasis Ecoagr, Shihezi, Peoples R China; [Jones, Brian Joseph] Univ Sydney, Fac Agr & Environm, Sydney, NSW 2006, Australia; [Sun, Yuqiang] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Shihezi University; University of Sydney; Hangzhou Normal University	Sun, YQ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	yqsun@hznu.edu.cn; sunjiezh@yahoo.com.cn	Jones, Brian m/E-8848-2016	Sun, Jie/0000-0002-8068-8102; Feng, Hongjie/0000-0001-8039-3227	National Basic Research Priorities Program [2007CD116210]; National Transgenic Major Projects [2011ZX08005]	National Basic Research Priorities Program(National Basic Research Program of China); National Transgenic Major Projects	This work was supported by the National Basic Research Priorities Program (Grant No: 2007CD116210) and National Transgenic Major Projects (No. 2011ZX08005). The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, AGRON ABROAD COTTON, V3, P172; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Castellarin SD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-12; Chen HJ, 2012, INT J MOL SCI, V13, P260, DOI 10.3390/ijms13010260; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Gould K. S., 2006, Flavonoids: chemistry, biochemistry and applications, P397; Gutha LR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-187; HALL TC, 1978, P NATL ACAD SCI USA, V75, P3196, DOI 10.1073/pnas.75.7.3196; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jaakola L, 2002, PLANT PHYSIOL, V130, P729, DOI 10.1104/pp.006957; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KOHEL RJ, 1985, CROP SCI, V25, P793, DOI 10.2135/cropsci1985.0011183X0025000500017x; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; Lunkenbein S, 2006, J AGR FOOD CHEM, V54, P2145, DOI 10.1021/jf052574z; Luo Ming, 2003, Acta Genetica Sinica, V30, P175; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; [邱新棉 Qiu Xinmian], 2004, [棉花学报, Cotton Science], V16, P249; Qiu XinMian, 2002, Scientia Agricultura Sinica, V35, P610; RYSER U, 1983, PROTOPLASMA, V117, P196, DOI 10.1007/BF01281823; Schoch GA, 2003, EUR J BIOCHEM, V270, P3684, DOI 10.1046/j.1432-1033.2003.03739.x; [Shi Yuzhen 石玉真], 2002, [棉花学报, Acta Gossypii Sinica], V14, P242; Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turnbull JJ, 2004, J BIOL CHEM, V279, P1206, DOI 10.1074/jbc.M309228200; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Ververidis Filippos, 2007, Biotechnology Journal, V2, P1214, DOI 10.1002/biot.200700084; Vreeland JM, 1999, SCI AM, V280, P112, DOI 10.1038/scientificamerican0499-112; Wang J, 2012, PHARMACOGN MAG, V8, P166, DOI 10.4103/0973-1296.96581; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xiao YH, 2007, BIOCHEM BIOPH RES CO, V358, P73, DOI 10.1016/j.bbrc.2007.04.084; YATSU LY, 1983, PLANT PHYSIOL, V73, P521, DOI 10.1104/pp.73.2.521; Zhan SH, 2008, CHINESE AGR SCI B, V24, P146; Zhao XiangQian, 2005, Acta Agronomica Sinica, V31, P456	40	42	50	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58820	10.1371/journal.pone.0058820	http://dx.doi.org/10.1371/journal.pone.0058820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527031	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100046
J	de Haan, TR; Beckers, L; de Jonge, RCJ; Spanjaard, L; van Toledo, L; Pajkrt, D; van Wassenaer-Leemhuis, AG; van der Lee, JH				de Haan, Timo R.; Beckers, Loes; de Jonge, Rogier C. J.; Spanjaard, Lodewijk; van Toledo, Letty; Pajkrt, Dasja; van Wassenaer-Leemhuis, Aleid G.; van der Lee, Johanna H.			Neonatal Gram Negative and Candida Sepsis Survival and Neurodevelopmental Outcome at the Corrected Age of 24 Months	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; LATE-ONSET SEPSIS; RISK-FACTORS; RESEARCH NETWORK; INFECTION; PREMATURITY; RETINOPATHY; MORTALITY; FUNGAL	Objectives: To evaluate the long term neurodevelopmental outcome of premature infants exposed to either gram-negative sepsis (GNS) or neonatal Candida sepsis (NCS), and to compare their outcome with premature infants without sepsis. Methods: Historical cohort study in a population of infants born at <30 weeks gestation and admitted to the Neonatal Intensive Care Unit (NICU) of the Academic Medical Center in Amsterdam during the period 1997-2007. Outcome of infants exposed to GNS or NCS and 120 randomly chosen uncomplicated controls (UC) from the same NICU were compared. Clinical data during hospitalization and neurodevelopmental outcome data (clinical neurological status; Bayley -test results and vision/hearing test results) at the corrected age of 24 months were collected. An association model with sepsis as the central determinant of either good or adverse outcome (death or severe developmental delay) was made, corrected for confounders using multiple logistic regression analysis. Results: Of 1362 patients, 55 suffered from GNS and 29 suffered from NCS; cumulative incidence 4.2% and 2.2%, respectively. During the follow-up period the mortality rate was 34% for both GNS and NCS and 5% for UC. The adjusted Odds Ratio (OR) [95% CI] for adverse outcome in the GNS group compared to the NCS group was 1.4 [0.4-4.9]. The adjusted ORs [95% CI] for adverse outcome in the GNS and NCS groups compared to the UC group were 4.8 [1.5-15.9] and 3.2 [0.7-14.7], respectively. Conclusions: We found no statistically significant difference in outcome at the corrected age of 24 months between neonatal GNS and NCS cases. Suffering from either gram -negative or Candida sepsis increased the odds for adverse outcome compared with an uncomplicated neonatal period.	[de Haan, Timo R.; Beckers, Loes; van Toledo, Letty; van Wassenaer-Leemhuis, Aleid G.] Acad Med Ctr Amsterdam, Emma Childrens Hosp, Dept Neonatol, Amsterdam, Netherlands; [de Jonge, Rogier C. J.] Erasmus MC Sophia Childrens Hosp, Dept Neonatol, Rotterdam, Netherlands; [Spanjaard, Lodewijk] Univ Amsterdam, Acad Med Ctr, Dept Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Pajkrt, Dasja] Acad Med Ctr Amsterdam, Dept Pediat Infect Dis, Amsterdam, Netherlands; [van der Lee, Johanna H.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Clin Epidemiol, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	de Haan, TR (corresponding author), Acad Med Ctr Amsterdam, Emma Childrens Hosp, Dept Neonatol, Amsterdam, Netherlands.	t.r.dehaan@amc.uva.nl	de Jonge, R./M-9912-2014	de Jonge, R./0000-0003-0595-1983				Bancalari E, 2006, SEMIN PERINATOL, V30, P164, DOI 10.1053/j.semperi.2006.05.002; Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6; Bayley N, 2011, BAYLEY SCALES INFANT, V3rd ed.; Benjamin Daniel K, 2004, J Perinatol, V24, P175, DOI 10.1038/sj.jp.7211068; Benjamin DK, 2010, PEDIATRICS, V126, pE865, DOI 10.1542/peds.2009-3412; Benjamin DK, 2006, PEDIATRICS, V117, P84, DOI 10.1542/peds.2004-2292; Benjamin DK, 2003, SEMIN PERINATOL, V27, P375, DOI 10.1016/S0146-0005(03)00061-2; Bharwani SK, 2008, J PERINATOL, V28, P61, DOI 10.1038/sj.jp.7211878; Chen MH, 2011, NEONATOLOGY, V99, P125, DOI 10.1159/000312821; Doctor BA, 2001, CLIN PEDIATR, V40, P473, DOI 10.1177/000992280104000901; Downey LC, 2010, EARLY HUM DEV, V86, pS7, DOI 10.1016/j.earlhumdev.2010.01.012; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Gordon A, 2006, PEDIATR INFECT DIS J, V25, P25, DOI 10.1097/01.inf.0000195628.35980.2e; GRAY JE, 1992, PEDIATRICS, V90, P561; Jary S, 2011, J PEDIAT; Khassawneh M, 2009, PEDIATR INT, V51, P332, DOI 10.1111/j.1442-200X.2008.02767.x; Klinger G, 2010, PEDIATRICS, V125, pE736, DOI 10.1542/peds.2009-2017; Leonard CH, 2001, J PEDIATR PSYCHOL, V26, P33, DOI 10.1093/jpepsy/26.1.33; Makhoul IR, 2007, J HOSP INFECT, V65, P237, DOI 10.1016/j.jhin.2006.12.004; Manzoni P, 2006, J PERINATOL, V26, P23, DOI 10.1038/sj.jp.7211420; Moylett Edina H, 2003, Semin Pediatr Infect Dis, V14, P115, DOI 10.1053/spid.2003.127128; Pereira SMP, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/427682; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Saiman L, 2000, PEDIATR INFECT DIS J, V19, P319, DOI 10.1097/00006454-200004000-00011; Samanta S, 2011, ARCH DIS CHILD-FETAL, V96, pF15, DOI 10.1136/adc.2009.169540; Sastre JBL, 2003, AM J PERINAT, V20, P153; Shetty SS, 2005, PEDIATR INFECT DIS J, V24, P601, DOI 10.1097/01.inf.0000168751.11375.d6; Stoll BJ, 2005, PEDIATR INFECT DIS J, V24, P635, DOI 10.1097/01.inf.0000168749.82105.64; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285	30	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59214	10.1371/journal.pone.0059214	http://dx.doi.org/10.1371/journal.pone.0059214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527140	Green Published, gold			2022-12-27	WOS:000316411600051
J	Mu, XD; Bellayr, I; Pan, HY; Choi, YH; Li, Y				Mu, Xiaodong; Bellayr, Ian; Pan, Haiying; Choi, Yohan; Li, Yong			Regeneration of Soft Tissues Is Promoted by MMP1 Treatment after Digit Amputation in Mice	PLOS ONE			English	Article							INJURED SKELETAL-MUSCLE; MATRIX METALLOPROTEINASES; LIMB REGENERATION; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX; NERVE REGENERATION; GENE-EXPRESSION; UTROPHIN GENE; CELL-ADHESION; GROWTH-FACTOR	The ratio of matrix metalloproteinases (MMPs) to the tissue inhibitors of metalloproteinases (TIMPs) in wounded tissues strictly control the protease activity of MMPs, and therefore regulate the progress of wound closure, tissue regeneration and scar formation. Some amphibians (i.e. axolotl/newt) demonstrate complete regeneration of missing or wounded digits and even limbs; MMPs play a critical role during amphibian regeneration. Conversely, mammalian wound healing re-establishes tissue integrity, but at the expense of scar tissue formation. The differences between amphibian regeneration and mammalian wound healing can be attributed to the greater ratio of MMPs to TIMPs in amphibian tissue. Previous studies have demonstrated the ability of MMP1 to effectively promote skeletal muscle regeneration by favoring extracellular matrix (ECM) remodeling to enhance cell proliferation and migration. In this study, MMP1 was administered to the digits amputated at the mid-second phalanx of adult mice to observe its effect on digit regeneration. Results indicated that the regeneration of soft tissue and the rate of wound closure were significantly improved by MMP1 administration, but the elongation of the skeletal tissue was insignificantly affected. During digit regeneration, more mutipotent progenitor cells, capillary vasculature and neuromuscular-related tissues were observed in MMP1 treated tissues; moreover, there was less fibrotic tissue formed in treated digits. In summary, MMP1 was found to be effective in promoting wound healing in amputated digits of adult mice.	[Mu, Xiaodong; Bellayr, Ian] Childrens Hosp UPMC, Stem Cell Res Ctr, Lab Mol Pathol, Pittsburgh, PA USA; [Mu, Xiaodong] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Bellayr, Ian] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Pan, Haiying; Choi, Yohan; Li, Yong] Univ Texas Houston, Sch Med, Dept Pediat Surg, Houston, TX 77030 USA; [Pan, Haiying; Choi, Yohan; Li, Yong] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell Res & Regenerat Med, Houston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Li, Y (corresponding author), Univ Texas Houston, Sch Med, Dept Pediat Surg, Houston, TX 77030 USA.	yong.li.1@uth.tmc.edu	Li, Yong/AAM-2367-2021	Li, Yong/0000-0001-7956-9600	NIH; DOD	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense)	This study was partially support from NIH and DOD grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106; Alameddine HS, 2012, NEUROBIOL DIS, V48, P508, DOI 10.1016/j.nbd.2012.07.023; Bates CA, 1999, EXP NEUROL, V155, P128, DOI 10.1006/exnr.1998.6972; Beare AHM, 2003, J INVEST DERMATOL, V120, P153, DOI 10.1046/j.1523-1747.2003.12019.x; Bedair H, 2007, J APPL PHYSIOL, V102, P2338, DOI 10.1152/japplphysiol.00670.2006; Bellayr IH, 2009, FUTURE MED CHEM, V1, P1095, DOI 10.4155/FMC.09.83; Bhogal RK, 2005, J CLIN IMMUNOL, V25, P592, DOI 10.1007/s10875-005-7827-3; Call MK, 2005, ADV BIOCHEM ENG BIOT, V93, P67, DOI 10.1007/b99967; Chen W, 2007, INT J BIOCHEM CELL B, V39, P997, DOI 10.1016/j.biocel.2007.01.023; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; DeLisser HM, 1997, AM J PATHOL, V151, P671; Demestre M, 1999, ANN NY ACAD SCI, V878, P658, DOI 10.1111/j.1749-6632.1999.tb07754.x; Dolapchieva S, 2002, ANN ANAT, V184, P137, DOI 10.1016/S0940-9602(02)80006-1; Doornaert B, 2003, AM J PHYSIOL-LUNG C, V284, pL119, DOI 10.1152/ajplung.00039.2002; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fitzgerald J, 2008, OSTEOARTHR CARTILAGE, V16, P1319, DOI 10.1016/j.joca.2008.03.014; Foster W, 2003, J ORTHOP RES, V21, P798, DOI 10.1016/S0736-0266(03)00059-7; Galvagni F, 2002, J BIOL CHEM, V277, P19106, DOI 10.1074/jbc.M109642200; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Harman AM, 2003, EXP NEUROL, V182, P180, DOI 10.1016/S0014-4886(03)00081-5; Heissig B, 2003, CURR OPIN HEMATOL, V10, P136, DOI 10.1097/00062752-200303000-00007; HUARD J, 1991, SYNAPSE, V7, P135, DOI 10.1002/syn.890070207; Kaar JL, 2008, ACTA BIOMATER, V4, P1411, DOI 10.1016/j.actbio.2008.03.010; Kalluri R, 2000, CURR OPIN NEPHROL HY, V9, P413, DOI 10.1097/00041552-200007000-00013; Kimura J, 1998, DEV GROWTH DIFFER, V40, P457; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Kuzuya Masafumi, 2003, J Atheroscler Thromb, V10, P275; LaFleur M, 1996, J EXP MED, V184, P2311; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Masaki H, 2007, DEV GROWTH DIFFER, V49, P89, DOI 10.1111/j.1440-169X.2007.00909.x; MIYATAKE M, 1991, MUSCLE NERVE, V14, P113, DOI 10.1002/mus.880140205; Muneoka Ken, 2008, Birth Defects Research, V84, P265, DOI 10.1002/bdrc.20137; Nguyen T M, 1992, FEBS Lett, V313, P19; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x; Ravanti L, 2000, INT J MOL MED, V6, P391; SAARIALHOKERE UK, 1992, J CLIN INVEST, V90, P1952, DOI 10.1172/JCI116073; Said S, 2004, ANAT REC PART A, V278A, P443, DOI 10.1002/ar.a.20034; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; SCHOFIELD J, 1993, DEV DYNAM, V198, P254, DOI 10.1002/aja.1001980403; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; van der Plas MC, 2006, J NEUROSCI, V26, P333, DOI 10.1523/JNEUROSCI.4069-05.2006; Varani J, 2008, BRIT J CANCER, V98, P1646, DOI 10.1038/sj.bjc.6604357; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Wang W, 2009, AM J PATHOL, V174, P541, DOI 10.2353/ajpath.2009.080509; Wilgus TA, 2007, OSTOMY WOUND MANAG, V53, P16; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xie J, 2008, CLIN EXP DERMATOL, V33, P176, DOI 10.1111/j.1365-2230.2007.02573.x; Xue ML, 2006, EXPERT OPIN THER TAR, V10, P143, DOI 10.1517/14728222.10.1.143; Yokoyama H, 2008, DEV GROWTH DIFFER, V50, P13, DOI 10.1111/j.1440-169x.2007.00973.x; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200	60	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59105	10.1371/journal.pone.0059105	http://dx.doi.org/10.1371/journal.pone.0059105			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527099	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600037
J	Shah, M; Wadood, A; Rahman, Z; Husnain, T				Shah, Masaud; Wadood, Abdul; Rahman, Ziaur; Husnain, Tayyab			Interaction and Inhibition of Dengue Envelope Glycoprotein with Mammalian Receptor DC-Sign, an In-Silico Approach	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; VIRUS-INFECTION; CARBOHYDRATE-RECOGNITION; ENDOTHELIAL-CELLS; STRUCTURAL BASIS; LIGAND-BINDING; PROTEIN; IDENTIFICATION; NONINTEGRIN; DOMAIN	Membrane fusion is the central molecular event during the entry of enveloped viruses into cells. The critical agents of this process are viral surface proteins, primed to facilitate cell bilayer fusion. The important role of Dendritic-cell-specific ICAM3-grabbing non-integrin (DC-SIGN) in Dengue virus transmission makes it an attractive target to interfere with Dengue virus Propagation. Receptor mediated endocytosis allows the entry of virions due to the presence of endosomal membranes and low pH-induced fusion of the virus. DC-SIGN is the best characterized molecule among the candidate protein receptors and is able to mediate infection with the four serotypes of dengue virus (DENV). Unrestrained pair wise docking was used for the interaction of dengue envelope protein with DC-SIGN and monoclonal antibody 2G12. Pre-processed the PDB coordinates of dengue envelope glycoprotein and other candidate proteins were prepared and energy minimized through AMBER99 force field distributed in MOE software. Protein-protein interaction server, ZDOCK was used to find molecular interaction among the candidate proteins. Based on these interactions it was found that antibody successfully blocks the glycosylation site ASN 67 and other conserved residues present at DC-SIGN-Den-E complex interface. In order to know for certain, the exact location of the antibody in the envelope protein, co-crystallize of the envelope protein with these compounds is needed so that their exact docking locations can be identified with respect to our results.	[Shah, Masaud; Rahman, Ziaur; Husnain, Tayyab] Univ Punjab, Natl Ctr Excellence Mol Biol CEMB, Bioinformat Res Lab, Lahore, Pakistan; [Shah, Masaud; Wadood, Abdul] Abdul Wali Khan Univ, Dept Biochem, Computat Med Chem Lab, Mardan, Pakistan	University of Punjab; Abdul Wali Khan University	Wadood, A (corresponding author), Abdul Wali Khan Univ, Dept Biochem, Computat Med Chem Lab, Mardan, Pakistan.	awadood@awkum.edu.pk; Zia.cemb@pu.edu.pk	Husnain, Tayyab/G-3805-2015; Shah, Masaud/K-8748-2016; Husnain, Tayyab/AAE-9033-2019; Wadood, Abdul/ABG-2789-2021		HEC Pakistan	HEC Pakistan(Higher Education Commission of Pakistan)	The principal author also pays thanks to HEC Pakistan for providing a scholarship to complete his M. Phil research work.	Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Carl W, 2006, J BIOL CHEM, V281, P37183; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Chen YP, 1996, J VIROL, V70, P8765, DOI 10.1128/JVI.70.12.8765-8772.1996; Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10; Engering A, 2004, AM J PATHOL, V164, P1587, DOI 10.1016/S0002-9440(10)63717-0; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Marianneau P, 1996, J GEN VIROL, V77, P2547, DOI 10.1099/0022-1317-77-10-2547; Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x; McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Taweechaisupapong S, 1996, J MED MICROBIOL, V45, P138, DOI 10.1099/00222615-45-2-138; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; vansder Schaar H. M., 2008, PLOS PATHOG, V4; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Wei HY, 2003, J GEN VIROL, V84, P3095, DOI 10.1099/vir.0.19308-0; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	54	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59211	10.1371/journal.pone.0059211	http://dx.doi.org/10.1371/journal.pone.0059211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527139	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600050
J	Zhong, XL; Isharwal, S; Naples, JM; Shiff, C; Veltri, RW; Shao, CB; Bosompem, KM; Sidransky, D; Hoque, MO				Zhong, Xiaoli; Isharwal, Sumit; Naples, Jean M.; Shiff, Clive; Veltri, Robert W.; Shao, Chunbo; Bosompem, Kwabena M.; Sidransky, David; Hoque, Mohammad O.			Hypermethylation of Genes Detected in Urine from Ghanaian Adults with Bladder Pathology Associated with Schistosoma haematobium Infection	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; NONNEOPLASTIC GASTRIC-MUCOSA; HELICOBACTER-PYLORI; PROMOTER METHYLATION; RUNX3 METHYLATION; CANCER-RISK; MICROSATELLITE ANALYSIS; MULTIPLE GENES; E-CADHERIN; CELLS	Purpose: Schistosoma haematobium is associated with chronic bladder damage and may subsequently induce bladder cancer in humans, thus posing a serious threat where the parasite is endemic. Here we evaluated aberrant promoter DNA methylation as a potential biomarker to detect severe bladder damage that is associated with schistosomiasis by analyzing urine specimens. Materials and Methods: A quantitative methylation-specific PCR (QMSP) assay was used to examine the methylation status of seven genes (RASSF1A, RAR beta 2, RUNX3, TIMP3, MGMT, P16, ARF) in 57 urine samples obtained from volunteers that include infected and uninfected by S. haematobium from an endemic region. The Fishers Exact Test and Logistic Regression analysis were used to evaluate the methylation status with bladder damage (as assessed by ultrasound examination) in subjects with S. haematobium infection. Results: RASSF1A and TIMP3 were significant to predict severe bladder damage both in univariate (p = 0.015 and 0.023 respectively) and in multivariate (p = 0.022 and 0.032 respectively) logistic regression analysis. Area under the receiver operator characteristic curves (AUC-ROC) for RASSF1A and TIMP3 to predict severe bladder damage were 67.84% and 63.73% respectively. The combined model, which used both RASSF1A and TIMP3 promoter methylation, resulted in significant increase in AUC-ROC compared to that of TIMP3 (77.55% vs. 63.73%. 29; p = 0.023). Conclusions: In this pilot study, we showed that aberrant promoter methylation of RASSF1A and TIMP3 are present in urine sediments of patients with severe bladder damage associated with S. haematobium infection and that may be used to develop non-invasive biomarker of S. haematobium exposure and early molecular risk assessmentof neoplastic transformation.	[Zhong, Xiaoli; Shao, Chunbo; Sidransky, David; Hoque, Mohammad O.] Johns Hopkins Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Naples, Jean M.; Shiff, Clive] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Isharwal, Sumit; Veltri, Robert W.] Johns Hopkins Univ Hosp, Brady Urol Res Inst, Baltimore, MD 21287 USA; [Bosompem, Kwabena M.] Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Hoque, Mohammad O.] Gono Univ, Dhaka, Bangladesh; [Isharwal, Sumit] Univ Minnesota, Dept Urol, Minneapolis, MN USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Ghana; University of Minnesota System; University of Minnesota Twin Cities	Shiff, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	cshiff@jhsph.edu; mhoque1@jhmi.edu		Hoque, Mohammad Obaidul/0000-0001-6701-9978	National Cancer Institute [PO1CA077664, 1R01CA163594-01]; Flight Attendant Medical Research Institute Young Clinical Scientist Award; International Association for the Study of Lung Cancer Young Investigator Award; Specialized Program of Research Excellence, National Institutes of Health (NIH)/National Cancer Institute (NCI) [P50 CA098252]; Johns Hopkins Faculty Grants in Global Health Program); NATIONAL CANCER INSTITUTE [P01CA077664, R01CA163594] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Flight Attendant Medical Research Institute Young Clinical Scientist Award; International Association for the Study of Lung Cancer Young Investigator Award; Specialized Program of Research Excellence, National Institutes of Health (NIH)/National Cancer Institute (NCI); Johns Hopkins Faculty Grants in Global Health Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: National Cancer Institute grant PO1CA077664 and 1R01CA163594-01 (D. S. and M. H.); Flight Attendant Medical Research Institute Young Clinical Scientist Award and International Association for the Study of Lung Cancer Young Investigator Award (M. H.). This work was also supported by Career development award to M. H. from Specialized Program of Research Excellence P50 CA098252 (T-C Wu), National Institutes of Health (NIH)/National Cancer Institute (NCI). M. H., C. S., J.N. acknowledge support from the Johns Hopkins Faculty Grants in Global Health Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoletti R, 2006, J UROLOGY, V175, P2032, DOI 10.1016/S0022-5347(06)00283-7; Belinsky SA, 2007, BRIT J CANCER, V96, P1278, DOI 10.1038/sj.bjc.6603721; Berger AP, 2002, EUR UROL, V41, P532, DOI 10.1016/S0302-2838(02)00073-8; Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; de Martel C, 2009, CRIT REV ONCOL HEMAT, V70, P183, DOI 10.1016/j.critrevonc.2008.07.021; Esteller M, 2001, CANCER RES, V61, P3225; Gutierrez MI, 2004, MODERN PATHOL, V17, P1268, DOI 10.1038/modpathol.3800177; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Huang FY, 2012, CANCER-AM CANCER SOC, V118, P4969, DOI 10.1002/cncr.27519; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; Jeong P, 2012, EJSO-EUR J SURG ONC, V38, P1095, DOI 10.1016/j.ejso.2012.07.116; Kaise M, 2008, HELICOBACTER, V13, P35, DOI 10.1111/j.1523-5378.2008.00572.x; Kato S, 2012, NEPHRON EXTRA, V2, P159, DOI 10.1159/000339437; Khurana S, 2005, Indian J Med Microbiol, V23, P74; Knapp DW, 2008, J UROLOGY, V180, P806, DOI 10.1016/j.juro.2008.06.073; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Leung WK, 2006, CLIN CANCER RES, V12, P3216, DOI 10.1158/1078-0432.CCR-05-2442; Liang JF, 2010, UROL INT, V85, P296, DOI 10.1159/000317455; Maekawa M, 2007, CURR MED CHEM, V14, P2642, DOI 10.2174/092986707782023172; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Maier S, 2002, J NUTR, V132, p2440S, DOI 10.1093/jn/132.8.2440S; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Mostafa MH, 1999, CLIN MICROBIOL REV, V12, P97, DOI 10.1128/CMR.12.1.97; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Parkin DM, 2008, SCAND J UROL NEPHROL, V42, P12, DOI 10.1080/03008880802285032; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; Riesz P, 2007, PATHOL ONCOL RES, V13, P187, DOI 10.1007/BF02893498; Ryan Julie L, 2010, Infect Agent Cancer, V5, P27, DOI 10.1186/1750-9378-5-27; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Serizawa RR, 2011, INT J CANCER, V129, P78, DOI 10.1002/ijc.25651; Shiff C, 2006, T ROY SOC TROP MED H, V100, P847, DOI 10.1016/j.trstmh.2005.10.010; Shiff C, 2010, T ROY SOC TROP MED H, V104, P3, DOI 10.1016/j.trstmh.2009.05.013; Shirodkar SP, 2009, CURR OPIN UROL, V19, P488, DOI 10.1097/MOU.0b013e32832eb3a0; Toyota M, 2011, PROG MOL BIOL TRANSL, V101, P447, DOI 10.1016/B978-0-12-387685-0.00014-7; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; WHO, 2000, TDRSTRSCH001 WHO; Wolff EM, 2008, CANCER RES, V68, P6208, DOI 10.1158/0008-5472.CAN-07-6616; Yan C, 2012, J SURG ONCOL, V105, P425, DOI 10.1002/jso.22087; Yoshida T, 2013, GASTRIC CANC OFFICIA; Yosry A, 2006, CONTRIB MICROBIOL, V13, P81, DOI 10.1159/000092967; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5	43	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59089	10.1371/journal.pone.0059089	http://dx.doi.org/10.1371/journal.pone.0059089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527093	gold, Green Submitted, Green Published			2022-12-27	WOS:000316411600036
J	He, W; Zhang, S; Song, AH; Yang, M; Jiao, JJ; Allison, DB; Heymsfield, SB; Zhu, SK				He, Wei; Zhang, Sha; Song, Aihua; Yang, Min; Jiao, Jingjing; Allison, David B.; Heymsfield, Steven B.; Zhu, Shankuan			Greater Abdominal Fat Accumulation Is Associated with Higher Metabolic Risk in Chinese than in White People: An Ethnicity Study	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; OBESITY; HYPERTENSION; PREVALENCE; DISEASE; WEIGHT; WOMEN; MEN; BMI	Introductin: Chinese are reported to have a higher percent body fat (%BF) and a higher percent trunk fat (%TF) than whites for a given body mass index (BMI). However, the associations of these ethnic differences in body composition with metabolic risks remain unknown. Methods and Procedures: A total of 1 029 Chinese from Hangzhou, China, and 207 whites from New York, NY, USA, were recruited in the present study. Body composition was measured using dual-energy X-ray absorptiometry (DXA). Analysis of covariance was used to assess the ethnic differences in fat, fat distribution, and metabolic risk factors. Results: After adjusting for BMI, age, and height, Chinese men had an average of 3.9% more % BF and 12.1% more % TF than white men; Chinese women had an average of 2.3% more % BF and 11.8% more % TF than white women. Compared with whites, higher metabolic risks were detected in Chinese for a given BMI after adjusting for age and height. Further adjustment for % BF did not change these ethnic disparities. However, after adjusting for % TF, the ethnic differences decreased and become insignificant in triglyceride, high-density lipoprotein cholesterol, and blood pressure (except for systolic blood pressure in men). For fasting plasma glucose, the ethnic differences persisted after adjustment for % BF, but decreased significantly from 0.910 to 0.686 mmol/L among men, and from 0.629 to 0.355 mmol/L among women, when the analyses were further controlled for % TF. Discussion: Chinese have both higher % BF and % TF than white people for a given BMI. However, only % TF could in part account for the higher metabolic risk observed in Chinese men and women.	[He, Wei; Zhang, Sha; Song, Aihua; Yang, Min; Jiao, Jingjing; Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Chron Dis Res Inst, Obes & Body Composit Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Min; Jiao, Jingjing; Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Hangzhou 310003, Zhejiang, Peoples R China; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Allison, David B.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Heymsfield, Steven B.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Zhejiang University; Zhejiang University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Zhu, SK (corresponding author), Zhejiang Univ, Sch Publ Hlth, Chron Dis Res Inst, Obes & Body Composit Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	zsk@zju.edu.cn	Heymsfield, Steven B/N-1968-2017; He, Wei/C-8441-2015	Heymsfield, Steven B/0000-0003-1127-9425; He, Wei/0000-0003-0161-3274; Allison, David/0000-0003-3566-9399	China Medical Board (CMB) [10-014]; Scholarship Award for Excellent Doctoral Student; Ministry of Education, China	China Medical Board (CMB); Scholarship Award for Excellent Doctoral Student; Ministry of Education, China(Ministry of Education, China)	This study was supported, in part, by funding from the China Medical Board (CMB) (grant 10-014) and the Scholarship Award for Excellent Doctoral Student granted by the Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; Deurenberg P, 2001, CURR OPIN CLIN NUTR, V4, P377, DOI 10.1097/00075197-200109000-00007; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Engeland A, 2003, EPIDEMIOLOGY, V14, P293, DOI 10.1097/00001648-200305000-00008; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Herrera BM, 2010, CURR DIABETES REP, V10, P498, DOI 10.1007/s11892-010-0153-z; Heymsfield SB, 2009, INT J OBESITY, V33, P1363, DOI 10.1038/ijo.2009.184; Juhaeri, 2002, INT J OBESITY, V26, P58, DOI 10.1038/sj.ijo.0801846; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Ko GTC, 2001, BRIT J NUTR, V85, P239, DOI 10.1079/BJN2000251; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Levine JA, 2008, CHINESE MED J-PEKING, V121, P1043, DOI 10.1097/00029330-200806010-00015; Lin WY, 2011, CAN MED ASSOC J, V183, pE329, DOI 10.1503/cmaj.101303; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lu H, 2011, OSTEOPOROSIS INT, V22, P3029, DOI 10.1007/s00198-010-1522-9; Luke A, 1997, AM J EPIDEMIOL, V145, P620, DOI 10.1093/oxfordjournals.aje.a009159; Meeuwsen S, 2010, CLIN NUTR, V29, P560, DOI 10.1016/j.clnu.2009.12.011; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Wang DY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019629, 10.1371/journal.pone.0019835]; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization Consultation on Obesity, 2000, OB PREV MAN GLOB EP; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P431; Zhu SK, 2011, CAN MED ASSOC J, V183, P645, DOI 10.1503/cmaj.110142; Zhu SK, 2005, AM J CLIN NUTR, V81, P409	37	30	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58688	10.1371/journal.pone.0058688	http://dx.doi.org/10.1371/journal.pone.0058688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516538	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400051
J	Cunha, MCR; Lima, FD; Vinolo, MAR; Hastreiter, A; Curi, R; Borelli, P; Fock, RA				Ramos Cunha, Mayara Caldas; Lima, Fabiana da Silva; Ramirez Vinolo, Marco Aurelio; Hastreiter, Araceli; Curi, Rui; Borelli, Primavera; Fock, Ricardo Ambrosio			Protein Malnutrition Induces Bone Marrow Mesenchymal Stem Cells Commitment to Adipogenic Differentiation Leading to Hematopoietic Failure	PLOS ONE			English	Article							C-KIT; EXPRESSION; RATS; INTERLEUKIN-3; GRANULOCYTE; ADIPOCYTES; GENERATION; DECREASES; COLONIES; THERAPY	Protein malnutrition (PM) results in pathological changes that are associated with peripheral leukopenia, bone marrow (BM) hypoplasia and alterations in the BM microenvironment leading to hematopoietic failure; however, the mechanisms involved are poorly understood. In this context, the BM mesenchymal stem cells (MSCs) are cells intimately related to the formation of the BM microenvironment, and their differentiation into adipocytes is important because adipocytes are cells that have the capability to negatively modulate hematopoiesis. Two-month-old male Balb/c mice were subjected to protein-energy malnutrition with a low-protein diet containing 2% protein, whereas control animals were fed a diet containing 12% protein. The hematopoietic parameters and the expression of CD45 and CD117 positive cells in the BM were evaluated. MSCs were isolated from BM, and their capability to produce SCF, IL-3, G-CSF and GM-CSF were analyzed. The expression of PPAR-gamma and C/EBP-alpha as well as the expression of PPAR-gamma and SREBP mRNAs were evaluated in MSCs together with their capability to differentiate into adipocytes in vitro. The malnourished animals had anemia and leukopenia as well as spleen and bone marrow hypoplasia and a reduction in the expression of CD45 and CD117 positive cells from BM. The MSCs of the malnourished mice presented an increased capability to produce SCF and reduced production of G-CSF and GM-CSF. The MSCs from the malnourished animals showed increased expression of PPAR-gamma protein and PPAR-gamma mRNA associated with an increased capability to differentiate into adipocytes. The alterations found in the malnourished animals allowed us to conclude that malnutrition committed MSC differentiation leading to adipocyte decision and compromised their capacity for cytokine production, contributing to an impaired hematopoietic microenvironment and inducing the bone marrow failure commonly observed in protein malnutrition states.	[Ramos Cunha, Mayara Caldas; Lima, Fabiana da Silva; Hastreiter, Araceli; Borelli, Primavera; Fock, Ricardo Ambrosio] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Analyses, Sao Paulo, Brazil; [Ramirez Vinolo, Marco Aurelio] Univ Campinas Unicamp, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, Brazil; [Curi, Rui] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Fock, RA (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Analyses, Sao Paulo, Brazil.	hemato@usp.br	Curi, Rui/C-9351-2012; Vinolo, Marco Aurélio R/K-3753-2012; Lima, Fabiana/AAZ-6275-2020; Borelli, Primavera/G-3422-2012; Lima, Fabiana/H-2479-2017; Hastreiter, Araceli A/K-3806-2012; Fock, Ricardo Ambrosio/C-6105-2012	Lima, Fabiana/0000-0003-3695-4458; Borelli, Primavera/0000-0001-9454-4372; Lima, Fabiana/0000-0003-3695-4458; Hastreiter, Araceli A/0000-0001-6226-8772; Fock, Ricardo Ambrosio/0000-0002-7964-5973; Vinolo, Marco Aurelio/0000-0003-1335-760X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2010/51747-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This investigation was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (2010/51747-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHKENASY A, 1957, AM J CLIN NUTR, V5, P14, DOI 10.1093/ajcn/5.1.14; BERNSTEIN ID, 1991, BLOOD, V77, P2316; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Borelli P, 2009, BRAZ J MED BIOL RES, V42, P523, DOI 10.1590/S0100-879X2009000600008; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Carrancio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026241; CATCHATOURIAN R, 1980, BLOOD, V55, P625; Dormady SP, 2001, J HEMATOTH STEM CELL, V10, P125, DOI 10.1089/152581601750098372; Fernandez-Varon E, 2007, VET J, V174, P33, DOI 10.1016/j.tvjl.2006.08.001; Flo J, 1996, CLIN IMMUNOL IMMUNOP, V80, P147, DOI 10.1006/clin.1996.0108; Fock RA, 2009, NUTRITION, V10, P1021; Fock RA, 2007, CYTOKINE, V40, P105, DOI 10.1016/j.cyto.2007.08.007; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kimura T, 1997, BLOOD, V90, P4767; KORNBERG A, 1946, SCIENCE, V103, P646, DOI 10.1126/science.103.2682.646; Landgraf MAV, 2005, J NUTR, V135, P1480, DOI 10.1093/jn/135.6.1480; Li T, 2011, BONE MARROW RES, DOI 10.1155/2011/353878; LIESVELD JL, 1995, EXP HEMATOL, V23, P202; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marti J, 2001, MED CLIN-BARCELONA, V116, P446, DOI 10.1016/S0025-7753(01)71865-9; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mourcin F, 2005, RADIAT RES, V164, P1, DOI 10.1667/RR3384; Musri MM, 2012, CURR OPIN CLIN NUTR, V15, P342, DOI 10.1097/MCO.0b013e3283546fba; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Olmos S, 2001, METABOLISM, V50, P1025, DOI 10.1053/meta.2001.25657; Ortiz M, 1999, IMMUNITY, V10, P173, DOI 10.1016/S1074-7613(00)80018-7; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rosen ED, 2000, GENE DEV, V14, P1293; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vituri CL, 2000, BRAZ J MED BIOL RES, V33, P889, DOI 10.1590/S0100-879X2000000800004; WARD P G, 1963, J Med Lab Technol, V20, P191; Xavier JG, 2007, HISTOL HISTOPATHOL, V22, P651, DOI 10.14670/HH-22.651; Zapata AG, 2012, ADV EXP MED BIOL, V741, P135, DOI 10.1007/978-1-4614-2098-9_10	40	39	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58872	10.1371/journal.pone.0058872	http://dx.doi.org/10.1371/journal.pone.0058872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516566	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400070
J	Zhang, X; Li, YH; Zhang, Y; Song, JC; Wang, QM; Zheng, LP; Liu, D				Zhang, Xian; Li, Yinghua; Zhang, Yang; Song, Jincheng; Wang, Qimin; Zheng, Luping; Liu, Dan			Beta-Elemene Blocks Epithelial-Mesenchymal Transition in Human Breast Cancer Cell Line MCF-7 through Smad3-Mediated Down-Regulation of Nuclear Transcription Factors	PLOS ONE			English	Article							NF-KAPPA-B; TGF-BETA; INDUCED EMT; E-CADHERIN; SNAIL; METASTASIS; MECHANISMS; APOPTOSIS; ARREST; COOPERATION	Epithelial-mesenchymal transition (EMT) is the first step required for breast cancer to initiate metastasis. However, the potential of drugs to block and reverse the EMT process are not well explored. In the present study, we investigated the inhibitory effect of beta-elemene (ELE), an active component of a natural plant-derived anti-neoplastic agent in an established EMT model mediated by transforming growth factor-beta1 (TGF-beta 1). We found that ELE (40 mu g/ml) blocked the TGF-beta 1-induced phenotypic transition in the human breast cancer cell line MCF-7. ELE was able to inhibit TGF-beta 1-mediated upregulation of mRNA and protein expression of nuclear transcription factors (SNAI1, SNAI2, TWIST and SIP1), potentially through decreasing the expression and phosphorylation of Smad3, a central protein mediating the TGF-beta 1 signalling pathway. These findings suggest a potential therapeutic benefit of ELE in treating basal-like breast cancer.	[Zhang, Xian; Li, Yinghua; Zhang, Yang] Dalian Med Univ, Affiliated Hosp 2, Dept Oncol, Dalian, Peoples R China; [Zhang, Xian; Zheng, Luping] Dalian Med Univ, Res Inst Integrated Tradit & Western Med, Dalian, Peoples R China; [Song, Jincheng; Liu, Dan] Dalian Med Univ, Grad Inst, Dalian, Peoples R China; [Wang, Qimin] Dalian Med Univ, Affiliated Hosp 2, Dept Pathol, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Zhang, Y (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Oncol, Dalian, Peoples R China.	dlzlzx001@yahoo.com.cn						Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chen X, 2012, MOL MED REPORT; Coradini D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/254085; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Drabsch Y, 2012, CANC METASTASIS REV; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Giordano A, 2012, MOL CANC THER; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Hsu HY, 2012, CARCINOGENESIS; Huang T, 2013, ONCOL REP, V29, P117, DOI 10.3892/or.2012.2080; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ismail IA, 2013, BREAST CANC RES TREA; Ito I, 2010, J BIOL CHEM, V285, P14747, DOI 10.1074/jbc.M109.093039; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Li L, 2011, MOL MED REP, V4, P1243, DOI 10.3892/mmr.2011.548; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Li X, 2005, CELL MOL LIFE SCI, V62, P894, DOI 10.1007/s00018-005-5027-1; Liu J, 2012, J PHARM PHARMACOL, V64, P146, DOI 10.1111/j.2042-7158.2011.01371.x; Liu J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-183; Lu JJ, 2012, J ETHNOPHARMACOL; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Meyer T, 1998, EUR J CANCER, V34, P214, DOI 10.1016/S0959-8049(97)10129-0; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Sehrawat A, 2012, CARCINOGENESIS; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tarasewicz E, 2012, CELL CYCLE, V11, P2443, DOI 10.4161/cc.20546; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yao YQ, 2008, CANCER LETT, V264, P127, DOI 10.1016/j.canlet.2008.01.049; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang B, 2012, BREAST CANCER RES TR, V136, P399, DOI 10.1007/s10549-012-2263-6; Zhao YS, 2012, J NEURO-ONCOL, V107, P307, DOI 10.1007/s11060-011-0770-7	51	39	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58719	10.1371/journal.pone.0058719	http://dx.doi.org/10.1371/journal.pone.0058719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516540	Green Submitted, gold, Green Published			2022-12-27	WOS:000316407400052
J	Chen, TC; Liu, YW; Huang, YH; Yeh, YC; Chou, TY; Wu, YC; Wu, CC; Chen, YR; Cheng, HC; Lu, PJ; Lai, JM; Huang, CYF				Chen, Tzu-Chi; Liu, Yu-Wen; Huang, Yei-Hsuan; Yeh, Yi-Chen; Chou, Teh-Ying; Wu, Yu-Chung; Wu, Chun-Chi; Chen, Yi-Rong; Cheng, Hui-Chuan; Lu, Pei-Jung; Lai, Jin-Mei; Huang, Chi-Ying F.			Protein Phosphorylation Profiling Using an In Situ Proximity Ligation Assay: Phosphorylation of AURKA-Elicited EGFR-Thr654 and EGFR-Ser1046 in Lung Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; ERBB SIGNALING NETWORK; AURORA-A; TYROSINE KINASE; GENE-EXPRESSION; POOR-PROGNOSIS; BREAST-CANCER; EGF RECEPTOR; MUTATIONS; GEFITINIB	The epidermal growth factor receptor (EGFR), which is up-regulated in lung cancer, involves the activation of mitogenic signals and triggers multiple signaling cascades. To dissect these EGFR cascades, we used 14 different phospho-EGFR antibodies to quantify protein phosphorylation using an in situ proximity ligation assay (in situ PLA). Phosphorylation at EGFR-Thr654 and -Ser1046 was EGF-dependent in the wild-type (WT) receptor but EGF-independent in a cell line carrying the EGFR-L858R mutation. Using a ProtoAarray (TM) containing similar to 5000 recombinant proteins on the protein chip, we found that AURKA interacted with the EGFR-L861Q mutant. Moreover, overexpression of EGFR could form a complex with AURKA, and the inhibitors of AURKA and EGFR decreased EGFR-Thr654 and -Ser1046 phosphorylation. Immunohistochemical staining of stage I lung adenocarcinoma tissues demonstrated a positive correlation between AURKA expression and phosphorylation of EGFR at Thr654 and Ser1046 in EGFR-mutant specimens, but not in EGFR-WT specimens. The interplay between EGFR and AURKA provides an explanation for the difference in EGF dependency between EGFR-WT and EGFR-mutant cells and may provide a new therapeutic strategy for lung cancer patients carrying EGFR mutations.	[Chen, Tzu-Chi; Huang, Yei-Hsuan; Yeh, Yi-Chen; Chou, Teh-Ying; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Liu, Yu-Wen; Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Yeh, Yi-Chen; Chou, Teh-Ying] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Wu, Yu-Chung] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Wu, Chun-Chi] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chen, Yi-Rong] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Taiwan; [Cheng, Hui-Chuan; Lu, Pei-Jung] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Lai, Jin-Mei] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chung Shan Medical University; National Health Research Institutes - Taiwan; National Cheng Kung University; Fu Jen Catholic University	Huang, CYF (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	cyhuang5@ym.edu.tw	Chen, Yi-Rong/CAH-7991-2022; Huang, Chi-Ying/AFL-7729-2022; Chen, Yi-Rong/CAF-2186-2022; Chen, Yi-Rong/E-3991-2010; Huang, Chi-Ying/AAG-7672-2022	Chen, Yi-Rong/0000-0002-4307-3002; Huang, Chi-Ying/0000-0003-4898-4937; Chen, Yi-Rong/0000-0002-4307-3002; Chen, Yi-Rong/0000-0002-4307-3002; Huang, Chi-Ying/0000-0003-4898-4937	National Science Council [NSC101-2325-B-010-011, NSC101-2627-B-010-001]; Center of Excellence for Cancer Research at Taipei Veterans General Hospital [DOH101-TD-C-111-007]; Ministry of Education, Aim for the Top University Plan (National Yang Ming University)	National Science Council(Ministry of Science and Technology, Taiwan); Center of Excellence for Cancer Research at Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education, Aim for the Top University Plan (National Yang Ming University)	This research was supported by grants from the National Science Council (NSC101-2325-B-010-011 and NSC101-2627-B-010-001), the Center of Excellence for Cancer Research at Taipei Veterans General Hospital (DOH101-TD-C-111-007), and the Ministry of Education, Aim for the Top University Plan (National Yang Ming University) to CYH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 2005, CANCER RES, V65, P226; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Chen YR, 2006, ONCOGENE, V25, P1205, DOI 10.1038/sj.onc.1209159; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; Dittmann K, 2010, FEBS LETT, V584, P3878, DOI 10.1016/j.febslet.2010.08.005; Erba EB, 2007, J PROTEOME RES, V6, P2768, DOI 10.1021/pr060675m; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gazdar AF, 2009, NEW ENGL J MED, V361, P1018, DOI 10.1056/NEJMe0905763; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lai CH, 2010, J CELL MOL MED, V14, P1520, DOI 10.1111/j.1582-4934.2009.00919.x; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lin YS, 2006, GENE EXPRESSION, V13, P15, DOI 10.3727/000000006783991962; Lo H-W, 2007, Br J Cancer, V96 Suppl, pR16; Lo HW, 2005, CANCER RES, V65, P338; LUND KA, 1990, J BIOL CHEM, V265, P20517; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PC, 2006, PHARMACOGENOMICS, V7, P597, DOI 10.2217/14622416.7.4.597; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Oberg K, 2010, ANN ONCOL, V21, pv220, DOI 10.1093/annonc/mdq191; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Ohsaki Y, 2000, ONCOL REP, V7, P603; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; RUSCH V, 1993, CANCER RES, V53, P2379; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sugimoto K, 2002, CELL STRUCT FUNCT, V27, P457, DOI 10.1247/csf.27.457; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	57	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e55657	10.1371/journal.pone.0055657	http://dx.doi.org/10.1371/journal.pone.0055657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520446	Green Submitted, gold, Green Published			2022-12-27	WOS:000318679900005
J	Riggins, DP; Narvaez, MJ; Martinez, KA; Harden, MM; Slonczewski, JL				Riggins, Daniel P.; Narvaez, Maria J.; Martinez, Keith A.; Harden, Mark M.; Slonczewski, Joan L.			Escherichia coli K-12 Survives Anaerobic Exposure at pH 2 without RpoS, Gad, or Hydrogenases, but Shows Sensitivity to Autoclaved Broth Products	PLOS ONE			English	Article							DEPENDENT ACID RESISTANCE; CYCLOPROPANE FATTY-ACIDS; DECARBOXYLASE GENES; SHIGELLA-FLEXNERI; FNR; CATABOLISM; EXPRESSION; PEROXIDE; PROTEINS; BACTERIA	Escherichia coli and other enteric bacteria survive exposure to extreme acid (pH 2 or lower) in gastric fluid. Aerated cultures survive via regulons expressing glutamate decarboxylase (Gad, activated by RpoS), cyclopropane fatty acid synthase (Cfa) and others. But extreme-acid survival is rarely tested under low oxygen, a condition found in the stomach and the intestinal tract. We observed survival of E. coli K-12 W3110 at pH 1.2-pH 2.0, conducting all manipulations (overnight culture at pH 5.5, extreme-acid exposure, dilution and plating) in a glove box excluding oxygen (10% H-2, 5% CO2, balance N-2). With dissolved O-2 concentrations maintained below 6 mM, survival at pH 2 required Cfa but did not require GadC, RpoS, or hydrogenases. Extreme-acid survival in broth (containing tryptone and yeast extract) was diminished in media that had been autoclaved compared to media that had been filtered. The effect of autoclaved media on extreme-acid survival was most pronounced when oxygen was excluded. Exposure to H2O2 during extreme-acid treatment increased the death rate slightly for W3110 and to a greater extent for the rpoS deletion strain. Survival at pH 2 was increased in strains lacking the anaerobic regulator fnr. During anaerobic growth at pH 5.5, strains deleted for fnr showed enhanced transcription of acid-survival genes gadB, cfa, and hdeA, as well as catalase (katE). We show that E. coli cultured under oxygen exclusion (<6 mu M O-2) requires mechanisms different from those of aerated cultures. Extreme acid survival is more sensitive to autoclave products under oxygen exclusion.	[Riggins, Daniel P.; Narvaez, Maria J.; Martinez, Keith A.; Harden, Mark M.; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA	Kenyon College	Slonczewski, JL (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu	Riggins, Daniel P/C-6560-2011	Riggins, Daniel P/0000-0002-6240-6212; Martinez II, Keith/0000-0002-4760-5221	National Science Foundation [MCB-1050080, STEM DUE-0965895]; Kenyon College	National Science Foundation(National Science Foundation (NSF)); Kenyon College	The funding is from grant MCB-1050080 from the National Science Foundation (http://www.nsf.gov/). M. Narvaez received a summer stipend from the National Science Foundation STEM DUE-0965895 to Kenyon College, and M. Harden received a summer stipend from Kenyon College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2002, J BACTERIOL, V184, P1402, DOI 10.1128/JB.184.5.1402-1406.2002; Andersen L.P., 2001, HELICOBACTER PYLORI; AUGER EA, 1989, MOL MICROBIOL, V3, P609, DOI 10.1111/j.1365-2958.1989.tb00208.x; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996; Bogosian G, 2000, J BACTERIOL, V182, P5070, DOI 10.1128/JB.182.18.5070-5075.2000; Brown JL, 1997, INT J FOOD MICROBIOL, V37, P163, DOI 10.1016/S0168-1605(97)00068-8; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Due VL, 2003, ACTA ANAESTH SCAND, V47, P372, DOI 10.1034/j.1399-6576.2003.00542.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Girgis HS, 2012, P NATL ACAD SCI USA, V109, P12740, DOI 10.1073/pnas.1205124109; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Hegele J, 2009, MOL NUTR FOOD RES, V53, P760, DOI 10.1002/mnfr.200800221; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2008, MOL MICROBIOL, V68, P801, DOI 10.1111/j.1365-2958.2008.06213.x; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kumar R, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-3; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; Mizunoe Y, 1999, ARCH MICROBIOL, V172, P63, DOI 10.1007/s002030050741; MOORE WEC, 1969, J INFECT DIS, V119, P641, DOI 10.1093/infdis/119.6.641; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Noguchi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010132; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; SCHROEDER LJ, 1955, J BIOL CHEM, V212, P973; Shabala L, 2008, RES MICROBIOL, V159, P458, DOI 10.1016/j.resmic.2008.04.011; Shalel-Levanon S, 2005, BIOTECHNOL BIOENG, V92, P147, DOI 10.1002/bit.20583; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; SMITH DK, 1992, J BACTERIOL, V174, P5820, DOI 10.1128/jb.174.18.5820-5826.1992; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Tolla DA, 2011, MOL MICROBIOL, V79, P149, DOI 10.1111/j.1365-2958.2010.07437.x; Unden G, 1997, MOL MICROBIOL, V25, P205, DOI 10.1046/j.1365-2958.1997.4731841.x; Zilberstein B, 2007, CLINICS, V62, P47, DOI 10.1590/S1807-59322007000100008	45	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56796	10.1371/journal.pone.0056796	http://dx.doi.org/10.1371/journal.pone.0056796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520457	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900016
J	Barrett, CL; Schwab, RB; Jung, H; Crain, B; Goff, DJ; Jamieson, CHM; Thistlethwaite, PA; Harismendy, O; Carson, DA; Frazer, KA				Barrett, Christian L.; Schwab, Richard B.; Jung, HyunChul; Crain, Brian; Goff, Daniel J.; Jamieson, Catriona H. M.; Thistlethwaite, Patricia A.; Harismendy, Olivier; Carson, Dennis A.; Frazer, Kelly A.			Transcriptome Sequencing of Tumor Subpopulations Reveals a Spectrum of Therapeutic Options for Squamous Cell Lung Cancer	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; TRAIL-INDUCED APOPTOSIS; PROSTATE-CANCER; OVARIAN-CANCER; STEM-CELLS; MULTIDRUG-RESISTANCE; SPLICING FACTORS; GENE-EXPRESSION; DOWN-REGULATION; C-FLIPL	Background: The only therapeutic options that exist for squamous cell lung carcinoma (SCC) are standard radiation and cytotoxic chemotherapy. Cancer stem cells (CSCs) are hypothesized to account for therapeutic resistance, suggesting that CSCs must be specifically targeted. Here, we analyze the transcriptome of CSC and non-CSC subpopulations by RNA-seq to identify new potential therapeutic strategies for SCC. Methods: We sorted a SCC into CD133- and CD133+ subpopulations and then examined both by copy number analysis (CNA) and whole genome and transcriptome sequencing. We analyzed The Cancer Genome Atlas (TCGA) transcriptome data of 221 SCCs to determine the generality of our observations. Results: Both subpopulations highly expressed numerous mRNA isoforms whose protein products are active drug targets for other cancers; 31 (25%) correspond to 18 genes under active investigation as mAb targets and an additional 4 (3%) are of therapeutic interest. Moreover, we found evidence that both subpopulations were proliferatively driven by very high levels of c-Myc and the TRAIL long isoform (TRAIL(L)) and that normal apoptotic responses to high expression of these genes was prevented through high levels of Mcl-1(L) and Bcl-x(L) and c-Flip(L)-isoforms for which drugs are now in clinical development. SCC RNA-seq data (n = 221) from TCGA supported our findings. Our analysis is inconsistent with the CSC concept that most cells in a cancer have lost their proliferative potential. Furthermore, our study suggests how to target both the CSC and non-CSC subpopulations with one treatment strategy. Conclusions: Our study is relevant to SCC in particular for it presents numerous potential options to standard therapy that target the entire tumor. In so doing, it demonstrates how transcriptome sequencing provides insights into the molecular underpinnings of cancer propagating cells that, importantly, can be leveraged to identify new potential therapeutic options for cancers beyond what is possible with DNA sequencing.	[Barrett, Christian L.; Schwab, Richard B.; Jung, HyunChul; Crain, Brian; Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Barrett, Christian L.; Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Barrett, Christian L.; Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Rady Childrens Hosp, La Jolla, CA 92093 USA; [Jung, HyunChul] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Schwab, Richard B.; Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Clin & Translat Res Inst, La Jolla, CA 92093 USA; [Thistlethwaite, Patricia A.] Univ Calif San Diego, Div Cardiothorac Surg, La Jolla, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Goff, Daniel J.; Jamieson, Catriona H. M.] Univ Calif San Diego, Dept Med, Stem Cell & Moores Canc Ctr, La Jolla, CA 92093 USA; [Carson, Dennis A.] Sanford Consortium Regenerat Med, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Frazer, KA (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	kafrazer@ucsd.edu	Schwab, Richard/AAX-9262-2020; Harismendy, Olivier/AAM-2072-2021	Harismendy, Olivier/0000-0002-8098-9888; Frazer, Kelly/0000-0002-6060-8902; Goff, Daniel/0000-0003-2109-1696	Center for Translational Science Award from the National Center for Research Resources [UL1RR031980, UL1TR000100]; National Cancer Institute [1R21CA152613-01, 1R21CA155615-01A1, CA69375]; California Institute for Regenerative Medicine [CL1-00502, RT1-01108, TR1-01250, TR2-01789]; National Institute of Allergy and Infectious Diseases [P30 AI036214]; NATIONAL CANCER INSTITUTE [R21CA155615, R21CA152613, R01CA069375] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	Center for Translational Science Award from the National Center for Research Resources; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Center for Translational Science Award (UL1RR031980 and UL1TR000100) from the National Center for Research Resources, three grants (1R21CA152613-01, 1R21CA155615-01A1, CA69375) from the National Cancer Institute, four grants from the California Institute for Regenerative Medicine (CL1-00502, RT1-01108, TR1-01250, TR2-01789) and a grant from the National Institute of Allergy and Infectious Diseases (P30 AI036214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2011, CANCER RES, V71, P2212, DOI 10.1158/0008-5472.CAN-10-3590; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dash R, 2011, P NATL ACAD SCI USA, V108, P8785, DOI 10.1073/pnas.1100769108; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding WX, 2009, ESSENTIALS OF APOPTOSIS, SECOND EDITION, P25, DOI 10.1007/978-1-60327-381-7_2; DiPaola RS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-1; Dunkle A, 2010, CELL DEATH DIFFER, V17, P994, DOI 10.1038/cdd.2009.201; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; El-Gazzar A, 2010, GYNECOL ONCOL, V117, P451, DOI 10.1016/j.ygyno.2010.02.024; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fagan DH, 2012, CANC RES IN PRESS, DOI 10.1158/0008-5472.CAN-12-0684; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Govindan SV, 2009, CLIN CANCER RES, V15, P6052, DOI 10.1158/1078-0432.CCR-09-0586; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haag C, 2011, GUT, V60, P225, DOI 10.1136/gut.2009.202325; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Heukamp LC, 2011, INTERNIST, V52, P146, DOI 10.1007/s00108-010-2698-y; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hwang JR, 2012, CARCINOGENESIS, V33, P77, DOI 10.1093/carcin/bgr257; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Kanekura T, 2010, J DERMATOL SCI, V57, P149, DOI 10.1016/j.jdermsci.2009.12.008; Kim SH, 2008, CANCER RES, V68, P2062, DOI 10.1158/0008-5472.CAN-07-6278; Koehler BC, 2009, WORLD J GASTROENTERO, V15, P5924, DOI 10.3748/wjg.15.5924; Kohmo S, 2010, CANCER RES, V70, P8025, DOI 10.1158/0008-5472.CAN-10-0996; Krieg A, 2003, BRIT J CANCER, V88, P918, DOI 10.1038/sj.bjc.6600772; Lacour S, 2001, CANCER RES, V61, P1645; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; Malhi H, 2006, ONCOGENE, V25, P7333, DOI 10.1038/sj.onc.1209765; McPherson JP, 2009, CELL DEATH DIFFER, V16, P331, DOI 10.1038/cdd.2008.167; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P7; Murayama Y, 2004, J CELL SCI, V117, P3379, DOI 10.1242/jcs.01201; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nakamoto T, 2009, J GASTROENTEROL, V44, P889, DOI 10.1007/s00535-009-0081-3; Ovalle S, 2007, INT J CANCER, V121, P2140, DOI 10.1002/ijc.22902; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Pham PV, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-209; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Raclaw KA, 2008, PROSTATE, V68, P1696, DOI 10.1002/pros.20844; Roland CL, 2007, SURGERY, V141, P705, DOI 10.1016/j.surg.2007.01.016; Roth A, 2007, MOL CANCER THER, V6, P2737, DOI 10.1158/1535-7163.MCT-07-0140; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Ueyama H, 2011, BIOCHEM BIOPH RES CO, V414, P60, DOI 10.1016/j.bbrc.2011.09.021; Uluckan O, 2009, CANCER RES, V69, P3196, DOI 10.1158/0008-5472.CAN-08-3358; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wiiger MT, 2010, CANCER IMMUNOL IMMUN, V59, P1665, DOI 10.1007/s00262-010-0892-3; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yamazaki M, 2012, ONCOL REP, V28, P49, DOI 10.3892/or.2012.1803; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Yu F, 2011, J NEURO-ONCOL, V103, P187, DOI 10.1007/s11060-010-0377-4; Zhang B, 2010, CANCER RES, V70, P6407, DOI 10.1158/0008-5472.CAN-10-1544; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559; Zhu HB, 2005, CANCER BIOL THER, V4, P393; Zierler S, 2011, J BIOL CHEM, V286, P39328, DOI 10.1074/jbc.M111.264341; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	91	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58714	10.1371/journal.pone.0058714	http://dx.doi.org/10.1371/journal.pone.0058714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527012	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562600034
J	Beasley, JC; Olson, ZH; Beatty, WS; Dharmarajan, G; Rhodes, OE				Beasley, James C.; Olson, Zachary H.; Beatty, William S.; Dharmarajan, Guha; Rhodes, Olin E., Jr.			Effects of Culling on Mesopredator Population Dynamics	PLOS ONE			English	Article							ORAL RABIES VACCINATION; MELES-MELES; BRUSHTAIL POSSUMS; PREDATOR REMOVAL; RACCOON RABIES; DISPERSAL; TUBERCULOSIS; ATTRIBUTES; REDUCTION; MOVEMENTS	Anthropogenic changes in land use and the extirpation of apex predators have facilitated explosive growth of mesopredator populations. Consequently, many species have been subjected to extensive control throughout portions of their range due to their integral role as generalist predators and reservoirs of zoonotic disease. Yet, few studies have monitored the effects of landscape composition or configuration on the demographic or behavioral response of mesopredators to population manipulation. During 2007 we removed 382 raccoons (Procyon lotor) from 30 forest patches throughout a fragmented agricultural ecosystem to test hypotheses regarding the effects of habitat isolation on population recovery and role of range expansion and dispersal in patch colonization of mesopredators in heterogeneous landscapes. Patches were allowed to recolonize naturally and demographic restructuring of patches was monitored from 2008-2010 using mark-recapture. An additional 25 control patches were monitored as a baseline measure of demography. After 3 years only 40% of experimental patches had returned to pre-removal densities. This stagnant recovery was driven by low colonization rates of females, resulting in little to no within-patch recruitment. Colonizing raccoons were predominantly young males, suggesting that dispersal, rather than range expansion, was the primary mechanism driving population recovery. Contrary to our prediction, neither landscape connectivity nor measured local habitat attributes influenced colonization rates, likely due to the high dispersal capability of raccoons and limited role of range expansion in patch colonization. Although culling is commonly used to control local populations of many mesopredators, we demonstrate that such practices create severe disruptions in population demography that may be counterproductive to disease management in fragmented landscapes due to an influx of dispersing males into depopulated areas. However, given the slow repopulation rates observed in our study, localized depopulation may be effective at reducing negative ecological impacts of mesopredators in fragmented landscapes at limited spatial and temporal scales.	[Beasley, James C.; Olson, Zachary H.; Beatty, William S.; Dharmarajan, Guha; Rhodes, Olin E., Jr.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia	Beasley, JC (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA.	beasley@srel.edu	Dharmarajan, Guha/W-1263-2019	Beatty, William/0000-0003-0013-3113	Department of Forestry and Natural Resources at Purdue University; USDA-APHIS National Wildlife Research Center	Department of Forestry and Natural Resources at Purdue University; USDA-APHIS National Wildlife Research Center	Funding was provided by the Department of Forestry and Natural Resources at Purdue University and the USDA-APHIS National Wildlife Research Center (http://www.aphis.usda.gov/wildlife_damage/nwrc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton BT, 2007, J WILDLIFE MANAGE, V71, P1234, DOI 10.2193/2006-014; Beasley JC, 2010, CAN J ZOOL, V88, P161, DOI 10.1139/Z09-137; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P1125, DOI 10.2193/2006-228; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P844, DOI 10.2193/2006-022; Beasley JC, 2012, J WILDLIFE MANAGE, V76, P1718, DOI 10.1002/jwmg.423; Beasley JC, 2011, LANDSCAPE ECOL, V26, P937, DOI 10.1007/s10980-011-9619-x; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; BOUTIN S, 1993, BEHAV ECOL, V4, P151, DOI 10.1093/beheco/4.2.151; Brashares Justin S., 2010, P221; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cheeseman C.L., 1993, P78; CLOUT MN, 1984, J ANIM ECOL, V53, P737, DOI 10.2307/4656; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Cullingham CI, 2009, MOL ECOL, V18, P43, DOI 10.1111/j.1365-294X.2008.03989.x; Dharmarajan G, 2012, BASIC APPL IN PRESS; Dharmarajan G, 2009, CAN J ZOOL, V87, P814, DOI 10.1139/Z09-072; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; Eagan TS, 2011, CAN J ZOOL, V89, P724, DOI 10.1139/Z11-045; Efford M, 2000, WILDLIFE RES, V27, P117, DOI 10.1071/WR99005; Engeman RM, 2005, ORYX, V39, P318, DOI 10.1017/S0030605305000876; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gehrt SD, 1998, J MAMMAL, V79, P859, DOI 10.2307/1383094; GRAU GA, 1970, J WILDLIFE MANAGE, V34, P364, DOI 10.2307/3799023; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Jaquiery J, 2008, ECOLOGY, V89, P2777, DOI 10.1890/07-1833.1; Ji W, 2001, MOL ECOL, V10, P1527, DOI 10.1046/j.1365-294X.2001.01287.x; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; McGarigal K, 2002, COMPUTER SOFTWARE PR; Olson ZH, 2012, OIKOS, V121, P77, DOI 10.1111/j.1600-0706.2011.19771.x; Page K, 2011, EMERG INFECT DIS, V17, P90, DOI 10.3201/eid1701.100876; Page LK, 2009, J PARASITOL, V95, P1314, DOI 10.1645/GE-1998.1; Pearse AT, 2004, J WILDLIFE MANAGE, V68, P342, DOI 10.2193/0022-541X(2004)068[0342:EOPROM]2.0.CO;2; Pope LC, 2007, MOL ECOL, V16, P4919, DOI 10.1111/j.1365-294X.2007.03553.x; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Root JJ, 2009, VECTOR-BORNE ZOONOT, V9, P583, DOI 10.1089/vbz.2008.0110; Rosatte R, 2001, J WILDLIFE DIS, V37, P265, DOI 10.7589/0090-3558-37.2.265; Rosatte R, 2007, J WILDLIFE MANAGE, V71, P2373, DOI 10.2193/2006-549; Rosatte R, 2006, J WILDLIFE DIS, V42, P589, DOI 10.7589/0090-3558-42.3.589; Schmidt KA, 2003, CONSERV BIOL, V17, P1141, DOI 10.1046/j.1523-1739.2003.02316.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Slate D, 2005, VIRUS RES, V111, P68, DOI 10.1016/j.virusres.2005.03.012; Smith LL, 2012, J WILDL MAN IN PRESS; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Sterner RT, 2006, BIOL CONSERV, V131, P163, DOI 10.1016/j.biocon.2006.05.004; Sterner RT, 2009, EMERG INFECT DIS, V15, P1176, DOI 10.3201/eid1508.081061; TORRENCE ME, 1992, J WILDLIFE DIS, V28, P369, DOI 10.7589/0090-3558-28.3.369; Tuyttens FAM, 2000, J ANIM ECOL, V69, P567, DOI 10.1046/j.1365-2656.2000.00419.x; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x	54	20	21	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58982	10.1371/journal.pone.0058982	http://dx.doi.org/10.1371/journal.pone.0058982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527065	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562600050
J	Niedringhaus, M; Chen, X; Conant, K; Dzakpasu, R				Niedringhaus, Mark; Chen, Xin; Conant, Katherine; Dzakpasu, Rhonda			Synaptic Potentiation Facilitates Memory-like Attractor Dynamics in Cultured In Vitro Hippocampal Networks	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PERSISTENT ACTIVITY; NEURAL-NETWORKS; DENTATE AREA; PLASTICITY; SYNAPSES; MODEL; GAMMA; THETA; INFORMATION	Collective rhythmic dynamics from neurons is vital for cognitive functions such as memory formation but how neurons self-organize to produce such activity is not well understood. Attractor-based computational models have been successfully implemented as a theoretical framework for memory storage in networks of neurons. Additionally, activity-dependent modification of synaptic transmission is thought to be the physiological basis of learning and memory. The goal of this study is to demonstrate that using a pharmacological treatment that has been shown to increase synaptic strength within in vitro networks of hippocampal neurons follows the dynamical postulates theorized by attractor models. We use a grid of extracellular electrodes to study changes in network activity after this perturbation and show that there is a persistent increase in overall spiking and bursting activity after treatment. This increase in activity appears to recruit more "errant" spikes into bursts. Phase plots indicate a conserved activity pattern suggesting that a synaptic potentiation perturbation to the attractor leaves it unchanged. Lastly, we construct a computational model to demonstrate that these synaptic perturbations can account for the dynamical changes seen within the network.	[Niedringhaus, Mark; Conant, Katherine; Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Chen, Xin; Dzakpasu, Rhonda] Georgetown Univ, Dept Phys, Washington, DC 20007 USA; [Conant, Katherine] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Dzakpasu, Rhonda] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University	Dzakpasu, R (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.	dzakpasu@physics.georgetown.edu	Dzakpasu, Rhonda/F-8060-2019	Dzakpasu, Rhonda/0000-0002-7223-4602	Luce Foundation; National Institutes of Health, National Institute on Aging [029806]	Luce Foundation; National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Niedringhaus, Dr. Chen and Dr. Dzakpasu were supported by the Luce Foundation. Dr. Conant was supported by a grant from the National Institutes of Health, National Institute on Aging (grant no. 029806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1987, PHYS REV A, V35, P2293, DOI 10.1103/PhysRevA.35.2293; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P275, DOI 10.1088/0954-898X/2/3/004; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1970, J PHYSIOL-LONDON, V207, pP61; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Brunel N, 2003, CEREB CORTEX, V13, P1151, DOI 10.1093/cercor/bhg096; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; Carnevale NT, 2006, NEURON BOOK; Chen X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031907; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Enoki R, 2009, NEURON, V62, P242, DOI 10.1016/j.neuron.2009.02.026; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GREBOGI C, 1987, SCIENCE, V238, P632, DOI 10.1126/science.238.4827.632; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Ide AN, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016008; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; Maffei A, 2009, CURR OPIN NEUROBIOL, V19, P168, DOI 10.1016/j.conb.2009.05.012; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Montgomery SM, 2008, J NEUROSCI, V28, P6731, DOI 10.1523/JNEUROSCI.1227-08.2008; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Payne HL, 2008, MOL MEMBR BIOL, V25, P353, DOI 10.1080/09687680801986480; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Rachmuth G, 2011, P NATL ACAD SCI USA, V108, pE1266, DOI 10.1073/pnas.1106161108; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Segev R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118102; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Stegenga J, 2010, BIOPHYS J, V98, P2452, DOI 10.1016/j.bpj.2010.02.026; Tiesinga PH, 2004, J PHYSIOL-PARIS, V98, P296, DOI 10.1016/j.jphysparis.2005.09.002; Tiesinga PHE, 2004, NEUROCOMPUTING, V58, P641, DOI 10.1016/j.neucom.2004.01.108; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vajda I, 2008, BIOPHYS J, V94, P5028, DOI 10.1529/biophysj.107.112730; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051907; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Winograd M, 2008, P NATL ACAD SCI USA, V105, P7298, DOI 10.1073/pnas.0800360105	68	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57144	10.1371/journal.pone.0057144	http://dx.doi.org/10.1371/journal.pone.0057144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526935	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600006
J	Savage, T; Derraik, JGB; Miles, HL; Mouat, F; Hofman, PL; Cutfield, WS				Savage, Tim; Derraik, Jose G. B.; Miles, Harriet L.; Mouat, Fran; Hofman, Paul L.; Cutfield, Wayne S.			Increasing Maternal Age Is Associated with Taller Stature and Reduced Abdominal Fat in Their Children	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; INSULIN-RESISTANCE; BIRTH-WEIGHT; CHILDHOOD OBESITY; GENE-EXPRESSION; RISK-FACTORS; YOUNG-ADULTS; LIFE; PREGNANCY; GROWTH	Background: Maternal age at childbirth continues to increase worldwide. We aimed to assess whether increasing maternal age is associated with changes in childhood height, body composition, and metabolism. Methods: 277 healthy pre-pubertal children, born 37-41 weeks gestation were studied. Assessments included: height and weight corrected for parental measurements, DEXA-derived body composition, fasting lipids, glucose, insulin, and hormonal profiles. Subjects were separated according to maternal age at childbirth: <30, 30-35, and >35 years. Results: Our cohort consisted of 126 girls and 151 boys, aged 7.4 +/- 2.2 years (range 3-10); maternal age at childbirth was 33.3 +/- 4.7 years (range 19-44). Children of mothers aged >35 and 30-35 years at childbirth were taller than children of mothers aged <30 years by 0.26 (p = 0.002) and 0.23 (p = 0.042) SDS, respectively. There was a reduction in childhood BMISDS with increasing maternal age at childbirth, and children of mothers aged >35 years at childbirth were 0.61 SDS slimmer than those of mothers <30 years (p = 0.049). Children of mothers aged 30-35 (p = 0.022) and >35 (p = 0.036) years at childbirth had abdominal adiposity reduced by 10% and 13%, respectively, compared to those in the <30 group. Children of mothers aged 30-35 years at childbirth displayed a 19% increase in IGF-concentrations compared to offspring in <30 group (p = 0.042). Conversely, IGF-II concentrations were lower among the children born to mothers aged 30-35 (6.5%; p = 0.004) and >35 (8.1%; p = 0.005) compared to those of mothers aged <30 years. Girls of mothers aged 30-35 years at childbirth also displayed improved HOMA-IR insulin sensitivity (p = 0.010) compared to girls born to mothers aged <30 years. Conclusions: Increasing maternal age at childbirth is associated with a more favourable phenotype (taller stature and reduced abdominal fat) in their children, as well as improved insulin sensitivity in girls.	[Savage, Tim; Derraik, Jose G. B.; Miles, Harriet L.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Savage, Tim; Miles, Harriet L.; Hofman, Paul L.; Cutfield, Wayne S.] Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Mouat, Fran] Starship Childrens Hosp, Auckland Dist Hlth Board, Auckland, New Zealand	University of Auckland; Auckland District Health Board; Starship Children's Hospital	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956	National Research Centre for Growth and Development (New Zealand)	National Research Centre for Growth and Development (New Zealand)	This study was supported by grants from the National Research Centre for Growth and Development (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; BINKIN NJ, 1988, PEDIATRICS, V82, P828; Blair NJ, 2007, ARCH DIS CHILD, V92, P866, DOI 10.1136/adc.2007.116855; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; CANO F, 1995, FERTIL STERIL, V64, P584, DOI 10.1016/S0015-0282(16)57797-8; Cardwell CR, 2010, DIABETES, V59, P486, DOI 10.2337/db09-1166; Crespi EJ, 2006, J PHYSIOL-LONDON, V572, P119, DOI 10.1113/jphysiol.2005.103929; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dursun P, 2006, MED HYPOTHESES, V66, P143, DOI 10.1016/j.mehy.2004.10.022; EBBIARY NAA, 1994, CLIN ENDOCRINOL, V41, P199, DOI 10.1111/j.1365-2265.1994.tb02530.x; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Fowke JH, 2010, ENDOCR-RELAT CANCER, V17, P51, DOI 10.1677/ERC-09-0023; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Gerritsen S, 2008, PORTRAIT HLTH KEY RE; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lammi N, 2007, DIABETOLOGIA, V50, P2433, DOI 10.1007/s00125-007-0843-5; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Lawlor DA, 2004, CIRCULATION, V110, P2417, DOI 10.1161/01.CIR.0000145165.80130.B5; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miles HL, 2005, REV ENDOCR METAB DIS, V6, P261, DOI 10.1007/s11154-005-6184-0; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Novotny R, 2007, OBESITY, V15, P1565, DOI 10.1038/oby.2007.185; OECD, 2018, OECD FAM DAT; PANAGIOTOPOULOU K, 1990, CANCER CAUSE CONTROL, V1, P119, DOI 10.1007/BF00053162; Pearce J, 2007, AM J PREV MED, V32, P375, DOI 10.1016/j.amepre.2007.01.009; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Savage T, 2012, HUM REPROD, V27, P3092, DOI 10.1093/humrep/des249; SHEAR CL, 1987, HYPERTENSION, V9, P236, DOI 10.1161/01.HYP.9.3.236; Statistics New Zealand, 2012, TOT CONF DISTR HLTH; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Tanner, 1989, FOETUS MAN PHYS GROW; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; TANNER JM, 1975, ARCH DIS CHILD, V50, P14, DOI 10.1136/adc.50.1.14; The University of Auckland, 2011, TE KUAKA, V3, P4; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Troisi R, 2003, CANCER CAUSE CONTROL, V14, P347, DOI 10.1023/A:1023934518975; VANNOORDZAADSTRA BM, 1991, BMJ-BRIT MED J, V302, P1361, DOI 10.1136/bmj.302.6789.1361; Wang MH, 2000, NATURE, V407, P469, DOI 10.1038/35035156; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Weiss R, 2005, BEST PRACT RES CL EN, V19, P405, DOI 10.1016/j.beem.2005.04.009; WHINCUP P, 1995, BRIT MED J, V311, P773, DOI 10.1136/bmj.311.7008.773; Whitley E, 2008, ANN HUM BIOL, V35, P518, DOI 10.1080/03014460802294250	58	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58869	10.1371/journal.pone.0058869	http://dx.doi.org/10.1371/journal.pone.0058869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527040	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600042
J	Hoef, JMV; Temesgen, H				Hoef, Jay M. Ver; Temesgen, Hailemariam			A Comparison of the Spatial Linear Model to Nearest Neighbor (k-NN) Methods for Forestry Applications	PLOS ONE			English	Article							ESTIMATING BASAL-AREA; REMOTELY-SENSED DATA; MULTIPLE IMPUTATION; SATELLITE IMAGERY; PREDICTION ERROR; ATTRIBUTES; GEOSTATISTICS; MANAGEMENT; INVENTORY; ACCURACY	Forest surveys provide critical information for many diverse interests. Data are often collected from samples, and from these samples, maps of resources and estimates of aerial totals or averages are required. In this paper, two approaches for mapping and estimating totals; the spatial linear model (SLM) and k-NN (k-Nearest Neighbor) are compared, theoretically, through simulations, and as applied to real forestry data. While both methods have desirable properties, a review shows that the SLM has prediction optimality properties, and can be quite robust. Simulations of artificial populations and resamplings of real forestry data show that the SLM has smaller empirical root-mean-squared prediction errors (RMSPE) for a wide variety of data types, with generally less bias and better interval coverage than k-NN. These patterns held for both point predictions and for population totals or averages, with the SLM reducing RMSPE from 9% to 67% over some popular k-NN methods, with SLM also more robust to spatially imbalanced sampling. Estimating prediction standard errors remains a problem for k-NN predictors, despite recent attempts using model-based methods. Our conclusions are that the SLM should generally be used rather than k-NN if the goal is accurate mapping or estimation of population totals or averages.	[Hoef, Jay M. Ver] NOAA Fisheries, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Temesgen, Hailemariam] Oregon State Univ, Coll Forestry, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University	Hoef, JMV (corresponding author), NOAA Fisheries, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	jay.verhoef@noaa.gov	Ver Hoef, Jay/C-8577-2017	Ver Hoef, Jay/0000-0003-4302-6895	Alaska Fisheries Science Center of National Oceanic and Atmospheric Administration (NOAA) Fisheries	Alaska Fisheries Science Center of National Oceanic and Atmospheric Administration (NOAA) Fisheries	This project received financial support from Alaska Fisheries Science Center of National Oceanic and Atmospheric Administration (NOAA) Fisheries. The findings and conclusions in the paper are those of the author(s) and do not necessarily represent the views of the National Marine Fisheries Service, NOAA. Any use of trade names is for description purposes only and does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldworth J, 2003, J STAT PLAN INFER, V112, P3, DOI 10.1016/S0378-3758(02)00321-X; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], J STAT SOFTW; Baffetta F, 2012, FOREST ECOL MANAG, V272, P35, DOI 10.1016/j.foreco.2011.06.037; Baffetta F, 2009, REMOTE SENS ENVIRON, V113, P463, DOI 10.1016/j.rse.2008.06.014; BOLTHAUSEN E, 1982, ANN PROBAB, V10, P1047, DOI 10.1214/aop/1176993726; CRESSIE N, 1992, MATH GEOL, V24, P45, DOI 10.1007/BF00890087; CRESSIE N, 1990, MATH GEOL, V22, P239, DOI 10.1007/BF00889887; CRESSIE N, 1985, J INT ASS MATH GEOL, V17, P563, DOI 10.1007/BF01032109; Cressie N., 2011, STAT SPATIO TEMPORAL; Cressie N, 2008, J R STAT SOC B, V70, P209, DOI 10.1111/j.1467-9868.2007.00633.x; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Eidsvik J, 2012, COMPUT STAT DATA AN, V56, P1362, DOI 10.1016/j.csda.2011.10.022; Fehrmann L, 2008, CAN J FOREST RES, V38, P1, DOI 10.1139/X07-119; Finley AO, 2008, REMOTE SENS ENVIRON, V112, P2203, DOI 10.1016/j.rse.2007.08.024; Finley AO, 2008, J AGR BIOL ENVIR ST, V13, P60, DOI 10.1198/108571108X273160; Finley AO, 2009, ANN APPL STAT, V3, P1052, DOI 10.1214/09-AOAS250; Frayer WE, 1999, J FOREST, V97, P4; Haara A, 1997, SCAND J FOREST RES, V12, P200, DOI 10.1080/02827589709355401; HANDCOCK MS, 1993, TECHNOMETRICS, V35, P403, DOI 10.2307/1270273; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Heisel Torben, 1999, Precision Agriculture, V1, P39, DOI 10.1023/A:1009921718225; HEYDE CC, 1994, STAT PROBABIL LETT, V21, P381, DOI 10.1016/0167-7152(94)00035-2; Holmstrom H, 2003, FOREST SCI, V49, P409; Johnston K., 2001, USING ARCGIS GEOSTAT, V300; Katila M, 2001, REMOTE SENS ENVIRON, V76, P16, DOI 10.1016/S0034-4257(00)00188-7; Kim HJ, 2006, REMOTE SENS ENVIRON, V104, P257, DOI 10.1016/j.rse.2006.04.009; Lahiri SN, 1999, J AM STAT ASSOC, V94, P86, DOI 10.2307/2669680; LeMay V, 2005, FOREST SCI, V51, P109; Magnussen S, 2009, REMOTE SENS ENVIRON, V113, P476, DOI 10.1016/j.rse.2008.04.018; Malinen J, 2003, SILVA FENN, V37, P109, DOI 10.14214/sf.514; Maltamo M, 2003, FORESTRY, V76, P449, DOI 10.1093/forestry/76.4.449; McRoberts RE, 2002, REMOTE SENS ENVIRON, V82, P457, DOI 10.1016/S0034-4257(02)00064-0; McRoberts RE, 2008, REMOTE SENS ENVIRON, V112, P2212, DOI 10.1016/j.rse.2007.07.025; McRoberts RE, 2007, REMOTE SENS ENVIRON, V111, P466, DOI 10.1016/j.rse.2007.04.002; McRoberts RE, 2009, REMOTE SENS ENVIRON, V113, P489, DOI 10.1016/j.rse.2008.06.015; MOEUR M, 1995, FOREST SCI, V41, P337; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Packalen P, 2007, REMOTE SENS ENVIRON, V109, P328, DOI 10.1016/j.rse.2007.01.005; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pierce KB, 2009, CAN J FOREST RES, V39, P1901, DOI 10.1139/X09-102; Putter H, 2001, BERNOULLI, V7, P421, DOI 10.2307/3318494; Raty M, 2012, FOREST ECOL MANAG, V263, P47, DOI 10.1016/j.foreco.2011.09.026; Ravenscroft PJ, 1994, GEOSTATISTICAL SIMUL, P79; Roesch F., 1999, J FOREST, V97, P44; Rubin DB, 1996, J AM STAT ASSOC, V91, P515, DOI 10.2307/2291641; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Schabenberger O., 2005, STAT METHODS SPATIAL; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Sironen S, 2008, FOREST ECOL MANAG, V256, P674, DOI 10.1016/j.foreco.2008.05.013; Sironen S, 2003, CAN J FOREST RES, V33, P444, DOI [10.1139/x02-162, 10.1139/X02-162]; Stage AR, 2007, FOREST SCI, V53, P62; STEIN ML, 1988, ANN STAT, V16, P55, DOI 10.1214/aos/1176350690; Temesgen H, 2003, FOREST ECOL MANAG, V177, P277, DOI 10.1016/S0378-1127(02)00321-3; Thompson S.K., 2012, SAMPLING, V2nd; Tomppo EO, 2009, REMOTE SENS ENVIRON, V113, P500, DOI 10.1016/j.rse.2008.05.021; Tuominen S, 2003, CAN J FOREST RES, V33, P624, DOI 10.1139/X02-199; Ver Hoef J, 2002, ECOSCIENCE, V9, P152, DOI 10.1080/11956860.2002.11682701; Ver Hoef JM, 2008, ENVIRON ECOL STAT, V15, P3, DOI 10.1007/s10651-007-0035-y; Ver Hoef JM, 2000, ASA P SECT STAT ENV, P93; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; ZIMMERMAN DL, 1992, ANN I STAT MATH, V44, P27, DOI 10.1007/BF00048668; [No title captured]	68	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59129	10.1371/journal.pone.0059129	http://dx.doi.org/10.1371/journal.pone.0059129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527110	Green Published, gold			2022-12-27	WOS:000317562100080
J	Martel, G; Berube, J; Rousseau, S				Martel, Guy; Berube, Julie; Rousseau, Simon			The Protein Kinase TPL2 Is Essential for ERK1/ERK2 Activation and Cytokine Gene Expression in Airway Epithelial Cells Exposed to Pathogen-Associated Molecular Patterns (PAMPs)	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; PSEUDOMONAS-AERUGINOSA; NF-KAPPA-B1 P105; LIPOPOLYSACCHARIDE ACTIVATION; CYSTIC-FIBROSIS; INNATE IMMUNITY; TNF-ALPHA; PATHWAY; ERK; MACROPHAGES	The epithelium forms a physical barrier important to the detection of pathogens. P. aeruginosa infections are frequently encountered in Cystic Fibrosis lungs, lead to ERK1/ERK2 activation and contribute to tissue destruction. We report here that in bronchial airway epithelial cells (BEAS-2B), diffusible material from P. aeruginosa and TLR2, TLR3 and TLR5 ligands activates ERK1/ERK2 via the protein kinase TPL2 and not the growth factor receptor EGFR. Activation of TPL2 by these agonists in airway epithelial cells requires the protein kinases TAK1 and IKK beta in accordance with the previously reported model of activation of TPL2 in macrophages. Inhibition of TPL2 activity with a pharmacological inhibitor (Compound 1) not only prevented ERK1/ERK2 activation but also decreased cytokine synthesis in response to pathogen-associated molecular patterns. These results suggest that inhibition of the protein kinase TPL2 is an attractive strategy to decrease inflammation in the lungs when it is not warranted.	[Rousseau, Simon] McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University	Rousseau, S (corresponding author), McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada.	simon.rousseau@mcgill.ca		Rousseau, Simon/0000-0002-8773-575X	Cystic Fibrosis Canada; Centre grant from Les Fonds de la Recherche en Sante du Quebec (FRSQ); CIHR Quebec Respiratory Health Network fellowship; FRSQ	Cystic Fibrosis Canada; Centre grant from Les Fonds de la Recherche en Sante du Quebec (FRSQ); CIHR Quebec Respiratory Health Network fellowship(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	The authors acknowledge the financial support of Cystic Fibrosis Canada. The Meakins-Christie Laboratories - MUHC-RI, are supported by a Centre grant from Les Fonds de la Recherche en Sante du Quebec (FRSQ). GM was supported by the CIHR Quebec Respiratory Health Network fellowship. SR would like to acknowledge a salary award from the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Beaudoin T, 2012, BIOCHEM BIOPH RES CO, V428, P150, DOI 10.1016/j.bbrc.2012.10.030; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Handoyo H, 2009, BIOCHEM J, V424, P109, DOI 10.1042/BJ20091271; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lang V, 2004, MOL CELL BIOL, V24, P5235, DOI 10.1128/MCB.24.12.5235-5248.2004; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Roussel L, 2011, J CYST FIBROS, V10, P107, DOI 10.1016/j.jcf.2010.11.005; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Zhang J, 2004, INVEST OPHTH VIS SCI, V45, P2569, DOI 10.1167/iovs.03-1323; Zhang Z, 2007, INFECT IMMUN, V75, P5985, DOI 10.1128/IAI.00678-07	23	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59116	10.1371/journal.pone.0059116	http://dx.doi.org/10.1371/journal.pone.0059116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527104	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100078
J	Srivastava, VK; Srivastava, S; Arora, A; Pratap, JV				Srivastava, Vijay Kumar; Srivastava, Shubra; Arora, Ashish; Pratap, J. Venkatesh			Structural Insights into Putative Molybdenum Cofactor Biosynthesis Protein C (MoaC2) from Mycobacterium tuberculosis H37Rv	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLYBDOPTERIN SYNTHASE; SEQUENCE ALIGNMENT; AUTOMATED DOCKING; ENZYME MOAA; EARLY STEPS; BINDING; MODEL	The Molybdenum cofactor (Moco) biosynthesis pathway is an evolutionary conserved pathway seen in almost all eukaryotes including the pathogenic species Mycobacterium tuberculosis. This pathway comprises of several novel reactions which include the initial formation of precursor Z from guanosine triphosphate (GTP), catalysed by two enzymes MoaA and MoaC. Although Moco biosynthesis is well understood, the first step is still not clear. In M. tuberculosis H37Rv, three orthologous genes of MoaC have been annotated: moaC1 (Rv3111), moaC2 (Rv0864) and moaC3 (Rv3324c). Rv0864 (MoaC2) is a 17.5 kDa protein and is reported to be down-regulated by similar to 3 times in the nutrient starvation model for Mycobacterium tuberculosis. The crystal structure of Moco-biosynthesis protein MoaC2 from Mycobacterium tuberculosis (2.20 angstrom resolution, space group P2(1)3) has been determined. Based on a comparative analysis of structures of homologous proteins, conserved residues were identified and are implicated in structural and functional roles. Molecular docking studies with probable ligands carried out in order to identify its ligand, suggests that pteridinebenzomonophosphate as the most likely ligand. Sequence based interaction study identified MoaA1 to interact with MoaC2. A homology model of MoaA1 was then complexed with MoaC2 and protein-protein interactions are also discussed.	[Srivastava, Vijay Kumar; Srivastava, Shubra; Arora, Ashish; Pratap, J. Venkatesh] CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Arora, A (corresponding author), CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, India.	ashish_arora@cdri.res.in; jvpratap@cdri.res.in		Srivastava, Vijay/0000-0003-3395-2051	Council of Scientific and Industrial Research, India (CSIR) [NWP0038]; CSIR [CMM0017]; DST	Council of Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	This work was supported by a Council of Scientific and Industrial Research, India (CSIR) network grant NWP0038 to AA. Computational support was from CSIR grant CMM0017 and DST grant to JVP. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2000, ACCELRYS VER 1 1, P92121; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2002, J BIOL CHEM, V277, P18303, DOI 10.1074/jbc.M200947200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; HOFF T, 1995, J BIOL CHEM, V270, P6100, DOI 10.1074/jbc.270.11.6100; Jarrett JT, 2003, CURR OPIN CHEM BIOL, V7, P174, DOI 10.1016/S1367-5931(03)00022-X; Kanaujia SP, 2010, ACTA CRYSTALLOGR D, V66, P821, DOI 10.1107/S0907444910019074; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Rieder C, 1998, EUR J BIOCHEM, V255, P24, DOI 10.1046/j.1432-1327.1998.2550024.x; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Srivastava S, 2012, ACTA CRYSTALLOGR F, V68, P687, DOI 10.1107/S174430911201665X; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Unkles SE, 1997, J BIOL CHEM, V272, P28381, DOI 10.1074/jbc.272.45.28381; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493; Wuebbens MM, 2000, STRUCTURE, V8, P709, DOI 10.1016/S0969-2126(00)00157-X; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082; Yoshida H, 2008, ACTA CRYSTALLOGR F, V64, P589, DOI 10.1107/S174430910801590X	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58333	10.1371/journal.pone.0058333	http://dx.doi.org/10.1371/journal.pone.0058333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526978	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100024
J	Wang, Y; Rawi, R; Wilms, C; Heider, D; Yang, RG; Hoffmann, D				Wang, Yan; Rawi, Reda; Wilms, Christoph; Heider, Dominik; Yang, Rongge; Hoffmann, Daniel			A Small Set of Succinct Signature Patterns Distinguishes Chinese and Non-Chinese HIV-1 Genomes	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; TYPE-1; CCR5; BINDING; LOOP; POTENT; GP120; SUSCEPTIBILITY; ASSOCIATIONS; RESISTANCE	The epidemiology of HIV-1 in China has unique features that may have led to unique viral strains. We therefore tested the hypothesis that it is possible to find distinctive patterns in HIV-1 genomes sampled in China. Using a rule inference algorithm we could indeed extract from sequences of the third variable loop (V3) of HIV-1 gp120 a set of 14 signature patterns that with 89% accuracy distinguished Chinese from non-Chinese sequences. These patterns were found to be specific to HIV-1 subtype, i.e. sequences complying with pattern 1 were of subtype B, pattern 2 almost exclusively covered sequences of subtype 01_AE, etc. We then analyzed the first of these signature patterns in depth, namely that L and W at two V3 positions are specifically occurring in Chinese sequences of subtype B/B' (3% false positives). This pattern was found to be in agreement with the phylogeny of HIV-1 of subtype B inside and outside of China. We could neither reject nor convincingly confirm that the pattern is stabilized by immune escape. For further interpretation of the signature pattern we used the recently developed measure of Direct Information, and in this way discovered evidence for physical interactions between V2 and V3. We conclude by a discussion of limitations of signature patterns, and the applicability of the approach to other genomic regions and other countries.	[Wang, Yan; Rawi, Reda; Wilms, Christoph; Heider, Dominik; Hoffmann, Daniel] Univ Duisburg Essen, Ctr Med Biol, Res Grp Bioinformat, Essen, Germany; [Wang, Yan; Yang, Rongge] Chinese Acad Sci, Wuhan Inst Virol, AIDS & HIV Res Grp, State Key Lab Virol, Wuhan, Peoples R China	University of Duisburg Essen; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Yang, RG (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, AIDS & HIV Res Grp, State Key Lab Virol, Wuhan, Peoples R China.	ryang@wh.iov.cn; daniel.hoffmann@uni-due.de	Hoffmann, Daniel/B-1314-2018; Hoffmann, Daniel/P-5624-2019; Heider, Dominik/F-8545-2010	Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869; Heider, Dominik/0000-0002-3108-8311	Deutsche Forschungsgemeinschaft [TRR60/A6]; University of Duisburg-Essen; Chinese Key National Science and Technology Program [2012ZX10001006-002]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Duisburg-Essen; Chinese Key National Science and Technology Program	The authors gratefully acknowledge funding by Deutsche Forschungsgemeinschaft (http://www.dfg.de), grant TRR60/A6; the University of Duisburg-Essen (http://www.uni-due.de); and the Chinese Key National Science and Technology Program in the 12th Five-Year Period, grant 2012ZX10001006-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Cohen W W, 1995, P 12 INT C MACH LEAR, V95, P115, DOI DOI 10.1016/B978-1-55860-377-6.50023-2; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng XT, 2008, ALGORITHMICA, V52, P1, DOI 10.1007/s00453-007-9001-1; Derdeyn CA, 2008, CURR OPIN HIV AIDS, V3, P16, DOI 10.1097/COH.0b013e3282f2982c; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Gerberry DJ, 2010, AIDS, V24, P1604, DOI 10.1097/QAD.0b013e328337b973; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hardie RA, 2008, AIDS, V22, P807, DOI 10.1097/QAD.0b013e3282f51b71; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; KALISH ML, 1994, AIDS RES HUM RETROV, V10, P1573, DOI 10.1089/aid.1994.10.1573; KASPER P, 1994, AIDS RES HUM RETROV, V10, P1669, DOI 10.1089/aid.1994.10.1669; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lacap PA, 2008, AIDS, V22, P1029, DOI 10.1097/QAD.0b013e3282ffb3db; LEITNER T, 2005, HIV SEQUENCE COMPEND; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; MANN DL, 1988, J IMMUNOL, V141, P1131; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Development Core Team, 2006, R LANG ENV STAT COMP; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Wainberg MA, 2004, AIDS, V18, pS63, DOI 10.1097/00002030-200406003-00012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Witten I.H., 2005, DATA MINING PRACTICA; Xiang SH, 2010, J VIROL, V84, P3147, DOI 10.1128/JVI.02587-09; Yang Z, 2001, Pac Symp Biocomput, P226; Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473	51	0	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58804	10.1371/journal.pone.0058804	http://dx.doi.org/10.1371/journal.pone.0058804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527028	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100044
J	Zhang, CY; Wei, YB; Zhao, XH; von Gadow, K				Zhang, Chunyu; Wei, Yanbo; Zhao, Xiuhai; von Gadow, Klaus			Spatial Characteristics of Tree Diameter Distributions in a Temperate Old-Growth Forest	PLOS ONE			English	Article							POINT PATTERN-ANALYSIS; TROPICAL FORESTS; RAIN-FOREST; COMPETITION; AGGREGATION; DEPENDENCE; DISPERSAL; POLLEN; CHINA; LIGHT	This contribution identifies spatial characteristics of tree diameter in a temperate forest in north-eastern China, based on a fully censused observational study area covering 5006600 m. Mark correlation analysis with three null hypothesis models was used to determine departure from expectations at different neighborhood distances. Tree positions are clumped at all investigated scales in all 37 studied species, while the diameters of most species are spatially negatively correlated, especially at short distances. Interestingly, all three cases showing short-distance attraction of dbh marks are associated with light-demanding shrub species. The short-distance attraction of dbh marks indicates spatially aggregated cohorts of stems of similar size. The percentage of species showing significant dbh suppression peaked at a 4 m distance under the heterogeneous Poisson model. At scales exceeding the peak distance, the percentage of species showing significant dbh suppression decreases sharply with increasing distances. The evidence from this large observational study shows that some of the variation of the spatial characteristics of tree diameters is related variations of topography and soil chemistry. However, an obvious interpretation of this result is still lacking. Thus, removing competitors surrounding the target trees is an effective way to avoid neighboring competition effects reducing the growth of valuable target trees in forest management practice.	[Zhang, Chunyu; Wei, Yanbo; Zhao, Xiuhai] Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing, Peoples R China; [von Gadow, Klaus] Univ Gottingen, Fac Forestry & Forest Ecol, D-37073 Gottingen, Germany	Beijing Forestry University; University of Gottingen	Zhang, CY (corresponding author), Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing, Peoples R China.	zcy_0520@163.com	von Gadow, Klaus/N-6368-2015; Zhang, Chunyu/GYA-2925-2022; Zhang, Chun-yu/HDP-5776-2022	Zhang, Chunyu/0000-0003-3091-5060; 	National Special Research Program for Forestry Welfare of China [200904022]; 12th five-year National Science and Technology plan of China [2012BAC01B03]; National Natural Science Foundation of China [31200315]	National Special Research Program for Forestry Welfare of China; 12th five-year National Science and Technology plan of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Special Research Program for Forestry Welfare of China (200904022), the 12th five-year National Science and Technology plan of China (2012BAC01B03), and the National Natural Science Foundation of China (31200315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baack EJ, 2005, HEREDITY, V94, P538, DOI 10.1038/sj.hdy.6800656; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Ewel JJ, 2008, P NATL ACAD SCI USA, V105, P18836, DOI 10.1073/pnas.0807216105; Getzin S, 2008, FOREST ECOL MANAG, V255, P2478, DOI 10.1016/j.foreco.2008.01.007; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kariuki M, 2006, FOREST ECOL MANAG, V225, P1, DOI 10.1016/j.foreco.2005.07.016; KONIG D, 1991, J MICROSC-OXFORD, V161, P405, DOI 10.1111/j.1365-2818.1991.tb03100.x; Kunstler G, 2011, J ECOL, V99, P300, DOI 10.1111/j.1365-2745.2010.01751.x; Lancaster J, 2004, ECOGRAPHY, V27, P94, DOI 10.1111/j.0906-7590.2004.03694.x; Lancaster J, 2006, ECOGRAPHY, V29, P385, DOI 10.1111/j.2006.0906-7590.04381.x; Lejeune O, 1999, J VEG SCI, V10, P201, DOI 10.2307/3237141; Niggemann M, 2012, J ECOL, V100, P264, DOI 10.1111/j.1365-2745.2011.01854.x; Parrott L, 2004, FOREST ECOL MANAG, V194, P29, DOI 10.1016/j.foreco.2004.01.051; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Pukkala T, 2012, MANAG FOR ECOSYST, V23, P1, DOI 10.1007/978-94-007-2202-6; R Core Team, 2012, R LANG ENV STAT COMP; Rejou-Mechain M, 2011, J ECOL, V99, P1373, DOI 10.1111/j.1365-2745.2011.01873.x; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Schlather M, 2004, J R STAT SOC B, V66, P79, DOI 10.1046/j.1369-7412.2003.05343.x; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Shi H, 2003, FOREST SCI, V49, P938; Stoll P, 2005, ECOLOGY, V86, P3048, DOI 10.1890/04-1540; Stoyan D., 1987, STOCHASTIC GEOMETRY; Stoyan D., 1994, FRACTALS RANDOM SHAP; Uriarte M, 2004, J ECOL, V92, P348, DOI 10.1111/j.0022-0477.2004.00867.x; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Yamakura T., 1995, TROPICS, V5, P41, DOI [10.3759/tropics.5.41, DOI 10.3759/tropics.5.41, DOI 10.3759/TROPICS.5.41]; Zhang C, 2012, SILVA FENN IN PRESS; Zhang CY, 2010, ACTA OECOL, V36, P306, DOI 10.1016/j.actao.2010.02.003; Zhang CY, 2009, ALLG FORST JAGDZTG, V180, P45; Zhang ZH, 2013, J PLANT ECOL, V6, P131, DOI 10.1093/jpe/rts027; Zhao Xiuhai, 2005, Yingyong Shengtai Xuebao, V16, P2236; Zhu N., 1994, NATURAL SECONDARY FO	42	8	10	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58983	10.1371/journal.pone.0058983	http://dx.doi.org/10.1371/journal.pone.0058983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527066	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100062
J	Du, NN; Peng, ZG; Bi, CW; Tang, S; Li, YH; Li, JR; Zhu, YP; Zhang, JP; Wang, YX; Jiang, JD; Song, DQ				Du, Na-Na; Peng, Zong-Gen; Bi, Chong-Wen; Tang, Sheng; Li, Ying-Hong; Li, Jian-Rui; Zhu, Yan-Ping; Zhang, Jing-Pu; Wang, Yan-Xiang; Jiang, Jian-Dong; Song, Dan-Qing			N-Substituted Benzyl Matrinic Acid Derivatives Inhibit Hepatitis C Virus (HCV) Replication through Down-Regulating Host Heat-Stress Cognate 70 (Hsc70) Expression	PLOS ONE			English	Article							PROTEASE INHIBITOR; RESISTANCE MUTATIONS; INFECTION; THERAPIES; PEGINTERFERON; BOCEPREVIR; RIBAVIRIN; NS3	Heat-stress cognate 70 (Hsc70) is a host factor that helps hepatitis C virus (HCV) to complete its life cycle in infected hepatocytes. Using Hsc70 as a target for HCV inhibition, a series of novel N-substituted benzyl matrinic/sophoridinic acid derivatives was synthesized and evaluated for their anti-HCV activity in vitro. Among these analogues, compound 7c possessing N-p-methylbenzyl afforded an appealing ability to inhibit HCV replication with SI value over 53. Furthermore, it showed a good oral pharmacokinetic profile with area-under-curve (AUC) of 13.4 mu M.h, and a considerably good safety in oral administration in mice (LD50>1000 mg/kg). As 7c suppresses HCV replication via an action mode distinctly different from that of the marketed anti-HCV drugs, it has been selected as a new mechanism anti-HCV candidate for further investigation, with an advantage of no or decreased chance to induce drug-resistant mutations.	[Du, Na-Na; Peng, Zong-Gen; Bi, Chong-Wen; Tang, Sheng; Li, Ying-Hong; Li, Jian-Rui; Zhu, Yan-Ping; Zhang, Jing-Pu; Wang, Yan-Xiang; Jiang, Jian-Dong; Song, Dan-Qing] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Du, Na-Na; Peng, Zong-Gen; Bi, Chong-Wen; Tang, Sheng; Li, Ying-Hong; Li, Jian-Rui; Zhu, Yan-Ping; Zhang, Jing-Pu; Wang, Yan-Xiang; Jiang, Jian-Dong; Song, Dan-Qing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Jiang, JD (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	jiang.jdong@163.com; songdanqingsdq@hotmail.com	Peng, Zong-Gen/GVU-2327-2022	Peng, Zong-Gen/0000-0001-7662-6892	Beijing Natural Science Foundation [7121009]; National S&T Major Special Project on Major New Drug Innovation [2012ZX09103101-037, 2012ZX09301002-001]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National S&T Major Special Project on Major New Drug Innovation	This work was supported by Beijing Natural Science Foundation (7121009) and the National S&T Major Special Project on Major New Drug Innovation (2012ZX09103101-037 and 2012ZX09301002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begisheva AI, 1968, KHIM PRIR SOEDIN, V4, P371; BROWN HC, 1973, J ORG CHEM, V38, P912, DOI 10.1021/jo00945a015; Du NN, 2011, BIOORG MED CHEM LETT, V21, P4732, DOI 10.1016/j.bmcl.2011.06.071; Gao LM, 2011, J MED CHEM, V54, P869, DOI 10.1021/jm101325h; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Kamaev FG, 1974, CHEM NAT COM, V10, P765; KELLY RC, 1979, J AM CHEM SOC, V101, P1054, DOI 10.1021/ja00498a056; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lv Q, 2008, HUAXUE SHIJI, V30, P147; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Mederacke I, 2009, CURR OPIN INVEST DR, V10, P181; NAGANO N, 1991, J ANTIBIOT, V44, P422, DOI 10.7164/antibiotics.44.422; OCHIAI E, 1961, CHEM PHARM BULL, V9, P92; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Peng ZG, 2010, HEPATOLOGY, V52, P845, DOI 10.1002/hep.23766; Pereira AA, 2009, NAT REV GASTRO HEPAT, V6, P403, DOI 10.1038/nrgastro.2009.92; Piai G, 2006, DIGEST DIS SCI, V51, P1619, DOI 10.1007/s10620-006-9110-8; Qiu P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp251; Smith RET, 2006, NAT REV DRUG DISCOV, V5, P715, DOI 10.1038/nrd2134; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Thompson AJV, 2009, ALIMENT PHARM THER, V29, P689, DOI 10.1111/j.1365-2036.2009.03927.x; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274	24	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58675	10.1371/journal.pone.0058675	http://dx.doi.org/10.1371/journal.pone.0058675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516533	gold, Green Submitted, Green Published			2022-12-27	WOS:000316407400047
J	Szabo, M; Veres, Z; Baranyai, Z; Jakab, F; Jemnitz, K				Szabo, Monika; Veres, Zsuzsa; Baranyai, Zsolt; Jakab, Ferenc; Jemnitz, Katalin			Comparison of Human Hepatoma HepaRG Cells with Human and Rat Hepatocytes in Uptake Transport Assays in Order to Predict a Risk of Drug Induced Hepatotoxicity	PLOS ONE			English	Article							SALT EXPORT PUMP; COTRANSPORTING POLYPEPTIDE NTCP; CYCLOSPORINE-A; FUNCTIONAL EXPRESSION; CYTOCHROMES P450; CULTURED HUMAN; BILE-ACIDS; INHIBITION; TAUROCHOLATE; METABOLISM	Human hepatocytes are the gold standard for toxicological studies but they have several drawbacks, like scarce availability, high inter-individual variability, a short lifetime, which limits their applicability. The aim of our investigations was to determine, whether HepaRG cells could replace human hepatocytes in uptake experiments for toxicity studies. HepaRG is a hepatoma cell line with most hepatic functions, including a considerable expression of uptake transporters in contrast to other hepatic immortalized cell lines. We compared the effect of cholestatic drugs (bosentan, cyclosporinA, troglitazone,) and bromosulfophthalein on the uptake of taurocholate and estrone-3-sulfate in human and rat hepatocytes and HepaRG cells. The substrate uptake was significantly slower in HepaRG cells than in human hepatocytes, still, in the presence of drugs we observed a concentration dependent decrease in uptake. In all cell types, the culture time had a significant impact not only on the uptake process but on the inhibitory effect of drugs too. The most significant drug effect was measured at 4 h after seeding. Our report is among the first concerning interactions of the uptake transporters in the HepaRG, at the functional level. Results of the present study clearly show that concerning the inhibition of taurocholate uptake by cholestatic drugs, HepaRG cells are closer to human hepatocytes than rat hepatocytes. In conclusion, we demonstrated that HepaRG cells may provide a suitable tool for hepatic uptake studies.	[Szabo, Monika; Veres, Zsuzsa; Jemnitz, Katalin] Hungarian Acad Sci, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary; [Baranyai, Zsolt; Jakab, Ferenc] Uzsoki Teaching Hosp, Dept Surg, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Jemnitz, K (corresponding author), Hungarian Acad Sci, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary.	jemnitz.katalin@ttk.mta.hu	Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973; Jemnitz, Katalin/0000-0003-1943-3108	 [KMOP-1.2-07/1-2008-0002];  [GOP-1.1.1-09/1-009-0054];  [ETT 2009-2011]	; ; 	This study was supported by KMOP-1.2-07/1-2008-0002, GOP-1.1.1-09/1-009-0054 and ETT 2009-2011 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini G, 2001, GASTROENTEROLOGY, V120, pA6; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; ARIAS IM, 1993, GASTROENTEROLOGY, V104, P1558, DOI 10.1016/0016-5085(93)90371-I; AZER SA, 1993, TRANSPL P, V25, P2892; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hariparsad N, 2008, DRUG METAB DISPOS, V36, P1046, DOI 10.1124/dmd.108.020677; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Jemnitz K, 2012, TOXICOL IN VITRO, V26, P174, DOI 10.1016/j.tiv.2011.11.005; Jemnitz K, 2010, TOXICOL SCI, V115, P80, DOI 10.1093/toxsci/kfq044; Jigorel E, 2005, DRUG METAB DISPOS, V33, P1418, DOI 10.1124/dmd.105.004762; Kaplowitz N, 2001, DRUG SAFETY, V24, P483, DOI 10.2165/00002018-200124070-00001; Kemp DC, 2005, TOXICOL SCI, V83, P207, DOI 10.1093/toxsci/kfi020; Kostrubsky VE, 2003, TOXICOL SCI, V76, P220, DOI 10.1093/toxsci/kfg217; Kotani N, 2012, MOL PHARMACEUT, V9, P3434, DOI 10.1021/mp300171p; Kouzuki H, 2000, J PHARMACOL EXP THER, V292, P505; Kusuhara H, 2009, DRUG METAB PHARMACOK, V24, P37, DOI 10.2133/dmpk.24.37; Le Vee M, 2006, EUR J PHARM SCI, V28, P109, DOI 10.1016/j.ejps.2006.01.004; Lengyel G, 2005, DRUG METAB DISPOS, V33, P1355, DOI 10.1124/dmd.105.004481; Leslie EM, 2007, J PHARMACOL EXP THER, V321, P1170, DOI 10.1124/jpet.106.119073; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacDonald JS, 2009, TOXICOL SCI, V110, P40, DOI 10.1093/toxsci/kfp088; Madan A, 2003, DRUG METAB DISPOS, V31, P421, DOI 10.1124/dmd.31.4.421; Marion MJ, 2010, METHODS MOL BIOL, V640, P261, DOI 10.1007/978-1-60761-688-7_13; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; Parent R, 2004, GASTROENTEROLOGY, V126, P1147, DOI 10.1053/j.gastro.2004.01.002; Rippin SJ, 2001, HEPATOLOGY, V33, P776, DOI 10.1053/jhep.2001.23433; SASSA S, 1987, BIOCHEM BIOPH RES CO, V143, P52, DOI 10.1016/0006-291X(87)90628-0; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Smith MT, 2003, CHEM RES TOXICOL, V16, P679, DOI 10.1021/tx034033e; STACEY NH, 1988, GASTROENTEROLOGY, V95, P780, DOI 10.1016/S0016-5085(88)80028-3; Stieger B, 2011, HANDB EXP PHARMACOL, V201, P205, DOI 10.1007/978-3-642-14541-4_5; Treiber A, 2004, J PHARMACOL EXP THER, V308, P1121, DOI 10.1124/jpet.103.061614; Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615	39	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059432	10.1371/journal.pone.0059432	http://dx.doi.org/10.1371/journal.pone.0059432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516635	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400111
J	Zhang, RF; Song, Y; Zhou, YY; Sun, LL				Zhang, Ruifang; Song, Yi; Zhou, Yuanyuan; Sun, Lulu			Comparison of Aortic Annulus Diameter Measurement between Multi-Detector Computed Tomography and Echocardiography: A Meta-Analysis	PLOS ONE			English	Article							VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; REGURGITATION; PROSTHESIS; DIMENSIONS; STENOSIS; ROOT	Background and Purpose: Accurate measurement of aortic annulus diameter is crucial for choosing suitable prosthetic size for transcatheter aortic valve implantation (TAVI). Several imaging methods are available for the measurement, but significant variability between different modalities has been observed. The purpose of this study was to systematically compare the measurements of aortic annulus diameter between multi-detector computed tomography (MDCT), transthoracic echocardiography (TTE), and transesophegeal echocardiography (TEE). Methods: PubMed and EMBASE databases between January 2000 and January 2012 were searched. We extracted data from eligible studies evaluating the aortic annulus diameter by MDCT and echocardiography (TTE, TEE, or both). We performed a random-effects meta-analysis to calculate the weighted mean differences of aortic annulus diameter measurement between MDCT, TTE, and TEE. Results: A total of 10 eligible studies involving 581 subjects with aortic valve stenosis were included. Aortic annulus diameter measured on coronal view by MDCT (25.3 +/- 0.52 mm) was respectively larger than that measured on sagittal view by MDCT (22.7 +/- 0.37 mm), TTE (22.6 +/- 0.28 mm), and TEE (23.1 +/- 0.32 mm). The weighted mean difference of aortic annulus diameter between coronal view by MDCT and TTE these two methods was 2.97 mm, followed by the weighted mean difference of 2.53 mm between coronal view and sagittal view by MDCT, and the mean difference of 1.74 mm between coronal view on MDCT and TEE (P<0.0001 for all). The weighted mean difference of aortic annulus diameter measurement between TEE and TTE was significant but somewhat small (0.45 mm, P = 0.007). Conclusion: Aortic annulus diameter measured on coronal view by MDCT was robustly and significantly larger than that obtained on sagittal view by MDCT, TTE, or TEE. Such variability of aortic annulus diameter measurement by different imaging modalities cannot be ignored when developing optimal strategies for selection of prosthetic valve size in TAVI.	[Zhang, Ruifang; Song, Yi; Zhou, Yuanyuan; Sun, Lulu] Zhengzhou Univ, Affiliated Hosp 1, Dept Ultrasound, Zhengzhou, Henan Province, Peoples R China	Zhengzhou University	Zhang, RF (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Ultrasound, Zhengzhou, Henan Province, Peoples R China.	zhangruifang999@hotmail.com	Zhang, Rui/GXN-3801-2022					Altiok E, 2011, HEART, V97, P1578, DOI 10.1136/hrt.2011.223974; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Dashkevich A, 2011, ANN THORAC SURG, V91, P709, DOI 10.1016/j.athoracsur.2010.09.038; Delgado V, 2010, EUR HEART J, V31, P1114, DOI 10.1093/eurheartj/ehq018; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Detaint D, 2009, JACC-CARDIOVASC INTE, V2, P821, DOI 10.1016/j.jcin.2009.07.003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gurvitch R, 2011, JACC-CARDIOVASC INTE, V4, P1235, DOI 10.1016/j.jcin.2011.07.014; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Helton TJ, 2011, INT J CARDIOVAS IMAG, V27, P1143, DOI 10.1007/s10554-011-9825-2; Hutter A, 2010, CATHETER CARDIO INTE, V76, P1009, DOI 10.1002/ccd.22654; Jabbour A, 2011, J AM COLL CARDIOL, V58, P2165, DOI 10.1016/j.jacc.2011.09.010; Koos R, 2012, INT J CARDIOL, V158, P353, DOI 10.1016/j.ijcard.2011.01.044; LaBounty TM, 2008, AM J ROENTGENOL, V191, P1652, DOI 10.2214/AJR.07.3703; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Rubio DM, 2011, ECHOCARDIOGR-J CARD, V28, P388, DOI 10.1111/j.1540-8175.2010.01353.x; Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063; Mizia-Stec K, 2012, INT J CARDIOVAS IMAG, V28, P343, DOI 10.1007/s10554-010-9784-z; Moss RR, 2008, JACC-CARDIOVASC IMAG, V1, P15, DOI 10.1016/j.jcmg.2007.09.004; Ng ACT, 2010, CIRC-CARDIOVASC IMAG, V3, P94, DOI 10.1161/CIRCIMAGING.109.885152; Sherif MA, 2010, J AM COLL CARDIOL, V56, P1623, DOI 10.1016/j.jacc.2010.06.035; Tops LF, 2008, JACC-CARDIOVASC IMAG, V1, P321, DOI 10.1016/j.jcmg.2007.12.006; Tzikas A, 2011, CATHETER CARDIO INTE, V77, P868, DOI 10.1002/ccd.22761; Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258; Wood DA, 2009, AM J CARDIOL, V103, P1295, DOI 10.1016/j.amjcard.2009.01.034; Zajarias A, 2009, J AM COLL CARDIOL, V53, P1829, DOI 10.1016/j.jacc.2008.11.059	27	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58729	10.1371/journal.pone.0058729	http://dx.doi.org/10.1371/journal.pone.0058729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516543	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400055
J	Caetano-Anolles, K; Caetano-Anolles, G				Caetano-Anolles, Kelsey; Caetano-Anolles, Gustavo			Structural Phylogenomics Reveals Gradual Evolutionary Replacement of Abiotic Chemistries by Protein Enzymes in Purine Metabolism	PLOS ONE			English	Article							PREBIOTIC SYNTHESIS; DOMAIN ORGANIZATION; AEROBIC METABOLISM; MOLECULAR CLOCK; ORIGIN; HISTORY; ARCHITECTURE; PROTEOMES; NETWORKS; WORLD	The origin of metabolism has been linked to abiotic chemistries that existed in our planet at the beginning of life. While plausible chemical pathways have been proposed, including the synthesis of nucleobases, ribose and ribonucleotides, the cooption of these reactions by modern enzymes remains shrouded in mystery. Here we study the emergence of purine metabolism. The ages of protein domains derived from a census of fold family structure in hundreds of genomes were mapped onto enzymes in metabolic diagrams. We find that the origin of the nucleotide interconversion pathway benefited most parsimoniously from the prebiotic formation of adenine nucleosides. In turn, pathways of nucleotide biosynthesis, catabolism and salvage originated similar to 300 million years later by concerted enzymatic recruitments and gradual replacement of abiotic chemistries. Remarkably, this process led to the emergence of the fully enzymatic biosynthetic pathway similar to 3 billion years ago, concurrently with the appearance of a functional ribosome. The simultaneous appearance of purine biosynthesis and the ribosome probably fulfilled the expanding matter-energy and processing needs of genomic information.	[Caetano-Anolles, Kelsey; Caetano-Anolles, Gustavo] Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA; [Caetano-Anolles, Kelsey] Chicago Sch Profess Psychol, Chicago, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Caetano-Anolles, G (corresponding author), Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA.	gca@uiuc.edu		Caetano-Anolles, Gustavo/0000-0001-5854-4121; Caetano-Anolles, Kelsey/0000-0001-6310-6679	National Science Foundation [MCB-0749836]; CREES-USDA	National Science Foundation(National Science Foundation (NSF)); CREES-USDA	Research was supported by the National Science Foundation (MCB-0749836) and CREES-USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2004, BIOCHEMISTRY-US, V43, P10328, DOI 10.1021/bi0491301; Becerra A, 1998, ORIGINS LIFE EVOL B, V28, P539, DOI 10.1023/A:1006500327962; Benner SA, 2012, ACCOUNTS CHEM RES, V45, P2025, DOI 10.1021/ar200332w; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Caetano-Anolles D, 2011, J MOL EVOL, V72, P14, DOI 10.1007/s00239-010-9400-9; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Caetano-Anolles G, 2012, J MOL MICRO IN PRESS; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2012, J MOL EVOL, V74, P1, DOI 10.1007/s00239-011-9480-1; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Caetano-Anolles G, 2009, INT J BIOCHEM CELL B, V41, P285, DOI 10.1016/j.biocel.2008.08.022; Danchin A, 2007, PROTEOMICS, V7, P875, DOI 10.1002/pmic.200600442; Delidovich IV, 2009, KINET CATAL+, V50, P297, DOI 10.1134/S0023158409020219; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Ferris JP, 2005, REV MINERAL GEOCHEM, V59, P187, DOI 10.2138/rmg.2005.59.8; FERRIS JP, 1984, TETRAHEDRON, V40, P1093, DOI 10.1016/S0040-4020(01)99315-9; FERRIS JP, 1984, CHEM ENG NEWS, V62, P22; FULLER WD, 1972, J MOL BIOL, V67, P25, DOI 10.1016/0022-2836(72)90383-X; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grant T, 2002, CLADISTICS, V18, P94, DOI 10.1006/clad.2002.0186; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Harish A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032776; Holm NG, 2012, GEOBIOLOGY, V10, P269, DOI 10.1111/j.1472-4669.2012.00323.x; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jiang YY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002426; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; Kim HS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-351; Kim HS, 2013, J INTEGR BIOINFORMAT, V10, DOI 10.2390/biecoll-jib-2013-214; Kim KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-13; Kim KM, 2012, STRUCTURE, V20, P67, DOI 10.1016/j.str.2011.11.003; Kim KM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-140; Kim KM, 2010, MOL BIOL EVOL, V27, P1710, DOI 10.1093/molbev/msq106; Lambert JB, 2010, SCIENCE, V327, P984, DOI 10.1126/science.1182669; Lazcano A, 1999, J MOL EVOL, V49, P424, DOI 10.1007/PL00006565; LOHRMANN R, 1977, J MOL EVOL, V10, P137, DOI 10.1007/BF01751807; Mittenthal Jay, 2012, Frontiers in Genetics, V3, P147, DOI [10.3389/fgene.2012.00147, 10.3389/fgene.2012.00172]; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nasir A, 2011, GENES-BASEL, V2, P869, DOI 10.3390/genes2040869; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; ORO J, 1962, ARCH BIOCHEM BIOPHYS, V96, P293, DOI 10.1016/0003-9861(62)90412-5; OSTERBERG R, 1973, J MOL EVOL, V2, P231, DOI 10.1007/BF01654004; OSTERBERG R, 1972, J MOL EVOL, V1, P241, DOI 10.1007/BF01660243; Pereto J, 2012, CHEM SOC REV, V41, P5394, DOI 10.1039/c2cs35054h; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Saladino R, 2011, ORIGINS LIFE EVOL B, V41, P317, DOI 10.1007/s11084-011-9236-3; Srinivasan V, 2009, BIOL BULL-US, V217, P222, DOI 10.1086/BBLv217n3p222; Sun FJ, 2009, J MOL EVOL, V69, P430, DOI 10.1007/s00239-009-9264-z; Swofford D.L., 1999, PHYLOGENETIC ANAL US; Teichmann SA, 2001, TRENDS BIOTECHNOL, V19, P482, DOI 10.1016/S0167-7799(01)01813-3; Teichmann SA, 2001, J MOL BIOL, V311, P693, DOI 10.1006/jmbi.2001.4912; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; YCAS M, 1974, J THEOR BIOL, V44, P145, DOI 10.1016/S0022-5193(74)80035-4; Zubay G, 2001, ORIGINS LIFE EVOL B, V31, P87, DOI 10.1023/A:1006722423070; Zubay G, 1994, CHEMTRACTS BIOCH MOL, V5, P179; Zubay G, 1993, CHEMTRACTS BIOCH MOL, V4, P317	61	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59300	10.1371/journal.pone.0059300	http://dx.doi.org/10.1371/journal.pone.0059300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516625	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200142
J	Jaworska, K; Gupta, S; Durda, K; Muszynska, M; Sukiennicki, G; Jaworowska, E; Grodzki, T; Sulikowski, M; Woloszczyk, P; Wojcik, J; Lubinski, J; Cybulski, C; Debniak, T; Lener, M; Morawski, AW; Krzystolik, K; Narod, SA; Sun, P; Lubinski, J; Jakubowska, A				Jaworska, Katrzyna; Gupta, Satish; Durda, Katarzyna; Muszynska, Magdalena; Sukiennicki, Grzegorz; Jaworowska, Ewa; Grodzki, Tomasz; Sulikowski, Mieczyslaw; Woloszczyk, Piotr; Wojcik, Janusz; Lubinski, Jakub; Cybulski, Cezary; Debniak, Tadeusz; Lener, Marcin; Morawski, Antoni W.; Krzystolik, Karol; Narod, Steven A.; Sun, Ping; Lubinski, Jan; Jakubowska, Anna			A Low Selenium Level Is Associated with Lung and Laryngeal Cancers	PLOS ONE			English	Article							SERUM SELENIUM; NUTRITIONAL PREVENTION; PROSTATE-CANCER; SUBSEQUENT RISK; VITAMIN-E; POLYMORPHISM; TRIAL; SUPPLEMENTATION; METABOLISM; SMOKING	Purpose: It has been suggested that selenium deficiency is a risk factor for several cancer types. We conducted a case-control study in Szczecin, a region of northwestern Poland, on 95 cases of lung cancer, 113 cases of laryngeal cancer and corresponding healthy controls. Methods: We measured the serum level of selenium and established genotypes for four variants in four selenoprotein genes (GPX1, GPX4, TXNRD2 and SEP15). Selenium levels in the cases were measured after diagnosis but before treatment. We calculated the odds of being diagnosed with lung or laryngeal cancer, conditional on selenium level and genotype. Results: Among lung cancer cases, the mean selenium level was 63.2 mu g/l, compared to a mean level of 74.6 mu g/l for their matched controls (p<0.0001). Among laryngeal cancer cases, the mean selenium level was 64.8 mu g/l, compared to a mean level of 77.1 mu g/l for their matched controls (p<0.0001). Compared to a serum selenium value below 60 mu g/l, a selenium level above 80 mu g/l was associated with an odds ratio of 0.10 (95% CI 0.03 to 0.34; p = 0.0002) for lung cancer and 0.23 (95% CI 0.09 to 0.56; p = 0.001) for laryngeal cancer. In analysis of four selenoprotein genes we found a modest evidence of association of genetic variant in GPX1 with the risk of lung and laryngeal cancers. Conclusion: A selenium level below 60 mu g/l is associated with a high risk of both lung and laryngeal cancer.	[Jaworska, Katrzyna; Gupta, Satish; Durda, Katarzyna; Muszynska, Magdalena; Sukiennicki, Grzegorz; Cybulski, Cezary; Debniak, Tadeusz; Lener, Marcin; Lubinski, Jan; Jakubowska, Anna] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Jaworska, Katrzyna; Gupta, Satish] Warsaw Med Univ, Postgrad Sch Mol Med, Warsaw, Poland; [Jaworowska, Ewa; Lubinski, Jakub] Pomeranian Med Univ, Dept Otolaryngol & Laryngol Oncol, Szczecin, Poland; [Grodzki, Tomasz; Wojcik, Janusz] Pomeranian Med Univ, Dept Gen Thorac Surg, Szczecin, Poland; [Sulikowski, Mieczyslaw] Pomeranian Med Univ, Szczecin, Poland; [Woloszczyk, Piotr] Pomeranian Med Univ, Dept Toxicol & Mol Pathobiochem, Szczecin, Poland; [Morawski, Antoni W.] West Pomeranian Univ Technol, Inst Chem & Environm Engn, Dept Water Technol & Environm Engn, Szczecin, Poland; [Krzystolik, Karol] Pomeranian Med Univ, Chair & Clin Ophthalmol, Szczecin, Poland; [Narod, Steven A.; Sun, Ping] Womens Coll Res Inst, Toronto, ON, Canada	Pomeranian Medical University; Medical University of Warsaw; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; West Pomeranian University of Technology; Pomeranian Medical University; University of Toronto; University Toronto Affiliates; Womens College Hospital	Jakubowska, A (corresponding author), Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland.	aniaj@sci.pam.szczecin.pl	Narod, Steven A/AAA-6112-2022; Jaworowska, Ewa/B-1211-2015; Waloszczyk, Piotr/A-8399-2015; Jakubowska, Anna/O-8050-2014; Krzystolik, Karol/A-8245-2015; Lubinski, Jan/C-4420-2017	Jaworowska, Ewa/0000-0001-9050-5042; Jakubowska, Anna/0000-0002-5650-0501; Krzystolik, Karol/0000-0002-7695-0788; Lubinski, Jan/0000-0003-2931-3003; Morawski, Antoni Waldemar/0000-0002-2606-4104	International PhD Projects Programme (MPD) of Foundation for Polish Science; European Union, Regional Development Fund; National Science Centre (NCN) grant [UMO-2011/03/N/NZ2/01539]	International PhD Projects Programme (MPD) of Foundation for Polish Science; European Union, Regional Development Fund; National Science Centre (NCN) grant	This project was realized within the International PhD Projects Programme (MPD) of Foundation for Polish Science, co-financed from European Union, Regional Development Fund. This study was supported by the National Science Centre (NCN) grant UMO-2011/03/N/NZ2/01539. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no financial or other relationships that might lead to a conflict of interests.	Comstock GW, 1997, CANCER EPIDEM BIOMAR, V6, P907; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Duncan A, 2012, AM J CLIN NUTR, V95, P64, DOI 10.3945/ajcn.111.023812; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P1962, DOI 10.1158/1055-9965.EPI-09-0003; GARLAND M, 1995, J NATL CANCER I, V87, P497, DOI 10.1093/jnci/87.7.497; Goodman GE, 2001, CANCER EPIDEM BIOMAR, V10, P1069; Hartman TJ, 2002, CANCER CAUSE CONTROL, V13, P923, DOI 10.1023/A:1021912117067; Jablonska E, 2008, EUR J NUTR, V47, P47, DOI 10.1007/s00394-008-0696-9; KABUTO M, 1994, CANCER EPIDEM BIOMAR, V3, P465; Knekt P, 1998, AM J EPIDEMIOL, V148, P975, DOI 10.1093/oxfordjournals.aje.a009574; KNEKT P, 1990, J NATL CANCER I, V82, P864, DOI 10.1093/jnci/82.10.864; KROMHOUT D, 1987, AM J CLIN NUTR, V45, P1361, DOI 10.1093/ajcn/45.5.1361; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MENKES MS, 1986, NEW ENGL J MED, V315, P1250, DOI 10.1056/NEJM198611133152003; NOMURA A, 1987, J NATL CANCER I, V79, P103; Raaschou-Nielsen O, 2007, CANCER LETT, V247, P293, DOI 10.1016/j.canlet.2006.05.006; Ratnasinghe D, 2000, CANCER CAUSE CONTROL, V11, P129, DOI 10.1023/A:1008977320811; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Reid ME, 2002, CANCER EPIDEM BIOMAR, V11, P1285; Renko K, 2009, FASEB J, V23, P1758, DOI 10.1096/fj.08-119370; Rosenberger A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-60; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; Skuladottir H, 2005, LUNG CANCER, V48, P187, DOI 10.1016/j.lungcan.2004.10.013; Sutherland A, 2010, GENES NUTR, V5, P215, DOI 10.1007/s12263-010-0176-8; VANDENBRANDT PA, 1993, CANCER RES, V53, P4860; Yang P, 2004, CARCINOGENESIS, V25, P1935, DOI 10.1093/carcin/bgh203; Zhou Lan, 2011, Zhongguo Fei Ai Za Zhi, V14, P39, DOI 10.3779/j.issn.1009-3419.2011.01.08; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771	32	50	51	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59051	10.1371/journal.pone.0059051	http://dx.doi.org/10.1371/journal.pone.0059051			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516596	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200129
J	Strak, M; Hoek, G; Godri, KJ; Gosens, I; Mudway, IS; van Oerle, R; Spronk, HMH; Cassee, FR; Lebret, E; Kelly, FJ; Harrison, RM; Brunekreef, B; Steenhof, M; Janssen, NAH				Strak, Maciej; Hoek, Gerard; Godri, Krystal J.; Gosens, Ilse; Mudway, Ian S.; van Oerle, Rene; Spronk, Henri M. H.; Cassee, Flemming R.; Lebret, Erik; Kelly, Frank J.; Harrison, Roy M.; Brunekreef, Bert; Steenhof, Maaike; Janssen, Nicole A. H.			Composition of PM Affects Acute Vascular Inflammatory and Coagulative Markers - The RAPTES Project	PLOS ONE			English	Article							AIRBORNE PARTICULATE MATTER; AIR-POLLUTION; CARDIOVASCULAR-DISEASE; DIESEL EXHAUST; TERM EXPOSURE; HEALTHY; COMPONENTS; PARTICLES; MORTALITY; RISK	Background: Exposure to ambient particulate matter (PM) has been associated with adverse cardiovascular effects in epidemiological studies. Current knowledge of independent effects of individual PM characteristics remains limited. Methods: Using a semi-experimental design we investigated which PM characteristics were consistently associated with blood biomarkers believed to be predictive of the risk of cardiovascular events. We exposed healthy adult volunteers at 5 different locations chosen to provide PM exposure contrasts with reduced correlations among PM characteristics. Each of the 31 volunteers was exposed for 5 h, exercising intermittently, 3-7 times at different sites from March to October 2009. Extensive on-site exposure characterization included measurements of PM mass and number concentration, elemental-(EC) and organic carbon (OC), trace metals, sulfate, nitrate, and PM oxidative potential (OP). Before and 2 h and 18 h after exposure we measured acute vascular blood biomarkers - C-reactive protein, fibrinogen, platelet counts, von Willebrand Factor, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex. We used two-pollutant models to assess which PM characteristics were most consistently associated with the measured biomarkers. Results and Conclusion: We found OC, nitrate and sulfate to be most consistently associated with different biomarkers of acute cardiovascular risk. Associations with PM mass concentrations and OP were less consistent, whereas other measured components of the air pollution mixture, including PNC, EC, trace metals and NO2, were not associated with the biomarkers after adjusting for other pollutants.	[Strak, Maciej; Gosens, Ilse; Cassee, Flemming R.; Lebret, Erik; Janssen, Nicole A. H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Environm Hlth MGO, Bilthoven, Netherlands; [Strak, Maciej; Hoek, Gerard; Cassee, Flemming R.; Lebret, Erik; Brunekreef, Bert; Steenhof, Maaike] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Strak, Maciej; Hoek, Gerard; Cassee, Flemming R.; Lebret, Erik; Brunekreef, Bert; Steenhof, Maaike] Univ Utrecht, Inst Risk Assessment Sci, Div Toxicol, Utrecht, Netherlands; [Godri, Krystal J.; Mudway, Ian S.; Kelly, Frank J.] Kings Coll London, Environm Res Grp, MRC HPA Ctr Environm Hlth, London WC2R 2LS, England; [Godri, Krystal J.; Harrison, Roy M.] Univ Birmingham, Sch Geog Earth & Environm Sci, Div Environm Hlth & Risk Management, Birmingham, W Midlands, England; [van Oerle, Rene; Spronk, Henri M. H.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Lab Clin Thrombosis & Haemostasis,Dept Internal M, Maastricht, Netherlands; [Harrison, Roy M.] King Abdulaziz Univ, Dept Environm Sci, Ctr Excellence Environm Studies, Jeddah 21413, Saudi Arabia; [Brunekreef, Bert] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University; Imperial College London; University of London; King's College London; University of Birmingham; Maastricht University; King Abdulaziz University; Utrecht University; Utrecht University Medical Center	Janssen, NAH (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Environm Hlth MGO, Bilthoven, Netherlands.	nicole.janssen@rivm.nl	Cassee, Flemming R/G-4241-2010; Kelly, Frank J/C-6125-2009; Harrison, Roy M/A-2256-2008	Cassee, Flemming R/0000-0001-9958-8630; Kelly, Frank J/0000-0003-2558-8392; Harrison, Roy M/0000-0002-2684-5226; Spronk, Henri/0000-0002-3858-334X; Lebret, Erik/0000-0003-2602-2155; Mudway, Ian/0000-0003-1239-5014; brunekreef, bert/0000-0001-9908-0060; Strak, Maciej/0000-0002-9085-6026; Steenhof, Maaike/0000-0002-8812-8476; Godri Pollitt, Krystal/0000-0001-7332-2228	RIVM Strategic Research Program [S630002]; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056B, G1000758, G0801056] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	RIVM Strategic Research Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The RAPTES project was funded by the RIVM Strategic Research Program (S630002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JG, 2008, INHAL TOXICOL, V20, P75, DOI [10.1080/08958370701665517, 10.1080/08958370701665517 ]; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Brunekreef B, 2010, EPIDEMIOLOGY, V21, P903, DOI 10.1097/EDE.0b013e3181f4e1e6; BURNETT RT, 1995, AM J EPIDEMIOL, V142, P15, DOI 10.1093/oxfordjournals.aje.a117540; Carlsten C, 2007, THROMB RES, V120, P849, DOI 10.1016/j.thromres.2007.01.005; Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111; Godri KJ, 2010, ENVIRON HEALTH PERSP, V118, P493, DOI 10.1289/ehp.0901303; Gong H, 2008, INHAL TOXICOL, V20, P533, DOI 10.1080/08958370801911340 ; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; Krewski D, 2000, REANALYSSI HARVARD 6; Krintus M, 2010, CLIN BIOCHEM, V43, P626, DOI 10.1016/j.clinbiochem.2009.12.013; Larsson BM, 2007, EUR RESPIR J, V29, P699, DOI 10.1183/09031936.00035706; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Nystrom AK, 2010, EUR RESPIR J, V36, P240, DOI 10.1183/09031936.00099909; Ostro B, 2007, ENVIRON HEALTH PERSP, V115, P13, DOI 10.1289/ehp.9281; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peng RD, 2009, ENVIRON HEALTH PERSP, V117, P957, DOI 10.1289/ehp.0800185; Pope CA, 2007, ENVIRON HEALTH PERSP, V115, P679, DOI 10.1289/ehp.9762; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC; Riediker M, 2007, INHAL TOXICOL, V19, P99, DOI 10.1080/08958370701495238; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Samet JM, 2009, AM J RESP CRIT CARE, V179, P1034, DOI 10.1164/rccm.200807-1043OC; Schlesinger RB, 2003, INHAL TOXICOL, V15, P197, DOI 10.1080/08958370304503; Solomon PA, 2008, J AIR WASTE MANAGE, V58, P164, DOI 10.3155/1047-3289.58.2.164; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; Steenhof M, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-26; Strak M, 2012, ENVIRON HEALTH PERSP, V120, P1183, DOI 10.1289/ehp.1104389; Strak M, 2011, ATMOS ENVIRON, V45, P4442, DOI 10.1016/j.atmosenv.2011.05.035; Trigg DE, 2011, SEMIN THROMB HEMOST, V37, P77, DOI 10.1055/s-0030-1270074; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Wagner DD, 2005, ARTERIOSCL THROM VAS, V25, P1321, DOI 10.1161/01.ATV.0000166521.90532.44; WHO, 2007, HTLH REL PART MATT V; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019; Zuurbier M, 2011, ENVIRON HEALTH PERSP, V119, P1384, DOI 10.1289/ehp.1003151	36	44	45	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58944	10.1371/journal.pone.0058944	http://dx.doi.org/10.1371/journal.pone.0058944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516583	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200124
J	Hattingen, E; Bahr, O; Rieger, J; Blasel, S; Steinbach, J; Pilatus, U				Hattingen, Elke; Bahr, Oliver; Rieger, Johannes; Blasel, Stella; Steinbach, Joachim; Pilatus, Ulrich			Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; P-31 MR SPECTROSCOPY; HIGH-GRADE GLIOMAS; BRAIN-TUMORS; SURVIVAL; CELLS; QUANTIFICATION; CRITERIA; INDEX; VITRO	Purpose: Metabolic changes upon antiangiogenic therapy of recurrent glioblastomas (rGBMs) may provide new biomarkers for treatment efficacy. Since in vitro models showed that phospholipid membrane metabolism provides specific information on tumor growth we employed in-vivo MR-spectroscopic imaging (MRSI) of human rGBMs before and under bevacizumab (BVZ) to measure concentrations of phosphocholine (PCho), phosphoethanolamine (PEth), glycerophosphocholine (GPC), and glyceroethanolamine (GPE). Methods: 1 H and 31 P MRSI was prospectively performed in 32 patients with rGBMs before and under BVZ therapy at 8 weeks intervals until tumor progression. Patients were dichotomized into subjects with long overall survival (OS) (<median OS) and short OS (>median OS) survival time from BVZ-onset. Metabolite concentrations from tumor tissue and their ratios were compared to contralateral normal-appearing tissue (control). Results: Before BVZ, 1 H-detectable choline signals (total GPC and PCho) in rGBMs were elevated but significance failed after dichotomizing. For metabolite ratios obtained by 31 P MRSI, the short-OS group showed higher PCho/GPC (p = 0.004) in rGBMs compared to control tissue before BVZ while PEth/GPE was elevated in rGBMs of both groups (long-OS p = 0.04; short-OS p = 0.003). Under BVZ, PCho/GPC and PEth/GPE in the tumor initially decreased (p = 0.04) but only PCho/GPC re-increased upon tumor progression (p = 0.02). Intriguingly, in normal-appearing tissue an initial PEth/GPE decrease (p = 0.047) was followed by an increase at the time of tumor progression (p = 0.031). Conclusion: An elevated PCho/GPC ratio in the short-OS group suggests that it is a negative predictive marker for BVZ efficacy. These gliomas may represent a malignant phenotype even growing under anti-VEGF treatment. Elevated PEth/GPE may represent an in-vivo biomarker more sensitive to GBM infiltration than MRI.	[Hattingen, Elke; Blasel, Stella; Pilatus, Ulrich] Goethe Univ Hosp Frankfurt, Inst Neuroradiol, Frankfurt, Germany; [Bahr, Oliver; Rieger, Johannes; Steinbach, Joachim] Goethe Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Hattingen, E (corresponding author), Goethe Univ Hosp Frankfurt, Inst Neuroradiol, Frankfurt, Germany.	elke.hattingen@kgu.de	Hattingen, Elke/D-7880-2015	Rieger, Johannes/0000-0002-7918-1777; Hattingen, Elke/0000-0002-8392-9004				Aiken NR, 1996, ANTICANCER RES, V16, P1393; Albers MJ, 2005, MAGN RESON MED, V53, P22, DOI 10.1002/mrm.20312; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Bahr O, 2011, NEURO-ONCOLOGY, V13, P1020, DOI 10.1093/neuonc/nor099; CADOUXHUDSON TAD, 1989, BRIT J CANCER, V60, P430, DOI 10.1038/bjc.1989.300; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Cohen BA, 2005, AM J NEURORADIOL, V26, P2170; CUADRADO A, 1993, ONCOGENE, V8, P2959; DALY PF, 1987, J BIOL CHEM, V262, P14875; Dowling C, 2001, AM J NEURORADIOL, V22, P604; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; GILLIES RJ, 1994, MAGNET RESON MED, V32, P310, DOI 10.1002/mrm.1910320306; Glunde K, 2008, CANCER RES, V68, P172, DOI 10.1158/0008-5472.CAN-07-2678; Glunde K, 2007, LANCET ONCOL, V8, P855, DOI 10.1016/S1470-2045(07)70289-9; Glunde K, 2006, NEOPLASIA, V8, P758, DOI 10.1593/neo.06187; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Guo J, 2012, ACTA NEUROCHIR, V154, P1361, DOI 10.1007/s00701-012-1418-x; Hattingen E, 2007, J MAGN RESON IMAGING, V26, P427, DOI 10.1002/jmri.20985; Hattingen E, 2011, NEURO-ONCOLOGY, V13, P1349, DOI 10.1093/neuonc/nor132; HEINDEL W, 1988, J COMPUT ASSIST TOMO, V12, P907, DOI 10.1097/00004728-198811000-00001; Herminghaus S, 2002, NMR BIOMED, V15, P385, DOI 10.1002/nbm.793; HIRATA F, 1980, SCIENCE, V209, P1082, DOI 10.1126/science.6157192; HUBESCH B, 1990, RADIOLOGY, V174, P401, DOI 10.1148/radiology.174.2.2296651; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Jensen JE, 2002, NMR BIOMED, V15, P338, DOI 10.1002/nbm.776; Kallenberg K, 2009, RADIOLOGY, V253, P805, DOI 10.1148/radiol.2533071654; Kim H, 2011, CANCER RES, V71, P3745, DOI 10.1158/0008-5472.CAN-10-2991; Kinoshita Y, 1997, NMR BIOMED, V10, P2, DOI 10.1002/(SICI)1099-1492(199701)10:1<2::AID-NBM442>3.0.CO;2-N; Kinoshita Yoshimasa, 1994, Neurologia Medico-Chirurgica, V34, P803, DOI 10.2176/nmc.34.803; Klomp DWJ, 2008, MAGN RESON MED, V60, P1298, DOI 10.1002/mrm.21733; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Luyten P R, 1989, NMR Biomed, V1, P177, DOI 10.1002/nbm.1940010405; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Maintz D, 2002, NMR BIOMED, V15, P18, DOI 10.1002/nbm.735; MARIS JM, 1985, NEW ENGL J MED, V312, P1500, DOI 10.1056/NEJM198506063122307; McKnight TR, 2002, J NEUROSURG, V97, P794, DOI 10.3171/jns.2002.97.4.0794; Mirbahai L, 2011, INT J BIOCHEM CELL B, V43, P990, DOI 10.1016/j.biocel.2010.07.002; Narayana A, 2012, INT J RADIAT ONCOL, V82, P77, DOI 10.1016/j.ijrobp.2010.10.038; Norden AD, 2009, J NEURO-ONCOL, V92, P149, DOI 10.1007/s11060-008-9745-8; Oh J, 2004, J MAGN RESON IMAGING, V19, P546, DOI 10.1002/jmri.20039; Pirzkall A, 2004, INT J RADIAT ONCOL, V59, P126, DOI 10.1016/j.ijrobp.2003.08.023; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; ROSS BD, 1988, MAGNET RESON MED, V6, P403, DOI 10.1002/mrm.1910060406; RUTTER A, 1995, INVEST RADIOL, V30, P359, DOI 10.1097/00004424-199506000-00006; SEGEBARTH CM, 1987, RADIOLOGY, V165, P215, DOI 10.1148/radiology.165.1.3628774; Sterin M, 2001, CANCER RES, V61, P7536; Stewart JD, 2012, P NATL ACAD SCI USA, V109, P8155, DOI 10.1073/pnas.1117654109; SUTTON LN, 1990, J NEUROSURG, V72, P65, DOI 10.3171/jns.1990.72.1.0065; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vanpouille C, 2009, EUR J NUCL MED MOL I, V36, P1256, DOI 10.1007/s00259-009-1101-5; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick A, 2011, ANN NEUROL, V69, P586, DOI 10.1002/ana.22336; Wright AJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-66; Xu T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-252	58	35	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56439	10.1371/journal.pone.0056439	http://dx.doi.org/10.1371/journal.pone.0056439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520454	Green Submitted, gold, Green Published			2022-12-27	WOS:000318679900013
J	Kyaw, MP; Nyunt, MH; Chit, K; Aye, MM; Aye, KH; Aye, MM; Lindegardh, N; Tarning, J; Imwong, M; Jacob, CG; Rasmussen, C; Perin, J; Ringwald, P; Nyunt, MM				Kyaw, Myat P.; Nyunt, Myat H.; Chit, Khin; Aye, Moe M.; Aye, Kyin H.; Aye, Moe M.; Lindegardh, Niklas; Tarning, Joel; Imwong, Mallika; Jacob, Christopher G.; Rasmussen, Charlotte; Perin, Jamie; Ringwald, Pascal; Nyunt, Myaing M.			Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar	PLOS ONE			English	Article							ARTEMISININ-RESISTANT MALARIA; PARASITE CLEARANCE; NO EVIDENCE; DIHYDROARTEMISININ; BIOAVAILABILITY; PROVINCE; SPREAD	Background: Plasmodium falciparum resistance to artemisinins, the first line treatment for malaria worldwide, has been reported in western Cambodia. Resistance is characterized by significantly delayed clearance of parasites following artemisinin treatment. Artemisinin resistance has not previously been reported in Myanmar, which has the highest falciparum malaria burden among Southeast Asian countries. Methods: A non-randomized, single-arm, open-label clinical trial of artesunate monotherapy (4 mg/kg daily for seven days) was conducted in adults with acute blood-smear positive P. falciparum malaria in Kawthaung, southern Myanmar. Parasite density was measured every 12 hours until two consecutive negative smears were obtained. Participants were followed weekly at the study clinic for three additional weeks. Co-primary endpoints included parasite clearance time (the time required for complete clearance of initial parasitemia), parasite clearance half-life (the time required for parasitemia to decrease by 50% based on the linear portion of the parasite clearance slope), and detectable parasitemia 72 hours after commencement of artesunate treatment. Drug pharmacokinetics were measured to rule out delayed clearance due to suboptimal drug levels. Results: The median (range) parasite clearance half-life and time were 4.8 (2.1-9.7) and 60 (24-96) hours, respectively. The frequency distributions of parasite clearance half-life and time were bimodal, with very slow parasite clearance characteristic of the slowest-clearing Cambodian parasites (half-life longer than 6.2 hours) in approximately 1/3 of infections. Fourteen of 52 participants (26.9%) had a measurable parasitemia 72 hours after initiating artesunate treatment. Parasite clearance was not associated with drug pharmacokinetics. Conclusions: A subset of P. falciparum infections in southern Myanmar displayed markedly delayed clearance following artemisinin treatment, suggesting either emergence of artemisinin resistance in southern Myanmar or spread to this location from its site of origin in western Cambodia. Resistance containment efforts are underway in Myanmar.	[Kyaw, Myat P.; Nyunt, Myat H.; Chit, Khin; Aye, Moe M.; Aye, Kyin H.; Aye, Moe M.] Dept Med Res Lower Myanmar, Yangon, Myanmar; [Lindegardh, Niklas; Tarning, Joel] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Lindegardh, Niklas; Tarning, Joel] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Imwong, Mallika] Mahidol Univ, Dept Mol Trop Med & Genet, Bangkok 10700, Thailand; [Jacob, Christopher G.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Ctr Vaccine Dev,Malaria Grp, Baltimore, MD 21201 USA; [Rasmussen, Charlotte; Ringwald, Pascal] WHO, Global Malaria Programme, Drug Resistance & Containment Unit, CH-1211 Geneva, Switzerland; [Perin, Jamie; Nyunt, Myaing M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Nyunt, Myaing M.] Johns Hopkins Univ, Sch Med, Div Clin Pharmacol, Baltimore, MD USA	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol University; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Nyunt, MM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	mnyunt@jhsph.edu	, Myat-Phone-Kyaw/P-1750-2019; Imwong, Mallika/ABE-6493-2020; Nyunt, Myat Htut/R-2424-2017	Nyunt, Myat Htut/0000-0002-2026-8026; Tarning, Joel/0000-0003-4566-4030	World Health Organization	World Health Organization(World Health Organization)	The study was supported by the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2011, GLOB PLAN ART RES CO; Behrens RH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-266; Binh TQ, 2001, BRIT J CLIN PHARMACO, V51, P541, DOI 10.1046/j.1365-2125.2001.01395.x; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Faiz MA, 2005, LANCET, V366, P717; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Hanpithakpong W, 2008, J CHROMATOGR B, V876, P61, DOI 10.1016/j.jchromb.2008.10.018; LOOAREESUWAN S, 1987, LANCET, V2, P1052, DOI 10.1016/S0140-6736(87)91479-6; Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058; Mayxay M, 2012, AM J TROP MED HYG, V86, P403, DOI 10.4269/ajtmh.2012.11-0497; Navaratnam V, 2000, CLIN PHARMACOKINET, V39, P255, DOI 10.2165/00003088-200039040-00002; Newton P, 2000, ANTIMICROB AGENTS CH, V44, P972, DOI 10.1128/AAC.44.4.972-977.2000; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nyunt MM, 2007, CLIN PHARMACOL THER, V82, P601, DOI 10.1038/sj.clpt.6100361; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Siripoon N, 2002, T ROY SOC TROP MED H, V96, P70, DOI 10.1016/S0035-9203(02)90246-4; Smithuis F, 2010, LANCET INFECT DIS, V10, P673, DOI 10.1016/S1473-3099(10)70187-0; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Starzengruber P, 2010, AM J TROP MED HYG, V83, P142; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Takala-Harrison S, 2011, AM J TROP MED HYG, V85, P315; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO and Department of Health Myanmar, 2011, STRAT FRAM ART RES C; *WHO EXP COMM MAL, 2000, WHO TECH REP SER, V892, pR1; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2009, WORKSH REV PLAN THER; WorldWide Antimalarial Resistance Network, 2012, TRACK RES ART COLL T; WorldWide Antimalarial Resistance Network, WWARN PAR CLEAR EST	37	159	168	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57689	10.1371/journal.pone.0057689	http://dx.doi.org/10.1371/journal.pone.0057689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520478	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900037
J	Lin, CY; Wei, PL; Chang, WJ; Huang, YK; Feng, SW; Lin, CT; Lee, SY; Huang, HM				Lin, Chun-Yen; Wei, Po-Li; Chang, Wei-Jen; Huang, Yung-Kai; Feng, Sheng-Wei; Lin, Che-Tong; Lee, Sheng-Yang; Huang, Haw-Ming			Slow Freezing Coupled Static Magnetic Field Exposure Enhances Cryopreservative Efficiency-A Study on Human Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; THEORETICAL PREDICTION; MEMBRANE-FLUIDITY; LIVING CELLS; SPERMATOZOA; GLYCEROL; WATER; BIOPRESERVATION; VITRIFICATION	The aim of this study was to assess the cryoprotective effect of static magnetic fields (SMFs) on human erythrocytes during the slow cooling procedure. Human erythrocytes suspended in 20% glycerol were slowly frozen with a 0.4-T or 0.8-T SMF and then moved to a -80 degrees C freezer for 24 hr. The changes in survival rate, morphology, and metabolites of the thawed erythrocytes were examined. To understand possible cryoprotective mechanisms of SMF, membrane fluidity and dehydration stability of SMF-exposed erythrocytes were tested. For each test, sham-exposed erythrocytes were used as controls. Our results showed that freezing coupled with 0.4-T or 0.8-T SMFs significantly increased the relative survival ratios of the frozen-thawed erythrocytes by 10% and 20% (p<0.001), respectively. The SMFs had no effect on erythrocyte morphology and metabolite levels. However, membrane fluidity of the samples exposed to 0.8-T SMF decreased significantly (p<0.05) in the hydrophobic regions. For the dehydration stability experiments, the samples exposed to 0.8-T SMF exhibited significantly lower (p<0.05) hemolysis. These results demonstrate that a 0.8-T SMF decreases membrane fluidity and enhances erythrocyte membrane stability to resist dehydration damage caused by slow cooling procedures.	[Lin, Chun-Yen; Chang, Wei-Jen; Feng, Sheng-Wei; Lin, Che-Tong; Lee, Sheng-Yang; Huang, Haw-Ming] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan; [Lin, Chun-Yen; Huang, Haw-Ming] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Huang, Yung-Kai] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Lee, SY (corresponding author), Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan.	hhm@tmu.edu.tw	Huang, Yung-Kai/C-7868-2012	Huang, Yung-Kai/0000-0002-4467-0300				Akhoondi M, 2011, BBA-BIOMEMBRANES, V1808, P642, DOI 10.1016/j.bbamem.2010.11.021; ALI MA, 2007, ROM J BIOPHYS, V17, P277; Alonso A, 1996, J INVEST DERMATOL, V106, P1058, DOI 10.1111/1523-1747.ep12338682; ANCHORDOGUY TJ, 1987, CRYOBIOLOGY, V24, P324, DOI 10.1016/0011-2240(87)90036-8; Baust J.M., 2002, CELL PRESERV TECHNOL, V1, P17, DOI DOI 10.1089/15383440260073266; Blesbois E, 2005, REPRODUCTION, V129, P371, DOI 10.1530/rep.1.00454; Chiu KH, 2007, ANN BIOMED ENG, V35, P1932, DOI 10.1007/s10439-007-9370-2; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Fowler A, 2005, ANN NY ACAD SCI, V1066, P119, DOI 10.1196/annals.1363.010; GAO DY, 1993, BIOL REPROD, V49, P112, DOI 10.1095/biolreprod49.1.112; Gkoumassi E, 2012, TRANSFUSION, V52, P489, DOI 10.1111/j.1537-2995.2011.03298.x; HIGASHI T, 1993, BLOOD, V82, P1328; Hubel A, 1997, TRANSFUS MED REV, V11, P224, DOI 10.1053/tmrv.1997.0110224; Iino M, 1997, BIOELECTROMAGNETICS, V18, P215, DOI 10.1002/(SICI)1521-186X(1997)18:3<215::AID-BEM3>3.0.CO;2-5; Iino W, 2001, BIOELECTROMAGNETICS, V22, P46, DOI 10.1002/1521-186X(200101)22:1<46::AID-BEM5>3.0.CO;2-0; Iwasaka M, 2003, BIOELECTROMAGNETICS, V24, P564, DOI 10.1002/bem.10131; Lagerberg JWM, 2007, TRANSFUSION, V47, P2242, DOI 10.1111/j.1537-2995.2007.01453.x; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Lin SL, 2008, ELECTROMAGN BIOL MED, V27, P55, DOI 10.1080/15368370701878960; Liu J, 2000, BIOL REPROD, V63, P1303, DOI 10.1095/biolreprod63.5.1303; Lynch AL, 2011, CRYOBIOLOGY, V63, P26, DOI 10.1016/j.cryobiol.2011.04.005; Lynch AL, 2010, BIOMATERIALS, V31, P6096, DOI 10.1016/j.biomaterials.2010.04.020; Marczak A, 2009, BIOELECTROCHEMISTRY, V74, P236, DOI 10.1016/j.bioelechem.2008.11.004; MARET G, 1977, PHYSICA B & C, V86, P1077, DOI 10.1016/0378-4363(77)90800-2; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; Meryman HT, 2007, TRANSFUSION, V47, P935, DOI 10.1111/j.1537-2995.2007.01212.x; MERYMAN HT, 1972, TRANSFUSION, V12, P145; Oldenhof H, 2010, CRYOBIOLOGY, V61, P115, DOI 10.1016/j.cryobiol.2010.06.002; PEGG DE, 1988, BIOPHYS J, V54, P471, DOI 10.1016/S0006-3495(88)82980-1; Quan GB, 2011, CRYOBIOLOGY, V62, P135, DOI 10.1016/j.cryobiol.2011.01.015; Schenck JF, 2005, PROG BIOPHYS MOL BIO, V87, P185, DOI 10.1016/j.pbiomolbio.2004.08.009; Schenck JF, 2000, J MAGN RESON IMAGING, V12, P2, DOI 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V; Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004; Stoll C, 2011, TRANSFUS MED HEMOTH, V38, P89, DOI 10.1159/000326900; Sumida Sajio, 2006, Cell and Tissue Banking, V7, P265, DOI 10.1007/s10561-006-9005-0; Thirumala S, 2005, J BIOMECH ENG-T ASME, V127, P295, DOI 10.1115/1.1865213; Thirumala S, 2003, CRYOBIOLOGY, V47, P109, DOI 10.1016/j.cryobiol.2003.08.003; Tiburu EK, 2001, BBA-BIOMEMBRANES, V1512, P206, DOI 10.1016/S0005-2736(01)00320-0; Valeri CR, 2007, TRANSFUS APHER SCI, V36, P133, DOI 10.1016/j.transci.2006.11.002; Vest R, 2006, J MEMBRANE BIOL, V211, P15, DOI 10.1007/s00232-005-7008-6; Woelders H, 2004, CRYOBIOLOGY, V49, P258, DOI 10.1016/j.cryobiol.2004.09.001; Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195	43	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58988	10.1371/journal.pone.0058988	http://dx.doi.org/10.1371/journal.pone.0058988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520546	Green Submitted, gold, Green Published			2022-12-27	WOS:000318679900106
J	Timofeeva, AM; Dmitrenok, PS; Konenkova, LP; Buneva, VN; Nevinsky, GA				Timofeeva, Anna M.; Dmitrenok, Pavel S.; Konenkova, Ludmila P.; Buneva, Valentina N.; Nevinsky, Georgy A.			Multiple Sites of the Cleavage of 21-and 25-Mer Encephalytogenic Oligopeptides Corresponding to Human Myelin Basic Protein (MBP) by Specific Anti-MBP Antibodies from Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							NATURAL CATALYTIC ANTIBODIES; DNA-HYDROLYZING ANTIBODIES; AMYLOLYTIC ACTIVITY; LIGHT-CHAIN; SCLEROSIS; SERA; AUTOANTIBODIES; AUTOIMMUNE; IGGS; HETEROGENEITY	IgGs from patients with multiple sclerosis and systemic lupus erythematosus (SLE) purified on MBP-Sepharose in contrast to canonical proteases hydrolyze effectively only myelin basic protein (MBP), but not many other tested proteins. Here we have shown for the first time that anti-MBP SLE IgGs hydrolyze nonspecific tri- and tetrapeptides with an extreme low efficiency and cannot effectively hydrolyze longer 20-mer nonspecific oligopeptides corresponding to antigenic determinants (AGDs) of HIV-1 integrase. At the same time, anti-MBP SLE IgGs efficiently hydrolyze oligopeptides corresponding to AGDs of MBP. All sites of IgG-mediated proteolysis of 21- and 25-mer encephalytogenic oligopeptides corresponding to two known AGDs of MBP were found by a combination of reverse-phase chromatography, TLC, and MALDI spectrometry. Several clustered major, moderate, and minor sites of cleavage were revealed in the case of 21- and 25-mer oligopeptides. The active sites of anti-MBP abzymes are localised on their light chains, while heavy chains are responsible for the affinity of protein substrates. Interactions of intact globular proteins with both light and heavy chains of abzymes provide high affinity to MBP and specificity of this protein hydrolysis. The affinity of anti-MBP abzymes for intact MBP is approximately 1000-fold higher than for the oligopeptides. The data suggest that all oligopeptides interact mainly with the light chains of different monoclonal abzymes of total pool of IgGs, which possesses a lower affinity for substrates, and therefore, depending on the oligopeptide sequences, their hydrolysis may be less specific than globular protein and can occur in several sites.	[Timofeeva, Anna M.; Buneva, Valentina N.; Nevinsky, Georgy A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia; [Dmitrenok, Pavel S.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far East Div, Vladivostok 690022, Russia; [Konenkova, Ludmila P.] Russian Acad Med Sci, Inst Clin Immunol, Siberian Div, Novosibirsk, Russia; [Buneva, Valentina N.; Nevinsky, Georgy A.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; Russian Academy of Medical Sciences; Russian Academy of Sciences; Novosibirsk State University	Nevinsky, GA (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia.	nevinsky@niboch.nsc.ru	Dmitrenok, Pavel S/N-3307-2013; Nevinsky, Georgy/E-6053-2012; Buneva, Valentina Nikolaevna/I-6329-2012; Timofeeva, Anna/J-8571-2015; Anna, Timofeeva/AAE-5092-2022	Dmitrenok, Pavel S/0000-0002-4416-7844; Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Timofeeva, Anna/0000-0002-1270-7164; Menzorova, Natalia/0000-0002-2616-7023	Presidium of the Russian Academy of Sciences [6.7, 5.13]; Russian Foundation for Basic Research [10-04-00281]; Siberian Division of the Russian Academy of Sciences	Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Siberian Division of the Russian Academy of Sciences(Russian Academy of Sciences)	This research was made possible in part by grants from the Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, 6.7; Fundamental Sciences to Medicine, 5.13), Russian Foundation for Basic Research (10-04-00281), and funds from the Siberian Division of the Russian Academy of Sciences.	Andrievskaya O A, 2000, Med Sci Monit, V6, P460; Archelos JJ, 2000, ANN NEUROL, V47, P694, DOI 10.1002/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W; Baranovskii AG, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1239; Baranovskii AG, 2001, IMMUNOL LETT, V76, P163, DOI 10.1016/S0165-2478(01)00185-7; BCh Hhachn, 1996, SYSTEMIC LIPUS ERYTH, P407; Bezuglova AM, 2011, J MOL RECOGNIT, V24, P960, DOI 10.1002/jmr.1143; Boiko A N, 1995, Mol Biol (Mosk), V29, P727; David B.S., 2005, CATALYTIC ANTIBODIES, P1; Fersht A., 1985, ENZYME STRUCTURE MEC; GAO QS, 1994, J BIOL CHEM, V269, P32389; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Kozyr AV, 1998, APPL BIOCHEM BIOTECH, V75, P45, DOI 10.1007/BF02787708; Kulminskaya AA, 2004, TRENDS GLYCOSCI GLYC, V16, P17, DOI 10.4052/tigg.16.17; Legostaeva GA, 2010, J CELL MOL MED, V14, P699, DOI 10.1111/j.1582-4934.2009.00738.x; LI L, 1995, J IMMUNOL, V154, P3328; Nevinsky G.A., 2010, AUTOIMMUNE DIS SYMPT, P1; Nevinsky G.A., 2011, UNDERSTANDING HIVAID, P151, DOI DOI 10.5772/22294; Nevinsky G.A., 2005, CATALYTIC ANTIBODIES, P503; Nevinsky G.A., 2002, PROTEIN PROTEIN INTE, P1; Nevinsky GA, 2003, J CELL MOL MED, V7, P265, DOI 10.1111/j.1582-4934.2003.tb00227.x; Nevinsky GA, 2002, J IMMUNOL METHODS, V269, P235, DOI 10.1016/S0022-1759(02)00234-X; Nevinsky GA, 2010, THESCIENTIFICWORLDJO, V10, P1203, DOI 10.1100/tsw.2010.98; O'Connor KC, 2001, J CLIN IMMUNOL, V21, P81, DOI 10.1023/A:1011064007686; Odintsova ES, 2012, J MOL RECOGNIT, V25, P193, DOI 10.1002/jmr.2159; Odintsova ES, 2011, INT IMMUNOL, V23, P601, DOI 10.1093/intimm/dxr065; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Paul S, 1997, J IMMUNOL, V159, P1530; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; Pisetsky DS, 2001, ISRAEL MED ASSOC J, V3, P850; Polosukhina DI, 2006, IMMUNOL LETT, V103, P75, DOI 10.1016/j.imlet.2005.10.018; Polosukhina DI, 2005, MED SCI MONITOR, V11, pBR266; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Poser CM, 1984, DIAGNOSIS MULTIPLE S, P3; Savel'ev AN, 1999, PROTEIN PEPTIDE LETT, V6, P179; Saveliev AN, 2003, IMMUNOL LETT, V86, P291, DOI 10.1016/S0165-2478(03)00042-7; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Thiagarajan P, 2000, BIOCHEMISTRY-US, V39, P6459, DOI 10.1021/bi992588w; Williamson RA, 2001, P NATL ACAD SCI USA, V98, P1793, DOI 10.1073/pnas.031567598	39	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e51600	10.1371/journal.pone.0051600	http://dx.doi.org/10.1371/journal.pone.0051600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520443	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900002
J	Li, W; Yang, G; Zhang, AL; Xu, LX				Li, Wei; Yang, Geer; Zhang, Aili; Xu, Lisa X.			Numerical Study of Cell Cryo-Preservation: A Network Model of Intracellular Ice Formation	PLOS ONE			English	Article							REFERENCE PHASE ANALYSIS; BIOLOGICAL CELLS; THERMAL-STRESSES; DIFFUSION; GROWTH; PERMEABILITY; POTASSIUM; TRANSPORT; KINETICS; TRACHEA	In this study, a new intracellular ice formation network model, coupled with an improved cell dehydration model has been developed. The non-uniform dehydration of the cell during freezing is simulated with moving boundary condition. Internal cell structures like cell nucleus are taken into consideration. The IIF network model is developed from classic diffusion limited IIF model in order to simulate spatial ice growth pattern inside cells. Simulation results suggest that cell nuclear plays a significant role in cryo-dehydration and would affect water/CPA concentration gradient inside the cell. At the same time, the ice growth pattern of exogenous IIF hypothesis is examined in the model. It is consistent with our previous experiments, in which we witnessed the intracellular ice first grown into the nucleus before spreading to the whole intercellular space. According to this model, the water concentration difference between nucleus and cytoplasm during cryo-dehydration could partly explain why ice crystal in the nucleus grows faster. However, it is not the dominate factor. Higher diffusion coefficient in cell nucleus might play a more important role in the phenomenon.	[Li, Wei; Yang, Geer; Zhang, Aili; Xu, Lisa X.] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Zhang, Aili; Xu, Lisa X.] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, AL (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	zhangaili@sjtu.edu.cn; lisaxu@sjtu.edu.cn			National Natural Science Foundation of China [NSFC51076095]; Shanghai Municipal Science and Technology Commission [11DZ2211000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work has been supported by the National Natural Science Foundation of China (NSFC51076095) and Shanghai Municipal Science and Technology Commission (11DZ2211000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JJH, 2011, DIFFUSION MRI THEORY, P110; [Anonymous], 2002, THEORY TRANSFORMATIO; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Brockbank KGM, 2012, CELL TISSUE BANK, V13, P663, DOI 10.1007/s10561-011-9288-7; Bruna P, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337407; Brunette I, 2001, CORNEA, V20, P590, DOI 10.1097/00003226-200108000-00007; Charras GT, 2009, J CELL SCI, V122, P3233, DOI 10.1242/jcs.049262; Chen C, 2008, CRYOLETTERS, V29, P371; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; FELDHERR CM, 1973, EXPERIENTIA, V29, P546, DOI 10.1007/BF01926655; Grant SC, 2001, MAGN RESON MED, V46, P1107, DOI 10.1002/mrm.1306; He X, 2006, J APPL PHYS, V100; He XM, 2005, J BIOMECH ENG-T ASME, V127, P656, DOI 10.1115/1.1934021; HOROWITZ SB, 1979, BIOPHYS J, V25, P33, DOI 10.1016/S0006-3495(79)85276-5; HOROWITZ SB, 1972, J CELL BIOL, V54, P609, DOI 10.1083/jcb.54.3.609; HOROWITZ SB, 1981, MOL CELL BIOL, V1, P769, DOI 10.1128/MCB.1.9.769; HOROWITZ SB, 1979, BIOPHYS J, V25, P45, DOI 10.1016/S0006-3495(79)85277-7; HOROWITZ SB, 1974, J CELL BIOL, V60, P405, DOI 10.1083/jcb.60.2.405; HOROWITZ SB, 1968, J GEN PHYSIOL, V51, P703, DOI 10.1085/jgp.51.6.703; Jaeger M, 1999, BIOPHYS J, V77, P1257, DOI 10.1016/S0006-3495(99)76977-8; KARLSSON JOM, 1994, J APPL PHYS, V75, P4442, DOI 10.1063/1.355959; LEVIN RL, 1976, BIOPHYS J, V16, P1411, DOI 10.1016/S0006-3495(76)85784-0; Mabrut JY, 2001, TRANSPLANT P, V33, P609, DOI 10.1016/S0041-1345(00)02166-7; Mao L, 2003, INT J HEAT MASS TRAN, V46, P5123, DOI 10.1016/S0017-9310(03)00364-8; MASTRO AM, 1984, P NATL ACAD SCI-BIOL, V81, P3414, DOI 10.1073/pnas.81.11.3414; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Peters Reiner, 2006, V322, P235; Rabin Y, 1998, J APPL MECH-T ASME, V65, P328, DOI 10.1115/1.2789058; RUBINSKY B, 1980, CRYOBIOLOGY, V17, P66, DOI 10.1016/0011-2240(80)90009-7; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; Toner Mehmet, 1993, Advances in Low-Temperature Biology, V2, P1; Xu H, 2009, CRYOBIOLOGY, V58, P225, DOI 10.1016/j.cryobiol.2008.12.009; Yang G, 2009, J APPL PHYS, V105, DOI 10.1063/1.3124371; Yang G, 2009, CRYOBIOLOGY, V58, P96, DOI 10.1016/j.cryobiol.2008.10.123; Zhao G, 2006, AICHE J, V52, P2596, DOI 10.1002/aic.10851; Zhao G, 2005, CRYOLETTERS, V26, P239	38	2	3	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58343	10.1371/journal.pone.0058343	http://dx.doi.org/10.1371/journal.pone.0058343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526979	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600019
J	You, B; Huang, SD; Qin, Q; Yi, B; Yuan, Y; Xu, ZY; Sun, JX				You, Bei; Huang, Shengdong; Qin, Qing; Yi, Bing; Yuan, Yang; Xu, Zhiyun; Sun, Jianxin			Glyceraldehyde-3-Phosphate Dehydrogenase Interacts with Proapoptotic Kinase Mst1 to Promote Cardiomyocyte Apoptosis	PLOS ONE			English	Article							STE20-LIKE PROTEIN-KINASE; NUCLEAR TRANSLOCATION; CANCER DEVELOPMENT; CARDIAC MYOCYTES; HIPPO PATHWAY; PHOSPHORYLATION; GAPDH; BINDING; INHIBITION; ACTIVATION	Mammalian sterile 20-like kinase 1 (Mst1) is a critical component of the Hippo signaling pathway, which regulates a variety of biological processes ranging from cell contact inhibition, organ size control, apoptosis and tumor suppression in mammals. Mst1 plays essential roles in the heart disease since its activation causes cardiomyocyte apoptosis and dilated cardiomyopathy. However, the mechanism underlying Mst1 activation in the heart remains unknown. In a yeast two-hybrid screen of a human heart cDNA library with Mst1 as bait, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was identified as an Mst1-interacting protein. The interaction of GAPDH with Mst1 was confirmed by co-immunoprecipitation in both co-transfected HEK293 cells and mouse heart homogenates, in which GAPDH interacted with the kinase domain of Mst1, whereas the C-terminal catalytic domain of GAPDH mediated its interaction with Mst1. Moreover, interaction of Mst1 with GAPDH caused a robust phosphorylation of GAPDH and markedly increased the Mst1 activity in cells. Chelerythrine, a potent inducer of apoptosis, substantially increased the nuclear translocation and interaction of GAPDH and Mst1 in cardiomyocytes. Overexpression of GAPDH significantly augmented the Mst1 mediated apoptosis, whereas knockdown of GAPDH markedly attenuated the Mst1 activation and cardiomyocyte apoptosis in response to either chelerythrine or hypoxia/reoxygenation. These findings reveal a novel function of GAPDH in Mst1 activation and cardiomyocyte apoptosis and suggest that disruption of GAPDH interaction with Mst1 may prevent apoptosis related heart diseases such as heart failure and ischemic heart disease.	[You, Bei; Huang, Shengdong; Yuan, Yang; Xu, Zhiyun; Sun, Jianxin] Second Mil Med Univ, Changhai Hosp, Inst Cardiothorac Surg, Shanghai, Peoples R China; [Qin, Qing; Yi, Bing; Sun, Jianxin] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Naval Medical University; Jefferson University	Sun, JX (corresponding author), Second Mil Med Univ, Changhai Hosp, Inst Cardiothorac Surg, Shanghai, Peoples R China.	jianxin.sun@jefferson.edu			National Natural Science Foundation of China [381170114]; National Institutes of Health [R01HL103869]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Natural Science Foundation of China [grant number 381170114] and the National Institutes of Health [grant number R01HL103869] (to JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Inadomi C, 2012, BIOCHEM BIOPH RES CO, V425, P656, DOI 10.1016/j.bbrc.2012.07.118; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Madsen-Bouterse S, 2010, INVEST OPHTH VIS SCI, V51, P1765, DOI 10.1167/iovs.09-4171; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Ren AX, 2008, CANCER RES, V68, P2266, DOI 10.1158/0008-5472.CAN-07-6248; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sun JX, 2006, CIRC RES, V99, P468, DOI 10.1161/01.RES.0000239410.65551.b3; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tajima H, 1999, NEUROREPORT, V10, P2029, DOI 10.1097/00001756-199907130-00007; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Yao LL, 2012, J CELL PHYSIOL, V227, P3518, DOI 10.1002/jcp.24053; You B, 2009, BIOCHEM J, V418, P93, DOI 10.1042/BJ20081340; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011	40	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58697	10.1371/journal.pone.0058697	http://dx.doi.org/10.1371/journal.pone.0058697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527007	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600032
J	Rusmini, M; Griseri, P; Lantieri, F; Matera, I; Hudspeth, KL; Roberto, A; Mikulak, J; Avanzini, S; Rossi, V; Mattioli, G; Jasonni, V; Ravazzolo, R; Pavan, WJ; Pini-Prato, A; Ceccherini, I; Mavilio, D				Rusmini, Marta; Griseri, Paola; Lantieri, Francesca; Matera, Ivana; Hudspeth, Kelly L.; Roberto, Alessandra; Mikulak, Joanna; Avanzini, Stefano; Rossi, Valentina; Mattioli, Girolamo; Jasonni, Vincenzo; Ravazzolo, Roberto; Pavan, William J.; Pini-Prato, Alessio; Ceccherini, Isabella; Mavilio, Domenico			Induction of RET Dependent and Independent ProInflammatory Programs in Human Peripheral Blood Mononuclear Cells from Hirschsprung Patients	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ENTERIC NERVOUS-SYSTEM; NEURAL CREST; INCREASED EXPRESSION; HEMATOPOIETIC-CELLS; GDNF GENE; TGF-BETA; DISEASE; PROTOONCOGENE; MUTATIONS	Hirschsprung disease (HSCR) is a rare congenital anomaly characterized by the absence of enteric ganglia in the distal intestinal tract. While classified as a multigenic disorder, the altered function of the RET tyrosine kinase receptor is responsible for the majority of the pathogenesis of HSCR. Recent evidence demonstrate a strong association between RET and the homeostasis of immune system. Here, we utilize a unique cohort of fifty HSCR patients to fully characterize the expression of RET receptor on both innate (monocytes and Natural Killer lymphocytes) and adaptive (B and T lymphocytes) human peripheral blood mononuclear cells (PBMCs) and to explore the role of RET signaling in the immune system. We show that the increased expression of RET receptor on immune cell subsets from HSCR individuals correlates with the presence of loss-of-function RET mutations. Moreover, we demonstrate that the engagement of RET on PBMCs induces the modulation of several inflammatory genes. In particular, RET stimulation with glial-cell line derived neurotrophic factor family (GDNF) and glycosyl-phosphatidylinositol membrane anchored co-receptor alpha 1 (GFR alpha 1) trigger the up-modulation of genes encoding either for chemokines (CCL20, CCL2, CCL3, CCL4, CCL7, CXCL1) and cytokines (IL-1 beta, IL-6 and IL-8) and the down-regulation of chemokine/cytokine receptors (CCR2 and IL8-R alpha). Although at different levels, the modulation of these "RET-dependent genes'' occurs in both healthy donors and HSCR patients. We also describe another set of genes that, independently from RET stimulation, are differently regulated in healthy donors versus HSCR patients. Among these "RET-independent genes'', there are CSF-1R, IL1-R1, IL1-R2 and TGF beta-1, whose levels of transcripts were lower in HSCR patients compared to healthy donors, thus suggesting aberrancies of inflammatory responses at mucosal level. Overall our results demonstrate that immune system actively participates in the physiopathology of HSCR disease by modulating inflammatory programs that are either dependent or independent from RET signaling.	[Rusmini, Marta; Griseri, Paola; Matera, Ivana; Ravazzolo, Roberto; Ceccherini, Isabella] Ist Giannina Gaslini, Genet Mol Lab, IRCCS, I-16148 Genoa, Italy; [Rusmini, Marta; Lantieri, Francesca; Ravazzolo, Roberto] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy; [Rusmini, Marta; Hudspeth, Kelly L.; Roberto, Alessandra; Mikulak, Joanna; Ravazzolo, Roberto; Mavilio, Domenico] Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy; [Hudspeth, Kelly L.; Ravazzolo, Roberto; Mavilio, Domenico] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Avanzini, Stefano; Rossi, Valentina; Mattioli, Girolamo; Jasonni, Vincenzo; Ravazzolo, Roberto; Pini-Prato, Alessio] Giannina Gaslini Inst, Dept Pediat Surg, IRCCS, Genoa, Italy; [Ravazzolo, Roberto] Univ Genoa, DINOGMI Dept, Genoa, Italy; [Pavan, William J.] NHGRI, Mouse Embryol Sect, Genet Dis Res Branch, Bethesda, MD 20892 USA	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Milan; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Mavilio, D (corresponding author), Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy.	domenico.mavilio@humanitas.it	Pini Prato, Alessio/F-3145-2018; Mattioli, Girolamo/AAA-8487-2020; griseri, paola/AAJ-4823-2020; Avanzini, Stefano/J-4211-2018; Ceccherini, Isabella/P-8195-2014; mikulak, joanna/AAB-3070-2022; rusmini, marta/K-7042-2016; Mavilio, Domenico/E-5194-2017	Pini Prato, Alessio/0000-0003-3080-7481; Mattioli, Girolamo/0000-0003-4355-1446; Avanzini, Stefano/0000-0003-0833-2934; Ceccherini, Isabella/0000-0001-8732-1955; mikulak, joanna/0000-0001-8310-9543; rusmini, marta/0000-0002-3109-413X; Pavan, William/0000-0001-8281-5120; Roberto, Alessandra/0000-0001-6615-0026; Mavilio, Domenico/0000-0001-6147-0952	Fondazione Umberto Veronesi; Istituto Superiore di Sanita; Italian Ministry of Health (Bando Giovani Ricercatori) [GR-2008-1135082]; European Union [204188]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000070] Funding Source: NIH RePORTER	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Istituto Superiore di Sanita; Italian Ministry of Health (Bando Giovani Ricercatori)(Ministry of Health, Italy); European Union(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	MR is a recipient of a fellowship awarded by the Fondazione Umberto Veronesi. This work is supported by Istituto Superiore di Sanita (E-Rare grant, 2007 call awarded to IC), by Italian Ministry of Health (Bando Giovani Ricercatori GR-2008-1135082 awarded to DM) and by European Union (Marie Curie International Reintegration grant number 204188 awarded to DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; AVANTAGGIATO V, 1994, CELL GROWTH DIFFER, V5, P305; BADNER JA, 1990, AM J HUM GENET, V46, P568; Barembaum M, 2005, SEMIN CELL DEV BIOL, V16, P642, DOI 10.1016/j.semcdb.2005.06.006; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Brunham LR, 2005, PLOS GENET, V1, P739, DOI 10.1371/journal.pgen.0010083; Carlomagno F, 1996, EMBO J, V15, P2717, DOI 10.1002/j.1460-2075.1996.tb00632.x; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eketjall S, 2002, HUM MOL GENET, V11, P325, DOI 10.1093/hmg/11.3.325; ELHALABY EA, 1995, J PEDIATR SURG, V30, P1023, DOI 10.1016/0022-3468(95)90334-8; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fernandez RM, 2005, J MED GENET, V42, P322, DOI 10.1136/jmg.2004.023960; Franci C, 1996, J IMMUNOL, V157, P5606; FUJIMOTO T, 1988, PEDIATR RES, V24, P152, DOI 10.1203/00006450-198808000-00002; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Gattei V, 1997, BLOOD, V89, P2925; Griseri P, 2005, HUM MUTAT, V25, P189, DOI 10.1002/humu.20135; Hofstra RMW, 2000, HUM MUTAT, V15, P418, DOI 10.1002/(SICI)1098-1004(200005)15:5<418::AID-HUMU3>3.0.CO;2-2; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Iwashita T, 1996, ONCOGENE, V12, P481; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Kwon DH, 2012, INSECT BIOCHEM MOLEC, V42, P212, DOI 10.1016/j.ibmb.2011.12.003; Lantieri F, 2006, ANN HUM GENET, V70, P12, DOI 10.1111/j.1529-8817.2005.00196.x; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; Lee HJ, 2005, INFLAMM BOWEL DIS, V11, P1070, DOI 10.1097/01.MIB.0000187576.26043.ac; Leon TYY, 2009, J PEDIATR SURG, V44, P1904, DOI 10.1016/j.jpedsurg.2008.11.055; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lindahl M, 2001, J BIOL CHEM, V276, P9344, DOI 10.1074/jbc.M008279200; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luzi E, 2010, CANCER GENE THER, V17, P814, DOI 10.1038/cgt.2010.39; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Murphy F, 2005, PEDIATR SURG INT, V21, P773, DOI 10.1007/s00383-005-1551-1; Nakayama S, 1999, BRIT J HAEMATOL, V105, P50, DOI 10.1046/j.1365-2141.1999.01311.x; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Pachnis V, 1998, AM J PHYSIOL-GASTR L, V275, pG183, DOI 10.1152/ajpgi.1998.275.2.G183; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Padgett RW, 2007, DEVELOPMENT, V134, P3565, DOI 10.1242/dev.005926; Parisi MA, 2000, CURR OPIN PEDIATR, V12, P610, DOI 10.1097/00008480-200012000-00017; PASINI B, 1995, ONCOGENE, V11, P1737; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; Prato AP, 2008, PEDIATR SURG INT, V24, P175, DOI 10.1007/s00383-007-2089-1; Puppo F, 2002, FEBS LETT, V523, P123, DOI 10.1016/S0014-5793(02)02957-5; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Sancandi M, 2003, J MED GENET, V40, P714, DOI 10.1136/jmg.40.9.714; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Sribudiani Y, 2011, GASTROENTEROLOGY, V140, P572, DOI 10.1053/j.gastro.2010.10.044; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; TSUZUKI T, 1995, ONCOGENE, V10, P191; Turner MD, 2012, BIOSCIENCE REP, V32, P105, DOI 10.1042/BSR20110089; Vargas-Leal V, 2005, J IMMUNOL, V175, P2301, DOI 10.4049/jimmunol.175.4.2301; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Verbeek HHG, 2011, J CLIN ENDOCR METAB, V96, pE991, DOI 10.1210/jc.2010-2381; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; Yang CH, 2006, J MOL HISTOL, V37, P69, DOI 10.1007/s10735-006-9035-8; Zeilhofer HU, 2000, CURR OPIN HEMATOL, V7, P178, DOI 10.1097/00062752-200005000-00009	77	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59066	10.1371/journal.pone.0059066	http://dx.doi.org/10.1371/journal.pone.0059066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527089	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600033
J	Rahman, MA; Shinjo, R; Oomori, T; Worheide, G				Rahman, M. Azizur; Shinjo, Ryuichi; Oomori, Tamotsu; Woerheide, Gert			Analysis of the Proteinaceous Components of the Organic Matrix of Calcitic Sclerites from the Soft Coral Sinularia sp.	PLOS ONE			English	Article							ACTIN-BINDING PROTEINS; SEA-URCHIN EGG; GORGONIAN LEPTOGORGIA-VIRGULATA; CARBONIC-ANHYDRASE; CALCIFIED ENDOSKELETON; PROTEOMIC ANALYSIS; MOLECULAR-WEIGHT; STRUCTURAL PROTEINS; SPICULE FORMATION; GELATION PROTEIN	An organic matrix consisting of a protein-polysaccharide complex is generally accepted as an important medium for the calcification process. While the role this "calcified organic matrix'' plays in the calcification process has long been appreciated, the complex mixture of proteins that is induced and assembled during the mineral phase of calcification remains uncharacterized in many organisms. Thus, we investigated organic matrices from the calcitic sclerites of a soft coral, Sinularia sp., and used a proteomic approach to identify the functional matrix proteins that might be involved in the biocalcification process. We purified eight organic matrix proteins and performed in-gel digestion using trypsin. The tryptic peptides were separated by nano-liquid chromatography (nano-LC) and analyzed by tandem mass spectrometry (MS/MS) using a matrix-assisted laser desorption/ionization (MALDI) - time-of-flight-time-of-flight (TOF-TOF) mass spectrometer. Periodic acid Schiff staining of an SDS-PAGE gel indicated that four proteins were glycosylated. We identified several proteins, including a form of actin, from which we identified a total of 183 potential peptides. Our findings suggest that many of those peptides may contribute to biocalcification in soft corals.	[Rahman, M. Azizur; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Shinjo, Ryuichi] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 90301, Japan; [Oomori, Tamotsu] Univ Ryukyus, Dept Chem, Nishihara, Okinawa 90301, Japan; [Woerheide, Gert] Bavarian State Collect Palaeontol & Geol, Munich, Germany; [Woerheide, Gert] Univ Munich, GeoBio Ctr, Munich, Germany	University of Munich; University of the Ryukyus; University of the Ryukyus; University of Munich	Rahman, MA (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Toronto, ON, Canada.	azizur31@yahoo.com	Wörheide, Gert/C-1080-2008; Rahman, Dr. Azizur/A-9413-2018	Wörheide, Gert/0000-0002-6380-7421; Rahman, Dr. Azizur/0000-0002-7648-8642	Alexander von Humboldt Foundation Research Fellowship; German Science Foundation (DFG); Grants-in-Aid for Scientific Research [25400519] Funding Source: KAKEN	Alexander von Humboldt Foundation Research Fellowship(Alexander von Humboldt Foundation); German Science Foundation (DFG)(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by an Alexander von Humboldt Foundation Research Fellowship to MAR. GW is supported by the German Science Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340; Aizenberg J, 1996, Connect Tissue Res, V34, P255, DOI 10.3109/03008209609005269; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562; CRAIG SW, 1982, METHOD ENZYMOL, V85, P316; DECARO A, 1982, BIOCHEM J, V205, P543, DOI 10.1042/bj2050543; Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI 10.1038/NCHEM.899; Floquet N, 2011, AM MINERAL, V96, P1228, DOI 10.2138/am.2011.3805; Fukuda I, 2002, DNA RES, V9, P217, DOI 10.1093/dnares/9.6.217; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; GOLDBERG WM, 1987, B MAR SCI, V40, P287; HAGMANN J, 1992, J BIOL CHEM, V267, P14424; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; HARTWIG JH, 1979, J MOL BIOL, V134, P539, DOI 10.1016/0022-2836(79)90366-8; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; KINGSLEY RJ, 1982, CELL TISSUE RES, V223, P325, DOI 10.1007/BF01258493; KINGSLEY RJ, 1983, COMP BIOCHEM PHYS B, V76, P443, DOI 10.1016/0305-0491(83)90273-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWENSTAM HA, 1989, B MAR SCI, V45, P243; MABUCHI I, 1987, J BIOCHEM-TOKYO, V102, P947, DOI 10.1093/oxfordjournals.jbchem.a122136; MAEKAWA S, 1986, ZOOL SCI, V3, P1029; MAJORAN S, 1987, ZOOL SCR, V16, P277, DOI 10.1111/j.1463-6409.1987.tb00074.x; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-33; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; Marie B, 2008, CHEMBIOCHEM, V9, P2515, DOI 10.1002/cbic.200800159; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; MARUYAMA K, 1977, J BIOCHEM-TOKYO, V81, P215, DOI 10.1093/oxfordjournals.jbchem.a131438; MITTERER RM, 1978, B MAR SCI, V28, P173; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Nemoto M, 2012, PROTEOMICS, V12, P2890, DOI 10.1002/pmic.201100473; POLLARD TD, 1981, J BIOL CHEM, V256, P7666; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; POLLARD TD, 1984, J CELL BIOL, V99, P1970, DOI 10.1083/jcb.99.6.1970; POLLARD TD, 1986, BIOPHYS J, V49, P149, DOI 10.1016/S0006-3495(86)83630-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Quinn P, 2006, APPL ENVIRON MICROB, V72, P5512, DOI 10.1128/AEM.00343-06; Rahman MA, 2008, J CRYST GROWTH, V310, P3528, DOI 10.1016/j.jcrysgro.2008.04.056; Rahman MA, 2008, MAR BIOTECHNOL, V10, P31, DOI 10.1007/s10126-007-9030-4; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Rahman MA, 2011, J BIOL CHEM, V286, P31638, DOI 10.1074/jbc.M109.070185; Rahman MA, 2011, J CRYST GROWTH, V324, P177, DOI 10.1016/j.jcrysgro.2011.03.021; Rahman MA, 2009, CONNECT TISSUE RES, V50, P285, DOI 10.3109/03008200802714933; Rahman MA, 2005, PROTEOMICS, V5, P885, DOI 10.1002/pmic.200401130; Rahman MA, 2005, J EXP MAR BIOL ECOL, V321, P71, DOI 10.1016/j.jembe.2005.01.012; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmidt W.J., 1924, BAUSTEINE TIERKORPER; SEGREST JP, 1971, BIOCHEM BIOPH RES CO, V44, P390, DOI 10.1016/0006-291X(71)90612-7; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Tentori E, 2011, J MORPHOL, V272, P614, DOI 10.1002/jmor.10942; TOMPA AS, 1977, COMP BIOCHEM PHYS B, V56, P279, DOI 10.1016/0305-0491(77)90016-5; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; YONEMURA S, 1987, CELL MOTIL CYTOSKEL, V7, P46, DOI 10.1002/cm.970070107; YOUNG SD, 1971, COMP BIOCHEM PHYSIOL, V40, P113, DOI 10.1016/0305-0491(71)90067-8	59	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58781	10.1371/journal.pone.0058781	http://dx.doi.org/10.1371/journal.pone.0058781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23527022	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400062
J	Volpato, GL; Bovi, TS; de Freitas, RHA; da Silva, DF; Delicio, HC; Giaquinto, PC; Barreto, RE				Volpato, Gilson L.; Bovi, Thais S.; de Freitas, Renato H. A.; da Silva, Danielle F.; Delicio, Helton C.; Giaquinto, Percilia C.; Barreto, Rodrigo Egydio			Red Light Stimulates Feeding Motivation in Fish but Does Not Improve Growth	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RECIRCULATING SYSTEM CONDITIONS; JUNDIA RHAMDIA-QUELEN; NILE TILAPIA; OREOCHROMIS-NILOTICUS; STRESS-RESPONSE; ENVIRONMENTAL COLOR; REARING DENSITY; EURASIAN PERCH; FOOD-INTAKE	Nile tilapia fish were individually reared under similar light levels for 8 weeks under five colored light spectra (maximum wavelength absorbance): white (full light spectrum), blue (similar to 452 nm), green (similar to 516 nm), yellow (similar to 520 nm) or red (similar to 628 nm). The effects of light on feeding, latency to begin feeding, growth and feed conversion were measured during the last 4 weeks of the study (i.e., after acclimation). We found that red light stimulates feeding, as in humans, most likely by affecting central control centers, but the extra feeding is not converted into growth.	[Volpato, Gilson L.; Bovi, Thais S.; da Silva, Danielle F.; Delicio, Helton C.; Giaquinto, Percilia C.; Barreto, Rodrigo Egydio] Sao Paulo State Univ UNESP, Biosci Inst, Dept Physiol, Caunesp, Botucatu, SP, Brazil; [de Freitas, Renato H. A.] Sao Paulo State Univ UNESP, Biosci Inst, Lab Fish Biol & Genet, Dept Morphol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Volpato, GL (corresponding author), Sao Paulo State Univ UNESP, Biosci Inst, Dept Physiol, Caunesp, Botucatu, SP, Brazil.	volpgil@gmail.com	Volpato, Gilson/B-2304-2008; Barreto, Rodrigo E/A-3440-2013; Delicio, Helton/B-5443-2014; Giaquinto, Percilia/A-8395-2018	Barreto, Rodrigo E/0000-0002-4611-0059; Giaquinto, Percilia/0000-0003-4591-4415; Freitas, Renato H A/0000-0002-9053-9186	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [proc. 302022/2006-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; proc. 302022/2006-6; G.L. Volpato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Tawwab M, 2010, AQUACULTURE, V298, P267, DOI 10.1016/j.aquaculture.2009.10.027; Azaza MS, 2010, AQUACULTURE, V309, P193, DOI 10.1016/j.aquaculture.2010.09.026; Biswas AK, 2005, AQUACULTURE, V250, P666, DOI 10.1016/j.aquaculture.2005.04.047; Barcellos Leonardo José Gil, 2006, Cienc. Rural, V36, P1249, DOI 10.1590/S0103-84782006000400031; Barcellos LJG, 2009, AQUACULTURE, V288, P51, DOI 10.1016/j.aquaculture.2008.11.002; Han D, 2005, AQUACULTURE, V248, P299, DOI 10.1016/j.aquaculture.2005.03.016; Karakatsouli N, 2008, AQUACULT ENG, V38, P36, DOI 10.1016/j.aquaeng.2007.10.006; Karakatsouli N, 2007, AQUAC RES, V38, P1152, DOI 10.1111/j.1365-2109.2007.01780.x; Karakatsouli N, 2007, AQUACULT ENG, V36, P302, DOI 10.1016/j.aquaeng.2007.01.005; Karakatsouli N, 2010, AQUACULT ENG, V42, P121, DOI 10.1016/j.aquaeng.2010.01.001; Leonardi MO, 2003, AQUACULTURE, V221, P581, DOI 10.1016/S0044-8486(03)00032-2; Lisney TJ, 2010, J EXP BIOL, V213, P1453, DOI 10.1242/jeb.036897; Luchiari AC, 2008, J FISH BIOL, V72, P1504, DOI 10.1111/j.1095-8649.2008.01824.x; Luchiari AC, 2009, J APPL ICHTHYOL, V25, P162, DOI 10.1111/j.1439-0426.2008.01203.x; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Pottinger TG, 2006, AQUACULTURE, V256, P140, DOI 10.1016/j.aquaculture.2006.01.023; Puvanendran V, 2002, AQUACULTURE, V248, P299; Ruchin A.B., 2002, J ICHTHYOL, V42, P191; Ruchin AB, 2004, FISH PHYSIOL BIOCHEM, V30, P175, DOI 10.1007/s10695-005-1263-4; Singh S., 2006, MANAG DECIS ECON, V44, P783; Stoner AW, 2006, FISH RES, V81, P202, DOI 10.1016/j.fishres.2006.07.005; Strand A, 2007, AQUACULTURE, V272, P312, DOI 10.1016/j.aquaculture.2007.08.052; Tamazouzt L, 2000, AQUACULTURE, V182, P85, DOI 10.1016/S0044-8486(99)00244-6; Villamizar N, 2011, AQUACULTURE, V315, P86, DOI 10.1016/j.aquaculture.2010.10.036; Volpato GL, 2004, BRAZ J MED BIOL RES, V37, P479, DOI 10.1590/S0100-879X2004000400004; Volpato GL, 2001, BRAZ J MED BIOL RES, V34, P1041, DOI 10.1590/S0100-879X2001000800011; Xie S, 2011, AQUACULT NUTR, V17, pE683, DOI 10.1111/j.1365-2095.2010.00827.x	27	23	29	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59134	10.1371/journal.pone.0059134	http://dx.doi.org/10.1371/journal.pone.0059134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516606	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400094
J	Bosdriesz, JR; Lichthart, N; Witvliet, MI; Busschers, WB; Stronks, K; Kunst, AE				Bosdriesz, Jizzo R.; Lichthart, Nienke; Witvliet, Margot I.; Busschers, Wim B.; Stronks, Karien; Kunst, Anton E.			Smoking Prevalence among Migrants in the US Compared to the US-Born and the Population in Countries of Origin	PLOS ONE			English	Article							TOBACCO CONTROL; CIGARETTE PRICES; NATIVE-BORN; ACCULTURATION; IMMIGRANTS; MIGRATION; AMERICANS; MORTALITY; IMPACT; POLICY	Objectives: Smoking among migrants is known to differ from the host population, but migrants' smoking is rarely ever compared to the prevalence of smoking in their country of origin. The goal of this study is to compare the smoking prevalence among migrants to that of both the US-born population and the countries of origin. Further analyses assess the influence of sex, age at time of entry to the US and education level. Methods: Data of 248,726 US-born and migrants from 14 countries were obtained from the Tobacco Use Supplement to the Current Population Survey (TUS-CPS) from 2006-2007. Data on 108,653 respondents from the corresponding countries of origin were taken from the World Health Survey (WHS) from 2002-2005. Results: The prevalence of smoking among migrants (men: 14.2%, women: 4.1%) was lower than both the US-born group (men: 21.4%, women: 18.1%) and countries of origin (men: 39.4%, women: 11.0%). The gender gap among migrants was smaller than in the countries of origin. Age at time of entry to the US was not related to smoking prevalence for migrants. The risk of smoking for high-educated migrants was closer to their US counterparts. Conclusions: The smoking prevalence among migrants is consistently lower than both the country of origin levels and the US level. The theory of segmented assimilation is supported by some results of this study, but not all. Other mechanisms that might influence the smoking prevalence among migrants are the 'healthy migrant effect' or the stage of the smoking epidemic at the time of migration.	[Bosdriesz, Jizzo R.; Lichthart, Nienke; Witvliet, Margot I.; Busschers, Wim B.; Stronks, Karien; Kunst, Anton E.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Bosdriesz, JR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.bosdriesz@amc.uva.nl	Bosdriesz, Jizzo/Q-6250-2016	Bosdriesz, Jizzo/0000-0002-1038-7814; Stronks, Karien/0000-0002-0921-2232; Kunst, Anton/0000-0002-3313-5273				Acevedo-Garcia D, 2005, SOC SCI MED, V61, P1223, DOI 10.1016/j.socscimed.2005.01.027; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Amos A, 2012, TOB CONTROL, V21, P236, DOI 10.1136/tobaccocontrol-2011-050280; Arends-Toth J, 2004, INT J INTERCULT REL, V28, P19, DOI 10.1016/j.ijintrel.2003.09.001; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Blecher E, 2008, J HEALTH ECON, V27, P930, DOI 10.1016/j.jhealeco.2008.02.010; Blue L, 2011, INT J EPIDEMIOL, V40, P786, DOI 10.1093/ije/dyr011; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P605; Chen J, 1996, Health Rep, V8, P29; Choi S, 2008, J CARDIOVASC NURS, V23, P67, DOI 10.1097/01.JCN.0000305057.96247.f2; COULTAS DB, 1988, AM REV RESPIR DIS, V137, P810, DOI 10.1164/ajrccm/137.4.810; Dinno A, 2009, SOC SCI MED, V68, P1439, DOI 10.1016/j.socscimed.2009.02.003; Doku D, 2010, AFR HEALTH SCI, V10, P201; Elder JP, 2002, AM J PREV MED, V23, P269, DOI 10.1016/S0749-3797(02)00515-9; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Guindon GE, 2002, TOB CONTROL, V11, P35, DOI 10.1136/tc.11.1.35; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Mackay J, 2012, PUBLIC HEALTH, V126, P199, DOI 10.1016/j.puhe.2012.01.027; Murray C., 2003, HLTH SYSTEMS PERFORM, P115; Page A, 2007, B WORLD HEALTH ORGAN, V85, P474, DOI 10.2471/BLT.06.036202; PORTES A, 2001, LEGACIES STORY IMMIG, P44; Shiffman S, 1999, Nicotine Tob Res, V1 Suppl 2, pS153; Singh GK, 2001, AM J PUBLIC HEALTH, V91, P392, DOI 10.2105/AJPH.91.3.392; Stoddard P, 2009, SOC SCI MED, V69, P94, DOI 10.1016/j.socscimed.2009.03.035; U.S.Department of Health & Human Services, 1990, SELF GUID STRAT SMOK; US Department of Commerce CB, 2008, NAT CANC I SPONS TOB; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Warner KE, 2010, NICOTINE TOB RES, V12, P876, DOI 10.1093/ntr/ntq125; WEWERS ME, 1995, AM J RESP CRIT CARE, V152, P1917, DOI 10.1164/ajrccm.152.6.8520755; Wilkinson AV, 2005, AM J PUBLIC HEALTH, V95, P1043, DOI 10.2105/AJPH.2004.055319; World Health Organisation Health statistics and health information systems, 2011, WORLD HLTH SURVEY	31	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58654	10.1371/journal.pone.0058654	http://dx.doi.org/10.1371/journal.pone.0058654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520525	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900085
J	Holland, B; Wong, J; Li, M; Rasheed, S				Holland, Bryan; Wong, Jonathan; Li, Meng; Rasheed, Suraiya			Identification of Human MicroRNA-Like Sequences Embedded within the Protein-Encoding Genes of the Human Immunodeficiency Virus	PLOS ONE			English	Article							RNA INTERFERENCE; HIV-1 INFECTION; CELLS; EXPRESSION; RETROVIRUSES; TARGET; CD4; SUSCEPTIBILITY; REPLICATION; BIOGENESIS	Background: MicroRNAs (miRNAs) are highly conserved, short (18-22 nts), non-coding RNA molecules that regulate gene expression by binding to the 3' untranslated regions (3'UTRs) of mRNAs. While numerous cellular microRNAs have been associated with the progression of various diseases including cancer, miRNAs associated with retroviruses have not been well characterized. Herein we report identification of microRNA-like sequences in coding regions of several HIV-1 genomes. Results: Based on our earlier proteomics and bioinformatics studies, we have identified 8 cellular miRNAs that are predicted to bind to the mRNAs of multiple proteins that are dysregulated during HIV-infection of CD4+ T-cells in vitro. In silico analysis of the full length and mature sequences of these 8 miRNAs and comparisons with all the genomic and subgenomic sequences of HIV-1 strains in global databases revealed that the first 18/18 sequences of the mature hsa-miR-195 sequence (including the short seed sequence), matched perfectly (100%), or with one nucleotide mismatch, within the envelope (env) genes of five HIV-1 genomes from Africa. In addition, we have identified 4 other miRNA-like sequences (hsa-miR-30d, hsamiR- 30e, hsa-miR-374a and hsa-miR-424) within the env and the gag-pol encoding regions of several HIV-1 strains, albeit with reduced homology. Mapping of the miRNA-homologues of env within HIV-1 genomes localized these sequence to the functionally significant variable regions of the env glycoprotein gp120 designated V1, V2, V4 and V5. Conclusions: We conclude that microRNA-like sequences are embedded within the protein-encoding regions of several HIV1 genomes. Given that the V1 to V5 regions of HIV-1 envelopes contain specific, well-characterized domains that are critical for immune responses, virus neutralization and disease progression, we propose that the newly discovered miRNA-like sequences within the HIV-1 genomes may have evolved to self-regulate survival of the virus in the host by evading innate immune responses and therefore influencing persistence, replication and/or pathogenicity.	[Holland, Bryan; Wong, Jonathan; Li, Meng; Rasheed, Suraiya] Univ So Calif, Keck Sch Med, Lab Viral Oncol & Prote Res, Los Angeles, CA 90033 USA	University of Southern California	Rasheed, S (corresponding author), Univ So Calif, Keck Sch Med, Lab Viral Oncol & Prote Res, Los Angeles, CA 90033 USA.	srasheed@usc.edu			University of Southern California-Rasheed Research Endowment Fund	University of Southern California-Rasheed Research Endowment Fund	This study was supported by the University of Southern California-Rasheed Research Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Antonov AV, 2009, NUCLEIC ACIDS RES, V37, pW323, DOI 10.1093/nar/gkp313; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041574; CHENGMAYER C, 1990, J VIROL, V64, P4390, DOI 10.1128/JVI.64.9.4390-4398.1990; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; Gong TWL, 2001, MAMM GENOME, V12, P852, DOI 10.1007/s00335-001-3037-3; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hakim ST, 2008, BIOCHEM BIOPH RES CO, V369, P357, DOI 10.1016/j.bbrc.2008.02.025; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Houzet L, 2011, BBA-GENE REGUL MECH, V1809, P686, DOI 10.1016/j.bbagrm.2011.05.009; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kaul D, 2009, MOL CELL BIOCHEM, V323, P143, DOI 10.1007/s11010-008-9973-4; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Meissner EG, 2005, VIROLOGY, V336, P184, DOI 10.1016/j.virol.2005.03.032; Morikita T, 1997, AIDS RES HUM RETROV, V13, P1291, DOI 10.1089/aid.1997.13.1291; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pilakka-Kanthikeel S, 2011, J NEUROVIROL, V17, P416, DOI 10.1007/s13365-011-0046-1; RASHEED S, 1986, VIROLOGY, V150, P1, DOI 10.1016/0042-6822(86)90260-6; Rasheed S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-75; Rasheed S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003003; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sun GH, 2011, TRENDS PHARMACOL SCI, V32, P675, DOI 10.1016/j.tips.2011.07.003; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Wang WF, 2012, J BIOL CHEM, V287, P35455, DOI 10.1074/jbc.M112.362400; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Zhu HC, 2012, BRAIN RES BULL, V88, P596, DOI 10.1016/j.brainresbull.2012.05.018; Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145	47	18	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58586	10.1371/journal.pone.0058586	http://dx.doi.org/10.1371/journal.pone.0058586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520522	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900082
J	Lacotte, S; Decossas, M; Le Coz, C; Brun, S; Muller, S; Dumortier, H				Lacotte, Stephanie; Decossas, Marion; Le Coz, Carole; Brun, Susana; Muller, Sylviane; Dumortier, Helene			Early Differentiated CD138(high)MHCII(+)IgG(+) Plasma Cells Express CXCR3 and Localize into Inflamed Kidneys of Lupus Mice	PLOS ONE			English	Article							CHEMOKINE RECEPTOR EXPRESSION; B-LYMPHOCYTE HOMEOSTASIS; AUTOANTIBODY PRODUCTION; RHEUMATOID-ARTHRITIS; IMMUNOLOGICAL MEMORY; SECRETING CELLS; RESPONSIVENESS; ERYTHEMATOSUS; MAINTENANCE; SUBSETS	Humoral responses are central to the development of chronic autoimmune diseases such as systemic lupus erythematosus. Indeed, autoantibody deposition is responsible for tissue damage, the kidneys being one of the main target organs. As the source of pathogenic antibodies, plasma cells are therefore critical players in this harmful scenario, both at systemic and local levels. The aim of the present study was to analyze plasma cells in NZB/W lupus mice and to get a better understanding of the mechanisms underlying their involvement in the renal inflammation process. Using various techniques (i.e. flow cytometry, quantitative PCR, ELISpot), we identified and extensively characterized three plasma cell intermediates, according to their B220/CD138/MHCII expression levels. Each of these cell subsets displays specific proliferation and antibody secretion capacities. Moreover, we evidenced that the inflammation-related CXCR3 chemokine receptor is uniquely expressed by CD138(high)MHCII(+) plasma cells, which encompass both short-and long-lived cells and mostly produce IgG (auto) antibodies. Expression of CXCR3 allows efficient chemotactic responsiveness of these cells to cognate chemokines, which production is up-regulated in the kidneys of diseased NZB/W mice. Finally, using fluorescence and electron microscopy, we demonstrated the presence of CD138(+)CXCR3(+)IgG(+) cells in inflammatory areas in the kidneys, where they are very likely involved in the injury process. Thus, early differentiated CD138(high)MHCII(+) rather than terminally differentiated CD138(high)MHCII(low) plasma cells may be involved in the renal inflammatory injury in lupus, due to CXCR3 expression and IgG secretion.	[Lacotte, Stephanie; Decossas, Marion; Le Coz, Carole; Brun, Susana; Muller, Sylviane; Dumortier, Helene] CNRS, Inst Biol Mol & Cellulaire, Lab Excellence Medalis, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dumortier, H (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Lab Excellence Medalis, F-67084 Strasbourg, France.	H.Dumortier@ibmc-cnrs.unistra.fr	Brun, Susana/J-9865-2016; Muller, Sylviane/J-5319-2014; Stéphanie, LACOTTE/I-1693-2019	Brun, Susana/0000-0002-7031-9733; Stéphanie, LACOTTE/0000-0002-5921-6389; Le Coz, Carole/0000-0002-9228-5896; decossas, marion/0000-0003-0810-4309	Centre National pour la Recherche Scientifique (CNRS); Roche (Apollo-B grant); Fondation Arthritis-Courtin; Fondation pour la Recherche Medicale	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Roche (Apollo-B grant); Fondation Arthritis-Courtin; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National pour la Recherche Scientifique (CNRS) and by Roche (Apollo-B grant). Stephanie Lacotte and Susana Brun wish to thank the Fondation Arthritis-Courtin and Fondation pour la Recherche Medicale, respectively, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Arch JRS, 2002, J ENDOCRINOL INVEST, V25, P867, DOI 10.1007/BF03344050; Astorri E, 2010, J IMMUNOL, V185, P3359, DOI 10.4049/jimmunol.1001836; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Decossas M, 2003, J COMP NEUROL, V462, P302, DOI 10.1002/cne.10734; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Enghard P, 2009, ARTHRITIS RHEUM, V60, P199, DOI 10.1002/art.24136; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Gomez-Puerta JA, 2008, AUTOIMMUN REV, V7, P606, DOI 10.1016/j.autrev.2008.06.005; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Johansson C, 2005, CLIN EXP IMMUNOL, V141, P279, DOI 10.1111/j.1365-2249.2005.02843.x; Katrin M, 2012, ARTHRITIS RHEUM, V64, P1237; Kohler RE, 2008, BRAIN PATHOL, V18, P504, DOI 10.1111/j.1750-3639.2008.00154.x; Lacotte S, 2010, J IMMUNOL, V184, P3937, DOI 10.4049/jimmunol.0902595; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Le Pottier L, 2009, J IMMUNOL, V182, P3540, DOI 10.4049/jimmunol.0803588; Lin KI, 2003, IMMUNOL REV, V194, P19, DOI 10.1034/j.1600-065X.2003.00040.x; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Marques CP, 2011, J VIROL, V85, P6136, DOI 10.1128/JVI.00202-11; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; MULLER S, 1987, MOL IMMUNOL, V24, P779, DOI 10.1016/0161-5890(87)90062-9; Nacionales DC, 2009, J IMMUNOL, V182, P4226, DOI 10.4049/jimmunol.0800771; Nanki T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2823; Nicholas MIW, 2008, CLIN IMMUNOL, V126, P189, DOI 10.1016/j.clim.2007.10.004; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Odendahl M, 2003, ANN RHEUM DIS, V62, P851, DOI 10.1136/ard.62.9.851; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Plum L, 2005, PHYSIOLOGY, V20, P152, DOI 10.1152/physiol.00049.2004; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Ruth JH, 2001, ARTHRITIS RHEUM, V44, P2750, DOI 10.1002/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C; Starke C, 2011, EUR J IMMUNOL, V41, P2107, DOI 10.1002/eji.201041315; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; STEWARD MW, 1976, CLIN EXP IMMUNOL, V26, P363; THEOFILOPOULOS AN, 1980, J EXP MED, V151, P446, DOI 10.1084/jem.151.2.446; Tokoyoda K, 2009, EUR J IMMUNOL, V39, P2095, DOI 10.1002/eji.200939500; Traynor AE, 2000, LANCET, V356, P701, DOI 10.1016/S0140-6736(00)02627-1; Tsubaki T, 2005, CLIN EXP IMMUNOL, V141, P363, DOI 10.1111/j.1365-2249.2005.02850.x; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Wehrli N, 2001, EUR J IMMUNOL, V31, P609, DOI 10.1002/1521-4141(200102)31:2<609::AID-IMMU609>3.0.CO;2-9; Wijtmans M, 2008, CHEMMEDCHEM, V3, P861, DOI 10.1002/cmdc.200700365; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Wrammert J, 2002, EUR J IMMUNOL, V32, P97, DOI 10.1002/1521-4141(200201)32:1<97::AID-IMMU97>3.0.CO;2-Y	55	44	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58140	10.1371/journal.pone.0058140	http://dx.doi.org/10.1371/journal.pone.0058140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520491	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900050
J	Veronesi, E; Henstock, M; Gubbins, S; Batten, C; Manley, R; Barber, J; Hoffmann, B; Beer, M; Attoui, H; Mertens, PPC; Carpenter, S				Veronesi, Eva; Henstock, Mark; Gubbins, Simon; Batten, Carrie; Manley, Robyn; Barber, James; Hoffmann, Bernd; Beer, Martin; Attoui, Houssam; Mertens, Peter Paul Clement; Carpenter, Simon			Implicating Culicoides Biting Midges as Vectors of Schmallenberg Virus Using Semi-Quantitative RT-PCR	PLOS ONE			English	Article							BLUETONGUE VIRUS; AKABANE VIRUS; ARBOVIRUS VECTORS; CERATOPOGONIDAE; DIPTERA; VARIIPENNIS; INFECTION; EUROPE; CATTLE; JAPAN	Background: The recent unprecedented emergence of arboviruses transmitted by Culicoides biting midges in northern Europe has necessitated the development of techniques to differentiate competent vector species. At present these techniques are entirely reliant upon interpretation of semi-quantitative RT-PCR (sqPCR) data in the form of C-q values used to infer the presence of viral RNA in samples. Methodology/Principal Findings: This study investigates the advantages and limitations of sqPCR in this role by comparing infection and dissemination rates of Schmallenberg virus (SBV) in two colony lines of Culicoides. Through the use of these behaviorally malleable lines we provide tools for demarcating arbovirus infection and dissemination rates in Culicoides which to date have prevented clear implication of primary vector species in northern Europe. The study demonstrates biological transmission of SBV in an arthropod vector, supporting the conclusions from field-caught Culicoides and provides a general framework for future assessment of vector competence of Culicoides for arboviruses using sqPCR. Conclusions/Significance: When adopting novel diagnostic technologies, correctly implicating vectors of arboviral pathogens requires a coherent laboratory framework to fully understand the implications of results produced in the field. This study illustrates these difficulties and provides a full examination of sqPCR in this role for the Culicoides-arbovirus system.	[Veronesi, Eva; Henstock, Mark; Gubbins, Simon; Batten, Carrie; Manley, Robyn; Barber, James; Attoui, Houssam; Mertens, Peter Paul Clement; Carpenter, Simon] Pirbright Inst, VVD Program, Pirbright, Surrey, England; [Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Friedrich Loeffler Institute	Carpenter, S (corresponding author), Pirbright Inst, VVD Program, Pirbright, Surrey, England.	simon.carpenter@pirbright.ac.uk		Gubbins, Simon/0000-0003-0538-4173; Batten, Carrie/0000-0003-4274-7375; Mertens, Peter/0000-0002-3438-3738; Veronesi, Eva/0000-0003-3411-7891; Attoui, Houssam/0000-0001-9639-9981	Department for Environment, Food and Rural Affairs (Defra) [SE0542]; European Union [EDENext: FP7-HEALTH-353 2010/nr.261504]; Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/I/00001445]; BBSRC [BBS/E/I/00001445, BBS/E/I/00001701] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001445, BBS/E/I/00001701] Funding Source: researchfish	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); European Union(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Department for Environment, Food and Rural Affairs (Defra) (grant code SE0542), the European Union (grant code EDENext: FP7-HEALTH-353 2010/nr.261504) and the Biotechnology and Biological Sciences Research Council (BBSRC) (grant code: BBS/E/I/00001445). This manuscript is cataloged as paper 066 of EDENext. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUSAIDY SM, 1991, EPIDEMIOL INFECT, V106, P403, DOI 10.1017/S095026880004855X; Becker ME, 2010, J MED ENTOMOL, V47, P269, DOI 10.1603/ME09211; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; BOORMAN J, 1987, MED VET ENTOMOL, V1, P211, DOI 10.1111/j.1365-2915.1987.tb00346.x; BOORMAN J, 1974, B ENTOMOL RES, V64, P371, DOI 10.1017/S0007485300031254; BRAVERMAN Y, 1981, INSECT SCI APPL, V2, P157, DOI 10.1017/S1742758400000953; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; De Regge N, 2012, TRANSBOUNDARY EMERGI; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Elbers ARW, 2012, EMERG INFECT DIS, V18, P1065, DOI 10.3201/eid1807.120323; Elbers ARW, 2013, EMERGING INFECT DIS; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; Gelman A., 2004, BAYESIAN DATA ANAL, P668; Goller KV, 2012, EMERGING IN IN PRESS, V18; Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoffmann B, 2009, EMERG INFECT DIS, V15, P1481, DOI 10.3201/eid1509.090562; JENNINGS DM, 1988, VET MICROBIOL, V17, P1, DOI 10.1016/0378-1135(88)90074-0; JENNINGS M, 1989, VET MICROBIOL, V21, P125, DOI 10.1016/0378-1135(89)90024-2; JOCHIM MM, 1966, AM J EPIDEMIOL, V84, P241; JONES RH, 1974, J MED ENTOMOL, V11, P316, DOI 10.1093/jmedent/11.3.316; KUROGI H, 1987, VET MICROBIOL, V15, P243, DOI 10.1016/0378-1135(87)90078-2; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Muller M. J., 1982, Arbovirus research in Australia. Proceedings 3rd symposium. 15-17 February 1982, P43; MULLER MJ, 1995, VET MICROBIOL, V46, P101, DOI 10.1016/0378-1135(95)00076-M; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; RFfS Computing, 2012, R LANG PROGR ENV STA; Sabio IJ, 2006, J MED ENTOMOL, V43, P1020, DOI 10.1603/0022-2585(2006)43[1020:DOWNVR]2.0.CO;2; Sarkar D., 2019, NLME LINEAR NONLINEA; Stram Y, 2004, VIRUS RES, V104, P93, DOI 10.1016/j.virusres.2004.03.004; THEODORIDIS A, 1979, ONDERSTEPOORT J VET, V46, P191; Vanbinst T, 2009, TRANSBOUND EMERG DIS, V56, P170, DOI 10.1111/j.1865-1682.2009.01077.x; Veronesi E, 2009, VET PARASITOL, V163, P370, DOI 10.1016/j.vetpar.2009.04.031; Veronesi E, 2008, J MED ENTOMOL, V45, P129, DOI 10.1603/0022-2585(2008)45[129:QBVIAC]2.0.CO;2; Yanase T, 2005, ARCH VIROL, V150, P361, DOI 10.1007/s00705-004-0419-3; Yanase T, 2005, J MED ENTOMOL, V42, P63, DOI 10.1603/0022-2585(2005)042[0063:IOBAFC]2.0.CO;2	41	97	103	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57747	10.1371/journal.pone.0057747	http://dx.doi.org/10.1371/journal.pone.0057747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520481	Green Submitted, gold, Green Published			2022-12-27	WOS:000318679900040
J	Vilar, S; Uriarte, E; Santana, L; Tatonetti, NP; Friedman, C				Vilar, Santiago; Uriarte, Eugenio; Santana, Lourdes; Tatonetti, Nicholas P.; Friedman, Carol			Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints	PLOS ONE			English	Article							IN-VITRO; MECHANISM; FRAMEWORK; QSAR	Drug-drug interactions (DDIs) constitute an important problem in postmarketing pharmacovigilance and in the development of new drugs. The effectiveness or toxicity of a medication could be affected by the co-administration of other drugs that share pharmacokinetic or pharmacodynamic pathways. For this reason, a great effort is being made to develop new methodologies to detect and assess DDIs. In this article, we present a novel method based on drug interaction profile fingerprints (IPFs) with successful application to DDI detection. IPFs were generated based on the DrugBank database, which provided 9,454 well-established DDIs as a primary source of interaction data. The model uses IPFs to measure the similarity of pairs of drugs and generates new putative DDIs from the non-intersecting interactions of a pair. We described as part of our analysis the pharmacological and biological effects associated with the putative interactions; for example, the interaction between haloperidol and dicyclomine can cause increased risk of psychosis and tardive dyskinesia. First, we evaluated the method through hold-out validation and then by using four independent test sets that did not overlap with DrugBank. Precision for the test sets ranged from 0.4-0.5 with more than two fold enrichment factor enhancement. In conclusion, we demonstrated the usefulness of the method in pharmacovigilance as a DDI predictor, and created a dataset of potential DDIs, highlighting the etiology or pharmacological effect of the DDI, and providing an exploratory tool to facilitate decision support in DDI detection and patient safety.	[Vilar, Santiago; Tatonetti, Nicholas P.; Friedman, Carol] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10027 USA; [Vilar, Santiago; Uriarte, Eugenio; Santana, Lourdes] Univ Santiago de Compostela, Fac Pharm, Dept Organ Chem, Santiago De Compostela, Spain	Columbia University; Universidade de Santiago de Compostela	Vilar, S (corresponding author), Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10027 USA.	sav7003@dbmi.columbia.edu	Uriarte, Eugenio EU/F-5691-2012; Santana, Lourdes/L-2981-2014	Uriarte, Eugenio EU/0000-0001-6218-2899; Santana, Lourdes/0000-0001-6056-8253; Tatonetti, Nicholas/0000-0002-2700-2597; Vilar Varela, Santiago/0000-0003-2663-4370	Plan Galego de Investigacion, Innovacion e Crece-mento (I2C); European Social Fund (ESF); Angeles Alvarino program from Xunta de Galicia (Spain);  [R01 LM010016];  [R01 LM010016-0S1];  [R01 LM010016-0S2];  [R01 LM008635]; NATIONAL LIBRARY OF MEDICINE [R01LM010016, R01LM008635] Funding Source: NIH RePORTER	Plan Galego de Investigacion, Innovacion e Crece-mento (I2C); European Social Fund (ESF)(European Social Fund (ESF)); Angeles Alvarino program from Xunta de Galicia (Spain); ; ; ; ; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants R01 LM010016 (CF), R01 LM010016- 0S1 (CF), R01 LM010016-0S2 (CF), R01 LM008635 (CF), "Plan Galego de Investigacion, Innovacion e Crece-mento 2011-2015 (I2C)", European Social Fund (ESF) and Angeles Alvarino program from Xunta de Galicia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOE VERS 2011 10; [Anonymous], 2011, DRUGD H SYST MICR HE; Arikuma T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S11; Bjornsson TD, 2003, DRUG METAB DISPOS, V31, P815, DOI 10.1124/dmd.31.7.815; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Costanzi S, 2011, CHEMMEDCHEM, V6, P1452, DOI 10.1002/cmdc.201100139; Dickins M., 2004, DRUG DISCOV TODAY BI, V2, P38, DOI [DOI 10.1016/S1741-8364(04)02388-1, 10.1016/S1741-8364(04)02388-1]; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Eckert H, 2006, J CHEM INF MODEL, V46, P2515, DOI 10.1021/ci600303b; Ewing T, 2006, J CHEM INF MODEL, V46, P2423, DOI 10.1021/ci060155b; Fowler S, 2008, AAPS J, V10, P410, DOI 10.1208/s12248-008-9042-7; Gedeck P, 2008, CURR OPIN DRUG DISC, V11, P569; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Harpaz R, 2011, CLIN PHARMACOL THER, V89, P243, DOI 10.1038/clpt.2010.285; Harpaz Rave, 2010, AMIA Annu Symp Proc, V2010, P281; Hudelson MG, 2008, J MED CHEM, V51, P648, DOI 10.1021/jm701130z; Jonker DM, 2005, PHARMACOL THERAPEUT, V106, P1, DOI 10.1016/j.pharmthera.2004.10.014; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Meinertz T, 2001, EUR HEART J SUPPL, V3, pK89, DOI 10.1016/S1520-765X(01)90011-2; Nisius B, 2009, CHEMMEDCHEM, V4, P1859, DOI 10.1002/cmdc.200900243; Percha B, 2012, BIOCOMPUT-PAC SYM, P410; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; Vilar S, 2006, J MED CHEM, V49, P1118, DOI 10.1021/jm050932j; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Wang XY, 2009, J AM MED INFORM ASSN, V16, P328, DOI 10.1197/jamia.M3028; Winkler David A, 2002, Brief Bioinform, V3, P73, DOI 10.1093/bib/3.1.73; Zhang L, 2009, AAPS J, V11, P300, DOI 10.1208/s12248-009-9106-3	29	67	68	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58321	10.1371/journal.pone.0058321	http://dx.doi.org/10.1371/journal.pone.0058321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520498	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900057
J	Vandenwijngaert, S; Pokreisz, P; Hermans, H; Gillijns, H; Pellens, M; Bax, NAM; Coppiello, G; Oosterlinck, W; Balogh, A; Papp, Z; Bouten, CVC; Bartunek, J; D'hooge, J; Luttun, A; Verbeken, E; Herregods, MC; Herijgers, P; Bloch, KD; Janssens, S				Vandenwijngaert, Sara; Pokreisz, Peter; Hermans, Hadewich; Gillijns, Hilde; Pellens, Marijke; Bax, Noortje A. M.; Coppiello, Giulia; Oosterlinck, Wouter; Balogh, Agnes; Papp, Zoltan; Bouten, Carlijn V. C.; Bartunek, Jozef; D'hooge, Jan; Luttun, Aernout; Verbeken, Erik; Herregods, Marie Christine; Herijgers, Paul; Bloch, Kenneth D.; Janssens, Stefan			Increased Cardiac Myocyte PDE5 Levels in Human and Murine Pressure Overload Hypertrophy Contribute to Adverse LV Remodeling	PLOS ONE			English	Article							PHOSPHODIESTERASE TYPE 5; ADVANCED HEART-FAILURE; PULMONARY-HYPERTENSION; INHIBITION; SILDENAFIL; EXPRESSION; CONTRACTILITY; MYOCARDIUM; STIFFNESS; 1-YEAR	Background: The intracellular second messenger cGMP protects the heart under pathological conditions. We examined expression of phosphodiesterase 5 (PDE5), an enzyme that hydrolyzes cGMP, in human and mouse hearts subjected to sustained left ventricular (LV) pressure overload. We also determined the role of cardiac myocyte-specific PDE5 expression in adverse LV remodeling in mice after transverse aortic constriction (TAC). Methodology/Principal Findings: In patients with severe aortic stenosis (AS) undergoing valve replacement, we detected greater myocardial PDE5 expression than in control hearts. We observed robust expression in scattered cardiac myocytes of those AS patients with higher LV filling pressures and BNP serum levels. Following TAC, we detected similar, focal PDE5 expression in cardiac myocytes of C57BL/6NTac mice exhibiting the most pronounced LV remodeling. To examine the effect of cell-specific PDE5 expression, we subjected transgenic mice with cardiac myocyte-specific PDE5 overexpression (PDE5TG) to TAC. LV hypertrophy and fibrosis were similar as in WT, but PDE5-TG had increased cardiac dimensions, and decreased dP/dt(max) and dP/dt(min) with prolonged tau (P, 0.05 for all). Greater cardiac dysfunction in PDE5-TG was associated with reduced myocardial cGMP and SERCA2 levels, and higher passive force in cardiac myocytes in vitro. Conclusions/Significance: Myocardial PDE5 expression is increased in the hearts of humans and mice with chronic pressure overload. Increased cardiac myocyte-specific PDE5 expression is a molecular hallmark in hypertrophic hearts with contractile failure, and represents an important therapeutic target.	[Vandenwijngaert, Sara; Pokreisz, Peter; Hermans, Hadewich; Gillijns, Hilde; Pellens, Marijke; Coppiello, Giulia; Oosterlinck, Wouter; Bartunek, Jozef; D'hooge, Jan; Luttun, Aernout; Herregods, Marie Christine; Herijgers, Paul; Janssens, Stefan] Katholieke Univ Leuven, Dept Cardiovasc Sci, Louvain, Belgium; [Bax, Noortje A. M.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Balogh, Agnes; Papp, Zoltan] Univ Debrecen, Med & Hlth Sci Ctr, Res Ctr Mol Med, Div Clin Physiol,Inst Cardiol, H-4012 Debrecen, Hungary; [Bartunek, Jozef] Onze Lieve Vrouw Hosp, Ctr Cardiovasc, Aalst, Belgium; [Verbeken, Erik] Katholieke Univ Leuven, Dept Imaging & Pathol, Louvain, Belgium; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Anesthesia Ctr Crit Care Res, Boston, MA 02114 USA; [Bloch, Kenneth D.] Harvard Univ, Sch Med, Boston, MA USA	KU Leuven; Eindhoven University of Technology; University of Debrecen; Cardiovascular Center Aalst; KU Leuven; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Janssens, S (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Louvain, Belgium.	stefan.janssens@med.kuleuven.be	Bouten, Carlijn/AAT-5187-2020; Herijgers, Paul/B-8064-2013; Luttun, Aernout/AAZ-6540-2020; Pokreisz, Peter/AAY-7350-2020	Bouten, Carlijn/0000-0003-1035-5094; Herijgers, Paul/0000-0003-0951-8132; Luttun, Aernout/0000-0001-7902-9524; Pokreisz, Peter/0000-0003-2810-9000; Coppiello, Giulia/0000-0001-6896-1084; Bax, Noortje/0000-0002-3602-6400; D'hooge, Jan/0000-0002-2346-142X	Fund for Scientific Research Flanders; Departmental Research Grant of KU Leuven [PF10/014]; European Research Council [FP-7-StG-IMAGINED 203291];  [TAMOP-4.2.2.A-11/1/KONV-2012-0045]	Fund for Scientific Research Flanders(FWO); Departmental Research Grant of KU Leuven; European Research Council(European Research Council (ERC)European Commission); 	This work was supported by the Fund for Scientific Research Flanders (to SV, PP, and SJ), and a Departmental Research Grant of KU Leuven (PF10/014). The work was also supported by the TAMOP-4.2.2.A-11/1/KONV-2012-0045 project (to AB and ZP), and a European Research Council Starting Grant FP-7-StG-IMAGINED 203291 (to AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Hammond J, 2012, J MOL CELL CARDIOL, V52, P330, DOI 10.1016/j.yjmcc.2011.07.029; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kukreja RC, 2012, J AM COLL CARDIOL, V59, P1921, DOI 10.1016/j.jacc.2011.09.086; Lehnart SE, 2009, HEART FAIL REV, V14, P213, DOI 10.1007/s10741-009-9146-x; Lindman BR, 2012, CIRCULATION, V125, P2353, DOI 10.1161/CIRCULATIONAHA.111.081125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZB, 2010, CIRCULATION, V121, P1474, DOI 10.1161/CIRCULATIONAHA.109.906818; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Papp Z, 2002, J PHYSIOL-LONDON, V543, P177, DOI 10.1113/jphysiol.2002.022145; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Sastry BKS, 2004, J AM COLL CARDIOL, V43, P1149, DOI 10.1016/j.jacc.2003.10.056; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Vandeput F, 2009, J PHARMACOL EXP THER, V330, P884, DOI 10.1124/jpet.109.154468; Zhang ML, 2010, J AM COLL CARDIOL, V56, P2021, DOI 10.1016/j.jacc.2010.08.612	24	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58841	10.1371/journal.pone.0058841	http://dx.doi.org/10.1371/journal.pone.0058841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527037	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600013
J	Xu, WD; Watts, DM; Costanzo, MC; Tang, XL; Venegas, LA; Jiao, F; Sette, A; Sidney, J; Sewell, AK; Wooldridge, L; Makino, S; Morrill, JC; Peters, CJ; Kan-Mitchell, J				Xu, Weidong; Watts, Douglas M.; Costanzo, Margaret C.; Tang, Xiaolei; Venegas, Leon A.; Jiao, Feng; Sette, Alessandro; Sidney, John; Sewell, Andrew K.; Wooldridge, Linda; Makino, Shinji; Morrill, John C.; Peters, Clarence J.; Kan-Mitchell, June			The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8(+) T Cell Antigen and Elicits Memory Responses	PLOS ONE			English	Article							IMMUNE-RESPONSES; MONOCLONAL-ANTIBODIES; LABORATORY INFECTION; DOMESTIC RUMINANTS; RHESUS MACAQUES; DENDRITIC CELLS; INFLUENZA-VIRUS; INDIRECT ELISA; IGG ANTIBODY; VACCINE	There is no licensed human vaccine currently available for Rift Valley Fever Virus (RVFV), a Category A high priority pathogen and a serious zoonotic threat. While neutralizing antibodies targeting the viral glycoproteins are protective, they appear late in the course of infection, and may not be induced in time to prevent a natural or bioterrorism-induced outbreak. Here we examined the immunogenicity of RVFV nucleocapsid (N) protein as a CD8(+) T cell antigen with the potential for inducing rapid protection after vaccination. HLA-A*0201 (A2)-restricted epitopic determinants were identified with N-specific CD8(+) T cells from eight healthy donors that were primed with dendritic cells transduced to express N, and subsequently expanded in vitro by weekly re-stimulations with monocytes pulsed with 59 15mer overlapping peptides (OLPs) across N. Two immunodominant epitopes, VT9 (VLSEWLPVT, N121-129) and IL9 (ILDAHSLYL, N165-173), were defined. VT9- and IL9-specific CD8(+) T cells identified by tetramer staining were cytotoxic and polyfunctional, characteristics deemed important for viral control in vivo. These peptides induced specific CD8(+) T cell responses in A2-transgenic mice, and more importantly, potent N-specific CD8(+) T cell reactivities, including VT9- and IL9-specific ones, were mounted by mice after a booster vaccination with the live attenuated RVF MP-12. Our data suggest that the RVFV N protein is a potent human T cell immunogen capable of eliciting broad, immunodominant CD8(+) T cell responses that are potentially protective. Understanding the immune responses to the nucleocapsid is central to the design of an effective RVFV vaccine irrespective of whether this viral protein is effective as a stand-alone immunogen or only in combination with other RVFV antigens.	[Xu, Weidong; Watts, Douglas M.; Costanzo, Margaret C.; Tang, Xiaolei; Venegas, Leon A.; Jiao, Feng; Kan-Mitchell, June] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Xu, Weidong; Watts, Douglas M.; Costanzo, Margaret C.; Tang, Xiaolei; Venegas, Leon A.; Jiao, Feng; Kan-Mitchell, June] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Sette, Alessandro; Sidney, John] La Jolla Inst Allergy & Immunol, Ctr Infect Dis, La Jolla, CA USA; [Sewell, Andrew K.; Wooldridge, Linda] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Makino, Shinji; Morrill, John C.; Peters, Clarence J.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; La Jolla Institute for Immunology; Cardiff University; University of Texas System; University of Texas Medical Branch Galveston	Kan-Mitchell, J (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	jkanmitchell@utep.edu	Tang, Xiaolei/AAT-7669-2021; Sette, Alessandro/AFO-8916-2022; Ibrahim, Essam Hassan/G-1960-2018; Makino, Shinji/E-8014-2015; Sewell, Andrew/GPT-4220-2022	Tang, Xiaolei/0000-0003-1492-9622; Ibrahim, Essam Hassan/0000-0003-0130-2257; Makino, Shinji/0000-0002-7831-1576; Sewell, Andrew/0000-0003-3194-3135; Wooldridge, Linda/0000-0002-6213-347X	National Institutes of Health (NIH) [AI064069, AI77413, U54 AI057156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, R01AI077413, R01AI064069] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) research grants AI064069 and AI77413 to June Kan-Mitchell, and U54 AI057156 to David H. Walker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AA, 2010, INT J INFECT DIS, V14, pE179, DOI 10.1016/j.ijid.2009.03.029; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; BESSELAAR TG, 1991, ARCH VIROL, V121, P111, DOI 10.1007/BF01316748; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Boshra H, 2011, VACCINE; Boshra H, 2011, J VIROL, V85, P6098, DOI 10.1128/JVI.02641-10; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dungu B, 2010, VACCINE, V28, P4581, DOI 10.1016/j.vaccine.2010.04.085; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Ertelt JM, 2011, IMMUNOLOGY, V134, P487, DOI 10.1111/j.1365-2567.2011.03510.x; Fafetine JM, 2007, VET MICROBIOL, V121, P29, DOI 10.1016/j.vetmic.2006.11.008; Francis T, 1935, J EXP MED, V62, P433, DOI 10.1084/jem.62.3.433; Fruci D, 2003, J IMMUNOL, V170, P2977, DOI 10.4049/jimmunol.170.6.2977; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Greenbaum J, 2011, IMMUNOGENETICS; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; Hanke T, 2011, EUR J IMMUNOL, V41, P3390, DOI 10.1002/eji.201190072; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; HEISE MT, 2009, EPIDEMIOL INFECT, P1; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2012, ANTIVIR RES, V95, P293, DOI 10.1016/j.antiviral.2012.06.001; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Jansen Van Vuren P, 2010, OPEN VACCINE J, V3, P114; Kan-Mitchell J, 2004, J IMMUNOL, V172, P5249, DOI 10.4049/jimmunol.172.9.5249; Kan-Mitchell J, 2006, J IMMUNOL, V176, P6690, DOI 10.4049/jimmunol.176.11.6690; KARK JD, 1982, AM J EPIDEMIOL, V116, P808, DOI 10.1093/oxfordjournals.aje.a113471; Kern F, 2005, TRENDS IMMUNOL, V26, P477, DOI 10.1016/j.it.2005.07.005; Koup RA, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007252; La Rosa C, 2002, BLOOD, V100, P3681, DOI 10.1182/blood-2002-03-0926; Lagerqvist N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-6; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lorenzo G, 2010, VACCINE, V28, P2937, DOI 10.1016/j.vaccine.2010.02.018; Lorenzo G, 2008, VACCINE, V26, P5255, DOI 10.1016/j.vaccine.2008.07.042; Makedonas G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000798; Mandell RB, 2010, VIROLOGY, V397, P187, DOI 10.1016/j.virol.2009.11.001; Martin-Folgar R, 2010, MABS-AUSTIN, V2, P275, DOI 10.4161/mabs.2.3.11676; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Metwally S, 2008, FOREIGN ANIMAL DIS; Morrill JC, 1997, AM J VET RES, V58, P1110; MORRILL JC, 1991, VACCINE, V9, P35, DOI 10.1016/0264-410X(91)90314-V; Morrill JC, 1997, AM J VET RES, V58, P1104; Morrill JC, 2003, VACCINE, V21, P2994, DOI 10.1016/S0264-410X(03)00131-2; Morrill JC, 2011, J INFECT DIS, V204, P617, DOI 10.1093/infdis/jir354; Morrill JC, 2011, J INFECT DIS, V204, P229, DOI 10.1093/infdis/jir249; Moutaftsi M, 2009, EUR J IMMUNOL, V39, P717, DOI 10.1002/eji.200838815; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Nderitu L, 2011, J INFECT DIS, V203, P655, DOI 10.1093/infdis/jiq004; Paweska JT, 2008, VET MICROBIOL, V127, P21, DOI 10.1016/j.vetmic.2007.07.031; Paweska JT, 2007, J VIROL METHODS, V146, P119, DOI 10.1016/j.jviromet.2007.06.006; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Pichlmair A, 2010, VECTOR-BORNE ZOONOT, V10, P701, DOI 10.1089/vbz.2009.0248; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Ronnblom L, 2011, UPSALA J MED SCI, V116, P227, DOI 10.3109/03009734.2011.624649; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; Schaubert KL, 2007, J IMMUNOL, V178, P7756, DOI 10.4049/jimmunol.178.12.7756; Schaubert KL, 2010, EUR J IMMUNOL, V40, P1950, DOI 10.1002/eji.200940079; Schmaljohn C.S., 2001, FIELDS VIROLOGY; Schwentker FF, 1934, J EXP MED, V59, P305, DOI 10.1084/jem.59.3.305; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SETTE A, 1994, J IMMUNOL, V153, P5586; Sidney J, 2001, HUM IMMUNOL, V62, P1200, DOI 10.1016/S0198-8859(01)00319-6; SIDNEY J, 1998, MEASUREMENT MHC PEPT, P19; SMITHBURN KC, 1949, J IMMUNOL, V62, P213; Thirdborough SM, 2008, EUR J IMMUNOL, V38, P364, DOI 10.1002/eji.200737832; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; van Vuren PJ, 2007, J VIROL METHODS, V140, P106, DOI 10.1016/j.jviromet.2006.11.005; van Vuren PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025027; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; Wallace DB, 2006, VACCINE, V24, P7181, DOI 10.1016/j.vaccine.2006.06.041; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Williams R, 2011, J VIROL METHODS, V177, P140, DOI 10.1016/j.jviromet.2011.07.011; Wooldridge L, 2005, J BIOL CHEM, V280, P27491, DOI 10.1074/jbc.M500555200; WRAITH DC, 1987, J GEN VIROL, V68, P433, DOI 10.1099/0022-1317-68-2-433	86	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59210	10.1371/journal.pone.0059210	http://dx.doi.org/10.1371/journal.pone.0059210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527138	gold, Green Published, Green Submitted			2022-12-27	WOS:000316411600049
J	Meunier, C; Van der Kraak, L; Turbide, C; Groulx, N; Labouba, I; Cingolani, P; Blanchette, M; Yeretssian, G; Mes-Masson, AM; Saleh, M; Beauchemin, N; Gros, P				Meunier, Charles; Van der Kraak, Lauren; Turbide, Claire; Groulx, Normand; Labouba, Ingrid; Cingolani, Pablo; Blanchette, Mathieu; Yeretssian, Garabet; Mes-Masson, Anne-Marie; Saleh, Maya; Beauchemin, Nicole; Gros, Philippe			Positional Mapping and Candidate Gene Analysis of the Mouse Ccs3 Locus That Regulates Differential Susceptibility to Carcinogen-Induced Colorectal Cancer	PLOS ONE			English	Article							NF-KAPPA-B; GENOME-WIDE ASSOCIATION; COLON-CANCER; CROHNS-DISEASE; IKK-BETA; SECONDARY STRUCTURE; ULCERATIVE-COLITIS; MULTIPLE-MYELOMA; INNATE IMMUNITY; CHROMOSOME 3	The Ccs3 locus on mouse chromosome 3 regulates differential susceptibility of A/J (A, susceptible) and C57BL/6J (B6, resistant) mouse strains to chemically-induced colorectal cancer (CRC). Here, we report the high-resolution positional mapping of the gene underlying the Ccs3 effect. Using phenotype/genotype correlation in a series of 33 AcB/BcA recombinant congenic mouse strains, as well as in groups of backcross populations bearing unique recombinant chromosomes for the interval, and in subcongenic strains, we have delineated the maximum size of the Ccs3 physical interval to a similar to 2.15 Mb segment. This interval contains 12 annotated transcripts. Sequencing of positional candidates in A and B6 identified many either low-priority coding changes or non-protein coding variants. We found a unique copy number variant (CNV) in intron 15 of the Nfkb1 gene. The CNV consists of two copies of a 54 bp sequence immediately adjacent to the exon 15 splice site, while only one copy is found in CRC-susceptible A. The Nfkb1 protein (p105/p50) expression is much reduced in A tumors compared to normal A colonic epithelium as analyzed by immunohistochemistry. Studies in primary macrophages from A and B6 mice demonstrate a marked differential activation of the Nf kappa B pathway by lipopolysaccharide (kinetics of stimulation and maximum levels of phosphorylated I kappa B alpha), with a more robust activation being associated with resistance to CRC. Nf kappa B has been previously implicated in regulating homeostasis and inflammatory response in the intestinal mucosa. The interval contains another positional candidate Slc39a8 that is differentially expressed in A vs B6 colons, and that has recently been associated in CRC tumor aggressiveness in humans.	[Meunier, Charles; Van der Kraak, Lauren; Groulx, Normand; Beauchemin, Nicole; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Turbide, Claire; Beauchemin, Nicole; Gros, Philippe] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Labouba, Ingrid; Mes-Masson, Anne-Marie] Univ Montreal, CHU Montreal, Ctr Rech, Montreal, PQ, Canada; [Labouba, Ingrid; Mes-Masson, Anne-Marie] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Cingolani, Pablo; Blanchette, Mathieu] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Yeretssian, Garabet; Saleh, Maya; Gros, Philippe] McGill Univ, McGill Complex Traits Grp, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; McGill University; McGill University	Gros, P (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	philippe.gros@mcgill.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Saleh, Maya/0000-0003-1538-9146	Canadian Cancer Society Research Institute; Cancer Research Society Inc.; Goodman Cancer Research Centre; McGill Integrated Cancer Research Training Program (MICRTP); Peter Quinlan Foundation through the McGill University Faculty of Medicine	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research Society Inc.; Goodman Cancer Research Centre; McGill Integrated Cancer Research Training Program (MICRTP); Peter Quinlan Foundation through the McGill University Faculty of Medicine	This work was supported by research grants to PG and NB from the Canadian Cancer Society Research Institute [www.cancer.ca/Research.aspx], the Cancer Research Society Inc. [www.src-crs.ca/en-CA] and the Canderel Initiative Program [www.deficanderel.com/3/donate.htm] of the Goodman Cancer Research Centre [cancercentre.mcgill.ca/research/]. PG is a James McGill Professor of Biochemistry. CM received studentship support and travel awards from the McGill Integrated Cancer Research Training Program (MICRTP) and the Peter Quinlan Foundation [www.mcgill.ca/gcc-research/funding/] through the McGill University Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Alkhayat AH, 1998, HUM MOL GENET, V7, P75, DOI 10.1093/hmg/7.1.75; Angel JM, 2000, MOL CARCINOGEN, V27, P47, DOI 10.1002/(SICI)1098-2744(200001)27:1<47::AID-MC7>3.0.CO;2-7; Balkwill GD, 2007, ORG BIOMOL CHEM, V5, P832, DOI 10.1039/b616820e; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bissahoyo A, 2005, TOXICOL SCI, V88, P340, DOI 10.1093/toxsci/kfi313; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Cazier JB, 2010, J PATHOL, V220, P255, DOI 10.1002/path.2650; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; Dragani TA, 2003, CANCER RES, V63, P3011; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIJNEMAN RJA, 1995, CANCER RES, V55, P3179; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Galvez-Peralta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036055; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Hsu LC, 2011, NAT IMMUNOL, V12, P144, DOI 10.1038/ni.1976; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; JACOBY RF, 1994, GENOMICS, V22, P381, DOI 10.1006/geno.1994.1399; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; Landt SG, 2005, J MOL BIOL, V351, P982, DOI 10.1016/j.jmb.2005.07.001; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Lubbe SJ, 2012, CARCINOGENESIS, V33, P108, DOI 10.1093/carcin/bgr243; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Meunier C, 2010, ONCOGENE, V29, P647, DOI 10.1038/onc.2009.369; Meunier C, 2011, CELL CYCLE, V10, P1739, DOI 10.4161/cc.10.11.15817; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Moen CJA, 1996, P NATL ACAD SCI USA, V93, P1082, DOI 10.1073/pnas.93.3.1082; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nambiar PR, 2003, INT J ONCOL, V22, P145; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Quigley D, 2009, NAT REV GENET, V10, P651, DOI 10.1038/nrg2617; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Ruivenkamp C, 2003, ONCOGENE, V22, P3472, DOI 10.1038/sj.onc.1206246; Ruivenkamp CAL, 2003, ONCOGENE, V22, P7258, DOI 10.1038/sj.onc.1207096; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Spiro C, 1997, J BIOL CHEM, V272, P33145, DOI 10.1074/jbc.272.52.33145; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; Suzui M, 2002, CANCER LETT, V183, P31, DOI 10.1016/S0304-3835(02)00114-3; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tong X, 2004, MOL CELL BIOCHEM, V265, P171, DOI 10.1023/B:MCBI.0000044394.66951.4d; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Van Der Kraak L, 2010, ONCOTARGET, V1, P436; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982	75	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58733	10.1371/journal.pone.0058733	http://dx.doi.org/10.1371/journal.pone.0058733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516545	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400057
J	Rahn, JJ; Stackley, KD; Chan, SSL				Rahn, Jennifer J.; Stackley, Krista D.; Chan, Sherine S. L.			Opa1 Is Required for Proper Mitochondrial Metabolism in Early Development	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; MOUSE MODEL; ZEBRAFISH; MUTATIONS; FUSION; GENE; MORPHOLOGY; MTDNA; PATHOPHYSIOLOGY; DEFICIENCY	Opa1 catalyzes fusion of inner mitochondrial membranes and formation of the cristae. OPA1 mutations in humans lead to autosomal dominant optic atrophy. OPA1 knockout mice lose viability around embryonic day 9 from unknown reasons, indicating that OPA1 is essential for embryonic development. Zebrafish are an attractive model for studying vertebrate development and have been used for many years to describe developmental events that are difficult or impractical to view in mammalian models. In this study, Opa1 was successfully depleted in zebrafish embryos using antisense morpholinos, which resulted in disrupted mitochondrial morphology. Phenotypically, these embryos exhibited abnormal blood circulation and heart defects, as well as small eyes and small pectoral fin buds. Additionally, startle response was reduced and locomotor activity was impaired. Furthermore, Opa1 depletion caused bioenergetic defects, without impairing mitochondrial efficiency. In response to mitochondrial dysfunction, a transient upregulation of the master regulator of mitochondrial biogenesis, pgc1a, was observed. These results not only reveal a new Opa1-associated phenotype in a vertebrate model system, but also further elucidates the absolute requirement of Opa1 for successful vertebrate development.	[Rahn, Jennifer J.; Stackley, Krista D.; Chan, Sherine S. L.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA	Medical University of South Carolina	Chan, SSL (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	chans@musc.edu			National Institutes of Health [R00ES015555, 5P20RR024485-02, 8 P20 GM103542-02]; Medical University of South Carolina; South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, National Institutes of Health/National Center for Research Resources [UL1RR029882, UL1 TR000062]; Cancer Center Support [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024485, UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina; South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, National Institutes of Health/National Center for Research Resources; Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health awards R00ES015555, 5P20RR024485-02 and 8 P20 GM103542-02, startup funds provided by the Medical University of South Carolina, and the South Carolina Clinical and Translational Research Institute/Medical University of South Carolina CTSA, National Institutes of Health/National Center for Research Resources (UL1RR029882 and UL1 TR000062). Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akepati VR, 2008, J NEUROCHEM, V106, P372, DOI 10.1111/j.1471-4159.2008.05401.x; Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.044305; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Ferre M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gottlieb RA, 2011, BBA-MOL CELL RES, V1813, P1295, DOI 10.1016/j.bbamcr.2010.11.017; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1; Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; Liu JD, 2012, CIRC RES, V110, P870, DOI 10.1161/CIRCRESAHA.111.246504; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; Ong SB, 2012, ANTIOXID REDOX SIGNA; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Ranieri M, 2012, J NEUROL SCI, V315, P146, DOI 10.1016/j.jns.2011.12.002; Sambrook J., 2001, MOL CLONING LAB MANU; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Teixido E, 2012, TOXICOL IN VITRO; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; van der Bliek AM, 2009, EMBO J, V28, P1533, DOI 10.1038/emboj.2009.130; Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Williams PA, 2011, VISION RES, V51, P229, DOI 10.1016/j.visres.2010.08.031; Williams PA, 2010, BRAIN, V133, P2942, DOI 10.1093/brain/awq218; Ylikallio E, 2010, NUCLEIC ACIDS RES, V38, P8208, DOI 10.1093/nar/gkq735	54	37	37	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59218	10.1371/journal.pone.0059218	http://dx.doi.org/10.1371/journal.pone.0059218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516612	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400097
J	Xu, X; Liu, XL; Ling, Q; Wei, Q; Liu, ZK; Xu, XW; Zhou, L; Zhang, M; Wu, J; Huang, JR; Sheng, JF; Zheng, SS; Li, LJ				Xu, Xiao; Liu, Xiaoli; Ling, Qi; Wei, Qiang; Liu, Zhikun; Xu, Xiaowei; Zhou, Lin; Zhang, Min; Wu, Jian; Huang, Jianrong; Sheng, Jifang; Zheng, Shusen; Li, Lanjuan			Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; BIOARTIFICIAL LIVER; EXPERIENCE; THERAPY; PERFUSION	Background: The search for a strategy to provide temporary liver support and salvage the patients with acute-on-chronic liver failure (ACLF) remains an important issue. This study was designed to evaluate the experience in artificial liver support system (ALSS) combined with liver transplantation (LT) in the treatment of ACLF. Methodology/Principal Findings: One hundred and seventy one patients with HBV related ACLF undergoing LT between January 2001 and December 2009 were included. Of the 171 patients, 115 received 247 sessions of plasma exchange-centered ALSS treatment prior to LT (ALSS-LT group) and the other 56 received emergency LT (LT group). The MELD score were 31 +/- 6 and 30 +/- 7 in ALSS-LT group and LT group. ALSS treatment resulted in improvement of liver function and better tolerance to LT. The average level of serum total bilirubin before LT was lower than that before the first time of ALSS treatment. The median waiting time for a donor liver was 12 days (2-226 days) from the first run of ALSS treatment to LT. Compared to LT group, the beneficial influences of ALSS on intraoperative blood loss and endotracheal intubation time were also observed in ALSS-LT group. The 1-year and 5-year survival rates in the ALSS-LT group and LT group were 79.2% and 83%, 69.7% and 78.6%. Conclusions/Significance: Plasma exchange-centered ALSS is beneficial in salvaging patients with ACLF when a donor liver is not available. The consequential LT is the fundamental treatment modality to rescue these patients and lead to a similar survival rate as those patients receiving emergency transplantation.	[Xu, Xiao; Ling, Qi; Wei, Qiang; Liu, Zhikun; Zhou, Lin; Zhang, Min; Wu, Jian; Zheng, Shusen] Zhejiang Univ, Sch Med,Dept Surg, Affiliated Hosp 1,Div Hepatobiliary & Pancreat Su, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Xiaoli; Xu, Xiaowei; Huang, Jianrong; Sheng, Jifang; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med,Dept Surg, Affiliated Hosp 1,Div Hepatobiliary & Pancreat Su, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China.	zyzss@zju.edu.cn; ljli@zju.edu.cn	Liu, Xiaoli/HGE-7614-2022		National Science and Technology Major Project [2012ZX10002004]; National High Technology Research and Development Program of China (863 Program) [2012AA020204]; National Basic Research Program of China (973 program) [2009CB522404]	National Science and Technology Major Project; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 program)(National Basic Research Program of China)	Financial support to the project: this work was supported by the National Science and Technology Major Project (2012ZX10002004), the National High Technology Research and Development Program of China (863 Program 2012AA020204) and the National Basic Research Program of China (973 program 2009CB522404). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adam R, 2009, SEMIN LIVER DIS, V29, P3, DOI 10.1055/s-0029-1192052; Borra M, 2002, INT J ARTIF ORGANS, V25, P939, DOI 10.1177/039139880202501008; Chamuleau RAFM, 2003, ARTIF CELL BLOOD SUB, V31, P117, DOI 10.1081/BIO-120020168; Chan C, 2004, LIVER TRANSPLANT, V10, P1331, DOI 10.1002/lt.20229; De Silvestro G, 2000, INT J ARTIF ORGANS, V23, P454, DOI 10.1177/039139880002300708; Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5; Faenza S, 2004, TRANSPL P, V36, P555, DOI 10.1016/j.transproceed.2004.02.039; Felldin M, 2003, TRANSPLANT P, V35, P822, DOI 10.1016/S0041-1345(03)00086-1; Ichida T, 2003, INTERNAL MED, V42, P920, DOI 10.2169/internalmedicine.42.920; Kjaergard LL, 2003, JAMA-J AM MED ASSOC, V289, P217, DOI 10.1001/jama.289.2.217; Kozaki K, 2004, THER APHER DIAL, V8, P174, DOI 10.1111/j.1526-0968.2004.00133.x; Li LJ, 2006, THER APHER DIAL, V10, P160, DOI 10.1111/j.1744-9987.2006.00358.x; Lu AW, 2008, HEPATOB PANCREAT DIS, V7, P357; Matsui Y, 2008, HEPATOL RES, V38, P987, DOI 10.1111/j.1872-034X.2008.00372.x; Nitta M, 2002, THER APHER, V6, P208, DOI 10.1046/j.1526-0968.2002.00434.x; Onodera Kazuhiko, 2006, J Artif Organs, V9, P17, DOI 10.1007/s10047-005-0320-1; Palmes D, 2000, J INVEST SURG, V13, P299; Pascher A, 2002, XENOTRANSPLANTATION, V9, P309, DOI 10.1034/j.1399-3089.2002.01076.x; Patzer II John F, 2002, Hepatobiliary Pancreat Dis Int, V1, P18; Santoro A, 2004, INT J ARTIF ORGANS, V27, P176, DOI 10.1177/039139880402700304; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Sechser A, 2001, Clin Liver Dis, V5, P415, DOI 10.1016/S1089-3261(05)70172-0; Ueda Y, 2003, ASAIO J, V49, P401, DOI 10.1097/01.MAT.0000074112.70566.20; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wu Jian, 2004, Hepatobiliary Pancreat Dis Int, V3, P170; Xu X, 2008, HEPATOB PANCREAT DIS, V7, P465	26	41	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58738	10.1371/journal.pone.0058738	http://dx.doi.org/10.1371/journal.pone.0058738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516546	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400058
J	Zhang, SF; Zhao, FP; Wei, CH; Sheng, XH; Ren, HX; Xu, LY; Lu, J; Liu, JS; Zhang, L; Du, LX				Zhang, Shifang; Zhao, Fuping; Wei, Caihong; Sheng, Xihui; Ren, Hangxing; Xu, Lingyang; Lu, Jian; Liu, Jiasen; Zhang, Li; Du, Lixin			Identification and Characterization of the miRNA Transcriptome of Ovis aries	PLOS ONE			English	Article							MICRORNA CATALOG; GENES; RNAS; SPECIFICITY; EXPRESSION; MECHANISM; EVOLUTION; MUTATION; CLONING; MOUSE	The discovery and identification of Ovis aries (sheep) miRNAs will further promote the study of miRNA functions and gene regulatory mechanisms. To explore the microRNAome (miRNAome) of sheep in depth, samples were collected that included eight developmental stages: the longissimus dorsi muscles of Texel fetuses at 70, 85, 100, 120, and 135 days, and the longissimus dorsi muscles of Ujumqin fetuses at 70, 85, 100, 120, and 135 d, and lambs at 0 (birth), 35, and 70 d. These samples covered all of the representative periods of Ovis aries growth and development throughout gestation (about 150 d) and 70 d after birth. Texel and Ujumqin libraries were separately subjected to Solexa deep sequencing; 35,700,772 raw reads were obtained overall. We used ACGT101-miR v4.2 to analyze the sequence data. Following meticulous comparisons with mammalian mature miRNAs, precursor hairpins (pre-miRNAs), and the latest sheep genome, we substantially extended the Ovis aries miRNAome. The list of pre-miRNAs was extended to 2,319, expressing 2,914 mature miRNAs. Among those, 1,879 were genome mapped to unique miRNAs, representing 2,436 genome locations, and 1,754 pre-miRNAs were mapped to chromosomes. Furthermore, the Ovis aries miRNAome was processed using an elaborate bioinformatic analysis that examined multiple end sequence variation in miRNAs, precursors, chromosomal localizations, species-specific expressions, and conservative properties. Taken together, this study provides the most comprehensive and accurate exploration of the sheep miRNAome, and draws conclusions about numerous characteristics of Ovis aries miRNAs, including miRNAs and isomiRs.	[Zhang, Shifang; Zhao, Fuping; Wei, Caihong; Sheng, Xihui; Ren, Hangxing; Xu, Lingyang; Lu, Jian; Liu, Jiasen; Zhang, Li; Du, Lixin] Chinese Acad Agr Sci, Inst Anim Sci, Natl Ctr Mol Genet & Breeding Anim, Beijing 100193, Peoples R China; [Sheng, Xihui] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Ren, Hangxing] Chongqing Acad Anim Sci, Chongqing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Beijing University of Agriculture	Zhang, L (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Natl Ctr Mol Genet & Breeding Anim, Beijing 100193, Peoples R China.	zhangli@263.net; lxdu@263.net	Xu, Lingyang/W-8664-2019		Twelfth Five-Year-Plan of the Chinese 863 Program [2011AA100307-02]; National Natural Science Foundation of China [30972094]; China Agriculture Research System [CARS-39]	Twelfth Five-Year-Plan of the Chinese 863 Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by funding from the Twelfth Five-Year-Plan of the Chinese 863 Program (2011AA100307-02), the National Natural Science Foundation of China (30972094) and the China Agriculture Research System (CARS-39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren HX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-411; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Sheng XH, 2011, MOL BIOL REP, V38, P3161, DOI 10.1007/s11033-010-9987-3; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yao J, 2011, BIOSCI BIOTECH BIOCH, V75, P54, DOI 10.1271/bbb.100530; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031; Zhang YF, 2009, SCI CHINA SER C, V52, P261, DOI 10.1007/s11427-009-0032-5	43	20	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58905	10.1371/journal.pone.0058905	http://dx.doi.org/10.1371/journal.pone.0058905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516575	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200121
J	Fischer, M; Wernike, K; Freuling, CM; Muller, T; Aylan, O; Brochier, B; Cliquet, F; Vazquez-Moron, S; Hostnik, P; Huovilainen, A; Isaksson, M; Kooi, EA; Mooney, J; Turcitu, M; Rasmussen, TB; Revilla-Fernandez, S; Smreczak, M; Fooks, AR; Marston, DA; Beer, M; Hoffmann, B				Fischer, Melina; Wernike, Kerstin; Freuling, Conrad M.; Mueller, Thomas; Aylan, Orhan; Brochier, Bernard; Cliquet, Florence; Vazquez-Moron, Sonia; Hostnik, Peter; Huovilainen, Anita; Isaksson, Mats; Kooi, Engbert A.; Mooney, Jean; Turcitu, Mihai; Rasmussen, Thomas B.; Revilla-Fernandez, Sandra; Smreczak, Marcin; Fooks, Anthony R.; Marston, Denise A.; Beer, Martin; Hoffmann, Bernd			Step Forward in Molecular Diagnostics of Lyssaviruses - Results of a Ring Trial among European Laboratories	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RABIES VIRUS-RNA; REAL-TIME PCR; RT-PCR; SALIVA SAMPLES; VIRAL-RNA; BAT; ASSAY; INFECTION; GENOTYPES	Rabies is a lethal and notifiable zoonotic disease for which diagnostics have to meet the highest standards. In recent years, an evolution was especially seen in molecular diagnostics with a wide variety of different detection methods published. Therefore, a first international ring trial specifically designed on the use of reverse transcription polymerase chain reaction (RT-PCR) for detection of lyssavirus genomic RNA was organized. The trial focussed on assessment and comparison of the performance of conventional and real-time assays. In total, 16 European laboratories participated. All participants were asked to investigate a panel of defined lyssavirus RNAs, consisting of Rabies virus (RABV) and European bat lyssavirus 1 and 2 (EBLV-1 and -2) RNA samples, with systems available in their laboratory. The ring trial allowed the important conclusion that conventional RT-PCR assays were really robust assays tested with a high concordance between different laboratories and assays. The real-time RT-PCR system by Wakeley et al. (2005) in combination with an intercalating dye, and the combined version by Hoffmann and co-workers (2010) showed good sensitivity for the detection of all RABV samples included in this test panel. Furthermore, all used EBLV-specific assays, real-time RT-PCRs as well as conventional RT-PCR systems, were shown to be suitable for a reliable detection of EBLVs. It has to be mentioned that differences were seen in the performance between both the individual RT-PCR systems and the laboratories. Laboratories which used more than one molecular assay for testing the sample panel always concluded a correct sample result. Due to the markedly high genetic diversity of lyssaviruses, the application of different assays in diagnostics is needed to achieve a maximum of diagnostic accuracy. To improve the knowledge about the diagnostic performance proficiency testing at an international level is recommended before using lyssavirus molecular diagnostics e.g. for confirmatory testing.	[Fischer, Melina; Wernike, Kerstin; Beer, Martin; Hoffmann, Bernd] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Freuling, Conrad M.; Mueller, Thomas] Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany; [Aylan, Orhan] Etlik Cent Vet Control & Res Inst, Ankara, Turkey; [Brochier, Bernard] Sci Inst Publ Hlth, Brussels, Belgium; [Cliquet, Florence] Anses Nancy Technopole Agr & Vet, Malzeville, France; [Vazquez-Moron, Sonia] Ctr Nacl Microbiol, Inst Salud Carlos Ill, Majadahonda, Spain; [Hostnik, Peter] Natl Vet Inst, Ljubljana, Slovenia; [Huovilainen, Anita] Finnish Food Safety Author, Helsinki, Finland; [Isaksson, Mats] Swedish Natl Vet Inst, Uppsala, Sweden; [Kooi, Engbert A.] Cent Vet Inst, Lelystad, Netherlands; [Mooney, Jean] Cent Vet Res Lab, Div Virol, Celbridge, Ireland; [Turcitu, Mihai] Inst Diag & Anim Hlth, Bucharest, Romania; [Rasmussen, Thomas B.] Tech Univ Denmark, Natl Vet Inst, Lindholm, Denmark; [Revilla-Fernandez, Sandra] Inst Vet Dis Control, Modling, Austria; [Smreczak, Marcin] Natl Inst Vet Res, Pulawy, Poland; [Fooks, Anthony R.; Marston, Denise A.] Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Ministry of Food, Agriculture & Livestock - Turkey; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Finnish Food Authority; National Veterinary Institute SVA; Wageningen University & Research; Technical University of Denmark; National Veterinary Institute - National Research Institute; Veterinary Laboratories Agency	Hoffmann, B (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	bernd.hoffmann@fli.bund.de	Fooks, Anthony R/F-5418-2010; Vázquez-Morón, Sonia/H-7019-2013; Smreczak, Marcin/D-2168-2012; Marston, Denise A/D-7993-2011; Smreczak, Marcin/AAL-1027-2020	Vázquez-Morón, Sonia/0000-0002-0977-741X; Marston, Denise A/0000-0001-9215-088X; CLIQUET, Florence/0000-0003-2237-1243	EU [FOOD-CT2006-016236]; German federal ministry for education and research (BMBF) [01KI1016A]; OIE [GKB/KH2009/22]	EU(European Commission); German federal ministry for education and research (BMBF)(Federal Ministry of Education & Research (BMBF)); OIE	This work was performed in the frame of EU-funded Network of Excellence for Epizootic Disease Diagnosis and Control (EPIZONE, contract FOOD-CT2006-016236, www.epizone-eu.net) and partially through the German federal ministry for education and research (BMBF, grant 01KI1016A, www.bmbf.de). Gratefully acknowledged is the support through the OIE funded laboratory twinning project on rabies between Friedrich-Loeffler-Institute and EVCCRI (File Ref: GKB/KH2009/22, wwwoie.int). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black EM, 2002, J VIROL METHODS, V105, P25, DOI 10.1016/S0166-0934(02)00062-9; Coertse J, 2010, J CLIN MICROBIOL, V48, P3949, DOI 10.1128/JCM.01256-10; Crepin P, 1998, J CLIN MICROBIOL, V36, P1117, DOI 10.1128/JCM.36.4.1117-1121.1998; Dacheux L, 2008, CLIN INFECT DIS, V47, P1410, DOI 10.1086/592969; Dacheux L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000765; David D, 2002, VET MICROBIOL, V87, P111, DOI 10.1016/S0378-1135(02)00041-X; De Benedictis P, 2011, J CLIN MICROBIOL, V49, P1932, DOI 10.1128/JCM.02015-10; Dean D. J., 1996, P88; Dietzgen RG, 2011, VIRUS TAXONOMY CLASS; East ML, 2001, P NATL ACAD SCI USA, V98, P15026, DOI 10.1073/pnas.261411898; Echevarria JE, 2001, J CLIN MICROBIOL, V39, P3678, DOI 10.1128/JCM.39.10.3678-3683.2001; Fischer M, 2012, BERL MUNCH TIERARZTL, V125, P264, DOI 10.2376/0005-9366-125-264; Fooks AR, 2012, COMP OIE GL IN PRESS; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Hayman DTS, 2011, J VIROL METHODS, V177, P87, DOI 10.1016/j.jviromet.2011.07.002; Hayman DT, 2011, J VIROL METHODS; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hoffmann B, 2010, J CLIN MICROBIOL, V48, P3970, DOI 10.1128/JCM.00612-10; Hoffmann B, 2011, J VET DIAGN INVEST, V23, P999, DOI 10.1177/1040638711416849; Hughes GJ, 2004, J CLIN MICROBIOL, V42, P299, DOI 10.1128/JCM.42.1.299-306.2004; Ito M, 2001, J VET MED SCI, V63, P1309, DOI 10.1292/jvms.63.1309; Kuzmin IV, 2005, VIRUS RES, V111, P28, DOI 10.1016/j.virusres.2005.03.008; Muller T, 2004, J VET MED B, V51, P49, DOI 10.1111/j.1439-0450.2003.00725.x; Nadin-Davis SA, 2009, J MED VIROL, V81, P1484, DOI 10.1002/jmv.21547; Nagaraj T, 2006, J CLIN VIROL, V36, P17, DOI 10.1016/j.jcv.2006.01.009; Office International des Epizooties, 2008, RAB OIE MAN DIAGN TE, P307; Orlowska A, 2008, B VET I PULAWY, V52, P313; Picard-Meyer E, 2004, VACCINE, V22, P1921, DOI 10.1016/j.vaccine.2003.11.015; Robardet E, 2011, J VIROL METHODS, V177, P15, DOI 10.1016/j.jviromet.2011.06.004; Saengseesom Wachiraporn, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P53; Shankar V, 2004, J WILDLIFE DIS, V40, P403, DOI 10.7589/0090-3558-40.3.403; Vos A, 2004, J VET MED B, V51, P327, DOI 10.1111/j.1439-0450.2004.00793.x; Vos A, 2004, J VET MED B, V51, P55, DOI 10.1111/j.1439-0450.2004.00730.x; Wacharapluesadee S, 2008, J VIROL METHODS, V151, P317, DOI 10.1016/j.jviromet.2008.05.004; Wacharapluesadee S, 2012, J VIROL METHODS, V184, P109, DOI 10.1016/j.jviromet.2012.05.013; Wakeley PR, 2005, J CLIN MICROBIOL, V43, P2786, DOI 10.1128/JCM.43.6.2786-2792.2005; Whitby JE, 1997, J WILDLIFE DIS, V33, P912, DOI 10.7589/0090-3558-33.4.912; WHO, 2005, WHO TECH REP SER, V931, P1	41	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58372	10.1371/journal.pone.0058372	http://dx.doi.org/10.1371/journal.pone.0058372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520505	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900064
J	Khan, MA; Ellis, EM; Tissera, HA; Alvi, MY; Rahman, FF; Masud, F; Chow, A; Howe, S; Dhanasekaran, V; Ellis, BR; Gubler, DJ				Khan, Mohammad A.; Ellis, Esther M.; Tissera, Hasitha A.; Alvi, Mohammad Y.; Rahman, Fatima F.; Masud, Faisal; Chow, Angelia; Howe, Shiqin; Dhanasekaran, Vijaykrishna; Ellis, Brett R.; Gubler, Duane J.			Emergence and Diversification of Dengue 2 Cosmopolitan Genotype in Pakistan, 2011	PLOS ONE			English	Article							VIRUS; SEROTYPE-3; KARACHI; FEVER	Major dengue epidemics have been observed in the Indian subcontinent since the 1980s and have occurred with increased hospitalizations and mortality. In 2011, the first major epidemic of dengue occurred in Lahore, the second largest city in Pakistan, and resulted in 21,685 confirmed cases and 350 deaths. To investigate the possible viral causes for the increased epidemic activity, we determined the predominant serotype and characterized the viruses genetically. Of 50 patients carefully selected as probable dengue fever or dengue hemorrhagic fever, 34 were positive by virologic testing (i.e. PCR and/or virus isolation). DENV-2 was detected in 32 patients and DENV-1 in two. A total of 24 partial and three full DENV genomes were sequenced. Phylogenetic analyses of the capsid (C), pre-membrane (prM), and envelope genes comprising 2500 nucleotides in length indicated that all DENV-2 isolates in Pakistan since 2007 form a monophyletic lineage that is endemic in the country. These viruses were all of the cosmopolitan genotype (IV) and most closely related to viruses isolated in India and Sri Lanka in the past two decades. Phylogenetic analyses of data currently available in GenBank suggest that the Cosmopolitan genotype has diverged into two geographically distinct sub-lineages: sub-lineage IV-a has only been observed in Southeast Asia, China and Oceania, while IV-b is prevalent in the Indian subcontinent. These results highlight the increased diversity of dengue viruses as they spread geographically within the region.	[Khan, Mohammad A.; Alvi, Mohammad Y.; Rahman, Fatima F.; Masud, Faisal] Serv Hosp, Serv Inst Med Sci, Lahore, Pakistan; [Ellis, Esther M.; Chow, Angelia; Howe, Shiqin; Dhanasekaran, Vijaykrishna; Ellis, Brett R.; Gubler, Duane J.] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Tissera, Hasitha A.] Minist Hlth, Epidemiol Unit, Colombo, Sri Lanka	National University of Singapore	Gubler, DJ (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.	duane.gubler@duke-nus.edu.sg	Tissera, Hasitha/AAQ-2516-2020; Dhanasekaran, Vijaykrishna/D-1011-2010; Vijaykrishna, Dhanasekaran/AAG-2077-2020; Rahman, Mustafizur/G-1998-2012	Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Rahman, Fatima/0000-0003-1312-1007				Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182; Chan YC, 1995, T ROY SOC TROP MED H, V89, P619, DOI 10.1016/0035-9203(95)90412-3; Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013; Fatima Z, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-200; GUBLER DJ, 1978, AM J TROP MED HYG, V27, P581, DOI 10.4269/ajtmh.1978.27.581; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; HAYES CG, 1982, T ROY SOC TROP MED H, V76, P431, DOI 10.1016/0035-9203(82)90130-4; Humayoun MA, 2010, INT J INFECT DIS, V14, pE54, DOI 10.1016/j.ijid.2009.10.008; Jamil B, 2007, EMERG INFECT DIS, V13, P182, DOI 10.3201/eid1301.060376; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Mahmood N, 2012, AM J MED SCI, V343, P61, DOI 10.1097/MAJ.0b013e3182217001; Messer WB, 2003, EMERG INFECT DIS, V9, P800; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Raheel U, 2011, J INFECT DEV COUNTR, V5, P239, DOI 10.3855/jidc.1017; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Suchita Chaudhry, 2006, Dengue Bulletin, V30, P121; Tissera HA, 2011, EMERG INFECT DIS, V17, P2053, DOI 10.3201/eid1711.101893; World Health Organization, 2009, DENGUE GUIDELINES DI	20	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56391	10.1371/journal.pone.0056391	http://dx.doi.org/10.1371/journal.pone.0056391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520453	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900012
J	Landis, RC; Branch-Beckles, SL; Crichlow, S; Hambleton, IR; Best, A				Landis, R. Clive; Branch-Beckles, Songee Lynn; Crichlow, Shawna; Hambleton, Ian R.; Best, Anton			Ten Year Trends in Community HIV Viral Load in Barbados: Implications for Treatment as Prevention	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS TYPE-1; PROSPECTIVE COHORT; TRANSMISSION; CARE; INFECTION; ACCESS; METAANALYSIS; STRATEGIES; EPIDEMIC	Background: Treatment as prevention is a paradigm in HIV medicine which describes the public health benefit of antiretroviral therapy (ART). It is based on research showing substantial reductions in the risk of HIV transmission in persons with optimally suppressed HIV-1 Viral Loads (VL). The present study describes ten year VL trends at the national HIV treatment unit and estimates VL suppression at a population level in Barbados, a Caribbean island with a population of 277,000, an estimated adult HIV prevalence of 1.2%, and served by a single treatment unit. Methods: The national HIV treatment centre of the Barbados Ministry of Health has a client VL database extending back to inception of the clinic in 2002 (n = 1,462 clients, n = 17,067 VL measurements). Optimal VL suppression was defined at a threshold value of <= 200 viral copies/mL. Results: Analysis of VL trends showed a statistically significant improvement in VL suppression between 2002 to 2011, from 33.6% of clients achieving the 200 copies/mL threshold in 2002 to 70.3% in 2011 (P<0.001). Taking into account the proportion of clients alive and in care and on ART, the known diagnosed HIV population in Barbados, and estimates of unknown HIV infections, this translates into an estimated 26.2% VL suppression at a population level at the end of 2010. Conclusions: We have demonstrated a significant trend towards optimal VL suppression in clients utilizing the services of the national HIV treatment program in Barbados over a 10-year period. Estimates of VL suppression at a population level are similar to reports in developed countries that applied similar methodologies and this could suggest a public health benefit of ART in minimizing the risk of sexual transmission of HIV. Continued efforts are warranted to extend HIV testing to hidden populations in Barbados and linking infected persons to care earlier in their disease.	[Landis, R. Clive; Branch-Beckles, Songee Lynn; Hambleton, Ian R.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Branch-Beckles, Songee Lynn; Crichlow, Shawna; Best, Anton] Minist Hlth, HIV STI Programme, Ladymeade Reference Unit, Bridgetown, Barbados	University West Indies Mona Jamaica; University of the West Indies Open Campus	Landis, RC (corresponding author), Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados.	clive.landis@cavehill.uwi.edu	Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794	Ministry of Health, Government of Barbados	Ministry of Health, Government of Barbados	Ministry of Health, Government of Barbados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A., 2011, COCHRANE DATABASE SY; [Anonymous], 2011, BARB HIV AIDS SURV R; [Anonymous], 2011, UNAIDS WORLD AIDS DA; [Anonymous], 2007, REP BARB NAT YOUTH K; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P1618; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bombereau G., 2008, SOCIAL CULTURAL FACT; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2011, GUID COMM VIR LOAD F; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Figueroa JP, 2008, W INDIAN MED J, V57, P195; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gomez AM, 2009, J ADOLESCENT HEALTH, V44, P508, DOI 10.1016/j.jadohealth.2008.09.012; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Holder L., 2011, EC IMPACT ANAL HIV E; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kempadoo K., 2006, GENDER SEXUALITY IMP; Law MG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-10; Le Franc E, 2008, REV PANAM SALUD PUBL, V24, P409, DOI 10.1590/S1020-49892008001200005; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; National Centre in HIV Research, 2011, HIV AIDS HEP SEX TRA; Ogunnaike-Cooke S, 2007, G BEHAV SURVEILLANCE; Organisation of Eastern Caribbean States and Health Economics Unit, 2011, KNOWL ATT BEL PRACT; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Stanley SK, 1996, NEW ENGL J MED, V334, P1222, DOI 10.1056/NEJM199605093341903; Vernazza P, 2008, LANCET, V372, P1806, DOI 10.1016/S0140-6736(08)61753-5; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231	40	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58590	10.1371/journal.pone.0058590	http://dx.doi.org/10.1371/journal.pone.0058590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520523	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900083
J	Maurage, P; de Timary, P; Moulds, ML; Wong, QJJ; Collignon, M; Philippot, P; Heeren, A				Maurage, Pierre; de Timary, Philippe; Moulds, Michelle L.; Wong, Quincy J. J.; Collignon, Marie; Philippot, Pierre; Heeren, Alexandre			Maladaptive Social Self-Beliefs in Alcohol-Dependence: A Specific Bias towards Excessive High Standards	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSION; ANXIOUS INDIVIDUALS; PSYCHOMETRIC PROPERTIES; INTERPERSONAL PROBLEMS; ANXIETY; DISTRACTION; DEPRESSION; COGNITION; EFFICACY; DEFICITS	Background: Emotional and interpersonal impairments associated with alcohol-dependence have been recently explored, but the distorted cognitive representations underlying these deficits remain poorly understood. The present study aims at exploring the presence of maladaptive social self-beliefs among alcohol-dependent individuals, as these biased self-beliefs have been recently shown to play a crucial role in the development and maintenance of other psychopathological states (social anxiety and depression). Methodology/Principal findings: Twenty-five recently detoxified alcohol-dependent participants and 25 matched controls filled in self-report questionnaires evaluating maladaptive social self-beliefs, interpersonal problems and several comorbid states (anxiety, social anxiety, depression). As compared to controls, alcohol-dependent individuals showed higher scores than controls for the three subcategories of maladaptive social self-beliefs (high standards, conditional beliefs and unconditional beliefs). Our key finding was that when comorbidities were controlled for, alcohol-dependence was associated with a specific bias towards exaggerated high standards in social contexts. Moreover, these high standards beliefs were strongly correlated with interpersonal problems. Conclusions/Significance: These results provide the first insights into the influence of cognitive biases on interpersonal problems in addictive states, and suggest that maladaptive self-beliefs could have a central influence on the development and maintenance of alcohol-dependence.	[Maurage, Pierre; de Timary, Philippe; Collignon, Marie; Philippot, Pierre; Heeren, Alexandre] Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, B-1348 Louvain, Belgium; [de Timary, Philippe] St Luc Univ Hosp, Dept Psychiat, Brussels, Belgium; [Moulds, Michelle L.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Wong, Quincy J. J.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of New South Wales Sydney; Macquarie University	Maurage, P (corresponding author), Catholic Univ Louvain, Psychol Sci Res Inst, Lab Expt Psychopathol, B-1348 Louvain, Belgium.	pierre.maurage@uclouvain.be	Wong, Quincy/K-6950-2019; Heeren, Alexandre/U-9748-2019	Wong, Quincy/0000-0001-9393-4301; Heeren, Alexandre/0000-0003-0553-6149; Moulds, Michelle/0000-0001-7064-4248; Maurage, Pierre/0000-0003-0197-0810				BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; Bergin JL, 2012, INT J EAT DISORDER, V45, P776, DOI 10.1002/eat.22012; Bruchon-Schweitzer M., 1993, ADAPTATION FRANCOPHO; Clark D. M., 2001, INT HDB SOCIAL ANXIE, P406; Clark DM, 2010, SOCIAL PHOBIA DIAGNO, P69; COLLET L, 1986, Encephale, V12, P77; Cox BJ, 1998, BEHAV MODIF, V22, P285, DOI 10.1177/01454455980223004; de Sousa Cordovil M, 2010, PERS INDIV DIFFER, V48, P16; Douilliez C., 2008, REV FRANCOPHONE CLIN, V13, P1; Fein G, 2007, DRUG ALCOHOL DEPEN, V87, P139, DOI 10.1016/j.drugalcdep.2006.08.009; Feldman R. S., 1991, STUDIES EMOTION SOCI, P329, DOI DOI 10.1037/A0036052; Goldin PR, 2010, EMOTION, V10, P83, DOI 10.1037/a0018441; HANSENNE M, 1993, PSYCHOL MED, V25, P86; Harper C, 2005, CURR OPIN PHARMACOL, V5, P73, DOI 10.1016/j.coph.2004.06.011; Heeren A, 2012, BEHAV RES THER, V50, P30, DOI 10.1016/j.brat.2011.10.005; Heeren A, 2012, CAN J BEHAV SCI, V44, P99, DOI 10.1037/a0026249; HOROWITZ LM, 1988, J CONSULT CLIN PSYCH, V56, P885, DOI 10.1037/0022-006X.56.6.885; Iorgulescu Gabriela, 2010, J Med Life, V3, P458; Kornreich C, 2002, ALCOHOL ALCOHOLISM, V37, P394, DOI 10.1093/alcalc/37.4.394; Maurage P, 2012, NEUROPSYCHOPHARMACOL, V37, P2067, DOI 10.1038/npp.2012.54; Maurage P, 2011, ALCOHOL CLIN EXP RES, V35, P1662, DOI 10.1111/j.1530-0277.2011.01512.x; McIntosh C, 2004, J NEUROL NEUROSUR PS, V75, P16, DOI 10.1136/jnnp.2004.045708; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Monnot M, 2002, J NEUROPSYCH CLIN N, V14, P321, DOI 10.1176/appi.neuropsych.14.3.321; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1097/00000374-199906000-00010; Phillips WJ, 2010, CLIN PSYCHOL REV, V30, P691, DOI 10.1016/j.cpr.2010.05.002; Pitel AL, 2007, ALCOHOL CLIN EXP RES, V31, P1169, DOI 10.1111/j.1530-0277.2007.00418.x; Rhem J, 2012, EUR NEUROPS IN PRESS; Scherer M, 2011, J ADDICT DIS, V30, P382, DOI 10.1080/10550887.2011.609804; Schomerus G, 2011, DRUG ALCOHOL DEPEN, V114, P12, DOI 10.1016/j.drugalcdep.2010.08.013; Spielberger C, 1983, MANUAL STATE TRAIT A; Stowkowy J, 2012, EARLY INTERV PSYCHIA, V6, P87, DOI 10.1111/j.1751-7893.2011.00297.x; Taieb O, 2002, ANN MED INTERNE, V153, pIS51; Trucco EM, 2007, AM J ADDICTION, V16, P85, DOI 10.1080/10550490601184183; Uekermann J, 2008, ADDICTION, V103, P726, DOI 10.1111/j.1360-0443.2008.02157.x; WATSON D, 1969, J CONSULT CLIN PSYCH, V33, P448, DOI 10.1037/h0027806; Wong QJJ, 2012, J BEHAV THER EXP PSY, V43, P1064, DOI 10.1016/j.jbtep.2012.05.002; Wong QJJ, 2011, BEHAV RES THER, V49, P700, DOI 10.1016/j.brat.2011.07.007; Wong QJJ, 2011, J PSYCHOPATHOL BEHAV, V33, P273, DOI 10.1007/s10862-010-9208-3; Wong QJJ, 2011, J BEHAV THER EXP PSY, V42, P171, DOI 10.1016/j.jbtep.2010.11.004; Wong QJJ, 2009, BEHAV RES THER, V47, P861, DOI 10.1016/j.brat.2009.06.014; Zywiak WH, 2003, J SUBST ABUSE TREAT, V25, P287, DOI 10.1016/S0740-5472(03)00118-1	43	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58928	10.1371/journal.pone.0058928	http://dx.doi.org/10.1371/journal.pone.0058928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520543	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900103
J	Munshaw, RG; Palen, WJ; Courcelles, DM; Finlay, JC				Munshaw, Robin G.; Palen, Wendy J.; Courcelles, Danielle M.; Finlay, Jacques C.			Predator-Driven Nutrient Recycling in California Stream Ecosystems	PLOS ONE			English	Article							CRITICAL THERMAL MAXIMA; FOOD-WEB STRUCTURE; FRESH-WATER; PHOSPHORUS-LIMITATION; WESTERN OREGON; GIZZARD SHAD; FISH; NITROGEN; STOICHIOMETRY; EXCRETION	Nutrient recycling by consumers in streams can influence ecosystem nutrient availability and the assemblage and growth of photoautotrophs. Stream fishes can play a large role in nutrient recycling, but contributions by other vertebrates to overall recycling rates remain poorly studied. In tributaries of the Pacific Northwest, coastal giant salamanders (Dicamptodon tenebrosus) occur at high densities alongside steelhead trout (Oncorhynchus mykiss) and are top aquatic predators. We surveyed the density and body size distributions of D. tenebrosus and O. mykiss in a California tributary stream, combined with a field study to determine mass-specific excretion rates of ammonium (N) and total dissolved phosphorus (P) for D. tenebrosus. We estimated O. mykiss excretion rates (N, P) by bioenergetics using field-collected data on the nutrient composition of O. mykiss diets from the same system. Despite lower abundance, D. tenebrosus biomass was 2.5 times higher than O. mykiss. Mass-specific excretion summed over 170 m of stream revealed that O. mykiss recycle 1.7 times more N, and 1.2 times more P than D. tenebrosus, and had a higher N:P ratio (8.7) than that of D. tenebrosus (6.0), or the two species combined (7.5). Through simulated trade-offs in biomass, we estimate that shifts from salamander biomass toward fish biomass have the potential to ease nutrient limitation in forested tributary streams. These results suggest that natural and anthropogenic heterogeneity in the relative abundance of these vertebrates and variation in the uptake rates across river networks can affect broad-scale patterns of nutrient limitation.	[Munshaw, Robin G.; Palen, Wendy J.; Courcelles, Danielle M.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Finlay, Jacques C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Simon Fraser University; University of Minnesota System; University of Minnesota Twin Cities	Munshaw, RG (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada.	rgm1@sfu.ca	Finlay, Jacques/B-6081-2011	Finlay, Jacques/0000-0002-7968-7030; Munshaw, Robin/0000-0002-6203-8923	National Science and Engineering Research Council of Canada's USRA; National Science and Engineering Research Council of Canada's Discovery Grant program; Canada Research Chairs program	National Science and Engineering Research Council of Canada's USRA; National Science and Engineering Research Council of Canada's Discovery Grant program; Canada Research Chairs program(Canada Research Chairs)	This work was supported by the National Science and Engineering Research Council of Canada's USRA and Discovery Grant program (www.nserc-crsng.gc.ca), and the Canada Research Chairs program (www.chairs-chaires.gc.ca). No individuals employed or contracted by the funders played any role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	ANTONELLI A L, 1972, Northwest Science, V46, P277; Atkinson CL, 2010, STABLE ISOTOPIC SIGN, DOI DOI 10.1899/09-083.1.ACCESSED; Attayde JL, 1999, OECOLOGIA, V121, P47, DOI 10.1007/s004420050906; AZAD HS, 1970, ENVIRON SCI TECHNOL, V4, P737, DOI 10.1021/es60044a008; Beard KH, 2002, OECOLOGIA, V133, P583, DOI 10.1007/s00442-002-1071-9; BENKE AC, 1993, PROC INT ASSOC THEOR, V25, P15; BORMANN FH, 1967, SCIENCE, V155, P424, DOI 10.1126/science.155.3761.424; Bowman MF, 2005, FRESHWATER BIOL, V50, P1836, DOI 10.1111/j.1365-2427.2005.01454.x; Brodman Robert, 2003, Herpetological Review, V34, P116; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BURTON TM, 1975, ECOLOGY, V56, P1068, DOI 10.2307/1936147; Busby P. J., 1996, STATUS REV W COAST S; CORN PS, 1989, FOREST ECOL MANAG, V29, P39, DOI 10.1016/0378-1127(89)90055-8; Davic R.D., 1983, THESIS KENT STATE U; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; DAVIC RD, 1987, HERPETOLOGICA, V43, P357; DeMott WR, 1998, LIMNOL OCEANOGR, V43, P1147, DOI 10.4319/lo.1998.43.6.1147; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Evans DH, 1999, PHYSL FISHES; Ewing RD, 2002, AQUACULTURE, V209, P139, DOI 10.1016/S0044-8486(01)00755-4; FEDER ME, 1983, HERPETOLOGICA, V39, P291; Feminella JW, 1995, J N AM BENTHOL SOC, V14, P465, DOI 10.2307/1467536; Filippelli GM, 2002, REV MINERAL GEOCHEM, V48, P391, DOI 10.2138/rmg.2002.48.10; Fillatre EK, 2003, MOL ECOL, V12, P1793, DOI 10.1046/j.1365-294X.2003.01869.x; Finlay JC, 2011, ECOLOGY, V92, P140, DOI 10.1890/09-2243.1; FITZPATRICK LC, 1973, ECOL MONOGR, V43, P43, DOI 10.2307/1942158; GOOD DA, 1989, EVOLUTION, V43, P728, DOI 10.1111/j.1558-5646.1989.tb05172.x; GRANDE M, 1991, J FRESHWATER ECOL, V6, P275, DOI 10.1080/02705060.1991.9665304; GRIFFITHS D, 1994, BIOL J LINN SOC, V51, P337, DOI 10.1006/bijl.1994.1028; HAWKINS CP, 1983, CAN J FISH AQUAT SCI, V40, P1173, DOI 10.1139/f83-134; HE X, 1993, T AM FISH SOC, V122, P773, DOI 10.1577/1548-8659(1993)122<0773:FWSALT>2.3.CO;2; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Hillebrand H, 2005, J ECOL, V93, P758, DOI 10.1111/j.1365-2745.2005.00978.x; Hood JM, 2005, OECOLOGIA, V146, P247, DOI 10.1007/s00442-005-0202-5; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; Kajimura M, 2004, J EXP BIOL, V207, P1993, DOI 10.1242/jeb.00901; Knoll LB, 2009, OIKOS, V118, P1732, DOI 10.1111/j.1600-0706.2009.17367.x; KRAFT CE, 1992, CAN J FISH AQUAT SCI, V49, P2596, DOI 10.1139/f92-287; Lau MR, 1984, THESIS CALIFORNIA ST; LEE RM, 1980, T AM FISH SOC, V109, P632, DOI 10.1577/1548-8659(1980)109&lt;632:CTMOFT&gt;2.0.CO;2; Leroux SJ, 2010, ECOLOGY, V91, P2162, DOI 10.1890/09-0133.1; Liess A, 2009, GASTROPOD GRAZERS AF, DOI DOI 10.1899/08-115.1.ACCESSED; Mather ME, 1995, CAN J FISH AQUAT SCI, V52, P2327, DOI 10.1139/f95-825; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; McManamay RA, 2010, DOES DIET INFLUENCE, DOI DOI 10.1899/09-152.1.ACCESSED; MORRIS DP, 1988, FRESHWATER BIOL, V20, P315, DOI 10.1111/j.1365-2427.1988.tb00457.x; Moslemi JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038806; MUNRO AF, 1953, BIOCHEM J, V54, P29, DOI 10.1042/bj0540029; Nehlsen W, 1997, PACIFIC SALMON THEIR; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; NUSSBAUM R A, 1973, Northwest Science, V47, P218; Nussbaum RA., 1983, AMPHIBIANS REPTILES; Parker Michael S., 1994, Northwestern Naturalist, V74, P77, DOI 10.2307/3536601; PARKER MS, 1991, J HERPETOL, V25, P355, DOI 10.2307/1564597; PARKER MS, 1994, COPEIA, P705, DOI 10.2307/1447187; PARKER MS, 1992, THESIS U CALIFORNIA; Pough F.H., 1983, P141; Power ME, 2002, ECOL RES, V17, P451, DOI 10.1046/j.1440-1703.2002.00503.x; POWER ME, 1985, ECOLOGY, V66, P1448, DOI 10.2307/1938007; RAO GMM, 1968, CAN J ZOOLOG, V46, P781, DOI 10.1139/z68-108; Roni P, 2002, T AM FISH SOC, V131, P743, DOI 10.1577/1548-8659(2002)131<0743:HUBFAP>2.0.CO;2; Sabo JL, 2002, J N AM BENTHOL SOC, V21, P336, DOI 10.2307/1468420; Sanches LF, 2011, HYDROBIOLOGIA, V669, P35, DOI 10.1007/s10750-011-0661-0; Schade JD, 2011, FRESHWATER BIOL, V56, P424, DOI 10.1111/j.1365-2427.2010.02509.x; Schaus MH, 1997, LIMNOL OCEANOGR, V42, P1386, DOI 10.4319/lo.1997.42.6.1386; Schindler DE, 2001, ECOSYSTEMS, V4, P308, DOI 10.1007/s10021-001-0013-4; SCHINDLER DE, 1993, T AM FISH SOC, V122, P756, DOI 10.1577/1548-8659(1993)122<0756:FWSAPC>2.3.CO;2; Schindler DE, 1997, ECOLOGY, V78, P1816; SCHINDLER DW, 1978, LIMNOL OCEANOGR, V23, P478, DOI 10.4319/lo.1978.23.3.0478; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Shapovalov L., 1954, LIFE HIST STEELHEAD; Small GE, 2011, ECOLOGY, V92, P386, DOI 10.1890/10-0081.1; Smith HW, 1929, J BIOL CHEM, V81, P407; Spooner DE, 2008, OECOLOGIA, V158, P307, DOI 10.1007/s00442-008-1132-9; Taylor JM, 2011, NUTR ENRICHMENT EFFE; THORPE JE, 1982, AQUACULTURE, V28, P123, DOI 10.1016/0044-8486(82)90015-1; UNDERHAY EE, 1955, BIOCHEM J, V61, P544, DOI 10.1042/bj0610544; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Vanni MJ, 2002, ECOL LETT, V5, P285, DOI 10.1046/j.1461-0248.2002.00314.x; Vanni MJ, 1997, ECOLOGY, V78, P21; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Veraart AJ, 2008, J PHYCOL, V44, P564, DOI 10.1111/j.1529-8817.2008.00503.x; Villeger S, 2012, FRESHWATER BIOL, V57, P2330, DOI 10.1111/fwb.12009; Welsh HH, 1998, ECOL APPL, V8, P1118; Welsh HH, 2002, J WILDLIFE MANAGE, V66, P581, DOI 10.2307/3803126; Whiles MR, 2009, LIMNOL OCEANOGR-METH, V7, P1; Whiles MR, 2012, ECOSYSTEMS; WHITFORD WG, 1967, PHYSIOL ZOOL, V40, P127, DOI 10.1086/physzool.40.2.30152447; Whitledge GW, 1997, T AM FISH SOC, V126, P1030, DOI 10.1577/1548-8659(1997)126&lt;1030:LEOABM&gt;2.3.CO;2; Wilson HF, 2011, GLOBAL CHANGE BIOL, V17, P130, DOI 10.1111/j.1365-2486.2010.02284.x; Wright PM, 1996, PHYSIOL ZOOL, V69, P1057, DOI 10.1086/physzool.69.5.30164246; ZWEIFEL RG, 1957, ECOLOGY, V38, P64, DOI 10.2307/1932126	95	17	17	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58542	10.1371/journal.pone.0058542	http://dx.doi.org/10.1371/journal.pone.0058542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520520	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900079
J	Nymark, M; Valle, KC; Hancke, K; Winge, P; Andresen, K; Johnsen, G; Bones, AM; Brembu, T				Nymark, Marianne; Valle, Kristin C.; Hancke, Kasper; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Bones, Atle M.; Brembu, Tore			Molecular and Photosynthetic Responses to Prolonged Darkness and Subsequent Acclimation to Re-Illumination the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							FLUORESCENCE EXCITATION-SPECTRA; CHLOROPHYLL-BINDING-PROTEINS; DIADINOXANTHIN DE-EPOXIDASE; XANTHOPHYLL-CYCLE ACTIVITY; MESSENGER-RNA CHANGES; PHOTOSYSTEM-II; CELL-CYCLE; ENERGY-TRANSFER; PROTON GRADIENT; HIGH LIGHT	Photosynthetic diatoms that live suspended throughout the water column will constantly be swept up and down by vertical mixing. When returned to the photic zone after experiencing longer periods in darkness, mechanisms exist that enable the diatoms both to survive sudden light exposure and immediately utilize the available energy in photosynthesis and growth. We have investigated both the response to prolonged darkness and the re-acclimation to moderate intensity white irradiance (E = 100 mu mol m(-2) s(-1)) in the diatom Phaeodactylum tricornutum, using an integrated approach involving global transcriptional profiling, pigment analyses, imaging and photo-physiological measurements. The responses were studied during continuous white light, after 48 h of dark treatment and after 0.5 h, 6 h, and 24 h of re-exposure to the initial irradiance. The analyses resulted in several intriguing findings. Dark treatment of the cells led to 1) significantly decreased nuclear transcriptional activity, 2) distinct intracellular changes, 3) fixed ratios of the light-harvesting pigments despite a decrease in the total cell pigment pool, and 4) only a minor drop in photosynthetic efficiency (Phi(PSII_max)). Re-introduction of the cells to the initial light conditions revealed 5) distinct expression profiles for nuclear genes involved in photosynthesis and those involved in photoprotection, 6) rapid rise in photosynthetic parameters (alpha and rETR(max)) within 0.5 h of reexposure to light despite a very modest de novo synthesis of photosynthetic compounds, and 7) increasingly efficient resonance energy transfer from fucoxanthin chlorophyll a/c-binding protein complexes to photosystem II reaction centers during the first 0.5 h, supporting the observations stated in 6). In summary, the results show that despite extensive transcriptional, metabolic and intracellular changes, the ability of cells to perform photosynthesis was kept intact during the length of the experiment. We conclude that P. tricornutum maintains a functional photosynthetic apparatus during dark periods that enables prompt recovery upon re-illumination.	[Nymark, Marianne; Valle, Kristin C.; Hancke, Kasper; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Bones, Atle M.; Brembu, Tore] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Bones, AM (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway.	atle.bones@ntnu.no; tore.brembu@ntnu.no	Nymark, Marianne/H-2535-2016; Bones, Atle M/C-6202-2014; Brembu, Tore/J-7166-2015	Nymark, Marianne/0000-0002-0672-0653; Bones, Atle M/0000-0003-0544-7437; Brembu, Tore/0000-0001-5622-8037	Norwegian Research Council [184146]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council (grant # 184146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska I, 2004, REGULATION PHOTOSYNT, P487; ANDERSON OR, 1975, J PHYCOL, V11, P272, DOI 10.1111/j.0022-3646.1975.00272.x; Andersson U, 2003, PLANT PHYSIOL, V132, P811, DOI 10.1104/pp.102.019281; Antia NJ, 1970, PHYCOLOGIA, V9, P272; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Barber J, 2000, BBA-BIOENERGETICS, V1459, P239, DOI 10.1016/S0005-2728(00)00158-4; Ramos JBE, 2012, MAR ECOL PROG SER, V452, P11, DOI 10.3354/meps09606; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOROWITZKA MA, 1978, J PHYCOL, V14, P10; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brunet C., 2011, PHYTOPLANKTON PIGMEN, P445, DOI [10.1017/CBO9780511732263.017, DOI 10.1017/CBO9780511732263.017]; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; Butler W.L., SPECTRAL CHARACTERIS, P343, DOI [10.1016/C2013-0-12536-6, DOI 10.1016/C2013-0-12536-6]; CLAYTON R, 1980, PHOTOSYNTHESIS PHYS; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; Cruz S, 2011, J EXP BOT, V62, P509, DOI 10.1093/jxb/erq284; Dambek M, 2012, J EXP BOT, V63, P5607, DOI 10.1093/jxb/ers211; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; de Weerd FL, 2002, BIOPHYS J, V82, P1586, DOI 10.1016/S0006-3495(02)75510-0; Dimier C, 2007, J PHYCOL, V43, P937, DOI 10.1111/j.1529-8817.2007.00381.x; Dittami SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-365; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Engelken J, 2012, ADV PHOTOSYNTH RESP, V33, P265, DOI 10.1007/978-94-007-1533-2_11; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gildenhoff N, 2010, BBA-BIOENERGETICS, V1797, P543, DOI 10.1016/j.bbabio.2010.01.024; GOEDHEER JC, 1969, BIOCHIM BIOPHYS ACTA, V172, P252, DOI 10.1016/0005-2728(69)90068-1; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; GRIFFITHS DJ, 1973, MAR BIOL, V21, P91, DOI 10.1007/BF00354603; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; Gundermann K, 2008, PHOTOSYNTH RES, V95, P229, DOI 10.1007/s11120-007-9262-1; Hannah MA, 2008, NAT BIOTECHNOL, V26, P741, DOI 10.1038/nbt0708-741; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; HERRIN DL, 1986, J CELL BIOL, V103, P1837, DOI 10.1083/jcb.103.5.1837; Hoffman GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-101; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huysman MJJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r17; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1055/s-2007-978491; Jeffrey S.W., 2011, PHYTOPLANKTON PIGMEN, P3, DOI [10.1017/cbo9780511732263, DOI 10.1017/CBO9780511732263.004]; Johnsen G, 1997, LIMNOL OCEANOGR, V42, P1166, DOI 10.4319/lo.1997.42.5_part_2.1166; Johnsen G., 2011, PHYTOPLANKTON PIGMEN, P496, DOI DOI 10.1017/CB09780511732263.019; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Juhas M, 2012, J EXP BOT, V63, P3673, DOI 10.1093/jxb/ers049; KIEFER DA, 1992, ENVIR SCI R, V43, P155; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; KOPF U, 1984, ANAL CHEM, V56, P1931, DOI 10.1021/ac00275a039; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Lavaud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036806; Leblanc C, 1999, PLANT MOL BIOL, V40, P1031, DOI 10.1023/A:1006256300969; Lee J, 2002, PHOTOSYNTH RES, V72, P295, DOI 10.1023/A:1019881306640; Lepetit B, 2007, BIOCHEMISTRY-US, V46, P9813, DOI 10.1021/bi7008344; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; LEWIS MR, 1984, NATURE, V311, P49, DOI 10.1038/311049a0; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; LODISH H, 2003, MOL CELL BIOL; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lutz VA, 1998, J PHYCOL, V34, P214, DOI 10.1046/j.1529-8817.1998.340214.x; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Misquitta Rachel W., 2005, Plant Tissue Culture, V15, P83; Montechiaro F, 2006, PHYCOLOGIA, V45, P704, DOI 10.2216/06-15.1; NEORI A, 1988, MAR ECOL PROG SER, V44, P297, DOI 10.3354/meps044297; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Oeltjen A, 2004, INT MICROBIOL, V7, P127; Oeltjen A, 2002, PLANT BIOLOGY, V4, P250, DOI 10.1055/s-2002-25737; OWENS TG, 1989, BIOPHYS J, V56, P95, DOI 10.1016/S0006-3495(89)82654-2; PELTIER G, 1991, P NATL ACAD SCI USA, V88, P4791, DOI 10.1073/pnas.88.11.4791; Peters E, 1996, J EXP MAR BIOL ECOL, V207, P25, DOI 10.1016/S0022-0981(96)02520-8; Peters E, 1996, J EXP MAR BIOL ECOL, V207, P43, DOI 10.1016/0022-0981(95)02519-7; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porra R. J., 2011, PHYTOPLANKTON PIGMEN, P78; Premvardhan L, 2010, BBA-BIOENERGETICS, V1797, P1647, DOI 10.1016/j.bbabio.2010.05.002; PREZELIN BB, 1981, CAN B FISH AQUAT SCI, P1; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rayko E, 2010, NEW PHYTOL, V188, P52, DOI 10.1111/j.1469-8137.2010.03371.x; Rodriguez F, 2006, MAR BIOL, V148, P963, DOI 10.1007/s00227-005-0138-7; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SAKSHAUG E, 1991, DEEP-SEA RES, V38, P415, DOI 10.1016/0198-0149(91)90044-G; Savard F, 1996, PLANT MOL BIOL, V32, P461, DOI 10.1007/BF00019098; SETIF P, 1980, ARCH BIOCHEM BIOPHYS, V204, P477, DOI 10.1016/0003-9861(80)90059-4; SICKOGOAD L, 1986, J PHYCOL, V22, P22, DOI 10.1111/j.1529-8817.1986.tb02510.x; SICKOGOAD L, 1989, J PLANKTON RES, V11, P375, DOI 10.1093/plankt/11.2.375; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suggett DJ, 2010, DEVEL APPL PHYCOL, V4, P103, DOI 10.1007/978-90-481-9268-7_6; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; VERNOTTE C, 1992, PHOTOSYNTH RES, V32, P45, DOI 10.1007/BF00028797; VIERLING E, 1983, PLANT PHYSIOL, V72, P625, DOI 10.1104/pp.72.3.625; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Zhu SH, 2008, ENERGY SUN, P261; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	107	88	88	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58722	10.1371/journal.pone.0058722	http://dx.doi.org/10.1371/journal.pone.0058722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520530	gold, Green Submitted, Green Published			2022-12-27	WOS:000318679900090
J	van den Berg, S; Laman, JD; Boon, L; ten Kate, MT; de Knegt, GJ; Verdijk, RM; Verbrugh, HA; Nouwen, JL; Bakker-Woudenberg, IAJM				van den Berg, Sanne; Laman, Jon D.; Boon, Louis; ten Kate, Marian T.; de Knegt, Gerjo J.; Verdijk, Rob M.; Verbrugh, Henri A.; Nouwen, Jan L.; Bakker-Woudenberg, Irma A. J. M.			Distinctive Cytokines as Biomarkers Predicting Fatal Outcome of Severe Staphylococcus aureus Bacteremia in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; INTERLEUKIN-1 RECEPTOR ANTAGONIST; SEVERE SEPSIS; FACTOR-ALPHA; MONOCLONAL-ANTIBODY; SEPTIC SHOCK; DOUBLE-BLIND; MULTICENTER; SERUM	Invasive Staphylococcus aureus infections are frequently associated with bacteraemia. To support clinical decisions on antibiotic therapy, there is an urgent need for reliable markers as predictors of infection outcome. In the present study in mice, bacteraemia was established by intravenous inoculation of a clinical S. aureus isolate at the LD50 inoculum. As potential biomarkers for fatal outcome, blood culture (qualitative and quantitative), serum levels of C-reactive protein (CRP), as well as 31 selected cytokines and chemokines were assessed during the first three days of infection. A positive S. aureus blood culture, the quantitative blood culture, CRP levels, and levels of eight cytokines were indicative for the presence of S. aureus bacteraemia. However, only tumor necrosis factor (TNF) alpha, interleukin (IL) 1 alpha, and keratinocyte chemoattractant (KC; a functional homologue of human IL-8) were each significantly elevated in eventually non-surviving infected mice versus eventually surviving infected mice. In severe S. aureus bacteraemia in mice, TNF-alpha, IL-1 alpha, and KC are biomarkers predicting fatal outcome of infection. KC was a biomarker elevated irrespective the progression of infection, which is very interesting regarding clinical application in view of the heterogeneity of patients experiencing bacteraemia in this respect.	[van den Berg, Sanne; ten Kate, Marian T.; de Knegt, Gerjo J.; Verbrugh, Henri A.; Nouwen, Jan L.; Bakker-Woudenberg, Irma A. J. M.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Laman, Jon D.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Verdijk, Rob M.] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Bioceros B.V.; Erasmus University Rotterdam; Erasmus MC	van den Berg, S (corresponding author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.vandenberg@erasmusmc.nl	Boon, Laurence/HCI-3629-2022	Verdijk, Robert M/0000-0003-1437-214X; Boon, Louis/0000-0002-0937-9171; van den Berg, Sanne/0000-0001-9209-0178	Top Institute Pharma project [T4-213]	Top Institute Pharma project	This work was in part supported by Top Institute Pharma project T4-213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Arnalich F, 1999, J INFECT DIS, V180, P908, DOI 10.1086/314963; Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000; Ashare A, 2005, AM J PHYSIOL-LUNG C, V288, pL633, DOI 10.1152/ajplung.00231.2004; Balci C, 2003, CRIT CARE, V7, P85, DOI 10.1186/cc1843; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cohen J, 1996, CRIT CARE MED, V24, P1431, DOI 10.1097/00003246-199609000-00002; Cohen J, 1999, J INFECT DIS, V180, P116, DOI 10.1086/314839; DANDONA P, 1994, J CLIN ENDOCR METAB, V79, P1605, DOI 10.1210/jc.79.6.1605; De Steenwinkel JEM, 2009, INT J IMMUNOPATH PH, V22, P723, DOI 10.1177/039463200902200318; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Grobmyer SR, 2000, CRIT CARE MED, V28, P1276, DOI 10.1097/00003246-200005000-00003; Johansson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026928; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lausevic Z, 2010, VOJNOSANIT PREGL, V67, P893, DOI 10.2298/VSP1011893L; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mathiak G, 2001, SHOCK, V15, P176, DOI 10.1097/00024382-200115030-00003; MATHISON JC, 1988, J CLIN INVEST, V81, P1925, DOI 10.1172/JCI113540; Meisner M, 2002, CLIN CHIM ACTA, V323, P17, DOI 10.1016/S0009-8981(02)00101-8; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; Osuchowski MF, 2007, J IMMUNOL, V179, P623, DOI 10.4049/jimmunol.179.1.623; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Reichelt ME, 2011, INT J CARDIOL; Reinhart K, 1996, CRIT CARE MED, V24, P733, DOI 10.1097/00003246-199605000-00003; Seishima M, 2009, CLIN EXP DERMATOL, V34, pE632, DOI 10.1111/j.1365-2230.2009.03353.x; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; van den Berg S, 2011, J IMMUNOL METHODS, V365, P142, DOI 10.1016/j.jim.2010.12.013; vanderPoll T, 1997, J INFECT DIS, V175, P118, DOI 10.1093/infdis/175.1.118; VIGUSHIN DM, 1993, J CLIN INVEST, V91, P1351, DOI 10.1172/JCI116336; WAKABAYASHI GO, 1991, FASEB J, V5, P338, DOI 10.1096/fasebj.5.3.1825816; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	39	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59107	10.1371/journal.pone.0059107	http://dx.doi.org/10.1371/journal.pone.0059107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520553	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900113
J	Gustafsson, RKL; Engdahl, EE; Hammarfjord, O; Adikari, SB; Lourda, M; Klingstrom, J; Svensson, M; Fogdell-Hahn, A				Gustafsson, Rasmus K. L.; Engdahl, Elin E.; Hammarfjord, Oscar; Adikari, Sanjaya B.; Lourda, Magda; Klingstrom, Jonas; Svensson, Mattias; Fogdell-Hahn, Anna			Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication	PLOS ONE			English	Article							MXA GENE-EXPRESSION; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; HUMAN-HERPESVIRUS-6 INFECTION; EXANTHEM-SUBITUM; VIRUS; RECEPTOR; DIFFERENTIATION; VALIDATION; MATURATION	Human herpesvirus 6A (HHV-6A) is a common virus with a worldwide distribution that has been associated with multiple sclerosis. Whether HHV-6A can replicate in dendritic cells (DC) and how the infection might modulate the functional properties of the cell are currently not well known and need further investigations. Here, we show that a non-productive infection of HHV-6A in DC leads to the up-regulation of HLA-ABC, via autocrine IFN-alpha signaling, as well as the up-regulation of HLA-DR and CD86. However, HHV-6A exposure reduces IL-8 secretion by DC and their capacity to stimulate allogenic T cell proliferation. The ability to suppress DC functions important for activation of innate and adaptive immune responses might be one successful strategy by which HHV-6A avoids the induction of appropriate host defense mechanisms, and thus facilitating persistent infection.	[Gustafsson, Rasmus K. L.; Engdahl, Elin E.; Fogdell-Hahn, Anna] Karolinska Inst, Dept Clin Neurosci, Multiple Sclerosis Res Grp, Stockholm, Sweden; [Hammarfjord, Oscar; Lourda, Magda; Klingstrom, Jonas; Svensson, Mattias] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Adikari, Sanjaya B.] Univ Peradeniya, Fac Med, Peradeniya, Sri Lanka; [Lourda, Magda] Karolinska Univ Hosp, Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Klingstrom, Jonas] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; University of Peradeniya; Karolinska Institutet; Karolinska University Hospital; Swedish Institute for Infectious Disease Control	Gustafsson, RKL (corresponding author), Karolinska Inst, Dept Clin Neurosci, Multiple Sclerosis Res Grp, Stockholm, Sweden.	Rasmus.Gustafsson@ki.se	Lourda, Magdalini/AFT-2982-2022	Lourda, Magdalini/0000-0003-3155-1123; Adikari, Sanjaya/0000-0002-9069-7475; Svensson, Mattias/0000-0003-1695-7934; Klingstrom, Jonas/0000-0001-9076-1441; Fogdell-Hahn, Anna/0000-0002-0311-9184	Board of Doctoral Education at Karolinska Institutet [4769/07-225]; Swedish Association for Persons with Neurological Disabilities; Swedish Dental Society; BiogenIdec; Merck Serono; Sanofi-Aventis; Swedish Research Council; KI Funds [2008Fobi0783]; IMI-grant (ABIRISK project)	Board of Doctoral Education at Karolinska Institutet; Swedish Association for Persons with Neurological Disabilities; Swedish Dental Society; BiogenIdec(Biogen); Merck Serono(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Swedish Research Council(Swedish Research CouncilEuropean Commission); KI Funds; IMI-grant (ABIRISK project)	This work was supported from grant 4769/07-225 from faculty funds from the Board of Doctoral Education at Karolinska Institutet and a grant from the Swedish Association for Persons with Neurological Disabilities; grant from the Swedish Dental Society; unrestricted grant from BiogenIdec, Merck Serono and Sanofi-Aventis; grant from The Swedish Research Council; grants from KI Funds; grant 2008Fobi0783 from KI funds; IMI-grant (ABIRISK project); and unrestricted grant from BiogenIdec, Merck Serono and Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 1999, J VIROL, V73, P4019, DOI 10.1128/JVI.73.5.4019-4028.1999; Atta-ur-Rahman, 1999, CURR PHARM DESIGN, V5, P241; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bertelsen LB, 2010, SCAND J IMMUNOL, V71, P431, DOI 10.1111/j.1365-3083.2010.02389.x; Bertolotto A, 2007, J IMMUNOL METHODS, V321, P19, DOI 10.1016/j.jim.2006.12.012; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Goodman AD, 2003, J INFECT DIS, V187, P1365, DOI 10.1086/368172; Gustafsson RKL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-311; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Harberts E, 2011, P NATL ACAD SCI USA, V108, P13734, DOI 10.1073/pnas.1105143108; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Hirata Y, 2001, J MED VIROL, V65, P576, DOI 10.1002/jmv.2075; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Jaworska J, 2010, P NATL ACAD SCI USA, V107, P8369, DOI 10.1073/pnas.0909951107; Kakimoto M, 2002, J VIROL, V76, P10338, DOI 10.1128/JVI.76.20.10338-10345.2002; Liszewski MK, 2005, SPRINGER SEMIN IMMUN, V27, P345, DOI 10.1007/s00281-005-0002-3; LUSSO P, 1988, J EXP MED, V167, P1659, DOI 10.1084/jem.167.5.1659; Murakami Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-91; Nitsche A, 2001, J INFECT DIS, V183, P130, DOI 10.1086/317651; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; REED L. J., 1938, AMER JOUR HYG, V27, P493; RONNI T, 1993, J IMMUNOL, V150, P1715; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; SCHIRMER EC, 1991, P NATL ACAD SCI USA, V88, P5922, DOI 10.1073/pnas.88.13.5922; Smith AP, 2005, J VIROL, V79, P2807, DOI 10.1128/JVI.79.5.2807-2813.2005; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Suga S, 1998, PEDIATRICS, V102, P900, DOI 10.1542/peds.102.4.900; Sullivan BM, 2008, J VIROL, V82, P602, DOI 10.1128/JVI.01571-07; TAKAHASHI K, 1989, J VIROL, V63, P3161, DOI 10.1128/JVI.63.7.3161-3163.1989; Takemoto M, 2009, VIROLOGY; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; YAMANISHI K, 1988, LANCET, V1, P1065; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e58122	10.1371/journal.pone.0058122	http://dx.doi.org/10.1371/journal.pone.0058122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526966	Green Published, Green Submitted, gold			2022-12-27	WOS:000315637900091
J	Campeanu, S; Craik, FIM; Alain, C				Campeanu, Sandra; Craik, Fergus I. M.; Alain, Claude			Voice Congruency Facilitates Word Recognition	PLOS ONE			English	Article							LONG-TERM-MEMORY; SPEAKERS VOICE; SPOKEN WORDS; ITEM MEMORY; RETRIEVAL; CONTEXT; IMPLICIT; TALKER; YOUNG	Behavioral studies of spoken word memory have shown that context congruency facilitates both word and source recognition, though the level at which context exerts its influence remains equivocal. We measured event-related potentials (ERPs) while participants performed both types of recognition task with words spoken in four voices. Two voice parameters (i.e., gender and accent) varied between speakers, with the possibility that none, one or two of these parameters was congruent between study and test. Results indicated that reinstating the study voice at test facilitated both word and source recognition, compared to similar or no context congruency at test. Behavioral effects were paralleled by two ERP modulations. First, in the word recognition test, the left parietal old/new effect showed a positive deflection reflective of context congruency between study and test words. Namely, the same speaker condition provided the most positive deflection of all correctly identified old words. In the source recognition test, a right frontal positivity was found for the same speaker condition compared to the different speaker conditions, regardless of response success. Taken together, the results of this study suggest that the benefit of context congruency is reflected behaviorally and in ERP modulations traditionally associated with recognition memory.	[Campeanu, Sandra; Craik, Fergus I. M.; Alain, Claude] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Campeanu, Sandra; Craik, Fergus I. M.; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto	Campeanu, S (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	scampeanu@research.baycrest.org		Craik, Fergus/0000-0001-8073-3236	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by grants from the Canadian Institutes of Health Research to Claude Alain and from the Natural Sciences and Engineering Research Council of Canada to Claude Alain and to Fergus Craik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan K, 1998, ACTA PSYCHOL, V98, P231, DOI 10.1016/S0001-6918(97)00044-9; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P206, DOI 10.3758/BF03206883; CHURCH BA, 1994, J EXP PSYCHOL LEARN, V20, P521, DOI 10.1037/0278-7393.20.3.521; CRAIK FIM, 1974, Q J EXP PSYCHOL, V26, P274, DOI 10.1080/14640747408400413; GEISELMAN RE, 1977, MEM COGNITION, V5, P658, DOI 10.3758/BF03197412; GEISELMAN RE, 1976, MEM COGNITION, V4, P483, DOI 10.3758/BF03213208; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Johnson R, 1998, INT J PSYCHOPHYSIOL, V29, P83, DOI 10.1016/S0167-8760(98)00006-3; Kucera H., 1967, COMPUTATIONAL ANAL P; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; NAVEHBENJAMIN M, 1995, PSYCHOL AGING, V10, P284, DOI 10.1037/0882-7974.10.2.284; NavehBenjamin M, 1996, Q J EXP PSYCHOL-A, V49, P780, DOI 10.1080/027249896392595; PALMERI TJ, 1993, J EXP PSYCHOL LEARN, V19, P309, DOI 10.1037/0278-7393.19.2.309; Picton TW, 2000, CLIN NEUROPHYSIOL, V111, P53, DOI 10.1016/S1388-2457(99)00227-8; Pilotti M, 2002, MEM COGNITION, V30, P226, DOI 10.3758/BF03195283; PISONI DB, 1993, SPEECH COMMUN, V13, P109, DOI 10.1016/0167-6393(93)90063-Q; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; Schloerscheidt AM, 2004, NEUROPSYCHOLOGIA, V42, P451, DOI 10.1016/j.neuropsychologia.2003.08.010; Senkfor AJ, 1998, J EXP PSYCHOL LEARN, V24, P1005, DOI 10.1037/0278-7393.24.4.1005; Tendolkar I, 2004, BIOL PSYCHOL, V66, P235, DOI 10.1016/j.biopsycho.2003.10.009; WILDING EL, 1995, NEUROPSYCHOLOGIA, V33, P743, DOI 10.1016/0028-3932(95)00017-W; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594	24	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58778	10.1371/journal.pone.0058778	http://dx.doi.org/10.1371/journal.pone.0058778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23527021	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600039
J	Wynd, S; Westaway, M; Vohra, S; Kawchuk, G				Wynd, Shari; Westaway, Michael; Vohra, Sunita; Kawchuk, Greg			The Quality of Reports on Cervical Arterial Dissection following Cervical Spinal Manipulation	PLOS ONE			English	Article							ALTERNATIVE MEDICAL PROCEDURE; VERTEBRAL ARTERY; CHIROPRACTIC MANIPULATION; NECK MANIPULATION; CAROTID-ARTERY; RISK-FACTOR; SYSTEMATIC REVIEWS; STROKE; THERAPY; COMPLICATIONS	Background: Cervical artery dissection (CAD) and stroke are serious harms that are sometimes associated with cervical spinal manipulation therapy (cSMT). Because of the relative rarity of these adverse events, studying them prospectively is challenging. As a result, systematic review of reports describing these events offers an important opportunity to better understand the relation between adverse events and cSMT. Of note, the quality of the case report literature in this area has not yet been assessed. Purpose: 1) To systematically collect and synthesize available reports of CAD that have been associated with cSMT in the literature and 2) assess the quality of these reports. Methods: A systematic review of the literature was conducted using several databases. All clinical study designs involving CADs associated with cSMT were eligible for inclusion. Included studies were screened by two independent reviewers for the presence/absence of 11 factors considered to be important in understanding the relation between CAD and cSMT. Results: Overall, 43 articles reported 901 cases of CAD and 707 incidents of stroke reported to be associated with cSMT. The most common type of stroke reported was ischemic stroke (92%). Time-to-onset of symptoms was reported most frequently (95%). No single case included all 11 factors. Conclusions: This study has demonstrated that the literature infrequently reports useful data toward understanding the association between cSMT, CADs and stroke. Improving the quality, completeness, and consistency of reporting adverse events may improve our understanding of this important relation.	[Wynd, Shari] Texas Chiropract Coll, Pasadena, TX 77505 USA; [Westaway, Michael] Univ Alberta, Lifemark Hlth, Calgary, AB, Canada; [Vohra, Sunita] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada; [Vohra, Sunita] Alberta Innovates Hlth Solut, Complementary & Alternat Res & Educ Program, Pediat Complementary & Alternat Med Res & Educ Ne, Edmonton, AB, Canada; [Kawchuk, Greg] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada	University of Alberta; University of Alberta; Alberta Innovates; University of Alberta	Wynd, S (corresponding author), Texas Chiropract Coll, Pasadena, TX 77505 USA.	swynd@txchiro.edu	Vohra, Sunita/F-5755-2016; Wynd, Shari E/E-8948-2017	Vohra, Sunita/0000-0002-6210-7933; Wynd, Shari E/0000-0002-8523-5137	Canada Research Chairs program; Alberta Innovates-Health Solutions	Canada Research Chairs program(Canada Research Chairs); Alberta Innovates-Health Solutions	Greg Kawchuk receives salary support from the Canada Research Chairs program. Sunita Vohra receives salary support from Alberta Innovates-Health Solutions. Training support for Shari Wynd was provided by the Alberta Canadian Institutes of Health Research (CIHR) Training Program in Bone and Joint Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels E, 2006, J NEUROIMAGING, V16, P24, DOI 10.1177/1051228405280646; Beaudry M, 2003, CAN J NEUROL SCI, V30, P320, DOI 10.1017/S0317167100003024; Bekavac N, 2006, EXPLORE-NY, V2, P150, DOI 10.1016/j.explore.2006.01.001; Beran RG, 2000, MED J AUSTRALIA, V173, P213, DOI 10.5694/j.1326-5377.2000.tb125606.x; Bergmann TF, 2011, CHIROPRACTIC TECHNIQ, V3rd; Bin Saeed A, 2000, CAN J NEUROL SCI, V27, P292, DOI 10.1017/S0317167100001025; Biondi D M, 2000, J Am Osteopath Assoc, V100, pS7; Cagnie B, 2006, SURG RADIOL ANAT, V28, P129, DOI 10.1007/s00276-005-0060-1; Caso V, 2005, FRONT NEUROL NEUROSC, V20, P44, DOI 10.1159/000088134; Cassidy JD, 2008, SPINE, V33, pS176, DOI 10.1097/BRS.0b013e3181644600; Cerimagic D, 2008, SOUTH MED J, V101, P568, DOI 10.1097/SMJ.0b013e31816c012b; Chen WL, 2006, EMERG MED J, V23, pE1, DOI 10.1136/emj.2004.015636; Choi S, 2010, J MANIP PHYSIOL THER, V34, P15; Cimini N, 2004, EUR NEUROL, V52, P207, DOI 10.1159/000082037; Colloca CJ, 2005, J MANIP PHYSIOL THER, V28, P414, DOI 10.1016/j.jmpt.2005.06.004; Czechowsky D, 2002, CEREBROVASC DIS, V13, P192, DOI 10.1159/000047775; Devereaux MW, 2000, J NEURO-OPHTHALMOL, V20, P236, DOI 10.1097/00041327-200020040-00004; Dittrich R, 2007, CEREBROVASC DIS, V23, P275, DOI 10.1159/000098327; Dorland, 2011, DORLANDS MED DICT; Dupeyron A., 2003, Annales de Readaptation et de Medecine Physique, V46, P33, DOI 10.1016/S0168-6054(02)00351-3; Dziewas R, 2003, J NEUROL, V250, P1179, DOI 10.1007/s00415-003-0174-5; Ernst E, 2010, INT J CLIN PRACT, V64, P1162, DOI 10.1111/j.1742-1241.2010.02352.x; Gouveia LO, 2009, SPINE, V34, pE405, DOI 10.1097/BRS.0b013e3181a16d63; Gross AR, 2004, SPINE, V29, P1541, DOI 10.1097/01.BRS.0000131218.35875.ED; Haldeman S, 2002, J NEUROL, V249, P1098, DOI 10.1007/s00415-002-0783-4; Haldeman S, 2002, SPINE, V27, P49, DOI 10.1097/00007632-200201010-00012; Haldeman S, 2001, CAN MED ASSOC J, V165, P905; Haldeman Scott, 2002, Spine J, V2, P334, DOI 10.1016/S1529-9430(02)00411-4; Haneline Michael T, 2009, Spine (Phila Pa 1976), V34, P2475, DOI 10.1097/BRS.0b013e3181b96cbe; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hurwitz EL, 2005, SPINE, V30, P1477, DOI 10.1097/01.brs.0000167821.39373.c1; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jay Walter M, 2003, Semin Ophthalmol, V18, P205, DOI 10.1080/08820530390895217; Jeret JS, 2002, CEREBROVASC DIS, V13, P210, DOI 10.1159/000047778; KAWCHUK GN, 1993, J MANIP PHYSIOL THER, V16, P573; Kawchuk GN, 2008, J NEUROL, V255, P371, DOI 10.1007/s00415-008-0667-3; Kelly W, 2009, THERAPIE, V64, P289, DOI 10.2515/therapie/2009041; Khan AM, 2005, MT SINAI J MED, V72, P207; Leach RA, 2010, J MANIP PHYSIOL THER, V33, P62, DOI 10.1016/j.jmpt.2009.11.004; Leon-Sanchez A, 2007, SOUTH MED J, V100, P201, DOI 10.1097/SMJ.0b013e31802ed21f; Licht PB, 2002, J MANIP PHYSIOL THER, V25, P568, DOI 10.1067/mmt.2002.128367; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; Misra UK, 2001, SPINAL CORD, V39, P112, DOI 10.1038/sj.sc.3101105; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nadgir RN, 2003, NEURORADIOLOGY, V45, P311, DOI 10.1007/s00234-003-0944-x; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Nazir FS, 2004, NEUROLOGY, V62, P1646, DOI 10.1212/01.WNL.0000123017.81529.32; Norris JW, 2001, CAN MED ASSOC J, V165, P887; Panagariya A, 2004, J Assoc Physicians India, V52, P556; Parwar BL, 2001, AM J OPHTHALMOL, V131, P523, DOI 10.1016/S0002-9394(00)00829-1; Pezzini A, 2002, J NEUROL, V249, P1401, DOI 10.1007/s00415-002-0851-9; Preul C, 2010, CLIN NEURORADIOL, V20, P255, DOI 10.1007/s00062-010-0021-x; Preutu G, 2009, INT J MUSCULOSKEL ME, V31, P149; Quintana JG, 2002, NEUROLOGY, V58, P1434, DOI 10.1212/WNL.58.9.1434; Reuter U, 2006, J NEUROL, V253, P724, DOI 10.1007/s00415-006-0099-x; Rothwell DM, 2001, STROKE, V32, P1054, DOI 10.1161/01.STR.32.5.1054; Sedat J, 2002, J MANIP PHYSIOL THER, V25, P588, DOI 10.1067/mmt.2002.128955; Sharmini J, 2010, NEUROL ASIA, V15, P167; Siegel D, 2001, AM J EMERG MED, V19, P171, DOI 10.1053/ajem.2001.21351; Silver B, 2006, CAN J NEUROL SCI, V33, P246, DOI 10.1017/S0317167100005084; Smith WS, 2003, NEUROLOGY, V60, P1424, DOI 10.1212/01.WNL.0000063305.61050.E6; Sorinola Olanrewaju, 2004, BMC Med Educ, V4, P4, DOI 10.1186/1472-6920-4-4; Stevinson G, 2001, J ROY SOC MED, V94, P107, DOI 10.1177/014107680109400302; Terret A, 2001, CURRENT CONCEPTS VER; Thomas LC, 2010, MAN THER; Tinel D., 2008, Annales de Readaptation et de Medecine Physique, V51, P403, DOI 10.1016/j.annrmp.2008.04.010; Touze E, 2003, NEUROLOGY, V61, P572, DOI 10.1212/01.WNL.0000078886.33560.A5; Trivedi A, 2007, ANN INDIAN ACAD NE S, P7; Vertinsky AT, 2008, AM J NEURORADIOL, V29, P1753, DOI 10.3174/ajnr.A1189; Weber M, 2004, J NEUROL, V251, P624, DOI 10.1007/s00415-004-0411-6; Yoshida S, 2000, NEUROL MED-CHIR, V40, P211, DOI 10.2176/nmc.40.211; Young Morgan, 2009, Spine (Phila Pa 1976), V34, P2476, DOI 10.1097/BRS.0b013e3181b96edd; Young YH, 2003, LARYNGOSCOPE, V113, P659, DOI 10.1097/00005537-200304000-00014	73	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59170	10.1371/journal.pone.0059170	http://dx.doi.org/10.1371/journal.pone.0059170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527121	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600060
J	Eini, O; Yang, NN; Pyvovarenko, T; Pillman, K; Bazanova, N; Tikhomirov, N; Eliby, S; Shirley, N; Sivasankar, S; Tingey, S; Langridge, P; Hrmova, M; Lopato, S				Eini, Omid; Yang, Nannan; Pyvovarenko, Tatiana; Pillman, Katherine; Bazanova, Natalia; Tikhomirov, Natalia; Eliby, Serik; Shirley, Neil; Sivasankar, Shoba; Tingey, Scott; Langridge, Peter; Hrmova, Maria; Lopato, Sergiy			Complex Regulation by Apetala2 Domain-Containing Transcription Factors Revealed through Analysis of the Stress-Responsive TdCor410b Promoter from Durum Wheat	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; TRITICUM-AESTIVUM L.; DNA-BINDING DOMAIN; GCC-BOX; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; DIFFERENTIAL EXPRESSION; FREEZING TOLERANCE; ACIDIC DEHYDRIN; LOW-TEMPERATURE	Expression of the wheat dehydrin gene Cor410b is induced several fold above its non-stressed levels upon exposure to stresses such as cold, drought and wounding. Deletion analysis of the TdCor410b promoter revealed a single functional C-repeat (CRT) element. Seven transcription factors (TFs) were shown to bind to this CRT element using yeast one-hybrid screens of wheat and barley cDNA libraries, of which only one belonged to the DREB class of TFs. The remaining six encoded ethylene response factors (ERFs) belong to three separate subfamilies. Analysis of binding selectivity of these TFs indicated that all seven could bind to the CRT element (GCCGAC), and that three of the six ERFs could bind both to the CRT element and the ethylene-responsive GCC-box (GCCGCC). The TaERF4 subfamily members specifically bound the CRT element, and did not bind either the GCC-box or DRE element (ACCGAC). Molecular modeling and site-directed mutagenesis identified a single residue Pro42 in the Apetala2 (AP2) domain of TaERF4-like proteins that is conserved in monocotyledonous plants and is responsible for the recognition selectivity of this subfamily. We suggest that both DREB and ERF proteins regulate expression of the Cor410b gene through a single, critical CRT element. Members of the TaERF4 subfamily are specific, positive regulators of Cor410b gene expression.	[Eini, Omid; Yang, Nannan; Pyvovarenko, Tatiana; Pillman, Katherine; Bazanova, Natalia; Tikhomirov, Natalia; Eliby, Serik; Shirley, Neil; Langridge, Peter; Hrmova, Maria; Lopato, Sergiy] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Sivasankar, Shoba] DuPont Ag Biotechnol, Johnston, IA USA; [Tingey, Scott] DuPont Ag Biotechnol, Wilmington, DE USA	University of Adelaide; DuPont; DuPont	Hrmova, M (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia.	maria.hrmova@adeaide.edu.au; sergiy.lopato@acpfg.com.au	Langridge, Peter/G-5864-2010; Hrmova, Maria/AAH-3951-2020; Pillman, Katherine A/M-5723-2019	Langridge, Peter/0000-0001-9494-400X; Pillman, Katherine A/0000-0002-5869-889X; Yang, Nannan/0000-0002-0032-6348; Eliby, Serik/0000-0003-1134-4960; Shirley, Neil/0000-0001-8114-9891; Hrmova, Maria/0000-0002-3545-0605	Masters of Plant Biotechnology Project at the University of Adelaide [Plant SC 7229A WT, SC7229B WT]; Australian Research Council; Grains Research and Development Corporation; Government of South Australia; DuPont Ag Biotechnology Company	Masters of Plant Biotechnology Project at the University of Adelaide; Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); Government of South Australia; DuPont Ag Biotechnology Company	This work was supported by the Masters of Plant Biotechnology Project (Plant SC 7229A WT & SC7229B WT) at the University of Adelaide, by the Australian Research Council, the Grains Research and Development Corporation, the Government of South Australia and the DuPont Ag Biotechnology Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except SS and ST (DuPont Ag Biotechnology Company), who were involved in the manuscript preparation.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Canella D, 2010, BBA-GENE REGUL MECH, V1799, P454, DOI 10.1016/j.bbagrm.2009.11.017; Cao WH, 2006, PLANT CELL ENVIRON, V29, P1210, DOI 10.1111/j.1365-3040.2006.01501.x; Cao YF, 2006, J PLANT PHYSIOL, V163, P1167, DOI 10.1016/j.jplph.2005.11.004; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; Chen XJ, 2008, INT J MOL SCI, V9, P2601, DOI 10.3390/ijms9122601; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; CLOSE TJ, 1989, PLANT MOL BIOL, V13, P95, DOI 10.1007/BF00027338; Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; DANYLUK J, 1994, FEBS LETT, V344, P20, DOI 10.1016/0014-5793(94)00353-X; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Ganeshan S, 2008, J EXP BOT, V59, P2393, DOI 10.1093/jxb/ern112; Gao MJ, 2002, PLANT MOL BIOL, V49, P459, DOI 10.1023/A:1015570308704; Ginalski K, 2003, NUCLEIC ACIDS RES, V31, P3804, DOI 10.1093/nar/gkg504; GROSSI M, 1995, PLANT SCI, V105, P71, DOI 10.1016/0168-9452(94)04043-G; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Hao DY, 2002, BIOCHEMISTRY-US, V41, P4202, DOI 10.1021/bi015979v; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Houde M, 2004, PLANT BIOTECHNOL J, V2, P381, DOI 10.1111/j.1467-7652.2004.00082.x; Huang ZeJun, 2004, Acta Phytopathologica Sinica, V34, P193; James VA, 2008, TRANSGENIC RES, V17, P93, DOI 10.1007/s11248-007-9086-y; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; Kizis D, 2002, PLANT J, V30, P679, DOI 10.1046/j.1365-313X.2002.01325.x; Kovalchuk N, 2009, PLANT MOL BIOL, V71, P81, DOI 10.1007/s11103-009-9510-1; Lascombe MB, 2008, PROTEIN SCI, V17, P1522, DOI 10.1110/ps.035972.108; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JH, 2004, PLANT MOL BIOL, V55, P61, DOI 10.1007/s11103-004-0417-6; Lee SC, 2005, MOL CELLS, V19, P212; Li M, 2008, PLANT BIOTECHNOL J, V6, P465, DOI 10.1111/j.1467-7652.2008.00333.x; LIN CT, 1990, PLANT PHYSIOL, V94, P1078, DOI 10.1104/pp.94.3.1078; Lin R, 2007, PHYSIOL MOL PLANT P, V70, P60, DOI 10.1016/j.pmpp.2007.06.002; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lopato S, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-3; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; Nishiuchi T, 2002, PLANT MOL BIOL, V49, P473, DOI 10.1023/A:1015553232309; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Pasquato L, 2005, SUPRAMOL CHEM, V17, P163, DOI 10.1080/10610270412331328817; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SANFORD JC, 1993, METHOD ENZYMOL, V217, P483; Sasaki K, 2007, PLANT J, V50, P1079, DOI 10.1111/j.1365-313X.2007.03111.x; SHIMADA T, 1969, CAN J GENET CYTOL, V11, P294, DOI 10.1139/g69-037; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Solano R, 1998, CURR OPIN PLANT BIOL, V1, P393, DOI 10.1016/S1369-5266(98)80262-8; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wang SC, 2009, J MOL RECOGNIT, V22, P474, DOI 10.1002/jmr.965; WELIN BV, 1994, PLANT MOL BIOL, V26, P131, DOI 10.1007/BF00039526; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Xue GP, 2002, BBA-GENE STRUCT EXPR, V1577, P63, DOI 10.1016/S0167-4781(02)00410-4; Yamaguchi-Shinozaki K., 1994, JIRCAS Journal, P69; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Yi SY, 2004, PLANT PHYSIOL, V136, P2862, DOI 10.1104/pp.104.042903; Zhang ZY, 2007, J EXP BOT, V58, P2993, DOI 10.1093/jxb/erm151	87	25	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58713	10.1371/journal.pone.0058713	http://dx.doi.org/10.1371/journal.pone.0058713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527011	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100037
J	Hartman, WH; Richardson, CJ				Hartman, Wyatt H.; Richardson, Curtis J.			Differential Nutrient Limitation of Soil Microbial Biomass and Metabolic Quotients (qCO(2)): Is There a Biological Stoichiometry of Soil Microbes?	PLOS ONE			English	Article							N-P STOICHIOMETRY; ORGANIC-MATTER DECOMPOSITION; FRESH-WATER; LAND-USE; BACTERIAL COMMUNITIES; PHOSPHORUS DYNAMICS; GROWTH-RATE; ECOENZYMATIC STOICHIOMETRY; ELEMENTAL STOICHIOMETRY; NITROGEN-FERTILIZATION	Background: Variation in microbial metabolism poses one of the greatest current uncertainties in models of global carbon cycling, and is particularly poorly understood in soils. Biological Stoichiometry theory describes biochemical mechanisms linking metabolic rates with variation in the elemental composition of cells and organisms, and has been widely observed in animals, plants, and plankton. However, this theory has not been widely tested in microbes, which are considered to have fixed ratios of major elements in soils. Methodology/Principal Findings: To determine whether Biological Stoichiometry underlies patterns of soil microbial metabolism, we compiled published data on microbial biomass carbon (C), nitrogen (N), and phosphorus (P) pools in soils spanning the global range of climate, vegetation, and land use types. We compared element ratios in microbial biomass pools to the metabolic quotient qCO(2) (respiration per unit biomass), where soil C mineralization was simultaneously measured in controlled incubations. Although microbial C, N, and P stoichiometry appeared to follow somewhat constrained allometric relationships at the global scale, we found significant variation in the C: N: P ratios of soil microbes across land use and habitat types, and size-dependent scaling of microbial C: N and C: P (but not N: P) ratios. Microbial stoichiometry and metabolic quotients were also weakly correlated as suggested by Biological Stoichiometry theory. Importantly, we found that while soil microbial biomass appeared constrained by soil N availability, microbial metabolic rates (qCO(2)) were most strongly associated with inorganic P availability. Conclusions/Significance: Our findings appear consistent with the model of cellular metabolism described by Biological Stoichiometry theory, where biomass is limited by N needed to build proteins, but rates of protein synthesis are limited by the high P demands of ribosomes. Incorporation of these physiological processes may improve models of carbon cycling and understanding of the effects of nutrient availability on soil C turnover across terrestrial and wetland habitats.	[Hartman, Wyatt H.; Richardson, Curtis J.] Duke Univ, Nicholas Sch Environm, Duke Univ Wetland Ctr, Durham, NC 27708 USA	Duke University	Hartman, WH (corresponding author), Duke Univ, Nicholas Sch Environm, Duke Univ Wetland Ctr, Durham, NC 27708 USA.	wyatt.hartman@duke.edu	Richardson, Curt/P-5905-2019; Richardson, Curtis J/A-8202-2009	Hartman, Wyatt/0000-0001-7312-3229	National Science Foundation; Duke Wetland Center Graduate Student Endowment	National Science Foundation(National Science Foundation (NSF)); Duke Wetland Center Graduate Student Endowment	This work was funded by a Graduate Research Fellowship from the National Science Foundation awarded to Wyatt Hartman, with additional support from the Duke Wetland Center Graduate Student Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; ANDERSON TH, 1993, SOIL BIOL BIOCHEM, V25, P393, DOI 10.1016/0038-0717(93)90140-7; ANDERSON TH, 1990, SOIL BIOL BIOCHEM, V22, P251, DOI 10.1016/0038-0717(90)90094-G; Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Blagodatskaya EV, 1998, SOIL BIOL BIOCHEM, V30, P1269, DOI 10.1016/S0038-0717(98)00050-9; Bradford MA, 2008, FUNCT ECOL, V22, P964, DOI 10.1111/j.1365-2435.2008.01404.x; Bradford MA, 2010, GLOBAL CHANGE BIOL, V16, P1576, DOI 10.1111/j.1365-2486.2009.02040.x; Bradford MA, 2009, ECOL LETT, V12, pE15, DOI 10.1111/j.1461-0248.2009.01332.x; Brake M, 1999, SOIL BIOL BIOCHEM, V31, P1489, DOI 10.1016/S0038-0717(99)00053-X; BRATBAK G, 1985, APPL ENVIRON MICROB, V49, P1488, DOI 10.1128/AEM.49.6.1488-1493.1985; Brookes P., 2001, MICROBES ENVIRON, V16, P131, DOI [10.1264/jsme2.2001.131, DOI 10.1264/JSME2.2001.131]; Chan LK, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00159; Chapin FS, 2009, J ECOL, V97, P840, DOI 10.1111/j.1365-2745.2009.01529.x; Chen CR, 2008, FOREST ECOL MANAG, V255, P396, DOI 10.1016/j.foreco.2007.10.040; Chen CR, 2000, PLANT SOIL, V220, P151, DOI 10.1023/A:1004712401721; Chen CR, 2004, BIOL FERT SOILS, V40, P313, DOI 10.1007/s00374-004-0781-z; Chen CR, 2003, FOREST ECOL MANAG, V177, P539, DOI 10.1016/S0378-1127(02)00450-4; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Cleveland CC, 2004, BIOTROPICA, V36, P184, DOI 10.1111/j.1744-7429.2004.tb00311.x; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cotner JB, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00132; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; Devi NB, 2006, APPL SOIL ECOL, V31, P220, DOI 10.1016/j.apsoil.2005.05.005; Doi H, 2010, OIKOS, V119, P752, DOI 10.1111/j.1600-0706.2009.18540.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fierer N, 2011, ISME J, DOI [10.1038/ismej.2011.1159-DOI:1010.1038/ismej.2011.1159, DOI 10.1038/ISMEJ.2011.1159-D0I:1010.1038/ISMEJ.2011.1159]; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Franklin O, 2011, AM NAT, V177, pE29, DOI 10.1086/657684; Gusewell S, 2009, FUNCT ECOL, V23, P211, DOI 10.1111/j.1365-2435.2008.01478.x; Gundersen K, 2002, LIMNOL OCEANOGR, V47, P1525, DOI 10.4319/lo.2002.47.5.1525; Gusewell S, 2003, ECOL APPL, V13, P372, DOI 10.1890/1051-0761(2003)013[0372:BNRAIO]2.0.CO;2; Hall EK, 2011, ECOSYSTEMS, V14, P261, DOI 10.1007/s10021-010-9408-4; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Hedin LO, 2004, P NATL ACAD SCI USA, V101, P10849, DOI 10.1073/pnas.0404222101; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hull D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000204; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jonasson S, 1996, OECOLOGIA, V106, P507, DOI 10.1007/BF00329709; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Karpinets TV, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-30; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li YS, 2006, BIOL FERT SOILS, V43, P107, DOI 10.1007/s00374-005-0069-y; Makino W, 2004, AQUAT MICROB ECOL, V34, P33, DOI 10.3354/ame034033; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Manzoni S, 2009, SOIL BIOL BIOCHEM, V41, P1355, DOI 10.1016/j.soilbio.2009.02.031; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; McDowell RW, 2007, EUR J SOIL SCI, V58, P1348, DOI 10.1111/j.1365-2389.2007.00933.x; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; McLatchey GP, 1998, J ENVIRON QUAL, V27, P1268, DOI 10.2134/jeq1998.00472425002700050036x; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Olsen S.R., 1954, ESTIMATION AVAILABLE; QIAN SS, 2009, ENV ECOLOGICAL STAT; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Ramirez KS, 2010, SOIL BIOL BIOCHEM, V42, P2336, DOI 10.1016/j.soilbio.2010.08.032; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Ross DJ, 1999, SOIL BIOL BIOCHEM, V31, P803, DOI 10.1016/S0038-0717(98)00180-1; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P926, DOI 10.1016/j.soilbio.2010.02.009; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Sardans J, 2011, BIOGEOCHEMISTRY, DOI [10.1007/s10533-10011-19640-10539, DOI 10.1007/S10533-10011-19640-10539]; Schilling EB, 2005, SOIL SCI SOC AM J, V69, P1185, DOI 10.2136/sssaj2002.0343; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schmidt IK, 2002, PLANT SOIL, V242, P93, DOI 10.1023/A:1019642007929; Scott JT, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00042; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Sinsabaugh RL, 2011, BIOGEOCHEMISTRY, DOI [10.1007/s10533-10011-19676-x, DOI 10.1007/S10533-10011-19676-X]; Sinsabaugh RL, 2011, BIOGEOCHEMISTRY, V102, P31, DOI 10.1007/s10533-010-9482-x; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; SPARLING GP, 1994, BIOL FERT SOILS, V17, P91, DOI 10.1007/BF00337739; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Sterner RW, 2008, LIMNOL OCEANOGR, V53, P1169, DOI 10.4319/lo.2008.53.3.1169; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P260, DOI 10.1016/j.soilbio.2009.10.026; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Wallenstein MD, 2012, BIOGEOCHEMISTRY, V109, P35, DOI 10.1007/s10533-011-9641-8; Warton DI, 2011, METHODS ECOLOGY EVOL, DOI [10.1111/j.2041-1210X.2011.00153.x, DOI 10.1111/J.2041-1210X.2011.00153.X]; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Yeates GW, 1998, J ROY SOC NEW ZEAL, V28, P523, DOI 10.1080/03014223.1998.9517574	96	158	166	24	306	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57127	10.1371/journal.pone.0057127	http://dx.doi.org/10.1371/journal.pone.0057127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526933	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100005
J	Kratchmarov, R; Taylor, MP; Enquist, LW				Kratchmarov, Radomir; Taylor, Matthew P.; Enquist, Lynn W.			Role of Us9 Phosphorylation in Axonal Sorting and Anterograde Transport of Pseudorabies Virus	PLOS ONE			English	Article							II MEMBRANE-PROTEIN; CELLS; ALPHAHERPESVIRUS; INFECTION; KINESIN; CULTURE; MOTOR; MOTIF; TAIL	Alphaherpes viruses, such as pseudorabies virus (PRV), undergo anterograde transport in neuronal axons to facilitate anterograde spread within hosts. Axonal sorting and anterograde transport of virions is dependent on the viral membrane protein Us9, which interacts with the host motor protein Kif1A to direct transport. Us9-Kif1A interactions are necessary but not sufficient for these processes, indicating that additional cofactors or post-translational modifications are needed. In this study, we characterized two conserved serine phosphorylation sites (S51 and S53) in the PRV Us9 protein that are necessary for anterograde spread in vivo. We assessed the subcellular localization of phospho-Us9 subspecies during infection of neurons and found that the phospho-form is detectable on the majority, but not all, of axonal vesicles containing Us9 protein. In biochemical assays, phospho-Us9 was enriched in lipid raft membrane microdomains, though Us9 phosphorylation did not require prior lipid raft association. During infections of chambered neuronal cultures, we observed only a modest reduction in anterograde spread capacity for diserine mutant Us9, and no defect for monoserine mutants. Conversely, mutation of the kinase recognition sequence residues adjacent to the phosphorylation sites completely abrogated anterograde spread. In live-cell imaging analyses, anterograde transport of virions was reduced during infection with a recombinant PRV strain expressing GFP-tagged diserine mutant Us9. Phosphorylation was not required for Us9-Kif1A interaction, suggesting that Us9-Kif1A binding is a distinct step from the activation and/or stabilization of the transport complex. Taken together, our findings indicate that, while not essential, Us9 phosphorylation enhances Us9-Kif1A-based transport of virions in axons to modulate the overall efficiency of long-distance anterograde spread of infection.	[Kratchmarov, Radomir; Taylor, Matthew P.; Enquist, Lynn W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Enquist, LW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	lenquist@princeton.edu		Kratchmarov, Radomir/0000-0002-6796-8564; Taylor, Matthew/0000-0003-0199-7175	United States National Institutes of Health [R37 NS033506-16, R01 NS060699-03]; American Cancer Society [PF-10-057-01-MPC]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033506, R01NS033506, R01NS060699] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	LWE and RK are supported by the United States National Institutes of Health grants R37 NS033506-16 and R01 NS060699-03. MPT is supported by an American Cancer Society Postdoctoral Research Fellowship (PF-10-057-01-MPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brideau AD, 2000, J VIROL, V74, P4549, DOI 10.1128/JVI.74.10.4549-4561.2000; Brideau AD, 1998, J VIROL, V72, P4560, DOI 10.1128/JVI.72.6.4560-4570.1998; Brideau AD, 2000, J VIROL, V74, P834, DOI 10.1128/JVI.74.2.834-845.2000; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Ch'ng Toh Hean, 2005, Methods Mol Biol, V292, P299; Chowdhury SI, 2011, VET MICROBIOL, V152, P270, DOI 10.1016/j.vetmic.2011.05.012; Cohen JI, 2001, VIROLOGY, V280, P62, DOI 10.1006/viro.2000.0741; Cristea Ileana M, 2011, Cold Spring Harb Protoc, V2011, DOI [10.1101/pdb.prot5611, 10.1101/pdb.prot5610]; Curanovic Dusica, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2604s43; Daheshia M, 1998, CURR OPIN MICROBIOL, V1, P430, DOI 10.1016/S1369-5274(98)80061-1; Favoreel HW, 2004, J VIROL, V78, P5279, DOI 10.1128/JVI.78.10.5279-5287.2004; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Kramer T, 2012, CELL HOST MICROBE, V12, P806, DOI 10.1016/j.chom.2012.10.013; Kratchmarov R, 2012, REV MED VIROL, V22, P378, DOI 10.1002/rmv.1724; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Lyman MG, 2007, J VIROL, V81, P11363, DOI 10.1128/JVI.01281-07; Lyman MG, 2009, J VIROL, V83, P6978, DOI 10.1128/JVI.00598-09; Lyman MG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000065; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Smith G, 2012, ANNU REV MICROBIOL, V66, P153, DOI 10.1146/annurev-micro-092611-150051; Taylor MP, 2012, MBIO, V3, DOI 10.1128/mBio.00063-12; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tomishima MJ, 2001, J CELL BIOL, V154, P741, DOI 10.1083/jcb.200011146; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0	26	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58776	10.1371/journal.pone.0058776	http://dx.doi.org/10.1371/journal.pone.0058776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527020	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100040
J	Linnman, C; Becerra, L; Lebel, A; Berde, C; Grant, PE; Borsook, D				Linnman, Clas; Becerra, Lino; Lebel, Alyssa; Berde, Charles; Grant, P. Ellen; Borsook, David			Transient and Persistent Pain Induced Connectivity Alterations in Pediatric Complex Regional Pain Syndrome	PLOS ONE			English	Article							SYNDROME TYPE-I; FUNCTIONAL CONNECTIVITY; BASAL GANGLIA; CINGULATE CORTEX; PERIAQUEDUCTAL GRAY; SYNDROME TYPE-1; NOXIOUS HEAT; BRAIN; CHILDREN; FMRI	Evaluation of pain-induced changes in functional connectivity was performed in pediatric complex regional pain syndrome (CRPS) patients. High field functional magnetic resonance imaging was done in the symptomatic painful state and at follow up in the asymptomatic pain free/recovered state. Two types of connectivity alterations were defined: (1) Transient increases in functional connectivity that identified regions with increased cold-induced functional connectivity in the affected limb vs. unaffected limb in the CRPS state, but with normalized connectivity patterns in the recovered state; and (2) Persistent increases in functional connectivity that identified regions with increased cold-induced functional connectivity in the affected limb as compared to the unaffected limb that persisted also in the recovered state (recovered affected limb versus recovered unaffected limb). The data support the notion that even after symptomatic recovery, alterations in brain systems persist, particularly in amygdala and basal ganglia systems. Connectivity analysis may provide a measure of temporal normalization of different circuits/regions when evaluating therapeutic interventions for this condition. The results add emphasis to the importance of early recognition and management in improving outcome of pediatric CRPS.	[Linnman, Clas; Becerra, Lino; Lebel, Alyssa; Berde, Charles; Borsook, David] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Pain & Analgesia Imaging Neurosci PAIN Grp, Boston, MA USA; [Linnman, Clas; Becerra, Lino; Lebel, Alyssa; Grant, P. Ellen; Borsook, David] Harvard Univ, Sch Med, Ctr Pain & Brain, Boston, MA USA; [Grant, P. Ellen] Boston Childrens Hosp, Dept Med, Ctr Fetal Neonatal Neuroimaging & Dev Sci, Boston, MA USA; [Grant, P. Ellen] Boston Childrens Hosp, Dept Radiol, Ctr Fetal Neonatal Neuroimaging & Dev Sci, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Linnman, C (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Pain & Analgesia Imaging Neurosci PAIN Grp, Boston, MA USA.	Clas.Linnman@childrens.harvard.edu	Grant, Peter/HIR-3733-2022	Grant, Patricia/0000-0003-1005-4013; Linnman, Clas/0000-0001-8449-894X	Mayday Foundation, New York; NINDS [R01NS065051]; Sara Page Mayo Endowment for Pediatric Pain Research; L Herlands Fund for Pain Research; International Association for the Study of Pain Early Career Award; Swedish Society for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050, R01NS065051] Funding Source: NIH RePORTER	Mayday Foundation, New York; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sara Page Mayo Endowment for Pediatric Pain Research; L Herlands Fund for Pain Research; International Association for the Study of Pain Early Career Award; Swedish Society for Medical Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by a grant from the Mayday Foundation, New York (D. B. A. L. C. B.). NINDS R01NS065051 (D. B.), the Sara Page Mayo Endowment for Pediatric Pain Research (C. B.), L Herlands Fund for Pain Research (D. B., L. B.), the International Association for the Study of Pain Early Career Award (C. L.) and the Swedish Society for Medical Research (C. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baliki MN, 2011, J NEUROSCI, V31, P13981, DOI 10.1523/JNEUROSCI.1984-11.2011; Becerra L, 2009, CNS MEASURES PAIN RE; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B; Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04; de Jong JR, 2005, PAIN, V116, P264, DOI 10.1016/j.pain.2005.04.019; Diers M, 2012, EXP BRAIN RES, V218, P619, DOI 10.1007/s00221-012-3055-2; Freund W, 2011, CLIN J PAIN, V27, P796, DOI 10.1097/AJP.0b013e31821d9063; Freund W, 2010, CLIN J PAIN, V26, P339, DOI 10.1097/AJP.0b013e3181cb4055; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fukumoto M, 1999, LANCET, V354, P1790, DOI 10.1016/S0140-6736(99)03746-0; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Gieteling EW, 2008, PAIN, V134, P302, DOI 10.1016/j.pain.2007.04.029; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Goni J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017408; Gustin SM, 2010, PAIN, V151, P69, DOI 10.1016/j.pain.2010.06.022; Harris EJ, 2012, J AM PODIAT MED ASSN, V102, P99, DOI 10.7547/1020099; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Janig W, 2002, CLIN AUTON RES, V12, P150, DOI 10.1007/s10286-002-0022-1; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Kachko L, 2008, PEDIATR INT, V50, P523, DOI 10.1111/j.1442-200X.2008.02625.x; Kishima H, 2010, NEUROIMAGE, V49, P2564, DOI 10.1016/j.neuroimage.2009.10.054; Klega A, 2010, NEUROLOGY, V75, P129, DOI 10.1212/WNL.0b013e3181e7ca2e; Krause P, 2006, CLIN NEUROPHYSIOL, V117, P169, DOI 10.1016/j.clinph.2005.09.012; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lebel A, 2008, BRAIN, V131, P1854, DOI 10.1093/brain/awn123; Libon DJ, 2010, J INT NEUROPSYCH SOC, V16, P566, DOI 10.1017/S1355617710000214; Linnman C, 2012, PAIN, V153, P444, DOI 10.1016/j.pain.2011.11.006; Low AK, 2007, J PEDIATR ORTHOPED, V27, P567, DOI 10.1097/BPO.0b013e318070cc4d; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Maihofner C, 2005, PAIN, V114, P93, DOI 10.1016/j.pain.2004.12.001; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; Mhuircheartaigh RN, 2010, J NEUROSCI, V30, P9095, DOI 10.1523/JNEUROSCI.5516-09.2010; Moulton EA, 2007, NEUROIMAGE, V35, P1586, DOI 10.1016/j.neuroimage.2007.02.001; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Mutso AA, 2012, J NEUROSCI, V32, P5747, DOI 10.1523/JNEUROSCI.0587-12.2012; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Pantazatos SP, 2012, NEUROIMAGE; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sherry DD, 1999, CLIN J PAIN, V15, P218, DOI 10.1097/00002508-199909000-00009; Shiraishi Satoe, 2006, Radiat Med, V24, P335, DOI 10.1007/s11604-006-0035-0; Simons LE, 2012, HUMAN BRAIN MAPPING; Starr CJ, 2011, BRAIN, V134, P1987, DOI 10.1093/brain/awr117; Strawn JR, 2012, DEPRESS ANXIETY, V29, P328, DOI 10.1002/da.21913; Talairach J., 1988, COPLANAR STEREOTAXIC; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Upadhyay J, 2012, NEUROIMAGE, V59, P3762, DOI 10.1016/j.neuroimage.2011.11.034; Ushida T, 2010, OPEN NEUROIMAGING J, V24, P182; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Villablanca J R, 1975, Acta Neurol Latinoam, V21, P157; Villablanca JR, 2010, ACTA NEUROBIOL EXP, V70, P95; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Walton KD, 2010, PAIN, V150, P41, DOI 10.1016/j.pain.2010.02.023; Wu CT, 2006, CLIN NUCL MED, V31, P317, DOI 10.1097/01.rlu.0000218538.06832.69; Wunderlich Arthur P, 2011, Open Neuroimag J, V5, P1, DOI 10.2174/1874440001105010001	64	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57205	10.1371/journal.pone.0057205	http://dx.doi.org/10.1371/journal.pone.0057205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526938	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100009
J	Mahida, JP; Antczak, C; DeCarlo, D; Champ, KG; Francis, JH; Marr, B; Polans, AS; Albert, DM; Abramson, DH; Djaballah, H				Mahida, Jeni P.; Antczak, Christophe; DeCarlo, Daniel; Champ, Kathryn G.; Francis, Jasmine H.; Marr, Brian; Polans, Arthur S.; Albert, Daniel M.; Abramson, David H.; Djaballah, Hakim			A Synergetic Screening Approach with Companion Effector for Combination Therapy: Application to Retinoblastoma	PLOS ONE			English	Article							INDUCED APOPTOSIS; IN-VITRO; RESVERATROL; RESISTANCE; AGENTS; EXPRESSION; INHIBITORS; MELANOMA; CELLS	For many cancers, the lack of potency and the toxicity of current drugs limits the dose achievable in patients and the efficacy of treatment. Among them, retinoblastoma is a rare cancer of the eye for which better chemotherapeutic options are needed. Combination therapy is a compelling approach to enhance the efficacy of current treatment, however clinical trials to test rationally designed combinations of approved drugs are slow and expensive, and limited by our lack of in-depth knowledge of drug specificity. Since many patients already turn to nutraceuticals in hopes of improving their condition, we hypothesized that certain approved drugs could potentially synergize with widely consumed supplements. Following this hypothesis, we devised an alternative screening strategy aimed at taking advantage of a bait compound such as a nutraceutical with potential therapeutic benefits but low potency, by screening chemical libraries for approved drugs that synergize with this companion effector. As a proof of concept, we sought to identify approved drugs with synergetic therapeutic effects toward retinoblastoma cells in combination with the antioxidant resveratrol, popular as a supplement. We systematically tested FDA-approved drugs and known bioactives seeking to identify such pairs, which led to uncovering only a few additive combinations; but to our surprise, we identified a class of anticancer drugs widely used in the clinic whose therapeutic effect is antagonized with resveratrol. Our observations could explain in part why some patients do not respond well to treatment. Our results validate this alternative approach, and we expect that our companion effector strategy could significantly impact both drug discovery and the nutraceutical industry.	[Mahida, Jeni P.; Antczak, Christophe; DeCarlo, Daniel; Champ, Kathryn G.; Djaballah, Hakim] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, HTS Core Facil, New York, NY 10021 USA; [Francis, Jasmine H.; Marr, Brian; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Dept Surg, Ophthalm Oncol Serv, New York, NY 10021 USA; [Polans, Arthur S.; Albert, Daniel M.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Wisconsin System; University of Wisconsin Madison	Antczak, C (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, HTS Core Facil, 1275 York Ave, New York, NY 10021 USA.	antczakc@mskcc.org	Antczak, Christophe/E-8573-2013	Djaballah, Hakim/0000-0002-6039-0181; Francis, Jasmine/0000-0002-7637-3108	Fund for Ophthalmic Knowledge; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of MSKCC; William Randolph Hearst Fund in Experimental Therapeutics; Lillian S. Wells Foundation; National Institutes of Health/National Cancer Institute (NIH/NCI) Cancer Center Support Grant [5 P30 CA008748-44]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of MSKCC; William Randolph Hearst Fund in Experimental Therapeutics; Lillian S. Wells Foundation; National Institutes of Health/National Cancer Institute (NIH/NCI) Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the Fund for Ophthalmic Knowledge. The HTS Core Facility is partially funded by Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center of MSKCC, the William Randolph Hearst Fund in Experimental Therapeutics, the Lillian S. Wells Foundation, and by a National Institutes of Health/National Cancer Institute (NIH/NCI) Cancer Center Support Grant 5 P30 CA008748-44. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2004, CANCER RES, V64, P1452, DOI 10.1158/0008-5472.CAN-03-2414; Ambrosini G, 2010, MEK INHIBITOR AZD624, P17; Antczak C, 2007, J BIOMOL SCREEN, V12, P521, DOI 10.1177/1087057107300463; Antczak C, 2012, J BIOMOL SCREEN, V17, P885, DOI 10.1177/1087057112446174; Antczak C, 2009, INVEST OPHTH VIS SCI, V50, P3065, DOI 10.1167/iovs.08-3158; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bock C, 2012, NAT REV CANCER, V12, P494, DOI 10.1038/nrc3297; Chantada GL, 2011, PEDIATR BLOOD CANCER, V56, P341, DOI 10.1002/pbc.22843; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen MH, 2008, CIRCULATION, V118, P84, DOI 10.1161/CIRCULATIONAHA.108.776831; Chen ZH, 2004, CARCINOGENESIS, V25, P2005, DOI 10.1093/carcin/bgh183; Chun YJ, 1999, BIOCHEM BIOPH RES CO, V262, P20, DOI 10.1006/bbrc.1999.1152; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; FOURNIER GA, 1987, INVEST OPHTH VIS SCI, V28, P690; Fulda S, 2010, DRUG DISCOV TODAY, V15, P757, DOI 10.1016/j.drudis.2010.07.005; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Holbeck S, 2012, EUR J CANCER, V48, P11, DOI 10.1016/S0959-8049(12)71826-9; Hu J, 2009, INT J CANCER, V124, P1700, DOI 10.1002/ijc.24104; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Lee G, 2012, NAT BIOTECHNOL; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; MA LD, 1991, J BIOL CHEM, V266, P5593; Mao QQ, 2010, MOL NUTR FOOD RES, V54, P1574, DOI 10.1002/mnfr.200900392; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; Patel M, 2011, OPHTHALMIC GENET, V32, P147, DOI 10.3109/13816810.2010.544530; Qin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049969; Rossi D, 2012, MOLECULES, V17, P12393, DOI 10.3390/molecules171012393; Sareen D, 2006, INVEST OPHTH VIS SCI, V47, P3708, DOI 10.1167/iovs.06-0119; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; Shum D, 2008, J ENZYM INHIB MED CH, V23, P931, DOI [10.1080/14756360701810082, 10.1080/14756360701810082 ]; Soto BL, 2011, CANCER IMMUNOL IMMUN, V60, P731, DOI 10.1007/s00262-011-0971-0; Subramanian L, 2010, CLIN CANCER RES, V16, P5942, DOI 10.1158/1078-0432.CCR-10-1486; van Ginkel PR, 2008, INVEST OPHTH VIS SCI, V49, P1299, DOI 10.1167/iovs.07-1233; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881	36	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59156	10.1371/journal.pone.0059156	http://dx.doi.org/10.1371/journal.pone.0059156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527118	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100084
J	Wang, Z; Ocampo, MA; Pang, RD; Bota, M; Bradesi, S; Mayer, EA; Holschneider, DP				Wang, Zhuo; Ocampo, Marco A.; Pang, Raina D.; Bota, Mihail; Bradesi, Sylvie; Mayer, Emeran A.; Holschneider, Daniel P.			Alterations in Prefrontal-Limbic Functional Activation and Connectivity in Chronic Stress-Induced Visceral Hyperalgesia	PLOS ONE			English	Article							BRAIN-GUT AXIS; CHRONIC RESTRAINT STRESS; CENTRAL-NERVOUS-SYSTEM; DENDRITIC REORGANIZATION; VOLUNTARY SUPPRESSION; PERIAQUEDUCTAL GRAY; CEREBRAL ACTIVATION; PYRAMIDAL NEURONS; FOS EXPRESSION; AMYGDALA	Repeated water avoidance stress (WAS) induces sustained visceral hyperalgesia (VH) in rats measured as enhanced visceromotor response to colorectal distension (CRD). This model incorporates two characteristic features of human irritable bowel syndrome (IBS), VH and a prominent role of stress in the onset and exacerbation of IBS symptoms. Little is known regarding central mechanisms underlying the stress-induced VH. Here, we applied an autoradiographic perfusion method to map regional and network-level neural correlates of VH. Adult male rats were exposed to WAS or sham treatment for 1 hour/day for 10 days. The visceromotor response was measured before and after the treatment. Cerebral blood flow (CBF) mapping was performed by intravenous injection of radiotracer ([C-14]-iodoantipyrine) while the rat was receiving a 60-mmHg CRD or no distension. Regional CBF-related tissue radioactivity was quantified in autoradiographic images of brain slices and analyzed in 3-dimensionally reconstructed brains with statistical parametric mapping. Compared to sham rats, stressed rats showed VH in association with greater CRD-evoked activation in the insular cortex, amygdala, and hypothalamus, but reduced activation in the prelimbic area (PrL) of prefrontal cortex. We constrained results of seed correlation analysis by known structural connectivity of the PrL to generate structurally linked functional connectivity (SLFC) of the PrL. Dramatic differences in the SLFC of PrL were noted between stressed and sham rats under distension. In particular, sham rats showed negative correlation between the PrL and amygdala, which was absent in stressed rats. The altered pattern of functional brain activation is in general agreement with that observed in IBS patients in human brain imaging studies, providing further support for the face and construct validity of the WAS model for IBS. The absence of prefrontal cortex-amygdala anticorrelation in stressed rats is consistent with the notion that impaired corticolimbic modulation acts as a central mechanism underlying stress-induced VH.	[Wang, Zhuo; Ocampo, Marco A.; Holschneider, Daniel P.] Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 93385 USA; [Pang, Raina D.; Holschneider, Daniel P.] Univ So Calif, Program Neurosci, Los Angeles, CA USA; [Bota, Mihail] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Holschneider, Daniel P.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Bradesi, Sylvie; Mayer, Emeran A.] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Bradesi, Sylvie; Mayer, Emeran A.; Holschneider, Daniel P.] Univ Calif Los Angeles, Dept Med, Ctr Neurobiol Stress, Los Angeles, CA 90024 USA; [Mayer, Emeran A.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Mayer, Emeran A.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Mayer, Emeran A.] Univ Calif Los Angeles, Dept Biobehav Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Holschneider, DP (corresponding author), Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 93385 USA.	holschne@usc.edu		Wang, Zhuo/0000-0003-1531-8065; Holschneider, Daniel/0000-0002-4297-8280	United States National Institutes of Health [P50DK064539, R24AT002681]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R24AT002681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064539] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by United States National Institutes of Health grants P50DK064539 (Mayer) and R24AT002681 (Mayer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 1998, J COMP NEUROL, V401, P455; Bardin L, 2009, BEHAV BRAIN RES, V205, P360, DOI 10.1016/j.bbr.2009.07.005; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Berman SM, 2002, GASTROENTEROLOGY, V123, P969, DOI 10.1053/gast.2002.35990; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Bonhomme V, 2011, CURR OPIN ANESTHESIO, V24, P474, DOI 10.1097/ACO.0b013e32834a12a1; Borszcz GS, 2006, PAIN, V123, P155, DOI 10.1016/j.pain.2006.02.026; Bota M, 2005, NEUROINFORMATICS, V3, P15, DOI 10.1385/NI:3:1:015; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; Chung KKK, 2000, NEUROSCIENCE, V95, P453; Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Correll CM, 2005, BIOL PSYCHIAT, V58, P382, DOI 10.1016/j.biopsych.2005.04.009; Costa A, 2005, NEUROSCI LETT, V383, P7, DOI 10.1016/j.neulet.2005.03.026; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; Fields HL, 2000, PROG BRAIN RES, V122, P245; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Gibney SM, 2010, NEUROSCIENCE, V165, P675, DOI 10.1016/j.neuroscience.2009.08.076; Greenwood-Van Meerveld B, 2001, BRAIN RES, V893, P135, DOI 10.1016/S0006-8993(00)03305-9; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; Holschneider DP, 2002, AM J PHYSIOL-HEART C, V283, pH1713, DOI 10.1152/ajpheart.00362.2002; HOLSTEGE G, 1992, EUR J MORPHOL, V30, P67; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jasmin L, 2004, J COMP NEUROL, V468, P425, DOI 10.1002/cne.10978; Jasmin L, 2003, NATURE, V424, P316, DOI 10.1038/nature01808; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Ji GC, 2010, J NEUROSCI, V30, P5451, DOI 10.1523/JNEUROSCI.0225-10.2010; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Larauche M, 2012, EXP NEUROL, V233, P49, DOI 10.1016/j.expneurol.2011.04.020; Lee H, 2012, NEUROIMAGE, V62, P1575, DOI 10.1016/j.neuroimage.2012.05.044; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Liebregts T, 2007, EUR J PAIN, V11, P216, DOI 10.1016/j.ejpain.2006.02.007; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Martinez V, 2006, BRAIN RES, V1086, P168, DOI 10.1016/j.brainres.2006.02.063; Mayer EA, 2009, NEUROGASTROENT MOTIL, V21, P579, DOI 10.1111/j.1365-2982.2009.01304.x; Mayer EA, 2006, GASTROENTEROLOGY, V131, P1925, DOI 10.1053/j.gastro.2006.10.026; Mayer EA, 2011, ANNU REV MED, V62, P381, DOI 10.1146/annurev-med-012309-103958; MCINTOSH AR, 1991, BRAIN RES, V547, P295, DOI 10.1016/0006-8993(91)90974-Z; Myers B, 2012, AM J PHYSIOL-GASTR L, V302, pG260, DOI 10.1152/ajpgi.00353.2011; Naliboff BD, 2001, PSYCHOSOM MED, V63, P365, DOI 10.1097/00006842-200105000-00006; Nallasamy N, 2011, NEUROSCIENTIST, V17, P94, DOI 10.1177/1073858410374126; Neugebauer V, 2003, J NEUROPHYSIOL, V89, P716, DOI 10.1152/jn.00799.2002; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; PAXINOS G, 2005, RAT BRAIN STEREOTATI; PEREZJARANAY JM, 1991, BRAIN RES, V564, P97, DOI 10.1016/0006-8993(91)91357-7; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Radley JJ, 2011, J NEUROSCI, V31, P9683, DOI 10.1523/JNEUROSCI.6040-10.2011; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Robinson OJ, 2012, NEUROIMAGE, V60, P523, DOI 10.1016/j.neuroimage.2011.11.096; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Snowball RK, 2000, NEUROSCIENCE, V99, P351, DOI 10.1016/S0306-4522(00)00203-7; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stam R, 2002, GASTROENTEROLOGY, V123, P1216, DOI 10.1053/gast.2002.36029; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Tillisch K, 2008, ANN NY ACAD SCI, V1144, P256, DOI 10.1196/annals.1418.025; Torres ILD, 2003, NEUROSCI RES, V45, P277, DOI 10.1016/S0168-0102(02)00232-8; Tramullas M, 2012, STRESS, V15, P281, DOI 10.3109/10253890.2011.622816; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vogt B., 2004, RAT NERVOUS SYSTEM, P705; Vyas A, 2003, BRAIN RES, V965, P290, DOI 10.1016/S0006-8993(02)04162-8; Vyas A, 2002, J NEUROSCI, V22, P6810; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; Wang Z, 2008, PAIN, V138, P233, DOI 10.1016/j.pain.2008.04.018; Wang Z, 2011, PAIN, V152, P2746, DOI 10.1016/j.pain.2011.08.022; Wang Z, 2009, PAIN, V145, P120, DOI 10.1016/j.pain.2009.05.025; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Wouters MM, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01919.x	80	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59138	10.1371/journal.pone.0059138	http://dx.doi.org/10.1371/journal.pone.0059138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527114	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100082
J	Richardson, SJ; Allen, RB; Buxton, RP; Easdale, TA; Hurst, JM; Morse, CW; Smissen, RD; Peltzer, DA				Richardson, Sarah J.; Allen, Robert B.; Buxton, Rowan P.; Easdale, Tomas A.; Hurst, Jennifer M.; Morse, Christopher W.; Smissen, Rob D.; Peltzer, Duane A.			Intraspecific Relationships among Wood Density, Leaf Structural Traits and Environment in Four Co-Occurring Species of Nothofagus in New Zealand	PLOS ONE			English	Article							DRY-MATTER CONTENT; 2 TROPICAL FORESTS; FUNCTIONAL TRAIT; SOIL CHRONOSEQUENCE; GLOBAL PATTERNS; CARBON GAIN; STEM TRAITS; ROOT TRAITS; LIFE-SPAN; AREA	Plant functional traits capture important variation in plant strategy and function. Recent literature has revealed that within-species variation in traits is greater than previously supposed. However, we still have a poor understanding of how intraspecific variation is coordinated among different traits, and how it is driven by environment. We quantified intraspecific variation in wood density and five leaf traits underpinning the leaf economics spectrum (leaf dry matter content, leaf mass per unit area, size, thickness and density) within and among four widespread Nothofagus tree species in southern New Zealand. We tested whether intraspecific relationships between wood density and leaf traits followed widely reported interspecific relationships, and whether variation in these traits was coordinated through shared responses to environmental factors. Sample sites varied widely in environmental variables, including soil fertility (25-900 mg kg(-1) total P), precipitation (668-4875 mm yr(-1)), temperature (5.2-12.4 degrees C mean annual temperature) and latitude (41-46 degrees S). Leaf traits were strongly correlated with one another within species, but not with wood density. There was some evidence for a positive relationship between wood density and leaf tissue density and dry matter content, but no evidence that leaf mass or leaf size were correlated with wood density; this highlights that leaf mass per unit area cannot be used as a surrogate for component leaf traits such as tissue density. Trait variation was predicted by environmental factors, but not consistently among different traits; e. g., only leaf thickness and leaf density responded to the same environmental cues as wood density. We conclude that although intraspecific variation in wood density and leaf traits is strongly driven by environmental factors, these responses are not strongly coordinated among functional traits even across co-occurring, closely-related plant species.	[Richardson, Sarah J.; Allen, Robert B.; Buxton, Rowan P.; Easdale, Tomas A.; Hurst, Jennifer M.; Morse, Christopher W.; Smissen, Rob D.; Peltzer, Duane A.] Landcare Res, Lincoln, New Zealand	Landcare Research - New Zealand	Richardson, SJ (corresponding author), Landcare Res, Lincoln, New Zealand.	richardsons@landcareresearch.co.nz	Peltzer, Duane A/A-9463-2009; Richardson, Sarah J/D-3353-2015	Peltzer, Duane A/0000-0001-7724-3738; Richardson, Sarah J/0000-0002-4097-0381; Easdale, Tomas A./0000-0001-5086-8527; Smissen, Rob/0000-0001-6299-1987	Landcare Research Capability Funding; New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group; National Vegetation Survey Databank	Landcare Research Capability Funding; New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group(New Zealand Ministry of Business, Innovation and Employment (MBIE)); National Vegetation Survey Databank	Funding provided by Landcare Research Capability Funding; Core funding for Crown Research Institutes from the New Zealand Ministry of Business, Innovation and Employment's Science and Innovation Group; and the National Vegetation Survey Databank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Ackerly DD, 2002, PHYS PLANT EC 39 S B, P391; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baltzer JL, 2009, AM J BOT, V96, P2214, DOI 10.3732/ajb.0800414; BARAJASMORALES J, 1987, IAWA BULL, V8, P143, DOI 10.1163/22941932-90001041; BARAJASMORALES J, 1985, IAWA BULL, V6, P355, DOI 10.1163/22941932-90000962; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Castro-Diez P, 2000, OECOLOGIA, V124, P476, DOI 10.1007/PL00008873; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Craine JM, 2003, OECOLOGIA, V134, P471, DOI 10.1007/s00442-002-1155-6; Craine JM, 2010, PLANT SOIL, V337, P193, DOI 10.1007/s11104-010-0515-y; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; De Frenne P, 2011, ECOGRAPHY, V34, P132, DOI 10.1111/j.1600-0587.2010.06399.x; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Holdaway RJ, 2011, J ECOL, V99, P954, DOI 10.1111/j.1365-2745.2011.01821.x; Hovenden MJ, 2006, NEW PHYTOL, V169, P291, DOI 10.1111/j.1469-8137.2005.01585.x; Hulshof CM, 2010, FUNCT ECOL, V24, P217, DOI 10.1111/j.1365-2435.2009.01614.x; Ishida A, 2008, OECOLOGIA, V156, P193, DOI 10.1007/s00442-008-0965-6; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019992; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Kooyman RM, 2009, ANN BOT-LONDON, V104, P987, DOI 10.1093/aob/mcp185; Leathwick JR, 2003, CONSERV BIOL, V17, P1612, DOI 10.1111/j.1523-1739.2003.00469.x; Leathwick JR, 1998, J VEG SCI, V9, P719, DOI 10.2307/3237290; Leathwick JR, 2001, NEW ZEAL J BOT, V39, P447; Lusk CH, 2008, TRENDS ECOL EVOL, V23, P299, DOI 10.1016/j.tree.2008.02.006; Magnani F, 2009, NEW PHYTOL, V184, P277, DOI 10.1111/j.1469-8137.2009.03035.x; Malhado ACM, 2009, BIOGEOSCIENCES, V6, P1563, DOI 10.5194/bg-6-1563-2009; Markesteijn L, 2011, PLANT CELL ENVIRON, V34, P137, DOI 10.1111/j.1365-3040.2010.02231.x; Martinez-Cabrera HI, 2009, AM J BOT, V96, P1388, DOI 10.3732/ajb.0800237; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; Mason NWH, 2012, J ECOL, V100, P678, DOI [10.1111/j.1365-2745.2012.01965.x, 10.1111/j.1365-2745.2012.01965.X]; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Niinemets U, 2002, ANN BOT-LONDON, V89, P191, DOI 10.1093/aob/mcf025; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Palow DT, 2012, FUNCT ECOL, V26, P1144, DOI 10.1111/j.1365-2435.2012.02019.x; Pickup M, 2005, FUNCT ECOL, V19, P88, DOI 10.1111/j.0269-8463.2005.00927.x; Pohlman CL, 2005, J BIOGEOGR, V32, P341, DOI 10.1111/j.1365-2699.2004.01181.x; POOLE A. L., 1958, TRANS ROY SOC NEW ZEALAND, V85, P551; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Richardson SJ, 2008, FUNCT ECOL, V22, P738, DOI 10.1111/j.1365-2435.2008.01426.x; Richardson SJ, 2010, NEW ZEAL J ECOL, V34, P306; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Silvertown J, 1996, PHILOS T ROY SOC B, V351, P1233, DOI 10.1098/rstb.1996.0106; Sugiyama S, 2003, PLANT ECOL, V169, P295, DOI 10.1023/A:1026081122985; Sundqvist MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027056; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Wardle J., 1984, NZ BEECHES ECOLOGY U; WEBB LJ, 1959, J ECOL, V47, P551, DOI 10.2307/2257290; Wiemann MC, 2002, WOOD FIBER SCI, V34, P96; WILCOX MD, 1983, NEW ZEAL J ECOL, V6, P19; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wiser SK, 2011, APPL VEG SCI, V14, P506, DOI 10.1111/j.1654-109X.2011.01146.x; WITKOWSKI ETF, 1991, OECOLOGIA, V88, P486, DOI 10.1007/BF00317710; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2006, PHYSIOL PLANTARUM, V127, P445, DOI 10.1111/j.1399-3054.2006.00699.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zhang JL, 2009, FUNCT ECOL, V23, P658, DOI 10.1111/j.1365-2435.2009.01552.x	71	29	33	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58878	10.1371/journal.pone.0058878	http://dx.doi.org/10.1371/journal.pone.0058878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527041	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600014
J	van der Knaap, N; Grady, BPX; van der Loeff, MFS; Heijman, T; Speksnijder, A; Geskus, R; Prins, M				van der Knaap, Nienke; Grady, Bart P. X.; van der Loeff, Maarten F. Schim; Heijman, Titia; Speksnijder, Arjen; Geskus, Ronald; Prins, Maria			Drug Users in Amsterdam: Are They Still at Risk for HIV?	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C-VIRUS; PROSPECTIVE COHORT; RUSSIAN-FEDERATION; SAN-FRANCISCO; SEX WORKERS; INJECTION; PREVALENCE	Background and Aims: To examine whether drug users (DU) in the Amsterdam Cohort Study (ACS) are still at risk for HIV, we studied trends in HIV incidence and injecting and sexual risk behaviour from 1986 to 2011. Methods: The ACS is an open, prospective cohort study on HIV. Calendar time trends in HIV incidence were modelled using Poisson regression. Trends in risk behaviour were modelled via generalized estimating equations. In 2010, a screening for STI (chlamydia, gonorrhoea and syphilis) was performed. Determinants of unprotected sex were studied using logistic regression analysis. Results: The HIV incidence among 1298 participants of the ACS with a total follow-up of 12,921 person-years (PY) declined from 6.0/100 PY (95% confidence interval [CI] 3.2-11.1) in 1986 to less than 1/100 PY from 1997 onwards. Both injection and sexual risk behaviour declined significantly over time. Out of 197 participants screened for STI in 2010-2011, median age 49 years (IQR 43-59), only 5 (2.5%) were diagnosed with an STI. In multivariable analysis, having a steady partner (aOR 4.1, 95% CI 1.6-10.5) was associated with unprotected sex. HIV-infected participants were less likely to report unprotected sex (aOR 0.07, 95% CI 0.02-0.37). Conclusions: HIV incidence and injection risk behaviour declined from 1986 onwards. STI prevalence is low; unprotected sex is associated with steady partners and is less common among HIV-infected participants. These findings indicate a low transmission risk of HIV and STI, which suggests that DU do not play a significant role in the current spread of HIV in Amsterdam.	[van der Knaap, Nienke; Grady, Bart P. X.; van der Loeff, Maarten F. Schim; Heijman, Titia; Speksnijder, Arjen; Geskus, Ronald; Prins, Maria] Publ Hlth Serv, Amsterdam, Netherlands; [van der Knaap, Nienke] Univ Amsterdam, Amsterdam, Netherlands; [Grady, Bart P. X.; van der Loeff, Maarten F. Schim; Heijman, Titia; Prins, Maria] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Ctr Infect Dis & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Speksnijder, Arjen] Publ Hlth Serv, Publ Hlth Lab, Amsterdam, Netherlands; [Prins, Maria] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Geskus, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Grady, BPX (corresponding author), Publ Hlth Serv, Amsterdam, Netherlands.	bgrady@ggd.amsterdam.nl	Geskus, Ronald B/H-3684-2019; Speksnijder, Arjen/M-3406-2017; Grady, Bart/F-3410-2013	Geskus, Ronald B/0000-0002-2740-3155; Speksnijder, Arjen/0000-0002-1966-7265; Heijman, Titia/0000-0002-1944-2007	Netherlands National Institute for Public Health; Environment; PHSA Research and Development fund	Netherlands National Institute for Public Health; Environment; PHSA Research and Development fund	The Amsterdam Cohort Studies (ACS) on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam (PHSA), the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Netherlands National Institute for Public Health and the Environment (website: http://www.amsterdamcohortstudies.org/). The PHSA Research and Development fund provided additional funding for the sexually transmitted infections (STI) screening conducted in 2011. The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Atun RA, 2008, HEALTH POLICY, V86, P181, DOI 10.1016/j.healthpol.2007.10.004; Bachmann LH, 2000, AM J PUBLIC HEALTH, V90, P1615, DOI 10.2105/AJPH.90.10.1615; Booth RE, 2000, DRUG ALCOHOL DEPEN, V58, P219, DOI 10.1016/S0376-8716(99)00094-0; Buster MCA, 2009, EUR ADDICT RES, V15, P179, DOI 10.1159/000228928; Crawford ND, 2010, JAIDS-J ACQ IMM DEF, V55, pS84, DOI 10.1097/QAI.0b013e3181fbca5a; de Vos AS, 2013, ADDICTION; Des Jarlais DC, 2011, SUBST USE MISUSE, V46, P131, DOI 10.3109/10826084.2011.521456; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2011, HIV AIDS SURV EUR 20; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2010, TRENDS INJ DRUG US E; Fennema JSA, 1997, SEX TRANSM DIS, V24, P363, DOI 10.1097/00007435-199707000-00010; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hastie T., 1992, GEN ADDITIVE MODELS; Heijman TLJ, 2007, SEX TRANSM DIS, V34, P508, DOI 10.1097/01.olq.0000251209.52901.c3; Heymans R, 2012, J INFECT DIS; Huo DZ, 2009, SEX TRANSM DIS, V36, P35, DOI 10.1097/OLQ.0b013e318186dee3; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Kral AH, 2000, J ACQ IMMUN DEF SYND, V24, P162; Kuyper Laura M, 2005, Can J Infect Dis Med Microbiol, V16, P225; Kwiatkowski CF, 2003, JAIDS-J ACQ IMM DEF, V33, pS131, DOI 10.1097/00126334-200306012-00010; Landes M, 2007, EUR J EPIDEMIOL, V22, P925, DOI 10.1007/s10654-007-9188-0; Lindenburg CEA, 2006, AIDS, V20, P1771, DOI 10.1097/01.aids.0000242824.59377.53; Lopez WD, 2010, ADDICT BEHAV, V35, P432, DOI 10.1016/j.addbeh.2009.12.010; Lowndes CM, 2003, SEX TRANSM DIS, V30, P46, DOI 10.1097/00007435-200301000-00010; Lukashov VV, 2012, J ACQUIR IMMUNE DEFI; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mehta SH, 2011, J INFECT DIS, V203, P587, DOI 10.1093/infdis/jiq112; Minkin MJ, 2010, MATURITAS, V67, P114, DOI 10.1016/j.maturitas.2010.05.003; Niccolai LM, 2009, J URBAN HEALTH, V86, pS131, DOI 10.1007/s11524-009-9369-0; Ouellet LJ, 2000, J ACQ IMMUN DEF SYND, V25, P443, DOI 10.1097/00126334-200012150-00010; Platt L, 2011, SEX TRANSM INFECT, V87, P377, DOI 10.1136/sti.2011.049544; Plitt SS, 2005, SEX TRANSM DIS, V32, P446, DOI 10.1097/01.olq.0000154567.21291.59; Rothenberg R, 2009, J URBAN HEALTH, V86, pS144, DOI 10.1007/s11524-009-9374-3; Roy E, 2011, AIDS, V25, P1897, DOI 10.1097/QAD.0b013e32834ad6bb; Savona N, 2011, SEX TRANSM INFECT, V87, P70, DOI 10.1136/sti.2010.048009; Smit C, 2006, ADDICTION, V101, P433, DOI 10.1111/j.1360-0443.2006.01339.x; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Trienekens Suzan, 2012, SEXUALLY TRANSMITTED; van Bergen JEAM, 2011, CHLAMYDIA SCREENING; van de Laar TJW, 2005, J MED VIROL, V77, P509, DOI 10.1002/jmv.20486; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; van Ooyen-Houben M. M. J., 2010, NATL DRUG MONITOR JA; van Veen MG, 2010, ARCH SEX BEHAV, V39, P714, DOI 10.1007/s10508-008-9396-z; VANDENHOEK JAR, 1988, AIDS, V2, P55, DOI 10.1097/00002030-198802000-00010; Wiessing L, 2010, EURO SURVEILL, V15; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59125	10.1371/journal.pone.0059125	http://dx.doi.org/10.1371/journal.pone.0059125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109ZS	23527107	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600041
J	Johnen, H; Gonzalez-Silva, L; Carramolino, L; Flores, JM; Torres, M; Salvador, JM				Johnen, Heiko; Gonzalez-Silva, Laura; Carramolino, Laura; Maria Flores, Juana; Torres, Miguel; Salvador, Jesus M.			Gadd45g Is Essential for Primary Sex Determination, Male Fertility and Testis Development	PLOS ONE			English	Article							CRITICAL TIME WINDOW; SRY EXPRESSION; GENOTOXIC-STRESS; CELL-CYCLE; MICE; FAMILY; REVERSAL; GENE; GADD45A-DEFICIENT; DIFFERENTIATION	In humans and most mammals, differentiation of the embryonic gonad into ovaries or testes is controlled by the Y-linked gene SRY. Here we show a role for the Gadd45g protein in this primary sex differentiation. We characterized mice deficient in Gadd45a, Gadd45b and Gadd45g, as well as double-knockout mice for Gadd45ab, Gadd45ag and Gadd45bg, and found a specific role for Gadd45g in male fertility and testis development. Gadd45g-deficient XY mice on a mixed 129/C57BL/6 background showed varying degrees of disorders of sexual development (DSD), ranging from male infertility to an intersex phenotype or complete gonadal dysgenesis (CGD). On a pure C57BL/6 (B6) background, all Gadd45g(-/-) XY mice were born as completely sex-reversed XY-females, whereas lack of Gadd45a and/or Gadd45b did not affect primary sex determination or testis development. Gadd45g expression was similar in female and male embryonic gonads, and peaked around the time of sex differentiation at 11.5 days post-coitum (dpc). The molecular cause of the sex reversal was the failure of Gadd45g(-/-) XY gonads to achieve the SRY expression threshold necessary for testes differentiation, resulting in ovary and Mullerian duct development. These results identify Gadd45g as a candidate gene for male infertility and 46, XY sex reversal in humans.	[Johnen, Heiko; Gonzalez-Silva, Laura; Salvador, Jesus M.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Carramolino, Laura; Torres, Miguel] Ctr Nacl Invest Cardiovasc, Dept Cardiovasc Dev & Repair, Madrid, Spain; [Maria Flores, Juana] Univ Complutense Madrid, Sch Vet, Anim Surg & Med Dept, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid	Salvador, JM (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Campus Cantoblanco, Madrid, Spain.	jmsalvador@cnb.csic.es	Torres, Miguel/CAG-0003-2022; Torres, Miguel/A-7388-2013; Carramolino, Laura/H-5886-2015	Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767; Carramolino, Laura/0000-0002-1661-618X; Gonzalez-Silva, Laura/0000-0001-8625-1473; Salvador, Jesus Maria/0000-0002-1087-9675	European Research Council (ERC) [FP7-208250-1]; Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias) [PI081718, PI1101411]; Ministerio de Ciencia e Innovacion [200820I109]; Spanish Ministry of Science and Innovation (MICINN) JAE Programme (CSIC)	European Research Council (ERC)(European Research Council (ERC)European Commission); Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation (MICINN) JAE Programme (CSIC)	This work was supported by grants from the European Research Council (ERC; FP7-208250-1), the Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias, PI081718, PI1101411), and the Ministerio de Ciencia e Innovacion (200820I109) to JMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank V Cano for technical support, B Pintado for technical advice, E Samper for performing the FISH chromosome painting, and C Mark for editorial assistance. LGS receives a predoctoral fellowship from the Spanish Ministry of Science and Innovation (MICINN) JAE Programme (CSIC).	Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Blackless M, 2000, AM J HUM BIOL, V12, P151, DOI 10.1002/(SICI)1520-6300(200003/04)12:2<151::AID-AJHB1>3.0.CO;2-F; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Cai Q, 2006, AM J PHYSIOL-RENAL, V291, pF341, DOI 10.1152/ajprenal.00518.2005; Cederroth CR, 2007, MOL CELL ENDOCRINOL, V265, P3, DOI 10.1016/j.mce.2006.12.029; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gierl MS, 2012, DEV CELL, V23, P1032, DOI 10.1016/j.devcel.2012.09.014; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1136/adc.2006.098319, 10.1016/j.jpurol.2006.03.004]; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kaufmann LT, 2011, MECH DEVELOP, V128, P401, DOI 10.1016/j.mod.2011.08.002; Kaufmann LT, 2011, GENE EXPR PATTERNS, V11, P465, DOI 10.1016/j.gep.2011.07.005; Li YM, 2012, METHODS MOL BIOL, V825, P3, DOI 10.1007/978-1-61779-436-0_1; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Munger SC, 2009, GENE DEV, V23, P2521, DOI 10.1101/gad.1835809; Nakayama K, 1999, J BIOL CHEM, V274, P24766, DOI 10.1074/jbc.274.35.24766; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006	32	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58751	10.1371/journal.pone.0058751	http://dx.doi.org/10.1371/journal.pone.0058751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516551	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200110
J	Borgeaud, C; van de Waal, E; Bshary, R				Borgeaud, Christele; van de Waal, Erica; Bshary, Redouan			Third-Party Ranks Knowledge in Wild Vervet Monkeys (Chlorocebus aethiops pygerythrus)	PLOS ONE			English	Article							TRANSITIVE INFERENCE; GROUP-SIZE; CLASSIFICATION; CONTEXT; KINSHIP	The Machiavellian/Social Intelligence Hypothesis proposes that a complex social environment selected for advanced cognitive abilities in vertebrates. In primates it has been proposed that sophisticated social strategies like obtaining suitable coalition partners are an important component of social intelligence. Knowing the rank relationships between group members is a basic requirement for the efficient use of coalitions and the anticipation of counter-coalitions. Experimental evidence for such knowledge currently exists in only few species. Here, we conducted rank reversal playback experiments on adult females belonging to three different groups of free-ranging vervet monkeys (Chlorocebus aethiops pygerythrus) to test their knowledge of the female hierarchy. Playbacks simulating rank reversals (subordinate aggressing a dominant) induced longer looking times than playbacks simulating a dominant aggressing a subordinate. Vervet monkey females therefore seem to compute the rank relationships between other females. Our results suggest that detailed social knowledge about rank relationships may be widespread in primates and potentially also in other species living in stable groups.	[Borgeaud, Christele; Bshary, Redouan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [van de Waal, Erica] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Borgeaud, Christele; van de Waal, Erica; Bshary, Redouan] Inkawu Vervet Project, Swart Mfolozi, KwaZulu Natal, South Africa	University of Neuchatel; University of St Andrews	Borgeaud, C (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	christele.borgeaud@unine.ch		van de Waal, Erica/0000-0001-7778-418X; Bshary, Redouan/0000-0001-7198-8472	Swiss National Science Foundation (Sinergia) [CRSI33_133040]	Swiss National Science Foundation (Sinergia)(Swiss National Science Foundation (SNSF))	This study was financed by the Swiss National Science Foundation (Sinergia: CRSI33_133040), www.snsf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN C, 1980, BEHAV ECOL SOCIOBIOL, V6, P315, DOI 10.1007/BF00292774; Barton R. A., 1997, EVOLUTION SOCIAL BRA; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bshary R, 2002, BEHAV ECOL SOCIOBIOL, V52, P365, DOI 10.1007/s00265-002-0527-6; Bshary Redouan, 2011, P209; Byrne R., 1988, MACHIAVELLIAN INTELL; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; CHENEY DL, 1995, J COMP PSYCHOL, V109, P134, DOI 10.1037/0735-7036.109.2.134; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; DAVIS H, 1992, J COMP PSYCHOL, V106, P342, DOI 10.1037/0735-7036.106.4.342; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; DEWAAL F, 1982, CHIMPANZEE POLITICS; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Engh AL, 2005, ANIM BEHAV, V69, P209, DOI 10.1016/j.anbehav.2004.04.013; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; McGregor PK, 2005, ANIMAL COMMUNICATION; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Schino G, 2006, ANIM BEHAV, V71, P1069, DOI 10.1016/j.anbehav.2005.07.019; Silk JB, 1999, ANIM BEHAV, V58, P45, DOI 10.1006/anbe.1999.1129; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Taborsky B, 2012, TRENDS ECOL EVOL, V27, P679, DOI 10.1016/j.tree.2012.09.003; Whiten A., 1997, MACHIAVELLIAN INTELL, DOI [10.1017/CBO9780511525636, DOI 10.1017/CBO9780511525636]; Xing J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-5	31	23	23	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58562	10.1371/journal.pone.0058562	http://dx.doi.org/10.1371/journal.pone.0058562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520521	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900081
J	Gaudreau, K; Sanford, CJ; Cheverie, C; McClure, C				Gaudreau, Katherine; Sanford, Carolyn J.; Cheverie, Connie; McClure, Carol			The Effect of a Smoking Ban on Hospitalization Rates for Cardiovascular and Respiratory Conditions in Prince Edward Island, Canada	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SECONDHAND SMOKE; 2ND-HAND SMOKE; PUBLIC PLACES; EXPOSURE; ASSOCIATION; RISK; LEGISLATION; WORKERS; HEALTH	Background: This is the first study to have examined the effect of smoking bans on hospitalizations in the Atlantic Canadian socio-economic, cultural and climatic context. On June 1, 2003 Prince Edward Island (PEI) enacted a province-wide smoking ban in public places and workplaces. Changes in hospital admission rates for cardiovascular (acute myocardial infarction, angina, and stroke) and respiratory (chronic obstructive pulmonary disease and asthma) conditions were examined before and after the smoking ban. Methods: Crude annual and monthly admission rates for the above conditions were calculated from April 1, 1995 to December 31, 2008 in all PEI acute care hospitals. Autoregressive Integrated Moving Average time series models were used to test for changes in mean and trend of monthly admission rates for study conditions, control conditions and a control province after the comprehensive smoking ban. Age-and sex-based analyses were completed. Results: The mean rate of acute myocardial infarctions was reduced by 5.92 cases per 100,000 person-months (P = 0.04) immediately after the smoking ban. The trend of monthly angina admissions in men was reduced by 20.44 cases per 100,000 person-months (P = 0.01) in the 67 months after the smoking ban. All other cardiovascular and respiratory admission changes were non-significant. Conclusions: A comprehensive smoking ban in PEI reduced the overall mean number of acute myocardial infarction admissions and the trend of angina hospital admissions.	[Gaudreau, Katherine; Sanford, Carolyn J.; Cheverie, Connie; McClure, Carol] Chief Publ Hlth Off, Dept Hlth & Wellness, Epidemiol Unit, Charlottetown, PE, Canada		McClure, C (corresponding author), Chief Publ Hlth Off, Dept Hlth & Wellness, Epidemiol Unit, Charlottetown, PE, Canada.	cmcclure@ihis.org			Canadian Chronic Disease Surveillance System (Public Health Agency of Canada)	Canadian Chronic Disease Surveillance System (Public Health Agency of Canada)	This project was funded by the Canadian Chronic Disease Surveillance System (Public Health Agency of Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, REP GLOB TOB EP 2009; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Barr CD, 2012, AM J EPIDEMIOL, V176, P642, DOI 10.1093/aje/kws267; Bates MN, 2002, TOB CONTROL, V11, P125, DOI 10.1136/tc.11.2.125; Bell C, 2010, P EDWARD ISLAND HLTH; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; Box G., 1970, TIME SERIES ANAL; Canadian Chronic Disease Surveillance System (CCDSS), CCDSS ALG ASTHM COPD; Canadian Institutes for Health Information (CIHI) Canadian Institute for Health Information (CIHI), 2011, DISCH ABSTR DAT DAD; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Desjardins R-M, 2005, SOCIOECONOMIC PROFIL; Dobre I., 2008, J APPL QUANTITATIVE, V3, P156; Dove MS, 2010, AM J PUBLIC HEALTH, V100, P2206, DOI 10.2105/AJPH.2009.189662; Eisner Mark D, 2009, Int J Chron Obstruct Pulmon Dis, V4, P169; Eisner MD, 2005, THORAX, V60, P814, DOI 10.1136/thx.2004.037283; Environmental Technology Advancement Directorate, 2004, NAT AIR POLL SURV NA; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Gasparrini A, 2009, EUR J EPIDEMIOL, V24, P597, DOI 10.1007/s10654-009-9377-0; Glantz SA, 2008, PREV MED, V47, P452, DOI 10.1016/j.ypmed.2008.06.007; Government of Canada NRC, 2011, ATL MAR EC; Government of Canada SC, 2001, STAT CAN POP DWELL C; Government of Canada SC, 2011, STAT CAN 2006 CENS T; Government of Canada SC, 2011, STAT CAN 2006 COMM P; Griffiths D, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/209370; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Iribarren C, 2004, NEUROEPIDEMIOLOGY, V23, P38, DOI 10.1159/000073973; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; Lemstra M, 2008, CAN J PUBLIC HEALTH, V99, P62, DOI 10.1007/BF03403743; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Marlow ML, 2012, APPL ECON LETT, V19, P1577, DOI 10.1080/13504851.2011.639730; McCord J, 2008, CIRCULATION, V117, P1897, DOI 10.1161/CIRCULATIONAHA.107.188950; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; Panagiotakos DB, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-9; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pierce JP, 2008, LANCET ONCOL, V9, P614, DOI 10.1016/S1470-2045(08)70167-0; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Shetty KD, 2011, J POLICY ANAL MANAG, V30, P6, DOI 10.1002/pam.20548; Stata Corp LP, 2007, STAT REL 10 TIM SER; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; Valente P, 2007, TOB CONTROL, V16, P312, DOI 10.1136/tc.2006.019646; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	44	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56102	10.1371/journal.pone.0056102	http://dx.doi.org/10.1371/journal.pone.0056102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520450	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900009
J	Hernandez-Sanabria, E; Goonewardene, LA; Wang, ZQ; Zhou, M; Moore, SS; Guan, LL				Hernandez-Sanabria, Emma; Goonewardene, Laksiri A.; Wang, Zhiquan; Zhou, Mi; Moore, Stephen S.; Guan, Le Luo			Influence of Sire Breed on the Interplay among Rumen Microbial Populations Inhabiting the Rumen Liquid of the Progeny in Beef Cattle	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; FEED-EFFICIENCY; BACTERIAL COMMUNITY; GUT MICROBIOME; PERFORMANCE; PREVOTELLA; DIVERSITY; METHANE; TRAITS; FLUID	This study aimed to evaluate whether the host genetic background impact the ruminal microbial communities of the progeny of sires from three different breeds under different diets. Eighty five bacterial and twenty eight methanogen phylotypes from 49 individuals of diverging sire breed (Angus, ANG; Charolais, CHA; and Hybrid, HYB), fed high energy density (HE) and low energy density (LE) diets were determined and correlated with breed, rumen fermentation and phenotypic variables, using multivariate statistical approaches. When bacterial phylotypes were compared between diets, ANG offspring showed the lowest number of diet-associated phylotypes, whereas CHA and HYB progenies had seventeen and twenty-three diet-associated phylotypes, respectively. For the methanogen phylotypes, there were no sire breed-associated phylotypes; however, seven phylotypes were significantly different among breeds on either diet (P<0.05). Sire breed did not influence the metabolic variables measured when high energy diet was fed. A correlation matrix of all pairwise comparisons among frequencies of bacterial and methanogen phylotypes uncovered their relationships with sire breed. A cluster containing methanogen phylotypes M16 (Methanobrevibacter gottschalkii) and M20 (Methanobrevibacter smithii), and bacterial phylotype B62 (Robinsoniella sp.) in Angus offspring fed low energy diet reflected the metabolic interactions among microbial consortia. The clustering of the phylotype frequencies from the three breeds indicated that phylotypes detected in CHA and HYB progenies are more similar among them, compared to ANG animals. Our results revealed that the frequency of particular microbial phylotypes in the progeny of cattle may be influenced by the sire breed when different diets are fed and ultimately further impact host metabolic functions, such as feed efficiency.	[Hernandez-Sanabria, Emma; Goonewardene, Laksiri A.; Wang, Zhiquan; Zhou, Mi; Moore, Stephen S.; Guan, Le Luo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Moore, Stephen S.] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	University of Alberta; University of Queensland	Guan, LL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca		Hernandez Sanabria, Emma/0000-0002-5845-9821; Moore, Stephen/0000-0002-9758-166X; Zhou, Mi/0000-0001-9056-9468	Alberta Livestock Industry Development Fund; Alberta Livestock Meat Agency; Alberta Agricultural Research Institute [ALIDF/ALMA/AARI 2007F041R, ALMA2010R086R]; CONACyT Scholarship	Alberta Livestock Industry Development Fund; Alberta Livestock Meat Agency; Alberta Agricultural Research Institute; CONACyT Scholarship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by the Alberta Livestock Industry Development Fund, Alberta Livestock Meat Agency, Alberta Agricultural Research Institute (ALIDF/ALMA/AARI 2007F041R and ALMA2010R086R), and by a CONACyT Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan R, 2008, J PEDIATR GASTR NUTR, V46, P514, DOI 10.1097/MPG.0b013e31815ce599; Beh EJ, 2004, INT STAT REV, V72, P257; Ben-Dov E, 2006, APPL ENVIRON MICROB, V72, P6902, DOI 10.1128/AEM.00849-06; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bevans DW, 2005, J ANIM SCI, V83, P1116; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Crater AR, 2007, J MAMMAL, V88, P625, DOI 10.1644/06-MAMM-A-170R1.1; Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1; Dickinson W, 2008, PROC CORRESP CATEGOR; Durunna ON, 2011, J ANIM SCI, V89, P158, DOI 10.2527/jas.2009-2514; Edwards JE, 2008, ANIMAL, V2, P653, DOI 10.1017/S1751731108002164; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Ferrell CL, 2006, J ANIM SCI, V84, P2515, DOI 10.2527/jas.2005-746; GOMEZALARCON RA, 1982, APPL ENVIRON MICROB, V44, P346, DOI 10.1128/AEM.44.2.346-350.1982; Goonewardene LA, 2003, LIVEST PROD SCI, V81, P47, DOI 10.1016/S0301-6226(02)00194-X; Guan LL, 2008, FEMS MICROBIOL LETT, V288, P85, DOI 10.1111/j.1574-6968.2008.01343.x; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Hernandez-Sanabria E, 2012, APPL ENVIRON MICROB, V78, P1203, DOI 10.1128/AEM.05114-11; Hernandez-Sanabria E, 2010, APPL ENVIRON MICROB, V76, P6338, DOI 10.1128/AEM.01052-10; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kim C.C., 2012, IDENTIFICATION RUMEN; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Lodge-Ivey SL, 2009, J ANIM SCI, V87, P2333, DOI 10.2527/jas.2008-1472; Mader CJ, 2009, J ANIM SCI, V87, P1548, DOI 10.2527/jas.2008-0914; Mckay SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-37; Michelland RJ, 2009, J APPL MICROBIOL, V107, P1642, DOI 10.1111/j.1365-2672.2009.04346.x; Mujibi FDN, 2010, J ANIM SCI, V88, P3789, DOI 10.2527/jas.2009-2407; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nkrumah JD, 2006, J ANIM SCI, V84, P145; OHERRIN SM, 1993, APPL ENVIRON MICROB, V59, P748, DOI 10.1128/AEM.59.3.748-755.1993; Olfert E.D., 1993, CANADIAN COUNCIL ANI, V1; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; SAS Institute Inc, 2010, SAS IML STUD 3 2 US; Sasaki K, 2011, APPL MICROBIOL BIOT, V90, P1555, DOI 10.1007/s00253-011-3215-5; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Sun YZ, 2010, ANIMAL, V4, P210, DOI 10.1017/S175173110999111X; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tims S, 2011, METHAGENOMICS HUMAN; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Wallace RJ, 2008, ANIMAL, V2, P661, DOI 10.1017/S1751731108001687; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Webster NS, 2007, FEMS MICROBIOL ECOL, V59, P81, DOI 10.1111/j.1574-6941.2006.00195.x; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Zhou M, 2010, APPL ENVIRON MICROB, V76, P3776, DOI 10.1128/AEM.00010-10; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	53	55	56	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58461	10.1371/journal.pone.0058461	http://dx.doi.org/10.1371/journal.pone.0058461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520513	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900072
J	Sun, Y; Zhang, WJ; Xu, YH; Quinn, B; Dasgupta, N; Liou, B; Setchell, KDR; Grabowski, GA				Sun, Ying; Zhang, Wujuan; Xu, You-Hai; Quinn, Brian; Dasgupta, Nupur; Liou, Benjamin; Setchell, Kenneth D. R.; Grabowski, Gregory A.			Substrate Compositional Variation with Tissue/Region and Gba1 Mutations in Mouse Models-Implications for Gaucher Disease	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; SAPOSIN C DEFICIENCY; GLUCOSYLSPHINGOSINE ACCUMULATION; GLUCOCEREBROSIDASE GENE; GLUCOSYLCERAMIDE; PHENOTYPE; VARIANTS; GENOTYPE; TISSUES; SPLEEN	Gaucher disease results from GBA1 mutations that lead to defective acid beta-glucosidase (GCase) mediated cleavage of glucosylceramide (GC) and glucosylsphingosine as well as heterogeneous manifestations in the viscera and CNS. The mutation, tissue, and age-dependent accumulations of different GC species were characterized in mice with Gba1 missense mutations alone or in combination with isolated saposin C deficiency (C*). Gba1 heteroallelism for D409V and null alleles (9V/null) led to GC excesses primarily in the visceral tissues with preferential accumulations of lung GC24:0, but not in liver, spleen, or brain. Age-dependent increases of different GC species were observed. The combined saposin C deficiency (C*) with V394L homozygosity (4L;C*) showed major GC18:0 degradation defects in the brain, whereas the analogous mice with D409H homozygosity and C* (9H;C*) led to all GC species accumulating in visceral tissues. Glucosylsphingosine was poorly degraded in brain by V394L and D409H GCases and in visceral tissues by D409V GCase. The neonatal lethal N370S/N370S genotype had insignificant substrate accumulations in any tissue. These results demonstrate age, organ, and mutation-specific quantitative differences in GC species and glucosylsphingosine accumulations that can have influence in the tissue/regional expression of Gaucher disease phenotypes.	[Sun, Ying; Xu, You-Hai; Quinn, Brian; Dasgupta, Nupur; Liou, Benjamin; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati, OH USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Univ Cincinnati, Coll Med, Div Pathol & Lab Med, Cincinnati, OH USA; [Sun, Ying; Xu, You-Hai; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Sun, Ying; Xu, You-Hai; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Grabowski, GA (corresponding author), Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati, OH USA.	greg.grabowski@cchmc.org			National Institutes of Health grant [R01 NS/DK 36729]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an National Institutes of Health grant to GAG (R01 NS/DK 36729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CONRADI NG, 1984, ACTA NEUROPATHOL, V65, P99, DOI 10.1007/BF00690463; Elstein D, 2005, GENET TEST, V9, P26, DOI 10.1089/gte.2005.9.26; Gornati R, 2002, J INHERIT METAB DIS, V25, P47, DOI 10.1023/A:1015137917508; Grabowski GA, 2010, ONLINE METABOLIC MOL; Grabowski GA, 2006, METABOLIC MOL BASES; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; KUSKE TT, 1972, J LAB CLIN MED, V80, P523; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; MARINETTI GV, 1960, J LIPID RES, V1, P203; Michelin K, 2005, CLIN CHIM ACTA, V362, P101, DOI 10.1016/j.cccn.2005.06.010; MIYATAKE T, 1972, BIOCHEM BIOPH RES CO, V48, P538, DOI 10.1016/0006-291X(72)90381-6; NILSSON O, 1982, CLIN GENET, V22, P274; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; NILSSON O, 1982, BIOCHIM BIOPHYS ACTA, V712, P453, DOI 10.1016/0005-2760(82)90272-7; NILSSON O, 1985, CLIN GENET, V27, P443; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; RAGHAVAN SS, 1973, BIOCHEM BIOPH RES CO, V54, P256, DOI 10.1016/0006-291X(73)90916-9; Saadat L, 2010, GLIA, V58, P391, DOI 10.1002/glia.20930; Sandhoff K, 1998, ANN NY ACAD SCI, V845, P139, DOI 10.1111/j.1749-6632.1998.tb09667.x; Schueler UH, 2003, NEUROBIOL DIS, V14, P595, DOI 10.1016/j.nbd.2003.08.016; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2003, J BIOL CHEM, V278, P31918, DOI 10.1074/jbc.M302752200; Sun Y, 2012, J BIOL CHEM, V287, P4275, DOI 10.1074/jbc.M111.280016; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Sun Y, 2010, HUM MOL GENET, V19, P634, DOI 10.1093/hmg/ddp531; SUOMI WD, 1965, J LIPID RES, V6, P211; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	34	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57560	10.1371/journal.pone.0057560	http://dx.doi.org/10.1371/journal.pone.0057560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520473	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900032
J	Taylor, H; Barua, N; Bienemann, A; Wyatt, M; Castrique, E; Foster, R; Luz, M; Fibiger, C; Mohr, E; Gill, S				Taylor, Hannah; Barua, Neil; Bienemann, Alison; Wyatt, Marcella; Castrique, Emma; Foster, Rebecca; Luz, Matthias; Fibiger, Christian; Mohr, Erich; Gill, Steven			Clearance and Toxicity of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHu GDNF) Following Acute Convection-Enhanced Delivery into the Striatum	PLOS ONE			English	Article							AGED RHESUS-MONKEYS; NEURONS IN-VITRO; INTRAPUTAMENAL INFUSION; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; RECEPTOR; PROTEIN; BRAIN; PROTECTION; PUTAMEN	Background: Despite promising early results, clinical trials involving the continuous delivery of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) into the putamen for the treatment of Parkinson's disease have shown evidence of poor distribution and toxicity due to point-source accumulation. Convection-enhanced delivery (CED) has the potential to facilitate more widespread and clinically effective drug distribution. Aims: We investigated acute CED of r-metHuGDNF into the striatum of normal rats in order to assess tissue clearance, toxicity (neuron loss, gliosis, microglial activation, and decreases in synaptophysin), synaptogenesis and neurite-outgrowth. We investigated a range of clinically relevant infused concentrations (0.1, 0.2, 0.6 and 1.0 mu g/mu L) and time points (2 and 4 weeks) in order to rationalise a dosing regimen suitable for clinical translation. Results: Two weeks after single dose CED, r-metHuGDNF was below the limit of detection by ELISA but detectable by immunohistochemistry when infused at low concentrations (0.1 and 0.2 mu g/mu L). At these concentrations, there was no associated neuronal loss (neuronal nuclei, NeuN, immunohistochemistry) or synaptic toxicity (synaptophysin ELISA). CED at an infused concentration of 0.2 mu g/mu L was associated with a significant increase in synaptogenesis (p < 0.01). In contrast, high concentrations of r-metHuGDNF (above 0.6 mu g/mu L) were associated with neuronal and synaptic toxicity (p < 0.01). Markers for gliosis (glial fibrillary acidic protein, GFAP) and microglia (ionized calcium-binding adapter molecule 1, Iba1) were restricted to the needle track and the presence of microglia had diminished by 4 weeks post-infusion. No change in neurite outgrowth (Growth associated protein 43, GAP43, mRNA) compared to artificial cerebral spinal fluid (aCSF) control was observed with any infused concentration. Conclusion: The results of this study suggest that acute CED of low concentrations of GDNF, with dosing intervals determined by tissue clearance, has most potential for effective clinical translation by optimising distribution and minimising the risk of toxic accumulation.	[Taylor, Hannah; Barua, Neil; Bienemann, Alison; Wyatt, Marcella; Castrique, Emma; Foster, Rebecca; Gill, Steven] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Barua, Neil; Gill, Steven] Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England; [Luz, Matthias; Fibiger, Christian; Mohr, Erich] MedGenesis Therapeutix Inc, Victoria, BC, Canada	University of Bristol	Gill, S (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	steven.gill@nbt.nhs.uk	Foster, Rebecca/GSM-6886-2022	Luz, Matthias/0000-0001-6646-3655	Functional Neurosurgery Research Fund; Medgenesis Therapeutix Inc.	Functional Neurosurgery Research Fund; Medgenesis Therapeutix Inc.	Functional Neurosurgery Research Fund and Medgenesis Therapeutix Inc. The funders had no role in data collection and analysis, or decision to publish.	Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Alfano I, 2007, BIOCHEM J, V404, P131, DOI 10.1042/BJ20061747; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bienemann A, 2012, J NEUROSCI METH, V203, P284, DOI 10.1016/j.jneumeth.2011.10.002; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Clarkson ED, 1995, NEUROREPORT, V7, P145, DOI 10.1097/00001756-199512290-00035; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gimenez F, 2011, NEUROIMAGE, V54, pS189, DOI 10.1016/j.neuroimage.2010.01.023; Grondin R, 2003, J NEUROSCI, V23, P1974; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; Hou JGG, 1996, BRAIN RES, V724, P145, DOI 10.1016/0006-8993(96)00311-3; Hovland DN, 2007, TOXICOL PATHOL, V35, P1013, DOI 10.1177/01926230701481899; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kearns CM, 1997, J NEUROSCI, V17, P7111; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Lang AE, 2006, LANCET NEUROL, V5, P200, DOI 10.1016/S1474-4422(06)70359-3; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Love S, 2005, NAT MED, V11, P703, DOI 10.1038/nm0705-703; Maswood N, 2002, NEUROBIOL AGING, V23, P881, DOI 10.1016/S0197-4580(02)00022-2; Morrison PF, 2007, J NEUROSURG, V107, P74, DOI 10.3171/JNS-07/07/0074; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Piltonen M, 2009, EXP NEUROL, V219, P499, DOI 10.1016/j.expneurol.2009.07.002; Salvatore MF, 2006, EXP NEUROL, V202, P497, DOI 10.1016/j.expneurol.2006.07.015; Sarabi A, 2001, J COMP NEUROL, V441, P106, DOI 10.1002/cne.1400; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Siew LK, 2004, J NEUROSCI METH, V139, P153, DOI 10.1016/j.jneumeth.2004.04.020; Slevin John T, 2006, Neurosurg Focus, V20, pE1; Sullivan AM, 1998, EUR J NEUROSCI, V10, P57; Tatarewicz SM, 2007, J CLIN IMMUNOL, V27, P620, DOI 10.1007/s10875-007-9117-8; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Yin DL, 2011, NEUROIMAGE, V54, pS196, DOI 10.1016/j.neuroimage.2009.08.069	31	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e56186	10.1371/journal.pone.0056186	http://dx.doi.org/10.1371/journal.pone.0056186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526931	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600004
J	Aslanidi, GV; Rivers, AE; Ortiz, L; Song, LJ; Ling, C; Govindasamy, L; Van Vliet, K; Tan, MQ; Agbandje-McKenna, M; Srivastava, A				Aslanidi, George V.; Rivers, Angela E.; Ortiz, Luis; Song, Liujiang; Ling, Chen; Govindasamy, Lakshmanan; Van Vliet, Kim; Tan, Mengqun; Agbandje-McKenna, Mavis; Srivastava, Arun			Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?	PLOS ONE			English	Article							HIGH-EFFICIENCY TRANSDUCTION; INTRACELLULAR TRAFFICKING; GENE-TRANSFER; NEXT-GENERATION; RAAV VECTORS; TYPE-2; MUTATIONS; HEMOPHILIA; SEROTYPE-2; RESPONSES	The ubiquitin-proteasome pathway plays a critical role in the intracellular trafficking of AAV2 vectors, and phosphorylation of certain surface-exposed amino acid residues on the capsid provides the primary signal for ubiquitination. Removal of several critical tyrosine (Y) and serine (S) residues on the AAV2 capsid has been shown to significantly increase transduction efficiency compared with the wild-type (WT) vectors. In the present study, site-directed mutagenesis of each of the 17 surface-exposed threonine (T) residues was conducted, and the transduction efficiency of four of these mutants, T455V, T491V, T550V, and T659V, was observed to increase up to 4-fold in human HEK293 cells in vitro. The most critical Y, S, and T mutations were subsequently combined, and the quadruple-mutant (Y444+500+730F+T491V) AAV2 vector was identified as the most efficient. This vector increased the transduction efficiency similar to 24-fold over the WT AAV2 vector, and similar to 2-3-fold over the previously described triple-mutant (Y444+500+730F) vector in a murine hepatocyte cell line, H2.35, in vitro. Similar results were obtained in murine hepatocytes in vivo following tail vein injection of the Y444+500+730F+T491V scAAV2 vector, and whole-body bioluminescence imaging of C57BL/6 mice. The increase in the transduction efficiency of the Y-T quadruple-mutant over that of the Y triple-mutant correlated with an improved nuclear translocation of the vectors, which exceeded 90%. These observations suggest that further optimization of the AAV2 capsid by targeting amino acid residues involved in phosphorylation may not be possible. This study has thus led to the generation of a novel Y444+500+730F+T491V quadruple-mutant AAV2 vector with potential for use in liver-directed human gene therapy.	[Aslanidi, George V.; Rivers, Angela E.; Ortiz, Luis; Song, Liujiang; Ling, Chen; Srivastava, Arun] Univ Florida, Coll Med, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32605 USA; [Aslanidi, George V.; Rivers, Angela E.; Ling, Chen; Agbandje-McKenna, Mavis; Srivastava, Arun] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL USA; [Aslanidi, George V.; Rivers, Angela E.; Ling, Chen; Agbandje-McKenna, Mavis; Srivastava, Arun] Univ Florida, Coll Med, Genet Inst, Gainesville, FL USA; [Rivers, Angela E.] Univ Illinois, Dept Pediat, Div Hematol Oncol, Chicago, IL USA; [Song, Liujiang; Tan, Mengqun] Cent S Univ, Xiangya Sch Med, Dept Physiol, Expt Hematol Lab, Changsha, Hunan, Peoples R China; [Song, Liujiang; Tan, Mengqun] Shenzhen Inst Xiangya Biomed, Shenzhen, Peoples R China; [Govindasamy, Lakshmanan; Van Vliet, Kim; Agbandje-McKenna, Mavis] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Srivastava, Arun] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Srivastava, Arun] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Central South University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Aslanidi, GV (corresponding author), Univ Florida, Coll Med, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL 32605 USA.	aslanidi@peds.ufl.edu	Van Vliet, Kim/AAK-7368-2021; Aslanidi, George/C-5680-2019	Aslanidi, George/0000-0002-2726-8627; Van Vliet, Kim/0000-0001-7802-9514; Ling, Chen/0000-0003-1527-1471; Rivers, Angela/0000-0002-7989-0522	Public Health Service from the National Institutes of Health [R01 GM-082946, P01 DK-058327, R01 HL-097088]; Bayer Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103172, R01HL097088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; Bayer Hemophilia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by Public Health Service grants R01 GM-082946 (to MA-M), and P01 DK-058327 (Project 1), and R01 HL-097088 from the National Institutes of Health, and Special Award from the Bayer Hemophilia Foundation (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Aslanidi G, 2009, P NATL ACAD SCI USA, V106, P5059, DOI 10.1073/pnas.0810614106; Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bleker S, 2006, J VIROL, V80, P810, DOI 10.1128/JVI.80.2.810-820.2006; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; DiPritmio N, 2008, J VIROL, V82, P5178, DOI 10.1128/JVI.02721-07; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Govindasamy L, 2006, J VIROL, V80, P11556, DOI 10.1128/JVI.01536-06; Hansen J, 2000, J VIROL, V74, P992, DOI 10.1128/JVI.74.2.992-996.2000; Hansen J, 2001, J VIROL, V75, P4080, DOI 10.1128/JVI.75.9.4080-4090.2001; Harbison CE, 2008, TRENDS MICROBIOL, V16, P208, DOI 10.1016/j.tim.2008.01.012; High KA, 2011, METHODS MOL BIOL, V807, P429, DOI 10.1007/978-1-61779-370-7_18; Jayandharan GR, 2011, P NATL ACAD SCI USA, V108, P3743, DOI 10.1073/pnas.1012753108; Kohlbrenner E, 2005, MOL THER, V12, P1217, DOI 10.1016/j.ymthe.2005.08.018; Li CW, 2012, J VIROL, V86, P7752, DOI 10.1128/JVI.00675-12; Lochrie MA, 2006, J VIROL, V80, P821, DOI 10.1128/JVI.80.2.821-834.2006; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Markusic DM, 2010, MOL THER, V18, P2048, DOI 10.1038/mt.2010.172; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; Mendell JR, 2012, NEUROSCI LETT, V12, P341; Mingozzi F, 2007, CURR GENE THER, V7, P316, DOI 10.2174/156652307782151425; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Muzyczka N, 2005, HUM GENE THER, V16, P408, DOI 10.1089/hum.2005.16.408; Nam HJ, 2011, J VIROL, V85, P11791, DOI 10.1128/JVI.05305-11; Naumer M, 2012, J VIROL, V86, P13038, DOI 10.1128/JVI.01675-12; Nonnenmacher M, 2012, GENE THER, V19, P649, DOI 10.1038/gt.2012.6; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Srivastava A, 2008, J CELL BIOCHEM, V105, P17, DOI 10.1002/jcb.21819; Vandenberghe LH, 2009, GENE THER, V16, P311, DOI 10.1038/gt.2008.170; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013; Xiao W, 2002, J VIROL, V76, P11505, DOI 10.1128/JVI.76.22.11505-11517.2002; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Zhong L, 2008, VIROLOGY, V381, P194, DOI 10.1016/j.virol.2008.08.027; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zhong L, 2007, MOL THER, V15, P1323, DOI 10.1038/sj.mt.6300170; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	50	63	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59142	10.1371/journal.pone.0059142	http://dx.doi.org/10.1371/journal.pone.0059142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527116	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100083
J	Cramer, ERA				Cramer, Emily R. A.			Physically Challenging Song Traits, Male Quality, and Reproductive Success in House Wrens	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; VOCAL PERFORMANCE; MICROSATELLITE LOCI; BIRDSONG PERFORMANCE; SEXUAL SELECTION; PRACTICAL GUIDE; BANDED WREN; EVOLUTION; CONSISTENCY; SIGNAL	Physically challenging signals are likely to honestly indicate signaler quality. In trilled bird song two physically challenging parameters are vocal deviation (the speed of sound frequency modulation) and trill consistency (how precisely syllables are repeated). As predicted, in several species, they correlate with male quality, are preferred by females, and/or function in male-male signaling. Species may experience different selective pressures on their songs, however; for instance, there may be opposing selection between song complexity and song performance difficulty, such that in species where song complexity is strongly selected, there may not be strong selection on performance-based traits. I tested whether vocal deviation and trill consistency are signals of male quality in house wrens (Troglodytes aedon), a species with complex song structure. Males' singing ability did not correlate with male quality, except that older males sang with higher trill consistency, and males with more consistent trills responded more aggressively to playback (although a previous study found no effect of stimulus trill consistency on males' responses to playback). Males singing more challenging songs did not gain in polygyny, extra-pair paternity, or annual reproductive success. Moreover, none of the standard male quality measures I investigated correlated with mating or reproductive success. I conclude that vocal deviation and trill consistency do not signal male quality in this species.	[Cramer, Emily R. A.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Cramer, Emily R. A.] Cornell Lab Ornithol, Ithaca, NY USA; [Cramer, Emily R. A.] Univ Oslo, Nat Hist Museum, Oslo, Norway	Cornell University; Cornell University; University of Oslo	Cramer, ERA (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	becky.cramer@nhm.uio.no			Cornell Lab of Ornithology; American Ornithologists' Union; Animal Behavior Society; Cornell Sigma Xi Chapter; NSF; Nordic Research Opportunity supplement; Department of Neurobiology and Behavior; Einhorn Discovery Grant	Cornell Lab of Ornithology; American Ornithologists' Union; Animal Behavior Society; Cornell Sigma Xi Chapter; NSF(National Science Foundation (NSF)); Nordic Research Opportunity supplement; Department of Neurobiology and Behavior; Einhorn Discovery Grant	Funding was from the Cornell Lab of Ornithology, the American Ornithologists' Union, the Animal Behavior Society, The Cornell Sigma Xi Chapter, an NSF predoctoral fellowship with a Nordic Research Opportunity supplement, and the Department of Neurobiology and Behavior to ERAC; an Einhorn Discovery Grant to Katie LaBarbera that funded paternity analysis she and the author shared; and the Cornell Chapter of Sigma Xi, the National Academy of Sciences, the Scientific Research Society, the American Ornithologists Union, and an Andrew W. Mellon Student Research Award to Paulo Llambias for establishing the field site and funding for 2008 paternity analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay E, 2007, EVOL ECOL RES, V9, P855; Andersson Malte, 1994; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Bates D, 2012, LME4 LINEAR MIXED EF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bioacoustics Research Program, RAVEN PRO 1 4; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brar RK, 2007, MOL ECOL NOTES, V7, P69, DOI 10.1111/j.1471-8286.2006.01530.x; Byers BE, 2007, BEHAV ECOL, V18, P130, DOI 10.1093/beheco/arl058; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Cabe PR, 2001, MOL ECOL NOTES, V1, P155, DOI 10.1046/j.1471-8278.2001.00057.x; Cardoso GC, 2007, BEHAV ECOL, V18, P1051, DOI 10.1093/beheco/arm078; Cardoso GC, 2012, ETHOLOGY, V118, P584, DOI 10.1111/j.1439-0310.2012.02047.x; Cardoso GC, 2011, AM NAT, V178, P679, DOI 10.1086/662160; Caro SP, 2010, BEHAV ECOL, V21, P562, DOI 10.1093/beheco/arq022; Catchpole C.K., 2008, BIRDSONG BIOLOGICAL; Christensen R, 2006, J AVIAN BIOL, V37, P617, DOI 10.1111/j.0908-8857.2006.03684.x; Cortopassi Kathryn A., 2000, Bioacoustics, V11, P89; Cramer E.R.A., 2012, THESIS; Cramer ERA, 2007, J AVIAN BIOL, V38, P122, DOI 10.1111/j.2006.0908-8857.03839.x; Cramer ERA, 2013, BEHAV ECOL, V24, P412, DOI 10.1093/beheco/ars178; Cramer ERA, 2013, J ORNITHOL, V154, P129, DOI 10.1007/s10336-012-0878-3; Cramer ERA, 2012, ETHOLOGY, V118, P975, DOI 10.1111/j.1439-0310.2012.02091.x; Cramer ERA, 2011, CONDOR, V113, P637, DOI 10.1525/cond.2011.100233; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dawson DA, 2000, MOL ECOL, V9, P1941, DOI 10.1046/j.1365-294x.2000.01094-14.x; de Kort SR, 2009, BEHAV ECOL, V20, P200, DOI 10.1093/beheco/arn135; de Kort SR, 2009, P ROY SOC B-BIOL SCI, V276, P2315, DOI 10.1098/rspb.2009.0127; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; DuBois AL, 2011, BEHAV ECOL SOCIOBIOL, V65, P717, DOI 10.1007/s00265-010-1073-2; Eckerle KP, 2006, BEHAVIOUR, V143, P253, DOI 10.1163/156853906775900694; Forsman AM, 2008, MOL ECOL, V17, P3697, DOI 10.1111/j.1365-294X.2008.03860.x; Garcia-Fernandez V, 2013, ANIM BEHAV; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hill CE, 2011, BEHAV ECOL, V22, P73, DOI 10.1093/beheco/arq171; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Holveck MJ, 2008, BEHAV ECOL, V19, P1267, DOI 10.1093/beheco/arn078; HURLY TA, 1992, J COMP PSYCHOL, V106, P388, DOI 10.1037/0735-7036.106.4.388; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; Jarvis ED, 2008, NATURES MUSIC THE SC, P226; Johnsen A, 2003, OECOLOGIA, V136, P476, DOI 10.1007/s00442-003-1286-4; Johnson LS, 2009, P ROY SOC B-BIOL SCI, V276, P2285, DOI 10.1098/rspb.2009.0283; Johnson LS, 1996, BEHAVIOUR, V133, P357, DOI 10.1163/156853996X00495; JOHNSON LS, 1991, BEHAVIOUR, V116, P190, DOI 10.1163/156853991X00030; Johnson LS, 2002, BEHAV ECOL, V13, P670, DOI 10.1093/beheco/13.5.670; JOHNSON LS, 1990, J FIELD ORNITHOL, V61, P273; Johnson LS, 1998, BIRDS OF NORTH AMERI; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; LaBarbera K, 2010, BEHAV ECOL, V21, P773, DOI 10.1093/beheco/arq052; Lesnoff M., 2012, AOD ANALYSIS OF OVER; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIFJELD JT, 1994, J AVIAN BIOL, V25, P244, DOI 10.2307/3677082; LIGHTBODY JP, 1987, ANIM BEHAV, V35, P1670, DOI 10.1016/S0003-3472(87)80060-X; Llambias PE, 2012, CONDOR, V114, P629, DOI 10.1525/cond.2012.110066; Logue DM, 2008, AM NAT, V172, P34, DOI 10.1086/587849; LOHR B, 1994, BEHAVIOUR, V130, P1, DOI 10.1163/156853994X00109; Masters BS, 2009, CONDOR, V111, P365, DOI 10.1525/cond.2009.080063; Masters BS, 2003, P ROY SOC B-BIOL SCI, V270, P1393, DOI 10.1098/rspb.2003.2380; Millet S, 2007, DEV COMP IMMUNOL, V31, P188, DOI 10.1016/j.dci.2006.05.013; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Ots I, 1998, FUNCT ECOL, V12, P700, DOI 10.1046/j.1365-2435.1998.00219.x; Pinheiro J, 2012, NONLINEAR MIXED EFFE; PLATT ME, 1987, J FIELD ORNITHOL, V58, P190; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Podos J, 2009, ADV STUD BEHAV, V40, P159, DOI 10.1016/S0065-3454(09)40005-6; Price JJ, 2004, BEHAV ECOL, V15, P485, DOI 10.1093/beheco/arh040; R Development Core Team, 2012, R LANG ENV STAT COMP; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Rivera-Gutierrez HF, 2012, ANIM BEHAV, V83, P1279, DOI 10.1016/j.anbehav.2012.03.001; Rivera-Gutierrez HF, 2011, BIOL LETTERS, V7, P339, DOI 10.1098/rsbl.2010.0962; Sakata JT, 2012, J EXP BIOL, V215, P201, DOI 10.1242/jeb.056911; SAS Institute Inc, JMP 7 0; Searcy W, 2005, THE EVOLUTION OF ANI; Sewall KB, 2010, HORM BEHAV, V58, P544, DOI 10.1016/j.yhbeh.2010.04.002; Smith JM, 1995, J THEOR BIOL, V177, P305; Smithson M, 2001, EDUC PSYCHOL MEAS, V61, P605, DOI 10.1177/00131640121971392; Sockman KW, 2009, ANIM BEHAV, V77, P663, DOI 10.1016/j.anbehav.2008.11.016; Soukup SS, 1997, ANIM BEHAV, V54, P1089, DOI 10.1006/anbe.1997.0556; Suthers RA, 2001, NETH J ZOOL, V51, P217, DOI 10.1163/156854201750385163; Vallet E, 1998, ANIM BEHAV, V55, P291, DOI 10.1006/anbe.1997.0631; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Vehrencamp SL, 2013, BEHAV ECOL SOCIOBIOL, V67, P409, DOI 10.1007/s00265-012-1461-x; Vehrencamp S. L., 2000, ANIMAL SIGNALS SIGNA, P277; Wegrzyn E, 2010, ANIM BEHAV, V79, P1363, DOI 10.1016/j.anbehav.2010.03.012; Whittingham LA, 2005, BEHAV ECOL, V16, P138, DOI 10.1093/beheco/arh140; Zuur Alain F., 2009, P1	90	36	36	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59208	10.1371/journal.pone.0059208	http://dx.doi.org/10.1371/journal.pone.0059208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527137	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100093
J	Deblois, CP; Marchand, A; Juneau, P				Deblois, Charles P.; Marchand, Axelle; Juneau, Philippe			Comparison of Photoacclimation in Twelve Freshwater Photoautotrophs (Chlorophyte, Bacillaryophyte, Cryptophyte and Cyanophyte) Isolated from a Natural Community	PLOS ONE			English	Article							LIGHT-SATURATED PHOTOSYNTHESIS; SPECIES COMPOSITION; CAROTENOID PROTEIN; ENERGY-DISSIPATION; PHYTOPLANKTON; CYANOBACTERIA; FLUORESCENCE; IRRADIANCE; GROWTH; ACCLIMATION	Different representative of algae and cyanobacteria were isolated from a freshwater habitat and cultivated in laboratory to compare their photoacclimation capacity when exposed to a wide range of light intensity and to understand if this factor may modify natural community dominance. All species successfully acclimated to all light intensities and the response of phytoplankton to increased light intensity was similar and included a decrease of most photosynthetic pigments accompanied by an increase in photoprotective pigment content relative to Chl a. Most species also decreased their light absorption efficiency on a biovolume basis. This decrease not only resulted in a lower fraction of energy absorbed by the cell, but also to a lower transfer of energy to PSII and PSI. Furthermore, energy funnelled to PSII or PSI was also rearranged in favour of PSII. High light acclimated organisms also corresponded to high non-photochemical quenching and photosynthetic electron transport reduction state and to a low W'M. Thus photoacclimation processes work toward reducing the excitation pressure in high light environment through a reduction of light absorption efficiency, but also by lowering conversion efficiency. Interestingly, all species of our study followed that tendency despite being of different functional groups (colonial, flagellated, different sizes) and of different phylogeny demonstrating the great plasticity and adaptation ability of freshwater phytoplankton to their light environment. These adjustments may explain the decoupling between growth rate and photosynthesis observed above photosynthesis light saturation point for all species. Even if some species did reach higher growth rate in our conditions and thus, should dominate in natural environment with respect to light intensity, we cannot exclude that other environmental factors also influence the population dynamic and make the outcome harder to predict.	[Deblois, Charles P.; Marchand, Axelle; Juneau, Philippe] Univ Quebec, Dept Sci Biol, TOXEN, Ecotoxicol Aquat Microorganisms Lab, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Juneau, P (corresponding author), Univ Quebec, Dept Sci Biol, TOXEN, Ecotoxicol Aquat Microorganisms Lab, CP 8888, Montreal, PQ H3C 3P8, Canada.	juneau.philippe@uqam.ca		Juneau, Philippe/0000-0002-7259-9636	NSCERC [145590074]; FQRNT-Action concertee [2009-CY-130520]	NSCERC; FQRNT-Action concertee(FQRNT)	NSCERC Discovery Grant #145590074 (http://www.nserc-crsng.gc.ca/index_eng.asp), FQRNT-Action concertee #2009-CY-130520 (http://www.fqrnt.gouv.qc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELIOVICH A, 1972, Journal of Bacteriology, V111, P682; AGUSTI S, 1992, LIMNOL OCEANOGR, V37, P434, DOI 10.4319/lo.1992.37.2.0434; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Choudhury NK, 2001, PHOTOSYNTHETICA, V39, P481, DOI 10.1023/A:1015647708360; Cullen J.J., 1998, NAT ASI SER G ECOL S, V41, P559; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; Dubinsky Z, 2009, AQUAT MICROB ECOL, V56, P163, DOI 10.3354/ame01345; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; ELOFF JN, 1976, APPL ENVIRON MICROB, V31, P119, DOI 10.1128/AEM.31.1.119-126.1976; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; FALKOWSKI PG, 1985, LIMNOL OCEANOGR, V30, P311, DOI 10.4319/lo.1985.30.2.0311; FEE EJ, 1976, LIMNOL OCEANOGR, V21, P767, DOI 10.4319/lo.1976.21.6.0767; FISHER T, 1989, PLANT CELL PHYSIOL, V30, P221, DOI 10.1093/oxfordjournals.pcp.a077733; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; GEIDER RJ, 1986, MAR ECOL PROG SER, V30, P93, DOI 10.3354/meps030093; GERBER S, 1995, FEMS MICROBIOL ECOL, V16, P33, DOI 10.1016/0168-6496(94)00067-7; Gilbert M, 2000, PHOTOSYNTHETICA, V38, P111, DOI 10.1023/A:1026708327185; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Hancke TB, 2008, J PHYCOL, V44, P803, DOI 10.1111/j.1529-8817.2008.00509.x; Havens KE, 1998, FRESHWATER BIOL, V39, P547, DOI 10.1046/j.1365-2427.1998.00308.x; HERZIG R, 1992, ISRAEL J BOT, V41, P199; Huner N., 2003, LIGHT HARVESTING ANT, P402; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Johnsen G, 1997, LIMNOL OCEANOGR, V42, P1166, DOI 10.4319/lo.1997.42.5_part_2.1166; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Juneau P, 2005, PHOTOSYNTHETICA, V43, P75, DOI 10.1007/s11099-005-5083-7; Kana TM, 1997, NEW PHYTOL, V137, P629, DOI 10.1046/j.1469-8137.1997.00857.x; KANA TM, 1987, DEEP-SEA RES, V34, P497, DOI 10.1016/0198-0149(87)90002-1; Karapetyan NV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1127, DOI 10.1134/S0006297907100100; Kirilovsky D, 2012, BBA-BIOENERGETICS, V1817, P158, DOI 10.1016/j.bbabio.2011.04.013; KIRK J T O, 1986, Canadian Bulletin of Fisheries and Aquatic Sciences, P501; KOPF U, 1984, ANAL CHEM, V56, P1931, DOI 10.1021/ac00275a039; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lichtenthaler H.K., 1985, BIOL SOC T, V11, P591, DOI DOI 10.1042/BST0110591; Litchman E, 2003, AQUAT MICROB ECOL, V31, P241, DOI 10.3354/ame031241; Liu SW, 2012, PHYCOL RES, V60, P61, DOI 10.1111/j.1440-1835.2011.00636.x; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Mur LR, 1995, WATER SCI TECHNOL, V32, P25, DOI 10.1016/0273-1223(95)00676-1; Quinn P.G., 2003, EXPT DESIGN DATA ANA; RAPS S, 1983, PLANT PHYSIOL, V72, P829, DOI 10.1104/pp.72.3.829; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Raven JA, 2002, J PHYCOL, V38, P11, DOI 10.1046/j.1529-8817.2002.01125.x; Reynolds CS, 1998, HYDROBIOLOGIA, V370, P11, DOI 10.1023/A:1017062213207; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; RICHARDSON K, 1983, NEW PHYTOL, V93, P157, DOI 10.1111/j.1469-8137.1983.tb03422.x; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; Ritchie RJ, 2008, PHOTOSYNTH RES, V96, P201, DOI 10.1007/s11120-008-9300-7; Rolland A, 2005, J PLANKTON RES, V27, P683, DOI 10.1093/plankt/fbi042; Schanz Ferdinand, 1997, Oceanography and Marine Biology an Annual Review, V35, P71; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Sonoike K, 2001, PLANT CELL PHYSIOL, V42, P379, DOI 10.1093/pcp/pce046; Steiger S, 1999, J PHOTOCH PHOTOBIO B, V52, P14, DOI 10.1016/S1011-1344(99)00094-9; Subramaniam A, 1999, LIMNOL OCEANOGR, V44, P608, DOI 10.4319/lo.1999.44.3.0608; Suggett DJ, 2007, J PHYCOL, V43, P1209, DOI 10.1111/j.1529-8817.2007.00406.x; SUKENIK A, 1987, BIOCHIM BIOPHYS ACTA, V891, P205, DOI 10.1016/0005-2728(87)90216-7; Tamary E, 2012, BBA-BIOENERGETICS, V1817, P319, DOI 10.1016/j.bbabio.2011.11.008; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008679; ZIMMERMAN RC, 1987, MAR BIOL, V95, P209, DOI 10.1007/BF00409007	68	29	30	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57139	10.1371/journal.pone.0057139	http://dx.doi.org/10.1371/journal.pone.0057139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526934	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100006
J	Kogel, T; Rudolf, R; Hodneland, E; Copier, J; Regazzi, R; Tooze, SA; Gerdes, HH				Kogel, Tanja; Rudolf, Rudiger; Hodneland, Erlend; Copier, John; Regazzi, Romano; Tooze, Sharon A.; Gerdes, Hans-Hermann			Rab3D Is Critical for Secretory Granule Maturation in PC12 Cells	PLOS ONE			English	Article							AP-1 ADAPTER COMPLEX; MYOSIN VA; NEUROENDOCRINE CELLS; SECRETOGRANIN-II; LINKS RAB27A; PROTEIN; EXOCYTOSIS; ACTIN; BIOGENESIS; TRANSPORT	Neuropeptide-and hormone-containing secretory granules (SGs) are synthesized at the trans-Golgi network (TGN) as immature secretory granules (ISGs) and complete their maturation in the F-actin-rich cell cortex. This maturation process is characterized by acidification-dependent processing of cargo proteins, condensation of the SG matrix and removal of membrane and proteins not destined to mature secretory granules (MSGs). Here we addressed a potential role of Rab3 isoforms in these maturation steps by expressing their nucleotide-binding deficient mutants in PC12 cells. Our data show that the presence of Rab3D(N135I) decreases the restriction of maturing SGs to the F-actin-rich cell cortex, blocks the removal of the endoprotease furin from SGs and impedes the processing of the luminal SG protein secretogranin II. This strongly suggests that Rab3D is implicated in the subcellular localization and maturation of ISGs.	[Kogel, Tanja; Hodneland, Erlend; Gerdes, Hans-Hermann] Univ Bergen, Dept Biomed, Bergen, Norway; [Rudolf, Rudiger; Gerdes, Hans-Hermann] Heidelberg Univ, Interdisciplinary Ctr Neurobiol, Heidelberg, Germany; [Copier, John; Tooze, Sharon A.] London Res Inst Canc Res United Kingdom, Lincolns Inn Fields Labs, London, England; [Regazzi, Romano] Univ Lausanne, Dept Fundamental Neurosci, CH-1000 Lausanne, Switzerland	University of Bergen; Ruprecht Karls University Heidelberg; University of Lausanne	Gerdes, HH (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	hans-hermann.gerdes@biomed.uib.no	Rudolf, Rüdiger/A-6476-2009	Rudolf, Rüdiger/0000-0002-0833-1053; Tooze, Sharon/0000-0002-2182-3116; Regazzi, Romano/0000-0002-9773-2915; Kogel, Tanja/0000-0002-3507-3395; Kogel, Tanja/0000-0002-6876-2998	Landesgraduiertenkolleg Baden-Wurttemberg, Germany; Studienstiftung des deutschen Volkes; SFB [Ge 550/3-1, Ge 550/3-2, Ge 550/3-3]; Norwegian Research Council; Norwegian Cancer Society; Cancer Research UK; Cancer Research UK [15153] Funding Source: researchfish	Landesgraduiertenkolleg Baden-Wurttemberg, Germany; Studienstiftung des deutschen Volkes; SFB(Austrian Science Fund (FWF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	TK was supported by stipends of the Landesgraduiertenkolleg Baden-Wurttemberg, Germany. R. Rudolf was supported by a stipend from the "Studienstiftung des deutschen Volkes". HHG was a recipient of grants of the SFB (Ge 550/3-1,-2,-3), the Norwegian Research Council and the Norwegian Cancer Society. ST and JC were supported by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahras M, 2006, J CELL BIOL, V173, P241, DOI 10.1083/jcb.200506163; Baldini G, 1998, J CELL BIOL, V140, P305, DOI 10.1083/jcb.140.2.305; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; Dittie AS, 1996, J CELL BIOL, V132, P523, DOI 10.1083/jcb.132.4.523; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; Dittie AS, 1999, J CELL SCI, V112, P3955; Eaton BA, 2000, J NEUROSCI, V20, P7334; ERMAK TH, 1983, ANAT RECORD, V207, P487, DOI 10.1002/ar.1092070310; Fernandez CJ, 1997, MOL BIOL CELL, V8, P2171, DOI 10.1091/mbc.8.11.2171; Ferraro F, 2007, MOL BIOL CELL; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukuda Mitsunori, 2004, Tanpakushitsu Kakusan Koso, V49, P2186; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Hannah MJ, 2003, J CELL SCI, V116, P3939, DOI 10.1242/jcs.00711; HEUMANN R, 1983, EXP CELL RES, V145, P179, DOI 10.1016/S0014-4827(83)80019-6; Huttner WB, 1989, CURR OPIN CELL BIOL, V1, P648, DOI 10.1016/0955-0674(89)90029-X; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; Kaether C, 1997, EUR J CELL BIOL, V74, P133; Kakhlon O, 2006, EMBO J, V25, P1590, DOI 10.1038/sj.emboj.7601067; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; Kogel T, 2010, TRAFFIC, V11, P637, DOI 10.1111/j.1600-0854.2010.01048.x; Kogel T, 2010, TRAFFIC; Martelli AM, 2000, TRAFFIC, V1, P976, DOI 10.1034/j.1600-0854.2000.011207.x; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; Miller KE, 2000, J BIOL CHEM, V275, P2598, DOI 10.1074/jbc.275.4.2598; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; OHASHI M, 1994, J BIOL CHEM, V269, P24897; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Stroupe C, 2000, J MOL BIOL, V304, P585, DOI 10.1006/jmbi.2000.4236; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Urbe S, 1997, BIOCHEM J, V321, P65, DOI 10.1042/bj3210065; Urbe S, 1998, J CELL BIOL, V143, P1831, DOI 10.1083/jcb.143.7.1831; van Weeren L, 2004, AM J RESP CELL MOL, V30, P288, DOI 10.1165/rcmb.2003-0264OC; Wu XF, 1998, CELL MOTIL CYTOSKEL, V40, P286, DOI 10.1002/(SICI)1097-0169(1998)40:3<286::AID-CM7>3.0.CO;2-B; Wu XF, 1997, J CELL SCI, V110, P847	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57321	10.1371/journal.pone.0057321	http://dx.doi.org/10.1371/journal.pone.0057321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526941	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000317562100011
J	Rola-Luszczak, M; Pluta, A; Olech, M; Donnik, I; Petropavlovskiy, M; Gerilovych, A; Vinogradova, I; Choudhury, B; Kuzmak, J				Rola-Luszczak, Marzena; Pluta, Aneta; Olech, Monika; Donnik, Irina; Petropavlovskiy, Maxim; Gerilovych, Anton; Vinogradova, Irina; Choudhury, Bhudipa; Kuzmak, Jacek			The Molecular Characterization of Bovine Leukaemia Virus Isolates from Eastern Europe and Siberia and Its Impact on Phylogeny	PLOS ONE			English	Article							ENV GENE; MUTATIONS; GENOTYPES; BLV; SUBSTITUTIONS; SEQUENCE; FUSION; MODEL; DNA	Recent studies have shown that bovine leukemia virus (BLV) sequences can be classified into seven distinct genotypes based on full gp51 sequence. This classification was based on available sequence data that mainly represented the BLV population that is circulating in cattle from the US and South America. In order to aid with a global perspective inclusion of data from Eastern Europe is required. In this study we examined 44 BLV isolates from different geographical regions of Poland, Belarus, Ukraine, and Russia. Phylogenetic analysis based on a 444bp fragment of env gene revealed that most of isolates belonged to genotypes 4 and 7. Furthermore, we confirmed the existence of a new genotype, genotype 8, which was highly supported by phylogenetic computations. A significant number of amino acid substitutions were found in the sequences of the studied Eastern European isolates, of which 71% have not been described previously. The substitutions encompassed mainly the C-part of the CD4+ epitope, zinc binding peptide region, CD8+ T cell epitope, and overlapping linear epitope E. These observations highlight the use of sequence data to both elucidate phylogenetic relationships and the potential effect on serological detection of geographically diverse isolates.	[Rola-Luszczak, Marzena; Pluta, Aneta; Olech, Monika; Kuzmak, Jacek] Natl Inst Vet Res, Dept Biochem, Pulawy, Poland; [Donnik, Irina; Petropavlovskiy, Maxim] State Sci Res Inst Vet Med, Ekaterinburg, Russia; [Gerilovych, Anton] Natl Sci Ctr Inst Expt & Clin Vet Med, Kharkov, Ukraine; [Vinogradova, Irina] All Russian Res Inst Anim Breeding, Dubrovitsy, Moscow Region, Russia; [Choudhury, Bhudipa] Anim Hlth & Vet Labs Agcy AHVLA, Dept Virol, New Haw, Surrey, England	National Veterinary Institute - National Research Institute; Russian Academy of Sciences; Ural Federal Agrarian Scientific Research Centre; National Academy of Agrarian Sciences of Ukraine; National Scientific Center "Institute of Experimental & Clinical Veterinary Medicine"; L.K. Ernst Federal Science Center for Animal Husbandry	Rola-Luszczak, M (corresponding author), Natl Inst Vet Res, Dept Biochem, Pulawy, Poland.	mrolka@piwet.pulawy.pl	Petropavlovskiy, Maxim/E-1178-2017; Donnik, Irina/AAD-4952-2022; Choudhury, Bhudipa/D-3863-2011; Donnik, Irina/R-6535-2017; Sergeevna, Krivonogova Anna/U-8086-2017; Vinogradova, Irina/GSO-2033-2022; Gerilovych, Anton/N-5608-2019	Petropavlovskiy, Maxim/0000-0002-9892-6092; Choudhury, Bhudipa/0000-0002-1392-6414; Rola-Luszczak, Marzena/0000-0003-3209-3427; Gerilovych, Anton/0000-0002-3280-4172; Donnik, Irina/0000-0002-8593-7470				Asfaw Y, 2005, ARCH VIROL, V150, P493, DOI 10.1007/s00705-004-0433-5; Balic D, 2012, ARCH VIROL, V157, P1281, DOI 10.1007/s00705-012-1300-4; Beier D, 2001, BERL MUNCH TIERARZTL, V114, P252; BRUCK C, 1984, VIROLOGY, V136, P20, DOI 10.1016/0042-6822(84)90244-7; Camargos MF, 2007, VIRUS GENES, V34, P343, DOI 10.1007/s11262-006-0011-x; Camargos MF, 2002, J VET MED B, V49, P325, DOI 10.1046/j.1439-0450.2002.00582.x; COULSTON J, 1990, J GEN VIROL, V71, P1737, DOI 10.1099/0022-1317-71-8-1737; Drummond AJ, 2010, GENEIOUS V5 5 CREATE; Dube S, 2000, VIROLOGY, V277, P379, DOI 10.1006/viro.2000.0622; Fechner H, 1997, VIROLOGY, V237, P261, DOI 10.1006/viro.1997.8784; Felmer R, 2005, VET MICROBIOL, V108, P39, DOI 10.1016/j.vetmic.2005.04.005; Gatot JS, 2002, J VIROL, V76, P7956, DOI 10.1128/JVI.76.16.7956-7967.2002; GHYSDAEL J, 1984, CURR TOP MICROBIOL, V112, P1; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Hall BG, 2006, ANN EPIDEMIOL, V16, P157, DOI 10.1016/j.annepidem.2005.04.010; Hemmatzadeh F, 2007, VET RES COMMUN, V31, P783, DOI 10.1007/s11259-007-0012-9; Inoue E, 2011, ARCH VIROL, V156, P1137, DOI 10.1007/s00705-011-0955-6; Johnson R., 1992, Veterinary Bulletin, V62, P287; Johnston ER, 2002, J VIROL, V76, P10861, DOI 10.1128/JVI.76.21.10861-10872.2002; Kettmann R., 1994, The retroviridae: Volume 3, P39; King A. M., 2012, VIRUS TAXONOMY CLASS; Licursi M, 2002, VIRUS RES, V86, P101, DOI 10.1016/S0168-1702(02)00059-X; MAMOUN RZ, 1990, J VIROL, V64, P4180, DOI 10.1128/JVI.64.9.4180-4188.1990; MANSKY LM, 1994, J VIROL, V68, P494, DOI 10.1128/JVI.68.1.494-499.1994; Matsumura K, 2011, VIRUS RES, V155, P343, DOI 10.1016/j.virusres.2010.11.005; Moratorio G, 2010, ARCH VIROL, V155, P481, DOI 10.1007/s00705-010-0606-3; Rodriguez SM, 2011, VIRUSES-BASEL, V3, P1210, DOI 10.3390/v3071210; Rodriguez SM, 2009, J GEN VIROL, V90, P2788, DOI 10.1099/vir.0.011791-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salemi M, 2003, PHYLOGENETIC HDB, P101; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WILLEMS L, 1993, J VIROL, V67, P1086, DOI 10.1128/JVI.67.2.1086-1089.1993; Zavorotinskaya T, 1999, J VIROL, V73, P5034, DOI 10.1128/JVI.73.6.5034-5042.1999; Zhao XR, 2007, GENOMICS, V89, P502, DOI 10.1016/j.ygeno.2006.12.007	35	50	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58705	10.1371/journal.pone.0058705	http://dx.doi.org/10.1371/journal.pone.0058705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527009	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100036
J	Subramaniyan, M; Ecker, AS; Berens, P; Tolias, AS				Subramaniyan, Manivannan; Ecker, Alexander S.; Berens, Philipp; Tolias, Andreas S.			Macaque Monkeys Perceive the Flash Lag Illusion	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; MOTION EXTRAPOLATION; MOVING-OBJECTS; PSYCHOPHYSICS; PERCEPTION; MECHANISMS; LATENCIES; MOVEMENT; DELAYS	Transmission of neural signals in the brain takes time due to the slow biological mechanisms that mediate it. During such delays, the position of moving objects can change substantially. The brain could use statistical regularities in the natural world to compensate neural delays and represent moving stimuli closer to real time. This possibility has been explored in the context of the flash lag illusion, where a briefly flashed stimulus in alignment with a moving one appears to lag behind the moving stimulus. Despite numerous psychophysical studies, the neural mechanisms underlying the flash lag illusion remain poorly understood, partly because it has never been studied electrophysiologically in behaving animals. Macaques are a prime model for such studies, but it is unknown if they perceive the illusion. By training monkeys to report their percepts unbiased by reward, we show that they indeed perceive the illusion qualitatively similar to humans. Importantly, the magnitude of the illusion is smaller in monkeys than in humans, but it increases linearly with the speed of the moving stimulus in both species. These results provide further evidence for the similarity of sensory information processing in macaques and humans and pave the way for detailed neurophysiological investigations of the flash lag illusion in behaving macaques.	[Subramaniyan, Manivannan; Ecker, Alexander S.; Berens, Philipp; Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ecker, Alexander S.; Berens, Philipp] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp] Univ Tubingen, Inst Theoret Phys, Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp; Tolias, Andreas S.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Tolias, Andreas S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Tolias, Andreas S.] Rice Univ, Dept Computat & Appl Math, Houston, TX USA	Baylor College of Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society; Baylor College of Medicine; Rice University	Tolias, AS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	astolias@bcm.edu	Berens, Philipp/A-5653-2009; Ecker, Alexander S/A-5184-2010	Berens, Philipp/0000-0002-0199-4727; Ecker, Alexander S/0000-0003-2392-5105	National Eye Institute-United States National Institutes of Health (NIH) [R01 EY018847, 5-T32-EY07001-37, 5-P30-EY002520-33]; NIH-Pioneer award [DPI EY023176]; McKnight Endowment Fund; Arnold & Beckman Foundation; German Excellency Initiative through the Werner Reichardt Centre for Integrative Neuroscience Tubingen [EXC307, 2008/15]; German National Academic Foundation; NATIONAL EYE INSTITUTE [P30EY002520, T32EY007001, DP1EY023176, R01EY018847] Funding Source: NIH RePORTER	National Eye Institute-United States National Institutes of Health (NIH); NIH-Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund; Arnold & Beckman Foundation; German Excellency Initiative through the Werner Reichardt Centre for Integrative Neuroscience Tubingen; German National Academic Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute-United States National Institutes of Health (NIH) Grants R01 EY018847, 5-T32-EY07001-37, 5-P30-EY002520-33, the NIH-Pioneer award DPI EY023176, the McKnight Endowment Fund, the Arnold & Beckman Foundation, the German Excellency Initiative through the Werner Reichardt Centre for Integrative Neuroscience Tubingen (EXC307), grant 2008/15 and the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2003, CURR BIOL, V13, P59, DOI 10.1016/S0960-9822(02)01402-1; Bachmann T, 2001, VISION RES, V41, P1103, DOI 10.1016/S0042-6989(01)00003-7; BALDO MVC, 1995, NATURE, V378, P565, DOI 10.1038/378565a0; Baldo MVC, 2002, PERCEPTION, V31, P17, DOI 10.1068/p3302; Bedell HE, 2000, J OPT SOC AM A, V17, P947, DOI 10.1364/JOSAA.17.000947; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brenner E, 2000, VISION RES, V40, P1645, DOI 10.1016/S0042-6989(00)00067-5; Dash S, 2009, J VISION, V9, DOI 10.1167/9.9.5; DOMINGUEZ KE, 1954, J GENET PSYCHOL, V85, P105, DOI 10.1080/00221325.1954.10532865; Eagleman DM, 2007, J VISION, V7, DOI 10.1167/7.4.3; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Friedman HS, 1999, PERCEPTION, V28, P1383, DOI 10.1068/p2831; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Fu YX, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0003.2001; Huang X, 2002, J NEUROSCI, V22, P9618; Jancke D, 2004, J PHYSIOL-LONDON, V556, P971, DOI 10.1113/jphysiol.2003.058941; Kanai R, 2004, VISION RES, V44, P2605, DOI 10.1016/j.visres.2003.10.028; Kerzel D, 2003, CURR BIOL, V13, P1975, DOI 10.1016/j.cub.2003.10.054; Kleiner M, 2007, PERCEPTION, V36, P14; Krekelberg B, 1999, VISION RES, V39, P2669, DOI 10.1016/S0042-6989(98)00287-9; Krekelberg B, 2000, VISION RES, V40, P201, DOI 10.1016/S0042-6989(99)00168-6; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Lebedev MA, 2001, J NEUROPHYSIOL, V85, P1395, DOI 10.1152/jn.2001.85.4.1395; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Libedinsky C, 2009, J VISION, V9, DOI 10.1167/9.1.14; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; MAGUIRE WM, 1980, INVEST OPHTH VIS SCI, V19, P321; Murakami I, 2001, VISION RES, V41, P3101, DOI 10.1016/S0042-6989(01)00193-6; Murakami I, 2001, J VISION, V1, P126, DOI 10.1167/1.2.6; Nijhawan R, 2003, CURR BIOL, V13, P749, DOI 10.1016/S0960-9822(03)00248-3; Nijhawan R, 2001, PERCEPTION, V30, P263, DOI 10.1068/p3172; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Ogmen H, 2004, VISION RES, V44, P2109, DOI 10.1016/j.visres.2004.04.003; Patel S S, 2000, Science, V290, P1051; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; Sary G, 2008, EUR J NEUROSCI, V28, P2137, DOI 10.1111/j.1460-9568.2008.06499.x; Schlag J, 2000, NATURE, V403, P38, DOI 10.1038/47402; Sheth BR, 2008, BEHAV BRAIN SCI, V31, P215, DOI 10.1017/S0140525X08003981; Sheth BR, 2000, NAT NEUROSCI, V3, P489, DOI 10.1038/74865; Sundberg KA, 2006, NEURON, V49, P447, DOI 10.1016/j.neuron.2005.12.023; WALKER JT, 1982, HUM FACTORS, V24, P213, DOI 10.1177/001872088202400207; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	48	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58788	10.1371/journal.pone.0058788	http://dx.doi.org/10.1371/journal.pone.0058788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527024	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100042
J	Wang, YJ; Liu, W; Chen, C; Yan, LM; Song, J; Guo, KY; Wang, G; Wu, QH; Gu, WW				Wang, Yu-Jue; Liu, Wen; Chen, Chi; Yan, Li-Meng; Song, Jun; Guo, Kun-Yuan; Wang, Gang; Wu, Qing-Hong; Gu, Wei-Wang			Irradiation Induced Injury Reduces Energy Metabolism in Small Intestine of Tibet Minipigs	PLOS ONE			English	Article							INDUCED GASTROINTESTINAL SYNDROME; LITTER SIZE; RADIATION; LACTATION; PREGNANCY; DENSITY; P53	Background: The radiation-induced energy metabolism dysfunction related to injury and radiation doses is largely elusive. The purpose of this study is to investigate the early response of energy metabolism in small intestinal tissue and its correlation with pathologic lesion after total body X-ray irradiation (TBI) in Tibet minipigs. Methods and Results: 30 Tibet minipigs were assigned into 6 groups including 5 experimental groups and one control group with 6 animals each group. The minipigs in these experimental groups were subjected to a TBI of 2, 5, 8, 11, and 14 Gy, respectively. Small intestine tissues were collected at 24 h following X-ray exposure and analyzed by histology and high performance liquid chromatography (HPLC). DNA contents in this tissue were also examined. Irradiation causes pathologic lesions and mitochondrial abnormalities. The Deoxyribonucleic acid (DNA) content-corrected and uncorrected adenosine-triphosphate (ATP) and total adenine nucleotides (TAN) were significantly reduced in a dose-dependent manner by 2-8 Gy exposure, and no further reduction was observed over 8 Gy. Conclusion: TBI induced injury is highly dependent on the irradiation dosage in small intestine and inversely correlates with the energy metabolism, with its reduction potentially indicating the severity of injury.	[Wang, Yu-Jue; Liu, Wen; Wu, Qing-Hong; Gu, Wei-Wang] Southern Med Univ, Dept Lab Anim Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Yu-Jue] Pearl Lab Anim Sci & Tech Co Ltd, Dongguan, Peoples R China; [Chen, Chi; Song, Jun] Peoples Hosp Guizhou Prov, Dept Hematol, Guiyang, Guizhou, Peoples R China; [Yan, Li-Meng] Southern Med Univ, Zhujiang Hosp, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Guo, Kun-Yuan] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China; [Wang, Gang] Med Coll Guiyang, Affiliated Oncol Hosp, Dept Oncol, Guiyang, Guizhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Guo, KY (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	doctorguokunyuan@yahoo.com.cn; doctorguweiwang@yahoo.com.cn	Wang, Yujue/HHN-4296-2022		International Cooperation of Science [2011DFA33290]; Science Project of Guangdong province [2010A011200003, 2010A030400001, 2012B010300001]	International Cooperation of Science; Science Project of Guangdong province	This study was supported by International Cooperation of Science, 2011DFA33290 and Science Project of Guangdong province, 2010A011200003, 2010A030400001, 2012B010300001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Circu ML, 2009, FREE RADICAL BIO MED, V47, P1190, DOI 10.1016/j.freeradbiomed.2009.07.032; Ewer AK, 2004, GUT, V53, P207, DOI 10.1136/gut.2003.024521; Jones AM, 2008, AM J PHYSIOL-REG I, V294, pR585, DOI 10.1152/ajpregu.00731.2007; Jung YS, 2012, DNA REPAIR, V11, P177, DOI 10.1016/j.dnarep.2011.10.017; Kan HE, 2010, NMR BIOMED, V23, P995, DOI 10.1002/nbm.1517; Kim GJ, 2006, MUTAGENESIS, V21, P361, DOI 10.1093/mutage/gel048; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kopyl'chuk G P, 2005, Radiats Biol Radioecol, V45, P397; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kuliszkiewicz-Janus M, 2009, CELL MOL BIOL LETT, V14, P35, DOI 10.2478/s11658-008-0032-7; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Pearce LL, 2001, NITRIC OXIDE-BIOL CH, V5, P128, DOI 10.1006/niox.2001.0338; PELLETIER G, 1986, J NUTR, V116, P1480, DOI 10.1093/jn/116.8.1480; PELLETIER G, 1987, J NUTR, V117, P1759, DOI 10.1093/jn/117.10.1759; Reyngoudt H, 2011, CEPHALALGIA, V31, P1243, DOI 10.1177/0333102410394675; Rubio CA, 1996, DIGEST DIS SCI, V41, P392, DOI 10.1007/BF02093834; Wang YJ, 2012, EUR RADIOL, V22, P1844, DOI 10.1007/s00330-012-2451-0; Wu SJ, 2012, J RADIAT RES, V53, P18, DOI 10.1269/jrr.11077	19	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58970	10.1371/journal.pone.0058970	http://dx.doi.org/10.1371/journal.pone.0058970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527059	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100060
J	Nicolau, DV; Paszek, E; Fulga, F; Nicolau, DV				Nicolau, Dan V.; Paszek, Ewa; Fulga, Florin; Nicolau, Dan V., Jr.			Protein Molecular Surface Mapped at Different Geometrical Resolutions	PLOS ONE			English	Article							VORONOI DIAGRAM; SHAPE; AREA; ADSORPTION; HYDROPHOBICITY; RECOGNITION; EFFICIENT; PACKING; VOLUME; HEMOGLOBIN	Many areas of biochemistry and molecular biology, both fundamental and applications-orientated, require an accurate construction, representation and understanding of the protein molecular surface and its interaction with other, usually small, molecules. There are however many situations when the protein molecular surface gets in physical contact with larger objects, either biological, such as membranes, or artificial, such as nanoparticles. The contribution presents a methodology for describing and quantifying the molecular properties of proteins, by geometrical and physico-chemical mapping of the molecular surfaces, with several analytical relationships being proposed for molecular surface properties. The relevance of the molecular surface-derived properties has been demonstrated through the calculation of the statistical strength of the prediction of protein adsorption. It is expected that the extension of this methodology to other phenomena involving proteins near solid surfaces, in particular the protein interaction with nanoparticles, will result in important benefits in the understanding and design of protein-specific solid surfaces.	[Nicolau, Dan V.; Paszek, Ewa; Fulga, Florin] Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England; [Nicolau, Dan V.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada; [Nicolau, Dan V., Jr.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Liverpool; McGill University; University of California System; University of California Berkeley	Nicolau, DV (corresponding author), Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England.	dan.nicolau@mcgill.ca		Nicolau, Dan V/0000-0002-9956-0600	Defense Advanced Research Projects Agency (DARPA) [F30602-00-2-0614]; European Union Seventh Framework Programme [214538]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Union Seventh Framework Programme(European Commission)	This work has been supported by the Defense Advanced Research Projects Agency (DARPA), under SymBioSys Program, Grant Contract No. F30602-00-2-0614); and by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 214538, project Bio-Inspired Self-assembled Nano-Enabled Surfaces (BISNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayeyard J, 2010, MICROELECTRON ENG, V87, P760, DOI 10.1016/j.mee.2009.11.136; Banerji A, 2011, CELL MOL LIFE SCI, V68, P2711, DOI 10.1007/s00018-011-0722-6; Banerji A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007361; Banerji A, 2009, EUR BIOPHYS J BIOPHY, V38, P577, DOI 10.1007/s00249-009-0409-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Brockwell DJ, 2000, CURR OPIN STRUC BIOL, V10, P16, DOI 10.1016/S0959-440X(99)00043-3; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Can T, 2006, J MOL GRAPH MODEL, V25, P442, DOI 10.1016/j.jmgm.2006.02.012; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1985, J APPL CRYSTALLOGR, V18, P499, DOI 10.1107/S0021889885010779; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Cristea PD, 2012, MATER SCI FORUM, V721, P319, DOI 10.4028/www.scientific.net/MSF.721.319; Dawson KA, 2009, NAT NANOTECHNOL, V4, P84, DOI 10.1038/nnano.2008.426; DODD LR, 1991, MOL PHYS, V72, P1313, DOI 10.1080/00268979100100941; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; EISENHABER F, 1993, J COMPUT CHEM, V14, P1272, DOI 10.1002/jcc.540141103; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Eyrisch S, 2009, J COMPUT AID MOL DES, V23, P73, DOI 10.1007/s10822-008-9239-y; Fersht A., 1985, ENZYME STRUCTURE MEC; Filipponi L, 2009, BIOSENS BIOELECTRON, V24, P1850, DOI 10.1016/j.bios.2008.09.015; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; GIBSON KD, 1988, MOL PHYS, V64, P641, DOI 10.1080/00268978800100453; GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001; Hawkins KR, 2007, LAB CHIP, V7, P281, DOI 10.1039/b612894g; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P6101, DOI 10.1021/bi047813a; Kavanaugh JS, 1998, BIOCHEMISTRY-US, V37, P4358, DOI 10.1021/bi9708702; KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0; KELLOGG GE, 1991, J COMPUT AID MOL DES, V5, P545, DOI 10.1007/BF00135313; Kim DS, 2006, COMPUT AIDED DESIGN, V38, P431, DOI 10.1016/j.cad.2005.11.008; Kim D, 2008, J MOL GRAPH MODEL, V26, P1104, DOI 10.1016/j.jmgm.2007.10.002; Kinjo AR, 2005, BIOINFORMATICS, V21, P2167, DOI 10.1093/bioinformatics/bti330; Kinjo AR, 2005, PROTEINS, V58, P158, DOI 10.1002/prot.20300; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202; LEGRAND SM, 1993, J COMPUT CHEM, V14, P349, DOI 10.1002/jcc.540140309; Lin SL, 1996, J MOL GRAPHICS, V14, P78, DOI 10.1016/0263-7855(96)00030-6; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Mukhopadhyay R, 2006, ANAL CHEM, V78, P7379, DOI 10.1021/ac069476c; Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus; Nicolau DV, 2008, LANGMUIR, V24, P4420, DOI 10.1021/la8004486; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; Putta S, 2007, CURR TOP MED CHEM, V7, P1514, DOI 10.2174/156802607782194770; Rawat N, 2012, J PHYS CHEM B, V116, P6326, DOI 10.1021/jp3016529; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Rosen M, 1998, PROTEIN ENG, V11, P263, DOI 10.1093/protein/11.4.263; Ryu J, 2007, COMPUT AIDED DESIGN, V39, P1042, DOI 10.1016/j.cad.2006.10.008; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Sawant PD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2132080; Scarsi M, 1999, PROTEINS, V37, P565, DOI 10.1002/(SICI)1097-0134(19991201)37:4<565::AID-PROT7>3.0.CO;2-V; Serdyuk IN, 1997, BIOFIZIKA, V42, P1206; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Takano K, 2001, BIOCHEMISTRY-US, V40, P4853, DOI 10.1021/bi002792f; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Vasina EN, 2009, LAB CHIP, V9, P891, DOI 10.1039/b813475h; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang B, 2008, P NATL ACAD SCI USA, V105, P18171, DOI 10.1073/pnas.0807296105; WANG HJ, 1991, J COMPUT CHEM, V12, P868, DOI 10.1002/jcc.540120712; Wilson R, 2011, ANGEW CHEM INT EDIT, V50, P2151, DOI 10.1002/anie.201005975; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; ZAUHAR RJ, 1990, J COMPUT CHEM, V11, P603, DOI 10.1002/jcc.540110509	73	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58896	10.1371/journal.pone.0058896	http://dx.doi.org/10.1371/journal.pone.0058896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516572	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400074
J	Jia, CH; Hayoz, S; Hutch, CR; Iqbal, TR; Pooley, AE; Hegg, CC				Jia, Cuihong; Hayoz, Sebastien; Hutch, Chelsea R.; Iqbal, Tania R.; Pooley, Apryl E.; Hegg, Colleen C.			An IP3R3-and NPY-Expressing Microvillous Cell Mediates Tissue Homeostasis and Regeneration in the Mouse Olfactory Epithelium	PLOS ONE			English	Article							PURINERGIC RECEPTOR ACTIVATION; NEUROPEPTIDE-Y; NEURONAL DIFFERENTIATION; CALCIUM; RELEASE; NEUROGENESIS; SIGNAL; ADULT; SYSTEM; ATP	Calcium-dependent release of neurotrophic factors plays an important role in the maintenance of neurons, yet the release mechanisms are understudied. The inositol triphosphate (IP3) receptor is a calcium release channel that has a physiological role in cell growth, development, sensory perception, neuronal signaling and secretion. In the olfactory system, the IP3 receptor subtype 3 (IP3R3) is expressed exclusively in a microvillous cell subtype that is the predominant cell expressing neurotrophic factor neuropeptide Y (NPY). We hypothesized that IP3R3-expressing microvillous cells secrete sufficient NPY needed for both the continual maintenance of the neuronal population and for neuroregeneration following injury. We addressed this question by assessing the release of NPY and the regenerative capabilities of wild type, IP3R3(+/-), and IP3R3(-/-) mice. Injury, simulated using extracellular ATP, induced IP3 receptor-mediated NPY release in wild-type mice. ATP-evoked NPY release was impaired in IP3R3(-/-) mice, suggesting that IP3R3 contributes to NPY release following injury. Under normal physiological conditions, both IP3R3(-/-) mice and explants from these mice had fewer progenitor cells that proliferate and differentiate into immature neurons. Although the number of mature neurons and the in vivo rate of proliferation were not altered, the proliferative response to the olfactotoxicant satratoxin G and olfactory bulb ablation injury was compromised in the olfactory epithelium of IP3R3(-/-) mice. The reductions in both NPY release and number of progenitor cells in IP3R3(-/-) mice point to a role of the IP3R3 in tissue homeostasis and neuroregeneration. Collectively, these data suggest that IP3R3 expressing microvillous cells are actively responsive to injury and promote recovery.	[Jia, Cuihong; Hayoz, Sebastien; Hegg, Colleen C.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Hutch, Chelsea R.; Iqbal, Tania R.; Pooley, Apryl E.; Hegg, Colleen C.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Hutch, Chelsea R.; Hegg, Colleen C.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Hegg, CC (corresponding author), Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA.	hegg@msu.edu	Pooley, Apryl/K-6592-2019	Iqbal, Tania/0000-0002-6982-7650	NIH [DC006897]; MSU institutional funds; NIEHS [T32 ES007255]; NINDS [T32 NS044928]; Swiss Fellowship for Advanced Researchers [PA 00P3_131493]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS044928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSU institutional funds; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss Fellowship for Advanced Researchers; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was supported by NIH DC006897 and MSU institutional funds. CRH was supported by NIEHS T32 ES007255. TRI and AP was supported by NINDS T32 NS044928. SH was supported by Swiss Fellowship for Advanced Researchers PA 00P3_131493. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Bauer S, 2003, J NEUROSCI, V23, P1792; BERNATH S, 1988, NEUROSCIENCE, V27, P563, DOI 10.1016/0306-4522(88)90289-8; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLONDEL O, 1994, J BIOL CHEM, V269, P27167; Carr VM, 1998, J NEUROBIOL, V34, P377, DOI 10.1002/(SICI)1097-4695(199803)34:4<377::AID-NEU7>3.0.CO;2-3; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cowan CM, 2002, MICROSC RES TECHNIQ, V58, P204, DOI 10.1002/jemt.10150; Doyle KL, 2008, J NEUROCHEM, V105, P641, DOI 10.1111/j.1471-4159.2007.05188.x; Elsaesser R, 2005, EUR J NEUROSCI, V21, P2692, DOI 10.1111/j.1460-9568.2005.04108.x; Fang KM, 2009, J NEUROCHEM, V111, P1225, DOI 10.1111/j.1471-4159.2009.06409.x; Fukuda N, 2008, EUR J NEUROSCI, V27, P2665, DOI 10.1111/j.1460-9568.2008.06240.x; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gayle S, 2005, CELL TISSUE RES, V319, P27, DOI 10.1007/s00441-004-0979-2; Goetze B, 2002, CHEM SENSES, V27, P817, DOI 10.1093/chemse/27.9.817; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Gutierrez-Martin Y, 2011, J BIOL CHEM, V286, P11370, DOI 10.1074/jbc.M110.139410; Hansel DE, 2001, J NEUROSCI RES, V66, P1, DOI 10.1002/jnr.1191; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hayoz S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-53; Hegg CC, 2006, GLIA, V53, P182, DOI 10.1002/glia.20258; Hegg CC, 2003, J NEUROSCI, V23, P8291; Hegg CC, 2010, EUR J NEUROSCI, V32, P1632, DOI 10.1111/j.1460-9568.2010.07449.x; Huard JMT, 1998, J COMP NEUROL, V400, P469; Jia C, 2011, NEUROSCIENCE, V177, P335, DOI 10.1016/j.neuroscience.2010.12.039; Jia C, 2009, NEUROSCIENCE, V163, P120, DOI 10.1016/j.neuroscience.2009.06.040; Jia CH, 2012, MOL CELL NEUROSCI, V49, P158, DOI 10.1016/j.mcn.2011.11.004; Jia CH, 2011, TOXICOL SCI, V124, P169, DOI 10.1093/toxsci/kfr213; Jia CH, 2010, TOXICOL SCI, V115, P547, DOI 10.1093/toxsci/kfq071; Jia CH, 2010, NEUROBIOL DIS, V38, P405, DOI 10.1016/j.nbd.2010.02.013; Kanekar S, 2009, J NEUROSCI RES, V87, P1424, DOI 10.1002/jnr.21954; LAZAROWSKI ER, 1995, BRIT J PHARMACOL, V116, P1619, DOI 10.1111/j.1476-5381.1995.tb16382.x; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; MacDonald KPA, 1996, J NEUROSCI RES, V44, P27, DOI 10.1002/(SICI)1097-4547(19960401)44:1<27::AID-JNR4>3.0.CO;2-K; Mackay-Sim A, 2000, PROG NEUROBIOL, V62, P527, DOI 10.1016/S0301-0082(00)00009-5; Montani G, 2006, EUR J NEUROSCI, V24, P20, DOI 10.1111/j.1460-9568.2006.04878.x; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Nucifora FC, 1996, MOL BIOL CELL, V7, P949, DOI 10.1091/mbc.7.6.949; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; PRENTKI M, 1984, NATURE, V309, P562, DOI 10.1038/309562a0; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; Sharp AH, 1999, J COMP NEUROL, V406, P207; Trudeau LE, 1996, J NEUROSCI, V16, P46; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Young J T, 1981, Fundam Appl Toxicol, V1, P309, DOI 10.1016/S0272-0590(81)80037-1	46	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58668	10.1371/journal.pone.0058668	http://dx.doi.org/10.1371/journal.pone.0058668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516531	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200105
J	Jeong, SJ; Ho, CH; Choi, SD; Kim, J; Lee, EJ; Gim, HJ				Jeong, Su-Jong; Ho, Chang-Hoi; Choi, Sung-Deuk; Kim, Jinwon; Lee, Eun-Ju; Gim, Hyeon-Ju			Satellite Data-Based Phenological Evaluation of the Nationwide Reforestation of South Korea	PLOS ONE			English	Article							CARBON-DIOXIDE; FOREST; SEASON; TRANSITIONS; RESPONSES; IMPACTS; TRENDS	Through the past 60 years, forests, now of various age classes, have been established in the southern part of the Korean Peninsula through nationwide efforts to reestablish forests since the Korean War (1950-53), during which more than 65% of the nation's forest was destroyed. Careful evaluation of long-term changes in vegetation growth after reforestation is one of the essential steps to ensuring sustainable forest management. This study investigated nationwide variations in vegetation phenology using satellite-based growing season estimates for 1982-2008. The start of the growing season calculated from the normalized difference vegetation index (NDVI) agrees reasonably with the ground-observed first flowering date both temporally (correlation coefficient, r = 0.54) and spatially (r = 0.64) at the 95% confidence level. Over the entire 27-year period, South Korea, on average, experienced a lengthening of the growing season of 4.5 days decade(-1), perhaps due to recent global warming. The lengthening of the growing season is attributed mostly to delays in the end of the growing season. The retrieved nationwide growing season data were used to compare the spatial variations in forest biomass carbon density with the time-averaged growing season length for 61 forests. Relatively higher forest biomass carbon density was observed over the regions having a longer growing season, especially for the regions dominated by young (<30 year) forests. These results imply that a lengthening of the growing season related to the ongoing global warming may have positive impacts on carbon sequestration, an important aspect of large-scale forest management for sustainable development.	[Jeong, Su-Jong] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Ho, Chang-Hoi; Gim, Hyeon-Ju] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Choi, Sung-Deuk] Ulsan Natl Inst Sci & Technol, Sch Urban & Environm Engn, Ulsan, South Korea; [Kim, Jinwon] Univ Calif Los Angeles, Dept Meteorol, Los Angeles, CA USA; [Lee, Eun-Ju] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Princeton University; Seoul National University (SNU); Ulsan National Institute of Science & Technology (UNIST); University of California System; University of California Los Angeles; Seoul National University (SNU)	Ho, CH (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.	hoch@cpl.snu.ac.kr	Ho, Chang-Hoi/H-8354-2015; Jeong, Su-Jong/J-4110-2014; Choi, Sung-Deuk/F-4827-2010	Choi, Sung-Deuk/0000-0003-1024-2620	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0093458]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2011, FOREST TRANSITION S, P198; Choi SD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001914; Choi SD, 2004, ENVIRON SCI TECHNOL, V38, P484, DOI 10.1021/es034533u; Chung U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027439; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Dragoni D, 2012, AGR FOREST METEOROL, V157, P96, DOI 10.1016/j.agrformet.2012.01.019; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; Fisher JI, 2006, REMOTE SENS ENVIRON, V100, P265, DOI 10.1016/j.rse.2005.10.022; Garrity SR, 2011, AGR FOREST METEOROL, V151, P1741, DOI 10.1016/j.agrformet.2011.07.008; Gonsamo A, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002070; Ho CH, 2006, INT J CLIMATOL, V26, P2117, DOI 10.1002/joc.1356; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; Intergovernmental Panel on Climate Change, 1996, IPCC GUID NAT GREENH; Jeong JH, 2011, INT J CLIMATOL, V31, P1488, DOI 10.1002/joc.2178; Jeong SJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001868; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Julien Y, 2009, INT J REMOTE SENS, V30, P3495, DOI 10.1080/01431160802562255; Kang JH, 2009, ATMOS-KOREA, V19, P169; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kim KD, 1988, J KOREAN FOR ENG, V8, P94; Korea Forest Research Institute, 1996, KOR FOR GREENH GAS; Korea Forest Service, 1988, HIST FOR REH S KOR; Korea Forest Service, 2000, STAT YB FOR 1954 200; Lee KyeongHak, 1997, FRI Journal of Forest Science (Seoul), P152; Lee MH, 2012, CLIMATIC CHANGE, V113, P301, DOI 10.1007/s10584-011-0345-9; Liang LA, 2011, REMOTE SENS ENVIRON, V115, P143, DOI 10.1016/j.rse.2010.08.013; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Pan Y, 2011, SCIENCE, V14, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rotzer T, 2004, INT J BIOMETEOROL, V48, P109, DOI 10.1007/s00484-003-0191-1; Schwartz MD, 2010, INT J CLIMATOL, V30, P1614, DOI 10.1002/joc.2008; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Wu CY, 2012, AGR FOREST METEOROL, V164, P29, DOI 10.1016/j.agrformet.2012.05.002; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	44	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58900	10.1371/journal.pone.0058900	http://dx.doi.org/10.1371/journal.pone.0058900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520541	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900101
J	Keurentjes, JC; Blane, D; Bartley, M; Keurentjes, JJB; Fiocco, M; Nelissen, RG				Keurentjes, J. Christiaan; Blane, David; Bartley, Melanie; Keurentjes, Johan J. B.; Fiocco, Marta; Nelissen, Rob G.			Socio-Economic Position Has No Effect on Improvement in Health-Related Quality of Life and Patient Satisfaction in Total Hip and Knee Replacement: A Cohort Study	PLOS ONE			English	Article							ELECTIVE TOTAL HIP; JOINT REPLACEMENT; UNITED-STATES; ARTHROPLASTY; POPULATION; EXPECTATIONS; REVISION; SURGERY; SF-36; RATES	Introduction: Considerable evidence suggests that patients with more advantaged Socio-Economic Positions undergo Total Hip and Knee Replacement (THR/TKR) more often, despite having a lower need. We questioned whether more disadvantaged Socio-Economic Position is associated with an lower improvement in Health-Related Quality of Life (HRQoL) and a lower patient satisfaction after THR/TKR. Methods: Patients who underwent primary THR/TKR in one academic and three community hospitals between 2005 and 2009, were eligible for inclusion. The highest completed levels of schooling were aggregated to index social class. We compared the improvement in HRQoL and postoperative satisfaction with surgery (measured using the Short-Form 36 (SF36) and an 11-point numeric rating scale of satisfaction) between the aggregated groups of highest completed levels of schooling, using linear mixed model analysis, with center as a random effect and potential confounders (i.e. age, gender, Body Mass Index and Charnley's comorbidity classification) as fixed effects. Results: 586 THR patients and 400 TKR patients (40% of all eligible patients) agreed to participate and completed all questionnaires sufficiently. We found no differences in HRQoL improvement in any dimension of the SF36 in THR patients. Patients with a higher completed level of schooling had a larger improvement in role-physical (9.38 points, 95%-CI: 0.3418.4), a larger improvement in general health (3.67 points, 95%-CI: 0.56-6.79) and a smaller improvement in mental health (3.60 points, 95%-CI: 0.82-6.38) after TKR. Postoperative patient satisfaction did not differ between different highest completed level of schooling groups. Discussion: Completed level of schooling has no effect on the improvement in HRQoL and patient satisfaction in a Dutch THR population and a small effect in a similar TKR population. Undertreatment of patients with more disadvantaged Socio-Economic Position cannot be justified, given the similar improvement in HRQoL and postoperative level of satisfaction with surgery between the social groups examined.	[Keurentjes, J. Christiaan; Nelissen, Rob G.] Leiden Univ, Med Ctr, Dept Orthopaed Surg, Leiden, Netherlands; [Blane, David] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Bartley, Melanie] UCL, Dept Epidemiol & Publ Hlth, London, England; [Keurentjes, Johan J. B.] Kadaster Dutch Land Registry Off, Dept Informat & Management, Apeldoorn, Netherlands; [Fiocco, Marta] Leiden Univ, Med Ctr, Dept Med Stat & BioInformat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Imperial College London; University of London; University College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Keurentjes, JC (corresponding author), Leiden Univ, Med Ctr, Dept Orthopaed Surg, Leiden, Netherlands.	j.c.keurentjes@lumc.nl	Nelissen, Rob/AAD-8134-2020; Dijkstra, Sander/F-2513-2017	Nelissen, Rob/0000-0003-1228-4162; Dijkstra, Sander/0000-0001-5368-757X	Dutch Arthritis Association [LLP-013]; ESRC [ES/J019119/1] Funding Source: UKRI	Dutch Arthritis Association; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Ongoing research grant of the Dutch Arthritis Association to Prof. Dr. Nelissen, Department of Orthopaedic Surgery, Leiden University Medical Center, grant number LLP-013 (http://www.reumafonds.nl/informatie-voor-doelgroepen/professionals/ongoing-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Baker PN, 2007, J BONE JOINT SURG BR, V89B, P893, DOI 10.1302/0301-620X.89B7.19091; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Brennan SL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-63; Brokelman RBG, 2003, J BONE JOINT SURG BR, V85B, P495, DOI 10.1302/0301-620X.85B4.13411; Bruyere O, 2012, ARCH ORTHOPAEDIC TRA; Butler RA, 2011, CLIN ORTHOP RELAT R, V469, P339, DOI 10.1007/s11999-010-1519-x; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; Davis ET, 2008, INT J QUAL HEALTH C, V20, P40, DOI 10.1093/intqhc/mzm059; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724; Dunbar MJ, 2004, ACTA ORTHOP SCAND, V75, P119, DOI 10.1080/00016470412331294355; Escobar A, 2007, RHEUMATOLOGY, V46, P112, DOI 10.1093/rheumatology/kel184; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Frie KG, 2012, J CLIN EPIDEMIOL, V65, P619, DOI 10.1016/j.jclinepi.2011.12.001; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gandhi R, 2008, J RHEUMATOL, V35, P2415, DOI 10.3899/jrheum.080295; Garellick G, 2000, CLIN ORTHOP RELAT R, P157; Gill TMFeinstein AR, JAMA J AM MED ASS, V272, P619; Hartge P, 2006, EPIDEMIOLOGY, V17, P252, DOI 10.1097/01.ede.0000209441.24307.92; Hawkins K, 2011, POPUL HEALTH MANAG, V14, P231, DOI 10.1089/pop.2010.0042; Honaker J, 2011, J STAT SOFTW, V45, P1; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Jones J, 1996, J Health Soc Policy, V8, P49, DOI 10.1300/J045v08n01_05; Judge A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4092; Judge A, 2009, J PUBLIC HEALTH-UK, V31, P413, DOI 10.1093/pubmed/fdp061; Keurentjes JC, 2012, BONE JOINT RES, V1, P71, DOI 10.1302/2046-3758.15.2000065; Keurentjes JC, 2012, BONE JOINT RES, V1, P258, DOI 10.1302/2046-3758.110.2000104; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Krieger N, 2001, J EPIDEMIOL COMMUN H, V55, P693, DOI 10.1136/jech.55.10.693; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lingard EA, 2006, J BONE JOINT SURG AM, V88A, P1201, DOI 10.2106/JBJS.E.00147; Lostao L, 2011, HEALTH PLACE, V17, P830, DOI 10.1016/j.healthplace.2011.03.006; Majeed A, 2002, J PUBLIC HEALTH MED, V24, P21, DOI 10.1093/pubmed/24.1.21; Malchau H, 2005, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000193517.19556.e4; Mota REM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-225; Muldoon MF, 1998, BMJ-BRIT MED J, V316, P542, DOI 10.1136/bmj.316.7130.542; Ng CY, 2007, J BONE JOINT SURG BR, V89B, P868, DOI 10.1302/0301-620X.89B7.18482; Nilsdotter AK, 2009, ACTA ORTHOP, V80, P55, DOI 10.1080/17453670902805007; Noble PC, 2006, CLIN ORTHOP RELAT R, P35, DOI 10.1097/011.blo.0000238825.63648.1e; Ostendorf M, 2004, J BONE JOINT SURG BR, V86B, P801, DOI 10.1302/0301-620X.86B6.14950; PETERSON MGE, 1992, J BONE JOINT SURG AM, V74A, P1530, DOI 10.2106/00004623-199274100-00012; Quintana JM, 2009, CLIN ORTHOP RELAT R, V467, P2886, DOI 10.1007/s11999-009-0868-9; Roos EM, 2003, CURR OPIN RHEUMATOL, V15, P160, DOI 10.1097/00002281-200303000-00014; Rubin DB, 2004, MULTIPLE IMPUTATION; Schreurs BW, 2009, J BONE JOINT SURG BR, V91B, P1148, DOI 10.1302/0301-620X.91B9.21750; Steel N, 2006, RHEUMATOLOGY, V45, P1437, DOI 10.1093/rheumatology/kel131; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Team RDC, 2008, LANG ENV STAT COMP, V1; Vissers MM, 2011, PHYS THER, V91, P615, DOI 10.2522/ptj.20100201; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wolterbeek N, 2011, CLIN BIOMECHANICS BR, DOI [10.1016/j.clinbiomech.2011.10.013, DOI 10.1016/J.CLINBI0-MECH.2011.10.013]; Yong PFK, 2004, ANN RHEUM DIS, V63, P1483, DOI 10.1136/ard.2003.013938	54	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56785	10.1371/journal.pone.0056785	http://dx.doi.org/10.1371/journal.pone.0056785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520456	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900015
J	Lenz, F; Chechkin, AV; Klages, R				Lenz, Friedrich; Chechkin, Aleksei V.; Klages, Rainer			Constructing a Stochastic Model of Bumblebee Flights from Experimental Data	PLOS ONE			English	Article							SEARCH PATTERNS; LEVY FLIGHT; SAMPLING RATE; MOVEMENT; ANIMALS; DISPERSAL; SUCCESS	The movement of organisms is subject to a multitude of influences of widely varying character: from the bio-mechanics of the individual, over the interaction with the complex environment many animals live in, to evolutionary pressure and energy constraints. As the number of factors is large, it is very hard to build comprehensive movement models. Even when movement patterns in simple environments are analysed, the organisms can display very complex behaviours. While for largely undirected motion or long observation times the dynamics can sometimes be described by isotropic random walks, usually the directional persistence due to a preference to move forward has to be accounted for, e. g., by a correlated random walk. In this paper we generalise these descriptions to a model in terms of stochastic differential equations of Langevin type, which we use to analyse experimental search flight data of foraging bumblebees. Using parameter estimates we discuss the differences and similarities to correlated random walks. From simulations we generate artificial bumblebee trajectories which we use as a validation by comparing the generated ones to the experimental data.	[Lenz, Friedrich; Klages, Rainer] Queen Mary Univ London, Sch Math Sci, London, England; [Chechkin, Aleksei V.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Chechkin, Aleksei V.] NSC KIPT, Inst Theoret Phys, Kharkov, Ukraine	University of London; Queen Mary University London; Max Planck Society	Lenz, F (corresponding author), Queen Mary Univ London, Sch Math Sci, London, England.	f.lenz@qmul.ac.uk	Chechkin, Aleksei/D-2147-2015; Klages, Rainer/B-7194-2008	Klages, Rainer/0000-0003-3811-3070; Chechkin, Aleksei/0000-0002-3803-1174				Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Batschelet E, 1981, CIRCULAR STAT BIOL; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; BOVET P, 1988, J THEOR BIOL, V131, P419, DOI 10.1016/S0022-5193(88)80038-9; Codling EA, 2005, J THEOR BIOL, V233, P573, DOI 10.1016/j.jtbi.2004.11.008; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Friedrich R, 1997, PHYS REV LETT, V78, P863, DOI 10.1103/PhysRevLett.78.863; Giuggioli L, 2012, J MATH BIOL, V64, P647, DOI 10.1007/s00285-011-0431-7; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Ings TC, 2008, CURR BIOL, V18, P1520, DOI 10.1016/j.cub.2008.07.074; Ings TC, 2009, P ROY SOC B-BIOL SCI, V276, P2031, DOI 10.1098/rspb.2008.1748; James A, 2010, B MATH BIOL, V72, P896, DOI 10.1007/s11538-009-9473-z; Kai ET, 2009, P NATL ACAD SCI USA, V106, P8245, DOI 10.1073/pnas.0811034106; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; Lenz F, 2009, EUR PHYS J B, V72, P467, DOI 10.1140/epjb/e2009-00364-3; Lenz F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.098103; Lindner B, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/063026; Mashanova A, 2010, J R SOC INTERFACE, V7, P199, DOI 10.1098/rsif.2009.0121; Miramontes O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034317; Pearson K, 1905, NATURE, V72; Peruani F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.010602; Petrovskii S, 2009, AM NAT, V173, P278, DOI 10.1086/595755; Plank MJ, 2009, ECOLOGY, V90, P3546, DOI 10.1890/09-0079.1; Press W. H., 1992, ART SCI COMPUTING; Ragwitz M, 2001, PHYS REV LETT, P87; Reynolds AM, 2010, PHYSICA A, V389, P4740, DOI 10.1016/j.physa.2010.06.027; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Romanczuk P, 2012, EUR PHYS J-SPEC TOP, V202, P1, DOI 10.1140/epjst/e2012-01529-y; Romanczuk P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.230601; Santos MC, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434017; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	40	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59036	10.1371/journal.pone.0059036	http://dx.doi.org/10.1371/journal.pone.0059036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520551	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900111
J	Qu, XH; Jin, FC; Hao, YQ; Li, HW; Tang, TT; Wang, H; Yan, WL; Dai, KR				Qu, Xinhua; Jin, Fangchun; Hao, Yongqiang; Li, Huiwu; Tang, Tingting; Wang, Hao; Yan, Weili; Dai, Kerong			Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW SERUM MAGNESIUM; DIETARY MAGNESIUM; ATHEROSCLEROSIS RISK; SECONDARY PREVENTION; COLORECTAL-CANCER; PUBLICATION BIAS; TREND ESTIMATION; DRINKING-WATER; BLOOD-PRESSURE	Background: Prospective studies that have examined the association between dietary magnesium intake and serum magnesium concentrations and the risk of cardiovascular disease (CVD) events have reported conflicting findings. We undertook a meta-analysis to evaluate the association between dietary magnesium intake and serum magnesium concentrations and the risk of total CVD events. Methodology/Principal Findings: We performed systematic searches on MEDLINE, EMBASE, and OVID up to February 1, 2012 without limits. Categorical, linear, and nonlinear, dose-response, heterogeneity, publication bias, subgroup, and meta-regression analysis were performed. The analysis included 532,979 participants from 19 studies (11 studies on dietary magnesium intake, 6 studies on serum magnesium concentrations, and 2 studies on both) with 19,926 CVD events. The pooled relative risks of total CVD events for the highest vs. lowest category of dietary magnesium intake and serum magnesium concentrations were 0.85 (95% confidence interval 0.78 to 0.92) and 0.77 (0.66 to 0.87), respectively. In linear dose-response analysis, only serum magnesium concentrations ranging from 1.44 to 1.8 mEq/L were significantly associated with total CVD events risk (0.91, 0.85 to 0.97) per 0.1 mEq/L (P-nonlinearity = 0.465). However, significant inverse associations emerged in nonlinear models for dietary magnesium intake (P-nonlinearity = 0.024). The greatest risk reduction occurred when intake increased from 150 to 400 mg/d. There was no evidence of publication bias. Conclusions/Significance: There is a statistically significant nonlinear inverse association between dietary magnesium intake and total CVD events risk. Serum magnesium concentrations are linearly and inversely associated with the risk of total CVD events.	[Qu, Xinhua; Jin, Fangchun; Hao, Yongqiang; Li, Huiwu; Tang, Tingting; Dai, Kerong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant, Shanghai 200030, Peoples R China; [Wang, Hao] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol & Biostat, Shanghai 200030, Peoples R China; [Yan, Weili] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dai, KR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant, Shanghai 200030, Peoples R China.	krdai@163.com	Tang, Tingting/B-1361-2013; Qu, Xinhua/Q-3950-2016	Tang, Tingting/0000-0002-1670-7452; Qu, Xinhua/0000-0002-8889-0890	Fund for National Basic Research Program of China [2012CB619101]; Major Basic Research of Science and Technology Commission of Shanghai Municipality [11DJ1400303]; Key Disciplines of Shanghai Municipal Education Commission [J50206]	Fund for National Basic Research Program of China(National Basic Research Program of China); Major Basic Research of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Disciplines of Shanghai Municipal Education Commission	This study was supported by Fund for National Basic Research Program of China (Grant No. 2012CB619101), Major Basic Research of Science and Technology Commission of Shanghai Municipality (Grant No. 11DJ1400303), and Key Disciplines of Shanghai Municipal Education Commission (Grant No. J50206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2003, AM J CARDIOL, V92, P665, DOI 10.1016/s0002-9149(03)00819-1; Adamopoulos C, 2009, INT J CARDIOL, V136, P270, DOI 10.1016/j.ijcard.2008.05.006; Al-Delaimy WK, 2004, J AM COLL NUTR, V23, P63, DOI 10.1080/07315724.2004.10719344; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; Berg AO, 2003, ANN INTERN MED, V139, P51, DOI 10.7326/0003-4819-139-1-200307010-00013; BURCH GE, 1977, AM HEART J, V94, P649, DOI 10.1016/S0002-8703(77)80137-3; Chakraborti S, 2002, MOL CELL BIOCHEM, V238, P163, DOI 10.1023/A:1019998702946; Chavkin W, 1997, NEW ENGL J MED, V336, P1321; Chen Y, 2012, INT J CARDIOL, DOI 10.1016/j.ijcard.2012.04.041; Cheng TO, 2012, INT J CARDIOL, V154, P233, DOI 10.1016/j.ijcard.2011.12.023; Chiuve SE, 2011, AM J CLIN NUTR, V93, P253, DOI 10.3945/ajcn.110.002253; Cotruvo J., 2009, CALCIUM MAGNESIUM DR; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Ford ES, 1999, INT J EPIDEMIOL, V28, P645, DOI 10.1093/ije/28.4.645; Fox CH, 2003, J NATL MED ASSOC, V95, P257; GARTSIDE PS, 1995, J AM COLL NUTR, V14, P71; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Houston M, 2011, J CLIN HYPERTENS, V13, P843, DOI 10.1111/j.1751-7176.2011.00538.x; Iso H, 1999, STROKE, V30, P1772, DOI 10.1161/01.STR.30.9.1772; Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3; Kaluza J, 2010, AM J EPIDEMIOL, V171, P801, DOI 10.1093/aje/kwp467; Khan AM, 2010, AM HEART J, V160, P715, DOI 10.1016/j.ahj.2010.06.036; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; Larsson SC, 2008, ARCH INTERN MED, V168, P459, DOI 10.1001/archinte.168.5.459; Larsson SC, 2012, AM J CLIN NUTR, V95, P362, DOI 10.3945/ajcn.111.022376; Larsson SC, 2011, STROKE, V42, P2746, DOI 10.1161/STROKEAHA.111.622142; Larsson SC, 2011, AM J EPIDEMIOL, V174, P35, DOI 10.1093/aje/kwr051; Larsson SC, 2010, JAMA-J AM MED ASSOC, V303, P1077, DOI 10.1001/jama.2010.263; Leone N, 2006, EPIDEMIOLOGY, V17, P308, DOI 10.1097/01.ede.0000209454.41466.b7; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Liao FZ, 1998, AM HEART J, V136, P480, DOI 10.1016/S0002-8703(98)70224-8; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lipsky MS, 2008, AM MED ASS GUIDE PRE; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mendis S., 2011, GLOB ATL CARD DIS PR; Mitka M, 2006, JAMA-J AM MED ASSOC, V296, P30, DOI 10.1001/jama.296.1.30; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Moshfegh A, 2005, WHAT WE EAT AM NHANE, P1; NIH, DIET FACT SHEET MA S; Ohira T, 2009, AM J EPIDEMIOL, V169, P1437, DOI 10.1093/aje/kwp071; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Peacock JM, 2010, AM HEART J, V160, P464, DOI 10.1016/j.ahj.2010.06.012; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Qu X, 2011, INT J CARDIOL; Reffelmann T, 2011, ATHEROSCLEROSIS, V219, P280, DOI 10.1016/j.atherosclerosis.2011.05.038; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rosanoff A, 2012, NUTR REV, V70, P153, DOI 10.1111/j.1753-4887.2011.00465.x; Sanjuliani AF, 1996, INT J CARDIOL, V56, P177, DOI 10.1016/S0167-5273(96)02716-7; Song YQ, 2012, AM J CLIN NUTR, V95, P269, DOI 10.3945/ajcn.111.031104; Song YQ, 2005, AM J CARDIOL, V96, P1135, DOI 10.1016/j.amjcard.2005.06.045; Strazzullo Pasquale, 2009, BMJ, V339, pb4567, DOI 10.1136/bmj.b4567; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tanne JH, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e22; Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Weisinger JR, 1998, LANCET, V352, P391, DOI 10.1016/S0140-6736(97)10535-9; Weng LC, 2008, STROKE, V39, P3152, DOI 10.1161/STROKEAHA.108.524934; WHO, 2002, RED RISKS PROM HLTH; Wu SJ, 2012, AM J MED, V125, P551, DOI 10.1016/j.amjmed.2012.01.022; Yang CY, 1999, AM J HYPERTENS, V12, P894, DOI 10.1016/S0895-7061(99)00065-5; Yang CY, 1998, STROKE, V29, P411, DOI 10.1161/01.STR.29.2.411; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang W, 2012, ATHEROSCLEROSIS, V221, P587, DOI 10.1016/j.atherosclerosis.2012.01.034	72	133	134	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57720	10.1371/journal.pone.0057720	http://dx.doi.org/10.1371/journal.pone.0057720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520480	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900039
J	Salvucci, M; Neufeld, Z; Newsholme, P				Salvucci, Manuela; Neufeld, Zoltan; Newsholme, Philip			Mathematical Model of Metabolism and Electrophysiology of Amino Acid and Glucose Stimulated Insulin Secretion: In Vitro Validation Using a beta-Cell Line	PLOS ONE			English	Article							MITOCHONDRIAL CALCIUM; L-ALANINE; AMPLIFYING PATHWAYS; ELECTRICAL-ACTIVITY; PANCREATIC-ISLETS; L-GLUTAMINE; OSCILLATIONS; RAT; BRIN-BD11; MESSENGER	We integrated biological experimental data with mathematical modelling to gain insights into the role played by L-alanine in amino acid-stimulated insulin secretion (AASIS) and in D-glucose-stimulated insulin secretion (GSIS), details important to the understanding of complex beta-cell metabolic coupling relationships. We present an ordinary differential equations (ODEs) based simplified kinetic model of core metabolic processes leading to ATP production (glycolysis, TCA cycle, L-alanine-specific reactions, respiratory chain, ATPase and proton leak) and Ca2+ handling (essential channels and pumps in the plasma membrane) in pancreatic beta-cells and relate these to insulin secretion. Experimental work was performed using a clonal rat insulin-secreting cell line (BRIN-BD11) to measure the consumption or production of a range of important biochemical parameters (D-glucose, L-alanine, ATP, insulin secretion) and Ca2+ levels. These measurements were then used to validate the theoretical model and fine-tune the parameters. Mathematical modelling was used to predict L-lactate and L-glutamate concentrations following D-glucose and/or L-alanine challenge and Ca2+ levels upon stimulation with a non metabolizable L-alanine analogue. Experimental data and mathematical model simulations combined suggest that L-alanine produces a potent insulinotropic effect via both a stimulatory impact on b-cell metabolism and as a direct result of the membrane depolarization due to Ca2+ influx triggered by L-alanine/Na+ co-transport. Our simulations indicate that both high intracellular ATP and Ca2+ concentrations are required in order to develop full insulin secretory responses. The model confirmed that K-ATP(+) channel independent mechanisms of stimulation of intracellular Ca2+ levels, via generation of mitochondrial coupling messengers, are essential for promotion of the full and sustained insulin secretion response in beta-cells.	[Salvucci, Manuela; Newsholme, Philip] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Neufeld, Zoltan] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia; [Newsholme, Philip] Curtin Univ, Sch Biomed Sci, Perth, WA, Australia	University College Dublin; University of Queensland; Curtin University	Salvucci, M (corresponding author), Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland.	manuela.salvucci@gmail.com	Newsholme, Philip/D-4939-2016; Neufeld, Zoltan/C-3008-2011	Newsholme, Philip/0000-0002-0500-6984; Neufeld, Zoltan/0000-0003-3236-9278	Irish Research Council for Science, Engineering and Technology; School of Biomolecular and Biomedical Science, University College Dublin	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology); School of Biomolecular and Biomedical Science, University College Dublin	This work was supported by a postgraduate award to MS from the Irish Research Council for Science, Engineering and Technology. The study was additionally supported by the School of Biomolecular and Biomedical Science, University College Dublin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHS MJ, 1991, J THEOR BIOL, V150, P109, DOI 10.1016/S0022-5193(05)80478-3; Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; BOHNENSACK R, 1981, BIOCHIM BIOPHYS ACTA, V634, P203, DOI 10.1016/0005-2728(81)90139-0; Brennan L, 2003, DIABETOLOGIA, V46, P1512, DOI 10.1007/s00125-003-1184-7; Brennan L, 2002, DIABETES, V51, P1714, DOI 10.2337/diabetes.51.6.1714; Cunningham GA, 2005, CLIN SCI, V109, P447, DOI 10.1042/CS20050149; Dixon G, 2003, J ENDOCRINOL, V179, P447, DOI 10.1677/joe.0.1790447; DUNNE MJ, 1990, EXP PHYSIOL, V75, P771, DOI 10.1113/expphysiol.1990.sp003459; Fridlyand LE, 2010, AM J PHYSIOL-ENDOC M, V299, pE517, DOI 10.1152/ajpendo.00177.2010; Fridlyand LE, 2009, BIOPHYS J, V96, P3126, DOI 10.1016/j.bpj.2009.01.029; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Fridlyand LE, 2003, AM J PHYSIOL-ENDOC M, V285, pE138, DOI 10.1152/ajpendo.00194.2002; Fridlyand LE, 2011, PROG BIOPHYS MOL BIO, V107, P293, DOI 10.1016/j.pbiomolbio.2011.09.001; Fridlyand LE, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-15; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; HELLMAN B, 1971, ENDOCRINOLOGY, V89, P1432, DOI 10.1210/endo-89-6-1432; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Jiang N, 2007, MAMM GENOME, V18, P508, DOI 10.1007/s00335-007-9011-y; Kiely A, 2007, J ENDOCRINOL, V195, P113, DOI 10.1677/JOE-07-0306; Korzeniewski B, 2000, BIOPHYS CHEM, V83, P19, DOI 10.1016/S0301-4622(99)00120-9; Krause MS, 2011, J ENDOCRINOL, V211, P87, DOI 10.1530/JOE-11-0236; Liu Zhenping LY, 2008, DIABETES METAB, V27, P12; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, CELL MOL LIFE SCI, V59, P1803, DOI 10.1007/PL00012507; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1174, DOI 10.1152/ajpcell.1998.274.4.C1174; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1158, DOI 10.1152/ajpcell.1998.274.4.C1158; MALAISSE WJ, 1982, J BIOL CHEM, V257, P8731; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Mao CS, 2004, AM J PHYSIOL-ENDOC M, V287, pE50, DOI 10.1152/ajpendo.00555.2003; McClenaghan NH, 2009, CLIN SCI, V116, P341, DOI 10.1042/CS20080138; McClenaghan NH, 1998, BIOCHEM BIOPH RES CO, V249, P299, DOI 10.1006/bbrc.1998.9136; McClenaghan NH, 1996, J ENDOCRINOL, V151, P349, DOI 10.1677/joe.0.1510349; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Menge BA, 2010, REGUL PEPTIDES, V160, P75, DOI 10.1016/j.regpep.2009.08.001; Miwa Y, 1999, JPN J PHYSIOL, V49, P353, DOI 10.2170/jjphysiol.49.353; Nazaret C, 2009, J THEOR BIOL, V258, P455, DOI 10.1016/j.jtbi.2008.09.037; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Nielsen K, 1998, BIOPHYS CHEM, V72, P49, DOI 10.1016/S0301-4622(98)00122-7; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; PRENTKI M, 1983, J BIOL CHEM, V258, P4239; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Sherman A, 2010, MATH BIOSCI, V227, P12, DOI 10.1016/j.mbs.2010.05.005; Tamarina NA, 2005, AM J PHYSIOL-ENDOC M, V289, pE578, DOI 10.1152/ajpendo.00054.2005; Westermark PO, 2007, AM J PHYSIOL-ENDOC M, V292, pE373, DOI 10.1152/ajpendo.00589.2005; Westermark PO, 2003, BIOPHYS J, V85, P126, DOI 10.1016/S0006-3495(03)74460-9; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; Yugi K, 2004, BIOINFORMATICS, V20, P1795, DOI 10.1093/bioinformatics/bth125	61	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e52611	10.1371/journal.pone.0052611	http://dx.doi.org/10.1371/journal.pone.0052611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520444	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900003
J	Hu, SW; Ni, W; Sai, WJF; Zi, H; Qiao, J; Wang, PY; Sheng, JL; Chen, CF				Hu, Shengwei; Ni, Wei; Sai, Wujiafu; Zi, Ha; Qiao, Jun; Wang, Pengyang; Sheng, Jinliang; Chen, Chuangfu			Knockdown of Myostatin Expression by RNAi Enhances Muscle Growth in Transgenic Sheep	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; IN-VIVO; GENE; PROMOTER; CATTLE; MASS; HYPERTROPHY; MUTATION; MICE; INTERFERENCE	Myostatin (MSTN) has been shown to be a negative regulator of skeletal muscle development and growth. MSTN dysfunction therefore offers a strategy for promoting animal growth performance in livestock production. In this study, we investigated the possibility of using RNAi-based technology to generate transgenic sheep with a double-muscle phenotype. A shRNA expression cassette targeting sheep MSTN was used to generate stable shRNA-expressing fibroblast clones. Transgenic sheep were further produced by somatic cell nuclear transfer (SCNT) technology. Five lambs developed to term and three live lambs were obtained. Integration of shRNA expression cassette in three live lambs was confirmed by PCR. RNase protection assay showed that the shRNAs targeting MSTN were expressed in muscle tissues of three transgenic sheep. MSTN expression was significantly inhibited in muscle tissues of transgenic sheep when compared with control sheep. Moreover, transgenic sheep showed a tendency to faster increase in body weight than control sheep. Histological analysis showed that myofiber diameter of transgenic sheep M17 were bigger than that of control sheep. Our findings demonstrate a promising approach to promoting muscle growth in livestock production.	[Hu, Shengwei; Ni, Wei; Sai, Wujiafu; Zi, Ha; Qiao, Jun; Wang, Pengyang; Sheng, Jinliang; Chen, Chuangfu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Peoples R China; [Hu, Shengwei; Ni, Wei; Chen, Chuangfu] Shihezi Univ, Key Lab Agrobiotechnol, Shihezi, Peoples R China	Shihezi University; Shihezi University	Chen, CF (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Peoples R China.	chencf1962@yahoo.com	Hu, Shengwei/AGP-1699-2022		973 Program [2010CB530200]; National Natural Science Foundation of China (NSFC) [31201800, 31260534]; Bingtuan Twelve Five-year Special Projects [2012BB051]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Bingtuan Twelve Five-year Special Projects	This work was supported by grants from the 973 Program (2010CB530200), The National Natural Science Foundation of China (NSFC) (31201800, 31260534) and the Bingtuan Twelve Five-year Special Projects (2012BB051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta J, 2005, J BIOTECHNOL, V119, P324, DOI 10.1016/j.jbiotec.2005.04.023; Arthur PF, 1995, AUST J AGR RES, V46, P1493, DOI 10.1071/AR9951493; Bellinge RHS, 2005, ANIM GENET, V36, P1, DOI 10.1111/j.1365-2052.2004.01229.x; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Duan B, 2012, THERIOGENOLOGY, V78, P793, DOI 10.1016/j.theriogenology.2012.03.027; Fletcher CJ, 2007, REPRODUCTION, V133, P243, DOI 10.1530/rep.1.01203; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Guo ZS, 1996, GENE THER, V3, P802; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hu SW, 2012, J ANIM VET ADV, V11, P1868; Hu SW, 2011, BIOTECHNOL LETT, V33, P1949, DOI 10.1007/s10529-011-0667-8; Hu SW, 2011, ANIM BIOTECHNOL, V22, P170, DOI 10.1080/10495398.2011.580669; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Lee CY, 2009, BIOCHEM BIOPH RES CO, V387, P766, DOI 10.1016/j.bbrc.2009.07.110; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; [赛务加甫 SAI Wujiafu], 2008, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V39, P1343; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Tessanne K, 2012, MOL REPROD DEV, V79, P176, DOI 10.1002/mrd.22007; TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728; Wang PY, 2010, ANTIVIR RES, V87, P265, DOI 10.1016/j.antiviral.2010.02.319; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	32	34	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58521	10.1371/journal.pone.0058521	http://dx.doi.org/10.1371/journal.pone.0058521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526994	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562600027
J	Laist, DW; Taylor, C; Reynolds, JE				Laist, David W.; Taylor, Cynthia; Reynolds, John E., III			Winter Habitat Preferences for Florida Manatees and Vulnerability to Cold	PLOS ONE			English	Article							WARM-WATER REFUGES	To survive cold winter periods most, if not all, Florida manatees rely on warm-water refuges in the southern two-thirds of the Florida peninsula. Most refuges are either warm-water discharges from power plant and natural springs, or passive thermal basins that temporarily trap relatively warm water for a week or more. Strong fidelity to one or more refuges has created four relatively discrete Florida manatee subpopulations. Using statewide winter counts of manatees from 1999 to 2011, we provide the first attempt to quantify the proportion of animals using the three principal refuge types (power plants, springs, and passive thermal basins) statewide and for each subpopulation. Statewide across all years, 48.5% of all manatees were counted at power plant outfalls, 17.5% at natural springs, and 34.9% at passive thermal basins or sites with no known warm-water features. Atlantic Coast and Southwest Florida subpopulations comprised 82.2% of all manatees counted (45.6% and 36.6%, respectively) with each subpopulation relying principally on power plants (66.6% and 47.4%, respectively). The upper St. Johns River and Northwest Florida subpopulations comprised 17.8% of all manatees counted with almost all animals relying entirely on springs (99.2% and 88.6% of those subpopulations, respectively). A record high count of 5,076 manatees in January 2010 revealed minimum sizes for the four subpopulations of: 230 manatees in the upper St. Johns River; 2,548 on the Atlantic Coast; 645 in Northwest Florida; and 1,774 in Southwest Florida. Based on a comparison of carcass recovery locations for 713 manatees killed by cold stress between 1999 and 2011 and the distribution of known refuges, it appears that springs offer manatees the best protection against cold stress. Long-term survival of Florida manatees will require improved efforts to enhance and protect manatee access to and use of warm-water springs as power plant outfalls are shut down.	[Laist, David W.] Marine Mammal Commiss, Bethesda, MD 20814 USA; [Taylor, Cynthia] Sea Shore Alliance, Sarasota, FL USA; [Reynolds, John E., III] Mote Marine Lab, Sarasota, FL 34236 USA	Mote Marine Laboratory & Aquarium	Laist, DW (corresponding author), Marine Mammal Commiss, Bethesda, MD 20814 USA.	dlaist@mmc.gov						Barlas ME, 2011, F28521011F FWCFWRI; BOSSART GD, 2002, AQUAT MAMM, V29, P9, DOI DOI 10.1578/016754203101024031; Deutsch CJ, 2003, J WILDLIFE MANAGEM S, V67; Haubold E. M., 2006, FINAL BIOL STATUS RE; Laist DW, 2005, MAR MAMMAL SCI, V21, P739, DOI 10.1111/j.1748-7692.2005.tb01263.x; Laist DW, 2005, COAST MANAGE, V33, P279, DOI 10.1080/08920750590952018; Lefebvre Lynn W., 2001, P425; Marsh H, 2011, CONSERVATION SCI SIR; Moore J. C., 1951, Quarterly Journal of the Florida Academy of Sciences, V14, P1; National Weather Service, 2010, SUMM HIST COLD EP JA; Provancha J, 2012, CARRYING CAPACITY MA; Reynolds III JE, 1983, SERIES ANN SURVEY RE; Runge MC, 2004, MAR MAMMAL SCI, V20, P361, DOI 10.1111/j.1748-7692.2004.tb01167.x; Runge MC, 2007, 20071082 PAT WILDL R; Scott T.M., 2002, 85 FLOR GEOL SURV; Stith BM, 2011, ESTUAR COAST, V34, P106, DOI 10.1007/s12237-010-9286-1; Taylor CR, 2006, SURVEY FLORIDA SPRIN; U.S. Fish and Wildlife Service, 2001, FLOR MAN REC PLAN TR; U.S. Fish and Wildlife Service, 2007, W IND MAN TRICH MAN; Valade JA, 2009, MAN POP EC MAN WORKS; Warm Water Task Force, 2004, REC FUT MAN IN PRESS	21	20	20	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58978	10.1371/journal.pone.0058978	http://dx.doi.org/10.1371/journal.pone.0058978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527063	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600048
J	Nordin, O; Donald, W; Ming, WH; Ney, TG; Mohamed, KA; Halim, NAA; Winskill, P; Hadi, AA; Muhammad, ZS; Lacroix, R; Scaife, S; McKemey, AR; Beech, C; Shahnaz, M; Alphey, L; Nimmo, DD; Nazni, WA; Lee, HL				Nordin, Oreenaiza; Donald, Wesley; Ming, Wong Hong; Ney, Teoh Guat; Mohamed, Khairul Asuad; Halim, Nor Azlina Abdul; Winskill, Peter; Hadi, Azahari Abdul; Muhammad, Zulkamal Safi'in; Lacroix, Renaud; Scaife, Sarah; McKemey, Andrew Robert; Beech, Camilla; Shahnaz, Murad; Alphey, Luke; Nimmo, Derric David; Nazni, Wasi Ahmed; Lee, Han Lim			Oral Ingestion of Transgenic RIDL Ae. aegypti Larvae Has No Negative Effect on Two Predator Toxorhynchites Species	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; AEDES-AEGYPTI; GENE-EXPRESSION; NATURAL TRANSFORMATION; CULICIDAE; DIPTERA; DOMINANT; DENGUE; CELLS; PATTERNS	Dengue is the most important mosquito-borne viral disease. No specific treatment or vaccine is currently available; traditional vector control methods can rarely achieve adequate control. Recently, the RIDL (Release of Insect carrying Dominant Lethality) approach has been developed, based on the sterile insect technique, in which genetically engineered 'sterile' homozygous RIDL male insects are released to mate wild females; the offspring inherit a copy of the RIDL construct and die. A RIDL strain of the dengue mosquito, Aedes aegypti, OX513A, expresses a fluorescent marker gene for identification (DsRed2) and a protein (tTAV) that causes the offspring to die. We examined whether these proteins could adversely affect predators that may feed on the insect. Aedes aegypti is a peri-domestic mosquito that typically breeds in small, rain-water-filled containers and has no specific predators. Toxorhynchites larvae feed on small aquatic organisms and are easily reared in the laboratory where they can be fed exclusively on mosquito larvae. To evaluate the effect of a predator feeding on a diet of RIDL insects, OX513A Ae. aegypti larvae were fed to two different species of Toxorhynchites (Tx. splendens and Tx. amboinensis) and effects on life table parameters of all life stages were compared to being fed on wild type larvae. No significant negative effect was observed on any life table parameter studied; this outcome and the benign nature of the expressed proteins (tTAV and DsRed2) indicate that Ae. aegypti OX513A RIDL strain is unlikely to have any adverse effects on predators in the environment.	[Nordin, Oreenaiza; Donald, Wesley; Ming, Wong Hong; Ney, Teoh Guat; Mohamed, Khairul Asuad; Halim, Nor Azlina Abdul; Hadi, Azahari Abdul; Muhammad, Zulkamal Safi'in; Shahnaz, Murad; Nazni, Wasi Ahmed; Lee, Han Lim] Inst Med Res, Med Entomol Unit, Kuala Lumpur 50588, Malaysia; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Winskill, Peter; Lacroix, Renaud; Scaife, Sarah; McKemey, Andrew Robert; Beech, Camilla; Alphey, Luke; Nimmo, Derric David] Oxitec Ltd, Oxford, England; [Winskill, Peter] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Res Council Ctr Outbreak Anal & Modelling, London, England	Kementerian Kesihatan Malaysia; University of Oxford; Imperial College London	Nimmo, DD (corresponding author), Oxitec Ltd, Oxford, England.	derric.nimmo@oxitec.com	Ahmad, Nazni/AAN-2498-2021	Alphey, Luke/0000-0002-2916-3802; Winskill, Peter/0000-0003-3001-4959; Beech, Camilla/0000-0001-8348-9566	Malaysian National Institutes of Health Research Grant [JPP-IMR-06-053]; Biotechnology and Biological Sciences Research Council training grant [BB/I015957/1]; National Institutes of Health from the Ministry of Health, Malaysia [JPP-IMR 06-053]; Oxitec Ltd.	Malaysian National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council training grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health from the Ministry of Health, Malaysia; Oxitec Ltd.	This project was financially supported by a Malaysian National Institutes of Health Research Grant (JPP-IMR-06-053); a Biotechnology and Biological Sciences Research Council training grant (BB/I015957/1); and a grant from the National Institutes of Health from the Ministry of Health, Malaysia (code: JPP-IMR 06-053). Oxitec Ltd. provided salary and other support for the research program of those authors employed by the company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Those authors affiliated to Oxitec Limited or Oxitec Sdn Bhd (as noted in the author list) are past or present employees or sponsored students of Oxitec Limited or Oxitec Sdn Bhd, which therefore provided salary and other support for the research program. Also, some of these employees have shares or share options in Oxitec Ltd. Oxitec and the University of Oxford own intellectual property related to the subject matter of this study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors declare no conflicting interests.	Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Amalraj D. Dominic, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P177; Amalraj DD, 2005, MEM I OSWALDO CRUZ, V100, P893, DOI 10.1590/S0074-02762005000800012; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Bertolla F, 1999, RES MICROBIOL, V150, P375, DOI 10.1016/S0923-2508(99)80072-2; Blum S, 1997, J VECTOR ECOL, V22, P23; Campos RE, 2000, J MED ENTOMOL, V37, P385, DOI 10.1603/0022-2585(2000)037[0385:LTOTRD]2.0.CO;2; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Chadee DD, 2009, TROP MED INT HEALTH, V14, P220, DOI 10.1111/j.1365-3156.2008.02216.x; Dyck V, 2005, INTEGRATED PEST MANA; FOCKS DA, 1985, J ECON ENTOMOL, V78, P622, DOI 10.1093/jee/78.3.622; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129; Harbach R.E., 1980, TAXONOMISTS GLOSSARY; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2; JONES JC, 1973, BIOL BULL, V145, P127, DOI 10.2307/1540353; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Koenraadt CJM, 2008, AM J TROP MED HYG, V79, P230, DOI 10.4269/ajtmh.2008.79.230; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; Lee HL, 2013, TRANSGENIC RES, V22, P47, DOI 10.1007/s11248-012-9625-z; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657; Nielsen KM, 1998, APMIS, V106, P77, DOI 10.1111/j.1600-0463.1998.tb05653.x; Nishizawa K, 2006, PLANT CELL REP, V25, P1355, DOI 10.1007/s00299-006-0210-x; Nyamah MA, 2011, TROP BIOMED, V28, P312; Pavely C, 2006, EARLY FOOD SAFETY EV; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Richards HA, 2003, J NUTR, V133, P1909, DOI 10.1093/jn/133.6.1909; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Schonig Kai, 2003, Methods Mol Biol, V209, P69; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Smrchek JC, 1998, HDB ENV RISK ASSESSM, P24; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wenck A, 2003, PLANT CELL REP, V22, P244, DOI 10.1007/s00299-003-0690-x; WHO/TDR, 2009, DENG GUID DIAGN TREA; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319; Zhou HX, 2009, INT J BIOL SCI, V5, P171	46	8	10	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58805	10.1371/journal.pone.0058805	http://dx.doi.org/10.1371/journal.pone.0058805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527029	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600041
J	Seibold, MA; Smith, RW; Urbanek, C; Groshong, SD; Cosgrove, GP; Brown, KK; Schwarz, MI; Schwartz, DA; Reynolds, SD				Seibold, Max A.; Smith, Russell W.; Urbanek, Cydney; Groshong, Steve D.; Cosgrove, Gregory P.; Brown, Kevin K.; Schwarz, Marvin I.; Schwartz, David A.; Reynolds, Susan D.			The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; INTERSTITIAL PNEUMONIA; MARKER EXPRESSION; STEM-CELLS; LUNG; MUC5B; PROMOTER	Background: We previously identified a MUC5B gene promoter-variant that is a risk allele for sporadic and familial Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia (IPF/UIP). This allele was strongly associated with increased MUC5B gene expression in lung tissue from unaffected subjects. Despite the strong association of this airway epithelial marker with disease, little is known of mucin expressing structures or of airway involvement in IPF/UIP. Methods: Immunofluorescence was used to subtype mucus cells according to MUC5B and MUC5AC expression and to identify ciliated, basal, and alveolar type II (ATII) cells in tissue sections from control and IPF/UIP subjects. Staining patterns were quantified for distal airways (Control and IPF/UIP) and in honeycomb cysts (HC). Results: MUC5B-expressing cells (EC) were detected in the majority of control distal airways. MUC5AC-EC were identified in half of these airways and only in airways that contained MUC5B-EC. The frequency of MUC5B+ and MUC5AC+ distal airways was increased in IPF/UIP subjects. MUC5B-EC were the dominant mucus cell type in the HC epithelium. The distal airway epithelium from control and IPF/UIP subjects and HC was populated by basal and ciliated cells. Most honeycombing regions were distinct from ATII hyperplasic regions. ATII cells were undetectable in the overwhelming majority of HC. Conclusions: The distal airway contains a pseudostratified mucocilary epithelium that is defined by basal epithelial cells and mucus cells that express MUC5B predominantly. These data suggest that the HC is derived from the distal airway.	[Seibold, Max A.; Urbanek, Cydney; Schwartz, David A.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Seibold, Max A.; Smith, Russell W.; Reynolds, Susan D.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Groshong, Steve D.; Cosgrove, Gregory P.; Brown, Kevin K.; Schwarz, Marvin I.; Schwartz, David A.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Reynolds, SD (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	reynoldss@njhealth.org	Brown, Kevin/ABF-2544-2020		Chapman Foundation; NIH [HL075585, HL075585-S1, RC1HL099461]; National Heart, Lung and Blood Institute [R01-HL095393, R01-HL097163, R01-HL095397, P50-HL0894932, P01-HL092870, RC2-HL101715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095393, R01HL097163, P01HL092870, RC1HL099461, R01HL075585, R01HL095397, RC2HL101715] Funding Source: NIH RePORTER	Chapman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by the Chapman Foundation (MAS, DAS), NIH RO1 (HL075585) and Supplement (HL075585-S1) to SDR and RC1HL099461 (SDR), and National Heart, Lung and Blood Institute (R01-HL095393, R01-HL097163, R01-HL095397, P50-HL0894932, P01-HL092870, and RC2-HL101715) awarded to DAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2011, AM J ROENTGENOL, V196, P773, DOI 10.2214/AJR.10.4873; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Chilosi M, 2002, LAB INVEST, V82, P1335, DOI 10.1097/01.LAB.0000032380.82232.67; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; COALSON JJ, 1982, VIRCHOWS ARCH A, V395, P181, DOI 10.1007/BF00429611; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; Daly HE, 1997, TOXICOL APPL PHARM, V142, P303, DOI 10.1006/taap.1996.8056; Dupuit F, 2000, AM J PHYSIOL-LUNG C, V278, pL165, DOI 10.1152/ajplung.2000.278.1.L165; ENGELHARDT JF, 1995, DEVELOPMENT, V121, P2031; Hegab A. E., 2011, STEM CELLS; HYDE DM, 1992, AM REV RESPIR DIS, V146, P1042, DOI 10.1164/ajrccm/146.4.1042; Iyonaga K, 1997, J PATHOL, V182, P217; Johkoh T, 1999, J COMPUT ASSIST TOMO, V23, P174, DOI 10.1097/00004728-199903000-00003; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Rock JR, 2010, DIS MODEL MECH; Rousseau K, 2003, HYBRIDOMA HYBRIDOM, V22, P293, DOI 10.1089/153685903322538818; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504	26	154	155	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58658	10.1371/journal.pone.0058658	http://dx.doi.org/10.1371/journal.pone.0058658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527003	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600029
J	Chattoraj, P; Yang, Q; Khandai, A; Al-Hendy, O; Ismail, N				Chattoraj, Partho; Yang, Qin; Khandai, Ankita; Al-Hendy, Omar; Ismail, Nahed			TLR2 and Nod2 Mediate Resistance or Susceptibility to Fatal Intracellular Ehrlichia Infection in Murine Models of Ehrlichiosis	PLOS ONE			English	Article							CD4(+) T-CELLS; ANIMAL-MODEL; IFN-GAMMA; MONOCYTOTROPIC EHRLICHIOSIS; INFLAMMATORY RESPONSES; EFFECTOR MECHANISM; TNF-ALPHA; CHAFFEENSIS; RECOGNITION; IMMUNITY	Our murine models of human monocytic ehrlichiosis (HME) have shown that severe and fatal ehrlichiosis is due to generation of pathogenic T cell responses causing immunopathology and multi-organ failure. However, the early events in the liver, the main site of infection, are not well understood. In this study, we examined the liver transcriptome during the course of lethal and nonlethal infections caused by Ixodes ovatus Ehrlichia and Ehrlichia muris, respectively. On day 3 post-infection (p.i.), although most host genes were down regulated in the two groups of infected mice compared to naive counterparts, lethal infection induced significantly higher expression of caspase 1, caspase 4, nucleotide binding oligomerization domain-containing proteins (Nod1), tumor necrosis factor-alpha, interleukin 10, and CCL7 compared to nonlethal infection. On day 7 p.i., lethal infection induced highly significant upregulation of type-1 interferon, several inflammatory cytokines and chemokines, which was associated with increased expression levels of Toll-like receptor-2 (TLR2), Nod2, MyD88, nuclear factor-kappa B (NF-kB), Caspase 4, NLRP1, NLRP12, Pycard, and IL-1 beta, suggesting enhanced TLR signals and inflammasomes activation. We next evaluated the participation of TLR2 and Nod2 in the host response during lethal Ehrlichia infection. Although lack of TLR2 impaired bacterial elimination and increased tissue necrosis, Nod2 deficiency attenuated pathology and enhanced bacterial clearance, which correlated with increased interferon-gamma and interleukin-10 levels and a decreased frequency of pathogenic CD8(+) T cells in response to lethal infection. Thus, these data indicate that Nod2, but not TLR2, contributes to susceptibility to severe Ehrlichia-induced shock. Together, our studies provide, for the first time, insight into the diversity of host factors and novel molecular pathogenic mechanisms that may contribute to severe HME.	[Chattoraj, Partho; Yang, Qin; Khandai, Ankita; Al-Hendy, Omar; Ismail, Nahed] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ismail, N (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	ismailn@upmc.edu		Yang, Qin/0000-0001-8690-4809	National Institutes of Health [R56AI097679-01A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by National Institutes of Health grants (R56AI097679-01A, to NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Carrol ED, 2011, J IMMUNOL, V186, P2329, DOI 10.4049/jimmunol.1002402; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292; Crane MJ, 2009, J IMMUNOL, V183, P2810, DOI 10.4049/jimmunol.0900205; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DUMLER JS, 1993, HUM PATHOL, V24, P391; FICHTENBAUM CJ, 1993, AM J MED, V95, P351, DOI 10.1016/0002-9343(93)90302-6; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Ghose P, 2011, J IMMUNOL, V187, P1333, DOI 10.4049/jimmunol.1100092; Hamburg BJ, 2008, MEDICINE, V87, P53, DOI 10.1097/MD.0b013e318168da1d; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Haring JS, 2009, INFECT IMMUN, V77, P1894, DOI 10.1128/IAI.01315-08; Hokeness-Antonelli KL, 2007, J IMMUNOL, V179, P6176, DOI 10.4049/jimmunol.179.9.6176; Huang HB, 2008, INFECT IMMUN, V76, P3405, DOI 10.1128/IAI.00056-08; Humann J, 2010, J IMMUNOL, V184, P5172, DOI 10.4049/jimmunol.0903759; Ismail N, 2006, INFECT IMMUN, V74, P1846, DOI 10.1128/IAI.74.3.1846-1856.2006; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Ismail N, 2007, INFECT IMMUN, V75, P4608, DOI 10.1128/IAI.00198-07; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Mercier BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042170; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miura K, 2009, INFECT IMMUN, V77, P245, DOI 10.1128/IAI.00979-08; Miura K, 2007, INFECT IMMUN, V75, P3604, DOI 10.1128/IAI.02028-06; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Okada H, 2001, J COMP PATHOL, V124, P165, DOI 10.1053/jcpa.2000.0447; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Olano JP, 2002, MED CLIN N AM, V86, P375, DOI 10.1016/S0025-7125(03)00093-2; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pedra JHF, 2007, J IMMUNOL, V179, P4783, DOI 10.4049/jimmunol.179.7.4783; Pitt JM, 2012, J IMMUNOL, V189, P4079, DOI 10.4049/jimmunol.1201061; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rahman MA, 2012, J INFECT DIS, V206, P110, DOI 10.1093/infdis/jis313; Ratnasamy N, 1996, CLIN INFECT DIS, V23, P314, DOI 10.1093/clinids/23.2.314; Sehdev AES, 2003, AM J CLIN PATHOL, V119, P859, DOI 10.1309/F7EAB5P7321716LJ; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Sotomayor EA, 2001, AM J PATHOL, V158, P757, DOI 10.1016/S0002-9440(10)64018-7; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Stevenson HL, 2010, AM J PATHOL, V177, P766, DOI 10.2353/ajpath.2010.091110; Stevenson HL, 2006, INFECT IMMUN, V76, P1434; Szymczak WA, 2009, J IMMUNOL, V183, P1964, DOI 10.4049/jimmunol.0901316; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Walker DH, 1997, ARCH PATHOL LAB MED, V121, P785; Winslow GM, 1998, INFECT IMMUN, V66, P3892, DOI 10.1128/IAI.66.8.3892-3899.1998; Yamauchi K, 2008, J IMMUNOL, V180, P1207, DOI 10.4049/jimmunol.180.2.1207	63	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58514	10.1371/journal.pone.0058514	http://dx.doi.org/10.1371/journal.pone.0058514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526993	Green Published, gold, Green Accepted			2022-12-27	WOS:000317562100029
J	Fard, SS; Jarrin, M; Boije, H; Fillon, V; All-Eriksson, C; Hallbook, F				Fard, Shahrzad Shirazi; Jarrin, Miguel; Boije, Henrik; Fillon, Valerie; All-Eriksson, Charlotta; Hallbook, Finn			Heterogenic Final Cell Cycle by Chicken Retinal Lim1 Horizontal Progenitor Cells Leads to Heteroploid Cells with a Remaining Replicated Genome	PLOS ONE			English	Article							INTERKINETIC NUCLEAR MIGRATION; NEURONS ARISE; DNA-CONTENT; GROWTH; PROLIFERATION; EXPRESSION; MITOSIS; G(2)/M; PHOSPHORYLATION; NEUROEPITHELIUM	Retinal progenitor cells undergo apical mitoses during the process of interkinetic nuclear migration and newly generated post-mitotic neurons migrate to their prospective retinal layer. Whereas this is valid for most types of retinal neurons, chicken horizontal cells are generated by delayed non-apical mitoses from dedicated progenitors. The regulation of such final cell cycle is not well understood and we have studied how Lim1 expressing horizontal progenitor cells (HPCs) exit the cell cycle. We have used markers for S-and G2/M-phase in combination with markers for cell cycle regulators Rb1, cyclin B1, cdc25C and p27Kip1 to characterise the final cell cycle of HPCs. The results show that Lim1+ HPCs are heterogenic with regards to when and during what phase they leave the final cell cycle. Not all horizontal cells were generated by a non-apical (basal) mitosis; instead, the HPCs exhibited three different behaviours during the final cell cycle. Thirty-five percent of the Lim1+ horizontal cells was estimated to be generated by non-apical mitoses. The other horizontal cells were either generated by an interkinetic nuclear migration with an apical mitosis or by a cell cycle with an S-phase that was not followed by any mitosis. Such cells remain with replicated DNA and may be regarded as somatic heteroploids. The observed heterogeneity of the final cell cycle was also seen in the expression of Rb1, cyclin B1, cdc25C and p27Kip1. Phosphorylated Rb1-Ser608 was restricted to the Lim1+ cells that entered S-phase while cyclin B1 and cdc25C were exclusively expressed in HPCs having a basal mitosis. Only HPCs that leave the cell cycle after an apical mitosis expressed p27Kip1. We speculate that the cell cycle heterogeneity with formation of heteroploid cells may present a cellular context that contributes to the suggested propensity of these cells to generate cancer when the retinoblastoma gene is mutated.	[Fard, Shahrzad Shirazi; Jarrin, Miguel; Boije, Henrik; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Fillon, Valerie] INRA, Lab Genet Cellulaire, Castanet Tolosan, France; [All-Eriksson, Charlotta] Karolinska Inst, St Eriks Ogonsjukhus, Stockholm, Sweden	Uppsala University; INRAE; Karolinska Institutet; Linkoping University	Hallbook, F (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	finn.hallbook@neuro.uu.se	All-Ericsson, Charlotta/C-3642-2016; Fillon, Valerie/GWR-2196-2022	All-Ericsson, Charlotta/0000-0002-8428-6418; Hallbook, Finn/0000-0001-7552-187X	Barncancerfonden; Swedish Research Council [20859-01-3, 12187-15-3]; Ogonfonden; Kronprinsessan Margaretas arbetsnamnd for synskadade; Synframjandets forskningsfond; St Eriks Ogonsjukhus forskningsstipendier	Barncancerfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ogonfonden; Kronprinsessan Margaretas arbetsnamnd for synskadade; Synframjandets forskningsfond; St Eriks Ogonsjukhus forskningsstipendier	The work was supported by Barncancerfonden, Swedish Research Council (20859-01-3, 12187-15-3), Ogonfonden, Kronprinsessan Margaretas arbetsnamnd for synskadade, Synframjandets forskningsfond and St Eriks Ogonsjukhus forskningsstipendier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Boije H, 2009, DEV BIOL, V330, P105, DOI 10.1016/j.ydbio.2009.03.013; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Cook B, 1998, J COMP NEUROL, V396, P12, DOI 10.1002/(SICI)1096-9861(19980622)396:1<12::AID-CNE2>3.0.CO;2-L; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Edqvist PHD, 2006, EUR J HISTOCHEM, V50, P147; Edqvist PHD, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-46; Edqvist PHD, 2004, DEVELOPMENT, V131, P1343, DOI 10.1242/dev.01018; Godinho L, 2007, NEURON, V56, P597, DOI 10.1016/j.neuron.2007.09.036; Goodall N, 2009, EXP EYE RES, V89, P511, DOI 10.1016/j.exer.2009.05.014; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HERMAN CJ, 1969, BRAIN RES, V15, P35, DOI 10.1016/0006-8993(69)90308-4; HERMAN CJ, 1968, SCIENCE, V160, P537, DOI 10.1126/science.160.3827.537; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Ka S, 2011, NEUROGENETICS, V12, P211, DOI 10.1007/s10048-011-0290-9; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; LAPHAM LW, 1968, SCIENCE, V159, P310, DOI 10.1126/science.159.3812.310; Lee EJ, 2003, EUR J NEUROSCI, V17, P1542, DOI 10.1046/j.1460-9568.2003.02583.x; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; MESSIER PE, 1974, DEV BIOL, V36, P218, DOI 10.1016/0012-1606(74)90206-1; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Morillo SM, 2010, P NATL ACAD SCI USA, V107, P109, DOI 10.1073/pnas.0906121107; MORRIS VB, 1995, CELL PROLIFERAT, V28, P373, DOI 10.1111/j.1365-2184.1995.tb00079.x; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Perdiguero E, 2004, CELL CYCLE, V3, P733; Ploeger LS, 2005, CELL ONCOL, V27, P225; Poche RA, 2007, J NEUROSCI, V27, P14099, DOI 10.1523/JNEUROSCI.4046-07.2007; Poche RA, 2009, DEVELOPMENT, V136, P2141, DOI 10.1242/dev.033175; PRADA C, 1991, EUR J NEUROSCI, V3, P1187; Prasov L, 2012, MOL CELL NEUROSCI, V50, P160, DOI 10.1016/j.mcn.2012.05.002; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Ring H, 2010, VISUAL NEUROSCI, V27, P149, DOI 10.1017/S0952523810000180; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Skibbens RV, 2009, CURR BIOL, V19, pR1126, DOI 10.1016/j.cub.2009.10.067; Solovei I, 2010, METHODS MOL BIOL, V659, P71, DOI 10.1007/978-1-60761-789-1_5; Srinivasan SV, 2007, J BIOL CHEM, V282, P23867, DOI 10.1074/jbc.M700542200; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Suga A, 2009, DEV BIOL, V330, P318, DOI 10.1016/j.ydbio.2009.04.002; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Tekola P, 1996, J PATHOL, V180, P214; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; Wakabayashi T, 2008, NEUROSCI LETT, V442, P249, DOI 10.1016/j.neulet.2008.07.030; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318; ZOOROB R, 1996, ANIM GENET, V27	55	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59133	10.1371/journal.pone.0059133	http://dx.doi.org/10.1371/journal.pone.0059133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527113	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100081
J	Feng, JF; Qiu, L; Zhang, L; Li, XM; Yang, YW; Zeng, P; Guo, XZ; Qin, Y; Liu, HC; Han, XM; Li, YP; Xu, W; Sun, SY; Wang, LQ; Quan, H; Xia, LJ; Hu, HZ; Zhong, FC; Duan, R				Feng, Jia-fu; Qiu, Ling; Zhang, Lin; Li, Xue-mei; Yang, Yu-wei; Zeng, Ping; Guo, Xiu-zhi; Qin, Yan; Liu, Hong-chun; Han, Xing-min; Li, Yan-peng; Xu, Wei; Sun, Shu-yan; Wang, Li-qiang; Quan, Hui; Xia, Li-jun; Hu, Hong-zhang; Zhong, Fang-cai; Duan, Rong			Multicenter Study of Creatinine- and/or Cystatin C-Based Equations for Estimation of Glomerular Filtration Rates in Chinese Patients with Chronic Kidney Disease	PLOS ONE			English	Article							RENAL-TRANSPLANTATION VALIDATION; SERUM CREATININE; PERFORMANCE EVALUATION; POSITION STATEMENT; ASSAY; MARKER; IMMUNOASSAY; DYSFUNCTION; PREDICTION; DIAGNOSIS	Objective: To establish equations for the estimation of glomerular filtration rates (eGFRs) based on serum creatinine (SCr) and/or serum cystatin C (SCysC) in Chinese patients with chronic kidney disease (CKD), and to compare the new equations with both the reference GFR (rGFR) and the literature equations to evaluate their applicability. Methods: The 788 Chinese CKD patients were randomly divided into two groups, the training group and the testing group, to establish new eGFR-formulas based on serum CysC and to validate the established formulas, respectively. 99m Tc-DTPA clearance (as the rGFR), serum Cr, and serum CysC were determined for all patients, and GFR was calculated using the Cockcroft-Gault equation (eGFR1), the MDRD formula (eGFR2), the CKD-EPI formulas (eGFR3, eGFR4), and the Chinese eGFR Investigation Collaboration formulas (eGFR5, eGFR6). The accuracy of each eGFR was compared with the rGFR. Results: The training and testing groups' mean GFRs were 50.84 +/- 31.36 mL/min/1.73 m(2) and 54.16 +/- 29.45 mL/min/1.73 m 2, respectively. The two newly developed eGFR formulas were fitted using iterative computation: eGFR7 = 173: 9 x CysC(-0: 725) x Cr-0: 184 X age(-0: 193) x 0: 89(iffemale)(R-2 = 0: 734) and eGFR8 = 78: 64 x CysC(-0: 964)(R-2 = 0: 764). Significant correlation was observed between each eGFR and the rGFR. However, proportional errors and constant errors were observed between rGFR and eGFR1, eGFR2, eGFR4, eGFR5 or eGFR6, and constant errors were observed between eGFR3 and rGFR, as revealed by the Passing & Bablok plot analysis. The Bland-Altman analysis illustrated that the 95% limits of agreement of all equations exceeded the previously accepted limits of <60 mL/min N.1.73 m(2), except the equations of eGFR7 and eGFR8. Conclusion: The newly developed formulas, eGFR7 and eGFR8, provide precise and accurate GFR estimation using serum CysC detection alone or in combination with serum Cr detection. Differences in detection methods should be carefully considered when choosing literature eGFR equations to avoid misdiagnosis and mistreatment.	[Feng, Jia-fu; Yang, Yu-wei; Zeng, Ping] Mianyang Cent Hosp, Mianyang, Sichuan Provinc, Peoples R China; [Zhang, Lin] Mianyang Cent Hosp, Kidney Internal Med Dept, Mianyang, Sichuan Provinc, Peoples R China; [Qiu, Ling; Guo, Xiu-zhi; Qin, Yan] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Li, Xue-mei] Peking Union Med Coll Hosp, Kidney Internal Med Dept, Beijing, Peoples R China; [Liu, Hong-chun] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan Province, Peoples R China; [Han, Xing-min; Li, Yan-peng] Zhengzhou Univ, Affiliated Hosp 1, Dept Nucl Med, Zhengzhou, Henan Province, Peoples R China; [Xu, Wei; Sun, Shu-yan; Wang, Li-qiang] Jilin Univ, Bethune Hosp 1, Jilin, Jilin Province, Peoples R China; [Quan, Hui; Xia, Li-jun; Hu, Hong-zhang] Nucl Ind 416 Hosp, Dept Lab, Chengdu, Sichuan Provinc, Peoples R China; [Zhong, Fang-cai] First Peoples Hosp Neijiang, Dept Lab, Neijiang, Sichuan Provinc, Peoples R China; [Duan, Rong] First Peoples Hosp Neijiang, Kidney Internal Med Dept, Neijiang, Sichuan Provinc, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Zhengzhou University; Zhengzhou University; Jilin University	Feng, JF (corresponding author), Mianyang Cent Hosp, Mianyang, Sichuan Provinc, Peoples R China.	jiafufeng@yahoo.com.cn	deng, qiongxia/A-3206-2017	Zhang, Lin/0000-0002-2064-8440; Feng, Jiafu/0000-0001-8829-1516	Science & Technology Department of Sichuan Province, China [2009SZ0066]; Sichuan Maker Biotechnology Co., Ltd.	Science & Technology Department of Sichuan Province, China; Sichuan Maker Biotechnology Co., Ltd.	This work was partially supported by the Science & Technology Department of Sichuan Province, China (2009SZ0066) (http://www.scst.gov.cn/ info) and Sichuan Maker Biotechnology Co., Ltd. (http://makerbio.company.lookchem.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Turkmani MR, 2008, CLIN CHIM ACTA, V398, P75, DOI 10.1016/j.cca.2008.08.016; Bargnoux AS, 2012, CLIN BIOCHEM, V45, P151, DOI 10.1016/j.clinbiochem.2011.10.018; Bargnoux AS, 2011, CLIN CHEM LAB MED, V49, P265, DOI 10.1515/CCLM.2011.043; Bargnoux AS, 2012, CLIN CHEM LAB MED, V50, P133, DOI 10.1515/CCLM.2011.725; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blaufox MD, 1996, J NUCL MED, V37, P1883; Cai XY, 2012, CLIN CHEM LAB MED, V50, P667, DOI 10.1515/cclm-2011-0838; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Conde-Sanchez M, 2010, CLIN BIOCHEM, V43, P921, DOI 10.1016/j.clinbiochem.2010.04.057; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferguson MA, 2012, CLIN CHEM, V58, P680, DOI 10.1373/clinchem.2011.167494; Flodin M, 2009, CLIN BIOCHEM, V42, P873, DOI 10.1016/j.clinbiochem.2009.02.024; Florkowski Christopher M, 2011, Clin Biochem Rev, V32, P75; Fricker M, 2003, KIDNEY INT, V63, P1944, DOI 10.1046/j.1523-1755.2003.00925.x; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Hansson LO, 2010, SCAND J CLIN LAB INV, V70, P347, DOI 10.3109/00365513.2010.491124; Herget-Rosenthal S, 2004, ANN CLIN BIOCHEM, V41, P111, DOI 10.1258/000456304322879980; Hojs R, 2008, RENAL FAILURE, V30, P181, DOI 10.1080/08860220701810315; Hojs R, 2010, NEPHRON CLIN PRACT, V114, pC118, DOI 10.1159/000254384; Horio M, 2011, CLIN EXP NEPHROL, V15, P868, DOI 10.1007/s10157-011-0525-y; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jaisuresh K, 2012, EXP CLIN TRANSPLANT, V10, P14, DOI 10.6002/ect.2011.0101; Kotajima N, 2010, J INT MED RES, V38, P1365, DOI 10.1177/147323001003800418; Krishnamurthy N, 2011, INDIAN J CLIN BIOCHE, V26, P120, DOI 10.1007/s12291-010-0084-0; Kumaresan Ramanathan, 2011, Oman Med J, V26, P421, DOI 10.5001/omj.2011.107; Larsson A, 2008, CLIN BIOCHEM, V41, P1355, DOI 10.1016/j.clinbiochem.2008.07.003; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Liu J, 2012, TRANSPL P, V44, P1250, DOI 10.1016/j.transproceed.2012.01.138; Liu WS, 2012, J CLIN LAB ANAL, V26, P206, DOI 10.1002/jcla.21495; Liu X, 2012, INTERN MED J, V42, pe59, DOI 10.1111/j.1445-5994.2010.02398.x; Ma YC, 2007, KIDNEY INT, V72, P1535, DOI 10.1038/sj.ki.5002566; Ma YC, 2007, NEPHROL DIAL TRANSPL, V22, P417, DOI 10.1093/ndt/gfl603; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Poreba R, 2011, TOXICOLOGY, V283, P88, DOI 10.1016/j.tox.2011.02.008; Robles NR, 2012, RENAL FAILURE, V34, P871, DOI 10.3109/0886022X.2012.687345; Roos JF, 2007, CLIN BIOCHEM, V40, P383, DOI 10.1016/j.clinbiochem.2006.10.026; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Salgado JV, 2010, BRAZ J MED BIOL RES, V43, P528, DOI 10.1590/S0100-879X2010000600002; Sjostrom PA, 2009, SCAND J CLIN LAB INV, V69, P65, DOI 10.1080/00365510802326469; Slort PR, 2012, PEDIATR NEPHROL, V27, P843, DOI 10.1007/s00467-011-2073-9; Sohrabian A, 2012, CLIN BIOCHEM, V45, P339, DOI 10.1016/j.clinbiochem.2011.12.027; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Voskoboev NV, 2012, CLIN CHEM LAB MED, V50, P1591, DOI 10.1515/cclm-2012-0063; Wang XJ, 2011, CLIN CHIM ACTA, V412, P1793, DOI 10.1016/j.cca.2011.05.033; Yap M, 2011, J REN CARE, V37, P155, DOI 10.1111/j.1755-6686.2011.00228.x	49	32	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57240	10.1371/journal.pone.0057240	http://dx.doi.org/10.1371/journal.pone.0057240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526939	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100010
J	Range, H; Poitou, C; Boillot, A; Ciangura, C; Katsahian, S; Lacorte, JM; Czernichow, S; Meilhac, O; Bouchard, P; Chaussain, C				Range, Helene; Poitou, Christine; Boillot, Adrien; Ciangura, Cecile; Katsahian, Sandrine; Lacorte, Jean-Marc; Czernichow, Sebastien; Meilhac, Olivier; Bouchard, Philippe; Chaussain, Catherine			Orosomucoid, a New Biomarker in the Association between Obesity and Periodontitis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ALPHA(1)-ACID GLYCOPROTEIN; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; EUROPEAN WORKSHOP; SERUM; HEALTH; POPULATION; ADIPOSITY	Epidemiological data indicate an association between periodontitis and obesity. The biological mechanisms of this relationship remain unclear. A cross-sectional study was conducted to evaluate the relationship between periodontitis and the common systemic inflammatory markers in 32 morbidly obese patients recruited in a Clinical Nutrition department. Periodontal condition was evaluated using pocket depth (PD) measurement, a classical clinical marker of ongoing periodontitis. Major periodontal risk factors were recorded (age, gender, diabetes and smoking status), as well as plasma levels of inflammatory markers (CRP, orosomucoid, IL-6) and adipokines (adiponectin, leptin). All patients included in the sample exhibited evidence of periodontitis, 16 of whom were diagnosed as having severe disease. Adjusted logistic regression analysis indicated that the severity of periodontitis was associated with the plasma level of orosomucoid (p < 0.04) after adjustment for age, gender and smoking. Our study thus suggests that the severity of periodontitis, in morbidly obese patients, is associated with the increase of orosomucoid levels.	[Range, Helene; Boillot, Adrien; Bouchard, Philippe] Univ Paris 07, Rothschild Hosp, AP HP, Dept Periodontol,Serv Odontol,UFR Odontol, Paris, France; [Range, Helene; Meilhac, Olivier] Univ Paris 07, Bichat Hosp, AP HP, INSERM,Cardiovasc Hematol Bioengn & Remodeling U6, Paris, France; [Poitou, Christine; Ciangura, Cecile] Hop La Pitie Salpetriere, AP HP, Nutr & Endocrinol Dept, Paris, France; [Poitou, Christine; Ciangura, Cecile] CRNH Ile France, Paris, France; [Poitou, Christine; Ciangura, Cecile] Inst Cardiometab & Nutr ICAN, Paris, France; [Poitou, Christine] Cordeliers Res Ctr, Team Nutri 7, INSERM, U872, Paris, France; [Poitou, Christine] Univ Paris 06, UMR S 872, Paris, France; [Boillot, Adrien; Czernichow, Sebastien] Ctr Res Epidemiol & Populat Hlth, INSERM, U1018, Villejuif, France; [Katsahian, Sandrine] Univ Paris 07, St Louis Hosp, AP HP, Dept Biostat, Paris, France; [Lacorte, Jean-Marc] Hop La Pitie Salpetriere, AP HP, Dept Endocrinol & Oncol Biochem, Paris, France; [Czernichow, Sebastien] Versailles St Quentin Univ, Ambroise Pare Hosp, AP HP, Dept Nutr, Boulogne, France; [Chaussain, Catherine] Univ Paris 05, Bretonneau Hosp, AP HP, Serv Odontol,UFR Odontol,EA 2496, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite	Bouchard, P (corresponding author), Univ Paris 07, Rothschild Hosp, AP HP, Dept Periodontol,Serv Odontol,UFR Odontol, Paris, France.	phbouch@noos.fr	Rangé, Hélène/ABA-6442-2020; Poitou, Christine/GVT-6117-2022; Meilhac, Olivier/N-4385-2017	Rangé, Hélène/0000-0002-4761-0805; Poitou, Christine/0000-0001-7769-6331; Bouchard, Philippe/0000-0003-2500-3219; Chaussain, Catherine/0000-0002-3463-3936; KATSAHIAN, Sandrine/0000-0002-7261-0671; Meilhac, Olivier/0000-0002-3740-7539	Assistance Publique-Hopitaux de Paris (AP-HP) (Contrat de Recherche Clinique) [NCT 0047658]	Assistance Publique-Hopitaux de Paris (AP-HP) (Contrat de Recherche Clinique)	This clinical investigation was promoted and supported by Assistance Publique-Hopitaux de Paris (AP-HP) (Contrat de Recherche Clinique, NCT 0047658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albandar JM, 2002, PERIODONTOL 2000, V29, P31, DOI 10.1034/j.1600-0757.2002.290103.x; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Benguigui C, 2012, ORAL DIS, V18, P748, DOI 10.1111/j.1601-0825.2012.01940.x; Boillot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021508; Bouchard P, 2006, J PERIODONTOL, V77, P479, DOI 10.1902/jop.2006.050128; Bouchard P, 2010, EUR HEART J SUPPL, V12, pB13, DOI 10.1093/eurheartj/suq001; Bourgeois D, 2007, J PERIODONTAL RES, V42, P219, DOI 10.1111/j.1600-0765.2006.00936.x; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Charles MA, 2008, OBESITY, V16, P2180, DOI [10.1038/oby.2008.285, 10.1038/oby.2008.286]; Chen LP, 2006, AM J KIDNEY DIS, V47, P815, DOI 10.1053/j.ajkd.2006.01.018; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; DEGRAAF TW, 1994, J RHEUMATOL, V21, P2209; Endo Y, 2010, J PERIODONTOL, V81, P520, DOI 10.1902/jop.2009.090574; Engstrom G, 2004, ARTERIOSCL THROM VAS, V24, P1498, DOI 10.1161/01.ATV.0000134293.31512.be; Fillol F, 2011, BRIT J NUTR, V106, P1602, DOI 10.1017/S0007114511002030; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Glurich I, 2002, CLIN DIAGN LAB IMMUN, V9, P425, DOI 10.1128/CDLI.9.2.425-432.2002; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; Hayashi S, 2001, VET RES COMMUN, V25, P117, DOI 10.1023/A:1006404902214; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Jimenez M, 2012, OBESITY, V20, P1718, DOI 10.1038/oby.2011.291; Kinane D, 2008, J CLIN PERIODONTOL, V35, P333, DOI 10.1111/j.1600-051X.2008.01278.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; Machin D, 2009, SAMPLE SIZE TABLES C, P256; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Page R C, 1998, Ann Periodontol, V3, P108, DOI 10.1902/annals.1998.3.1.108; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Range H, 2012, J CLIN PERIODONTOL, V39, P799, DOI 10.1111/j.1600-051X.2012.01913.x; Richette P, 2011, ANN RHEUM DIS, V70, P139, DOI 10.1136/ard.2010.134015; Saito T, 2008, J DENT RES, V87, P319, DOI 10.1177/154405910808700416; Saito T, 2007, PERIODONTOL 2000, V43, P254, DOI 10.1111/j.1600-0757.2006.00186.x; Savage A, 2009, J CLIN PERIODONTOL, V36, P458, DOI 10.1111/j.1600-051X.2009.01408.x; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Spiller F, 2012, DIABETES, V61, P1584, DOI 10.2337/db11-0825; Suvan J, 2011, OBES REV, V12, pe381, DOI 10.1111/j.1467-789X.2010.00808.x; van Dielen FMH, 2004, J CLIN ENDOCR METAB, V89, P4062, DOI 10.1210/jc.2003-032125; Veyrune JL, 2008, OBES SURG, V18, P1467, DOI 10.1007/s11695-008-9443-9; Ziakas A, 2009, MED SCI MONITOR, V15, pCR177	44	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57645	10.1371/journal.pone.0057645	http://dx.doi.org/10.1371/journal.pone.0057645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526947	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100015
J	Sun, XW; Liu, DY; Zhang, XF; Li, WB; Liu, H; Hong, WG; Jiang, CB; Guan, N; Ma, CX; Zeng, HP; Xu, CH; Song, J; Huang, L; Wang, CM; Shi, JJ; Wang, R; Zheng, XH; Lu, CY; Wang, XW; Zheng, HK				Sun, Xiaowen; Liu, Dongyuan; Zhang, Xiaofeng; Li, Wenbin; Liu, Hui; Hong, Weiguo; Jiang, Chuanbei; Guan, Ning; Ma, Chouxian; Zeng, Huaping; Xu, Chunhua; Song, Jun; Huang, Long; Wang, Chunmei; Shi, Junjie; Wang, Rui; Zheng, Xianhu; Lu, Cuiyun; Wang, Xiaowu; Zheng, Hongkun			SLAF-seq: An Efficient Method of Large-Scale De Novo SNP Discovery and Genotyping Using High-Throughput Sequencing	PLOS ONE			English	Article							GENOME SEQUENCE; MAP; DNA; DOMESTICATION; POLYMORPHISMS; TECHNOLOGY; DIVERSITY; SELECTION; PRIMERS; MARKERS	Large-scale genotyping plays an important role in genetic association studies. It has provided new opportunities for gene discovery, especially when combined with high-throughput sequencing technologies. Here, we report an efficient solution for large-scale genotyping. We call it specific-locus amplified fragment sequencing (SLAF-seq). SLAF-seq technology has several distinguishing characteristics: i) deep sequencing to ensure genotyping accuracy; ii) reduced representation strategy to reduce sequencing costs; iii) pre-designed reduced representation scheme to optimize marker efficiency; and iv) double barcode system for large populations. In this study, we tested the efficiency of SLAF-seq on rice and soybean data. Both sets of results showed strong consistency between predicted and practical SLAFs and considerable genotyping accuracy. We also report the highest density genetic map yet created for any organism without a reference genome sequence, common carp in this case, using SLAF-seq data. We detected 50,530 high-quality SLAFs with 13,291 SNPs genotyped in 211 individual carp. The genetic map contained 5,885 markers with 0.68 cM intervals on average. A comparative genomics study between common carp genetic map and zebrafish genome sequence map showed high-quality SLAF-seq genotyping results. SLAF-seq provides a high-resolution strategy for large-scale genotyping and can be generally applicable to various species and populations.	[Sun, Xiaowen; Zhang, Xiaofeng; Zheng, Xianhu; Lu, Cuiyun] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Harbin, Peoples R China; [Liu, Dongyuan; Li, Wenbin; Liu, Hui; Hong, Weiguo; Jiang, Chuanbei; Guan, Ning; Ma, Chouxian; Zeng, Huaping; Xu, Chunhua; Song, Jun; Huang, Long; Wang, Chunmei; Shi, Junjie; Wang, Rui; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China; [Li, Wenbin] Northeast Agr Univ, Key Lab Soybean Biol, Chinese Minist Educ, Harbin, Peoples R China; [Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China	Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Sun, XW (corresponding author), Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Harbin, Peoples R China.	sunxw2002@163.com; zhenghk@biomarker.com.cn	Zheng, xianhu/F-1739-2014; Hong, Weiguo/ABD-4294-2020; Sun, Xiaowen/F-1516-2014; Wang, Xiaowu/L-2579-2019	Zheng, xianhu/0000-0002-6206-8567; 	Key Project of Chinese National Programs for Fundamental Research and Development [2010CB126305]; National High Technology Research and Development Program of China [2011AA100402]	Key Project of Chinese National Programs for Fundamental Research and Development; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by Key Project of Chinese National Programs for Fundamental Research and Development (No. 2010CB126305) and the National High Technology Research and Development Program of China (2011AA100402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bindler G, 2011, THEOR APPL GENET, V123, P219, DOI 10.1007/s00122-011-1578-8; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lucito R, 1998, P NATL ACAD SCI USA, V95, P4487, DOI 10.1073/pnas.95.8.4487; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050	32	533	626	7	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58700	10.1371/journal.pone.0058700	http://dx.doi.org/10.1371/journal.pone.0058700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527008	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100035
J	Wiria, AE; Hamid, F; Wammes, LJ; Kaisar, MMM; May, L; Prasetyani, MA; Wahyuni, S; Djuardi, Y; Ariawan, I; Wibowo, H; Lell, B; Sauerwein, R; Brice, GT; Sutanto, I; van Lieshout, L; de Craen, AJM; van Ree, R; Verweij, JJ; Tsonaka, R; Houwing-Duistermaat, JJ; Luty, AJF; Sartono, E; Supali, T; Yazdanbakhsh, M				Wiria, Aprilianto E.; Hamid, Firdaus; Wammes, Linda J.; Kaisar, Maria M. M.; May, Linda; Prasetyani, Margaretta A.; Wahyuni, Sitti; Djuardi, Yenny; Ariawan, Iwan; Wibowo, Heri; Lell, Bertrand; Sauerwein, Robert; Brice, Gary T.; Sutanto, Inge; van Lieshout, Lisette; de Craen, Anton J. M.; van Ree, Ronald; Verweij, Jaco J.; Tsonaka, Roula; Houwing-Duistermaat, Jeanine J.; Luty, Adrian J. F.; Sartono, Erliyani; Supali, Taniawati; Yazdanbakhsh, Maria			The Effect of Three-Monthly Albendazole Treatment on Malarial Parasitemia and Allergy: A Household-Based Cluster-Randomized, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; PLASMODIUM-FALCIPARUM INFECTION; ANTHELMINTIC TREATMENT; PRESCHOOL-CHILDREN; RESEARCH AGENDA; DISEASES; ATOPY; SUSCEPTIBILITY; ELIMINATION; PREVALENCE	Background: Helminth infections are proposed to have immunomodulatory activities affecting health outcomes either detrimentally or beneficially. We evaluated the effects of albendazole treatment, every three months for 21 months, on STH, malarial parasitemia and allergy. Methods and Findings: A household-based cluster-randomized, double-blind, placebo-controlled trial was conducted in an area in Indonesia endemic for STH. Using computer-aided block randomization, 481 households (2022 subjects) and 473 households (1982 subjects) were assigned to receive placebo and albendazole, respectively, every three months. The treatment code was concealed from trial investigators and participants. Malarial parasitemia and malaria-like symptoms were assessed in participants older than four years of age while skin prick test (SPT) to allergens as well as reported symptoms of allergy in children aged 5-15 years. The general impact of treatment on STH prevalence and body mass index (BMI) was evaluated. Primary outcomes were prevalence of malarial parasitemia and SPT to any allergen. Analysis was by intention to treat. At 9 and 21 months post-treatment 80.8% and 80.1% of the study subjects were retained, respectively. The intensive treatment regiment resulted in a reduction in the prevalence of STH by 48% in albendazole and 9% in placebo group. Albendazole treatment led to a transient increase in malarial parasitemia at 6 months post treatment (OR 4.16(1.35-12.80)) and no statistically significant increase in SPT reactivity (OR 1.18(0.74-1.86) at 9 months or 1.37 (0.93-2.01) 21 months). No effect of anthelminthic treatment was found on BMI, reported malaria-like-and allergy symptoms. No adverse effects were reported. Conclusions: The study indicates that intensive community treatment of 3 monthly albendazole administration for 21 months over two years leads to a reduction in STH. This degree of reduction appears safewithout any increased risk of malaria or allergies.	[Wiria, Aprilianto E.; Kaisar, Maria M. M.; Prasetyani, Margaretta A.; Djuardi, Yenny; Wibowo, Heri; Sutanto, Inge; Supali, Taniawati] Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia; [Wiria, Aprilianto E.; Hamid, Firdaus; Wammes, Linda J.; Kaisar, Maria M. M.; May, Linda; Prasetyani, Margaretta A.; Djuardi, Yenny; van Lieshout, Lisette; Verweij, Jaco J.; Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Hamid, Firdaus] Hasanuddin Univ, Fac Med, Dept Microbiol, Makassar, Indonesia; [Wahyuni, Sitti] Hasanuddin Univ, Fac Med, Dept Parasitol, Makassar, Indonesia; [Ariawan, Iwan] Univ Indonesia, Sch Publ Hlth, Dept Biostat, Jakarta, Indonesia; [Lell, Bertrand] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Lell, Bertrand] Univ Tubingen, Inst Trop Med, Dept Parasitol, Tubingen, Germany; [Sauerwein, Robert; Luty, Adrian J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Brice, Gary T.] Naval Med Res Unit 2, Jakarta, Indonesia; [de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands; [Tsonaka, Roula; Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands	University of Indonesia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universitas Hasanuddin; Universitas Hasanuddin; University of Indonesia; Eberhard Karls University of Tubingen; Radboud University Nijmegen; Naval Medical Research Center (NMRC); US Naval Medical Research Unit-2 (NAMRU-2); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Supali, T (corresponding author), Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia.	taniawati@yahoo.com; M.Yazdanbakhsh@lumc.nl	Sauerwein, Robert/C-8519-2013; Wiria, Aprilianto Eddy/AAZ-2419-2021; Houwing-Duistermaat, Jeanne/V-9048-2018; Hamid, Firdaus/M-6862-2017; Yazdanbakhsh, Maria/AAI-3996-2020; Djuardi, Yenny/AGP-5890-2022; Luty, Adrian/CAH-2547-2022	Wiria, Aprilianto Eddy/0000-0002-6482-424X; Hamid, Firdaus/0000-0003-1788-0836; Yazdanbakhsh, Maria/0000-0002-7666-1441; Verweij, Jaco J./0000-0001-8553-931X; Luty, Adrian John Frederick/0000-0001-8830-3425; Kaisar, Maria M. M./0000-0002-7515-7673; Wibowo, Heri/0000-0001-7708-5135; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137	Royal Netherlands Academy of Arts and Science (KNAW) [KNAW-05-PP-35]; European Commission [INCO-CT-2006-031714, INCO-CT-2006-032436, Glofal FP6-2003-FOOD-2-B]; Prof. Dr. P.C. Flu Foundation	Royal Netherlands Academy of Arts and Science (KNAW); European Commission(European CommissionEuropean Commission Joint Research Centre); Prof. Dr. P.C. Flu Foundation	This study was funded by The Royal Netherlands Academy of Arts and Science (KNAW), Ref.KNAW-05-PP-35, European Commission contracts INCO-CT-2006-031714 and INCO-CT-2006-032436, Glofal FP6-2003-FOOD-2-B, and the Prof. Dr. P.C. Flu Foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; Alderman H, 2006, BRIT MED J, V333, P122, DOI 10.1136/bmj.38877.393530.7C; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brutus L, 2007, AM J TROP MED HYG, V77, P1091, DOI 10.4269/ajtmh.2007.77.1091; Cooper PJ, 2006, LANCET, V367, P1598, DOI 10.1016/S0140-6736(06)68697-2; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Djuardi Y, 2011, PARASITOLOGY, V138, P1508, DOI 10.1017/S0031182011000588; Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Feary J, 2011, ALLERGY, V66, P569, DOI 10.1111/j.1398-9995.2010.02512.x; Flohr C, 2010, CLIN EXP ALLERGY, V40, P131, DOI 10.1111/j.1365-2222.2009.03346.x; Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x; Hamid F, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-83; Harijanto Paul N, 2010, Acta Med Indones, V42, P51; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kirwan P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-277; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lau S, 2006, LANCET, V367, P1556, DOI 10.1016/S0140-6736(06)68670-4; Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mpairwe H, 2011, PEDIAT ALLERG IMM-UK, V22, P305, DOI 10.1111/j.1399-3038.2010.01122.x; Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Specht S, 2007, LANCET, V369, P446, DOI 10.1016/S0140-6736(07)60210-4; Szefler SJ, 2008, J ALLERGY CLIN IMMUN, V121, P614, DOI 10.1016/j.jaci.2007.11.033; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; Utzinger J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001646; Webb EL, 2011, LANCET, V377, P52, DOI 10.1016/S0140-6736(10)61457-2; WHO, 2010, GUID TREATM MAL, V2nd; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77	33	43	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57899	10.1371/journal.pone.0057899	http://dx.doi.org/10.1371/journal.pone.0057899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526959	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100017
J	Caceres, IA; Arcaya, M; Declercq, E; Belanoff, CM; Janakiraman, V; Cohen, B; Ecker, J; Smith, LA; Subramanian, SV				Caceres, Isabel A.; Arcaya, Mariana; Declercq, Eugene; Belanoff, Candice M.; Janakiraman, Vanitha; Cohen, Bruce; Ecker, Jeffrey; Smith, Lauren A.; Subramanian, S. V.			Hospital Differences in Cesarean Deliveries in Massachusetts (US) 2004-2006: The Case against Case-Mix Artifact	PLOS ONE			English	Article							BIRTH-RATES; PHYSICIAN FACTOR; VAGINAL BIRTHS; UNITED-STATES; RISK; SECTION; ADJUSTMENT; OUTCOMES; WOMEN; TERM	Objective: We examined the extent to which differences in hospital-level cesarean delivery rates in Massachusetts were attributable to hospital-level, rather than maternal, characteristics. Methods: Birth certificate and maternal in-patient hospital discharge records for 2004-06 in Massachusetts were linked. The study population was nulliparous, term, singleton, and vertex births (NTSV) (n = 80,371) in 49 hospitals. Covariates included mother's age, race/ethnicity, education, infant birth weight, gestational age, labor induction (yes/no), hospital shift at time of birth, and preexisting health conditions. We estimated multilevel logistic regression models to assess the likelihood of a cesarean delivery Results: Overall, among women with NTSV births, 26.5% births were cesarean, with a range of 14% to 38.3% across hospitals. In unadjusted models, the between-hospital variance was 0.103 (SE 0.022); adjusting for demographic, socioeconomic and preexisting medical conditions did not reduce any hospital-level variation 0.108 (SE 0.023). Conclusion: Even after adjusting for both socio-demographic and clinical factors, the chance of a cesarean delivery for NTSV pregnancies varied according to hospital, suggesting the importance of hospital practices and culture in determining a hospital's cesarean rate.	[Caceres, Isabel A.; Cohen, Bruce] Massachusetts Dept Publ Hlth, Bur Hlth Informat Stat Res & Evaluat, Boston, MA USA; [Arcaya, Mariana; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Declercq, Eugene; Belanoff, Candice M.] Boston Univ, Dept Community Hlth Sci, Boston, MA 02215 USA; [Janakiraman, Vanitha; Ecker, Jeffrey] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Smith, Lauren A.] Massachusetts Dept Hlth, Boston, MA USA	Massachusetts Department of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Massachusetts General Hospital	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu		Belanoff, Candice/0000-0002-2491-7548; Declercq, Eugene/0000-0001-5411-3033	Centers for Disease Control and Prevention [200-2009-31671CDC]; National Cancer Institute's joint Harvard School of Public Health-Dana-Farber Cancer Institute Educational Program in Cancer Prevention Research; National Institutes of Health (NIH) [3R25CA057711-18S1]; NIH [NHLBI K25 HL081275]; Robert Wood Johnson Investigator Award in Healthy Policy Research; NATIONAL CANCER INSTITUTE [R25CA057711] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute's joint Harvard School of Public Health-Dana-Farber Cancer Institute Educational Program in Cancer Prevention Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Investigator Award in Healthy Policy Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct funding was available for this study. The data for this study was provided by the Pregnancy to Early Life Longitudinal (PELL) data system which is supported by the Centers for Disease Control and Prevention Contract 200-2009-31671CDC. MA is supported as a predoctoral fellow by the National Cancer Institute's joint Harvard School of Public Health-Dana-Farber Cancer Institute Educational Program in Cancer Prevention Research, supported by National Institutes of Health (NIH) grant number 3R25CA057711-18S1. S.V. Subramanian is supported by the NIH Career Development Award (NHLBI K25 HL081275) and the Robert Wood Johnson Investigator Award in Healthy Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baicker K, 2006, HEALTH AFFAIR, V25, pW355, DOI 10.1377/hlthaff.25.w355; Bailit JL, 1999, OBSTET GYNECOL, V93, P1025, DOI 10.1016/S0029-7844(98)00536-5; Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; Clark SL, 2007, AM J OBSTET GYNECOL, V196, P526, DOI 10.1016/j.ajog.2007.02.021; Coonrod DV, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.026; Declercq E, 2007, OBSTET GYNECOL, V109, P669, DOI 10.1097/01.AOG.0000255668.20639.40; DEMOTT RK, 1990, AM J OBSTET GYNECOL, V162, P1593, DOI 10.1016/0002-9378(90)90925-W; DEREGT RH, 1986, NEW ENGL J MED, V315, P619, DOI 10.1056/NEJM198609043151005; Ehrenthal DB, 2010, OBSTET GYNECOL, V116, P35, DOI 10.1097/AOG.0b013e3181e10c5c; Garcia FAR, 2001, OBSTET GYNECOL, V97, P567, DOI 10.1016/S0029-7844(00)01219-9; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; GOYERT GL, 1989, NEW ENGL J MED, V320, P706, DOI 10.1056/NEJM198903163201106; Health MDoP, 2010, CHANGES IN THE CESAR; Health MDoP, 2009, MASSACHUSETTS BIRTHS; Knight M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5255; Kuklina EV, 2009, OBSTET GYNECOL, V113, P293, DOI 10.1097/AOG.0b013e3181954e5b; Lasswell SM, 2010, JAMA-J AM MED ASSOC, V304, P992, DOI 10.1001/jama.2010.1226; Linton A, 2005, OBSTET GYNECOL, V105, P598, DOI 10.1097/01.AOG.0000149158.21586.58; Lipkind HS, 2009, OBSTET GYNECOL, V113, P1239, DOI 10.1097/AOG.0b013e3181a4c3e5; MacDorman MF, 2008, BIRTH-ISS PERINAT C, V35, P3, DOI 10.1111/j.1523-536X.2007.00205.x; Main EK, 2006, AM J OBSTET GYNECOL, V194, P1644, DOI 10.1016/j.ajog.2006.03.013; Martin JA, 2010, NATL VITAL STAT REP, V59, P3; Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3; Menacker Fay, 2010, NCHS Data Brief, P1; Murthy K, 2007, OBSTET GYNECOL, V110, P1264, DOI 10.1097/01.AOG.0000287294.89148.23; NEWTON ER, 1989, J REPROD MED, V34, P407; Rasbash J, 2009, MLWIN VERSION 2 1 CE; ROCK SM, 1993, PUBLIC HEALTH REP, V108, P514; Simpson LL, 2012, SEMIN PERINATOL, V36, P328, DOI 10.1053/j.semperi.2012.04.015; Stivanello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028060; Subramanian S. V., 2003, Neighborhoods and health, P65; Taljaard M, 2009, PAEDIATR PERINAT EP, V23, P574, DOI 10.1111/j.1365-3016.2009.01072.x; Tita ATN, 2012, SEMIN PERINATOL, V36, P324, DOI 10.1053/j.semperi.2012.04.014; Zhang J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.058	34	52	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e57817	10.1371/journal.pone.0057817	http://dx.doi.org/10.1371/journal.pone.0057817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526952	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600006
J	Narayanaswamy, BE; Coll, M; Danovaro, R; Davidson, K; Ojaveer, H; Renaud, PE				Narayanaswamy, Bhavani E.; Coll, Marta; Danovaro, Roberto; Davidson, Keith; Ojaveer, Henn; Renaud, Paul E.			Synthesis of Knowledge on Marine Biodiversity in European Seas: From Census to Sustainable Management	PLOS ONE			English	Article							MICROBIAL DIVERSITY; ECOSYSTEM; CONSERVATION; RESILIENCE; HABITATS; PATTERNS; IMPACTS; DECLINE; SHARKS	The recently completed European Census of Marine Life, conducted within the framework of the global Census of Marine Life programme (2000-2010), markedly enhanced our understanding of marine biodiversity in European Seas, its importance within ecological systems, and the implications for human use. Here we undertake a synthesis of present knowledge of biodiversity in European Seas and identify remaining challenges that prevent sustainable management of marine biodiversity in one of the most exploited continents of the globe. Our analysis demonstrates that changes in faunal standing stock with depth depends on the size of the fauna, with macrofaunal abundance only declining with increasing water depth below 1000 m, whilst there was no obvious decrease in meiofauna with increasing depth. Species richness was highly variable for both deep water macro-and meio-fauna along latitudinal and longitudinal gradients. Nematode biodiversity decreased from the Atlantic into the Mediterranean whilst latitudinal related biodiversity patterns were similar for both faunal groups investigated, suggesting that the same environmental drivers were influencing the fauna. While climate change and habitat degradation are the most frequently implicated stressors affecting biodiversity throughout European Seas, quantitative understanding, both at individual and cumulative/synergistic level, of their influences are often lacking. Full identification and quantification of species, in even a single marine habitat, remains a distant goal, as we lack integrated data-sets to quantify these. While the importance of safeguarding marine biodiversity is recognised by policy makers, the lack of advanced understanding of species diversity and of a full survey of any single habitat raises huge challenges in quantifying change, and facilitating/prioritising habitat/ecosystem protection. Our study highlights a pressing requirement for more complete biodiversity surveys to be undertaken within contrasting habitats, together with investigations in biodiversity-ecosystem functioning links and identification of separate and synergistic/cumulative humaninduced impacts on biodiversity.	[Narayanaswamy, Bhavani E.; Davidson, Keith] Scottish Assoc Marine Sci, Scottish Marine Inst, Oban, Argyll, Scotland; [Coll, Marta] Sci Spanish Council ICM CSIC, Inst Ciencies Mar, Barcelona, Spain; [Danovaro, Roberto] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [Ojaveer, Henn] Univ Tartu, Estonian Marine Inst, Parnu, Estonia; [Renaud, Paul E.] Akvaplan NIVA, Fram Ctr Climate & Environm, Tromso, Norway; [Renaud, Paul E.] Univ Ctr Svalbard, Longyearbyen, Norway	UHI Millennium Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Marche Polytechnic University; University of Tartu; Estonian Marine Institute; Akvaplan-niva; University Centre Svalbard (UNIS)	Narayanaswamy, BE (corresponding author), Scottish Assoc Marine Sci, Scottish Marine Inst, Oban, Argyll, Scotland.	Bhavani.Narayanaswamy@sams.ac.uk	Ojaveer, Henn/K-2160-2016; Renaud, Paul E/C-7191-2008; Davidson, Keith/A-5474-2013; Coll, Marta/A-9488-2012	Ojaveer, Henn/0000-0003-2742-6063; Davidson, Keith/0000-0001-9269-3227; Coll, Marta/0000-0001-6235-5868; Narayanaswamy, Bhavani/0000-0002-5810-9127	Total Foundation; Census of Marine Life [OL100098]; European Community; Spanish National program Ramon y Cajal; national funding within the frame of the project RITMARE; Estonian Ministry of Education and Research [SF0180005s10]; European Community [266445]; project 'The status of marine biodiversity and its potential futures in the Estonian coastal sea' of Environmental Protection and Technology Programme of the European Regional Fund [3.2.0802.11-0029]; European Census of Marine Life; Census of Marine Life; EU	Total Foundation(Total SA); Census of Marine Life; European Community(European Commission); Spanish National program Ramon y Cajal(German Research Foundation (DFG)); national funding within the frame of the project RITMARE; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Community(European Commission); project 'The status of marine biodiversity and its potential futures in the Estonian coastal sea' of Environmental Protection and Technology Programme of the European Regional Fund; European Census of Marine Life; Census of Marine Life; EU(European Commission)	BN was supported by the Total Foundation and a grant from the Census of Marine Life (OL100098), funding to MC was given by a European Community Marie-Curie Postdoctoral Fellowship through the International Outgoing Fellowships to ECOFUN, and by the Spanish National program Ramon y Cajal whilst RD was supported by the national funding within the frame of the project RITMARE. The contribution of HO was partially financed by the Estonian Ministry of Education and Research (grant SF0180005s10) and by the European Community's Seventh Framework Programme (FP7/2007-2013 under Grant Agreement No. 266445) for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS). Contribution of HO was also supported by the project 'The status of marine biodiversity and its potential futures in the Estonian coastal sea' 3.2.0802.11-0029 of Environmental Protection and Technology Programme of the European Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the support given by the European Census of Marine Life and the Census of Marine Life. The authors are also indebted to all those who have undertaken the research through the various Census of Marine Life projects, EU-funded MarBEF, HERMES and HERMIONE programmes, as well as those that have been nationally funded. We would also like to thank all the regional experts who have provided their input into estimating biodiversity threats both for now and the future.	Abdul Malak D., 2011, OVERVIEW CONSERVATIO; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2000, NATURE BIODIVERSITY, P1; Ausubel J.H., 1999, OCEANOGRAPHY, V12, P4, DOI [10.5670/oceanog.1999.17, DOI 10.5670/OCEANOG.1999.17]; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Beaumont NJ, 2008, MAR POLLUT BULL, V56, P386, DOI 10.1016/j.marpolbul.2007.11.013; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Boedeker Dieter, 2007, Baltic Sea Environment Proceedings, V113, P1; Bongiorni L, 2010, BIOL CONSERV, V143, P1687, DOI 10.1016/j.biocon.2010.04.009; Boxshall C., 2009, MARINE BIODIVERSITY; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2012, FISH FISH, V13, P60, DOI 10.1111/j.1467-2979.2011.00420.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Commission of the European Communities (CEC), 2010, OFFICIAL J EUROPEAN, V232, P14; Costello MJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P319, DOI 10.1111/j.1466-8238.2010.00603.x; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2008, ECOGRAPHY, V31, P231, DOI 10.1111/j.0906-7590.2008.5484.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2007, ESTUAR COAST SHELF S, V75, P4, DOI 10.1016/j.ecss.2007.02.030; Danovaro R, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P115; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2006, CAN J FISH AQUAT SCI, V63, P1267, DOI 10.1139/F06-035; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Ferreira JG, 2011, ESTUAR COAST SHELF S, V93, P117, DOI 10.1016/j.ecss.2011.03.014; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fonselius S, 2003, J SEA RES, V49, P229, DOI 10.1016/S1385-1101(03)00035-2; Fraschetti S, 2011, AQUAT CONSERV, V21, P299, DOI 10.1002/aqc.1185; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Gorley C.K., 2006, GETTING STARTED PRIM; HELCOM, 2009, BALT SEA ENV P B, V116B, P1; ICES, 2011, ICES ADV 2011; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Katsanevakis S, 2011, OCEAN COAST MANAGE, V54, P807, DOI 10.1016/j.ocecoaman.2011.09.002; Kroncke I, 2003, MAR ECOL-P S Z N I, V24, P193, DOI 10.1046/j.0173-9565.2003.00825.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; Lotze HK, 2005, HELGOLAND MAR RES, V59, P84, DOI 10.1007/s10152-004-0209-z; MarBEF, 2004, EUR NOD OC BIOG INF; May RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001130; McCann K, 2007, NATURE, V446, P29, DOI 10.1038/446029a; McCarthy J., 2005, CLIMATE CHANGE CONTE; Medlin Linda K., 2010, Diversity, V2, P973, DOI 10.3390/d2070973; Meynard CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036443; MFSD, 2008, **NON-TRADITIONAL**, V164, P19; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Narayanaswamy BE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014295; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Ojaveer H, 2007, FISH RES, V87, P102, DOI 10.1016/j.fishres.2007.08.011; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Olenin S, 1999, HYDROBIOLOGIA, V393, P233, DOI 10.1023/A:1003511003766; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Portman ME, 2012, AMBIO IN PRESS; Queffelec B, 2009, MAR POLICY, V33, P871, DOI 10.1016/j.marpol.2009.04.016; Rees H.L., 2007, ICES COOPERATIVE RES, V288, P258; Renaud PE, 2009, MAR ECOL PROG SER, V382, P239, DOI 10.3354/meps07963; Rilov G, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-10; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Stein Ulrike, 1990, Mitteilungen aus dem Zoologischen Museum der Christian-Albrechts-Universitaet zu Kiel Supplement, V3, P1; Stelzenmuller V, 2012, MAR POLICY IN PRESS; Vandepitte L, 2011, HYDROBIOLOGIA, V667, P1, DOI 10.1007/s10750-011-0656-x; Vira B, 2009, CONSERV LETT, V2, P158, DOI 10.1111/j.1755-263X.2009.00063.x; Whitfield J, 2005, SCIENCE, V310, P960, DOI 10.1126/science.310.5750.960; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; *WSSD, 2002, WORLD SUMM SUST DEV; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	78	29	30	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58909	10.1371/journal.pone.0058909	http://dx.doi.org/10.1371/journal.pone.0058909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527045	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600015
J	DesRochers, TM; Suter, L; Roth, A; Kaplan, DL				DesRochers, Teresa M.; Suter, Laura; Roth, Adrian; Kaplan, David L.			Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity	PLOS ONE			English	Article							CIS-PLATINUM NEPHROTOXICITY; PROXIMAL TUBULAR CELLS; PRIMARY CULTURES; COCULTURE MODEL; 2 STRAINS; BIOMARKERS; TOXICITY; INJURY; CYTOTOXICITY; TRANSPORTERS	The staggering cost of bringing a drug to market coupled with the extremely high failure rate of prospective compounds in early phase clinical trials due to unexpected human toxicity makes it imperative that more relevant human models be developed to better predict drug toxicity. Drug-induced nephrotoxicity remains especially difficult to predict in both preclinical and clinical settings and is often undetected until patient hospitalization. Current pre-clinical methods of determining renal toxicity include 2D cell cultures and animal models, both of which are incapable of fully recapitulating the in vivo human response to drugs, contributing to the high failure rate upon clinical trials. We have bioengineered a 3D kidney tissue model using immortalized human renal cortical epithelial cells with kidney functions similar to that found in vivo. These 3D tissues were compared to 2D cells in terms of both acute (3 days) and chronic (2 weeks) toxicity induced by Cisplatin, Gentamicin, and Doxorubicin using both traditional LDH secretion and the pre-clinical biomarkers Kim-1 and NGAL as assessments of toxicity. The 3D tissues were more sensitive to drug-induced toxicity and, unlike the 2D cells, were capable of being used to monitor chronic toxicity due to repeat dosing. The inclusion of this tissue model in drug testing prior to the initiation of phase I clinical trials would allow for better prediction of the nephrotoxic effects of new drugs.	[DesRochers, Teresa M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA USA; [Suter, Laura; Roth, Adrian] F Hoffmann La Roche & Co Ltd, Nonclin Safety, CH-4002 Basel, Switzerland	Tufts University; Roche Holding	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA USA.	david.kaplan@tufts.edu	Suter-Dick, Laura/A-9093-2019	Suter-Dick, Laura/0000-0002-1449-3913; DesRochers, Teresa/0000-0003-3819-5491	National Institutes of Health [EB002520]; F. Hoffmann La Roche, Ltd.; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F. Hoffmann La Roche, Ltd.(Hoffmann-La Roche); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by the National Institutes of Health (EB002520) and F. Hoffmann La Roche, Ltd. 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astashkina AI, 2012, BIOMATERIALS, V33, P4712, DOI 10.1016/j.biomaterials.2012.03.001; Astashkina AI, 2012, BIOMATERIALS, V33, P4700, DOI 10.1016/j.biomaterials.2012.02.063; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Canton I, 2010, BIOTECHNOL BIOENG, V106, P794, DOI 10.1002/bit.22742; CHABARDES D, 1980, J CLIN INVEST, V65, P439, DOI 10.1172/JCI109687; Chang R, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045004; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; CHEN JC, 1990, TOXICOL APPL PHARM, V103, P463, DOI 10.1016/0041-008X(90)90319-P; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; Cummings BS, 2000, J PHARMACOL EXP THER, V293, P677; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DOBYAN DC, 1980, J PHARMACOL EXP THER, V213, P551; El Mouedden M, 2000, TOXICOL SCI, V56, P229, DOI 10.1093/toxsci/56.1.229; Food and Drug Administration, 2004, INN STAGN CHALL OPP; Fuchs TC, 2011, AAPS J, V13, P615, DOI 10.1208/s12248-011-9301-x; Garrett SH, 1998, ENVIRON HEALTH PERSP, V106, P587, DOI 10.2307/3434234; Gautier JC, 2010, TOXICOL PATHOL, V38, P943, DOI 10.1177/0192623310379139; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; GOLDSTEIN RS, 1981, TOXICOL APPL PHARM, V60, P163, DOI 10.1016/0041-008X(91)90220-9; Guo QS, 2008, EUR J CELL BIOL, V87, P251, DOI 10.1016/j.ejcb.2007.11.004; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Harpur E, 2011, TOXICOL SCI, V122, P235, DOI 10.1093/toxsci/kfr112; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hoffmann D, 2010, TOXICOL SCI, V116, P8, DOI 10.1093/toxsci/kfq029; Hu T, 2010, TOXICOL IN VITRO, V24, P1450, DOI 10.1016/j.tiv.2010.03.013; Kirsch-Volders M, 2011, MUTAGENESIS, V26, P177, DOI 10.1093/mutage/geq068; Knight A, 2008, REV RECENT CLIN TRIA, V3, P89, DOI 10.2174/157488708784223844; Lan SF, 2011, TOXICOL APPL PHARM, V256, P62, DOI 10.1016/j.taap.2011.07.013; LEVI J, 1980, J PHARMACOL EXP THER, V213, P545; Li W, 2006, TOXICOL IN VITRO, V20, P669, DOI 10.1016/j.tiv.2005.09.016; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Nakamura K, 2011, J BIOSCI BIOENG, V111, P78, DOI 10.1016/j.jbiosc.2010.08.008; NANUS DM, 1991, ONCOGENE, V6, P2105; Pannu N, 2008, CRIT CARE MED, V36, pS216, DOI 10.1097/CCM.0b013e318168e375; Presnell SC, 2011, TISSUE ENG PART C-ME, V17, P261, DOI [10.1089/ten.tec.2010.0399, 10.1089/ten.TEC.2010.0399]; Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267; Rached E, 2008, TOXICOL SCI, V103, P371, DOI 10.1093/toxsci/kfn040; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sasaki D, 2011, BIOMARKERS, V16, P553, DOI 10.3109/1354750X.2011.613123; Schmitz C, 2002, J BIOL CHEM, V277, P618, DOI 10.1074/jbc.M109959200; Servais H, 2006, ANTIMICROB AGENTS CH, V50, P1213, DOI 10.1128/AAC.50.4.1213-1221.2006; Sung JH, 2009, LAB CHIP, V9, P1385, DOI 10.1039/b901377f; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; TURNER RJ, 1977, P NATL ACAD SCI USA, V74, P2825, DOI 10.1073/pnas.74.7.2825; Weiland C, 2007, TOXICOL IN VITRO, V21, P466, DOI 10.1016/j.tiv.2006.10.008; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Wu Y, 2009, TOXICOL IN VITRO, V23, P1170, DOI 10.1016/j.tiv.2009.06.003	48	87	92	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59219	10.1371/journal.pone.0059219	http://dx.doi.org/10.1371/journal.pone.0059219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516613	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400098
J	Zhuang, L; Sachdev, PS; Trollor, JN; Reppermund, S; Kochan, NA; Brodaty, H; Wen, W				Zhuang, Lin; Sachdev, Perminder S.; Trollor, Julian N.; Reppermund, Simone; Kochan, Nicole A.; Brodaty, Henry; Wen, Wei			Microstructural White Matter Changes, Not Hippocampal Atrophy, Detect Early Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							APOE EPSILON-4 ALLELE; ALZHEIMERS-DISEASE; WALLERIAN DEGENERATION; NEUROTROPHIC FACTOR; FORNIX INFARCTION; CORPUS-CALLOSUM; WATER DIFFUSION; TAU PATHOLOGY; BRAIN; MRI	Background: Alzheimer's disease (AD) is generally considered to be characterized by pathology in gray matter of the brain, but convergent evidence suggests that white matter degradation also plays a vital role in its pathogenesis. The evolution of white matter deterioration and its relationship with gray matter atrophy remains elusive in amnestic mild cognitive impairment (aMCI), a prodromal stage of AD. Methods: We studied 155 cognitively normal (CN) and 27 'late' aMCI individuals with stable diagnosis over 2 years, and 39 'early' aMCI individuals who had converted from CN to aMCI at 2-year follow up. Diffusion tensor imaging (DTI) tractography was used to reconstruct six white matter tracts three limbic tracts critical for episodic memory function - the fornix, the parahippocampal cingulum, and the uncinate fasciculus; two cortico-cortical association fiber tracts - superior longitudinal fasciculus and inferior longitudinal fasciculus; and one projection fiber tract - corticospinal tract. Microstructural integrity as measured by fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and axial diffusivity (AxD) was assessed for these tracts. Results: Compared with CN, late aMCI had lower white matter integrity in the fornix, the parahippocampal cingulum, and the uncinate fasciculus, while early aMCI showed white matter damage in the fornix. In addition, fornical measures were correlated with hippocampal atrophy in late aMCI, whereas abnormality of the fornix in early aMCI occurred in the absence of hippocampal atrophy and did not correlate with hippocampal volumes. Conclusions: Limbic white matter tracts are preferentially affected in the early stages of cognitive dysfunction. Microstructural degradation of the fornix preceding hippocampal atrophy may serve as a novel imaging marker for aMCI at an early stage.	[Zhuang, Lin; Sachdev, Perminder S.; Trollor, Julian N.; Reppermund, Simone; Kochan, Nicole A.; Brodaty, Henry; Wen, Wei] Univ New S Wales, Ctr Healthy Brain Ageing, Randwick, NSW, Australia; [Sachdev, Perminder S.; Kochan, Nicole A.; Wen, Wei] Prince Wales Hosp, Neuropsychiat Inst, Euroa Ctr, Randwick, NSW 2031, Australia; [Brodaty, Henry] Univ New S Wales, Fac Med, Sch Psychiat, Primary Dementia Collaborat Res Ctr, Randwick, NSW, Australia; [Trollor, Julian N.] Univ New S Wales, Fac Med, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Randwick, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Wen, W (corresponding author), Univ New S Wales, Ctr Healthy Brain Ageing, Randwick, NSW, Australia.	w.wen@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Trollor, Julian/0000-0002-7685-2977; Wen, Wei/0000-0003-2753-3870	Australian National Health and Medical Research Council (NHMRC) [350833, 510175]; Australian Research Council Discovery Grant [ARC DP-0774213]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Grant(Australian Research Council)	This study was funded by an Australian National Health and Medical Research Council (NHMRC) Program Grant ID 350833, NHMRC Project Grant ID 510175, and Australian Research Council Discovery Grant ID ARC DP-0774213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Aggleton JP, 2000, BRAIN, V123, P800, DOI 10.1093/brain/123.4.800; Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belarbi K, 2011, CURR ALZHEIMER RES, V8, P633, DOI 10.2174/156720511796717230; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Bozoki AC, HUM BRAIN M IN PRESS; Brickman AM, 2012, ARCH NEUROL-CHICAGO, P1; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; Desai MK, 2010, AM J PATHOL, V177, P1422, DOI 10.2353/ajpath.2010.100087; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Dickerson BC, 2001, NEUROBIOL AGING, V22, P747, DOI 10.1016/S0197-4580(01)00271-8; Dickerson B, 2011, NEUROLOGY, V76, pA659; Duara R, 2008, NEUROLOGY, V71, P1986, DOI 10.1212/01.wnl.0000336925.79704.9f; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Gold BT, 2010, NEUROIMAGE, V52, P1487, DOI 10.1016/j.neuroimage.2010.05.036; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Hattingen E, 2007, J NEUROL NEUROSUR PS, V78, P655, DOI 10.1136/jnnp.2006.109801; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Lee DY, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00001; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Moudgil SS, 2000, STROKE, V31, P1418, DOI 10.1161/01.STR.31.6.1418; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Niewiadomska G, 2005, ANN NY ACAD SCI, V1048, P287, DOI 10.1196/annals.1342.026; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Persson J, 2006, NEUROLOGY, V66, P1029, DOI 10.1212/01.wnl.0000204180.25361.48; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pievani M, 2010, HUM BRAIN MAPP, V31, P1862, DOI 10.1002/hbm.20978; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Salo A, 2001, INT PSYCHOGERIATR, V13, P451, DOI 10.1017/S1041610201007864; Selnes Per, 2012, Alzheimers Dement, V8, pS112, DOI 10.1016/j.jalz.2011.07.001; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; Strauss E, 2006, COMPENDIUM NEUROPSYC; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yaffe K, 2006, DEMENT GERIATR COGN, V22, P312, DOI 10.1159/000095427; Zhang HB, 2011, J NEUROL NEUROSUR PS, V82, P487, DOI 10.1136/jnnp.2010.217133; Zhuang L, 2012, NEUROLOGY, V79, P748, DOI 10.1212/WNL.0b013e3182661f4d	64	98	100	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58887	10.1371/journal.pone.0058887	http://dx.doi.org/10.1371/journal.pone.0058887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516569	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400072
J	den Haan, AD; Veldkamp, MW; Bakker, D; Boink, GJJ; Janssen, RB; de Bakker, JMT; Tan, HL				den Haan, A. Denise; Veldkamp, Marieke W.; Bakker, Diane; Boink, Geert J. J.; Janssen, Rob B.; de Bakker, Jacques M. T.; Tan, Hanno L.			Organ Explant Culture of Neonatal Rat Ventricles: A New Model to Study Gene and Cell Therapy	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; SMOOTH MUSCLE ACTIN; IN-VITRO; IMPULSE PROPAGATION; CONDUCTION-VELOCITY; ELECTRICAL-PROPERTIES; POTASSIUM CHANNEL; CARDIAC MYOCYTES; INWARD RECTIFIER; HEART-CELLS	Testing cardiac gene and cell therapies in vitro requires a tissue substrate that survives for several days in culture while maintaining its physiological properties. The purpose of this study was to test whether culture of intact cardiac tissue of neonatal rat ventricles (organ explant culture) may be used as a model to study gene and cell therapy. We compared (immuno) histology and electrophysiology of organ explant cultures to both freshly isolated neonatal rat ventricular tissue and monolayers. (Immuno) histologic studies showed that organ explant cultures retained their fiber orientation, and that expression patterns of alpha-actinin, connexin-43, and alpha-smooth muscle actin did not change during culture. Intracellular voltage recordings showed that spontaneous beating was rare in organ explant cultures (20%) and freshly isolated tissue (17%), but common (82%) in monolayers. Accordingly, resting membrane potential was -83.9 +/- 4.4 mV in organ explant cultures, -80.5 +/- 3.5 mV in freshly isolated tissue, and -60.9 +/- 4.3 mV in monolayers. Conduction velocity, measured by optical mapping, was 18.2 +/- 1.0 cm/s in organ explant cultures, 18.0 +/- 1.2 cm/s in freshly isolated tissue, and 24.3 +/- 0.7 cm/s in monolayers. We found no differences in action potential duration (APD) between organ explant cultures and freshly isolated tissue, while APD of monolayers was prolonged (APD at 70% repolarization 88.8 +/- 7.8, 79.1 +/- 2.9, and 134.0 +/- 4.5 ms, respectively). Organ explant cultures and freshly isolated tissue could be paced up to frequencies within the normal range for neonatal rat (CL 150 ms), while monolayers could not. Successful lentiviral (LV) transduction was shown via Egfp gene transfer. Co-culture of organ explant cultures with spontaneously beating cardiomyocytes increased the occurrence of spontaneous beating activity of organ explant cultures to 86%. We conclude that organ explant cultures of neonatal rat ventricle are structurally and electrophysiologically similar to freshly isolated tissue and a suitable new model to study the effects of gene and cell therapy.	[den Haan, A. Denise; Veldkamp, Marieke W.; Bakker, Diane; Boink, Geert J. J.; Janssen, Rob B.; de Bakker, Jacques M. T.; Tan, Hanno L.] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands; [de Bakker, Jacques M. T.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Tan, HL (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Heart, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.l.tan@amc.uva.nl	Boink, Gerard/H-4843-2015	Boink, Gerard/0000-0002-6592-5106	the Netherlands Organization for Scientific Research (NWO) [ZonMW-Vici 918.86.616]	the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO, ZonMW-Vici 918.86.616, to HLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea S, 1999, CIRC RES, V84, P1365; Askar SFA, 2011, CARDIOVASC RES, V90, P295, DOI 10.1093/cvr/cvr011; Ausma J, 1997, AM J PATHOL, V151, P985; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Boink GJJ, 2008, J GENE MED, V10, P487, DOI 10.1002/jgm.1172; BUCHANAN JW, 1985, CIRC RES, V56, P696, DOI 10.1161/01.RES.56.5.696; Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433; Bursac N, 2003, TISSUE ENG, V9, P1243, DOI 10.1089/10763270360728152; Coppen SR, 1998, CIRC RES, V82, P232; Darrow BJ, 1996, CIRC RES, V79, P174, DOI 10.1161/01.RES.79.2.174; DEJONG F, 1992, CIRC RES, V71, P240, DOI 10.1161/01.RES.71.2.240; Desplantez T, 2004, PFLUG ARCH EUR J PHY, V448, P363, DOI 10.1007/s00424-004-1250-0; FAST VG, 1995, CARDIOVASC RES, V30, P449, DOI 10.1016/0008-6363(95)00071-2; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; Formigli L, 2005, AM J PHYSIOL-CELL PH, V288, pC795, DOI 10.1152/ajpcell.00345.2004; Gaughan JP, 1998, AM J PHYSIOL-HEART C, V275, pH577, DOI 10.1152/ajpheart.1998.275.2.H577; GILES WR, 1985, J PHYSIOL-LONDON, V368, P243, DOI 10.1113/jphysiol.1985.sp015856; Habeler W, 2009, CARDIOVASC RES, V81, P253, DOI 10.1093/cvr/cvn299; JONGSMA HJ, 1983, J MOL CELL CARDIOL, V15, P123, DOI 10.1016/0022-2828(83)90288-2; JOURDON P, 1980, J MOL CELL CARDIOL, V12, P1441, DOI 10.1016/0022-2828(80)90127-3; JOYNER RW, 1982, CIRC RES, V50, P192, DOI 10.1161/01.RES.50.2.192; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; KOVAL M, 1995, J CELL BIOL, V130, P987, DOI 10.1083/jcb.130.4.987; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; LESLIE KO, 1991, AM J PATHOL, V139, P207; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Martinez AD, 2002, CIRC RES, V90, P1100, DOI 10.1161/01.RES.0000019580.64013.31; McCain ML, 2012, AM J PHYSIOL-HEART C, V302, pH443, DOI 10.1152/ajpheart.01218.2010; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Munoz V, 2007, CIRC RES, V101, P475, DOI 10.1161/CIRCRESAHA.107.149617; Nygren A, 2003, AM J PHYSIOL-HEART C, V284, pH892, DOI 10.1152/ajpheart.00648.2002; Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168, DOI 10.1152/ajpheart.2001.280.1.H168; Pillekamp F, 2007, STEM CELLS, V25, P174, DOI 10.1634/stemcells.2006-0094; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; ROHR S, 1991, CIRC RES, V68, P114, DOI 10.1161/01.RES.68.1.114; ROSEN MR, 1981, AM J PHYSIOL, V240, pH546, DOI 10.1152/ajpheart.1981.240.4.H546; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Salameh A, 2004, EUR J PHARMACOL, V503, P9, DOI 10.1016/j.ejphar.2004.09.024; Sekar RB, 2007, AM J PHYSIOL-HEART C, V293, pH2757, DOI 10.1152/ajpheart.00477.2007; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; SMOTHERMAN WP, 1991, PHYSIOL BEHAV, V50, P47, DOI 10.1016/0031-9384(91)90496-B; Spach MS, 2000, CIRC RES, V86, pE23; Stuckmann I, 2003, DEV BIOL, V255, P334, DOI 10.1016/S0012-1606(02)00078-7; SUN LS, 1993, CARDIOVASC RES, V27, P459, DOI 10.1093/cvr/27.3.459; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; TUCKER DC, 1985, AM J PHYSIOL, V248, pR601, DOI 10.1152/ajpregu.1985.248.5.R601; van den Hoff MJB, 1999, DEV BIOL, V212, P477, DOI 10.1006/dbio.1999.9366; VANKEMPEN MJA, 1991, CIRC RES, V68, P1638, DOI 10.1161/01.RES.68.6.1638; VARMUS HE, 1973, P NATL ACAD SCI USA, V70, P3067, DOI 10.1073/pnas.70.11.3067; Veldkamp MW, 1999, CARDIOVASC RES, V42, P424, DOI 10.1016/S0008-6363(99)00046-2; Walsh KB, 2002, CARDIOVASC RES, V55, P64, DOI 10.1016/S0008-6363(02)00403-0; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559	54	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59290	10.1371/journal.pone.0059290	http://dx.doi.org/10.1371/journal.pone.0059290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516623	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200140
J	Carrington, LB; Armijos, MV; Lambrechts, L; Barker, CM; Scott, TW				Carrington, Lauren B.; Armijos, M. Veronica; Lambrechts, Louis; Barker, Christopher M.; Scott, Thomas W.			Effects of Fluctuating Daily Temperatures at Critical Thermal Extremes on Aedes aegypti Life-History Traits	PLOS ONE			English	Article							DENGUE VIRUS TRANSMISSION; CLIMATE-CHANGE; CULICIDAE; DIPTERA; MOSQUITOS; SURVIVAL; VECTOR; AUSTRALIA; MICROCLIMATE; CALIFORNIA	Background: The effect of temperature on insect biology is well understood under constant temperature conditions, but less so under more natural, fluctuating conditions. A fluctuating temperature profile around a mean of 26 degrees C can alter Aedes aegypti vector competence for dengue viruses as well as numerous life-history traits, however, the effect of fluctuations on mosquitoes at critical thermal limits is unknown. Methodology/Principal Findings: We investigated the effects of large and small daily temperature fluctuations at low (16 degrees C) and high (35-37 degrees C) mean temperatures, after we identified these temperatures as being thresholds for immature development and/or adult reproduction under constant temperature conditions. We found that temperature effects on larval development time, larval survival and adult reproduction depend on the combination of mean temperature and magnitude of fluctuations. Importantly, observed degree-day estimates for mosquito development under fluctuating temperature profiles depart significantly (around 10-20%) from that predicted by constant temperatures of the same mean. At low mean temperatures, fluctuations reduce the thermal energy required to reach pupation relative to constant temperature, whereas at high mean temperatures additional thermal energy is required to complete development. A stage-structured model based on these empirical data predicts that fluctuations can significantly affect the intrinsic growth rate of mosquito populations. Conclusions/Significance: Our results indicate that by using constant temperatures, one could under- or over-estimate values for numerous life-history traits compared to more natural field conditions dependent upon the mean temperature. This complexity may in turn reduce the accuracy of population dynamics modeling and downstream applications for mosquito surveillance and disease prevention.	[Carrington, Lauren B.; Armijos, M. Veronica; Scott, Thomas W.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Carrington, Lauren B.; Armijos, M. Veronica; Barker, Christopher M.; Scott, Thomas W.] Univ Calif Davis, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Lambrechts, Louis] Inst Pasteur, CNRS URA 3012, Paris, France; [Barker, Christopher M.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Barker, Christopher M.; Scott, Thomas W.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of California System; University of California Davis; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Carrington, LB (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	lbcarrington@gmail.com	Lambrechts, Louis/A-2057-2010; Barker, Christopher/K-1415-2018	Lambrechts, Louis/0000-0001-5958-2138; Barker, Christopher/0000-0002-7941-346X; Carrington, Lauren Bree/0000-0001-9273-7912	Ecology of Infectious Disease program of the National Science Foundation [EF-0914384]; CDC, Climate Change: Environmental Impact on Human Health [U01 EH000418]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000418] Funding Source: NIH RePORTER	Ecology of Infectious Disease program of the National Science Foundation; CDC, Climate Change: Environmental Impact on Human Health; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work was funded by grant EF-0914384 from the Ecology of Infectious Disease program of the National Science Foundation. CMB also acknowledges financial support from grant U01 EH000418 from CDC, Climate Change: Environmental Impact on Human Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499; Barbazan P, 2010, MED VET ENTOMOL, V24, P66, DOI 10.1111/j.1365-2915.2009.00848.x; Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242; Carrington LB, 2013, AM J TROPICAL MED HY; Caswell, 2000, MATRIX POPULATION MO; Christophers, 1960, AEDES AEGYPTI L YELL; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Hartley DM, 2012, AM J TROP MED HYG, V86, P884, DOI 10.4269/ajtmh.2012.11-0342; Koenraadt CJM, 2008, AM J TROP MED HYG, V79, P230, DOI 10.4269/ajtmh.2008.79.230; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Le Van JH, 1940, PUBLIC HEALTH REP, V55, P900, DOI 10.2307/4583293; MCLEAN DM, 1975, MOSQ NEWS, V35, P322; MEYER RP, 1990, J MED ENTOMOL, V27, P607, DOI 10.1093/jmedent/27.4.607; Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9; Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021; R Core Team, 2012, R LANG ENV STAT COMP; Richardson K, 2011, J MED ENTOMOL, V48, P914, DOI 10.1603/ME10204; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x; Schaffner F, 2009, EUROPEAN CTR DIS PRE; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wong J, 2011, J MED ENTOMOL, V48, P45, DOI 10.1603/ME10149	28	115	120	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58824	10.1371/journal.pone.0058824	http://dx.doi.org/10.1371/journal.pone.0058824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520534	gold, Green Submitted, Green Published			2022-12-27	WOS:000318679900094
J	Chen, HQ; Gu, ZN; Zhang, H; Wang, MX; Chen, W; Lowther, WT; Chen, YQ				Chen, Haiqin; Gu, Zhennan; Zhang, Hao; Wang, Mingxuan; Chen, Wei; Lowther, W. Todd; Chen, Yong Q.			Expression and Purification of Integral Membrane Fatty Acid Desaturases	PLOS ONE			English	Article							MORTIERELLA-ALPINA; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS EXPRESSION; SUBSTRATE-SPECIFICITY; GENE; IDENTIFICATION; CANCER; FUNGUS; YEAST	Fatty acid desaturase enzymes perform dehydrogenation reactions leading to the insertion of double bonds in fatty acids, and are divided into soluble and integral membrane classes. Crystal structures of soluble desaturases are available; however, membrane desaturases have defied decades of efforts due largely to the difficulty of generating recombinant desaturase proteins for crystallographic analysis. Mortierella alpina is an oleaginous fungus which possesses eight membrane desaturases involved in the synthesis of saturated, monounsaturated and polyunsaturated fatty acids. Here, we describe the successful expression, purification and enzymatic assay of three M. alpina desaturases (FADS15, FADS12, and FADS9-I). Estimated yields of desaturases with purity >95% are approximately 3.5% (Ca. 4.6 mg/L of culture) for FADS15, 2.3% (Ca. 2.5 mg/L of culture) for FADS12 and 10.7% (Ca. 37.5 mg/L of culture) for FADS9-I. Successful expression of high amounts of recombinant proteins represents a critical step towards the structural elucidation of membrane fatty acid desaturases.	[Chen, Haiqin; Gu, Zhennan; Zhang, Hao; Wang, Mingxuan; Chen, Wei; Chen, Yong Q.] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Chen, Haiqin; Gu, Zhennan; Chen, Yong Q.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA	Jiangnan University; Wake Forest University; Wake Forest University	Chen, YQ (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	yqchen@wakehealth.edu	Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708	National Institutes of Health [R01CA107668, R01CA163273, P01CA106742]; Program for Changjiang Scholars; National Natural Science Foundation of China [21276108, 31125021]; Fundamental Research Funds for the Central Universities [JUSRP51320B]; State Scholarship Fund from the China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA163273, R01CA107668, P30CA012197, P01CA106742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Scholarship Fund from the China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health grants R01CA107668, R01CA163273 and P01CA106742, the Program for Changjiang Scholars, the National Natural Science Foundation of China (No. 21276108 and No. 31125021), the Fundamental Research Funds for the Central Universities (No. JUSRP51320B), and the State Scholarship Fund from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berquin IM, 2011, CANCER METAST REV, V30, P295, DOI 10.1007/s10555-011-9299-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCH K, 1969, ACCOUNTS CHEM RES, V2, P193, DOI 10.1021/ar50019a001; Chen YQ, 2007, CANCER METAST REV, V26, P535, DOI 10.1007/s10555-007-9075-x; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Jonsson TJ, 2009, J BIOL CHEM, V284, P33305, DOI 10.1074/jbc.M109.036400; Kim SH, 2011, BIOTECHNOL LETT, V33, P1185, DOI 10.1007/s10529-011-0555-2; Knutzon DS, 1998, J BIOL CHEM, V273, P29360, DOI 10.1074/jbc.273.45.29360; Li M, 2011, BIOTECHNOL LETT, V33, P1823, DOI 10.1007/s10529-011-0626-4; MacKenzie DA, 2002, MICROBIOL-SGM, V148, P1725, DOI 10.1099/00221287-148-6-1725; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Reed DW, 2000, PLANT PHYSIOL, V122, P715, DOI 10.1104/pp.122.3.715; Sakuradani E, 2005, APPL MICROBIOL BIOT, V66, P648, DOI 10.1007/s00253-004-1760-x; Sakuradani E, 2003, BIOSCI BIOTECH BIOCH, V67, P704, DOI 10.1271/bbb.67.704; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028319	21	22	24	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58139	10.1371/journal.pone.0058139	http://dx.doi.org/10.1371/journal.pone.0058139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520490	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900049
J	Fu, KW; Chau, M				Fu, King-wa; Chau, Michael			Reality Check for the Chinese Microblog Space: A Random Sampling Approach	PLOS ONE			English	Article							COUNT DATA	Chinese microblogs have drawn global attention to this online application's potential impact on the country's social and political environment. However, representative and reliable statistics on Chinese microbloggers are limited. Using a random sampling approach, this study collected Chinese microblog data from the service provider, analyzing the profile and the pattern of usage for 29,998 microblog accounts. From our analysis, 57.4% (95% CI 56.9%,58.0%) of the accounts' timelines were empty. Among the 12,774 non-zero statuses samples, 86.9% (95% CI 86.2%,87.4%) did not make original post in a 7-day study period. By contrast, 0.51% (95% CI 0.4%,0.65%) wrote twenty or more original posts and 0.45% (95% CI 0.35%,0.60%) reposted more than 40 unique messages within the 7-day period. A small group of microbloggers created a majority of contents and drew other users' attention. About 4.8% (95% CI 4.4%,5.2%) of the 12,774 users contributed more than 80% (95% CI, 78.6%,80.3%) of the original posts and about 4.8% (95% CI 4.5%,5.2%) managed to create posts that were reposted or received comments at least once. Moreover, a regression analysis revealed that volume of followers is a key determinant of creating original microblog posts, reposting messages, being reposted, and receiving comments. Volume of friends is found to be linked only with the number of reposts. Gender differences and regional disparities in using microblogs in China are also observed.	[Fu, King-wa] Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China; [Chau, Michael] Univ Hong Kong, Sch Business, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Fu, KW (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China.	kwfu@hku.hk	Fu, King-wa/A-2385-2010; Chau, Michael/A-4427-2010	Fu, King-wa/0000-0001-8157-5276; Chau, Michael/0000-0003-4579-4329	University of Hong Kong	University of Hong Kong(University of Hong Kong)	This study is funded by The University of Hong Kong, Seed Funding Programme for Basic Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYD D, 2010, 43 HAW INT C SYST SC, V43, P1; Canaves S, 2011, IEEE SPECTRUM, V48, P74, DOI 10.1109/MSPEC.2011.5779799; Chao L., 2012, WALL STREET J; Chen GM, 2011, COMPUT HUM BEHAV, V27, P755, DOI 10.1016/j.chb.2010.10.023; China Internet Network Information Center, 2012, 30 CHIN INT NETW INF; Dou WY, 2006, J ADVERTISING, V35, P101, DOI 10.1080/00913367.2006.10639230; Fu KW, 2013, IEEE INTERN IN PRESS; Gang Q., 2011, CHANGING MEDIA CHANG, P38; Hampton K., 2011, SOCIAL NETWORKING SI; Hassid J, 2012, APSA 2012 ANN M PAP; Huberman B., 2008, 1 MONDAY, V14, P1, DOI [10.5210/fm.v14i1.2317, DOI 10.5210/FM.V14I1.2317]; iResearch, 2011, CHIN MICR IND US RES; Kempf AM, 2007, ANNU REV PUBL HEALTH, V28, P113, DOI 10.1146/annurev.publhealth.28.021406.144059; Kwak H., 2010, WEB C 2010 P WORLD W, P591; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; National Bureau of Statistics, 2012, INC GAP CHIN URB RUR; Qiang XA, 2011, J DEMOCR, V22, P47; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reuters, 2012, MICR US CHIN QUADR 2; Romero DM, 2011, LECT NOTES ARTIF INT, V6913, P18, DOI 10.1007/978-3-642-23808-6_2; Suh B, 2010, 2010 IEEE 2 INT C SO, V2, P177, DOI [10.1109/SocialCom.2010.33, DOI 10.1109/SOCIALCOM.2010.33]; Wines M., 2010, NY TIMES; Yang Guobin, 2009, POWER INTERNET CHINA; Yang X, 2010, NY TIMES; Yu L, 2011, ARXIV11073522; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhu JJH, 2011, SOC SCI COMPUT REV, V29, P327, DOI 10.1177/0894439310382512	27	62	62	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58356	10.1371/journal.pone.0058356	http://dx.doi.org/10.1371/journal.pone.0058356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520502	Green Published, gold			2022-12-27	WOS:000318679900061
J	Hernandez-Maqueda, JG; Luna-Ulloa, LB; Santoyo-Ramos, P; Castaneda-Patlan, MC; Robles-Flores, M				Hernandez-Maqueda, Jose G.; Bernardo Luna-Ulloa, Luis; Santoyo-Ramos, Paula; Cristina Castaneda-Patlan, M.; Robles-Flores, Martha			Protein Kinase C Delta Negatively Modulates Canonical Wnt Pathway and Cell Proliferation in Colon Tumor Cell Lines	PLOS ONE			English	Article							CATENIN DESTRUCTION COMPLEX; BETA-CATENIN; MEDIATED REGULATION; APC; PHOSPHORYLATION; SUPPRESSOR; BINDING; ACTIVATION; MUTATIONS; MECHANISM	The tumor suppressor Adenomatous Polyposis coli (APC) gene is mutated or lost in most colon cancers. Alterations in Protein kinase C (PKC) isozyme expression and aberrant regulation also comprise early events in intestinal carcinomas. Here we show that PKC delta expression levels are decreased in colon tumor cell lines with respect to non-malignant cells. Reciprocal co-immunoprecipitation and immunofluorescence studies revealed that PKC delta interacts specifically with both full-length (from non-malignant cells) and truncated APC protein (from cancerous cells) at the cytoplasm and at the cell nucleus. Selective inhibition of PKC delta in cancer SW480 cells, which do not possess a functional beta-catenin destruction complex, did not affect beta-catenin-mediated transcriptional activity. However, in human colon carcinoma RKO cells, which have a normal beta-catenin destruction complex, negatively affected beta-catenin-mediated transcriptional activity, cell proliferation, and the expression of Wnt target genes C-MYC and CYCLIN D1. These negative effects were confirmed by siRNA-mediated knockdown of PKC delta and by the expression of a dominant negative form of PKC delta in RKO cells. Remarkably, the PKC delta stably depleted cells exhibited augmented tumorigenic activity in grafted mice. We show that PKC delta functions in a mechanism that involves regulation of beta-catenin degradation, because PKC delta inhibition induces beta-catenin stabilization at the cytoplasm and its nuclear presence at the C-MYC enhancer even without Wnt3a stimulation. In addition, expression of a dominant form of PKC delta diminished APC phosphorylation in intact cells, suggesting that PKC delta may modulate canonical Wnt activation negatively through APC phosphorylation.	[Hernandez-Maqueda, Jose G.; Bernardo Luna-Ulloa, Luis; Santoyo-Ramos, Paula; Cristina Castaneda-Patlan, M.; Robles-Flores, Martha] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Robles-Flores, M (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City, DF, Mexico.	rmartha@servidor.unam.mx		Castaneda-Patlan, Maria Cristina/0000-0002-2551-4847	Universidad Nacional Autonoma de Mexico [DGAPA-UNAM IN226111]; CONACYT [151731]; CONACYT, Mexico	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grants from the Universidad Nacional Autonoma de Mexico (DGAPA-UNAM IN226111) to MRF and from CONACYT (151731) to MRF. JGHM was supported by a doctoral fellowship from CONACYT, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Luna-Ulloa LB, 2011, CARCINOGENESIS, V32, P1615, DOI 10.1093/carcin/bgr190; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Brocardo M, 2008, TRENDS CELL BIOL, V18, P587, DOI 10.1016/j.tcb.2008.09.002; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; Davidson Nicholas O., 2007, Keio Journal of Medicine, V56, P14; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Easwaran V, 1999, J BIOL CHEM, V274, P16641, DOI 10.1074/jbc.274.23.16641; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Gokmen-Polar Y, 2001, CANCER RES, V61, P1375; Guo JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007982; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Li WQ, 1996, ONCOGENE, V13, P731; Liu J, 2006, J MOL BIOL, V360, P133, DOI 10.1016/j.jmb.2006.04.064; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Perletti GP, 1999, ONCOGENE, V18, P1251, DOI 10.1038/sj.onc.1202408; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Trzepacz C, 1997, J BIOL CHEM, V272, P21681, DOI 10.1074/jbc.272.35.21681; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Zhang F, 2000, P NATL ACAD SCI USA, V97, P12577, DOI 10.1073/pnas.230435597; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200	36	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58540	10.1371/journal.pone.0058540	http://dx.doi.org/10.1371/journal.pone.0058540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520519	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900078
J	Schroeder, JH; Bell, LS; Janas, ML; Turner, M				Schroeder, Jan-Hendrik; Bell, Lewis S.; Janas, Michelle L.; Turner, Martin			Pharmacological Inhibition of Glycogen Synthase Kinase 3 Regulates T Cell Development In Vitro	PLOS ONE			English	Article							BETA-SELECTION CHECKPOINT; THYMOCYTE DEVELOPMENT; THYMIC DEVELOPMENT; PRE-TCR; NOTCH; DIFFERENTIATION; ACTIVATION; RECEPTOR; IL-7; PHOSPHORYLATION	The development of functional T cells requires receptor-mediated transition through multiple checkpoints in the thymus. Double negative 3 (DN3) thymocytes are selected for the presence of a rearranged TCR beta chain in a process termed beta-selection which requires signalling via the pre-TCR, Notch1 and CXCL12. Signal integration by these receptors converges on core pathways including the Phosphatidylinositol-3-kinase (PI3K) pathway. Glycogen Synthase Kinase 3 (GSK3) is generally thought to be negatively regulated by the PI3K pathway but its role in beta-selection has not been characterised. Here we show that developmental progression of DN3 thymocytes is promoted following inhibition of GSK3 by the synthetic compound CHIR99021. CHIR99021 allows differentiation in the absence of pre-TCR-, Notch1- or CXCL12-mediated signalling. It antagonizes IL-7-mediated inhibition of DP thymocyte differentiation and increases IL-7-promoted cell recovery. These data indicate a potentially important role for inactivation of GSK3 during beta-selection. They might help to establish an in vitro stromal cell-free culture system of thymocyte development and offer a new platform for screening regulators of proliferation, differentiation and apoptosis.	[Schroeder, Jan-Hendrik; Bell, Lewis S.; Janas, Michelle L.; Turner, Martin] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Babraham Res Campus, Cambridge, England.	martin.turner@babraham.ac.uk	Turner, Martin/N-9976-2014	Turner, Martin/0000-0002-3801-9896; Bell, Lewis/0000-0002-9412-7066; Schroeder, Jan-Hendrik/0000-0001-5114-4918	Biotechnology and Biological Sciences Research Council; BBSRC [BB/F02066X/1, BB/H023690/1, BBS/E/B/000C0407] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/F02066X/1, 976494, BB/H023690/1, BBS/E/B/0000C206, BB/C51889X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balciunaite G, 2005, EUR J IMMUNOL, V35, P1292, DOI 10.1002/eji.200425822; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Pooter R, 2007, CURR OPIN IMMUNOL, V19, P163, DOI 10.1016/j.coi.2007.02.011; El Kassar N, 2004, BLOOD, V104, P1419, DOI 10.1182/blood-2004-01-0201; Falk I, 1996, J EXP MED, V184, P2327, DOI 10.1084/jem.184.6.2327; Gounari F, 2005, NAT IMMUNOL, V6, P800, DOI 10.1038/ni1228; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Janas ML, 2011, J IMMUNOL, V187, P4667, DOI 10.4049/jimmunol.1101949; Janas ML, 2010, TRENDS IMMUNOL, V31, P370, DOI 10.1016/j.it.2010.07.002; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008	31	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58501	10.1371/journal.pone.0058501	http://dx.doi.org/10.1371/journal.pone.0058501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526989	Green Published, gold			2022-12-27	WOS:000317562600026
J	Scott, TP; Fischer, M; Khaiseb, S; Freuling, C; Hoper, D; Hoffmann, B; Markotter, W; Muller, T; Nel, LH				Scott, Terence P.; Fischer, Melina; Khaiseb, Siegfried; Freuling, Conrad; Hoeper, Dirk; Hoffmann, Bernd; Markotter, Wanda; Mueller, Thomas; Nel, Louis H.			Complete Genome and Molecular Epidemiological Data Infer the Maintenance of Rabies among Kudu (Tragelaphus strepsiceros) in Namibia	PLOS ONE			English	Article							VIRUS; TRANSMISSION; EMERGENCE; EVOLUTION; AFRICA	Rabies in kudu is unique to Namibia and two major peaks in the epizootic have occurred since it was first noted in 1977. Due to the large numbers of kudu that were affected, it was suspected that horizontal transmission of rabies occurs among kudu and that rabies was being maintained independently within the Namibian kudu population - separate from canid cycles, despite geographic overlap. In this study, it was our aim to show, through phylogenetic analyses, that rabies was being maintained independently within the Namibian kudu population. We also tested, through complete genome sequencing of four rabies virus isolates from jackal and kudu, whether specific mutations occurred in the virus genome due to host adaptation. We found the separate grouping of all rabies isolates from kudu to those of any other canid species in Namibia, suggesting that rabies was being maintained independently in kudu. Additionally, we noted several mutations unique to isolates from kudu, suggesting that these mutations may be due to the adaptation of rabies to a new host. In conclusion, we show clear evidence that rabies is being maintained independently in the Namibian kudu population - a unique phenomenon with ecological and economic impacts.	[Scott, Terence P.; Markotter, Wanda; Nel, Louis H.] Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa; [Fischer, Melina; Freuling, Conrad; Hoeper, Dirk; Hoffmann, Bernd; Mueller, Thomas] Friedrich Loeffler Inst, Greifswald, Germany; [Khaiseb, Siegfried] Cent Vet Labs, Windhoek, Namibia	University of Pretoria; Friedrich Loeffler Institute	Nel, LH (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa.	louis.nel@up.ac.za	Nel, Louis H/F-1001-2012; Scott, Terence/J-8877-2019	Nel, Louis H/0000-0001-8963-0153; Scott, Terence/0000-0001-5027-0031; Markotter, Wanda/0000-0002-7550-0080; Hoper, Dirk/0000-0001-8408-2274	National Research Foundation; German federal ministry for education and research (BMBF) [01KI1016A]	National Research Foundation; German federal ministry for education and research (BMBF)(Federal Ministry of Education & Research (BMBF))	TS, WM and LHN would like to thank the National Research Foundation for funding. MF, BH, CF, DH and TM would like to thank the German federal ministry for education and research (BMBF, grant 01KI1016A) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNARD BJH, 1981, J S AFR VET ASSOC, V52, P309; BARNARD BJH, 1982, ONDERSTEPOORT J VET, V49, P191; BARNARD BJH, 1979, ONDERSTEPOORT J VET, V46, P155; BECK AM, 1987, AM J PUBLIC HEALTH, V77, P42, DOI 10.2105/AJPH.77.1.42; Bourhy H, 1999, J GEN VIROL, V80, P2545, DOI 10.1099/0022-1317-80-10-2545; Cherian SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030315; Cohen C, 2007, EMERG INFECT DIS, V13, P1879, DOI 10.3201/eid1312.070836; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holmes EC, 2002, VIROLOGY, V292, P247, DOI 10.1006/viro.2001.1271; HUBSCHLE OJB, 1988, REV INFECT DIS, V10, pS629; Johnson N, 2004, VET MICROBIOL, V101, P31, DOI 10.1016/j.vetmic.2004.03.007; Kuzmin IV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002786; Mansfield Karen, 2006, BMC Vet Res, V2, P2, DOI 10.1186/1746-6148-2-2; Markotter W, 2006, EMERG INFECT DIS, V12, P1913; Nel LH, 2007, CURR TOP MICROBIOL, V315, P161; Petersen B, 2012, EMERG INFECT DIS, V18, P2007; Sabeta CT, 2007, VIRUS RES, V129, P1, DOI 10.1016/j.virusres.2007.04.024; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TORDO N, 1986, P NATL ACAD SCI USA, V83, P3914, DOI 10.1073/pnas.83.11.3914	21	19	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58739	10.1371/journal.pone.0058739	http://dx.doi.org/10.1371/journal.pone.0058739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527015	gold, Green Published			2022-12-27	WOS:000317562600037
J	Bashash, M; Shah, A; Hislop, G; Treml, M; Bretherick, K; Janoo-Gilani, R; Leach, S; Le, N; Bajdik, C; Brooks-Wilson, A				Bashash, Morteza; Shah, Amil; Hislop, Greg; Treml, Martin; Bretherick, Karla; Janoo-Gilani, Rozmin; Leach, Stephen; Le, Nhu; Bajdik, Chris; Brooks-Wilson, Angela			Genetic Polymorphisms at TIMP3 Are Associated with Survival of Adenocarcinoma of the Gastroesophageal Junction	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TISSUE INHIBITOR; ESOPHAGEAL CANCER; PROMOTER METHYLATION; GASTRIC CARDIA; MATRIX; METALLOPROTEINASE-3; EXPRESSION; HYPERMETHYLATION; IDENTIFICATION	The poor survival of adenocarcinomas of the gastroesophageal junction (GEJ) makes them clinically important. Discovery of host genetic factors that affect outcome may guide more individualized treatment. This study tests whether constitutional genetic variants in matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) genes are associated with outcome of GEJ adenocarcinoma. Single nucleotide polymorphisms (SNPs) at four TIMP (TIMP1-4) and three MMP genes (MMP2, MMP7 and MMP9) were genotyped in DNA samples from a prospective cohort of patients with primary adenocarcinoma of the GEJ admitted to the British Columbia Cancer Agency. Cox proportional hazards regression, with adjustment for patient, disease and treatment variables, was used to estimate the association of SNPs with survival. Genotypes for 85 samples and 48 SNPs were analyzed. Four SNPs across TIMP3, (rs130274, rs715572, rs1962223 and rs5754312) were associated with survival. Interaction analyses revealed that the survival associations with rs715572 and rs5754312 are specific and significant for 5FU+cisplatin treated patients. Sanger sequencing of the TIMP3 coding and promoter regions revealed an additional SNP, rs9862, also associated with survival. TIMP3 genetic variants are associated with survival and may be potentially useful in optimizing treatment strategies for individual patients.	[Bashash, Morteza; Hislop, Greg; Janoo-Gilani, Rozmin; Le, Nhu; Bajdik, Chris] British Columbia Canc Agcy, Canc Control Res Program, Vancouver, BC V5Z 4E6, Canada; [Bashash, Morteza] Univ British Columbia, Interdisciplinary Oncol Program, Vancouver, BC V5Z 1M9, Canada; [Shah, Amil] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Shah, Amil] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Treml, Martin; Bretherick, Karla; Janoo-Gilani, Rozmin; Leach, Stephen; Brooks-Wilson, Angela] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Hislop, Greg; Bajdik, Chris] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Le, Nhu] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Simon Fraser University	Brooks-Wilson, A (corresponding author), British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	abrooks-wilson@bcgsc.ca	Brooks-Wilson, Angela/E-9399-2012	Brooks-Wilson, Angela/0000-0003-1009-6408; Bretherick, Karla/0000-0002-6606-802X	Canadian Cancer Society [STU-08-019764]; Michael Smith Foundation for Health Research (MSFHR); British Columbia Cancer Foundation	Canadian Cancer Society(Canadian Cancer Society (CCS)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); British Columbia Cancer Foundation	MB was supported by the Canadian Cancer Society (STU-08-019764), the Michael Smith Foundation for Health Research (MSFHR) and the British Columbia Cancer Foundation. CB and ABW are Senior Scholars of the MSFHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 1999, CANCER RES, V59, P798; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bashash M, 2008, CAN J GASTROENTEROL, V22, P143, DOI 10.1155/2008/645107; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beranek M, 2000, MOL CELL PROBE, V14, P265, DOI 10.1006/mcpr.2000.0315; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Bourboulia D, 2010, SEMIN CANC BIOL; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Comoglio PM, 2005, NAT MED, V11, P1156, DOI 10.1038/nm1105-1156; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Darnton SJ, 2005, INT J CANCER, V115, P351, DOI 10.1002/ijc.20830; Edge SB, 2010, AJCC CANC STAGING MA; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hamilton JP, 2006, CLIN GASTROENTEROL H, V4, P701, DOI 10.1016/j.cgh.2006.03.007; Jeong DH, 2006, INT J GYNECOL CANCER, V16, P1234, DOI 10.1111/j.1525-1438.2006.00522.x; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kubo A, 2002, CANCER, V95, P2096, DOI 10.1002/cncr.10940; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; Mannello F, 2001, APOPTOSIS, V6, P479, DOI 10.1023/A:1012493808790; nand-Apte B, 1996, BIOCHEMCELL BIOL, V74, P853; Nayak CS, 2007, LARYNGOSCOPE, V117, P1376, DOI 10.1097/MLG.0b013e31806865a8; Ninomiya I, 2008, ONCOL REP, V20, P1489, DOI 10.3892/or_00000170; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Peng B, 2010, MUTAGENESIS, V25, P371, DOI 10.1093/mutage/geq015; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Peterson NB, 2009, INT J CANCER, V125, P844, DOI 10.1002/ijc.24405; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Salmela MT, 2001, BRIT J CANCER, V85, P383, DOI 10.1054/bjoc.2001.1929; Sasaki S, 2008, ONCOL REP, V19, P407; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020; Spencer VA, 2007, ADV CANCER RES, V97, P275, DOI 10.1016/S0065-230X(06)97012-2; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506	37	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59157	10.1371/journal.pone.0059157	http://dx.doi.org/10.1371/journal.pone.0059157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527119	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100085
J	Guardo, AC; Alvarez-Fernandez, C; Arberas, H; Garcia-Perez, J; Garcia, F; Bargallo, ME; Maleno, MJ; Gatell, JM; Mothe, B; Alcami, J; Sanchez-Palomino, S; Plana, M				Crespo Guardo, Alberto; Alvarez-Fernandez, Carmen; Arberas, Hodei; Garcia-Perez, Javier; Garcia, Felipe; Enric Bargallo, Manuel; Jose Maleno, Maria; Maria Gatell, Jose; Mothe, Beatriz; Alcami, Jose; Sanchez-Palomino, Sonsoles; Plana, Montserrat			Use of RT-Defective HIV Virions: New Tool to Evaluate Specific Response in Chronic Asymptomatic HIV-Infected Individuals	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; VIRAL REPLICATION; PEPTIDE SETS; SUBTYPE-A; ALVAC-HIV; HLA-B; PROTEINS; IMMUNITY	Background: Generation of new reagents that can be used to screen or monitor HIV-1-specific responses constituted an interesting field in the development of HIV vaccines to improve their efficacy. Methods: We have evaluated the specific T cell response against different types of NL4-3 virions (including NL4-3 aldrithiol-2 treated, NL4-3/DRT and R5 envelopes: NL4-3/Delta RT/Delta Env[AC10] and NL4-3/Delta RT/Delta Env[Bal]) and against pools of overlapping peptides (15 mer) encompassing the HIV-1 Gag and Nef regions. Cryopreserved PBMC from a subset of 69 chronic asymptomatic HIV positive individuals have been employed using different techniques including IFN-gamma ELISPOT assay, surface activation markers and intracellular cytokine staining (ICS) by flow cytometry. Results: The differential response obtained against NL4-3 aldrithiol-2 treated and NL4-3/Delta RT virions (25% vs 55%, respectively) allow us to divide the population in three groups: "full-responders" (positive response against both viral particles), "partial-responders" (positive response only against NL4-3/Delta RT virions) and "non-responders" (negative responses). There was no difference between X4 and R5 envelopes. The magnitude of the total responses was higher against NL4-3/Delta RT and was positively correlated with gender and inverse correlated with viral load. On the contrary CD4+ T cell count was not associated with this response. In any case responses to the viruses tended to be lower in magnitude than those detected by the overlapping peptides tested. Finally we have found an increased frequency of HLA-B27 allele (23% vs 9%) and a significant reduction in some activation markers (CD69 and CD38) on T cells surface in responders vs non-responders individuals. Conclusions: In summary these virions could be considered as alternative and useful reagents for screening HIV-1-specific T cell responses in HIV exposed uninfected people, HIV infected patients and to assess immunogenicity of new prototypes both in vitro and in vaccine trials, by a feasible, simply, effective and low cost assay.	[Crespo Guardo, Alberto; Alvarez-Fernandez, Carmen; Arberas, Hodei; Enric Bargallo, Manuel; Jose Maleno, Maria; Sanchez-Palomino, Sonsoles; Plana, Montserrat] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Retrovirol & Viral Immunopathol Lab, Barcelona, Spain; [Crespo Guardo, Alberto; Alvarez-Fernandez, Carmen; Arberas, Hodei; Garcia, Felipe; Enric Bargallo, Manuel; Jose Maleno, Maria; Maria Gatell, Jose; Sanchez-Palomino, Sonsoles; Plana, Montserrat] Catalan Program HIV Vaccine Dev HIVACAT, Barcelona, Spain; [Garcia, Felipe; Maria Gatell, Jose] Univ Barcelona, Hosp Clin, IDIBAPS, Infect Dis Unit, Barcelona, Spain; [Garcia-Perez, Javier; Alcami, Jose] Inst Salud Carlos III, Natl Ctr Microbiol, AIDS Immunopathol Unit, Madrid, Spain; [Mothe, Beatriz] Hosp Badalona Germans Trias & Pujol, Inst Recerca SIDA IrsiCaixa HIVACAT, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa	Plana, M (corresponding author), Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Retrovirol & Viral Immunopathol Lab, Barcelona, Spain.	mplana@clinic.ub.es	Alcami, Pepe/T-2242-2018; García-Pérez, Javier/F-9248-2019; , Felipe/F-4242-2014; Plana, Montserrat/AAA-5124-2020	Alcami, Pepe/0000-0003-0023-7377; García-Pérez, Javier/0000-0001-7551-7803; , Felipe/0000-0001-7658-5832; Mothe, Beatriz/0000-0001-9975-407X; Alvarez-Fernandez, Carmen/0000-0003-0060-0447	RIS - Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [ISCIII-RETIC RD06/0006]; HIVACAT - Catalan Program for HIV Vaccine Development; Spanish Health Institute Carlos III (ISCIII); Health Department of the Catalan Government (Generalitat de Catalunya);  [FIS PI040503];  [FIS PI070291];  [FIS PI1200969]	RIS - Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III; HIVACAT - Catalan Program for HIV Vaccine Development; Spanish Health Institute Carlos III (ISCIII); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); ; ; 	This study was partially supported by grants FIS PI040503, FIS PI070291, FIS PI1200969, RIS - Red Tematica Cooperativa de Grupos de Investigacion en Sida del Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (ISCIII-RETIC RD06/0006), HIVACAT - Catalan Program for HIV Vaccine Development. Dr. Montserrat Plana is a researcher from the Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and is supported by the Spanish Health Institute Carlos III (ISCIII) and the Health Department of the Catalan Government (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Alvarez-Fernandez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048848; BENDER A, 1995, J EXP MED, V182, P1663, DOI 10.1084/jem.182.6.1663; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Currier JR, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-8; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gomez C, 2005, CELL MICROBIOL, V7, P621, DOI 10.1111/j.1462-5822.2005.00516.x; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Karlsson RK, 2004, J IMMUNOL METHODS, V285, P89, DOI 10.1016/j.jim.2003.11.013; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Larsson M, 2002, AIDS, V16, P1319, DOI 10.1097/00002030-200207050-00003; Lopez A, 2009, VACCINE, V27, P6166, DOI 10.1016/j.vaccine.2009.08.021; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles Stephen A., 2002, Curr Infect Dis Rep, V4, P461, DOI 10.1007/s11908-002-0014-2; Migueles SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002002; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; Paris R, 2004, TISSUE ANTIGENS, V64, P251, DOI 10.1111/j.1399-0039.2004.00270.x; Paris R, 2012, VACCINE, V30, P832, DOI 10.1016/j.vaccine.2011.11.002; Plana M, 2004, JAIDS-J ACQ IMM DEF, V36, P791, DOI 10.1097/00126334-200407010-00005; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Russell ND, 2003, J INFECT DIS, V187, P226, DOI 10.1086/367702; Rutebemberwa A, 2007, AIDS RES HUM RETROV, V23, P532, DOI 10.1089/aid.2006.0136; Sabado RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004256; Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181; Shacklett BL, 2002, CLIN EXP IMMUNOL, V130, P172, DOI 10.1046/j.1365-2249.2002.01981.x; Sun Y, 2003, J IMMUNOL METHODS, V272, P23, DOI 10.1016/S0022-1759(02)00328-9; Trigona WL, 2003, J INTERF CYTOK RES, V23, P369, DOI 10.1089/107999003322226023; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x	48	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58927	10.1371/journal.pone.0058927	http://dx.doi.org/10.1371/journal.pone.0058927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516578	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400077
J	Kim, JH; Yoon, YJ; Lee, J; Choi, EJ; Yi, N; Park, KS; Park, J; Lotvall, J; Kim, YK; Gho, YS				Kim, Ji Hyun; Yoon, Yae Jin; Lee, Jaewook; Choi, Eun-Jeong; Yi, Namwoo; Park, Kyong-Su; Park, Jaesung; Lotvall, Jan; Kim, Yoon-Keun; Gho, Yong Song			Outer Membrane Vesicles Derived from Escherichia coli Up-Regulate Expression of Endothelial Cell Adhesion Molecules In Vitro and In Vivo	PLOS ONE			English	Article							MULTIPLE ORGAN DYSFUNCTION; INNATE IMMUNE-RESPONSE; LEUKOCYTE ADHESION; EPITHELIAL-CELLS; E-SELECTIN; PSEUDOMONAS-AERUGINOSA; NEUTROPHIL MIGRATION; LIPOPOLYSACCHARIDE; INFLAMMATION; SEPSIS	Escherichia coli, as one of the gut microbiota, can evoke severe inflammatory diseases including peritonitis and sepsis. Gram-negative bacteria including E. coli constitutively release nano-sized outer membrane vesicles (OMVs). Although E. coli OMVs can induce the inflammatory responses without live bacteria, the effect of E. coli OMVs in vivo on endothelial cell function has not been previously elucidated. In this study, we show that bacteria-free OMVs increased the expression of endothelial intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1, and enhanced the leukocyte binding on human microvascular endothelial cells in vitro. Inhibition of NF-kappa B and TLR4 reduced the expression of cell adhesion molecules in vitro. OMVs given intraperitoneally to the mice induced ICAM-1 expression and neutrophil sequestration in the lung endothelium, and the effects were reduced in ICAM-1(-/-) and TLR4(-/-) mice. When compared to free lipopolysaccharide, OMVs were more potent in inducing both ICAM-1 expression as well as leukocyte adhesion in vitro, and ICAM-1 expression and neutrophil sequestration in the lungs in vivo. This study shows that OMVs potently up-regulate functional cell adhesion molecules via NF-kappa B- and TLR4-dependent pathways, and that OMVs are more potent than free lipopolysaccharide.	[Kim, Ji Hyun; Lee, Jaewook; Choi, Eun-Jeong; Park, Kyong-Su; Kim, Yoon-Keun; Gho, Yong Song] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea; [Yoon, Yae Jin] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Yi, Namwoo; Park, Jaesung] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, South Korea; [Lotvall, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med,Krefting Res Ctr, Gothenburg, Sweden	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Gothenburg	Kim, YK (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea.	juinea@postech.ac.kr; ysgho@postech.ac.kr	Lee, Jaewook/AAO-9331-2020	Lotvall, Jan/0000-0001-9195-9249	Korean Ministry of Education, Science and Technology [FPR08B1-240]; National Research Foundation of Korea (NRF); Korea government (MEST) [20120005634]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the Korean Ministry of Education, Science and Technology, FPR08B1-240 of the 21C Frontier Functional Proteomics Program, and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 20120005634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGACE WW, 1995, INFECT IMMUN, V63, P4054, DOI 10.1128/IAI.63.10.4054-4062.1995; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Batra S, 2012, J IMMUNOL, V188, P3458, DOI 10.4049/jimmunol.1101985; Baumgarten G, 2006, EUR J ANAESTH, V23, P1041, DOI 10.1017/S0265021506001098; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Cook-Mills JM, 2005, J LEUKOCYTE BIOL, V77, P487, DOI 10.1189/jlb.0904554; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; DRAKE TA, 1993, AM J PATHOL, V142, P1458; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Harding M, 2012, CURR OPIN MICROBIOL, V15, P85, DOI 10.1016/j.mib.2011.11.010; Hilbert DW, 2008, MICROBES INFECT, V10, P114, DOI 10.1016/j.micinf.2007.10.012; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee HM, 2010, BIOCHEM BIOPH RES CO, V397, P251, DOI 10.1016/j.bbrc.2010.05.094; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; May AK, 2000, INFECT IMMUN, V68, P176, DOI 10.1128/IAI.68.1.176-183.2000; Mirlashari MR, 2002, APMIS, V110, P193, DOI 10.1034/j.1600-0463.2002.100301.x; Mirlashari MR, 2002, PLATELETS, V13, P91, DOI 10.1080/09537100220122448; Namork E, 2002, LANCET, V360, P1741, DOI 10.1016/S0140-6736(02)11721-1; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Shin TS, 2010, ALLERGY, V65, P1256, DOI 10.1111/j.1398-9995.2010.02359.x; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Srisatjaluk R, 1999, MICROB PATHOGENESIS, V27, P81, DOI 10.1006/mpat.1999.0287; Winzer K, 2003, NAT MED, V9, P1118, DOI 10.1038/nm0903-1118; Xu HL, 2010, J PATHOL, V220, P490, DOI 10.1002/path.2666	41	28	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59276	10.1371/journal.pone.0059276	http://dx.doi.org/10.1371/journal.pone.0059276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516621	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400105
J	Choi, SJ; Shin, IJ; Je, KH; Min, EK; Kim, EJ; Kim, HS; Choe, S; Kim, DE; Lee, DK				Choi, Sung Ji; Shin, Ik Jae; Je, Kang-Hoon; Min, Eun Kyoung; Kim, Eun Ji; Kim, Hee-Sun; Choe, Senyon; Kim, Dong-Eog; Lee, Dong Kun			Hypoxia Antagonizes Glucose Deprivation on Interleukin 6 Expression in an Akt Dependent, but HIF-1/2 alpha Independent Manner	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; INFLAMMATORY RESPONSE; GENE-EXPRESSION; BRAIN; INDUCTION; RECEPTOR; CELLS; NEUROPROTECTION	Although both glucose deprivation and hypoxia have been reported to promote cascades of biological alterations that lead to induction of inflammatory mediators, we hypothesized that glucose deprivation and hypoxia might show neutral, synergistic or antagonistic effects to each other on gene expression of inflammatory mediators depending on the regulatory components in their promoters. Gene expression of interleukin 6 (IL-6) was analyzed by real-time PCR, ELISA, or Western blot. Effects of glucose deprivation and/or hypoxia on activation of signaling pathways were analyzed by time-dependent phosphorylation patterns of signaling molecules. We demonstrate that hypoxia antagonized the effects of glucose deprivation on induction of IL-6 gene expression in microglia, macrophages, and monocytes. Hypoxia also antagonized thapsigargin-induced IL-6 gene expression. Hypoxia enhanced phosphorylation of Akt, and inhibition of Akt was able to reverse the effects of hypoxia on IL-6 gene expression. However, inhibition of HIF-1/2 alpha did not reverse the effects of hypoxia on IL-6 gene expression. In addition, phosphorylation of p38, but not JNK, was responsible for the effects of glucose deprivation on IL-6 gene expression.	[Choi, Sung Ji; Min, Eun Kyoung; Kim, Eun Ji; Choe, Senyon; Lee, Dong Kun] Joint Ctr Biosci, Lab Genome Drug Med, Inchon, South Korea; [Shin, Ik Jae; Je, Kang-Hoon; Kim, Dong-Eog] Dongguk Univ, Ilsan Hosp, Dept Neurol, Mol Imaging & Neurovasc Res MINER Lab, Goyang, South Korea; [Kim, Hee-Sun] Ewha Womans Univ, Coll Med, Dept Neurosci, Seoul, South Korea	Dongguk University; NHIS Ilsan Hospital; Ewha Womans University	Kim, DE (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Neurol, Mol Imaging & Neurovasc Res MINER Lab, Goyang, South Korea.	kdongeog@duih.org; dklee.jcb@gmail.com		Shin, Ikjae/0000-0001-6582-8827	IFEZ; Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs [A101904]	IFEZ; Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs	This study was supported by IFEZ and a grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs (A101904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Deguchi JO, 2009, ARTERIOSCL THROM VAS, V29, P1664, DOI 10.1161/ATVBAHA.109.194043; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Faggioli L, 1997, EUR J IMMUNOL, V27, P3022, DOI 10.1002/eji.1830271140; Fitzgerald JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030712; Fougeray S, 2011, Cell Death Dis, V2, pe143, DOI 10.1038/cddis.2011.26; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Ishibashi N, 2002, J IMMUNOL, V168, P1926, DOI 10.4049/jimmunol.168.4.1926; Jung JE, 2011, STROKE, V42, P3574, DOI 10.1161/STROKEAHA.111.626648; Kaluz S, 2008, CLIN CHIM ACTA, V395, P6, DOI 10.1016/j.cca.2008.05.002; Kim NG, 2003, MOL BRAIN RES, V114, P107, DOI 10.1016/S0169-328X(03)00135-9; Kitamura Y, 2004, J PHARMACOL SCI, V94, P203, DOI 10.1254/jphs.94.203; Klausen T, 1997, EUR J APPL PHYSIOL, V76, P480, DOI 10.1007/s004210050278; Kraskiewicz H, 2012, TRENDS PHARMACOL SCI, V33, P53, DOI 10.1016/j.tips.2011.10.002; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lee DK, 2012, CELL PHYSIOL BIOCHEM, V30, P499, DOI 10.1159/000341433; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; McNay EC, 2006, DIABETES, V55, P1088, DOI 10.2337/diabetes.55.04.06.db05-1314; Montero M, 2002, FASEB J, V16, P1955, DOI 10.1096/fj.02-0553fje; Olli K, 2013, BRIT J NUTR, V109, P43, DOI 10.1017/S0007114512000888; Pan H, 2012, BIOCHEM BIOPH RES CO, V420, P685, DOI 10.1016/j.bbrc.2012.03.069; Peters LR, 2011, J IMMUNOL, V187, P919, DOI 10.4049/jimmunol.1100690; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Urner M, 2012, CLIN EXP IMMUNOL, V169, P119, DOI 10.1111/j.1365-2249.2012.04595.x; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang MJ, 2001, J NEUROIMMUNOL, V112, P28, DOI 10.1016/S0165-5728(00)00374-X; Whiteley W, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000145; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamada K, 2002, NEWS PHYSIOL SCI, V17, P127, DOI 10.1152/nips.01384.2001; Yamada KA, 2004, PEDIATR RES, V55, P372, DOI 10.1203/01.PDR.0000110523.07240.C1; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yuskaitis CJ, 2009, CELL SIGNAL, V21, P264, DOI 10.1016/j.cellsig.2008.10.014	46	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58662	10.1371/journal.pone.0058662	http://dx.doi.org/10.1371/journal.pone.0058662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520526	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900086
J	Lane, KR; Yu, YB; Lackey, PE; Chen, X; Marzluff, WF; Cook, JG				Lane, Karen R.; Yu, Yanbao; Lackey, Patrick E.; Chen, Xian; Marzluff, William F.; Cook, Jeanette Gowen			Cell Cycle-Regulated Protein Abundance Changes in Synchronously Proliferating HeLa Cells Include Regulation of Pre-mRNA Splicing Proteins	PLOS ONE			English	Article							LOOP BINDING-PROTEIN; DNA-REPLICATION; QUANTITATIVE PHOSPHOPROTEOMICS; TRIGGERS DEGRADATION; UBIQUITIN LIGASE; CDT1 DEGRADATION; HNRNP A1; END; PHOSPHORYLATION; IDENTIFICATION	Cell proliferation involves dramatic changes in DNA metabolism and cell division, and control of DNA replication, mitosis, and cytokinesis have received the greatest attention in the cell cycle field. To catalogue a wider range of cell cycle-regulated processes, we employed quantitative proteomics of synchronized HeLa cells. We quantified changes in protein abundance as cells actively progress from G1 to S phase and from S to G2 phase. We also describe a cohort of proteins whose abundance changes in response to pharmacological inhibition of the proteasome. Our analysis reveals not only the expected changes in proteins required for DNA replication and mitosis but also cell cycle-associated changes in proteins required for biological processes not known to be cell-cycle regulated. For example, many pre-mRNA alternative splicing proteins are down-regulated in S phase. Comparison of this dataset to several other proteomic datasets sheds light on global mechanisms of cell cycle phase transitions and underscores the importance of both phosphorylation and ubiquitination in cell cycle changes.	[Lane, Karen R.; Marzluff, William F.; Cook, Jeanette Gowen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Yu, Yanbao; Lackey, Patrick E.; Chen, Xian; Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Chen, Xian; Cook, Jeanette Gowen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Marzluff, William F.] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cook, JG (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	jgcook@email.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Yu, Yanbao/G-3035-2010	Yu, Yanbao/0000-0003-2994-1974; Cook, Jeanette/0000-0003-0849-7405	NCI Center Core Support Grant [P30CA06086]; University Cancer Research Fund; United States National Institutes of Health (NIH) [R01AI064806, 1U24CA160035]; NIH [GM29832, GM083024]; NATIONAL CANCER INSTITUTE [U24CA160035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083024, R01GM029832] Funding Source: NIH RePORTER	NCI Center Core Support Grant; University Cancer Research Fund; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Flow cytometry was performed in the Flow Cytometry Core Facility at the University of North Carolina at Chapel Hill which is supported in part by an NCI Center Core Support Grant (P30CA06086) to the UNC Lineberger Comprehensive Cancer Center. A portion of this work was supported by a pilot grant from the University Cancer Research Fund. XC is supported by United States National Institutes of Health (NIH) R01AI064806 and 1U24CA160035. WFM is supported by NIH GM29832. JGC is supported by NIH GM083024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011429; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chen X, 2000, ANAL CHEM, V72, P1134, DOI 10.1021/ac9911600; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; Han YH, 2009, ONCOL REP, V22, P215, DOI 10.3892/or_00000427; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Koseoglu MM, 2008, MOL CELL BIOL, V28, P4469, DOI 10.1128/MCB.01416-07; Koseoglu MM, 2010, CELL CYCLE, V9, P3857, DOI 10.4161/cc.9.19.13300; Lam BJ, 2002, RNA, V8, P1233, DOI 10.1017/S1355838202028030; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McCormack PL, 2012, DRUGS; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Takahashi Y, 2000, GENE DEV, V14, P804; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; TSUBUKI S, 1993, BIOCHEM BIOPH RES CO, V196, P1195, DOI 10.1006/bbrc.1993.2378; Vij R, 2012, BRIT J HAEMATOL, V158, P739, DOI 10.1111/j.1365-2141.2012.09232.x; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003; Zhu HN, 2002, RAPID COMMUN MASS SP, V16, P2115, DOI 10.1002/rcm.831; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	67	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58456	10.1371/journal.pone.0058456	http://dx.doi.org/10.1371/journal.pone.0058456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520512	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900071
J	Acerbi, A; Lampos, V; Garnett, P; Bentley, RA				Acerbi, Alberto; Lampos, Vasileios; Garnett, Philip; Bentley, R. Alexander			The Expression of Emotions in 20th Century Books	PLOS ONE			English	Article							RANDOM DRIFT; EVOLUTION; LANGUAGE; DIVERSITY; RATES	We report here trends in the usage of "mood" words, that is, words carrying emotional content, in 20th century English language books, using the data set provided by Google that includes word frequencies in roughly 4% of all books published up to the year 2008. We find evidence for distinct historical periods of positive and negative moods, underlain by a general decrease in the use of emotion-related words through time. Finally, we show that, in books, American English has become decidedly more "emotional" than British English in the last half-century, as a part of a more general increase of the stylistic divergence between the two variants of English language.	[Acerbi, Alberto; Bentley, R. Alexander] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Acerbi, Alberto] Stockholm Univ, Ctr Study Cultural Evolut, S-10691 Stockholm, Sweden; [Lampos, Vasileios] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Garnett, Philip] Univ Durham, Dept Anthropol, Durham, England	University of Bristol; Stockholm University; University of Sheffield; Durham University	Acerbi, A (corresponding author), Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England.	alberto.acerbi@gmail.com	Bentley, R Alexander/GWZ-8982-2022; Garnett, Philip/H-1909-2012	Garnett, Philip/0000-0001-6651-0220; Acerbi, Alberto/0000-0001-5827-8003; Lampos, Vasileios/0000-0001-8555-2063; Bentley, R. Alexander/0000-0001-9086-2197	Leverhulme Trust; Swedish Research Council; "Uniquely Human" project; TrendMiner project (EU-FP7-ICT) [287863]; Newton International Fellowship	Leverhulme Trust(Leverhulme Trust); Swedish Research Council(Swedish Research CouncilEuropean Commission); "Uniquely Human" project; TrendMiner project (EU-FP7-ICT); Newton International Fellowship	This research was partially supported by the Leverhulme Trust "Tipping Points" program. A. Acerbi was initially supported by the "Uniquely Human" project funded by the Swedish Research Council, and then by a Newton International Fellowship. V. Lampos acknowledges the support from the TrendMiner project (EU-FP7-ICT n.287863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032541; Acerbi A, 2009, P NATL ACAD SCI USA, V106, P18931, DOI 10.1073/pnas.0908889106; Agarwal A., 2011, P WORKSHOP LANGUAGES, P30; Altmann EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019009; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Bentley RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047966; Bentley RA, 2010, SOC SCI MED, V71, P482, DOI 10.1016/j.socscimed.2010.03.042; Bentley RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003057; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Berger J, 2009, P NATL ACAD SCI USA, V106, P8146, DOI 10.1073/pnas.0812647106; Calvo RA, 2010, IEEE T AFFECT COMPUT, V1, P18, DOI 10.1109/T-AFFC.2010.1; Chaumartin F, 2007, PROC 4 INT WORKSHOP, P422, DOI DOI 10.3115/1621474.1621568; DeWall CN, 2011, PSYCHOL AESTHET CREA, V5, P200, DOI 10.1037/a0023195; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Fortunato L, 2010, PHILOS T R SOC B, V365, P3913, DOI 10.1098/rstb.2010.0017; Go A., 2009, CS224N PROJECT REPOR, V1; Hahn MW., 2003, P R SOC LOND B, V270, pS1, DOI [10.1098/rspb.2002.2234, DOI 10.1098/RSPB.2002.2234]; Hu X., 2009, AM MUSIC, V183, P2; Hughes JM, 2012, P NATL ACAD SCI USA, V109, P7682, DOI 10.1073/pnas.1115407109; Lansdall-Welfare T., 2012, P 21 INT C WORLD WID, P1221, DOI [10.1145/2187980.2188264, DOI 10.1145/2187980.2188264]; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; Mateos P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022943; Mesoudi A, 2006, BEHAV BRAIN SCI, V29, P329, DOI 10.1017/S0140525X06009083; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Nettle D, 1999, P NATL ACAD SCI USA, V96, P3325, DOI 10.1073/pnas.96.6.3325; Nettle D, 2007, P NATL ACAD SCI USA, V104, P10755, DOI 10.1073/pnas.0704517104; Neviarouskaya A, 2007, LECT NOTES COMPUT SC, V4738, P218; Nichols J, 2008, CURR ANTHROPOL, V49, P1107, DOI 10.1086/592436; O'Connor B, 2012, P INT AAI C WEBL SOC; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pak A, 2010, LREC, V10, P1320, DOI DOI 10.17148/IJARCCE.2016.51274; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Roberts K, 2012, BIOMED INFORM INSIGH, V5, P195, DOI 10.4137/BII.S8958; Saavedra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026705; Saavedra S, 2011, P NATL ACAD SCI USA, V108, P5296, DOI 10.1073/pnas.1018462108; Schellenberg EG, 2012, PSYCHOL AESTHET CREA, V6, P196, DOI 10.1037/a0028024; Shapiro J, 2012, NEW YORK TIMES  0715, P14; Sperber Dan, 1996, EXPLAINING CULTURE N; Strapparava C, 2006, LREC, P423; Strapparava C, 2004, P 4 INT C LANG RES E, P1413; Strapparava C, 2008, APPLIED COMPUTING 2008, VOLS 1-3, P1556; Twenge JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040181; Weinberger D, 2011, SCI AM, V305, P52, DOI 10.1038/scientificamerican1211-52	47	68	69	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59030	10.1371/journal.pone.0059030	http://dx.doi.org/10.1371/journal.pone.0059030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527080	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000317562600052
J	Lu, CC; Chen, TH; Wu, JR; Chen, HH; Yu, HY; Tarn, WY				Lu, Chia-Chen; Chen, Tz-Hao; Wu, Jhe-Rong; Chen, Hung-Hsi; Yu, Hsin-Yi; Tarn, Woan-Yuh			Phylogenetic and Molecular Characterization of the Splicing Factor RBM4	PLOS ONE			English	Article							SR PROTEIN; RNA; SEQUENCES; LARK	The mammalian multi-functional RNA-binding motif 4 (RBM4) protein regulates alterative splicing of precursor mRNAs and thereby affects pancreas and muscle cell differentiation. RBM4 homologs exist in all metazoan lineages. The C-terminal unstructured domain of RBM4 is evolutionarily divergent and contains stretches of low-complexity sequences, including single amino acid and/or dipeptide repeats. Here we examined the splicing activity, phosphorylation potential, and subcellular localization of RBM4 homologs from a wide range of species. The results show that these RBM4 homologs exert different effects on 59 splice site utilization and exon selection, and exhibit different subnuclear localization patterns. Therefore, the C-terminal domain of RBM4 may contribute to functional divergence between homologs. On the other hand, analysis of chimeric human RBM4 proteins containing heterologous sequences at the C-terminus revealed that the N-terminal RNA binding domain of RBM4 could have a dominant role in determining splicing outcome. Finally, all RBM4 homologs examined could be phosphorylated by an SR protein kinase, suggesting that they are regulated by a conserved mechanism in different species. This study offers a first clue to functional evolution of a splicing factor.	[Lu, Chia-Chen; Chen, Tz-Hao; Wu, Jhe-Rong; Chen, Hung-Hsi; Yu, Hsin-Yi; Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Tarn, WY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	wtarn@ibms.sinica.edu.tw	Tarn, Woan-Yuh/N-8464-2018		National Science Council of Taiwan [NSC 100-2311-B-001-011-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC 100-2311-B-001-011-MY3 of the National Science Council of Taiwan (http://web1.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Hsu IW, 2005, J BIOL CHEM, V280, P34507, DOI 10.1074/jbc.M507658200; Huang YM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001107; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Kar A, 2006, J BIOL CHEM, V281, P24479, DOI 10.1074/jbc.M603971200; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lavoie H, 2003, HUM MOL GENET, V12, P2967, DOI 10.1093/hmg/ddg329; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lin Jung-Chun, 2012, Front Biosci (Schol Ed), V4, P181; Lin JC, 2011, J CELL BIOL, V193, P509, DOI 10.1083/jcb.201007131; Lin JC, 2009, J BIOL CHEM, V284, P34658, DOI 10.1074/jbc.M109.032946; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Markus MA, 2006, DNA CELL BIOL, V25, P457, DOI 10.1089/dna.2006.25.457; Markus MA, 2009, INT J BIOCHEM CELL B, V41, P740, DOI 10.1016/j.biocel.2008.05.027; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Suzuki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016880	21	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59092	10.1371/journal.pone.0059092	http://dx.doi.org/10.1371/journal.pone.0059092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527094	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100073
J	James, ER; Okamoto, N; Burki, F; Scheffrahn, RH; Keeling, PJ				James, Erick R.; Okamoto, Noriko; Burki, Fabien; Scheffrahn, Rudolf H.; Keeling, Patrick J.			Cthulhu Macrofasciculumque n. g., n. sp and Cthylla Microfasciculumque n. g., n. sp., a Newly Identified Lineage of Parabasalian Termite Symbionts	PLOS ONE			English	Article							PHYLOGENETIC POSITION; MOLECULAR PHYLOGENY; SEQUENCE ALIGNMENT; MORPHOLOGY; HYPERMASTIGIDA; TERMOPSIDIS; FLAGELLATE	The parabasalian symbionts of lower termite hindgut communities are well-known for their large size and structural complexity. The most complex forms evolved multiple times independently from smaller and simpler flagellates, but we know little of the diversity of these small flagellates or their phylogenetic relationships to more complex lineages. To understand the true diversity of Parabasalia and how their unique cellular complexity arose, more data from smaller and simpler flagellates are needed. Here, we describe two new genera of small-to-intermediate size and complexity, represented by the type species Cthulhu macrofasciculumque and Cthylla microfasciculumque from Prorhinotermes simplex and Reticulitermes virginicus, respectively (both hosts confirmed by DNA barcoding). Both genera have a single anterior nucleus embeded in a robust protruding axostyle, and an anterior bundle flagella (and likely a single posterior flagellum) that emerge slightly subanteriorly and have a distinctive beat pattern. Cthulhu is relatively large and has a distinctive bundle of over 20 flagella whereas Cthylla is smaller, has only 5 anterior flagella and closely resembles several other parababsalian genera. Molecular phylogenies based on small subunit ribosomal RNA (SSU rRNA) show both genera are related to previously unidentified environmental sequences from other termites (possibly from members of the Tricercomitidae), which all branch as sisters to the Hexamastigitae. Altogether, Cthulhu likely represents another independent origin of relatively high cellular complexity within parabasalia, and points to the need for molecular characterization of other key taxa, such as Tricercomitus.	[James, Erick R.; Okamoto, Noriko; Burki, Fabien; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada; [Scheffrahn, Rudolf H.] Univ Florida, Res & Educ Ctr, Davie, FL USA	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; State University System of Florida; University of Florida	Keeling, PJ (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada.	pkeeling@mail.ubc.ca	James, Erick R/D-4725-2012; Burki, Fabien/F-4818-2010	Burki, Fabien/0000-0002-8248-8462; Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Research Council of Canada [227301]; Tula Foundation; Terminix International	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tula Foundation; Terminix International	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (227301) and a grant from the Tula Foundation to the Centre for Microbial Diversity and Evolution. Specimens of P. simplex were collected as part of a Caribbean Basin survey of termite diversity funded by Terminix International. PJK is a Fellow of the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUGEROLLE G, 1991, PROTOPLASMA, V164, P70, DOI 10.1007/BF01320816; Brugerolle G, 2001, EUR J PROTISTOL, V37, P103, DOI 10.1078/0932-4739-00814; Brugerolle G., 1977, Proceedings of the 5th International Congress of Protozoology, New York, 26 June - 2 July 1977., P14; Brugerolle Guy, 2002, P1196; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carpenter KJ, 2007, J EUKARYOT MICROBIOL, V54, P325, DOI 10.1111/j.1550-7408.2007.00263.x; Carpenter KJ, 2009, J EUKARYOT MICROBIOL, V56, P305, DOI 10.1111/j.1550-7408.2009.00406.x; Cepicka I, 2010, PROTIST, V161, P400, DOI 10.1016/j.protis.2009.11.005; CLEVELAND LR, 1934, MEM AM ACAD ARTS, V17, P1; Dolan MF, 2000, ACTA PROTOZOOL, V39, P275; Gile GH, 2011, INT J SYST EVOL MICR, V61, P2547, DOI 10.1099/ijs.0.028480-0; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grasse P.-P., 1945, ANN SCI NAT ZOOL, V11, P147; Grassi B, 1917, ATTI R ACCAD LINCE 5, V12, P331; Guindon S, 2003, SYST BIOL, V61, P539; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Keelig PJ, 2002, EUR J PROTISTOL, V38, P279, DOI 10.1078/0932-4739-00874; Kirby H., 1942, University of California Publications in Zoology, V45, P93; Kirby H, 1939, P CAL ACAD SCI, V22, P270; KIRBY HAROLD, 1929, UNIV CALIFORNIA PUBL ZOOL, V31, P417; Kirby Harold, 1944, UNIV CALIFORNIA PUBL ZOOL, V49, P185; KIRBY HAROLD, 1932, UNIV CALIFORNIA PUBL ZOOL, V37, P349; KIRBY HAROLD, 1930, UNIV CALIFORNIA PUBL ZOOL, V33, P393; Maass A, 2006, EUR J PROTISTOL, V42, P125, DOI 10.1016/j.ejop.2006.03.001; Noda S, 2009, MOL PHYLOGENET EVOL, V52, P217, DOI 10.1016/j.ympev.2009.03.011; NYLANDER J.A.A., 2004, MRAIC PL PROGRAM DIS; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saldarriaga JF, 2011, J EUKARYOT MICROBIOL, V58, P487, DOI 10.1111/j.1550-7408.2011.00575.x; Trager W, 1934, BIOL BULL-US, V66, P182, DOI 10.2307/1537331; Yamin M.A., 1979, Sociobiology, V4, P1	30	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58509	10.1371/journal.pone.0058509	http://dx.doi.org/10.1371/journal.pone.0058509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526991	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600008
J	Biedermann, L; Zeitz, J; Mwinyi, J; Sutter-Minder, E; Rehman, A; Ott, SJ; Steurer-Stey, C; Frei, A; Frei, P; Scharl, M; Loessner, MJ; Vavricka, SR; Fried, M; Schreiber, S; Schuppler, M; Rogler, G				Biedermann, Luc; Zeitz, Jonas; Mwinyi, Jessica; Sutter-Minder, Eveline; Rehman, Ateequr; Ott, Stephan J.; Steurer-Stey, Claudia; Frei, Anja; Frei, Pascal; Scharl, Michael; Loessner, Martin J.; Vavricka, Stephan R.; Fried, Michael; Schreiber, Stefan; Schuppler, Markus; Rogler, Gerhard			Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; PHYLOGENETIC DIVERSITY; ENVIRONMENTAL-FACTORS; CLINICAL-COURSE; GUT MICROBIOME; IMMUNE-SYSTEM; WEIGHT-GAIN; OBESITY; ECOLOGY	Background: The human intestinal microbiota is a crucial factor in the pathogenesis of various diseases, such as metabolic syndrome or inflammatory bowel disease (IBD). Yet, knowledge about the role of environmental factors such as smoking (which is known to influence theses aforementioned disease states) on the complex microbial composition is sparse. We aimed to investigate the role of smoking cessation on intestinal microbial composition in 10 healthy smoking subjects undergoing controlled smoking cessation. Methods: During the observational period of 9 weeks repetitive stool samples were collected. Based on abundance of 16S rRNA genes bacterial composition was analysed and compared to 10 control subjects (5 continuing smokers and 5 non-smokers) by means of Terminal Restriction Fragment Length Polymorphism analysis and high-throughput sequencing. Results: Profound shifts in the microbial composition after smoking cessation were observed with an increase of Firmicutes and Actinobacteria and a lower proportion of Bacteroidetes and Proteobacteria on the phylum level. In addition, after smoking cessation there was an increase in microbial diversity. Conclusions: These results indicate that smoking is an environmental factor modulating the composition of human gut microbiota. The observed changes after smoking cessation revealed to be similar to the previously reported differences in obese compared to lean humans and mice respectively, suggesting a potential pathogenetic link between weight gain and smoking cessation. In addition they give rise to a potential association of smoking status and the course of IBD.	[Biedermann, Luc; Mwinyi, Jessica; Frei, Pascal; Scharl, Michael; Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Zeitz, Jonas] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland; [Mwinyi, Jessica] Univ Zurich Hosp, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Sutter-Minder, Eveline; Loessner, Martin J.; Schuppler, Markus] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland; [Rehman, Ateequr; Ott, Stephan J.; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Ott, Stephan J.; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Div Gen Internal Med, Kiel, Germany; [Steurer-Stey, Claudia; Frei, Anja] Univ Zurich, Inst Gen Practice, Zurich, Switzerland; [Steurer-Stey, Claudia; Frei, Anja] Univ Zurich Hosp, Smoking Consulting Programme, CH-8091 Zurich, Switzerland; [Vavricka, Stephan R.] Hosp Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Zurich; University of Zurich; University Zurich Hospital; Triemli Hospital	Rogler, G (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	gerhard.rogler@usz.ch	Rogler, Gerhard/O-5308-2015; Rehman, Ateequr/O-3727-2016; Biedermann, Luc/J-2654-2017; Hofmann, Martina/ABB-7916-2020; Schuppler, Markus/B-3713-2016; Ott, Stephan J/G-1965-2010; Loessner, Martin J/B-4316-2012	Rogler, Gerhard/0000-0002-1733-9188; Rehman, Ateequr/0000-0002-5664-4628; Loessner, Martin J/0000-0002-8162-2631; Frei, Anja/0000-0002-7134-1000; Scharl, Michael/0000-0002-6729-1469	Swiss National Science Foundation [320000-114009/1, 310030-120312]; Swiss IBD Cohort [3347CO-108792]; Zurich Centre for Integrative Human Physiology of the University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort; Zurich Centre for Integrative Human Physiology of the University of Zurich	This research was supported by research grants from the Swiss National Science Foundation to SRV (Grant No 320000-114009/1), to GR (Grant No. 310030-120312) and the Swiss IBD Cohort (Grant No. 3347CO-108792), and by the Zurich Centre for Integrative Human Physiology of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Beaugerie L, 2001, AM J GASTROENTEROL, V96, P2113, DOI 10.1016/S0002-9270(01)02507-2; Birrenbach T, 2004, INFLAMM BOWEL DIS, V10, P848, DOI 10.1097/00054725-200411000-00019; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Codling C, 2010, DIGEST DIS SCI, V55, P392, DOI 10.1007/s10620-009-0934-x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cosnes J, 2006, ACTA ENDOSC, V36, P679, DOI 10.1007/BF03018510; Cosnes J, 1996, GASTROENTEROLOGY, V110, P424, DOI 10.1053/gast.1996.v110.pm8566589; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; DALLOSSO HM, 1984, INT J OBESITY, V8, P365; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faith DP, 2004, CONSERV BIOL, V18, P255, DOI 10.1111/j.1523-1739.2004.00330.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Ferrara CM, 2001, INT J OBESITY, V25, P1322, DOI 10.1038/sj.ijo.0801716; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HOLDSTOCK G, 1984, BRIT MED J, V288, P362, DOI 10.1136/bmj.288.6414.362; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LINDBERG E, 1992, GUT, V33, P779, DOI 10.1136/gut.33.6.779; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Minh BQ, 2006, SYST BIOL, V55, P769, DOI 10.1080/10635150600981604; Nos P, 2011, WORLD J GASTROENTERO, V17, P3567, DOI 10.3748/wjg.v17.i31.3567; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; RODIN J, 1987, ADDICT BEHAV, V12, P303, DOI 10.1016/0306-4603(87)90045-1; Seksik P, 2009, INFLAMM BOWEL DIS, V15, P734, DOI 10.1002/ibd.20828; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stamler J, 1997, AM J CLIN NUTR, V65, P374; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wu GD, 2011, SCIENCE	42	242	249	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59260	10.1371/journal.pone.0059260	http://dx.doi.org/10.1371/journal.pone.0059260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516617	Green Accepted, Green Published, gold			2022-12-27	WOS:000316407400102
J	Bohringer, D; Lang, S; Reinhard, T				Boehringer, Daniel; Lang, Stefan; Reinhard, Thomas			Cell-by-Cell Alignment of Repeated Specular Microscopy Images from the Same Eye	PLOS ONE			English	Article							CORNEAL ENDOTHELIUM; CLINICAL-TRIALS	Purpose: Modern specular microscopes (SM) robustly depict the same central area of the corneal endothelium at different time points through a built-in fixation light. However, repeated image acquisitions slightly shift and rotate because of minute changes in head position in the chin and forehead rest. This prevents the manual retrieval of individual corneal endothelial cells (CECs) in repeated measurements because SM images usually lack obvious landmarks. We devised and validated an image registration algorithm that aligns SM images from the same eye to make corresponding CECs coincide. Methods: We retrospectively selected 27 image pairs for the presence of significant image overlap. Each image pair had been recorded on the same day and of the same eye. We applied our registration method in each image pair. Two observers independently validated, by means of alternation flicker, that the image pairs had been correctly aligned. We also repeatedly applied our registration method on unrelated image pairs by randomly drawing images and making certain that the images did not originate from the same eye. This was done to assess the specifity of our method. Results: All automated registrations of the same-day and same-eye image pairs were accurate. However, one single image incorrectly failed to trigger the non-match diagnosis twice in 81 registration attempts between unrelated images. As it turned out, this particular image depicted only 73 CECs. The average number of CECs was 253 (range 73-393). Conclusion: Repeated non-contact SM images can be automatedly aligned so that the corresponding CECs coincide. Any successful alignment can be considered as proof of the retrieval of identical CECs as soon as at least 100 CEC centroids have been identified. We believe our method is the first to robustly confirm endothelial stability in individual eyes.	[Boehringer, Daniel; Lang, Stefan; Reinhard, Thomas] Univ Eye Hosp, Cornea Reading Ctr, Freiburg, Germany	University of Freiburg	Bohringer, D (corresponding author), Univ Eye Hosp, Cornea Reading Ctr, Freiburg, Germany.	daniel.boehringer@uniklinik-freiburg.de	Lang, Stefan J./I-5169-2019	Lang, Stefan J./0000-0002-5324-7002				Abib FC, 2012, CORNEA, V31, P546, DOI 10.1097/ICO.0b013e3181cc7961; Berger JW, 2000, OPHTHALMOLOGY, V107, P1316, DOI 10.1016/S0161-6420(00)00157-3; Bohringer D, 2012, KLIN MONATSBL AUGENH, V229, P628, DOI 10.1055/s-0031-1299508; Bohringer D, 2012, CORNEA IN PRESS; Bucht C, 2011, ACTA OPHTHALMOL, V89, pe242, DOI 10.1111/j.1755-3768.2010.01974.x; Erickson BJ, 2011, AM J NEURORADIOL, V32, P1652, DOI 10.3174/ajnr.A2596; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014; Mamalis N, 2000, Curr Opin Ophthalmol, V11, P289, DOI 10.1097/00055735-200008000-00011; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; SHERRARD ES, 1976, EXP EYE RES, V22, P347, DOI 10.1016/0014-4835(76)90227-X; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222	12	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59261	10.1371/journal.pone.0059261	http://dx.doi.org/10.1371/journal.pone.0059261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516618	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400103
J	Iqbal, AJ; Regan-Komito, D; Christou, I; White, GE; McNeill, E; Kenyon, A; Taylor, L; Kapellos, TS; Fisher, EA; Channon, KM; Greaves, DR				Iqbal, Asif J.; Regan-Komito, Daniel; Christou, Ivy; White, Gemma E.; McNeill, Eileen; Kenyon, Amy; Taylor, Lewis; Kapellos, Theodore S.; Fisher, Edward A.; Channon, Keith M.; Greaves, David R.			A Real Time Chemotaxis Assay Unveils Unique Migratory Profiles amongst Different Primary Murine Macrophages	PLOS ONE			English	Article							CC-CHEMOKINE BLOCKADE; CHRONIC INFLAMMATION; GENE-EXPRESSION; CELL-MIGRATION; RESOLUTION; ANTIGEN; RECRUITMENT; RECEPTORS; PATHWAYS; CHEMERIN	Chemotaxis assays are an invaluable tool for studying the biological activity of inflammatory mediators such as CC chemokines, which have been implicated in a wide range of chronic inflammatory diseases. Conventional chemotaxis systems such as the modified Boyden chamber are limited in terms of the data captured given that the assays are analysed at a single time-point. We report the optimisation and validation of a label-free, real-time cell migration assay based on electrical cell impedance to measure chemotaxis of different primary murine macrophage populations in response to a range of CC chemokines and other chemoattractant signalling molecules. We clearly demonstrate key differences in the migratory behavior of different murine macrophage populations and show that this dynamic system measures true macrophage chemotaxis rather than chemokinesis or fugetaxis. We highlight an absolute requirement for G alpha i signaling and actin cytoskeletal rearrangement as demonstrated by Pertussis toxin and cytochalasin D inhibition. We also studied the chemotaxis of CD14(+) human monocytes and demonstrate distinct chemotactic profiles amongst different monocyte donors to CCL2. This real-time chemotaxis assay will allow a detailed analysis of factors that regulate macrophage responses to chemoattractant cytokines and inflammatory mediators.	[Iqbal, Asif J.; Regan-Komito, Daniel; Christou, Ivy; White, Gemma E.; Kenyon, Amy; Taylor, Lewis; Kapellos, Theodore S.; Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [McNeill, Eileen; Channon, Keith M.] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Fisher, Edward A.] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY USA; [Fisher, Edward A.] Marc & Ruti Bell Program Vasc Biol, New York, NY USA	University of Oxford; University of Oxford; New York University	Iqbal, AJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	asif.iqbal@path.ox.ac.uk; david.greaves@path.ox.ac.uk	Fisher, Edward/ABE-7469-2020	Kenyon, Amy/0000-0001-9248-576X; Greaves, David/0000-0003-2856-9410; Fisher, Edward/0000-0001-9802-143X; channon, keith/0000-0002-1043-4342; McNeill, Eileen/0000-0003-0971-9858; Iqbal, Asif/0000-0002-3224-3651	British Heart Foundation [RG/10/15/28578]; British Heart Foundation [PG/10/60/28496, RG/12/5/29576] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10247] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the British Heart Foundation (RG/10/15/28578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 1997, J CELL SCI, V110, P707; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BUECHI M, 1979, J CELL BIOL, V83, P338, DOI 10.1083/jcb.83.2.338; Bursill CA, 2004, CIRCULATION, V110, P2460, DOI 10.1161/01.CIR.0000145122.58420.CO; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; Davies John Q, 2005, Methods Mol Biol, V290, P105; Davies John Q, 2005, Methods Mol Biol, V290, P91; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gilbert J, 2011, AM J CARDIOL, V107, P906, DOI 10.1016/j.amjcard.2010.11.005; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Kamdar SJ, 1996, CELL IMMUNOL, V174, P165, DOI 10.1006/cimm.1996.0306; KOWOLENKO M, 1990, J IMMUNOL METHODS, V127, P71, DOI 10.1016/0022-1759(90)90342-S; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Su YC, 2012, BIOCH BIOPHYS ACTA; Sun MJ, 2012, ANAL BIOCHEM, V425, P96, DOI 10.1016/j.ab.2012.03.010; Szekanecz Z, 2011, NETH J MED, V69, P356; Turchyn LR, 2007, COMPARATIVE MED, V57, P574; Ungefroren H, 2011, INT J ONCOL, V38, P797, DOI 10.3892/ijo.2011.897; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; White GE, 2011, MOL PHARMACOL, V80, P328, DOI 10.1124/mol.111.071985; Willoughby DA, 2000, INT J IMMUNOPHARMACO, V22, P1131, DOI 10.1016/S0192-0561(00)00064-3; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; ZICHA D, 1991, J CELL SCI, V99, P769	36	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58744	10.1371/journal.pone.0058744	http://dx.doi.org/10.1371/journal.pone.0058744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516549	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400060
J	Johansson, T; Norris, T; Peilot-Sjogren, H				Johansson, Teres; Norris, Tyrrell; Peilot-Sjogren, Helena			Yellow Fluorescent Protein-Based Assay to Measure GABA(A) Channel Activation and Allosteric Modulation in CHO-K1 Cells	PLOS ONE			English	Article							CHLORIDE CHANNELS; RECEPTOR FUNCTION; SUBTYPES; PHARMACOLOGY; AGONISTS	The gamma-aminobutyric acid A (GABA(A)) ion channels are important drug targets for treatment of neurological and psychiatric disorders. Finding GABA(A) channel subtype selective allosteric modulators could lead to new improved treatments. However, the progress in this area has been obstructed by the challenging task of developing functional assays to support screening efforts and the generation of cells expressing functional GABA(A) ion channels with the desired subtype composition. To address these challenges, we developed a yellow fluorescent protein (YFP)-based assay to be able to study allosteric modulation of the GABA(A) ion channel using cryopreserved, transiently transfected, assay-ready cells. We show for the first time how the MaxCyte STX electroporation instrument can be used to generate CHO-K1 cells expressing functional GABA(A) alpha 2 beta 3 gamma 2 along with a halide sensing YFP-H148Q/I152L (YFP-GABA(A2) cells). As a basis for a cell-based assay capable of detecting allosteric modulators, experiments with antagonist, ion channel blocker and modulators were used to verify GABA(A) subunit composition and functionality. We found that the I- concentration used in the YFP assay affected both basal quench of YFP and potency of GABA. For the first time the assay was used to study modulation of GABA with 7 known modulators where statistical analysis showed that the assay can distinguish modulatory pEC(50) differences of 0.15. In conclusion, the YFP assay proved to be a robust, reproducible and inexpensive assay. These data provide evidence that the assay is suitable for high throughput screening (HTS) and could be used to discover novel modulators acting on GABA(A) ion channels.	[Johansson, Teres; Norris, Tyrrell; Peilot-Sjogren, Helena] AstraZeneca Res & Dev, Discovery Sci Cellular Reagents & Assay Dev, Molndal, Sweden	AstraZeneca	Peilot-Sjogren, H (corresponding author), AstraZeneca Res & Dev, Discovery Sci Cellular Reagents & Assay Dev, Molndal, Sweden.	Helena.Peilot@astrazeneca.com			AstraZeneca Research Development	AstraZeneca Research Development	The study was funded by AstraZeneca Research & Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atack JR, 2011, CURR TOP MED CHEM, V11, P1176; Atack JR, 2006, J PHARMACOL EXP THER, V316, P410, DOI 10.1124/jpet.105.089920; Barnard EA, 1998, PHARMACOL REV, V50, P291; Chang YC, 1996, J NEUROSCI, V16, P5415; Elagoz A, 2004, BRIT J PHARMACOL, V141, P37, DOI 10.1038/sj.bjp.0705592; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gamper Nikita, 2005, Journal of Pharmacological and Toxicological Methods, V51, P177, DOI 10.1016/j.vascn.2004.08.008; Gilbert D, 2009, J BIOMOL SCREEN, V14, P86, DOI 10.1177/1087057108328017; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Kruger W, 2005, NEUROSCI LETT, V380, P340, DOI 10.1016/j.neulet.2005.01.065; Liu J, 2008, ASSAY DRUG DEV TECHN, V6, P781, DOI [10.1089/adt.2008.161, 10.1089/adt.2008.0161]; McCabe C, 2004, NEUROPHARMACOLOGY, V46, P171, DOI 10.1016/j.neuropharm.2003.09.004; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mennerick S, 2010, J NEUROSCI, V30, P2871, DOI 10.1523/JNEUROSCI.5607-09.2010; Phez E, 2005, BBA-GEN SUBJECTS, V1724, P248, DOI 10.1016/j.bbagen.2005.04.005; ROBERTSON B, 1989, J PHYSIOL-LONDON, V411, P285, DOI 10.1113/jphysiol.1989.sp017574; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Smith AJ, 2003, ANAL BIOANAL CHEM, V377, P843, DOI 10.1007/s00216-003-2172-y; Sui JL, 2010, ASSAY DRUG DEV TECHN, V8, P656, DOI 10.1089/adt.2010.0312; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Wolff C, 2003, J BIOMOL SCREEN, V8, P533, DOI 10.1177/1087057103257806	24	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59429	10.1371/journal.pone.0059429	http://dx.doi.org/10.1371/journal.pone.0059429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516634	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400110
J	Barker, JL; Barclay, P; Reeve, HK				Barker, Jessica L.; Barclay, Pat; Reeve, H. Kern			Competition over Personal Resources Favors Contribution to Shared Resources in Human Groups	PLOS ONE			English	Article							EXPLAIN HUMAN COOPERATION; TUG-OF-WAR; PROSOCIAL PREFERENCES; BEHAVIORAL ECOLOGY; INSECT SOCIETIES; TOLERATED THEFT; ECONOMIC MAN; EVOLUTION; REPRODUCTION; CONFLICT	Members of social groups face a trade-off between investing selfish effort for themselves and investing cooperative effort to produce a shared group resource. Many group resources are shared equitably: they may be intrinsically non-excludable public goods, such as vigilance against predators, or so large that there is little cost to sharing, such as cooperatively hunted big game. However, group members' personal resources, such as food hunted individually, may be monopolizable. In such cases, an individual may benefit by investing effort in taking others' personal resources, and in defending one's own resources against others. We use a game theoretic "tug-of-war'' model to predict that when such competition over personal resources is possible, players will contribute more towards a group resource, and also obtain higher payoffs from doing so. We test and find support for these predictions in two laboratory economic games with humans, comparing people's investment decisions in games with and without the options to compete over personal resources or invest in a group resource. Our results help explain why people cooperatively contribute to group resources, suggest how a tragedy of the commons may be avoided, and highlight unifying features in the evolution of cooperation and competition in human and non-human societies.	[Barker, Jessica L.; Reeve, H. Kern] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Barclay, Pat] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada	Cornell University; University of Guelph	Barker, JL (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA.	jlbarker@arizona.edu		Barker, Jessica/0000-0002-8369-4823; Barclay, Pat/0000-0002-7905-9069	National Science Foundation Doctoral Dissertation Improvement [1010461]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Science Foundation Doctoral Dissertation Improvement(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Science Foundation Doctoral Dissertation Improvement Grant #1010461 to JLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay P, 2004, EVOL HUM BEHAV, V25, P209, DOI 10.1016/j.evolhumbehav.2004.04.002; Barclay P, 2011, J THEOR BIOL, V281, P47, DOI 10.1016/j.jtbi.2011.04.023; Barker JL, 2012, BEHAV ECOL, V23, P735, DOI 10.1093/beheco/ars020; Benedict R., 1934, PATTERNS CULTURE; Bird RLB, 1997, CURR ANTHROPOL, V38, P49, DOI 10.1086/204581; BIRDDAVID N, 1990, CURR ANTHROPOL, V31, P189, DOI 10.1086/203825; Boehm C., 1999, HIERARCHY FOREST EVO; Bolles AS, 1903, MONEY BANKING FINANC; Bonckaert W, 2011, BEHAV ECOL SOCIOBIOL, V65, P633, DOI 10.1007/s00265-010-1064-3; Boone JL, 1992, EVOLUTIONARY ECOLOGY, P301; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; Bradley BJ, 2005, P NATL ACAD SCI USA, V102, P9418, DOI 10.1073/pnas.0502019102; Burton-Chellew MN, 2013, P NATL ACAD SCI USA, V110, P216, DOI 10.1073/pnas.1210960110; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Cashdan Elizabeth A., 1990, RISK UNCERTAINTY TRI; Cashdan Elizabeth A, 1992, EVOLUTIONARY ECOLOGY, P237; Chapman MR, 1996, ANIM BEHAV, V52, P83, DOI 10.1006/anbe.1996.0154; Davis DD., 1993, EXP ECON, DOI [10.1515/9780691233376, DOI 10.1515/9780691233376]; DAWES RM, 1988, J ECON PERSPECT, V2, P187, DOI 10.1257/jep.2.3.187; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dugatkin L.A., 1997, COOPERATION ANIMALS; DUGATKIN LA, 1991, BEHAV ECOL SOCIOBIOL, V29, P127, DOI 10.1007/BF00166487; El Mouden C, 2010, EVOLUTION, V64, P2139, DOI 10.1111/j.1558-5646.2010.00963.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Frank R.H, 2013, FALLING RISING INEQU, DOI DOI 10.1525/9780520957435; Frank SA, 2003, EVOLUTION, V57, P693; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Frank SA, 2009, SPRINGER SER GAME TH, P3, DOI 10.1007/978-3-540-85436-4_1; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Gintis H, 2001, MORAL SENTIMENTS MAT, P3; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammond RL, 2004, PLOS BIOL, V2, P1472, DOI 10.1371/journal.pbio.0020248; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HAWKES K, 1991, PHILOS T R SOC B, V334, P243, DOI 10.1098/rstb.1991.0113; Hawkes K, 2001, CURR ANTHROPOL, V42, P681, DOI 10.1086/322559; Hawkes K., 2001, MEAT EATING HUMAN EV, P219; Heg D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1249, DOI 10.1007/s00265-008-0553-0; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hildreth R, 1837, HISTORY BANKS; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; JONES NGB, 1984, ETHOL SOCIOBIOL, V5, P1; JONES NGB, 1987, SOC SCI INFORM, V26, P31; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kummerli R, 2010, P NATL ACAD SCI USA, V107, P10125, DOI 10.1073/pnas.1000829107; KUMMER H, 1991, ANIM BEHAV, V42, P529, DOI 10.1016/S0003-3472(05)80238-6; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Mace R, 2012, P ROY SOC B-BIOL SCI, V279, P2219, DOI 10.1098/rspb.2011.2424; Marlowe FW, 2004, RES ECON ANTHROPOL, V23, P69, DOI 10.1016/S0190-1281(04)23003-7; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Michod RE, 2001, HEREDITY, V86, P1, DOI 10.1046/j.1365-2540.2001.00808.x; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Penn DJ, 2003, Q REV BIOL, V78, P275, DOI 10.1086/377051; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; Rustagi D, 2010, SCIENCE, V330, P961, DOI 10.1126/science.1193649; Scott-Phillips TC, 2011, PERSPECT PSYCHOL SCI, V6, P38, DOI 10.1177/1745691610393528; SHERMAN PW, 1995, BEHAV ECOL, V6, P102, DOI 10.1093/beheco/6.1.102; Stanford Craig B., 2001, P122; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; Stevens JR, 2002, BEHAV ECOL, V13, P393, DOI 10.1093/beheco/13.3.393; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Tucker B, 2004, RES ECON ANTHROPOL, V23, P45, DOI 10.1016/S0190-1281(04)230002-5; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wenseleers T, 2004, J EVOLUTION BIOL, V17, P1035, DOI 10.1111/j.1420-9101.2004.00751.x; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041; Winterhalder B, 1996, ETHOL SOCIOBIOL, V17, P37, DOI 10.1016/0162-3095(95)00126-3; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; Yamagishi T, 2009, P NATL ACAD SCI USA, V106, P11520, DOI 10.1073/pnas.0900636106; Zizzo DJ, 2004, RES EC INEQ, V11, P215; Zizzo DJ, 2001, ANN EC STAT, P39, DOI [DOI 10.1017/S0266462300006280, DOI 10.2307/20076295]	83	8	8	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58826	10.1371/journal.pone.0058826	http://dx.doi.org/10.1371/journal.pone.0058826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520535	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900095
J	Liu, D; Hu, K; Niemann, M; Herrmann, S; Cikes, M; Stork, S; Beer, M; Gaudron, PD; Morbach, C; Knop, S; Geissinger, E; Ertl, G; Bijnens, B; Weidemann, F				Liu, Dan; Hu, Kai; Niemann, Markus; Herrmann, Sebastian; Cikes, Maja; Stoerk, Stefan; Beer, Meinrad; Gaudron, Philipp Daniel; Morbach, Caroline; Knop, Stefan; Geissinger, Eva; Ertl, Georg; Bijnens, Bart; Weidemann, Frank			Impact of Regional Left Ventricular Function on Outcome for Patients with AL Amyloidosis	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; NORMAL EJECTION FRACTION; LIGHT-CHAIN AMYLOIDOSIS; SYSTOLIC DYSFUNCTION; MAGNETIC-RESONANCE; WALL STRESS; STRAIN; MELPHALAN; ECHOCARDIOGRAPHY; HYPERTROPHY	Objectives: The aim of this study was to explore the left ventricular (LV) deformation changes and the potential impact of deformation on outcome in patients with proven light-chain (AL) amyloidosis and LV hypertrophy. Background: Cardiac involvement in AL amyloidosis patients is associated with poor outcome. Detecting regional cardiac function by advanced non-invasive techniques might be favorable for predicting outcome. Methods: LV longitudinal, circumferential and radial peak systolic strains (Ssys) were assessed by speckle tracking imaging (STI) in 44 biopsy-proven systemic AL amyloidosis patients with LV hypertrophy (CA) and in 30 normal controls. Patients were divided into compensated (n = 18) and decompensated (n = 26) group based on clinical assessment and followed-up for a median period of 345 days. Results: Ejection fraction (EF) was preserved while longitudinal Ssys (LSsys) was significantly reduced in both compensated and decompensated groups. Survival was significantly reduced in decompensated group (35% vs. compensated 78%, P = 0.001). LSsys were similar in apical segments and significantly reduced in basal segments between two patient groups. LSsys at mid-segments were significantly reduced in all LV walls of decompensated group. Patients were further divided into 4 subgroups according to the presence or absence of reduced LSsys in no (normal), only basal (mild), basal and mid (intermediate) and all segments of the septum (severe). This staging revealed continuously worse prognosis in proportion to increasing number of segments with reduced LSsys (mortality: normal 14%, mild 27%, intermediate 67%, and severe 64%). Mid-septum LSsys<11% suggested a 4.8-fold mortality risk than mid-septum LSsys >= 11%. Multivariate regression analysis showed NYHA class and mid-septum LSsys were independent predictors for survival. Conclusions: Reduced deformation at mid-septum is associated with worse prognosis in systemic amyloidosis patients with LV hypertrophy.	[Liu, Dan; Hu, Kai; Niemann, Markus; Herrmann, Sebastian; Stoerk, Stefan; Gaudron, Philipp Daniel; Morbach, Caroline; Ertl, Georg; Weidemann, Frank] Univ Wurzburg, Dept Internal Med 1, D-97070 Wurzburg, Germany; [Liu, Dan; Hu, Kai; Niemann, Markus; Herrmann, Sebastian; Stoerk, Stefan; Gaudron, Philipp Daniel; Morbach, Caroline; Ertl, Georg; Weidemann, Frank] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Cikes, Maja] Univ Hosp Ctr Zagreb, Dept Cardiovasc Dis, Zagreb, Croatia; [Cikes, Maja] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Beer, Meinrad] Univ Wurzburg, Dept Radiol, D-97070 Wurzburg, Germany; [Knop, Stefan] Univ Wurzburg, Dept Internal Med 2, D-97070 Wurzburg, Germany; [Geissinger, Eva] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany; [Bijnens, Bart] ICREA Univ Pompeu Fabra, Barcelona, Spain; [Bijnens, Bart] Katholieke Univ Leuven, Dept Cardiovasc Dis, Louvain, Belgium	University of Wurzburg; University of Wurzburg; University of Zagreb; University of Zagreb; University of Wurzburg; University of Wurzburg; University of Wurzburg; ICREA; Pompeu Fabra University; KU Leuven	Weidemann, F (corresponding author), Univ Wurzburg, Dept Internal Med 1, D-97070 Wurzburg, Germany.	Weidemann_F@medizin.uni-wuerzburg.de	Beer, Meinrad/C-5241-2019; Bijnens, Bart H/C-2955-2008; Bijnens, Bart/AAE-7186-2021; Stork, Stefan/AAR-4182-2020; Morbach, Caroline/AAL-2121-2020	Beer, Meinrad/0000-0001-7523-1979; Bijnens, Bart H/0000-0003-3130-6937; Bijnens, Bart/0000-0003-3130-6937; Stork, Stefan/0000-0002-1771-7249; Morbach, Caroline/0000-0002-0920-6094	Bundesministerium fur Bildung und Forschung [BMBF01 EO1004]; ICREA Funding Source: Custom	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); ICREA(ICREA)	This work was supported by grants from the Bundesministerium fur Bildung und Forschung (BMBF01 EO1004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis NJ, 2008, INT J CARDIOL, V123, P240, DOI 10.1016/j.ijcard.2007.02.046; AURIGEMMA GP, 1995, J AM COLL CARDIOL, V26, P195, DOI 10.1016/0735-1097(95)00153-Q; Balzer P, 1999, AM J PHYSIOL-HEART C, V277, pH901, DOI 10.1152/ajpheart.1999.277.3.H901; Bellavia D, 2007, J AM SOC ECHOCARDIOG, V20, P1194, DOI 10.1016/j.echo.2007.02.025; Brenner DA, 2004, CIRC RES, V94, P1008, DOI 10.1161/01.RES.0000126569.75419.74; Cikes M, 2010, NAT REV CARDIOL, V7, P384, DOI 10.1038/nrcardio.2010.56; Dubrey SW, 1998, QJM-MON J ASSOC PHYS, V91, P141, DOI 10.1093/qjmed/91.2.141; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Gardiner C, 2000, BRIT J HAEMATOL, V111, P1230, DOI 10.1046/j.1365-2141.2000.02466.x; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; HAMER JPM, 1992, EUR HEART J, V13, P623, DOI 10.1093/oxfordjournals.eurheartj.a060225; Jiang L, 2003, EUR HEART J, V24, P742, DOI 10.1016/S0195-668X(02)00655-3; Koyama J, 2002, AM J CARDIOL, V89, P1067, DOI 10.1016/S0002-9149(02)02277-4; Koyama J, 2003, CIRCULATION, V107, P2446, DOI 10.1161/01.CIR.0000068313.67758.4F; Koyama J, 2004, J AM SOC ECHOCARDIOG, V17, P36, DOI 10.1016/j.echo.2003.09.014; Koyama J, 2010, JACC-CARDIOVASC IMAG, V3, P333, DOI 10.1016/j.jcmg.2009.11.013; Kristen AV, 2007, EUR J HEART FAIL, V9, P617, DOI 10.1016/j.ejheart.2007.01.012; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Lebovic D, 2008, BRIT J HAEMATOL, V143, P369, DOI 10.1111/j.1365-2141.2008.07327.x; LEVY D, 1992, CLIN EXP HYPERTENS A, V14, P85, DOI 10.3109/10641969209036173; Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Palladini G, 2001, PACE, V24, P1228, DOI 10.1046/j.1460-9592.2001.01228.x; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Rahman JE, 2004, J AM COLL CARDIOL, V43, P410, DOI 10.1016/j.jacc.2003.08.043; Sanderson JE, 2006, PROG CARDIOVASC DIS, V49, P196, DOI 10.1016/j.pcad.2006.08.005; Sun JP, 2009, AM J CARDIOL, V103, P411, DOI 10.1016/j.amjcard.2008.09.102; Cibeira MT, 2011, BLOOD, V118, P4346, DOI 10.1182/blood-2011-01-330738; Teske Arco J, 2007, Cardiovasc Ultrasound, V5, P27; Yang H, 2003, J AM SOC ECHOCARDIOG, V16, P233, DOI 10.1067/mje.2003.60	33	23	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56923	10.1371/journal.pone.0056923	http://dx.doi.org/10.1371/journal.pone.0056923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520459	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900018
J	Thung, L; Chakravorty, D; Trusov, Y; Jones, AM; Botella, JR				Thung, Leena; Chakravorty, David; Trusov, Yuri; Jones, Alan M.; Botella, Jose Ramon			Signaling Specificity Provided by the Arabidopsis thaliana Heterotrimeric G-Protein gamma Subunits AGG1 and AGG2 Is Partially but Not Exclusively Provided through Transcriptional Regulation	PLOS ONE			English	Article							G-BETA SUBUNIT; ALPHA-SUBUNIT; ABSCISIC-ACID; NECROTROPHIC PATHOGENS; CHANNEL REGULATION; COUPLED RECEPTORS; MOLECULAR-CLONING; BINDING PROTEIN; CELL-DIVISION; BLUE-LIGHT	The heterotrimeric G-protein complex in Arabidopsis thaliana consists of one alpha, one beta and three gamma subunits. While two of the gamma subunits, AGG1 and AGG2 have been shown to provide functional selectivity to the G beta gamma dimer in Arabidopsis, it is unclear if such selectivity is embedded in their molecular structures or conferred by the different expression patterns observed in both subunits. In order to study the molecular basis for such selectivity we tested genetic complementation of AGG1- and AGG2 driven by the respectively swapped gene promoters. When expressed in the same tissues as AGG1, AGG2 rescues some agg1 mutant phenotypes such as the hypersensitivity to Fusarium oxysporum and D-mannitol as well as the altered levels of lateral roots, but does not rescue the early flowering phenotype. Similarly, AGG1 when expressed in the same tissues as AGG2 rescues the osmotic stress and lateral-root phenotypes observed in agg2 mutants but failed to rescue the heat-stress induction of flowering. The fact that AGG1 and AGG2 are functionally interchangeable in some pathways implies that, at least for those pathways, signaling specificity resides in the distinctive spatiotemporal expression patterns exhibited by each gamma subunit. On the other hand, the lack of complementation for some phenotypes indicates that there are pathways in which signaling specificity is provided by differences in the primary AGG1 and AGG2 amino acid sequences.	[Thung, Leena; Chakravorty, David; Trusov, Yuri; Botella, Jose Ramon] Univ Queensland, Sch Agr & Food Sci, Plant Genet Engn Lab, Brisbane, Qld, Australia; [Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Botella, JR (corresponding author), Univ Queensland, Sch Agr & Food Sci, Plant Genet Engn Lab, Brisbane, Qld, Australia.	J.botella@uq.edu.au	Botella, Jose R/D-9766-2011	Botella, Jose R/0000-0002-4446-3432; Chakravorty, David/0000-0002-6591-4853; Trusov, Yuri/0000-0001-8215-5492	Australian Research Council [DP1094152]; National Institute of General Medical Sciences [R01GM065989]; National Science Foundation [MCB-0723515, MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-05er15671]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1158054] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Australian Research Council [Grant number DP1094152]. This work was supported by grants from the National Institute of General Medical Sciences (R01GM065989 and National Science Foundation (MCB-0723515 and MCB-0718202) to AMJ. The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through the grant DE-FG02-05er15671 to AMJ funded preliminary studies on lateral root phenotypes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; Agrios G. N., 2005, PLANT PATHOL; Anderson DJ, 2007, PLANT CELL REP, V26, P1469, DOI 10.1007/s00299-007-0356-1; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; ARMSTRONG F, 1995, PLANT J, V8, P187, DOI 10.1046/j.1365-313X.1995.08020187.x; Assmann SM, 1996, TRENDS PLANT SCI, V1, P73, DOI 10.1016/S1360-1385(96)89035-2; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balcueva EA, 2000, EXP CELL RES, V257, P310, DOI 10.1006/excr.2000.4893; Bhardwaj D, 2012, PLANT PHYSIOL BIOCH, V58, P1, DOI 10.1016/j.plaphy.2012.06.005; Booker FL, 2004, NEW PHYTOL, V162, P633, DOI 10.1111/j.1469-8137.2004.01081.x; Botella JR, 2012, TRENDS PLANT SCI, V17, P563, DOI 10.1016/j.tplants.2012.06.002; Botto JF, 2009, PHOTOCHEM PHOTOBIOL, V85, P949, DOI 10.1111/j.1751-1097.2008.00505.x; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Chakravorty D, 2012, PLANTA, V235, P615, DOI 10.1007/s00425-011-1526-5; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2004, PLANT PHYSIOL, V135, P1; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; ESKINS K, 1992, PHYSIOL PLANTARUM, V86, P439, DOI 10.1111/j.1399-3054.1992.tb01341.x; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; Hooley R, 1999, PLANT PHYSIOL BIOCH, V37, P393, DOI 10.1016/S0981-9428(99)80045-X; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; Jiang K, 2012, PLANT PHYSIOL, V159, P975, DOI 10.1104/pp.112.196337; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2003, PLANT PHYSIOL, V131, P1623, DOI 10.1104/pp.102.017624; Jones JC, 2011, CHEM ENG PROG, V107, P4; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Jones JC, 2011, J BIOL CHEM, V286, P13143, DOI 10.1074/jbc.M110.190355; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kelly MN, 2003, PLANTA, V216, P674, DOI 10.1007/s00425-002-0900-8; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; KISSELEV O, 1993, J BIOL CHEM, V268, P24519; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Koornneef M, 1998, PLANT PHYSIOL BIOCH, V36, P83, DOI 10.1016/S0981-9428(98)80093-4; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kushwah S, 2011, PLANT PHYSIOL, V156, P1851, DOI 10.1104/pp.111.175794; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; LEE RH, 1992, J BIOL CHEM, V267, P24776; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Liu MY, 1997, J BIOL CHEM, V272, P18801, DOI 10.1074/jbc.272.30.18801; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Madueno F, 1996, SEMIN CELL DEV BIOL, V7, P401, DOI 10.1006/scdb.1996.0050; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; MAUCHMANI B, 1994, MOL PLANT MICROBE IN, V7, P378, DOI 10.1094/MPMI-7-0378; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; McIntire WE, 2002, METHOD ENZYMOL, V343, P372; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Misra S, 2007, PLANT J, V51, P656, DOI 10.1111/j.1365-313X.2007.03169.x; Moro S, 2003, CHEM COMMUN, P2949, DOI 10.1039/b303439a; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Okamoto H, 2001, PLANT CELL, V13, P1639, DOI 10.1105/tpc.13.7.1639; Okamoto H, 2009, J EXP BOT, V60, P1991, DOI 10.1093/jxb/erp060; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Purnell MP, 2007, PLANT PHYSIOL, V143, P530, DOI 10.1104/pp.106.091330; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Smrcka AV, 2010, P NATL ACAD SCI USA, V107, P639, DOI 10.1073/pnas.0909503107; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; STERNWEIS PC, 1994, CURR OPIN CELL BIOL, V6, P198, DOI 10.1016/0955-0674(94)90136-8; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Trusov Y, 2008, PLANT PHYSIOL, V147, P636, DOI 10.1104/pp.108.117655; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Trusov Y, 2012, J PLANT BIOCHEM BIOT, V21, pS40, DOI 10.1007/s13562-012-0140-3; Trusov Yuri, 2012, BMC Res Notes, V5, P608, DOI 10.1186/1756-0500-5-608; Trusov Y, 2010, SIGNAL COMMUN PLANTS, P221, DOI 10.1007/978-3-642-03524-1_12; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang L, 2006, CELL RES, V16, P916, DOI 10.1038/sj.cr.7310111; Wang L, 2010, SIGNAL COMMUN PLANTS, P135, DOI 10.1007/978-3-642-03524-1_8; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; WARPEHA KMF, 1991, P NATL ACAD SCI USA, V88, P8925, DOI 10.1073/pnas.88.20.8925; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Wever W, 2010, TRANSGENIC RES, V19, P667, DOI 10.1007/s11248-009-9332-6; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583; Zhang W, 2008, PLANT J, V56, P984, DOI 10.1111/j.1365-313X.2008.03657.x; Zhu HF, 2009, MOL PLANT, V2, P513, DOI 10.1093/mp/ssp001	102	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58503	10.1371/journal.pone.0058503	http://dx.doi.org/10.1371/journal.pone.0058503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520518	gold, Green Published			2022-12-27	WOS:000318679900077
J	Lee, JE; Gohda, T; Walker, WH; Skupien, J; Smiles, AM; Holak, RR; Jeong, J; McDonnell, KP; Krolewski, AS; Niewczas, MA				Lee, Jung Eun; Gohda, Tomohito; Walker, William H.; Skupien, Jan; Smiles, Adam M.; Holak, Rita R.; Jeong, Jackson; McDonnell, Kevin P.; Krolewski, Andrzej S.; Niewczas, Monika A.			Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1	PLOS ONE			English	Article							GROWTH-FACTOR 23; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; RECEPTORS 1; KLOTHO; INFLAMMATION; FACTOR-23; FGF23; FIBROBLAST-GROWTH-FACTOR-23; MICROALBUMINURIA	Introduction: Recent studies demonstrated that circulating fibroblast growth factor (FGF)-23 was associated with risk of end stage renal disease (ESRD) and mortality. This study aims to examine whether the predictive effect of FGF-23 is independent from circulating levels of tumor necrosis factor receptor 1 (TNFR1), a strong predictor of ESRD in Type 2 diabetes (T2D). Methods: We studied 380 patients with T2D who were followed for 8-12 years and were used previously to examine the effect of TNFR1. Baseline plasma FGF-23 was measured by immunoassay. Results: During follow-up, 48 patients (13%) developed ESRD and 83 patients (22%) died without ESRD. In a univariate analysis, baseline circulating levels of FGF-23 and TNFR1 were significantly higher in subjects who subsequently developed ESRD or died without ESRD than in those who remained alive. In a Cox proportional hazard model, baseline concentration of FGF-23 was associated with increased risk of ESRD, however its effect was no longer significant after controlling for TNFR1 and other clinical characteristics (HR 1.3, p = 0.15). The strong effect of circulating level of TNFR1 on risk of ESRD was not changed by including circulating levels of FGF-23 (HR 8.7, p<0.001). In the Cox multivariate model, circulating levels of FGF-23 remained a significant independent predictor of all-cause mortality unrelated to ESRD (HR 1.5, p<0.001). Conclusions: We demonstrated that the effect of circulating levels of FGF-23 on the risk of ESRD is accounted for by circulating levels of TNFR1. We confirmed that circulating levels of FGF-23 have an independent effect on all-cause mortality in T2D.	[Lee, Jung Eun; Gohda, Tomohito; Walker, William H.; Skupien, Jan; Smiles, Adam M.; Holak, Rita R.; Jeong, Jackson; McDonnell, Kevin P.; Krolewski, Andrzej S.; Niewczas, Monika A.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Lee, Jung Eun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Nephrol, Seoul, South Korea; [Lee, Jung Eun; Gohda, Tomohito; Skupien, Jan; Krolewski, Andrzej S.; Niewczas, Monika A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gohda, Tomohito] Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan; [Skupien, Jan] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland	Harvard University; Joslin Diabetes Center, Inc.; Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Harvard Medical School; Juntendo University; Jagiellonian University; Collegium Medicum Jagiellonian University	Niewczas, MA (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	Monika.Niewczas@joslin.harvard.edu	lee, je/O-6247-2014; GOHDA, TOMOHITO/Y-6867-2019	GOHDA, TOMOHITO/0000-0002-0513-4433	National Institutes of Health [DK041526, DK067638]; DERC Joslin Diabetes Center Pilot and Feasibility grant; JDRF [3-2009-397]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041526, R01DK067638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DERC Joslin Diabetes Center Pilot and Feasibility grant; JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health DK041526 and DK067638 (ASK), DERC Joslin Diabetes Center Pilot and Feasibility grant (MAN) and a JDRF fellowship grant 3-2009-397 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3; AGODOA LY, 1995, AM J KIDNEY DIS, V25, P119, DOI 10.1016/0272-6386(95)90638-X; Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; Baum M, 2005, KIDNEY INT, V68, P1148, DOI 10.1111/j.1523-1755.2005.00506.x; Bergstralh E., SAS MACRO PERFORMS C; Bernheim J, 2011, NEPHROL DIAL TRANSPL, V26, P2433, DOI 10.1093/ndt/gfr208; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Krieger NS, 2012, AM J PHYSIOL-RENAL, V303, pF431, DOI 10.1152/ajprenal.00199.2012; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; MacIsaac RJ, 2011, CURR OPIN NEPHROL HY, V20, P246, DOI 10.1097/MNH.0b013e3283456546; McEwen LN, 2011, DIABETES CARE, pdc11; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Prie D, 2010, CLIN J AM SOC NEPHRO, V5, P1717, DOI 10.2215/CJN.02680310; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Seiler S, 2013, KIDNEY INT, V83, P121, DOI 10.1038/ki.2012.288; Shab-Bidar S, 2012, DIABETES-METAB RES, V28, P424, DOI 10.1002/dmrr.2290; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	38	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58007	10.1371/journal.pone.0058007	http://dx.doi.org/10.1371/journal.pone.0058007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526964	gold, Green Published			2022-12-27	WOS:000317562600012
J	Weaver, JM; Yang, HM; Roumanes, D; Lee, FEH; Wu, HL; Treanor, JJ; Mosmann, TR				Weaver, Jason M.; Yang, Hongmei; Roumanes, David; Lee, F. Eun-Hyung; Wu, Hulin; Treanor, John J.; Mosmann, Tim R.			Increase in IFN gamma-IL-2(+) Cells in Recent Human CD4 T Cell Responses to 2009 Pandemic H1N1 Influenza	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; CENTRAL MEMORY; IN-VIVO; IMMUNE-RESPONSES; VIRUS; VACCINES; PROTECTION; SUBSETS; BINDING; LIVE	Human CD4 T cell recall responses to influenza virus are strongly biased towards Type 1 cytokines, producing IFN gamma, IL-2 and TNF alpha. We have now examined the effector phenotypes of CD4 T cells in more detail, particularly focusing on differences between recent versus long-term, multiply-boosted responses. Peptides spanning the proteome of temporally distinct influenza viruses were distributed into pools enriched for cross-reactivity to different influenza strains, and used to stimulate antigen-specific CD4 T cells representing recent or long-term memory. In the general population, peptides unique to the long-circulating influenza A/New Caledonia/20/99 (H1N1) induced Th1-like responses biased toward the expression of IFN gamma+TNF alpha(+) CD4 T cells. In contrast, peptide pools enriched for non-cross-reactive peptides of the pandemic influenza A/California/04/09 (H1N1) induced more IFN gamma-IL-2(+)TNF alpha(+) T cells, similar to the IFN gamma-IL-2(+) non-polarized, primed precursor T cells (Thpp) that are a predominant response to protein vaccination. These results were confirmed in a second study that compared samples taken before the 2009 pandemic to samples taken one month after PCR-confirmed A/California/04/09 infection. There were striking increases in influenza-specific TNF alpha(+), IFN gamma(+), and IL-2(+) cells in the post-infection samples. Importantly, peptides enriched for non-cross-reactive A/California/04/09 specificities induced a higher proportion of Thpp-like IFN gamma-IL-2(+)TNF alpha(+) CD4 T cells than peptide pools cross-reactive with previous influenza strains, which induced more Th1 (IFN gamma+TNF alpha(+)) responses. These IFN gamma-IL-2(+)TNF alpha(+) CD4 T cells may be an important target population for vaccination regimens, as these cells are induced upon infection, may have high proliferative potential, and may play a role in providing future effector cells during subsequent infections.	[Weaver, Jason M.; Roumanes, David; Mosmann, Tim R.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Yang, Hongmei; Wu, Hulin] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Lee, F. Eun-Hyung] Univ Rochester, Med Ctr, Dept Med, Div Pulm Med, Rochester, NY 14642 USA; [Treanor, John J.] Univ Rochester, Med Ctr, Dept Med, Div Infect Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Mosmann, TR (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu			National Institutes of Health [K23 AI67501, HHSN266200500030C (N01-AI50029), AI054953];  [HHSN266200700008C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050029, K23AI067501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract HHSN266200700008C to JJT, and by grants K23 AI67501 and HHSN266200500030C (N01-AI50029) to FEL and AI054953 to TRM from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Bartz AE, 1999, BASIC STATISTICAL CO; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P631; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Chaves FA, 2012, J IMMUNOL, V188, P4235, DOI 10.4049/jimmunol.1103640; Coffman RL, 1999, CURR TOP MICROBIOL, V238, P1; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2011, VACCINE; Diethelm-Okita BM, 2000, J INFECT DIS, V181, P1001, DOI 10.1086/315324; DiethelmOkita BM, 1997, J INFECT DIS, V175, P382, DOI 10.1093/infdis/175.2.382; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Durando P, 2011, HUM VACCINES, V7, P29, DOI 10.4161/hv.7.0.14560; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Fearon DT, 2006, IMMUNOL REV, V211, P104, DOI 10.1111/j.0105-2896.2006.00390.x; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geginat J, 2003, PATHOL BIOL, V51, P64, DOI 10.1016/S0369-8114(03)00098-1; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; He XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002574; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Jelley-Gibbs DM, 2005, J EXP MED, V201, P1101, DOI 10.1084/jem.20041852; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Masopust D, 2006, J IMMUNOL, V177, P831, DOI 10.4049/jimmunol.177.2.831; Mosmann TR, 2009, IMMUNOL RES; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ravkov EV, 2003, J IMMUNOL, V170, P2461, DOI 10.4049/jimmunol.170.5.2461; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; SAD S, 1994, J IMMUNOL, V153, P3514; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmolke M, 2010, CELL MICROBIOL, V12, P873, DOI 10.1111/j.1462-5822.2010.01475.x; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Stubbe M, 2006, J IMMUNOL, V177, P8185, DOI 10.4049/jimmunol.177.11.8185; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Wang JCE, 2009, J IMMUNOL METHODS, V341, P106, DOI 10.1016/j.jim.2008.11.002; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Wirth TC, 2011, EUR J IMMUNOL, V41, P1321, DOI 10.1002/eji.201040730; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang L, 2005, J IMMUNOL, V175, P6458, DOI 10.4049/jimmunol.175.10.6458; Yu K, 2001, THEORETICAL DETERMIN; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	63	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57275	10.1371/journal.pone.0057275	http://dx.doi.org/10.1371/journal.pone.0057275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526940	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600007
J	Xu, Y; Xu, SY; Wu, QQ; Guo, YJ				Xu, Yue; Xu, ShuiYang; Wu, QingQing; Guo, YuJie			Tobacco Knowledge among Adults in Zhejiang Province, China	PLOS ONE			English	Article							SMOKING; CESSATION	Objective: The aims of current study were to assess the level of tobacco knowledge, anti-tobacco messages and major information channels in Zhejiang. Methods: Face-to-face interviews were conducted with 2112 adults in Zhejiang. Data on demographic information, smoking status, tobacco knowledge, anti-tobacco messages and major information channels was collected. Results: The findings revealed that only 31.87% of the population were aware that smoking could cause all three diseases (stoke, heart disease, and lung cancer), 86.09% were aware that smoking causes lung cancer, 46.43% and 42.40% were aware that smoking causes stroke and heart attack, respectively. Residence and education level had significant effects on awareness, while the effects of smoking status, gender, age, and household monthly income were not significant. There were five major information channels as follows: television (67.52%), newspapers or magazines (40.79%), billboards (30.02%), public walls (24.72), and radio (23.79%). Respondents got the following anti-tobacco messages from mass media: "No smoking in public" (66.34%), "No smoking in front of other people" (35.18%) and "Not offering cigarettes to one another" (22.82%). Conclusions: The tobacco knowledge among residents in Zhejiang province is relatively poor. Improved information channels and content of anti-tobacco messages are necessary to increase the public's tobacco knowledge, particularly among rural residents and people with less education.	[Xu, Yue; Xu, ShuiYang; Wu, QingQing; Guo, YuJie] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China		Xu, Y (corresponding author), Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	mikexuy@gmail.com			National Institutes of Health (NIH) [R01 RFA- TW-06-006]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was received from National Institutes of Health (NIH) project "Epidemiology and Intervention Research for Tobacco Control in China" (R01 RFA- TW-06-006). Additional technical support was provided by the Institute of Basic Medical Sciences at Chinese Academy of Medical Sciences and School of Basic Medicine at Peking Union Medical College and by the Chinese Center for Disease Control & Prevention (China CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curry SJ, 1997, ADDICT BEHAV, V22, P727, DOI 10.1016/S0306-4603(97)00059-2; Fong GT, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2010.036483; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Hammond D, 2006, TOB CONTROL, V15, P19, DOI 10.1136/tc.2005.012294; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hyland A, 2004, NICOTINE TOB RES, V6, P363, DOI 10.1080/14622200412331320761; Li Q, 2010, TOB CONTROL S2, P63; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Li X, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.031336; Ministry of Education of the people's republic of China, 2010, OP FURTH STRENGTH TO; Ministry of Health of the people's republic of China, 2009, DEC SMOK HLTH I CHIN; National Cancer Institute, 2008, NAT CANC I TOB CONTR, V19; Palipudi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033466; People's Daliy Online, 2009, PEOPLES DALIY ONLINE; Romer D, 2001, SMOKING: RISK, PERCEPTION, & POLICY, P64; Sargent JD, 2007, PEDIATRICS, V119, pE1167, DOI 10.1542/peds.2006-2897; Thomson George, 2005, N Z Med J, V118, pU1407; Viswanath K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011365; Wikipedia, 2004, LIST PEOPL REP CHIN; World Health Organization, 2006, FRAM CONV TOB CONTR; World Health Organization, 2008, WHO REP GLOB TOB EP; Xu Y, 2011, CHINESE J HLTH ED, V27, P563; [徐玉文 XU Yuwen], 2007, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V28, P418; Yang, 2005, DEATHS THEIR RISK FA; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P420, DOI 10.1016/S0895-3988(11)60001-9; Yang Y, 2010, BIOMED ENVIRON SCI, V23, P437, DOI 10.1016/S0895-3988(11)60004-4	26	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59172	10.1371/journal.pone.0059172	http://dx.doi.org/10.1371/journal.pone.0059172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527122	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600061
J	Anderson, MJ; Tolimieri, N; Millar, RB				Anderson, Marti J.; Tolimieri, Nick; Millar, Russell B.			Beta Diversity of Demersal Fish Assemblages in the North-Eastern Pacific: Interactions of Latitude and Depth	PLOS ONE			English	Article							SPECIES-RICHNESS; GROUNDFISH ASSEMBLAGES; HABITAT HETEROGENEITY; SPATIAL-PATTERNS; SCALE PATTERNS; TAXONOMIC DISTINCTNESS; BENTHIC BIODIVERSITY; CONTINENTAL-SLOPE; GLOBAL PATTERNS; ATLANTIC-OCEAN	Knowledge of broad-scale global patterns in beta diversity (i.e., variation or turnover in identities of species) for marine systems is in its infancy. We analysed the beta diversity of groundfish communities along the North American Pacific coast, from trawl data spanning 32.57 degrees N to 48.52 degrees N and 51 m to 1200 m depth. Analyses were based on both the Jaccard measure and the probabilistic Raup-Crick measure, which accounts for variation in alpha diversity. Overall, beta diversity decreased with depth, and this effect was strongest at lower latitudes. Superimposed on this trend were peaks in beta diversity at around 400-600 m and also around 1000-1200 m, which may indicate high turnover around the edges of the oxygen minimum zone. Beta diversity was also observed to decrease with latitude, but this effect was only observed in shallower waters (<200 m); latitudinal turnover began to disappear at depths >800 m. At shallower depths (, 200 m), peaks in latitudinal turnover were observed at similar to 43 degrees N, 39 degrees N, 35 degrees N and 31 degrees N, which corresponded well with several classically observed oceanographic boundaries. Turnover with depth was stronger than latitudinal turnover, and is likely to reflect strong environmental filtering over relatively short distances. Patterns in beta diversity, including latitude-by-depth interactions, should be integrated with other biodiversity measures in ecosystem-based management and conservation of groundfish communities.	[Anderson, Marti J.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Tolimieri, Nick] Natl Ocean & Atmospher Adm, Northwest Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA USA; [Millar, Russell B.] Univ Auckland, Dept Stat, Auckland 1, New Zealand	Massey University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Auckland	Anderson, MJ (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand.	m.j.anderson@massey.ac.nz	Anderson, Marti J./AAQ-9038-2021	Anderson, Marti J./0000-0002-4018-4049	Royal Society of New Zealand Marsden Grant [MAU0713]	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ))	M.J. Anderson was supported by a Royal Society of New Zealand Marsden Grant no. MAU0713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2005, J ANIM ECOL, V74, P636, DOI 10.1111/j.1365-2656.2005.00959.x; Anderson MJ, 2005, J EXP MAR BIOL ECOL, V320, P35, DOI 10.1016/j.jembe.2004.12.023; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Builder-Ramsey T, 2002, NMFSNWFSC55 NOAA US; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Clarke A, 2000, J ANIM ECOL, V69, P799, DOI 10.1046/j.1365-2656.2000.00440.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cook SE, 2008, MAR ENVIRON RES, V66, pS80, DOI 10.1016/j.marenvres.2008.09.002; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Fahr J, 2011, ECOGRAPHY, V34, P177, DOI 10.1111/j.1600-0587.2010.05510.x; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Garcia SM, 2005, ICES J MAR SCI, V62, P311, DOI 10.1016/j.icesjms.2004.12.003; Gaston Kevin J., 1996, P202; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GASTON KJ, 1995, P ROY SOC B-BIOL SCI, V260, P149, DOI 10.1098/rspb.1995.0072; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Gooday AJ, 2010, MAR ECOL-EVOL PERSP, V31, P125, DOI 10.1111/j.1439-0485.2009.00348.x; Gray JS, 2001, SCI MAR, V65, P41, DOI 10.3989/scimar.2001.65s241; Harborne AR, 2006, ECOLOGY, V87, P2871, DOI 10.1890/0012-9658(2006)87[2871:MTBDOC]2.0.CO;2; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Harrison S, 1997, ECOLOGY, V78, P1898, DOI 10.1890/0012-9658(1997)078[1898:HNHPAT]2.0.CO;2; Harte J, 1997, OIKOS, V80, P417, DOI 10.2307/3546614; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; HORN MH, 1978, J BIOGEOGR, V5, P23, DOI 10.2307/3038105; Horn MH, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P3; Juan-Jorda MJ, 2009, FISH OCEANOGR, V18, P1, DOI 10.1111/j.1365-2419.2008.00489.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Keller AA, 2007, 2003 US W COAST BOTT; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Lecchini D, 2007, CORAL REEFS, V26, P423, DOI 10.1007/s00338-007-0212-3; Levin LA, 2009, MARINE ECOLOGY, V31, P94; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Manthey M, 2009, J ECOL, V97, P18, DOI 10.1111/j.1365-2745.2008.01450.x; McClain CR, 2012, P ROY SOC B-BIOL SCI, V279, P1993, DOI 10.1098/rspb.2011.2166; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; MCNEILL SE, 1994, BIODIVERS CONSERV, V3, P586, DOI 10.1007/BF00114203; Merigot B, 2007, FISH RES, V88, P120, DOI 10.1016/j.fishres.2007.08.003; Merigot B, 2007, ESTUAR COAST SHELF S, V73, P123, DOI 10.1016/j.ecss.2006.12.017; Millar RB, 2011, ECOLOGY, V92, P1717, DOI 10.1890/11-0029.1; Mumby PJ, 2001, OECOLOGIA, V128, P274, DOI 10.1007/s004420100643; MURRAY SN, 1981, J BIOGEOGR, V8, P339, DOI 10.2307/2844755; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; NEWELL IRWIN M., 1948, PROC AMER PHIL SOC, V92, P155; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; POFF NL, 1990, ENVIRON MANAGE, V14, P629, DOI 10.1007/BF02394714; Price ARG, 1999, BIOL J LINN SOC, V66, P187, DOI 10.1111/j.1095-8312.1999.tb01883.x; Priede IG, 2010, MAR ECOL-EVOL PERSP, V31, P247, DOI 10.1111/j.1439-0485.2009.00330.x; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; RAUP DM, 1979, J PALEONTOL, V53, P1213; Renaud PE, 2009, MAR ECOL PROG SER, V382, P239, DOI 10.3354/meps07963; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; SAMSON FB, 1982, TRANS N AM WILDL NAT, V47, P421; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Stuart CT, 2009, MAR ECOL-EVOL PERSP, V30, P164, DOI 10.1111/j.1439-0485.2008.00269.x; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tolimieri N, 2007, ENVIRON BIOL FISH, V78, P241, DOI 10.1007/s10641-006-9093-5; Tolimieri N, 2006, T AM FISH SOC, V135, P317, DOI 10.1577/T05-092.1; Tolimieri N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010653; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vellend M, 2001, J VEG SCI, V12, P545, DOI 10.2307/3237006; Vellend M, 2007, J ECOL, V95, P565, DOI 10.1111/j.1365-2745.2007.01233.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yeh J, 2009, DEEP-SEA RES PT I, V56, P251, DOI 10.1016/j.dsr.2008.08.005; Zintzen V, 2011, ECOGRAPHY, V34, P306, DOI 10.1111/j.1600-0587.2010.06546.x	89	38	39	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57918	10.1371/journal.pone.0057918	http://dx.doi.org/10.1371/journal.pone.0057918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526960	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100018
J	Lensen, KJDF; Voskuyl, AE; van der Laken, CJ; Comans, EFI; van Schaardenburg, D; Arntzenius, AB; Zwijnenburg, T; Stam, F; Gompelman, M; van der Zant, FM; van Paassen, AQA; Voerman, BJ; Smit, F; Anten, S; Siegert, CE; Binnerts, A; Smulders, YM				Lensen, Karel-Jan D. F.; Voskuyl, Alexandre E.; van der Laken, Conny J.; Comans, Emile F. I.; van Schaardenburg, Dirkjan; Arntzenius, Alex B.; Zwijnenburg, Ton; Stam, Frank; Gompelman, Michelle; v. d. Zant, Friso M.; van Paassen, Anneke Q. A.; Voerman, Bert J.; Smit, Frits; Anten, Sander; Siegert, Carl E.; Binnerts, Arjen; Smulders, Yvo M.			18F-Fluorodeoxyglucose Positron Emission Tomography in Elderly Patients with an Elevated Erythrocyte Sedimentation Rate of Unknown Origin	PLOS ONE			English	Article							GIANT-CELL ARTERITIS; DIAGNOSTIC PERFORMANCE; POLYMYALGIA-RHEUMATICA; FDG-PET; FEVER; MULTICENTER; INVOLVEMENT; MRI; CT	Patients with an elevated erythrocyte sedimentation rate (ESR) and non-specific symptoms often pose a diagnostic dilemma. PET/CT visualises infection, inflammation and malignancy, all of which may cause elevated ESR. The objective of this study was to determine the contribution of 18F-fluorodeoxglucose positron emission tomography (PET/CT) in the diagnostic work-up of referred patients with an elevated ESR, in whom initial routine evaluation did not reveal a diagnosis. We conducted a combined retrospective (A) and prospective (B) study in elderly (>50 years) patients with a significantly elevated ESR of >= 50 mm/h and non-specific complaints. In study A, 30 patients were included. Malignancy (8 patients), auto-inflammatory disease (8 patients, including 5 with large-vessel vasculitis) and infection (3 patients) were suggested by PET/CT. Two scans showed non-specific abnormalities and 9 scans were normal. Of the 21 abnormal PET/CT results, 12 diagnoses were independently confirmed and two alternative diagnosis were made. Two diagnoses were established in patients with a normal scan. In study B, 58 patients in whom a prior protocolised work-up was non-diagnostic, were included. Of these, 25 PET/CT-scans showed suspected auto-inflammatory disease, particularly large-vessel vasculitis (14 cases). Infection and malignancy was suspected in 5 and 3 cases, respectively. Seven scans demonstrated non-specific abnormalities, 20 were normal. Of the 40 abnormal PET/CT results, 22 diagnoses were confirmed, 3 alternative diagnoses were established. Only one diagnosis was established in the 20 patients with a normal scan. In both studies, the final diagnosis was based on histology, clinical follow-up, response to therapy or additional imaging. In conclusion, PET/CT may be of potential value in the diagnostic work-up of patients with elevated ESR if routine evaluation reveals no diagnosis. In particular, large-vessel vasculitis appears to be a common finding. A normal PET/CT scan in these patients suggests that it is safe to follow a wait-and-see policy.	[Lensen, Karel-Jan D. F.; Smulders, Yvo M.] VU Univ Med Ctr Amsterdam, Dept Internal Med, Amsterdam, Netherlands; [Lensen, Karel-Jan D. F.; Smulders, Yvo M.] VU Univ Med Ctr Amsterdam, Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands; [Voskuyl, Alexandre E.; van der Laken, Conny J.] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Comans, Emile F. I.] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med, Amsterdam, Netherlands; [van Schaardenburg, Dirkjan] Jan van Breemen Inst Reade, Dept Rheumatol, Amsterdam, Netherlands; [Arntzenius, Alex B.] Spaarne Hosp, Dept Internal Med, Hoofddorp, Netherlands; [Zwijnenburg, Ton] Spaarne Hosp, Dept Nucl Med, Hoofddorp, Netherlands; [Stam, Frank; Gompelman, Michelle] Med Ctr Alkmaar, Dept Internal Med, Alkmaar, Netherlands; [v. d. Zant, Friso M.] Med Ctr Alkmaar, Dept Nucl Med, Alkmaar, Netherlands; [van Paassen, Anneke Q. A.] Kennemer Gasthuis, Dept Internal Med, Haarlem, Netherlands; [Voerman, Bert J.] Amstelland Hosp, Dept Internal Med, Amstelveen, Netherlands; [Smit, Frits] Rijnland Hosp, Dept Internal Med, Leiderdorp, Netherlands; [Anten, Sander] Rijnland Hosp, Dept Nucl Med, Leiderdorp, Netherlands; [Siegert, Carl E.] Sint Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; [Binnerts, Arjen] Zaans Med Ctr, Dept Internal Med, Zaandam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Spaarne Hospital; Spaarne Hospital; Medical Center Of Alkmaar; Medical Center Of Alkmaar; Spaarne Hospital; Rijnland Hospital; Rijnland Hospital; Sint Lucas Andreas Hospital	Smulders, YM (corresponding author), VU Univ Med Ctr Amsterdam, Dept Internal Med, Amsterdam, Netherlands.	y.smulders@vumc.nl	Smulders, YM/AAG-7506-2021; Gompelman, Michelle/H-2503-2017	Anten, Sander/0000-0002-6371-6255; Gompelman, Michelle/0000-0002-8568-5437; Voskuyl, Alexandre/0000-0002-9699-1827	dutch arthritis foundation	dutch arthritis foundation	The work was sponsored by a grant provided by the dutch arthritis foundation (www.reumafonds.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balink H, 2009, CLIN NUCL MED, V34, P862, DOI 10.1097/RLU.0b013e3181becfb1; Belhocine T, 2004, EUR J NUCL MED MOL I, V31, P1055, DOI 10.1007/s00259-004-1547-4; Besson FL, 2011, EUR J NUCL MED MOL I, V38, P1764, DOI 10.1007/s00259-011-1830-0; Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Bleeker-Rovers CP, 2009, SEMIN NUCL MED, V39, P81, DOI 10.1053/j.semnuclmed.2008.10.002; Bley TA, 2005, MAGN RESON MATER PHY, V18, P193, DOI 10.1007/s10334-005-0119-3; Blockmans D, 2000, AM J MED, V108, P246, DOI 10.1016/S0002-9343(99)00424-6; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; Buysschaert Ian, 2004, Eur J Intern Med, V15, P151, DOI 10.1016/j.ejim.2004.01.018; Cankurtaran M, 2009, ARCH GERONTOL GERIAT; Federici L, 2010, INT J CLIN PRACT, V64, P55, DOI 10.1111/j.1742-1241.2008.01774.x; Fuchs M, 2012, EUR J NUCL MED MOL I, V39, P344, DOI 10.1007/s00259-011-1967-x; GERBER NJ, 1984, EUR NEUROL, V23, P410, DOI 10.1159/000115723; Henes JC, 2008, CLIN EXP RHEUMATOL, V26, pS47; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Janssen SP, 2008, J VASC SURG, V48, P1025, DOI 10.1016/j.jvs.2008.04.054; Jaruskova M, 2006, EUR J NUCL MED MOL I, V33, P913, DOI 10.1007/s00259-006-0064-z; Keidar Z, 2008, J NUCL MED, V49, P1980, DOI 10.2967/jnumed.108.054692; Kubota K, 2011, ANN NUCL MED, V25, P355, DOI 10.1007/s12149-011-0470-6; LIE JT, 1995, SEMIN ARTHRITIS RHEU, V24, P422, DOI 10.1016/S0049-0172(95)80010-7; Lorenzen J, 2001, NUCL MED COMMUN, V22, P779, DOI 10.1097/00006231-200107000-00009; Markl M, 2006, J MAGN RESON IMAGING, V24, P423, DOI 10.1002/jmri.20639; Mourad O, 2003, ARCH INTERN MED, V163, P545, DOI 10.1001/archinte.163.5.545; Narvaez J, 2005, RHEUMATOLOGY, V44, P479, DOI 10.1093/rheumatology/keh513; Nuenninghoff DM, 2003, ARTHRITIS RHEUM-US, V48, P3522, DOI 10.1002/art.11353; Ostberg G, 1973, ACTA PATHOL MICR S59, P59; Ostberg G, 1973, ACTA PATHOL MIC S237, P237; Prieto-Gonzalez S, 2012, ANN RHEUM DIS, V71, P1170, DOI 10.1136/annrheumdis-2011-200865; Rosenbaum J, 2011, HELL J NUCL MED, V14, P255; Saadeh C, 1998, SOUTHERN MED J, V91, P220; Sheng JF, 2011, EUR J INTERN MED, V22, P112, DOI 10.1016/j.ejim.2010.09.015; SHUSTERMAN N, 1985, ARCH INTERN MED, V145, P1796, DOI 10.1001/archinte.145.10.1796; Townsend DW, 2008, SEMIN NUCL MED, V38, P152, DOI 10.1053/j.semnuclmed.2008.01.003; Vanderschueren S, 2009, EUR J INTERN MED, V20, P415, DOI 10.1016/j.ejim.2009.01.002; Wagner AD, 2005, ANN RHEUM DIS, V64, P105, DOI 10.1136/ard.2003.018259; WYLER DJ, 1977, SOUTHERN MED J, V70, P1428, DOI 10.1097/00007611-197712000-00015; Younge BR, 2004, MAYO CLIN PROC, V79, P483, DOI 10.4065/79.4.483	38	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58917	10.1371/journal.pone.0058917	http://dx.doi.org/10.1371/journal.pone.0058917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527049	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100055
J	Ogwang, C; Afolabi, M; Kimani, D; Jagne, YJ; Sheehy, SH; Bliss, CM; Duncan, CJA; Collins, KA; Knight, MAG; Kimani, E; Anagnostou, NA; Berrie, E; Moyle, S; Gilbert, SC; Spencer, AJ; Soipei, P; Mueller, J; Okebe, J; Colloca, S; Cortese, R; Viebig, NK; Roberts, R; Gantlett, K; Lawrie, AM; Nicosia, A; Imoukhuede, EB; Bejon, P; Urban, BC; Flanagan, KL; Ewer, KJ; Chilengi, R; Hill, AVS; Bojang, K				Ogwang, Caroline; Afolabi, Muhammed; Kimani, Domtila; Jagne, Ya Jankey; Sheehy, Susanne H.; Bliss, Carly M.; Duncan, Christopher J. A.; Collins, Katharine A.; Knight, Miguel A. Garcia; Kimani, Eva; Anagnostou, Nicholas A.; Berrie, Eleanor; Moyle, Sarah; Gilbert, Sarah C.; Spencer, Alexandra J.; Soipei, Peninah; Mueller, Jenny; Okebe, Joseph; Colloca, Stefano; Cortese, Riccardo; Viebig, Nicola K.; Roberts, Rachel; Gantlett, Katherine; Lawrie, Alison M.; Nicosia, Alfredo; Imoukhuede, Egeruan B.; Bejon, Philip; Urban, Britta C.; Flanagan, Katie L.; Ewer, Katie J.; Chilengi, Roma; Hill, Adrian V. S.; Bojang, Kalifa			Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults	PLOS ONE			English	Article							VIRUS ANKARA VACCINES; FOWLPOX STRAIN FP9; T-CELLS RECOGNIZE; CIRCUMSPOROZOITE PROTEIN; IMMUNE-RESPONSES; RANDOMIZED-TRIAL; VIRAL VECTORS; RECOMBINANT; ADENOVIRUS; CHILDREN	Background: Heterologous prime boost immunization with chimpanzee adenovirus 63 (ChAd63) and Modified vaccinia Virus Ankara (MVA) vectored vaccines is a strategy recently shown to be capable of inducing strong cell mediated responses against several antigens from the malaria parasite. ChAd63-MVA expressing the Plasmodium falciparum pre-erythrocytic antigen ME-TRAP (multiple epitope string with thrombospondin-related adhesion protein) is a leading malaria vaccine candidate, capable of inducing sterile protection in malaria naive adults following controlled human malaria infection (CHMI). Methodology: We conducted two Phase Ib dose escalation clinical trials assessing the safety and immunogenicity of ChAd63-MVA ME-TRAP in 46 healthy malaria exposed adults in two African countries with similar malaria transmission patterns. Results: ChAd63-MVA ME-TRAP was shown to be safe and immunogenic, inducing high-level T cell responses (median >1300 SFU/million PBMC). Conclusions: ChAd63-MVA ME-TRAP is a safe and highly immunogenic vaccine regimen in adults with prior exposure to malaria. Further clinical trials to assess safety and immunogenicity in children and infants and protective efficacy in the field are now warranted.	[Ogwang, Caroline; Kimani, Domtila; Knight, Miguel A. Garcia; Kimani, Eva; Soipei, Peninah; Bejon, Philip; Urban, Britta C.; Chilengi, Roma] Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya; [Afolabi, Muhammed; Jagne, Ya Jankey; Mueller, Jenny; Okebe, Joseph; Flanagan, Katie L.; Bojang, Kalifa] MRC Unit, Fajara, Gambia; [Sheehy, Susanne H.; Duncan, Christopher J. A.; Anagnostou, Nicholas A.; Roberts, Rachel; Gantlett, Katherine; Lawrie, Alison M.; Hill, Adrian V. S.] Churchill Hosp, Jenner Inst, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Bliss, Carly M.; Collins, Katharine A.; Gilbert, Sarah C.; Spencer, Alexandra J.; Ewer, Katie J.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst Labs, Oxford, England; [Berrie, Eleanor; Moyle, Sarah] Univ Oxford, Churchill Hosp, Clin Biomfg Facil, Oxford, England; [Colloca, Stefano; Cortese, Riccardo; Nicosia, Alfredo] Okairos AG, Rome, Italy; [Nicosia, Alfredo] CEINGE, Naples, Italy; [Viebig, Nicola K.; Imoukhuede, Egeruan B.] European Vaccine Initiat, Heidelberg, Germany; [Nicosia, Alfredo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Urban, Britta C.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Jenner Institute; University of Oxford; University of Oxford; CEINGE Biotecnologie Avanzate; University of Naples Federico II; Liverpool School of Tropical Medicine; University of Liverpool	Sheehy, SH (corresponding author), Churchill Hosp, Jenner Inst, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England.	Susanne.sheehy@ndm.ox.ac.uk	Collins, Katharine/N-4369-2015; Spencer, Alexandra/AAE-6494-2019; Urban, Britta/W-6087-2018; Okebe, Joseph/Y-1664-2019; Ewer, Katie J/B-4328-2011; Gilbert, Sarah C./H-2857-2019; Duncan, Christopher/A-2018-2012	Collins, Katharine/0000-0002-7080-2215; Spencer, Alexandra/0000-0001-7958-6961; Urban, Britta/0000-0002-4197-8393; Okebe, Joseph/0000-0001-5466-1611; Ewer, Katie J/0000-0001-9827-9836; Gilbert, Sarah C./0000-0002-6823-9750; Afolabi, Muhammed/0000-0002-9967-6419; Imoukhuede, Egeruan Babatunde/0000-0001-6679-0904; OGWANG, CAROLINE/0000-0003-2689-9459; Garcia Knight, Miguel Antonio/0000-0001-9556-3719; Bliss, Carly/0000-0002-5117-1016; Hodgson, Susanne/0000-0002-0895-3442; Bojang, Kalifa/0000-0001-7506-0938; Duncan, Christopher/0000-0003-4181-2315; Flanagan, Katie/0000-0002-1575-1953	European and Developing Countries Clinical Trials Partnership (EDCTP); UK National Institute of Health Research through the Oxford Biomedical Research Centre [A91301 Adult Vaccine]; Wellcome Trust [084113/Z/07/Z]; Medical Research Council; Medical Research Council [MC_UP_A900_1118, G1002624, G0502018] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10233] Funding Source: researchfish; MRC [G1002624, G0502018, MC_UP_A900_1118] Funding Source: UKRI	European and Developing Countries Clinical Trials Partnership (EDCTP); UK National Institute of Health Research through the Oxford Biomedical Research Centre; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was performed by the Malaria Vectored Vaccines Consortium (MVVC), a four year integrated project funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). The work was also supported by the UK National Institute of Health Research through the Oxford Biomedical Research Centre (http://www.oxfordbrc.org/) [A91301 Adult Vaccine], the Wellcome Trust (http://www.wellcome.ac.uk/) [084113/Z/07/Z] and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Bejon P, 2006, CLIN INFECT DIS, V42, P1102, DOI 10.1086/501459; Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Gilbert SC, 1997, NAT BIOTECHNOL, V15, P1280, DOI 10.1038/nbt1197-1280; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; Greenwood B, 2011, LANCET INFECT DIS, V11, P75, DOI 10.1016/S1473-3099(11)70001-9; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hill AV, 2012, NEW ENGL J MED, P366; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; Imoukhuede EB, 2006, VACCINE, V24, P6526, DOI 10.1016/j.vaccine.2006.06.022; KHUSMITH S, 1994, INFECT IMMUN, V62, P2979, DOI 10.1128/IAI.62.7.2979-2983.1994; Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Moorthy VS, 2003, J INFECT DIS, V188, P1239, DOI 10.1086/378515; Moorthy VS, 2003, VACCINE, V21, P1995, DOI 10.1016/S0264-410X(02)00771-5; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Prieur E, 2004, P NATL ACAD SCI USA, V101, P290, DOI 10.1073/pnas.0307158101; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwenk RJ, 2011, TRENDS PARASITOL, V27, P306, DOI 10.1016/j.pt.2011.02.002; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Sherman ACL, 2012, NEW ENGL J MED, V366, P764, DOI 10.1056/NEJMc1200170; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2000, BENCH AIDS DIAGN MAL	49	50	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57726	10.1371/journal.pone.0057726	http://dx.doi.org/10.1371/journal.pone.0057726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526949	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000317562100016
J	Siekmeier, PJ; vanMaanen, DP				Siekmeier, Peter J.; vanMaanen, David P.			Development of Antipsychotic Medications with Novel Mechanisms of Action Based on Computational Modeling of Hippocampal Neuropathology	PLOS ONE			English	Article							PERSISTENT NA+ CURRENT; BIPOLAR DISORDER; SCHIZOPHRENIA-PATIENTS; SYNAPTIC PLASTICITY; COGNITIVE DEFICITS; GAMMA-OSCILLATIONS; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; MAJOR DEPRESSION; RECOMBINANT AMPA	A large number of cellular level abnormalities have been identified in the hippocampus of schizophrenic subjects. Nonetheless, it remains uncertain how these pathologies interact at a system level to create clinical symptoms, and this has hindered the development of more effective antipsychotic medications. Using a 72-processor supercomputer, we created a tissue level hippocampal simulation, featuring multicompartmental neuron models with multiple ion channel subtypes and synaptic channels with realistic temporal dynamics. As an index of the schizophrenic phenotype, we used the specific inability of the model to attune to 40 Hz (gamma band) stimulation, a well-characterized abnormality in schizophrenia. We examined several possible combinations of putatively schizophrenogenic cellular lesions by systematically varying model parameters representing NMDA channel function, dendritic spine density, and GABA system integrity, conducting 910 trials in total. Two discrete "clusters'' of neuropathological changes were identified. The most robust was characterized by co-occurring modest reductions in NMDA system function (-30%) and dendritic spine density (-30%). Another set of lesions had greater NMDA hypofunction along with low level GABA system dysregulation. To the schizophrenic model, we applied the effects of 1,500 virtual medications, which were implemented by varying five model parameters, independently, in a graded manner; the effects of known drugs were also applied. The simulation accurately distinguished agents that are known to lack clinical efficacy, and identified novel mechanisms (e.g., decrease in AMPA conductance decay time constant, increase in projection strength of calretinin-positive interneurons) and combinations of mechanisms that could re-equilibrate model behavior. These findings shed light on the mechanistic links between schizophrenic neuropathology and the gamma band oscillatory abnormalities observed in the illness. As such, they generate specific falsifiable hypotheses, which can guide postmortem and other laboratory research. Significantly, this work also suggests specific non-obvious targets for potential pharmacologic agents.	[Siekmeier, Peter J.; vanMaanen, David P.] McLean Hosp, Lab Computat Neurosci, Belmont, MA 02178 USA; [Siekmeier, Peter J.; vanMaanen, David P.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Siekmeier, PJ (corresponding author), McLean Hosp, Lab Computat Neurosci, 115 Mill St, Belmont, MA 02178 USA.	psiekmeier@mclean.harvard.edu			National Institute of Mental Health [K08 MH072771, P50 MH060450]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060450, K08MH072771] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by National Institute of Mental Health grants K08 MH072771 and P50 MH060450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Arai AC, 2002, J PHARMACOL EXP THER, V303, P1075, DOI 10.1124/jpet.102.040360; Atack JR, 2010, J PHARMACOL EXP THER, V332, P17, DOI 10.1124/jpet.109.157909; Bayarri MJ, 2007, ANN STAT, V35, P1874, DOI 10.1214/009053607000000163; Beasley CL, 2002, BIOL PSYCHIAT, V52, P708, DOI 10.1016/S0006-3223(02)01360-4; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Benes FM, 1996, SYNAPSE, V22, P338; Bergeron R, 2005, NEUROPSYCHOPHARMACOL, V30, P7, DOI 10.1038/sj.npp.1300559; Berk R, 2007, STAT SCI, V17, P173; BIRD ED, 1977, LANCET, V2, P1157, DOI 10.1016/S0140-6736(77)91542-2; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; CHAO TI, 1995, NEUROREPORT, V6, P1778, DOI 10.1097/00001756-199509000-00017; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Coyle JT, 2010, DIALOGUES CLIN NEURO, V12; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; Denolle T, 2002, FUND CLIN PHARMACOL, V16, P527, DOI 10.1046/j.1472-8206.2002.00110.x; DEUTZ NEP, 1986, EUR J PHARMACOL, V125, P429, DOI 10.1016/0014-2999(86)90799-5; DeVito LM, 2011, GENES BRAIN BEHAV, V10, P210, DOI 10.1111/j.1601-183X.2010.00656.x; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Easterling R, 2002, STAT FDN VALIDATION; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; Ferrarelli F, 2008, AM J PSYCHIAT, V165, P996, DOI 10.1176/appi.ajp.2008.07111733; FINK M, 1979, THER DRUG MONIT, V1, P93, DOI 10.1097/00007691-197901000-00010; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Goff DC, 2008, NEUROPSYCHOPHARMACOL, V33, P465, DOI 10.1038/sj.npp.1301444; Greene R, 2001, HIPPOCAMPUS, V11, P569, DOI 10.1002/hipo.1072.abs; Grove SJA, 2010, J MED CHEM, V53, P7271, DOI 10.1021/jm1000419; Harrison PJ, 2003, ANN NY ACAD SCI, V1003, P94, DOI 10.1196/annals.1300.006; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Heckers S, 2010, CURR TOP BEHAV NEURO, V4, P529, DOI 10.1007/7854_2010_43; Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19; HERKES GK, 1993, J CLIN NEUROPHYSIOL, V10, P210, DOI 10.1097/00004691-199304000-00008; Hirano S, 2008, J NEUROSCI, V28, P4897, DOI 10.1523/JNEUROSCI.5031-07.2008; HOFFMAN RE, 1989, SCHIZOPHRENIA BULL, V15, P477, DOI 10.1093/schbul/15.3.477; HOFFMAN RE, 1987, ARCH GEN PSYCHIAT, V44, P178; Hoffman RE, 2003, KAPLAN SADOCKS SYNOP; JOHANSEN TH, 1995, MOL PHARMACOL, V48, P946; KILPATRICK CJ, 1984, BRIT J CLIN PHARMACO, V17, P539, DOI 10.1111/j.1365-2125.1984.tb02387.x; Kissler J, 2000, CLIN NEUROPHYSIOL, V111, P2079, DOI 10.1016/S1388-2457(00)00425-9; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lampl I, 1998, J PHARMACOL EXP THER, V284, P228; Law AJ, 2004, AM J PSYCHIAT, V161, P1848, DOI 10.1176/appi.ajp.161.10.1848; Law AJ, 2001, NEUROREPORT, V12, P2971, DOI 10.1097/00001756-200109170-00043; Lewis DA, 2008, AM J PSYCHIAT, V165, P1585, DOI 10.1176/appi.ajp.2008.08030395; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; Lisman J, 2012, CURR OPIN NEUROBIOL, V22, P537, DOI 10.1016/j.conb.2011.10.018; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Sannita WG, 1999, NEUROPSYCHOBIOLOGY, V40, P158, DOI 10.1159/000026614; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Siekmeier PJ, 2007, SCHIZOPHR RES, V89, P177, DOI 10.1016/j.schres.2006.08.007; Siekmeier PJ, 2009, BEHAV BRAIN RES, V200, P220, DOI 10.1016/j.bbr.2009.01.021; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Stilo Simona A, 2010, Dialogues Clin Neurosci, V12, P305; Teale P, 2008, NEUROIMAGE, V42, P1481, DOI 10.1016/j.neuroimage.2008.06.020; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Traub RD, 1995, J COMPUT NEUROSCI, V2, P291, DOI 10.1007/BF00961441; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; TSAI GC, 1995, ARCH GEN PSYCHIAT, V52, P829; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VANWIERINGEN A, 1989, NEUROPSYCHOBIOLOGY, V21, P157, DOI 10.1159/000118570; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wang XJ, 2006, PHARMACOPSYCHIATRY, V39, pS80, DOI 10.1055/s-2006-931501	73	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58607	10.1371/journal.pone.0058607	http://dx.doi.org/10.1371/journal.pone.0058607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526999	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100032
J	Perez-Madrid, A; Lapas, LC; Rubi, JM				Perez-Madrid, Agustin; Lapas, Luciano C.; Miguel Rubi, J.			A Thermokinetic Approach to Radiative Heat Transfer at the Nanoscale	PLOS ONE			English	Article								Radiative heat exchange at the nanoscale presents a challenge for several areas due to its scope and nature. Here, we provide a thermokinetic description of microscale radiative energy transfer including phonon-photon coupling manifested through a non-Debye relaxation behavior. We show that a lognormal-like distribution of modes of relaxation accounts for this non-Debye relaxation behavior leading to the thermal conductance. We also discuss the validity of the fluctuation-dissipation theorem. The general expression for the thermal conductance we obtain fits existing experimental results with remarkable accuracy. Accordingly, our approach offers an overall explanation of radiative energy transfer through micrometric gaps regardless of geometrical configurations and distances.	[Perez-Madrid, Agustin; Miguel Rubi, J.] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Catalunya, Spain; [Lapas, Luciano C.] Univ Fed Integracao, Inst Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil	University of Barcelona	Perez-Madrid, A (corresponding author), Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Catalunya, Spain.	agustiperezmadrid@ub.edu; luciano.lapas@pq.cnpq.br; mrubi@ub.edu	Lapas, Luciano/F-8718-2012; Lapas, Luciano Calheiros/O-7628-2019; Lapas, Luciano/B-1581-2008	Lapas, Luciano/0000-0002-0029-5625; Lapas, Luciano Calheiros/0000-0002-0029-5625; Lapas, Luciano/0000-0002-0029-5625	MICINN of the Spanish Government [FIS2008-04386]; Fundacao Araucaria and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian Government; Generalitat de Catalunya	MICINN of the Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacao Araucaria and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian Government; Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by MICINN of the Spanish Government, under Grant No. FIS2008-04386, and by Fundacao Araucaria and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico of the Brazilian Government. JMR acknowledges financial support from Generalitat de Catalunya under program ICREA Academia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2007, INT J ENERG RES, V31, P689, DOI 10.1002/er.1286; Biehs SA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.234301; Chumakov AI, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225501; De Groot S. R., 1984, NONEQUILIBRIUM THERM; Debye PJW, 1929, POLAR MOL; DENISOV YV, 1990, JETP LETT+, V52, P411; Domingues G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.085901; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GRAEBNER JE, 1986, PHYS REV B, V34, P5696, DOI 10.1103/PhysRevB.34.5696; LYNN JW, 1973, PHYS REV B, V8, P3493, DOI 10.1103/PhysRevB.8.3493; Morozhenko V., 2012, INFRARED RAD; Mulet JP, 2002, MICROSCALE THERM ENG, V6, P209, DOI 10.1080/10893950290053321; Pan JL, 2000, OPT LETT, V25, P369, DOI 10.1364/OL.25.000369; Pendry JB, 1999, J PHYS-CONDENS MAT, V11, P6621, DOI 10.1088/0953-8984/11/35/301; Perez-Madrid A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155417; Perez-Madrid A, 2010, J NON-EQUIL THERMODY, V35, P279, DOI 10.1515/JNETDY.2010.17; Perez-Madrid A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.048301; Planck M. K. E. L., 1991, THEORY HEAT RAD; POLDER D, 1971, PHYS REV B, V4, P3303, DOI 10.1103/PhysRevB.4.3303; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; RYTOV S. M., 1959, THEORY ELECT FLUCTUA; Sasihithlu K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.161406; Shen S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4723713; Shen S, 2009, NANO LETT, V9, P2909, DOI 10.1021/nl901208v; Shintani H, 2008, NAT MATER, V7, P870, DOI 10.1038/nmat2293; Yager WA, 1936, PHYSICS-J GEN APPL P, V7, P434, DOI 10.1063/1.1745355; Zanatta M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.212201; Zhang Z.M., 2007, NANOMICROSCALE HEAT	29	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58770	10.1371/journal.pone.0058770	http://dx.doi.org/10.1371/journal.pone.0058770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527019	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600010
J	Nurena, CR; Brown, B; Galea, JT; Sanchez, H; Blas, MM				Nurena, Cesar R.; Brown, Brandon; Galea, Jerome T.; Sanchez, Hugo; Blas, Magaly M.			HPV and Genital Warts among Peruvian Men Who Have Sex with Men and Transgender People: Knowledge, Attitudes and Treatment Experiences	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SEXUALLY-TRANSMITTED INFECTIONS; QUALITY-OF-LIFE; ANOGENITAL WARTS; THE-LITERATURE; ANAL CANCER; HIV; PREVALENCE; BURDEN; IMPACT	Background: Several studies have assessed the epidemiology of HPV infection among MSM, but no qualitative studies have specifically assessed how HPV and genital warts (GW) affect South American men who have sex with men (MSM) and maleto-female transgendered women (TG). This study explored the knowledge, attitudes and experiences of Peruvian MSM and TG regarding HPV and GW. Methods: We performed a qualitative study consisting of fifteen in-depth interviews and three focus groups carried out in Lima, Peru with diverse MSM and TG groups, including sex workers. Resulting data were analyzed by applying a systematic comparative and descriptive content analysis. Results: While knowledge of HPV was limited, awareness of GW was common, particularly among TG persons and sex workers. Still, few participants recognized that GW are sexually transmitted, and many had problems differentiating between GW and other STI/anogenital conditions. Stigmatizing experiences were common during sexual encounters with people who had visible GW. Shame, emotional and physical troubles, and embarrassing sexual experiences were reported by individuals with GW. Search for treatment was mediated by peers, but stigma and apparent health services' inability to deal with GW limited the access to effective medical care. Conclusions: In Peru, public health interventions should strengthen services for HPV/GW management and increase accurate knowledge of the transmission, treatment, and sequelae of HPV/GW in MSM and TG populations.	[Nurena, Cesar R.] Univ Nacl Mayor San Marcos, Escuela Antropol, Lima 14, Peru; [Brown, Brandon] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA; [Galea, Jerome T.; Sanchez, Hugo] Epicentro, Lima, Peru; [Blas, Magaly M.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru	Universidad Nacional Mayor de San Marcos; University of California System; University of California Irvine; Universidad Peruana Cayetano Heredia	Brown, B (corresponding author), Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA.	brandojb@uci.edu	Galea, Jerome T./AAF-2172-2019; Galea, Jerome T/HGV-0203-2022	Galea, Jerome T./0000-0001-8732-6959; Galea, Jerome T/0000-0001-8732-6959; Nurena, Cesar R./0000-0002-3290-7948; Brown, Brandon/0000-0002-6348-4108	NIH [T32 MH080634]; FIC/NIH [1R01TW008398]; UCLA AIDS Institute International Travel grant; Merck Investigator-Initiated Studies Program of Merck Co Inc.; FOGARTY INTERNATIONAL CENTER [R01TW008398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIC/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); UCLA AIDS Institute International Travel grant; Merck Investigator-Initiated Studies Program of Merck Co Inc.; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded, in part, by NIH grant T32 MH080634, FIC/NIH grant 1R01TW008398 to Magaly Blas, and the UCLA AIDS Institute International Travel grant. Supported in part by a research grant from the Merck Investigator-Initiated Studies Program of Merck & Co Inc. The opinions expressed in this paper are of the authors and do not necessarily represent those of Merck & Co Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badia Xavier, 2005, Health Qual Life Outcomes, V3, P24, DOI 10.1186/1477-7525-3-24; Baer H, 2000, J COMMUN HEALTH, V25, P67, DOI 10.1023/A:1005192902137; Bertram CC, 2008, AM J HEALTH EDUC, V39, P15, DOI 10.1080/19325037.2008.10599009; Blackwell CW, 2011, J ASSOC NURSE AIDS C, V22, P444, DOI 10.1016/j.jana.2011.08.004; Blas MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027334; Brewer NT, 2010, J BEHAV MED, V33, P274, DOI 10.1007/s10865-010-9251-2; Brown B, 2012, VIRUSES-BASEL, V4, P3851, DOI 10.3390/v4123851; Brown B, 2010, VACCINE, V28, P7743, DOI 10.1016/j.vaccine.2010.09.063; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Colon-Lopez V, 2010, P R HEALTH SCI J, V29, P232; Cuschieri KS, 2006, J MED SCREEN, V13, P201, DOI 10.1177/096914130601300408; Dediol I, 2009, J EUR ACAD DERMATOL, V23, P1035, DOI 10.1111/j.1468-3083.2009.03242.x; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Gorbach P, 2007, QUALITATIVE METHODS, P447; Hammarlund K, 2007, INT J MENS HLTH, V6, P100; Ireland JA, 2005, INT J STD AIDS, V16, P667, DOI 10.1258/095646205774357334; Jeynes C, 2009, INT J STD AIDS, V20, P557, DOI 10.1258/ijsa.2008.008412; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Klug SJ, 2008, PREV MED, V46, P87, DOI 10.1016/j.ypmed.2007.09.003; Lee Mortensen Gitte, 2010, BMC Res Notes, V3, P280, DOI 10.1186/1756-0500-3-280; Malta M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-18; Maw RD, 1998, INT J STD AIDS, V9, P571, DOI 10.1258/0956462981921143; Mortensen GL, 2010, DAN MED BULL, V57; Mortensen GL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-113; Nurena CR, 2011, CULT HEALTH SEX, V13, P1207, DOI 10.1080/13691058.2011.609908; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pitts MK, 2007, SEX TRANSM DIS, V34, P170, DOI 10.1097/01.olq.0000230436.83029.ce; Quinn R, 2012, AIDS RES HUM RETROV, V28, P1734, DOI [10.1089/aid.2011.0307, 10.1089/AID.2011.0307]; Salazar Ximena, 2006, Cad. Saúde Pública, V22, P2097, DOI 10.1590/S0102-311X2006001000015; Sanchez DM, 2012, INT J STD AIDS, V23, P41, DOI 10.1258/ijsa.2011.011163; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Skaaby S, 2011, INT J STD AIDS, V22, P214, DOI 10.1258/ijsa.2011.010372; Tider DS, 2005, INT J STD AIDS, V16, P707, DOI 10.1258/095646205774357389; Woodhall S, 2008, SEX TRANSM INFECT, V84, P161, DOI 10.1136/sti.2007.029512	38	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58684	10.1371/journal.pone.0058684	http://dx.doi.org/10.1371/journal.pone.0058684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516536	Green Published, gold			2022-12-27	WOS:000316407400049
J	Taib, N; Mangot, JF; Domaizon, I; Bronner, G; Debroas, D				Taib, Najwa; Mangot, Jean-Francois; Domaizon, Isabelle; Bronner, Gisele; Debroas, Didier			Phylogenetic Affiliation of SSU rRNA Genes Generated by Massively Parallel Sequencing: New Insights into the Freshwater Protist Diversity	PLOS ONE			English	Article							MICROBIAL DIVERSITY; SMALL EUKARYOTES; DEEP-SEA; ENVIRONMENTAL SURVEYS; MOLECULAR DIVERSITY; MAXIMUM-LIKELIHOOD; MARINE ECOSYSTEMS; TROPHIC STATUS; COMMUNITY; RARE	Recent advances in next-generation sequencing (NGS) technologies spur progress in determining the microbial diversity in various ecosystems by highlighting, for example, the rare biosphere. Currently, high-throughput pyrotag sequencing of PCR-amplified SSU rRNA gene regions is mainly used to characterize bacterial and archaeal communities, and rarely to characterize protist communities. In addition, although taxonomic assessment through phylogeny is considered as the most robust approach, similarity and probabilistic approaches remain the most commonly used for taxonomic affiliation. In a first part of this work, a tree-based method was compared with different approaches of taxonomic affiliation (BLAST and RDP) of 18S rRNA gene sequences and was shown to be the most accurate for near full-length sequences and for 400 bp amplicons, with the exception of amplicons covering the V5-V6 region. Secondly, the applicability of this method was tested by running a full scale test using an original pyrosequencing dataset of 18S rRNA genes of small lacustrine protists (0.2-5 mu m) from eight freshwater ecosystems. Our results revealed that i) fewer than 5% of the operational taxonomic units (OTUs) identified through clustering and phylogenetic affiliation had been previously detected in lakes, based on comparison to sequence in public databases; ii) the sequencing depth provided by the NGS coupled with a phylogenetic approach allowed to shed light on clades of freshwater protists rarely or never detected with classical molecular ecology approaches; and iii) phylogenetic methods are more robust in describing the structuring of under-studied or highly divergent populations. More precisely, new putative clades belonging to Mamiellophyceae, Foraminifera, Dictyochophyceae and Euglenida were detected. Beyond the study of protists, these results illustrate that the tree-based approach for NGS based diversity characterization allows an in-depth description of microbial communities including taxonomic profiling, community structuring and the description of clades of any microorganisms (protists, Bacteria and Archaea).	[Taib, Najwa; Mangot, Jean-Francois; Bronner, Gisele; Debroas, Didier] Univ Clermont Ferrand 2, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Taib, Najwa; Mangot, Jean-Francois; Bronner, Gisele; Debroas, Didier] CNRS, LMGE, UMR 6023, Aubiere, France; [Mangot, Jean-Francois; Domaizon, Isabelle] INRA, UMR CARRTEL 42, Thonon Les Bains, France; [Mangot, Jean-Francois; Domaizon, Isabelle] Univ Savoie, UMR CARRTEL 42, Le Bourget Du Lac, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); INRAE; Universite de Savoie	Debroas, D (corresponding author), Univ Clermont Ferrand 2, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, BP 10448, Clermont Ferrand, France.	Didier.Debroas@univ-bpclermont.fr	Domaizon, Isabelle/A-2517-2011; Mangot, Jean-François/A-8918-2010	Domaizon, Isabelle/0000-0001-9785-3082; Mangot, Jean-François/0000-0002-6225-8889; Bronner, Gisele/0000-0002-4863-4518	Le sonseil regional d'auvergne	Le sonseil regional d'auvergne	Funding came from Le sonseil regional d'auvergne "http://www.conseil-general.com/conseil-regional/conseil-regional-auvergne.htm". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Alverson AJ, 2005, J PHYCOL, V41, P1248, DOI 10.1111/j.1529-8817.2005.00136.x; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dawson Scott C, 2009, J Biol, V8, P105, DOI 10.1186/jbiol201; De Leon KB, 2012, MICROB ECOL, V64, P499, DOI 10.1007/s00248-012-0043-9; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Groisillier A, 2006, AQUAT MICROB ECOL, V42, P277, DOI 10.3354/ame042277; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartman AL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-317; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Holzmann M, 2003, J EUKARYOT MICROBIOL, V50, P135, DOI 10.1111/j.1550-7408.2003.tb00248.x; Hugenholtz P, 2002, GENOME BIOL, V3; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Lefranc M, 2005, APPL ENVIRON MICROB, V71, P5935, DOI 10.1128/AEM.71.10.5935-5942.2005; Lepere C, 2006, APPL ENVIRON MICROB, V72, P2971, DOI 10.1128/AEM.72.4.2971-2981.2006; Lepere C, 2008, APPL ENV MICROBIOLOG; Lepere C, 2007, FEMS MICROBIOL ECOL, V61, P483, DOI 10.1111/j.1574-6941.2007.00359.x; Lepere C, 2010, ISME J, V4, P1509, DOI 10.1038/ismej.2010.83; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Mangot JF, 2011, HYDROBIOLOGIA, V659, P37, DOI 10.1007/s10750-010-0268-x; Marin B, 2010, PROTIST, V161, P304, DOI 10.1016/j.protis.2009.10.002; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Mori H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-332; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Not F, 2004, APPL ENVIRON MICROB, V70, P4064, DOI 10.1128/AEM.70.7.4064-4072.2004; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Pandey Ram Vinay, 2010, BMC Res Notes, V3, P3, DOI 10.1186/1756-0500-3-3; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Core Team, 2012, R LANG ENV STAT COMP; Rasconi S, 2011, AQUAT MICROB ECOL, V62, P123, DOI 10.3354/ame01448; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards TA, 2005, ENVIRON MICROBIOL, V7, P1413, DOI 10.1111/j.1462-2920.2005.00828.x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Tarbe AL, 2011, AQUAT MICROB ECOL, V62, P177, DOI 10.3354/ame01465; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Y, 1999, NUCLEIC ACIDS RES, V27, P179, DOI 10.1093/nar/27.1.179; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DM, 2008, HEREDITY, V100, P207, DOI 10.1038/sj.hdy.6801011; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	80	70	71	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58950	10.1371/journal.pone.0058950	http://dx.doi.org/10.1371/journal.pone.0058950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516585	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400082
J	Tsai, CA; Liu, LYD				Tsai, Chen-An; Liu, Li-Yu Daisy			Identifying Gene Set Association Enrichment Using the Coefficient of Intrinsic Dependence	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; KYOTO ENCYCLOPEDIA; TARGET GENES; CANCER; PATHWAY; KEGG	Gene set testing problem has become the focus of microarray data analysis. A gene set is a group of genes that are defined by a priori biological knowledge. Several statistical methods have been proposed to determine whether functional gene sets express differentially (enrichment and/or deletion) in variations of phenotypes. However, little attention has been given to analyzing the dependence structure among gene sets. In this study, we have proposed a novel statistical method of gene set association analysis to identify significantly associated gene sets using the coefficient of intrinsic dependence. The simulation studies show that the proposed method outperforms the conventional methods to detect general forms of association in terms of control of type I error and power. The correlation of intrinsic dependence has been applied to a breast cancer microarray dataset to quantify the un-supervised relationship between two sets of genes in the tumor and non-tumor samples. It was observed that the existence of gene-set association differed across various clinical cohorts. In addition, a supervised learning was employed to illustrate how gene sets, in signaling transduction pathways or subnetworks regulated by a set of transcription factors, can be discovered using microarray data. In conclusion, the coefficient of intrinsic dependence provides a powerful tool for detecting general types of association. Hence, it can be useful to associate gene sets using microarray expression data. Through connecting relevant gene sets, our approach has the potential to reveal underlying associations by drawing a statistically relevant network in a given population, and it can also be used to complement the conventional gene set analysis.	[Tsai, Chen-An; Liu, Li-Yu Daisy] Natl Taiwan Univ, Dept Agron, Div Biometr, Taipei, Taiwan	National Taiwan University	Liu, LYD (corresponding author), Natl Taiwan Univ, Dept Agron, Div Biometr, Taipei, Taiwan.	lyliu@ntu.edu.tw		Tsai, Chen-An/0000-0002-7490-4331; Liu, Li-yu/0000-0001-6997-8101	National Science of Council, Taiwan [NSC 101-2118-M-002-005, NSC99-2118-M-002-004]	National Science of Council, Taiwan	This study was supported by National Science of Council grants (NSC 101-2118-M-002-005 to Dr. CA Tsai and NSC99-2118-M-002-004 to Dr. LYD Liu), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, HDB METHODS APPL STA; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bellman R., 1961, ADAPTIVE CONTROL PRO; Cover T.M., 2005, ELEMENTS INFORM THEO, DOI 10.1002/047174882x.ch2; FRIEDMAN JH, 1981, J AM STAT ASSOC, V76, P817, DOI 10.2307/2287576; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fung DCY, 2011, METHODS MOL BIOL, V781, P311, DOI 10.1007/978-1-61779-276-2_15; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hsing TL, 2005, PATTERN RECOGN, V38, P623, DOI 10.1016/j.patcog.2004.09.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung J-H, 2011, BRIEFINGS BIOINFORMA; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Jung JH, 2010, MOL CELLS, V29, P449, DOI 10.1007/s10059-010-0055-6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Lee Eunjee, 2007, BMC Proc, V1 Suppl 1, pS90; LEURGANS SE, 1993, J ROY STAT SOC B MET, V55, P725; Liese F, 2008, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-73194-0_1; Liu L-YD, 2005, THESIS TEXAS A M U C; Liu LYD, 2012, CANCER INFORM, V11, P87, DOI 10.4137/CIN.S8633; Liu LYD, 2012, CANCER INFORM, V11, P113, DOI 10.4137/CIN.S8470; Liu LYD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-85; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nasser S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S3; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; Stephens M.A., 1986, GOODNESS OF FIT TECH, DOI DOI 10.1201/9780203753064-4; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Todd AT, 2010, PLANT J, V62, P589, DOI 10.1111/j.1365-313X.2010.04186.x; Ziegler S, 2005, FEBS J, V272, P1600, DOI 10.1111/j.1742-4658.2005.04581.x	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58851	10.1371/journal.pone.0058851	http://dx.doi.org/10.1371/journal.pone.0058851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516564	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400068
J	Yang, DG; Zhou, YX; Yang, CW				Yang, Dagan; Zhou, Yunxian; Yang, Chunwei			Analysis of Laboratory Repeat Critical Values at a Large Tertiary Teaching Hospital in China	PLOS ONE			English	Article							PATHOLOGISTS Q-PROBES; SERUM; NOTIFICATION	Context: As a patient safety measure, laboratories are required to have a critical values policy by regulatory agencies. Unfortunately, little information is available on repeat critical values for the same analyte(s) on the same patient. Objective: To investigate the occurrence and distribution of repeat critical values and the relationship between the frequency of such values and patient outcome to provide information for hospitals on improving reporting policies. Methods: Eleven laboratory critical value lists, including chemistry and hematology analytes, were selected from a tertiary hospital in China in the year 2010. The distribution and interval time for each repeat critical value were calculated. Serum potassium and platelet count were used as examples to illustrate the relationship between the frequency of the repeat critical values and patient outcome. Results: All test items on the critical value list were prone to the occurrence of repeat critical values. On average, each patient who experienced critical values had 2.10 occurrences. The median interval time for each repeat critical value varied, with most being longer than 8 hours. For those patients who had repeat critical values of serum potassium and platelet count, along with the increased frequency, the patients had a longer hospital stay and a generally worse outcome. Conclusions: Patient can have a number of repeat critical values and the frequency of these values is closely related to patient outcome. A careful evaluation is warranted if a laboratory chooses to adopt a policy of not reporting each repeat critical value.	[Yang, Dagan; Yang, Chunwei] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Yunxian] Zhejiang Chinese Med Univ, Sch Nursing, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Chinese Medical University	Zhou, YX (corresponding author), Zhejiang Chinese Med Univ, Sch Nursing, Hangzhou, Zhejiang, Peoples R China.	yunxianzhou@hotmail.com			Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	The work was sponsored by Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. URL http://www.zjwst.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ChineseMedical Doctor Association, 2009, GUID IMPL PAT SAF GO; College of American Pathologists, 2010, LAB GEN CHECKL COMP; Dighe AS, 2008, ARCH PATHOL LAB MED, V132, P1666, DOI 10.1043/1543-2165(2008)132[1666:SOCVRA]2.0.CO;2; Dighe AS, 2006, AM J CLIN PATHOL, V125, P758, DOI 10.1309/R53XVC2U5CH6TNG8; Genzen JR, 2011, AM J CLIN PATHOL, V135, P505, DOI 10.1309/AJCP9IZT7BMBCJRS; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; Greinacher A, 2011, HEMATOLOGY AM SOC HE, P135; Howanitz JH, 2006, ARCH PATHOL LAB MED, V130, P828; Howanitz JH, 2007, AM J CLIN PATHOL, V127, P56, DOI 10.1309/Q3Y27QQLEL19340A; Howanitz PJ, 2002, ARCH PATHOL LAB MED, V126, P663; International Organization for Standardization, 2007, 151892007 ISO; Kost GJ, 2011, CLIN CHEM LAB MED, V49, P167, DOI 10.1515/CCLM.2011.033; LUNDBERG GD, 1990, JAMA-J AM MED ASSOC, V263, P709, DOI 10.1001/jama.263.5.709; Mirzoyev SA, 2010, RESUSCITATION, V81, P1632, DOI 10.1016/j.resuscitation.2010.08.007; Pai M, 2011, AM J CLIN PATHOL, V136, P836, DOI 10.1309/AJCP8O8GIPPPNUSH; Sanjay O P, 2004, Indian J Clin Biochem, V19, P40, DOI 10.1007/BF02872387; Valenstein PN, 2008, ARCH PATHOL LAB MED, V132, P1862, DOI 10.1043/1543-2165-132.12.1862; Wagar EA, 2007, ARCH PATHOL LAB MED, V131, P1769; Wagar EA, 2007, ARCH PATHOL LAB MED, V131, P44	19	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059518	10.1371/journal.pone.0059518	http://dx.doi.org/10.1371/journal.pone.0059518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516637	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400113
J	Kumazawa-Manita, N; Hama, H; Miyawaki, A; Iriki, A				Kumazawa-Manita, Noriko; Hama, Hiroshi; Miyawaki, Atsushi; Iriki, Atsushi			Tool Use Specific Adult Neurogenesis and Synaptogenesis in Rodent (Octodon degus) Hippocampus	PLOS ONE			English	Article							SYNAPSIN-I; ENRICHED ENVIRONMENT; PREFRONTAL CORTEX; NEURONS; ACTIVATION; PROTEINS	We previously demonstrated that degus (Octodon degus), which are a species of small caviomorph rodents, could be trained to use a T-shaped rake as a hand tool to expand accessible spaces. To elucidate the neurobiological underpinnings of this higher brain function, we compared this tool use learning task with a simple spatial (radial maze) memory task and investigated the changes that were induced in the hippocampal neural circuits known to subserve spatial perception and learning. With the exposure to an enriched environment in home cage, adult neurogenesis in the dentate gyrus of the hippocampus was augmented by tool use learning, but not radial maze learning, when compared to control conditions. Furthermore, the proportion of new synapses formed in the CA3 region of the hippocampus, the target area for projections of mossy fiber axons emanating from newborn neurons, was specifically increased by tool use learning. Thus, active tool use behavior by rodents, learned through multiple training sessions, requires the hippocampus to generate more novel neurons and synapses than spatial information processing in radial maze learning.	[Kumazawa-Manita, Noriko; Iriki, Atsushi] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan; [Hama, Hiroshi; Miyawaki, Atsushi] RIKEN Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan	RIKEN; RIKEN	Iriki, A (corresponding author), RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan.	iriki@brain.riken.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235	Funding Program for World-leading Innovative R&D on Science and Technology; JSPS, MEXT Japan	Funding Program for World-leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS, MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS, MEXT Japan, and the Funding Program for World-leading Innovative R&D on Science and Technology (AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00173; Akchiche N, 2010, HIPPOCAMPUS, V20, P949, DOI 10.1002/hipo.20690; Ambrogini P, 2010, HIPPOCAMPUS, V20, P799, DOI 10.1002/hipo.20679; ANDERSON JR, 1990, FOLIA PRIMATOL, V54, P138, DOI 10.1159/000156437; Baber C, 2006, APPL ERGON, V37, P3, DOI 10.1016/j.apergo.2005.06.004; Bernabeu R, 2000, J CEREBR BLOOD F MET, V20, P1669, DOI 10.1097/00004647-200012000-00006; Bluff LA, 2010, P ROY SOC B-BIOL SCI, V277, P1377, DOI 10.1098/rspb.2009.1953; Braun K, 2001, NEUROSCIENCE, V103, P861, DOI 10.1016/S0306-4522(01)00074-4; Breuer T, 2005, PLOS BIOL, V3, P2041, DOI 10.1371/journal.pbio.0030380; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Cheke LG, 2011, ANIM COGN; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Clark PJ, 2012, HIPPOCAMPUS, V22, P1860, DOI 10.1002/hipo.22020; Dubreuil D, 2003, NEUROBIOL LEARN MEM, V79, P109, DOI 10.1016/S1074-7427(02)00023-0; ELFERINK LA, 1993, J CELL SCI, P75; Epp JR, 2011, NEUROBIOL LEARN MEM, V95, P316, DOI 10.1016/j.nlm.2011.01.001; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8; HAYASHI T, 1994, CELL STRUCT FUNCT, V19, P253, DOI 10.1247/csf.19.253; Helmeke C, 2009, NEUROSCIENCE, V163, P790, DOI 10.1016/j.neuroscience.2009.07.008; Iriki A, 1996, NEUROREPORT, V7, P2325; Jacobs GH, 2003, J COMP PHYSIOL A, V189, P347, DOI 10.1007/s00359-003-0408-0; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Markakis EA, 1999, J COMP NEUROL, V406, P449; MCPHERSON PS, 1994, P NATL ACAD SCI USA, V91, P6486, DOI 10.1073/pnas.91.14.6486; MELLONI RH, 1993, J COMP NEUROL, V327, P507, DOI 10.1002/cne.903270404; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mustroph ML, 2012, NEUROSCIENCE, V219, P62, DOI 10.1016/j.neuroscience.2012.06.007; Okanoya K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001860; Pechstein Arndt, 2010, Front Synaptic Neurosci, V2, P143, DOI 10.3389/fnsyn.2010.00143; Poeggel G, 1996, BRAIN RES, V743, P162, DOI 10.1016/S0006-8993(96)01039-6; Poeggel G, 2005, J NEUROBIOL, V62, P42, DOI 10.1002/neu.20070; Poeggel G, 2003, NEUROSCIENCE, V116, P617, DOI 10.1016/S0306-4522(02)00751-0; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; TARELLI FT, 1992, NEURON, V9, P1143, DOI 10.1016/0896-6273(92)90072-L; Thomsen LR, 2007, ANIM COGN, V10, P477, DOI 10.1007/s10071-007-0075-6	42	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58649	10.1371/journal.pone.0058649	http://dx.doi.org/10.1371/journal.pone.0058649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516527	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200101
J	Lund, TC; Kobs, AJ; Kramer, A; Nyquist, M; Kuroki, MT; Osborn, J; Lidke, DS; Low-Nam, ST; Blazar, BR; Tolar, J				Lund, Troy C.; Kobs, Amanda J.; Kramer, Ashley; Nyquist, Mick; Kuroki, Marcos T.; Osborn, John; Lidke, Diane S.; Low-Nam, Shalini T.; Blazar, Bruce R.; Tolar, Jakub			Bone Marrow Stromal and Vascular Smooth Muscle Cells Have Chemosensory Capacity via Bitter Taste Receptor Expression	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MILK-PROTEINS; TRANSDUCTION; PRESSURE; SWEET; BLOOD; BUDS	The ability of cells to detect changes in the microenvironment is important in cell signaling and responsiveness to environmental fluctuations. Our interest is in understanding how human bone marrow stromal-derived cells (MSC) and their relatives, vascular smooth muscle cells (VSMC), interact with their environment through novel receptors. We found, through a proteomics screen, that MSC express the bitter taste receptor, TAS2R46, a protein more typically localized to the taste bud. Expression was also confirmed in VSMCs. A prototypical bitter compound that binds to the bitter taste receptor class, denatonium, increased intracellular calcium release and decreased cAMP levels as well as increased the extracellular release of ATP in human MSC. Denatonium also bound and activated rodent VSMC with a change in morphology upon compound exposure. Finally, rodents given denatonium in vivo had a significant drop in blood pressure indicating a vasodilator response. This is the first description of chemosensory detection by MSC and VSMCs via a taste receptor. These data open a new avenue of research into discovering novel compounds that operate through taste receptors expressed by cells in the marrow and vascular microenvironments.	[Lund, Troy C.; Kobs, Amanda J.; Kramer, Ashley; Nyquist, Mick; Blazar, Bruce R.; Tolar, Jakub] Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN 55455 USA; [Kuroki, Marcos T.; Osborn, John] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA; [Lidke, Diane S.; Low-Nam, Shalini T.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Lidke, Diane S.; Low-Nam, Shalini T.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of New Mexico; University of New Mexico	Lund, TC (corresponding author), Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN 55455 USA.	lundx072@umn.edu		Kuroki, Marcos/0000-0001-7343-2873; Tolar, Jakub/0000-0002-0957-4380				Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Deshpande DA, 2010, NATURE MED; Faroni A, 2011, J NEUROSCI RES, V89, P1351, DOI 10.1002/jnr.22652; GALMICHE MC, 1993, BLOOD, V82, P66, DOI 10.1182/blood.V82.1.66.bloodjournal82166; Hoogduijn MJ, 2009, STEM CELLS DEV, V18, P103, DOI 10.1089/scd.2008.0032; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2010, J PHYSIOL-LONDON, V588, P2343, DOI 10.1113/jphysiol.2010.191106; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; Ishimaru Y, 2009, ODONTOLOGY, V97, P1, DOI 10.1007/s10266-008-0095-y; Kim UK, 2004, J DENT RES, V83, P448, DOI 10.1177/154405910408300603; Kinnamon SC, 2009, ANN NY ACAD SCI, V1170, P55, DOI 10.1111/j.1749-6632.2009.04106.x; Kinnamon SC, 2009, SCIENCE, V325, P1081, DOI 10.1126/science.1179180; Lindemann B, 1996, CURR BIOL, V6, P1234, DOI 10.1016/S0960-9822(96)00704-X; Lund TC, 2008, HAEMATOLOGICA, V93, P908, DOI 10.3324/haematol.12384; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meisel H, 1999, ANTON LEEUW INT J G, V76, P207, DOI 10.1023/A:1002063805780; Palmer RK, 2007, MOL INTERV, V7, P87, DOI 10.1124/mi.7.2.9; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; SCHLIMME E, 1995, NAHRUNG, V39, P1, DOI 10.1002/food.19950390102; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Slack J. P., 2010, CURR BIOL; Veitenheimer B, 2011, AM J PHYSIOL-REG I, V300, pR460, DOI 10.1152/ajpregu.00371.2010; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Zhang Y, 2010, NEUROSCIENCE, V169, P1421, DOI 10.1016/j.neuroscience.2010.05.021	29	46	47	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58945	10.1371/journal.pone.0058945	http://dx.doi.org/10.1371/journal.pone.0058945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520545	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900105
J	Quan, QK; Wang, J; Li, X; Wang, Y				Quan, QianKun; Wang, Jue; Li, Xi; Wang, Yi			Ginsenoside Rg1 Decreases A beta(1-42) Level by Upregulating PPAR gamma and IDE Expression in the Hippocampus of a Rat Model of Alzheimer's Disease	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; AMYLOID-BETA-PEPTIDE; A-BETA; TRANSGENIC MICE; IN-VITRO; BRAIN; PROTECTS; ROSIGLITAZONE; PIOGLITAZONE; NEPRILYSIN	Background and Purpose: The present study was designed to examine the effects of ginsenoside Rg1 on expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) and insulin-degrading enzyme (IDE) in the hippocampus of rat model of Alzheimer's disease (AD) to determine how ginsenoside Rg1 (Rg1) decreases A beta levels in AD. Experimental Approach: Experimental AD was induced in rats by a bilateral injection of 10 mg soluble beta-amyloid peptide 1-42 (A beta(1-42)) into the CA1 region of the hippocampus, and the rats were treated with Rg1 (10 mg.kg(-1), intraperitoneally) for 28 days. The Morris water maze was used to test spatial learning and memory performance. Hematoxylin-eosin staining was performed to analyze the hippocampal histopathological damage. Immunohistochemistry, western blotting, and realtime PCR were used to detect A beta(1-42), PPAR gamma, and insulin-degrading enzyme (IDE) expression in the hippocampus. Key Results: Injection of soluble A beta(1-42) into the hippocampus led to significant dysfunction of learning and memory, hippocampal histopathological abnormalities and increased A beta(1-42) levels in the hippocampus. Rg1 treatment significantly improved learning and memory function, attenuated hippocampal histopathological abnormalities, reduced A beta(1-42) levels and increased PPAR gamma and IDE expression in the hippocampus; these effects of Rg1 could be effectively inhibited by GW9662, a PPAR gamma antagonist. Conclusions and Implications: Given that PPAR gamma can upregulate IDE expression and IDE can degrade A beta(1-42), these results indicate that Rg1 can increase IDE expression in the hippocampus by upregulating PPAR gamma, leading to decreased A beta levels, attenuated hippocampal histopathological abnormalities and improved learning and memory in a rat model of AD.	[Quan, QianKun; Wang, Jue; Wang, Yi] Xi An Jiao Tong Univ, Natl Engn Res Ctr Hlth Care & Med Devices, Xian Jiaotong Univ Branch, Key Lab Biomed Informat Engn,Minist Educ,Sch Life, Xian 710049, Peoples R China; [Quan, QianKun; Wang, Jue; Wang, Yi] Xi An Jiao Tong Univ, Natl Engn Res Ctr Hlth Care & Med Devices, Xian Jiaotong Univ Branch, Inst Biomed Engn,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Li, Xi] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Geriatr, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, J (corresponding author), Xi An Jiao Tong Univ, Natl Engn Res Ctr Hlth Care & Med Devices, Xian Jiaotong Univ Branch, Key Lab Biomed Informat Engn,Minist Educ,Sch Life, Xian 710049, Peoples R China.	juewang@mail.xjtu.edu.cn	Wang, Jue/GVU-0480-2022		National Natural Science Foundation of China [81071150, 30670660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81071150 and 30670660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Aubert RE, 2010, DIABETES OBES METAB, V12, P716, DOI 10.1111/j.1463-1326.2010.01225.x; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Dorfman VB, 2010, NEUROBIOL AGING, V31, P1743, DOI 10.1016/j.neurobiolaging.2008.09.016; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Chen YB, 2009, NEURAL REGEN RES, V4, P590, DOI 10.3969/j.issn.1673-5374.2009.08.005; Cheng Y, 2005, ACTA PHARMACOL SIN, V26, P143, DOI 10.1111/j.1745-7254.2005.00034.x; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Gong L, 2011, PHARM BIOL, V49, P501, DOI 10.3109/13880209.2010.521514; Goyal SN, 2011, DIABETES OBES METAB, V13, P533, DOI 10.1111/j.1463-1326.2011.01377.x; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Kumar A, 2007, PHARMACOL REP, V59, P274; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Logroscino G, 2004, BMJ-BRIT MED J, V328, P548, DOI 10.1136/bmj.37977.495729.EE; Luo DZ, 2011, EUR J PHARMACOL, V664, P14, DOI 10.1016/j.ejphar.2011.04.045; Marr RA, 2003, J NEUROSCI, V23, P1992; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; Mook-Jung I, 2001, J NEUROSCI RES, V63, P509, DOI 10.1002/jnr.1045; Ni HX, 2010, MOL BIOL REP, V37, P2975, DOI 10.1007/s11033-009-9864-0; Peila R, 2004, NEUROLOGY, V63, P228, DOI 10.1212/01.WNL.0000129989.28404.9B; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Rosi S, 2005, NEUROSCIENCE, V134, P671, DOI 10.1016/j.neuroscience.2005.04.029; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Shi YQ, 2010, J ALZHEIMERS DIS, V19, P977, DOI 10.3233/JAD-2010-1296; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tucker HM, 2000, J NEUROSCI, V20, P3937; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Vepsalainen S, 2008, NEUROSCI LETT, V438, P216, DOI 10.1016/j.neulet.2008.04.025; Wang AT, 2010, ANN INTERN MED, V153, DOI 10.7326/0003-4819-153-12-201012210-02011; Wang YJ, 2010, BRAIN BEHAV IMMUN, V24, P1281, DOI 10.1016/j.bbi.2010.05.010; Wang YH, 2009, J ASIAN NAT PROD RES, V11, P604, DOI 10.1080/10286020902843152; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Yamaguchi Y, 1997, EUR J PHARMACOL, V329, P37, DOI 10.1016/S0014-2999(97)10115-7; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001; Zhou J, 2011, BRAIN RES, V1388, P141, DOI 10.1016/j.brainres.2011.02.064; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	52	61	74	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59155	10.1371/journal.pone.0059155	http://dx.doi.org/10.1371/journal.pone.0059155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520555	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900115
J	Shibayama, J; Taylor, TG; Venable, PW; Rhodes, NL; Gil, RB; Warren, M; Wende, AR; Abel, ED; Cox, J; Spitzer, KW; Zaitsev, AV				Shibayama, Junko; Taylor, Tyson G.; Venable, Paul W.; Rhodes, Nathaniel L.; Gil, Ryan B.; Warren, Mark; Wende, Adam R.; Abel, E. Dale; Cox, James; Spitzer, Kenneth W.; Zaitsev, Alexey V.			Metabolic Determinants of Electrical Failure in Ex-Vivo Canine Model of Cardiac Arrest: Evidence for the Protective Role of Inorganic Pyrophosphate	PLOS ONE			English	Article							DURATION VENTRICULAR-FIBRILLATION; K-ATP CHANNEL; INHIBITION; ACTIVATION; HEART; POTASSIUM; ISCHEMIA; CARDIOMYOCYTES; OSCILLATIONS; ASYSTOLE	Rationale: Deterioration of ventricular fibrillation (VF) into asystole or severe bradycardia (electrical failure) heralds a fatal outcome of cardiac arrest. The role of metabolism in the timing of electrical failure remains unknown. Objective: To determine metabolic factors of early electrical failure in an Ex-vivo canine model of cardiac arrest (VF+global ischemia). Methods and Results: Metabolomic screening was performed in left ventricular biopsies collected before and after 0.3, 2, 5, 10 and 20 min of VF and global ischemia. Electrical activity was monitored via plunge needle electrodes and pseudo-ECG. Four out of nine hearts exhibited electrical failure at 10.1 +/- 0.9 min (early-asys), while 5/9 hearts maintained VF for at least 19.7 min (late-asys). As compared to late-asys, early-asys hearts had more ADP, less phosphocreatine, and higher levels of lactate at some time points during VF/ischemia (all comparisons p < 0.05). Pre-ischemic samples from late-asys hearts contained similar to 25 times more inorganic pyrophosphate (PPi) than early-asys hearts. A mechanistic role of PPi in cardioprotection was then tested by monitoring mitochondrial membrane potential (Delta Psi) during 20 min of simulated-demand ischemia using potentiometric probe TMRM in rabbit adult ventricular myocytes incubated with PPi versus control group. Untreated myocytes experienced significant loss of Delta Psi while in the PPi-treated myocytes DY was relatively maintained throughout 20 min of simulated-demand ischemia as compared to control (p < 0.05). Conclusions: High tissue level of PPi may prevent Delta Psi m loss and electrical failure at the early phase of ischemic stress. The link between the two protective effects may involve decreased rates of mitochondrial ATP hydrolysis and lactate accumulation.	[Shibayama, Junko; Taylor, Tyson G.; Venable, Paul W.; Rhodes, Nathaniel L.; Gil, Ryan B.; Warren, Mark; Spitzer, Kenneth W.; Zaitsev, Alexey V.] Univ Utah, Nora Eccles Harrison Cardiovascr Res & Training I, Salt Lake City, UT 84112 USA; [Wende, Adam R.; Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Program Mol Med, Salt Lake City, UT USA; [Cox, James] Univ Utah, Metab Core Res Facil, Salt Lake City, UT USA; [Cox, James] Univ Utah, Dept Biochem, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zaitsev, AV (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovascr Res & Training I, Salt Lake City, UT 84112 USA.	zaitsev@cvrti.utah.edu	Wende, Adam/AFG-8878-2022	Wende, Adam/0000-0002-5536-4675; Taylor, Tyson/0000-0003-0116-0770; Abel, E. Dale/0000-0001-5290-0738; Zaitsev, Artem/0000-0002-2314-0482	NIH NRSA fellowship [5-F32-HL-097576]; NIH [5-R01-HL-088444, 5 R01 HL103877-02, 5R37HL0042873-24]; Nora Eccles Treadwell Foundation research grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042873, F32HL097576, R01HL103877, R01HL088444] Funding Source: NIH RePORTER	NIH NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nora Eccles Treadwell Foundation research grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH NRSA fellowship 5-F32-HL-097576 (J.S.), NIH Grants 5-R01-HL-088444 (A.V.Z.), 5 R01 HL103877-02 (A.V.Z.) and 5R37HL0042873-24 (K.W.S.), and Nora Eccles Treadwell Foundation research grant (A.V.Z.).	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; Ayoub IM, 2007, CRIT CARE MED, V35, P2329, DOI 10.1097/01.CCM.0000280569.87413.74; Baker M, 2011, NAT METHODS, V8, P117, DOI 10.1038/nmeth0211-117; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Cross HR, 1996, CIRC RES, V78, P482, DOI 10.1161/01.RES.78.3.482; DAVIDSON AM, 1989, BIOCHEM J, V258, P817, DOI 10.1042/bj2580817; Gang UJO, 2010, EUROPACE, V12, P254, DOI 10.1093/europace/eup383; Ganitkevich V, 2010, J GEN PHYSIOL, V135, P307, DOI 10.1085/jgp.200910332; HALESTRAP AP, 1986, BIOCHEM J, V239, P559, DOI 10.1042/bj2390559; Hallstrom A, 2009, RESUSCITATION, V80, P975, DOI 10.1016/j.resuscitation.2009.05.019; Henry P, 1996, CARDIOVASC RES, V32, P930; Hong MY, 2011, FASEB J, V25, P2456, DOI 10.1096/fj.10-176669; JENNINGS RB, 1985, ANNU REV PHYSIOL, V47, P727, DOI 10.1146/annurev.ph.47.030185.003455; JENNINGS RB, 1981, CIRC RES, V49, P892, DOI 10.1161/01.RES.49.4.892; KEUNG EC, 1991, J CLIN INVEST, V88, P1772, DOI 10.1172/JCI115497; KOYANO T, 1993, J PHYSIOL-LONDON, V463, P747, DOI 10.1113/jphysiol.1993.sp019620; KUSUOKA H, 1992, CIRC RES, V71, P1111, DOI 10.1161/01.RES.71.5.1111; MANSUROVA SE, 1975, FEBS LETT, V55, P94, DOI 10.1016/0014-5793(75)80967-7; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; PEREIRADASILVA L, 1993, ARCH BIOCHEM BIOPHYS, V304, P310, DOI 10.1006/abbi.1993.1355; PEUHKURINEN KJ, 1983, AM J PHYSIOL, V244, pH281, DOI 10.1152/ajpheart.1983.244.2.H281; ROVETTO MJ, 1975, CIRC RES, V37, P742, DOI 10.1161/01.RES.37.6.742; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Tang WC, 2000, AM J PHYSIOL-HEART C, V279, pH1609, DOI 10.1152/ajpheart.2000.279.4.H1609; Taylor TG, 2012, AM J PHYSIOL-HEART C, V302, pH2396, DOI 10.1152/ajpheart.00752.2011; Taylor TG, 2011, CIRCULATION, V124; VANHEEL B, 1992, CARDIOVASC RES, V26, P1030, DOI 10.1093/cvr/26.11.1030; Venable PW, 2010, AM J PHYSIOL-HEART C, V299, pH1405, DOI 10.1152/ajpheart.00419.2010; Volonte MG, 2004, J PHARMACEUT BIOMED, V35, P647, DOI 10.1016/j.jpba.2004.02.002; Warren M, 2010, AM J PHYSIOL-HEART C, V299, pH1271, DOI 10.1152/ajpheart.00248.2010; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Wiggers CJ, 1930, AM HEART J, V5, P351, DOI 10.1016/S0002-8703(30)90334-1; WORLEY SJ, 1985, AM J CARDIOL, V55, P813, DOI 10.1016/0002-9149(85)90162-6; Xu HX, 2001, J BIOL CHEM, V276, P12898, DOI 10.1074/jbc.M009631200; Yi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034524; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57821	10.1371/journal.pone.0057821	http://dx.doi.org/10.1371/journal.pone.0057821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520482	Green Submitted, gold, Green Published			2022-12-27	WOS:000318679900041
J	Ahn, RW; Barrett, SL; Raja, MR; Jozefik, JK; Spaho, L; Chen, HM; Bally, MB; Mazar, AP; Avram, MJ; Winter, JN; Gordon, LI; Shea, LD; O'Halloran, TV; Woodruff, TK				Ahn, Richard W.; Barrett, Susan L.; Raja, Meera R.; Jozefik, Jennifer K.; Spaho, Lidia; Chen, Haimei; Bally, Marcel B.; Mazar, Andrew P.; Avram, Michael J.; Winter, Jane N.; Gordon, Leo I.; Shea, Lonnie D.; O'Halloran, Thomas V.; Woodruff, Teresa K.			Nano-Encapsulation of Arsenic Trioxide Enhances Efficacy against Murine Lymphoma Model while Minimizing Its Impact on Ovarian Reserve In Vitro and In Vivo	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; PHASE-II TRIAL; ANTITUMOR-ACTIVITY; BREAST-CANCER; CELL LINES; FERTILITY; PHARMACOKINETICS; TOXICITY; MICE; PRESERVATION	Advances in cancer therapy have increased the rate of survival of young cancer patients; however, female lymphoma patients frequently face a temporary or permanent loss of fertility when treated with traditional cytotoxic agents. The potential loss of fertility is an important concern that can influence treatment decisions for many premenopausal cancer patients. The negative effect of chemotherapeutic agents and treatment protocols to patients' fertility-referred to as fertotoxicity-are thus an increasingly important cancer survivorship issue. We have developed a novel nanoscale formulation of arsenic trioxide, a potent drug for treatment of hematological malignancies, and demonstrate that it has significantly better activity in a murine lymphoma model than the free drug. In parallel, we have developed a novel in vitro assay of ovarian follicle function that predicts in vivo ovarian toxicity of therapeutic agents. Our results reveal that the nanotherapeutic agent is not only more active against lymphoma, but is fertoprotective, i.e., it is much less deleterious to ovarian function than the parent drug. Thus, our in vitro assay allows rapid evaluation of both established and experimental anticancer drugs on ovarian reserve and can inform the selection of efficacious and fertility-sparing treatment regimens for reproductive-age women diagnosed with cancer.	[Ahn, Richard W.; Raja, Meera R.; Chen, Haimei; Mazar, Andrew P.; O'Halloran, Thomas V.] Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL 60201 USA; [Ahn, Richard W.; Chen, Haimei; Mazar, Andrew P.; Avram, Michael J.; Winter, Jane N.; Gordon, Leo I.; O'Halloran, Thomas V.; Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [Barrett, Susan L.; Jozefik, Jennifer K.; Spaho, Lidia; Woodruff, Teresa K.] Northwestern Univ, Dept Obstet & Gynecol, Evanston, IL USA; [Barrett, Susan L.] Northwestern Univ, Ctr Reprod Sci, Reprod Biol Training Program, Evanston, IL USA; [Bally, Marcel B.] Univ British Columbia, Ctr Drug Res & Dev, Vancouver, BC V5Z 1M9, Canada; [Avram, Michael J.] Northwestern Univ, Feinberg Sch Med, Dept Anesthesiol, Chicago, IL 60611 USA; [Avram, Michael J.] Northwestern Univ, Feinberg Sch Med, Mary Beth Donnelley Clin Pharmacol Core Facil, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Winter, Jane N.; Gordon, Leo I.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Winter, Jane N.; Gordon, Leo I.] Northwestern Univ, Lymphoma Program, Feinberg Sch Med, Chicago, IL 60611 USA; [Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Bally, Marcel B.] BC Canc Agcy, Dept Adv Therapeut, Vancouver, BC, Canada	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Northwestern University; University of British Columbia; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; British Columbia Cancer Agency	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem, Chem Life Proc Inst, Evanston, IL 60201 USA.	t-ohalloran@northwestern.edu; tkw@northwestern.edu	Avram, Michael/M-7681-2019; O'Halloran, Thomas/ABE-6125-2021; Shea, Lonnie D/B-7615-2009	O'Halloran, Thomas/0000-0001-8732-5059; Gordon, Leo/0000-0003-1666-7064; Ahn, Richard/0000-0001-6728-0009; Dague, Etienne/0000-0003-3290-9166; Woodruff, Teresa/0000-0002-1197-3399; Bally, Marcel/0000-0002-1994-4787; Winter, Jane/0000-0001-7542-3305	Oncofertility Consortium Grants National Institutes of Health (NIH) [RL1HD058295, PL1EB008542]; Reproductive Biology Training Grant [T32 HD07068]; NIH-NCI Cancer Nanotechnology Platform Partnerships [U01CA151461]; Center of Cancer Nanotechnology Excellence Grant [U54CA119341]; Northwestern University [P30CA060553];  [BC073413]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RL1HD058295, T32HD007068] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA151461, P30CA060553, U54CA119341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [PL1EB008542] Funding Source: NIH RePORTER	Oncofertility Consortium Grants National Institutes of Health (NIH); Reproductive Biology Training Grant; NIH-NCI Cancer Nanotechnology Platform Partnerships; Center of Cancer Nanotechnology Excellence Grant; Northwestern University; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Oncofertility Consortium Grants National Institutes of Health (NIH) RL1HD058295 and PL1EB008542 to TKW; Reproductive Biology Training Grant T32 HD07068; NIH-NCI Cancer Nanotechnology Platform Partnerships Grant U01CA151461 to TVO; Center of Cancer Nanotechnology Excellence Grant U54CA119341; and Core Grant P30CA060553 to the Robert H. Lurie Comprehensive Cancer Center (RHLCC) of Northwestern University (http://nih.gov/). RWA was a CDMRP Breast Cancer Research Program Predoctoral Fellow (Grant #BC073413, http://cdmrp.army.mil/) and Malkin Fellow of the RHLCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Sanjay K., 2007, V138, P15; Ahn RW, 2010, CLIN CANCER RES, V16, P3607, DOI 10.1158/1078-0432.CCR-10-0068; Bael TE, 2008, MELANOMA RES, V18, P147, DOI 10.1097/CMR.0b013e3282f2a7ae; Baljeyic M, 2011, HEMATOL ONCOL CLIN N, V25, P1215, DOI 10.1016/j.hoc.2011.10.002; Barrett SL, 2010, BIOL REPROD, V82, P1180, DOI 10.1095/biolreprod.109.082933; Bhalla S, 2010, BRIT J HAEMATOL, V150, P365, DOI 10.1111/j.1365-2141.2010.08197.x; Chen HM, 2006, J AM CHEM SOC, V128, P13348, DOI 10.1021/ja064864h; Chen H, 2009, MOL CANCER THER, V8, P1955, DOI 10.1158/1535-7163.MCT-09-0045; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; DIEHL V, 1981, J CANCER RES CLIN, V101, P111, DOI 10.1007/BF00405072; Dolniak B, 2008, J BIOL CHEM, V283, P12034, DOI 10.1074/jbc.M708816200; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Golub MS, 1998, J TOXICOL ENV HEAL B, V1, P199, DOI 10.1080/10937409809524552; Gracia Clarisa R., 2007, V138, P57; Griffin RJ, 2003, INT J HYPERTHER, V19, P575, DOI 10.1080/0265673031000124316; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Holson JF, 2000, FOOD CHEM TOXICOL, V38, P459, DOI 10.1016/S0278-6915(00)00015-6; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kchour G, 2009, BLOOD, V113, P6528, DOI 10.1182/blood-2009-03-211821; Kindler HL, 2008, AM J CLIN ONCOL-CANC, V31, P553, DOI 10.1097/COC.0b013e318178e4cd; Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016; Levine J, 2010, J CLIN ONCOL, V28, P4831, DOI 10.1200/JCO.2009.22.8312; Lu WL, 2004, J PHARMACOL SCI, V95, P381, DOI 10.1254/jphs.FPJ04001X; MAYHEW EG, 1992, INT J CANCER, V51, P302, DOI 10.1002/ijc.2910510221; Maziasz T, 2010, TOXICOL PATHOL, V38, P148, DOI 10.1177/0192623309356448; Miller WH, 2002, CANCER RES, V62, P3893; Navarro PAAS, 2004, BIOL REPROD, V70, P980, DOI 10.1095/biolreprod.103.020586; NILSSON K, 1977, INT J CANCER, V19, P337, DOI 10.1002/ijc.2910190309; Oktay K, 2008, CURR OPIN OBSTET GYN, V20, P408, DOI 10.1097/GCO.0b013e328307ebad; Partridge AH, 2004, J CLIN ONCOL, V22, P4174, DOI 10.1200/jco.2004.01.159; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Tallman MS, 2009, BLOOD, V114, P5126, DOI 10.1182/blood-2009-07-216457; Tucker CA, 2008, MOL CANCER THER, V7, P749, DOI 10.1158/1535-7163.MCT-07-0302; Vernaeve V, 2007, HUM REPROD, V22, P2863, DOI 10.1093/humrep/dem276; Walters KA, 2008, BIOL REPROD, V78, P380, DOI 10.1095/biolreprod.107.064089; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81; Xu M, 2011, BIOL REPROD, V84, P689, DOI 10.1095/biolreprod.110.088674	40	58	60	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58491	10.1371/journal.pone.0058491	http://dx.doi.org/10.1371/journal.pone.0058491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526987	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600024
J	Charpentier, C; Champenois, K; Gervais, A; Landman, R; Joly, V; Le Gac, S; Larrouy, L; Damond, F; Brun-Vezinet, F; Descamps, D; Yazdanpanah, Y				Charpentier, Charlotte; Champenois, Karen; Gervais, Anne; Landman, Roland; Joly, Veronique; Le Gac, Sylvie; Larrouy, Lucile; Damond, Florence; Brun-Vezinet, Francoise; Descamps, Diane; Yazdanpanah, Yazdan			Predictive Value of Liver Enzymes and Inflammatory Biomarkers for the Severity of Liver Fibrosis Stage in HIV/HCV Co-Infected Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; HIV-INFECTION; INDIVIDUALS; RISK	Objective: The aim of our study was to assess a possible association between plasma inflammatory biomarkers (CRP, IL-6, soluble CD14) and the extent of fibrosis or cirrhosis using a FibroScan (R) in HIV/HCV co-infected patients. Methods: This cross-sectional study assessed 60 HIV/HCV co-infected patients who had paired plasma samples and FibroScan (R) values available. All included patients were controlled for HIV infection (HIV-1 RNA <50 copies/mL) and had detectable HCV RNA levels. Levels of three biomarkers were measured in all samples using commercial ELISA kits. Multivariate logistic regression models identified factors associated with the METAVIR stages of fibrosis (F0-F2 vs. F3-F4). Results: In univariate logistic regression analyses, in addition to sCD14 (odds ratio [OR] = 3.23, 95% confidence interval [95% CI] = 1.30-7.97, P= 0.01), aspartate aminotransferase (AST), alanine aminotransferase, platelet counts, and CD4 cell counts were associated with the stage of liver fibrosis and, thus, were introduced into the model. However, only AST (OR = 1.06, 95% CI = 1.02-1.10, P = 0.0009) was independently associated with F3-F4 stage liver fibrosis. Conclusions: In our study of HIV/HCV co-infected patients, sCD14 plasma level, a biomarker of monocyte activation, was not independently associated with the F3-F4 stage of liver fibrosis. We hypothesize that the higher levels of inflammation markers observed in HIV/HCV co-infected patients, compared to HCV mono-infected patients, prevent this association being observed within this population.	[Charpentier, Charlotte; Larrouy, Lucile; Damond, Florence; Brun-Vezinet, Francoise; Descamps, Diane] Univ Paris 07, HUPNVS, Grp Hosp Bichat Claude Bernard, AP HP,Lab Virol,PRES Sorbonne Paris Cite,EA4409, Paris, France; [Champenois, Karen] Inserm ATIP Avenir Modelisat Aide Decis & Cout Ef, Lille, France; [Gervais, Anne; Landman, Roland; Joly, Veronique; Le Gac, Sylvie; Yazdanpanah, Yazdan] Univ Paris 07, HUPNVS, Grp Hosp Bichat Claude Bernard,EA4409, AP HP,Serv Malad Infect & Trop,PRES Sorbonne Pari, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Charpentier, C (corresponding author), Univ Paris 07, HUPNVS, Grp Hosp Bichat Claude Bernard, AP HP,Lab Virol,PRES Sorbonne Paris Cite,EA4409, Paris, France.	charlotte.charpentier@bch.aphp.fr	Charpentier, Charlotte/C-3579-2019		French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS]); European Community [223131]	French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS])(ANRS); European Community(European Commission)	This study was supported by French National Agency for Research on AIDS and viral hepatitis (Agence Nationale de Recherches sur le SIDA et les hepatites virales [ANRS]) and from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)" (grant no. 223131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Carton JA, 2011, ANTIVIR THER, V16, P27, DOI 10.3851/IMP1708; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Macias J, 2010, 17 C RETR OPP INF 16; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Vermehren J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-27	10	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59205	10.1371/journal.pone.0059205	http://dx.doi.org/10.1371/journal.pone.0059205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527135	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100091
J	Galan-Jimenez, MD; Mishael, YG; Nir, S; Morillo, E; Undabeytia, T				del Carmen Galan-Jimenez, Maria; Mishael, Yael-Golda; Nir, Shlomo; Morillo, Esmeralda; Undabeytia, Tomas			Factors Affecting the Design of Slow Release Formulations of Herbicides Based on Clay-Surfactant Systems. A Methodological Approach	PLOS ONE			English	Article							MONOVALENT ORGANIC CATIONS; SOLID-WATER INTERFACE; NONIONIC SURFACTANTS; ADSORPTION; MONTMORILLONITE; SEPIOLITE; SORPTION; METRIBUZIN; SOIL; NORFLURAZON	A search for clay-surfactant based formulations with high percentage of the active ingredient, which can yield slow release of active molecules is described. The active ingredients were the herbicides metribuzin (MZ), mesotrione (MS) and flurtamone (FL), whose solubilities were examined in the presence of four commercial surfactants; (i) neutral: two berols (B048, B266) and an alkylpolyglucoside (AG6202); (ii) cationic: an ethoxylated amine (ET/15). Significant percent of active ingredient (a. i.) in the clay/surfactant/herbicide formulations could be achieved only when most of the surfactant was added as micelles. MZ and FL were well solubilized by berols, whereas MS by ET/15. Sorption of surfactants on the clay mineral sepiolite occurred mostly by sorption of micelles, and the loadings exceeded the CEC. Higher loadings were determined for B266 and ET/15. The sorption of surfactants was modeled by using the Langmuir-Scatchard equation which permitted the determination of binding coefficients that could be used for further predictions of the sorbed amounts of surfactants under a wide range of clay/surfactant ratios. A possibility was tested of designing clay-surfactant based formulations of certain herbicides by assuming the same ratio between herbicides and surfactants in the formulations as for herbicides incorporated in micelles in solution. Calculations indicated that satisfactory FL formulations could not be synthesized. The experimental fractions of herbicides in the formulations were in agreement with the predicted ones for MS and MZ. The validity of this approach was confirmed in in vitro release tests that showed a slowing down of the release of a. i. from the designed formulations relative to the technical products. Soil dissipation studies with MS formulations also showed improved bioactivity of the clay-surfactant formulation relative to the commercial one. This methodological approach can be extended to other clay-surfactant systems for encapsulation and slow release of target molecules of interest.	[del Carmen Galan-Jimenez, Maria; Morillo, Esmeralda; Undabeytia, Tomas] Inst Nat Resources & Agrobiol, Spanish Res Council, Agrochem & Soil Conservat Dept, Seville, Spain; [Mishael, Yael-Golda; Nir, Shlomo] Hebrew Univ Jerusalem, Seagram Ctr Soil & Water Sci, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Hebrew University of Jerusalem	Undabeytia, T (corresponding author), Inst Nat Resources & Agrobiol, Spanish Res Council, Agrochem & Soil Conservat Dept, Seville, Spain.	undabeyt@irnase.csic.es	Mishael, Yael/AAB-1826-2020; Morillo, Esmeralda/E-2180-2017	Morillo, Esmeralda/0000-0002-4485-2315	Spanish Ministry of Economy and Competitiveness [CTM2009-07425, PRI-PIBAR-1393]; Junta de Andalucia [P09-RNM4581]; European Social Fund	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Social Fund(European Social Fund (ESF))	This research was supported by the projects CTM2009-07425 and PRI-PIBAR-1393 from the Spanish Ministry of Economy and Competitiveness, and Junta de Andalucia Project P09-RNM4581. These projects received funding by the European Social Fund. M.C. Galan-Jimenez acknowledges a research contract from Junta de Andalucia in the frame of the project P09-RNM4581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay G, 2005, J COLLOID INTERF SCI, V281, P27, DOI 10.1016/j.jcis.2004.08.080; Backhaus WK, 2001, J COLLOID INTERF SCI, V242, P6, DOI 10.1006/jcis.2001.7781; Bojemueller E, 2001, APPL CLAY SCI, V18, P277, DOI 10.1016/S0169-1317(01)00027-8; CASES JM, 1992, LANGMUIR, V8, P1251, DOI 10.1021/la00041a005; Daniel PE, 2002, ENVIRON TOXICOL CHEM, V21, P2567, DOI 10.1897/1551-5028(2002)021&lt;2567:AAMSIS&gt;2.0.CO;2; Deng YJ, 2006, COLLOID POLYM SCI, V284, P347, DOI 10.1007/s00396-005-1388-0; Denoyel R, 1991, COLLOID INTERFACE SC, V43, P555; El-Nahhal Y, 2001, J AGR FOOD CHEM, V49, P5364, DOI 10.1021/jf010561p; Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045; Harvey CC, 2006, DEV CLAY SCI, V1, P501, DOI 10.1016/S1572-4352(05)01016-0; Henriksen T, 2004, J ENVIRON QUAL, V33, P619, DOI 10.2134/jeq2004.0619; Hou YB, 2010, LANGMUIR, V26, P28, DOI 10.1021/la903672r; Levis SR, 2003, INT J PHARM, V253, P145, DOI 10.1016/S0378-5173(02)00702-0; LEVITZ P, 1991, LANGMUIR, V7, P1595, DOI 10.1021/la00056a010; Li ZH, 2003, CLAY CLAY MINER, V51, P445, DOI 10.1346/CCMN.2003.0510411; Maqueda C, 2008, J AGR FOOD CHEM, V56, P11941, DOI 10.1021/jf802364t; Maqueda C, 2009, APPL CLAY SCI, V46, P289, DOI 10.1016/j.clay.2009.08.019; Mishael YG, 2003, J AGR FOOD CHEM, V51, P2253, DOI 10.1021/jf0261497; Mishael YG, 2002, J AGR FOOD CHEM, V50, P2856, DOI 10.1021/jf011496m; Nennemann A, 2001, APPL CLAY SCI, V18, P285, DOI 10.1016/S0169-1317(01)00025-4; Nir S, 2000, ENVIRON SCI TECHNOL, V34, P1269, DOI 10.1021/es9903781; Paria S, 2004, ADV COLLOID INTERFAC, V110, P75, DOI 10.1016/j.cis.2004.03.001; Park JK, 2008, INT J PHARM, V359, P198, DOI 10.1016/j.ijpharm.2008.04.012; Radian A, 2008, ENVIRON SCI TECHNOL, V42, P1511, DOI 10.1021/es7023753; Rehab A, 2002, J POLYM SCI POL CHEM, V40, P2513, DOI 10.1002/pola.10326; Ruiz-Hitzky E, 2001, J MATER CHEM, V11, P86, DOI 10.1039/b003197f; RUIZHITZKY E, 1976, CLAY CLAY MINER, V24, P25, DOI 10.1346/CCMN.1976.0240102; Rytwo G, 1998, CLAY CLAY MINER, V46, P340, DOI 10.1346/CCMN.1998.0460313; Sabah E, 2002, WATER RES, V36, P3957, DOI 10.1016/S0043-1354(02)00110-0; Sanchez-Verdejo T, 2008, ENVIRON SCI TECHNOL, V42, P5779, DOI 10.1021/es800743p; Shen YH, 2000, CHEMOSPHERE, V41, P711, DOI 10.1016/S0045-6535(99)00436-1; Sonon LS, 2005, CLAY CLAY MINER, V53, P45, DOI 10.1346/CCMN.2005.0530106; Toerne K, 2001, LANGMUIR, V17, P6119, DOI 10.1021/la010559s; Undabeytia T, 2000, J AGR FOOD CHEM, V48, P4767, DOI 10.1021/jf9907945; Undabeytia T, 2000, J AGR FOOD CHEM, V48, P4774, DOI 10.1021/jf9912405; Undabeytia T, 2004, LANGMUIR, V20, P6605, DOI 10.1021/la0494472; Undabeytia T, 2003, ENVIRON SCI TECHNOL, V37, P4475, DOI 10.1021/es0343508; Undabeytia T, 2008, WATER RES, V42, P1211, DOI 10.1016/j.watres.2007.09.004; Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007	39	8	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59060	10.1371/journal.pone.0059060	http://dx.doi.org/10.1371/journal.pone.0059060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527087	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100071
J	Wei, KC; Chu, PC; Wang, HYJ; Huang, CY; Chen, PY; Tsai, HC; Lu, YJ; Lee, PY; Tseng, IC; Feng, LY; Hsu, PW; Yen, TC; Liu, HL				Wei, Kuo-Chen; Chu, Po-Chun; Wang, Hay-Yan Jack; Huang, Chiung-Yin; Chen, Pin-Yuan; Tsai, Hong-Chieh; Lu, Yu-Jen; Lee, Pei-Yun; Tseng, I-Chou; Feng, Li-Ying; Hsu, Peng-Wei; Yen, Tzu-Chen; Liu, Hao-Li			Focused Ultrasound-Induced Blood-Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study	PLOS ONE			English	Article							ANTITUMOR AGENT TEMOZOLOMIDE; RECURRENT MALIGNANT GLIOMA; HUMAN PLASMA; ADJUVANT TEMOZOLOMIDE; RAT; DISRUPTION; CHEMOTHERAPY; PERMEABILITY; DOXORUBICIN; TUMOR	The purpose of this study is to assess the preclinical therapeutic efficacy of magnetic resonance imaging (MRI)-monitored focused ultrasound (FUS)-induced blood-brain barrier (BBB) disruption to enhance Temozolomide (TMZ) delivery for improving Glioblastoma Multiforme (GBM) treatment. MRI-monitored FUS with microbubbles was used to transcranially disrupt the BBB in brains of Fisher rats implanted with 9L glioma cells. FUS-BBB opening was spectrophotometrically determined by leakage of dyes into the brain, and TMZ was quantitated in cerebrospinal fluid (CSF) and plasma by LC-MS\MS. The effects of treatment on tumor progression (by MRI), animal survival and brain tissue histology were investigated. Results demonstrated that FUS-BBB opening increased the local accumulation of dyes in brain parenchyma by 3.8-/2.1-fold in normal/tumor tissues. Compared to TMZ alone, combined FUS treatment increased the TMZ CSF/plasma ratio from 22.7% to 38.6%, reduced the 7-day tumor progression ratio from 24.03 to 5.06, and extended the median survival from 20 to 23 days. In conclusion, this study provided preclinical evidence that FUS BBB-opening increased the local concentration of TMZ to improve the control of tumor progression and animal survival, suggesting its clinical potential for improving current brain tumor treatment.	[Wei, Kuo-Chen; Huang, Chiung-Yin; Chen, Pin-Yuan; Tsai, Hong-Chieh; Lu, Yu-Jen; Tseng, I-Chou; Feng, Li-Ying; Hsu, Peng-Wei] Chang Gung Univ, Dept Neurosurg, Tao Yuan, Taiwan; [Wei, Kuo-Chen; Huang, Chiung-Yin; Chen, Pin-Yuan; Tsai, Hong-Chieh; Lu, Yu-Jen; Tseng, I-Chou; Feng, Li-Ying; Hsu, Peng-Wei; Yen, Tzu-Chen] Mem Hosp, Tao Yuan, Taiwan; [Chu, Po-Chun; Lee, Pei-Yun; Liu, Hao-Li] Chang Gung Univ, Dept Elect Engn, Tao Yuan, Taiwan; [Wang, Hay-Yan Jack] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Yen, Tzu-Chen] Chang Gung Univ, Dept Nucl Med, Tao Yuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Univ, Mol Imaging Ctr, Tao Yuan, Taiwan; [Liu, Hao-Li] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Chang Gung University; Chang Gung University; Chang Gung University	Wei, KC (corresponding author), Chang Gung Univ, Dept Neurosurg, Tao Yuan, Taiwan.	kuochenwei@adm.cgmh.org.tw; haoliliu@mail.cgu.edu.tw		Tsai, Hong-Chieh/0000-0003-3994-1601; Wei, Kuochen/0000-0003-3505-2196	National Science Council, TAIWAN [99-2321-B-182-008-, 100-2321-B-182-010, 100-2120-M-182A-001-, 101-2221-E-182-002-MY3]	National Science Council, TAIWAN(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, TAIWAN; Grant Nos. 99-2321-B-182-008-, 100-2321-B-182-010, 100-2120-M-182A-001-, and 101-2221-E-182-002-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SD, 1999, CLIN CANCER RES, V5, P309; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Brem S, 2007, CANCER CHEMOTH PHARM, V60, P643, DOI 10.1007/s00280-006-0407-2; Brock CS, 1998, CANCER RES, V58, P4363; BURGER PC, 1987, MAYO CLIN PROC, V62, P527, DOI 10.1016/S0025-6196(12)65479-2; Chowdhury SK, 1999, J PHARMACEUT BIOMED, V19, P659, DOI 10.1016/S0731-7085(98)00198-8; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Doolittle ND, 2000, CANCER, V88, P637, DOI 10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; GROOTHUIS DR, 1982, J NEUROPATH EXP NEUR, V41, P164, DOI 10.1097/00005072-198203000-00006; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; GUMERLOCK MK, 1992, J NEURO-ONCOL, V12, P33; HALPERIN EC, 1988, INT J RADIAT ONCOL, V15, P505, DOI 10.1016/S0360-3016(98)90036-0; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Hynynen K, 2003, ACT NEUR S, V86, P555; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; JUDY KD, 1995, J NEUROSURG, V82, P481, DOI 10.3171/jns.1995.82.3.0481; Kim H, 2001, J PHARMACEUT BIOMED, V24, P461, DOI 10.1016/S0731-7085(00)00466-0; Kim HK, 1997, J CHROMATOGR B, V703, P225, DOI 10.1016/S0378-4347(97)00431-3; Lidar Z, 2004, J NEUROSURG, V100, P472, DOI 10.3171/jns.2004.100.3.0472; Liu HL, 2010, P NATL ACAD SCI USA, V107, P15205, DOI 10.1073/pnas.1003388107; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; NEUWELT EA, 1982, P NATL ACAD SCI-BIOL, V79, P4420, DOI 10.1073/pnas.79.14.4420; NEUWELT EA, 1986, NEUROSURGERY, V19, P573, DOI 10.1227/00006123-198610000-00011; NEUWELT EA, 1985, CANCER RES, V45, P2827; NEUWELT EA, 1986, CANCER, V58, P1609, DOI 10.1002/1097-0142(19861015)58:8<1609::AID-CNCR2820580805>3.0.CO;2-7; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Parney IF, 2005, J NEUROSURG, V102, P267, DOI 10.3171/jns.2005.102.2.0267; Portnow J, 2009, CLIN CANCER RES, V15, P7092, DOI 10.1158/1078-0432.CCR-09-1349; Reyderman L, 2004, XENOBIOTICA, V34, P487, DOI 10.1080/00498250410001685737; SHAPIRO WR, 1992, J NEUROSURG, V76, P772, DOI 10.3171/jns.1992.76.5.0772; SHEN F, 1995, J CHROMATOGR B, V667, P291, DOI 10.1016/0378-4347(95)00040-P; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Treat LH, 2012, ULTRASOUND MED BIOL, V38, P1716, DOI 10.1016/j.ultrasmedbio.2012.04.015; TSANG LLH, 1991, CANCER CHEMOTH PHARM, V27, P342, DOI 10.1007/BF00688855; Wei KC, 2012, AJNR AM J NEURORADIO; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79	42	147	151	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58995	10.1371/journal.pone.0058995	http://dx.doi.org/10.1371/journal.pone.0058995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527068	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100063
J	Weiger, MC; Vedham, V; Stuelten, CH; Shou, KR; Herrera, M; Sato, M; Losert, W; Parent, CA				Weiger, Michael C.; Vedham, Vidya; Stuelten, Christina H.; Shou, Karen; Herrera, Mark; Sato, Misako; Losert, Wolfgang; Parent, Carole A.			Real-Time Motion Analysis Reveals Cell Directionality as an Indicator of Breast Cancer Progression	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTOR; MESENCHYMAL TRANSITION; CARCINOMA-CELLS; MIGRATION; INVASION; EXPRESSION; MODEL; BETA; MOTILITY; METASTASIS	Cancer cells alter their migratory properties during tumor progression to invade surrounding tissues and metastasize to distant sites. However, it remains unclear how migratory behaviors differ between tumor cells of different malignancy and whether these migratory behaviors can be utilized to assess the malignant potential of tumor cells. Here, we analyzed the migratory behaviors of cell lines representing different stages of breast cancer progression using conventional migration assays or time-lapse imaging and particle image velocimetry (PIV) to capture migration dynamics. We find that the number of migrating cells in transwell assays, and the distance and speed of migration in unconstrained 2D assays, show no correlation with malignant potential. However, the directionality of cell motion during 2D migration nicely distinguishes benign and tumorigenic cell lines, with tumorigenic cell lines harboring less directed, more random motion. Furthermore, the migratory behaviors of epithelial sheets observed under basal conditions and in response to stimulation with epidermal growth factor (EGF) or lysophosphatitic acid (LPA) are distinct for each cell line with regard to cell speed, directionality, and spatiotemporal motion patterns. Surprisingly, treatment with LPA promotes a more cohesive, directional sheet movement in lung colony forming MCF10CA1a cells compared to basal conditions or EGF stimulation, implying that the LPA signaling pathway may alter the invasive potential of MCF10CA1a cells. Together, our findings identify cell directionality as a promising indicator for assessing the tumorigenic potential of breast cancer cell lines and show that LPA induces more cohesive motility in a subset of metastatic breast cancer cells.	[Weiger, Michael C.; Vedham, Vidya; Stuelten, Christina H.; Shou, Karen; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Herrera, Mark; Losert, Wolfgang] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Sato, Misako] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Parent, CA (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	parentc@mail.nih.gov		Stuelten, Christina/0000-0002-2850-5399	Center for Cancer Research, NCI, National Institutes of Health; NIH [R01GM085574]; NATIONAL CANCER INSTITUTE [ZIABC011216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085574] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25871241] Funding Source: KAKEN	Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health. WL acknowledges support by NIH grant R01GM085574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CJ, 2003, CANCER METAST REV, V22, P301, DOI 10.1023/A:1023726827771; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Dawson PJ, 1996, AM J PATHOL, V148, P313; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Ferrero JM, 2001, ANN ONCOL, V12, P841, DOI 10.1023/A:1011183421477; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Garcia R, 2006, CELL CYCLE, V5, P2820, DOI 10.4161/cc.5.23.3535; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harma V, 2012, ONCOGENE, V31, P2075, DOI 10.1038/onc.2011.396; Howlader N, 2011, SEER CANC STAT REV 1; Joslin EJ, 2007, J CELL SCI, V120, P3688, DOI 10.1242/jcs.010488; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Komachi M, 2009, CARCINOGENESIS, V30, P457, DOI 10.1093/carcin/bgp011; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; Meyer AS, 2012, J CELL BIOL, V197, P721, DOI 10.1083/jcb.201201003; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nie F, 2012, CANCER-AM CANCER SOC, V118, P5198, DOI 10.1002/cncr.27553; Nikolic DL, 2006, AM J PHYSIOL-CELL PH, V291, pC68, DOI 10.1152/ajpcell.00411.2005; Nnetu KD, 2012, SOFT MATTER, V8, P6913, DOI 10.1039/c2sm07208d; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Palmieri D, 2005, JNCI-J NATL CANCER I, V97, P632, DOI 10.1093/jnci/dji111; Panupinthu N, 2010, BRIT J CANCER, V102, P941, DOI 10.1038/sj.bjc.6605588; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Pradeep CR, 2012, ONCOGENE, V31, P3569, DOI 10.1038/onc.2011.547; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; ROSEN P, 1980, P NATL ACAD SCI-BIOL, V77, P4760, DOI 10.1073/pnas.77.8.4760; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; SOULE HD, 1990, CANCER RES, V50, P6075; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Stuelten CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009832; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Verbeek BS, 1998, FEBS LETT, V425, P145, DOI 10.1016/S0014-5793(98)00224-5; Wells A, 2002, ACTA ONCOL, V41, P124, DOI 10.1080/028418602753669481; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yang ZB, 2004, CLIN CANCER RES, V10, P658, DOI 10.1158/1078-0432.CCR-0382-03; Yarrow JC, 2005, CHEM BIOL, V12, P385, DOI 10.1016/j.chembiol.2005.01.015; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302	66	46	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58859	10.1371/journal.pone.0058859	http://dx.doi.org/10.1371/journal.pone.0058859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527039	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100052
J	Lin, YJ; Huang, LH; Huang, CT				Lin, Yu-Ju; Huang, Li-Hsin; Huang, Ching-Tsan			Enhancement of Heterologous Gene Expression in Flammulina velutipes Using Polycistronic Vectors Containing a Viral 2A Cleavage Sequence	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; MULTIPLE PROTEINS; MEDIATED TRANSFORMATION; SCHIZOPHYLLUM-COMMUNE; AGARICUS-BISPORUS; COPRINUS-CINEREUS; GPD PROMOTER; POLYPROTEIN; INTRONS; PEPTIDE	Agrobacterium tumefaciens-mediated transformation for edible mushrooms has been previously established. However, the enhancement of heterologous protein production and the expression of multi-target genes remains a challenge. In this study, heterologous protein expression in the enoki mushroom Flammulina velutipes was notably enhanced using 2A peptide-mediated cleavage to co-express multiple copies of single gene. The polycistronic expression vectors were constructed by connecting multi copies of the enhanced green fluorescent protein (egfp) gene using 2A peptides derived from porcine teschovirus-1. The P2A peptides properly self-cleaved as shown by the formation of the transformants with antibiotic resistant capacity and exciting green fluorescence levels after introducing the vectors into F. velutipes mycelia. The results of western blot analysis, epifluorescent microscopy and EGFP production showed that heterologous protein expression in F. velutipes using the polycistronic strategy increased proportionally as the gene copy number increased from one to three copies. In contrast, much lower EGFP levels were detected in the F. velutipes transformants harboring four copies of the egfp gene due to mRNA instability. The polycistronic strategy using 2A peptide-mediated cleavage developed in this study can not only be used to express single gene in multiple copies, but also to express multiple genes in a single reading frame. It is a promising strategy for the application of mushroom molecular pharming.	[Lin, Yu-Ju; Huang, Li-Hsin; Huang, Ching-Tsan] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	National Taiwan University	Huang, CT (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	cthuang@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013; Huang, Ching-Tsan/B-5359-2009	Huang, Ching-Tsan/0000-0003-1019-784X; Huang, Li-Hsin/0000-0003-4593-9268; Lin, Yu Ju/0000-0001-9911-0602	National Science Council ROC [NSC99-2313-B-002-033-MY3]	National Science Council ROC(Ministry of Science and Technology, Taiwan)	The financial support of the National Science Council of the ROC (Grant No. NSC99-2313-B-002-033-MY3) is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; Burns C, 2005, FUNGAL GENET BIOL, V42, P191, DOI 10.1016/j.fgb.2004.11.005; Chang SW, 2006, J AGR FOOD CHEM, V54, P815, DOI 10.1021/jf052183k; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; Cheng SJ, 2009, BIORESOURCE TECHNOL, V100, P4475, DOI 10.1016/j.biortech.2009.04.021; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Ding Y, 2011, MICROBIOL RES, V166, P314, DOI 10.1016/j.micres.2010.07.001; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; Horn ME, 2004, PLANT CELL REP, V22, P711, DOI 10.1007/s00299-004-0767-1; Hu T, 2009, BIOTECHNOL LETT, V31, P353, DOI 10.1007/s10529-008-9882-3; Kilaru S, 2006, APPL MICROBIOL BIOT, V71, P200, DOI 10.1007/s00253-005-0128-1; Kuo CY, 2010, BOT STUD, V51, P303; Kuo CY, 2004, APPL MICROBIOL BIOT, V65, P593, DOI 10.1007/s00253-004-1635-1; Lugones LG, 1999, MOL MICROBIOL, V32, P681, DOI 10.1046/j.1365-2958.1999.01373.x; Okamoto T, 2010, BIOSCI BIOTECH BIOCH, V74, P2327, DOI 10.1271/bbb.100398; Park S, 2009, BIOTECHNOL LETT, V31, P911, DOI 10.1007/s10529-009-9951-2; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Scholtmeijer K, 2001, APPL ENVIRON MICROB, V67, P481, DOI 10.1128/AEM.67.1.481-483.2001; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Zeng QD, 2001, TRENDS GENET, V17, P682, DOI 10.1016/S0168-9525(01)02498-2	35	16	19	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59099	10.1371/journal.pone.0059099	http://dx.doi.org/10.1371/journal.pone.0059099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516605	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400093
J	Rath, T; Hage, L; Kugler, M; Menendez, KM; Zachoval, R; Naehrlich, L; Schulz, R; Roderfeld, M; Roeb, E				Rath, Timo; Hage, Lisa; Kuegler, Marion; Menendez, Katrin Menendez; Zachoval, Reinhart; Naehrlich, Lutz; Schulz, Richard; Roderfeld, Martin; Roeb, Elke			Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; TISSUE INHIBITOR; LONG PENTRAXIN; EXPRESSION; ENDOGLIN; METALLOPROTEINASES; BIOPSY; PTX3	Background and Aims: Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools for CFLD are lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CFLD. Methods: 45 CF patients were included in the study and received transient elastography. Differential regulation of 220 different serum proteins was assessed in a subgroup of patients with and without CFLD. Most interesting candidate proteins were further quantified and validated by ELISA in the whole patient cohort. To assess a potential relation of biomarker expression to the degree of hepatic fibrosis, serum biomarkers were further determined in 18 HCV patients where liver histology was available. Results: 43 serum proteins differed at least 2-fold in patients with CFLD compared to those without liver disease as identified in proteome profiling. In ELISA quantifications, TIMP-4 and Endoglin were significantly up-regulated in patients with CFLD as diagnosed by clinical guidelines or increased liver stiffness. Pentraxin-3 was significantly decreased in patients with CFLD. Serum TIMP-4 and Endoglin showed highest values in HCV patients with liver cirrhosis compared to those with fibrosis but without cirrhosis. At a cut-off value of 6.3 kPa, transient elastography compassed a very high diagnostic accuracy and specificity for the detection of CFLD. Among the biomarkers, TIMP-4 and Endoglin exhibited a high diagnostic accuracy for CFLD. Diagnostic sensitivities and negative predictive values were increased when elastography and TIMP-4 and Endoglin were combined for the detection of CFLD. Conclusions: Serum TIMP-4 and Endoglin are increased in CFLD and their expression correlates with hepatic staging. Determination of TIMP-4 and Endoglin together with transient elastography can increase the sensitivity for the non-invasive diagnosis of CFLD.	[Rath, Timo; Hage, Lisa; Kuegler, Marion; Menendez, Katrin Menendez; Roderfeld, Martin; Roeb, Elke] Univ Giessen, Dept Internal Med, Div Gastroenterol, Giessen, Germany; [Zachoval, Reinhart] Univ Munich, Dept Gastroenterol, Munich, Germany; [Naehrlich, Lutz] Univ Giessen, Dept Pediat, Div Pulmonol, D-35390 Giessen, Germany; [Schulz, Richard] Univ Giessen, Dept Internal Med, Div Pulmonol, Giessen, Germany	Justus Liebig University Giessen; University of Munich; Justus Liebig University Giessen; Justus Liebig University Giessen	Roeb, E (corresponding author), Univ Giessen, Dept Internal Med, Div Gastroenterol, Giessen, Germany.	Elke.Roeb@innere.med.uni-giessen.de	, Martin/AHD-5202-2022; Naehrlich, Lutz/F-4574-2015	, Martin/0000-0002-3232-1277; Naehrlich, Lutz/0000-0002-7146-6997; Rath, Timo/0000-0002-7728-9338	Deutsche Forschungsgemeinschaft [RO 957/7-1, RO 957/8-1]; University Medical Center Giessen and Marburg [UKGM 10/2010GI]; ZooMAP (Bundesministerium fA 1/4 Jr Bildung und Forschung, BMBF) [01KI1003E]; Justus-Liebig-University Giessen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Medical Center Giessen and Marburg; ZooMAP (Bundesministerium fA 1/4 Jr Bildung und Forschung, BMBF); Justus-Liebig-University Giessen	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 957/7-1 and RO 957/8-1), a research Grant of the University Medical Center Giessen and Marburg (UKGM 10/2010GI), and from ZooMAP (01KI1003E, Bundesministerium fA 1/4 Jr Bildung und Forschung, BMBF). Dr. Timo Rath has received grants for young researchers ("Anschubfinanzierung'') from the Justus-Liebig-University Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ES, 2011, EUR J CLIN MICROBIOL, V30, P761, DOI 10.1007/s10096-010-1149-y; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892; Bissell DM, 2001, HEPATOLOGY, V34, P859, DOI 10.1053/jhep.2001.28457; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boker KHW, 2000, HEPATO-GASTROENTEROL, V47, P812; Bont L, 2001, J INFECT DIS, V184, P355, DOI 10.1086/322035; Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Breton E, 2009, ARCH PEDIATRIE, V16, P1005, DOI 10.1016/j.arcped.2009.03.021; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Castera L, 1999, HEPATOLOGY, V30, P1529, DOI 10.1002/hep.510300624; Castera L, 2011, BEST PRACT RES CL GA, V25, P291, DOI 10.1016/j.bpg.2011.02.003; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Clemente M, 2006, J VIRAL HEPATITIS, V13, P625, DOI 10.1111/j.1365-2893.2006.00733.x; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Colombo C, 2002, HEPATOLOGY, V36, P1374, DOI 10.1053/jhep.2002.37136; Colombo C, 2006, J PEDIATR GASTR NUTR, V43, pS49, DOI 10.1097/01.mpg.0000226390.02355.52; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Garcia-Alvarez M, 2011, CYTOKINE, V54, P244, DOI 10.1016/j.cyto.2011.03.001; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gault Rachel, 2002, Pediatr Phys Ther, V14, P157; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gressner AM, 2009, WORLD J GASTROENTERO, V15, P2433, DOI 10.3748/wjg.15.2433; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Herrmann U, 2010, BEST PRACT RES CL GA, V24, P585, DOI 10.1016/j.bpg.2010.08.003; Karlas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042139; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; Lichtinghagen R, 2003, CLIN SCI, V105, P373, DOI 10.1042/CS20030098; Lindblad A, 1999, HEPATOLOGY, V30, P1151, DOI 10.1002/hep.510300527; Malbrunot-Wagner AC, 2011, J CYST FIBROS; Menten R, 2010, PEDIATR RADIOL, V40, P1231, DOI 10.1007/s00247-009-1531-z; Meurer SK, 2005, J BIOL CHEM, V280, P3078, DOI 10.1074/jbc.M405411200; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Moriyama M, 2005, INTERVIROLOGY, V48, P223, DOI 10.1159/000084599; Moyer K, 2009, CURR OPIN GASTROEN, V25, P272, DOI 10.1097/MOG.0b013e3283298865; Nadler EP, 2010, J SURG RES, V159, P611, DOI 10.1016/j.jss.2009.10.038; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Patel K, 2004, J HEPATOL, V41, P935, DOI 10.1016/j.jhep.2004.08.008; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; RAMSEY BW, 1994, J PEDIATR-US, V124, P177, DOI 10.1016/S0022-3476(94)70301-9; Rath T, 2012, DIGEST LIVER DIS, V44, P780, DOI 10.1016/j.dld.2012.04.008; Rath T, 2011, SCAND J GASTROENTERO, V46, P1369, DOI 10.3109/00365521.2011.613949; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rodgarkia-Dara C, 2006, MUTAT RES-REV MUTAT, V613, P123, DOI 10.1016/j.mrrev.2006.07.002; Rodriguez-Barbero A, 2001, BIOCHEM BIOPH RES CO, V282, P142, DOI 10.1006/bbrc.2001.4526; Roeb E, 1997, J HEPATOL, V27, P535, DOI 10.1016/S0168-8278(97)80359-5; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; SHIOTA G, 1995, HEPATOLOGY, V21, P106, DOI 10.1002/hep.1840210119; Sokol RJ, 1999, J PEDIATR GASTR NUTR, V28, pS1, DOI 10.1097/00005176-199900001-00001; TSUBOUCHI H, 1992, LANCET, V340, P307, DOI 10.1016/0140-6736(92)92396-W; Witters P, 2009, J CYST FIBROS, V8, P392, DOI 10.1016/j.jcf.2009.08.001; Yagmur E, 2007, EUR J GASTROEN HEPAT, V19, P755, DOI 10.1097/MEG.0b013e3282202bea; Yamagami H, 2001, INTERVIROLOGY, V44, P36, DOI 10.1159/000050028; Yata Y, 1999, J HEPATOL, V30, P425, DOI 10.1016/S0168-8278(99)80101-9; Yoneda M, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-53; Zhang LP, 1999, J HEPATOL, V31, P703, DOI 10.1016/S0168-8278(99)80351-1	63	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58955	10.1371/journal.pone.0058955	http://dx.doi.org/10.1371/journal.pone.0058955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516586	gold, Green Submitted, Green Published			2022-12-27	WOS:000316407400083
J	Tsuji, M; Yokota, Y; Shimohara, K; Kudoh, S; Hoshino, T				Tsuji, Masaharu; Yokota, Yuji; Shimohara, Kodai; Kudoh, Sakae; Hoshino, Tamotsu			An Application of Wastewater Treatment in a Cold Environment and Stable Lipase Production of Antarctic Basidiomycetous Yeast Mrakia blollopis	PLOS ONE			English	Article							SP NOV.; PURIFICATION; TEMPERATURE	Milk fat curdle in sewage is one of the refractory materials for active sludge treatment under low temperature conditions. For the purpose of solving this problem by using a bio-remediation agent, we screened Antarctic yeasts and isolated SK-4 strain from algal mat of sediments of Naga-ike, a lake in Skarvsnes, East Antarctica. The yeast strain showed high nucleotide sequence homologies (> 99.6%) to Mrakia blollopis CBS8921(T) in ITS and D1/D2 sequences and had two unique characteristics when applied on an active sludge; i.e., it showed a potential to use various carbon sources and to grow under vitamin-free conditions. Indeed, it showed a biochemical oxygen demand (BOD) removal rate that was 1.25-fold higher than that of the control. We considered that the improved BOD removal rate by applying SK-4 strain was based on its lipase activity and characteristics. Finally, we purified the lipase from SK-4 and found that the enzyme was quite stable under wide ranges of temperatures and pH, even in the presence of various metal ions and organic solvents. SK-4, therefore, is a promising bio-remediation agent for cleaning up unwanted milk fat curdles from dairy milk wastewater under low temperature conditions.	[Tsuji, Masaharu; Hoshino, Tamotsu] Natl Inst Adv Ind Sci & Technol, BRRC, Higashihiroshima, Hiroshima, Japan; [Yokota, Yuji] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido, Japan; [Shimohara, Kodai] Hokkaido High Technol Coll HHT, Eniwa, Hokkaido, Japan; [Kudoh, Sakae] NIPR, Tachikawa, Tokyo, Japan; [Hoshino, Tamotsu] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Hokkaido University	Hoshino, T (corresponding author), Natl Inst Adv Ind Sci & Technol, BRRC, Higashihiroshima, Hiroshima, Japan.	tamotsu.hoshino@aist.go.jp		Tsuji, Masaharu/0000-0002-9375-7998				Bab'eva IP, 2002, MICROBIOLOGY+, V71, P449, DOI 10.1023/A:1019801828620; Berekaa MM, 2009, WORLD J MICROB BIOT, V25, P287, DOI 10.1007/s11274-008-9891-3; BIDDLESTONE AJ, 1991, PROCESS BIOCHEM, V26, P265, DOI 10.1016/0032-9592(91)85012-D; Chevalier P, 2000, J APPL PHYCOL, V12, P105, DOI 10.1023/A:1008168128654; Fadiloglu Sibel, 2002, Turkish Journal of Engineering and Environmental Sciences, V26, P249; FELL JW, 1969, ANTON VAN LEE J M S, V35, P433, DOI 10.1007/BF02219163; Healy MG, 2007, BIORESOURCE TECHNOL, V98, P2268, DOI 10.1016/j.biortech.2006.07.036; Hirayama-Katayama K, 2003, POLAR BIOSCIENCE, V16, P43; Hoshino T, 1997, EUR J PLANT PATHOL, V103, P357, DOI 10.1023/A:1008646303944; IEFUJI H, 1994, BIOSCI BIOTECH BIOCH, V58, P2261, DOI 10.1271/bbb.58.2261; IIZUMI T, 1990, AGR BIOL CHEM TOKYO, V54, P1253, DOI 10.1080/00021369.1990.10870128; Kamini NR, 2000, PROCESS BIOCHEM, V36, P317, DOI 10.1016/S0032-9592(00)00228-4; Kato K, 2010, 12 INT C WETL SYST W; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CY, 2001, ENZYME MICROB TECH, V29, P258, DOI 10.1016/S0141-0229(01)00396-9; Margesin R, 2008, INT J SYST EVOL MICR, V58, P2977, DOI 10.1099/ijs.0.2008/000836-0; Shah SB, 2002, J ENVIRON SCI HEAL B, V37, P493, DOI 10.1081/PFC-120014879; Shimohara K., 2012, J WATER WASTE, V54, P691; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taoka Y, 2011, J BIOSCI BIOENG, V111, P420, DOI 10.1016/j.jbiosc.2010.12.010; Thomas-Hall SR, 2010, EXTREMOPHILES, V14, P47, DOI 10.1007/s00792-009-0286-7; Xin Ming-xiu, 2007, Journal of Zhejiang University-Science B, V8, P260, DOI 10.1631/jzus.2007.B0260; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9; Ying C, 2010, BIORESOURCE TECHNOL, V101, P4349, DOI 10.1016/j.biortech.2010.01.087	24	38	40	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59376	10.1371/journal.pone.0059376	http://dx.doi.org/10.1371/journal.pone.0059376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516630	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400108
J	Mirebeau-Prunier, D; Le Pennec, S; Jacques, C; Fontaine, JF; Gueguen, N; Boutet-Bouzamondo, N; Donnart, A; Malthiery, Y; Savagner, F				Mirebeau-Prunier, Delphine; Le Pennec, Soazig; Jacques, Caroline; Fontaine, Jean-Fred; Gueguen, Naig; Boutet-Bouzamondo, Nathalie; Donnart, Audrey; Malthiery, Yves; Savagner, Frederique			Estrogen-Related Receptor Alpha Modulates Lactate Dehydrogenase Activity in Thyroid Tumors	PLOS ONE			English	Article							ERR-ALPHA; MITOCHONDRIAL BIOGENESIS; CANCER METABOLISM; GAMMA; GENE; PHOSPHOFRUCTOKINASE; RESPIRATION; PROGRESSION; GLYCOLYSIS; EXPRESSION	Metabolic modifications of tumor cells are hallmarks of cancer. They exhibit an altered metabolism that allows them to sustain higher proliferation rates in hostile environment outside the cell. In thyroid tumors, the expression of the estrogen-related receptor alpha (ERR alpha), a major factor of metabolic adaptation, is closely related to the oxidative metabolism and the proliferative status of the cells. To elucidate the role played by ERR alpha in the glycolytic adaptation of tumor cells, we focused on the regulation of lactate dehydrogenases A and B (LDHA, LDHB) and the LDHA/LDHB ratio. Our study included tissue samples from 10 classical and 10 oncocytic variants of follicular thyroid tumors and 10 normal thyroid tissues, as well as samples from three human thyroid tumor cell lines: FTC-133, XTC.UC1 and RO82W-1. We identified multiple cis-acting promoter elements for ERR alpha, in both the LDHA and LDHB genes. The interaction between ERR alpha and LDH promoters was confirmed by chromatin immunoprecipitation assays and in vitro analysis for LDHB. Using knock-in and knock-out cellular models, we found an inverse correlation between ERR alpha expression and LDH activity. This suggests that thyroid tumor cells may reprogram their metabolic pathways through the up-regulation of ERR alpha by a process distinct from that proposed by the recently revisited Warburg hypothesis.	[Mirebeau-Prunier, Delphine; Le Pennec, Soazig; Jacques, Caroline; Boutet-Bouzamondo, Nathalie; Malthiery, Yves; Savagner, Frederique] INSERM, UMR694, Angers, France; [Mirebeau-Prunier, Delphine; Le Pennec, Soazig; Jacques, Caroline; Boutet-Bouzamondo, Nathalie; Malthiery, Yves; Savagner, Frederique] Univ Angers, Angers, France; [Mirebeau-Prunier, Delphine; Gueguen, Naig; Malthiery, Yves; Savagner, Frederique] CHU Angers, Dept Biochim Genet, Angers, France; [Fontaine, Jean-Fred] Max Delbruck Ctr Mol Med, Berlin, Germany; [Donnart, Audrey] INSERM, UMR915, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mirebeau-Prunier, D (corresponding author), INSERM, UMR694, Angers, France.	deprunier@chu-angers.fr	Fontaine, Jean-Fred/GNP-2904-2022; Prunier, Delphine/K-3301-2015; LE PENNEC, Soazig/H-3817-2017; Donnart, Audrey/D-4055-2015	Fontaine, Jean-Fred/0000-0002-1101-4091; 	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by grants from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Cai Q, 2012, ONCOGENE; Charest-Marcotte A, 2010, GENE DEV, V24, P537, DOI 10.1101/gad.1871610; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Downer J, 2006, J THEOR BIOL, V240, P464, DOI 10.1016/j.jtbi.2005.10.007; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; DUMONT JE, 1962, BIOCHIM BIOPHYS ACTA, V56, P382, DOI 10.1016/0006-3002(62)90586-3; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; He X, 2012, DEV DYNAM, V241, P975, DOI 10.1002/dvdy.23769; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Jacques C, 2009, BRIT J CANCER, V101, P132, DOI 10.1038/sj.bjc.6605111; Jose C., 2010, BIOCHIM BIOPHYS ACTA, V1807, P552; Kim JH, 2011, EXP CELL RES, V317, P1108, DOI 10.1016/j.yexcr.2011.02.011; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; de Souza ECL, 2011, EXPERT OPIN THER TAR, V15, P1099, DOI 10.1517/14728222.2011.594044; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x; Nie YH, 2009, J CELL MOL MED, V13, P3051, DOI 10.1111/j.1582-4934.2008.00382.x; Quistorff B, 2011, AGING-US, V3, P457, DOI 10.18632/aging.100329; SanchezMartinez C, 1997, FEBS LETT, V409, P86, DOI 10.1016/S0014-5793(97)00496-1; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Swiderek K, 2011, ARCH BIOCHEM BIOPHYS, V505, P33, DOI 10.1016/j.abb.2010.10.010; TYLER DD, 1968, BIOCHEM J, V106, P123, DOI 10.1042/bj1060123; Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200; VORA S, 1985, CANCER RES, V45, P2993; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zielke A, 1998, THYROID, V8, P475, DOI 10.1089/thy.1998.8.475; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	39	42	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58683	10.1371/journal.pone.0058683	http://dx.doi.org/10.1371/journal.pone.0058683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516535	Green Published, gold, Green Accepted			2022-12-27	WOS:000316849200106
J	Azad, GK; Singh, V; Golla, U; Tomar, RS				Azad, Gajendra Kumar; Singh, Vikash; Golla, Upendarrao; Tomar, Raghuvir S.			Depletion of Cellular Iron by Curcumin Leads to Alteration in Histone Acetylation and Degradation of Sml1p in Saccharomyces cerevisiae	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE; DNA-DAMAGE; CHROMATIN DYNAMICS; PROTEIN; TRANSCRIPTION; REPLICATION; ACTIVATION; INHIBITOR; GENES; HYPOACETYLATION	Curcumin, a naturally occurring polyphenolic compound, is known to possess diverse pharmacological properties. There is a scarcity of literature documenting the exact mechanism by which curcumin modulates its biological effects. In the present study, we have used yeast as a model organism to dissect the mechanism underlying the action of curcumin. We found that the yeast mutants of histone proteins and chromatin modifying enzymes were sensitive to curcumin and further supplementation of iron resulted in reversal of the changes induced by curcumin. Additionally, treatment of curcumin caused the iron starvation induced expression of FET3, FRE1 genes. We also demonstrated that curcumin induces degradation of Sml1p, a ribonucleotide reductase inhibitor involved in regulating dNTPs production. The degradation of Sml1p was mediated through proteasome and vacuole dependent protein degradation pathways. Furthermore, curcumin exerts biological effect by altering global proteome profile without affecting chromatin architecture. These findings suggest that the medicinal properties of curcumin are largely contributed by its cumulative effect of iron starvation and epigenetic modifications.	[Azad, Gajendra Kumar; Singh, Vikash; Golla, Upendarrao; Tomar, Raghuvir S.] Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal, India.	rst@iiserb.ac.in	Golla, Upendar Rao/D-5933-2017; Singh, Vikash/HCI-9902-2022; Azad, Gajendra/K-3381-2014; Azad, Gajendra Kumar/AAC-7014-2019	Golla, Upendar Rao/0000-0003-0519-7087; Singh, Vikash/0000-0002-5325-1386; Azad, Gajendra/0000-0003-0338-3265; Azad, Gajendra Kumar/0000-0001-5478-526X	Department of Biotechnology (DBT) Government of India; Council of Scientific and Industrial Research (CSIR) Government of India; Council of Scientific and Industrial Research (CSIR)	Department of Biotechnology (DBT) Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR) Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was fiancially supported by the funds from Department of Biotechnology (DBT) and Council of Scientific and Industrial Research (CSIR) Government of India to RST. No external funding for this study was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Toshi Tsukiyama, Randall Morse, J. D. Boeke, Mark Parthun, John Wyrick, Peter Samson, Yuki Yamaguchi, Michael. S. Kobor, C. D. Allis, Zhiguo Zhang and Joseph Reese for providing yeast strains. Authors acknowledge Naveen Verma and Prabhat Singh for critical reading of this manuscript. We are thankful to the Director of IISER Bhopal for providing infrastructure facility and funds for this study. Members of the chromatin biology laboratory are acknowledged for helpful discussions throughout this work. Council of Scientific and Industrial Research (CSIR) is acknowledged for fellowship support to GKA.	Agrawal Shyam Sunder, 2012, Cardiovasc Psychiatry Neurol, V2012, P942981, DOI 10.1155/2012/942981; Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Azad GK, 2012, BIOCHEM PHARMACOL, V83, P296, DOI 10.1016/j.bcp.2011.10.011; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam M, 2003, J BIOSCIENCES, V28, P715, DOI 10.1007/BF02708432; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; Burgis NE, 2007, CHEM RES TOXICOL, V20, P1843, DOI 10.1021/tx700126e; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Chen H, 1999, ANTICANCER RES, V19, P3675; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Chuengsamarn S, 2012, DIABETES CARE; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; Erlich RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003717; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gao SM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-27; Gray S. G., 2001, Current Molecular Medicine (Hilversum), V1, P401, DOI 10.2174/1566524013363537; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Gunjan A, 2010, FUTURE MED CHEM, V2, P543, DOI 10.4155/FMC.10.18; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Huertas D, 2009, EPIGENETICS-US, V4, P31, DOI 10.4161/epi.4.1.7733; Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003; Jiao Y, 2009, BLOOD, V113, P462, DOI 10.1182/blood-2008-05-155952; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kang JH, 2005, BIOCHEM PHARMACOL, V69, P1205, DOI 10.1016/j.bcp.2005.01.014; Kang SK, 2006, STEM CELLS DEV, V15, P165, DOI 10.1089/scd.2006.15.165; Kawano A, 2011, GENES CELLS, V16, P590, DOI 10.1111/j.1365-2443.2011.01512.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurup VP, 2008, MOL NUTR FOOD RES, V52, P1031, DOI 10.1002/mnfr.200700293; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P603, DOI 10.1111/j.1745-7254.2005.00081.x; Liu YH, 1997, ONCOL RES, V9, P19; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Messner DJ, 2009, LIVER INT, V29, P63, DOI 10.1111/j.1478-3231.2008.01793.x; Minear S, 2011, EUKARYOT CELL, V10, P1574, DOI 10.1128/EC.05163-11; Munshi A, 2009, J GENET GENOMICS, V36, P75, DOI 10.1016/S1673-8527(08)60094-6; Neely KE, 2002, MOL GENET METAB, V76, P1, DOI 10.1016/S1096-7192(02)00014-8; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Puig S, 2004, J BIOL CHEM, V279, P30298, DOI 10.1074/jbc.M313463200; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Sanvisens N, 2011, MOL CELL, V44, P759, DOI 10.1016/j.molcel.2011.09.021; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Scully R, 2010, NAT REV MOL CELL BIO, V11, P164, DOI 10.1038/nrm2855; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Shu LM, 2011, AAPS J, V13, P606, DOI 10.1208/s12248-011-9300-y; Srividya I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031288; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Theil EC, 2011, J NUTR, V141, p724S, DOI 10.3945/jn.110.127639; Tsaponina O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002061; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	67	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59003	10.1371/journal.pone.0059003	http://dx.doi.org/10.1371/journal.pone.0059003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520547	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900107
J	Dey, SK; Chisti, MJ; Das, SK; Shaha, CK; Ferdous, F; Farzana, FD; Ahmed, S; Malek, MA; Faruque, ASG; Ahmed, T; Salam, MA				Dey, Sanjoy Kumer; Chisti, Mohammod Jobayer; Das, Sumon Kumar; Shaha, Chandan Kumar; Ferdous, Farzana; Farzana, Fahmida Dil; Ahmed, Shahnawaz; Malek, Mohammad Abdul; Faruque, Abu Syed Golam; Ahmed, Tahmeed; Salam, Mohammed Abdus			Characteristics of Diarrheal Illnesses in Non-Breast Fed Infants Attending a Large Urban Diarrheal Disease Hospital in Bangladesh	PLOS ONE			English	Article							BREAST-FED INFANTS; SECRETORY IMMUNOGLOBULIN-A; ROTAVIRUS DIARRHEA; HUMAN-MILK; CAMPYLOBACTER DIARRHEA; DEVELOPING-COUNTRIES; ESCHERICHIA-COLI; IGA ANTIBODIES; PROTECTION; CHILDREN	Background: Lack of breast feeding is associated with higher morbidity and case-fatality from both bacterial and viral etiologic diarrheas. However, there is very limited data on the characteristics of non-breastfed infants attending hospital with diarrheal illnesses caused by common bacterial and viral pathogens. Our objective was to assess the impact of lack of breast feeding on diarrheal illnesses in infants living in urban Bangladesh. Methods: We extracted data of infants (0-11 months) for analyses from the data archive of Diarrheal Disease Surveillance System (DDSS) of the Dhaka Hospital of icddr,b for the period 2008-2011. Results: The prevalence of breastfeeding in infants attending the hospital with diarrhea reduced from 31% in 2008 to 17% in 2011, with corresponding increase in the prevalence of non-breastfed (chi square for trend <0.001). Among breastfed infants, the incidence of rotavirus infections was higher (43%) among the 0-5 months age group than infants aged 9-11 months (18%). On the other hand, among non-breastfed infants, the incidence of rotavirus infections was much higher (82%) among 9-11 months old infants compared to those in 0-5 months age group (57%) (chi square for trend <0.001). Very similar trends were also observed in the incidence of cholera and ETEC diarrheas among different age groups of breastfed and non-breastfed infants (chi square for trend 0.020 and 0.001 respectively). However, for shigellosis, the statistical difference remained unchanged among both the groups (chi square for trend 0.240). Conclusion and Significance: We observed protective role of breastfeeding in infantile diarrhea caused by the major viral and common bacterial agents. These findings underscore the importance of promotion and expansion of breastfeeding campaigns in Bangladesh and elsewhere.	[Dey, Sanjoy Kumer; Shaha, Chandan Kumar] Bangabandhu Sheikh Mujib Med Univ, Dept Neonatol, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Das, Sumon Kumar; Ferdous, Farzana; Farzana, Fahmida Dil; Ahmed, Shahnawaz; Malek, Mohammad Abdul; Faruque, Abu Syed Golam; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Bangladesh Icddr B, Dhaka 1000, Bangladesh; [Salam, Mohammed Abdus] Icddr B, RAS, Dhaka, Bangladesh	Bangabandhu Sheikh Mujib Medical University (BSMMU); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Faruque, ASG (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Bangladesh Icddr B, GPO Box 128, Dhaka 1000, Bangladesh.	gfaruque@icddrb.org	Dey, Sanjoy Kumer/AAN-6937-2020; Das, Sumon Kumar/T-6384-2019; Chisti, Mohammod J/A-7216-2018; Das, Sumon Kumar/AAD-1551-2019	Ahmed, Shahnawaz/0000-0001-8339-4137; FERDOUS, FARZANA/0000-0002-6373-3581	icddr,b; Government of the People's Republic of Bangladesh through its IHP under HNPSP	icddr,b; Government of the People's Republic of Bangladesh through its IHP under HNPSP	Diarrhoeal Disease Surveillance System at the Dhaka Hospital of icddr,b was funded by icddr,b and the Government of the People's Republic of Bangladesh through its IHP under HNPSP. icddr,b acknowledges with gratitude the commitment of the Government of the People's Republic of Bangladesh to its research efforts. icddr,b also gratefully acknowledges the following donors which provide unrestricted support to the Centre's research efforts: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Cooperation (SDC), and Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; Chisti MJ, 2011, ACTA PAEDIATR, V100, pE275, DOI 10.1111/j.1651-2227.2011.02368.x; CLEMENS J, 1993, PEDIATRICS, V92, P680; CRUZ JR, 1988, ACTA PAEDIATR SCAND, V77, P658, DOI 10.1111/j.1651-2227.1988.tb10726.x; Faruque ASG, 2004, SCAND J INFECT DIS, V36, P204, DOI 10.1080/00365540410019219; GLASS RI, 1986, ACTA PAEDIATR SCAND, V75, P713, DOI 10.1111/j.1651-2227.1986.tb10279.x; GLASS RI, 1983, NEW ENGL J MED, V308, P1389, DOI 10.1056/NEJM198306093082304; GLASS RI, 1989, ACTA PAEDIATR SCAND, P131; Glass RI, 2003, CONTROL FOOD FLUID I, P17; Hanson Lars A., 1994, Acta Paediatrica Japonica, V36, P557; HAYANI KC, 1991, J CLIN MICROBIOL, V29, P2599, DOI 10.1128/JCM.29.11.2599-2603.1991; HAYANI KC, 1992, J PEDIATR-US, V121, P852, DOI 10.1016/S0022-3476(05)80327-0; Liu L, 2012, LANCET; MACAULAY D, 1961, ARCH DIS CHILD, V36, P543, DOI 10.1136/adc.36.189.543; Morrow AL, 2005, J NUTR, V135, P1304, DOI 10.1093/jn/135.5.1304; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Morrow Ardythe L, 2004, Semin Pediatr Infect Dis, V15, P221, DOI 10.1053/j.spid.2004.07.002; Naficy AB, 1999, AM J EPIDEMIOL, V150, P770, DOI 10.1093/oxfordjournals.aje.a010080; Podewils Laura Jean, 2004, Semin Pediatr Infect Dis, V15, P155, DOI 10.1053/j.spid.2004.05.008; Qadri F, 2005, EMERG INFECT DIS, V11, P1104, DOI 10.3201/eid1107.041266; Rahman M, 2003, J CLIN MICROBIOL, V41, P2088, DOI 10.1128/JCM.41.5.2088-2095.2003; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; RUIZPALACIOS GM, 1990, J PEDIATR-US, V116, P707, DOI 10.1016/S0022-3476(05)82652-6; Strina A, 2012, T ROY SOC TROP MED H, V106, P445, DOI 10.1016/j.trstmh.2012.02.001; TORRES O, 1993, ACTA PAEDIATR, V82, P835, DOI 10.1111/j.1651-2227.1993.tb17622.x; World Health Organization, 1987, MAN LAB INV AC ENT I	28	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58228	10.1371/journal.pone.0058228	http://dx.doi.org/10.1371/journal.pone.0058228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520496	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900055
J	Doncic, A; Eser, U; Atay, O; Skotheim, JM				Doncic, Andreas; Eser, Umut; Atay, Oguzhan; Skotheim, Jan M.			An Algorithm to Automate Yeast Segmentation and Tracking	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IMAGE-ANALYSIS; BUDDING YEAST; BIOLOGICAL NOISE; CELL-CYCLE; TRANSCRIPTION; LOCALIZATION; VARIABILITY; FEEDBACK; WHI5	Our understanding of dynamic cellular processes has been greatly enhanced by rapid advances in quantitative fluorescence microscopy. Imaging single cells has emphasized the prevalence of phenomena that can be difficult to infer from population measurements, such as all-or-none cellular decisions, cell-to-cell variability, and oscillations. Examination of these phenomena requires segmenting and tracking individual cells over long periods of time. However, accurate segmentation and tracking of cells is difficult and is often the rate-limiting step in an experimental pipeline. Here, we present an algorithm that accomplishes fully automated segmentation and tracking of budding yeast cells within growing colonies. The algorithm incorporates prior information of yeast-specific traits, such as immobility and growth rate, to segment an image using a set of threshold values rather than one specific optimized threshold. Results from the entire set of thresholds are then used to perform a robust final segmentation.	[Doncic, Andreas; Atay, Oguzhan; Skotheim, Jan M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Eser, Umut] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Skotheim, JM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	skotheim@stanford.edu	Skotheim, Jan/C-3238-2015	Skotheim, Jan/0000-0001-8420-6820; Atay, Oguzhan/0000-0002-7203-9575	National Institutes of Health [GM092925]; Burroughs Wellcome Fund CASI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund CASI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health grant GM092925 and Burroughs Wellcome Fund CASI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chen S-C, 2006, 2006 IEEE S COMP INT, DOI [10.1109/CIBCB.2006.330975, DOI 10.1109/CIBCB.2006.330975]; Chen SC, 2007, BIOINFORMATICS, V23, pI66, DOI 10.1093/bioinformatics/btm206; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Carvalho MAG, 2007, IMAGE VISION COMPUT, V25, P34, DOI 10.1016/j.imavis.2006.01.006; Delgado-Gonzalo R, 2010, I S BIOMED IMAGING, P544, DOI 10.1109/ISBI.2010.5490288; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Doncic A, 2011, MOL CELL, V43, P528, DOI 10.1016/j.molcel.2011.06.025; Eser U, 2011, MOL CELL, V43, P515, DOI 10.1016/j.molcel.2011.06.024; Haidekker MA, 2011, ADV BIOMEDICAL IMAGE, Vxi; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Huh S, 2009, CYTOM PART A, V75A, P934, DOI 10.1002/cyto.a.20793; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kim K, 2010, PROC SPIE, V7798, DOI 10.1117/12.859770; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Lee PJ, 2008, BIOTECHNIQUES, V44, P91, DOI 10.2144/000112673; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Niemisto Antti, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2353; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Pelet S, 2012, INTEGR BIOL-UK, V4, P1274, DOI 10.1039/c2ib20139a; Robinson A, 1998, BIOTECHNOL TECH, V12, P763, DOI 10.1023/A:1008816702162; Rue H, 1998, STAT COMPUT, V8, P221, DOI 10.1023/A:1008953210305; Saito TL, 2005, NUCLEIC ACIDS RES, V33, pW753, DOI 10.1093/nar/gki451; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012	32	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57970	10.1371/journal.pone.0057970	http://dx.doi.org/10.1371/journal.pone.0057970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520484	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900043
J	Murata, H; Hirasawa, H; Aoyama, Y; Sugisaki, K; Araie, M; Mayama, C; Aihara, M; Asaoka, R				Murata, Hiroshi; Hirasawa, Hiroyo; Aoyama, Yuka; Sugisaki, Kenji; Araie, Makoto; Mayama, Chihiro; Aihara, Makoto; Asaoka, Ryo			Identifying Areas of the Visual Field Important for Quality of Life in Patients with Glaucoma	PLOS ONE			English	Article							MOTOR-VEHICLE COLLISIONS; MOBILITY PERFORMANCE; DEFECTS; IMPAIRMENT; SEVERITY; IMPACT; TASKS; RISK; DISABILITY; INDICATORS	Purpose: The purpose of this study was to create a vision-related quality of life (VRQoL) prediction system to identify visual field (VF) test points associated with decreased VRQoL in patients with glaucoma. Method: VRQoL score was surveyed in 164 patients with glaucoma using the 'Sumi questionnaire'. A binocular VF was created from monocular VFs by using the integrated VF (IVF) method. VRQoL score was predicted using the 'Random Forest' method, based on visual acuity (VA) of better and worse eyes (better-eye and worse-eye VA) and total deviation (TD) values from the IVF. For comparison, VRQoL scores were regressed (linear regression) against: (i) mean of TD (IVF MD); (ii) better-eye VA; (iii) worse-eye VA; and (iv) IVF MD and better- and worse-eye VAs. The rank of importance of IVF test points was identified using the Random Forest method. Results: The root mean of squared prediction error associated with the Random Forest method (0.30 to 1.97) was significantly smaller than those with linear regression models (0.34 to 3.38, p<0.05, ten-fold cross validation test). Worse-eye VA was the most important variable in all VRQoL tasks. In general, important VF test points were concentrated along the horizontal meridian. Particular areas of the IVF were important for different tasks: peripheral superior and inferior areas in the left hemifield for the 'letters and sentences' task, peripheral, mid-peripheral and para-central inferior regions for the 'walking' task, the peripheral superior region for the 'going out' task, and a broad scattered area across the IVF for the 'dining' task. Conclusion: The VRQoL prediction model with the Random Forest method enables clinicians to better understand patients' VRQoL based on standard clinical measurements of VA and VF.	[Murata, Hiroshi; Hirasawa, Hiroyo; Aoyama, Yuka; Sugisaki, Kenji; Araie, Makoto; Mayama, Chihiro; Aihara, Makoto; Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; [Sugisaki, Kenji] Tokyo Koseinenkin Hosp, Tokyo, Japan; [Araie, Makoto] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan; [Aihara, Makoto] Shirato Eye Clin, Tokyo, Japan	University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp						Altangerel Undraa, 2003, Curr Opin Ophthalmol, V14, P100, DOI 10.1097/00055735-200304000-00009; Asaoka R, 2011, INVEST OPHTH VIS SCI, V52, P7007, DOI 10.1167/iovs.11-7643; Aspinall PA, 2008, INVEST OPHTH VIS SCI, V49, P1907, DOI 10.1167/iovs.07-0559; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Black AA, 2008, OPTOMETRY VISION SCI, V85, P489, DOI 10.1097/OPX.0b013e31817882db; Bouckaert R. R., 2003, P 20 INT C MACH LEAR, P51, DOI DOI 10.5555/3041838.3041845; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burr JM, 2007, OPTOMETRY VISION SCI, V84, P797, DOI 10.1097/OPX.0b013e3181339f30; CAPRIOLI J, 1984, AM J OPHTHALMOL, V97, P730, DOI 10.1016/0002-9394(84)90505-1; Coleman AL, 2009, J AM GERIATR SOC, V57, P1825, DOI 10.1111/j.1532-5415.2009.02432.x; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Crabb DP, 2004, BRIT J OPHTHALMOL, V88, P1191, DOI 10.1136/bjo.2003.035949; Crabb DP, 1998, BRIT J OPHTHALMOL, V82, P1236, DOI 10.1136/bjo.82.11.1236; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Douglas PK, 2011, NEUROIMAGE, V56, P544, DOI 10.1016/j.neuroimage.2010.11.002; Friedman DS, 2007, OPHTHALMOLOGY, V114, P2232, DOI 10.1016/j.ophtha.2007.02.001; Gutierrez P, 1997, ARCH OPHTHALMOL-CHIC, V115, P777, DOI 10.1001/archopht.1997.01100150779014; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; Hyman LG, 2005, OPHTHALMOLOGY, V112, P1505, DOI 10.1016/j.ophtha.2005.03.028; Ishii T, 2003, INTEGRATED METHODOLO, P107; Janz NK, 2001, OPHTHALMOLOGY, V108, P887, DOI 10.1016/S0161-6420(00)00624-2; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Lachenmayr B J, 1995, Ger J Ophthalmol, V4, P175; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Magacho L, 2004, OPHTHAL EPIDEMIOL, V11, P263, DOI 10.1080/09286580490515251; Maindonald J. H., 2010, CAMBRIDGE SERIES STA; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Maroco Joao, 2011, BMC Res Notes, V4, P299, DOI 10.1186/1756-0500-4-299; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McKean-Cowdin R, 2007, AM J OPHTHALMOL, V143, P1013, DOI 10.1016/j.ajo.2007.02.022; Nelson P, 2003, J GLAUCOMA, V12, P139, DOI 10.1097/00061198-200304000-00009; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Odberg T, 2001, ACTA OPHTHALMOL SCAN, V79, P121, DOI 10.1034/j.1600-0420.2001.079002121.x; Parrish RK, 1997, ARCH OPHTHALMOL-CHIC, V115, P1447, DOI 10.1001/archopht.1997.01100160617016; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Ringsdorf L, 2006, J GLAUCOMA, V15, P414, DOI 10.1097/01.ijg.0000212252.72207.c2; Rosenholtz R, 2012, J VISION, V12, DOI 10.1167/12.4.14; Segal MR, 2001, BIOMETRICS, V57, P632, DOI 10.1111/j.0006-341X.2001.00632.x; Shah M., 2011, EVALUATING LEARNING, DOI [10.1017/CBO9780511921803, DOI 10.1017/CBO9780511921803]; Sherwood MB, 1998, OPHTHALMOLOGY, V105, P561, DOI 10.1016/S0161-6420(98)93043-3; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sumi I, 2003, OPHTHALMOLOGY, V110, P332, DOI 10.1016/S0161-6420(02)01742-6; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; Szlyk JP, 2001, OPHTHALMOLOGY, V108, P65, DOI 10.1016/S0161-6420(00)00413-9; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P2803; Varma R, 2006, OPHTHALMOLOGY, V113, P1846, DOI 10.1016/j.ophtha.2006.04.028; Viswanathan AC, 1999, ARCH OPHTHALMOL-CHIC, V117, P450; West SK, 2002, ARCH OPHTHALMOL-CHIC, V120, P774; White Stuart C, 2006, Gend Med, V3, P110, DOI 10.1016/S1550-8579(06)80200-7; Wilson MR, 1998, OPHTHALMOLOGY, V105, P2112, DOI 10.1016/S0161-6420(98)91135-6; ZEYEN TG, 1993, OPHTHALMOLOGY, V100, P518	54	74	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58695	10.1371/journal.pone.0058695	http://dx.doi.org/10.1371/journal.pone.0058695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520528	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900088
J	Peterson, SN; Snesrud, E; Liu, J; Ong, AC; Kilian, M; Schork, NJ; Bretz, W				Peterson, Scott N.; Snesrud, Erik; Liu, Jia; Ong, Ana C.; Kilian, Mogens; Schork, Nicholas J.; Bretz, Walter			The Dental Plaque Microbiome in Health and Disease	PLOS ONE			English	Article							MOLECULAR ANALYSIS; STREPTOCOCCUS-MUTANS; CARIES; DIVERSITY; CHILDREN; BACTERIA; PROGRAM	Dental decay is one of the most prevalent chronic diseases worldwide. A variety of factors, including microbial, genetic, immunological, behavioral and environmental, interact to contribute to dental caries onset and development. Previous studies focused on the microbial basis for dental caries have identified species associated with both dental health and disease. The purpose of the current study was to improve our knowledge of the microbial species involved in dental caries and health by performing a comprehensive 16S rDNA profiling of the dental plaque microbiome of both caries-free and caries-active subjects. Analysis of over 50,000 nearly full-length 16S rDNA clones allowed the identification of 1,372 operational taxonomic units (OTUs) in the dental plaque microbiome. Approximately half of the OTUs were common to both caries-free and caries-active microbiomes and present at similar abundance. The majority of differences in OTU's reflected very low abundance phylotypes. This survey allowed us to define the population structure of the dental plaque microbiome and to identify the microbial signatures associated with dental health and disease. The deep profiling of dental plaque allowed the identification of 87 phylotypes that are over-represented in either caries-free or caries-active subjects. Among these signatures, those associated with dental health outnumbered those associated with dental caries by nearly two-fold. A comparison of this data to other published studies indicate significant heterogeneity in study outcomes and suggest that novel approaches may be required to further define the signatures of dental caries onset and progression.	[Peterson, Scott N.; Snesrud, Erik; Liu, Jia; Ong, Ana C.] J Craig Venter Inst, Rockville, MD USA; [Kilian, Mogens] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Schork, Nicholas J.] Scripps Translat Sci Inst & Scripps Hlth, La Jolla, CA USA; [Bretz, Walter] NYU, Coll Dent, Dept Cariol & Comprehens Care, New York, NY USA	J. Craig Venter Institute; Aarhus University; New York University	Peterson, SN (corresponding author), J Craig Venter Inst, Rockville, MD USA.	speterson@sanfordburnham.org		Kilian, Mogens/0000-0002-5861-0472; Schork, Nicholas/0000-0003-0920-5013	J. Craig Venter Institute; National Institute of Dentistry and Craniofacial Research (NIDCR); National Institutes of Health (NIH), Department of Health and Human Services [NIH-1R01DE019665-01]; NIDCR-NIH grant [DE15351]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015351] Funding Source: NIH RePORTER	J. Craig Venter Institute; National Institute of Dentistry and Craniofacial Research (NIDCR); National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR-NIH grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project has been supported with funds from the J. Craig Venter Institute and with Federal funds from the National Institute of Dentistry and Craniofacial Research (NIDCR), National Institutes of Health (NIH), Department of Health and Human Services, under Grant No. NIH-1R01DE019665-01 and partially funded by NIDCR-NIH grant DE15351. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Acs George, 1999, Pediatric Dentistry, V21, P109; [Anonymous], 2000, J Calif Dent Assoc, V28, P685; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Corby PM, 2007, TWIN RES HUM GENET, V10, P821, DOI 10.1375/twin.10.6.821; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Darveau RP, 1997, PERIODONTOL 2000, V14, P12, DOI 10.1111/j.1600-0757.1997.tb00190.x; de Soet JJ, 2000, CARIES RES, V34, P486, DOI 10.1159/000016628; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Haas Brian J, 2011, Mycology, V2, P118; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HOSHINO E, 1980, ARCH ORAL BIOL, V25, P211, DOI 10.1016/0003-9969(80)90023-0; HOWELL A, 1961, BACTERIOL REV, V25, P162, DOI 10.1128/MMBR.25.2.162-171.1961; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hutter G, 2003, MICROBIOL-SGM, V149, P67, DOI 10.1099/mic.0.25791-0; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Kaste LM, 1996, J DENT RES, V75, P631, DOI 10.1177/002203459607502S03; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2006, BIOINFORMATICS, V22, P887, DOI 10.1093/bioinformatics/btl019; LOESCHE WJ, 1976, J DENT RES, V55, pA87, DOI 10.1177/002203457605500127011; Low Wendy, 1999, Pediatric Dentistry, V21, P325; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Neafsey Daniel E, 2011, Genome Biol, V12, P303, DOI 10.1186/gb-2011-12-3-303; NOORDA WD, 1988, CARIES RES, V22, P342, DOI 10.1159/000261134; Schneiderman A, 1997, CARIES RES, V31, P103, DOI 10.1159/000262384; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; SYED SA, 1972, APPL MICROBIOL, V24, P638, DOI 10.1128/AEM.24.4.638-644.1972; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Zandona AGF, 2000, EARLY DETECTION DENT, VII	42	117	127	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58487	10.1371/journal.pone.0058487	http://dx.doi.org/10.1371/journal.pone.0058487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520516	Green Published, gold			2022-12-27	WOS:000318679900075
J	Volta, V; Ranzato, E; Martinotti, S; Gallo, S; Russo, MV; Mutti, L; Biffo, S; Burlando, B				Volta, Viviana; Ranzato, Elia; Martinotti, Simona; Gallo, Simone; Russo, Maria Veronica; Mutti, Luciano; Biffo, Stefano; Burlando, Bruno			Preclinical Demonstration of Synergistic Active Nutrients/Drug (AND) Combination as a Potential Treatment for Malignant Pleural Mesothelioma	PLOS ONE			English	Article							GAMMA-CATENIN; CANCER CELLS; GREEN TEA; VITAMIN-E; IN-VIVO; ASCORBATE; GEMCITABINE; EPIGALLOCATECHIN-3-GALLATE; INHIBITION; MANAGEMENT	Malignant pleural mesothelioma (MPM) is a poor prognosis disease lacking adequate therapy. We have previously shown that ascorbic acid administration is toxic to MPM cells. Here we evaluated a new combined therapy consisting of ascorbate/epigallocatechin-3-gallate/gemcitabine mixture (called AND, for Active Nutrients/Drug). In vitro effects of AND therapy on various MPM cell lines revealed a synergistic cytotoxic mechanism. In vivo experiments on a xenograft mouse model for MPM, obtained by REN cells injection in immunocompromised mice, showed that AND strongly reduced the size of primary tumor as well as the number and size of metastases, and prevented abdominal hemorrhage. Kaplan Meier curves and the log-rank test indicated a marked increase in the survival of AND-treated animals. Histochemical analysis of dissected tumors showed that AND induced a shift from cell proliferation to apoptosis in cancer cells. Lysates of tumors from AND-treated mice, analyzed with an antibody array, revealed decreased TIMP-1 and -2 expressions and no effects on angiogenesis regulating factors. Multiplex analysis for signaling protein phosphorylation exhibited inactivation of cell proliferation pathways. The complex of data showed that the AND treatment is synergistic in vitro on MPM cells, and blocks in vivo tumor progression and metastasization in REN-based xenografts. Hence, the AND combination is proposed as a new treatment for MPM.	[Volta, Viviana; Gallo, Simone; Russo, Maria Veronica; Biffo, Stefano] Ist Sci San Raffaele, Mol Histol & Cell Growth Lab, I-20132 Milan, Italy; [Ranzato, Elia; Martinotti, Simona; Biffo, Stefano; Burlando, Bruno] Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, Alessandria, Italy; [Mutti, Luciano] Vercelli Natl Hlth Trust, Dept Gen Med, Vercelli, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Eastern Piedmont Amedeo Avogadro	Burlando, B (corresponding author), Univ Piemonte Orientale, Dipartimento Sci & Innovaz Tecnol, Alessandria, Italy.	burlando@unipmn.it	Martinotti, Simona/ABF-3600-2020; Mutti, Luciano/A-3545-2011	Mutti, Luciano/0000-0002-1578-2637; Martinotti, Simona/0000-0003-2891-1810; Burlando, Bruno/0000-0001-7545-0311; biffo, stefano/0000-0002-3780-1050; Volta, Viviana/0000-0001-9999-3732	Fondazione Buzzi Unicem (Casale Monferrato, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC); University of Piemonte Orientale; Italian Ministry of University and Research (MIUR)	Fondazione Buzzi Unicem (Casale Monferrato, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); University of Piemonte Orientale; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Fondazione Buzzi Unicem (Casale Monferrato, Italy, www.fondazionebuzziunicem.org) and Associazione Italiana per la Ricerca sul Cancro (AIRC, www.airc.it). ER is recipient of a Research Fellowship from the University of Piemonte Orientale. SM is recipient of a PhD scholarship from the Italian Ministry of University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2006, ANTICANCER RES, V26, P3237; Azam S, 2004, TOXICOL IN VITRO, V18, P555, DOI 10.1016/j.tiv.2003.12.012; Belli C, 2009, EXPERT OPIN EMERG DR, V14, P423, DOI 10.1517/14728210903074563; Bertino P, 2008, CLIN CANCER RES, V14, P541, DOI 10.1158/1078-0432.CCR-07-1388; Bocci G, 2005, BRIT J CANCER, V93, P319, DOI 10.1038/sj.bjc.6602720; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; Carbone M, 2007, NAT REV CANCER, V7, P147, DOI 10.1038/nrc2068; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Ellis P, 2006, J THORAC ONCOL, V1, P591, DOI 10.1097/01243894-200607000-00017; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Espey MG, 2011, FREE RADICAL BIO MED, V50, P1610, DOI 10.1016/j.freeradbiomed.2011.03.007; Feng MQ, 2011, J CANCER, V2, P123, DOI 10.7150/jca.2.123; Frizelle SP, 2000, CANCER GENE THER, V7, P1421, DOI 10.1038/sj.cgt.7700241; Grad JM, 2001, DRUG RESIST UPDATE, V4, P85, DOI 10.1054/drup.2001.0192; Harris JE, 2011, J SURG RES, V171, pE75, DOI 10.1016/j.jss.2011.06.058; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P626, DOI 10.1016/j.fct.2005.07.005; Kindler HL, 2002, SEMIN ONCOL, V29, P70, DOI 10.1053/sonc.2002.30232; Kroczynska B, 2006, P NATL ACAD SCI USA, V103, P14128, DOI 10.1073/pnas.0604544103; Lang M, 2009, LIVER INT, V29, P670, DOI 10.1111/j.1478-3231.2009.01984.x; Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039; Luo T, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2473; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Martinotti S, 2011, TOXICOL IN VITRO, V25, P1568, DOI 10.1016/j.tiv.2011.05.023; Mereles D, 2011, INT J MOL SCI, V12, P5592, DOI 10.3390/ijms12095592; Montanaro F, 2009, INT J CANCER, V124, P201, DOI 10.1002/ijc.23874; Nagy B, 2002, ANTICANCER RES, V22, P135; Orecchia S, 2004, LUNG CANCER, V45, pS37, DOI 10.1016/j.lungcan.2004.04.027; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; Padayatty SJ, 2000, J AM COLL NUTR, V19, P423, DOI 10.1080/07315724.2000.10718941; PEPE MS, 1989, BIOMETRICS, V45, P497, DOI 10.2307/2531492; Ranzato E, 2012, J CELL MOL MED, V16, P2667, DOI 10.1111/j.1582-4934.2012.01584.x; Ranzato E, 2011, AM J RESP CELL MOL, V44, P108, DOI 10.1165/rcmb.2009-0340OC; Reagan-Shaw S, 2008, PROSTATE, V68, P1624, DOI 10.1002/pros.20824; Riordan Hugh D, 2005, P R Health Sci J, V24, P269; Scherpereel A, 2010, EUR RESPIR J, V35, P479, DOI [10.3779/j.issn.1009-3419.2010.10.14, 10.1183/09031936.00063109]; SMYTHE WR, 1994, CANCER RES, V54, P2055; Sugarbaker DJ, 1998, CHEST, V113, p61S, DOI 10.1378/chest.113.1_Supplement.61S; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Wang Lin-Run, 2005, J Zhejiang Univ Sci B, V6, P446, DOI 10.1631/jzus.2005.B0446; West SD, 2006, CLIN CHEST MED, V27, P335, DOI 10.1016/j.ccm.2006.01.004; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Zauderer MG, 2011, CURR TREAT OPTION ON, V12, P163, DOI 10.1007/s11864-011-0146-4	49	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58051	10.1371/journal.pone.0058051	http://dx.doi.org/10.1371/journal.pone.0058051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23526965	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100070
J	Georgescauld, F; Moynie, L; Habersetzer, J; Cervoni, L; Mocan, I; Borza, T; Harris, P; Dautant, A; Lascu, I				Georgescauld, Florian; Moynie, Lucile; Habersetzer, Johann; Cervoni, Laura; Mocan, Iulia; Borza, Tudor; Harris, Pernile; Dautant, Alain; Lascu, Ioan			Intersubunit Ionic Interactions Stabilize the Nucleoside Diphosphate Kinase of Mycobacterium tuberculosis	PLOS ONE			English	Article							THERMAL-STABILITY; ESCHERICHIA-COLI; DICTYOSTELIUM-DISCOIDEUM; MOLTEN-GLOBULE; PROTEIN; ENZYME; SALT; DNA; THERMOSTABILITY; DENATURATION	Most nucleoside diphosphate kinases (NDPKs) are hexamers. The C-terminal tail interacting with the neighboring subunits is crucial for hexamer stability. In the NDPK from Mycobacterium tuberculosis (Mt) this tail is missing. The quaternary structure of Mt-NDPK is essential for full enzymatic activity and for protein stability to thermal and chemical denaturation. We identified the intersubunit salt bridge Arg(80) -Asp(93) as essential for hexamer stability, compensating for the decreased intersubunit contact area. Breaking the salt bridge by the mutation D93N dramatically decreased protein thermal stability. The mutation also decreased stability to denaturation by urea and guanidinium. The D93N mutant was still hexameric and retained full activity. When exposed to low concentrations of urea it dissociated into folded monomers followed by unfolding while dissociation and unfolding of the wild type simultaneously occur at higher urea concentrations. The dissociation step was not observed in guanidine hydrochloride, suggesting that low concentration of salt may stabilize the hexamer. Indeed, guanidinium and many other salts stabilized the hexamer with a half maximum effect of about 0.1 M, increasing protein thermostability. The crystal structure of the D93N mutant has been solved.	[Georgescauld, Florian; Moynie, Lucile; Habersetzer, Johann; Mocan, Iulia; Dautant, Alain; Lascu, Ioan] Univ Bordeaux, IBGC, Bordeaux, France; [Georgescauld, Florian; Moynie, Lucile; Habersetzer, Johann; Mocan, Iulia; Dautant, Alain; Lascu, Ioan] CNRS UMR 5095, IBGC, Bordeaux, France; [Cervoni, Laura] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Rome, Italy; [Borza, Tudor] Inst Pasteur, CNRS URA 2185, Lab Chim Struct Macromol, Paris, France; [Harris, Pernile] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Sapienza University Rome; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen	Dautant, A (corresponding author), Univ Bordeaux, IBGC, Bordeaux, France.	A.Dautant@ibgc.cnrs.fr; I.Lascu@ibgc.cnrs.fr	Harris, Pernille/G-7289-2011; Borza, Tudor/A-8510-2012; Georgescauld, Florian/AAH-7125-2019; Borza, Tudor/M-4937-2019	Harris, Pernille/0000-0002-6806-4903; Borza, Tudor/0000-0002-2527-6551; Borza, Tudor/0000-0002-2527-6551; Georgescauld, Florian/0000-0003-0530-1884; Moynie, Lucile/0000-0002-4097-4331	Centre National de la Recherche scientifique; Region Aquitaine; University Bordeaux Segalen	Centre National de la Recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Aquitaine(Region Nouvelle-Aquitaine); University Bordeaux Segalen	This work was supported by grants from the Centre National de la Recherche scientifique (http://www.cnrs.fr/), the Region Aquitaine (http://aquitaine.fr/) and the University Bordeaux Segalen (http://www.univ-bordeauxsegalen.fr/fr/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, CCP4 NEWSL, V42; Arai S, 2012, PROTEIN SCI, V21, P498, DOI 10.1002/pro.2032; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Bogin O, 2002, PROTEIN SCI, V11, P2561, DOI 10.1110/ps.0222102; Boissier F, 2012, PROTEINS, V80, P1658, DOI 10.1002/prot.24062; Cervoni L, 2003, BIOCHEMISTRY-US, V42, P14599, DOI 10.1021/bi035273w; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; Chopra P, 2004, FEBS LETT, V571, P212, DOI 10.1016/j.febslet.2004.06.073; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erent M, 2001, EUR J BIOCHEM, V268, P1972, DOI 10.1046/j.1432-1327.2001.2076.doc.x; Ganaie AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027590; Gianni S, 2001, PROTEIN SCI, V10, P1685, DOI 10.1110/ps.5101; Giartosio A, 1996, J BIOL CHEM, V271, P17845, DOI 10.1074/jbc.271.30.17845; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Janin J, 2002, METHOD ENZYMOL, V354, P118; Karlsson A, 1996, J BIOL CHEM, V271, P19928, DOI 10.1074/jbc.271.33.19928; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Krishnan MN, 2005, J GEN PHYSIOL, V126, P271, DOI 10.1085/jgp.200509323; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2005, NUCLEIC ACIDS RES, V33, P2707, DOI 10.1093/nar/gki568; Kwon WS, 1996, PROTEIN ENG, V9, P1197, DOI 10.1093/protein/9.12.1197; Lack NA, 2009, BIOCHEM J, V418, P369, DOI 10.1042/BJ20082011; Lai ZH, 1997, BIOCHEMISTRY-US, V36, P10230, DOI 10.1021/bi963195p; LASCU I, 1983, EUR J BIOCHEM, V135, P497, DOI 10.1111/j.1432-1033.1983.tb07679.x; LASCU I, 1993, J BIOL CHEM, V268, P20268; Lascu I, 1997, J BIOL CHEM, V272, P15599, DOI 10.1074/jbc.272.25.15599; LASCU I, 1992, J BIOL CHEM, V267, P12775; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lascu I, 2006, J BIOENERG BIOMEMBR, V38, P265, DOI 10.1007/s10863-006-9042-1; Leslie A, 1992, NEWSLETTER PROTEIN C; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Luke K, 2006, ARCH BIOCHEM BIOPHYS, V456, P8, DOI 10.1016/j.abb.2006.10.003; Ma DQ, 2004, J BIOL CHEM, V279, P18073, DOI 10.1074/jbc.M400185200; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; Mei G, 2005, FEBS J, V272, P16, DOI 10.1111/j.1432-1033.2004.04407.x; Mesnildrey S, 1998, J BIOL CHEM, V273, P4436, DOI 10.1074/jbc.273.8.4436; Moynie L, 2007, PROTEINS, V67, P755, DOI 10.1002/prot.21316; Munier-Lehmann H, 1999, PROTEINS, V36, P238, DOI 10.1002/(SICI)1097-0134(19990801)36:2<238::AID-PROT9>3.0.CO;2-K; Munier-Lehmann H, 2001, PROTEIN SCI, V10, P1195, DOI 10.1110/ps.45701; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Saini AK, 2004, J BIOL CHEM, V279, P50142, DOI 10.1074/jbc.M409944200; Sedlak E, 2008, ARCH BIOCHEM BIOPHYS, V474, P128, DOI 10.1016/j.abb.2008.02.037; Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; STEIF C, 1993, BIOCHEMISTRY-US, V32, P3867, DOI 10.1021/bi00066a005; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Timmons L, 2000, J BIOENERG BIOMEMBR, V32, P293, DOI 10.1023/A:1005545214937; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Tokunaga H, 2008, FEBS LETT, V582, P1049, DOI 10.1016/j.febslet.2008.02.054; Tokunaga H, 2010, ENZYME MICROB TECH, V46, P129, DOI 10.1016/j.enzmictec.2009.10.009; WILLIAMS RL, 1993, J MOL BIOL, V234, P1230, DOI 10.1006/jmbi.1993.1673	56	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57867	10.1371/journal.pone.0057867	http://dx.doi.org/10.1371/journal.pone.0057867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23526954	gold, Green Submitted, Green Published			2022-12-27	WOS:000315637900055
J	Stelling, AL; Toher, D; Uckermann, O; Tavkin, J; Leipnitz, E; Schweizer, J; Cramm, H; Steiner, G; Geiger, KD; Kirsch, M				Stelling, Allison L.; Toher, Deirdre; Uckermann, Ortrud; Tavkin, Jelena; Leipnitz, Elke; Schweizer, Julia; Cramm, Holger; Steiner, Gerald; Geiger, Kathrin D.; Kirsch, Matthias			Infrared Spectroscopic Studies of Cells and Tissues: Triple Helix Proteins as a Potential Biomarker for Tumors	PLOS ONE			English	Article							ATTENUATED TOTAL REFLECTION; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-SPACE; FTIR SPECTROSCOPY; GLIOMA INVASION; BRAIN; IR; GLIOBLASTOMA; CLASSIFICATION; EXPRESSION	In this work, the infrared (IR) spectra of living neural cells in suspension, native brain tissue, and native brain tumor tissue were investigated. Methods were developed to overcome the strong IR signal of liquid water so that the signal from the cellular biochemicals could be seen. Measurements could be performed during surgeries, within minutes after resection. Comparison between normal tissue, different cell lineages in suspension, and tumors allowed preliminary assignments of IR bands to be made. The most dramatic difference between tissues and cells was found to be in weaker IR absorbances usually assigned to the triple helix of collagens. Triple helix domains are common in larger structural proteins, and are typically found in the extracellular matrix (ECM) of tissues. An algorithm to correct offsets and calculate the band heights and positions of these bands was developed, so the variance between identical measurements could be assessed. The initial results indicate the triple helix signal is surprisingly consistent between different individuals, and is altered in tumor tissues. Taken together, these preliminary investigations indicate this triple helix signal may be a reliable biomarker for a tumor-like microenvironment. Thus, this signal has potential to aid in the intra-operational delineation of brain tumor borders.	[Stelling, Allison L.; Tavkin, Jelena; Schweizer, Julia; Cramm, Holger; Steiner, Gerald] Tech Univ Dresden, Fac Med, Dresden, Germany; [Toher, Deirdre] Univ W England, Dept Engn Design & Math, Fac Environm & Technol, Bristol BS16 1QY, Avon, England; [Uckermann, Ortrud; Leipnitz, Elke; Kirsch, Matthias] Tech Univ Dresden, Fac Med, Dept Neurosurg, Dresden, Germany; [Uckermann, Ortrud; Leipnitz, Elke; Geiger, Kathrin D.; Kirsch, Matthias] Tech Univ Dresden, Univ Hosp, Dresden, Germany; [Geiger, Kathrin D.] Tech Univ Dresden, Fac Med, Inst Pathol, Dept Neuropathol, Dresden, Germany; [Kirsch, Matthias] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; University of West England; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Stelling, AL (corresponding author), Tech Univ Dresden, Fac Med, Dresden, Germany.	antistokes@gmail.com; Kathrin.Geiger@uniklinikum-dresden.de	Kirsch, Matthias/F-2824-2014; Toher, Deirdre/M-3952-2015	Stelling, Allison/0000-0002-0368-0852; Toher, Deirdre/0000-0003-0788-6142	Grant: Medi-CARS; Bundesministerium fur Bildung und Forschung, Germany	Grant: Medi-CARS; Bundesministerium fur Bildung und Forschung, Germany(Federal Ministry of Education & Research (BMBF))	Funding provided by Grant: Medi-CARS, funding source: Bundesministerium fur Bildung und Forschung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campos B, 2011, GLIA, V59, P1974, DOI 10.1002/glia.21239; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Diem M, 2009, APPL SPECTROSC, V63, p307A, DOI 10.1366/000370209789806894; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; FAHRENFORT J, 1962, SPECTROCHIM ACTA, V18, P1103, DOI 10.1016/S0371-1951(62)80230-6; Franco SJ, 2011, DEV NEUROBIOL, V71, P889, DOI 10.1002/dneu.20946; Gasper R, 2009, BBA-BIOMEMBRANES, V1788, P1263, DOI 10.1016/j.bbamem.2009.02.016; Gonzalez-Segura A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027442; GRENELL RG, 1958, J NEUROCHEM, V2, P138, DOI 10.1111/j.1471-4159.1958.tb12359.x; HARRICK NJ, 1960, J PHYS CHEM-US, V64, P1110, DOI 10.1021/j100838a005; HARRICK NJ, 1960, PHYS REV LETT, V4, P224, DOI 10.1103/PhysRevLett.4.224; Hertzburg G, 1945, MOL SPECTRA MOL STRU; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Iconomidou VA, 2007, INT J BIOL MACROMOL, V41, P102, DOI 10.1016/j.ijbiomac.2007.01.002; JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V; Knels L, 2011, EUR J NEUROSCI, V34, P548, DOI 10.1111/j.1460-9568.2011.07790.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mackanos MA, 2010, TRENDS BIOTECHNOL, V28, P317, DOI 10.1016/j.tibtech.2010.04.001; Marcsisin EJ, 2010, ANALYST, V135, P3227, DOI 10.1039/c0an00548g; Marechal Y, 2011, J MOL STRUCT, V1004, P146, DOI 10.1016/j.molstruc.2011.07.054; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Noreen R, 2011, ANAL BIOANAL CHEM, V401, P845, DOI 10.1007/s00216-011-4899-1; Okuyama K, 2009, BIOPOLYMERS, V91, P361, DOI 10.1002/bip.21138; Pacifico A, 2003, VIB SPECTROSC, V32, P107, DOI 10.1016/S0924-2031(03)00051-1; PARKER FS, 1967, ANAL BIOCHEM, V18, P414, DOI 10.1016/0003-2697(67)90099-1; Pellegatta S, 2006, NEUROBIOL DIS, V21, P314, DOI 10.1016/j.nbd.2005.07.016; Pope WB, 2012, AM J NEURORADIOL, V33, P1059, DOI 10.3174/ajnr.A2917; R Development Core Team, 2012, R LANG ENV STAT COMP; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; RIGAS B, 1992, CANCER RES, V52, P84; Salzer R., 2014, INFRARED RAMAN SPECT; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Seppanen A, 2007, BRAIN RES, V1158, P50, DOI 10.1016/j.brainres.2007.04.073; Steiner G, 2008, CYTOM PART A, V73A, P1158, DOI 10.1002/cyto.a.20639; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Taylor AM, 1933, J OPT SOC AM, V23, P206, DOI 10.1364/JOSA.23.000206; Whelan DR, 2011, NUCLEIC ACIDS RES, V39, P5439, DOI 10.1093/nar/gkr175; Zhang H, 2010, BIOPHYS J, V99, P1284, DOI 10.1016/j.bpj.2010.06.023; Zhang XQ, 2011, J SURG RES, V171, P650, DOI 10.1016/j.jss.2010.05.031; Zhao R, 2010, ANALYST, V135, P53, DOI 10.1039/b914311d	42	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58332	10.1371/journal.pone.0058332	http://dx.doi.org/10.1371/journal.pone.0058332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526977	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562600018
J	de Amorim, GC; Prochnicka-Chalufour, A; Delepelaire, P; Lefevre, J; Simenel, C; Wandersman, C; Delepierre, M; Izadi-Pruneyre, N				de Amorim, Gisele Cardoso; Prochnicka-Chalufour, Ada; Delepelaire, Philippe; Lefevre, Julien; Simenel, Catherine; Wandersman, Cecile; Delepierre, Muriel; Izadi-Pruneyre, Nadia			The Structure of HasB Reveals a New Class of TonB Protein Fold	PLOS ONE			English	Article							OUTER-MEMBRANE RECEPTOR; C-TERMINAL DOMAIN; DEPENDENT ENERGY TRANSDUCTION; SERRATIA-MARCESCENS; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; HEMOPHORE; TRANSPORT; ENVELOPE; COMPLEX	TonB is a key protein in active transport of essential nutrients like vitamin B12 and metal sources through the outer membrane transporters of Gram-negative bacteria. This inner membrane protein spans the periplasm, contacts the outer membrane receptor by its periplasmic domain and transduces energy from the cytoplasmic membrane pmf to the receptor allowing nutrient internalization. Whereas generally a single TonB protein allows the acquisition of several nutrients through their cognate receptor, in some species one particular TonB is dedicated to a specific system. Despite a considerable amount of data available, the molecular mechanism of TonB-dependent active transport is still poorly understood. In this work, we present a structural study of a TonB-like protein, HasB dedicated to the HasR receptor. HasR acquires heme either free or via an extracellular heme transporter, the hemophore HasA. Heme is used as an iron source by bacteria. We have solved the structure of the HasB periplasmic domain of Serratia marcescens and describe its interaction with a critical region of HasR. Some important differences are observed between HasB and TonB structures. The HasB fold reveals a new structural class of TonB-like proteins. Furthermore, we have identified the structural features that explain the functional specificity of HasB. These results give a new insight into the molecular mechanism of nutrient active transport through the bacterial outer membrane and present the first detailed structural study of a specific TonB-like protein and its interaction with the receptor.	[de Amorim, Gisele Cardoso; Prochnicka-Chalufour, Ada; Lefevre, Julien; Simenel, Catherine; Delepierre, Muriel; Izadi-Pruneyre, Nadia] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, Dept Biol Struct & Chim, Paris, France; [de Amorim, Gisele Cardoso; Prochnicka-Chalufour, Ada; Lefevre, Julien; Simenel, Catherine; Delepierre, Muriel; Izadi-Pruneyre, Nadia] CNRS, UMR 3528, Paris, France; [Delepelaire, Philippe] Univ Paris Diderot, CNRS, UMR 7099, Inst Biol Physicochim, Paris, France; [Wandersman, Cecile] Inst Pasteur, Unite Membranes Bacteriennes, Dept Microbiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Izadi-Pruneyre, N (corresponding author), Inst Pasteur, Unite Resonance Magnet Nucl Biomol, Dept Biol Struct & Chim, Paris, France.	nadia.izadi@pasteur.fr	Amorim, Gisele/D-7876-2013; Amorim, Gisele/GRN-8305-2022; Amorim, Gisele/O-9231-2019	Amorim, Gisele/0000-0003-4348-9515; Amorim, Gisele/0000-0003-4348-9515; Amorim, Gisele/0000-0003-4348-9515; Izadi-Pruneyre, Nadia/0000-0002-6864-2961; Delepelaire, Philippe/0000-0002-5190-7118	Institut Pasteur; CNRS; ANR (Agence Nationale de la Recherche) [08-BLAN-HEMETRANS]; Mairie de Paris; ANR	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Mairie de Paris(Region Ile-de-France); ANR(French National Research Agency (ANR))	This work was funded by the Institut Pasteur, the CNRS and a grant from the ANR (Agence Nationale de la Recherche, 08-BLAN-HEMETRANS). GCA was funded by postdoctoral fellowships from the Mairie de Paris and the ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGERER A, 1992, J BACTERIOL, V174, P1378, DOI 10.1128/jb.174.4.1378-1387.1992; Benevides-Matos N, 2008, J BACTERIOL, V190, P21, DOI 10.1128/JB.01389-07; Braun V, 2006, BIOMETALS, V19, P103, DOI 10.1007/s10534-005-8253-y; BREWER S, 1990, J MOL BIOL, V216, P883, DOI 10.1016/S0022-2836(99)80008-4; Brinkman KK, 2008, J BACTERIOL, V190, P421, DOI 10.1128/JB.01093-07; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caillet-Saguy C, 2009, J AM CHEM SOC, V131, P1736, DOI 10.1021/ja804783x; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Chu BCH, 2007, BIOMETALS, V20, P467, DOI 10.1007/s10534-006-9049-4; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KADNER RJ, 1995, J BACTERIOL, V177, P4829, DOI 10.1128/jb.177.17.4829-4835.1995; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Larsen RA, 1996, J BACTERIOL, V178, P1363, DOI 10.1128/jb.178.5.1363-1373.1996; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; Lefevre J, 2007, BIOMOL NMR ASSIGN, V1, P197, DOI 10.1007/s12104-007-9055-7; Lefevre J, 2008, J MOL BIOL, V378, P840, DOI 10.1016/j.jmb.2008.03.044; Letoffe S, 2004, J BACTERIOL, V186, P4067, DOI 10.1128/JB.186.13.4067-4074.2004; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lopez CS, 2009, BIOCHEM J, V418, P49, DOI 10.1042/BJ20081462; Paquelin A, 2001, MOL MICROBIOL, V42, P995, DOI 10.1046/j.1365-2958.2001.02628.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; POSTLE K, 1993, J BIOENERG BIOMEMBR, V25, P591; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	43	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58964	10.1371/journal.pone.0058964	http://dx.doi.org/10.1371/journal.pone.0058964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527057	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100058
J	Li, DD; Hu, FL; Wang, F; Cui, BB; Dong, XS; Zhang, WC; Lin, CQ; Li, X; Wang, D; Zhao, YS				Li, Dandan; Hu, Fulan; Wang, Fan; Cui, Binbin; Dong, Xinshu; Zhang, Wencui; Lin, Chunqing; Li, Xia; Wang, Da; Zhao, Yashuang			Prevalence of Pathological Germline Mutations of hMLH1 and hMSH2 Genes in Colorectal Cancer	PLOS ONE			English	Article							MISMATCH-REPAIR GENES; NONPOLYPOSIS COLON-CANCER; TUMOR MICROSATELLITE INSTABILITY; REVISED BETHESDA GUIDELINES; LYNCH-SYNDROME; HNPCC FAMILIES; AMSTERDAM CRITERIA; PUBLICATION BIAS; MSH2 MUTATIONS; MLH1 MUTATIONS	The prevalence of pathological germline mutations in colorectal cancer has been widely studied, as germline mutations in the DNA mismatch repair genes hMLH1 and hMSH2 confer a high risk of colorectal cancer. However, because the sample size and population of previous studies are very different from each other, the conclusions still remain controversial. In this paper, Databases such as PubMed were applied to search for related papers. The data were imported into Comprehensive Meta-Analysis V2, which was used to estimate the weighted prevalence of hMLH1 and hMSH2 pathological mutations and compare the differences of prevalence among different family histories, ethnicities and related factors. This study collected and utilized data from 102 papers. In the Amsterdam-criteria positive group, the prevalence of pathological germline mutations of the hMLH1 and hMSH2 genes was 28.55% (95% CI 26.04%-31.19%) and 19.41% (95% CI 15.88%-23.51%), respectively, and the prevalence of germline mutations in hMLH1/hMSH2 was 15.44%/10.02%, 20.43%/13.26% and 15.43%/11.70% in Asian, American multiethnic and European/Australian populations, respectively. Substitution mutations accounted for the largest proportion of germline mutations (hMLH1: 52.34%, hMSH2: 43.25%). The total prevalence of mutations of hMLH1 and hMSH2 in Amsterdam-criteria positive, Amsterdam-criteria negative and sporadic colorectal cancers was around 45%, 25% and 15%, respectively, and there were no obvious differences in the prevalence of germline mutations among different ethnicities.	[Li, Dandan; Hu, Fulan; Wang, Fan; Zhang, Wencui; Lin, Chunqing; Li, Xia; Zhao, Yashuang] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China; [Cui, Binbin; Dong, Xinshu] Harbin Med Univ, Tumor Hosp, Dept Abdominal Surg, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Da] Harbin Med Univ, Dept Sci & Technol Adm, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.	zhao_yashuang@263.net	Wang, Fan/I-6099-2019; li, xia/HHZ-7468-2022; Lin, Chunqing/ABF-2894-2020; Zhao, Yashuang/I-6145-2019	Wang, Fan/0000-0002-9869-9504; 	National Natural Science Foundation of China [30671801]; Harbin Foundation for the Returned Scholars [2005AFLXJ017]; Health Bureau of Heilongjiang Province [2005-103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Foundation for the Returned Scholars; Health Bureau of Heilongjiang Province	This work was supported by grants from the National Natural Science Foundation of China (Grant number 30671801), the Harbin Foundation for the Returned Scholars (Grant number 2005AFLXJ017), and the Health Bureau of Heilongjiang Province (Grant number 2005-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; AALTONEN LA, 1994, ANTICANCER RES, V14, P1657; Abe Y, 2000, J SURG ONCOL, V74, P249, DOI 10.1002/1096-9098(200008)74:4<249::AID-JSO2>3.0.CO;2-S; Apessos A, 2005, BRIT J CANCER, V92, P396, DOI 10.1038/sj.bjc.6602260; Bai YQ, 1999, INT J CANCER, V82, P512, DOI 10.1002/(SICI)1097-0215(19990812)82:4<512::AID-IJC7>3.0.CO;2-8; Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Bapat BV, 1999, HUM GENET, V104, P167, DOI 10.1007/s004390050931; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Bartosova Z, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9127; Beck NE, 1997, BRIT J SURG, V84, P233, DOI 10.1002/bjs.1800840228; Beck NE, 1997, HUM GENET, V99, P219, DOI 10.1007/s004390050343; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boland CR, 1998, CANCER RES, V58, P5248; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BUERSTEDDE JM, 1995, J MED GENET, V32, P909, DOI 10.1136/jmg.32.11.909; Caldes T, 2002, INT J CANCER, V98, P774, DOI 10.1002/ijc.10240; Calistri D, 2000, INT J CANCER, V89, P87, DOI 10.1002/(SICI)1097-0215(20000120)89:1<87::AID-IJC14>3.0.CO;2-9; Canard G., 2011, ANN SURG ONCOL; Casey G, 2005, JAMA-J AM MED ASSOC, V293, P799, DOI 10.1001/jama.293.7.799; Cederquist K, 2004, INT J CANCER, V109, P370, DOI 10.1002/ijc.11718; Cederquist K, 2001, INT J CANCER, V91, P486, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1093>3.0.CO;2-P; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Coggins RP, 2005, GUT, V54, P636, DOI 10.1136/gut.2003.017517; Coleman MG, 2001, BRIT J CANCER, V85, P1486, DOI 10.1054/bjoc.2001.2058; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; Cravo M, 1999, J PATHOL, V188, P252, DOI 10.1002/(SICI)1096-9896(199907)188:3<252::AID-PATH354>3.0.CO;2-3; Cui L, 2004, WORLD J GASTROENTERO, V10, P209; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; Curia MC, 1999, CANCER RES, V59, P3570; de Leon MP, 1999, GUT, V45, P32, DOI 10.1136/gut.45.1.32; Dietmaier W, 1997, CANCER RES, V57, P4749; Dieumegard B, 2000, BRIT J CANCER, V82, P871, DOI 10.1054/bjoc.1999.1014; Dunlop MG, 2000, BRIT J CANCER, V83, P1643, DOI 10.1054/bjoc.2000.1520; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996; Fidalgo P, 2000, EUR J HUM GENET, V8, P49, DOI 10.1038/sj.ejhg.5200393; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Froggatt NJ, 1996, J MED GENET, V33, P726, DOI 10.1136/jmg.33.9.726; Genuardi M, 1998, INT J CANCER, V75, P835, DOI 10.1002/(SICI)1097-0215(19980316)75:6<835::AID-IJC4>3.0.CO;2-W; Ghimenti C, 1999, BRIT J CANCER, V80, P11, DOI 10.1038/sj.bjc.6690314; Giraldo A, 2005, FAM CANCER, V4, P285, DOI 10.1007/s10689-005-4523-7; Goldberg Y, 2008, FAM CANCER, V7, P309, DOI 10.1007/s10689-008-9191-y; Green SE, 1998, INT J COLORECTAL DIS, V13, P3, DOI 10.1007/s003840050123; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Heinimann K, 1999, CANCER, V85, P2512, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2512::AID-CNCR4>3.0.CO;2-G; Herfarth KKF, 1997, GENE CHROMOSOME CANC, V18, P42, DOI 10.1002/(SICI)1098-2264(199701)18:1<42::AID-GCC5>3.0.CO;2-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hutter P, 1998, INT J CANCER, V78, P680, DOI 10.1002/(SICI)1097-0215(19981209)78:6<680::AID-IJC3>3.0.CO;2-U; Jeong SY, 2003, DIS COLON RECTUM, V46, P1069, DOI 10.1007/s10350-004-7282-x; Jin HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-44; Katballe N, 2002, GUT, V50, P43, DOI 10.1136/gut.50.1.43; KohonenCorish M, 1996, AM J HUM GENET, V59, P818; Kouraklis G, 2005, DIGEST DIS SCI, V50, P336, DOI 10.1007/s10620-005-1607-z; Kurzawski G, 2006, CLIN GENET, V69, P40, DOI 10.1111/j.1399-0004.2006.00550.x; Lamberti C, 1999, GUT, V44, P839, DOI 10.1136/gut.44.6.839; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; Liu SR, 2004, WORLD J GASTROENTERO, V10, P2647, DOI 10.3748/wjg.v10.i18.2647; Liu T, 1998, CLIN GENET, V53, P131; Liu T, 2001, CANCER RES, V61, P7798; Luo DC, 2005, WORLD J GASTROENTERO, V11, P1673; Lynch HT, 1999, J MED GENET, V36, P801; Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.3.CO;2-Q; Maliaka YK, 1996, HUM GENET, V97, P251, DOI 10.1007/BF02265276; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; Mauillon JL, 1996, CANCER RES, V56, P5728; Millar AL, 1999, HUM MOL GENET, V8, P823, DOI 10.1093/hmg/8.5.823; MIYAKI M, 1995, J MOL MED-JMM, V73, P515; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; Montera M, 2000, J Med Genet, V37, pE7, DOI 10.1136/jmg.37.7.e7; Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245; Nilbert M, 2009, FAM CANCER, V8, P75, DOI 10.1007/s10689-008-9199-3; Nomura S, 2000, BIOCHEM BIOPH RES CO, V271, P120, DOI 10.1006/bbrc.2000.2547; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; Palicio M, 2002, J Med Genet, V39, pE29, DOI 10.1136/jmg.39.6.e29; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Papp J, 2007, WORLD J GASTROENTERO, V13, P2727, DOI 10.3748/wjg.v13.i19.2727; Park JG, 1999, INT J CANCER, V82, P516, DOI 10.1002/(SICI)1097-0215(19990812)82:4<516::AID-IJC8>3.0.CO;2-U; Parkin WSL, 1997, IARC PUBL, Vi-xxxiv, P1; Peel DJ, 2000, J NATL CANCER I, V92, P1517, DOI 10.1093/jnci/92.18.1517; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Pensotti V, 1997, GENE CHROMOSOME CANC, V19, P135; Percesepe A, 2001, J CLIN ONCOL, V19, P3944, DOI 10.1200/JCO.2001.19.19.3944; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pistorius SR, 2000, INT J COLORECTAL DIS, V15, P255; Planck M, 1999, INT J CANCER, V83, P197, DOI 10.1002/(SICI)1097-0215(19991008)83:2<197::AID-IJC9>3.0.CO;2-X; Pucciarelli S, 2003, DIS COLON RECTUM, V46, P305, DOI 10.1007/s10350-004-6546-9; Raedle J, 2001, ANN INTERN MED, V135, P566, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00007; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ravnik-Glavac M, 2000, J MED GENET, V37, P533, DOI 10.1136/jmg.37.7.533; Robinson KL, 2007, J NATL CANCER I, V99, P291, DOI 10.1093/jnci/djk051; Roh SA, 2003, J KOREAN MED SCI, V18, P387, DOI 10.3346/jkms.2003.18.3.387; Rossi BM, 2002, ANN SURG ONCOL, V9, P555, DOI 10.1245/aso.2002.9.6.555; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; Sarroca C, 2000, DIS COLON RECTUM, V43, P353, DOI 10.1007/BF02258301; Scartozzi M, 2002, J CLIN ONCOL, V20, P1203, DOI 10.1200/JCO.20.5.1203; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942; Sheng J Q, 2008, Cytogenet Genome Res, V122, P22, DOI 10.1159/000151312; Sheng Jian Qiu, 2006, Chin J Dig Dis, V7, P197, DOI 10.1111/j.1443-9573.2006.00269.x; Shin Young-Kyoung, 2004, Hum Mutat, V24, P351, DOI 10.1002/humu.9277; Southey MC, 2005, J CLIN ONCOL, V23, P6524, DOI 10.1200/JCO.2005.04.671; Spaepen M, 2006, FAM CANCER, V5, P179, DOI 10.1007/s10689-005-5958-6; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; TANNERGARD P, 1995, CANCER RES, V55, P6092; Taylor CE, 2003, HUM MUTAT, V22, P428, DOI 10.1002/humu.10291; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Tomlinson IPM, 1997, J MED GENET, V34, P39, DOI 10.1136/jmg.34.1.39; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Viel A, 1997, GENE CHROMOSOME CANC, V18, P8, DOI 10.1002/(SICI)1098-2264(199701)18:1<8::AID-GCC2>3.0.CO;2-7; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963; Wahlberg SS, 1997, INT J CANCER, V74, P134, DOI 10.1002/(SICI)1097-0215(19970220)74:1<134::AID-IJC22>3.3.CO;2-1; Wang CF, 2007, WORLD J GASTROENTERO, V13, P6254, DOI 10.3748/wjg.13.6254; Wang Q, 1999, HUM GENET, V105, P79, DOI 10.1007/s004390051067; Wang Q, 1997, INT J CANCER, V73, P831, DOI 10.1002/(SICI)1097-0215(19971210)73:6<831::AID-IJC11>3.0.CO;2-7; Wang XL, 2006, WORLD J GASTROENTERO, V12, P4074, DOI 10.3748/wjg.v12.i25.4074; Weber TK, 1999, JAMA-J AM MED ASSOC, V281, P2316, DOI 10.1001/jama.281.24.2316; Weber TK, 1997, CANCER RES, V57, P3798; Wehner M, 1997, HUM MUTAT, V10, P241; Wei SC, 2003, CLIN GENET, V64, P243, DOI 10.1034/j.1399-0004.2003.00123.x; Wei WQ, 2010, J BIOINFORM COMPUT B, V8, P111, DOI 10.1142/S0219720010005154; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; Wolf B, 2005, WIEN KLIN WOCHENSCHR, V117, P269, DOI 10.1007/s00508-005-0337-8; Wu Y, 1997, GENE CHROMOSOME CANC, V18, P269, DOI 10.1002/(SICI)1098-2264(199704)18:4<269::AID-GCC4>3.0.CO;2-Z; Yan HL, 2008, CANCER SCI, V99, P770, DOI 10.1111/j.1349-7006.2008.00737.x; Yuan Y, 2004, CHINESE MED J-PEKING, V117, P748; Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968; Zhang CH, 2008, WORLD J GASTROENTERO, V14, P298, DOI 10.3748/wjg.14.298; Zhao YS, 2009, J TOXICOL ENV HEAL A, V72, P690, DOI 10.1080/15287390902841003	137	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e51240	10.1371/journal.pone.0051240	http://dx.doi.org/10.1371/journal.pone.0051240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526924	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100002
J	Morales, SOC				Caballero Morales, Santiago Omar			Economic Statistical Design of Integrated X-bar-S Control Chart with Preventive Maintenance and General Failure Distribution	PLOS ONE			English	Article							R-CHARTS; MODEL; CONSTRAINTS; SYSTEMS	The application of Preventive Maintenance (PM) and Statistical Process Control (SPC) are important practices to achieve high product quality, small frequency of failures, and cost reduction in a production process. However there are some points that have not been explored in depth about its joint application. First, most SPC is performed with the X-bar control chart which does not fully consider the variability of the production process. Second, many studies of design of control charts consider just the economic aspect while statistical restrictions must be considered to achieve charts with low probabilities of false detection of failures. Third, the effect of PM on processes with different failure probability distributions has not been studied. Hence, this paper covers these points, presenting the Economic Statistical Design (ESD) of joint X-bar-S control charts with a cost model that integrates PM with general failure distribution. Experiments showed statistically significant reductions in costs when PM is performed on processes with high failure rates and reductions in the sampling frequency of units for testing under SPC.	Technol Univ Mixteca, Huajuapan De Leon, Oaxaca, Mexico		Morales, SOC (corresponding author), Technol Univ Mixteca, Huajuapan De Leon, Oaxaca, Mexico.	scaballero@mixteco.utm.mx		Caballero-Morales, Santiago-Omar/0000-0002-9986-7768				Ben-Daya M, 2000, EUR J OPER RES, V120, P131, DOI 10.1016/S0377-2217(98)00379-8; Caballero-Morales SO, 2012, RES COMPUTING SCI, V55, P81; Cassady CR, 2000, IIE TRANS, V32, P471, DOI 10.1023/A:1007693017671; Charongrattanasakul P, 2011, EXPERT SYST APPL, V38, P5178, DOI 10.1016/j.eswa.2010.10.044; Chen W.S., 2011, J APPL OPER RES, V36, P103; Chiu H. N., 1995, J QUAL MAINT ENG, V1, P17, DOI DOI 10.1108/13552519510105188; Collani V, 1989, J QUAL TECHNOL, V21, P87; Davis RB, 1999, J QUAL TECHNOL, V31, P246; Duncan A.J, 1986, QUALITY CONTROL IND; DUNCAN AJ, 1956, J AM STAT ASSOC, V51, P228, DOI 10.2307/2281343; Heikes RG., 1974, AIIE T, V6, P55, DOI [10.1080/05695557408974933, DOI 10.1080/05695557408974933]; Kethley RB, 2004, IIE TRANS, V36, P855, DOI 10.1080/07408170490473033; Lee BH, 2000, QUAL ENG, V13, P581, DOI DOI 10.1080/08982110108918688; Linderman K, 2005, EUR J OPER RES, V164, P324, DOI 10.1016/j.ejor.2003.11.026; Linderman K, 2000, J QUAL TECHNOL, V32, P457; LORENZEN TJ, 1986, TECHNOMETRICS, V28, P3, DOI 10.2307/1269598; McWilliams TP, 2001, J QUAL TECHNOL, V33, P234; Mehrafrooz Z, 2011, COMPUT IND ENG, V61, P1245, DOI 10.1016/j.cie.2011.07.017; MONTGOMERY DC, 1995, J QUAL TECHNOL, V27, P250, DOI 10.1080/00224065.1995.11979597; Montgomery DC, 2009, STAT QUALITY CONTROL, V7th; Panagiotidou S, 2009, RELIAB ENG SYST SAFE, V94, P732, DOI 10.1016/j.ress.2008.07.003; Rahim Abdur, 2011, International Journal of Industrial and Systems Engineering, V7, P477, DOI 10.1504/IJISE.2011.039671; Rahim M., 1987, ENG OPTIMIZ, V12, P63; RAHIM MA, 1993, NAV RES LOG, V40, P787, DOI 10.1002/1520-6750(199310)40:6<787::AID-NAV3220400605>3.0.CO;2-4; RAHIM MA, 1989, J QUAL TECHNOL, V21, P65, DOI 10.1080/00224065.1989.11979140; Ruvalcaba RA, 2004, THESIS U AM PUEBLA M; SANIGA EM, 1989, TECHNOMETRICS, V31, P313, DOI 10.2307/3556141; SANIGA EM, 1995, J QUAL TECHNOL, V27, P56, DOI 10.1080/00224065.1995.11979559; Tobias P. A, 1986, APPL RELIABILITY; Yang S.F., 1997, INT J QUAL RELIAB MA, V14, P948; Yang SF, 1998, INT J QUALITY RELIAB, V15, P259, DOI [10.1108/02656719810209446, DOI 10.1108/02656719810209446]; Yeung TG, 2008, IIE TRANS, V40, P147, DOI 10.1080/07408170701592515; Zhang Y, 2011, QUALITY RELIABILITY, V28, P19; Zhou WH, 2008, MATH COMPUT MODEL, V47, P1389, DOI 10.1016/j.mcm.2007.09.008	34	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59039	10.1371/journal.pone.0059039	http://dx.doi.org/10.1371/journal.pone.0059039			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527082	gold, Green Published			2022-12-27	WOS:000316411600030
J	Bonin, RP; Zurek, AA; Yu, JY; Bayliss, DA; Orser, BA				Bonin, Robert P.; Zurek, Agnieszka A.; Yu, Jieying; Bayliss, Douglas A.; Orser, Beverley A.			Hyperpolarization-Activated Current (I-h) Is Reduced in Hippocampal Neurons from Gabra5-/- Mice	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; SUBUNIT-DEFICIENT MICE; GABA(A) RECEPTOR; ALPHA-5 SUBUNIT; TONIC INHIBITION; INTRINSIC EXCITABILITY; PHYSIOLOGICAL-FUNCTION; STATUS EPILEPTICUS; KNOCKOUT MICE; A RECEPTORS	Changes in the expression of gamma-aminobutyric acid type A (GABA(A)) receptors can either drive or mediate homeostatic alterations in neuronal excitability. A homeostatic relationship between alpha 5 subunit-containing GABA(A) (alpha 5GABA(A)) receptors that generate a tonic inhibitory conductance, and HCN channels that generate a hyperpolarization-activated cation current (I-h) was recently described for cortical neurons, where a reduction in I-h was accompanied by a reciprocal increase in the expression of alpha 5GABA(A) receptors resulting in the preservation of dendritosomatic synaptic function. Here, we report that in mice that lack the alpha 5 subunit gene (Gabra5-/-), cultured embryonic hippocampal pyramidal neurons and ex vivo CA1 hippocampal neurons unexpectedly exhibited a decrease in I-h current density (by 40% and 28%, respectively), compared with neurons from wild-type (WT) mice. The resting membrane potential and membrane hyperpolarization induced by blockade of I-h with ZD-7288 were similar in cultured WT and Gabra5-/- neurons. In contrast, membrane hyperpolarization measured after a train of action potentials was lower in Gabra5-/- neurons than in WT neurons. Also, membrane impedance measured in response to low frequency stimulation was greater in cultured Gabra5-/- neurons. Finally, the expression of HCN1 protein that generates I-h was reduced by 41% in the hippocampus of Gabra5-/- mice. These data indicate that loss of a tonic GABAergic inhibitory conductance was followed by a compensatory reduction in I-h. The results further suggest that the maintenance of resting membrane potential is preferentially maintained in mature and immature hippocampal neurons through the homeostatic co-regulation of structurally and biophysically distinct cation and anion channels.	[Bonin, Robert P.; Zurek, Agnieszka A.; Yu, Jieying; Orser, Beverley A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Bayliss, Douglas A.] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA USA; [Orser, Beverley A.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Orser, Beverley A.] Sunnybrook Hlth Sci Ctr, Dept Anesthesia, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Virginia; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Orser, BA (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	beverley.orser@utoronto.ca		Bonin, Robert/0000-0002-3287-6803; Zurek, Agnieszka/0000-0001-9957-3324	National Institutes of Health [GM66181]; Canadian Institutes of Health Research [MOP 38028, MOP 79428]; Canada Research Chair; Fonds de Recherche du Quebec - Sante; Natural Sciences and Engineering Council; Ontario Students Opportunity Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Students Opportunity Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by a grant from the National Institutes of Health (GM66181) to DAB, a grant from the Canadian Institutes of Health Research (MOP 38028, MOP 79428) and a Canada Research Chair to BAO. RPB is supported by Fonds de Recherche du Quebec - Sante, RPB and AAZ by the Natural Sciences and Engineering Council, and JY is supported by the Ontario Students Opportunity Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bonin RP, 2007, J NEUROPHYSIOL, V98, P2244, DOI 10.1152/jn.00482.2007; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Caraiscos VB, 2007, MOL PHARMACOL, V71, P1277, DOI 10.1124/mol.106.033563; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Chen XD, 2009, J NEUROPHYSIOL, V101, P129, DOI 10.1152/jn.01352.2007; Collinson N, 2002, J NEUROSCI, V22, P5572; Disterhoft JF, 2004, AGEING RES REV, V3, P383, DOI 10.1016/j.arr.2004.07.001; Fu XW, 1997, J NEUROPHYSIOL, V78, P2235, DOI 10.1152/jn.1997.78.5.2235; Gibson JR, 2006, J NEUROPHYSIOL, V96, P420, DOI 10.1152/jn.01203.2005; Glykys J, 2006, J NEUROPHYSIOL, V95, P2796, DOI 10.1152/jn.01122.2005; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Jung S, 2011, J NEUROSCI, V31, P14291, DOI 10.1523/JNEUROSCI.1148-11.2011; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1998, J NEUROSCI, V18, P7613; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Saab BJ, 2010, ANESTHESIOLOGY, V113, P1061, DOI 10.1097/ALN.0b013e3181f56228; Schulz DJ, 2006, J EXP BIOL, V209, P4821, DOI 10.1242/jeb.02567; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; STORM JF, 1990, PROG BRAIN RES, V83, P161; Stradleigh TW, 2011, J COMP NEUROL, V519, P2546, DOI 10.1002/cne.22638; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vargas-Caballero M, 2010, NEUROPHARMACOLOGY, V58, P668, DOI 10.1016/j.neuropharm.2009.11.005; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; WISDEN W, 1992, J NEUROSCI, V12, P1040; Zurek AA, 2012, ANESTH ANALG, V114, P845, DOI 10.1213/ANE.0b013e31824720da	37	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58679	10.1371/journal.pone.0058679	http://dx.doi.org/10.1371/journal.pone.0058679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516534	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400048
J	Du, RF; Mercante, D; Fang, ZD				Du, Ruofei; Mercante, Donald; Fang, Zhide			An Artificial Functional Family Filter in Homolog Searching in Next-generation Sequencing Metagenomics	PLOS ONE			English	Article							COG DATABASE; GENOMICS; ANNOTATION; TOOL	In functional metagenomics, BLAST homology search is a common method to classify metagenomic reads into protein/domain sequence families such as Clusters of Orthologous Groups of proteins (COGs) in order to quantify the abundance of each COG in the community. The resulting functional profile of the community is then used in downstream analysis to correlate the change in abundance to environmental perturbation, clinical variation, and so on. However, the short read length coupled with next-generation sequencing technologies poses a barrier in this approach, essentially because similarity significance cannot be discerned by searching with short reads. Consequently, artificial functional families are produced, in which those with a large number of reads assigned decreases the accuracy of functional profile dramatically. There is no method available to address this problem. We intended to fill this gap in this paper. We revealed that BLAST similarity scores of homologues for short reads from COG protein members coding sequences are distributed differently from the scores of those derived elsewhere. We showed that, by choosing an appropriate score cut-off, we are able to filter out most artificial families and simultaneously to preserve sufficient information in order to build the functional profile. We also showed that, by incorporated application of BLAST and RPS-BLAST, some artificial families with large read counts can be further identified after the score cutoff filtration. Evaluated on three experimental metagenomic datasets with different coverages, we found that the proposed method is robust against read coverage and consistently outperforms the other E-value cutoff methods currently used in literatures.	[Du, Ruofei; Mercante, Donald; Fang, Zhide] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Fang, ZD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA USA.	zfang@lsuhsc.edu	Du, Ruofei/Q-6245-2017	Du, Ruofei/0000-0002-4006-7416	National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; Louisiana Clinical and Translational Science Center of Pennington Biomedical Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Louisiana Clinical and Translational Science Center of Pennington Biomedical Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center of Pennington Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 2001, NUCLEIC ACIDS RES, V29, P351, DOI 10.1093/nar/29.2.351; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Dalevi D, 2008, BIOINFORMATICS, V24, pI7, DOI 10.1093/bioinformatics/btn276; Dembo A., 1994, ANN PROBAB, V22, P2022; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hastie T., 2009, UNSUPERVISED LEARNIN; Kaufmann M, 2006, CURR BIOINFORM, V1, P291, DOI 10.2174/157489306777828017; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Korf I., 2003, BLAST ESSENTIAL GUID; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Zhang Q, 2012, BIOCOMPUT-PAC SYM, P259; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zhou J., 2004, MICROBIAL FUNCTIONAL	27	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58669	10.1371/journal.pone.0058669	http://dx.doi.org/10.1371/journal.pone.0058669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516532	Green Submitted, gold, Green Published			2022-12-27	WOS:000316407400046
J	Rinderknecht, JD; Goldinger, SM; Rozati, S; Kamarashev, J; Kerl, K; French, LE; Dummer, R; Belloni, B				Rinderknecht, Jeannine D.; Goldinger, Simone M.; Rozati, Sima; Kamarashev, Jivko; Kerl, Katrin; French, Lars E.; Dummer, Reinhard; Belloni, Benedetta			RASopathic Skin Eruptions during Vemurafenib Therapy	PLOS ONE			English	Article							BRAF INHIBITORS; METASTATIC MELANOMA; KINASE INHIBITORS; RAF INHIBITORS; MUTATIONS; TUMORS; ACTIVATE; PATHWAY	Purpose: Vemurafenib is a potent inhibitor of V600 mutant BRAF with significant impact on progression-free and overall survival in advanced melanoma. Cutaneous side effects are frequent. This single-center observational study investigates clinical and histological features of these class-specific cutaneous adverse reactions. Patients and Methods: Patients were all treated with Vemurafenib 960 mg b.i.d. within local ethic committees approved clinical trials. All skin reactions were collected and documented prospectively. Cutaneous reactions were classified by reaction pattern as phototoxic and inflammatory, hair and nail changes, keratinocytic proliferations and melanocytic disorders. Results: Vemurafenib was well tolerated, only in two patients the dose had to be reduced to 720 mg due to arthralgia. 26/28 patients (93%) experienced cutaneous side effects. Observed side effects included UVA dependent photosensitivity (n = 16), maculopapular exanthema (n = 14), pruritus (n = 8), folliculitis (n = 5), burning feet (n = 3), hair thinning (mild alopecia) (n = 8), curly hair (n = 2) and nail changes (n = 2). Keratosis pilaris and acanthopapilloma were common skin reactions (n = 12/n = 13), as well as plantar hyperkeratosis (n = 4), keratoacanthoma (n = 5) and invasive squamous cell carcinoma (n = 4). One patient developed a second primary melanoma after more than 4 months of therapy (BRAF and RAS wild type). Conclusion: Vemurafenib has a broad and peculiar cutaneous side effect profile involving epidermis and adnexa overlapping with the cutaneous manifestations of genetic diseases characterized by activating germ line mutations of RAS (RASopathy). They must be distinguished from allergic drug reaction. Regular skin examination and management by experienced dermatologists as well as continuous prophylactic photo protection including an UVA optimized sun screen is mandatory.	[Rinderknecht, Jeannine D.; Goldinger, Simone M.; Rozati, Sima; Kamarashev, Jivko; Kerl, Katrin; French, Lars E.; Dummer, Reinhard; Belloni, Benedetta] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Dummer, R (corresponding author), Univ Zurich Hosp, Dept Dermatol, Gloriastr 31, CH-8091 Zurich, Switzerland.	reinhard.dummer@usz.ch	French, Lars/AAL-5977-2020	French, Lars/0000-0002-4629-1486	Gottfried und Julia Bangerter-Rhyner-Stiftung; G+B Schwyzer Stiftung; MSD scholarship grant for oncologic research	Gottfried und Julia Bangerter-Rhyner-Stiftung; G+B Schwyzer Stiftung; MSD scholarship grant for oncologic research	This work was supported in part by the Gottfried und Julia Bangerter-Rhyner-Stiftung and the G+B Schwyzer Stiftung. B. Belloni is supported by MSD scholarship grant for oncologic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anforth R, 2012, J CLIN ONCOL, V30, pE165, DOI 10.1200/JCO.2011.39.8594; Arnault JP, 2012, CLIN CANCER RES, V18, P263, DOI 10.1158/1078-0432.CCR-11-1344; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Boyd KP, 2012, J AM ACAD DERMATOL, V67, P1375, DOI 10.1016/j.jaad.2012.06.045; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cichowski K, 2010, NATURE, V464, P358, DOI 10.1038/464358a; Dalle S, 2011, NEW ENGL J MED, V365, P1448, DOI 10.1056/NEJMc1108651; Dummer R, 2012, BRIT J DERMATOL, V167, P965, DOI 10.1111/bjd.12080; Dummer R, 2011, J CLIN ONCOL, V29; Dummer R, 2012, NEW ENGL J MED, V366, P480, DOI 10.1056/NEJMc1113752; Eggermont AMM, 2011, EUR J CANCER, V47, P2150, DOI 10.1016/j.ejca.2011.06.052; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hafner C, 2007, J INVEST DERMATOL, V127, P1572, DOI 10.1038/sj.jid.5700772; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Robert C, 2005, LANCET ONCOL, V6, P491, DOI 10.1016/S1470-2045(05)70243-6; Robert C, 2011, CURR OPIN ONCOL, V23, P177, DOI 10.1097/CCO.0b013e3283436e8c; Schad K, 2010, CLIN CANCER RES, V16, P1058, DOI 10.1158/1078-0432.CCR-09-1766; Siegel DH, 2012, BRIT J DERMATOL, V166, P601, DOI 10.1111/j.1365-2133.2011.10744.x; Siegel DH, 2011, BRIT J DERMATOL, V164, P521, DOI 10.1111/j.1365-2133.2010.10122.x; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Weeraratna AT, 2012, NEW ENGL J MED, V366, P271, DOI 10.1056/NEJMe1111636; Zimmer L, J CLIN ONCO IN PRESS; Zimmer L, J DTSCH DER IN PRESS; Zimmer L, 2012, ARCH DERMATOL, V148, P357, DOI 10.1001/archdermatol.2011.2842	29	61	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58721	10.1371/journal.pone.0058721	http://dx.doi.org/10.1371/journal.pone.0058721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516541	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000316407400053
J	Yuan, ZJ; Shen, YJ				Yuan, Zaijian; Shen, Yanjun			Estimation of Agricultural Water Consumption from Meteorological and Yield Data: A Case Study of Hebei, North China	PLOS ONE			English	Article							WINTER-WHEAT; USE EFFICIENCY; EVAPOTRANSPIRATION; FIELD	Over-exploitation of groundwater resources for irrigated grain production in Hebei province threatens national grain food security. The objective of this study was to quantify agricultural water consumption (AWC) and irrigation water consumption in this region. A methodology to estimate AWC was developed based on Penman-Monteith method using meteorological station data (1984-2008) and existing actual ET (2002-2008) data which estimated from MODIS satellite data through a remote sensing ET model. The validation of the model using the experimental plots (50 m(2)) data observed from the Luancheng Agro-ecosystem Experimental Station, Chinese Academy of Sciences, showed the average deviation of the model was 23.7% for non-rainfed plots. The total AWC and irrigation water (mainly groundwater) consumption for Hebei province from 1984-2008 were then estimated as 864 km(3) and 139 km(3), respectively. In addition, we found the AWC has significantly increased during the past 25 years except for a few counties located in mountainous regions. Estimations of net groundwater consumption for grain food production within the plain area of Hebei province in the past 25 years accounted for 113 km(3) which could cause average groundwater decrease of 7. m over the plain. The integration of meteorological and satellite data allows us to extend estimation of actual ET beyond the record available from satellite data, and the approach could be applicable in other regions globally where similar data are available.	[Yuan, Zaijian] Hebei Univ Sci & Technol, Sch Econ & Management, Shijiazhuang, Peoples R China; [Yuan, Zaijian; Shen, Yanjun] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China	Hebei University of Science & Technology; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Shen, YJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China.	yjshen@sjziam.ac.cn	Shen, Yanjun/A-4630-2013; Shen, Yanjun/K-3323-2019	Shen, Yanjun/0000-0002-2251-2889; Shen, Yanjun/0000-0002-2251-2889	Natural Science Foundation of China (NSFC); Chinese Academy of Sciences (CAS) [40901130, 40871021, KSCX2-EW-J-5]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	The Natural Science Foundation of China (NSFC) and Chinese Academy of Sciences (CAS) supported this work through grants 40901130, 40871021, and KSCX2-EW-J-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Cao GL, 2011, THESIS U ALABAMA TUS; Chen W, 1999, GROUNDWATER HEBEI PR; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; HEILIG GK, 1999, CHINA FOOD CAN CHINA; Ji ZH, 2010, S TO N WATER TRANSFE, V8, P79; [季志恒 JI Zhi-heng], 2010, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V8, P73; Li HJ, 2008, AGR WATER MANAGE, V95, P1271, DOI 10.1016/j.agwat.2008.05.003; Liu XiaoYing, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P155; Long D, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016542; Shen YJ, 2002, HYDROL PROCESS, V16, P2173, DOI 10.1002/hyp.1149; [孙才志 SUN Caizhi], 2010, [生态学报, Acta Ecologica Sinica], V30, P1312; Sun HY, 2010, AGR WATER MANAGE, V97, P1139, DOI 10.1016/j.agwat.2009.06.004; Wu BF, 2012, J HYDROL, V436, P67, DOI 10.1016/j.jhydrol.2012.02.043; Yang H, 2003, AGR WATER MANAGE, V61, P143, DOI 10.1016/S0378-3774(02)00164-6; Yang YM, 2010, AGR WATER MANAGE, V97, P1711, DOI 10.1016/j.agwat.2010.06.002; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069; Zhang YC, 2011, J HYDROL, V408, P203, DOI 10.1016/j.jhydrol.2011.07.036	18	88	109	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58685	10.1371/journal.pone.0058685	http://dx.doi.org/10.1371/journal.pone.0058685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516537	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400050
J	Biernacka, JM; Geske, JR; Schneekloth, TD; Frye, MA; Cunningham, JM; Choi, DS; Tapp, CL; Lewis, BR; Drews, MS; Pietrzak, TL; Colby, CL; Hall-Flavin, DK; Loukianova, LL; Heit, JA; Mrazek, DA; Karpyak, VM				Biernacka, Joanna M.; Geske, Jennifer R.; Schneekloth, Terry D.; Frye, Mark A.; Cunningham, Julie M.; Choi, Doo-Sup; Tapp, Courtney L.; Lewis, Bradley R.; Drews, Maureen S.; Pietrzak, Tracy L.; Colby, Colin L.; Hall-Flavin, Daniel K.; Loukianova, Larissa L.; Heit, John A.; Mrazek, David A.; Karpyak, Victor M.			Replication of Genome Wide Association Studies of Alcohol Dependence: Support for Association with Variation in ADH1C	PLOS ONE			English	Article							DEHYDROGENASE; GENETICS; POLYMORPHISMS; GENES	a Genome-wide association studies (GWAS) have revealed many single nucleotide polymorphisms (SNPs) associated with complex traits. Although these studies frequently fail to identify statistically significant associations, the top association signals from GWAS may be enriched for true associations. We therefore investigated the association of alcohol dependence with 43 SNPs selected from association signals in the first two published GWAS of alcoholism. Our analysis of 808 alcohol-dependent cases and 1,248 controls provided evidence of association of alcohol dependence with SNP rs1614972 in the ADH1C gene (unadjusted p = 0.0017). Because the GWAS study that originally reported association of alcohol dependence with this SNP [1] included only men, we also performed analyses in sex-specific strata. The results suggest that this SNP has a similar effect in both sexes (men: OR (95%CI) = 0.80 (0.66, 0.95); women: OR (95%CI) = 0.83 (0.66, 1.03)). We also observed marginal evidence of association of the rs1614972 minor allele with lower alcohol consumption in the non-alcoholic controls (p = 0.081), and independently in the alcohol-dependent cases (p = 0.046). Despite a number of potential differences between the samples investigated by the prior GWAS and the current study, data presented here provide additional support for the association of SNP rs1614972 in ADH1C with alcohol dependence and extend this finding by demonstrating association with consumption levels in both non-alcoholic and alcohol-dependent populations. Further studies should investigate the association of other polymorphisms in this gene with alcohol dependence and related alcohol-use phenotypes.	[Biernacka, Joanna M.; Schneekloth, Terry D.; Frye, Mark A.; Choi, Doo-Sup; Tapp, Courtney L.; Hall-Flavin, Daniel K.; Loukianova, Larissa L.; Mrazek, David A.; Karpyak, Victor M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Biernacka, Joanna M.; Geske, Jennifer R.; Lewis, Bradley R.; Colby, Colin L.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Drews, Maureen S.; Pietrzak, Tracy L.] Mayo Clin, Dept Informat Technol, Rochester, MN USA; [Heit, John A.] Mayo Clin, Dept Internal Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Biernacka, JM (corresponding author), Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA.	biernacka.joanna@mayo.edu	Choi, Doo-Sup/G-9474-2012; Karpyak, Victor M./AGJ-2595-2022	Choi, Doo-Sup/0000-0002-6796-9938; Karpyak, Victor M./0000-0002-9552-6130	S.C. Johnson Program in Genomics of Addiction (Mayo Clinic); NIAAA [P20 AA17830Z]; United States National Institutes of Health (NIH) GEI [U01HG004438]; NIDA; NIH [HHSN268200782096C];  [HG04735]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017830] Funding Source: NIH RePORTER	S.C. Johnson Program in Genomics of Addiction (Mayo Clinic); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); United States National Institutes of Health (NIH) GEI; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by S.C. Johnson Program in Genomics of Addiction (Mayo Clinic) and NIAAA (P20 AA17830Z, PI D.A. Mrazek). Controls were recruited and genotyped as part of the GWAS of Venous Thrombosis study (grant HG04735, PI J.A. Heit). Genotyping for SAGE was funded by United States National Institutes of Health (NIH) GEI (U01HG004438), NIAAA, NIDA, and the NIH contract HHSN268200782096C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Cornelis MC, 2010, GENET EPIDEMIOL, V34, P364, DOI 10.1002/gepi.20492; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Esserlind AL, 2013, EUR J NEURO IN PRESS; Frank J, 2012, ADDICT BIOL, V17, P171, DOI 10.1111/j.1369-1600.2011.00395.x; Gizer IR, 2011, ALCOHOL CLIN EXP RES, V35, P2008, DOI 10.1111/j.1530-0277.2011.01552.x; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Heit JA, 2011, J THROMB HAEMOST, V9, P1133, DOI 10.1111/j.1538-7836.2011.04272.x; Johnson RA, 2002, APPL MULTIVARIATE ST, p[xviii, 767]; Karpyak VM, 2010, ADDICT BIOL, V15, P23, DOI 10.1111/j.1369-1600.2009.00183.x; Karpyak VM, 2009, ALCOHOL CLIN EXP RES, V33, P712, DOI 10.1111/j.1530-0277.2008.00888.x; Karpyak VM, 2012, ADDICT BIOL IN PRESS; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kuo PH, 2008, ALCOHOL CLIN EXP RES, V32, P785, DOI 10.1111/j.1530-0277.2008.00642.x; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; Manolio TA, 2009, PHARMACOGENOMICS, V10, P235, DOI 10.2217/14622416.10.2.235; Martinez C, 2010, HEPATOLOGY, V51, P491, DOI 10.1002/hep.23341; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tolstrup JS, 2008, PHARMACOGENOMICS J, V8, P220, DOI 10.1038/sj.tpj.6500471; Treutlein J, 2011, CURR PSYCHIAT REP, V13, P147, DOI 10.1007/s11920-011-0176-4; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Wang HS, 2010, HUM GENET, V128, P165, DOI 10.1007/s00439-010-0841-4; Zuo LJ, 2012, NEUROPSYCHOPHARMACOL, V37, P557, DOI 10.1038/npp.2011.229	30	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58798	10.1371/journal.pone.0058798	http://dx.doi.org/10.1371/journal.pone.0058798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516558	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200115
J	de Melo, IS; Jimenez-Nunez, MD; Iglesias, C; Campos-Caro, A; Moreno-Sanchez, D; Ruiz, FA; Bolivar, J				de Melo, Ivan S.; Jimenez-Nunez, Maria D.; Iglesias, Concepcion; Campos-Caro, Antonio; Moreno-Sanchez, David; Ruiz, Felix A.; Bolivar, Jorge			NOA36 Protein Contains a Highly Conserved Nucleolar Localization Signal Capable of Directing Functional Proteins to the Nucleolus, in Mammalian Cells	PLOS ONE			English	Article							SEQUENCE REQUIREMENTS; TARGETING SIGNAL; DNA-DAMAGE; NUCLEAR; IDENTIFICATION; RNA; POLYPHOSPHATE; COMPLEX; DOMAIN; GENE	NOA36/ZNF330 is an evolutionarily well-preserved protein present in the nucleolus and mitochondria of mammalian cells. We have previously reported that the pro-apoptotic activity of this protein is mediated by a characteristic cysteine-rich domain. We now demonstrate that the nucleolar localization of NOA36 is due to a highly-conserved nucleolar localization signal (NoLS) present in residues 1-33. This NoLS is a sequence containing three clusters of two or three basic amino acids. We fused the amino terminal of NOA36 to eGFP in order to characterize this putative NoLS. We show that a cluster of three lysine residues at positions 3 to 5 within this sequence is critical for the nucleolar localization. We also demonstrate that the sequence as found in human is capable of directing eGFP to the nucleolus in several mammal, fish and insect cells. Moreover, this NoLS is capable of specifically directing the cytosolic yeast enzyme polyphosphatase to the target of the nucleolus of HeLa cells, wherein its enzymatic activity was detected. This NoLS could therefore serve as a very useful tool as a nucleolar marker and for directing particular proteins to the nucleolus in distant animal species.	[de Melo, Ivan S.; Iglesias, Concepcion; Bolivar, Jorge] Univ Cadiz, Fac Ciencias, Dept Biomed Biotecnol & Salud Publ, Cadiz, Spain; [Jimenez-Nunez, Maria D.; Campos-Caro, Antonio; Moreno-Sanchez, David; Ruiz, Felix A.] Hosp Univ Puerta del Mar, Unidad Invest, Cadiz, Spain; [Jimenez-Nunez, Maria D.; Campos-Caro, Antonio; Moreno-Sanchez, David; Ruiz, Felix A.] Univ Cadiz, Fac Med, Dept Biomed Biotecnol & Salud Publ, Cadiz, Spain	Universidad de Cadiz; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz	Bolivar, J (corresponding author), Univ Cadiz, Fac Ciencias, Dept Biomed Biotecnol & Salud Publ, Cadiz, Spain.	jorge.bolivar@uca.es	BOLIVAR, JORGE/G-4322-2015; Campos-Caro, Antonio/T-2807-2019; Ruiz, Felix A./B-1032-2008	BOLIVAR, JORGE/0000-0002-2645-9528; Campos-Caro, Antonio/0000-0001-8532-2153; Ruiz, Felix A./0000-0003-0748-5015	EU-FEDER; Spanish Ministry of Economy and Competitiveness [SAF2003-06398, BFU2009-09074, FIS/PI10/01222]; "Consejeria de Economia, Innovacion y Ciencia'' of the Junta de Andalucia [PAIDI CTS 569, P07-CTS-02765]	EU-FEDER(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); "Consejeria de Economia, Innovacion y Ciencia'' of the Junta de Andalucia	This work was supported by grants from EU-FEDER and the Spanish Ministry of Economy and Competitiveness (SAF2003-06398 and BFU2009-09074 to JB and FIS/PI10/01222 to FAR), and by a grant from the "Consejeria de Economia, Innovacion y Ciencia" of the Junta de Andalucia (PAIDI CTS 569 to JB and P07-CTS-02765 to FAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; Bolivar J, 1999, CELL MOL BIOL, V45, P277; Bolivar J, 2001, CYTOGENET CELL GENET, V93, P234, DOI 10.1159/000056989; Bolivar J, 1999, J BIOL CHEM, V274, P36456, DOI 10.1074/jbc.274.51.36456; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; de Melo IS, 2009, BBA-MOL CELL RES, V1793, P1876, DOI 10.1016/j.bbamcr.2009.10.011; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; FRYER JL, 1965, ANN NY ACAD SCI, V126, P566, DOI 10.1111/j.1749-6632.1965.tb14303.x; Goatley LC, 1999, J GEN VIROL, V80, P525, DOI 10.1099/0022-1317-80-3-525; Guo H, 2009, VIRUS RES, V145, P312, DOI 10.1016/j.virusres.2009.07.024; Guo YX, 2003, VIROLOGY, V306, P225, DOI 10.1016/S0042-6822(02)00081-8; Hahn MA, 2007, FEBS LETT, V581, P5070, DOI 10.1016/j.febslet.2007.09.050; HATANAKA M, 1990, BIOESSAYS, V12, P143, DOI 10.1002/bies.950120310; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Jimenez-Nunez MD, 2012, HAEMATOLOGICA; Kubota S, 1996, J VIROL, V70, P1282, DOI 10.1128/JVI.70.2.1282-1287.1996; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liu JL, 1997, J VIROL, V71, P3188, DOI 10.1128/JVI.71.4.3188-3196.1997; Liu JY, 2006, FEBS LETT, V580, P1405, DOI 10.1016/j.febslet.2006.01.064; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Ma N, 2007, J CELL SCI, V120, P2091, DOI 10.1242/jcs.008771; MAEDA Y, 1992, EMBO J, V11, P3695, DOI 10.1002/j.1460-2075.1992.tb05454.x; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pellar GJ, 2003, CHROMOSOMA, V111, P461, DOI 10.1007/s00412-003-0231-y; Piston DW, 1999, METHOD CELL BIOL, V58, P31; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Reed ML, 2007, J VIROL, V81, P4298, DOI 10.1128/JVI.02239-06; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Scott M, 2001, NUCLEIC ACIDS RES, V29, P2052, DOI 10.1093/nar/29.10.2052; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; SIOMI H, 1988, CELL, V55, P197, DOI 10.1016/0092-8674(88)90043-8; SIOMI H, 1990, J VIROL, V64, P1803, DOI 10.1128/JVI.64.4.1803-1807.1990; Song ZY, 2005, ONCOGENE, V24, P2723, DOI 10.1038/sj.onc.1208097; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Tan DSW, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-17; Ueki N, 1998, BIOCHEM BIOPH RES CO, V252, P97, DOI 10.1006/bbrc.1998.9606; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; von Kobbe C, 2002, J CELL SCI, V115, P3901, DOI 10.1242/jcs.00076; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Yoshitome S, 2012, BIOCHEM BIOPH RES CO, V422, P770, DOI 10.1016/j.bbrc.2012.05.080	55	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59065	10.1371/journal.pone.0059065	http://dx.doi.org/10.1371/journal.pone.0059065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516598	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200131
J	Tsukahara, T; Haniu, H; Matsuda, Y				Tsukahara, Tamotsu; Haniu, Hisao; Matsuda, Yoshikazu			PTB-Associated Splicing Factor (PSF) Is a PPAR gamma-Binding Protein and Growth Regulator of Colon Cancer Cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PROLIFERATION; RNA; DIFFERENTIATION; TRANSCRIPTION; MITOCHONDRIA; SUPERFAMILY; EXPRESSION; PROMOTES; DOMAIN	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor that plays an essential role in cell proliferation, apoptosis, and inflammation. It is over-expressed in many types of cancer, including colon, stomach, breast, and lung cancer, suggesting that regulation of PPAR gamma might affect cancer pathogenesis. Here, using a proteomic approach, we identify PTB-associated splicing factor (PSF) as a novel PPAR gamma-interacting protein and demonstrate that PSF is involved in several important regulatory steps of colon cancer cell proliferation. To investigate the relationship between PSF and PPAR gamma in colon cancer, we evaluated the effects of PSF expression in DLD-1 and HT-29 colon cancer cell lines, which express low and high levels of PPAR gamma, respectively PSF affected the ability of PPAR gamma to bind, and expression of PSF siRNA significantly suppressed the proliferation of colon cancer cells. Furthermore, PSF knockdown induced apoptosis via activation of caspase-3. Interestingly, DLD-1 cells were more susceptible to PSF knockdown-induced cell death than HT-29 cells. Our data suggest that PSF is an important regulator of cell death that plays critical roles in the survival and growth of colon cancer cells. The PSF-PPAR gamma axis may play a role in the control of colorectal carcinogenesis. Taken together, this study is the first to describe the effects of PSF on cell proliferation, tumor growth, and cell signaling associated with PPAR gamma.	[Tsukahara, Tamotsu] Shinshu Univ, Sch Med, Dept Integrat Physiol & Biosyst Control, Asahi Ku, Matsumoto, Nagano 390, Japan; [Haniu, Hisao] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Asahi Ku, Matsumoto, Nagano 390, Japan; [Matsuda, Yoshikazu] Nihon Pharmaceut Univ, Clin Pharmacol Educ Ctr, Ina, Saitama, Japan	Shinshu University; Shinshu University	Tsukahara, T (corresponding author), Shinshu Univ, Sch Med, Dept Integrat Physiol & Biosyst Control, Asahi Ku, Matsumoto, Nagano 390, Japan.	ttamotsu@shinshu-u.ac.jp	Tsukahara, Tamotsu/ABB-3631-2021	Tsukahara, Tamotsu/0000-0001-6469-920X	Japan Society for the Promotion of Science [22591482]; Takeda Science Foundation; Astellas foundation for research on metabolic disorders	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas foundation for research on metabolic disorders	This work was supported by Grants-in-Aid for Scientific Research (C) 22591482 (to Tamotsu Tsukahara) from the Japan Society for the Promotion of Science, and Grants-in-Aid from Takeda Science Foundation (to Tamotsu Tsukahara) and Astellas foundation for research on metabolic disorders (to Tamotsu Tsukahara). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett DK, 1996, DEV DYNAM, V205, P64, DOI 10.1002/(SICI)1097-0177(199601)205:1<64::AID-AJA6>3.0.CO;2-3; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Bull AW, 2003, ARCH PATHOL LAB MED, V127, P1121; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Choi IK, 2008, INVEST NEW DRUG, V26, P283, DOI 10.1007/s10637-007-9108-x; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Goldberg RM, 2006, ONCOLOGIST, V11, P981, DOI 10.1634/theoncologist.11-9-981; Gupta RA, 2001, J BIOL CHEM, V276, P29681, DOI 10.1074/jbc.M103779200; Haddad AJ, 2011, INT J SURG ONCOL, V2011, DOI 10.1155/2011/285840; Haniu H, 2006, PROTEOMICS, V6, P3251, DOI 10.1002/pmic.200500813; Henics T, 1999, BIOL CELL, V91, P485, DOI 10.1016/S0248-4900(00)88205-2; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kitamura S, 1999, JPN J CANCER RES, V90, P75, DOI 10.1111/j.1349-7006.1999.tb00668.x; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Liu DC, 2004, ACTA PHARMACOL SIN, V25, P1312; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Ondrey F, 2009, CLIN CANCER RES, V15, P2, DOI 10.1158/1078-0432.CCR-08-0326; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Plotz M, 2012, CELL DEATH DIFFER; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Radhakrishnan SK, 2005, CELL CYCLE, V4, P582, DOI 10.4161/cc.4.4.1583; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Sato H, 2000, BRIT J CANCER, V83, P1394, DOI 10.1054/bjoc.2000.1457; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song X, 2005, P NATL ACAD SCI USA, V102, P12189, DOI 10.1073/pnas.0505179102; Song X, 2004, P NATL ACAD SCI USA, V101, P621, DOI 10.1073/pnas.0307794100; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Tsukahara T, 2012, BIOCHEM BIOPH RES CO, V424, P524, DOI 10.1016/j.bbrc.2012.06.149; Tsukahara T, 2010, PROSTAG OTH LIPID M, V93, P126, DOI 10.1016/j.prostaglandins.2010.09.002; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Urban RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE794, DOI 10.1152/ajpendo.00174.2002; Wang G, 2009, P NATL ACAD SCI USA, V106, P16794, DOI 10.1073/pnas.0909022106; Yuqi Liu, 2009, BMC Med Genet, V10, P114, DOI 10.1186/1471-2350-10-114	43	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58749	10.1371/journal.pone.0058749	http://dx.doi.org/10.1371/journal.pone.0058749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516550	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200109
J	Baumgartner, J; Bertinetti, L; Widdrat, M; Hirt, AM; Faivre, D				Baumgartner, Jens; Bertinetti, Luca; Widdrat, Marc; Hirt, Ann M.; Faivre, Damien			Formation of Magnetite Nanoparticles at Low Temperature: From Superparamagnetic to Stable Single Domain Particles	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MAGNETOTACTIC BACTERIA; X-RAY; MAGNETOSOMES; SIZE; PRECIPITATION; NANOCRYSTALS; BIOMINERALIZATION; TRANSITION; OXIDATION	The room temperature co-precipitation of ferrous and ferric iron under alkaline conditions typically yields superparamagnetic magnetite nanoparticles below a size of 20 nm. We show that at pH = 9 this method can be tuned to grow larger particles with single stable domain magnetic (> 20-30 nm) or even multi-domain behavior (> 80 nm). The crystal growth kinetics resembles surprisingly observations of magnetite crystal formation in magnetotactic bacteria. The physicochemical parameters required for mineralization in these organisms are unknown, therefore this study provides insight into which conditions could possibly prevail in the biomineralizing vesicle compartments (magnetosomes) of these bacteria.	[Baumgartner, Jens; Bertinetti, Luca; Widdrat, Marc; Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Hirt, Ann M.] ETH, Inst Geophys, CH-8093 Zurich, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Faivre, D (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.	damien.faivre@mpikg.mpg.de	bertinetti, luca/G-1436-2013; Bertinetti, Luca/M-8242-2016; Hirt, Ann M/M-5540-2016; faivre, damien/D-3713-2009	bertinetti, luca/0000-0002-4666-9610; Bertinetti, Luca/0000-0002-4666-9610; Hirt, Ann M/0000-0002-2193-0472; faivre, damien/0000-0001-6191-3389	Max Planck Society; ERC [256915-MB2]; European Union [NMP4-SL-2010-245542-Bio2MaN4MRI]	Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); European Union(European Commission)	The research was supported by the Max Planck Society, the ERC through a Starting Grant to D.F. (256915-MB2) and the FP 7 of the European Union (NMP4-SL-2010-245542-Bio2MaN4MRI as a collaborative grant) to A.M.H. and D.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya Y, 2007, BIOMATERIALS, V28, P5381, DOI 10.1016/j.biomaterials.2007.07.051; Arakaki A, 2003, J BIOL CHEM, V278, P8745, DOI 10.1074/jbc.M211729200; Arakaki A, 2010, J COLLOID INTERF SCI, V343, P65, DOI 10.1016/j.jcis.2009.11.043; Bremholm M, 2009, ANGEW CHEM INT EDIT, V48, P4788, DOI 10.1002/anie.200901048; BUTLER RF, 1975, J GEOPHYS RES, V80, P4049, DOI 10.1029/JB080i029p04049; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; Cuyper MD, 2003, J PHYS CONDENS MATT, V15, pS1425; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Faivre D, 2004, GEOCHIM COSMOCHIM AC, V68, P4395, DOI 10.1016/j.gca.2004.03.016; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2008, AM MINERAL, V93, P463, DOI 10.2138/am.2008.2678; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; Fischer A, 2011, J R SOC INTERFACE, V8, P1011, DOI 10.1098/rsif.2010.0576; FRANKEL RB, 1983, BIOCHIM BIOPHYS ACTA, V763, P147, DOI 10.1016/0167-4889(83)90038-1; FRANKEL RB, 1979, SCIENCE, V203, P1355, DOI 10.1126/science.203.4387.1355; Galloway JM, 2012, SMALL, V8, P204, DOI 10.1002/smll.201101627; Galloway JM, 2011, J MATER CHEM, V21, P15244, DOI [10.1039/c1jm12003d/, 10.1039/c1jm12003d]; Goya GF, 2003, J APPL PHYS, V94, P3520, DOI 10.1063/1.1599959; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; Kopp RE, 2008, EARTH-SCI REV, V86, P42, DOI 10.1016/j.earscirev.2007.08.001; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Lefevre CT, 2011, ENVIRON MICROBIOL, V13, P2342, DOI 10.1111/j.1462-2920.2011.02505.x; Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866; MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188; MOSKOWITZ BM, 1988, J MAGN MAGN MATER, V73, P273, DOI 10.1016/0304-8853(88)90093-5; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nyiro-Kosa I, 2009, EUR J MINERAL, V21, P293, DOI 10.1127/0935-1221/2009/0021-1920; OZDEMIR O, 1993, GEOPHYS RES LETT, V20, P1671, DOI 10.1029/93GL01483; Paris O, 2007, J APPL CRYSTALLOGR, V40, pS466, DOI 10.1107/S0021889806045444; Perez-Gonzalez T, 2011, J SUPERCOND NOV MAGN, V24, P549, DOI 10.1007/s10948-010-0999-y; Prozorov T, 2007, ACS NANO, V1, P228, DOI 10.1021/nn700194h; Prozorov T, 2007, ADV FUNCT MATER, V17, P951, DOI 10.1002/adfm.200609448; ROBERTS AP, 1995, J GEOPHYS RES-SOL EA, V100, P17909, DOI 10.1029/95JB00672; Salazar JS, 2011, CHEM MATER, V23, P1379, DOI 10.1021/cm103188a; Scheffel A, 2008, J BACTERIOL, V190, P377, DOI 10.1128/JB.01371-07; Senn MS, 2012, NATURE, V481, P173, DOI 10.1038/nature10704; Staniland S, 2008, NAT NANOTECHNOL, V3, P158, DOI 10.1038/nnano.2008.35; Tanaka M, 2011, J BIOL CHEM, V286, P6386, DOI 10.1074/jbc.M110.183434; Vayssieres L, 2007, APPL PHYS A-MATER, V89, P1, DOI 10.1007/s00339-007-4039-0; Vayssieres L, 1998, J COLLOID INTERF SCI, V205, P205, DOI 10.1006/jcis.1998.5614; Verwey EJW, 1939, NATURE, V144, P327, DOI 10.1038/144327b0; Wang WJ, 2012, LANGMUIR, V28, P4274, DOI 10.1021/la205074n; YAACOB II, 1994, J COLLOID INTERF SCI, V168, P289, DOI 10.1006/jcis.1994.1423; Yang YB, 2006, J MAGN MAGN MATER, V305, P40, DOI 10.1016/j.jmmm.2005.11.028	46	65	67	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57070	10.1371/journal.pone.0057070	http://dx.doi.org/10.1371/journal.pone.0057070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520462	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900021
J	Lagrain, B; Brunnbauer, M; Rombouts, I; Koehler, P				Lagrain, Bert; Brunnbauer, Markus; Rombouts, Ine; Koehler, Peter			Identification of Intact High Molecular Weight Glutenin Subunits from the Wheat Proteome Using Combined Liquid Chromatography-Electrospray Ionization Mass Spectrometry	PLOS ONE			English	Article							TOP-DOWN PROTEOMICS; SIGNAL SUPPRESSION; STORAGE PROTEINS; QUALITY; RESOLUTION; VARIETIES	The present paper describes a method for the identification of intact high molecular weight glutenin subunits (HMW-GS), the quality determining proteins from the wheat storage proteome. The method includes isolation of HMW-GS from wheat flour, further separation of HMW-GS by reversed-phase high-performance liquid chromatography (RP-HPLC), and their subsequent molecular identification with electrospray ionization mass spectrometry using a quadrupole-time-of-flight mass analyzer. For HMW-GS isolation, wheat proteins were reduced and extracted from flour with 50% 1-propanol containing 1% dithiothreitol. HMW-GS were then selectively precipitated from the protein mixture by adjusting the 1-propanol concentration to 60%. The composition of the precipitated proteins was first evaluated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with Coomassie staining and RP-HPLC with ultraviolet detection. Besides HMW-GS (>= 65%), the isolated proteins mainly contained omega 5-gliadins. Secondly, the isolated protein fraction was analyzed by liquid chromatography-mass spectrometry. Optimal chromatographic separation of HMW-GS from the other proteins in the isolated fraction was obtained when the mobile phase contained 0.1% trifluoroacetic acid as ion-pairing agent. Individual HMW-GS were then identified by determining their molecular masses from the high-resolution mass spectra and comparing these with theoretical masses calculated from amino acid sequences. Using formic acid instead of trifluoroacetic acid in the mobile phase increased protein peak intensities in the base peak mass chromatogram. This allowed the detection of even traces of other wheat proteins than HMW-GS in the isolated fraction, but the chromatographic separation was inferior with a major overlap between the elution ranges of HMW-GS and omega-gliadins. Overall, the described method allows a rapid assessment of wheat quality through the direct determination of the HMW-GS composition and offers a basis for further top-down proteomics of individual HMW-GS and the entire wheat glutenin fraction.	[Lagrain, Bert; Brunnbauer, Markus; Rombouts, Ine; Koehler, Peter] German Res Ctr Food Chem, Freising Weihenstephan, Germany; [Lagrain, Bert; Rombouts, Ine] Katholieke Univ Leuven, Lab Food Chem & Biochem, Louvain, Belgium; [Lagrain, Bert; Rombouts, Ine] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, Louvain, Belgium	Leibniz-Institute for Food Systems Biology at the Technical University of Munich; KU Leuven; KU Leuven	Lagrain, B (corresponding author), German Res Ctr Food Chem, Freising Weihenstephan, Germany.	bert.lagrain@biw.kuleuven.be	Rombouts, Ine/GRS-4802-2022	Rombouts, Ine/0000-0002-4145-5832; Lagrain, Bert/0000-0002-9707-1977	FWO	FWO(FWO)	BL wishes to acknowledge the Research Foundation - Flanders (FWO, Brussels, Belgium; www.fwo.be) for his position as postdoctoral fellow. IR wishes to acknowledge the Special Research Fund (KU Leuven, Leuven, Belgium; www.kuleuven.be) for a position as postdoctoral fellow. IR and BL both wish to acknowledge the FWO for financial support during a research stay at the German Research Center for Food Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; AOAC, 1995, OFFICIAL METHODS ANA, V16th; APFFEL A, 1995, J CHROMATOGR A, V712, P177, DOI 10.1016/0021-9673(95)00175-M; Bean SR, 2000, J CHROMATOGR A, V881, P23, DOI 10.1016/S0021-9673(99)01270-4; Bollecker SSJ, 1998, J AGR FOOD CHEM, V46, P4814, DOI 10.1021/jf980280q; Capriotti AL, 2011, J CHROMATOGR A, V1218, P8760, DOI 10.1016/j.chroma.2011.05.094; Cunsolo V, 2004, J MASS SPECTROM, V39, P66, DOI 10.1002/jms.558; Cunsolo V, 2003, RAPID COMMUN MASS SP, V17, P442, DOI 10.1002/rcm.938; Delcour JA, 2012, ANNU REV FOOD SCI T, V3, P469, DOI 10.1146/annurev-food-022811-101303; Di Stefano V, 2012, J CHROMATOGR A, V1259, P74, DOI 10.1016/j.chroma.2012.04.023; Dupont FM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-10; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; FERRIGE AG, 1991, RAPID COMMUN MASS SP, V5, P374, DOI 10.1002/rcm.1290050810; Gao LY, 2010, J AGR FOOD CHEM, V58, P2777, DOI 10.1021/jf903363z; Gustavsson SA, 2001, J CHROMATOGR A, V937, P41, DOI 10.1016/S0021-9673(01)01328-0; HICKMAN DR, 1995, J CEREAL SCI, V22, P99, DOI 10.1016/0733-5210(95)90038-1; HUEBNER FR, 1985, J CHROMATOGR, V327, P333, DOI 10.1016/S0021-9673(01)81662-9; Kasarda DD, 1998, CEREAL CHEM, V75, P70, DOI 10.1094/CCHEM.1998.75.1.70; Kelleher NL, 1999, J AM CHEM SOC, V121, P806, DOI 10.1021/ja973655h; Lagrain B, 2012, J CEREAL SCI, V56, P726, DOI 10.1016/j.jcs.2012.08.003; Liu L, 2009, J CEREAL SCI, V50, P295, DOI 10.1016/j.jcs.2009.05.006; Lutz E, 2012, J AGR FOOD CHEM, V60, P3708, DOI 10.1021/jf204973u; Mamone G, 2000, RAPID COMMUN MASS SP, V14, P897, DOI 10.1002/(SICI)1097-0231(20000530)14:10<897::AID-RCM962>3.0.CO;2-Z; Mamone G, 2009, J CHROMATOGR A, V1216, P7130, DOI 10.1016/j.chroma.2009.07.052; MARCHYLO BA, 1989, J CEREAL SCI, V9, P113, DOI 10.1006/jcrs.1998.0225; McLafferty FW, 2011, ANNU REV ANAL CHEM, V4, P1, DOI 10.1146/annurev-anchem-061010-114018; Muccilli V, 2005, PROTEOMICS, V5, P719, DOI 10.1002/pmic.200401029; PAYNE PI, 1981, THEOR APPL GENET, V60, P229, DOI 10.1007/BF02342544; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Qian YW, 2008, J AM SOC MASS SPECTR, V19, P1542, DOI 10.1016/j.jasms.2008.06.008; Roels SP, 1996, J CEREAL SCI, V24, P227, DOI 10.1006/jcrs.1996.0055; Stephenson JL, 2002, CURR OPIN BIOTECH, V13, P57, DOI 10.1016/S0958-1669(02)00285-9; van Eckert R, 2006, J CEREAL SCI, V43, P331, DOI 10.1016/j.jcs.2005.12.009; Wang K, 2012, HEREDITAS, V149, P41, DOI 10.1111/j.1601-5223.2011.02215.x; Wang YJ, 2005, J CHROMATOGR A, V1073, P35, DOI 10.1016/j.chroma.2004.08.140; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wieser H, 2009, EUR FOOD RES TECHNOL, V229, P523, DOI 10.1007/s00217-009-1081-5; Zhang Q, 2008, J CEREAL SCI, V47, P252, DOI 10.1016/j.jcs.2007.04.013	38	23	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58682	10.1371/journal.pone.0058682	http://dx.doi.org/10.1371/journal.pone.0058682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520527	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900087
J	Puppo, A; Bello, A; Manfredi, A; Cesi, G; Marrocco, E; Della Corte, M; Rossi, S; Giunti, M; Bacci, ML; Simonelli, F; Surace, EM; Kobinger, GP; Auricchio, A				Puppo, Agostina; Bello, Alexander; Manfredi, Anna; Cesi, Giulia; Marrocco, Elena; Della Corte, Michele; Rossi, Settimio; Giunti, Massimo; Bacci, Maria Laura; Simonelli, Francesca; Surace, Enrico Maria; Kobinger, Gary P.; Auricchio, Alberto			Recombinant Vectors Based on Porcine Adeno-Associated Viral Serotypes Transduce the Murine and Pig Retina	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; LONG-TERM PRESERVATION; MEDIATED GENE-TRANSFER; RPE65 MUTATIONS; VISUAL FUNCTION; MOUSE MODEL; SIALIC-ACID; THERAPY; EXPRESSION; ROD	Recombinant adeno-associated viral (AAV) vectors are known to safely and efficiently transduce the retina. Among the various AAV serotypes available, AAV2/5 and 2/8 are the most effective for gene transfer to photoreceptors (PR), which are the most relevant targets for gene therapy of inherited retinal degenerations. However, the search for novel AAV serotypes with improved PR transduction is ongoing. In this work we tested vectors derived from five AAV serotypes isolated from porcine tissues (referred to as porcine AAVs, four of which are newly identified) for their ability to transduce both the murine and the cone-enriched pig retina. Porcine AAV vectors expressing EGFP under the control of the CMV promoter were injected subretinally either in C57BL/6 mice or Large White pigs. The resulting retinal tropism was analyzed one month later on histological sections, while levels of PR transduction were assessed by Western blot. Our results show that all porcine AAV transduce murine and porcine retinal pigment epithelium and PR upon subretinal administration. AAV2/po1 and 2/po5 are the most efficient porcine AAVs for murine PR transduction and exhibit the strongest tropism for pig cone PR. The levels of PR transduction obtained with AAV2/po1 and 2/po5 are similar, albeit not superior, to those obtained with AAV2/5 and AAV2/8, which evinces AAV2/po1 and 2/po5 to be promising vectors for retinal gene therapy.	[Puppo, Agostina; Manfredi, Anna; Cesi, Giulia; Marrocco, Elena; Surace, Enrico Maria; Auricchio, Alberto] Telethon Inst Genet & Med, Naples, Italy; [Auricchio, Alberto] Univ Naples Federico II, Dept Med Translat Sci, Naples, Italy; [Bello, Alexander; Kobinger, Gary P.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada; [Bello, Alexander; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Della Corte, Michele; Rossi, Settimio; Simonelli, Francesca] Univ Naples 2, Dept Ophthalmol, Naples, Italy; [Giunti, Massimo; Bacci, Maria Laura] Univ Bologna, Dept Vet Med Sci, Bologna, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Public Health Agency of Canada; University of Manitoba; Universita della Campania Vanvitelli; University of Bologna	Auricchio, A (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	auricchio@tigem.it	Simonelli, Francesca/AHE-7571-2022; Rossi, Settimio/AHI-1119-2022; AURICCHIO, Alberto/AHE-7979-2022; Manfredi, Anna/ABC-8588-2021	Simonelli, Francesca/0000-0001-8520-6769; AURICCHIO, Alberto/0000-0002-0832-2472; Bacci, Maria Laura/0000-0001-6702-5868; DELLA CORTE, MICHELE/0000-0003-1320-1883; Surace, Enrico Maria/0000-0002-2975-942X	European Community's Seventh Framework Programme [FP7] [242013]; Fondazione Telethon Project [TGM11MT1]	European Community's Seventh Framework Programme [FP7](European Commission); Fondazione Telethon Project(Fondazione Telethon)	The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no 242013 [TREATRUSH] and from Fondazione Telethon Project no TGM11MT1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; Allocca M, 2011, INVEST OPHTH VIS SCI, V52, P5713, DOI 10.1167/iovs.10-6269; Ashtari M, 2011, J CLIN INVEST, V121, P2160, DOI 10.1172/JCI57377; Auricchio A, 2002, MOL THER, V6, P238, DOI 10.1006/mthe.2002.0660; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Auricchio A, 2011, HUM GENE THER, V22, P1169, DOI 10.1089/hum.2011.2521; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bello A, 2009, GENE THER, V16, P1320, DOI 10.1038/gt.2009.82; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Boye SL, 2011, INVEST OPHTH VIS SCI, V52, P7098, DOI 10.1167/iovs.11-7867; Boye SE, 2012, HUM GENE THER, V23, P1101, DOI 10.1089/hum.2012.125; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Colella P, 2012, HUM GENE THER, V23, P796, DOI 10.1089/hum.2012.123; Daiger SP SL, 2011, RETNET RETINAL INFOR; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Drittanti L, 2000, GENE THER, V7, P924, DOI 10.1038/sj.gt.3301191; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Harris, 2001, RETINA, P2068; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hendrickson A, 2002, EXP EYE RES, V74, P435, DOI 10.1006/exer.2002.1181; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Li AM, 2002, INVEST OPHTH VIS SCI, V43, P1375; Liang FQ, 2001, METH MOLEC MED, V47, P125, DOI 10.1385/1-59259-085-3:125; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Mieziewska K, 1996, MICROSC RES TECHNIQ, V35, P463; Mihelec M, 2011, HUM GENE THER, V22, P1179, DOI 10.1089/hum.2011.069; Min SH, 2005, MOL THER, V12, P644, DOI 10.1016/j.ymthe.2005.06.002; Mohand-Said S, 2001, PROG RETIN EYE RES, V20, P451, DOI 10.1016/S1350-9462(01)00006-4; Mussolino C, 2011, GENE THER, V18, P637, DOI 10.1038/gt.2011.3; Mussolino C, 2011, EMBO MOL MED, V3, P118, DOI 10.1002/emmm.201000119; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; Noel JM, 2012, EXP EYE RES, V97, P137, DOI 10.1016/j.exer.2011.12.018; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Perabo L, 2008, COMB CHEM HIGH T SCR, V11, P118; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Smith AJ, 2003, MOL THER, V8, P188, DOI 10.1016/S1525-0016(03)00144-8; Sommer JR, 2011, BRIT J OPHTHALMOL, V95, P1749, DOI 10.1136/bjophthalmol-2011-300417; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Vandenberghe L.H., 2011, SCI TRANSL MED, V3; VESTRE WA, 1984, VET CLIN N AM-LARGE, V6, P667; Walters RW, 2004, J VIROL, V78, P3361, DOI 10.1128/JVI.78.7.3361-3371.2004; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; Yang PZ, 2002, INVEST OPHTH VIS SCI, V43, P1488; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	58	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59025	10.1371/journal.pone.0059025	http://dx.doi.org/10.1371/journal.pone.0059025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520549	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900109
J	Saito, M; Seo, Y; Yano, Y; Momose, K; Hirano, H; Yoshida, M; Azuma, T				Saito, Masaya; Seo, Yasushi; Yano, Yoshihiko; Momose, Kenji; Hirano, Hirotaka; Yoshida, Masaru; Azuma, Takeshi			Reduction in Non-Protein Respiratory Quotient Is Related to Overall Survival after Hepatocellular Carcinoma Treatment	PLOS ONE			English	Article							TRANSCATHETER OILY CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; LATE EVENING SNACK; LIVER-CIRRHOSIS; TRANSARTERIAL CHEMOEMBOLIZATION; ARTERIAL CHEMOEMBOLIZATION; PROGNOSTIC-FACTORS; ENERGY-METABOLISM; CLIP SCORE; MANAGEMENT	Background: Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular carcinoma (HCC) that can occasionally lead to the shortening of life expectancy. We aimed to make a new and more accurate prognostic model taking into account the course of disease after TACE. Methodology/Principal Findings: We performed a prospective cohort study involving 100 HCC patients who underwent TACE at Kobe University Hospital. Indirect calorimetry and blood biochemical examinations were performed before and 7 days after TACE. Time-dependent and time-fixed factors associated with 1-year mortality after TACE were assessed by multivariate analyses. A predictive model of 1-year mortality was established by the combination of odds ratios of these factors. Multivariate analyses showed that the ratio of non-protein respiratory quotient (npRQ) (7 days after/before TACE) and Cancer of Liver Italian Program (CLIP) score were independent factors of 1-year mortality after TACE (p = 0.014 and 0.013, respectively). Patient-specific 1-year mortality risk scores can be calculated by summarizing the individual risk scores and looking up the patient-specific risk on the graph. Conclusions: The short-term reduction of npRQ was a time-dependent prognostic factor associated with overall survival in HCC patients undergoing TACE. CLIP score was a time-fixed prognostic factor associated with overall survival. Using the prediction model, which consists of the combination of time-dependent (npRQ ratio) and time-fixed (CLIP score) prognostic factors, 1-year mortality risk after TACE would be better estimated by taking into account changes during the course of disease.	[Saito, Masaya; Seo, Yasushi; Yano, Yoshihiko; Momose, Kenji; Hirano, Hirotaka; Yoshida, Masaru; Azuma, Takeshi] Kobe Univ, Dept Internal Med, Grad Sch Med, Div Gastroenterol, Kobe, Hyogo 657, Japan; [Yano, Yoshihiko] Kobe Univ, Ctr Infect Dis, Grad Sch Med, Kobe, Hyogo 657, Japan; [Yoshida, Masaru] Kobe Univ, Dept Internal Med, Grad Sch Med, Div Metabol Res, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University	Azuma, T (corresponding author), Kobe Univ, Dept Internal Med, Grad Sch Med, Div Gastroenterol, Kobe, Hyogo 657, Japan.	azumat@med.kobe-u.ac.jp			Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was supported by Grant-in-Aid for Research Activity Start-up [MS], and was also supported by grants for the Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [MY and TA]. MS had a role in study design, data collection, and analysis, and all authors including MS, MY and TA had a role in decision to publish and preparation of the manuscript.	[Anonymous], 1998, HEPATOLOGY, V28, P751; BISMUTH H, 1992, AM J SURG, V163, P387, DOI 10.1016/0002-9610(92)90039-T; BRONOWICKI JP, 1994, CANCER, V74, P16, DOI 10.1002/1097-0142(19940701)74:1<16::AID-CNCR2820740105>3.0.CO;2-V; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Cabibbo G, 2011, ALIMENT PHARM THER, V34, P196, DOI 10.1111/j.1365-2036.2011.04694.x; Camma C, 2009, LIVER INT, V29, P478, DOI 10.1111/j.1478-3231.2009.01994.x; Dhanasekaran R, 2010, HPB, V12, P174, DOI 10.1111/j.1477-2574.2009.00138.x; Harima Y, 2010, HEPATOL RES, V40, P574, DOI 10.1111/j.1872-034X.2010.00665.x; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kawaoka T, 2010, HEPATOL RES, V40, P1082, DOI 10.1111/j.1872-034X.2010.00714.x; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Kudo M, 2007, ONCOLOGY-BASEL, V72, P2, DOI 10.1159/000111702; LAUTZ HU, 1992, CLIN INVESTIGATOR, V70, P478, DOI 10.1007/BF00210228; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; MONDAZZI L, 1994, HEPATOLOGY, V19, P1115, DOI 10.1002/hep.1840190508; Nakaya Y, 2007, NUTRITION, V23, P113, DOI 10.1016/j.nut.2006.10.008; Nanashima A, 2004, EJSO-EUR J SURG ONC, V30, P765, DOI 10.1016/j.ejso.2004.05.003; OKUDA K, 1984, HEPATOLOGY, V4, pS3, DOI 10.1002/hep.1840040703; OWEN OE, 1983, J CLIN INVEST, V72, P1821, DOI 10.1172/JCI111142; Poon RTP, 2004, ALIMENT PHARM THERAP, V19, P779, DOI 10.1111/j.1365-2036.2004.01920.x; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Saito M, 2012, ALIMENT PHARM THER, V35, P861, DOI 10.1111/j.1365-2036.2012.05021.x; Saito M, 2012, J GASTROENTEROL, V47, P704, DOI 10.1007/s00535-012-0535-x; STUART K, 1993, CANCER, V72, P3202, DOI 10.1002/1097-0142(19931201)72:11<3202::AID-CNCR2820721112>3.0.CO;2-4; Tajika M, 2002, NUTRITION, V18, P229, DOI 10.1016/S0899-9007(01)00754-7; Terakura Y, 2010, J NUTR SCI VITAMINOL, V56, P372, DOI 10.3177/jnsv.56.372; Tsuchiya M, 2005, HEPATOL RES, V31, P95, DOI 10.1016/j.hepres.2004.11.009; Ueno S, 2001, HEPATOLOGY, V34, P529, DOI 10.1053/jhep.2001.27219; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; VETTER D, 1991, HEPATOLOGY, V13, P427, DOI 10.1002/hep.1840130308; YAMADA R, 1990, CARDIOVASC INTER RAD, V13, P135, DOI 10.1007/BF02575464	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e55441	10.1371/journal.pone.0055441	http://dx.doi.org/10.1371/journal.pone.0055441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520445	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900004
J	Westreich, D; Maskew, M; Evans, D; Firnhaber, C; Majuba, P; Sanne, I				Westreich, Daniel; Maskew, Mhairi; Evans, Denise; Firnhaber, Cindy; Majuba, Pappie; Sanne, Ian			Incident Pregnancy and Time to Death or AIDS among HIV-Positive Women Receiving Antiretroviral Therapy	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; SINGLE-DOSE NEVIRAPINE; TO-CHILD TRANSMISSION; SOUTH-AFRICA; DISEASE PROGRESSION; PROSPECTIVE COHORT; GREATER ADHERENCE; NONPREGNANT WOMEN; FOLLOW-UP; SURVIVAL	Background: Little is known about the impact of pregnancy on response to highly active antiretroviral therapy (HAART) in sub-Saharan Africa. We examined the effect of incident pregnancy after HAART initiation on clinical response to HAART. Methods: We evaluated a prospective clinical cohort of adult women initiating HAART in Johannesburg, South Africa between 1 April 2004 and 31 March 2011, and followed up until an event, transfer, drop-out, or administrative end of follow-up on 30 September 2011. Women over age 45 and women who were pregnant at HAART initiation were excluded from the study. Main exposure was having experienced pregnancy after HAART initiation; main outcome was death and (separately) death or new AIDS event. We calculated adjusted hazard ratios (HRs) and 95% confidence limits (CL) using marginal structural Cox proportional hazards models. Results: The study included 7,534 women, and 20,813 person-years of follow-up; 918 women had at least one recognized pregnancy during follow-up. For death alone, the weighted (adjusted) HR was 0.84 (95% CL 0.44, 1.60). Sensitivity analyses confirmed main results, and results were similar for analysis of death or new AIDS event. Incident pregnancy was associated with a substantially reduced hazard of drop-out (HR = 0.62, 95% CL 0.51, 0.75). Conclusions: Recognized incident pregnancy after HAART initiation was not associated with increases in hazard of clinical events, but was associated with a decreased hazard of drop-out. High rates of pregnancy after initiation of HAART may point to a need to better integrate family planning services into clinical care for HIV-infected women.	[Westreich, Daniel] Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA; [Westreich, Daniel] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Maskew, Mhairi; Evans, Denise] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Maskew, Mhairi; Evans, Denise; Firnhaber, Cindy; Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Clin HIV Res Unit, Johannesburg, South Africa; [Firnhaber, Cindy; Majuba, Pappie; Sanne, Ian] Right Care, Johannesburg, South Africa	Duke University; Duke University; University of Witwatersrand; University of Witwatersrand	Westreich, D (corresponding author), Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA.	daniel.westreich@duke.edu	Sanne, Ian/ABH-2231-2020	Westreich, Daniel/0000-0003-3069-1650; MASKEW, MHAIRI/0000-0003-4238-0200	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health & Human Development [R00-HD-06-3961]; National Institute of Allergy and Infectious Diseases through the Duke Center for AIDS Research [P30-AI-064518]; National and Gauteng Department of Health; United States President's Emergency Plan for AIDS Relief (PEPFAR); USAID to Right to Care and the Institution [674-A-00-08-00007-00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD063961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Institute of Allergy and Infectious Diseases through the Duke Center for AIDS Research; National and Gauteng Department of Health; United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID to Right to Care and the Institution(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health & Human Development [grant number R00-HD-06-3961 to D.W.]; National Institute of Allergy and Infectious Diseases through the Duke Center for AIDS Research [grant number P30-AI-064518]. The clinical activities of the Helen Joseph Hospital are supported by the National and Gauteng Department of Health and the United States President's Emergency Plan for AIDS Relief (PEPFAR) in a grant by USAID to Right to Care and the Institution (674-A-00-08-00007-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWEEKA F, 2007, 14 C RETR OPP INF LO; Bardeguez AD, 2008, JAIDS-J ACQ IMM DEF, V48, P408, DOI 10.1097/QAI.0b013e31817bbe80; Black V, 2008, JAIDS-J ACQ IMM DEF, V49, P276, DOI 10.1097/QAI.0b013e318189a769; Chen PL, 2008, J INFECT DIS, V197, P1075, DOI 10.1086/529046; Chi BH, 2007, AIDS, V21, P957, DOI 10.1097/QAD.0b013e32810996b2; Coffie PA, 2008, CLIN INFECT DIS, V46, P611, DOI 10.1086/526780; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Floridia M, 2008, PHARMACOL RES, V58, P173, DOI 10.1016/j.phrs.2008.07.007; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Fox MP, 2012, INT J EPIDE IN PRESS; Fox MP, 2012, INT J EPIDEMIOL; French R, 1998, BRIT J OBSTET GYNAEC, V105, P827, DOI 10.1111/j.1471-0528.1998.tb10226.x; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Keiser O, 2008, AIDS, V22, P2323, DOI 10.1097/QAD.0b013e3283189bf1; Kingston MA, 2007, INT J STD AIDS, V18, P787, DOI 10.1258/095646207782212216; MacCarthy S, 2009, AIDS BEHAV; Matsui D., 2012, OBSTET GYNECOL INT, V2012, DOI DOI 10.1155/2012/796590]; Mirochnick M, 2004, CLIN PHARMACOKINET, V43, P1071, DOI 10.2165/00003088-200443150-00002; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Nachega JB, 2012, AIDS; Petersen ML, 2006, JAIDS-J ACQ IMM DEF, V43, pS96, DOI 10.1097/01.qai.0000248344.95135.8d; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Vaz MJR, 2007, INT J STD AIDS, V18, P28, DOI 10.1258/095646207779949808; Roustit M, 2008, BRIT J CLIN PHARMACO, V66, P179, DOI 10.1111/j.1365-2125.2008.03220.x; Rubin DB, 2004, MULTIPLE IMPUTATION; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; South African National Department of Health, 2008, NAT HIV SYPH PREV SU; Tai JH, 2007, J INFECT DIS, V196, P1044, DOI 10.1086/520814; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; *UNAIDS WHO, 2007, AIDS EP UPD 2007; Van der Paal L, 2007, TROP MED INT HEALTH, V12, P920, DOI [10.1111/j.1365-3156.2007.01873.x, 10.1111/j.1365-3156.2007.001873.x]; Westreich D, 2012, J ACQUIR IMMUNE DEFI; Westreich D, 2012, INFECT DIS IN PRESS; Westreich D, 2012, AIDS; Westreich D, 2008, J INFECT DIS, V197, P1074, DOI 10.1086/529045; Westreich D, 2007, J INFECT DIS, V195, P837, DOI 10.1086/511276; Westreich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022778; Westreich D, 2010, AM J EPIDEMIOL, V171, P691, DOI 10.1093/aje/kwp418; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; WHO, 2007, WHO CAS DEF IN PRESS; Zhang MJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-82; Zorrilla CD, 2003, CELL MOL BIOL, V49, P1187	52	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58117	10.1371/journal.pone.0058117	http://dx.doi.org/10.1371/journal.pone.0058117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520489	Green Published, gold			2022-12-27	WOS:000318679900048
J	Xiong, YS; Yu, J; Li, C; Zhu, L; Wu, LJ; Zhong, RQ				Xiong, Yi-song; Yu, Juan; Li, Chang; Zhu, Lin; Wu, Li-juan; Zhong, Ren-qian			The Role of Siglec-1 and SR-BI Interaction in the Phagocytosis of Oxidized Low Density Lipoprotein by Macrophages	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; FOAM-CELL-FORMATION; RECEPTOR; SIALOADHESIN; LDL; EXPRESSION; BINDS; ATHEROSCLEROSIS; ACCUMULATION; MONOCYTES	Background: Macrophages play a proatherosclerotic role in atherosclerosis via oxLDL uptake. As an adhesion molecular of I-type lectins, Siglec-1 is highly expressed on circulating monocytes and plaque macrophages of atherosclerotic patients, but the exact role of Siglec-1 has not been elucidated. Methods: In this study, oxLDL was used to stimulate Siglec-1 and some oxLDL receptors (SR-BI, CD64, CD32B, LOX-1 and TLR-4) expression on bone marrow-derived macrophages, whereas small interfering RNA was used to down-regulate Siglec-1. Meanwhile, an ELISA-based assay for Siglec-1-oxLDL interaction was performed, and co-immunoprecipitation (co-IP) and laser scanning confocal microscopy (LSCM) were used to determine the role of Siglec-1 in oxLDL uptake by macrophages. Results: We found that oxLDL could up-regulate the expression of various potential oxLDL receptors, including Siglec-1, in a dose-dependent manner. Moreover, down-regulation of Siglec-1 could attenuate oxLDL uptake by Oil red O staining. LSCM revealed that Siglec-1 and CD64/SR-BI may colocalize on oxLDL-stimulated macrophage surface, whereas co-IP showed that Siglec-1 and SR-BI can be immunoprecipitated by each other. However, no direct interaction between Siglec-1 and oxLDL was found in the in vitro protein interaction system. Conclusions: Thus, Siglec-1 can interact with SR-BI in the phagocytosis of oxLDL by macrophages, rather than act as an independent receptor for oxLDL.	[Xiong, Yi-song; Wu, Li-juan] Chengdu Mil Gen Hosp, Dept Lab Med, Chengdu, Peoples R China; [Yu, Juan; Li, Chang; Zhong, Ren-qian] Second Mil Med Univ, Changzheng Hosp, Dept Lab Med, Shanghai, Peoples R China; [Yu, Juan; Li, Chang; Zhong, Ren-qian] Clin Immunol Ctr PLA, Shanghai, Peoples R China; [Zhu, Lin] Second Mil Med Univ, Changzheng Hosp, Dept Cardiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wu, LJ (corresponding author), Chengdu Mil Gen Hosp, Dept Lab Med, Chengdu, Peoples R China.	lijuanwu1126@126.com; rqzhong@yahoo.com			Hi-Tech research and development program of China (863 Program) [2006AA02Z496]; Funds for Excellent Department Leader, Science and Technology Commission of Shanghai Municipality [07XD14013]; National Natural Science Foundation of China [81072479, 81170263]	Hi-Tech research and development program of China (863 Program)(National High Technology Research and Development Program of China); Funds for Excellent Department Leader, Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hi-Tech research and development program of China (863 Program) (2006AA02Z496), Funds for Excellent Department Leader, Science and Technology Commission of Shanghai Municipality (07XD14013), and The National Natural Science Foundation of China (81072479, 81170263). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes YC, 1999, BLOOD, V93, P1245, DOI 10.1182/blood.V93.4.1245.404k09_1245_1252; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1995, J CLIN INVEST, V95, P635, DOI 10.1172/JCI117708; Delputte PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016827; Feng JW, 2000, J LIPID RES, V41, P688; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; Fujita Y, 2009, CLIN CHEM, V55, P285, DOI 10.1373/clinchem.2008.119750; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Kataoka H, 2001, ARTERIOSCL THROM VAS, V21, P955, DOI 10.1161/01.ATV.21.6.955; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Laukkanen J, 2000, CIRCULATION, V101, P1091, DOI 10.1161/01.CIR.101.10.1091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuura E, 2006, LUPUS, V15, P478, DOI 10.1191/0961203306lu2337oa; Nicolaou G, 2010, CURR OPIN LIPIDOL, V21, P427, DOI 10.1097/MOL.0b013e32833cacd5; Paul SP, 2000, BLOOD, V96, P483; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schiopu A, 2007, J AM COLL CARDIOL, V50, P2313, DOI 10.1016/j.jacc.2007.07.081; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; STANTON LW, 1992, J BIOL CHEM, V267, P22446; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Van Gorp H, 2009, ARCH VIROL, V154, P1939, DOI 10.1007/s00705-009-0527-1; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Xiong YS, 2009, CLIN BIOCHEM, V42, P1057, DOI 10.1016/j.clinbiochem.2009.02.026; Xu WY, 2007, MOL IMMUNOL, V44, P2315, DOI 10.1016/j.molimm.2006.11.013; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zou ZC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024559	35	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58831	10.1371/journal.pone.0058831	http://dx.doi.org/10.1371/journal.pone.0058831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520536	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900096
J	Riedel, T; Gomez-Consarnau, L; Tomasch, J; Martin, M; Jarek, M; Gonzalez, JM; Spring, S; Rohlfs, M; Brinkhoff, T; Cypionka, H; Goker, M; Fiebig, A; Klein, J; Goesmann, A; Fuhrman, JA; Wagner-Dobler, I				Riedel, Thomas; Gomez-Consarnau, Laura; Tomasch, Juergen; Martin, Madeleine; Jarek, Michael; Gonzalez, Jose M.; Spring, Stefan; Rohlfs, Meike; Brinkhoff, Thorsten; Cypionka, Heribert; Goeker, Markus; Fiebig, Anne; Klein, Johannes; Goesmann, Alexander; Fuhrman, Jed A.; Wagner-Doebler, Irene			Genomics and Physiology of a Marine Flavobacterium Encoding a Proteorhodopsin and a Xanthorhodopsin-Like Protein	PLOS ONE			English	Article							DRIVEN PROTON TRANSLOCATION; FRESH-WATER; LIGHT; SEQUENCE; BACTERIAL; RHODOPSIN; GENETICS; SYSTEM; PUMP; CELL	Proteorhodopsin (PR) photoheterotrophy in the marine flavobacterium Dokdonia sp. PRO95 has previously been investigated, showing no growth stimulation in the light at intermediate carbon concentrations. Here we report the genome sequence of strain PRO95 and compare it to two other PR encoding Dokdonia genomes: that of strain 4H-3-7-5 which shows the most similar genome, and that of strain MED134 which grows better in the light under oligotrophic conditions. Our genome analysis revealed that the PRO95 genome as well as the 4H-3-7-5 genome encode a protein related to xanthorhodopsins. The genomic environment and phylogenetic distribution of this gene suggest that it may have frequently been recruited by lateral gene transfer. Expression analyses by RT-PCR and direct mRNA-sequencing showed that both rhodopsins and the complete beta-carotene pathway necessary for retinal production are transcribed in PRO95. Proton translocation measurements showed enhanced proton pump activity in response to light, supporting that one or both rhodopsins are functional. Genomic information and carbon source respiration data were used to develop a defined cultivation medium for PRO95, but reproducible growth always required small amounts of yeast extract. Although PRO95 contains and expresses two rhodopsin genes, light did not stimulate its growth as determined by cell numbers in a nutrient poor seawater medium that mimics its natural environment, confirming previous experiments at intermediate carbon concentrations. Starvation or stress conditions might be needed to observe the physiological effect of light induced energy acquisition.	[Riedel, Thomas; Tomasch, Juergen; Martin, Madeleine; Jarek, Michael; Rohlfs, Meike; Wagner-Doebler, Irene] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Gomez-Consarnau, Laura; Fuhrman, Jed A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Gonzalez, Jose M.] Univ La Laguna, Dept Microbiol, Tenerife, Spain; [Spring, Stefan; Goeker, Markus; Fiebig, Anne] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany; [Brinkhoff, Thorsten; Cypionka, Heribert] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany; [Klein, Johannes] Tech Univ Carolo Wilhelmina Braunschweig, Dept Microbiol, D-38106 Braunschweig, Germany; [Goesmann, Alexander] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; University of Southern California; Universidad de la Laguna; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Carl von Ossietzky Universitat Oldenburg; Braunschweig University of Technology; University of Bielefeld	Riedel, T (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	Thomas.Riedel@helmholtz-hzi.de	Spring, Stefan/N-6933-2013; Gomez-Consarnau, Laura/AAM-1319-2021; Gonzalez, Jose M./C-3333-2013; Wagner-Döbler, Irene/Y-1685-2019; Fuhrman, Jed A/C-6461-2013; Göker, Markus/AAX-6258-2021	Spring, Stefan/0000-0001-6247-0938; Gonzalez, Jose M./0000-0002-9926-3323; Fuhrman, Jed A/0000-0002-2361-1985; Göker, Markus/0000-0002-5144-6200; Goesmann, Alexander/0000-0002-7086-2568; Tomasch, Jurgen/0000-0002-3914-2781; Wagner-Dobler, Irene/0000-0001-5883-2502	DFG [Transregio-SFB 51 Roseobacter]; Swedish Research Council [623-2009-7258]	DFG(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	TR, JT, HC, TB, MG, AF, IWD gratefully acknowledge funding by the DFG Transregio-SFB 51 Roseobacter, and LGC by the Swedish Research Council (Project 623-2009-7258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque L, 2005, FEMS MICROBIOL LETT, V247, P161, DOI 10.1016/j.femsle.2005.05.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armstrong GA, 1997, ANNU REV MICROBIOL, V51, P629, DOI 10.1146/annurev.micro.51.1.629; Atamna-Ismaeel N, 2008, ISME J, V2, P656, DOI 10.1038/ismej.2008.27; Balashov SP, 2007, CELL MOL LIFE SCI, V64, P2323, DOI 10.1007/s00018-007-7167-y; Balashov SP, 2008, BIOPHYS J, V95, P2402, DOI 10.1529/biophysj.108.132175; Balashov SP, 2010, BIOCHEMISTRY-US, V49, P9792, DOI 10.1021/bi1014166; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Becq J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009989; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bohlin J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-104; Borthwick AD, 2012, CHEM REV, V112, P3641, DOI 10.1021/cr200398y; Cottrell MT, 2009, APPL ENVIRON MICROB, V75, P4958, DOI 10.1128/AEM.00117-09; de Carvalho MP, 2012, CURR MED CHEM, V19, P3564; de la Torre JR, 2003, P NATL ACAD SCI USA, V100, P12830, DOI 10.1073/pnas.2133554100; FITZ RM, 1989, ARCH MICROBIOL, V152, P369, DOI 10.1007/BF00425175; FITZ RM, 1991, ARCH MICROBIOL, V155, P444, DOI 10.1007/BF00244959; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Giovannoni SJ, 2012, ISME J; Giovannoni SJ, 2012, P NATL ACAD SCI USA, V109, P13888, DOI 10.1073/pnas.1211722109; Gomez E, 2012, GENE, V497, P263, DOI 10.1016/j.gene.2012.01.069; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Gomez-Pereira PR, 2012, ENVIRON MICROBIOL, V14, P52, DOI 10.1111/j.1462-2920.2011.02555.x; Gonzalez JM, 2008, P NATL ACAD SCI USA, V105, P8724, DOI 10.1073/pnas.0712027105; Gonzalez JM, 2011, APPL ENVIRON MICROB, V77, P8676, DOI 10.1128/AEM.06152-11; Holert J, 2011, ENV MICROBIOL REP, V3, P136, DOI 10.1111/j.1758-2229.2010.00199.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Ivanova N, 2011, STAND GENOMIC SCI, V4, P91, DOI 10.4056/sigs.1563919; Jiao NZ, 2010, J BACTERIOL, V192, P1169, DOI 10.1128/JB.01504-09; Kang I, 2010, J BACTERIOL, V192, P4798, DOI 10.1128/JB.00761-10; KIM SK, 1992, ANNU REV MICROBIOL, V46, P117, DOI 10.1146/annurev.mi.46.100192.001001; Kimura H, 2011, ISME J, V5, P1641, DOI 10.1038/ismej.2011.36; Klippel B, 2011, J BACTERIOL, V193, P4545, DOI 10.1128/JB.05518-11; Koh EY, 2010, APPL ENVIRON MICROB, V76, P5918, DOI 10.1128/AEM.00562-10; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Oh TK, 2011, INT J SYST EVOL MICR; Riedel T, 2012, STAND GENOMIC SCI, V7, P107, DOI 10.4056/sigs.3216895; Riedel T, 2010, APPL ENVIRON MICROB, V76, P3187, DOI 10.1128/AEM.02971-09; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Sabehi G, 2007, ISME J, V1, P48, DOI 10.1038/ismej.2007.10; Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI USA, V109, P14041, DOI 10.1073/pnas.1208755109; Scholes P, 1971, J Bioenerg, V1, P309; Shanker U, 2012, ORIGINS LIFE EVOL B, V42, P31, DOI 10.1007/s11084-012-9266-5; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Staden R, 2000, Methods Mol Biol, V132, P115; Steindler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019725; Su HS, 2001, MICROBIOL-UK, V147, P581, DOI 10.1099/00221287-147-3-581; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Trappen S, 2004, INT J SYST EVOL MICR, V54, P445, DOI 10.1099/ijs.0.02922-0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038749; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Yoshitsugu M, 2009, BIOCHEMISTRY-US, V48, P4324, DOI 10.1021/bi900228a; Yoshizawa S, 2012, ENVIRON MICROBIOL, V14, P1240, DOI 10.1111/j.1462-2920.2012.02702.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng QA, 2011, J BACTERIOL, V193, P2074, DOI 10.1128/JB.00121-11	82	33	37	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57487	10.1371/journal.pone.0057487	http://dx.doi.org/10.1371/journal.pone.0057487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23526944	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900024
J	Karabencheva-Christova, TG; Carlsson, U; Balali-Mood, K; Black, GW; Christov, CZ				Karabencheva-Christova, Tatyana G.; Carlsson, Uno; Balali-Mood, Kia; Black, Gary W.; Christov, Christo Z.			Conformational Effects on the Circular Dichroism of Human Carbonic Anhydrase II: A Multilevel Computational Study	PLOS ONE			English	Article							TEM-1 BETA-LACTAMASE; MOLECULAR-DYNAMICS; ROTATIONAL STRENGTHS; SIDE-CHAINS; CHIROPTICAL PROPERTIES; LINEAR DICHROISM; NEAR-ULTRAVIOLET; FAR-ULTRAVIOLET; GAS-PHASE; CLASS-A	Circular Dichroism (CD) spectroscopy is a powerful method for investigating conformational changes in proteins and therefore has numerous applications in structural and molecular biology. Here a computational investigation of the CD spectrum of the Human Carbonic Anhydrase II (HCAII), with main focus on the near-UV CD spectra of the wild-type enzyme and it seven tryptophan mutant forms, is presented and compared to experimental studies. Multilevel computational methods (Molecular Dynamics, Semiempirical Quantum Mechanics, Time-Dependent Density Functional Theory) were applied in order to gain insight into the mechanisms of interaction between the aromatic chromophores within the protein environment and understand how the conformational flexibility of the protein influences these mechanisms. The analysis suggests that combining CD semi empirical calculations, crystal structures and molecular dynamics (MD) could help in achieving a better agreement between the computed and experimental protein spectra and provide some unique insight into the dynamic nature of the mechanisms of chromophore interactions.	[Karabencheva-Christova, Tatyana G.; Black, Gary W.; Christov, Christo Z.] Northumbria Univ, Sch Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Carlsson, Uno] Linkoping Univ, IFM Dept Chem, Linkoping, Sweden; [Balali-Mood, Kia] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Northumbria University; Linkoping University; University of Oxford	Christov, CZ (corresponding author), Northumbria Univ, Sch Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	christo.christov@northumbria.ac.uk		Black, Gary/0000-0003-3697-0714	UK National Service for Computational Chemistry Software; UK National Supercomputer Service Hector; Marie Curie Fellowships (FP7 of EU); Engineering and Physical Sciences Research Council [EP/J003921/1] Funding Source: researchfish; EPSRC [EP/J003921/1] Funding Source: UKRI	UK National Service for Computational Chemistry Software; UK National Supercomputer Service Hector; Marie Curie Fellowships (FP7 of EU); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study is done using support from UK National Service for Computational Chemistry Software, UK National Supercomputer Service Hector and Marie Curie Fellowships (FP7 of EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Andrew CD, 2002, J AM CHEM SOC, V124, P12706, DOI 10.1021/ja027629h; BAYLEY PM, 1969, J PHYS CHEM-US, V73, P228, DOI 10.1021/j100721a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berova N, 2007, CHEM SOC REV, V36, P914, DOI 10.1039/b515476f; Besley NA, 1999, J AM CHEM SOC, V121, P9636, DOI 10.1021/ja990627l; Bulheller BM, 2007, PHYS CHEM CHEM PHYS, V9, P2020, DOI 10.1039/b615870f; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Casida ME, 2012, ANNU REV PHYS CHEM, V63, P287, DOI [10.1146/annurev-physchem-032511-143803, 10.1146/annurev-physchem-032511-443803]; Christov C, 2006, J MOL MODEL, V12, P411, DOI 10.1007/s00894-005-0061-3; Christov C, 2004, CHEM PHYS LETT, V400, P524, DOI 10.1016/j.cplett.2004.11.008; Christov C, 2004, CHEM PHYS LETT, V396, P282, DOI 10.1016/j.cplett.2004.08.035; Christov C, 2008, CHEM PHYS LETT, V456, P89, DOI 10.1016/j.cplett.2008.03.012; Christov C, 2011, THEOR CHEM ACC, V128, P25, DOI 10.1007/s00214-010-0744-4; Christov CZ, 2008, COMPUT BIOL CHEM, V32, P167, DOI 10.1016/j.compbiolchem.2008.02.003; Dennington R., 2016, GAUSSVIEW VERSION 6; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Frisch G. W., 2013, GAUSSIAN 09; Furche F., 2005, ANN REPORTS COMPUTAT, V1, P19, DOI [10.1016/s1574-1400(05)01002-9, DOI 10.1016/S1574-1400(05)01002-9]; GOUX WJ, 1980, J AM CHEM SOC, V102, P7080, DOI 10.1021/ja00543a033; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hudecova J, 2012, CHEMPHYSCHEM, V13, P2748, DOI 10.1002/cphc.201200201; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karabencheva T, 2010, ADV PROTEIN CHEM STR, V80, P85, DOI [10.1016/S1876-1623(10)80003-3, 10.1016/B978-0-12-381264-3.00003-5]; Karabencheva T, 2010, BIOPHYS CHEM, V151, P39, DOI 10.1016/j.bpc.2010.05.003; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Li M, 2006, BIOCHEMISTRY-US, V45, P4775, DOI 10.1021/bi051847g; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; MCCAMMON JA, 1999, SIMPLICITY COMPLEXIT; Robinson D, 2009, J PHYS CHEM B, V113, P14521, DOI 10.1021/jp9071108; Robinson D, 2009, J PHYS CHEM B, V113, P2535, DOI 10.1021/jp808943d; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Rogers DM, 2003, J PHYS CHEM A, V107, P11191, DOI 10.1021/jp036081d; Rogers DM, 2004, BIOCHEMISTRY-US, V43, P11092, DOI 10.1021/bi049031n; Rosenfeld L, 1929, Z PHYS, V52, P161, DOI 10.1007/BF01342393; Roy A, 2009, CHIRALITY, V21, pE163, DOI 10.1002/chir.20792; Woody R.W., 1996, CIRCULAR DICHROISM C, P25, DOI DOI 10.1007/978-1-4757-2508-7_2; Woody R.W., 2007, METHODS PROTEIN STRU, P291; Woody RW, 1999, J CHEM PHYS, V111, P2844, DOI 10.1063/1.479562; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Woody RW, 1996, CIRCULAR DICHROISM C, P109; [No title captured]	46	17	17	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56874	10.1371/journal.pone.0056874	http://dx.doi.org/10.1371/journal.pone.0056874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23526922	Green Accepted, Green Published, gold			2022-12-27	WOS:000316849500038
J	Foster, NL; Foggo, A; Howell, KL				Foster, Nicola L.; Foggo, Andrew; Howell, Kerry L.			Using Species-Area Relationships to Inform Baseline Conservation Targets for the Deep North East Atlantic	PLOS ONE			English	Article							PORCUPINE SEABIGHT; ABYSSAL-PLAIN; BIODIVERSITY; SEA; DIVERSITY; HABITAT; PATTERNS; ZONATION; COMMONNESS; ASTEROIDEA	Demands on the resources of the deep-sea have increased in recent years. Consequently, the need to create and implement a comprehensive network of Marine Protected Areas (MPAs) to help manage and protect these resources has become a global political priority. Efforts are currently underway to implement MPA networks in the deep North East Atlantic. To ensure these networks are effective, it is essential that baseline information be available to inform the conservation planning process. Using empirical data, we calculated conservation targets for sessile benthic invertebrates in the deep North East Atlantic for consideration during the planning process. We assessed Species-Area Relationships across two depth bands (200-1100 m and 1100-1800 m) and nine substrata. Conservation targets were predicted for each substratum within each depth band using z-values obtained from fitting a power model to the Species-Area Relationships of observed and estimated species richness (Chao1). Results suggest an MPA network incorporating 10% of the North East Atlantic's deepsea area would protect approximately 58% and 49% of sessile benthic species for the depth bands 200-1100 m and 1100-1800 m, respectively. Species richness was shown to vary with substratum type indicating that, along with depth, substratum information needs to be incorporated into the conservation planning process to ensure the most effective MPA network is implemented in the deep North East Atlantic.	[Foster, Nicola L.; Foggo, Andrew; Howell, Kerry L.] Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Plymouth	Howell, KL (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	kerry.howell@plymouth.ac.uk	Foster, Nicola L/A-3885-2012; Howell, Kerry/H-5044-2013	Foster, Nicola L/0000-0001-9796-1753; Howell, Kerry/0000-0003-3359-1778	Department for Business, Enterprise and Regulatory Reform through Strategic Environmental Assessment 7; Department for Environment, Food and Rural Affairs; Census of Seamounts, a joint Research Councils of the UK fellowship; University of Plymouth's Marine Biology and Ecology Research Centre; University of PlymouthTMs Faculty of Science and Engineering	Department for Business, Enterprise and Regulatory Reform through Strategic Environmental Assessment 7; Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Census of Seamounts, a joint Research Councils of the UK fellowship; University of Plymouth's Marine Biology and Ecology Research Centre; University of PlymouthTMs Faculty of Science and Engineering	Data collection was funded by the Department for Business, Enterprise and Regulatory Reform through Strategic Environmental Assessment 7 (formerly the Department for Trade and Industry) and the Department for Environment, Food and Rural Affairs through their advisors the Joint Nature Conservation Committee and the offshore Special Areas for Conservation programme. Data analysis was partially funded by a mini grant awarded to K. L. H. from the Census of Seamounts, a joint Research Councils of the UK fellowship awarded to K. L. H., University of Plymouth's Marine Biology and Ecology Research Centre and University of Plymouth (TM) s Faculty of Science and Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airame S, 2003, ECOL APPL, V13, pS170; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Ballentine B, 1997, DESIGN PRINCIPLES SY; Buscombe D, 2009, SEDIMENTOLOGY, V56, P421, DOI 10.1111/j.1365-3091.2008.00977.x; Campbell R. A., 1983, DEEPSEA BIOL SEA, P473; Carney RS, 1983, DEEP SEA BIOL, P371; Chittaro PM, 2010, CONSERV BIOL, V24, P197, DOI 10.1111/j.1523-1739.2009.01323.x; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Desmet P, 2004, ECOL SOC, V9; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Foggo A, 2003, MAR ECOL PROG SER, V248, P15, DOI 10.3354/meps248015; FOLK RL, 1954, J GEOL, V62, P344, DOI 10.1086/626171; GAGE JD, 1986, P ROY SOC EDINB B, V88, P159, DOI 10.1017/S026972700000453X; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gladstone W, 2007, AQUAT CONSERV, V17, P71, DOI 10.1002/aqc.759; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GRASSLE JF, 1975, DEEP-SEA RES, V22, P457, DOI 10.1016/0011-7471(75)90020-0; HAEDRICH RL, 1980, MAR BIOL, V57, P165, DOI 10.1007/BF00390735; Hill JL, 2001, APPL GEOGR, V21, P157, DOI 10.1016/S0143-6228(01)00002-9; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Howell KL, 2010, J MAR BIOL ASSOC UK, V90, P33, DOI 10.1017/S0025315409991299; Howell K.L, 2010, DEEP SEA SPECIES IMA; Howell KL, 2010, BIOL CONSERV, V143, P1041, DOI 10.1016/j.biocon.2010.02.001; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; LAMPITT RS, 1986, MAR BIOL, V93, P69, DOI 10.1007/BF00428656; LEDANOIS E, 1948, PROFONDEURS MER; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Liu XQ, 2010, DIVERS DISTRIB, V16, P932, DOI 10.1111/j.1472-4642.2010.00706.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUNDAELV T, 1971, Thalassia Jugoslavica, V7, P201; Ma MH, 2002, AGR ECOSYST ENVIRON, V89, P137, DOI 10.1016/S0167-8809(01)00325-5; MAC ARTHUR ROBERT H., 1967; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McClain CR, 2010, ECOLOGY, V91, P964, DOI 10.1890/09-0087.1; *NAT RES COUNC, 2000, MAR PROT AR TOOLS SU; Neigel JE, 2003, ECOL APPL, V13, pS138; Olabarria C, 2005, DEEP-SEA RES PT I, V52, P15, DOI 10.1016/j.dsr.2004.09.005; Paterson G.L.J., 1985, P491; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; REED TM, 1983, BIOL CONSERV, V25, P263, DOI 10.1016/0006-3207(83)90039-3; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; Rex MA, 1983, DEEP SEA BIOL; Roberts C., 2000, WWF ENDANGERED SEAS; ROBERTS CM, 2006, ROADMAP RECOVERY GLO; Rondinini C, 2010, BIOL CONSERV, V143, P1646, DOI 10.1016/j.biocon.2010.03.037; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROWE GT, 1971, B MAR SCI, V21, P556; ROWE GT, 1969, DEEP-SEA RES, V16, P531, DOI 10.1016/0011-7471(69)90041-2; Sanders H. L., 1965, Deep-Sea Research, V12, P845; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; SIBUET M, 1977, DEEP-SEA RES, V24, P549, DOI 10.1016/0146-6291(77)90527-6; Smith AB, 2010, BIOL CONSERV, V143, P555, DOI 10.1016/j.biocon.2009.11.003; Solan M, 2003, J EXP MAR BIOL ECOL, V285, P313, DOI 10.1016/S0022-0981(02)00535-X; Stuart CT, 2009, MAR ECOL-EVOL PERSP, V30, P164, DOI 10.1111/j.1439-0485.2008.00269.x; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wright JE, 1977, INTRO OCEANS	61	12	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58941	10.1371/journal.pone.0058941	http://dx.doi.org/10.1371/journal.pone.0058941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527053	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562600046
J	Lee, Y; Collier, TC; Sanford, MR; Marsden, CD; Fofana, A; Cornel, AJ; Lanzaro, GC				Lee, Yoosook; Collier, Travis C.; Sanford, Michelle R.; Marsden, Clare D.; Fofana, Abdrahamane; Cornel, Anthony J.; Lanzaro, Gregory C.			Chromosome Inversions, Genomic Differentiation and Speciation in the African Malaria Mosquito Anopheles gambiae	PLOS ONE			English	Article							MOLECULAR-FORMS; GENETIC DIFFERENTIATION; NUCLEOTIDE VARIABILITY; REPRODUCTIVE ISOLATION; WEST-AFRICA; S-FORMS; DROSOPHILA; DIVERGENCE; EVOLUTION; COMPLEX	The African malaria vector, Anopheles gambiae, is characterized by multiple polymorphic chromosomal inversions and has become widely studied as a system for exploring models of speciation. Near complete reproductive isolation between different inversion types, known as chromosomal forms, has led to the suggestion that A. gambiae is in early stages of speciation, with divergence evolving in the face of considerable gene flow. We compared the standard chromosomal arrangement (Savanna form) with genomes homozygous for j, b, c, and u inversions (Bamako form) in order to identify regions of genomic divergence with respect to inversion polymorphism. We found levels of divergence between the two sub-taxa within some of these inversions (2Rj and 2Rb), but at a level lower than expected and confined near the inversion breakpoints, consistent with a gene flux model. Unexpectedly, we found that the majority of diverged regions were located on the X chromosome, which contained half of all significantly diverged regions, with much of this divergence located within exons. This is surprising given that the Bamako and Savanna chromosomal forms are both within the S molecular form that is defined by a locus near centromere of X chromosome. Two X-linked genes (a heat shock protein and P450 encoding genes) involved in reproductive isolation between the M and S molecular forms of A. gambiae were also significantly diverged between the two chromosomal forms. These results suggest that genes mediating reproductive isolation are likely located on the X chromosome, as is thought to be the case for the M and S molecular forms. We conclude that genes located on the sex chromosome may be the major force driving speciation between these chromosomal forms of A. gambiae.	[Lee, Yoosook; Collier, Travis C.; Sanford, Michelle R.; Marsden, Clare D.; Lanzaro, Gregory C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Vector Genet Lab, Davis, CA 95616 USA; [Cornel, Anthony J.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Fofana, Abdrahamane] Univ Mali, Fac Med, Malaria Res & Training Ctr, Bamako, Mali	University of California System; University of California Davis; University of California System; University of California Davis; University of Bamako	Lee, Y (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Vector Genet Lab, Davis, CA 95616 USA.	yoslee@ucdavis.edu	Sanford, Michelle/C-9575-2011	Sanford, Michelle/0000-0001-6212-4023; Lee, Yoosook/0000-0002-1392-7177	National Institutes of Health [R01 AI40308, D43 TW007390, T32AI074550]; University of California Malaria Research and Control Program (MRCG); FOGARTY INTERNATIONAL CENTER [D43TW007390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074550, R01AI040308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Malaria Research and Control Program (MRCG); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this paper was supported by grants from the National Institutes of Health to GCL (R01 AI40308, D43 TW007390, and T32AI074550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the University of California Malaria Research and Control Program (MRCG) which procured funding for the custom-designed A. gambiae WGTM used in this study. We thank Matt Rolston who performed microarry hybridization at the UC Davis School of Medicine Microarray Core Facility. We thank Drs. Yury Goltsev (Stanford University), Ki-Hong Jung (Kyung-Hee University, Korea) and Matteo Pellegrini (University of California-Los Angeles) for advice on the microarray data analysis.	Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Ashburner M., 1989, DROSOPHILA; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; CHOVNICK A, 1973, GENETICS, V75, P123; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Coyne JA, 2004, SPECIATION, pxiii; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; di Deco M.A., 1980, Parassitologia (Rome), V22, P304; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; DOBZHANSKY T, 1947, GENETICS, V32, P142; Dobzhansky T., 1949, HEREDITAS, V35, P210, DOI 10.1111/j.1601-5223.1949.tb03334.x; Dulai KS, 1999, GENOME RES, V9, P629; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; HODGES JL, 1963, ANN MATH STAT, V34, P598, DOI 10.1214/aoms/1177704172; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; HUNT R H, 1973, Parassitologia (Rome), V15, P137; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; Lanzaro GC, 1998, P NATL ACAD SCI USA, V95, P14260, DOI 10.1073/pnas.95.24.14260; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lee Y, 2004, AN INDIVIDUAL LEVEL; Lee Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-75; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r24; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x; Navarro A, 1997, GENETICS, V147, P931; Navarro A, 1997, GENETICS, V146, P695; Navarro A, 2000, GENETICS, V155, P685; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; OHNO S., 1970, Evolution by gene duplication.; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Persiani A, 1986, Ann Ist Super Sanita, V22, P221; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Reinhold K, 1998, BEHAV ECOL SOCIOBIOL, V44, P1, DOI 10.1007/s002650050508; Riehle MM, 2011, SCIENCE, V331, P596, DOI 10.1126/science.1196759; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Roberts PA, 1976, THE GENETIC AND BIOL, P67; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027920; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; SINGER B, 1986, NEW DEV STAT PSYCHOL, P129; Slotman MA, 2006, GENETICS, V174, P2081, DOI 10.1534/genetics.106.059949; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STROBECK C, 1983, GENETICS, V103, P545; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; STURTEVANT A. H., 1926, BIOL ZENTRALBL, V46, P697; Taylor C, 2001, GENETICS, V157, P743; Ting CT, 2004, P NATL ACAD SCI USA, V101, P12232, DOI 10.1073/pnas.0401975101; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Tripet F, 2005, GENETICS, V169, P313, DOI 10.1534/genetics.104.026534; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Wang R, 2001, P NATL ACAD SCI USA, V98, P10769, DOI 10.1073/pnas.191003598; Wang-Sattler R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001249; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	73	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57887	10.1371/journal.pone.0057887	http://dx.doi.org/10.1371/journal.pone.0057887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526957	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562600010
J	Xiao, XZ; Yuan, J; Haik, S; Cali, I; Zhan, YA; Moudjou, M; Li, BY; Laplanche, JL; Laude, H; Langeveld, J; Gambetti, P; Kitamoto, T; Kong, QZ; Brandel, JP; Cobb, BA; Petersen, RB; Zou, WQ				Xiao, Xiangzhu; Yuan, Jue; Haik, Stephane; Cali, Ignazio; Zhan, Yian; Moudjou, Mohammed; Li, Baiya; Laplanche, Jean-Louis; Laude, Hubert; Langeveld, Jan; Gambetti, Pierluigi; Kitamoto, Tetsuyuki; Kong, Qingzhong; Brandel, Jean-Philippe; Cobb, Brian A.; Petersen, Robert B.; Zou, Wen-Quan			Glycoform-Selective Prion Formation in Sporadic and Familial Forms of Prion Disease	PLOS ONE			English	Article							PROTEASE-SENSITIVE PRIONOPATHY; SCRAPIE; PRP; MUTATION; SUSCEPTIBILITY; ASSOCIATION; CONFORMERS; FRAGMENT; ANTIBODY	The four glycoforms of the cellular prion protein (PrPC) variably glycosylated at the two N-linked glycosylation sites are converted into their pathological forms (PrPSc) in most cases of sporadic prion diseases. However, a prominent molecular characteristic of PrPSc in the recently identified variably protease-sensitive prionopathy (VPSPr) is the absence of a diglycosylated form, also notable in familial Creutzfeldt-Jakob disease (fCJD), which is linked to mutations in PrP either from Val to Ile at residue 180 (fCJD(V180I)) or from Thr to Ala at residue 183 (fCJD(T183A)). Here we report that fCJD(V180I), but not fCJD(T183A), exhibits a proteinase K (PK)-resistant PrP (PrPres) that is markedly similar to that observed in VPSPr, which exhibits a five-step ladder-like electrophoretic profile, a molecular hallmark of VPSPr. Remarkably, the absence of the diglycosylated PrPres species in both fCJD(V180I) and VPSPr is likewise attributable to the absence of PrPres glycosylated at the first N-linked glycosylation site at residue 181, as in fCJD(T183A). In contrast to fCJD(T183A), both VPSPr and fCJD(V180I) exhibit glycosylation at residue 181 on di- and monoglycosylated (mono181) PrP prior to PK-treatment. Furthermore, PrPV180I with a typical glycoform profile from cultured cells generates detectable PrPres that also contains the diglycosylated PrP in addition to mono-and unglycosylated forms upon PK-treatment. Taken together, our current in vivo and in vitro studies indicate that sporadic VPSPr and familial CJD(V180I) share a unique glycoform-selective prion formation pathway in which the conversion of diglycosylated and mono181 PrPC to PrPSc is inhibited, probably by a dominant-negative effect, or by other co-factors.	[Xiao, Xiangzhu; Yuan, Jue; Cali, Ignazio; Zhan, Yian; Li, Baiya; Gambetti, Pierluigi; Kong, Qingzhong; Cobb, Brian A.; Petersen, Robert B.; Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Haik, Stephane; Brandel, Jean-Philippe] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, UMRS 975,Equipe Malad Prions Maladie Alzheimer, Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] INSERM, U975, Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] CNRS, UMR 7225, Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] Hop La Pitie Salpetriere, AP HP, Paris, France; [Moudjou, Mohammed; Laude, Hubert] INRA, UR892, Jouy En Josas, France; [Laplanche, Jean-Louis] Hop Lariboisiere, UF Genet Mol, F-75475 Paris, France; [Langeveld, Jan] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Gambetti, Pierluigi; Kong, Qingzhong; Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH USA; [Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Div CJD Sci & Technol, Dept Prion Res,Ctr Translat & Adv Anim Res Human, Sendai, Miyagi 980, Japan; [Petersen, Robert B.; Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA; [Petersen, Robert B.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Zhan, Yian; Zou, Wen-Quan] Nanchang Univ, Affiliated Hosp 1, Dept Crit Care Med, Nanchang, Jiangxi, Peoples R China; [Zou, Wen-Quan] Case Western Reserve Univ, Sch Med, Natl Ctr Regenerat Med, Cleveland, OH USA; [Zou, Wen-Quan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Case Western Reserve University; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Wageningen University & Research; Case Western Reserve University; Tohoku University; Case Western Reserve University; Case Western Reserve University; Nanchang University; Case Western Reserve University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zou, WQ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	wenquan.zou@case.edu	xiao, xiangzhu/B-9300-2014; LAPLANCHE, Jean-Louis/S-8707-2016; cali, ignazio/AAS-1127-2020; Zou, Wenquan/GWQ-3489-2022; Cali, Ignazio/AAH-6093-2020; Haik, Stephane/M-7247-2018; Zou, Wenquan/ABF-2875-2020	xiao, xiangzhu/0000-0002-8013-9074; cali, ignazio/0000-0001-5770-3848; LAPLANCHE, Jean-Louis/0000-0003-2836-2903	Chinese National Key Clinical Department Project; National Institutes of Health (NIH) [R01NS062787]; CJD Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; President's Discretionary Fund (Case Western Reserve University); NIH [AG-08012, AG-14359]; Centers for Disease Control and Prevention [UR8/CCU515004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359, P50AG008012] Funding Source: NIH RePORTER	Chinese National Key Clinical Department Project; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CJD Foundation; Alliance BioSecure; University Center on Aging and Health; McGregor Foundation; President's Discretionary Fund (Case Western Reserve University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YAZ was supported by a grant from the Chinese National Key Clinical Department Project. This study was supported by grants to WQZ from the National Institutes of Health (NIH) R01NS062787, the CJD Foundation, Alliance BioSecure, the University Center on Aging and Health with the support of the McGregor Foundation and the President's Discretionary Fund (Case Western Reserve University) as well as to PG from NIH AG-08012, AG-14359 and the Centers for Disease Control and Prevention Contract UR8/CCU515004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capellari Sabina, 2000, Journal of Alzheimer's Disease, V2, P27; Chasseigneaux S, 2006, NEUROSCI LETT, V408, P165, DOI 10.1016/j.neulet.2006.08.008; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cong XJ, 2013, J BIOMOL STRUCT DYN, V31, P829, DOI 10.1080/07391102.2012.712477; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Gambetti P, 2011, PRION, V5, P14; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Giaccone G, 2007, J NEUROL NEUROSUR PS, V78, P1379, DOI 10.1136/jnnp.2007.115444; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Moudjou M, 2004, J VIROL, V78, P9270, DOI 10.1128/JVI.78.17.9270-9276.2004; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Nixon R, 2000, BRAIN PATHOL, V10, P670; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Salamat MK, 2011, J VIROL, V85, P3077, DOI 10.1128/JVI.02257-10; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tateishi J, 1996, NEUROLOGY, V46, P532, DOI 10.1212/WNL.46.2.532; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Xanthopoulos K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005633; Xiao XZ, 2011, PRION, V5, P98; Yuan J, 2008, CELL MOL LIFE SCI, V65, P631, DOI 10.1007/s00018-007-7478-z; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zanusso G, 2007, ARCH NEUROL-CHICAGO, V64, P595, DOI 10.1001/archneur.64.4.595; Zou RS, 2011, AGING-US, V3, P968, DOI 10.18632/aging.100370; Zou WQ, 2011, PRION, V5, P172, DOI 10.4161/pri.5.3.16894; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	40	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58786	10.1371/journal.pone.0058786	http://dx.doi.org/10.1371/journal.pone.0058786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527023	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100041
J	Latina, A; Gullo, D; Trimarchi, F; Benvenga, S				Latina, Adele; Gullo, Damiano; Trimarchi, Francesco; Benvenga, Salvatore			Hashimoto's Thyroiditis: Similar and Dissimilar Characteristics in Neighboring Areas. Possible Implications for the Epidemiology of Thyroid Cancer	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC THYROIDITIS	Context: Medical centers worldwide report an increased frequency of Hashimoto's thyroiditis (HT) and thyroid cancer (TC), two environmentally influenced diseases. In Sicily, data on HT are available for the province of Messina (1975-2005); data on TC are available for the whole island (2002-2004), with the volcanic province of Catania having the highest incidence. Objective: To replicate in Catania, on comparable years, the HT data of Messina. Design, Methods, Setting: Review of the clinical records of patients in years 1995-2005 to compare presentation and yearly changes of HT. During 1995-2005, records were computer stored in the Endocrine Divisions of the University Hospitals of Catania and Messina, two tertiary referral centers. Results: Catania is outnumbered by Messina (742 vs. 3,409 HT patients). Similar were the linear increase in the yearly number of HT patients, rates of thyroid dysfunctions though with different proportions of subclinical and overt hypothyroidism, and rates of positiveness for TgAb or TPOAb. Different were age and its yearly trend; gender distribution and rates of the sonography variants, though yearly trends were similar. Conclusion: The HT epidemics is smaller in Catania, with changes in presentation overlapping partially those in Messina. Whatever environmental factors might be involved, they (and/or their intensity) were not necessarily the same in these provinces. Intriguingly, the expected number of TC in HT patients with thyroid nodules in Catania is congruent with that of the general population of this province, but it is far less than in the Messina province. Thus, TC and HT incidences could be influenced by distinct environmental factors.	[Latina, Adele; Gullo, Damiano] Univ Catania, Sch Med, Garibaldi Nesima Hosp, Endocrinol Div,Dept Clin & Mol Biomed, Catania, Italy; [Trimarchi, Francesco; Benvenga, Salvatore] Univ Messina, Endocrinol Sect, Expt Clin Dept Med & Pharmacol, Messina, Italy; [Benvenga, Salvatore] Univ Messina, Master Program Childhood Adolescent & Womens Endo, Messina, Italy	Presidio Ospedaliero Garibaldi-Nesima; University of Catania; University of Messina; University of Messina	Gullo, D (corresponding author), Univ Catania, Sch Med, Garibaldi Nesima Hosp, Endocrinol Div,Dept Clin & Mol Biomed, Catania, Italy.	segmeint@unict.it	Gullo, Damiano/GNP-5649-2022	Gullo, Damiano/0000-0002-4034-6378	Italian MIUR PRIN project [2008SYHYKS_003]	Italian MIUR PRIN project(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was partially supported by the Italian MIUR PRIN project 2008SYHYKS_003 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anil C, 2010, THYROID, V20, P601, DOI 10.1089/thy.2009.0450; Benvenga S., 2004, CURRENT OPINION ENDO, V11, P209, DOI [10.1097/01.med.0000137759.57791.f8, DOI 10.1097/01.MED.0000137759.57791.F8]; Benvenga S, 2008, THYROID, V18, P429, DOI 10.1089/thy.2007.0234; Erdogan M, 2009, ENDOCRINE, V36, P486, DOI 10.1007/s12020-009-9258-z; Feldt-Rasmussen U, 2010, HORM-INT J ENDOCRINO, V9, P109, DOI 10.14310/horm.2002.1261; Guarneri Fabrizio, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P398, DOI 10.1097/MED.0b013e3282ef1c48; Kebebew E, 2001, WORLD J SURG, V25, P632, DOI 10.1007/s002680020165; Kim EY, 2009, CLIN ENDOCRINOL, V71, P581, DOI 10.1111/j.1365-2265.2009.03537.x; Koch CA, 2001, J ENDOCRINOL INVEST, V24, P659, DOI 10.1007/BF03343911; Pellegriti G, 2009, JNCI-J NATL CANCER I, V101, P1575, DOI 10.1093/jnci/djp354; Rizzo M, 2010, ANN ENDOCRINOL-PARIS, V71, P525, DOI 10.1016/j.ando.2010.06.006; Spencer CA, 2007, J CLIN ENDOCR METAB, V92, P4236, DOI 10.1210/jc.2007-0287; Wartofsky L, 2010, HORM-INT J ENDOCRINO, V9, P103, DOI 10.14310/horm.2002.1260	13	39	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e55450	10.1371/journal.pone.0055450	http://dx.doi.org/10.1371/journal.pone.0055450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526929	gold, Green Submitted, Green Published			2022-12-27	WOS:000316411600002
J	Alanazi, MS; Parine, NR; Shaik, JP; Alabdulkarim, HA; Ajaj, SA; Khan, Z				Alanazi, Mohammad Saud; Parine, Narasimha Reddy; Shaik, Jilani Purusottapatnam; Alabdulkarim, Huda A.; Ajaj, Sana Abdulla; Khan, Zahid			Association of Single Nucleotide Polymorphisms in Wnt Signaling Pathway Genes with Breast Cancer in Saudi Patients	PLOS ONE			English	Article							BETA-CATENIN; COLORECTAL-CANCER; SUPPRESSOR GENE; TCF7L2 VARIANT; APC GENE; RISK; EXPRESSION; SUSCEPTIBILITY; LUNG; AXIN	Breast cancer is a complex heterogeneous disease involving genetic and epigenetic alterations in genes encoding proteins that are components of various signaling pathways. Candidate gene approach have identified association of genetic variants in the Wnt signaling pathway genes and increased susceptibility to several diseases including breast cancer. Due to the rarity of somatic mutations in key genes of Wnt pathway, we investigated the association of genetic variants in these genes with predisposition to breast cancers. We performed a case-control study to identify risk variants by examining 15 SNPs located in 8 genes associated with Wnt signaling. Genotypic analysis of individual locus showed statistically significant association of five SNPs located in beta-catenin, AXIN2, DKK3, SFRP3 and TCF7L2 with breast cancers. Increased risk was observed only with the SNP in b-catenin while the other four SNPs conferred protection against breast cancers. Majority of these associations persisted after stratification of the cases based on estrogen receptor status and age of on-set of breast cancer. The rs7775 SNP in exon 6 of SFRP3 gene that codes for either arginine or glycine exhibited very strong association with breast cancer, even after Bonferroni's correction. Apart from these five variants, rs3923086 in AXIN2 and rs3763511 in DKK4 that did not show any association in the overall population were significantly associated with early on-set and estrogen receptor negative breast cancers, respectively. This is the first study to utilize pathway based approach to identify association of risk variants in the Wnt signaling pathway genes with breast cancers. Confirmation of our findings in larger populations of different ethnicities would provide evidence for the role of Wnt pathway as well as screening markers for early detection of breast carcinomas.	[Alanazi, Mohammad Saud; Parine, Narasimha Reddy; Shaik, Jilani Purusottapatnam; Khan, Zahid] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia; [Alabdulkarim, Huda A.] Comprehens Canc Ctr King Fahad Med City, Riyadh, Saudi Arabia; [Ajaj, Sana Abdulla] King Saud Univ, Coll Med, Dept Family Med, Riyadh 11461, Saudi Arabia	King Saud University; King Fahad Medical City; King Saud University	Khan, Z (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	zahidatkhan@yahoo.com	Parine, Narasimha Reddy/B-7975-2011	Parine, Narasimha Reddy/0000-0002-0765-9022	National Science, Technology and Innovation Plan strategic technologies program [10BIO897-2]	National Science, Technology and Innovation Plan strategic technologies program	This study was financially supported by a grant from National Science, Technology and Innovation Plan strategic technologies program number 10BIO897-2 in the Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, MODERN PATHOL, V20, P711, DOI 10.1038/modpathol.3800822; Anderson WF, 2006, BREAST CANCER RES TR, V100, P121, DOI 10.1007/s10549-006-9231-y; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Burwinkel B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-268; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Connor AE, 2012, BREAST CANCER RES TR, V136, P593, DOI 10.1007/s10549-012-2299-7; Cuilliere-Dartigues P, 2006, ONCOGENE, V25, P4441, DOI 10.1038/sj.onc.1209471; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ferlay J, 2010, IARC CANCERBASE; Fernandez-Rozadilla C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012673; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goode EL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-312; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; Hazra A, 2008, CANCER CAUSE CONTROL, V19, P975, DOI 10.1007/s10552-008-9164-3; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jin Z, 2001, BRIT J CANCER, V85, P69, DOI 10.1054/bjoc.2001.1853; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Kanzaki H, 2006, INT J MOL MED, V18, P279; Klarmann GJ, 2008, EPIGENETICS-US, V3, P59, DOI 10.4161/epi.3.2.5899; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; Naidu R, 2012, MED ONCOL, V29, P411, DOI 10.1007/s12032-011-9837-8; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Saudi National Cancer Registry, 2011, CANC INC SURV REP SA; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Tseng RC, 2008, ONCOGENE, V27, P4488, DOI 10.1038/onc.2008.83; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Wang SZ, 2012, MUTAGENESIS, V27, P623, DOI 10.1093/mutage/ges027; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449	45	40	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059555	10.1371/journal.pone.0059555	http://dx.doi.org/10.1371/journal.pone.0059555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516639	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400115
J	Imuta, K; Scarf, D; Pharo, H; Hayne, H				Imuta, Kana; Scarf, Damian; Pharo, Henry; Hayne, Harlene			Drawing a Close to the Use of Human Figure Drawings as a Projective Measure of Intelligence	PLOS ONE			English	Article							CHILDRENS VERBAL REPORTS; PSYCHOLOGICAL-ASSESSMENT; A-PERSON; INTELLECTUAL EVALUATIONS; VALIDITY; CONCLUSIONS; ADOLESCENTS; ABUSE	The practice of using children's human figure drawings (HFDs) to assess their intellectual ability is pervasive among psychologists and therapists in many countries. Since the first systematic scoring system for HFDs was published in 1926, their continued popularity has led to the development of several revised versions of the test. Most recently, the Draw-A-Person Intellectual Ability Test for children, adolescents, and adults (DAP:IQ) was published. It is the most up-to-date form of HFD test designed to assess intellectual functioning across a wide age range. In the present study, we assessed the validity of the DAP:IQ as a screening measure of intelligence in both children and adults. In Experiment 1, 100 4- to 5-year-old children completed the DAP:IQ and the Wechsler Preschool and Primary Scale of Intelligence-Third Edition. In Experiment 2, 100 adults completed the DAP:IQ and the Wechsler Abbreviated Scale of Intelligence. In both experiments, we found only weak to modest correlations between scores on the DAP:IQ and the Wechsler tests. Furthermore, when we compared individual's scores on the two tests, the DAP:IQ yielded high false positive and false negative rates when screening for borderline and superior intellectual functioning. Based on these findings, and based on the lack of validity of previous HFD tests, we conclude that practitioners should not rely on HFD tests as a projective measure of intelligence.	[Imuta, Kana; Scarf, Damian; Pharo, Henry; Hayne, Harlene] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago	Hayne, H (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	harlene.hayne@otago.ac.nz	Imuta, Kana/A-4533-2018	Imuta, Kana/0000-0002-6513-6254; Scarf, Damian/0000-0002-9486-8059	Marsden grant from the Marsden Fund of the Royal Society of New Zealand [UOO0916]	Marsden grant from the Marsden Fund of the Royal Society of New Zealand	This research was supported by Marsden grant UOO0916 from the Marsden Fund of the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell SC, 1996, J CLIN PSYCHOL, V52, P67, DOI 10.1002/(SICI)1097-4679(199601)52:1<67::AID-JCLP9>3.3.CO;2-C; Abell SC, 1998, J CLIN PSYCHOL, V54, P811, DOI 10.1002/(SICI)1097-4679(199810)54:6<811::AID-JCLP8>3.3.CO;2-H; Abell SC, 2001, J PSYCHOEDUC ASSESS, V19, P204, DOI 10.1177/073428290101900301; AIKMAN KG, 1992, J CLIN PSYCHOL, V48, P114, DOI 10.1002/1097-4679(199201)48:1<114::AID-JCLP2270480116>3.0.CO;2-Y; Allen B, 2012, TRAUMA VIOLENCE ABUS, V13, P97, DOI 10.1177/1524838012440339; [Anonymous], 2014, KAUFMAN TEST ED ACHI; Barlow CM, 2011, APPL COGNITIVE PSYCH, V25, P480, DOI 10.1002/acp.1716; Barnes E., 1893, PEDAGOGICAL SEMINARY, V2, P416; BUTLER S, 1995, DEV PSYCHOL, V31, P597, DOI 10.1037/0012-1649.31.4.597; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Carmody DP, 2011, OPEN CRIMINOLOGY J, V4, P1; CARRAN DT, 1992, TOP EARLY CHILD SPEC, V12, P196, DOI 10.1177/027112149201200205; Cashel ML, 2002, PROF PSYCHOL-RES PR, V33, P446, DOI 10.1037//0735-7028.33.5.446; CHANTLER L, 1993, CHILD ABUSE NEGLECT, V17, P271, DOI 10.1016/0145-2134(93)90046-8; Cherney ID., 2006, ED PSYCHOL, V26, P127, DOI [10.1080/01443410500344167, DOI 10.1080/01443410500344167]; Claparede E, 1907, ARCH PSYCHOLOGIE, V6, P276; Cooke E, 1885, ART TEACHING CHILD N; Costenbader V, 2000, PSYCHOL SCHOOLS, V37, P323, DOI 10.1002/1520-6807(200007)37:4<333::AID-PITS3>3.0.CO;2-M; Drake JE, 2009, PHILOS T R SOC B, V364, P1449, DOI 10.1098/rstb.2008.0295; Garb H N, 2000, Child Maltreat, V5, P161, DOI 10.1177/1077559500005002007; Gardner H., 1980, ARTFUL SCRIBBLES SIG; GOH DS, 1981, PROF PSYCHOL, V12, P696, DOI 10.1037/0735-7028.12.6.696; Golomb C., 1974, YOUNG CHILDRENS SCUL; Goodenough FL., 1926, MEASUREMENT INTELLIG; Gross J, 1998, J EXP PSYCHOL-APPL, V4, P163, DOI 10.1037/1076-898X.4.2.163; Gross J, 1999, J EXP PSYCHOL-APPL, V5, P265, DOI 10.1037/1076-898X.5.3.265; Gross J, 2009, APPL COGNITIVE PSYCH, V23, P953, DOI 10.1002/acp.1518; Hammill D.D., 2005, DETROIT TESTS LEARNI; Harris, 1963, CHILDRENS DRAWINGS M; Holtzman WH, 1993, SCHOOL PSYCHOL QUART, V8, P189, DOI DOI 10.1037/H0088270; Honores L, 2011, INT J PSYCHOL RES, V4, P57; Ivanoff E., 1909, ARCH PSYCHOLOGIC, V8, P97; Joiner TE, 1996, J PERS ASSESS, V67, P127, DOI 10.1207/s15327752jpa6701_10; Kellogg R., 1970, ANAL CHILDRENS ART; Knoff HM, 1993, SCHOOL PSYCHOL QUART, V8, P191, DOI DOI 10.1037/H0088272; LASSITER KS, 1995, PSYCHOL SCHOOLS, V32, P170, DOI 10.1002/1520-6807(199507)32:3<170::AID-PITS2310320303>3.0.CO;2-K; LUBIN B, 1984, AM PSYCHOL, V39, P451, DOI 10.1037/0003-066X.39.4.451; Matto HC, 2002, PSYCHOL ASSESSMENT, V14, P221, DOI 10.1037//1040-3590.14.2.221; Motta RW, 1993, SCHOOL PSYCHOL QUART, V8, P197, DOI DOI 10.1037/H0088274; MOTTRON L, 1995, PSYCHOL MED, V25, P639, DOI 10.1017/S0033291700033547; Naglieri J., 1992, PSYCHOL ASSESSMENT, V4, P156, DOI DOI 10.1037/1040-3590.4.2.156; NAGLIERI J. A., 1993, SCHOOL PSYCHOL QUART, V8, P170, DOI [10.1037/h0088275, DOI 10.1037/H0088275]; Naglieri J. A., 1985, MATRIX ANALOGIES TES; Naglieri J. A., 1988, DRAW A PERSON QUANTI; Ochoa SH, 2004, J PSYCHOEDUC ASSESS, V22, P185, DOI 10.1177/073428290402200301; OCONNOR N, 1987, PSYCHOL MED, V17, P79, DOI 10.1017/S0033291700013003; OCONNOR N, 1990, J CHILD PSYCHOL PSYC, V31, P203, DOI 10.1111/j.1469-7610.1990.tb01562.x; Ozer S, 2010, PROCD SOC BEHV, V5, P449, DOI 10.1016/j.sbspro.2010.07.121; Ozer S, 2009, EDUC PSYCHOL-UK, V29, P701, DOI 10.1080/01443410903210387; Patterson T, 2011, APPL COGNITIVE PSYCH, V25, P119, DOI 10.1002/acp.1650; PREWETT P. N., 1988, J PSYCHOEDUCATIONAL, V6, P347, DOI [10.1177/073428298800600403, DOI 10.1177/073428298800600403]; PREWETT PN, 1989, PSYCHOL SCHOOLS, V26, P254, DOI 10.1002/1520-6807(198907)26:3<254::AID-PITS2310260306>3.0.CO;2-C; REISMAN JM, 1973, J SCHOOL PSYCHOL, V11, P239, DOI 10.1016/0022-4405(73)90030-7; Reynolds CR, 2004, DRAW A PERSON INTELL; Riethmiller RJ, 1997, J PERS ASSESS, V69, P459, DOI 10.1207/s15327752jpa6903_1; ROBACK HB, 1968, PSYCHOL BULL, V70, P1, DOI 10.1037/h0026010; Sattler J., 2004, ASSESSMENT CHILDREN; Schepers S, 2012, EUR J PEDIATR, V171, P43, DOI 10.1007/s00431-011-1476-8; SCOTT LH, 1981, PSYCHOL BULL, V89, P483, DOI 10.1037/0033-2909.89.3.483; Selfe L., 1983, NORMAL ANOMALOUS REP; SUTTER EG, 1986, PSYCHOL SCHOOLS, V23, P365, DOI 10.1002/1520-6807(198610)23:4<365::AID-PITS2310230409>3.0.CO;2-F; SWENSEN CH, 1968, PSYCHOL BULL, V70, P20, DOI 10.1037/h0026011; SWENSEN CH, 1957, PSYCHOL BULL, V54, P431, DOI 10.1037/h0041404; Thomas GV, 1998, BRIT J CLIN PSYCHOL, V37, P127, DOI 10.1111/j.2044-8260.1998.tb01289.x; WATKINS CE, 1995, PROF PSYCHOL-RES PR, V26, P54, DOI 10.1037/0735-7028.26.1.54; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WECHSLER D, 1991, WECHSLER INTELLIGENC, V3; Wechsler D., 2014, WECHSLER PRESCHOOL P; Wechsler D., 2012, WECHSLER PRESCHOOL P, VFourth; Wesson M, 2001, APPL COGNITIVE PSYCH, V15, P301, DOI 10.1002/acp.706; Willcock E, 2011, J EXP CHILD PSYCHOL, V110, P444, DOI 10.1016/j.jecp.2011.04.013; Williams TO, 2006, J PSYCHOEDUC ASSESS, V24, P137, DOI 10.1177/0734282905285249; Wilson MS, 1996, SCHOOL PSYCHOL REV, V25, P9; Wisniewski J. J., 1989, J PSYCHOEDUCATIONAL, V7, P346, DOI DOI 10.1177/073428298900700408; Wrightson L., 2000, CANADIAN J SCH PSYCH, V16, P95, DOI [10.1177/082957350001600107, DOI 10.1177/082957350001600107]	75	24	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58991	10.1371/journal.pone.0058991	http://dx.doi.org/10.1371/journal.pone.0058991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516590	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400086
J	Ngo, D; Cheng, Q; O'Connor, AE; DeBoer, KD; Lo, CY; Beaulieu, E; De Seram, M; Hobbs, RM; O'Bryan, MK; Morand, EF				Ngo, Devi; Cheng, Qiang; O'Connor, Anne E.; DeBoer, Kathleen D.; Lo, Camden Y.; Beaulieu, Elaine; De Seram, Mia; Hobbs, Robin M.; O'Bryan, Moira K.; Morand, Eric F.			Glucocorticoid-Induced Leucine Zipper (GILZ) Regulates Testicular FOXO1 Activity and Spermatogonial Stem Cell (SSC) Function	PLOS ONE			English	Article							MALE-FERTILITY; ARTHRITIS; MOUSE; SPERMATOGENESIS; EXPRESSION; PATHWAY; GENE; MICE	Spermatogonia stem cell (SSC) self-renewal and differentiation are tightly regulated processes that ensure a continued production of mature sperm throughout male adulthood. In the present study, we investigated the role of glucocorticoid-induced leucine zipper (GILZ) in maintenance of the male germline and spermatogenesis. GILZ was detectable in germ cells of wild type mice on the day of birth, suggesting a role for GILZ in prospermatogonia and SSC pool formation. Gilz KO mice were generated and adult males were azoospermic and sterile. During the first wave of spermatogenesis in Gilz KO mice, spermatogenesis arrested part way through pachytene of meiosis I. Subsequent waves resulted in a progressive depletion of germ cells through apoptosis to ultimately produce a Sertoli cell-only phenotype. Further, in contrast to wild type littermates, PLZF(+) cells were detected in the peri-luminal region of Gilz KO mice at day 6 post-natal, suggesting a defect in prospermatogonia migration in the absence of GILZ. At age 30 days, transient accumulation of PLZF(+) cells in a subset of tubules and severely compromised spermatogenesis were observed in Gilz KO mice, consistent with defective SSC differentiation. GILZ deficiency was associated with an increase in FOXO1 transcriptional activity, which leads to activation of a selective set of FOXO1 target genes, including a pro-apoptotic protein, BIM. On the other hand, no evidence of a heightened immune response was observed. Together, these results suggest that GILZ suppresses FOXO1 nuclear translocation, promotes SSC differentiation over self-renewal, and favours germ cell survival through inhibition of BIM-dependent pro-apoptotic signals. These findings provide a mechanism for the effects of GILZ on spermatogenesis and strengthen the case for GILZ being a critical molecule in the regulation of male fertility.	[Ngo, Devi; Cheng, Qiang; Beaulieu, Elaine; Morand, Eric F.] Monash Univ, Monash Med Ctr, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [O'Connor, Anne E.; DeBoer, Kathleen D.; De Seram, Mia; Hobbs, Robin M.; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Lo, Camden Y.] Monash Univ, Monash Micro Imaging, Clayton, Vic, Australia; [De Seram, Mia; Hobbs, Robin M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	Monash University; Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University	Cheng, Q (corresponding author), Monash Univ, Monash Med Ctr, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia.	colin.cheng@monash.edu; eric.morand@monash.edu	Ngo, Devi/P-2594-2015; O'Connor, Anne/AAI-6479-2020; Morand, Eric F/I-4718-2013; O'Bryan, Moira K/F-8256-2012; Morand, Eric/AAT-3259-2021; Hobbs, Robin/I-2577-2014	O'Connor, Anne/0000-0001-9334-4256; Morand, Eric F/0000-0002-9507-3338; O'Bryan, Moira K/0000-0001-7298-4940; Morand, Eric/0000-0002-9507-3338; Beaulieu, Elaine/0000-0002-9529-9943; Hobbs, Robin/0000-0002-3853-2614	National Health and Medical Research Council (NHMRC) of Australia [APP1011670]; NHMRC fellowship [545805]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the National Health and Medical Research Council (NHMRC)(http://www.nhmrc.gov.au/) of Australia (Grant number: APP1011670). Moira K. O'Bryan is the recipient of a NHMRC fellowship (# 545805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Beaulieu E, 2011, NAT REV RHEUMATOL, V7, P340, DOI 10.1038/nrrheum.2011.59; Beaulieu E, 2010, ARTHRITIS RHEUM-US, V62, P2651, DOI 10.1002/art.27566; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Bruscoli S, 2012, J BIOL CHEM, V287, P1242, DOI 10.1074/jbc.M111.316372; Bruscoli S, 2010, J BIOL CHEM, V285, P10385, DOI 10.1074/jbc.M109.070136; Cheng QA, 2010, J IMMUNOL, V185, P1238, DOI 10.4049/jimmunol.0904104; de Late PL, 2010, J BIOL CHEM, V285, P5594, DOI 10.1074/jbc.M109.068346; Fallahi M, 2010, GENES-BASEL, V1, P469, DOI 10.3390/genes1030469; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Joha S, 2012, ONCOGENE, V31, P1419, DOI 10.1038/onc.2011.328; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Meng J, 2011, BIOL REPROD, V85, P254, DOI 10.1095/biolreprod.110.090621; Ngo D, ARTHRITIS RHEUM; O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Reinholdt LG, 2009, CHROMOSOMA, V118, P723, DOI 10.1007/s00412-009-0230-8; Romero Y, 2012, SEX DEV, V6, P169, DOI 10.1159/000338415; Russell LD, 2008, INT J ANDROL, V16, P83; Suarez PE, 2012, MOL ENDOCRINOL, V26, P1000, DOI 10.1210/me.2011-1249; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	29	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59149	10.1371/journal.pone.0059149	http://dx.doi.org/10.1371/journal.pone.0059149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516608	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400095
J	Suidan, GL; Duerschmied, D; Dillon, GM; Vanderhorst, V; Hampton, TG; Wong, SL; Voorhees, JR; Wagner, DD				Suidan, Georgette L.; Duerschmied, Daniel; Dillon, Gregory M.; Vanderhorst, Veronique; Hampton, Thomas G.; Wong, Siu Ling; Voorhees, Jaymie R.; Wagner, Denisa D.			Lack of Tryptophan Hydroxylase-1 in Mice Results in Gait Abnormalities	PLOS ONE			English	Article							SEROTONIN; DYNAMICS; BEHAVIOR; ANXIETY; ATTENTION; INFLAMMATION; DISRUPTION; EXPRESSION; MODEL; TPH1	The role of peripheral serotonin in nervous system development is poorly understood. Tryptophan hydroxylase-1 (TPH1) is expressed by non-neuronal cells including enterochromaffin cells of the gut, mast cells and the pineal gland and is the rate-limiting enzyme involved in the biosynthesis of peripheral serotonin. Serotonin released into circulation is taken up by platelets via the serotonin transporter and stored in dense granules. It has been previously reported that mouse embryos removed from Tph1-deficient mothers present abnormal nervous system morphology. The goal of this study was to assess whether Tph1-deficiency results in behavioral abnormalities. We did not find any differences between Tph1-deficient and wild-type mice in general motor behavior as tested by rotarod, grip-strength test, open field and beam walk. However, here we report that Tph1 (-/-) mice display altered gait dynamics and deficits in rearing behavior compared to wild-type (WT) suggesting that tryptophan hydroxylase-1 expression has an impact on the nervous system.	[Suidan, Georgette L.; Duerschmied, Daniel; Wong, Siu Ling; Voorhees, Jaymie R.; Wagner, Denisa D.] Immune Dis Inst, Boston, MA USA; [Suidan, Georgette L.; Duerschmied, Daniel; Wong, Siu Ling; Voorhees, Jaymie R.; Wagner, Denisa D.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Wagner, Denisa D.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Suidan, Georgette L.; Duerschmied, Daniel; Wong, Siu Ling; Wagner, Denisa D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Duerschmied, Daniel] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 1, Freiburg, Germany; [Dillon, Gregory M.] Harvard NeuroDiscovery Ctr, Neurobehav Lab, Boston, MA USA; [Dillon, Gregory M.; Vanderhorst, Veronique] Harvard Univ, Sch Med, Boston, MA USA; [Vanderhorst, Veronique] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Hampton, Thomas G.] Neurosci Discovery Core, Framingham, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Freiburg; Harvard University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Wagner, DD (corresponding author), Immune Dis Inst, Boston, MA USA.	Denisa.Wagner@childrens.harvard.edu	Duerschmied, D./K-8182-2015; Duerschmied, D./AAB-5139-2021; Wong, Siu Ling Christine/A-9895-2019	Duerschmied, D./0000-0001-5249-4012; Duerschmied, D./0000-0001-5249-4012; 	National Heart, Lung and Blood Institute of the National Institutes of Health [R01 HL041002]; National Research Service Award from the National Institutes of Neurological Disease and Stroke of the National Institutes of Health [1F32NS073245]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079623, F32NS073245] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award from the National Institutes of Neurological Disease and Stroke of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was generously supported by National Heart, Lung and Blood Institute of the National Institutes of Health grant R01 HL041002 (to DDW) and a National Research Service Award from the National Institutes of Neurological Disease and Stroke of the National Institutes of Health grant 1F32NS073245 (to GLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Berryman ER, 2009, J MUSCULOSKEL NEURON, V9, P89; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Carter MD, 2011, AUTISM RES, V4, P57, DOI 10.1002/aur.180; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Christensen HD, 2000, NEUROTOXICOL TERATOL, V22, P733, DOI 10.1016/S0892-0362(00)00099-4; Chu V, 2002, MUSCLE NERVE, V26, P513, DOI 10.1002/mus.10223; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Crawley J., 2007, WHATS WRONG MY MOUSE, V2nd; DeLorey TM, 2008, BEHAV BRAIN RES, V187, P207, DOI 10.1016/j.bbr.2007.09.009; Dillon GM, 2009, BEHAV BRAIN RES, V204, P67, DOI 10.1016/j.bbr.2009.04.036; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Dunbar MJ, 2010, J PHYSIOL-LONDON, V588, P139, DOI 10.1113/jphysiol.2009.177378; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Goldberg NRS, 2011, J NEUROSCI RES, V89, P1698, DOI 10.1002/jnr.22699; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Halmoy A, 2010, ARCH GEN PSYCHIAT, V67, P1033, DOI 10.1001/archgenpsychiatry.2010.124; Hampton TG, 2004, PHYSIOL BEHAV, V82, P381, DOI 10.1016/j.physbeh.2004.04.006; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Kale A, 2004, ALCOHOL CLIN EXP RES, V28, P1839, DOI 10.1097/01.ALC.0000148103.09378.81; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Morelli E, 2011, J NEUROSCI, V31, P15742, DOI 10.1523/JNEUROSCI.2989-11.2011; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakamura K, 2006, J NEUROSCI, V26, P530, DOI 10.1523/JNEUROSCI.1835-05.2006; Nantel-Vivier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020304; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Piesla MJ, 2009, BRAIN RES, V1295, P89, DOI 10.1016/j.brainres.2009.07.091; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; VILENSKY JA, 1981, ARCH NEUROL-CHICAGO, V38, P646, DOI 10.1001/archneur.1981.00510100074013; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; Zill P, 2009, NEUROSCIENCE, V159, P1274, DOI 10.1016/j.neuroscience.2009.01.006	45	14	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59032	10.1371/journal.pone.0059032	http://dx.doi.org/10.1371/journal.pone.0059032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516593	Green Published, gold			2022-12-27	WOS:000316407400088
J	Smithers, LG; Golley, RK; Mittinty, MN; Brazionis, L; Northstone, K; Emmett, P; Lynch, JW				Smithers, Lisa G.; Golley, Rebecca K.; Mittinty, Murthy N.; Brazionis, Laima; Northstone, Kate; Emmett, Pauline; Lynch, John W.			Do Dietary Trajectories between Infancy and Toddlerhood Influence IQ in Childhood and Adolescence? Results from a Prospective Birth Cohort Study	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; PATTERNS; ASSOCIATIONS; INTELLIGENCE; PARAMETERS; CHILDREN; MODEL; AGE	Objective: We examined whether trajectories of dietary patterns from 6 to 24 months of age are associated with intelligence quotient (IQ) in childhood and adolescence. Methods: Participants were children enrolled in a prospective UK birth cohort (n = 7652) who had IQ measured at age 8 and/or 15 years. Dietary patterns were previously extracted from questionnaires when children were aged 6, 15 and 24 months using principal component analysis. Dietary trajectories were generated by combining scores on similar dietary patterns across each age, using multilevel mixed models. Associations between dietary trajectories and IQ were examined in generalized linear models with adjustment for potential confounders. Results: Four dietary pattern trajectories were constructed from 6 to 24 months of age and were named according to foods that made the strongest contribution to trajectory scores; Healthy (characterised by breastfeeding at 6 months, raw fruit and vegetables, cheese and herbs at 15 and 24 months); Discretionary (biscuits, chocolate, crisps at all ages), Traditional (meat, cooked vegetables and puddings at all ages) and, Ready-to-eat (use of ready-prepared baby foods at 6 and 15 months, biscuits, bread and breakfast cereals at 24 months). In fully-adjusted models, a 1 SD change in the Healthy trajectory was weakly associated with higher IQ at age 8 (1.07 (95%CI 0.17, 1.97)) but not 15 years (0.49 (-0.28, 1.26)). Associations between the Discretionary and Traditional trajectories with IQ at 8 and 15 years were as follows; Discretionary; 8 years -0.35(-1.03, 0.33), 15 years -0.73(-1.33, -0.14) Traditional; 8 years -0.19(-0.71, 0.33) 15 years -0.41(-0.77, -0.04)). The Ready-to-eat trajectory had no association with IQ at either age (8 years 0.32(-4.31, 4.95), 15 years 1.11(-3.10, 5.33). Conclusions: The Discretionary and Traditional dietary pattern trajectories from 6 to 24 months of age, over the period when food patterns begin to emerge, are weakly associated with IQ in adolescence.	[Smithers, Lisa G.; Mittinty, Murthy N.; Brazionis, Laima; Lynch, John W.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Golley, Rebecca K.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Northstone, Kate; Emmett, Pauline; Lynch, John W.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Adelaide; University of South Australia; University of Bristol	Smithers, LG (corresponding author), Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia.	lisa.smithers@adelaide.edu.au	Emmett, Pauline/AAL-6815-2021; Smithers, Lisa/D-1605-2009; Lynch, John W/A-4797-2008; Golley, Rebecca K/D-1606-2009; Northstone, Kate/A-8165-2011	Smithers, Lisa/0000-0002-6585-7836; Lynch, John W/0000-0003-2781-7902; Northstone, Kate/0000-0002-0602-1983; Golley, Rebecca/0000-0001-5197-7987; Emmett, Pauline/0000-0003-1076-4779	UK Medical Research Council [74882]; Wellcome Trust [076467]; Australia Fellowship [570120]; National Health and Medical Research Council of Australia [478115]; European Community [245012]; Danone; Pfizer; Plum Baby; Medical Research Council [G9815508] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Australia Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); European Community(European Commission); Danone(Danone Nutricia); Pfizer(Pfizer); Plum Baby; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (grant number 74882, http:\\www.mrc.ac.uk), the Wellcome Trust (grant number 076467, http:\\www.wellcome.ac.uk) and the University of Bristol provide core support for the ALSPAC study (http:\\www.bris.ac.uk). JWL is supported by an Australia Fellowship (570120) and RKG with a Postdoctoral Training Fellowship (478115) from the National Health and Medical Research Council of Australia (http:\\www.nhmrc.gov.au). LGS, LB and MNM are supported by funds from the Australia Fellowship awarded to JWL. KN and PE are partly supported by European Community's Seventh Framework Programme (245012, http://ec.europa.eu/research/fp7/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. KN and PE have received support from Danone and PE has received support from Pfizer and Plum Baby, who might have an interest in the submitted work. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; Caldwell B.M., 1979, HOME OBSERVATION MEA; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Gale CR, 2009, J CHILD PSYCHOL PSYC, V50, P816, DOI 10.1111/j.1469-7610.2008.02029.x; Hoefer C, 1929, J AMER MED ASSOC, V92, P615, DOI 10.1001/jama.1929.02700340015006; Jones G, 2006, J ECON GROWTH, V11, P71, DOI 10.1007/s10887-006-7407-2; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kussmann M, 2010, NUTR REV, V68, pS38, DOI 10.1111/j.1753-4887.2010.00326.x; Li EN, 2004, BIOMETRICS, V60, P1, DOI 10.1111/j.0006-341X.2004.00170.x; Little R. J. A., 2002, STAT ANAL MISSING DA; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Mikkilae V, 2007, BRIT J NUTR, V98, P218, DOI 10.1017/S0007114507691831; Mishra GD, 2006, BRIT J NUTR, V96, P735, DOI 10.1079/BJN20061871; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Noble S, 2006, J HUM NUTR DIET, V19, P303, DOI 10.1111/j.1365-277X.2006.00708.x; North K, 2000, EUR J CLIN NUTR, V54, P73, DOI 10.1038/sj.ejcn.1600896; Northstone K, 2011, J EPIDEMIOL COMMUNIT, DOI [10. 1111/j.1740-8709.2012.00399.x, DOI 10.1111/J.1740-8709.2012.00399.X]; Northstone K, 2008, BRIT J NUTR, V99, P1099, DOI 10.1017/S0007114507842802; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS; Pachucki MA, 2012, INT J OBESITY, V36, P686, DOI 10.1038/ijo.2011.133; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Smithers LG, 2012, EUR J CLIN NUTR, V66, P658, DOI 10.1038/ejcn.2011.219; Smithers LG, 2012, NUTRIENTS, V4, P935, DOI 10.3390/nu4080935; Smithers LG, 2012, EUR J EPIDEMIOL, V27, P525, DOI 10.1007/s10654-012-9715-5; Smithers LG, 2011, NUTR REV, V69, P449, DOI 10.1111/j.1753-4887.2011.00407.x; Wang CY, 2000, BIOMETRICS, V56, P487, DOI 10.1111/j.0006-341X.2000.00487.x; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1992, WECHSLER INTELLIGENC; Williams J, 1999, BMJ-BRIT MED J, V318, P396	31	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58904	10.1371/journal.pone.0058904	http://dx.doi.org/10.1371/journal.pone.0058904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516574	Green Published, gold, Green Accepted			2022-12-27	WOS:000316849200120
J	Bergwitz, C; Wee, MJ; Sinha, S; Huang, JN; DeRobertis, C; Mensah, LB; Cohen, J; Friedman, A; Kulkarni, M; Hu, YH; Vinayagam, A; Schnall-Levin, M; Berger, B; Perkins, LA; Mohr, SE; Perrimon, N				Bergwitz, Clemens; Wee, Mark J.; Sinha, Sumi; Huang, Joanne; DeRobertis, Charles; Mensah, Lawrence B.; Cohen, Jonathan; Friedman, Adam; Kulkarni, Meghana; Hu, Yanhui; Vinayagam, Arunachalam; Schnall-Levin, Michael; Berger, Bonnie; Perkins, Lizabeth A.; Mohr, Stephanie E.; Perrimon, Norbert			Genetic Determinants of Phosphate Response in Drosophila	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; VASCULAR CALCIFICATION; INORGANIC-PHOSPHATE; IN-VITRO; PROTEIN; EXPRESSION; BONE; REGULATOR; DATABASE; CALCIUM	Phosphate is required for many important cellular processes and having too little phosphate or too much can cause disease and reduce life span in humans. However, the mechanisms underlying homeostatic control of extracellular phosphate levels and cellular effects of phosphate are poorly understood. Here, we establish Drosophila melanogaster as a model system for the study of phosphate effects. We found that Drosophila larval development depends on the availability of phosphate in the medium. Conversely, life span is reduced when adult flies are cultured on high phosphate medium or when hemolymph phosphate is increased in flies with impaired Malpighian tubules. In addition, RNAi-mediated inhibition of MAPK-signaling by knockdown of Ras85D, phl/D-Raf or Dsor1/MEK affects larval development, adult life span and hemolymph phosphate, suggesting that some in vivo effects involve activation of this signaling pathway by phosphate. To identify novel genetic determinants of phosphate responses, we used Drosophila hemocyte-like cultured cells (S2R+) to perform a genome-wide RNAi screen using MAPK activation as the readout. We identified a number of candidate genes potentially important for the cellular response to phosphate. Evaluation of 51 genes in live flies revealed some that affect larval development, adult life span and hemolymph phosphate levels.	[Bergwitz, Clemens; Wee, Mark J.; Sinha, Sumi; Huang, Joanne; DeRobertis, Charles; Mensah, Lawrence B.; Cohen, Jonathan] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Friedman, Adam; Kulkarni, Meghana; Hu, Yanhui; Vinayagam, Arunachalam; Perkins, Lizabeth A.; Mohr, Stephanie E.; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA USA; [Schnall-Levin, Michael; Berger, Bonnie] MIT, Dept Math & Comp Sci, Cambridge, MA 02139 USA; [Schnall-Levin, Michael; Berger, Bonnie] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bergwitz, C (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	cwhb2002@yahoo.com		Hu, Yanhui/0000-0003-1494-1402; arunachalam, vinayagam/0000-0003-0091-4497; Perrimon, Norbert/0000-0001-7542-472X; Mohr, Stephanie/0000-0001-9639-7708	Harvard Catalyst; NIDDK [1K08 DK08361]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947, R01GM067761] Funding Source: NIH RePORTER	Harvard Catalyst; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	CB received funding for this project by the Harvard Catalyst and NIDDK 1K08 DK08361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge D, 2010, ANNU REV GENOM HUM G, V11, P189, DOI 10.1146/annurev-genom-082908-150158; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Bergwitz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031730; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693; Bevington A, 1992, CLIN CHEM ENZYMOL CO, V4, P235; Bringhurst FR, 2006, ENDOCRINOLOGY, V5, P805; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chertow GM, 1999, CLIN NEPHROL, V51, P18; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; De Beur SMJ, 2002, J BONE MINER RES, V17, P1102, DOI 10.1359/jbmr.2002.17.6.1102; Dinur M, 2006, MOL ENDOCRINOL, V20, P1652, DOI 10.1210/me.2005-0333; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Hou SC, 2009, FEBS LETT, V583, P2765, DOI 10.1016/j.febslet.2009.07.025; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Ito E, 2010, INT J HEMATOL, V92, P413, DOI 10.1007/s12185-010-0693-7; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; KILAV R, 1995, J CLIN INVEST, V96, P327, DOI 10.1172/JCI118038; KRAUS ME, 1994, MOL CELL BIOL, V14, P5360, DOI 10.1128/MCB.14.8.5360; Laplantine E, 2002, J CELL BIOL, V158, P741, DOI 10.1083/jcb.200205025; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lopez-Mejia IC, 2011, HUM MOL GENET, V20, P4540, DOI 10.1093/hmg/ddr385; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Mason DA, 2009, SEMIN CELL DEV BIOL, V20, P582, DOI 10.1016/j.semcdb.2009.02.006; McGee-Lawrence ME, 2012, BONE; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Moallem E, 1998, J BIOL CHEM, V273, P5253, DOI 10.1074/jbc.273.9.5253; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Nair D, 1997, J BIOL CHEM, V272, P18920, DOI 10.1074/jbc.272.30.18920; Nechama M, 2008, FASEB J, V22, P3458, DOI 10.1096/fj.08-107250; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018; Perez VI, 2011, J GERONTOL A-BIOL, V66, P1286, DOI 10.1093/gerona/glr125; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; Razzaque MS, 2009, NEPHROL DIAL TRANSPL, V24, P4, DOI 10.1093/ndt/gfn620; Roberts D. B., 1998, PRACTICAL APPROACH S; Rossi F, 2002, DEV BIOL, V247, P271, DOI 10.1006/dbio.2002.0691; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Smith RK, 2002, DEVELOPMENT, V129, P71; Sprecher E, 2010, J INVEST DERMATOL, V130, P652, DOI 10.1038/jid.2009.337; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; TENENHOUSE HS, 1989, BIOCHIM BIOPHYS ACTA, V984, P207, DOI 10.1016/0005-2736(89)90218-6; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zhang MYH, 2012, ENDOCRINOLOGY, V153, P1806, DOI 10.1210/en.2011-1831; Zhao HW, 2011, PLACENTA, V32, pS104, DOI 10.1016/j.placenta.2010.11.017	73	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e56753	10.1371/journal.pone.0056753	http://dx.doi.org/10.1371/journal.pone.0056753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520455	Green Published, gold			2022-12-27	WOS:000318679900014
J	Kanari, Y; Sato, Y; Aoyama, S; Muta, T				Kanari, Yasuyoshi; Sato, Yuki; Aoyama, Satoru; Muta, Tatsushi			Thioredoxin-Interacting Protein Gene Expression via MondoA Is Rapidly and Transiently Suppressed during Inflammatory Responses	PLOS ONE			English	Article							UP-REGULATED PROTEIN-1; TXNIP; GLUCOSE; BINDING; LOCALIZATION; METABOLISM; DIFFERENTIATION; GROWTH; VDUP1	Whereas accumulating evidence indicates that a number of inflammatory genes are induced by activation of nuclear factor-kappa B and other transcription factors, less is known about genes that are suppressed by proinflammatory stimuli. Here we show that expression of thioredoxin-interacting protein (Txnip) is dramatically suppressed both in mRNA and protein levels upon stimulation with lipopolysaccharide in mouse and human macrophages. In addition to lipopolysaccharide, a Toll-like receptor 4 ligand, stimulation with other Toll-like receptor ligands such as CpG DNA also suppressed Txnip expression. Not only the Toll-like receptor ligands, but also other proinflammatory stimulators, such as interleukin-1 beta and tumor necrosis factor-alpha elicited the similar response in fibroblasts. Suppression of Txnip by lipopolysaccharide is accompanied by a decrease of the glucose sensing transcription factor MondoA in the nuclei and dissociation of the MondoA:Mlx complex that bound to the carbohydrate-response elements in the Txnip promoter in unstimulated cells. Lipopolysaccharide-mediated decrease of nuclear MondoA was inhibited in the presence of 2-deoxyglucose. Furthermore, blockage of glyceraldehyde-3-phosphate dehydrogenase by iodoacetate alleviated the suppression of Txnip mRNA by lipopolysaccharide, suggesting the involvement of glucose-metabolites in the regulation. Since Txnip is implicated in the regulation of glucose metabolism, this observation links between inflammatory responses and metabolic regulation.	[Kanari, Yasuyoshi; Muta, Tatsushi] Tohoku Univ, Lab Cell Recognit & Response, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Kanari, Yasuyoshi; Muta, Tatsushi] Ctr Ecosyst Management Adapting Global Change, Global Ctr Excellence Program, Sendai, Miyagi, Japan; [Sato, Yuki; Aoyama, Satoru; Muta, Tatsushi] Tohoku Univ, Fac Sci, Dept Biol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Muta, T (corresponding author), Tohoku Univ, Lab Cell Recognit & Response, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	tmuta@biology.tohoku.ac.jp	Sato, Yuki/GWZ-1382-2022	Sato, Yuki/0000-0002-3758-3452	Ministry of Education, Culture, Sports, Science and Technology of Japan [21117004]; Japan Society for the Promotion of Science [21390088]; Takeda Science Foundation; Naito Foundation; Asahi Grass Foundation; Suzuken Memorial Foundation; Novartis Foundation for the Promotion of Science; Japan Foundation for Applied Enzymology; Global COE Program "Center for ecosystem management adapting to global change" of the Ministry of Education, Culture, Sports, Science and Technology of Japan [J03];  [22590345]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Asahi Grass Foundation; Suzuken Memorial Foundation; Novartis Foundation for the Promotion of Science; Japan Foundation for Applied Enzymology; Global COE Program "Center for ecosystem management adapting to global change" of the Ministry of Education, Culture, Sports, Science and Technology of Japan; 	This work was supported in part by Grant-in-Aid for Scientific Research on Innovative Areas (21117004) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TM, Grant-in-Aid for Scientific Research (B) (21390088) from the Japan Society for the Promotion of Science to TM, and Grant-in-Aid for Scientific Research (C) (22590345) to YK, and grants to TM from Takeda Science Foundation, the Naito Foundation, the Asahi Grass Foundation, Suzuken Memorial Foundation, the Novartis Foundation for the Promotion of Science, and the Japan Foundation for Applied Enzymology, and by the Global COE Program "Center for ecosystem management adapting to global change"(J03) of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; Elgort Marc G, 2010, Genes Cancer, V1, P893, DOI 10.1177/1947601910389604; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mousa SA, 2009, AGING-US, V1, P412, DOI 10.18632/aging.100035; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Shao WJ, 2010, CELL SIGNAL, V22, P1240, DOI 10.1016/j.cellsig.2010.04.001; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Yu FX, 2010, J BIOL CHEM, V285, P25822, DOI 10.1074/jbc.M110.108290; Yu FX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008397; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59026	10.1371/journal.pone.0059026	http://dx.doi.org/10.1371/journal.pone.0059026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520550	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900110
J	Marques-Pita, M; Rocha, LM				Marques-Pita, Manuel; Rocha, Luis M.			Canalization and Control in Automata Networks: Body Segmentation in Drosophila melanogaster	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS; BOOLEAN NETWORK; COMPLEX-SYSTEMS; CELL-CYCLE; MODELS; ROBUSTNESS; EVOLUTION; EMERGENT; POLARITY; DYNAMICS	We present schema redescription as a methodology to characterize canalization in automata networks used to model biochemical regulation and signalling. In our formulation, canalization becomes synonymous with redundancy present in the logic of automata. This results in straightforward measures to quantify canalization in an automaton (micro-level), which is in turn integrated into a highly scalable framework to characterize the collective dynamics of large-scale automata networks (macro-level). This way, our approach provides a method to link micro-to macro-level dynamics - a crux of complexity. Several new results ensue from this methodology: uncovering of dynamical modularity (modules in the dynamics rather than in the structure of networks), identification of minimal conditions and critical nodes to control the convergence to attractors, simulation of dynamical behaviour from incomplete information about initial conditions, and measures of macro-level canalization and robustness to perturbations. We exemplify our methodology with a well-known model of the intra-and inter cellular genetic regulation of body segmentation in Drosophila melanogaster. We use this model to show that our analysis does not contradict any previous findings. But we also obtain new knowledge about its behaviour: a better understanding of the size of its wild-type attractor basin (larger than previously thought), the identification of novel minimal conditions and critical nodes that control wild-type behaviour, and the resilience of these to stochastic interventions. Our methodology is applicable to any complex network that can be modelled using automata, but we focus on biochemical regulation and signalling, towards a better understanding of the (decentralized) control that orchestrates cellular activity - with the ultimate goal of explaining how do cells and tissues 'compute'.	[Marques-Pita, Manuel; Rocha, Luis M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Marques-Pita, Manuel; Rocha, Luis M.] Indiana Univ, Bloomington, IN USA	Instituto Gulbenkian de Ciencia; Indiana University System; Indiana University Bloomington	Marques-Pita, M (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	marquesm@indiana.edu; rocha@indiana.edu	Marques-Pita, Manuel/AAI-2583-2021	Marques-Pita, Manuel/0000-0003-2180-6823; Rocha, Luis/0000-0001-9402-887X	Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/EIA-CCO/114108/2009]; Fundação para a Ciência e a Tecnologia [PTDC/EIA-CCO/114108/2009] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	Funding provided by Fundacao para a Ciencia e a Tecnologia (Portugal) grant PTDC/EIA-CCO/114108/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts B., 2003, MOL BIOL CELL; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Alexander RP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281pe44; Alvarez-Buylla ER, 2008, PLOS ONE, V3; [Anonymous], 2004, P WORKSH TUT 9 INT C; Assmann SM, 2009, METHODS MOL BIOL, V553, P207, DOI 10.1007/978-1-60327-563-7_10; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bjorklund A, 2006, ANN IEEE SYMP FOUND, P575; Blake A, 1938, CANONICAL EXPRESSION; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; CHANDRA AK, 1978, DISCRETE MATH, V24, P7, DOI 10.1016/0012-365X(78)90168-1; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; CONRAD M, 1990, BIOSYSTEMS, V24, P61, DOI 10.1016/0303-2647(90)90030-5; CRUTCHFIELD JP, 1995, P NATL ACAD SCI USA, V92, P10742, DOI 10.1073/pnas.92.23.10742; Eisenberg Daniel, 2015, J MENT HEALTH, V20, P222, DOI [10.3109/10673229.2012.712839, DOI 10.3109/09638237.2014.954693, 10.3109/08039481003777484]; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fraser HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008635; Gat-Viks I, 2003, BIOINFORMATICS, V19, pi108, DOI 10.1093/bioinformatics/btg1014; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Grefenstette J, 2006, BIOSYSTEMS; Harris Stephen E., 2002, Complexity, V7, P23, DOI 10.1002/cplx.10022; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Hooper J.E., 1992, Results and Problems in Cell Differentiation, V18, P1; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S, 2004, GENETIC NETWORKS CAN; KAUFFMAN SA, 1984, PHYSICA D, V10, P145, DOI 10.1016/0167-2789(84)90257-4; Klir G., 2002, ARCHITECTURE SYSTEMS, V2nd; Kolchinsky A., 2011, ADV ARTIFICIAL LIFE, P423; Kravets VN, 2000, ICCAD - 2000 : IEEE/ACM INTERNATIONAL CONFERENCE ON COMPUTER AIDED DESIGN, P526, DOI 10.1109/ICCAD.2000.896526; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Lu XM, 2010, CELL CYCLE, V9, P2908; Marques-Pita M., 2011, 2011 IEEE SSCI Symposium on Artificial Life (ALIFE), P233, DOI 10.1109/ALIFE.2011.5954670; Masel J, 2007, GENETICS, V175, P453, DOI 10.1534/genetics.106.065201; MCCLUSKEY EJ, 1956, BELL SYST TECH J, V35, P1445, DOI 10.1002/j.1538-7305.1956.tb03836.x; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Mitchell M., 1996, INTRO GENETIC ALGORI; Mitchell M, 2006, ARTIF INTELL, V170, P1194, DOI 10.1016/j.artint.2006.10.002; Peak D, 2004, P NATL ACAD SCI USA, V101, P918, DOI 10.1073/pnas.0307811100; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Quine W.V., 2018, AM MATH MON, V62, P627, DOI [10.1080/00029890.1955.11988710, DOI 10.1080/00029890.1955.11988710]; Raeymaekers L, 2002, J THEOR BIOL, V218, P331, DOI 10.1006/jtbi.2002.3081; Reichhardt CJO, 2007, J PHYS A-MATH THEOR, V40, P4339, DOI 10.1088/1751-8113/40/16/006; Rocha LM, 2005, ARTIF LIFE, V11, P189, DOI 10.1162/1064546053278964; Samaga R, 2010, J COMPUT BIOL, V17, P39, DOI 10.1089/cmb.2009.0121; Shannon C., 1938, T AIEE, V57, P713, DOI [10.1109/EE.1938.6431064, DOI 10.1109/EE.1938.6431064]; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; ten Tusscher KHWJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-159; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Valiant L. G., 1984, COMMUNICATIONS ACM; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Von Dassow G, 2002, J EXP ZOOL, V294, P179, DOI 10.1002/jez.10144; Waddington C H, 1957, STRATEGY GENES DISCU; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wallace D., 1998, GROUPS RINGS FIELDS; Willadsen K, 2007, J THEOR BIOL, V249, P749, DOI 10.1016/j.jtbi.2007.09.004; Wolpert L., 1998, PRINCIPLES DEV; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	64	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e55946	10.1371/journal.pone.0055946	http://dx.doi.org/10.1371/journal.pone.0055946			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520449	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900008
J	Odoi, KA; Huang, Y; Rezenom, YH; Liu, WR				Odoi, Keturah A.; Huang, Ying; Rezenom, Yohannes H.; Liu, Wenshe R.			Nonsense and Sense Suppression Abilities of Original and Derivative Methanosarcina mazei Pyrrolysyl-tRNA Synthetase-tRNA(Pyl) Pairs in the Escherichia coli BL21(DE3) Cell Strain	PLOS ONE			English	Article							UNNATURAL AMINO-ACIDS; GENETIC-CODE; L-PHENYLALANINE; FACILE SYSTEM; PROTEIN; LYSINE; ANALOG; UAG	Systematic studies of nonsense and sense suppression of the original and three derivative Methanosarcina mazei PylRS-tRNA(Pyl) pairs and cross recognition between nonsense codons and various tRNA(Pyl) anticodons in the Escherichia coli BL21(DE3) cell strain are reported. tRNA(CUA)(Pyl) is orthogonal in E. coli and able to induce strong amber suppression when it is co-expressed with pyrrolysyl-tRNA synthetase (PylRS) and charged with a PylRS substrate, N-8-tert-butoxycarbonyl-L- lysine (BocK). Similar totRNA(CUA)(Pyl), tRNA(UUA)(Pyl) is also orthogonal in E. coli and can be coupled with PylRS to genetically incorporate BocK at an ochre mutation site. Although tRNA(UUA)(Pyl) is expected to recognize a UAG codon based on the wobble hypothesis, the PylRS-tRNA(UUA)(Pyl) pair does not give rise to amber suppression that surpasses the basal amber suppression level in E. coli. E. coli itself displays a relatively high opal suppression level and tryptophan (Trp) is incorporated at an opal mutation site. Although the PylRS-tRNA(UCA)(Pyl) pair can be used to encode BocK at an opal codon, the pair fails to suppress the incorporation of Trp at the same site. tRNA(CCU)(Pyl) fails to deliver BocK at an AGG codon when co-expressed with PylRS in E. coli.	[Odoi, Keturah A.; Huang, Ying; Rezenom, Yohannes H.; Liu, Wenshe R.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Liu, WR (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	wliu@chem.tamu.edu	Liu, wenshe/O-4425-2014	Liu, wenshe/0000-0002-7078-6534	National Institute of Health [1R01CA161158]; Welch Foundation [A-1715]; NATIONAL CANCER INSTITUTE [R01CA161158] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health (grant 1R01CA161158) and the Welch Foundation (grant A-1715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Ai HW, 2010, CHEM COMMUN, V46, P5506, DOI 10.1039/c0cc00108b; Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; BARON C, 1991, J BIOL CHEM, V266, P20375; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Fekner T, 2009, ANGEW CHEM INT EDIT, V48, P1633, DOI 10.1002/anie.200805420; Fukunaga J, 2006, NUCLEIC ACIDS RES, V34, P3181, DOI 10.1093/nar/gkl414; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; GRIBSKOV M, 1984, NUCLEIC ACIDS RES, V12, P539, DOI 10.1093/nar/12.1Part2.539; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Huang Y, 2010, BIOORG MED CHEM LETT, V20, P878, DOI 10.1016/j.bmcl.2009.12.077; Li X, 2009, ANGEW CHEM INT EDIT, V48, P9184, DOI 10.1002/anie.200904472; Liu WSR, 2011, MOL BIOSYST, V7, P38, DOI 10.1039/c0mb00216j; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; SCHWYZER R, 1971, HELV CHIM ACTA, V54, P1395, DOI 10.1002/hlca.19710540521; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; SWANSON R, 1988, SCIENCE, V242, P1548, DOI 10.1126/science.3144042; Takimoto JK, 2011, ACS CHEM BIOL, V6, P733, DOI 10.1021/cb200057a; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; VOLD BS, 1982, NUCLEIC ACIDS RES, V10, P3125, DOI 10.1093/nar/10.10.3125; Wan W, 2010, ANGEW CHEM INT EDIT, V49, P3211, DOI 10.1002/anie.201000465; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang YS, 2012, J AM CHEM SOC, V134, P2950, DOI 10.1021/ja211972x; Wang YS, 2011, MOL BIOSYST, V7, P714, DOI 10.1039/c0mb00217h; Wang YS, 2010, MOL BIOSYST, V6, P1575, DOI 10.1039/c002155e; Wu B, 2012, CHEMBIOCHEM, V13, P1405, DOI 10.1002/cbic.201200281; Xie JM, 2004, NAT BIOTECHNOL, V22, P1297, DOI 10.1038/nbt1013; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yuan J, 2010, FEBS LETT, V584, P342, DOI 10.1016/j.febslet.2009.11.005; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	41	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57035	10.1371/journal.pone.0057035	http://dx.doi.org/10.1371/journal.pone.0057035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520461	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900020
J	Yoo, M; Khaled, M; Gibbs, KM; Kim, J; Kowalewski, B; Dierks, T; Schachner, M				Yoo, Myungsik; Khaled, Muntasir; Gibbs, Kurt M.; Kim, Jonghun; Kowalewski, Bjoern; Dierks, Thomas; Schachner, Melitta			Arylsulfatase B Improves Locomotor Function after Mouse Spinal Cord Injury	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; ENZYME-REPLACEMENT THERAPY; GLIAL SCAR; UP-REGULATION; CNS INJURY; BINDING PEPTIDES; HEPARAN-SULFATE; AXONAL REGROWTH; RECOVERY; GROWTH	Bacterial chondroitinase ABC (ChaseABC) has been used to remove the inhibitory chondroitin sulfate chains from chondroitin sulfate proteoglycans to improve regeneration after rodent spinal cord injury. We hypothesized that the mammalian enzyme arylsulfatase B (ARSB) would also enhance recovery after mouse spinal cord injury. Application of the mammalian enzyme would be an attractive alternative to ChaseABC because of its more robust chemical stability and reduced immunogenicity. A one-time injection of human ARSB into injured mouse spinal cord eliminated immunoreactivity for chondroitin sulfates within five days, and up to 9 weeks after injury. After a moderate spinal cord injury, we observed improvements of locomotor recovery assessed by the Basso Mouse Scale (BMS) in ARSB treated mice, compared to the buffer-treated control group, at 6 weeks after injection. After a severe spinal cord injury, mice injected with equivalent units of ARSB or ChaseABC improved similarly and both groups achieved significantly more locomotor recovery than the buffer-treated control mice. Serotonin and tyrosine hydroxylase immunoreactive axons were more extensively present in mouse spinal cords treated with ARSB and ChaseABC, and the immunoreactive axons penetrated further beyond the injury site in ARSB or ChaseABC treated mice than in control mice. These results indicate that mammalian ARSB improves functional recovery after CNS injury. The structural/molecular mechanisms underlying the observed functional improvement remain to be elucidated.	[Yoo, Myungsik; Khaled, Muntasir; Gibbs, Kurt M.; Kim, Jonghun; Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Yoo, Myungsik; Khaled, Muntasir; Gibbs, Kurt M.; Kim, Jonghun; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Kowalewski, Bjoern; Dierks, Thomas] Univ Bielefeld, Dept Chem, Bielefeld, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Guangdong, Peoples R China	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Bielefeld; Shantou University	Schachner, M (corresponding author), Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA.	schachner@stu.edu.cn	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339; Kim, Jonghun/0000-0002-9154-5529	New Jersey Commission for Spinal Cord Research; Deutsche Forschungsgemeinschaft	New Jersey Commission for Spinal Cord Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the New Jersey Commission for Spinal Cord Research and in part from Deutsche Forschungsgemeinschaft. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; ANSON DS, 1992, BIOCHEM J, V284, P789, DOI 10.1042/bj2840789; Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; Asher RA, 2000, J NEUROSCI, V20, P2427; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BOVOLENTA P, 1991, RESTOR NEUROL NEUROS, V2, P221, DOI 10.3233/RNN-1991-245609; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Butterfield KC, 2010, NEUROSCI LETT, V478, P82, DOI 10.1016/j.neulet.2010.04.070; Butterfield KC, 2010, BIOCHEMISTRY-US, V49, P1549, DOI 10.1021/bi9021044; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; Cavalcante LA, 2003, BRAZ J MED BIOL RES, V36, P993, DOI 10.1590/S0100-879X2003000800005; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dierks T, 1998, FEBS LETT, V423, P61, DOI 10.1016/S0014-5793(98)00065-9; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fehlings MG, 2008, J NEUROSURG-SPINE, V8, P205, DOI 10.3171/SPI/2008/8/3/205; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GORHAM SD, 1978, H-S Z PHYSIOL CHEM, V359, P1811; Hamai A, 1997, J BIOL CHEM, V272, P9123; Harmatz P, 2005, PEDIATRICS, V115, pE681, DOI 10.1542/peds.2004-1023; Harmatz P, 2004, J PEDIATR-US, V144, P574, DOI 10.1016/j.jpeds.2004.03.018; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; HUANG PP, 1994, J NEUROTRAUM, V11, P547, DOI 10.1089/neu.1994.11.547; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Iseda T, 2008, J NEUROTRAUM, V25, P334, DOI 10.1089/neu.2007.0289; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim BG, 2006, J COMP NEUROL, V497, P182, DOI 10.1002/cne.20980; Knaust A, 1998, BIOCHEMISTRY-US, V37, P13941, DOI 10.1021/bi9810205; Koshiishi I, 1998, ANAL BIOCHEM, V265, P49, DOI 10.1006/abio.1998.2883; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Liu J, 2006, J CELL SCI, V119, P933, DOI 10.1242/jcs.02796; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Munoz-Rojas MV, 2010, MOL GENET METAB, V99, P346, DOI 10.1016/j.ymgme.2009.11.008; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; PORTER MT, 1969, P NATL ACAD SCI USA, V62, P887, DOI 10.1073/pnas.62.3.887; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; Prabhakar V, 2009, J BIOL CHEM, V284, P974, DOI 10.1074/jbc.M806630200; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; SILVER J, 1994, J NEUROL, V242, pS22, DOI 10.1007/BF00939236; Skidmore MA, 2010, NAT PROTOC, V5, P1983, DOI 10.1038/nprot.2010.145; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; WASSERMAN SI, 1976, J CLIN INVEST, V57, P738, DOI 10.1172/JCI108332; Wilson MT, 2000, J COMP NEUROL, V424, P532, DOI 10.1002/1096-9861(20000828)424:3<532::AID-CNE10>3.0.CO;2-Z; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3	75	36	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57415	10.1371/journal.pone.0057415	http://dx.doi.org/10.1371/journal.pone.0057415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520469	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900028
J	Zhang, XJ; Liu, GZ; Kang, Y; Dong, ZG; Qian, QY; Ma, XT				Zhang, Xiaoju; Liu, Guangzhi; Kang, Yi; Dong, Zhaogang; Qian, Qiyu; Ma, Xitao			N-Cadherin Expression Is Associated with Acquisition of EMT Phenotype and with Enhanced Invasion in Erlotinib-Resistant Lung Cancer Cell Lines	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; MESENCHYMAL TRANSITION; ACQUIRED-RESISTANCE; GEFITINIB-RESISTANCE; MET AMPLIFICATION; EGFR; GROWTH; SENSITIVITY; MUTATIONS; ADHESION	Background: The epidermal growth-factor receptor tyrosine kinase inhibitors have been effective in non-small cell lung cancer patients. However, acquired resistance eventually develops in most patients despite an initial positive response. Emerging evidence suggests that there is a molecular connection between acquired resistance and the epithelial-mesenchymal transition (EMT). N-cadherin is involved in the EMT and in the metastasis of cancer cells. Here, we analyzed N-cadherin expression and function in erlotinib-resistant lung cancer cell lines. Methods: H1650 cell lines were used to establish the subline resistant to erlotinib(H1650ER). Then, induction of the EMT was analyzed using immunostaining and western blots in H1650ER cells. N-cadherin expression in the resistant cells was examined using FACS and western blot. In addition, an invasion assay was performed to characterize the resistant cells. The effects of N-cadherin on cell proliferation and invasion were analyzed. The association of N-cadherin expression with the EMT phenotype was investigated using immunohistochemical analysis of 13 archived, lung adenocarcinoma tissues, before and after treatment with erlotinib. Results: In H1650ER cells, N-cadherin expression was upregulated, paralleled by the reduced expression of E-cadherin. The marked histological change and the development of a spindle-like morphology suggest that H1650ER cells underwent an EMT, accompanied by a decrease in E-cadherin and an increase in vimentin. A change in the EMT status between pre-and post-treatment was observed in 11 out of 13 cases (79%). In biopsies of resistant cancers, N-cadherin expression was increased in 10 out of 13 cases. Induction of the EMT was consistent with aggressive characteristics. Inhibition of N-cadherin expression by siRNA was tested to reduce proliferation and invasion of H1650ER cells in vitro. Conclusions: Our data provide evidence that induction of the EMT contributes to the acquired resistance to EGFR-TKIs in lung cancer. It suggests that N-cadherin is a potential molecular target in the treatment of NSCLC.	[Zhang, Xiaoju; Qian, Qiyu; Ma, Xitao] Henan Prov Peoples Hosp, Dept Resp Med, Zhengzhou, Henan, Peoples R China; [Liu, Guangzhi] Henan Prov Peoples Hosp, Dept Obstet & Gynecol, Zhengzhou, Henan, Peoples R China; [Kang, Yi] Henan Prov Peoples Hosp, Dept Infect Dis, Zhengzhou, Henan, Peoples R China; [Dong, Zhaogang] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Shandong University	Ma, XT (corresponding author), Henan Prov Peoples Hosp, Dept Resp Med, Zhengzhou, Henan, Peoples R China.	maxitao@163.com		Liu, Guangzhi/0000-0002-4973-7113	Science Research Project of Henan Province	Science Research Project of Henan Province	Contract grant sponsor: the Science Research Project of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; Carney DN, 2002, NEW ENGL J MED, V346, P126, DOI 10.1056/NEJM200201103460211; Cha MY, 2012, INT J CANCER, V130, P2445, DOI 10.1002/ijc.26276; Ciolczyk-Wierzbicka D, 2012, CURR MED CHEM, V19, P145, DOI 10.2174/092986712803414006; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Friedel G, 2010, J CLIN ONCOL, V28, P942, DOI 10.1200/JCO.2008.21.7810; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Kase S, 2000, CLIN CANCER RES, V6, P4789; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li H, 2011, ADV MED SCI-POLAND, V56, P275, DOI 10.2478/v10039-011-0043-x; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nakagawa T, 2012, MOL CANCER THER, V11, P2149, DOI 10.1158/1535-7163.MCT-12-0195; Nalla AK, 2011, EXP CELL RES, V317, P2512, DOI 10.1016/j.yexcr.2011.07.024; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rebucci M, 2011, INT J ONCOL, V38, P189, DOI 10.3892/ijo_00000838; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tomita K, 2000, CANCER RES, V60, P3650; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P180, DOI 10.1016/j.urolonc.2008.09.041; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yamauchi M, 2011, AM J CANCER RES, V1, P823; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	40	95	108	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57692	10.1371/journal.pone.0057692	http://dx.doi.org/10.1371/journal.pone.0057692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520479	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900038
J	Martyniuk, CJ; Prucha, MS; Doperalski, NJ; Antczak, P; Kroll, KJ; Falciani, F; Barber, DS; Denslow, ND				Martyniuk, Christopher J.; Prucha, Melinda S.; Doperalski, Nicholas J.; Antczak, Philipp; Kroll, Kevin J.; Falciani, Francesco; Barber, David S.; Denslow, Nancy D.			Gene Expression Networks Underlying Ovarian Development in Wild Largemouth Bass (Micropterus salmoides)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; FOLLICLE-STIMULATING-HORMONE; BOUND PROGESTIN RECEPTORS; MESSENGER-RNA EXPRESSION; ACUTE REGULATORY PROTEIN; MORONE-SAXATILIS; GROWTH-HORMONE; MOLECULAR CHARACTERIZATION; STEROIDOGENIC ENZYMES; TISSUE-DISTRIBUTION	Background: Oocyte maturation in fish involves numerous cell signaling cascades that are activated or inhibited during specific stages of oocyte development. The objectives of this study were to characterize molecular pathways and temporal gene expression patterns throughout a complete breeding cycle in wild female largemouth bass to improve understanding of the molecular sequence of events underlying oocyte maturation. Methods: Transcriptomic analysis was performed on eight morphologically diverse stages of the ovary, including primary and secondary stages of oocyte growth, ovulation, and atresia. Ovary histology, plasma vitellogenin, 17 beta-estradiol, and testosterone were also measured to correlate with gene networks. Results: Global expression patterns revealed dramatic differences across ovarian development, with 552 and 2070 genes being differentially expressed during both ovulation and atresia respectively. Gene set enrichment analysis (GSEA) revealed that early primary stages of oocyte growth involved increases in expression of genes involved in pathways of B-cell and T-cell receptor-mediated signaling cascades and fibronectin regulation. These pathways as well as pathways that included adrenergic receptor signaling, sphingolipid metabolism and natural killer cell activation were down-regulated at ovulation. At atresia, down-regulated pathways included gap junction and actin cytoskeleton regulation, gonadotrope and mast cell activation, and vasopressin receptor signaling and up-regulated pathways included oxidative phosphorylation and reactive oxygen species metabolism. Expression targets for luteinizing hormone signaling were low during vitellogenesis but increased 150% at ovulation. Other networks found to play a significant role in oocyte maturation included those with genes regulated by members of the TGF-beta superfamily (activins, inhibins, bone morphogenic protein 7 and growth differentiation factor 9), neuregulin 1, retinoid X receptor, and nerve growth factor family. Conclusions: This study offers novel insight into the gene networks underlying vitellogenesis, ovulation and atresia and generates new hypotheses about the cellular pathways regulating oocyte maturation.	[Martyniuk, Christopher J.; Prucha, Melinda S.; Doperalski, Nicholas J.; Kroll, Kevin J.; Barber, David S.; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Martyniuk, Christopher J.; Prucha, Melinda S.; Doperalski, Nicholas J.; Kroll, Kevin J.; Barber, David S.; Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA; [Martyniuk, Christopher J.] Univ New Brunswick, Canadian Rivers Inst, St John, NB E2L 4L5, Canada; [Martyniuk, Christopher J.] Univ New Brunswick, Dept Biol, St John, NB E2L 4L5, Canada; [Antczak, Philipp; Falciani, Francesco] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of New Brunswick; University of New Brunswick; University of Liverpool	Denslow, ND (corresponding author), Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA.	ndenslow@ufl.edu	Antczak, Philipp/L-5879-2019	Antczak, Philipp/0000-0001-9600-7757; kroll, kevin j/0000-0002-5374-6733; Martyniuk, Christopher J./0000-0003-0921-4796	National Institutes of Health Pathway to Independence Award [K99 ES016767]; Superfund Basic Research Program from the National Institute of Environmental Health Sciences [RO1 ES015449]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015449, K99ES016767] Funding Source: NIH RePORTER	National Institutes of Health Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Superfund Basic Research Program from the National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded by a National Institutes of Health Pathway to Independence Award granted to C.J.M. (K99 ES016767) and by the Superfund Basic Research Program from the National Institute of Environmental Health Sciences to N.D. and D.B. (RO1 ES015449). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulleiro MJ, 2007, BIOL REPROD, V77, P504, DOI 10.1095/biolreprod.107.061598; Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; Billiau AD, 2001, TRANSPLANTATION, V71, P292, DOI 10.1097/00007890-200101270-00022; BLYTHE WG, 1994, GEN COMP ENDOCR, V94, P122, DOI 10.1006/gcen.1994.1066; Bobe J, 2004, BIOL REPROD, V71, P73, DOI 10.1095/biolreprod.103.025205; Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Bobe J, 2009, COMP BIOCHEM PHYS A, V153, P63, DOI 10.1016/j.cbpa.2008.10.021; Campbell B, 2006, BIOL REPROD, V75, P34, DOI 10.1095/biolreprod.105.049494; Chaves-Pozo E, 2010, MOL IMMUNOL, V47, P1757, DOI 10.1016/j.molimm.2010.02.030; Denslow ND, 1999, ECOTOXICOLOGY, V8, P385, DOI 10.1023/A:1008986522208; Dominguez GA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099812; Doperalski NJ, 2011, GEN COMP ENDOCR, V173, P86, DOI 10.1016/j.ygcen.2011.04.027; ERDO SL, 1984, J NEUROCHEM, V42, P1464, DOI 10.1111/j.1471-4159.1984.tb02810.x; Essex-Fraser PA, 2005, J BIOL CHEM, V280, P20268, DOI 10.1074/jbc.M412338200; Garcia-Reyero N, 2008, J FISH BIOL, V72, P2354, DOI 10.1111/j.1095-8649.2008.01904.x; Garczynski MA, 1997, BIOL REPROD, V57, P856, DOI 10.1095/biolreprod57.4.856; Gohin M, 2011, MOL REPROD DEV, V78, P510, DOI 10.1002/mrd.21335; Gomez JM, 1999, J REPROD FERTIL, V115, P275, DOI 10.1530/jrf.0.1150275; Grier H.J., 2009, REPROD BIOL PHYLOGEN; Hook SE, 2011, ENVIRON TOXICOL CHEM, V30, P309, DOI 10.1002/etc.407; Ings JS, 2006, MOL REPROD DEV, V73, P943, DOI 10.1002/mrd.20490; Kazeto Y, 2005, GEN COMP ENDOCR, V142, P204, DOI 10.1016/j.ygcen.2005.01.017; Kazeto Y, 2005, J MOL ENDOCRINOL, V34, P781, DOI 10.1677/jme.1.01721; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kocerha J, 2010, ENDOCRINOLOGY, V151, P341, DOI 10.1210/en.2009-0551; Kotelnikova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002365; KRISHNA A, 1989, J ENDOCRINOL, V120, P363, DOI 10.1677/joe.0.1200363; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; LARA HE, 1990, ENDOCRINOLOGY, V126, P364, DOI 10.1210/endo-126-1-364; Le Menn Francoise, 2007, P1; Lokman PM, 2003, J COMP PHYSIOL B, V173, P11, DOI 10.1007/s00360-002-0304-x; Luckenbach JA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-2; Ma XL, 2007, COMP BIOCHEM PHYS B, V147, P325, DOI 10.1016/j.cbpb.2007.01.021; Martyniuk CJ, 2013, NEUROTOXICOLOGY, V34, P105, DOI 10.1016/j.neuro.2012.09.012; Martyniuk CJ, 2012, INTEGR COMP BIOL, V52, P695, DOI 10.1093/icb/ics072; Martyniuk CJ, 2012, J PROTEOME RES, V11, P4147, DOI 10.1021/pr3002468; Martyniuk CJ, 2009, GEN COMP ENDOCR, V163, P306, DOI 10.1016/j.ygcen.2009.04.028; Mittelholzer C, 2009, GEN COMP ENDOCR, V160, P47, DOI 10.1016/j.ygcen.2008.10.015; Mylonas CC, 1998, GEN COMP ENDOCR, V110, P276, DOI 10.1006/gcen.1998.7073; Mylonas CC, 1997, GEN COMP ENDOCR, V108, P223, DOI 10.1006/gcen.1997.6967; Oliveira PF, 2009, REPRODUCTION, V137, P353, DOI 10.1530/REP-08-0363; Reading Benjamin J., 2012, BMC Research Notes, V5, P111, DOI 10.1186/1756-0500-5-111; Rocha A, 2009, GEN COMP ENDOCR, V162, P265, DOI 10.1016/j.ygcen.2009.03.023; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell DL, 1999, MOL ENDOCRINOL, V13, P2049, DOI 10.1210/me.13.12.2049; Sabo-Attwood T, 2004, MOL CELL ENDOCRINOL, V218, P107, DOI 10.1016/j.mce.2003.12.007; Sabo-Attwood T, 2007, J MOL ENDOCRINOL, V39, P223, DOI 10.1677/JME-07-0038; Santos EM, 2007, PHYSIOL GENOMICS, V30, P111, DOI 10.1152/physiolgenomics.00284.2006; Sepulveda MS, 2002, SCI TOTAL ENVIRON, V289, P133, DOI 10.1016/S0048-9697(01)01029-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tingaud-Sequeira A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-434; Tokumoto M, 2006, GEN COMP ENDOCR, V145, P101, DOI 10.1016/j.ygcen.2005.07.002; Trudeau VL, 2000, BIOCHEM CELL BIOL, V78, P241, DOI 10.1139/bcb-78-3-241; Tubbs C, 2010, GEN COMP ENDOCR, V165, P144, DOI 10.1016/j.ygcen.2009.06.017; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Villeneuve DL, 2010, AQUAT TOXICOL, V98, P354, DOI 10.1016/j.aquatox.2010.03.006; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967	57	43	44	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59093	10.1371/journal.pone.0059093	http://dx.doi.org/10.1371/journal.pone.0059093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527095	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600054
J	Taboada-Echalar, P; Alvarez-Iglesias, V; Heinz, T; Vidal-Bralo, L; Gomez-Carballa, A; Catelli, L; Pardo-Seco, J; Pastoriza, A; Carracedo, A; Torres-Balanza, A; Rocabado, O; Vullo, C; Salas, A				Taboada-Echalar, Patricia; Alvarez-Iglesias, Vanesa; Heinz, Tanja; Vidal-Bralo, Laura; Gomez-Carballa, Alberto; Catelli, Laura; Pardo-Seco, Jacobo; Pastoriza, Ana; Carracedo, Angel; Torres-Balanza, Antonio; Rocabado, Omar; Vullo, Carlos; Salas, Antonio			The Genetic Legacy of the Pre-Colonial Period in Contemporary Bolivians	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DIVERSITY; POPULATION-STRUCTURE; AMERINDIAN POPULATIONS; BANTU EXPANSIONS; SOUTH-AMERICA; Y-CHROMOSOME; MTDNA; ANCESTRY; ORIGIN; EVOLUTIONARY	Only a few genetic studies have been carried out to date in Bolivia. However, some of the most important (pre)historical enclaves of South America were located in these territories. Thus, the (sub)-Andean region of Bolivia was part of the Inca Empire, the largest state in Pre-Columbian America. We have genotyped the first hypervariable region (HVS-I) of 720 samples representing the main regions in Bolivia, and these data have been analyzed in the context of other pan-American samples (>19,000 HVS-I mtDNAs). Entire mtDNA genome sequencing was also undertaken on selected Native American lineages. Additionally, a panel of 46 Ancestry Informative Markers (AIMs) was genotyped in a sub-set of samples. The vast majority of the Bolivian mtDNAs (98.4%) were found to belong to the main Native American haplogroups (A: 14.3%, B: 52.6%, C: 21.9%, D: 9.6%), with little indication of sub-Saharan and/or European lineages; however, marked patterns of haplogroup frequencies between main regions exist (e. g. haplogroup B: Andean [71%], Sub-Andean [61%], Llanos [32%]). Analysis of entire genomes unraveled the phylogenetic characteristics of three Native haplogroups: the pan-American haplogroup B2b (originated similar to 21.4 thousand years ago [kya]), A2ah (similar to 5.2 kya), and B2o (similar to 2.6 kya). The data suggest that B2b could have arisen in North California (an origin even in the north most region of the American continent cannot be disregarded), moved southward following the Pacific coastline and crossed Meso-America. Then, it most likely spread into South America following two routes: the Pacific path towards Peru and Bolivia (arriving here at about similar to 15.2 kya), and the Amazonian route of Venezuela and Brazil southwards. In contrast to the mtDNA, Ancestry Informative Markers (AIMs) reveal a higher (although geographically variable) European introgression in Bolivians (25%). Bolivia shows a decreasing autosomal molecular diversity pattern along the longitudinal axis, from the Altiplano to the lowlands. Both autosomes and mtDNA revealed a low impact (1-2%) of a sub-Saharan component in Bolivians.	[Taboada-Echalar, Patricia; Alvarez-Iglesias, Vanesa; Heinz, Tanja; Vidal-Bralo, Laura; Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Pastoriza, Ana; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Unidade Xenet, Galicia, Spain; [Taboada-Echalar, Patricia; Alvarez-Iglesias, Vanesa; Heinz, Tanja; Vidal-Bralo, Laura; Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Pastoriza, Ana; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Galicia, Spain; [Torres-Balanza, Antonio; Rocabado, Omar] Fiscali Gen Estado Plurinacl Bolivia, Inst Invest Forenses, La Paz, Bolivia; [Catelli, Laura; Vullo, Carlos] Equipo Argentino Antropol Forense, Cordoba, Argentina; [Vullo, Carlos] Lab Inmunogenet & Diagnost Mol, Cordoba, Argentina	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Unidade Xenet, Galicia, Spain.	antonio.salas@usc.es	Carracedo, Angel/D-4257-2012; Gómez-Carballa, Alberto/I-4610-2014; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Pardo-Seco, Jacobo J/G-3752-2016	Carracedo, Angel/0000-0003-1085-8986; Gómez-Carballa, Alberto/0000-0003-0927-1272; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Pardo-Seco, Jacobo J/0000-0002-8059-8908; VULLO, CARLOS/0000-0002-1950-7667	European Union under REA [290344]; Ministerio de Ciencia e Innovacion [SAF2008-02971]; Plan Galego IDT, Xunta de Galicia [EM 2012/045]	European Union under REA; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT, Xunta de Galicia	The research leading to these results has received funding from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7/2007-2013/under REA grant agreement no 290344, and the grants from the "Ministerio de Ciencia e Innovacion'' (SAF2008-02971) and from the Plan Galego IDT, Xunta de Galicia (EM 2012/045) given to A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2012, INT J LEGAL MED, V126, P901, DOI 10.1007/s00414-012-0762-y; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Barbieri C, 2011, AM J HUM BIOL, V23, P89, DOI 10.1002/ajhb.21107; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3; Bert F, 2004, ANN HUM BIOL, V31, P9, DOI 10.1080/03014460310001616464; Bobillo M.C., 2010, INT J LEGAL MED, V74, P65; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Bortolini MC, 1997, AM J PHYS ANTHROPOL, V103, P147, DOI 10.1002/(SICI)1096-8644(199706)103:2<147::AID-AJPA1>3.0.CO;2-R; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Cann HM, 2002, SCIENCE, V296, P261; Carvajal-Carmona LG, 2000, AM J HUM GENET, V67, P1287, DOI 10.1016/S0002-9297(07)62956-5; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Cerezo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007902; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Corella A, 2007, ANN HUM BIOL, V34, P34, DOI 10.1080/03014460601075819; Costa HA, 2010, J FORENSIC LEG MED, V17, P247, DOI 10.1016/j.jflm.2010.02.011; de St Pierre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051311; Dornelles CL, 2004, AM J HUM BIOL, V16, P479, DOI 10.1002/ajhb.20038; EXCOFFIER L, 1992, GENETICS, V131, P479; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Falush D, 2003, GENETICS, V164, P1567; Fuselli S, 2003, MOL BIOL EVOL, V20, P1682, DOI 10.1093/molbev/msg188; Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554; Gaya-Vidal M, 2011, AM J PHYS ANTHROPOL, V145, P215, DOI 10.1002/ajpa.21487; GINTHER C, 1993, EXS, V67, P211; Gomez-Carballa A, 2012, AM J PHYS ANTHROPOL, V147, P78, DOI 10.1002/ajpa.21629; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Heinz T, 2012, FORENSIC SCI I UNPUB; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Li H, 2007, AM J PHYS ANTHROPOL, V134, P481, DOI 10.1002/ajpa.20690; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Molina Barrios R, 2005, PUEBLOS INDIGENAS BO; Monson K.L., 2002, FORENSIC SCI COMMUNI, V4; Murray-McIntosh RP, 1998, P NATL ACAD SCI USA, V95, P9047, DOI 10.1073/pnas.95.15.9047; Perego UA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038337; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Pereira R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029684; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Reich D, 2012, NATURE IN PRESS; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2012, FORENSIC SCI INT-GEN, V6, pE182, DOI 10.1016/j.fsigen.2012.06.015; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; [Team TRC TheR.C.T.], 2012, R LANG ENV STAT COMP; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Watkins WS, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-39	71	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58980	10.1371/journal.pone.0058980	http://dx.doi.org/10.1371/journal.pone.0058980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527064	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600049
J	Cowper-Smith, CD; Harris, J; Eskes, GA; Westwood, DA				Cowper-Smith, Christopher D.; Harris, Jonathan; Eskes, Gail A.; Westwood, David A.			Spatial Interactions between Successive Eye and Arm Movements: Signal Type Matters	PLOS ONE			English	Article							MOTOR CORTEX; SUPERIOR COLLICULUS; TARGET SELECTION; INHIBITION; RETURN; ORGANIZATION; STIMULATION; LOCATIONS; VOLUNTARY; DIRECTION	Spatial interactions between consecutive movements are often attributed to inhibition of return (IOR), a phenomenon in which responses to previously signalled locations are slower than responses to unsignalled locations. In two experiments using peripheral target signals offset by 0 degrees, 90 degrees, or 180 degrees, we show that consecutive saccadic (Experiment 1) and reaching (Experiment 3) responses exhibit a monotonic pattern of reaction times consistent with the currently established spatial distribution of IOR. In contrast, in two experiments with central target signals (i.e., arrowheads pointing at target locations), we find a non-monotonic pattern of reaction times for saccades (Experiment 2) and reaching movements (Experiment 4). The difference in the patterns of results observed demonstrates different behavioral effects that depend on signal type. The pattern of results observed for central stimuli are consistent with a model in which neural adaptation is occurring within motor networks encoding movement direction in a distributed manner.	[Cowper-Smith, Christopher D.; Eskes, Gail A.; Westwood, David A.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [Harris, Jonathan; Westwood, David A.] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada; [Eskes, Gail A.] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Westwood, DA (corresponding author), Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada.	David.Westwood@DAL.CA		Westwood, David/0000-0003-3317-0447; Eskes, Gail/0000-0001-5867-9616	Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS); Dalhousie Faculty of Medicine Clinical Research Scholar Award; CIHR New Investigator Award; NSERC Discovery Grant	Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS)(Canadian Institutes of Health Research (CIHR)); Dalhousie Faculty of Medicine Clinical Research Scholar Award; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	CCS was supported by studentships from the Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS). GA was supported by a Dalhousie Faculty of Medicine Clinical Research Scholar Award, and DAW was supported by a CIHR New Investigator Award and an NSERC Discovery Grant; these grants also supported the research itself. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Bennett PJ, 2001, PSYCHOL SCI, V12, P76, DOI 10.1111/1467-9280.00313; Berlucchi G, 2006, COGN NEUROPSYCHOL, V23, P1065, DOI 10.1080/02643290600588426; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Cowper-Smith CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013330; Crapse TB, 2009, J NEUROSCI, V29, P5308, DOI 10.1523/JNEUROSCI.4906-08.2009; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Eisenberg M, 2010, J NEUROSCI, V30, P8897, DOI 10.1523/JNEUROSCI.0007-10.2010; Fecteau JH, 2005, J COGNITIVE NEUROSCI, V17, P1714, DOI 10.1162/089892905774589235; Fischer MH, 2003, PERCEPT PSYCHOPHYS, V65, P379, DOI 10.3758/BF03194569; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; Machado L, 2004, Q J EXP PSYCHOL-A, V57, P789, DOI 10.1080/02724980343000486; Macinnes Joseph W, 2003, ScientificWorldJournal, V3, P75; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; MAYLOR EA, 1985, J EXP PSYCHOL HUMAN, V11, P777, DOI 10.1037/0096-1523.11.6.777; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3231, DOI 10.1152/jn.00487.2006; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; PRATT J, 1995, J EXP PSYCHOL HUMAN, V21, P1343, DOI 10.1037/0096-1523.21.6.1343; Pratt J, 1998, CAN J EXP PSYCHOL, V52, P213, DOI 10.1037/h0087294; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; RAFAL R, 1994, CAN J EXP PSYCHOL, V48, P284, DOI 10.1037/1196-1961.48.2.284; RAFAL RD, 1989, J EXP PSYCHOL HUMAN, V15, P673, DOI 10.1037/0096-1523.15.4.673; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Satel J, 2012, EXP BRAIN RES, V223, P469, DOI 10.1007/s00221-012-3274-6; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; Schneider WX, 1995, VISUAL SELECTIVE ATTENTION, P331, DOI 10.1080/13506289508401737; Snyder JJ, 2001, J EXP PSYCHOL HUMAN, V27, P1420, DOI 10.1037//0096-1523.27.6.1420; Spalek TM, 2005, PSYCHOL SCI, V16, P15, DOI 10.1111/j.0956-7976.2005.00774.x; Taylor TL, 1998, PSYCHON B REV, V5, P625, DOI 10.3758/BF03208839; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639; Tipper SP, 1996, J EXP PSYCHOL HUMAN, V22, P1289, DOI 10.1037//0096-1523.22.5.1289; Wang ZG, 2012, EXP BRAIN RES, V218, P441, DOI 10.1007/s00221-012-3033-8	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58850	10.1371/journal.pone.0058850	http://dx.doi.org/10.1371/journal.pone.0058850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527038	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100051
J	Liu, XQ; Liu, Y; Zhang, YJ; Chen, ZH; Tang, ZW; Xu, QQ; Wang, Y; Zhao, P; Qi, ZT				Liu, Xiaoqing; Liu, Yuan; Zhang, Yanjun; Chen, Zhihui; Tang, Ziwei; Xu, Qingqiang; Wang, Yue; Zhao, Ping; Qi, Zhongtian			Pre-Existing Immunity with High Neutralizing Activity to 2009 Pandemic H1N1 Influenza Virus in Shanghai Population	PLOS ONE			English	Article							MATCHING PATTERNS; HEMAGGLUTININ; NEURAMINIDASE; TRANSMISSION; INFECTION; VACCINES; H5N1	Pre-existing immunity is an important factor countering the pandemic potential of an emerging influenza virus strain. Thus, studying of pre-existing immunity to the 2009 pandemic H1N1 virus (2009 H1N1) will advance our understanding of the pathogenesis and epidemiology of this emerging pathogen. In the present study, sera were collected from 486 individuals in a hospital in Shanghai, China, before the 2009 H1N1 influenza pandemic. The serum anti-hemagglutinins (HA) antibody, hemagglutination inhibition (HI) antibody and neutralizing antibody against the 2009 H1N1 were assayed. Among this population, 84.2%, 14.61% and 26.5% subjects possessed anti-HA antibody, HI antibody and neutralizing antibody, respectively. Although neutralizing antibody only existed in those sera with detectable anti-HA antibody, there was no obvious correlation between the titers of anti-HA and neutralizing antibody. However, the titers of anti-HA and neutralizing antibody against seasonal H1N1 virus were highly correlated. In the same population, there was no correlation between titers of neutralizing antibody against 2009 H1N1 and seasonal H1N1. DNA immunization performed on mice demonstrated that antibodies to the HA of 2009 pandemic and seasonal H1N1 influenza viruses were strain-specific and had no cross-neutralizing activity. In addition, the predicted conserved epitope in the HA of 2009 H1N1 and recently circulating seasonal H1N1 virus, GLFGAIAGFIE, was not an immunologically valid B-cell epitope. The data in this report are valuable for advancing our understanding of 2009 H1N1 influenza virus infection.	[Liu, Xiaoqing; Liu, Yuan; Zhang, Yanjun; Tang, Ziwei; Xu, Qingqiang; Zhao, Ping; Qi, Zhongtian] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China; [Chen, Zhihui] Second Mil Med Univ, Dept Infect Dis, Changhai Hosp, Shanghai, Peoples R China; [Wang, Yue] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Naval Medical University; Naval Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	euy-tokyo@umin.ac.jp; pnzhao@163.com; qizt@smmu.edu.cn			Natural Science Foundation of China [81071364, 31170150]; Shanghai Leading Academic Discipline Project [B901]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by research grants from Natural Science Foundation of China (81071364, 31170150) and Shanghai Leading Academic Discipline Project (B901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Cao JY, 2009, HEPATOL INT, V3, P356, DOI 10.1007/s12072-008-9116-8; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Democratis J, 2006, J ANTIMICROB CHEMOTH, V58, P911, DOI 10.1093/jac/dkl376; DOWDLE WR, 1977, J INFECT DIS, V136, pS386, DOI 10.1093/infdis/136.Supplement_3.S386; Du N, 2010, J VIROL, V84, P7822, DOI 10.1128/JVI.00069-10; Fang J, 2011, J VIROL METHODS, V173, P314, DOI 10.1016/j.jviromet.2011.03.001; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kwan-Gett TS, 2009, DISASTER MED PUBLIC, V3, pS109, DOI 10.1097/DMP.0b013e3181c6b818; Lemaitre M, 2011, CLIN MICROBIOL INFEC, V17, P732, DOI 10.1111/j.1469-0691.2010.03352.x; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V390, P1305, DOI 10.1016/j.bbrc.2009.10.142; Liu YA, 2010, VACCINE, V29, P183, DOI 10.1016/j.vaccine.2010.10.059; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Mathews JD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-128; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Subbarao K, 1999, ADV VIRUS RES, V54, P349, DOI 10.1016/S0065-3527(08)60371-1; Tang JW, 2010, EMERG INFECT DIS, V16, P874, DOI 10.3201/eid1605.091678; Taubenberger JK, 2007, ANTIVIR THER, V12, P581; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015825; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Zhang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009167; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040	43	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58810	10.1371/journal.pone.0058810	http://dx.doi.org/10.1371/journal.pone.0058810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527030	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100045
J	Pauliah, SS; Shankaran, S; Wade, A; Cady, EB; Thayyil, S				Pauliah, Shreela S.; Shankaran, Seetha; Wade, Angie; Cady, Ernest B.; Thayyil, Sudhin			Therapeutic Hypothermia for Neonatal Encephalopathy in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; RANDOMIZED-CONTROLLED-TRIAL; LOW-RESOURCE SETTINGS; PERINATAL ASPHYXIA; NEWBORN-INFANTS; MILD HYPOTHERMIA; TERM; OUTCOMES; OPINION; DEATHS	Although selective or whole body cooling combined with optimal intensive care improves outcomes following neonatal encephalopathy in high-income countries, the safety and efficacy of cooling in low-and middle-income countries is not known. Objective: We performed a systematic review and meta-analysis of all published randomised or quasi-randomised controlled trials of cooling therapy for neonatal encephalopathy in low-and middle-income countries. Results: Seven trials, comprising a total of 567 infants were included in the meta-analysis. Most study infants had mild (15%) or moderate encephalopathy (48%) and did not receive invasive ventilation (88%). Cooling devices included water-circulating cooling caps, frozen gel packs, ice, water bottles, and phase-changing material. No statistically significant reduction in neonatal mortality was seen with cooling (risk ratio: 0.74, 95% confidence intervals: 0.44 to 1.25). Data on other neonatal morbidities and long-term neurological outcomes were insufficient. Conclusion: Cooling therapy was not associated with a statistically significant reduction in neonatal mortality in low-and middle-income countries although the confidence intervals were wide and not incompatible with results seen in high-income countries. The apparent lack of treatment effect may be due to the heterogeneity and poor quality of the included studies, inefficiency of the low technology cooling devices, lack of optimal neonatal intensive care, sedation and ventilatory support, overuse of oxygen, or may be due to the intrinsic difference in the population, for example higher rates of perinatal infection, obstructed labor, intrauterine growth retardation and maternal malnutrition. Evaluation of the safety and efficacy of cooling in adequately powered randomised controlled trials is required before cooling is offered in routine clinical practice in low-and middle-income countries.	[Pauliah, Shreela S.; Thayyil, Sudhin] UCL, Inst Womens Hlth, London, England; [Shankaran, Seetha] Wayne State Univ, Childrens Hosp Michigan, Sch Med, Detroit, MI USA; [Shankaran, Seetha] Hutzel Womens Hosp, Detroit, MI USA; [Wade, Angie] UCL, Inst Child Hlth, London, England; [Cady, Ernest B.] Univ Coll Hosp NHS Fdn Trust, London, England	University of London; University College London; Children's Hospital of Michigan; Wayne State University; University of London; University College London; University of London; University College London	Thayyil, S (corresponding author), UCL, Inst Womens Hlth, London, England.	s.thayyil@ucl.ac.uk		Thayyil, Sudhin/0000-0001-8795-5165	National Institute for Health Research [NIHR/CS/010/022] Funding Source: researchfish; Department of Health [NIHR/CS/010/022] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Akisu M, 2003, PROSTAG LEUKOTR ESS, V69, P45, DOI 10.1016/S0952-3278(03)00055-3; Bharadwaj SK, 2012, J TROP PEDIATRICS, V58, P382, DOI 10.1093/tropej/fms005; Bhat MA, 2006, ARCH DIS CHILD-FETAL, V91, pF464, DOI 10.1136/fnn.2006.097915; Blackmon L, 2004, PEDIATRICS, V114, P1341, DOI 10.1542/peds.2004-1697; Dalen ML, 2012, PEDIATR RES, V71, P247, DOI 10.1038/pr.2011.43; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Higgins RD, 2011, J PEDIATR-US, V159, P851, DOI 10.1016/j.jpeds.2011.08.004; Horn AR, 2006, SAMJ S AFR MED J, V96, P976; Horn AR, 2010, J TROP PEDIATRICS, V56, P172, DOI 10.1093/tropej/fmp089; Horn A, 2009, PEDIATRICS, V123, pE1090, DOI 10.1542/peds.2007-3766; Horn AR, 2012, J TROP PEDIATRICS, V58, P236, DOI 10.1093/tropej/fmr069; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Joolay Y, 2012, J PERINAT MED, V40, P447, DOI 10.1515/jpm-2011-0292; Kapetanakis A, 2009, ACTA PAEDIATR, V98, P631, DOI 10.1111/j.1651-2227.2008.01159.x; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS123, DOI 10.1016/j.ijgo.2009.07.021; Li Tongchuan, 2009, Hosp Pract (1995), V37, P147, DOI 10.3810/hp.2009.12.269; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; Mullany LC, 2010, SEMIN PERINATOL, V34, P426, DOI 10.1053/j.semperi.2010.09.007; Rajhans A, 2012, WHOLE BODY HYPOTHERM; Regier DA, 2010, VALUE HEALTH, V13, P695, DOI 10.1111/j.1524-4733.2010.00731.x; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Robertson NJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-138; Robertson NJ, 2010, SEMIN FETAL NEONAT M, V15, P276, DOI 10.1016/j.siny.2010.03.006; See K C, 2012, Med J Malaysia, V67, P265; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tann C, 2010, PED AC SOC ANN M VAN; Thayyil S, 2013, HYPOTHERMIA ENCEPHAL; Thayyil S, 2010, ARCH DIS CH IN PRESS; Thomas N, 2011, INDIAN PEDIATR, V48, P445, DOI 10.1007/s13312-011-0076-z; Thompson CM, 1997, ACTA PAEDIATR, V86, P757, DOI 10.1111/j.1651-2227.1997.tb08581.x; Thoresen M, 2001, PEDIATR RES, V50, P405, DOI 10.1203/00006450-200109000-00017; Wilkinson DJ, 2011, ARCH DIS CHILD-FETAL, V96, pF75, DOI 10.1136/adc.2010.184689; World Bank, 2011, WE CLASS COUNTR; Zhou WH, 2010, J PEDIATR-US, V157, P367, DOI 10.1016/j.jpeds.2010.03.030	37	116	117	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58834	10.1371/journal.pone.0058834	http://dx.doi.org/10.1371/journal.pone.0058834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527034	Green Published, gold			2022-12-27	WOS:000317562100049
J	Reyal, F; Hajage, D; Savignoni, A; Feron, JG; Bollet, MA; Kirova, Y; Fourquet, A; Pierga, JY; Cottu, P; Dieras, V; Fourchotte, V; Laki, F; Alran, S; Asselain, B; Vincent-Salomon, A; Sigal-Zafrani, B; Sastre-Garau, X				Reyal, Fabien; Hajage, David; Savignoni, Alexia; Feron, Jean-Guillaume; Bollet, Marc Andrew; Kirova, Youlia; Fourquet, Alain; Pierga, Jean-Yves; Cottu, Paul; Dieras, Veronique; Fourchotte, Virginie; Laki, Fatima; Alran, Severine; Asselain, Bernard; Vincent-Salomon, Anne; Sigal-Zafrani, Brigitte; Sastre-Garau, Xavier			Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; HIGH-DOSE CHEMOTHERAPY; CONSERVING THERAPY; LOCAL RECURRENCE; ADJUVANT THERAPY; CANCER PATIENTS; MARGIN STATUS; RISK-FACTORS; HER2 STATUS; SURVIVAL	Background: Molecular signatures may become of use in clinical practice to assess the prognosis of breast cancers. However, although international consensus conferences sustain the use of these new markers in the near future, concerns remain about their degree of discordance and cost-effectiveness in different international settings. The present study aims to validate Ki67 as prognostic factor in a large cohort of early-stage (pT1-pT2, pN0) breast cancer patients. Methods: 456 patients treated in 1995-1996 were identified in the Institut Curie database. Ki67 (MIB1) was retrospectively assessed by immunohistochemistry for all cases. The prognostic value of this index was compared to that of histological grade (HG), Estrogen receptor (ER) and HER2 status. Distant disease free interval, loco-regional recurrence, time-lapse from first metastatic diagnosis to death were analyzed. Results: All 456 patients were treated by lumpectomy plus axillary dissection and radiotherapy. 27 patients (5.9%) received systemic treatment. Tumors were classified as HG1 in 35%, HG2 in 42% and HG3 in 23% of cases. ER was expressed in 86% of the tumors, HER2 in 5% and 14% were triple negative. The median follow-up was 151 [5-191] months. Distant and loco-regional disease recurrences were observed in 16% and 18%, respectively. High (>20%) Ki67 rate [HR = 3 (1.8-4.8), p < 10-206] and HG3 [HR = 4.4 (2.2-8.6), p = 0.00002] were associated with an increased rate of distant relapse. In multivariate analysis, the Ki67 remained the only significant prognostic factor in the subgroups of ER positive HER2 negative [HR = 2.6 (1.5-4.6), p = 0.0006] and ER positive HER2 negative HG2 tumors [HR = 2.2 (1.01-4.8), p = 0.04]. Conclusions: We validate the prognosis value of the Ki67 rate in small size node negative breast cancer. We conclude that Ki67 is a potential cost-effective decision marker for adjuvant therapy in early-stage HG2, pT1-pT2, pN0, breast cancers.	[Reyal, Fabien; Feron, Jean-Guillaume; Fourchotte, Virginie; Laki, Fatima; Alran, Severine] Inst Curie, Dept Surg, Paris, France; [Hajage, David; Savignoni, Alexia; Asselain, Bernard] Inst Curie, Dept Biostat, Paris, France; [Bollet, Marc Andrew; Kirova, Youlia; Fourquet, Alain] Inst Curie, Dept Radiat Oncol, Paris, France; [Pierga, Jean-Yves; Cottu, Paul; Dieras, Veronique] Inst Curie, Dept Med Oncol, Paris, France; [Vincent-Salomon, Anne; Sigal-Zafrani, Brigitte; Sastre-Garau, Xavier] Inst Curie, Dept Tumor Biol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Sastre-Garau, X (corresponding author), Inst Curie, Dept Tumor Biol, Paris, France.	Xavier.sastre@curie.net	Cottu, Paul/ABC-8595-2020; Hajage, David/D-5226-2014	Hajage, David/0000-0002-8475-4090; Sastre-Garau, Xavier/0000-0001-5992-2083				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; Balaton A. J., 1995, Archives d'Anatomie et de Cytologie Pathologiques, V43, P93; Balaton AJ, 1996, ANN PATHOL, V16, P144; Blamey RW, 2007, EUR J CANCER, V43, P1548, DOI 10.1016/j.ejca.2007.01.016; Bollet MA, 2007, RADIOTHER ONCOL, V82, P272, DOI 10.1016/j.radonc.2007.01.001; Bollet MA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2343; Chang J, 2003, CANCER-AM CANCER SOC, V97, P545, DOI 10.1002/cncr.11083; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chia S, 2008, J CLIN ONCOL, V26, P5697, DOI 10.1200/JCO.2007.15.8659; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Colozza M, 2010, LANCET ONCOL, V11, P414, DOI 10.1016/S1470-2045(10)70089-9; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Elston C W, 2002, Histopathology, V41, P154; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; FOURQUET A, 1989, INT J RADIAT ONCOL, V17, P719, DOI 10.1016/0360-3016(89)90057-6; Freedman G, 1999, INT J RADIAT ONCOL, V44, P1005, DOI 10.1016/S0360-3016(99)00112-1; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Goldstein NS, 2003, AM J CLIN PATHOL, V120, P500, DOI 10.1309/8941VDAJMKY2GCLX; HORTOBAGYI GN, 1983, J CLIN ONCOL, V1, P776, DOI 10.1200/JCO.1983.1.12.776; Ikeda, 1999, Breast Cancer, V6, P93, DOI 10.1007/BF02966914; Jobsen JJ, 2003, INT J RADIAT ONCOL, V57, P724, DOI 10.1016/S0360-3016(03)00644-8; Kini VR, 1999, INT J RADIAT ONCOL, V43, P341, DOI 10.1016/S0360-3016(98)00395-2; Komoike Y, 2006, CANCER-AM CANCER SOC, V106, P35, DOI 10.1002/cncr.21551; Kreike B, 2008, INT J RADIAT ONCOL, V71, P1014, DOI 10.1016/j.ijrobp.2007.11.029; Kreike B, 2009, CLIN CANCER RES, V15, P4181, DOI 10.1158/1078-0432.CCR-08-2644; KURTZ JM, 1990, J CLIN ONCOL, V8, P591, DOI 10.1200/JCO.1990.8.4.591; Livi L, 2007, RADIOTHER ONCOL, V82, P287, DOI 10.1016/j.radonc.2006.11.009; McGrath S, 2010, AM J CLIN ONCOL-CANC, V33, P17, DOI 10.1097/COC.0b013e31819cccc3; Neuschatz AC, 2003, CANCER, V97, P30, DOI 10.1002/cncr.10981; Oh JL, 2006, INT J RADIAT ONCOL, V65, P1345, DOI 10.1016/j.ijrobp.2006.03.028; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Penault-Llorca F, 2010, ANN PATHOL, V30, P357, DOI 10.1016/j.annpat.2010.07.001; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Rizzieri DA, 1999, J CLIN ONCOL, V17, P3064, DOI 10.1200/JCO.1999.17.10.3064; Rowlings PA, 1999, JAMA-J AM MED ASSOC, V282, P1335, DOI 10.1001/jama.282.14.1335; SCHNITT SJ, 1994, CANCER, V74, P1746, DOI 10.1002/1097-0142(19940915)74:6<1746::AID-CNCR2820740617>3.0.CO;2-Y; SMITT MC, 1995, CANCER-AM CANCER SOC, V76, P259, DOI 10.1002/1097-0142(19950715)76:2<259::AID-CNCR2820760216>3.0.CO;2-2; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; VANDIEST PJ, 1992, PATHOL RES PRACT, V188, P405, DOI 10.1016/S0344-0338(11)80027-0; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Wazer DE, 1998, INT J RADIAT ONCOL, V40, P851, DOI 10.1016/S0360-3016(97)00861-4; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	53	26	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e55901	10.1371/journal.pone.0055901	http://dx.doi.org/10.1371/journal.pone.0055901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526930	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100004
J	Vrijens, K; Lin, WW; Cui, J; Farmer, D; Low, J; Pronier, E; Zeng, FY; Shelat, AA; Guy, K; Taylor, MR; Chen, TS; Roussel, MF				Vrijens, Karen; Lin, Wenwei; Cui, Jimmy; Farmer, Dana; Low, Jonathan; Pronier, Elodie; Zeng, Fu-Yue; Shelat, Anang A.; Guy, Kiplin; Taylor, Michael R.; Chen, Taosheng; Roussel, Martine F.			Identification of Small Molecule Activators of BMP Signaling	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; CEREBELLAR GRANULE NEURONS; ZEBRAFISH EMBRYO; HEDGEHOG PATHWAY; STEM-CELL; IN-VIVO; MEDULLOBLASTOMA; DIFFERENTIATION; RECEPTOR; PROLIFERATION	Bone Morphogenetic Proteins (BMPs) are morphogens that play a major role in regulating development and homeostasis. Although BMPs are used for the treatment of bone and kidney disorders, their clinical use is limited due to the supra-physiological doses required for therapeutic efficacy causing severe side effects. Because recombinant BMPs are expensive to produce, small molecule activators of BMP signaling would be a cost-effective alternative with the added benefit of being potentially more easily deliverable. Here, we report our efforts to identify small molecule activators of BMP signaling. We have developed a cell-based assay to monitor BMP signaling by stably transfecting a BMP-responsive human cervical carcinoma cell line (C33A) with a reporter construct in which the expression of luciferase is driven by a multimerized BMP-responsive element from the Id1 promoter. A BMP-responsive clone C33A-2D2 was used to screen a bioactive library containing similar to 5,600 small molecules. We identified four small molecules of the family of flavonoids all of which induced luciferase activity in a dose-dependent manner and ventralized zebrafish embryos. Two of the identified compounds induced Smad1, 5 phosphorylation (P-Smad), Id1 and Id2 expression in a dose-dependent manner demonstrating that our assays identified small molecule activators of BMP signaling.	[Vrijens, Karen; Farmer, Dana; Pronier, Elodie; Roussel, Martine F.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Lin, Wenwei; Cui, Jimmy; Low, Jonathan; Zeng, Fu-Yue; Shelat, Anang A.; Guy, Kiplin; Taylor, Michael R.; Chen, Taosheng] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Pronier, Elodie] Inst Gustave Roussy, INSERM, U1009, F-94805 Villejuif, France	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Roussel, MF (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA.	martine.roussel@stjude.org	Shelat, Anang/J-4995-2013; Lin, Wenwei/D-9241-2018; Roussel, Martine F/F-1469-2016; Taylor, Michael/K-1379-2013; Chen, Taosheng/I-6351-2013	Shelat, Anang/0000-0002-6266-2910; Lin, Wenwei/0000-0001-8754-6150; Roussel, Martine F/0000-0002-1740-8139; Chen, Taosheng/0000-0001-6420-3809	National Institutes of Health [CA-096832, CA-21765]; James McDonnell Foundation; Jennifer Lynn Keith American Brain Tumor Association Basic Research Fellowship; American Association for Cancer Research-Astellas United States of America Foundation Fellowship in Basic Cancer Research; American Lebanese-Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James McDonnell Foundation; Jennifer Lynn Keith American Brain Tumor Association Basic Research Fellowship; American Association for Cancer Research-Astellas United States of America Foundation Fellowship in Basic Cancer Research; American Lebanese-Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by grants from the National Institutes of Health CA-096832 (MFR) and Core Grant CA-21765 (MFR, TC, KG), the James McDonnell Foundation www.jsmf.org (MFR), the Jennifer Lynn Keith American Brain Tumor Association Basic Research Fellowship www.abta.org (KV), the American Association for Cancer Research-Astellas United States of America Foundation Fellowship in Basic Cancer Research www.aacr.org (KV), and the American Lebanese-Syrian Associated Charities of St. Jude Children's Research Hospital www.stjude.org. No individuals from the funders contributed to this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Androutsopoulos V, 2009, CANCER LETT, V274, P54, DOI 10.1016/j.canlet.2008.08.032; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bresnihan B, 1999, J RHEUMATOL, V26, P717; BURING K, 1970, CALC TISS RES, V4, P102, DOI 10.1007/BF02152374; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen Y, 1997, P NATL ACAD SCI USA, V94, P12938, DOI 10.1073/pnas.94.24.12938; Cooper BJ, 2006, J BIOL CHEM, V281, P22471, DOI 10.1074/jbc.M602520200; Dale L, 1999, BIOESSAYS, V21, P751, DOI 10.1002/(SICI)1521-1878(199909)21:9<751::AID-BIES6>3.0.CO;2-I; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Fisher S, 1997, DEVELOPMENT, V124, P1301; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Gottfried ON, 2008, NEUROSURGERY, V63, P380, DOI 10.1227/01.NEU.0000324990.04818.13; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Jeong J, 2010, KOREAN J UROL, V51, P511, DOI 10.4111/kju.2010.51.8.511; Kieran MW, 2010, J CLIN ONCOL, V28, P4783, DOI 10.1200/JCO.2010.28.3481; Kimura H, 2008, CANCER CELL, V13, P249, DOI 10.1016/j.ccr.2008.01.027; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Li GH, 2005, J BONE MINER RES, V20, P1611, DOI 10.1359/JBMR.050513; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Makita H, 1996, CANCER RES, V56, P4904; Mirzoeva S, 2008, MOL CARCINOGEN, V47, P686, DOI 10.1002/mc.20421; Moustakas A, 2002, GENE DEV, V16, P1867, DOI 10.1101/gad.1016802; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Oetgen ME, 2010, J PEDIATR ORTHOPED, V30, P192, DOI 10.1097/BPO.0b013e3181d075ab; Pardridge William M, 2005, NeuroRx, V2, P3; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Pinho RS, 2011, J PEDIAT HEMATOL ONC, V33, P605, DOI 10.1097/MPH.0b013e31822031d9; Reddi AH, 2009, CYTOKINE GROWTH F R, V20, P341, DOI 10.1016/j.cytogfr.2009.10.015; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shin GC, 2009, CHEM-BIOL INTERACT, V182, P29, DOI 10.1016/j.cbi.2009.07.016; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Tsukamoto S, 2005, BIOL PHARM BULL, V28, P2000, DOI 10.1248/bpb.28.2000; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; VUKICEVIC S, 1989, P NATL ACAD SCI USA, V86, P8793, DOI 10.1073/pnas.86.22.8793; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang J, 2010, CIRC RES, V107, P252, DOI 10.1161/CIRCRESAHA.109.209940; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	53	48	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59045	10.1371/journal.pone.0059045	http://dx.doi.org/10.1371/journal.pone.0059045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527084	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562100069
J	Cohen, N; Kravchenko-Balasha, N; Klein, S; Levitzki, A				Cohen, Noam; Kravchenko-Balasha, Nataly; Klein, Shoshana; Levitzki, Alexander			Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development-The Same Tumor by Different Means	PLOS ONE			English	Article							TYROSINE KINASE; CANCER; ARCHITECTURE; INFLAMMATION; PROGRESSION	Transformation is a complex process, involving many changes in the cell. In this work, we investigated the transcriptional changes that arose during the development of squamous cell carcinoma (SCC) in mice. Using microarray analysis, we looked at gene expression during different stages in cancer progression in 31 mice. By analyzing tumor progression in each mouse separately, we were able to define the global changes that were common to all 31 mice, as well as significant changes that occurred in fewer individuals. We found that different genes can contribute to the tumorigenic process in different mice, and that there are many ways to acquire the malignant properties defined by Hanahan and Weinberg as "hallmarks of cancer''. Eventually, however, all these changes lead to a very similar cancerous phenotype. The finding that gene expression is strongly heterogeneous in tumors that were induced by a standardized protocol in closely related mice underscores the need for molecular characterization of human tumors and personalized therapy.	[Cohen, Noam; Kravchenko-Balasha, Nataly; Klein, Shoshana; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel.	alex.levitzki@mail.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479	European Research Council under the European Union [249898]	European Research Council under the European Union(European Research Council (ERC))	Funding provided by a grant from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 249898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2009, CANCER-AM CANCER SOC, V115, P5421, DOI 10.1002/cncr.24616; Awada A, 2012, CURR OPIN ONCOL, V24, P297, DOI 10.1097/CCO.0b013e3283521349; Blay JY, 2012, LANCET ONCOL, V13, P448, DOI 10.1016/S1470-2045(12)70156-0; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Croteau W, 2013, J CELL PHYSIOL, V228, P773, DOI 10.1002/jcp.24225; Druker BJ, 2002, ONCOGENE, V21, P8541, DOI 10.1038/sj.onc.1206081; Fujii H, 2000, CANCER RES, V60, P114; Gagnon-Bartsch J, 2011, BIOSTATISTICS; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Klein S, 2007, ADV CANCER RES, V97, P295, DOI 10.1016/S0065-230X(06)97013-4; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Levitzki A, 2010, MOL ASPECTS MED, V31, P287, DOI 10.1016/j.mam.2010.04.001; McDermott U, 2009, J CLIN ONCOL, V27, P5650, DOI 10.1200/JCO.2009.22.9054; Nistico P, 2012, COLD SPRING HARB PER, V4; PAPADAKIS E, 1992, INT J ONCOL, V1, P403; Popken-Harris P, 2006, VIRUS RES, V119, P177, DOI 10.1016/j.virusres.2006.01.006; Quigley DA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r5; Quigley DA, 2009, NATURE, V458, P505, DOI 10.1038/nature07683; Shi YZ, 2000, CLIN CANCER RES, V6, P4096; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Ton CC, 2011, BREAST CANCER RES TR, V125, P879, DOI 10.1007/s10549-010-1159-6; Veyrieras JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030629; Wu TD, 2001, J PATHOL, V195, P53, DOI 10.1002/1096-9896(200109)195:1<53::AID-PATH891>3.0.CO;2-H; Yauch RL, 2012, CURR OPIN GENET DEV, V22, P45, DOI 10.1016/j.gde.2012.01.003	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e57748	10.1371/journal.pone.0057748	http://dx.doi.org/10.1371/journal.pone.0057748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526950	gold, Green Published, Green Submitted			2022-12-27	WOS:000316411600005
J	Coudrain, V; Herzog, F; Entling, MH				Coudrain, Valerie; Herzog, Felix; Entling, Martin H.			Effects of Habitat Fragmentation on Abundance, Larval Food and Parasitism of a Spider-Hunting Wasp	PLOS ONE			English	Article							HYMENOPTERA CRABRONIDAE; STRUCTURAL CONNECTIVITY; POPULATION-DENSITY; INVESTMENT RATIOS; NATURAL ENEMIES; SEX-ALLOCATION; PREY SELECTION; LANDSCAPE; TRYPOXYLON; SPHECIDAE	Habitat fragmentation strongly affects species distribution and abundance. However, mechanisms underlying fragmentation effects often remain unresolved. Potential mechanisms are (1) reduced dispersal of a species or (2) altered species interactions in fragmented landscapes. We studied if abundance of the spider-hunting and cavity-nesting wasp Trypoxylon figulus Linnaeus (Hymenoptera: Crabronidae) is affected by fragmentation, and then tested for any effect of larval food (bottom up regulation) and parasitism (top down regulation). Trap nests of T. figulus were studied in 30 agricultural landscapes of the Swiss Plateau. The sites varied in the level of isolation from forest (adjacent, in the open landscape but connected, isolated) and in the amount of woody habitat (from 4 % to 74 %). We recorded wasp abundance (number of occupied reed tubes), determined parasitism of brood cells and analysed the diversity and abundance of spiders that were deposited as larval food. Abundances of T. figulus were negatively related to forest cover in the landscape. In addition, T. figulus abundances were highest at forest edges, reduced by 33.1% in connected sites and by 79.4% in isolated sites. The mean number of spiders per brood cell was lowest in isolated sites. Nevertheless, structural equation modelling revealed that this did not directly determine wasp abundance. Parasitism was neither related to the amount of woody habitat nor to isolation and did not change with host density. Therefore, our study showed that the abundance of T. figulus cannot be fully explained by the studied trophic interactions. Further factors, such as dispersal and habitat preference, seem to play a role in the population dynamics of this widespread secondary carnivore in agricultural landscapes.	[Coudrain, Valerie; Herzog, Felix] Res Stn Agroscope Reckenholz Tanikon ART, Zurich, Switzerland; [Coudrain, Valerie] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Coudrain, Valerie; Entling, Martin H.] Univ Koblenz Landau, Inst Environm Sci, Landau Pfalz, Germany	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; University of Bern; University of Koblenz & Landau	Coudrain, V (corresponding author), Res Stn Agroscope Reckenholz Tanikon ART, Zurich, Switzerland.	valerie.coudrain@art.admin.ch	Entling, Martin H/C-6953-2008; Herzog, Felix/B-1911-2009	Herzog, Felix/0000-0001-9472-4891	Swiss National Science Foundation [3100A0-114058]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation under grant number 3100A0-114058. http://www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2007, J ANIM ECOL, V76, P1015, DOI 10.1111/j.1365-2656.2007.01264.x; Arbuckle J. L., 2003, AMOS 5 0 1; ASIS JD, 1994, J KANSAS ENTOMOL SOC, V67, P199; Bailey D, 2010, J APPL ECOL, V47, P1003, DOI 10.1111/j.1365-2664.2010.01858.x; Barthel J, 1995, P 15 EUR C AR, P11; Bellmann H, 1995, BIENEN WESPEN AMEISE; Blackledge TA, 2003, ECOL LETT, V6, P13, DOI 10.1046/j.1461-0248.2003.00384.x; Boccaccio L, 2009, BIOCONTROL, V54, P607, DOI 10.1007/s10526-009-9214-0; Bogya S., 1999, Acta Phytopathologica et Entomologica Hungarica, V34, P99; Bonte D, 2008, ECOGRAPHY, V31, P646, DOI 10.1111/j.0906-7590.2008.05508.x; Bruckmann SV, 2011, J INSECT CONSERV, V15, P707, DOI 10.1007/s10841-010-9370-7; Bucher R, 2011, ECOL ENTOMOL, V36, P680, DOI 10.1111/j.1365-2311.2011.01317.x; Cooper JK, 2012, ECOLOGY LETT; COVILLE RE, 1983, J KANSAS ENTOMOL SOC, V56, P205; Cronin JT, 2005, P ROY SOC B-BIOL SCI, V272, P2225, DOI 10.1098/rspb.2005.3286; DANFORTH BN, 1990, BEHAV ECOL SOCIOBIOL, V27, P159, DOI 10.1007/BF00180299; Elgar MA, 1999, BEHAVIOUR, V136, P147, DOI 10.1163/156853999501252; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farwig N, 2009, LANDSCAPE ECOL, V24, P919, DOI 10.1007/s10980-009-9376-2; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Gonzalez JM, 2004, CARIBB J SCI, V40, P52; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Grace JB., 2015, STRUCTURAL EQUATION; Hanggi A., 1995, MISC FAUNIST HELV; Herrmann JD, 2012, COMMUNITY ECOL, V13, P82, DOI 10.1556/ComEc.13.2012.1.10; Holt RD, 2003, ECOL STU AN, V162, P201; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Holzschuh A, 2009, ECOL APPL, V19, P123, DOI 10.1890/08-0384.1; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Ivanov S. P., 2006, ENTOMOLOGICAL REV, V86, P524, DOI DOI 10.1134/S0013873806050046; Kruess A, 2000, OECOLOGIA, V122, P129, DOI 10.1007/PL00008829; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Loyola RD, 2008, BASIC APPL ECOL, V9, P735, DOI 10.1016/j.baae.2007.06.016; Matthews RW, 2009, ANNU REV ENTOMOL, V54, P251, DOI 10.1146/annurev.ento.54.110807.090440; MEDLER JT, 1967, AM MIDL NAT, V78, P344, DOI 10.2307/2485235; Molumby A, 1997, BEHAV ECOL, V8, P279, DOI 10.1093/beheco/8.3.279; Mortelliti A, 2011, J APPL ECOL, V48, P153, DOI 10.1111/j.1365-2664.2010.01918.x; Mortelliti A, 2010, DIVERS DISTRIB, V16, P941, DOI 10.1111/j.1472-4642.2010.00701.x; Murray TE, 2009, APIDOLOGIE, V40, P211, DOI 10.1051/apido/2009015; O'Neill KM, 2007, ECOL ENTOMOL, V32, P123, DOI 10.1111/j.1365-2311.2006.00851.x; Olberg G, 1959, VERHALTEN SOLITAREN; Otto Stefan, 2007, Fragmenta Faunistica (Warsaw), V50, P57; Pekar S, 2000, EUR J ENTOMOL, V97, P47, DOI 10.14411/eje.2000.012; Polidori C, 2007, ANIM BIOL, V57, P11, DOI 10.1163/157075607780002005; Polidori C, 2009, J NAT HIST, V43, P2985, DOI 10.1080/00222930903383511; R Core Team, 2011, R LANG ENV STAT COMP; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; Roth D, 2006, OIKOS, V115, P277, DOI 10.1111/j.2006.0030-1299.15252; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Schuepp C, 2011, OECOLOGIA, V165, P713, DOI 10.1007/s00442-010-1746-6; Seidelmann K, 2010, BEHAV ECOL SOCIOBIOL, V64, P337, DOI 10.1007/s00265-009-0850-2; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sobek S, 2009, FOREST ECOL MANAG, V258, P609, DOI 10.1016/j.foreco.2009.04.026; Stamp NE, 2001, ECOL ENTOMOL, V26, P292, DOI 10.1046/j.1365-2311.2001.00325.x; Steffan-Dewenter I, 2002, ECOL ENTOMOL, V27, P631, DOI 10.1046/j.1365-2311.2002.00437.x; Stenchly K, 2007, CANOPY TEMPERATE FLO, P72; Strohm E, 1997, P ROY SOC B-BIOL SCI, V264, P423, DOI 10.1098/rspb.1997.0060; Tischendorf L, 2005, ECOL SOC, V10; Townsend PA, 2005, ECOLOGY, V86, P466, DOI 10.1890/03-0607; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Buschini MLT, 2010, ZOOL STUD, V49, P169; Ulbrich Karin, 2001, Web Ecology, V2, P57; Uma DB, 2010, ETHOLOGY, V116, P85, DOI 10.1111/j.1439-0310.2009.01715.x; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; WITT R, 1998, WESPEN BEOBACHTEN BE; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	70	28	29	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59286	10.1371/journal.pone.0059286	http://dx.doi.org/10.1371/journal.pone.0059286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516622	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400106
J	Huang, KL; Lin, KJ; Hsiao, IT; Kuo, HC; Hsu, WC; Chuang, WL; Kung, MP; Wey, SP; Hsieh, CJ; Wai, YY; Yen, TC; Huang, CC				Huang, Kuo-Lun; Lin, Kun-Ju; Hsiao, Ing-Tsung; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chuang, Wen-Li; Kung, Mei-Ping; Wey, Shiaw-Pyng; Hsieh, Chia-Ju; Wai, Yau-Yau; Yen, Tzu-Chen; Huang, Chin-Chang			Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [F-18]AV-45 Positron Emission Tomography in Chinese Population	PLOS ONE			English	Article							F 18; PET; BETA; DEMENTIA; BRAIN; RADIOLIGAND; PLAQUES; DERIVATIVES; BIOMARKERS; DIAGNOSIS	Background: To compare the neocortical amyloid loads among cognitively normal (CN), amnestic mild cognitive impairment (aMCI), and Alzheimer's disease (AD) subjects with [F-18]AV-45 positron emission tomography (PET). Materials and Methods: [F-18]AV-45 PET was performed in 11 CN, 13 aMCI, and 12 AD subjects to compare the cerebral cortex-to-whole cerebellum standard uptake value ratios (SUVRs) of global and individual volumes of interest (VOIs) cerebral cortex. The correlation between global cortical [F-18]AV-45 SUVRs and Mini-Mental State Examination (MMSE) scores was analyzed. Results: The global cortical [F-18]AV-45 SUVRs were significantly different among the CN (1.08 +/- 0.08), aMCI (1.27 +/- 0.06), and AD groups (1.34 +/- 0.13) (p = 0.0003) with amyloidosis positivity rates of 9%, 62%, and 92% in the three groups respectively. Compared to CN subjects, AD subjects had higher SUVRs in the global cortical, precuneus, frontal, parietal, occipital, temporal, and posterior cingulate areas; while aMCI subjects had higher values in the global cortical, precuneus, frontal, occipital and posterior cingulate areas. There were negative correlations of MMSE scores with SUVRs in the global cortical, precuneus, frontal, parietal, occipital, temporal, posterior cingulate and anterior cingulate areas on a combined subject pool of the three groups after age and education attainment adjustment. Conclusions: Amyloid deposition occurs relatively early in precuneus, frontal and posterior cingulate in aMCI subjects. Higher [F-18]AV-45 accumulation is present in parietal, occipital and temporal gyri in AD subjects compared to the aMCI group. Significant correlation between MMSE scores and [F-18]AV-45 SUVRs can be observed among CN, aMCI and AD subjects.	[Huang, Kuo-Lun; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chuang, Wen-Li; Huang, Chin-Chang] Chang Gung Mem Hosp, Dept Neurol, Tao Yuan, Taiwan; [Huang, Kuo-Lun; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chuang, Wen-Li; Huang, Chin-Chang] Chang Gung Mem Hosp, Dementia Ctr, Tao Yuan, Taiwan; [Huang, Kuo-Lun; Kuo, Hung-Chou; Hsu, Wen-Chuin; Chuang, Wen-Li; Huang, Chin-Chang] Chang Gung Univ, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Kung, Mei-Ping; Wey, Shiaw-Pyng; Hsieh, Chia-Ju; Yen, Tzu-Chen] Chang Gung Univ, Mol Imaging Ctr, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Kung, Mei-Ping; Wey, Shiaw-Pyng; Hsieh, Chia-Ju; Yen, Tzu-Chen] Chang Gung Univ, Dept Nucl Med, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Kung, Mei-Ping; Wey, Shiaw-Pyng; Hsieh, Chia-Ju; Yen, Tzu-Chen] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Wey, Shiaw-Pyng; Hsieh, Chia-Ju] Chang Gung Univ, Coll Med, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Lin, Kun-Ju; Hsiao, Ing-Tsung; Wey, Shiaw-Pyng; Hsieh, Chia-Ju] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Kung, Mei-Ping] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Wai, Yau-Yau] Chang Gung Mem Hosp, Dept Radiol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; University of Pennsylvania; Chang Gung Memorial Hospital	Yen, TC (corresponding author), Chang Gung Univ, Mol Imaging Ctr, Tao Yuan, Taiwan.	yentc1110@gmail.com; cch0537@adm.cgmh.org.tw	Lin, Kun-Ju/H-3120-2015	Lin, Kun-Ju/0000-0003-1933-4564; Hsiao, Ing-Tsung/0000-0002-5255-7498; Hsieh, Chia-Ju/0000-0002-2833-7727	National Science Council, Taiwan [NSC-97-2314-B-182A-050, NSC-98-2314-B-182-056, NSC-100-2314-B-182-003, NSC-100-2314-B-182A-091-MY3, NSC-101-2314-B-182A-061-MY2]; Chang Gung Memorial Hospital [CMRPG300071, CMRPG390793, CMRPD1A0312]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was carried out with financial support from the National Science Council, Taiwan (Grant NSC-97-2314-B-182A-050, NSC-98-2314-B-182-056, NSC-100-2314-B-182-003, NSC-100-2314-B-182A-091-MY3, and NSC-101-2314-B-182A-061-MY2), and Chang Gung Memorial Hospital (Grant CMRPG300071, CMRPG390793, and CMRPD1A0312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barthel H, 2010, J NUCL MED, V51; Barthel H, 2011, EUR J NUCL MED MOL I, V38, P1702, DOI 10.1007/s00259-011-1821-1; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Chetelat G, 2010, ANN NEUROL, V67, P317, DOI 10.1002/ana.21955; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Hatashita S, 2010, J ALZHEIMERS DIS, V21, P995, DOI 10.3233/JAD-2010-100222; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Hsiao IT, 2012, EUR J NUCL MED MOL I, V39, P613, DOI 10.1007/s00259-011-2051-2; Hsieh CJ, 2011, J NUCL MED, V52; Huang KL, 2012, J NEUROL SCI, V319, P124, DOI 10.1016/j.jns.2012.04.014; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Jobst K A, 1998, Int Psychogeriatr, V10, P271, DOI 10.1017/S1041610298005389; Juh R, 2004, EUR J RADIOL, V51, P223, DOI 10.1016/S0720-048X(03)00214-6; Kemppainen NM, 2007, NEUROLOGY, V68, P1603, DOI 10.1212/01.wnl.0000260969.94695.56; Klunk WE, 2001, LIFE SCI, V69, P1471, DOI 10.1016/S0024-3205(01)01232-2; Koole M, 2009, J NUCL MED, V50, P818, DOI 10.2967/jnumed.108.060756; Kudo Y, 2007, J NUCL MED, V48, P553, DOI 10.2967/jnumed.106.037556; LeVine H, 2010, NEUROBIOL AGING, V31, P542, DOI 10.1016/j.neurobiolaging.2008.05.026; Lin KJ, 2010, NUCL MED BIOL, V37, P497, DOI 10.1016/j.nucmedbio.2010.02.003; Lockhart A, 2007, BRAIN, V130, P2607, DOI 10.1093/brain/awm191; Lopponen M, 2003, AGE AGEING, V32, P606, DOI 10.1093/ageing/afg097; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Ono M, 2011, J MED CHEM, V54, P2971, DOI 10.1021/jm200057u; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Ranginwala NA, 2008, AM J GERIAT PSYCHIAT, V16, P384, DOI 10.1097/JGP.0b013e3181629971; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Senda M, 2010, J NUCL MED, V51; Seneca N, 2007, NUCL MED BIOL, V34, P681, DOI 10.1016/j.nucmedbio.2007.06.002; Shoghi-Jadid K, 2005, NUCL MED BIOL, V32, P337, DOI 10.1016/j.nucmedbio.2005.02.003; Small GW, 2006, J GERIATR PSYCH NEUR, V19, P180, DOI 10.1177/0891988706291089; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Teipel SJ, 2013, J ALZHEIMERS DIS, V33, pS329, DOI 10.3233/JAD-2012-129030; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang PN, 2011, J NEUROL NEUROSUR PS, V82, P165, DOI 10.1136/jnnp.2010.209122; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Yao CH, 2010, APPL RADIAT ISOTOPES, V68, P2293, DOI 10.1016/j.apradiso.2010.07.001	48	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58974	10.1371/journal.pone.0058974	http://dx.doi.org/10.1371/journal.pone.0058974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516589	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400085
J	Ndo, C; Simard, F; Kengne, P; Awono-Ambene, P; Morlais, I; Sharakhov, I; Fontenille, D; Antonio-Nkondjio, C				Ndo, Cyrille; Simard, Frederic; Kengne, Pierre; Awono-Ambene, Parfait; Morlais, Isabelle; Sharakhov, Igor; Fontenille, Didier; Antonio-Nkondjio, Christophe			Cryptic Genetic Diversity within the Anopheles nili group of Malaria Vectors in the Equatorial Forest Area of Cameroon (Central Africa)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; NATURAL-POPULATIONS; F-STATISTICS; GAMBIAE; TRANSMISSION; DIPTERA; DIFFERENTIATION; CULICIDAE; SOFTWARE	Background: The Anopheles nili group of mosquitoes includes important vectors of human malaria in equatorial forest and humid savannah regions of sub-Saharan Africa. However, it remains largely understudied, and data on its populations' bionomics and genetic structure are crucially lacking. Here, we used a combination of nuclear (i.e. microsatellite and ribosomal DNA) and mitochondrial DNA markers to explore and compare the level of genetic polymorphism and divergence among populations and species of the group in the savannah and forested areas of Cameroon, Central Africa. Principal Findings: All the markers provided support for the current classification within the An. nili group. However, they revealed high genetic heterogeneity within An. nili s.s. in deep equatorial forest environment. Nuclear markers showed the species to be composed of five highly divergent genetic lineages that differed by 1.8 to 12.9% of their Internal Transcribed Spacer 2 (ITS2) sequences, implying approximate divergence time of 0.82 to 5.86 million years. However, mitochondrial data only detected three major subdivisions, suggesting different evolutionary histories of the markers. Conclusions/Significance: This study enlightened additional cryptic genetic diversity within An. nili s.s. in the deep equatorial forest environment of South Cameroon, reflecting a complex demographic history for this major vector of malaria in this environment. These preliminary results should be complemented by further studies which will shed light on the distribution, epidemiological importance and evolutionary history of this species group in the African rainforest, providing opportunities for in-depth comparative studies of local adaptation and speciation in major African malaria vectors.	[Ndo, Cyrille; Kengne, Pierre; Awono-Ambene, Parfait; Morlais, Isabelle; Antonio-Nkondjio, Christophe] Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon; [Ndo, Cyrille; Simard, Frederic; Kengne, Pierre; Morlais, Isabelle; Fontenille, Didier] Inst Rech Dev, Unite Rech Mixte Malad Infect & Vecteurs Ecol Gen, Montpellier, France; [Ndo, Cyrille] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Sharakhov, Igor] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Antonio-Nkondjio, Christophe] Univ Bamenda, Fac Hlth Sci, Bambili, Cameroon	Institut de Recherche pour le Developpement (IRD); Virginia Polytechnic Institute & State University	Ndo, C (corresponding author), Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon.	cyrndo@yahoo.fr	SIMARD, Frederic/J-9489-2016; Sharakhov, Igor/B-1972-2008; FONTENILLE, didier/G-4091-2013; Frederic, SIMARD/AFV-5001-2022; Morlais, Isabelle/F-5078-2014; Morlais, Isabelle/Q-2171-2019	SIMARD, Frederic/0000-0002-2871-5329; Sharakhov, Igor/0000-0003-0752-3747; Frederic, SIMARD/0000-0002-2871-5329; Morlais, Isabelle/0000-0002-2962-7670; Morlais, Isabelle/0000-0002-2962-7670; Antonio Nkondjio, Christophe/0000-0003-0073-1578; KENGNE, Pierre/0000-0002-3069-3202; FONTENILLE, didier/0000-0002-0544-3885	UNICEF/United Nations Development Programme/World Bank/World Health Organization/TDR/Molecular Entomology [A60347]; National Institutes of Health [R21 AI079350]; French Institut de Recherche pour le Developpement (IRD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079350] Funding Source: NIH RePORTER	UNICEF/United Nations Development Programme/World Bank/World Health Organization/TDR/Molecular Entomology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Institut de Recherche pour le Developpement (IRD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a UNICEF/United Nations Development Programme/World Bank/World Health Organization/TDR/Molecular Entomology grant A60347 to CAN and a National Institutes of Health grant R21 AI079350 to IS. CN was supported by a student fellowship grant from the French Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adja AM, 2011, ANN TROP MED PARASIT, V105, P13, DOI 10.1179/136485910X12851868780388; Adja A M, 2006, Med Trop (Mars), V66, P449; [Anonymous], 1968, ANOPHELINAE AFR S SA; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Antonio-Nkondjio C, 2009, ACTA TROP, V112, P270, DOI 10.1016/j.actatropica.2009.08.009; Antonio-Nkondjio C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-120; Awono-Ambene HP, 2006, AM J TROP MED HYG, V75, P656, DOI 10.4269/ajtmh.2006.75.656; Awono-Ambene HP, 2004, J MED ENTOMOL, V41, P561, DOI 10.1603/0022-2585-41.4.561; Awono-Ambene P, 2009, SCI MED AFR, V1, P13; Ayala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-307; Berthomieu A, 2003, MOL ECOL NOTES, V3, P394, DOI 10.1046/j.1471-8286.2003.00462.x; Brunhes J, 1999, J AM MOSQUITO CONTR, V15, P552; CARNEVALE P, 1992, MED VET ENTOMOL, V6, P135, DOI 10.1111/j.1365-2915.1992.tb00590.x; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; Cornuet JM, 1996, GENETICS, V144, P2001; Deitz KC, 2012, J HERED, V103, P585, DOI 10.1093/jhered/ess025; DESALLE R, 1987, GENETICS, V116, P215; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Gillies MT, 1987, ANOPHELINAE AFRICA S, P143; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; HAMON J, 1961, Med Trop (Mars), V21(Special), P643; HOLM S, 1979, SCAND J STAT, V6, P65; Kamau L, 1998, HEREDITY, V80, P675, DOI 10.1046/j.1365-2540.1998.00327.x; Kengne P, 2007, MED VET ENTOMOL, V21, P177, DOI 10.1111/j.1365-2915.2007.00681.x; Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LeGoff G, 1997, PARASITE, V4, P187, DOI 10.1051/parasite/1997042187; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Manonmani AM, 2007, ACTA TROP, V104, P72, DOI 10.1016/j.actatropica.2007.07.002; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; Ndo C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-161; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; PASKEWITZ SM, 1993, J MED ENTOMOL, V30, P953, DOI 10.1093/jmedent/30.5.953; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Peery A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-202; Primmer CR, 1996, MOL ECOL, V5, P365, DOI 10.1046/j.1365-294X.1996.00092.x; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2011, P NATL ACAD SCI USA, V108, P11948, DOI 10.1073/pnas.1109368108; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ridl FC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-194; RIVOLA E., 1957, BULL SOC PATHOL EXOT, V50, P382; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHLOTTERER C, 1994, MOL BIOL EVOL, V11, P513; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharakhova MV, 2011, INFECT GENET EVOL, V11, P746, DOI 10.1016/j.meegid.2010.06.015; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Simard F, 1999, AM J TROP MED HYG, V60, P1000, DOI 10.4269/ajtmh.1999.60.1000; SLATKIN M, 1995, GENETICS, V139, P457; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walton C, 1998, J AM MOSQUITO CONTR, V14, P266; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wright S., 1978, EVOLUTION GENETIC PO	66	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58862	10.1371/journal.pone.0058862	http://dx.doi.org/10.1371/journal.pone.0058862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516565	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400069
J	Zhao, JB; Zhang, MJ; Li, W; Su, XF; Zhu, L; Hang, CH				Zhao, Jinbing; Zhang, Meijuan; Li, Wei; Su, Xingfen; Zhu, Lin; Hang, Chunhua			Suppression of JAK2/STAT3 Signaling Reduces End-to-End Arterial Anastomosis Induced Cell Proliferation in Common Carotid Arteries of Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NEOINTIMA FORMATION; MICROVASCULAR ANASTOMOSIS; VASCULAR INJURY; MOUSE MODEL; IN-VIVO; JAK/STAT PATHWAY; BALLOON INJURY; ANGIOTENSIN-II; ACTIVATION	Background: JAK2/STAT3 pathway was reported to play an essential role in the neointima formation after vascular intima injury. However, little is known regarding this pathway to the whole layer injury after end-to-end arterial anastomosis (AA). Here, we investigated the role of JAK2/STAT3 pathway in common carotid arterial (CCA) anastomosis-induced cell proliferation, phenotypic change of vascular smooth muscle cells (VSMCs) and re-endothelialization. Methods: CCAs of adult male Wistar rats were resected at 3, 7, 14, and 30 days after end-to-end CCA anastomosis. Activation of JAK2/STAT3 pathway was detected by Western blotting and Immunofluorescence, and expression of proliferating cell nuclear antigen (PCNA) was detected by Q-PCR and Western blotting. Under the treatment with AG490 (a JAK2 inhibitor), protein levels of JAK2, STAT3 and PCNA, morphological changes of artery, phenotypic change of VSMCs, and re-endothelialization were measured by Western blotting, H&E, Q-PCR, and Evans blue staining respectively. Results: The protein levels of p-JAK2, p-STAT3, and PCNA were up-regulated, peaked on the 7th day in the vessel wall after AA. AG490 down-regulated the levels of p-JAK2, p-STAT3, and PCNA on the 7th-day-group, resulting in reduced vessel wall proliferation on the 7th and 14th day after AA. Besides, AG490 switched the phenotypic change of VSMCs after AA representing inhibited mRNA levels of synthetic phase markers (osteopoitin and SMemb) and up-regulated contractile phase markers (ASMA, SM2 and SM22 alpha). Furthermore, AG490 did not affect the re-endothelialization process on all indicated time points after AA (the 3rd, 7th, 14th, and 30th day). Conclusion: Our study indicated that JAK2/STAT3 signaling pathway played an important role on cell proliferation of the injured vessel wall, and probably a promising target for the exploration of drugs increasing the patency or reducing the vascular narrowness after AA.	[Zhao, Jinbing; Li, Wei; Su, Xingfen; Zhu, Lin; Hang, Chunhua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Jinbing] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Zhang, Meijuan] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing University	Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	hang_neurosurgery@163.com	Li, Wei/ABE-4301-2021		National Natural Science Foundation, China [81171170, 81200897]; Nature Science Foundation of Jiangsu Province, China [BK2010459]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This study was supported by grants from National Natural Science Foundation, China (81171170, 81200897) and Nature Science Foundation of Jiangsu Province, China (BK2010459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARATH P, 1990, AM J CARDIOL, V65, P297, DOI 10.1016/0002-9149(90)90291-8; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; CLOWES AW, 1983, LAB INVEST, V49, P208; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dotson RJN, 1998, MICROSURG, V18, P125, DOI 10.1002/(SICI)1098-2752(1998)18:2<125::AID-MICR11>3.0.CO;2-#; Dudley AC, 2005, BIOCHEM J, V390, P427, DOI 10.1042/BJ20050351; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kirabo A, 2011, CARDIOVASC RES; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Lee DL, 2006, AM J PHYSIOL-HEART C, V290, pH935, DOI 10.1152/ajpheart.00708.2005; LIDMAN D, 1981, SCAND J PLAST RECONS, V15, P103, DOI 10.3109/02844318109103422; LINDNER V, 1993, CIRC RES, V73, P792, DOI 10.1161/01.RES.73.5.792; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald JD, 2005, SKULL BASE-INTERD AP, V15, P229, DOI 10.1055/s-2005-872598; Maeng M, 2003, SCAND CARDIOVASC J, V37, P34, DOI 10.1080/14017430310007018; Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684; Moroi M, 1998, J CLIN INVEST, V101, P1225, DOI 10.1172/JCI1293; Neeli I, 2004, J BIOL CHEM, V279, P46122, DOI 10.1074/jbc.M406922200; Neria F, 2007, AM J PHYSIOL-CELL PH, V292, pC1123, DOI 10.1152/ajpcell.00548.2005; Ni CW, 2004, AM J PHYSIOL-CELL PH, V287, pC771, DOI 10.1152/ajpcell.00532.2003; Okamoto E, 1996, LAB INVEST, V74, P120; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Radad K, 2007, J VET SCI, V8, P269, DOI 10.4142/jvs.2007.8.3.269; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; Sekhar LN, 2008, NEUROSURGERY, V62, P1373, DOI [10.1227/01.NEU.0000315873.41953.74, 10.1227/01.neu.0000333803.97703.c6]; Seki Y, 2000, CIRC RES, V87, P12, DOI 10.1161/01.RES.87.1.12; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Singh P, 2011, J OTOLARYNGOL-HEAD N, V40, pS59, DOI 10.2310/7070.2010.100092; Siow RCM, 2003, CARDIOVASC RES, V59, P212, DOI 10.1016/S0008-6363(03)00292-X; STEMERMAN MB, 1977, AM J PATHOL, V87, P125; Takase S, 2000, ANN VASC SURG, V14, P427, DOI 10.1007/s100169910092; Torella D, 2007, AM J PHYSIOL-HEART C, V292, pH2935, DOI 10.1152/ajpheart.00887.2006; WALL RT, 1980, THROMB RES, V18, P113, DOI 10.1016/0049-3848(80)90175-9; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Watanabe S, 2004, AM J NEPHROL, V24, P387, DOI 10.1159/000079706; Weissberg P L, 1995, Blood Press Suppl, V2, P68; WIESLANDER JB, 1984, SCAND J PLAST RECONS, V18, P193, DOI 10.3109/02844318409052837	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58730	10.1371/journal.pone.0058730	http://dx.doi.org/10.1371/journal.pone.0058730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516544	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400056
J	Kang, EH; Kim, JA; Oh, HW; Park, HM				Kang, Eun-Hye; Kim, Ji-ae; Oh, Hyun-Woo; Park, Hee-Moon			LAMMER Kinase LkhA Plays Multiple Roles in the Vegetative Growth and Asexual and Sexual Development of Aspergillus nidulans	PLOS ONE			English	Article							CELL-CYCLE REGULATORS; SR SPLICING FACTORS; PROTEIN-KINASE; TRANSCRIPTION FACTOR; SCHIZOSACCHAROMYCES-POMBE; COP9 SIGNALOSOME; CONIDIOPHORE DEVELOPMENT; OXIDATIVE STRESS; GENE-EXPRESSION; FISSION YEAST	LAMMER kinase plays pivotal roles in various physiological processes in eukaryotes; however, its function in filamentous fungi is not known. We performed molecular studies on the function of the Aspergillus nidulans LAMMER kinase, LkhA, and report its involvement in multiple developmental processes. The gene for LkhA was highly expressed during reproductive organ development, such as that of conidiophores and cleistothecia. During vegetative growth, the patterns of germ tube emergence and hyphal polarity were changed and septation was increased by lkhA deletion. Northern analyses showed that lkhA regulated the transcription of brlA, csnD, and ppoA, which supported the detrimental effect of lkhA-deletion on asexual and sexual differentiation. LkhA also affected expression of cyclin-dependent kinase NimX(cdc2), a multiple cell cycle regulator, and StuA, an APSES family of fungal transcription factors that play pivotal roles in multiple differentiation processes. Here, for the first time, we present molecular evidence showing that LAMMER kinase is involved in A. nidulans development by modulating the expression of key regulators of developmental processes.	[Kang, Eun-Hye; Park, Hee-Moon] Chungnam Natl Univ, Coll Biosci & Biotechnol, Dept Microbiol & Mol Biol, Taejon, South Korea; [Kim, Ji-ae; Oh, Hyun-Woo] Korea Res Inst Biosci & Biotechnol, Ind Biomat Res Ctr, Taejon, South Korea	Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Park, HM (corresponding author), Chungnam Natl Univ, Coll Biosci & Biotechnol, Dept Microbiol & Mol Biol, Taejon, South Korea.	hmpark@cnu.ac.kr	Heemoon, Park/F-5783-2013	Heemoon, Park/0000-0001-6780-9283	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0012791]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0012791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; Braus GH, 2010, CURR OPIN MICROBIOL, V13, P672, DOI 10.1016/j.mib.2010.09.011; Busby TM, 1996, GENETICS, V143, P155; Busch S, 2003, MOL MICROBIOL, V49, P717, DOI 10.1046/j.1365-2958.2003.03612.x; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Chamovitz DA, 2002, CURR BIOL, V12, pR232, DOI 10.1016/S0960-9822(02)00775-3; Cho Soo-Jin, 2010, Mycobiology, V38, P108, DOI 10.4489/MYCO.2010.38.2.108; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Dutton JR, 1997, EMBO J, V16, P5710, DOI 10.1093/emboj/16.18.5710; Garcia-Pedrajas MD, 2010, MOL PLANT MICROBE IN, V23, P211, DOI 10.1094/MPMI-23-2-0211; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Han S, 2001, MOL GENET GENOMICS, V266, P260, DOI 10.1007/s004380100552; Harrington BJ, 2003, LAB MED, V34, P361, DOI 10.1309/EPH2TDT8335GH0R3; HARRIS SD, 1994, GENETICS, V136, P517; Ipcho SVS, 2010, EUKARYOT CELL, V9, P1100, DOI 10.1128/EC.00064-10; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kang WH, 2007, FEBS LETT, V581, P3473, DOI 10.1016/j.febslet.2007.06.053; Kang WH, 2010, J BIOL CHEM, V285, P13797, DOI 10.1074/jbc.M110.113555; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kim HR, 2009, GENETICS, V182, P771, DOI 10.1534/genetics.109.101667; Kim KH, 2001, BIOCHEM BIOPH RES CO, V289, P1237, DOI 10.1006/bbrc.2001.6128; Kpebe A, 2008, GENETICS, V179, P1973, DOI 10.1534/genetics.108.087858; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; Matia-Gonzalez AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030067; MILLER KY, 1992, GENE DEV, V6, P1770, DOI 10.1101/gad.6.9.1770; Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279; Moser BA, 2000, CURR OPIN MICROBIOL, V3, P631, DOI 10.1016/S1369-5274(00)00152-1; Nahlik K, 2010, MOL MICROBIOL, V78, P964, DOI 10.1111/j.1365-2958.2010.07384.x; Nikolakaki E, 2002, BIOCHEMISTRY-US, V41, P2055, DOI 10.1021/bi011521h; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohara T, 2004, EUKARYOT CELL, V3, P1412, DOI 10.1128/EC.3.6.1412-1422.2004; OSMANI AH, 1994, J CELL SCI, V107, P1519; Osmani SA, 1996, BIOCHEM J, V317, P633, DOI 10.1042/bj3170633; PRADE RA, 1993, EMBO J, V12, P2439, DOI 10.1002/j.1460-2075.1993.tb05898.x; Rabinow L, 2010, J GENET, V89, P271, DOI 10.1007/s12041-010-0038-6; Sambrook J., 2002, MOL CLONING LAB MANU; Savaldi-Goldstein S, 2000, PLANT J, V21, P91, DOI 10.1046/j.1365-313x.2000.00657.x; Schier N, 2001, MOL CELL BIOL, V21, P4075, DOI 10.1128/MCB.21.12.4075-4088.2001; Sessa G, 1996, PLANT CELL, V8, P2223, DOI 10.1105/tpc.8.12.2223; Sohn K. T., 2002, Mycobiology, V30, P117; Tang ZH, 2003, EXP CELL RES, V283, P101, DOI 10.1016/S0014-4827(02)00022-8; Tang ZH, 2011, EXP CELL RES, V317, P2308, DOI 10.1016/j.yexcr.2011.06.014; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; Tong XZ, 2007, MOL PLANT MICROBE IN, V20, P1102, DOI 10.1094/MPMI-20-9-1102; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Wei HJ, 2001, FUNGAL GENET BIOL, V34, P217, DOI 10.1006/fgbi.2001.1303; Wolkow TD, 1996, J CELL SCI, V109, P2179; Wu JG, 1997, MOL CELL BIOL, V17, P6191, DOI 10.1128/MCB.17.10.6191; Ye XS, 1996, EMBO J, V15, P3599, DOI 10.1002/j.1460-2075.1996.tb00729.x; Ye XS, 1999, EMBO J, V18, P6994, DOI 10.1093/emboj/18.24.6994; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yun B, 2000, GENETICS, V156, P749; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160	63	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58762	10.1371/journal.pone.0058762	http://dx.doi.org/10.1371/journal.pone.0058762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516554	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200112
J	Borniger, JC; Chaudhry, A; Muehlenbein, MP				Borniger, Jeremy C.; Chaudhry, Adeel; Muehlenbein, Michael P.			Relationships among Musical Aptitude, Digit Ratio and Testosterone in Men and Women	PLOS ONE			English	Article							SEX-HORMONES; SPATIAL ABILITY; LENGTH RATIO; BRAIN; 2ND; PERFORMANCE; CORTISOL; FMRI; ORGANIZATION; ACTIVATION	Circulating adult testosterone levels, digit ratio (length of the second finger relative to the fourth finger), and directional asymmetry in digit ratio are considered sexually dimorphic traits in humans. These have been related to spatial abilities in men and women, and because similar brain structures appear to be involved in both spatial and musical abilities, neuroendocrine function may be related to musical as well as spatial cognition. To evaluate relationships among testosterone and musical ability in men and women, saliva samples were collected, testosterone concentrations assessed, and digit ratios calculated using standardized protocols in a sample of university students (N = 61), including both music and non-music majors. Results of Spearman correlations suggest that digit ratio and testosterone levels are statistically related to musical aptitude and performance only within the female sample: A) those females with greater self-reported history of exposure to music (p = 0.016) and instrument proficiency (p = 0.040) scored higher on the Advanced Measures of Music Audiation test, B) those females with higher left hand digit ratio (and perhaps lower fetal testosterone levels) were more highly ranked (p = 0.007) in the orchestra, C) female music students exhibited a trend (p = 0.082) towards higher testosterone levels compared to female non-music students, and D) female music students with higher rank in the orchestra/band had higher testosterone levels (p = 0.003) than lower ranked students. None of these relationships were significant in the male sample, although a lack of statistical power may be one cause. The effects of testosterone are likely a small part of a poorly understood system of biological and environmental stimuli that contribute to musical aptitude. Hormones may play some role in modulating the phenotype of musical ability, and this may be the case for females more so than males.	[Borniger, Jeremy C.; Chaudhry, Adeel; Muehlenbein, Michael P.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Muehlenbein, MP (corresponding author), Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA.	mpm1@indiana.edu	Borniger, Jeremy/AAQ-5049-2020	Borniger, Jeremy/0000-0002-5419-0271	Indiana University Hutton Honors College Undergraduate Summer Research	Indiana University Hutton Honors College Undergraduate Summer Research	This work was funded by the Indiana University Hutton Honors College Undergraduate Summer Research Grant and Thesis Award to both JB and AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2012, GEN COMP ENDOCR, V176, P279, DOI 10.1016/j.ygcen.2011.12.040; Bang AK, 2005, HUM REPROD, V20, P3109, DOI 10.1093/humrep/dei170; Benderlioglu Z, 2004, HORM BEHAV, V46, P558, DOI 10.1016/j.yhbeh.2004.06.004; Bodner M, 2001, NEUROL RES, V23, P683, DOI 10.1179/016164101101199108; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Burley NT, 2004, P ROY SOC B-BIOL SCI, V271, P239, DOI 10.1098/rspb.2003.2562; CHRISTIANSEN K, 1987, NEUROPSYCHOBIOLOGY, V18, P27, DOI 10.1159/000118389; Dorner G, 2001, NEUROENDOCRINOL LETT, V22, P403; Fukui H, 2003, NEUROENDOCRINOL LETT, V24, P173; Fukui H, 2001, ANN NY ACAD SCI, V930, P448, DOI 10.1111/j.1749-6632.2001.tb05767.x; Gordon Edwin, 1989, ADV MEASURES MUSIC A; GORDON EE, 1986, B COUN RES MUSIC ED, P17; GOUCHIE C, 1991, PSYCHONEUROENDOCRINO, V16, P323, DOI 10.1016/0306-4530(91)90018-O; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; HASSLER M, 1988, DEV NEUROPSYCHOL, V4, P129, DOI 10.1080/87565648809540399; Hassler M, 1989, Arch Psychol (Frankf), V141, P71; HASSLER M, 1990, MUSIC PERCEPT, V8, P35; HASSLER M, 1992, INT J NEUROSCI, V65, P45, DOI 10.3109/00207459209003277; Hassler M., 1987, PSYCHOL MUSIC, V15, P141; Hassler M., 1985, PSYCHOL OF MUSIC, V13, P99, DOI DOI 10.1177/0305735685132004; Hausmann M, 2000, BEHAV NEUROSCI, V114, P1245, DOI 10.1037/0735-7044.114.6.1245; Hetland L, 2000, J AESTHET EDUC, V34, P179, DOI 10.2307/3333643; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Jancke L, 1997, BRAIN COGNITION, V34, P424, DOI 10.1006/brcg.1997.0922; Kim H, 2006, BRAIN DEV-JPN, V28, P109, DOI 10.1016/j.braindev.2005.05.008; LEVI-STRAUSS Claude, 1983, RAW COOKED; Liening SH, 2010, PHYSIOL BEHAV, V99, P8, DOI 10.1016/j.physbeh.2009.10.001; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Manning JT., 2002, DIGIT RATIO POINTER; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Meister IG, 2004, COGNITIVE BRAIN RES, V19, P219, DOI 10.1016/j.cogbrainres.2003.12.005; Miller G, 2000, ORIGINS OF MUSIC, P329; MOCKEL M, 1994, EUR J APPL PHYSIOL, V68, P451, DOI 10.1007/BF00599512; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Muehlenbein MP, 2004, AM J PRIMATOL, V64, P71, DOI 10.1002/ajp.20062; Nepomnaschy PA, 2012, AM J HUM BIOL, V24, P515, DOI 10.1002/ajhb.22259; NYBORG H, 1983, ADV BEHAV RES THER, V5, P89, DOI 10.1016/0146-6402(83)90019-X; OLDFIELD RC, 1969, BRIT J PSYCHOL, V60, P91, DOI 10.1111/j.2044-8295.1969.tb01181.x; Patel RS, 2004, CLIN CHEM LAB MED, V42, P1424, DOI 10.1515/CCLM.2004.264; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; Puts DA, 2010, HORM BEHAV, V58, P282, DOI 10.1016/j.yhbeh.2010.03.005; Rahman Q, 2003, PSYCHONEUROENDOCRINO, V28, P288, DOI 10.1016/S0306-4530(02)00022-7; RAUSCHER FH, 1995, NEUROSCI LETT, V185, P44, DOI 10.1016/0304-3940(94)11221-4; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Rauscher FH, 1997, NEUROL RES, V19, P2; Sarnthein J, 1997, NEUROL RES, V19, P107; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Silverman I, 1999, PSYCHONEUROENDOCRINO, V24, P813, DOI 10.1016/S0306-4530(99)00031-1; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Sinha-Hikim I, 1998, J CLIN ENDOCR METAB, V83, P1312, DOI 10.1210/jc.83.4.1312; Sluming VA, 2000, EVOL HUM BEHAV, V21, P1; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	54	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57637	10.1371/journal.pone.0057637	http://dx.doi.org/10.1371/journal.pone.0057637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520475	Green Published, Green Accepted, gold			2022-12-27	WOS:000318679900034
J	Cardoso, T; Ribeiro, O; Aragao, I; Costa-Pereira, A; Sarmento, A				Cardoso, Teresa; Ribeiro, Orquidea; Aragao, Irene; Costa-Pereira, Altamiro; Sarmento, Antonio			The Impact of Healthcare-Associated Infection on Mortality: Failure in Clinical Recognition Is Related with Inadequate Antibiotic Therapy	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; COMMUNITY-ACQUIRED PNEUMONIA; EMPIRICAL THERAPY; DISEASES-SOCIETY; GUIDELINES; DEFINITIONS; BACTEREMIA; MANAGEMENT; OUTCOMES; SEPSIS	Purpose: To understand if clinicians can tell apart patients with healthcare-associated infections (HCAI) from those with community-acquired infections (CAI) and to determine the impact of HCAI in the adequacy of initial antibiotic therapy and hospital mortality. Methods: One-year prospective cohort study including all consecutive infected patients admitted to a large university tertiary care hospital. Results: A total of 1035 patients were included in this study. There were 718 patients admitted from the community: 225 (31%) with HCAI and 493 (69%) with CAI. Total microbiologic documentation rate of infection was 68% (n = 703): 56% in CAI, 73% in HCAI and 83% in hospital-acquired infections (HAI). Antibiotic therapy was inadequate in 27% of patients with HCAI vs. 14% of patients with CAI (p< 0.001). Among patients with HCAI, 47% received antibiotic therapy in accordance with international recommendations for treatment of CAI. Antibiotic therapy was inadequate in 36% of patients with HCAI whose treatment followed international recommendations for CAI vs. 19% in the group of HCAI patients whose treatment did not follow these guidelines (p = 0.014). Variables independently associated with inadequate antibiotic therapy were: decreased functional capacity (adjusted OR = 2.24), HCAI (adjusted OR = 2.09) and HAI (adjusted OR = 2.24). Variables independently associated with higher hospital mortality were: age (adjusted OR = 1.05, per year), severe sepsis (adjusted OR = 1.92), septic shock (adjusted OR = 8.13) and inadequate antibiotic therapy (adjusted OR = 1.99). Conclusions: HCAI was associated with an increased rate of inadequate antibiotic therapy but not with a significant increase in hospital mortality. Clinicians need to be aware of healthcare-associated infections among the group of infected patients arriving from the community since the existing guidelines regarding antibiotic therapy do not apply to this group and they will otherwise receive inadequate antibiotic therapy which will have a negative impact on hospital outcome.	[Cardoso, Teresa] Univ Porto, Abel Salazar Biomed Sci Inst, Hosp Geral Santo Antonio, Unidade Cuidados Intens Polivalente,Intens Care U, P-4100 Oporto, Portugal; [Ribeiro, Orquidea; Costa-Pereira, Altamiro] Univ Porto, Fac Med, Ctr Res Hlth Technol & Informat Syst CINTESIS, Dept Hlth Informat & Decis Sci, P-4100 Oporto, Portugal; [Aragao, Irene] Univ Porto, Hosp Geral Santo Antonio, Unidade Cuidados Intens Polivalente, Intens Care Unit, P-4100 Oporto, Portugal; [Sarmento, Antonio] Univ Porto, Hosp Sao Joao, Dept Infect Dis, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Sao Joao Hospital; Universidade do Porto	Cardoso, T (corresponding author), Univ Porto, Abel Salazar Biomed Sci Inst, Hosp Geral Santo Antonio, Unidade Cuidados Intens Polivalente,Intens Care U, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cardoso.tmc@gmail.com	Costa-Pereira, Altamiro/I-5987-2012; Sarmento, António/M-5235-2013; , CINTESIS/C-6631-2014	Costa-Pereira, Altamiro/0000-0001-8467-6398; Sarmento, António/0000-0001-5269-7231; , CINTESIS/0000-0001-7248-2086; Aragao, Irene/0000-0001-5750-2739	ASSUCIP (Associacao de Apoio a Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal); Teaching and Research Department (Departamento de Formacao, Ensino e Investigacao) of Oporto Hospital Centre [069/07(051-DEFI/084-CES)]	ASSUCIP (Associacao de Apoio a Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal); Teaching and Research Department (Departamento de Formacao, Ensino e Investigacao) of Oporto Hospital Centre	Supported by an unrestricted grant from ASSUCIP (Associacao de Apoio a Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal). Teresa Cardoso is partially funded by a PhD research grant from the Teaching and Research Department (Departamento de Formacao, Ensino e Investigacao) of Oporto Hospital Centre (reference number 069/07(051-DEFI/084-CES)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Duran S, 2012, J INFECTION, V64, P478, DOI 10.1016/j.jinf.2012.01.010; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bassetti M, 2012, CLIN MICROBIOL INFEC, V18, P862, DOI 10.1111/j.1469-0691.2011.03679.x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Cheong HS, 2007, J ANTIMICROB CHEMOTH, V60, P1355, DOI 10.1093/jac/dkm378; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gomez J, 2007, EUR J CLIN MICROBIOL, V26, P239, DOI 10.1007/s10096-007-0272-x; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leibovici L, 1998, J INTERN MED, V244, P379; Lenz R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-85; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07; Park HK, 2010, RESP MED, P1; Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P2658, DOI 10.1093/jac/dkq373; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Pop-Vicas AE, 2005, CLIN INFECT DIS, V40, P1792, DOI 10.1086/430314; Rello J, 2010, CHEST, V137, P1138, DOI 10.1378/chest.09-2175; Retamar P, 2012, ANTIMICROB AGENTS CH, V56, P472, DOI 10.1128/AAC.00462-11; Rodriguez-Bano J, 2009, J INFECTION, V58, P131, DOI 10.1016/j.jinf.2008.11.003; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Stryjewski ME, 2009, AM J MED, V122, P281, DOI 10.1016/j.amjmed.2008.09.040; Valles J, 2008, J INFECTION, V56, P27, DOI 10.1016/j.jinf.2007.10.001; World Health Organization, 2012, WORLD HLTH STAT 2012	32	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58418	10.1371/journal.pone.0058418	http://dx.doi.org/10.1371/journal.pone.0058418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520508	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900067
J	Gao, Y; Zhang, H; Gao, Q; Wang, LL; Zhang, FC; Siva, VS; Zhou, Z; Song, LS; Zhang, SC				Gao, Yang; Zhang, Huan; Gao, Qiang; Wang, Lingling; Zhang, Fuchong; Siva, Vinu S.; Zhou, Zhi; Song, Linsheng; Zhang, Shicui			Transcriptome Analysis of Artificial Hybrid Pufferfish Jiyan-1and Its Parental Species: Implications for Pufferfish Heterosis	PLOS ONE			English	Article							GENE-EXPRESSION; INSECTICIDE RESISTANCE; METABOLIC-ACTIVITY; CYTOCHROMES P450; RICE; DOMINANCE; REVEALS; GENOME; MAIZE; FUGU	Jiyan-1 puffer, the F1 hybrid of Takifugu rubripes and Takifugu flavidus, displays obvious heterosis in the growth performance, flavor and stress tolerance. In the present study, comparative analysis for the transcriptomes of T. rubripes, T. flavidus and Jiyan-1 was performed aiming to reveal the possible mechanisms of heterosis in pufferfish. Whole transcriptomes were sequenced using the SOLiD4 platform, and a total of 44,305 transcripts corresponding to 18,164 genes were identified collectively. A total of 14,148 transcripts were differentially expressed. By comparing the gene expression patterns of the three samples, the coexistence of overdominance, dominance, underdominance and additivity was observed in the gene action modes of Jiyan-1. There were 2,237 transcripts in the intersection of the differentially expressed transcripts from Jiyan-1 versus T. rubripes and Jiyan-1 versus T. flavidus, among which 213 transcripts were also in the T. rubripes versus T. flavidus. The potential functions of the remaining 2,024 transcripts were mainly associated with metabolic process, nucleotide binding and catalytic activity. The enrichment results indicated metabolism was the most activated biological function in the heterosis. In addition, 35 KEGG pathways were retrieved as affiliated with more than three differentially expressed transcripts and 8,579 potentially novel transcript isoforms were identified for Jiyan-1. The present study revealed the coexistence of multiple gene actions in the hybrid puffer, indicated the importance of metabolism, ion binding function and kinase activity, as well as provided a list of candidate genes and pathways for heterosis. It could be helpful for the better understanding of the determination and regulation mechanisms of heterosis.	[Gao, Yang; Zhang, Huan; Gao, Qiang; Wang, Lingling; Siva, Vinu S.; Zhou, Zhi; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Gao, Yang; Siva, Vinu S.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Fuchong] Ocean & Fishery Sci Res Inst Hebei Prov, Qinhuangdao, Peoples R China; [Zhang, Shicui] Ocean Univ China, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ocean University of China	Zhang, FC (corresponding author), Ocean & Fishery Sci Res Inst Hebei Prov, Qinhuangdao, Peoples R China.	fuchongz@yahoo.com.cn; lshsong@qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China (973 program) [2012CB114404]; Scientific and Technological Support Projects in Hebei Province [08240503D]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Scientific and Technological Support Projects in Hebei Province	This work was supported by National Basic Research Program of China (973 program, No. 2012CB114404 to SZ) and Scientific and Technological Support Projects in Hebei Province (No. 08240503D to FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D CB, 1908, SCIENCE, V28, P455; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; EBATO H, 1983, J NEUROCHEM, V40, P440, DOI 10.1111/j.1471-4159.1983.tb11302.x; Fan W, 2011, J FISHERIES CHINA, V7, P1065; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HSU T, 1992, SCIENCE, V257, P1946, DOI 10.1126/science.1411512; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Huan P, 2011, MAR BIOTECHNOL, V14, P1; Huang Y, 2006, PLANT MOL BIOL, V62, P579, DOI 10.1007/s11103-006-9040-z; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; Lariepe A, 2012, GENETICS, V190, P795, DOI 10.1534/genetics.111.133447; Lau WC, 2004, CIRCULATION, V109, P166, DOI 10.1161/01.CIR.0000112378.09325.F9; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030987; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; LI SL, 1969, THEOR APPL GENET, V39, P68, DOI 10.1007/BF00307719; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu XP, 2008, ANN NY ACAD SCI, V1148, P1, DOI 10.1196/annals.1410.082; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; Malau-Aduli AEO, 2000, J ANIM PHYSIOL AN N, V83, P113, DOI 10.1046/j.1439-0396.2000.00255.x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MCDANIEL RG, 1969, CROP SCI, V9, P823, DOI 10.2135/cropsci1969.0011183X000900060048x; MCDANIEL RG, 1968, GENETICS, V59, P465; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer RC, 2012, PLANT J, V71, P669, DOI 10.1111/j.1365-313X.2012.05021.x; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Pihlajamaki J, 2011, CELL METAB, V14, P208, DOI 10.1016/j.cmet.2011.06.007; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahman MA, 2005, AQUACULTURE, V245, P121, DOI 10.1016/j.aquaculture.2004.11.049; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; SHULL G.H., 1908, J HERED, V4, P296; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Song LS, 2001, MAR BIOTECHNOL, V3, P398, DOI 10.1007/s10126-001-0006-5; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Sun QX, 2004, PLANT SCI, V166, P651, DOI 10.1016/j.plantsci.2003.10.033; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; XIAO JH, 1995, GENETICS, V140, P745; YAMASHITA H, 1968, MAR BIOL, V1, P277, DOI 10.1007/BF00360776; Yao YY, 2005, PLANT MOL BIOL, V58, P367, DOI 10.1007/s11103-005-5102-x; Zhang GY, 2010, AQUACULTURE, V302, P71, DOI 10.1016/j.aquaculture.2010.02.005; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	64	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58453	10.1371/journal.pone.0058453	http://dx.doi.org/10.1371/journal.pone.0058453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520511	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900070
J	Sakimoto, S; Kidoya, H; Kamei, M; Naito, H; Yamakawa, D; Sakaguchi, H; Wakabayashi, T; Nishida, K; Takakura, N				Sakimoto, Susumu; Kidoya, Hiroyasu; Kamei, Motohiro; Naito, Hisamichi; Yamakawa, Daishi; Sakaguchi, Hirokazu; Wakabayashi, Taku; Nishida, Kohji; Takakura, Nobuyuki			An Angiogenic Role for Adrenomedullin in Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; CELLS; HYPOXIA; MICE; MACROPHAGES; INDUCTION; ISCHEMIA; PEPTIDE; MODEL	Purpose: Adrenomedullin (ADM) has been shown to take part in physiological and pathological angiogenesis. The purpose of this study was to investigate whether ADM signaling is involved in choroidal neovascularization (CNV) using a mouse model. Methods and Results: CNV was induced by laser photocoagulation in 8-week-old C57BL/6 mice. ADM mRNA expression significantly increased following treatment, peaking 4 days thereafter. The expression of ADM receptor (ADM-R) components (CRLR, RAMP2 and RAMP 3) was higher in CD31(+) CD45(-) endothelial cells (ECs) than CD31(-) CD45(-) non-ECs. Inflammatory stimulation upregulated the expression of ADM not only in cell lines but also in cells in primary cultures of the choroid/retinal pigment epithelium complex. Supernatants from TNF alpha-treated macrophage cell lines potentiated the proliferation of ECs and this was partially suppressed by an ADM antagonist, ADM (22-52). Intravitreous injection of ADM (22-52) or ADM neutralizing monoclonal antibody (mAb) after laser treatment significantly reduced the size of CNV compared with vehicle-treated controls (p<0.01). Conclusions: ADM signaling is involved in laser-induced CNV formation, because both an ADM antagonist and ADM mAb significantly inhibited it. Suppression of ADM signaling might be a valuable alternative treatment for CNV associated with age-related macular degeneration.	[Sakimoto, Susumu; Kidoya, Hiroyasu; Naito, Hisamichi; Yamakawa, Daishi; Wakabayashi, Taku; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan; [Sakimoto, Susumu; Kamei, Motohiro; Sakaguchi, Hirokazu; Wakabayashi, Taku; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Takakura, Nobuyuki] JST Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan.	ntakaku@biken.osaka-u.ac.jp		Nishida, Kohji/0000-0001-9069-3610; Naito, Hisamichi/0000-0002-0750-1743	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish.	Abe M, 2006, CLIN SCI, V111, P381, DOI 10.1042/CS20060137; Boguslawski G, 2004, J BIOL CHEM, V279, P5716, DOI 10.1074/jbc.M308625200; Campa C, 2008, INVEST OPHTH VIS SCI, V49, P1178, DOI 10.1167/iovs.07-1194; Chen L, 2012, MOL CELL BIOCHEM, V365, P263, DOI 10.1007/s11010-012-1267-1; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Eto T, 2001, PEPTIDES, V22, P1693, DOI 10.1016/S0196-9781(01)00513-7; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hague S, 2000, CLIN CANCER RES, V6, P2808; Hippenstiel S, 2002, CIRC RES, V91, P618, DOI 10.1161/01.RES.0000036603.61868.F9; Huang W, 2004, INVEST OPHTH VIS SCI, V45, P1507, DOI 10.1167/iovs.03-0731; Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; ISHIYAMA Y, 1993, EUR J PHARMACOL, V241, P271, DOI 10.1016/0014-2999(93)90214-3; Iwase T, 2005, CIRCULATION, V111, P356, DOI 10.1161/01.CIR.0000153352.29335.B9; Kaafarani I, 2009, FASEB J, V23, P3424, DOI 10.1096/fj.08-127852; Kim W, 2003, FASEB J, V17, P1937, DOI 10.1096/fj.02-1209fje; Kong XQ, 2008, CLIN INVEST MED, V31, pE117; Kubo A, 1998, J BIOL CHEM, V273, P16730, DOI 10.1074/jbc.273.27.16730; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Ogita T, 2001, J HYPERTENS, V19, P603, DOI 10.1097/00004872-200103001-00013; Ouafik L, 2002, AM J PATHOL, V160, P1279, DOI 10.1016/S0002-9440(10)62555-2; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rademaker MT, 1997, CIRCULATION, V96, P1983, DOI 10.1161/01.CIR.96.6.1983; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Saita M, 1998, AM J PHYSIOL-REG I, V274, pR979, DOI 10.1152/ajpregu.1998.274.4.R979; Sakimoto S, 2012, DEVELOPMENT, V139, P1327, DOI 10.1242/dev.072330; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; Udono T, 2000, INVEST OPHTH VIS SCI, V41, P1962; Udono T, 2001, INVEST OPHTH VIS SCI, V42, P1080; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5	39	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58096	10.1371/journal.pone.0058096	http://dx.doi.org/10.1371/journal.pone.0058096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520487	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900046
J	Talwar, S; Lynch, JW; Gilbert, DF				Talwar, Sahil; Lynch, Joseph W.; Gilbert, Daniel F.			Fluorescence-Based High-Throughput Functional Profiling of Ligand-Gated Ion Channels at the Level of Single Cells	PLOS ONE			English	Article							RECEPTOR CHLORIDE CHANNELS; GLYCINE RECEPTOR; GABA(A) RECEPTORS; DRUG DISCOVERY; BETA-SUBUNIT; PHARMACOLOGY; PHYSIOLOGY; TECHNOLOGY; EXPRESSION; MUTATIONS	Ion channels are involved in many physiological processes and are attractive targets for therapeutic intervention. Their functional properties vary according to their subunit composition, which in turn varies in a developmental and tissue-specific manner and as a consequence of pathophysiological events. Understanding this diversity requires functional analysis of ion channel properties in large numbers of individual cells. Functional characterisation of ligand-gated channels involves quantitating agonist and drug dose-response relationships using electrophysiological or fluorescence-based techniques. Electrophysiology is limited by low throughput and high-throughput fluorescence-based functional evaluation generally does not enable the characterization of the functional properties of each individual cell. Here we describe a fluorescence-based assay that characterizes functional channel properties at single cell resolution in high throughput mode. It is based on progressive receptor activation and iterative fluorescence imaging and delivers >100 dose-responses in a single well of a 384-well plate, using alpha 1-3 homomeric and alpha beta heteromeric glycine receptor (GlyR) chloride channels as a model system. We applied this assay with transiently transfected HEK293 cells co-expressing halide-sensitive yellow fluorescent protein and different GlyR subunit combinations. Glycine EC50 values of different GlyR isoforms were highly correlated with published electrophysiological data and confirm previously reported pharmacological profiles for the GlyR inhibitors, picrotoxin, strychnine and lindane. We show that inter and intra well variability is low and that clustering of functional phenotypes permits identification of drugs with subunit-specific pharmacological profiles. As this method dramatically improves the efficiency with which ion channel populations can be characterized in the context of cellular heterogeneity, it should facilitate systems-level analysis of ion channel properties in health and disease and the discovery of therapeutics to reverse pathological alterations.	[Talwar, Sahil; Lynch, Joseph W.; Gilbert, Daniel F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Gilbert, Daniel F.] Univ Erlangen Nurnberg, Inst Med Biotechnol, D-91054 Erlangen, Germany	University of Queensland; University of Queensland; University of Erlangen Nuremberg	Gilbert, DF (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	daniel.gilbert@mbt.uni-erlangen.de	Gilbert, Daniel F./F-8714-2011	/0000-0003-4431-4741	National Health and Medical Research Council; Australian Research Council; Central Office for International Affairs at FAU Erlangen, Germany	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Central Office for International Affairs at FAU Erlangen, Germany	The project was funded by the National Health and Medical Research Council and the Australian Research Council. Exchange between laboratories was supported by funds from the Central Office for International Affairs at FAU Erlangen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Chen CY, 2012, LAB CHIP, V12, P794, DOI 10.1039/c1lc20548j; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Eichler SA, 2008, J CELL MOL MED; Eichler SA, 2009, EUR J NEUROSCI, V30, P1077, DOI 10.1111/j.1460-9568.2009.06903.x; Erdmann G, 2012, BIOTECHNOL J, V7, P768, DOI 10.1002/biot.201200117; Esmaeili A, 2011, SPINAL CORD, V49, P280, DOI 10.1038/sc.2010.109; Fan LJ, 2009, BIOORG MED CHEM LETT, V19, P3932, DOI 10.1016/j.bmcl.2009.03.065; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Giddings AM, 2010, J BIOMOL SCREEN, V15, P1204, DOI 10.1177/1087057110384612; Gilbert D, 2007, CHEMBIOCHEM, V8, P89, DOI 10.1002/cbic.200600437; Gilbert D, 2009, J BIOMOL SCREEN, V14, P86, DOI 10.1177/1087057108328017; Gilbert DF, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.017.2009; Gilbert DF, 2009, J BIOMOL SCREEN, V14, P944, DOI 10.1177/1087057109339523; Gilbert DF, 2009, CYTOMETRY A; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Grigoriadis DE, 2009, NEUROPSYCHOPHARMACOL, V34, P106, DOI 10.1038/npp.2008.149; Hall M., 2009, SIGKDD EXPLORATIONS, V11; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hoggatt J, 2012, J CLIN INVEST, V122, P3029, DOI 10.1172/JCI60238; Islam R, 2012, BRIT J PHARMACOL, V165, P2707, DOI 10.1111/j.1476-5381.2011.01722.x; Kim MJ, 2011, LAB CHIP, V11, P104, DOI [10.1039/c0lc00110d, 10.1039/c01c00110d]; Kruger W, 2005, NEUROSCI LETT, V380, P340, DOI 10.1016/j.neulet.2005.01.065; Kummel A, 2011, J BIOMOL SCREEN, V16, P338, DOI 10.1177/1087057110395390; Legendre P, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.023.2009; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; McManus OB, 2004, ASSAY GUIDANCE MANUA; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Nakagawa T, 2010, MOL NEUROBIOL, V42, P161, DOI 10.1007/s12035-010-8149-x; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Neuzil P, 2012, NAT REV DRUG DISCOV, V11, P620, DOI 10.1038/nrd3799; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Quinlan JR., 1993, C45 PROGRAMS MACHINE; Raiteri M, 2006, PHARMACOL REV, V58, P162, DOI 10.1124/pr.58.2.5; Robinson JP, 2012, J LAB AUTOM; Sambrook J., 2006, CSH PROTOC; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Spencer CI, 2012, ASSAY DRUG DEV TECHN, V10, P313, DOI 10.1089/adt.2011.414; Stoelzle S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00076; Terstappen GC, 2010, FUTURE MED CHEM, V2, P715, DOI 10.4155/FMC.10.180; van Thriel C, 2012, NEUROTOXICOLOGY, V33, P911, DOI 10.1016/j.neuro.2011.10.002; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Weltzien F, 2012, J COMP NEUROL, V520, P3962, DOI 10.1002/cne.23139; Wickenden A, 2012, FUTURE MED CHEM, V4, P661, DOI [10.4155/FMC.12.4, 10.4155/fmc.12.4]; Winsky-Sommerer R, 2009, EUR J NEUROSCI, V29, P1779, DOI 10.1111/j.1460-9568.2009.06716.x	53	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58479	10.1371/journal.pone.0058479	http://dx.doi.org/10.1371/journal.pone.0058479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520514	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900073
J	Contreras-Shannon, V; Heart, DL; Paredes, RM; Navaira, E; Catano, G; Maffi, SK; Walss-Bass, C				Contreras-Shannon, Veronica; Heart, Dylan L.; Paredes, R. Madelaine; Navaira, Erica; Catano, Gabriel; Maffi, Shivani Kaushal; Walss-Bass, Consuelo			Clozapine-Induced Mitochondria Alterations and Inflammation in Brain and Insulin-Responsive Cells	PLOS ONE			English	Article							INDUCED METABOLIC ALTERATIONS; OXIDATIVE STRESS; RAT-BRAIN; ANTIPSYCHOTIC MEDICATIONS; POSSIBLE MECHANISM; ENERGY-METABOLISM; OBESITY; DYSFUNCTION; RESISTANCE; SCHIZOPHRENIA	Background: Metabolic syndrome (MetS) is a constellation of factors including abdominal obesity, hyperglycemia, dyslipidemias, and hypertension that increase morbidity and mortality from diabetes and cardiovascular diseases and affects more than a third of the population in the US. Clozapine, an atypical antipsychotic used for the treatment of schizophrenia, has been found to cause drug-induced metabolic syndrome (DIMS) and may be a useful tool for studying cellular and molecular changes associated with MetS and DIMS. Mitochondria dysfunction, oxidative stress and inflammation are mechanisms proposed for the development of clozapine-related DIMS. In this study, the effects of clozapine on mitochondrial function and inflammation in insulin responsive and obesity-associated cultured cell lines were examined. Methodology/Principal Findings: Cultured mouse myoblasts (C2C12), adipocytes (3T3-L1), hepatocytes (FL-83B), and monocytes (RAW 264.7) were treated with 0, 25, 50 and 75 mu M clozapine for 24 hours. The mitochondrial selective probe TMRM was used to assess membrane potential and morphology. ATP levels from cell lysates were determined by bioluminescence assay. Cytokine levels in cell supernatants were assessed using a multiplex array. Clozapine was found to alter mitochondria morphology, membrane potential, and volume, and reduce ATP levels in all cell lines. Clozapine also significantly induced the production of proinflammatory cytokines IL-6, GM-CSF and IL12-p70, and this response was particularly robust in the monocyte cell line. Conclusions/ Significance: Clozapine damages mitochondria and promotes inflammation in insulin responsive cells and obesity-associated cell types. These phenomena are closely associated with changes observed in human and animal studies of MetS, obesity, insulin resistance, and diabetes. Therefore, the use of clozapine in DIMS may be an important and relevant tool for investigating cellular and molecular changes associated with the development of these diseases in the general population.	[Contreras-Shannon, Veronica; Heart, Dylan L.] St Marys Univ, Dept Biol Sci, San Antonio, TX USA; [Paredes, R. Madelaine; Navaira, Erica; Walss-Bass, Consuelo] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Catano, Gabriel] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Catano, Gabriel] Univ Texas Hlth Sci Ctr San Antonio, Vet Adm Ctr Personalized Med, South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Maffi, Shivani Kaushal] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Maffi, Shivani Kaushal] Reg Acad Hlth Ctr Edinburg, Div Med Res, Edinburg, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Walss-Bass, C (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.	walss@uthscsa.edu	Catano, Gabriel/AAQ-5387-2020; Walss-Bass, Consuelo/K-5702-2015	Walss-Bass, Consuelo/0000-0003-2474-5448	St. Mary's University Undergraduate Research Office, Biaggini Undergraduate Research Scholarships, St. Mary's University; Department of Psychiatry, University of Texas Health Science Center at San Antonio	St. Mary's University Undergraduate Research Office, Biaggini Undergraduate Research Scholarships, St. Mary's University; Department of Psychiatry, University of Texas Health Science Center at San Antonio	Summer Undergraduate Research Fellowship from the St. Mary's University Undergraduate Research Office, Biaggini Undergraduate Research Scholarships, St. Mary's University. Friends for Psychiatric Research Grant from the Department of Psychiatry, University of Texas Health Science Center at San Antonio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig MR, 2010, J PSYCHIATR PRACT, V16, P325, DOI 10.1097/01.pra.0000388627.36781.6a; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Casademont J, 2007, J CLIN PSYCHOPHARM, V27, P284, DOI 10.1097/JCP.0b013e318054753e; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Collins TJ, 2003, J EXP BIOL, V206, P1993, DOI 10.1242/jeb.00244; Dikov D, 2010, EXP GERONTOL, V45, P586, DOI 10.1016/j.exger.2010.03.011; DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Fehsel K, 2005, J CLIN PSYCHOPHARM, V25, P419, DOI 10.1097/01.jcp.0000177668.42640.fe; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Galloway C.A., 2012, ANTIOXID REDOX SIGNA, DOI http://dx.doi.org/10.1089/ars.2012.4779; Goff DC, 2005, J CLIN PSYCHIAT, V66, P183, DOI 10.4088/JCP.v66n0205; Haupt DW, 2006, EUR NEUROPSYCHOPHARM, V16, pS149, DOI 10.1016/j.euroneuro.2006.06.003; Heiser P, 2010, J PSYCHOPHARMACOL, V24, P1499, DOI 10.1177/0269881109102538; Himmerich H, 2011, J PSYCHIATR RES, V45, P1358, DOI 10.1016/j.jpsychires.2011.04.009; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Iborra M, 2011, BIOCHEM SOC T, V39, P1102, DOI 10.1042/BST0391102; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Ji BH, 2009, J PROTEOME RES, V8, P3633, DOI 10.1021/pr800876z; Jou MJ, 2008, ADV DRUG DELIVER REV, V60, P1512, DOI 10.1016/j.addr.2008.06.004; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kluge M, 2009, PSYCHONEUROENDOCRINO, V34, P118, DOI 10.1016/j.psyneuen.2008.08.016; Lepping P, 2011, J CLIN PSYCHIAT, V72, P273, DOI 10.4088/JCP.09r05268yel; Lim L, 2012, CELL DEATH DIFFER, V19, P416, DOI 10.1038/cdd.2011.105; Lin DT, 2007, NEUROBIOL AGING, V28, P99, DOI 10.1016/j.neurobiolaging.2005.11.004; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Martinez HG, 2011, DIABETOLOGIA, V54, P2660, DOI 10.1007/s00125-011-2248-8; Martinez JA, 2006, J PHYSIOL BIOCHEM, V62, P303, DOI 10.1007/BF03165759; Mijevic C, 2010, PROG NEURO-PSYCHOPH, V34, P303, DOI 10.1016/j.pnpbp.2009.11.024; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P20; Okamoto K, 2012, BBA-GEN SUBJECTS, V1820, P595, DOI 10.1016/j.bbagen.2011.08.001; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pillai A, 2007, J PSYCHIATR RES, V41, P372, DOI 10.1016/j.jpsychires.2006.01.011; Pollmacher T, 2000, J PSYCHIATR RES, V34, P369, DOI 10.1016/S0022-3956(00)00032-7; Polydoro M, 2004, PHARMACOL BIOCHEM BE, V78, P751, DOI 10.1016/j.pbb.2004.05.018; Reinke A, 2004, NEUROSCI LETT, V372, P157, DOI 10.1016/j.neulet.2004.09.032; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Ruano G ZS, 2006, DRUG INDUCED METABOL, P277; Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Streck EL, 2007, N-S ARCH PHARMACOL, V376, P127, DOI 10.1007/s00210-007-0178-2; Sullivan PW, 2007, OBESITY, V15, P3150, DOI 10.1038/oby.2007.375; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Ulivieri C, 2010, TISSUE CELL, V42, P339, DOI 10.1016/j.tice.2010.10.004; Victor VM, 2011, CURR PHARM DESIGN, V17, P3947, DOI 10.2174/138161211798764915; Walss-Bass C, 2008, INT J NEUROPSYCHOPH, V11, P1097, DOI 10.1017/S1461145708008882; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wille E, 2011, EUR J HEALTH ECON, V12, P205, DOI 10.1007/s10198-010-0223-9	54	57	62	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59012	10.1371/journal.pone.0059012	http://dx.doi.org/10.1371/journal.pone.0059012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527073	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562600051
J	Liao, FL; Wang, L; Yang, LB; Zhang, LY; Peng, XB; Sun, MX				Liao, Fanglei; Wang, Lu; Yang, Li-Bo; Zhang, Liyao; Peng, Xiongbo; Sun, Meng-xiang			Antisense Oligodeoxynucleotide Inhibition as an Alternative and Convenient Method for Gene Function Analysis in Pollen Tubes	PLOS ONE			English	Article							PROTEIN; GROWTH; OLIGONUCLEOTIDE; RNA; DELIVERY; POTENT; ENDOCYTOSIS; IMPROVEMENT; FUSION; SIRNA	Antisense oligodeoxynucleotide (A-ODN) inhibition works well in animal cells. However, there have been few successful examples to date of its application in plants, and more specifically whether the technique can be used in pollen tubes as a model of plant cell growth. NtGNL1 plays an important role in pollen tube development and was thus selected as an indicator to assess the biological effects of A-ODN. An A-ODN inhibition technique was used to down-regulate NtGNL1 expression in tobacco pollen tubes and showed that A-ODNs could quickly enter pollen tubes through the thick wall and cell membrane and effectively block NtGNL1 expression. Phenotype analysis revealed that the down-regulation of NtGNL1 by A-ODNs resulted in abnormalities in endocytosis and subsequent vesicle trafficking, similar to the phenotypes of pollen tubes treated with NtGNL1 RNAi. This investigation confirmed that A-ODNs could specifically inhibit target gene expression, and furthermore demonstrated that A-ODN functioned in a concentration-and duration-dependent manner, because A-ODNs could be degraded when incubated with pollen tubes. Thus, the A-ODN technique was successfully used for gene function analysis in pollen tubes and appears to be an alternative and convenient technique when the in vitro pollen tube is used as the study model. This technique will greatly facilitate investigations on the molecular mechanism(s) underlying pollen tube growth.	[Liao, Fanglei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Liao, Fanglei; Wang, Lu; Yang, Li-Bo; Zhang, Liyao; Peng, Xiongbo; Sun, Meng-xiang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Zhejiang Normal University; Wuhan University	Liao, FL (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	fangleiliao@126.com; mxsun@whu.edu.cn			National Natural Science Foundation of China [31100228, 31000139]; Zhejiang Provincial Natural Science Foundation of China [Y3110218]; Open Foundation from Top Key Discipline of Modern Agricultural Biotechnology and Biological Control of Crop Diseases in Zhejiang Provincial Colleges [ZC323012042]; Zhejiang Normal University Doctoral Fund [ZC304010042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Open Foundation from Top Key Discipline of Modern Agricultural Biotechnology and Biological Control of Crop Diseases in Zhejiang Provincial Colleges; Zhejiang Normal University Doctoral Fund	The Project was supported by the National Natural Science Foundation of China (Grant No. 31100228, 31000139) and the Zhejiang Provincial Natural Science Foundation of China (Grant No. Y3110218) and also supported by the Open Foundation from Top Key Discipline of Modern Agricultural Biotechnology and Biological Control of Crop Diseases in Zhejiang Provincial Colleges (Grant No. ZC323012042) and the Zhejiang Normal University Doctoral Fund (Grant No. ZC304010042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MR, 2008, NUCLEIC ACIDS RES, V36, P2764, DOI 10.1093/nar/gkn115; Alam MR, 2010, OLIGONUCLEOTIDES, V20, P103, DOI 10.1089/oli.2009.0211; Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; BUCKHEIT RW, 1994, AIDS RES HUM RETROV, V10, P1497, DOI 10.1089/aid.1994.10.1497; Cao YQ, ZHONGHUA SHAO SHANG, V26, P128; Dinc E, 2011, PLANT PHYSIOL, V157, P1628, DOI 10.1104/pp.111.185462; ESTRUCH JJ, 1994, P NATL ACAD SCI USA, V91, P8837, DOI 10.1073/pnas.91.19.8837; Ferguson C, 1998, PLANTA, V206, P452, DOI 10.1007/s004250050421; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gewirtz AM, 1998, BLOOD, V92, P712, DOI 10.1182/blood.V92.3.712.415a32_712_736; Gilar M, 1998, J CHROMATOGR B, V714, P13, DOI 10.1016/S0378-4347(98)00160-1; GILES RV, 1992, NUCLEIC ACIDS RES, V20, P763, DOI 10.1093/nar/20.4.763; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kristen U, 1995, Methods Mol Biol, V43, P189; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Liao FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013401; Ming X, 2011, EXPERT OPIN DRUG DEL, V8, P435, DOI 10.1517/17425247.2011.561313; Moscatelli A, 2007, J CELL SCI, V120, P3804, DOI 10.1242/jcs.012138; Moutinho A, 2001, P NATL ACAD SCI USA, V98, P10481, DOI 10.1073/pnas.171104598; Moutinho A, 2001, SEX PLANT REPROD, V14, P101, DOI 10.1007/s004970100086; Nakano RT, 2009, PLANT CELL, V21, P3672, DOI 10.1105/tpc.109.068270; Olie RA, 2000, CANCER RES, V60, P2805; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Parton RM, 2001, J CELL SCI, V114, P2685; Qiu S, 2005, NUCLEIC ACIDS RES, V33, P1834, DOI 10.1093/nar/gki324; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Richter S, 2012, NAT CELL BIOL, V14, P80, DOI 10.1038/ncb2389; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Sandy P, 2005, BIOTECHNIQUES, V39, P215, DOI 10.2144/05392RV01; Sawidis T, 2008, PROTOPLASMA, V233, P95, DOI 10.1007/s00709-008-0306-y; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; Schussler MD, 2008, PLANT J, V56, P756, DOI 10.1111/j.1365-313X.2008.03632.x; Song XF, 2006, PLANT PHYSIOL, V141, P966, DOI 10.1104/pp.106.077818; SPEIR E, 1992, CIRCULATION, V86, P538, DOI 10.1161/01.CIR.86.2.538; Stephens AC, 2008, THROMB RES, V122, P99, DOI 10.1016/j.thromres.2007.08.021; Sun CX, 2007, PLANT J, V52, P1192, DOI 10.1111/j.1365-313X.2007.03287.x; Sun CX, 2005, PLANT J, V44, P128, DOI 10.1111/j.1365-313X.2005.02515.x; Sun MX, 2000, SEX PLANT REPROD, V12, P267; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Wang L, 2008, NEW PHYTOL, V179, P81, DOI 10.1111/j.1469-8137.2008.02444.x; WYATT JR, 1994, P NATL ACAD SCI USA, V91, P1356, DOI 10.1073/pnas.91.4.1356; Zhang Chuanbo, 2007, Methods Mol Biol, V361, P163; Zhang LY, 2007, J CHROMATOGR B, V859, P30, DOI 10.1016/j.jchromb.2007.09.022; Zhang LY, 2005, J CHROMATOGR A, V1100, P230, DOI 10.1016/j.chroma.2005.09.041	47	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59112	10.1371/journal.pone.0059112	http://dx.doi.org/10.1371/journal.pone.0059112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527102	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600056
J	Pronker, ES; Weenen, TC; Commandeur, H; Claassen, EHJHM; Osterhaus, ADME				Pronker, Esther S.; Weenen, Tamar C.; Commandeur, Harry; Claassen, Eric H. J. H. M.; Osterhaus, Albertus D. M. E.			Risk in Vaccine Research and Development Quantified	PLOS ONE			English	Article							DEVELOPMENT SUCCESS RATES; INFLUENZA VACCINES; TRANSITION; TRENDS; DRUG	To date, vaccination is the most cost-effective strategy to combat infectious diseases. Recently, a productivity gap affects the pharmaceutical industry. The productivity gap describes the situation whereby the invested resources within an industry do not match the expected product turn-over. While risk profiles (combining research and development timelines and transition rates) have been published for new chemical entities (NCE), little is documented on vaccine development. The objective is to calculate risk profiles for vaccines targeting human infectious diseases. A database was actively compiled to include all vaccine projects in development from 1998 to 2009 in the pre-clinical development phase, clinical trials phase I, II and III up to Market Registration. The average vaccine, taken from the preclinical phase, requires a development timeline of 10.71 years and has a market entry probability of 6%. Stratification by disease area reveals pandemic influenza vaccine targets as lucrative. Furthermore, vaccines targeting acute infectious diseases and prophylactic vaccines have shown to have a lower risk profile when compared to vaccines targeting chronic infections and therapeutic applications. In conclusion; these statistics apply to vaccines targeting human infectious diseases. Vaccines targeting cancer, allergy and autoimmune diseases require further analysis. Additionally, this paper does not address orphan vaccines targeting unmet medical needs, whether projects are in-licensed or self-originated and firm size and experience. Therefore, it remains to be investigated how these - and other - variables influence the vaccine risk profile. Although we find huge differences between the risk profiles for vaccine and NCE; vaccines outperform NCE when it comes to development timelines.	[Pronker, Esther S.] Vacceleron, Utrecht, Netherlands; [Pronker, Esther S.; Weenen, Tamar C.; Commandeur, Harry] Erasmus Univ, Fac Econ, Rotterdam, Netherlands; [Claassen, Eric H. J. H. M.] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Claassen, Eric H. J. H. M.; Osterhaus, Albertus D. M. E.] Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Pronker, ES (corresponding author), Vacceleron, Utrecht, Netherlands.	e.s.pronker@gmail.com			NGI; Dutch NGI	NGI; Dutch NGI	Research is supported by NGI 2009 Valorisation Award fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; Esther S. Pronker is completing her PhD program using funds from the Dutch NGI Valorisation award from 2009. A. D. M. E. Osterhaus wishes to declare, for the avoidance of any misunderstanding on competing interests, that he co-founded and is chief scientific officer of Viroclinics Biosciences BV a spin out of Erasmus MC. However, for clarification, no materials or support were received from the company, and no agreements were in place concerning the execution or publication of this work. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andre F E, 2002, Dev Biol (Basel), V110, P25; Andre FE, 2001, VACCINE, V19, P2206, DOI 10.1016/S0264-410X(00)00546-6; [Anonymous], 2009, DMHC2582; Archibugi D, 2004, RES POLICY, V33, P1657, DOI 10.1016/j.respol.2004.10.003; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Berthold DR, 2009, J CLIN ONCOL, V27, P1150, DOI 10.1200/JCO.2008.21.1938; Bunnage ME, 2011, NAT CHEM BIOL, V7, P335, DOI 10.1038/nchembio.581; Carney S, 2005, DRUG DISCOV TODAY, V10, P1011, DOI 10.1016/S1359-6446(05)03533-6; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Cunha BA, 2002, CLIN MICROBIOL INFEC, V8, P489, DOI 10.1046/j.1469-0691.2002.00496.x; Danzon PM, 2005, J HEALTH ECON, V24, P317, DOI 10.1016/j.jhealeco.2004.09.006; Data Monitor Business Intelligence, 2009, DMHC2516; Davis MM, 2011, VACCINE, V29, P9414, DOI 10.1016/j.vaccine.2011.09.128; Davis MM, 2010, VACCINE, V28, P1353, DOI 10.1016/j.vaccine.2009.11.007; Dimasi J, 2003, J HLTH EC, V22, P185; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; European Commission, 2009, COMM STAFF WORK DOC; European Commission, 2011, JOINT PROC AGR PROC; Jacobs P, 2010, VACCINE, V28, P2841, DOI 10.1016/j.vaccine.2010.01.056; Jennings LC, 2008, LANCET INFECT DIS, V8, P650, DOI 10.1016/S1473-3099(08)70232-9; Kieny MP, 2005, VACCINE, V23, P5705, DOI 10.1016/j.vaccine.2005.07.077; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Light DW, 2009, VACCINE, V27, P6627, DOI 10.1016/j.vaccine.2009.07.077; Lou K, 2006, NAT REV DRUG DISCOV, V5, P451, DOI 10.1038/nrd2063; Pronker ES, 2012, VACCINE, V30, P7344, DOI 10.1016/j.vaccine.2012.09.071; Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051; Riley S, 2008, RBHC0214; Sahoo A, 2008, BI00027012; Struck MM, 1996, NAT BIOTECHNOL, V14, P591, DOI 10.1038/nbt0596-591; U.S Department of Health and Human Services Food and Drug Administration, 2004, CHALL OPP CRIT PATH; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261	34	117	117	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57755	10.1371/journal.pone.0057755	http://dx.doi.org/10.1371/journal.pone.0057755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526951	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600008
J	Bullinaria, JA; Levy, JP				Bullinaria, John A.; Levy, Joseph P.			Limiting Factors for Mapping Corpus-Based Semantic Representations to Brain Activity	PLOS ONE			English	Article							WORD COOCCURRENCE STATISTICS; CONCRETE CONCEPTS; FMRI; METAANALYSIS; SIMILARITY; OBJECTS	To help understand how semantic information is represented in the human brain, a number of previous studies have explored how a linear mapping from corpus derived semantic representations to corresponding patterns of fMRI brain activations can be learned. They have demonstrated that such a mapping for concrete nouns is able to predict brain activations with accuracy levels significantly above chance, but the more recent elaborations have achieved relatively little performance improvement over the original study. In fact, the absolute accuracies of all these models are still currently rather limited, and it is not clear which aspects of the approach need improving in order to achieve performance levels that might lead to better accounts of human capabilities. This paper presents a systematic series of computational experiments designed to identify the limiting factors of the approach. Two distinct series of artificial brain activation vectors with varying levels of noise are introduced to characterize how the brain activation data restricts performance, and improved corpus based semantic vectors are developed to determine how the word set and model inputs affect the results. These experiments lead to the conclusion that the current state-of-the-art input semantic representations are already operating nearly perfectly (at least for non-ambiguous concrete nouns), and that it is primarily the quality of the fMRI data that is limiting what can be achieved with this approach. The results allow the study to end with empirically informed suggestions about the best directions for future research in this area.	[Bullinaria, John A.] Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England; [Levy, Joseph P.] Univ Roehampton, Dept Psychol, London, England	University of Birmingham; Roehampton University	Bullinaria, JA (corresponding author), Univ Birmingham, Sch Comp Sci, Birmingham B15 2TT, W Midlands, England.	j.a.bullinaria@cs.bham.ac.uk						Baroni M, 2009, LANG RESOUR EVAL, V43, P209, DOI 10.1007/s10579-009-9081-4; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Brants T., 2006, WEB 1T 5 GRAM VERSIO; Bullinaria J. A., 2008, P ESSLLI WORKSH DIST, P1; Bullinaria JA, 2007, BEHAV RES METHODS, V39, P510, DOI 10.3758/BF03193020; Bullinaria JA, 2012, BEHAV RES METHODS, V44, P890, DOI 10.3758/s13428-011-0183-8; Caron J, 2001, COMPUTATIONAL INFORMATION RETRIEVAL, P157; Chen X., 2012, P 2012 SIAM INT C DA, P212, DOI [10.1137/1.9781611972825.19, DOI 10.1137/1.9781611972825.19]; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Devereux Barry, 2010, P NAACL WORKSH COMP, P70; Erk Katrin, 2010, P 2010 WORKSH GEOM M, P17; French R. M., 2002, P 24 ANN C COGN SCI, P316; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Jelodar Ahmad Babaeian, 2010, P NAACL HLT 2010 1 W, P18; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Karypis G, 2003, 02017 U MINN DEP COM; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Levy JP, 2012, PROG NEURAL PROCESS, V20, P292; Liu H., 2009, P 26 ANN INT C MACHI, P649, DOI DOI 10.1145/1553374.1553458; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Mahon BZ, 2010, NEUROSCIENCE, V169, P279, DOI 10.1016/j.neuroscience.2010.04.029; Manning C.D., 1999, FDN STAT NATURAL LAN; Martin A, 2003, COGN NEUROPSYCHOL, V20, P195, DOI 10.1080/02643290342000050; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Murphy Brian, 2012, P 1 JOINT C LEX COMP, P114; Patel M, 1997, PERSP NEURAL COMP, P199; Pereira F.B., 2010, P 2010 IEEE C EV COM, P1, DOI DOI 10.1109/ICCCN.2010.5560019; Pereira F, 2013, ARTIF INTELL, V194, P240, DOI 10.1016/j.artint.2012.06.005; Raizada RDS, 2012, J COGNITIVE NEUROSCI, V24, P868, DOI 10.1162/jocn_a_00189; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Tyler LK, 2003, NEUROIMAGE, V18, P542, DOI 10.1016/S1053-8119(02)00047-2; Wang J, 2012, HUMAN BRAIN IN PRESS, V33; Wang J, 2010, HUM BRAIN MAPP, V31, P1459, DOI 10.1002/hbm.20950; Zhao Y, 2001, 01040 TR U MINN DEP	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57191	10.1371/journal.pone.0057191	http://dx.doi.org/10.1371/journal.pone.0057191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23526937	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100008
J	Gajendrarao, P; Krishnamoorthy, N; Kassem, HS; Moharem-Elgamal, S; Cecchi, F; Olivotto, I; Yacoub, MH				Gajendrarao, Poornima; Krishnamoorthy, Navaneethakrishnan; Kassem, Heba Sh; Moharem-Elgamal, Sarah; Cecchi, Franco; Olivotto, Iacopo; Yacoub, Magdi H.			Molecular Modeling of Disease Causing Mutations in Domain C1 of cMyBP-C	PLOS ONE			English	Article							BINDING-PROTEIN-C; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MYOSIN-BINDING; THICK FILAMENTS; GENETIC-BASIS; MUSCLE; PHOSPHORYLATION; CONTRACTION; REGULATOR; DYNAMICS	Cardiac myosin binding protein-C (cMyBP-C) is a multi-domain (C0-C10) protein that regulates heart muscle contraction through interaction with myosin, actin and other sarcomeric proteins. Several mutations of this protein cause familial hypertrophic cardiomyopathy (HCM). Domain C1 of cMyBP-C plays a central role in protein interactions with actin and myosin. Here, we studied structure-function relationship of three disease causing mutations, Arg177His, Ala216Thr and Glu258Lys of the domain C1 using computational biology techniques with its available X-ray crystal structure. The results suggest that each mutation could affect structural properties of the domain C1, and hence it's structural integrity through modifying intra-molecular arrangements in a distinct mode. The mutations also change surface charge distributions, which could impact the binding of C1 with other sarcomeric proteins thereby affecting contractile function. These structural consequences of the C1 mutants could be valuable to understand the molecular mechanisms for the disease.	[Gajendrarao, Poornima; Krishnamoorthy, Navaneethakrishnan; Yacoub, Magdi H.] Qatar Fdn, Qatar Cardiovasc Res Ctr, Doha, Qatar; [Kassem, Heba Sh; Moharem-Elgamal, Sarah; Yacoub, Magdi H.] Aswan Heart Ctr, BA HCM Natl Programme, Aswan, Egypt; [Kassem, Heba Sh] Alexandria Fac Med, Dept Pathol, Alexandria, Egypt; [Kassem, Heba Sh] Alexandria Fac Med, Clin Genom Ctr, Alexandria, Egypt; [Moharem-Elgamal, Sarah] Natl Heart Inst, Giza, Egypt; [Cecchi, Franco; Olivotto, Iacopo] Careggi Univ Hosp, Referral Ctr Myocardial Dis, Florence, Italy; [Yacoub, Magdi H.] Imperial Coll London, Natl Heart & Lung Inst, London, England	Qatar Foundation (QF); Qatar Cardiovascular Research Center; Egyptian Knowledge Bank (EKB); Aswan University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; University of Florence; Azienda Ospedaliero Universitaria Careggi; Imperial College London	Yacoub, MH (corresponding author), Qatar Fdn, Qatar Cardiovasc Res Ctr, Doha, Qatar.	m.yacoub@imperial.ac.uk	Olivotto, Iacopo/AAC-5950-2022	Olivotto, Iacopo/0000-0003-1751-9266; Krishnamoorthy, Navaneethakrishnan/0000-0002-5096-4612; Cecchi, Franco/0000-0002-2035-5621; Kassem, Heba Shaban H./0000-0001-7978-7798	Qatar Foundation through Qatar Cardiovascular research Center, Doha, Qatar; Magdi Yacoub Research Network, London, United Kingdom	Qatar Foundation through Qatar Cardiovascular research Center, Doha, Qatar(Qatar Foundation (QF)); Magdi Yacoub Research Network, London, United Kingdom	This research was supported by Qatar Foundation through Qatar Cardiovascular research Center, Doha, Qatar and it was also supported by Magdi Yacoub Research Network, London, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Andersen PS, 2004, EUR J HUM GENET, V12, P673, DOI 10.1038/sj.ejhg.5201190; [Anonymous], 2005, DISC STUD 2 0 US GUI; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Bennett PM, 1999, REV PHYSIOL BIOCH P, V138, P203, DOI 10.1007/BF02346664; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cecchi F, 2005, NAT CLIN PRACT CARD, V2, P324, DOI 10.1038/ncpcardio0248; Coppini R, 2012, CIRCULATION; DePalma S, 2009, GENOMICS CARDIOVASCU; EINHEBER S, 1990, P NATL ACAD SCI USA, V87, P2157, DOI 10.1073/pnas.87.6.2157; Erdmann J, 2003, CLIN GENET, V64, P339, DOI 10.1034/j.1399-0004.2003.00151.x; Fisher SJ, 2008, ACTA CRYSTALLOGR D, V64, P658, DOI 10.1107/S0907444908008792; Flashman E, 2004, CIRC RES, V94, P1279, DOI 10.1161/01.RES.0000127175.21818.C2; Fokstuen S, 2008, HUM MUTAT, V29, P879, DOI 10.1002/humu.20749; Fougerousse F, 1998, CIRC RES, V82, P130; Fraser JS, 2013, MOL CELL, V49, P222, DOI 10.1016/j.molcel.2013.01.003; Frey N, 2012, NAT REV CARDIOL, V9, P91, DOI 10.1038/nrcardio.2011.159; Gautel M, 1998, CIRC RES, V82, P124; Girolami F, 2006, J CARDIOVASC MED, V7, P601, DOI 10.2459/01.JCM.0000237908.26377.d6; Govada L, 2008, J MOL BIOL, V378, P387, DOI 10.1016/j.jmb.2008.02.044; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Idowu SM, 2003, J MOL BIOL, V329, P745, DOI 10.1016/S0022-2836(03)00425-X; Rodriguez-Garcia MI, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-67; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Kassem HS, 2013, J CARDIOVASC TRANSL, V6, P65, DOI 10.1007/s12265-012-9425-0; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Lu YL, 2012, J BIOL CHEM, V287, P31596, DOI 10.1074/jbc.M112.383299; Marian A J, 2001, Minerva Med, V92, P435; Maron BJ, 2004, AM J MED, V116, P63, DOI 10.1016/j.amjmed.2003.10.012; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Oakley CE, 2007, INT J BIOCHEM CELL B, V39, P2161, DOI 10.1016/j.biocel.2006.12.008; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Saltzman AJ, 2010, CIRC RES, V106, P1549, DOI 10.1161/CIRCRESAHA.109.216291; Schlossarek S, 2011, J MOL CELL CARDIOL, V50, P613, DOI 10.1016/j.yjmcc.2011.01.014; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shaffer JF, 2009, J MUSCLE RES CELL M, V30, P303, DOI 10.1007/s10974-010-9207-8; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Driest SL, 2005, MAYO CLIN PROC, V80, P463, DOI 10.4065/80.4.463; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Winegrad S, 1999, CIRC RES, V84, P1117, DOI 10.1161/01.RES.84.10.1117	54	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59206	10.1371/journal.pone.0059206	http://dx.doi.org/10.1371/journal.pone.0059206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527136	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100092
J	Takeshita, H; Shiozaki, A; Bai, XH; Iitaka, D; Kim, H; Yang, BB; Keshavjee, S; Liu, MY				Takeshita, Hiroki; Shiozaki, Atsushi; Bai, Xiao-Hui; Iitaka, Daisuke; Kim, Hyunhee; Yang, Burton B.; Keshavjee, Shaf; Liu, Mingyao			XB130, a New Adaptor Protein, Regulates Expression of Tumor Suppressive MicroRNAs in Cancer Cells	PLOS ONE			English	Article							BREAST-CANCER; SIGNAL-TRANSDUCTION; DOWN-REGULATION; THYROID-CANCER; C-MYC; CARCINOMA; TARGET; GROWTH; BIOGENESIS; COMPONENT	XB130, a novel adaptor protein, promotes cell growth by controlling expression of many related genes. MicroRNAs (miRNAs), which are frequently mis-expressed in cancer cells, regulate expression of targeted genes. In this present study, we aimed to explore the oncogenic mechanism of XB130 through miRNAs regulation. We analyzed miRNA expression in XB130 short hairpin RNA (shRNA) stably transfected WRO thyroid cancer cells by a miRNA array assay, and 16 miRNAs were up-regulated and 22 miRNAs were down-regulated significantly in these cells, in comparison with non-transfected or negative control shRNA transfected cells. We chose three of the up-regulated miRNAs (miR-33a, miR-149 and miR-193a-3p) and validated them by real-time qRT-PCR. Ectopic overexpression of XB130 suppressed these 3 miRNAs in MRO cells, a cell line with very low expression of XB130. Furthermore, we transfected miR mimics of these 3 miRNAs into WRO cells. They negatively regulated expression of oncogenes (miR-33a: MYC, miR-149: FOSL1, miR-193a-3p: SLC7A5), by targeting their 39 untranslated region, and reduced cell growth. Our results suggest that XB130 could promote growth of cancer cells by regulating expression of tumor suppressive miRNAs and their targeted genes.	[Takeshita, Hiroki; Shiozaki, Atsushi; Iitaka, Daisuke] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 602, Japan; [Takeshita, Hiroki; Bai, Xiao-Hui; Iitaka, Daisuke; Kim, Hyunhee; Keshavjee, Shaf; Liu, Mingyao] Toronto Gen Res Inst, Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Yang, Burton B.; Keshavjee, Shaf; Liu, Mingyao] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5S 1A1, Canada; [Yang, Burton B.; Keshavjee, Shaf; Liu, Mingyao] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada	Kyoto Prefectural University of Medicine; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto	Liu, MY (corresponding author), Toronto Gen Res Inst, Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON, Canada.	mingyao.liu@utoronto.ca		Keshavjee, Shaf/0000-0003-4547-8094; Liu, Mingyao/0000-0002-9188-8417	Canadian Institutes of Health Research (CIHR) [MOP-13270, MOP-42546, MOP-119514]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR) operating grants MOP-13270, MOP-42546 and MOP-119514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cerutti J, 1996, CLIN CANCER RES, V2, P119; Chang SH, 2011, NAT MED, V17, P1275, DOI 10.1038/nm.2459; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Csiszar A, 2006, BIOESSAYS, V28, P465, DOI 10.1002/bies.20411; Dorfleutner A, 2007, J CELL PHYSIOL, V213, P740, DOI 10.1002/jcp.21143; Flynn DC, 2001, ONCOGENE, V20, P6270, DOI 10.1038/sj.onc.1204769; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Geraldo MV, 2012, ONCOGENE, V31, P1910, DOI 10.1038/onc.2011.381; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kim CH, 2006, ANTICANCER RES, V26, P2943; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim Yong-Hyun, 2001, Korean Journal of Internal Medicine, V16, P93; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Liu W, 2011, LAB INVEST, V91, P147, DOI 10.1038/labinvest.2010.144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodyga M, 2002, AM J PHYSIOL-LUNG C, V283, pL265, DOI 10.1152/ajplung.00492.2001; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Lodyga M, 2010, J CELL SCI, V123, P4156, DOI 10.1242/jcs.071050; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Miko E, 2011, FEBS LETT, V585, P1191, DOI 10.1016/j.febslet.2011.03.039; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Shi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041660; Shiozaki A, 2012, ANN SURG ONCOL; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043646; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038049; Shiozaki Atsushi, 2011, J Clin Bioinforma, V1, P10, DOI 10.1186/2043-9113-1-10; Shiozaki A, 2011, AM J PATHOL, V178, P391, DOI 10.1016/j.ajpath.2010.11.024; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Thomas M, 2012, ONCOGENE, V31, P918, DOI 10.1038/onc.2011.278; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Xiao HL, 2013, J CELL PHYSIOL, V228, P416, DOI 10.1002/jcp.24146; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamanaka D, 2012, MOL ENDOCRINOL, V26, P1043, DOI 10.1210/me.2011-1349; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710	52	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59057	10.1371/journal.pone.0059057	http://dx.doi.org/10.1371/journal.pone.0059057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527086	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100070
J	Beuls, K; Steels, L				Beuls, Katrien; Steels, Luc			Agent-Based Models of Strategies for the Emergence and Evolution of Grammatical Agreement	PLOS ONE			English	Article							LANGUAGE; COMMUNICATION	Grammatical agreement means that features associated with one linguistic unit ( for example number or gender) become associated with another unit and then possibly overtly expressed, typically with morphological markers. It is one of the key mechanisms used in many languages to show that certain linguistic units within an utterance grammatically depend on each other. Agreement systems are puzzling because they can be highly complex in terms of what features they use and how they are expressed. Moreover, agreement systems have undergone considerable change in the historical evolution of languages. This article presents language game models with populations of agents in order to find out for what reasons and by what cultural processes and cognitive strategies agreement systems arise. It demonstrates that agreement systems are motivated by the need to minimize combinatorial search and semantic ambiguity, and it shows, for the first time, that once a population of agents adopts a strategy to invent, acquire and coordinate meaningful markers through social learning, linguistic self-organization leads to the spontaneous emergence and cultural transmission of an agreement system. The article also demonstrates how attested grammaticalization phenomena, such as phonetic reduction and conventionalized use of agreement markers, happens as a side effect of additional economizing principles, in particular minimization of articulatory effort and reduction of the marker inventory. More generally, the article illustrates a novel approach for studying how key features of human languages might emerge.	[Beuls, Katrien] Vrije Univ Brussel, Artificial Intelligence Lab, Brussels, Belgium; [Steels, Luc] UPF, CSIC, Inst Biol Evolut, ICREA, Barcelona, Spain; [Steels, Luc] Sony Comp Sci Lab, Paris, France	Vrije Universiteit Brussel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); ICREA; Pompeu Fabra University	Steels, L (corresponding author), UPF, CSIC, Inst Biol Evolut, ICREA, Barcelona, Spain.	steels@arti.vub.ac.be	Steels, Luc/H-6983-2015	Steels, Luc/0000-0001-9134-3663; Beuls, Katrien/0000-0003-4451-4778	ICREA (Catalan Institute for Advanced Studies); IWT (Flemish Fund for Applied Science); Marie Curie Integration grant (ITN); ICREA Funding Source: Custom	ICREA (Catalan Institute for Advanced Studies)(ICREA); IWT (Flemish Fund for Applied Science)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Marie Curie Integration grant (ITN); ICREA(ICREA)	The authors gratefully acknowledge support from ICREA (Catalan Institute for Advanced Studies) to L. S., the IWT (Flemish Fund for Applied Science) to K. B., and a Marie Curie Integration grant (ITN) to the Institut de Biologia Evolutiva (Barcelona). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikhenvald AY, 2003, J LINGUIST, V39, P1, DOI 10.1017/S0022226702001937; [Anonymous], 1999, ADV COMPLEX SYSTEMS; Aronoff M, 2005, YEARB MORPHOL, P19, DOI 10.1007/1-4020-2900-4_2; Baker Mark., 2008, SYNTAX AGREEMENT CON; Barlow M, 1988, AGREEMENT NATURAL LA; Barodal Johanna, 2009, ROLE SEMANTIC PRAGMA, P123, DOI DOI 10.1075/SLCS.108.09BAR; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Bell ET, 1938, ANN MATH, V39, P539, DOI 10.2307/1968633; Boeckx C, 2008, ASPECTS SYNTAX AGREE; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Copestake A., 2002, IMPLEMENTING TYPED F; Corbett G, 2006, CAMBRIDGE TXB LINGUI; Dall'Asta L, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036105; Dalrymple M, 2009, J LINGUIST, V45, P31, DOI 10.1017/S0022226708005513; De Vylder B, 2006, J THEOR BIOL, V242, P818, DOI 10.1016/j.jtbi.2006.05.024; Dixon R, 1996, AUSTR LANGUAGES; Dixon R, 1982, WHERE HAVE ALL ADJEC; Fu Eric, 2005, RISE AGREEMENT FORMA; Galantucci B, 2005, COGNITIVE SCI, V29, P737, DOI 10.1207/s15516709cog0000_34; Givon Talmy, 1976, SUBJECT TOPIC, P151; Hawkins J, 2005, EFFICIENCY COMPLEXIT; Heine Bernd., 2007, GENESIS GRAMMAR RECO; Hopper ETP, 1993, GRAMMATICALIZATION; Lehmann Christian, 1988, AGREEMENT NATURAL LA, P55; Lehmann Christian., 2015, THOUGHTS GRAMMATICAL; Lindblom Bjorn E. F., 1995, RIV LINGUISTICA, V7, P5; Loreto V, 1997, J STAT MECH-THEORY E; Luraghi S, 2011, FOLIA LINGUIST, V45, P435, DOI 10.1515/flin.2011.016; Malchukov Andrej., 2009, OXFORD HDB CASE, P219; Newmeyer Frederick J., 1998, LANGUAGE FORM LANGUA; Schulz R, 2011, ADAPT BEHAV, V19, P409, DOI 10.1177/1059712311421437; Selten R, 2007, P NATL ACAD SCI USA, V104, P7361, DOI 10.1073/pnas.0702077104; Smith K, 2003, ARTIF LIFE, V9, P371, DOI 10.1162/106454603322694825; Sole R, 2005, JRSOC INTERFACE, V7, P1647; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Steels L, 2003, TRENDS COGN SCI, V7, P308, DOI 10.1016/S1364-6613(03)00129-3; Steels L., 1998, Autonomous Agents and Multi-Agent Systems, V1, P169, DOI 10.1023/A:1010002801935; Steels L, 2011, PHYS LIFE REV, V8, P339, DOI 10.1016/j.plrev.2011.10.014; Steels Luc, 1995, Artificial Life, V2, P319; Steels Luc, 2011, DESIGN PATTERNS FLUI; TULVING E, 1983, PHILOS T ROY SOC B, V302, P361, DOI 10.1098/rstb.1983.0060; van Kemenade Ans, 1987, SYNTACTIC CASE MORPH; van Trijp R, 2012, DESIGN PATTERNS FLUI, P205; van Trijp R, 2012, FRONT ARTIF INTEL AP, V242, P798, DOI 10.3233/978-1-61499-098-7-798; Vogt P, 2012, COGNITIVE SCI, V36, P726, DOI 10.1111/j.1551-6709.2011.1226.x; Wellens P, 2008, CONNECT SCI, V20, P173, DOI 10.1080/09540090802091966; Welmers WE., 1973, AFRICAN LANGUAGE STR; Wright Joseph., 1906, OLD HIGH GERMAN PRIM	49	56	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58960	10.1371/journal.pone.0058960	http://dx.doi.org/10.1371/journal.pone.0058960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527055	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600019
J	Qi, L; Li, N; Huang, R; Song, Q; Wang, L; Zhang, Q; Su, RG; Kong, T; Tang, ML; Cheng, GS				Qi, Lin; Li, Ning; Huang, Rong; Song, Qin; Wang, Long; Zhang, Qi; Su, Ruigong; Kong, Tao; Tang, Mingliang; Cheng, Guosheng			The Effects of Topographical Patterns and Sizes on Neural Stem Cell Behavior	PLOS ONE			English	Article							PROGENITOR CELLS; NERVOUS-SYSTEM; DIFFERENTIATION; GROWTH; NANOTOPOGRAPHY; NANOSCALE; INDUCTION; DIAMETER; ADHESION; MATRIX	Engineered topographical manipulation, a paralleling approach with conventional biochemical cues, has recently attracted the growing interests in utilizations to control stem cell fate. In this study, effects of topological parameters, pattern and size are emphasized on the proliferation and differentiation of adult neural stem cells (ANSCs). We fabricate micro-scale topographical Si wafers with two different feature sizes. These topographical patterns present linear micro-pattern (LMP), circular micro-pattern (CMP) and dot micro-pattern (DMP). The results show that the three topography substrates are suitable for ANSC growth, while they all depress ANSC proliferation when compared to non-patterned substrates (control). Meanwhile, LMP and CMP with two feature sizes can both significantly enhance ANSC differentiation to neurons compared to control. The smaller the feature size is, the better upregulation applies to ANSC for the differentiated neurons. The underlying mechanisms of topography-enhanced neuronal differentiation are further revealed by directing suppression of mitogen-activated protein kinase/extracellular signaling-regulated kinase (MAPK/Erk) signaling pathway in ANSC using U0126, known to inhibit the activation of Erk. The statistical results suggest MAPK/Erk pathway is partially involved in topography-induced differentiation. These observations provide a better understanding on the different roles of topographical cues on stem cell behavior, especially on the selective differentiation, and facilitate to advance the field of stem cell therapy.	[Qi, Lin; Li, Ning; Huang, Rong; Song, Qin; Wang, Long; Zhang, Qi; Su, Ruigong; Kong, Tao; Tang, Mingliang; Cheng, Guosheng] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Dept Nanobiomed, Suzhou, Jiangsu, Peoples R China; [Huang, Rong; Wang, Long; Cheng, Guosheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tang, ML (corresponding author), Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Dept Nanobiomed, Suzhou, Jiangsu, Peoples R China.	mltang2010@sinano.ac.cn; gscheng2006@sinano.ac.cn	Zhang, Qi/M-1744-2017; li, ning/J-4537-2016; Cheng, Guosheng/S-3401-2016	Zhang, Qi/0000-0002-4743-029X; li, ning/0000-0003-0086-5664; Cheng, Guosheng/0000-0003-4810-9403	Strategic Priority Research Program from Chinese Academy of Sciences (CAS) [XDA01030200]; National Natural Science Foundation of China (NSFC) [31101059]; Ministry of Science and Technology (MOST) [2011CB965004]	Strategic Priority Research Program from Chinese Academy of Sciences (CAS); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	This work was funded by "Strategic Priority Research Program'' (Grant No. XDA01030200) from Chinese Academy of Sciences (CAS), National Natural Science Foundation of China (NSFC) (Grant No. 31101059) and Ministry of Science and Technology (MOST) (Grant No. 2011CB965004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024; Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923; Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061; Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Edgar D, 2004, PEDIATR SURG INT, V20, P737, DOI 10.1007/s00383-004-1288-2; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027; Hart A, 2007, J MATER SCI-MATER M, V18, P1211, DOI 10.1007/s10856-007-0157-7; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hsu SH, 2005, BIOTECHNOL BIOENG, V92, P579, DOI 10.1002/bit.20634; Hu J, 2008, BIOMATERIALS, V29, P3815, DOI 10.1016/j.biomaterials.2008.06.015; Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Mani N, 2005, EXP NEUROL, V192, P394, DOI 10.1016/j.expneurol.2004.12.022; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nomura Shinobu, 2006, J Artif Organs, V9, P90, DOI 10.1007/s10047-006-0329-0; Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d; Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029; Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Zhang XD, 2006, STEM CELLS, V24, P434, DOI 10.1634/stemcells.2005-0171	32	64	66	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59022	10.1371/journal.pone.0059022	http://dx.doi.org/10.1371/journal.pone.0059022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527077	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600028
J	Berger, A; Frelin, C; Shah, DK; Benveniste, P; Herrington, R; Gerard, NP; Zuniga-Pflucker, JC; Iscove, NN; Paige, CJ				Berger, Alexandra; Frelin, Catherine; Shah, Divya K.; Benveniste, Patricia; Herrington, Robert; Gerard, Norma P.; Zuniga-Pfluecker, Juan-Carlos; Iscove, Norman N.; Paige, Christopher J.			Neurokinin-1 Receptor Signalling Impacts Bone Marrow Repopulation Efficiency	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; SUBSTANCE-P; PROLIFERATION; INDUCTION; GENE	Tachykinins are a large group of neuropeptides with both central and peripheral activity. Despite the increasing number of studies reporting a growth supportive effect of tachykinin peptides in various in vitro stem cell systems, it remains unclear whether these findings are applicable in vivo. To determine how neurokinin-1 receptor (NK-1R) deficient hematopoietic stem cells would behave in a normal in vivo environment, we tested their reconstitution efficiency using competitive bone marrow repopulation assays. We show here that bone marrow taken from NK-1R deficient mice (Tacr1(-/-)) showed lineage specific B and T cell engraftment deficits compared to wild-type competitor bone marrow cells, providing evidence for an involvement of NK-1R signalling in adult hematopoiesis. Tachykinin knockout mice lacking the peptides SP and/or HK-1 (Tac1(-/-), Tac4(-/-) and Tac1(-/-)/Tac4(-/-) mice) repopulated a lethally irradiated wild-type host with similar efficiency as competing wild-type bone marrow. The difference between peptide and receptor deficient mice indicates a paracrine and/or endocrine mechanism of action rather than autocrine signalling, as tachykinin peptides are supplied by the host environment.	[Berger, Alexandra; Frelin, Catherine; Herrington, Robert; Iscove, Norman N.; Paige, Christopher J.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Frelin, Catherine; Herrington, Robert; Iscove, Norman N.; Paige, Christopher J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Shah, Divya K.; Benveniste, Patricia; Zuniga-Pfluecker, Juan-Carlos; Iscove, Norman N.; Paige, Christopher J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Shah, Divya K.; Benveniste, Patricia; Zuniga-Pfluecker, Juan-Carlos] Sunnybrook Res Inst, Toronto, ON, Canada; [Gerard, Norma P.] Harvard Univ, Childrens Hosp, Sch Med, Ina Sue Perlmutter Lab, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Boston Children's Hospital; Harvard Medical School	Paige, CJ (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	paige@uhnres.utoronto.ca	Zuniga-Pflucker, Juan C/H-1295-2012	Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Benveniste, Patricia/0000-0002-5673-0542	National Cancer Institute of Canada [015005]; Canadian Institute of Health Research [9862]; CIHR Fellowship; Canada Research Chair in Developmental Immunology	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Fellowship(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Developmental Immunology(Canada Research Chairs)	This study was supported by a Terry Fox Program Project Grant from the National Cancer Institute of Canada (grant #015005) and by funds from the Canadian Institute of Health Research (grant #9862). DKS was supported by a CIHR Fellowship award. JCZP is a recipient of the Canada Research Chair in Developmental Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YS, 2011, J CELL PHYSIOL, V226, P1204, DOI 10.1002/jcp.22447; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Berger A, 2005, J NEUROIMMUNOL, V164, P48, DOI 10.1016/j.jneuroim.2005.03.016; Berger A, 2012, GENES BRAIN BEHAV, V11, P568, DOI 10.1111/j.1601-183X.2012.00787.x; Berger A, 2010, BLOOD, V116, P3792, DOI 10.1182/blood-2010-06-291062; Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Hong HS, 2009, NAT MED, V15, P425, DOI 10.1038/nm.1909; Li Y, 2000, J HEMATOTH STEM CELL, V9, P445, DOI 10.1089/152581600419107; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Morteau O, 2001, NAT IMMUNOL, V2, P1088, DOI 10.1038/ni1201-1088; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Patacchini R, 2001, EUR J PHARMACOL, V429, P13, DOI 10.1016/S0014-2999(01)01301-2; Rameshwar P, 1996, BLOOD, V88, P98; Rameshwar P, 1997, J IMMUNOL, V158, P3417; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shahrokhi S, 2010, GROWTH FACTORS, V28, P66, DOI 10.3109/08977190903369404; Son MY, 2011, J CELL MOL MED, V15, P152, DOI 10.1111/j.1582-4934.2009.00956.x; Tarasov KV, 2002, NEUROPEPTIDES, V36, P239, DOI 10.1016/S0143-4179(02)00050-1	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58787	10.1371/journal.pone.0058787	http://dx.doi.org/10.1371/journal.pone.0058787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516556	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400063
J	Yoshida, C; Tsuji, AB; Sudo, H; Sugyo, A; Kikuchi, T; Koizumi, M; Arano, Y; Saga, T				Yoshida, Chisato; Tsuji, Atsushi B.; Sudo, Hitomi; Sugyo, Aya; Kikuchi, Tatsuya; Koizumi, Mitsuru; Arano, Yasushi; Saga, Tsuneo			Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer	PLOS ONE			English	Article							MESYLATE LACKS ACTIVITY; IMATINIB MESYLATE; PHASE-II; GROWTH; PROTEIN; INHIBITION; EXPRESSION; MUTATIONS; SURVIVAL; SCLC	Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains poor. Therefore, the development of more effective therapy is needed. We previously reported that high levels of an anti-c-kit antibody (12A8) accumulated in SCLC xenografts. In the present study, we evaluated the efficacy of two antibodies (12A8 and 67A2) for radioimmunotherapy (RIT) of an SCLC mouse model by labeling with the Y-90 isotope. Methods: In-111- or I-125-labeled antibodies were evaluated in vitro by cell binding, competitive inhibition and cellular internalization assays in c-kit-expressing SY cells and in vivo by biodistribution in SY-bearing mice. Therapeutic efficacy of Y-90-labeled antibodies was evaluated in SY-bearing mice upto day 28 and histological analysis was conducted at day 7. Results: [In-111]12A8 and [In-111]67A2 specifically bound to SY cells with high affinity (8.0 and 1.9 nM, respectively). 67A2 was internalized similar to 12A8. High levels of [In-111]12A8 and [In-111]67A2 accumulated in tumors, but not in major organs. [In-111]67A2 uptake by the tumor was 1.7 times higher than for [In-111]12A8. [Y-90]12A8, but not [Y-90]67A2, suppressed tumor growth in a dose-dependent manner. Tumors treated with 3.7 MBq of [Y-90]12A8, and 1.85 and 3.7 MBq of [Y-90]67A2 (absorbed doses were 21.0, 18.0 and 35.9 Gy, respectively) almost completely disappeared approximately 2 weeks after injection, and regrowth was not observed except for in one mouse treated with 1.85 MBq [Y-90]67A2. The area of necrosis and fibrosis increased depending on the RIT effect. Apoptotic cell numbers increased with increased doses of [Y-90]12A8, whereas no dose-dependent increase was observed following [Y-90]67A2 treatment. Body weight was temporarily reduced but all mice tolerated the RIT experiments well. Conclusion: Treatment with [Y-90]12A8 and [Y-90]67A2 achieved a complete therapeutic response when SY tumors received an absorbed dose greater than 18 Gy and thus are promising RIT agents for metastatic SCLC cells at distant sites.	[Yoshida, Chisato; Tsuji, Atsushi B.; Sudo, Hitomi; Sugyo, Aya; Koizumi, Mitsuru; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Chiba 260, Japan; [Yoshida, Chisato; Arano, Yasushi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chiba, Japan; [Kikuchi, Tatsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Chiba 260, Japan	National Institutes for Quantum Science & Technology; Chiba University; National Institutes for Quantum Science & Technology	Tsuji, AB (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Chiba 260, Japan.	a_tsuji@nirs.go.jp	TSUJI, Atsushi B/I-9922-2019	TSUJI, Atsushi B/0000-0003-2726-288X; Kikuchi, Tatsuya/0000-0003-2966-3126	National Institute of Radiological Sciences	National Institute of Radiological Sciences	This study was funded by National Institute of Radiological Sciences to TS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altundag O, 2005, CANCER, V104, P2033, DOI 10.1002/cncr.21407; Blackhall FH, 2007, CURR OPIN ONCOL, V19, P103, DOI 10.1097/CCO.0b013e328011bec3; Burger H, 2003, EUR J CANCER, V39, P793, DOI 10.1016/S0959-8049(03)00026-1; Cheson BD, 2003, BLOOD, V101, P391, DOI 10.1182/blood-2002-06-1793; Chute JP, 1997, MAYO CLIN PROC, V72, P901; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Eckerman EF, 2010, MIRD RADIONUCLIDE DA; El Maalouf Ghassan, 2007, Lung Cancer, V57 Suppl 2, pS30, DOI 10.1016/S0169-5002(07)70425-7; Elias AD, 1997, CHEST, V112, pS251, DOI 10.1378/chest.112.4_Supplement.251S; Fischer B, 2007, CANCER TREAT REV, V33, P391, DOI 10.1016/j.ctrv.2007.01.006; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; HIBI K, 1991, ONCOGENE, V6, P2291; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson BE, 2003, CLIN CANCER RES, V9, P5880; Kassis AI, 2008, SEMIN NUCL MED, V38, P358, DOI 10.1053/j.semnuclmed.2008.05.002; Kitamura Y, 2004, CELL MOL LIFE SCI, V61, P2924, DOI 10.1007/s00018-004-4273-y; Krug LM, 2005, CANCER, V103, P2128, DOI 10.1002/cncr.21000; Krystal GW, 2000, CLIN CANCER RES, V6, P3319; Lebitasy MP, 2001, BRIT J CANCER, V85, P808, DOI 10.1054/bjoc.2001.1955; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Lloyd Katherine P, 2002, Clin Lung Cancer, V3, P213, DOI 10.3816/CLC.2002.n.005; Loke KS, 2012, WORLD J NUCL MED, V10, P122; PACKER AI, 1995, MOL REPROD DEV, V42, P303, DOI 10.1002/mrd.1080420307; Pouget JP, 2011, NAT REV CLIN ONCOL, V8, P720, DOI 10.1038/nrclinonc.2011.160; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; SAGA T, 1991, CANCER RES, V51, P990; Saga T, 1997, JPN J CANCER RES, V88, P1171, DOI 10.1111/j.1349-7006.1997.tb00346.x; SEIFTER EJ, 1988, SEMIN ONCOL, V15, P278; SEKIDO Y, 1991, CANCER RES, V51, P2416; Sharkey RM, 2011, IMMUNOTHERAPY-UK, V3, P349, DOI 10.2217/IMT.10.114; Sihto H, 2005, J CLIN ONCOL, V23, P49, DOI 10.1200/JCO.2005.02.093; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Sogawa C, 2010, NUCL MED BIOL, V37, P179, DOI 10.1016/j.nucmedbio.2009.10.008; Sudo H, 2012, CANCER SCI, V103, P203, DOI 10.1111/j.1349-7006.2011.02126.x; Tolvanen T, 2010, EUR J NUCL MED MOL I, V37, P874, DOI 10.1007/s00259-009-1346-z; Wang WL, 2000, ONCOGENE, V19, P3521, DOI 10.1038/sj.onc.1203698; Yoshida C, 2011, NUCL MED BIOL, V38, P331, DOI 10.1016/j.nucmedbio.2010.10.005; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	39	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59248	10.1371/journal.pone.0059248	http://dx.doi.org/10.1371/journal.pone.0059248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516616	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400101
J	Drummond, ES; Muhling, J; Martins, RN; Wijaya, LK; Ehlert, EM; Harvey, AR				Drummond, Eleanor S.; Muhling, Jill; Martins, Ralph N.; Wijaya, Linda K.; Ehlert, Erich M.; Harvey, Alan R.			Pathology Associated with AAV Mediated Expression of Beta Amyloid or C100 in Adult Mouse Hippocampus and Cerebellum	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; NEUROFIBRILLARY TANGLE FORMATION; ALZHEIMERS-DISEASE; A-BETA; APOLIPOPROTEIN-E; PROTEIN-PRECURSOR; TRANSGENIC MICE; TAU PHOSPHORYLATION; GLIAL ACTIVATION; SENILE PLAQUES	Accumulation of beta amyloid (A beta) in the brain is a primary feature of Alzheimer's disease (AD) but the exact molecular mechanisms by which A beta exerts its toxic actions are not yet entirely clear. We documented pathological changes 3 and 6 months after localised injection of recombinant, bi-cistronic adeno-associated viral vectors (rAAV2) expressing human A beta 40-GFP, A beta 42-GFP, C100-GFP or C100(V717F)-GFP into the hippocampus and cerebellum of 8 week old male mice. Injection of all rAAV2 vectors resulted in wide-spread transduction within the hippocampus and cerebellum, as shown by expression of transgene mRNA and GFP protein. Despite the lack of accumulation of A beta protein after injection with AAV vectors, injection of rAAV2-A beta 42-GFP and rAAV2- C100(V717F)-GFP into the hippocampus resulted in significantly increased microgliosis and altered permeability of the blood brain barrier, the latter revealed by high levels of immunoglobulin G (IgG) around the injection site and the presence of IgG positive cells. In comparison, injection of rAAV2-A beta 40-GFP and rAAV2-C100-GFP into the hippocampus resulted in substantially less neuropathology. Injection of rAAV2 vectors into the cerebellum resulted in similar types of pathological changes, but to a lesser degree. The use of viral vectors to express different types of A beta and C100 is a powerful technique with which to examine the direct in vivo consequences of A beta expression in different regions of the mature nervous system and will allow experimentation and analysis of pathological AD-like changes in a broader range of species other than mouse.	[Drummond, Eleanor S.; Muhling, Jill; Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [Drummond, Eleanor S.; Martins, Ralph N.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Nedlands, WA 6009, Australia; [Martins, Ralph N.; Wijaya, Linda K.] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Sch Exercise Biomed & Hlth Sci, Churchlands, WA 6018, Australia; [Ehlert, Erich M.] Royal Acad Arts & Sci, Netherlands Inst Neurosci, Lab Neuroregenerat, Amsterdam, Netherlands	University of Western Australia; University of Western Australia; Edith Cowan University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Drummond, ES (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia.	E.Drummond@murdoch.edu.au	Ehlert, Erich M/A-4054-2012; Wijaya, Linda/CAF-1162-2022; Drummond, Eleanor/AAB-9731-2021	Wijaya, Linda/0000-0003-2603-7074; Martins, Ralph/0000-0002-4828-9363; Drummond, Eleanor/0000-0002-5466-4609; , Alan/0000-0002-2590-831X	School of Anatomy, Physiology and Human Biology, The University of Western Australia; Australian Postgraduate Award; Jean Rogerson Postgraduate Scholarship	School of Anatomy, Physiology and Human Biology, The University of Western Australia; Australian Postgraduate Award(Australian Government); Jean Rogerson Postgraduate Scholarship	This study was supported by funding from the School of Anatomy, Physiology and Human Biology, The University of Western Australia. ESD was supported by an Australian Postgraduate Award and Jean Rogerson Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EA, 2000, EXP NEUROL, V165, P221, DOI 10.1006/exnr.2000.7474; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bartlett JS, 1998, HUM GENE THER, V9, P1181, DOI 10.1089/hum.1998.9.8-1181; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Borghi R, 2010, J ALZHEIMERS DIS, V22, P771, DOI 10.3233/JAD-2010-100729; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; CANNING DR, 1993, EXP NEUROL, V124, P289, DOI 10.1006/exnr.1993.1199; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Causevic M, 2010, NEUROSCI LETT, V485, P162, DOI 10.1016/j.neulet.2010.08.088; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Cribbs DH, 1996, AM J PATHOL, V148, P1797; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dewachter I, 2002, J NEUROSCI, V22, P3445; Donahue JE, 2008, J NEUROPATH EXP NEUR, V67, P261, DOI 10.1097/NEN.0b013e31816a0dc8; Du J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005530; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Farkas IG, 2003, ACTA HISTOCHEM, V105, P115, DOI 10.1078/0065-1281-00696; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Hashimoto M, 2010, ACTA NEUROPATHOL, V119, P543, DOI 10.1007/s00401-010-0661-6; Hiltunen M, 2009, J ALZHEIMERS DIS, V18, P401, DOI 10.3233/JAD-2009-1154; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Ishibashi KI, 2006, J NEUROSCI RES, V84, P632, DOI 10.1002/jnr.20952; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jancso G, 1998, NEUROSCI LETT, V253, P139, DOI 10.1016/S0304-3940(98)00622-3; Jantaratnotai N, 2003, NEUROREPORT, V14, P1429, DOI 10.1097/00001756-200308060-00005; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; JOACHIM CL, 1989, AM J PATHOL, V135, P309; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kalaria RN, 1997, ANN NY ACAD SCI, V826, P263, DOI 10.1111/j.1749-6632.1997.tb48478.x; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lawlor PA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-11; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Marchi N, 2010, BRAIN RES, V1353, P176, DOI 10.1016/j.brainres.2010.06.051; MARUYAMA K, 1995, BIOCHEM BIOPH RES CO, V207, P971, DOI 10.1006/bbrc.1995.1280; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; MITA S, 1989, AM J PATHOL, V134, P1253; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Passini MA, 2006, J NEUROSCI, V26, P1334, DOI 10.1523/JNEUROSCI.2676-05.2006; Passos GF, 2010, BRAIN BEHAV IMMUN, V24, P493, DOI 10.1016/j.bbi.2009.12.003; Pihlaja R, 2008, GLIA, V56, P154, DOI 10.1002/glia.20599; PIKE CJ, 1994, NEUROSCIENCE, V63, P517, DOI 10.1016/0306-4522(94)90547-9; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rebeck GW, 2010, J BIOL CHEM, V285, P7440, DOI 10.1074/jbc.M109.083915; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmidt Stephen D., 2004, V299, P279; SEITZ RJ, 1985, ACTA NEUROPATHOL, V68, P15, DOI 10.1007/BF00688950; SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Siemers ER, 2010, CLIN NEUROPHARMACOL, V33, P67, DOI 10.1097/WNF.0b013e3181cb577a; Su GC, 1999, BRAIN RES, V818, P105, DOI 10.1016/S0006-8993(98)01143-3; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; Weldon DT, 1998, J NEUROSCI, V18, P2161; Yamagata K, 2001, DEMENT GERIATR COGN, V12, P57, DOI 10.1159/000051236; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	80	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59166	10.1371/journal.pone.0059166	http://dx.doi.org/10.1371/journal.pone.0059166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516609	Green Published, gold			2022-12-27	WOS:000316849200135
J	Hahn, T; Dresler, T; Pyka, M; Notebaert, K; Fallgatter, AJ				Hahn, Tim; Dresler, Thomas; Pyka, Martin; Notebaert, Karolien; Fallgatter, Andreas J.			Local Synchronization of Resting-State Dynamics Encodes Gray's Trait Anxiety	PLOS ONE			English	Article							BOLD ACTIVITY; AMYGDALA; BRAIN; PERSONALITY; SENSITIVITY; PUNISHMENT; DIMENSIONS; MODULATION; PREDICT; REWARD	The Behavioral Inhibition System (BIS) as defined within the Reinforcement Sensitivity Theory (RST) modulates reactions to stimuli indicating aversive events. Gray's trait Anxiety determines the extent to which stimuli activate the BIS. While studies have identified the amygdala-septo-hippocampal circuit as the key-neural substrate of this system in recent years and measures of resting-state dynamics such as randomness and local synchronization of spontaneous BOLD fluctuations have recently been linked to personality traits, the relation between resting-state dynamics and the BIS remains unexplored. In the present study, we thus examined the local synchronization of spontaneous fMRI BOLD fluctuations as measured by Regional Homogeneity (ReHo) in the hippocampus and the amygdala in twenty-seven healthy subjects. Correlation analyses showed that Gray's trait Anxiety was significantly associated with mean ReHo in both the amygdala and the hippocampus. Specifically, Gray's trait Anxiety explained 23% and 17% of resting-state ReHo variance in the left amygdala and the left hippocampus, respectively. In summary, we found individual differences in Gray's trait Anxiety to be associated with ReHo in areas previously associated with BIS functioning. Specifically, higher ReHo in resting-state neural dynamics corresponded to lower sensitivity to punishment scores both in the amygdala and the hippocampus. These findings corroborate and extend recent findings relating resting-state dynamics and personality while providing first evidence linking properties of resting-state fluctuations to Gray's BIS.	[Hahn, Tim] Goethe Univ Frankfurt, Dept Cognit Psychol 2, D-60054 Frankfurt, Germany; [Dresler, Thomas] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Dresler, Thomas; Fallgatter, Andreas J.] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Pyka, Martin] Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany; [Notebaert, Karolien] Katholieke Univ Leuven, Res Ctr Mkt & Consumer Sci, Louvain, Belgium	Goethe University Frankfurt; University of Wurzburg; Eberhard Karls University of Tubingen; Philipps University Marburg; KU Leuven	Hahn, T (corresponding author), Goethe Univ Frankfurt, Dept Cognit Psychol 2, D-60054 Frankfurt, Germany.	Hahn@psych.uni-frankfurt.de	Hahn, Tim/N-7250-2013	Hahn, Tim/0000-0002-8929-4134				Barros-Loscertales A, 2006, NEUROIMAGE, V33, P1011, DOI 10.1016/j.neuroimage.2006.07.025; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P1; Basar E, 1998, I BRAIN OSCILLATIONS; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Cherbuin N, 2008, SOC COGN AFFECT NEUR, V3, P262, DOI 10.1093/scan/nsn018; Chi SE, 2005, PERS INDIV DIFFER, V39, P669, DOI 10.1016/j.paid.2005.02.017; Corr PJ, 2008, REINFORCEMENT SENSITIVITY THEORY OF PERSONALITY, P1; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Gray J. A., 1991, EXPLORATIONS TEMPERA, P105, DOI [DOI 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4]; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hahn T, 2012, NEUROIMAGE, V59, P1842, DOI 10.1016/j.neuroimage.2011.08.042; Hahn T, 2010, BIOL PSYCHIAT, V68, P459, DOI 10.1016/j.biopsych.2010.04.033; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Most SB, 2006, NEUROIMAGE, V31, P934, DOI 10.1016/j.neuroimage.2005.12.031; Nierhaus T, 2009, MAGN RESON IMAGING, V27, P1140, DOI 10.1016/j.mri.2009.04.001; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Sava FA, 2006, PERS INDIV DIFFER, V41, P1445, DOI 10.1016/j.paid.2006.04.024; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wei LQ, 2011, BRAIN RES, V1419, P68, DOI 10.1016/j.brainres.2011.08.060; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	24	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58336	10.1371/journal.pone.0058336	http://dx.doi.org/10.1371/journal.pone.0058336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520499	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900058
J	Yan, FR; Huang, Y; Liu, JL; Lu, T; Lin, JG				Yan, Fang-Rong; Huang, Yuan; Liu, Jun-Lin; Lu, Tao; Lin, Jin-Guan			Bayesian Inference for Generalized Linear Mixed Model Based on the Multivariate t Distribution in Population Pharmacokinetic Study	PLOS ONE			English	Article							INDIVIDUALIZATION	This article provides a fully Bayesian approach for modeling of single-dose and complete pharmacokinetic data in a population pharmacokinetic (PK) model. To overcome the impact of outliers and the difficulty of computation, a generalized linear model is chosen with the hypothesis that the errors follow a multivariate Student t distribution which is a heavy-tailed distribution. The aim of this study is to investigate and implement the performance of the multivariate t distribution to analyze population pharmacokinetic data. Bayesian predictive inferences and the Metropolis-Hastings algorithm schemes are used to process the intractable posterior integration. The precision and accuracy of the proposed model are illustrated by the simulating data and a real example of theophylline data.	[Yan, Fang-Rong; Lin, Jin-Guan] Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China; [Yan, Fang-Rong; Huang, Yuan; Liu, Jun-Lin; Lu, Tao] China Pharmaceut Univ, Dept Math, Nanjing, Jiangsu, Peoples R China; [Yan, Fang-Rong; Huang, Yuan; Liu, Jun-Lin; Lu, Tao] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Lu, Tao] China Pharmaceut Univ, Lab Mol Design & Drug Discovery, Nanjing, Jiangsu, Peoples R China	Southeast University - China; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University	Yan, FR (corresponding author), Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China.	f.r.yan@163.com; lut163@163.com; jglin@seu.edu.cn	Wang, Yue/AAS-5975-2020; WANG, YUE/GWQ-9256-2022		NSFC [81130068, 1117165]; NSFCJS [BK2011058]; Fundamental Research Funds for the Central Universities [JKQ2011032]	NSFC(National Natural Science Foundation of China (NSFC)); NSFCJS; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work of Fang-Rong Yan, Yuan Huang, Jun-Lin Liu and Tao Lu was funded by NSFC (Program No.81130068) and the Fundamental Research Funds for the Central Universities (Program No.JKQ2011032). Jin-Guan Lin's work was supported by NSFC (Program No.1117165) and NSFCJS (Program No.BK2011058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chib S, 1999, STAT COMPUT, V9, P17, DOI 10.1023/A:1008853808677; Davidian M, 1995, STAT MED, V15, P1462; Ette EI, 2004, ANN PHARMACOTHER, V38, P2136, DOI 10.1345/aph.1E260; Ette EI, 2004, ANN PHARMACOTHER, V38, P1907, DOI 10.1345/aph.1E259; Fong YY, 2010, BIOSTATISTICS, V11, P397, DOI 10.1093/biostatistics/kxp053; Geweke J, 1993, J APPL ECONOMET, V8, P19; Gimenez O, 2010, ECOLOGY, V91, P951, DOI 10.1890/09-1903.1; Gomez E, 1998, COMMUN STAT-THEOR M, V27, P589, DOI 10.1080/03610929808832115; James WT, 2009, COMPUT METH PROG BIO, V96, P49; Kundu D, 1998, J STAT PLAN INFER, V70, P317, DOI 10.1016/S0378-3758(97)00190-0; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Liu I, 2009, STAT MED, V28, P412, DOI 10.1002/sim.3386; Natarajan R, 2000, J AM STAT ASSOC, V95, P227, DOI 10.2307/2669540; Robert V., 1994, International Journal of Bio-Medical Computing, V36, P153, DOI 10.1016/0020-7101(94)90109-0; Salway R, 2008, BIOMETRICS, V64, P620, DOI 10.1111/j.1541-0420.2007.00897.x; Samson A, 2006, COMPUT STAT DATA AN, V51, P1562, DOI 10.1016/j.csda.2006.05.007; SHEINER LB, 1982, J PHARM SCI, V71, P1344, DOI 10.1002/jps.2600711209; UPTON RA, 1982, J PHARMACOKINET BIOP, V10, P123, DOI 10.1007/BF01062330; VONESH EF, 1992, STAT MED, V11, P1929, DOI 10.1002/sim.4780111413; WADE JR, 1993, J PHARMACOKINET BIOP, V21, P209, DOI 10.1007/BF01059771; Wakefield J, 1996, J PHARMACOKINET BIOP, V24, P103, DOI 10.1007/BF02353512; Wakefield J, 2004, NONLINEAR REGRESSION, P119; Wakefield J, 1991, J R STAT SOC C, V43, P201; Wang JX, 2005, PHARM STAT, V4, P59, DOI 10.1002/pst.154; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	25	1	1	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58369	10.1371/journal.pone.0058369	http://dx.doi.org/10.1371/journal.pone.0058369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520504	Green Submitted, gold, Green Published			2022-12-27	WOS:000318679900063
J	Xiao, Q; Zhong, Y; Lu, DL; Gao, WJ; Jiao, Q; Lu, GM; Su, LY				Xiao, Qian; Zhong, Yuan; Lu, Dali; Gao, Weijia; Jiao, Qing; Lu, Guangming; Su, Linyan			Altered Regional Homogeneity in Pediatric Bipolar Disorder during Manic State: A Resting-State fMRI Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; VENTRAL PREFRONTAL CORTEX; MAJOR DEPRESSIVE DISORDER; WORKING-MEMORY TASK; FUNCTIONAL CONNECTIVITY; NEURAL CIRCUITRY; PSYCHIATRIC-DISORDERS; ORBITOFRONTAL CORTEX; NEURONAL ACTIVATION; FACIAL EXPRESSIONS	Pediatric bipolar disorder (PBD) is a severely debilitating illness, which is characterized by episodes of mania and depression separated by periods of remission. Previous fMRI studies investigating PBD were mainly task-related. However, little is known about the abnormalities in PBD, especially during resting state. Resting state brain activity measured by fMRI might help to explore neurobiological biomarkers of the disorder. Methods: Regional homogeneity (ReHo) was examined with resting-state fMRI (RS-fMRI) on 15 patients with PBD in manic state, with 15 age-and sex-matched healthy youth subjects as controls. Results: Compared with the healthy controls, the patients with PBD showed altered ReHo in the cortical and subcortical structures. The ReHo measurement of the PBD group was negatively correlated with the score of Young Mania Rating Scale (YMRS) in the superior frontal gyrus. Positive correlations between the ReHo measurement and the score of YMRS were found in the hippocampus and the anterior cingulate cortex in the PBD group. Conclusions: Altered regional brain activity is present in patients with PBD during manic state. This study presents new evidence for abnormal ventral-affective and dorsal-cognitive circuits in PBD during resting state and may add fresh insights into the pathophysiological mechanisms underlying PBD.	[Xiao, Qian; Lu, Dali; Gao, Weijia; Su, Linyan] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Jiao, Qing; Lu, Guangming] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China; [Zhong, Yuan] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China	Central South University; Nanjing University; Nanjing Normal University	Su, LY (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China.	xiaoqian851112@hotmail.com	Lu, Dali/GSE-4800-2022		Natural Science Foundation of China [81171291, 81201077]; Key Program for Guangming Lu [BWS11J063, 10z026]; Humanity and Social Science Youth foundation of Ministry of Education [11YJC190039]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Guangming Lu; Humanity and Social Science Youth foundation of Ministry of Education	Natural Science Foundation of China: No. 81171291, 81201077. Key Program for Guangming Lu (Grant No BWS11J063, and No 10z026). Humanity and Social Science Youth foundation of Ministry of Education: No. 11YJC190039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2005, BIPOLAR DISORD, V7, P577, DOI 10.1111/j.1399-5618.2005.00257.x; Adler CM, 2004, BIPOLAR DISORD, V6, P540, DOI 10.1111/j.1399-5618.2004.00117.x; Altshuler LL, 2005, BIOL PSYCHIAT, V58, P763, DOI 10.1016/j.biopsych.2005.09.012; [Anonymous], 2007, J AM ACAD CHILD PSY, V46, P107, DOI 10.1097/01.chi.0000242240.69678.c4; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumberg HP, 2006, BIOL PSYCHIAT, V59, P611, DOI 10.1016/j.biopsych.2005.08.031; Blumberg HP, 2005, BIPOLAR DISORD, V7, P570, DOI 10.1111/j.1399-5618.2005.00264.x; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P601, DOI 10.1001/archpsyc.60.6.601; Blumberg HP, 2003, AM J PSYCHIAT, V160, P1345, DOI 10.1176/appi.ajp.160.7.1345; Blumberg HP, 2000, BIOL PSYCHIAT, V48, P1045, DOI 10.1016/S0006-3223(00)00962-8; Blumberg HP, 1999, AM J PSYCHIAT, V156, P1986; BORUCHOW IB, 1991, ANN THORAC SURG, V51, P317, DOI 10.1016/0003-4975(91)90815-8; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chang K, 2005, J AM ACAD CHILD PSY, V44, P565, DOI 10.1097/01.chi.0000159948.75136.0d; Chang K, 2004, ARCH GEN PSYCHIAT, V61, P781, DOI 10.1001/archpsyc.61.8.781; Chen BK, 2004, BIOL PSYCHIAT, V56, P399, DOI 10.1016/j.biopsych.2004.06.024; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Chen CH, 2010, BIPOLAR DISORD, V12, P344, DOI 10.1111/j.1399-5618.2010.00801.x; Chen HH, 2004, NEUROSCI LETT, V363, P65, DOI 10.1016/j.neulet.2004.03.042; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; DelBello MP, 2004, BIPOLAR DISORD, V6, P43, DOI 10.1046/j.1399-5618.2003.00087.x; Dickstein DP, 2007, BIPOLAR DISORD, V9, P679, DOI 10.1111/j.1399-5618.2007.00418.x; Dickstein DP, 2010, BIOL PSYCHIAT, V68, P839, DOI 10.1016/j.biopsych.2010.06.029; Dickstein DP, 2005, J CHILD ADOL PSYCHOP, V15, P534, DOI 10.1089/cap.2005.15.534; Dickstein DP, 2005, ARCH GEN PSYCHIAT, V62, P734, DOI 10.1001/archpsyc.62.7.734; Elliott R, 2004, BIOL PSYCHIAT, V55, P1163, DOI 10.1016/j.biopsych.2004.03.007; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fountoulakis KN, 2008, BRAIN RES REV, V59, P9, DOI 10.1016/j.brainresrev.2008.04.005; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Glahn DC, 2010, HUM BRAIN MAPP, V31, P1041, DOI 10.1002/hbm.20918; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Johnson JG, 2000, AM J PSYCHIAT, V157, P1679, DOI 10.1176/appi.ajp.157.10.1679; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaur S, 2005, AM J PSYCHIAT, V162, P1637, DOI 10.1176/appi.ajp.162.9.1637; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kronhaus DM, 2006, BIPOLAR DISORD, V8, P28, DOI 10.1111/j.1399-5618.2006.00282.x; Lai CH, 2012, J AFFECT DISORDERS, V136, P453, DOI 10.1016/j.jad.2011.11.004; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; Leibenluft E, 2007, AM J PSYCHIAT, V164, P52, DOI 10.1176/appi.ajp.164.1.52; [李海军 LI Hai-jun], 2009, [中华精神科杂志, Chinese Journal of Psychiatry], V42, P193; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Malhi GS, 2007, BIPOLAR DISORD, V9, P345, DOI 10.1111/j.1399-5618.2007.00485.x; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Monks PJ, 2004, BIPOLAR DISORD, V6, P550, DOI 10.1111/j.1399-5618.2004.00147.x; Nelson EE, 2007, BIPOLAR DISORD, V9, P810, DOI 10.1111/j.1399-5618.2007.00419.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passarotti AM, 2010, J AM ACAD CHILD PSY, V49, P1064, DOI 10.1016/j.jaac.2010.07.009; Passarotti AM, 2010, J INT NEUROPSYCH SOC, V16, P106, DOI 10.1017/S1355617709991019; Paulus MP, 2002, NEUROPSYCHOPHARMACOL, V26, P53, DOI 10.1016/S0893-133X(01)00334-7; Pavuluri MN, 2008, J AM ACAD CHILD PSY, V47, P1273, DOI 10.1097/CHI.0b013e318185d2d1; Pavuluri MN, 2008, PSYCHIAT RES-NEUROIM, V162, P244, DOI 10.1016/j.pscychresns.2007.10.003; Pavuluri MN, 2007, BIOL PSYCHIAT, V62, P158, DOI 10.1016/j.biopsych.2006.07.011; Pavuluri MN, 2006, AM J PSYCHIAT, V163, P286, DOI 10.1176/appi.ajp.163.2.286; Pfeifer JC, 2008, J AM ACAD CHILD PSY, V47, P1289, DOI 10.1097/CHI.0b013e318185d299; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phillips ML, 2008, AM J PSYCHIAT, V165, P313, DOI 10.1176/appi.ajp.2007.07071066; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rich BA, 2008, J CHILD PSYCHOL PSYC, V49, P88, DOI 10.1111/j.1469-7610.2007.01819.x; Rich BA, 2006, P NATL ACAD SCI USA, V103, P8900, DOI 10.1073/pnas.0603246103; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Singh MK, 2010, J CHILD ADOL PSYCHOP, V20, P15, DOI 10.1089/cap.2009.0004; Surguladze SA, 2010, NEUROIMAGE, V53, P58, DOI 10.1016/j.neuroimage.2010.05.069; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Wallentin M, 2006, NEUROIMAGE, V32, P1850, DOI 10.1016/j.neuroimage.2006.05.002; [王丽 WANG Li], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P271; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wessa M, 2007, AM J PSYCHIAT, V164, P638, DOI 10.1176/appi.ajp.164.4.638; Wessa M, 2009, INT REV PSYCHIATR, V21, P357, DOI 10.1080/09540260902962156; WOOD A, 1995, J CHILD PSYCHOL PSYC, V36, P327, DOI 10.1111/j.1469-7610.1995.tb01828.x; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007	85	33	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57978	10.1371/journal.pone.0057978	http://dx.doi.org/10.1371/journal.pone.0057978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23526961	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100062
J	Hetzer, M; Sornette, D				Hetzer, Moritz; Sornette, Didier			The Co-Evolution of Fairness Preferences and Costly Punishment	PLOS ONE			English	Article							INDIRECT RECIPROCITY; SOCIAL PREFERENCES; EVOLUTION; COOPERATION; ALTRUISM; GENES; COMPETITION; BEHAVIOR; SPITE; CHIMPANZEES	We study the co-evolutionary emergence of fairness preferences in the form of other-regarding behavior and its effect on the origination of costly punishment behavior in public good games. Our approach closely combines empirical results from three experiments with an evolutionary simulation model. In this way, we try to fill a gap between the evolutionary theoretical literature on cooperation and punishment on the one hand and the empirical findings from experimental economics on the other hand. As a principal result, we show that the evolution among interacting agents inevitably favors a sense for fairness in the form of :disadvantageous inequity aversion". The evolutionary dominance and stability of disadvantageous inequity aversion is demonstrated by enabling agents to co-evolve with different self-and other-regarding preferences in a competitive environment with limited resources. Disadvantageous inequity aversion leads to the emergence of costly ("altruistic") punishment behavior and quantitatively explains the level of punishment observed in contemporary lab experiments performed on subjects with a western culture. Our findings corroborate, complement, and interlink the experimental and theoretical literature that has shown the importance of other-regarding behavior in various decision settings.	[Hetzer, Moritz; Sornette, Didier] Swiss Fed Inst Technol, Dept Management Technol & Econ, Chair Entrepreneurial Risks, Zurich, Switzerland; [Sornette, Didier] Swiss Finance Inst, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Hetzer, M (corresponding author), Swiss Fed Inst Technol, Dept Management Technol & Econ, Chair Entrepreneurial Risks, Zurich, Switzerland.	moritz.hetzer@gmail.com			ZKB (Zuercher Kantonal Bank); ETH Competence Center "Coping with Crises in Complex Socio-Economic Systems" (CCSS) through ETH [CH1-01-08-2]	ZKB (Zuercher Kantonal Bank); ETH Competence Center "Coping with Crises in Complex Socio-Economic Systems" (CCSS) through ETH	The work has been partially funded by ZKB (Zuercher Kantonal Bank - http://www.zkb.ch). We also acknowledge financial support from the ETH Competence Center "Coping with Crises in Complex Socio-Economic Systems" (CCSS) through ETH Research Grant CH1-01-08-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Anderson CM, 2006, GAME ECON BEHAV, V54, P1, DOI 10.1016/j.geb.2004.08.007; [Anonymous], 1996, ADAPTATION NATURAL S; Antal T, 2009, P NATL ACAD SCI USA, V106, P8597, DOI 10.1073/pnas.0902528106; ARTHUR WB, 1994, AM ECON REV, V84, P406; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bilancini E, 2009, J ECON BEHAV ORGAN, V70, P186, DOI 10.1016/j.jebo.2009.01.002; Binmore K, 2010, J ECON BEHAV ORGAN, V73, P87, DOI 10.1016/j.jebo.2008.10.019; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Bowles S, 1998, EVOL HUM BEHAV, V19, P3, DOI 10.1016/S1090-5138(98)00015-4; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Brauer J, 2006, P ROY SOC B-BIOL SCI, V273, P3123, DOI 10.1098/rspb.2006.3693; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Cason TN, 2002, EXP ECON, V5, P133, DOI 10.1023/A:1020317321607; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Coleman J. S., 1998, FDN SOCIAL THEORY; Danielson P, 2002, P NATL ACAD SCI USA, V99, P7237, DOI 10.1073/pnas.082079899; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Decker T, 2003, J CONFLICT RESOLUT, V47, P751, DOI 10.1177/0022002703258795; dos Santos M, 2011, P ROY SOC B-BIOL SCI, V278, P371, DOI 10.1098/rspb.2010.1275; Drickamer LC, 1995, ANIMAL BEHAV MECH EC; Eckel C, 2010, J ECON BEHAV ORGAN, V73, P109, DOI 10.1016/j.jebo.2009.03.026; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; FEHR E., 2006, HDB EC GIVING RECIPR; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fehr E, 2010, J ECON BEHAV ORGAN, V73, P101, DOI 10.1016/j.jebo.2009.12.001; Fowler JH, 2008, SCIENCE, V322, P912, DOI 10.1126/science.1158188; Fowler JH, 2005, NATURE, V433, DOI 10.1038/nature03256; Fudenberg D, 2010, J PUBLIC ECON, V94, P78, DOI 10.1016/j.jpubeco.2009.10.007; Gigerenzer G., 2002, BOUNDED RATIONALITY; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; Gintis H, 2010, J ECON BEHAV ORGAN, V73, P34, DOI 10.1016/j.jebo.2008.09.012; Gintis Herbert, 2001, 0110058 SANT FE I; Goodnight CJ, 2005, POPUL ECOL, V47, P3, DOI 10.1007/s10144-005-0207-2; Guala F, 2012, BEHAV BRAIN SCI, V35, DOI 10.1017/S0140525X11000069; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hetzer M, 2011, THEORY EVOLUTION FAI; Hil K, 2004, OXFORD SCHOLARSHIP O, V1, P382; Holland J.H., 1989, INDUCTION PROCESSES; Holmas TH, 2010, J ECON BEHAV ORGAN, V75, P261, DOI 10.1016/j.jebo.2010.03.024; Homans G.C., 1974, SOCIAL BEHAV ITS ELE; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Jablonka E, 2007, BEHAV BRAIN SCI, V30, P353, DOI 10.1017/S0140525X07002221; Jasny BR, 2008, SCIENCE, V322, P891, DOI 10.1126/science.322.5903.891; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Kennedy DM, 2008, ROUTLEDGE STUDIES CR; Kleiman MAR, 2009, BRUTE FAILS HAVE LES; Kleiman M, 2009, P NATL ACAD SCI USA, V106, P14230, DOI 10.1073/pnas.0905513106; Laland KN, 2000, BEHAV BRAIN SCI, V23, P131, DOI 10.1017/S0140525X00002417; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Marlowe FW, 2011, P ROY SOC B-BIOL SCI, V278, P2159, DOI 10.1098/rspb.2010.2342; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Noussair C, 2005, ECON INQ, V43, P649, DOI 10.1093/ei/cbi045; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; REEVE HK, 1993, Q REV BIOL, V68, P1, DOI 10.1086/417909; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Richerson P.J, 1988, CULTURE EVOLUTIONARY; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P1165, DOI 10.1073/pnas.1115219109; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; Simon H. A., 1982, MODELS BOUNDED RATIO; Sinha A, 2005, J BIOSCIENCES, V30, P51, DOI 10.1007/BF02705150; Takahashi JS, 2008, SCIENCE, V322, P909, DOI 10.1126/science.1158822; Tomasello M, 2008, NATURE, V454, P1057, DOI 10.1038/4541057a; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; WEST SA, EVOL HUM BEHAV, DOI DOI 10.1016/J.EVOLHUMBEHAV.2010.08.001; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047	93	9	9	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e54308	10.1371/journal.pone.0054308	http://dx.doi.org/10.1371/journal.pone.0054308			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23526926	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600002
J	Incicco, JJ; Gebhard, LG; Gonzalez-Lebrero, RM; Gamarnik, AV; Kaufman, SB				Jeremias Incicco, J.; Gebhard, Leopoldo G.; Gonzalez-Lebrero, Rodolfo M.; Gamarnik, Andrea V.; Kaufman, Sergio B.			Steady-State NTPase Activity of Dengue Virus NS3: Number of Catalytic Sites, Nucleotide Specificity and Activation by ssRNA	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; HEPATITIS-C VIRUS; TYPE-2 NONSTRUCTURAL PROTEIN-3; ATPASE ACTIVITY; KINETIC-ANALYSIS; HELICASE DOMAIN; PCRA HELICASE; RNA HELICASES; BINDING; ENZYME	Dengue virus nonstructural protein 3 (NS3) unwinds double stranded RNA driven by the free energy derived from the hydrolysis of nucleoside triphosphates. This paper presents the first systematic and quantitative characterization of the steady-state NTPase activity of DENV NS3 and their interaction with ssRNA. Substrate curves for ATP, GTP, CTP and UTP were obtained, and the specificity order for these nucleotides - evaluated as the ratio (k(cat)/K-M)- was GTP approximate to ATP approximate to CTP v UTP, which showed that NS3 have poor ability to discriminate between different NTPs. Competition experiments between the four substrates indicated that all of them are hydrolyzed in one and the same catalytic site of the enzyme. The effect of ssRNA on the ATPase activity of NS3 was studied using poly(A) and poly(C). Both RNA molecules produced a 10 fold increase in the turnover rate constant (k(cat)) and a 100 fold decrease in the apparent affinity (K-M) for ATP. When the ratio [RNA bases]/[NS3] was between 0 and similar to 20 the ATPase activity was inhibited by increasing both poly(A) and poly(C). Using the theory of binding of large ligands (NS3) to a one-dimensional homogeneous lattice of infinite length (RNA) we tested the hypothesis that inhibition is the result of crowding of NS3 molecules along the RNA lattices. Finally, we discuss why this hypothesis is consistent with the idea that the ATPase catalytic cycle is tightly coupled to the movement of NS3 helicase along the RNA.	[Jeremias Incicco, J.; Gonzalez-Lebrero, Rodolfo M.; Kaufman, Sergio B.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Jeremias Incicco, J.; Gonzalez-Lebrero, Rodolfo M.; Kaufman, Sergio B.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Gebhard, Leopoldo G.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Kaufman, SB (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina.	sbkauf@qb.ffyb.uba.ar		Gonzalez Lebrero, Rodolfo M./0000-0002-3832-2270; Kaufman, Sergio Benjamin/0000-0002-8763-4086	Universidad de Buenos Aires [UBACYT 20020110200182]; National Institutes of Health [1R01AI095175-01]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2010-2092]; Consejo Nacional de Investigaciones Cienticas y Tecnicas (CON-ICET) [PIP 112 201101 00655/12]; Universidad de Buenos Aires; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095175] Funding Source: NIH RePORTER	Universidad de Buenos Aires(University of Buenos Aires); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cienticas y Tecnicas (CON-ICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to SBK from Universidad de Buenos Aires (UBACYT 20020110200182); to AVG from National Institutes of Health (1R01AI095175-01) and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2010-2092); and to RMGL from Consejo Nacional de Investigaciones Cienticas y Tecnicas (CON-ICET)(PIP 112 201101 00655/12). RMGL, AVG and LGG are members of the CONICET. JJI was funded 11 by a doctoral fellowship from Universidad de Buenos Aires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; BOTTS J, 1958, T FARADAY SOC, V54, P593, DOI 10.1039/tf9585400593; BOTTS J, 1953, T FARADAY SOC, V49, P696, DOI 10.1039/tf9534900696; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHEVILLARD C, 1993, BIOCHEM J, V289, P599, DOI 10.1042/bj2890599; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fucito S, 2008, THESIS U BUENOS AIRE; Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; KELETI T, 1987, EUR J BIOCHEM, V170, P179, DOI 10.1111/j.1432-1033.1987.tb13684.x; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; LAIDLER KJ, 1988, J CHEM EDUC, V65, P250, DOI 10.1021/ed065p250; LAIDLER KJ, 1958, CHEM KINETICS ENZYME; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Liao JC, 2011, J BIOMOL STRUCT DYN, V29, P497, DOI 10.1080/07391102.2011.10507401; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P400; LONDON WP, 1968, B MATH BIOPHYS, V30, P253, DOI 10.1007/BF02476694; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Porter DJT, 1998, J BIOL CHEM, V273, P14247, DOI 10.1074/jbc.273.23.14247; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Rad B, 2012, BIOCHEMISTRY-US, V51, P2921, DOI 10.1021/bi3000676; Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; WOLFE AR, 1992, J MOL BIOL, V223, P1063, DOI 10.1016/0022-2836(92)90262-I; Wong I, 1996, BIOCHEMISTRY-US, V35, P5726, DOI 10.1021/bi952959i; World Health Organization, 2009, DENGUE GUIDELINES DI; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; YOUNG MC, 1994, J MOL BIOL, V235, P1436, DOI 10.1006/jmbi.1994.1099; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	54	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58508	10.1371/journal.pone.0058508	http://dx.doi.org/10.1371/journal.pone.0058508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526990	Green Published, gold			2022-12-27	WOS:000317562100027
J	Qin, T; Yan, GB; Ren, HY; Zhou, HJ; Wang, HX; Xu, Y; Zhao, MQ; Guan, H; Li, MC; Shao, ZJ				Qin, Tian; Yan, Gebin; Ren, Hongyu; Zhou, Haijian; Wang, Huanxin; Xu, Ying; Zhao, Mingqiang; Guan, Hong; Li, Machao; Shao, Zhujun			High Prevalence, Genetic Diversity and Intracellular Growth Ability of Legionella in Hot Spring Environments	PLOS ONE			English	Article							WATER DISTRIBUTION-SYSTEMS; AIR-CONDITIONING SYSTEMS; SEQUENCE-BASED SCHEME; LEGIONNAIRES-DISEASE; POTABLE WATER; PNEUMOPHILA; PNEUMONIA; OUTBREAK; SPP.; IDENTIFICATION	Background: Legionella is the causative agent of Legionnaires' disease, and hot springs are a major source of outbreaks of this disease. It is important from a public health perspective to survey hot spring environments for the presence of Legionella. Methods: Prospective surveillance of the extent of Legionella pollution was conducted at three hot spring recreational areas in Beijing, China in 2011. Pulsed-field gel electrophoresis (PFGE) and sequence-based typing (SBT) were used to describe the genetic polymorphism of isolates. The intracellular growth ability of the isolates was determined by interacting with J774 cells and plating the dilutions onto BCYE agar plates. Results: Overall, 51.9% of spring water samples showed Legionella-positive, and their concentrations ranged from 1 CFU/liter to 2,218 CFU/liter. The positive rates of Legionella were significantly associated with a free chlorine concentration of >= 0.2 mg/L, urea concentration of >= 0.05 mg/L, total microbial counts of >= 400 CFU/ml and total coliform of >= 3 MPN/L (p<0.01). The Legionella concentrations were significantly associated with sample temperature, pH, total microbial counts and total coliform (p<0.01). Legionella pneumophila was the most frequently isolated species (98.9%), and the isolated serogroups included serogroups 3 (25.3%), 6 (23.4%), 5 (19.2%), 1 (18.5%), 2 (10.2%), 8 (0.4%), 10 (0.8%), 9 (1.9%) and 12 (0.4%). Two hundred and twenty-eight isolates were analyzed by PFGE and 62 different patterns were obtained. Fifty-seven L. pneumophila isolates were selected for SBT analysis and divided into 35 different sequence types with 5 main clonal groups. All the 57 isolates had high intracellular growth ability. Conclusions: Our results demonstrated high prevalence and genetic polymorphism of Legionella in springs in Beijing, China, and the SBT and intracellular growth assay results suggested that the Legionella isolates of hot spring environments were pathogenic. Improved control and prevention strategies are urgently needed.	[Qin, Tian; Ren, Hongyu; Zhou, Haijian; Guan, Hong; Li, Machao; Shao, Zhujun] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yan, Gebin; Wang, Huanxin; Xu, Ying; Zhao, Mingqiang] Changping Dist Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Qin, T (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	qintian@icdc.cn; shaozhujun@icdc.cn			National Natural Science Foundation of China [81201251]; Science Foundation for the State Key Laboratory for Infectious Disease Prevention and Control from China, Chinese CDC [2011SKLID202]; Science Foundation for Youth from China CDC [2011A102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for the State Key Laboratory for Infectious Disease Prevention and Control from China, Chinese CDC; Science Foundation for Youth from China CDC	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81201251), the Science Foundation for the State Key Laboratory for Infectious Disease Prevention and Control from China, Chinese CDC (Grant No. 2011SKLID202) and the Science Foundation for Youth from China CDC (Grant No. 2011A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlas RM, 1999, ENVIRON MICROBIOL, V1, P283, DOI 10.1046/j.1462-2920.1999.00046.x; Bartram Jamie, 2007, P1; BLATT SP, 1993, AM J MED, V95, P16, DOI 10.1016/0002-9343(93)90227-G; Boccia S, 2006, INFECT CONT HOSP EP, V27, P459, DOI 10.1086/503642; Borella P, 2005, APPL ENVIRON MICROB, V71, P5805, DOI 10.1128/AEM.71.10.5805-5813.2005; BREIMAN RF, 1990, J INFECT DIS, V161, P1257, DOI 10.1093/infdis/161.6.1257; Brooks T, 2004, J TOXICOL ENV HEAL A, V67, P1845, DOI 10.1080/15287390490492449; Castilla J, 2008, EPIDEMIOL INFECT, V136, P823, DOI 10.1017/S0950268807009077; Declerck P, 2007, WATER RES, V41, P3159, DOI 10.1016/j.watres.2007.04.011; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Diederen BMW, 2008, J INFECTION, V56, P1, DOI 10.1016/j.jinf.2007.09.010; DONDERO TJ, 1980, NEW ENGL J MED, V302, P365, DOI 10.1056/NEJM198002143020703; Edagawa A, 2008, J APPL MICROBIOL, V105, P2104, DOI 10.1111/j.1365-2672.2008.03932.x; FANG GD, 1989, MEDICINE, V68, P116, DOI 10.1097/00005792-198903000-00005; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Furuhata Katsunori, 2004, Kansenshogaku Zasshi, V78, P710; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Garcia-Nunez M, 2008, FEMS IMMUNOL MED MIC, V52, P202, DOI 10.1111/j.1574-695X.2007.00362.x; Goutziana G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-390; Hsu BM, 2006, WATER RES, V40, P3267, DOI 10.1016/j.watres.2006.07.007; Huang SW, 2010, WATER RES, V44, P4805, DOI 10.1016/j.watres.2010.07.063; Ito I, 2002, INTERNAL MED, V41, P859, DOI 10.2169/internalmedicine.41.859; Karasudani Tatsuya, 2009, Kansenshogaku Zasshi, V83, P36; Lee HK, 2010, APPL ENVIRON MICROB, V76, P6547, DOI 10.1128/AEM.00422-10; Leoni E, 2001, WATER RES, V35, P3749, DOI 10.1016/S0043-1354(01)00075-6; Lin H, 2009, J APPL MICROBIOL, V106, P606, DOI 10.1111/j.1365-2672.2008.04031.x; Mouchtouri V, 2007, APPL ENVIRON MICROB, V73, P1489, DOI 10.1128/AEM.02191-06; Mouchtouri VA, 2010, AM J INFECT CONTROL, V38, P50, DOI 10.1016/j.ajic.2009.04.285; Ohno A, 2003, APPL ENVIRON MICROB, V69, P2540, DOI 10.1128/AEM.69.5.2540-2547.2003; Okada Mika, 2005, Kansenshogaku Zasshi, V79, P365; POND K, 2005, WATER RECREATION DIS, P76; Qin T, 2012, J MED MICROBIOL, V61, P1023, DOI 10.1099/jmm.0.040170-0; Qin T, 2012, WORLD J MICROB BIOT, V28, P1881, DOI 10.1007/s11274-011-0986-x; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; REINGOLD AL, 1984, J INFECT DIS, V149, P819, DOI 10.1093/infdis/149.5.819; Rivera JM, 2007, J HOSP INFECT, V67, P360, DOI 10.1016/j.jhin.2007.07.022; SHANDS KN, 1985, JAMA-J AM MED ASSOC, V253, P1412, DOI 10.1001/jama.253.10.1412; Sopena N, 1999, EUR J CLIN MICROBIOL, V18, P852, DOI 10.1007/s100960050419; Su HP, 2006, MICROBIOL IMMUNOL, V50, P371, DOI 10.1111/j.1348-0421.2006.tb03803.x; VERISSIMO A, 1991, APPL ENVIRON MICROB, V57, P2921; Yabuuchi Eiko, 2004, Kansenshogaku Zasshi, V78, P90; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; Zanetti F, 2000, EUR J ORAL SCI, V108, P22, DOI 10.1034/j.1600-0722.2000.00763.x; Zhou HJ, 2010, APPL ENVIRON MICROB, V76, P1334, DOI 10.1128/AEM.01455-09	45	21	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59018	10.1371/journal.pone.0059018	http://dx.doi.org/10.1371/journal.pone.0059018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527075	Green Submitted, Green Published, gold			2022-12-27	WOS:000316411600027
J	Zhu, W; Wu, Y; Xu, D; Li, YH; Ba, J; Zhang, XL; Wang, F; Yu, J				Zhu, Wei; Wu, Yan; Xu, Ding; Li, Yan-Hong; Ba, Jun; Zhang, Xiao-Long; Wang, Fang; Yu, Jing			Aspirin Use and Risk of Age-Related Macular Degeneration: A Meta-Analysis	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; CHOROIDAL NEOVASCULARIZATION; INTRAOCULAR HEMORRHAGE; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; 5-YEAR INCIDENCE; DECREASED RATES; MEDICATION USE; MACULOPATHY; EYE	Background: Age-related macular degeneration (AMD) is the main cause of blindness and the curative options are limited. The objective of this meta-analysis was to determine the association between aspirin use and risk of AMD. Methods: A comprehensive literature search was performed in PubMed, Embase, Web of Science, and reference lists. A meta-analysis was performed by STATA software. Results: Ten studies involving 171729 individuals examining the association between aspirin use and risk of AMD were included. Among the included studies, 2 were randomized-controlled trials (RCTs), 4 were case-control studies and 4 were cohort studies. The relative risks (RRs) were pooled using a random-effects model. Relative risks with 95% confidence intervals (CIs) of aspirin use as a risk for AMD. The pooled RR of 10 included studies between the use of aspirin and risk of AMD was 1.09 (95% CI, 0.96-1.24). The same result was detected in early and late stage AMD subgroup analysis. In the subgroup analyses, the pooled RR of RCTs, case-control studies and cohort studies were 0.81 (95% CI, 0.64-1.02), 1.02 (95% CI, 0.92-1.14) and 1.08 (95% CI, 0.91-1.28), respectively. Conclusions: The use of aspirin was not associated with the risk of AMD.	[Zhu, Wei; Wu, Yan; Xu, Ding; Li, Yan-Hong; Ba, Jun; Wang, Fang; Yu, Jing] Tongji Univ, Affiliated Peoples Hosp 10, Dept Ophthalmol, Shanghai 200092, Peoples R China; [Zhu, Wei; Wu, Yan; Zhang, Xiao-Long] Nanjing Med Univ, Dept Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China	Tongji University; Nanjing Medical University	Yu, J (corresponding author), Tongji Univ, Affiliated Peoples Hosp 10, Dept Ophthalmol, Shanghai 200092, Peoples R China.	dryujing@yahoo.com.cn	li, yan/GTI-4638-2022		National Nature Science Foundation [30901643]; Shanghai Science Committee Biology Department Pilot Project [10411964900]; New Excellence Project of Shanghai Health Bureau [XYQ2011067]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Science Committee Biology Department Pilot Project; New Excellence Project of Shanghai Health Bureau	This work was supported in whole or in part, by National Nature Science Foundation Project (30901643), Shanghai Science Committee Biology Department Pilot Project (10411964900) and The New Excellence Project of Shanghai Health Bureau (XYQ2011067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; [Anonymous], 1991, Ophthalmology, V98, P757; Ayyadevara S, 2012, ANTIOXID REDOX SIGNA; Baron JA, 2012, JNCI-J NATL CANCER I, V104, P1199, DOI 10.1093/jnci/djs338; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Becker RC, 2008, CHEST, V133, p776S, DOI 10.1378/chest.08-0685; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chew EY, 2012, OPHTHALMOLOGY, V119, P2282, DOI 10.1016/j.ophtha.2012.05.027; Chopdar A, 2003, BRIT MED J, V326, P485, DOI 10.1136/bmj.326.7387.485; Christen WG, 2001, ARCH OPHTHALMOL-CHIC, V119, P1143, DOI 10.1001/archopht.119.8.1143; Christen WG, 2009, OPHTHALMOLOGY, V116, P2386, DOI 10.1016/j.ophtha.2009.05.031; Clemons Traci E, 2005, Ophthalmology, V112, P533; Coleman AL, 2010, AM J OPHTHALMOL, V149, P160, DOI 10.1016/j.ajo.2009.07.025; de Jong PTVM, 2012, OPHTHALMOLOGY, V119, P112, DOI 10.1016/j.ophtha.2011.06.025; de Jong PTVM, 2010, OPHTHALMOLOGY, V117, P1279, DOI 10.1016/j.ophtha.2010.03.011; DeAngelis MM, 2004, ARCH OPHTHALMOL-CHIC, V122, P575, DOI 10.1001/archopht.122.4.575; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diehl AK, 2012, ANN INTERN MED, V157, pJC1; Douglas IJ, 2007, OPHTHALMOLOGY, V114, P1164, DOI 10.1016/j.ophtha.2006.09.018; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELBABA F, 1986, OPHTHALMOLOGY, V93, P1581; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Gaynes BI, 2004, AM J OPHTHALMOL, V138, P1089, DOI 10.1016/j.ajo.2004.08.048; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Hirvela H, 1996, OPHTHALMOLOGY, V103, P871, DOI 10.1016/S0161-6420(96)30593-9; Kiernan DF, 2010, RETINA-J RET VIT DIS, V30, P1573, DOI 10.1097/IAE.0b013e3181e2266d; KINGHAM JD, 1988, NEW ENGL J MED, V318, P1126; Klein BEK, 2012, JAMA-J AM MED ASSOC, V308, P2469, DOI 10.1001/jama.2012.65406; KLEIN ML, 1991, JAMA-J AM MED ASSOC, V266, P2279; Klein R, 2001, AM J OPHTHALMOL, V132, P128, DOI 10.1016/S0002-9394(00)00931-4; Klein R, 2001, ARCH OPHTHALMOL-CHIC, V119, P1354; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mascitelli L, 2010, MED HYPOTHESES, V74, P754, DOI 10.1016/j.mehy.2009.11.009; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; Millen AE, 2011, ARCH OPHTHALMOL-CHIC, V129, P481, DOI 10.1001/archophthalmol.2011.48; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moon BG, 2012, J KOREAN MED SCI, V27, P537, DOI 10.3346/jkms.2012.27.5.537; Nandish S, 2011, AM J CARDIOL, V108, p42B, DOI 10.1016/j.amjcard.2011.03.015; Olea JL, 2012, EUR J OPHTHALMOL, V22, P404, DOI 10.5301/ejo.5000023; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rudnicka AR, 2010, EYE, V24, P1199, DOI 10.1038/eye.2010.8; Samoocha David, 2010, J Med Internet Res, V12, pe23, DOI 10.2196/jmir.1286; Schaumberg DA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1259; Sperduto RD, 2001, OPHTHALMOLOGY, V108, P1400; Tilanus MAD, 2000, GRAEF ARCH CLIN EXP, V238, P482, DOI 10.1007/PL00007887; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; Wang JJ, 2003, OPHTHALMIC EPIDEMIOL, V10, P37, DOI 10.1076/opep.10.1.37.13776; Wilson HL, 2004, AM J OPHTHALMOL, V137, P615, DOI 10.1016/j.ajo.2003.10.025; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Yoshinaga N, 2011, LAB INVEST, V91, P1277, DOI 10.1038/labinvest.2011.101	55	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58821	10.1371/journal.pone.0058821	http://dx.doi.org/10.1371/journal.pone.0058821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516561	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400066
J	Trellet, M; Melquiond, ASJ; Bonvin, AMJJ				Trellet, Mikael; Melquiond, Adrien S. J.; Bonvin, Alexandre M. J. J.			A Unified Conformational Selection and Induced Fit Approach to Protein-Peptide Docking	PLOS ONE			English	Article							WEB SERVER; ALLOSTERIC TRANSITIONS; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; SPECIFICITY; HADDOCK; CAPRI; DETERMINANTS; RECOGNITION; PREDICTION	Protein-peptide interactions are vital for the cell. They mediate, inhibit or serve as structural components in nearly 40% of all macromolecular interactions, and are often associated with diseases, making them interesting leads for protein drug design. In recent years, large-scale technologies have enabled exhaustive studies on the peptide recognition preferences for a number of peptide-binding domain families. Yet, the paucity of data regarding their molecular binding mechanisms together with their inherent flexibility makes the structural prediction of protein-peptide interactions very challenging. This leaves flexible docking as one of the few amenable computational techniques to model these complexes. We present here an ensemble, flexible protein-peptide docking protocol that combines conformational selection and induced fit mechanisms. Starting from an ensemble of three peptide conformations (extended, a-helix, polyproline-II), flexible docking with HADDOCK generates 79.4% of high quality models for bound/unbound and 69.4% for unbound/unbound docking when tested against the largest protein-peptide complexes benchmark dataset available to date. Conformational selection at the rigid-body docking stage successfully recovers the most relevant conformation for a given protein-peptide complex and the subsequent flexible refinement further improves the interface by up to 4.5 angstrom interface RMSD. Cluster-based scoring of the models results in a selection of near-native solutions in the top three for similar to 75% of the successfully predicted cases. This unified conformational selection and induced fit approach to protein-peptide docking should open the route to the modeling of challenging systems such as disorder-order transitions taking place upon binding, significantly expanding the applicability limit of biomolecular interaction modeling by docking.	[Trellet, Mikael; Melquiond, Adrien S. J.; Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci Chem, Bijvoet Ctr Biomol Res, Computat Struct Biol Grp, Utrecht, Netherlands	Utrecht University	Melquiond, ASJ (corresponding author), Univ Utrecht, Fac Sci Chem, Bijvoet Ctr Biomol Res, Computat Struct Biol Grp, Utrecht, Netherlands.	a.s.j.melquiond@uu.nl; a.m.j.j.bonvin@uu.nl	Bonvin, Alexandre M.J.J./A-5420-2009; Trellet, Mikael/A-9370-2017	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Trellet, Mikael/0000-0001-6337-581X; Melquiond, Adrien/0000-0002-0167-3771	Netherlands Organization for Scientific Research [700.56.442]; WeNMR project (European FP7 e-Infrastructure grant) [261572]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); WeNMR project (European FP7 e-Infrastructure grant)	This work was supported by the Netherlands Organization for Scientific Research (www.nwo.nl) (VICI grant 700.56.442 to A.M.J.J.B.) and the WeNMR project (European FP7 e-Infrastructure grant, contract no. 261572, www.wenmr.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Ben-Shimon A, 2010, J MOL BIOL, V402, P259, DOI 10.1016/j.jmb.2010.07.021; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Casares S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-22; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dagliyan O, 2011, STRUCTURE, V19, P1837, DOI 10.1016/j.str.2011.09.014; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fischer E, 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Frydman-Marom A, 2011, AMYLOID, V18, P119, DOI 10.3109/13506129.2011.582902; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Hahn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032804; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hubbard S. J., 1993, NACCESS; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Karaca E, 2011, STRUCTURE, V19, P555, DOI 10.1016/j.str.2011.01.014; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; Kumar S, 2000, PROTEIN SCI, V9, P10; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Madine J, 2008, J AM CHEM SOC, V130, P7873, DOI 10.1021/ja075356q; Maes M, 2012, FEBS J, V279, P2795, DOI 10.1111/j.1742-4658.2012.08680.x; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Musi V, 2006, PROTEIN SCI, V15, P795, DOI 10.1110/ps.051785506; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Niv MY, 2005, J AM CHEM SOC, V127, P14072, DOI 10.1021/ja054195s; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Pons C, 2010, J MOL BIOL, V403, P217, DOI 10.1016/j.jmb.2010.08.029; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schrodinger L., 2020, PYMOL; Shtatland T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-280; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stigler RD, 1999, STRUCTURE, V7, P663, DOI 10.1016/S0969-2126(99)80087-2; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Trabuco LG, 2012, NUCLEIC ACIDS RES, V40, pW423, DOI 10.1093/nar/gks398; Tzakos AG, 2004, EUR J BIOCHEM, V271, P3399, DOI 10.1111/j.1432-1033.2004.04274.x; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; Wassenaar TA, 2011, CEUR; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Yamin G, 2009, BIOCHEMISTRY-US, V48, P11329, DOI 10.1021/bi901325g; Zhou YY, 1998, FOLD DES, V3, P513, DOI 10.1016/S1359-0278(98)00067-4	59	132	133	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58769	10.1371/journal.pone.0058769	http://dx.doi.org/10.1371/journal.pone.0058769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516555	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200113
J	Castro-Sesquen, YE; Gilman, RH; Yauri, V; Cok, J; Angulo, N; Escalante, H; Bern, C				Castro-Sesquen, Yagahira E.; Gilman, Robert H.; Yauri, Veronica; Cok, Jaime; Angulo, Noelia; Escalante, Hermes; Bern, Caryn			Detection of Soluble Antigen and DNA of Trypanosoma cruzi in Urine Is Independent of Renal Injury in the Guinea Pig Model	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CHRONIC CHAGAS-DISEASE; EXPERIMENTAL-INFECTION; PULMONARY TUBERCULOSIS; TRANSRENAL DNA; MICE; PCR; TRANSMISSION; DIAGNOSIS; SPECIMENS	The diagnosis of Chagas disease in humans is generally limited to the detection of specific antibodies. Detection of T. cruzi antigens in urine has been reported previously, but is not used in the diagnosis. In this study, soluble T. cruzi antigens and DNA were detected in urine samples and were associated with kidney injury and systemic detection of the parasite. We used 72 guinea pigs infected with T. cruzi Y strain and 18 non-infected guinea pigs. Blood, kidney, heart and urine samples were collected during the acute phase and chronic phase. Urine samples were concentrated by ultrafiltration. Antigens were detected by Western Blot using a polyclonal antibody against trypomastigote excretory-secretory antigen (TESA). T. cruzi DNA was detected by PCR using primers 121/122 and TcZ1/TcZ2. Levels of T. cruzi DNA in blood, heart and kidney were determined by quantitative PCR. T. cruzi antigens (75 kDa, 80 kDa, 120 kDa, 150 kDa) were detected in the acute phase (67.5%) and the chronic phase (45%). Parasite DNA in urine was detected only in the acute phase (45%). Kidney injury was characterized by high levels of proteinuria, kidney injury molecule-1 (KIM-1) and urea, and some histopathological changes such as inflammation, necrosis, fibrosis and scarce parasites. The detection of antigens and DNA in urine was associated with the presence of parasite DNA in blood and heart and with high levels of parasite DNA in blood, but not with the presence of parasite in kidney or kidney injury. These results suggest that the detection of T. cruzi in urine could be improved to be a valuable method for the diagnosis of Chagas disease, particularly in congenital Chagas disease and in immunocompromised patients.	[Castro-Sesquen, Yagahira E.; Angulo, Noelia] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Yauri, Veronica] Univ Nacl Mayor San Marcos, Fac Med Vet, Lima 14, Peru; [Cok, Jaime] Hosp Nacl Cayetano Heredia, Dept Pathol, Lima, Peru; [Escalante, Hermes] Univ Nacl Trujillo, Fac Ciencias Biol, Trujillo, Peru; [Escalante, Hermes] Ctr Anal & Invest Escalabs, Dept Invest & Prod, Trujillo, Peru; [Bern, Caryn] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA	Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Nacional Mayor de San Marcos; Universidad Nacional de Trujillo; University of California System; University of California San Francisco	Gilman, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	rgilman@jhsph.edu		Castro-Sesquen, Yagahira E./0000-0001-6824-9206; Bern, Caryn/0000-0001-8195-7303	Fogarty International Center [5 R24 TW007988, D43 TW006581]; National Institute of Allergy and Infectious Diseases at the National Institute of Health [R01 AI087776]; Centro de Analisis e Investigacion escalabs e.i.rl; MRC [MR/K007467/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [D43TW006581, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087776] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centro de Analisis e Investigacion escalabs e.i.rl; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by Fogarty International Center (5 R24 TW007988, D43 TW006581) and National Institute of Allergy and Infectious Diseases (R01 AI087776) at the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Hermes Escalante has been working in Centro de Analisis e Investigacion escalabs e.i.rl. Part of this research was funded by this company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Basquiera AL, 2003, HEART, V89, P1186, DOI 10.1136/heart.89.10.1186; Bern C, 2009, CLIN INFECT DIS, V49, P1667, DOI 10.1086/648070; Bertot GM, 1998, J PARASITOL, V84, P608, DOI 10.2307/3284731; Boczko J, 2005, J UROLOGY, V173, P1784, DOI 10.1097/01.ju.0000154170.87947.b8; Brinkman JW, 2007, NEPHROL DIAL TRANSPL, V22, P3670, DOI 10.1093/ndt/gfl803; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; Carvalho Maria Fernanda C., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P223, DOI 10.1590/S0036-46651997000400008; Castro-Sesquen YE, 2011, AM J PATHOL, V179, P281, DOI 10.1016/j.ajpath.2011.03.043; Corral RS, 1996, J CLIN MICROBIOL, V34, P1957, DOI 10.1128/JCM.34.8.1957-1962.1996; CORRAL RS, 1995, PARASITE, V2, P339; CORRAL RS, 1989, J CLIN MICROBIOL, V27, P145, DOI 10.1128/JCM.27.1.145-151.1989; COSTA RS, 1991, CLIN IMMUNOL IMMUNOP, V58, P102, DOI 10.1016/0090-1229(91)90152-Z; Cruz Dinna N, 2010, Congest Heart Fail, V16 Suppl 1, pS25, DOI 10.1111/j.1751-7133.2010.00163.x; de Oliveira GM, 2009, PARASITOL RES, V106, P111, DOI 10.1007/s00436-009-1637-0; Debrabant A, 2003, INT J PARASITOL, V33, P257, DOI 10.1016/S0020-7519(03)00008-0; ERMAN A, 1988, CLIN CHIM ACTA, V174, P255, DOI 10.1016/0009-8981(88)90051-4; Fitzwater S, 2008, AM J TROP MED HYG, V79, P768, DOI 10.4269/ajtmh.2008.79.768; FREILIJ HL, 1987, J CLIN MICROBIOL, V25, P133, DOI 10.1128/JCM.25.1.133-137.1987; Gonzalez G, 1996, SCAND J IMMUNOL, V44, P122, DOI 10.1046/j.1365-3083.1996.d01-290.x; Herrera L, 2001, MEM I OSWALDO CRUZ, V96, P713, DOI 10.1590/S0074-02762001000500024; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; ITO K, 1984, J BIOCHEM, V95, P1399, DOI 10.1093/oxfordjournals.jbchem.a134747; JAZIN EE, 1991, INFECT IMMUN, V59, P2189; Junqueira ACV, 1996, T ROY SOC TROP MED H, V90, P129, DOI 10.1016/S0035-9203(96)90111-X; Kashino SS, 2008, CLIN EXP IMMUNOL, V153, P56, DOI 10.1111/j.1365-2249.2008.03672.x; KATZIN A, 1989, T ROY SOC TROP MED H, V83, P341, DOI 10.1016/0035-9203(89)90497-5; KATZIN AM, 1989, EXP PARASITOL, V68, P208, DOI 10.1016/0014-4894(89)90099-4; KOIZUMI T, 1995, EXP ANIM TOKYO, V44, P181, DOI 10.1538/expanim.44.181; Lichtenstein AV, 2001, ANN NY ACAD SCI, V945, P239; Oliveira I, 2010, EXPERT REV ANTI-INFE, V8, P945, DOI 10.1586/ERI.10.74; *ORG PAN SAL, 2006, OPSHDMCD42506; Pinto Ana Yecê das Neves, 2004, Braz J Infect Dis, V8, P454, DOI 10.1590/S1413-86702004000600010; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Pizarro Juan Carlos, 2007, Kinetoplastid Biol Dis, V6, P1, DOI 10.1186/1475-9292-6-1; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338; Shane HL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000951; Su YH, 2004, ANN NY ACAD SCI, V1022, P81, DOI 10.1196/annals.1318.014; Toye B, 1998, J CLIN MICROBIOL, V36, P2356, DOI 10.1128/JCM.36.8.2356-2358.1998; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; Umezawa ES, 1996, J CLIN MICROBIOL, V34, P2143, DOI 10.1128/JCM.34.9.2143-2147.1996; UMEZAWA ES, 1993, EXP PARASITOL, V76, P352, DOI 10.1006/expr.1993.1043; Veland N, 2011, AM J TROP MED HYG, V84, P556, DOI 10.4269/ajtmh.2011.10-0556; Veloso VM, 2008, MEM I OSWALDO CRUZ, V103, P528, DOI 10.1590/S0074-02762008000600003; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; WINCKER P, 1994, FEMS MICROBIOL LETT, V124, P419, DOI 10.1111/j.1574-6968.1994.tb07318.x; Wincker P, 1997, PARASITOLOGY, V114, P367, DOI 10.1017/S0031182096008554	49	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58480	10.1371/journal.pone.0058480	http://dx.doi.org/10.1371/journal.pone.0058480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520515	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900074
J	Hou, XH; Lu, JM; Weng, JP; Ji, LN; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Ge, JP; Lin, LX; Chen, L; Guo, XH; Zhao, ZG; Li, Q; Zhou, ZG; Shan, GL; Yang, ZJ; Yang, WY; Jia, WP				Hou, Xuhong; Lu, Juming; Weng, Jianping; Ji, Linong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Ge, Jiapu; Lin, Lixiang; Chen, Li; Guo, Xiaohui; Zhao, Zhigang; Li, Qiang; Zhou, Zhiguang; Shan, Guangliang; Yang, Zhaojun; Yang, Wenying; Jia, Weiping		China Natl Diabet Metab Disorders	Impact of Waist Circumference and Body Mass Index on Risk of Cardiometabolic Disorder and Cardiovascular Disease in Chinese Adults: A National Diabetes and Metabolic Disorders Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CENTRAL OBESITY; INSULIN-RESISTANCE; FAT DISTRIBUTION; PREVALENCE; BMI; WEIGHT; HYPERTENSION; PREDICTORS; OVERWEIGHT	Background: We updated the prevalence of obesity and evaluated the clinical utility of separate and combined waist circumference (WC) or body mass index (BMI) category increments in identifying cardiometabolic disorder (CMD) and cardiovascular disease (CVD) risk in Chinese adults. Methods and Findings: 46,024 participants aged >= 20 years, a nationally representative sample surveyed in 2007-2008, were included in this analysis. Taking the cutoffs recommended by the Chinese Joint Committee for Developing Chinese Guidelines (JCDCG) and the Working Group on Obesity in China (WGOC) into account, the participants were divided into four WC and four BMI groups in 0.5-SD increments around the mean, and 16 cross-tabulated combination groups of WC and BMI. 27.1%, 31.4%, and 12.2% of Chinese adults are centrally obese, overweight, or obese according to JCDCG and WGOC criteria. After adjustment for confounders, after a 1-SD increment, WC is associated with a 1.7-fold or 2.2-fold greater risk of having DM or DM plus dyslipidemia than BMI, while BMI was associated with a 2.3-fold or 1.7-fold higher hypertension or hypertension plus dyslipidemia risk than WC. The combination of WC and BMI categories had stronger association with CMD risk, i.e., the adjusted ORs (95% CI) of having DM, hypertension, and dyslipidemia for the combined and separate highest WC and BMI categories were 2.19 (1.96-2.44) vs 1.88 (1.67-2.12) and 1.12 (0.99-1.26); 5.70 (5.24-6.19) vs 1.51 (1.39-1.65) and 1.69 (1.57-1.82); and 3.73 (3.42-4.07) vs 2.16 (1.98-2.35) and 1.33 (1.25-1.40), respectively. The combination of WC and BMI categories was more likely to identify individuals with lower WC and lower BMI at CVD risk, even after the effects of CMD were controlled (all P<0.05). Conclusion: Central obesity, overweight, and obesity are epidemic in Chinese adults. The combination of WC and BMI measures is superior to the separate indices in identifying CMD and CVD risk.	[Hou, Xuhong; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Dept Endocrinol & Metab, Guangzhou 510275, Guangdong, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang, Liaoning, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Dept Endocrinol & Metab, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Shaanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Endocrinol & Metab, Nanjing 210008, Jiangsu, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Dept Endocrinol & Metab, Urumqi, Xinjiang, Peoples R China; [Lin, Lixiang] Fujian Prov Hosp, Dept Endocrinol & Metab, Fuzhou, Fujiang, Peoples R China; [Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol & Metab, Jinan 250100, Shandong, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Zhao, Zhigang] Henan Prov Peoples Hosp, Dept Endocrinol & Metab, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Harbin, Heilongjiang, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Dept Endocrinol & Metab, Changsha, Hunan, Peoples R China; [Shan, Guangliang] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Epidemiol & Stat,Sch Basic Med, Beijing 100730, Peoples R China; [Yang, Zhaojun; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China	Shanghai Jiao Tong University; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Fujian Provincial Hospital; Shandong University; Peking University; Zhengzhou University; Harbin Medical University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; China-Japan Friendship Hospital	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012; Linong, Ji/AAB-6543-2020	Weng, Jianping/0000-0002-7889-1697; Zhou, Zhiguang/0000-0002-0374-1838	Chinese Medical Association Foundation; Chinese Diabetes Society	Chinese Medical Association Foundation; Chinese Diabetes Society	This work was supported by grants from the Chinese Medical Association Foundation and the Chinese Diabetes Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chalmers J, 1999, J HYPERTENS, V17, P151; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Elobeid MA, 2007, OBESITY, V15, P2380, DOI 10.1038/oby.2007.282; Freiberg MS, 2008, OBESITY, V16, P463, DOI 10.1038/oby.2007.75; Fukushima M, 1999, DIABETES CARE, V22, P1911, DOI 10.2337/diacare.22.11.1911; GE K, 1996, DIETARY NUTR STATUS, V1; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; Janiszewski PM, 2007, DIABETES CARE, V30, P3105, DOI 10.2337/dc07-0945; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Klein S, 2007, AM J CLIN NUTR, V85, P1197, DOI 10.1093/ajcn/85.5.1197; Ko GT, 2010, EUR J CLIN NUTR, V64, P549, DOI 10.1038/ejcn.2010.49; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Lofgren I, 2004, J NUTR, V134, P1071, DOI 10.1093/jn/134.5.1071; Luepker R. V., 2004, CARDIOVASCULAR SURVE; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Nyamdorj R, 2008, OBESITY, V16, P1622, DOI 10.1038/oby.2008.73; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Smith SC, 2010, ARCH INTERN MED, V170, P40, DOI 10.1001/archinternmed.2009.457; Suk SH, 2003, STROKE, V34, P1586, DOI 10.1161/01.STR.0000075294.98582.2F; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Walker SP, 1996, AM J EPIDEMIOL, V144, P1143, DOI 10.1093/oxfordjournals.aje.a008892; Wang J, 1996, OBES RES, V4, P377, DOI 10.1002/j.1550-8528.1996.tb00245.x; Wang LD, 2005, 2002 NUTR HLTH SURVE, P50; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wildman RP, 2005, AM J CLIN NUTR, V82, P1195, DOI 10.1093/ajcn/82.6.1195; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73	40	116	153	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57319	10.1371/journal.pone.0057319	http://dx.doi.org/10.1371/journal.pone.0057319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520466	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900025
J	Iwata, M; Madtes, DK; Abrams, K; Lamm, WJE; Glenny, RW; Nash, RA; Ramakrishnan, A; Torok-Storb, B				Iwata, Mineo; Madtes, David K.; Abrams, Kraig; Lamm, Wayne J. E.; Glenny, Robb W.; Nash, Richard A.; Ramakrishnan, Aravind; Torok-Storb, Beverly			Late Infusion of Cloned Marrow Fibroblasts Stimulates Endogenous Recovery from Radiation-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; TOTAL-BODY IRRADIATION; ARTERIAL INJURY; TRANSPLANTATION; REGENERATION; ENGRAFTMENT; REPAIR; IDENTIFICATION; HEMANGIOBLAST	In the current study, we used a canine model of radiation-induced lung injury to test the effect of a single i.v. infusion of 10x10(6)/kg of marrow fibroblasts on the progression of damage following 15 Gy exposure to the right lung. The fibroblasts, designated DS1 cells, are a cloned population of immortalized cells isolated from a primary culture of marrow stromal cells. DS1 cells were infused at week 5 post-irradiation when lung damage was evident by imaging with high-resolution computed tomography (CT). At 13 weeks post-irradiation we found that 4 out of 5 dogs receiving DS1 cells had significantly improved pulmonary function compared to 0 out of 5 control dogs (p = 0.047, Fisher's Exact). Pulmonary function was measured as the single breath diffusion capacity-hematocrit (DLCO-Hct), the total inspiratory capacity (IC), and the total lung capacity (TLC), which differed significantly between control and DS1-treated dogs; p = 0.002, p = 0.005, and p = 0.004, respectively. The DS1-treated dogs also had less pneumonitis detected by CT imaging and an increased number of TTF-1 (thyroid transcription factor 1, NKX2-1) positive cells in the bronchioli and alveoli compared to control dogs. Endothelial-like progenitor cells (ELC) of host origin, detected by colony assays, were found in peripheral blood after DS1 cell infusion. ELC numbers peaked one day after infusion, and were not detectable by 7 days. These data suggest that infusion of marrow fibroblasts stimulates mobilization of ELC, which is associated with a reduction in otherwise progressive radiation-induced lung injury. We hypothesize that these two observations are related, specifically that circulating ELC contribute to increased angiogenesis, which facilitates endogenous lung repair.	[Iwata, Mineo; Madtes, David K.; Abrams, Kraig; Nash, Richard A.; Ramakrishnan, Aravind; Torok-Storb, Beverly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Madtes, David K.; Lamm, Wayne J. E.; Glenny, Robb W.; Nash, Richard A.; Ramakrishnan, Aravind] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Glenny, Robb W.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Torok-Storb, B (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	btorokst@fhcrc.org			National Institutes of Health, Bethesda, Maryland [P30DK056465, U01HL099993]; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland [RC1 AI081298]; Synergy Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL094374, U01HL099993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI081298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Synergy Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful for research funding from the National Institutes of Health, Bethesda, Maryland, grants P30DK056465, and U01HL099993 to BTS, from the National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, grant RC1 AI081298 to RN, and the Synergy Fund to AR and DM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health nor its subsidiary Institutes and Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; BANNISTER LH, 1999, GRAYS ANATOMY, P1666; Burnham EL, 2005, AM J RESP CRIT CARE, V172, P854, DOI 10.1164/rccm.200410-1325OC; Burroughs L, 2005, BLOOD, V106, P4002, DOI 10.1182/blood-2005-05-1937; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Georges GE, 2000, BLOOD, V95, P3262, DOI 10.1182/blood.V95.10.3262.010k28_3262_3269; Ghosh SN, 2009, INT J RADIAT ONCOL, V74, P192, DOI 10.1016/j.ijrobp.2009.01.006; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hilgendorf I, 2005, VET RES COMMUN, V29, P103, DOI 10.1023/B:VERC.0000047486.01458.c5; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2008, CURR OPIN LIPIDOL, V19, P491, DOI 10.1097/MOL.0b013e32830dfe33; Hristov M, 2007, THROMB HAEMOSTASIS, V98, P274, DOI 10.1160/TH07-03-0181; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kotton DN, 2008, CELL TISSUE RES, V331, P145, DOI 10.1007/s00441-007-0479-2; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Levis J, 2008, AM J RESP CELL MOL, V38, P16, DOI 10.1165/rcmb.2007-0249OC; MacVittie TJ, 2005, HEALTH PHYS, V89, P546, DOI 10.1097/01.HP.0000173143.69659.5b; Mielcarek M, 2011, BIOL BLOOD MARROW TR, V17, P214, DOI 10.1016/j.bbmt.2010.08.015; Nash RA, 2009, AM J TRANSPLANT, V9, P1037, DOI 10.1111/j.1600-6143.2009.02619.x; NASH RA, 1994, BLOOD, V83, P1963; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; SCHARF SJ, 1995, BLOOD, V85, P1954, DOI 10.1182/blood.V85.7.1954.bloodjournal8571954; STORB R, 1985, IMMUNOL REV, V88, P215, DOI 10.1111/j.1600-065X.1985.tb01160.x; STORB R, 1994, BLOOD, V83, P3384; Thomas E.D., 1999, HEMATOPOIETIC CELL T, P1; Tilki D, 2009, TRENDS MOL MED, V15, P501, DOI 10.1016/j.molmed.2009.09.004; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Yan X, 2007, EXP HEMATOL, V35, P1466, DOI 10.1016/j.exphem.2007.05.012	40	2	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57179	10.1371/journal.pone.0057179	http://dx.doi.org/10.1371/journal.pone.0057179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520463	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900022
J	Sikora, M; Cieplak, M				Sikora, Mateusz; Cieplak, Marek			Formation of Cystine Slipknots in Dimeric Proteins	PLOS ONE			English	Article							MOLECULE FORCE SPECTROSCOPY; CRYSTAL-STRUCTURE; KNOT; TITIN; SUPERFAMILY; INHIBITION; STABILITY; STRENGTH; MODELS; BOND	We consider mechanical stability of dimeric and monomeric proteins with the cystine knot motif. A structure based dynamical model is used to demonstrate that all dimeric and some monomeric proteins of this kind should have considerable resistance to stretching that is significantly larger than that of titin. The mechanisms of the large mechanostability are elucidated. In most cases, it originates from the induced formation of one or two cystine slipknots. Since there are four termini in a dimer, there are several ways of selecting two of them to pull by. We show that in the cystine knot systems, there is strong anisotropy in mechanostability and force patterns related to the selection. We show that the thermodynamic stability of the dimers is enhanced compared to the constituting monomers whereas machanostability is either lower or higher.	[Sikora, Mateusz; Cieplak, Marek] Polish Acad Sci, Inst Phys, Warsaw, Poland	Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences	Cieplak, M (corresponding author), Polish Acad Sci, Inst Phys, Warsaw, Poland.	mc@ifpan.edu.pl			European Regional Development Fund under the Operational Programme Innovative Economy NanoFun [POIG.02.02.00-00-025/09]; Polish National Science Centre [2011/01/B/ST3/02190, 2011/01/N/ST3/02475]	European Regional Development Fund under the Operational Programme Innovative Economy NanoFun; Polish National Science Centre	The computer resources were financed by the European Regional Development Fund under the Operational Programme Innovative Economy NanoFun POIG.02.02.00-00-025/09. This research has been supported by the Polish National Science Centre Grants No. 2011/01/B/ST3/02190 (MC) and 2011/01/N/ST3/02475 (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Bell SL, 2001, BIOCHEM J, V357, P203, DOI 10.1042/0264-6021:3570203; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertz M, 2009, P NATL ACAD SCI USA, V106, P13307, DOI 10.1073/pnas.0902312106; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Bruinzeel W, 2012, PROTEIN EXPRES PURIF, V81, P25, DOI 10.1016/j.pep.2011.08.028; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Carrion-Vazquez M, 2009, ENCY COMPLEXITY SYST, P7026; Cieplak M, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2046609; Cieplak M, 2004, PROTEINS, V56, P285, DOI 10.1002/prot.20081; Cieplak M, 2006, BBA-BIOMEMBRANES, V1758, P537, DOI 10.1016/j.bbamem.2006.03.028; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Crampton N, 2010, CURR OPIN STRUC BIOL, V20, P508, DOI 10.1016/j.sbi.2010.05.005; de Young LR, 1999, PROTEIN SCI, V8, P2513; DeYoung LR, 1996, PROTEIN SCI, V5, P1554, DOI 10.1002/pro.5560050811; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Galera-Prat A, 2010, CURR OPIN STRUC BIOL, V20, P63, DOI 10.1016/j.sbi.2010.01.003; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; He CZ, 2012, J AM CHEM SOC, V134, P10428, DOI 10.1021/ja3003205; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Lee EH, 2006, STRUCTURE, V14, P497, DOI 10.1016/j.str.2005.12.005; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Miles LA, 2002, J BIOL CHEM, V277, P43033, DOI 10.1074/jbc.M206690200; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Muller YA, 2002, J BIOL CHEM, V277, P43410, DOI 10.1074/jbc.M206438200; MURRAYRUST J, 1993, STRUCTURE, V1, P153, DOI 10.1016/0969-2126(93)90029-G; NARHI LO, 1993, INT J PEPT PROT RES, V41, P8; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Peplowski L, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3553801; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Prestrelski SJ, 2009, INT J PEPT PROT RES, V44, P357; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schmidt SW, 2008, J AM CHEM SOC, V130, P3664, DOI 10.1021/ja710642a; Sikora M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.208101; Sikora M, 2011, PROTEINS, V79, P1786, DOI 10.1002/prot.23001; Sikora M, 2011, NUCLEIC ACIDS RES, V39, pD443, DOI 10.1093/nar/gkq851; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; SOCCI ND, 1994, J CHEM PHYS, V101, P1519, DOI 10.1063/1.467775; Sulkowska JI, 2008, BIOPHYS J, V95, P3174, DOI 10.1529/biophysj.107.127233; Sulkowska JI, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/283201; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57443	10.1371/journal.pone.0057443	http://dx.doi.org/10.1371/journal.pone.0057443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520470	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900029
J	Walker, SJ; Fortunato, J; Gonzalez, LG; Krigsman, A				Walker, Stephen J.; Fortunato, John; Gonzalez, Lenny G.; Krigsman, Arthur			Identification of Unique Gene Expression Profile in Children with Regressive Autism Spectrum Disorder (ASD) and Ileocolitis	PLOS ONE			English	Article							LYMPHOCYTE CYTOKINE PROFILES; GASTROINTESTINAL SYMPTOMS; ULCERATIVE-COLITIS; CROHNS-DISEASE; IMMUNE ACTIVATION; DIAGNOSIS; RESPONSES; INNATE; BRAIN	Gastrointestinal symptoms are common in children with autism spectrum disorder (ASD) and are often associated with mucosal inflammatory infiltrates of the small and large intestine. Although distinct histologic and immunohistochemical properties of this inflammatory infiltrate have been previously described in this ASD(GI) group, molecular characterization of these lesions has not been reported. In this study we utilize transcriptome profiling of gastrointestinal mucosal biopsy tissue from ASD(GI) children and three non-ASD control groups (Crohn's disease, ulcerative colitis, and histologically normal) in an effort to determine if there is a gene expression profile unique to the ASD(GI) group. Comparison of differentially expressed transcripts between the groups demonstrated that non-pathologic (normal) tissue segregated almost completely from inflamed tissue in all cases. Gene expression profiles in intestinal biopsy tissue from patients with Crohn's disease, ulcerative colitis, and ASD(GI), while having significant overlap with each other, also showed distinctive features for each group. Taken together, these results demonstrate that ASD(GI) children have a gastrointestinal mucosal molecular profile that overlaps significantly with known inflammatory bowel disease (IBD), yet has distinctive features that further supports the presence of an ASD-associated IBD variant, or, alternatively, a prodromal phase of typical inflammatory bowel disease. Although we report qPCR confirmation of representative differentially expressed transcripts determined initially by microarray, these findings may be considered preliminary to the extent that they require further confirmation in a validation cohort.	[Walker, Stephen J.] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27106 USA; [Fortunato, John] Wake Forest Univ Hlth Sci, Dept Pediat Sect Gastroenterol, Winston Salem, NC USA; [Gonzalez, Lenny G.] Dr Miguel Perez Carreno Hosp, Dept Pediat Gastroenterol, Caracas, Venezuela; [Krigsman, Arthur] Pediat Gastroenterol Resources New York & Texas, Far Rockaway, NY USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Walker, SJ (corresponding author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27106 USA.	swalker@wakehealth.edu			Jane Botsford Johnson Foundation	Jane Botsford Johnson Foundation	The authors are grateful to the Jane Botsford Johnson Foundation for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwood P, 2006, J NEUROIMMUNOL, V173, P126, DOI 10.1016/j.jneuroim.2005.12.007; Ashwood P, 2004, J CLIN IMMUNOL, V24, P664, DOI 10.1007/s10875-004-6241-6; Balzola F, 2005, AM J GASTROENTEROL, V100, P979, DOI 10.1111/j.1572-0241.2005.41202_4.x; Bauman ML, 2010, NEUROTHERAPEUTICS, V7, P320, DOI 10.1016/j.nurt.2010.06.001; Black C, 2002, BRIT MED J, V325, P419, DOI 10.1136/bmj.325.7361.419; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; de Magistris L, 2010, J PEDIATR GASTR NUTR, V51, P418, DOI 10.1097/MPG.0b013e3181dcc4a5; DEufemia P, 1996, ACTA PAEDIATR, V85, P1076, DOI 10.1111/j.1651-2227.1996.tb14220.x; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Furlano RI, 2001, J PEDIATR-US, V138, P366, DOI 10.1067/mpd.2001.111323; Galamb O, 2006, WORLD J GASTROENTERO, V12, P6998, DOI 10.3748/wjg.v12.i43.6998; Galiatsatos P, 2009, CAN J GASTROENTEROL, V23, P95, DOI 10.1155/2009/394317; Gonzalez L., 2005, ARCH VENEZ PUERIC PE, V69, P19; Horvath K, 2002, CURR OPIN PEDIATR, V14, P583, DOI 10.1097/00008480-200210000-00004; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Jarocka-Cyrta E, 2011, J AUTISM DEV DISORD, V41, P372, DOI 10.1007/s10803-010-1059-y; Jyonouchi H, 2005, NEUROPSYCHOBIOLOGY, V51, P77, DOI 10.1159/000084164; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Krigsman A., 2010, AUTISM INSIGHTS, V1, P1; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Levy SE, 2007, BIOL PSYCHIAT, V61, P492, DOI 10.1016/j.biopsych.2006.07.013; Ming X, 2008, J CHILD NEUROL, V23, P6, DOI 10.1177/0883073807307102; Torrente F, 2004, AM J GASTROENTEROL, V99, P598, DOI 10.1111/j.1572-0241.2004.04142.x; Torrente F, 2002, MOL PSYCHIATR, V7, P375, DOI 10.1038/sj/mp/4001077; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Von Stein P, 2008, GASTROENTEROLOGY, V134, P1869, DOI 10.1053/j.gastro.2008.02.083; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Wright N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1807; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110	32	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58058	10.1371/journal.pone.0058058	http://dx.doi.org/10.1371/journal.pone.0058058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520485	Green Published, gold			2022-12-27	WOS:000318679900044
J	Muennig, P; Kuebler, M; Kim, J; Todorovic, D; Rosen, Z				Muennig, Peter; Kuebler, Meghan; Kim, Jaeseung; Todorovic, Dusan; Rosen, Zohn			Gender Differences in Material, Psychological, and Social Domains of the Income Gradient in Mortality: Implications for Policy	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SOCIOECONOMIC-STATUS; PSYCHOSOCIAL FACTORS; PUBLICATION BIAS; RISK-FACTORS; HEALTH; STRESS; SUSCEPTIBILITY; EDUCATION; HAPPINESS	We set out to examine the material, psychological, and sociological pathways mediating the income gradient in health and mortality. We used the 2008 General Social Survey-National Death Index dataset (N = 26,870), which contains three decades of social survey data in the US linked to thirty years of mortality follow-up. We grouped a large number of variables into 3 domains: material, psychological, and sociological using factor analysis. We then employed discrete-time hazard models to examine the extent to which these three domains mediated the income-mortality association among men and women. Overall, the gradient was weaker for females than for males. While psychological and material factors explained mortality hazards among females, hazards among males were explained only by social capital. Poor health significantly predicted both income and mortality, particularly among females, suggesting a strong role for reverse causation. We also find that many traditional associations between income and mortality are absent in this dataset, such as perceived social status.	[Muennig, Peter; Kuebler, Meghan; Kim, Jaeseung; Rosen, Zohn] Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Todorovic, Dusan] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Columbia University	Kuebler, M (corresponding author), Columbia Univ, Dept Hlth Policy & Management, Mailman Sch Publ Hlth, New York, NY 10027 USA.	meghankuebler@gmail.com	Kim, Jaeseung/AAK-6641-2021	Muennig, Peter/0000-0002-4234-0498				Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; BORGHANS L, 2008, EC PSYCHOL PERSONALI; Buis ML, 2010, STATA J, V10, P11, DOI 10.1177/1536867X1001000104; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; Cohen S, 1997, PSYCHOSOM MED, V59, P213, DOI 10.1097/00006842-199705000-00001; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Cohen S, 1999, ANN NY ACAD SCI, V896, P246, DOI 10.1111/j.1749-6632.1999.tb08119.x; Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9; Costello EJ, 2010, JAMA-J AM MED ASSOC, V303, P1954, DOI 10.1001/jama.2010.621; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Deaton A, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.2.13; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; Eaker ED, 2007, PSYCHOSOM MED, V69, P509, DOI 10.1097/PSY.0b013e3180f62357; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; ELESH D, 1977, J HEALTH SOC BEHAV, V18, P391, DOI 10.2307/2955347; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans GW, 2002, CHILD DEV, V73, P1238, DOI 10.1111/1467-8624.00469; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Feldman PJ, 2003, HEALTH PSYCHOL, V22, P398, DOI 10.1037/0278-6133.22.4.398; Fuchs VR, 2004, J HEALTH ECON, V23, P653, DOI 10.1016/j.jhealeco.2004.04.004; GLENN ND, 1978, J MARRIAGE FAM, V40, P269, DOI 10.2307/350758; Goodman E, 2007, J ADOLESCENT HEALTH, V41, P479, DOI 10.1016/j.jadohealth.2007.05.020; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Graham C, 2008, HEALTH AFFAIR, V27, P72, DOI 10.1377/hlthaff.27.1.72; Irie M, 2001, INT ARCH OCC ENV HEA, V74, P153, DOI 10.1007/s004200000209; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 2010, SOCIAL CAPITAL HLTH; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; KEHRER BH, 1979, J HUM RESOUR, V14, P434, DOI 10.2307/145316; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Lynch JW, 1997, NEW ENGL J MED, V337, P1889, DOI 10.1056/NEJM199712253372606; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; Marmot M., 2004, STATUS SYNDROME YOUR; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mirowsky J, 2003, SOCIAL CAUSES PSYCHO; Muennig P, 2005, SOC SCI MED, V61, P2018, DOI 10.1016/j.socscimed.2005.04.005; Muennig P, 2008, J HEALTH CARE POOR U, V19, P574, DOI 10.1353/hpu.0.0018; Muennig P, 2008, AM J PUBLIC HEALTH, V98, P501, DOI 10.2105/AJPH.2007.114769; Muennig Peter, 2011, BMC Res Notes, V4, P385, DOI 10.1186/1756-0500-4-385; Muennig P, 2011, AM J PUBLIC HEALTH, V101, P512, DOI 10.2105/AJPH.2010.200063; Muennig P, 2010, AM J PUBLIC HEALTH, V100, P1758, DOI 10.2105/AJPH.2009.165019; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rhoe W, 2001, LOW INCOME HOME OWNE; SINGER JD, 1993, J EDUC STAT, V18, P155, DOI 10.2307/1165085; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Smith Tom W., 2011, GEN SOCIAL SURVEYS 1; Steffen PR, 2003, PSYCHOSOM MED, V65, P746, DOI 10.1097/01.PSY.0000079380.95903.78; Wilkinson R., 2009, SPIRIT LEVEL; Wright CE, 2005, PSYCHONEUROENDOCRINO, V30, P582, DOI 10.1016/j.psyneuen.2005.01.007; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138	59	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59191	10.1371/journal.pone.0059191	http://dx.doi.org/10.1371/journal.pone.0059191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SW	23527129	Green Published, gold			2022-12-27	WOS:000317562600062
J	Peng, L; Zhou, Y; Wang, YN; Mou, HB; Zhao, Q				Peng, Ling; Zhou, Yun; Wang, Yina; Mou, Haibo; Zhao, Qiong			Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the Literature	PLOS ONE			English	Article							PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; CYCLOOXYGENASE-2 EXPRESSION; RECTAL-CANCER; MOLECULAR TARGET; P53 ACCUMULATION; GROWTH-FACTOR; BETA-CATENIN; PREVENTION; CYCLO-OXYGENASE-2; OVEREXPRESSION	Background: Cyclooxygenase-2 (COX-2) is believed to be an important enzyme in the pathogenesis of colorectal cancer (CRC). Correlations between the expression of COX-2 with tumor growth and distant metastasis have become an issue; thus, attention has been paid to COX-2 as a prognostic factor. Various studies examined the relationship between COX-2 immunohistochemistry (IHC) overexpression with the clinical outcome in patients with colorectal cancer, but yielded conflicting results. The prognostic significance of COX-2 overexpression in colorectal cancer remains controversial. Methods: Electronic databases updated to October 2012 were searched to find relevant studies. A meta-analysis was conducted with eligible studies which quantitatively evaluated the relationship between COX-2 overexpression and survival of patients with colorectal cancer. Survival data were aggregated and quantitatively analyzed. Results: We performed a meta-analysis of 23 studies (n = 4567 patients) that evaluated the correlation between COX-2 overexpression detected by IHC and survival in patients with colorectal cancer. Combined hazard ratios suggested that COX-2 overexpression had an unfavorable impact on overall survival (OS) (HR [hazard ratio] = 1.193, 95% CI [confidence interval]: 1.02 similar to 1.37), but not disease free survival (DFS) (HR = 1.25, 95% CI: 0.99 similar to 1.50) in patients with colorectal cancer. Conclusions: Cox-2 overexpression in colorectal cancer detected by IHC appears to have slightly worse overall survival. However, the prognostic value of COX-2 on survival in colorectal cancer still needs further large-scale prospective trials to be clarified.	[Peng, Ling; Wang, Yina; Mou, Haibo; Zhao, Qiong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Yun] Zhejiang Food & Drug Adm, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhao, Q (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	doczq.2008@gmail.com			Medical Science Research Foundation of Health Bureau of Zhejiang Province [2012KYA072]; Administration of Traditional Chinese Medicine of Zhejiang Province [2012ZB084]	Medical Science Research Foundation of Health Bureau of Zhejiang Province; Administration of Traditional Chinese Medicine of Zhejiang Province	This study was supported by a grant from Medical Science Research Foundation of Health Bureau of Zhejiang Province (Grant number: 2012KYA072) and a grant from Administration of Traditional Chinese Medicine of Zhejiang Province (Grant number: 2012ZB084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrabi J, 2012, WORLD J GASTROENTERO, V18, P1793, DOI 10.3748/wjg.v18.i15.1793; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Buecher B, 2003, ALIMENT PHARM THER, V18, P731, DOI 10.1046/j.1365-2036.2003.01758.x; Chen SQ, 2008, SCAND J GASTROENTERO, V43, P456, DOI 10.1080/00365520701785194; Cressey R, 2006, CANCER LETT, V233, P232, DOI 10.1016/j.canlet.2005.03.023; de Heer P, 2007, CLIN CANCER RES, V13, P2955, DOI 10.1158/1078-0432.CCR-06-2042; Debucquoy A, 2009, INT J COLORECTAL DIS, V24, P129, DOI 10.1007/s00384-008-0608-8; Dimberg J, 1999, GUT, V45, P730, DOI 10.1136/gut.45.5.730; DUBOIS RN, 1994, AM J PHYSIOL, V266, pG822; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Fosslien E, 2000, CRIT REV CL LAB SCI, V37, P431, DOI 10.1080/10408360091174286; Fujita T, 1998, CANCER RES, V58, P4823; Fux R, 2005, CLIN CANCER RES, V11, P4754, DOI 10.1158/1078-0432.CCR-04-2586; Giralt J, 2006, ONCOLOGY-BASEL, V71, P312, DOI 10.1159/000107105; Hao XP, 1999, J PATHOL, V187, P295; Hida T, 1998, CANCER RES, V58, P3761; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Inafuku Y, 2009, CANCER SCI, V100, P852, DOI 10.1111/j.1349-7006.2009.01116.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JONES DA, 1993, J BIOL CHEM, V268, P9049; Joo YE, 2002, J GASTROINTEST CANC, V31, P147, DOI 10.1385/IJGC:31:1-3:147; Lagorce C, 2003, HISTOPATHOLOGY, V42, P457, DOI 10.1046/j.1365-2559.2003.01627.x; Li L, 2009, ALIMENT PHARM THER, V30, P589, DOI 10.1111/j.1365-2036.2009.04069.x; Lim SC, 2008, J SURG ONCOL, V97, P51, DOI 10.1002/jso.20907; Mascaux C, 2006, BRIT J CANCER, V95, P139, DOI 10.1038/sj.bjc.6603226; Masunaga R, 2000, CLIN CANCER RES, V6, P4064; Miladi-Abdennadher I, 2012, ACTA HISTOCHEM, V114, P577, DOI 10.1016/j.acthis.2011.11.002; Ogino S, 2009, AM J GASTROENTEROL, V104, P2047, DOI 10.1038/ajg.2009.281; Pancione M, 2009, HUM PATHOL, V40, P714, DOI 10.1016/j.humpath.2008.08.019; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Prescott SM, 2000, BBA-REV CANCER, V1470, pM69, DOI 10.1016/S0304-419X(00)00006-8; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Tomozawa S, 2000, BRIT J CANCER, V83, P324, DOI 10.1054/bjoc.2000.1270; Tucker ON, 1999, CANCER RES, V59, P987; Williams CS, 1996, AM J PHYSIOL-GASTR L, V270, pG393; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wu AW, 2003, WORLD J GASTROENTERO, V9, P1990, DOI 10.3748/wjg.v9.i9.1990; Yamac D, 2005, PATHOL RES PRACT, V201, P497, DOI 10.1016/j.prp.2005.04.006; Yamauchi T, 2002, DIS COLON RECTUM, V45, P98, DOI 10.1007/s10350-004-6120-5; Yoshinaga M, 2011, DIGEST DIS SCI, V56, P1194, DOI 10.1007/s10620-010-1389-9; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zhan J, 2004, CHINESE MED J-PEKING, V117, P1151; Zhang H, 2002, AM J GASTROENTEROL, V97, P1037; Zimmermann KC, 1999, CANCER RES, V59, P198	51	48	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58891	10.1371/journal.pone.0058891	http://dx.doi.org/10.1371/journal.pone.0058891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527044	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562600043
J	Babio, N; Ibarrola-Jurado, N; Bullo, M; Martinez-Gonzalez, MA; Warnberg, J; Salaverria, I; Ortega-Calvo, M; Estruch, R; Serra-Majem, L; Covas, MI; Sorli, JV; Salas-Salvado, J				Babio, Nancy; Ibarrola-Jurado, Nuria; Bullo, Monica; Angel Martinez-Gonzalez, Miguel; Waernberg, Julia; Salaverria, Itziar; Ortega-Calvo, Manuel; Estruch, Ramon; Serra-Majem, Lluis; Isabel Covas, Maria; Vicente Sorli, Jose; Salas-Salvado, Jordi		PREDIMED Study Investigators	White Blood Cell Counts as Risk Markers of Developing Metabolic Syndrome and Its Components in the Predimed Study	PLOS ONE			English	Article							DIFFERENTIAL LEUKOCYTE COUNTS; AGED JAPANESE MEN; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; SPANISH MEN; ASSOCIATION; OBESITY; POPULATION; FEATURES	Background: The Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities that includes hyperglucemia, hypertension, dyslipidemia and central obesity, conferring an increased risk of cardiovascular disease. The white blood cell (WBC) count has been proposed as a marker for predicting cardiovascular risk. However, few prospective studies have evaluated the relationship between WBC subtypes and risk of MetS. Methods: Participants were recruited from seven PREDIMED study centers. Both a baseline cross-sectional (n = 4,377) and a prospective assessment (n = 1,637) were performed. Participants with MetS at baseline were excluded from the longitudinal analysis. The median follow-up was 3.9 years. Anthropometric measurements, blood pressure, fasting glucose, lipid profile and WBC counts were assessed at baseline and yearly during the follow-up. Participants were categorized by baseline WBC and its subtype count quartiles. Adjusted logistic regression models were fitted to assess the risk of MetS and its components. Results: Of the 4,377 participants, 62.6% had MetS at baseline. Compared to the participants in the lowest baseline sex-adjusted quartile of WBC counts, those in the upper quartile showed an increased risk of having MetS (OR, 2.47; 95% CI, 2.03-2.99; P-trend < 0.001). This association was also observed for all WBC subtypes, except for basophils. Compared to participants in the lowest quartile, those in the top quartile of leukocyte, neutrophil and lymphocyte count had an increased risk of MetS incidence. Leukocyte and neutrophil count were found to be strongly associated with the MetS components hypertriglyceridemia and low HDL-cholesterol. Likewise, lymphocyte counts were found to be associated with the incidence of the MetS components low HDL-cholesterol and high fasting glucose. An increase in the total WBC during the follow-up was also associated with an increased risk of MetS. Conclusions: Total WBC counts, and some subtypes, were positively associated with MetS as well as hypertriglyceridemia, low HDL-cholesterol and high fasting glucose, all components of MetS.	[Babio, Nancy; Ibarrola-Jurado, Nuria; Bullo, Monica; Salas-Salvado, Jordi] Univ Rovira & Virgili, St Joan Hosp, Human Nutr Unit, IISPV, E-43201 Reus, Spain; [Babio, Nancy; Ibarrola-Jurado, Nuria; Bullo, Monica; Ortega-Calvo, Manuel; Estruch, Ramon; Salas-Salvado, Jordi] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Reus, Spain; [Angel Martinez-Gonzalez, Miguel] Univ Navarra, Med Sch Clin, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Waernberg, Julia] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Salaverria, Itziar] Univ Hosp Txagorritxu, Dept Cardiol, Vitoria, Spain; [Salaverria, Itziar] Esperanza Macarena Hlth Ctr, Primary Care Div Sevilla, Dept Family Med, Seville, Spain; [Estruch, Ramon] Univ Barcelona, Dept Internal Med, Hosp Clin, Barcelona, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Isabel Covas, Maria] Municipal Inst Med Res IMIM, Cardiovasc Epidemiol Unit, Barcelona, Spain; [Vicente Sorli, Jose] Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Vicente Sorli, Jose] CIBER Fisiopatol Obesidad & Nutr, Valencia, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra; Universidad de Malaga; University Hospital of Araba; University of Barcelona; Hospital Clinic de Barcelona; Universidad de Las Palmas de Gran Canaria; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Salas-Salvado, J (corresponding author), Univ Rovira & Virgili, St Joan Hosp, Human Nutr Unit, IISPV, C St Llorenc 21, E-43201 Reus, Spain.	jordi.salas@urv.cat	Bulló, Mònica/F-2925-2016; Ortega-Calvo, Manuel/D-6960-2015; Babio, Nancy/AAN-2715-2020; Ortega-Calvo, Manuel/I-4089-2019; Salas-Salvado, Jordi/C-7229-2017; Sanchez-Villegas, Almudena/T-6733-2019; IBIS, ATENCION PRIMARIA/I-3524-2016; Fito, Montserrat/C-1822-2012; Guasch-Ferre, Marta/H-6680-2019; Warnberg, Julia/G-1390-2011; Serra-Majem, Lluis/I-6708-2019; Casas, Rosa/ABD-1915-2020; Sorlí, José V/L-8758-2014; Algorta, Jaime/CAF-7793-2022; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Algorta, Jaime/K-9002-2012; Santos-Lozano, JM/J-9312-2018; Estruch, Ramon/AAZ-3723-2020; Lapetra, Jose/F-2552-2015; Toledo, Estefania/H-6211-2014; ZAZPE, ITZIAR/B-1970-2017	Bulló, Mònica/0000-0002-0218-7046; Ortega-Calvo, Manuel/0000-0003-2391-0106; Babio, Nancy/0000-0003-3527-5277; Ortega-Calvo, Manuel/0000-0003-2391-0106; Salas-Salvado, Jordi/0000-0003-2700-7459; Sanchez-Villegas, Almudena/0000-0001-7733-9238; Fito, Montserrat/0000-0002-1817-483X; Guasch-Ferre, Marta/0000-0001-8525-1404; Warnberg, Julia/0000-0002-8408-316X; Serra-Majem, Lluis/0000-0002-9658-9061; Casas, Rosa/0000-0002-0211-9166; Sorlí, José V/0000-0002-0130-2006; Algorta, Jaime/0000-0002-7042-5675; Algorta, Jaime/0000-0002-7042-5675; Santos-Lozano, JM/0000-0001-7097-5653; Bautista-Castano, Inmaculada/0000-0001-9257-8739; Diaz-Lopez, Andres/0000-0002-7500-5629; Martin Lujan, Francisco M/0000-0003-0359-3588; Salaverria Lete, Itziar/0000-0002-9504-4668; Fernandez-Ballart, Joan D./0000-0002-1320-6484; Toledo, Estefania/0000-0002-6263-4434; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Basora, Josep/0000-0003-0278-1149; ZAZPE, ITZIAR/0000-0002-8787-2981	Spanish Ministry of Health (ISCIII) [PI1001407]; Thematic Network [G03/140, RD06/0045]; FEDER (Fondo Europeo de Desarrollo Regional); Centre Catala de la Nutricio de l'Institut d'Estudis Catalans	Spanish Ministry of Health (ISCIII)(Instituto de Salud Carlos IIISpanish Government); Thematic Network; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Centre Catala de la Nutricio de l'Institut d'Estudis Catalans	This study was funded, in part, by the Spanish Ministry of Health (ISCIII), PI1001407, Thematic Network G03/140, RD06/0045, FEDER (Fondo Europeo de Desarrollo Regional), and the Centre Catala de la Nutricio de l'Institut d'Estudis Catalans. None of the funding sources played a role in the design, collection, analysis or interpretation of the data or in the decision to submit the manuscript for publication. CIBERobn is an initiative of ISCIII, Spain.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Ble A, 2001, NUTR METAB CARDIOVAS, V11, P221; Chen W, 2010, DIABETES CARE, V33, P2474, DOI 10.2337/dc10-0619; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; Elkind MS, 2001, STROKE, V32, P842, DOI 10.1161/01.STR.32.4.842; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; Gkrania-Klotsas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013405; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; Huang ZS, 2001, LIPIDS, V36, P237, DOI 10.1007/s11745-001-0713-9; Imano H, 2007, ATHEROSCLEROSIS, V195, P147, DOI 10.1016/j.atherosclerosis.2006.09.002; Ishizaka N, 2007, INTERNAL MED, V46, P1167, DOI 10.2169/internalmedicine.46.0136; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; KAWAKAMI M, 1981, J EXP MED, V154, P631, DOI 10.1084/jem.154.3.631; Kim DJ, 2008, J KOREAN MED SCI, V23, P193, DOI 10.3346/jkms.2008.23.2.193; Lao XQ, 2008, ATHEROSCLEROSIS, V201, P418, DOI 10.1016/j.atherosclerosis.2007.12.053; Nagasawa N, 2004, CIRC J, V68, P892, DOI 10.1253/circj.68.892; Nakanishi N, 2002, IND HEALTH, V40, P273, DOI 10.2486/indhealth.40.273; Nilsson G., 2007, Metabolic Syndrome and Related Disorders, V5, P359, DOI 10.1089/met.2007.0012; Oda E, 2012, HEART VESSELS, V27, P377, DOI 10.1007/s00380-011-0157-x; Oda E, 2009, INTERNAL MED, V48, P1343, DOI 10.2169/internalmedicine.48.2094; Odagiri K, 2011, INTERNAL MED, V50, P2491, DOI 10.2169/internalmedicine.50.5877; Ortega E, 2012, ATHEROSCLEROSIS, V221, P275, DOI 10.1016/j.atherosclerosis.2011.12.038; Phillips AC, 2010, ATHEROSCLEROSIS, V213, P294, DOI 10.1016/j.atherosclerosis.2010.08.047; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Shankar A, 2004, AM J HYPERTENS, V17, P233, DOI 10.1016/j.amjhyper.2003.11.005; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Tanigawa T, 2004, ATHEROSCLEROSIS, V173, P295, DOI 10.1016/j.atherosclerosis.2003.12.019; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Tsai JCR, 2007, DIABETES-METAB RES, V23, P111, DOI 10.1002/dmrr.647; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wang JJ, 2007, EUR HEART J, V28, P857, DOI 10.1093/eurheartj/ehl524; Wu CZ, 2010, ACTA DIABETOL, V47, P65, DOI 10.1007/s00592-009-0101-z	41	64	67	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58354	10.1371/journal.pone.0058354	http://dx.doi.org/10.1371/journal.pone.0058354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526980	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100025
J	Lee, DS; Chen, LJ; Li, CY; Liu, YS; Tan, XL; Lu, BR; Li, J; Gan, SX; Kang, SG; Suh, HS; Zhu, YY				Lee, Dong Sun; Chen, Li Juan; Li, Cheng Yun; Liu, Yongsheng; Tan, Xue Lin; Lu, Bao-Rong; Li, Juan; Gan, Shu Xian; Kang, Sang Gu; Suh, Hak Soo; Zhu, Youyong			The B-sister MADS Gene FST Determines Ovule Patterning and Development of the Zygotic Embryo and Endosperm	PLOS ONE			English	Article							FEMALE GAMETOPHYTE DEVELOPMENT; FLORAL ORGAN IDENTITY; GAMETIC CELL FATE; BOX GENES; SEED DEVELOPMENT; DOMAIN PROTEIN; RICE; ARABIDOPSIS; EXPRESSION; POLARITY	Many homeotic MADS-box genes have been identified as controllers of the floral transition and floral development. However, information regarding B-sister (B-s)-function genes in monocots is still limited. Here, we describe the functional characterization of a B-s-group MADS-box gene FEMALE-STERILE (FST), whose frame-shift mutation (fst) results in abnormal ovules and the complete abortion of zygotic embryos and endosperms in rice. Anatomical analysis showed that the defective development in the fst mutant exclusively occurred in sporophytic tissues including integuments, fertilized proembryos and endosperms. Analyses of the spatio-temporal expression pattern revealed that the prominent FST gene products accumulated in the inner integument, nucellar cell of the micropylar side, apical and base of the proembryos and free endosperm nuclei. Microarray and gene ontology analysis unraveled substantial changes in the expression level of many genes in the fst mutant ovules and seeds, with a subset of genes involved in several developmental and hormonal pathways appearing to be down-regulated. Using both forward and reverse genetics approaches, we demonstrated that rice FST plays indispensable roles and multiple functions during ovule and early seed development. These findings support a novel function for the B-s-group MADS-box genes in plants.	[Lee, Dong Sun; Li, Cheng Yun; Zhu, Youyong] Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist, Kunming, Peoples R China; [Lee, Dong Sun; Chen, Li Juan; Tan, Xue Lin; Li, Juan; Gan, Shu Xian] Yunnan Agr Univ, Rice Res Inst, Kunming, Peoples R China; [Chen, Li Juan; Tan, Xue Lin; Li, Juan; Gan, Shu Xian] Yunnan Agr Univ, Key Lab Mol Breeding Dian Type Japonica Hybrid Ri, Yunnan Educ Dept, Kunming, Peoples R China; [Liu, Yongsheng] Sichuan Univ, Minist Educ, Key Lab Bioresource & Ecoenvironm, Coll Life Sci,State Key Lab Hydraul & Mt River En, Chengdu 610064, Peoples R China; [Lu, Bao-Rong] Fudan Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Kang, Sang Gu] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea; [Suh, Hak Soo] Yeungnam Univ, Sch Biol Resources, Gyongsan, South Korea	Yunnan Agricultural University; Yunnan Agricultural University; Yunnan Agricultural University; Sichuan University; Fudan University; Yeungnam University; Yeungnam University	Zhu, YY (corresponding author), Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist, Kunming, Peoples R China.	yyzhu@ynau.edu.cn	Lee, Dong Sun/HGV-2436-2022; Lu, Bao-Rong/C-3130-2009	Lu, Bao-Rong/0000-0002-0214-2390	National Natural Science Foundation of China and Yunnan Province [U1136604]; Ministry of Science and Technology of China [2011CB100401]; Department of Science and Technology of Yunnan Province [2006C0006Z]	National Natural Science Foundation of China and Yunnan Province(Natural Science Foundation of Yunnan Province); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Department of Science and Technology of Yunnan Province	This study is supported by a grant from National Natural Science Foundation of China and Yunnan Province (U1136604), a grant from Ministry of Science and Technology of China (2011CB100401), and a grant from Department of Science and Technology of Yunnan Province (2006C0006Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Becker A, 2002, MOL GENET GENOMICS, V266, P942, DOI 10.1007/s00438-001-0615-8; Bencivenga S, 2011, SEX PLANT REPROD, V24, P113, DOI 10.1007/s00497-011-0162-3; Bowles DJ, 1991, MOL PLANT PATHOLOGY; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; de Folter S, 2006, PLANT J, V47, P934, DOI 10.1111/j.1365-313X.2006.02846.x; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe Pankaj, 2009, Commun Integr Biol, V2, P184; Engstrom EM, 2004, PLANT PHYSIOL, V135, P685, DOI 10.1104/pp.104.040394; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; Fujiwara Toru, 2002, Arabidopsis Book, V1, pe0020, DOI 10.1199/tab.0020; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hauser BA, 1998, GENETICS, V150, P411; Hu LF, 2011, PLANT CELL, V23, P515, DOI 10.1105/tpc.110.074369; Kater MM, 2006, J EXP BOT, V57, P3433, DOI 10.1093/jxb/erl097; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kelley DR, 2009, PLANT J, V57, P1054, DOI 10.1111/j.1365-313X.2008.03752.x; KIM WT, 1988, PLANT PHYSIOL, V88, P649, DOI 10.1104/pp.88.3.649; Lee D. S., 2002, International Rice Research Notes, V27, P22; Lee DS, 2003, THESIS LIB YEUNGNAM; Lee S, 2003, PLANT CELL PHYSIOL, V44, P1403, DOI 10.1093/pcp/pcg156; Li M, 2011, THEOR APPL GENET, V123, P411, DOI 10.1007/s00122-011-1593-9; Li SC, 2006, J INTEGR PLANT BIOL, V48, P307, DOI 10.1111/j.1744-7909.2006.00228.x; Liu YS, 2001, THEOR APPL GENET, V102, P1243, DOI 10.1007/s001220000520; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; Matias-Hernandez L, 2010, PLANT CELL, V22, P1702, DOI 10.1105/tpc.109.068627; Mizzotti C, 2012, PLANT J, V70, P409, DOI 10.1111/j.1365-313X.2011.04878.x; Moll C, 2008, PLANT J, V56, P913, DOI 10.1111/j.1365-313X.2008.03650.x; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nowack MK, 2010, BIOCHEM SOC T, V38, P604, DOI 10.1042/BST0380604; Nuccio ML, 1999, PLANT MOL BIOL, V39, P1153, DOI 10.1023/A:1006101404867; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; Prasad K, 2010, PLANT J, V62, P203, DOI 10.1111/j.1365-313X.2010.04139.x; Raffaella B, 2008, PLANT BIOSYST, V142, P643, DOI 10.1080/11263500802411098; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sang XC, 2012, PLANT PHYSIOL, V160, P788, DOI 10.1104/pp.112.200980; Souter M, 2000, J EXP BOT, V51, P971, DOI 10.1093/jexbot/51.347.971; Springer NM, 2002, PLANT PHYSIOL, V128, P1332, DOI 10.1104/pp.010742; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Vignols F, 1997, GENE, V195, P177, DOI 10.1016/S0378-1119(97)00137-6; Wang F, 2010, J INTEGRATIVE PLANT; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; XU DP, 1995, PLANT MOL BIOL, V28, P455, DOI 10.1007/BF00020394; YAMAGATA H, 1982, PLANT PHYSIOL, V70, P1094, DOI 10.1104/pp.70.4.1094; Yamaguchi T, 2006, TSW DEV EMBRYOL, V1, P99; Yang WC, 2010, ANNU REV PLANT BIOL, V61, P89, DOI 10.1146/annurev-arplant-042809-112203; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606; Yin LL, 2012, PLANT CELL, V24, P1049, DOI 10.1105/tpc.111.094854	56	30	40	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58748	10.1371/journal.pone.0058748	http://dx.doi.org/10.1371/journal.pone.0058748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527017	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100038
J	Walters, D; Stringer, S; Rolls, E				Walters, Daniel; Stringer, Simon; Rolls, Edmund			Path Integration of Head Direction: Updating a Packet of Neural Activity at the Correct Speed Using Axonal Conduction Delays	PLOS ONE			English	Article							SPATIAL VIEW CELLS; FREELY MOVING RATS; DORSAL TEGMENTAL NUCLEUS; CONTINUOUS ATTRACTOR; PRIMATE HIPPOCAMPUS; ENTORHINAL CORTEX; ANTERIOR THALAMUS; FIRING PROPERTIES; VESTIBULAR INPUT; PLACE CELLS	The head direction cell system is capable of accurately updating its current representation of head direction in the absence of visual input. This is known as the path integration of head direction. An important question is how the head direction cell system learns to perform accurate path integration of head direction. In this paper we propose a model of velocity path integration of head direction in which the natural time delay of axonal transmission between a linked continuous attractor network and competitive network acts as a timing mechanism to facilitate the correct speed of path integration. The model effectively learns a "look-up" table for the correct speed of path integration. In simulation, we show that the model is able to successfully learn two different speeds of path integration across two different axonal conduction delays, and without the need to alter any other model parameters. An implication of this model is that, by learning look-up tables for each speed of path integration, the model should exhibit a degree of robustness to damage. In simulations, we show that the speed of path integration is not significantly affected by degrading the network through removing a proportion of the cells that signal rotational velocity.	[Walters, Daniel; Stringer, Simon] Univ Oxford, Dept Expt Psychol, Oxford Ctr Theoret Neurosci & Artificial Intellig, Oxford OX1 2JD, England; [Rolls, Edmund] Oxford Ctr Computat Neurosci, Oxford, England	University of Oxford; University of Oxford	Walters, D (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford Ctr Theoret Neurosci & Artificial Intellig, Oxford OX1 2JD, England.	daniel.walters@psy.ox.ac.uk		Rolls, Edmund/0000-0003-3025-1292	Economic and Social Research Council (ESRC); Wellcome Trust	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Economic and Social Research Council (ESRC) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; [Anonymous], 1998, NEURAL NETWORKS BRAI; Bassett JP, 2001, J NEUROSCI, V21, P5740, DOI 10.1523/JNEUROSCI.21-15-05740.2001; Bassett JP, 2005, HEAD DIRECTION CELLS, P83; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blair HT, 1998, NEURON, V21, P1387, DOI 10.1016/S0896-6273(00)80657-1; BLAIR HT, 1995, J NEUROSCI, V15, P6260; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; CARR CE, 1990, J NEUROSCI, V10, P3227; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Goodridge JP, 1998, BEHAV NEUROSCI, V112, P749, DOI 10.1037/0735-7044.112.4.749; GOODRIDGE JP, 1995, BEHAV NEUROSCI, V109, P49, DOI 10.1037/0735-7044.109.1.49; Goodridge JP, 1997, J NEUROSCI, V17, P9315; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hahnloser RHR, 2003, NEUROSCIENCE, V120, P877, DOI 10.1016/S0306-4522(03)00201-X; Hertz JA, 2018, INTRO THEORY NEURAL; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Levine D. S., 1991, INTRO NEURAL COGNITI; MILES FA, 1979, ANNU REV PSYCHOL, V30, P327, DOI 10.1146/annurev.ps.30.020179.001551; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Ranck Jr J.B., 1985, ELECT ACTIVITY ARCHI; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Robertson RG, 1998, J NEUROPHYSIOL, V79, P1145, DOI 10.1152/jn.1998.79.3.1145; Robertson RG, 1999, HIPPOCAMPUS, V9, P206, DOI 10.1002/(SICI)1098-1063(1999)9:3<206::AID-HIPO2>3.0.CO;2-H; Rolls ET, 2006, REV NEUROSCIENCE, V17, P175; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Rolls ET, 2002, COMPUTATIONAL NEUROS; RUMELHART DE, 1985, COGNITIVE SCI, V9, P75, DOI 10.1207/s15516709cog0901_5; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sharp PE, 2001, BEHAV NEUROSCI, V115, P571, DOI 10.1037/0735-7044.115.3.571; Sharp PE, 2005, HEAD DIRECTION CELLS; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; Stackman RW, 1997, J NEUROSCI, V17, P4349; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Stackman RW, 1998, J NEUROSCI, V18, P9020; Stratton P, 2010, J COMPUT NEUROSCI, V28, P527, DOI 10.1007/s10827-010-0234-7; Stringer SM, 2006, NETWORK-COMP NEURAL, V17, P419, DOI 10.1080/09548980601004032; Stringer SM, 2005, NEUROBIOL LEARN MEM, V83, P79, DOI 10.1016/j.nlm.2004.08.003; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Stringer SN, 2002, NETWORK-COMP NEURAL, V13, P429, DOI 10.1088/0954-898X/13/4/301; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; TAUBE JS, 1990, J NEUROSCI, V10, P436; Taylor JG, 1999, BIOL CYBERN, V80, P393, DOI 10.1007/s004220050534; Walters DM, 2010, BIOL CYBERN, V103, P21, DOI 10.1007/s00422-009-0355-0	53	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58330	10.1371/journal.pone.0058330	http://dx.doi.org/10.1371/journal.pone.0058330			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526976	gold, Green Published			2022-12-27	WOS:000317562100023
J	Sun, Y; Hu, ZT; Goeb, Y; Dreier, L				Sun, Yu; Hu, Zhitao; Goeb, Yannick; Dreier, Lars			The F-Box Protein MEC-15 (FBXW9) Promotes Synaptic Transmission in GABAergic Motor Neurons in C. elegans	PLOS ONE			English	Article							GLR-1 GLUTAMATE RECEPTORS; UBIQUITIN LIGASE COMPLEX; CAENORHABDITIS-ELEGANS; SYSTEMATIC ANALYSIS; TOUCH SENSITIVITY; ABUNDANCE; BETA; MUTANTS; SCREEN; FBXO45	Ubiquitination controls the activity of many proteins and has been implicated in almost every aspect of neuronal cell biology. Characterizing the precise function of ubiquitin ligases, the enzymes that catalyze ubiquitination of target proteins, is key to understanding distinct functions of ubiquitination. F-box proteins are the variable subunits of the large family of SCF ubiquitin ligases and are responsible for binding and recognizing specific ubiquitination targets. Here, we investigated the function of the F-box protein MEC-15 (FBXW9), one of a small number of F-box proteins evolutionarily conserved from C. elegans to mammals. mec-15 is widely expressed in the nervous system including GABAergic and cholinergic motor neurons. Electrophysiological and behavioral analyses indicate that GABAergic synaptic transmission is reduced in mec-15 mutants while cholinergic transmission appears normal. In the absence of MEC-15, the abundance of the synaptic vesicle protein SNB-1 (synaptobrevin) is reduced at synapses and increased in cell bodies of GABAergic motor neurons, suggesting that MEC-15 affects the trafficking of SNB-1 between cell bodies and synapses and may promote GABA release by regulating the abundance of SNB-1 at synapses.	[Sun, Yu; Goeb, Yannick; Dreier, Lars] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Hu, Zhitao] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts General Hospital	Dreier, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	larsdreier@ucla.edu		Hu, Zhitao/0000-0002-2948-3339	University of California Los Angeles	University of California Los Angeles(University of California System)	This work received start-up funds from University of California Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bounoutas A, 2009, GENETICS, V183, P607, DOI 10.1534/genetics.109.105726; BRENNER S, 1974, GENETICS, V77, P71; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; CHALFIE M, 1985, J NEUROSCI, V5, P956; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jin YS, 1999, J NEUROSCI, V19, P539; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Maro GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004690; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Mehta N, 2004, GENETICS, V166, P1253, DOI 10.1534/genetics.166.3.1253; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; Park EK, 2007, TELECOMMUN SYST, V34, P1, DOI 10.1007/s11235-006-9029-6; Park M, 2011, NEURON, V70, P742, DOI 10.1016/j.neuron.2011.04.002; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Yamanaka A, 2002, CURR BIOL, V12, P267, DOI 10.1016/S0960-9822(02)00657-7; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yeh E, 2009, J NEUROSCI, V29, P5207, DOI 10.1523/JNEUROSCI.0637-09.2009	42	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59132	10.1371/journal.pone.0059132	http://dx.doi.org/10.1371/journal.pone.0059132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527112	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600042
J	Zhang, YKJ; Wu, KC; Klaassen, CD				Zhang, Yu-Kun Jennifer; Wu, Kai Connie; Klaassen, Curtis D.			Genetic Activation of Nrf2 Protects against Fasting-Induced Oxidative Stress in Livers of Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ENZYME GENES; EXPRESSION; DEFICIENCY; METABOLISM; TRANSPORT; PROFILES; PATHWAY; GAMMA; CD36	Acute fasting causes elevated oxidative stress. The current study investigated the effects of the nuclear factor erythoid 2-related factor 2 (Nrf2), the sensor of oxidative stress in cells, on energy homeostasis and liver pathophysiology during fasting. Feed was removed from mice possessing none (Nrf2-null), normal (wild-type, WT), enhanced (Keap1-knockdown, K1-KD), and maximum (hepatocyte-specific Keap1-knockout, K1-HKO) Nrf2 activity in liver for 24 h. Body weight, blood glucose, and blood lipid profiles were similar among mice with graded Nrf2 activity under either fed or fasted conditions. Fasting reduced liver size in mice expressing Nrf2, but not in Nrf2-null mice. Nrf2-null mice accumulated more non-esterified free fatty acids and triglycerides in liver after fasting than the other genotypes of mice. Fatty acids are mainly catabolized in mitochondria, and Nrf2-null mice had lower mitochondrial content in liver under control feeding conditions, which was further reduced by fasting. In contrast, mitochondrial contents in mice with enhanced Nrf2 activity were not affected by fasting. Oxidative stress, determined by staining of free radicals and quantification of malondialdehyde equivalents, was highest in Nrf2-null and lowest in K1-HKO mice after fasting. The exacerbated oxidative stress in livers of Nrf2-null mice is predicted to lead to damages to mitochondria, and therefore diminished oxidation and increased accumulation of lipids in livers of Nrf2-null mice. In summary, the Nrf2-regulated signaling pathway is critical in protecting mitochondria from oxidative stress during feed deprivation, which ensures efficient utilization of fatty acids in livers of mice.	[Zhang, Yu-Kun Jennifer; Wu, Kai Connie; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Klaassen, CD (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA.	CKLAASSE@kumc.edu	Wu, Kai/I-2202-2013		National Institutes of Health (NIH) [DK-081461, ES-019487, ES-009649]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487, R01ES009649] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health (NIH) grants: DK-081461, ES-019487, and ES-009649 (http://grants.nih.gov/grants/guide/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Awad S, 2009, CLIN NUTR, V28, P497, DOI 10.1016/j.clnu.2009.04.014; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Greco T, 2011, FREE RADICAL BIO MED, V51, P2164, DOI 10.1016/j.freeradbiomed.2011.09.017; Hota KB, 2011, HIPPOCAMPUS; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kitteringham NR, 2010, J PROTEOMICS, V73, P1612, DOI 10.1016/j.jprot.2010.03.018; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Marczuk-Krynicka Dorota, 2003, Med Sci Monit, V9, pBR131; MCGRATH LT, 1990, ANAL BIOCHEM, V187, P273, DOI 10.1016/0003-2697(90)90456-J; Milder JB, 2010, NEUROBIOL DIS, V40, P238, DOI 10.1016/j.nbd.2010.05.030; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Okada K, 2008, AM J PHYSIOL-GASTR L, V295, pG735, DOI 10.1152/ajpgi.90321.2008; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Tanito M, 2007, FREE RADICAL BIO MED, V42, P1838, DOI 10.1016/j.freeradbiomed.2007.03.018; Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22; Wilhelm J, 2009, MOL CELL BIOCHEM, V328, P167, DOI 10.1007/s11010-009-0086-5; Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8; Zhang YKJ, 2012, TOXICOL APPL PHARM, V264, P305, DOI 10.1016/j.taap.2012.09.014; Zhang YKJ, 2010, TOXICOL APPL PHARM, V245, P326, DOI 10.1016/j.taap.2010.03.016; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	35	60	62	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59122	10.1371/journal.pone.0059122	http://dx.doi.org/10.1371/journal.pone.0059122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527105	gold, Green Published, Green Submitted			2022-12-27	WOS:000316411600039
J	Chaudhary, S; Polaino, S; Shakya, VPS; Idnurm, A				Chaudhary, Suman; Polaino, Silvia; Shakya, Viplendra P. S.; Idnurm, Alexander			A New Genetic Linkage Map of the Zygomycete Fungus Phycomyces blakesleeanus	PLOS ONE			English	Article							ABNORMAL PHOTOTROPISM; CAROTENE BIOSYNTHESIS; MUTANTS; SEX; RECOMBINATION; EVOLUTION; CHROMOSOMES; MEIOSIS; LIGHT; PHOTORECEPTOR	Phycomyces blakesleeanus is a member of the subphylum Mucoromycotina. A genetic map was constructed from 121 progeny of a cross between two wild type isolates of P. blakesleeanus with 134 markers. The markers were mostly PCR-RFLPs. Markers were located on 46 scaffolds of the genome sequence, covering more than 97% of the genome. Analysis of the alleles in the progeny revealed nine or 12 linkage groups, depending on the log of the odds (LOD) score, across 1583.4 cM at LOD 5. The linkage groups were overlaid on previous mapping data from crosses between mutants, aided by new identification of the mutations in primary metabolism mutant strains. The molecular marker map, the phenotype map and the genome sequence are overall congruent, with some exceptions. The new genetic map provides a genome-wide estimate for recombination, with the average of 33.2 kb per cM. This frequency is one piece of evidence for meiosis during zygospore development in Mucoromycotina species. At the same time as meiosis, transmission of non-recombinant chromosomes is also evident in the mating process in Phycomyces. The new map provides scaffold ordering for the genome sequence and a platform upon which to identify the genes in mutants that are affected in traits of interest, such as carotene biosynthesis, phototropism or gravitropism, using positional cloning.	[Chaudhary, Suman; Polaino, Silvia; Shakya, Viplendra P. S.; Idnurm, Alexander] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, KS USA	University of Missouri System; University of Missouri Kansas City	Idnurm, A (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, KS USA.	idnurma@umkc.edu	Shakya, Viplendra P.S/N-7755-2017; Idnurm, Alexander/GPX-9055-2022; Idnurm, Alexander/K-8558-2013; Idnurm, Alexander/AAC-9614-2019	Shakya, Viplendra P.S/0000-0001-6429-8692; Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040; 	University of Missouri - Kansas City Women's Council; UMKC Faculty research grant; National Science Foundation [MCB-0920581]	University of Missouri - Kansas City Women's Council; UMKC Faculty research grant; National Science Foundation(National Science Foundation (NSF))	This research was funded by University of Missouri - Kansas City Women's Council fellowships, a UMKC Faculty research grant and a National Science Foundation grant (MCB-0920581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH GC, 1976, INTRO HIST MYCOLOGY; ALVAREZ MI, 1983, MOL GEN GENET, V191, P507, DOI 10.1007/BF00425770; ALVAREZ MI, 1983, GENETICS, V105, P873; ALVAREZ MI, 1980, MOL GEN GENET, V179, P447, DOI 10.1007/BF00425475; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; BERGMAN K, 1969, BACTERIOL REV, V33, P99, DOI 10.1128/MMBR.33.1.99-157.1969; BERGMAN K, 1973, MOL GEN GENET, V123, P1, DOI 10.1007/BF00282984; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Blakeslee A. F., 1906, ANN MYCOL, V4, P1; Blakeslee AF, 1904, P AM ACAD ARTS SCI, V40, P205, DOI DOI 10.2307/20021962; Burgeff H, 1924, BOT ABH, V4, P5; Burgeff H, 1928, Z VEREBUNGSL, V49, P26; CAMPUZANO V, 1995, CURR GENET, V27, P524, DOI 10.1007/BF00314442; CAMPUZANO V, 1993, CURR GENET, V24, P515, DOI 10.1007/BF00351715; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; Cerda-Olmedo E, 2001, FEMS MICROBIOL REV, V25, P503; Cerda -Olmedo E, 1987, PHYCOMYCES; CERDAOLMEDO E, 1975, GENET RES, V25, P285, DOI 10.1017/S0016672300015718; CORROCHANO LM, 1992, TRENDS GENET, V8, P268, DOI 10.1016/0168-9525(92)90252-Y; DIAZMINGUEZ JM, 1990, MOL GEN GENET, V224, P269, DOI 10.1007/BF00271561; Ehrenberg CG, 1820, VERHANDL GES NATURF, VI, P98; Eslava A.P., 1996, FUNGAL GENETICS PRIN, P385; ESLAVA AP, 1976, MOL GEN GENET, V147, P235, DOI 10.1007/BF00582874; ESLAVA AP, 1975, P NATL ACAD SCI USA, V72, P4076, DOI 10.1073/pnas.72.10.4076; ESLAVA AP, 1975, GENETICS, V80, P445; Fraser JA, 2004, MOL MICROBIOL, V51, P299, DOI 10.1046/j.1365-2958.2003.03874.x; GAUGER W, 1980, EXP MYCOL, V4, P56; GAUGER WL, 1977, J GEN MICROBIOL, V101, P211, DOI 10.1099/00221287-101-2-211; Gola S, 2003, CURR GENET, V42, P276, DOI 10.1007/s00294-002-0353-4; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Idnurm A, 2011, EUKARYOT CELL, V10, P1485, DOI 10.1128/EC.05149-11; JAMES FR, 1982, MYCOLOGIA, V74, P744, DOI 10.2307/3792860; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; KIRK PM, 2001, DICT FUNGI; Koehler KE, 1996, HUM MOL GENET, V5, P1495, DOI 10.1093/hmg/5.Supplement_1.1495; Larson EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011605; Lee J, 2008, APPL ENVIRON MICROB, V74, P2349, DOI 10.1128/AEM.01866-07; LIPSON ED, 1980, MOL GEN GENET, V179, P155, DOI 10.1007/BF00268458; LOPEZDIAZ I, 1983, MOL GEN GENET, V190, P318, DOI 10.1007/BF00330658; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Medina HR, 2011, MOL MICROBIOL, V82, P199, DOI 10.1111/j.1365-2958.2011.07805.x; Mehta BJ, 2001, GENETICS, V158, P635; Obraztsova IN, 2004, FUNGAL GENET BIOL, V41, P168, DOI 10.1016/j.fgb.2003.09.007; Ooijen JW, 2001, JOINMAP 3 0 SOFTWARE; Ootaki T, 1993, GENETIC NOMENCLATURE; OREJAS M, 1987, MOL GEN GENET, V210, P69, DOI 10.1007/BF00337760; Pomraning KR, 2011, EUKARYOT CELL, V10, P724, DOI 10.1128/EC.00016-11; REVUELTA JL, 1983, MOL GEN GENET, V192, P225, DOI 10.1007/BF00327670; RONCERO MIG, 1982, CURR GENET, V5, P5, DOI 10.1007/BF00445733; Sanz C, 2002, EUR J BIOCHEM, V269, P902, DOI 10.1046/j.0014-2956.2001.02724.x; Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106; Schimek C, 2009, PHYTOCHEMISTRY, V70, P1867, DOI 10.1016/j.phytochem.2009.07.014; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Tagua VG, 2012, FUNGAL GENET BIOL, V49, P398, DOI 10.1016/j.fgb.2012.03.002; WILLER M, 1995, MOL CELL BIOL, V15, P4964	60	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58931	10.1371/journal.pone.0058931	http://dx.doi.org/10.1371/journal.pone.0058931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516579	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400078
J	Herrmann, KH; Wolff, R; Scheibler, F; Waffenschmidt, S; Hemkens, LG; Sauerland, S; Antes, G				Herrmann, Kirsten H.; Wolff, Robert; Scheibler, Fueloep; Waffenschmidt, Siw; Hemkens, Lars G.; Sauerland, Stefan; Antes, Gerd			All Nations Depend on the Global Knowledge Pool - Analysis of Country of Origin of Studies Used for Health Technology Assessments in Germany	PLOS ONE			English	Article							BIBLIOMETRIC ANALYSIS; CLINICAL-RESEARCH; PUBLICATIONS; ANESTHESIA	Background: Health Technology Assessments (HTAs) are used to inform decision-making and their usefulness depends on the quality and relevance of research and specific studies for health-policy decisions. Little is known about the country of origin of studies used for HTAs. Objective: To investigate which countries have made the largest contributions to inform health policy decisions through studies included in HTAs in Germany. Methods: The country of origin was extracted from all studies included in HTAs of the German Institute for Quality and Efficiency in Health Care, (IQWiG), published from 2/2006 to 9/2010. Studies were ranked according to the total number of studies per country, adjusted for population size, gross domestic product (GDP), and total health expenditure. Results: 1087 studies were included in 54 HTA reports. Studies were assigned to 45 countries. Most of the studies (27%) originated from the United States (USA), 18% were multinational, followed by 7% from the United Kingdom (UK) and 5% from Germany. Nordic countries led the ranking when adjusting for population size/million (ranks 1-3,6,9/45 countries), GDP/billion US$ (1,2,5,9,14/45), or health expenditure/billion US$ (1,3,5,12,13/45). The relative contribution of the UK was stable in the analyses when adjusted for population size (7/45), GDP (7/45), and health expenditure (9/45), whereas the USA (13, 18, and 30/45) and Germany (17, 19, and 21/45) dropped in the ranking. Conclusions: More than half of the studies relevant for evidence-informed decision-making in Germany originated from the USA, followed by multinational research and the UK. Only 5% of the studies originated from Germany. According to our findings, there appears to be some discrepancy between the use of globally generated evidence and the contribution to the	[Herrmann, Kirsten H.; Scheibler, Fueloep; Waffenschmidt, Siw; Sauerland, Stefan] Inst Qual & Efficiency Hlth Care, Cologne, Germany; [Wolff, Robert; Antes, Gerd] Univ Hosp Freiburg, Inst Med Biometry & Med Informat, Dept Med Biometry & Stat, German Cochrane Ctr, Freiburg, Germany; [Wolff, Robert] Kleijnen Systemat Reviews Ltd, York, N Yorkshire, England; [Hemkens, Lars G.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland	University of Freiburg; Kleijnen Systematic Reviews; University of Basel	Herrmann, KH (corresponding author), Inst Qual & Efficiency Hlth Care, Cologne, Germany.	Kirsten.Herrmann@iqwig.de	Scheibler, Fülöp/AAX-6254-2020; Hemkens, Lars G./AAB-2653-2020; Wolff, Robert F/E-2322-2016	Hemkens, Lars G./0000-0002-3444-1432; Wolff, Robert F/0000-0003-3270-7791; Sauerland, Stefan/0000-0003-1048-796X; Waffenschmidt, Siw/0000-0001-6860-6699	Institute for Quality and Efficiency in Health Care	Institute for Quality and Efficiency in Health Care	This work was supported by the Institute for Quality and Efficiency in Health Care (www.iqwig.de). Neither the funder itself nor any individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WORLD HLTH STAT 2010; Antes G, 2012, LANCET, V379, P195, DOI 10.1016/S0140-6736(12)60084-1; Buchler MW, 2011, LANGENBECK ARCH SURG, V396, P937, DOI 10.1007/s00423-011-0842-3; Buhrlen B, 2010, CLIN RES GERMANY SPE; Figueredo E, 2003, ACTA ANAESTH SCAND, V47, P378, DOI 10.1034/j.1399-6576.2003.00105.x; Gil-Montoya JA, 2006, EUR J ORAL SCI, V114, P102, DOI 10.1111/j.1600-0722.2006.00244.x; Glanville J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1028; Gluud C, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-7; Health Technology Assessment International, 2011, WHAT IS HTAI; HEERSPINK HJ, 2008, BR J CLIN PHARMACOL, V66, P774; Higher Education Funding Council for England Scottish Funding Council Higher Education Funding Council for Wales Department for Employment and Learning, 2008, RES ASS EXERCISE RAE; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2007, STEM CELL TRANSPL AD; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2008, S0503 I QUAL WIRTSCH; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2009, SEL SER NOR REPT INH; Institute for Quality and Efficiency in Health Care, 2011, GEN METH VERS 4 0; International Monetary Fund, 2009, WORLD EC OUTL DAT CO; Kristensen FB, 2008, HLTH TECHNOLOGY ASSE; N'Dri K, 1997, Sante, V7, P246; Ozsunar Y, 2001, AM J ROENTGENOL, V177, P1281; Signore A, 2004, EUR J NUCL MED MOL I, V31, P882, DOI 10.1007/s00259-004-1455-7; Swaminathan M, 2007, ANESTH ANALG, V105, P1741, DOI 10.1213/01.ane.0000286149.57763.e7; van Rossum M, 2007, BRIT J SURG, V94, P244, DOI 10.1002/bjs.5571; Velasco M, 2008, HLTH TECHONOLOGY ASS; Wikipedia contributors, 2007, LIST COUNTR TOT HLTH; Wolff RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018798	25	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59213	10.1371/journal.pone.0059213	http://dx.doi.org/10.1371/journal.pone.0059213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516611	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400096
J	Samaranayake, D; Atencio, D; Morse, R; Wade, JT; Chaturvedi, V; Hanes, SD				Samaranayake, Dhanushki; Atencio, David; Morse, Randall; Wade, Joseph T.; Chaturvedi, Vishnu; Hanes, Steven D.			Role of Ess1 in Growth, Morphogenetic Switching, and RNA Polymerase II Transcription in Candida albicans	PLOS ONE			English	Article							COMBINATION ANTIFUNGAL THERAPY; BLOOD-STREAM INFECTIONS; SELECTABLE MARKER URA3; PROLYL-ISOMERASE; FUNGAL-INFECTIONS; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; NONCODING RNAS; AMPHOTERICIN-B; GUIDE SNORNAS	Candida albicans is a fungal pathogen that causes potentially fatal infections among immune-compromised individuals. The emergence of drug resistant C. albicans strains makes it important to identify new antifungal drug targets. Among potential targets are enzymes known as peptidyl-prolyl cis/trans isomerases (PPIases) that catalyze isomerization of peptide bonds preceding proline. We are investigating a PPIase called Ess1, which is conserved in all major human pathogenic fungi. Previously, we reported that C. albicans Ess1 is essential for growth and morphogenetic switching. In the present study, we re-evaluated these findings using more rigorous genetic analyses, including the use of additional CaESS1 mutant alleles, distinct marker genes, and the engineering of suitably-matched isogenic control strains. The results confirm that CaEss1 is essential for growth in C. albicans, but show that reduction of CaESS1 gene dosage by half (delta/+) does not interfere with morphogenetic switching. However, further reduction of CaEss1 levels using a conditional allele does reduce morphogenetic switching. We also examine the role of the linker alpha-helix that distinguishes C. albicans Ess1 from the human Pin1 enzyme, and present results of a genome-wide transcriptome analysis. The latter analysis indicates that CaEss1 has a conserved role in regulation of RNA polymerase II function, and is required for efficient termination of small nucleolar RNAs and repression of cryptic transcription in C. albicans.	[Samaranayake, Dhanushki; Morse, Randall; Wade, Joseph T.; Chaturvedi, Vishnu; Hanes, Steven D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA; [Samaranayake, Dhanushki; Morse, Randall; Wade, Joseph T.] NY State Dept Hlth, Div Genet, Wadsworth Ctr, Albany, NY USA; [Chaturvedi, Vishnu] NY State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY USA; [Hanes, Steven D.] NY State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA; [Atencio, David; Hanes, Steven D.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; Wadsworth Center; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Hanes, SD (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.	haness@upstate.edu		Chaturvedi, Vishnu/0000-0002-3922-9676; Wade, Joseph/0000-0002-9779-3160; Morse, Randall/0000-0003-0000-8718	NIH [R01-GM55108-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by an NIH grant (R01-GM55108-13) to S.D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00115; Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Bastidas RJ, 2008, CURR OPIN INVEST DR, V9, P856; Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Casalinuovo I A, 2004, Eur Rev Med Pharmacol Sci, V8, P69; Cassone A, 2012, AIDS, V26, P1457, DOI 10.1097/QAD.0b013e3283536ba8; Cheng SJ, 2003, INFECT IMMUN, V71, P6101, DOI 10.1128/IAI.71.10.6101-6103.2003; Cruz MC, 1999, MOL CELL BIOL, V19, P4101; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; De Rosa FG, 2009, MINERVA ANESTESIOL, V75, P453; Del Pozo JL, 2011, INT J ARTIF ORGANS, V34, P766, DOI 10.5301/ijao.5000023; Derkx PMF, 2001, MOL GENET GENOMICS, V266, P527, DOI 10.1007/s004380100586; Devasahayam G, 2002, GENETICS, V160, P37; Edlich E, 2006, HANDB EXP PHARM, V172, P359; Epstein JB, 2003, ORAL SURG ORAL MED O, V96, P154, DOI 10.1016/S1079-2104(03)00296-8; FONZI WA, 1993, GENETICS, V134, P717; Fridkin SK, 2006, PEDIATRICS, V117, P1680, DOI 10.1542/peds.2005-1996; Garbati MA, 2012, INT J INFECT DIS, V16, pE76, DOI 10.1016/j.ijid.2011.10.004; Gemmill TR, 2005, J BIOL CHEM, V280, P15510, DOI 10.1074/jbc.M412172200; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; HANI J, 1995, FEBS LETT, V365, P198, DOI 10.1016/0014-5793(95)00471-K; Huang M, 2012, FEMS MICRO LET; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jain A, 2010, J PHARM BIOALLIED SC, V2, P314, DOI 10.4103/0975-7406.72131; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Joseph JD, 2004, J BIOL CHEM, V279, P32373, DOI 10.1074/jbc.M405415200; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Klinke T, 2008, FEMS YEAST RES, V8, P858, DOI 10.1111/j.1567-1364.2008.00411.x; Kontoyiannis DP, 2004, BRIT J HAEMATOL, V126, P165, DOI 10.1111/j.1365-2141.2004.05007.x; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2005, BIOCHEMISTRY-US, V44, P6180, DOI 10.1021/bi050115l; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; LLOYD AT, 1992, NUCLEIC ACIDS RES, V20, P5289, DOI 10.1093/nar/20.20.5289; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lu KP, 1996, NATURE, V380, P544; Ma Z, 2012, MOL CELL BIOL, V32, P3594, DOI 10.1128/MCB.00672-12; Magee PT, 2003, INFECT IMMUN, V71, P2299, DOI 10.1128/IAI.71.5.2299-2309.2003; Mahboubi M, 2010, PHYTOMEDICINE, V17, P771, DOI 10.1016/j.phymed.2010.01.016; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; McNaughton L, 2010, BBA-PROTEINS PROTEOM, V1804, P1537, DOI 10.1016/j.bbapap.2010.03.005; Mean M, 2008, CRIT CARE, V12, DOI 10.1186/cc6212; Mitrovich QM, 2010, SCIENCE, V330, P838, DOI 10.1126/science.1194554; Moreno I, 2010, YEAST, V27, P77, DOI 10.1002/yea.1733; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; Muller FMC, 1999, EUR J PEDIATR, V158, P187, DOI 10.1007/PL00014357; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; ODDS FC, 1994, J MED VET MYCOL, V32, P1; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Pitman SK, 2011, EXPERT OPIN EMERGING; Porta A, 1999, J BACTERIOL, V181, P7516, DOI 10.1128/JB.181.24.7516-7523.1999; Ramon AM, 2003, EUKARYOT CELL, V2, P718, DOI 10.1128/EC.2.4.718-728.2003; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ren P, 2005, MICROBIOL-SGM, V151, P1593, DOI 10.1099/mic.0.27786-0; Sanchez AA, 2004, INFECT IMMUN, V72, P598, DOI 10.1128/IAI.72.1.598-601.2004; Schattner P, 2004, NUCLEIC ACIDS RES, V32, P4281, DOI 10.1093/nar/gkh768; Schelenz S, 2011, J ORAL PATHOL MED, V40, P83, DOI 10.1111/j.1600-0714.2010.00937.x; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Schiene-Fischer C, 2012, TOPICS CURR CHE 0520; Schmid J, 2011, J CLIN MICROBIOL, V49, P3250, DOI 10.1128/JCM.00941-11; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; SHERMAN F, 1991, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Singh N, 2004, TRANSPLANTATION, V77, P795, DOI 10.1097/01.TP.0000117252.75651.D6; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Sundstrom P, 2002, INFECT IMMUN, V70, P3281, DOI 10.1128/IAI.70.6.3281-3283.2002; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; van het Hoog M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r52; Vazquez JA, 2003, MED MYCOL, V41, P355, DOI 10.1080/13693780310001616528; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wellington M, 2005, YEAST, V22, P57, DOI 10.1002/yea.1191; Wilcox CB, 2004, GENETICS, V167, P93, DOI 10.1534/genetics.167.1.93; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Yang YL, 2011, MED MYCOL, V49, P103, DOI 10.3109/13693786.2010.487076; Yu CL, 2006, J BIOL CHEM, V281, P9755, DOI 10.1074/jbc.M513178200	88	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59094	10.1371/journal.pone.0059094	http://dx.doi.org/10.1371/journal.pone.0059094			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516603	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400092
J	Duan, J; Jiang, W; Cheng, ZY; Heikkila, JJ; Glick, BR				Duan, Jin; Jiang, Wei; Cheng, Zhenyu; Heikkila, John J.; Glick, Bernard R.			The Complete Genome Sequence of the Plant Growth-Promoting Bacterium Pseudomonas sp UW4	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; III SECRETION SYSTEM; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DEAMINASE; CHROMATE RESISTANCE DETERMINANT; ACC DEAMINASE; TRANSGENIC CANOLA; ESCHERICHIA-COLI; COMB-NOV; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE	The plant growth-promoting bacterium (PGPB) Pseudomonas sp. UW4, previously isolated from the rhizosphere of common reeds growing on the campus of the University of Waterloo, promotes plant growth in the presence of different environmental stresses, such as flooding, high concentrations of salt, cold, heavy metals, drought and phytopathogens. In this work, the genome sequence of UW4 was obtained by pyrosequencing and the gaps between the contigs were closed by directed PCR. The P. sp. UW4 genome contains a single circular chromosome that is 6,183,388 bp with a 60.05% G+C content. The bacterial genome contains 5,423 predicted protein-coding sequences that occupy 87.2% of the genome. Nineteen genomic islands (GIs) were predicted and thirty one complete putative insertion sequences were identified. Genes potentially involved in plant growth promotion such as indole-3-acetic acid (IAA) biosynthesis, trehalose production, siderophore production, acetoin synthesis, and phosphate solubilization were determined. Moreover, genes that contribute to the environmental fitness of UW4 were also observed including genes responsible for heavy metal resistance such as nickel, copper, cadmium, zinc, molybdate, cobalt, arsenate, and chromate. Whole-genome comparison with other completely sequenced Pseudomonas strains and phylogeny of four concatenated "housekeeping" genes (16S rRNA, gyrB, rpoB and rpoD) of 128 Pseudomonas strains revealed that UW4 belongs to the fluorescens group, jessenii subgroup.	[Duan, Jin; Jiang, Wei; Cheng, Zhenyu; Heikkila, John J.; Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Duan, J (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	jduan@uwaterloo.ca		Cheng, Zhenyu/0000-0002-7240-9126	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adaikkalam V, 2005, CAN J MICROBIOL, V51, P209, DOI 10.1139/W04-135; Adaikkalam V, 2002, MICROBIOL-SGM, V148, P2857, DOI 10.1099/00221287-148-9-2857; Alvarez AH, 1999, J BACTERIOL, V181, P7398, DOI 10.1128/JB.181.23.7398-7400.1999; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Brown GR, 2001, INT J SYST EVOL MICR, V51, P67, DOI 10.1099/00207713-51-1-67; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Caballero A, 2005, J BACTERIOL, V187, P396, DOI 10.1128/JB.187.1.396-399.2005; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canovas D, 2003, ENVIRON MICROBIOL, V5, P1242, DOI 10.1046/j.1462-2920.2003.00463.x; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; CERVANTES C, 1990, J BACTERIOL, V172, P287, DOI 10.1128/JB.172.1.287-291.1990; CHAMBERS LA, 1971, ARCH MIKROBIOL, V77, P165, DOI 10.1007/BF00408609; Cheng ZY, 2008, CAN J MICROBIOL, V54, P128, DOI 10.1139/w07-128; Cheng ZY, 2007, CAN J MICROBIOL, V53, P912, DOI 10.1139/W07-050; Cheng ZY, 2012, APPL SOIL ECOL, V61, P255, DOI 10.1016/j.apsoil.2011.10.006; Cheng ZY, 2009, PROTEOMICS, V9, P4271, DOI 10.1002/pmic.200900142; Cheng ZY, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-18; Cheng ZY, 2009, MOL PLANT MICROBE IN, V22, P686, DOI 10.1094/MPMI-22-6-0686; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Coenye T, 2001, INT J SYST EVOL MICR, V51, P183, DOI 10.1099/00207713-51-1-183; Cusano AM, 2011, ENV MICROBIOL REP, V3, P203, DOI 10.1111/j.1758-2229.2010.00209.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Denner EBM, 1999, INT J SYST BACTERIOL, V49, P1103, DOI 10.1099/00207713-49-3-1103; Drummond A., 2011, GENEIOUS V5 5; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Dutta D, 2007, INT J SYST EVOL MICR, V57, P353, DOI 10.1099/ijs.0.64638-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farwell AJ, 2007, ENVIRON POLLUT, V147, P540, DOI 10.1016/j.envpol.2006.10.014; Farwell AJ, 2006, PLANT SOIL, V288, P309, DOI 10.1007/s11104-006-9119-y; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; FUJITA MQ, 1989, MOL GEN GENET, V215, P381, DOI 10.1007/BF00427033; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gebhard S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-254; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GLICK BR, 1995, CAN J MICROBIOL, V41, P533, DOI 10.1139/m95-070; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grichko VP, 2001, PLANT PHYSIOL BIOCH, V39, P11, DOI 10.1016/S0981-9428(00)01212-2; Grichko VP, 2000, J BIOTECHNOL, V81, P45, DOI 10.1016/S0168-1656(00)00270-4; Grichko VP, 2000, CAN J MICROBIOL, V46, P1159, DOI 10.1139/cjm-46-12-1159; Grimes DJ, 1997, INT J SYST BACTERIOL, V47, P19, DOI 10.1099/00207713-47-1-19; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo WB, 2011, J BACTERIOL, V193, P3413, DOI 10.1128/JB.05068-11; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; GUTIERREZ JC, 1995, MOL MICROBIOL, V18, P579, DOI 10.1111/j.1365-2958.1995.mmi_18030579.x; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hao XL, 2012, J BACTERIOL, V194, P736, DOI 10.1128/JB.06475-11; Hao YU, 2007, CAN J MICROBIOL, V53, P1291, DOI 10.1139/W07-099; He MY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-221; Hemmerich C, 2010, BIOINFORMATICS, V26, P1122, DOI 10.1093/bioinformatics/btq090; Hilario E, 2004, ANTON LEEUW INT J G, V86, P51, DOI 10.1023/B:ANTO.0000024910.57117.16; Holt J., 1994, BERGEYS MANUAL DETER; Hontzeas N, 2005, APPL ENVIRON MICROB, V71, P7556, DOI 10.1128/AEM.71.11.7556-7558.2005; HRYNIEWICZ MM, 1991, J BACTERIOL, V173, P5876, DOI 10.1128/jb.173.18.5876-5886.1991; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jimenez JI, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P425; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; JOHNSON JL, 1989, INT J SYST BACTERIOL, V39, P230, DOI 10.1099/00207713-39-3-230; JUKES T H, 1969, P21; Kampfer P, 2008, INT J SYST EVOL MICR, V58, P136, DOI 10.1099/ijs.0.65450-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kertesz MA, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P323; Kimbrel JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-522; Kloda A, 2008, INT J BIOCHEM CELL B, V40, P164, DOI 10.1016/j.biocel.2007.02.003; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lamont IL, 2006, J BACTERIOL, V188, P3149, DOI 10.1128/JB.188.8.3149-3152.2006; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Li JP, 2001, CAN J MICROBIOL, V47, P359, DOI 10.1139/cjm-47-4-359; Li JP, 2000, CURR MICROBIOL, V41, P101, DOI 10.1007/s002840010101; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martin Y, 2011, J BIOL CHEM, V286, P27225, DOI 10.1074/jbc.M111.265116; Matilla MA, 2011, J BACTERIOL, V193, P1290, DOI 10.1128/JB.01281-10; Mavrodi DV, 2011, J BACTERIOL, V193, P177, DOI 10.1128/JB.00895-10; Mazurier S, 2004, FEMS MICROBIOL ECOL, V49, P455, DOI 10.1016/j.femsec.2004.04.019; McMorran BJ, 2001, MICROBIOL-SGM, V147, P1517, DOI 10.1099/00221287-147-6-1517; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; Molina MA, 2006, ENVIRON MICROBIOL, V8, P639, DOI 10.1111/j.1462-2920.2005.00940.x; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nie L, 2002, PLANT PHYSIOL BIOCH, V40, P355, DOI 10.1016/S0981-9428(02)01375-X; NIES A, 1990, J BIOL CHEM, V265, P5648; Ortet P, 2011, J BACTERIOL, V193, P3146, DOI 10.1128/JB.00411-11; OSTROWSKI J, 1990, J BACTERIOL, V172, P779, DOI 10.1128/jb.172.2.779-785.1990; OSTROWSKI J, 1989, J BACTERIOL, V171, P130, DOI 10.1128/jb.171.1.130-140.1989; OUZOUNIS C, 1991, FEBS LETT, V279, P73, DOI 10.1016/0014-5793(91)80254-Z; PALLERONI NJ, 1993, INT J SYST BACTERIOL, V43, P606, DOI 10.1099/00207713-43-3-606; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Peconek J, 2006, INT J SYST EVOL MICR, V56, P1953, DOI 10.1099/ijs.0.64355-0; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Peix A, 2007, INT J SYST EVOL MICR, V57, P1286, DOI 10.1099/ijs.0.64621-0; Peix A, 2009, INFECT GENET EVOL, V9, P1132, DOI 10.1016/j.meegid.2009.08.001; Pilsyk S, 2009, ACTA BIOCHIM POL, V56, P375; Pimentel BE, 2002, FEMS MICROBIOL LETT, V212, P249, DOI 10.1111/j.1574-6968.2002.tb11274.x; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Preston GM, 2001, MOL MICROBIOL, V41, P999, DOI 10.1046/j.1365-2958.2001.02560.x; Prieto M, 2007, PSEUDOMONAS MODEL SY, P397, DOI [10.1007/978-1-4020-6097-7_14, DOI 10.1007/978-1-4020-6097-7_14]; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Quadroni M, 1999, EUR J BIOCHEM, V266, P986, DOI 10.1046/j.1432-1327.1999.00941.x; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Rezzonico F, 2005, MOL PLANT MICROBE IN, V18, P991, DOI 10.1094/MPMI-18-0991; Rezzonico F, 2004, APPL ENVIRON MICROB, V70, P5119, DOI 10.1128/AEM.70.9.5119-5131.2004; Rivas R, 2007, INT J SYST EVOL MICR, V57, P1331, DOI 10.1099/ijs.0.64912-0; Robison MM, 2001, MOL PLANT PATHOL, V2, P135, DOI 10.1046/j.1364-3703.2001.00060.x; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rodriguez-Salazar J, 2009, FEMS MICROBIOL LETT, V296, P52, DOI 10.1111/j.1574-6968.2009.01614.x; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Saleh SS, 2001, CAN J MICROBIOL, V47, P698, DOI 10.1139/cjm-47-8-698; Satomi M, 2002, INT J SYST EVOL MICR, V52, P739, DOI [10.1099/ijs.0.01427-0, 10.1099/00207713-52-3-739]; SEGERS P, 1994, INT J SYST BACTERIOL, V44, P499, DOI 10.1099/00207713-44-3-499; Self WT, 2001, RES MICROBIOL, V152, P311, DOI 10.1016/S0923-2508(01)01202-5; Shah S, 1998, CAN J MICROBIOL, V44, P833, DOI 10.1139/cjm-44-9-833; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; Stearns JC, 2005, PLANT PHYSIOL BIOCH, V43, P701, DOI 10.1016/j.plaphy.2005.05.010; Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Tate R, 1997, J BACTERIOL, V179, P7343, DOI 10.1128/jb.179.23.7343-7350.1997; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THIARA AS, 1988, EMBO J, V7, P2255, DOI 10.1002/j.1460-2075.1988.tb03065.x; THIARA AS, 1993, MOL MICROBIOL, V8, P495, DOI 10.1111/j.1365-2958.1993.tb01593.x; THIARA AS, 1989, GENE, V81, P65, DOI 10.1016/0378-1119(89)90337-5; Toklikishvili N, 2010, PLANT PATHOL, V59, P1023, DOI 10.1111/j.1365-3059.2010.02326.x; Usdin K, 2008, GENOME RES, V18, P1011, DOI 10.1101/gr.070409.107; Valverde A, 2006, INT J SYST EVOL MICR, V56, P2631, DOI 10.1099/ijs.0.64402-0; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Verlinden RAJ, 2007, J APPL MICROBIOL, V102, P1437, DOI 10.1111/j.1365-2672.2007.03335.x; Viollet A, 2011, FEMS MICROBIOL ECOL, V75, P457, DOI 10.1111/j.1574-6941.2010.01021.x; Viti C, 2009, MICROBIOL-SGM, V155, P95, DOI 10.1099/mic.0.021873-0; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang CX, 2000, CAN J MICROBIOL, V46, P898, DOI 10.1139/cjm-46-10-898; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wilhelm S, 2007, J BACTERIOL, V189, P6695, DOI 10.1128/JB.00023-07; WILLEMS A, 1992, INT J SYST BACTERIOL, V42, P107, DOI 10.1099/00207713-42-1-107; WILLEMS A, 1990, INT J SYST BACTERIOL, V40, P384, DOI 10.1099/00207713-40-4-384; Wink J, 2003, INT J SYST EVOL MICR, V53, P721, DOI 10.1099/ijs.0.02286-0; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Ye J, 2007, FEBS LETT, V581, P3996, DOI 10.1016/j.febslet.2007.07.039; YEE TW, 1990, P NATL ACAD SCI USA, V87, P1278, DOI 10.1073/pnas.87.4.1278; Yeramian E, 1999, RES MICROBIOL, V150, P745, DOI 10.1016/S0923-2508(99)00118-7; Yu H, 2011, J BACTERIOL, V193, P5541, DOI 10.1128/JB.05663-11; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zurdo-Pineiro JL, 2007, INT J SYST EVOL MICR, V57, P784, DOI 10.1099/ijs.0.64613-0; ZYLSTRA GJ, 1989, J BIOL CHEM, V264, P14940	179	239	245	4	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58640	10.1371/journal.pone.0058640	http://dx.doi.org/10.1371/journal.pone.0058640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516524	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200099
J	Braverman, ER; Blum, K; Damle, UJ; Kerner, M; Dushaj, K; Oscar-Berman, M				Braverman, Eric R.; Blum, Kenneth; Damle, Uma J.; Kerner, Mallory; Dushaj, Kristina; Oscar-Berman, Marlene			Evoked Potentials and Neuropsychological Tests Validate Positron Emission Topography (PET) Brain Metabolism in Cognitively Impaired Patients	PLOS ONE			English	Article							MINI-MENTAL-STATE; FAMILIAL ALZHEIMER-DISEASE; CORTICAL THICKNESS; AMYLOID PATHOLOGY; MEMORY IMPAIRMENT; FDG-PET; DECLINE; DEMENTIA; MCI; CSF	Fluorodeoxyglucose (FDG) Positron Emission Topography (PET) brain hypometabolism (HM) correlates with diminished cognitive capacity and risk of developing dementia. However, because clinical utility of PET is limited by cost, we sought to determine whether a less costly electrophysiological measure, the P300 evoked potential, in combination with neuropsychological test performance, would validate PET HM in neuropsychiatric patients. We found that patients with amnestic and non-amnestic cognitive impairment and HM (n = 43) evidenced significantly reduced P300 amplitudes, delayed latencies, and neuropsychological deficits, compared to patients with normal brain metabolism (NM; n = 187). Data from patients with missing cognitive test scores (n = 57) were removed from the final sample, and logistic regression modeling was performed on the modified sample (n = 173, p = .000004). The logistic regression modeling, based on P300 and neuropsychological measures, was used to validate membership in the HM vs. NM groups. It showed classification validation in 13/25 HM subjects (52.0%) and in 125/148 NM subjects (84.5%), correlating with total classification accuracy of 79.8%. In this paper, abnormal P300 evoked potentials coupled with cognitive test impairment validates brain metabolism and mild/moderate cognitive impairment (MCI). To this end, we cautiously propose incorporating electrophysiological and neuropsychological assessments as cost-effective brain metabolism and MCI indicators in primary care. Final interpretation of these results must await required additional studies confirming these interesting results.	[Braverman, Eric R.; Blum, Kenneth; Damle, Uma J.; Kerner, Mallory; Dushaj, Kristina] PATH Fdn NY, Dept Clin Neurol, New York, NY 10010 USA; [Braverman, Eric R.; Blum, Kenneth] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA; [Braverman, Eric R.; Blum, Kenneth] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA; [Blum, Kenneth] Univ Vermont, Coll Med, Ctr Clin & Translat Sci, Global Integrated Serv Unit, Burlington, VT USA; [Oscar-Berman, Marlene] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Oscar-Berman, Marlene] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Oscar-Berman, Marlene] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Oscar-Berman, Marlene] Boston VA Healthcare Syst, Boston, MA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Vermont; Boston University; Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Braverman, ER (corresponding author), PATH Fdn NY, Dept Clin Neurol, New York, NY 10010 USA.	info@pathfoundationny.org	Braverman, Eric new/ABC-1152-2021	Berman, Marlene Oscar/0000-0003-0100-8883	Life Extension Foundation; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01 AA07112, K05 AA 00219]; Medical Research Service of the US Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA000219, R01AA007112] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000326] Funding Source: NIH RePORTER	Life Extension Foundation; National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Service of the US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	The authors are grateful to the Life Extension Foundation for their generous financial support to KB and the PATH Foundation NY. MOB is the recipient of grants from National Institute on Alcohol Abuse and Alcoholism (NIAAA) (R01 AA07112, K05 AA 00219) and from the Medical Research Service of the US Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahiskali M, 2009, IEEE ENG MED BIO, P2494, DOI 10.1109/IEMBS.2009.5335141; Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; Alzheimer's Association, 2011, ALZHEIMERS DEMENT, V7, P48; Apostolova LG, 2010, HUM BRAIN MAPP, V31, P786, DOI 10.1002/hbm.20905; ASHFORD JW, 1989, J GERONTOL, V44, pP139, DOI 10.1093/geronj/44.5.P139; Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Borroni B, 2006, NEUROBIOL AGING, V27, P24, DOI 10.1016/j.neurobiolaging.2004.12.010; Braverman ER, 2003, CLIN ELECTROENCEPHAL, V34, P124, DOI 10.1177/155005940303400306; Braverman ER, 2006, ADV THER, V23, P582, DOI 10.1007/BF02850047; Buchman AS, 2012, NEUROLOGY, V78, P228, DOI 10.1212/WNL.0b013e31824367c2; Correa F, 2012, CLIN PSYCHOL NEWS, V40, P33; De Marchis GM, 2010, DEMENT GERIATR COGN, V29, P259, DOI 10.1159/000288772; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; Dickerson BC, 2012, NEUROLOGY, V78, P84, DOI 10.1212/WNL.0b013e31823efc6c; Dlugaj M, 2012, J ALZHEIMERS DIS, V28, P503, DOI 10.3233/JAD-2011-111352; Doody RS, 2011, CLIN DRUG INVEST, V31, P483, DOI 10.2165/11588810-000000000-00000; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank Andrew R, 2008, Handb Clin Neurol, V89, P217, DOI 10.1016/S0072-9752(07)01220-1; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Golob EJ, 2009, NEUROLOGY, V73, P1649, DOI 10.1212/WNL.0b013e3181c1de77; Gualtieri CT, 2008, PROG NEURO-PSYCHOPH, V32, P962, DOI 10.1016/j.pnpbp.2007.12.030; Hathaway A, 2012, TOWNSEND LETT, V2012, P64; Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334; Herholz K, 2011, J NUCL MED, V52, P1218, DOI 10.2967/jnumed.111.090902; Jackson CE, 2008, ALZHEIMERS DEMENT, V4, pS137, DOI 10.1016/j.jalz.2007.10.008; Jacobs HIL, 2012, NEUROLOGY, V78, P352, DOI 10.1212/WNL.0b013e318245287d; Jamie Talan, 2012, NEUROLOGY TODAY, V12, P1; Kim SH, 2010, DEMENT GERIATR COGN, V29, P213, DOI 10.1159/000278422; Koivunen J, 2011, NEUROLOGY, V76, P1085, DOI 10.1212/WNL.0b013e318212015e; Lai CL, 2010, CLIN NEUROPHYSIOL, V121, P194, DOI 10.1016/j.clinph.2009.11.001; Liepelt I, 2009, MOVEMENT DISORD, V24, P1504, DOI 10.1002/mds.22662; Lockwood AH, 2008, J NEUROIMAGING, V18, P364, DOI 10.1111/j.1552-6569.2007.00196_1.x; MARSH JT, 1990, NEUROBIOL AGING, V11, P471, DOI 10.1016/0197-4580(90)90015-R; Mattsson N, 2012, NEUROLOGY, V78, P468, DOI 10.1212/WNL.0b013e3182477eed; McCarten JR, 2004, J ALZHEIMERS DIS, V6, P11; Negash Selam, 2008, Handb Clin Neurol, V88, P499, DOI 10.1016/S0072-9752(07)88026-2; Nieuwenhuis-Mark RE, 2010, J GERIATR PSYCH NEUR, V23, P151, DOI 10.1177/0891988710363714; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Quiroz YT, 2011, NEUROLOGY, V77, P469, DOI 10.1212/WNL.0b013e318227b1b0; Reinsel RA, 1995, ANN NY ACAD SCI, V769, P393, DOI 10.1111/j.1749-6632.1995.tb38154.x; Ridgway GR, 2012, NEUROLOGY, V79, P80, DOI 10.1212/WNL.0b013e31825dce28; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Sachdev PS, 2012, J AM GERIATR SOC, V60, P24, DOI 10.1111/j.1532-5415.2011.03774.x; Scazufca M, 2009, EUR ARCH PSY CLIN N, V259, P8, DOI 10.1007/s00406-008-0827-6; Silbert LC, 2012, NEUROLOGY, V79, P741, DOI 10.1212/WNL.0b013e3182661f2b; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Tarawneh R, 2012, NEUROLOGY, V78, P709, DOI 10.1212/WNL.0b013e318248e568; Tierney MC, 2000, ARCH FAM MED, V9, P527, DOI 10.1001/archfami.9.6.527; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van Deursen JA, 2009, BRAIN COGNITION, V69, P592, DOI 10.1016/j.bandc.2008.12.007; van Rossum IA, 2012, NEUROLOGY, V79, P1809, DOI 10.1212/WNL.0b013e3182704056; Vemuri P, 2011, NEUROIMAGE, V54, P985, DOI 10.1016/j.neuroimage.2010.09.004; Woo BKP, 2010, INT J GERIATR PSYCH, V25, P1150, DOI 10.1002/gps.2452; Wright DW, 2011, AM J ALZHEIMERS DIS, V26, P484, DOI 10.1177/1533317511426133	56	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e55398	10.1371/journal.pone.0055398	http://dx.doi.org/10.1371/journal.pone.0055398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526928	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600003
J	Wald, NJ; Bestwick, JP				Wald, Nicholas J.; Bestwick, Jonathan P.			Incorporating DNA Sequencing into Current Prenatal Screening Practice for Down's Syndrome	PLOS ONE			English	Article							RISK	Background: Prenatal screening for Down's syndrome is performed using biochemical and ultrasound markers measured in early pregnancy such as the Integrated test using first and second trimester markers. Recently, DNA sequencing methods have been introduced on free DNA in maternal plasma, yielding a high screening performance. These methods are expensive and there is a test failure rate. We determined the screening performance of merging the Integrated test with the newer DNA techniques in a protocol that substantially reduces the cost compared with universal DNA testing and still achieves high screening performance with no test failures. Methods: Published data were used to model screening performance of a protocol in which all women receive the first stage of the Integrated test at about 11 weeks of pregnancy. On the basis of this higher risk women have reflex DNA testing and lower risk women as well as those with a failed DNA test complete the Integrated test at about 15 weeks. Results: The overall detection rate was 95% with a 0.1% false-positive rate if 20% of women were selected to receive DNA testing. If all women had DNA testing the detection rate would be 3 to 4 percentage points higher with a false-positive rate 30 times greater if women with failed tests were treated as positive and offered a diagnostic amniocentesis, or 3 times greater if they had a second trimester screening test (Quadruple test) and treated as positive only if this were positive. The cost per women screened would be about one-fifth, compared with universal DNA testing, if the DNA test were 20 times the cost of the Integrated test. Conclusion: The proposed screening protocol achieves a high screening performance without programme test failures and at a substantially lower cost than offering all women DNA testing.	[Wald, Nicholas J.; Bestwick, Jonathan P.] Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England	University of London; Queen Mary University London	Wald, NJ (corresponding author), Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021					Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Morris J, 2005, J MED SCREEN, V12, P202, DOI 10.1258/096914105775220679; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; Morris JK, 2003, PRENATAL DIAG, V23, P252, DOI 10.1002/pd.568; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Office for National Statistics, 2008, BIRTH STAT ENGL WAL; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Wald NJ, 2013, J MED SCREE IN PRESS; Wright C, 2011, NAT MED, V17, P250, DOI 10.1038/nm0311-250; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993	15	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58732	10.1371/journal.pone.0058732	http://dx.doi.org/10.1371/journal.pone.0058732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527014	gold, Green Published			2022-12-27	WOS:000317562600036
J	Wu, HJ; Sun, HY; Wu, W; Zhang, YH; Qin, GW; Li, GR				Wu, Hui-Jun; Sun, Hai-Ying; Wu, Wei; Zhang, Yan-Hui; Qin, Guo-Wei; Li, Gui-Rong			Properties and Molecular Determinants of the Natural Flavone Acacetin for Blocking hKv4.3 Channels	PLOS ONE			English	Article							OUTWARD POTASSIUM CURRENT; KV4.3 K+ CHANNEL; J WAVE SYNDROMES; VENTRICULAR MYOCYTES; BRUGADA-SYNDROME; CHLORIDE CURRENT; ATRIAL MYOCYTES; CELLULAR BASIS; I-TO; MECHANISMS	The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I-to) in human atrial myocytes. However, the molecular determinants of acacetin for blocking I-to are unknown. The present study was designed to investigate the properties and molecular determinants of this compound for blocking hKv4.3 channels (coding I-to) stably expressed in HEK 293 cells using the approaches of whole-cell patch voltage-clamp technique and mutagenesis. It was found that acacetin inhibited hKv4.3 current by binding to both the closed and open channels, and decreased the recovery from inactivation. The blockade of hKv4.3 channels by acacetin was use- and frequency-dependent, and IC(50)s of acacetin for inhibiting hKv4.3 were 7.9, 6.1, 3.9, and 3.2 mu M, respectively, at 0.2, 0.5, 1, and 3.3 Hz. The mutagenesis study revealed that the hKv4.3 mutants T366A and T367A in the P-loop helix, and V392A, I395A and V399A in the S6-segment had a reduced channel blocking efficacy of acacetin (IC50, 44.5 mu M for T366A, 25.8 mu M for T367A, 17.6 mu M for V392A, 16.2 mu M for I395A, and 19.1 mu M for V399A). These results demonstrate the novel information that acacetin may inhibit the closed channels and block the open state of the channels by binding to their P-loop filter helix and S6 domain. The use-and rate-dependent blocking of hKv4.3 by acacetin is likely beneficial for managing atrial fibrillation.	[Wu, Hui-Jun; Sun, Hai-Ying; Wu, Wei; Zhang, Yan-Hui; Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept & Med, Pokfulam, Hong Kong, Peoples R China; [Qin, Guo-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Physiol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Hong Kong	Li, GR (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept & Med, Pokfulam, Hong Kong, Peoples R China.	grli@hkucc.hk	Li, Gui-Rong/C-4341-2009; , 李贵荣（沧海一粟）/AAZ-4335-2020; Zhang, Yanhui/L-5680-2017	, 李贵荣（沧海一粟）/0000-0002-9437-2280; Zhang, Yanhui/0000-0002-2179-2065	Sun Cheh Yeh Heart Foundation of Hong Kong; Innovation and Technology Commission of the Hong Kong SAR Government [ITS/339/09]; University of Hong Kong	Sun Cheh Yeh Heart Foundation of Hong Kong; Innovation and Technology Commission of the Hong Kong SAR Government; University of Hong Kong(University of Hong Kong)	The study was supported in part by Sun Cheh Yeh Heart Foundation of Hong Kong and a grant (ITS/339/09) from Innovation and Technology Commission of the Hong Kong SAR Government. Hui-Jun Wu, Wei Wu, and Yan-Hui Zhang were supported by a postgraduate scholarship from the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2004, AM J PHYSIOL-HEART C, V286, pH602, DOI 10.1152/ajpheart.00673.2003; Antzelevitch C, 2012, CIRC J, V76, P1054, DOI 10.1253/circj.CJ-12-0284; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Ashino S, 2011, CIRC J, V75, P2080, DOI 10.1253/circj.CJ-11-0227; Belhassen B, 2004, CIRCULATION, V110, P1731, DOI 10.1161/01.CIR.0000143159.30585.90; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; CAMPBELL DL, 1993, J GEN PHYSIOL, V101, P603, DOI 10.1085/jgp.101.4.603; Di Diego JM, 2002, CIRCULATION, V106, P2004, DOI 10.1161/01.CIR.0000032002.22105.7A; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Giudicessi JR, 2012, HUM MUTAT, V33, P989, DOI 10.1002/humu.22058; Himmel HM, 1999, AM J PHYSIOL-HEART C, V277, pH107, DOI 10.1152/ajpheart.1999.277.1.H107; Jeong I, 2011, BRIT J PHARMACOL, V163, P510, DOI 10.1111/j.1476-5381.2011.01210.x; Li G. R., 2010, USE ACACETIN RELATED; Li GR, 2000, AM J PHYSIOL-HEART C, V279, pH130, DOI 10.1152/ajpheart.2000.279.1.H130; LI GR, 1995, AM J PHYSIOL-HEART C, V269, pH463, DOI 10.1152/ajpheart.1995.269.2.H463; Li GR, 2004, J MOL CELL CARDIOL, V36, P495, DOI 10.1016/j.yjmcc.2004.01.005; Li GR, 2003, CARDIOVASC RES, V58, P89, DOI 10.1016/S0008-6363(02)00859-3; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li GR, 2008, CIRCULATION, V117, P2449, DOI 10.1161/CIRCULATIONAHA.108.769554; LIU DW, 1993, CIRC RES, V72, P671, DOI 10.1161/01.RES.72.3.671; Lukas A, 1996, CARDIOVASC RES, V32, P593, DOI 10.1016/0008-6363(96)00115-0; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nenov NI, 1998, CIRC RES, V83, P1224, DOI 10.1161/01.RES.83.12.1224; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; SCHACKOW TE, 1995, AM J PHYSIOL-CELL PH, V268, pC1002, DOI 10.1152/ajpcell.1995.268.4.C1002; Schweizer PA, 2010, CLIN RES CARDIOL, V99, P467, DOI 10.1007/s00392-010-0145-7; Tseng GN, 1996, J PHARMACOL EXP THER, V279, P865; Varro A, 2004, CURR MED CHEM, V11, P1, DOI 10.2174/0929867043456296; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; Wu HJ, 2011, J MOL CELL CARDIOL, V51, P966, DOI 10.1016/j.yjmcc.2011.08.022; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051550; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; Yang F, 2009, AM J MED, V122, P317, DOI 10.1016/j.amjmed.2008.11.019; Zhang YH, 2012, CARDIOVASC RES, V93, P424, DOI 10.1093/cvr/cvr347; Zhao ZH, 2012, CARDIOVASC RES, V95, P308, DOI 10.1093/cvr/cvs183	38	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e57864	10.1371/journal.pone.0057864	http://dx.doi.org/10.1371/journal.pone.0057864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526953	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562600009
J	Roffler-Tarlov, S; Liu, JH; Naumova, EN; Bernal-Ayala, MM; Mason, CA				Roffler-Tarlov, Suzanne; Liu, Jin Hong; Naumova, Elena N.; Bernal-Ayala, Maria Margarita; Mason, Carol A.			L-Dopa and the Albino Riddle: Content of L-Dopa in the Developing Retina of Pigmented and Albino Mice	PLOS ONE			English	Article							TYROSINASE GENE; EMBRYONIC-DEVELOPMENT; TRANSGENIC MICE; CELL PRODUCTION; OPTIC CHIASM; MOUSE RETINA; EXPRESSION; HYDROXYLASE; PATTERNS; MELANIN	Background: The absence or deficiency of melanin as in albinos, has detrimental effects on retinal development that include aberrant axonal projections from eye to brain and impaired vision. In pigmented retinal pigment epithelium (RPE), dihydroxyphenalanine (L-Dopa), an intermediate in the synthetic path for melanin, has been hypothesized to regulate the tempo of neurogenesis. The time course of expression of retinal L-Dopa, whether it is harbored exclusively in the RPE, the extent of deficiency in albinos compared to isogenic controls, and whether L-Dopa can be restored if exogenously delivered to the albino have been unknown. Methodology/Principal Findings: L-Dopa and catecholamines including dopamine extracted from retinas of pigmented (C57BL/6J) and congenic albino (C57BL/6J-tyr(c2j)) mice, were measured throughout development beginning at E10.5 and at maturity. L-Dopa, but not dopamine nor any other catecholamine, appears in pigmented retina as soon as tyrosinase is expressed in RPE at E10.5. In pigmented retina, L-Dopa content increases throughout pre-and postnatal development until the end of the first postnatal month after which it declines sharply. This time course reflects the onset and completion of retinal development. L-Dopa is absent from embryonic albino retina and is greatly reduced in postnatal albino retina compared to pigmented retina. Dopamine is undetectable in both albino and pigmented retinas until after the postnatal expression of the neuronal enzyme tyrosine hydroxylase. If provided to pregnant albino mothers, L-Dopa accumulates in the RPE of the fetuses. Conclusions: L-Dopa in pigmented RPE is most abundant during development after which content declines. This L-Dopa is not converted to dopamine. L-Dopa is absent or at low levels in albino retina and can be restored to the RPE by administration in utero. These findings further implicate L-Dopa as a factor in the RPE that could influence development, and demonstrate that administration of L-Dopa could be a means to rescue developmental abnormalities characteristic of albinos.	[Roffler-Tarlov, Suzanne] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Roffler-Tarlov, Suzanne; Liu, Jin Hong; Bernal-Ayala, Maria Margarita] Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; [Naumova, Elena N.] Tufts Univ, Dept Civil & Environm Engn, Medford, MA USA; [Mason, Carol A.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Mason, Carol A.] Columbia Univ Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Mason, Carol A.] Columbia Univ Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA	Tufts University; Tufts University; Tufts University; Columbia University; Columbia University; Columbia University	Roffler-Tarlov, S (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Suzanne.Tarlov@tufts.edu	Naumova, Elena/AAP-3395-2020	Naumova, Elena/0000-0002-9562-4734	Vision of Children Foundation;  [EY015290]; NATIONAL EYE INSTITUTE [R01EY015290, R01EY012736] Funding Source: NIH RePORTER	Vision of Children Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was funded by The Vision of Children Foundation and EY015290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beermann F, 2004, MAMM GENOME, V15, P749, DOI 10.1007/s00335-004-4002-8; BEERMANN F, 1992, P NATL ACAD SCI USA, V89, P2809, DOI 10.1073/pnas.89.7.2809; CREEL DJ, 1990, OPHTHALMIC PAED GEN, V11, P193, DOI 10.3109/13816819009020979; Cronin CA, 2003, J NEUROSCI, V23, P11692; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Eisenhofer G, 2003, FASEB J, V17, P1248, DOI 10.1096/fj.02-0736com; Garcia-Frigola C, 2010, EMBO J, V29, P3170, DOI 10.1038/emboj.2010.172; Gimenez E, 2004, PIGM CELL RES, V17, P363, DOI 10.1111/j.1600-0749.2004.00158.x; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; GUILLERY RW, 1990, OPHTHALMIC PAED GEN, V11, P177, DOI 10.3109/13816819009020977; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Ilia M, 2000, J COMP NEUROL, V420, P437; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; Jeffery G, 2001, PHYSIOL REV, V81, P1393, DOI 10.1152/physrev.2001.81.4.1393; Jeffery G, 1997, DEV BRAIN RES, V99, P95, DOI 10.1016/S0165-3806(96)00211-8; Kaas JH, 2005, ILAR J, V46, P357, DOI 10.1093/ilar.46.4.357; King RA, 2003, HUM GENET, V113, P502, DOI 10.1007/s00439-003-0998-1; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; Kraij-Hans I, 2006, J NEUROBIOL, V66, P47, DOI 10.1002/neu.20200; Kubrusly RCC, 2003, J NEUROCHEM, V86, P45, DOI 10.1046/j.1471-4159.2003.01813.x; Lavado A, 2006, J NEUROCHEM, V96, P1201, DOI 10.1111/j.1471-4159.2006.03657.x; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; NGUYENLEGROS J, 1994, INVEST OPHTH VIS SCI, V35, P2906; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; Rachel RA, 2002, J NEUROSCI, V22, P4249, DOI 10.1523/JNEUROSCI.22-11-04249.2002; Rebsam A, 2012, J NEUROSCI, V32, P4821, DOI 10.1523/JNEUROSCI.5050-11.2012; Reis RA, 2007, BRAIN RES BRAIN RES; Riley PA, 1999, CELL MOL BIOL, V45, P951; Rios M, 1999, J NEUROSCI, V19, P3519; Slotkin T A, 1988, Adv Exp Med Biol, V245, P283; Tian H, 2000, J NEUROSCI, V20, P7362; Tibber MS, 2007, J COMP NEUROL, V503, P128, DOI 10.1002/cne.21388; Tibber MS, 2006, J COMP NEUROL, V496, P369, DOI 10.1002/cne.20920; Witkovsky P, 2005, J COMP NEUROL, V481, P352, DOI 10.1002/cne.20389; Witkovsky P, 2008, J COMP NEUROL, V510, P158, DOI 10.1002/cne.21784; WULLE I, 1989, DEV BRAIN RES, V48, P59, DOI 10.1016/0165-3806(89)90093-X	38	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e57184	10.1371/journal.pone.0057184	http://dx.doi.org/10.1371/journal.pone.0057184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526936	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100007
J	Zheng, H; Ma, HP; Wang, J; Ma, M				Zheng, Hong; Ma, Hai-Ping; Wang, Jiang; Ma, Ming			Preoperative HO-1 Levels as Prognostic Factor for Adverse Cardiac Events in Elder Patients Undergoing Non-Cardiac Surgery	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; HEME OXYGENASE-1; HYPOXIA; EXPRESSION; APOPTOSIS; ISCHEMIA	Background: Hypoxia-inducible factor-1 alpha (HIF-1 alpha) and heme oxygenase-1(HO-1) are involved in the tissue hypoxic response. Hypothesis: HIF-1 alpha and HO-1 levels may predict cardiac ischemia and adverse cardiac events during non-cardiac surgery. Methods: HIF-1 alpha and HO-1 levels were determined in elderly patients undergoing non-cardiac surgery preoperatively and at 30 minutes, 48 and 72 hours postoperatively. Results were analyzed with respect to the occurrence of adverse cardiac events. Results: A total of 380 patients with a mean age of 65.3 years were included, and 54 (14.2%) who had adverse cardiac events during or after the surgery. HIF-1 alpha and HO-1 levels in the adverse cardiac event group were significantly higher than in the group without adverse cardiac events at each time point (all, P<0.05). In multivariates regression analysis, the odds of an adverse cardiac event was increased by every 1-year increase in age (odd ratio [OR] 1.39, P<0.001), abnormal ECG at baseline (OR 2.27, P = 0.048), myocardial infarction history (OR 3.18, P = 0.015), and positive baseline cTnI level were associated with an increased likelihood of an adverse cardiac event (OR 8.78, P = 0.019), and for every 1 unit increase of HO-1, the odds of an adverse cardiac event increased by 1.30 (P = 0.002). Conclusion: Determination of preoperative HO-1 levels may aid in identifying patients at risk of developing ischemic cardiac events.	[Zheng, Hong; Ma, Hai-Ping; Wang, Jiang; Ma, Ming] Xinjiang Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Urumqi, Peoples R China	Xinjiang Medical University	Wang, J (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Urumqi, Peoples R China.	wangjiang@sina.cn						Abbate A, 2005, EUR HEART J, V26, P2039, DOI 10.1093/eurheartj/ehi419; Abbate A, 2002, J CELL PHYSIOL, V193, P145, DOI 10.1002/jcp.10174; Auerbach AD, 2002, JAMA-J AM MED ASSOC, V287, P1445, DOI 10.1001/jama.287.11.1445; Cardiovascular Diseases Branch of Chinese Medical Association, 2001, CHINESE J CARDIOLOGY, V29, P710; *CRIT COMM NY HEAR, 1964, DIS HEART BLOOD VESS; Durante W, 2003, J CELL PHYSIOL, V195, P373, DOI 10.1002/jcp.10274; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Goei D, 2010, FUTUR CARDIOL, V6, P603, DOI [10.2217/fca.10.78, 10.2217/FCA.10.78]; Holscher M, 2012, CARDIOVASC RES, V94, P77, DOI 10.1093/cvr/cvs014; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kim SE, 2011, KOREAN CIRC J, V41, P11, DOI 10.4070/kcj.2011.41.1.11; Larsen K, 2010, TRENDS CARDIOVAS MED, V20, P58, DOI 10.1016/j.tcm.2010.04.001; Li YG, 2006, ACTA CARDIOL, V61, P295, DOI 10.2143/AC.61.3.2014831; Mercantini P, 2012, WORLD J SURG, V36, P24, DOI 10.1007/s00268-011-1354-6; Novo G, 2011, INT ANGIOL, V30, P242; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Romero L, 2001, ARCH SURG-CHICAGO, V136, P1370, DOI 10.1001/archsurg.136.12.1370; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314	24	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58567	10.1371/journal.pone.0058567	http://dx.doi.org/10.1371/journal.pone.0058567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526997	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100031
J	Fahim, MA; Howarth, FC; Nemmar, A; Qureshi, MA; Shafiullah, M; Jayaprakash, P; Hasan, MY				Fahim, Mohamed Abdelmonem; Howarth, Frank Christopher; Nemmar, Abderrahim; Qureshi, Mohamed Anwar; Shafiullah, Mohamed; Jayaprakash, Petrilla; Hasan, Mohamed Yousif			Vitamin E Ameliorates the Decremental Effect of Paraquat on Cardiomyocyte Contractility in Rats	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; OXYGEN FREE-RADICALS; PARKINSONS-DISEASE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; CARDIAC MYOCYTES; COMPLEX-I; HEART; CALCIUM; ATHEROSCLEROSIS	Background: Exposure to pesticides and industrial toxins are implicated in cardiovascular disease. Paraquat (PAR) is a toxic chemical widely used as an herbicide in developing countries and described as a major suicide agent. The hypothesis tested here is that PAR induced myocardial dysfunction may be attributed to altered mechanisms of Ca2+ transport which are in turn possibly linked to oxidative stress. The mechanisms of PAR induced myocardial dysfunction and the impact of antioxidant protection was investigated in rat ventricular myocytes. Methodology: Forty adult male Wistar rats were divided into 4 groups receiving the following daily intraperitoneal injections for 3 weeks: Group 1 PAR (10 mg/kg), Control Group 2 saline, Group 3 vitamin E (100 mg/kg) and Group 4 PAR (10 mg/kg) and vitamin E (100 mg/kg). Ventricular action potentials were measured in isolated perfused heart, shortening and intracellular Ca2+ in electrically stimulated ventricular myocytes by video edge detection and fluorescence photometry techniques, and superoxide dismutase (SOD) and catalase (CAT) levels in heart tissue. Principal Findings: Spontaneous heart rate, resting cell length, time to peak (TPK) and time to half (THALF) relaxation of myocyte shortening were unaltered. Amplitude of shortening was significantly reduced in PAR treated rats (4.99 +/- 0.26%) and was normalized by vitamin E (7.46 +/- 0.44%) compared to controls (7.87 +/- 0.52%). PAR significantly increased myocytes resting intracellular Ca2+ whilst TPK and THALF decay and amplitude of the Ca2+ transient were unaltered. The fura-2-cell length trajectory during the relaxation of the twitch contraction was significantly altered in myocytes from PAR treated rats compared to controls suggesting altered myofilament sensitivity to Ca2+ as it was normalized by vitamin E treatment. A significant increase in SOD and CAT activities was observed in both PAR and vitamin E plus PAR groups. Conclusions: PAR exposure compromised rats heart function and ameliorated by vitamin E treatment.	[Fahim, Mohamed Abdelmonem; Howarth, Frank Christopher; Nemmar, Abderrahim; Qureshi, Mohamed Anwar; Jayaprakash, Petrilla] United Arab Emirates Univ, Fac Med, Dept Physiol, Al Ain, U Arab Emirates; [Shafiullah, Mohamed; Hasan, Mohamed Yousif] United Arab Emirates Univ, Fac Med, Dept Pharmacol, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Fahim, MA (corresponding author), United Arab Emirates Univ, Fac Med, Dept Physiol, Al Ain, U Arab Emirates.	m.fahim@uaeu.ac.ae		Jayaprakash, Petrilla/0000-0001-5433-6587	Research Affairs at the UAE University [02-04-8-11/04]	Research Affairs at the UAE University	This work was financially supported by the Research Affairs at the UAE University under a contract no. 02-04-8-11/04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHANASELIS S, 1983, J TOXICOL-CUTAN OCUL, V2, P3, DOI 10.3109/15569528309088518; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BLAUSTEIN AS, 1986, AM J PHYSIOL, V250, pH595, DOI 10.1152/ajpheart.1986.250.4.H595; Ceaser EK, 2003, AM J PHYSIOL-HEART C, V285, pH2298, DOI 10.1152/ajpheart.00508.2003; Chan YC, 2007, TOXICOL IN VITRO, V21, P595, DOI 10.1016/j.tiv.2006.12.007; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cristovao AC, 2009, ANTIOXID REDOX SIGN, V11, P2105, DOI [10.1089/ars.2009.2459, 10.1089/ARS.2009.2459]; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Fahim MA, 2013, PHYSIOL RES, V62, P313, DOI 10.33549/physiolres.932386; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Howarth FC, 2007, EXP PHYSIOL, V92, P1029, DOI 10.1113/expphysiol.2007.038703; Howarth FC, 2008, MOL CELL BIOCHEM, V315, P69, DOI 10.1007/s11010-008-9790-9; Ikuo H, 2003, KAWASAKI IGAKKAISHI, V29, P231; KANEKO M, 1989, AM J PHYSIOL, V257, pH804, DOI 10.1152/ajpheart.1989.257.3.H804; KANEKO M, 1989, AM J PHYSIOL, V256, pH368, DOI 10.1152/ajpheart.1989.256.2.H368; Kaneko M, 1991, Bratisl Lek Listy, V92, P48; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Koo JR, 2002, AM J KIDNEY DIS, V39, P55, DOI 10.1053/ajkd.2002.29880; KOPPEL C, 1994, J TOXICOL-CLIN TOXIC, V32, P205, DOI 10.3109/15563659409000452; Lee HL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-7; Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Martinet W, 2001, CIRC RES, V88, P733, DOI 10.1161/hh0701.088684; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Nemmar A, 2009, TOXICOLOGY, V263, P84, DOI 10.1016/j.tox.2009.06.017; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; Raza H, 2000, J BIOCHEM MOL TOXIC, V14, P131, DOI 10.1002/(SICI)1099-0461(2000)14:3<131::AID-JBT2>3.0.CO;2-Q; Ren J, 2008, CRIT CARE MED, V36, P2106, DOI 10.1097/CCM.0b013e31817bf925; SAUNDERS N R, 1985, Journal of Thoracic and Cardiovascular Surgery, V89, P734; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; SPURGEON HA, 1992, J PHYSIOL-LONDON, V447, P83, DOI 10.1113/jphysiol.1992.sp018992; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tabata N, 1999, FORENSIC SCI INT, V100, P117, DOI 10.1016/S0379-0738(98)00190-X; Valenca SS, 2008, ENVIRON RES, V108, P199, DOI 10.1016/j.envres.2008.07.001; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; WATANABE N, 1986, BIOCHIM BIOPHYS ACTA, V883, P420, DOI 10.1016/0304-4165(86)90279-5	44	7	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e57651	10.1371/journal.pone.0057651	http://dx.doi.org/10.1371/journal.pone.0057651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23526948	gold, Green Published, Green Submitted			2022-12-27	WOS:000316411600004
J	Levin, L; Zelzion, E; Nachliel, E; Gutman, M; Tsfadia, Y; Einav, Y				Levin, Lihie; Zelzion, Ehud; Nachliel, Esther; Gutman, Menachem; Tsfadia, Yossi; Einav, Yulia			A Single Disulfide Bond Disruption in the beta 3 Integrin Subunit Promotes Thiol/Disulfide Exchange, a Molecular Dynamics Study	PLOS ONE			English	Article							GLANZMANN THROMBASTHENIA; CONFORMATIONAL-CHANGES; BETA(3) INTEGRINS; PLATELET INTEGRIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; REDOX CONTROL; BINDING SITE; I-LIKE; ACTIVATION	The integrins are a family of membrane receptors that attach a cell to its surrounding and play a crucial function in cell signaling. The combination of internal and external stimuli alters a folded non-active state of these proteins to an extended active configuration. The beta 3 subunit of the platelet alpha IIb beta 3 integrin is made of well-structured domains rich in disulfide bonds. During the activation process some of the disulfides are re-shuffled by a mechanism requiring partial reduction of some of these bonds; any disruption in this mechanism can lead to inherent blood clotting diseases. In the present study we employed Molecular Dynamics simulations for tracing the sequence of structural fluctuations initiated by a single cysteine mutation in the beta 3 subunit of the receptor. These simulations showed that in-silico protein mutants exhibit major conformational deformations leading to possible disulfide exchange reactions. We suggest that any mutation that prevents Cys560 from reacting with one of the Cys(567)-Cys(581) bonded pair, thus disrupting its ability to participate in a disulfide exchange reaction, will damage the activation mechanism of the integrin. This suggestion is in full agreement with previously published experiments. Furthermore, we suggest that rearrangement of disulfide bonds could be a part of a natural cascade of thiol/ disulfide exchange reactions in the alpha IIb beta 3 integrin, which are essential for the native activation process.	[Levin, Lihie; Zelzion, Ehud; Nachliel, Esther; Gutman, Menachem; Tsfadia, Yossi] Tel Aviv Univ, George S Wise Fac Life Sci, Biochem & Mol Biol Dept, IL-69978 Tel Aviv, Israel; [Zelzion, Ehud; Einav, Yulia] Holon Inst Technol, Fac Sci, Math Biol Unit, Holon, Israel	Tel Aviv University	Tsfadia, Y (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Biochem & Mol Biol Dept, IL-69978 Tel Aviv, Israel.	YossiT@tauex.tau.ac.il; yulia_e@hit.ac.il			Tel-Aviv University special vice president support for Molecular Dynamics Research	Tel-Aviv University special vice president support for Molecular Dynamics Research	Funding was provided by Tel-Aviv University special vice president support for Molecular Dynamics Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Butta N, 2003, BLOOD, V102, P2491, DOI 10.1182/blood-2003-01-0213; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; Chen P, 2001, J BIOL CHEM, V276, P38628, DOI 10.1074/jbc.M105737200; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; D'Andrea G, 2002, THROMB HAEMOSTASIS, V87, P1034, DOI 10.1055/s-0037-1613129; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Essex DW, 2004, ANTIOXID REDOX SIGN, V6, P736, DOI 10.1089/1523086041361622; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gaillard T, 2009, PROTEINS, V76, P977, DOI 10.1002/prot.22404; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Manickam N, 2011, J THROMB HAEMOST, V9, P1207, DOI 10.1111/j.1538-7836.2011.04266.x; Mansour W, 2011, J THROMB HAEMOST, V9, P192, DOI 10.1111/j.1538-7836.2010.04087.x; Milet-Marsal S, 2002, THROMB HAEMOSTASIS, V88, P104; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; Mor-Cohen R, 2012, J BIOL CHEM, V287, P8879, DOI 10.1074/jbc.M111.311043; Mor-Cohen R, 2008, J BIOL CHEM, V283, P19235, DOI 10.1074/jbc.M802399200; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Provasi D, 2009, PROTEINS, V77, P477, DOI 10.1002/prot.22463; Puklin-Faucher E, 2006, J CELL BIOL, V175, P349, DOI 10.1083/jcb.200602071; Puklin-Faucher E, 2009, J BIOL CHEM, V284, P36557, DOI 10.1074/jbc.M109.041194; Ruiz C, 2001, BLOOD, V98, P2432, DOI 10.1182/blood.V98.8.2432; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Sikora M, 2011, PROTEINS, V79, P1786, DOI 10.1002/prot.23001; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wouters MA, 2004, BIOESSAYS, V26, P73, DOI 10.1002/bies.10413; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	58	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59175	10.1371/journal.pone.0059175	http://dx.doi.org/10.1371/journal.pone.0059175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527123	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600044
J	Madsen, J; Gaiha, GD; Palaniyar, N; Dong, T; Mitchell, DA; Clark, HW				Madsen, Jens; Gaiha, Gaurav D.; Palaniyar, Nades; Dong, Tao; Mitchell, Daniel A.; Clark, Howard W.			Surfactant Protein D Modulates HIV Infection of Both T-Cells and Dendritic Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MANNOSE-BINDING LECTIN; HELICAL COILED-COIL; INFLUENZA-A VIRUS; CARBOHYDRATE-RECOGNITION; ENVELOPE GLYCOPROTEIN; PULMONARY COLLECTINS; ALVEOLAR MACROPHAGES; TYPE-1 INFECTIVITY; LIGAND-BINDING	Surfactant Protein D (SP-D) is an oligomerized C-type lectin molecule with immunomodulatory properties and involvement in lung surfactant homeostasis in the respiratory tract. SP-D binds to the enveloped viruses, influenza A virus and respiratory syncytial virus and inhibits their replication in vitro and in vivo. SP-D has been shown to bind to HIV via the HIV envelope protein gp120 and inhibit infectivity in vitro. Here we show that SP-D binds to different strains of HIV (BaL and IIIB) and the binding occurs at both pH 7.4 and 5.0 resembling physiological relevant pH values found in the body and the female urogenital tract, respectively. The binding of SP-D to HIV particles and gp120 was inhibited by the presence of several hexoses with mannose found to be the strongest inhibitor. Competition studies showed that soluble CD4 and CVN did not interfere with the interaction between SP-D and gp120. However, soluble recombinant DC-SIGN was shown to inhibit the binding between SP-D and gp120. SP-D agglutinated HIV and gp120 in a calcium dependent manner. SP-D inhibited the infectivity of HIV strains at both pH values of 7.4 and 5.0 in a concentration dependent manner. The inhibition of the infectivity was abolished by the presence of mannose. SP-D enhanced the binding of HIV to immature monocyte derived dendritic cells (iMDDCs) and was also found to enhance HIV capture and transfer to the T-cell like line PM1. These results suggest that SP-D can bind to and inhibit direct infection of T-cells by HIV but also enhance the transfer of infectious HIV particles from DCs to T-cells in vivo.	[Madsen, Jens; Clark, Howard W.] Univ Southampton, Southampton Gen Hosp, Dept Child Hlth, Sir Henry Wellcome Labs,Fac Med, Southampton, Hants, England; [Madsen, Jens; Clark, Howard W.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Gaiha, Gaurav D.] Massachusetts Gen Hosp, Massachusetts Inst Technol & Harvard, Ragon Inst, Charlestown, MA USA; [Palaniyar, Nades] Univ Toronto, SickKids Res Inst, Toronto, ON, Canada; [Dong, Tao] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, MRC, Oxford, England; [Mitchell, Daniel A.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England	University of Southampton; University of Southampton; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; University of Warwick	Madsen, J (corresponding author), Univ Southampton, Southampton Gen Hosp, Dept Child Hlth, Sir Henry Wellcome Labs,Fac Med, Southampton, Hants, England.	j.madsen@soton.ac.uk	Madsen, Jens/N-8082-2013; Mitchell, Daniel A/A-6580-2009	Madsen, Jens/0000-0003-1664-7645; Mitchell, Daniel A/0000-0003-0936-6212; Palaniyar, Nades/0000-0002-2170-8548; Clark, Howard/0000-0001-7354-2028; Dong, Tao/0000-0003-3545-3758	Medical Research Council (UK); Medical Research Council [G1001046, G0600520] Funding Source: researchfish; MRC [G0600520, G1001046] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; Borron PJ, 1998, J IMMUNOL, V161, P4599; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724; BrownAugsburger P, 1996, J BIOL CHEM, V271, P18912, DOI 10.1074/jbc.271.31.18912; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Cai GZ, 1999, AM J PHYSIOL-LUNG C, V276, pL131, DOI 10.1152/ajplung.1999.276.1.L131; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Deb R, 2007, J BIOL CHEM, V282, P36808, DOI 10.1074/jbc.M702336200; Duvoix A, 2010, PHYSL CONCENTRATION; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Gaiha GD, 2008, J IMMUNOL, V181, P601, DOI 10.4049/jimmunol.181.1.601; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Hansen S, 2007, AM J RESP CELL MOL, V36, P94, DOI 10.1165/rcmb.2006-0195OC; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; Hawgood S, 2004, J VIROL, V78, P8565, DOI 10.1128/JVI.78.16.8565-8572.2004; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Hong PWP, 2002, J VIROL, V76, P12855, DOI 10.1128/JVI.76.24.12855-12865.2002; HOPPE HJ, 1994, STRUCTURE, V2, P1129, DOI 10.1016/S0969-2126(94)00115-4; Kucejko W, 2009, FOLIA HISTOCHEM CYTO, V47, P225, DOI 10.2478/v10042-009-0028-9; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Leth-Larsen R, 2004, MOL HUM REPROD, V10, P149, DOI 10.1093/molehr/gah022; LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; Meschi J, 2005, J GEN VIROL, V86, P3097, DOI 10.1099/vir.0.80764-0; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; MONTEFIORI DC, 1988, P NATL ACAD SCI USA, V85, P9248, DOI 10.1073/pnas.85.23.9248; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; ONGRADI J, 1990, AIDS RES HUM RETROV, V6, P1433, DOI 10.1089/aid.1990.6.1433; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; PERSSON A, 1988, BIOCHEMISTRY-US, V27, P8576, DOI 10.1021/bi00423a011; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Ruano MLF, 2000, BIOCHEMISTRY-US, V39, P6529, DOI 10.1021/bi000188z; Saifuddin M, 2000, J GEN VIROL, V81, P949, DOI 10.1099/0022-1317-81-4-949; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; White MR, 2000, J IMMUNOL, V165, P2108, DOI 10.4049/jimmunol.165.4.2108; WHO, 2010, GLOB SUMM AIDS EP 20; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Wu ZW, 2006, AIDS RES HUM RETROV, V22, P508, DOI 10.1089/aid.2006.22.508; Wu ZW, 2004, AIDS RES HUM RETROV, V20, P600, DOI 10.1089/0889222041217400; Wu ZW, 2003, AIDS RES HUM RETROV, V19, P201, DOI 10.1089/088922203763315704; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	64	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59047	10.1371/journal.pone.0059047	http://dx.doi.org/10.1371/journal.pone.0059047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527085	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000316411600031
J	Yazid, S; Sinniah, A; Solito, E; Calder, V; Flower, RJ				Yazid, Samia; Sinniah, Ajantha; Solito, Egle; Calder, Virginia; Flower, Rod J.			Anti-Allergic Cromones Inhibit Histamine and Eicosanoid Release from Activated Human and Murine Mast Cells by Releasing Annexin A1	PLOS ONE			English	Article							PROTEIN-KINASE-C; ALKALINE-PHOSPHATASE INHIBITION; PERIPHERAL-BLOOD LEUKOCYTES; INDUCED AIRWAY RESPONSES; ANTI-ALLERGIC COMPOUNDS; NEDOCROMIL SODIUM; DISODIUM-CROMOGLYCATE; MEDIATOR RELEASE; MOUSE MODEL; ZYMOSAN INFLAMMATION	Background and Purpose: Although the 'cromones' (di-sodium cromoglycate and sodium nedocromil) are used to treat allergy and asthma, their 'mast cell stabilising' mechanism of pharmacological action has never been convincingly explained. Here, we investigate the hypothesis that these drugs act by stimulating the release of the anti-inflammatory protein Annexin-A1 (Anx-A1) from mast cells. Experimental approach: We used biochemical and immuno-neutralisation techniques to investigate the mechanism by which cromones suppress histamine and eicosanoid release from cord-derived human mast cells (CDMCs) or murine bone marrow-derived mast cells (BMDMCs) from wild type and Anx-A1 null mice. Key results: CDMCs activated by IgE-FcR epsilon 1 crosslinking, released histamine and prostaglandin (PG) D-2, which were inhibited (30-65%) by 5 min pre-treatment with cromoglycate (10 nM) or nedocromil (10 nM), as well as dexamethasone (2 nM) and human recombinant Anx-A1 (1-10 nM). In CDMCs cromones potentiated (2-5 fold) protein kinase C (PKC) phosphorylation and Anx-A1 phosphorylation and secretion (3-5 fold). Incubation of CDMCs with a neutralising anti-Anx-A1 monoclonal antibody reversed the cromone inhibitory effect. Nedocromil (10 nM) also inhibited (40-60%) the release of mediators from murine bone marrow derived-mast cells from wild type mice activated by compound 48/ 80 and IgE-FcR epsilon 1 crosslinking, but were inactive in such cells when these were prepared from Anx-A1 null mice or when the neutralising anti-Anx-A1 antibody was present. Conclusions and Implications: We conclude that stimulation of phosphorylation and secretion of Anx-A1 is an important component of inhibitory cromone actions on mast cells, which could explain their acute pharmacological actions in allergy. These findings also highlight a new pathway for reducing mediator release from these cells.	[Sinniah, Ajantha; Solito, Egle; Flower, Rod J.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Yazid, Samia; Calder, Virginia] Inst Ophthalmol, Div Mol Therapy, London, England	University of London; Queen Mary University London; University of London; University College London	Yazid, S (corresponding author), Inst Ophthalmol, Div Mol Therapy, London, England.	s.yazid@ucl.ac.uk	Sinniah, Ajantha/L-5684-2017; Calder, Virginia/AAG-8278-2020	Sinniah, Ajantha/0000-0002-7572-9926; Calder, Virginia/0000-0003-1422-2926; Solito, Egle/0000-0001-5279-0049	Wellcome Trust [085903]; Government of Malaysia	Wellcome Trust(Wellcome TrustEuropean Commission); Government of Malaysia	The authors acknowledge financial support from the Wellcome Trust (award number 085903) and the Government of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM WM, 1988, AM REV RESPIR DIS, V138, P1565, DOI 10.1164/ajrccm/138.6.1565; ABRAHAM WM, 1989, DRUGS, V37, P78, DOI 10.2165/00003495-198900371-00015; Abraham WM, 1989, DRUGS S1, V37, P127; AHLUWALIA A, 1994, BIOCHEM PHARMACOL, V48, P1647, DOI 10.1016/0006-2952(94)90210-0; Bandeira-Melo C, 2005, J PHARMACOL EXP THER, V313, P1416, DOI 10.1124/jpet.104.080473; Bansal SK, 1997, EUR RESPIR J, V10, P308, DOI 10.1183/09031936.97.10020308; BARNES PJ, 1993, ANNU REV MED, V44, P229, DOI 10.1146/annurev.me.44.020193.001305; Bena S, 2012, J BIOL CHEM; Bleecker ER, 1996, J ALLERGY CLIN IMMUN, V98, pS118, DOI 10.1016/S0091-6749(96)80139-4; Chung YW, 2004, PROTEOMICS, V4, P3328, DOI 10.1002/pmic.200400895; CHURCH MK, 1987, BRIT J PHARMACOL, V90, P421, DOI 10.1111/j.1476-5381.1987.tb08972.x; Cook E. B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P167, DOI 10.2174/1568010023344733; Corbel M, 1999, PULM PHARMACOL THER, V12, P165, DOI 10.1006/pupt.1999.0178; Cox J S, 1970, Arerugi, V19, P832; Cox J S, 1970, Adv Drug Res, V5, P115; COX JSG, 1970, RESPIRATION, V27, P292, DOI 10.1159/000192762; COX JSG, 1967, NATURE, V216, P1328, DOI 10.1038/2161328a0; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; Dahl C, 2002, J IMMUNOL METHODS, V262, P137, DOI 10.1016/S0022-1759(02)00011-X; Du T, 1996, J ALLERGY CLIN IMMUN, V98, P400, DOI 10.1016/S0091-6749(96)70164-1; EVANS TW, 1988, AM REV RESPIR DIS, V138, P395, DOI 10.1164/ajrccm/138.2.395; FOLKERTS G, 1993, BRIT J PHARMACOL, V108, P1083, DOI 10.1111/j.1476-5381.1993.tb13509.x; Galatowicz G, 2007, CLIN EXP ALLERGY, V37, P1648, DOI 10.1111/j.1365-2222.2007.02782.x; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; GOULDING NJ, 1990, LANCET, V335, P1416, DOI 10.1016/0140-6736(90)91445-G; GRACE RH, 1987, GUT, V28, P88, DOI 10.1136/gut.28.1.88; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; John CD, 2003, J NEUROENDOCRINOL, V15, P946, DOI 10.1046/j.1365-2826.2003.01081.x; KAY AB, 1987, J ALLERGY CLIN IMMUN, V80, P1, DOI 10.1016/S0091-6749(87)80183-5; KURIYAMA K, 1986, AGENTS ACTIONS, V18, P473, DOI 10.1007/BF01964949; Lee SH, 2012, BIOCHEM BIOPH RES CO, V417, P1024, DOI 10.1016/j.bbrc.2011.12.084; LUCAS AM, 1987, BIOCHEM PHARMACOL, V36, P562, DOI 10.1016/0006-2952(87)90368-6; MATTOLI S, 1990, INT ARCH ALLER A IMM, V92, P16, DOI 10.1159/000235218; Mulla A, 2005, J CLIN ENDOCR METAB, V90, P557, DOI 10.1210/jc.2004-1230; MURPHY S, 1987, DRUG INTEL CLIN PHAR, V21, P22, DOI 10.1177/10600280870211P102; Ng FSP, 2011, CLIN EXP ALLERGY, V41, P1793, DOI 10.1111/j.1365-2222.2011.03855.x; Oka T, 2012, LAB INVEST, V92, P1472, DOI 10.1038/labinvest.2012.116; OKAYAMA Y, 1992, CLIN EXP ALLERGY, V22, P401, DOI 10.1111/j.1365-2222.1992.tb03102.x; Oliani SM, 2000, LAB INVEST, V80, P1429, DOI 10.1038/labinvest.3780150; Orr TS, 1989, DRUGS S1, V37, P127; ORR TSC, 1989, DRUGS, V37, P113, DOI 10.2165/00003495-198900371-00020; PEARCE FL, 1982, J IMMUNOL, V128, P2481; PEERS SH, 1993, BRIT J PHARMACOL, V108, P66, DOI 10.1111/j.1476-5381.1993.tb13441.x; Perretti M, 1996, BRIT J PHARMACOL, V118, P605, DOI 10.1111/j.1476-5381.1996.tb15444.x; Pieretti S, 2004, PAIN, V109, P52, DOI 10.1016/j.pain.2004.01.009; RADEAU T, 1993, PULM PHARMACOL, V6, P27, DOI 10.1006/pulp.1993.1005; RAUD J, 1995, EUR J PHARMACOL, V282, P207, DOI 10.1016/0014-2999(95)00327-H; Rintala RJ, 2001, J PEDIATR SURG, V36, P1032, DOI 10.1053/jpsu.2001.24732; SAGIEISENBERG R, 1985, TRENDS PHARMACOL SCI, V6, P198, DOI 10.1016/0165-6147(85)90094-X; SCHWENDER CF, 1982, J MED CHEM, V25, P742, DOI 10.1021/jm00348a025; SCHWENDER CF, 1981, BIOCHEM PHARMACOL, V30, P217, DOI 10.1016/0006-2952(81)90081-2; Shichijo M, 1998, CLIN EXP ALLERGY, V28, P1228; SILVA JRLE, 1995, EUR RESPIR J, V8, P1321, DOI 10.1183/09031936.95.08081321; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; SUNG CP, 1977, INT ARCH ALLER A IMM, V55, P374, DOI 10.1159/000231948; SUNG CP, 1977, INT ARCH ALLER A IMM, V55, P385, DOI 10.1159/000231949; TARAYRE JP, 1989, PHARMACOL RES, V21, P385, DOI 10.1016/1043-6618(89)90156-4; TARAYRE JP, 1989, PHARMACOL RES, V21, P375, DOI 10.1016/1043-6618(89)90155-2; TARAYRE JP, 1982, AGENTS ACTIONS, V12, P662, DOI 10.1007/BF01965076; THEOHARIDES TC, 1980, SCIENCE, V207, P80, DOI 10.1126/science.6153130; Theoharides TC, 2000, J PHARMACOL EXP THER, V294, P810; THOMSON DS, 1973, CLIN EXP IMMUNOL, V13, P537; Viscardi RM, 1997, AM J RESP CRIT CARE, V156, P1523, DOI 10.1164/ajrccm.156.5.9611088; Wang LH, 1999, EUR J PHARMACOL, V371, P241, DOI 10.1016/S0014-2999(99)00179-X; WASSERMAN SI, 1995, ALLERGY PROC, V16, P67, DOI 10.2500/108854195778771390; WELLS E, 1983, BIOCHEM PHARMACOL, V32, P837, DOI 10.1016/0006-2952(83)90585-3; Yang YH, 2010, PHARMACOLOGY, V86, P1, DOI 10.1159/000314164; Yazid S, 2010, ARTERIOSCL THROM VAS, V30, P1718, DOI 10.1161/ATVBAHA.110.209536; Yazid S, 2009, BIOCHEM PHARMACOL, V77, P1814, DOI 10.1016/j.bcp.2009.03.010; Zuo YX, 2003, PAIN, V105, P467, DOI 10.1016/S0304-3959(03)00261-6	73	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58963	10.1371/journal.pone.0058963	http://dx.doi.org/10.1371/journal.pone.0058963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527056	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600020
J	Coburn, JM; Bernstein, N; Bhattacharya, R; Aich, U; Yarema, KJ; Elisseeff, JH				Coburn, Jeannine M.; Bernstein, Nicholas; Bhattacharya, Rahul; Aich, Udayanath; Yarema, Kevin J.; Elisseeff, Jennifer H.			Differential Response of Chondrocytes and Chondrogenic-Induced Mesenchymal Stem Cells to C1-OH Tributanoylated N-Acetylhexosamines	PLOS ONE			English	Article							DISCOIDIN-DOMAIN RECEPTOR-2; ARTICULAR-CARTILAGE; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; EXTRACELLULAR-MATRIX; FEMORAL CONDYLE; CULTURE-SYSTEM; OSTEOARTHRITIS; ACID; SOX9	Articular cartilage has a limited ability to self-repair because of its avascular nature and the low mitotic activity of the residing chondrocytes. There remains a significant need to develop therapeutic strategies to increase the regenerative capacity of cells that could repair cartilage. Multiple cell types, including chondrocytes and mesenchymal stem cells, have roles in articular cartilage regeneration. In this study, we evaluated a platform technology of multiple functionalized hexosamines, namely 3,4,6-O-tributanoylated-N-acetylgalactosamine (3,4,6-O-Bu(3)GalNAc), 3,4,6-O-tributanoylated-N-acetylmannosamine (3,4,6-O-Bu(3)ManNAc) and 3,4,6-O-Bu(3)GlcNAc, with the potential ability to reduce NF kappa B activity. Exposure of IL-1 beta-stimulated chondrocytes to the hexosamine analogs resulted in increased expression of ECM molecules and a corresponding improvement in cartilage-specific ECM accumulation. The greatest ECM accumulation was observed with 3,4,6-O-Bu(3)GalNAc. In contrast, mesenchymal stem cells (MSCs) exposed to 3,4,6-O-Bu(3)GalNAc exhibited a dose dependent decrease in chondrogenic differentation as indicated by decreased ECM accumulation. These studies established the disease modification potential of a hexosamine analog platform on IL-1 beta-stimulated chondrocytes. We determined that the modified hexosamine with the greatest potential for disease modification is 3,4,6-O-Bu(3)GalNAc. This effect was distinctly different with 3,4,6-O-Bu(3)GalNAc exposure to chondrogenic-induced MSCs, where a decrease in ECM accumulation and differentiation was observed. Furthermore, these studies suggest that NF kappa B pathway plays a complex role cartilage repair.	[Coburn, Jeannine M.; Bernstein, Nicholas; Bhattacharya, Rahul; Aich, Udayanath; Yarema, Kevin J.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA; [Coburn, Jeannine M.; Bernstein, Nicholas; Bhattacharya, Rahul; Aich, Udayanath; Yarema, Kevin J.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Coburn, Jeannine M.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Yarema, KJ (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21218 USA.	kyarema1@jhu.edu; jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010	Elisseeff, Jennifer/0000-0002-5066-1996; Coburn, Jeannine M./0000-0001-6354-5436	National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH) [R01AR054005]; Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship [NIA/NIH F31AG033999]; NATIONAL CANCER INSTITUTE [R01CA112314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG033999] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH); Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH) R01AR054005. JMC was supported in part by a Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship NIA/NIH F31AG033999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich U, 2008, ACS CHEM BIOL, V3, P230, DOI 10.1021/cb7002708; Aigner T, 2005, CYTOKINE, V31, P227, DOI 10.1016/j.cyto.2005.04.009; Buckwalter JA, 2003, J ORTHOP SPORT PHYS, V33, P578, DOI 10.2519/jospt.2003.33.10.578; Cameron M L, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P38, DOI 10.1007/BF01552652; Campbell CT, 2008, J MED CHEM, V51, P8135, DOI 10.1021/jm800873k; Catterall JB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3216; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W; Elmouelhi N, 2009, J MED CHEM, V52, P2515, DOI 10.1021/jm801661m; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fitzgerald GK, 2004, ARTHRIT RHEUM-ARTHR, V51, P941, DOI 10.1002/art.20825; Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242; Fujita T, 2004, J CELL BIOCHEM, V93, P374, DOI 10.1002/jcb.20192; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; GOLDRING MB, 1994, J CELL BIOCHEM, V54, P85, DOI 10.1002/jcb.240540110; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Kalson NS, 2010, INT J CLIN PRACT, V64, P1444, DOI 10.1111/j.1742-1241.2010.02420.x; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457; Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008; Lin CC, 2011, P NATL ACAD SCI USA, V108, P6380, DOI 10.1073/pnas.1014026108; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Owen HC, 2007, MOL CELL ENDOCRINOL, V264, P164, DOI 10.1016/j.mce.2006.11.006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sakai A, 1999, ARCH ORTHOP TRAUM SU, V119, P121, DOI 10.1007/s004020050374; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Vonk LA, 2011, RHEUMATOLOGY, V50, P463, DOI 10.1093/rheumatology/keq305; Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wu S, 2011, J BIOL CHEM; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655; ZIMMERMANN B, 1993, ANAT EMBRYOL, V187, P67	48	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58899	10.1371/journal.pone.0058899	http://dx.doi.org/10.1371/journal.pone.0058899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516573	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400075
J	Fei, J; Tamski, H; Cook, C; Santanam, N				Fei, Jia; Tamski, Holly; Cook, Carla; Santanam, Nalini			MicroRNA Regulation of Adipose Derived Stem Cells in Aging Rats	PLOS ONE			English	Article							STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; DEPOT ORIGIN; FAT TISSUE; IN-VITRO; ADIPOGENESIS; OBESITY	Background: Perturbations in abdominal fat secreted adipokines play a key role in metabolic syndrome. This process is further altered during the aging process, probably due to alterations in the preadipocytes (aka. stromal vascular fraction cells-SVF cells or adipose derived stem cells-ASCs) composition and/or function. Since microRNAs regulate genes involved both in development and aging processes, we hypothesized that the impaired adipose function with aging is due to altered microRNA regulation of adipogenic pathways in SVF cells. Methodology and Principal Findings: Alterations in mRNA and proteins associated with adipogenic differentiation (ERK5 and PPARg) but not osteogenic (RUNX2) pathways were observed in SVF cells isolated from visceral adipose tissue with aging (6 to 30 mo) in female Fischer 344 x Brown Norway Hybrid (FBN) rats. The impaired differentiation capacity with aging correlated with altered levels of miRNAs involved in adipocyte differentiation (miRNA-143) and osteogenic pathways (miRNA-204). Gain and loss of function studies using premir or antagomir-143 validated the age associated adipocyte dysfunction. Conclusions and Significance: Our studies for the first time indicate a role for miRNA mediated regulation of SVF cells with aging. This discovery is important in the light of the findings that dysfunctional adipose derived stem cells contribute to age related chronic diseases.	[Fei, Jia; Tamski, Holly; Cook, Carla; Santanam, Nalini] Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA	Marshall University	Santanam, N (corresponding author), Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.	santanam@marshall.edu		Santanam, Nalini/0000-0003-3343-6081	 [NIH5P20RR016477]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477] Funding Source: NIH RePORTER	; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by NIH5P20RR016477. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bays HE, 2011, J AM COLL CARDIOL, V57, P2461, DOI 10.1016/j.jacc.2011.02.038; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cartwright MJ, 2010, J GERONTOL A-BIOL, V65, P242, DOI 10.1093/gerona/glp213; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2004, J CELL SCI, V117, P417, DOI 10.1242/jcs.00866; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Fei J, 2010, ATHEROSCLEROSIS, V212, P488, DOI 10.1016/j.atherosclerosis.2010.06.044; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Gualillo O, 2007, TRENDS CARDIOVAS MED, V17, P275, DOI 10.1016/j.tcm.2007.09.005; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guo W, 2007, AM J PHYSIOL-ENDOC M, V292, pE1041, DOI 10.1152/ajpendo.00557.2006; Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690; Hong L, 2007, TISSUE ENG, V13, P1197, DOI 10.1089/ten.2006.0317; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Karagiannides I, 2006, J BIOL CHEM, V281, P23025, DOI 10.1074/jbc.M513187200; KIRKLAND JL, 1984, J AM GERIATR SOC, V32, P219, DOI 10.1111/j.1532-5415.1984.tb02006.x; Kirkland JL, 1997, J AM GERIATR SOC, V45, P959, DOI 10.1111/j.1532-5415.1997.tb02967.x; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Larkin LM, 2001, J GERONTOL A-BIOL, V56, pB486, DOI 10.1093/gerona/56.11.B486; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lin YF, 2008, CELL PROLIFERAT, V41, P803, DOI 10.1111/j.1365-2184.2008.00542.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; McGregor RA, 2011, CURR MOL MED, V11, P304; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Perissinotto E, 2002, BRIT J NUTR, V87, P177, DOI 10.1079/BJN2001487; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Sharma AM, 2003, GROWTH HORM IGF RES, V13, pS10, DOI 10.1016/S1096-6374(03)00047-9; Sharma G, 2005, MOL CELL ENDOCRINOL, V245, P93, DOI 10.1016/j.mce.2005.10.027; Shi YY, 2005, PLAST RECONSTR SURG, V116, P1686, DOI 10.1097/01.prs.0000185606.03222.a9; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Xu YF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-21; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zou CH, 2008, J NUTR BIOCHEM, V19, P277, DOI 10.1016/j.jnutbio.2007.06.006; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	53	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59238	10.1371/journal.pone.0059238	http://dx.doi.org/10.1371/journal.pone.0059238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516615	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400100
J	Schroder, MS; Stellmacher, A; Romorini, S; Marini, C; Montenegro-Venegas, C; Altrock, WD; Gundelfinger, ED; Fejtova, A				Schroeder, Markus S.; Stellmacher, Anne; Romorini, Stefano; Marini, Claudia; Montenegro-Venegas, Carolina; Altrock, Wilko D.; Gundelfinger, Eckart D.; Fejtova, Anna			Regulation of Presynaptic Anchoring of the Scaffold Protein Bassoon by Phosphorylation-Dependent Interaction with 14-3-3 Adaptor Proteins	PLOS ONE			English	Article							ZONE PRECURSOR VESICLES; LONG-TERM POTENTIATION; COFFIN-LOWRY SYNDROME; RIM-BINDING PROTEINS; ACTIVE ZONE; NEUROTRANSMITTER RELEASE; SYNAPTIC PLASTICITY; FIBER SYNAPSES; RIM1-ALPHA; FAMILY	The proper organization of the presynaptic cytomatrix at the active zone is essential for reliable neurotransmitter release from neurons. Despite of the virtual stability of this tightly interconnected proteinaceous network it becomes increasingly clear that regulated dynamic changes of its composition play an important role in the processes of synaptic plasticity. Bassoon, a core component of the presynaptic cytomatrix, is a key player in structural organization and functional regulation of presynaptic release sites. It is one of the most highly phosphorylated synaptic proteins. Nevertheless, to date our knowledge about functions mediated by any one of the identified phosphorylation sites of Bassoon is sparse. In this study, we have identified an interaction of Bassoon with the small adaptor protein 14-3-3, which depends on phosphorylation of the 14-3-3 binding motif of Bassoon. In vitro phosphorylation assays indicate that phosphorylation of the critical Ser-2845 residue of Bassoon can be mediated by a member of the 90-kDa ribosomal S6 protein kinase family. Elimination of Ser-2845 from the 14-3-3 binding motif results in a significant decrease of Bassoon's molecular exchange rates at synapses of living rat neurons. We propose that the phosphorylation-induced 14-3-3 binding to Bassoon modulates its anchoring to the presynaptic cytomatrix. This regulation mechanism might participate in molecular and structural presynaptic remodeling during synaptic plasticity.	[Schroeder, Markus S.; Stellmacher, Anne; Romorini, Stefano; Marini, Claudia; Montenegro-Venegas, Carolina; Altrock, Wilko D.; Gundelfinger, Eckart D.; Fejtova, Anna] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany; [Altrock, Wilko D.; Gundelfinger, Eckart D.] Ctr Behav Brain Sci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN)	Gundelfinger, ED (corresponding author), Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany.	eckart.gundelfinger@lin-magdeburg.de; Anna.Fejtova@lin-magdeburg.de	Fejtova, Anna/AAZ-1024-2020; Fejtova, Anna/E-6343-2015	Fejtova, Anna/0000-0002-1815-4409	DFG-SFB [779]; EC [222918]; European Regional Development Fonds and the Land Saxony-Anhalt [EFRE/LSA 2007-2013]	DFG-SFB(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fonds and the Land Saxony-Anhalt	This study was supported by DFG-SFB 779, the EC contract number 222918 (REPLACES) FP7 - Thematic priority HEALTH to EDG and the European Regional Development Fonds and the Land Saxony-Anhalt (EFRE/LSA 2007-2013) to EDG and AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dresbach T, 2006, J BIOL CHEM, V281, P6038, DOI 10.1074/jbc.M508784200; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Fejtova Anna, 2006, V43, P49, DOI 10.1007/012; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Finlin BS, 1999, ARCH BIOCHEM BIOPHYS, V368, P401, DOI 10.1006/abbi.1999.1316; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Gundelfinger ED, 2012, CURR OPIN NEUROBIOL, V22, P423, DOI 10.1016/j.conb.2011.10.005; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; ISOBE T, 1991, J MOL BIOL, V217, P125, DOI 10.1016/0022-2836(91)90616-E; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; Kaeser PS, 2009, NEURON, V64, P227, DOI 10.1016/j.neuron.2009.09.019; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Lanore F, 2010, J PHYSIOL-LONDON, V588, P2133, DOI 10.1113/jphysiol.2009.184929; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Maas C, 2012, J NEUROSCI, V32, P11095, DOI 10.1523/JNEUROSCI.0195-12.2012; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Matz J, 2010, P NATL ACAD SCI USA, V107, P8836, DOI 10.1073/pnas.0906087107; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Sgobio C, 2010, BIOL PSYCHIAT, V67, P567, DOI 10.1016/j.biopsych.2009.11.008; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; TRINIDAD JC, 2006, MOL CELL PROTEOMICS; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; Wang XW, 2009, J NEUROSCI, V29, P12584, DOI 10.1523/JNEUROSCI.1255-09.2009; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Weyhersmuller A, 2011, J NEUROSCI, V31, P6041, DOI 10.1523/JNEUROSCI.6698-10.2011; Wu M, 2006, ANAL BIOCHEM, V349, P186, DOI 10.1016/j.ab.2005.11.030; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang Y, 2010, J NEUROSCI, V30, P2542, DOI 10.1523/JNEUROSCI.4285-09.2010; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	65	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58814	10.1371/journal.pone.0058814	http://dx.doi.org/10.1371/journal.pone.0058814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516560	Green Submitted, gold, Green Published			2022-12-27	WOS:000316407400065
J	Thakur, PB; Vaughn-Diaz, VL; Greenwald, JW; Gross, DC				Thakur, Poulami Basu; Vaughn-Diaz, Vanessa L.; Greenwald, Jessica W.; Gross, Dennis C.			Characterization of Five ECF Sigma Factors in the Genome of Pseudomonas syringae pv. syringae B728a	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; TOMATO DC3000; ESCHERICHIA-COLI; LEAF SURFACES; PHASEOLICOLA 1448A; ALGINATE SYNTHESIS; CHROMOSOMAL GENES; HRPL REGULON; AERUGINOSA; IDENTIFICATION	Pseudomonas syringae pv. syringae B728a, a bacterial pathogen of bean, utilizes large surface populations and extracellular signaling to initiate a fundamental change from an epiphytic to a pathogenic lifestyle. Extracytoplasmic function (ECF) sigma (s) factors serve as important regulatory factors in responding to various environmental signals. Bioinformatic analysis of the B728a genome revealed 10 ECF sigma factors. This study analyzed deletion mutants of five previously uncharacterized ECF sigma factor genes in B728a, including three FecI-type ECF sigma factors (ECF5, ECF6, and ECF7) and two ECF sigma factors placed in groups ECF11 and ECF18. Transcriptional profiling by qRT-PCR analysis of ECF sigma factor mutants was used to measure expression of their associated anti-sigma and outer membrane receptor proteins, and expression of genes associated with production of extracellular polysaccharides, fimbriae, glycine betaine and syringomycin. Notably, the B728aDecf7 mutant displayed reduced swarming and had decreased expression of CupC fimbrial genes. Growth and pathogenicity assays, using a susceptible bean host, revealed that none of the tested sigma factor genes are required for in planta growth and lesion formation.	[Thakur, Poulami Basu; Vaughn-Diaz, Vanessa L.; Greenwald, Jessica W.; Gross, Dennis C.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gross, DC (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	d-gross@tamu.edu			Texas A&M University AgriLife Research project [H-8832]	Texas A&M University AgriLife Research project	This work was supported by Texas A&M University AgriLife Research project no. H-8832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Brinkman FSL, 1999, J BACTERIOL, V181, P4746, DOI 10.1128/JB.181.16.4746-4754.1999; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Burch AY, 2012, J BACTERIOL, V194, P1287, DOI 10.1128/JB.06058-11; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Butcher BG, 2011, J BACTERIOL, V193, P4598, DOI 10.1128/JB.00340-11; Chatterjee A, 2007, APPL ENVIRON MICROB, V73, P3684, DOI 10.1128/AEM.02445-06; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dufour YS, 2008, J MOL BIOL, V383, P713, DOI 10.1016/j.jmb.2008.08.017; Duque E, 2007, J BACTERIOL, V189, P207, DOI 10.1128/JB.00950-06; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Firoved AM, 2002, J BACTERIOL, V184, P1057, DOI 10.1128/jb.184.4.1057-1064.2002; Greenwald JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034804; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; House BL, 2004, APPL ENVIRON MICROB, V70, P2806, DOI 10.1128/AEM.70.5.2806-2815.2004; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jones AM, 2011, J BACTERIOL, V193, P2767, DOI 10.1128/JB.00069-10; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Keith LMW, 1999, J BACTERIOL, V181, P7176, DOI 10.1128/JB.181.23.7176-7184.1999; KIDAMBI SP, 1995, APPL ENVIRON MICROB, V61, P2172, DOI 10.1128/AEM.61.6.2172-2179.1995; KING EO, 1954, J LAB CLIN MED, V44, P301; Kinscherf TG, 1999, J BACTERIOL, V181, P4133, DOI 10.1128/JB.181.13.4133-4136.1999; Kitten T, 1998, MOL MICROBIOL, V28, P917, DOI 10.1046/j.1365-2958.1998.00842.x; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Laue H, 2006, MICROBIOL-SGM, V152, P2909, DOI 10.1099/mic.0.28875-0; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Loper JE, 2007, PHYTOPATHOLOGY, V97, P233, DOI 10.1094/PHYTO-97-2-0233; Marco ML, 2005, ENVIRON MICROBIOL, V7, P1379, DOI 10.1111/j.1462-2920.2005.00825.x; Markel E, 2013, APPL ENVIRON MICROB, V79, P725, DOI 10.1128/AEM.02801-12; Martinez-Bueno MA, 2002, ENVIRON MICROBIOL, V4, P842, DOI 10.1046/j.1462-2920.2002.00371.x; Matsumoto A, 2009, APPL ENVIRON MICROB, V75, P1679, DOI 10.1128/AEM.00024-09; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Monier JM, 2005, MICROB ECOL, V49, P343, DOI 10.1007/s00248-004-0007-9; Oguiza JA, 2005, TRENDS MICROBIOL, V13, P565, DOI 10.1016/j.tim.2005.10.005; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Owen JG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-218; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; PenalozaVazquez A, 1997, J BACTERIOL, V179, P4464, DOI 10.1128/jb.179.14.4464-4472.1997; Poole K, 2003, FRONT BIOSCI-LANDMRK, V8, pD661, DOI 10.2741/1051; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; Records AR, 2010, J BACTERIOL, V192, P3584, DOI 10.1128/JB.00114-10; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; SAWAHEL W, 1993, BIOTECHNOL TECH, V7, P261, DOI 10.1007/BF00150895; Schenk A, 2008, MICROBIOL-SGM, V154, P413, DOI 10.1099/mic.0.2007/012864-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; Scholz-Schroeder BK, 2001, MOL PLANT MICROBE IN, V14, P336, DOI 10.1094/MPMI.2001.14.3.336; Staron A, 2010, MICROBE, V5, P164; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; VIDAVER AK, 1967, APPL MICROBIOL, V15, P1523, DOI 10.1128/AEM.15.6.1523-1524.1967; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Wang N, 2006, MOL PLANT MICROBE IN, V19, P257, DOI 10.1094/MPMI-19-0257; Wang N, 2006, J BACTERIOL, V188, P160, DOI 10.1128/JB.188.1.160-168.2006; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yamamoto S, 2009, GENE, V438, P57, DOI 10.1016/j.gene.2009.02.015; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	73	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58846	10.1371/journal.pone.0058846	http://dx.doi.org/10.1371/journal.pone.0058846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516563	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400067
J	Chou, CH; Doong, ML; Fuh, JL; Wu, JC; Wang, SJ				Chou, Chi-Hsiang; Doong, Ming-Luen; Fuh, Jong-Ling; Wu, Jaw-Ching; Wang, Shuu-Jiun			Queckenstedt's Test Affects More than Jugular Venous Congestion in Rat	PLOS ONE			English	Article							DRAINAGE	Jugular venous compression by the Queckenstedt's test (Q-test) increases the intracranial pressure, but the effects of isolated jugular venous congestion are not well known. Intraventricular pressure (IVP) was compared during direct obstruction of the common jugular veins (bilateral CJV clipping) and during external compression of bilateral CJV flows (Q-test) in a rat model. Intracerebroventricular catheters were inserted into the right lateral ventricle of nine male Sprague-Dawley rats (371.1 +/- 44.8 g, 82.2 +/- 12.0 days old). The initial mean IVP, arterial pressure (MAP), and pulse rate were 2.8 +/- 1.3 mmHg, 88.8 +/- 12.7 mmHg, and 348.3 +/- 69.1 beats/min, respectively. The mean IVP increment and MAP decrement were 6.5 +/- 2.5 and 13.5 +/- 5.7 mmHg, respectively, during the Q-test, compared to 2.3 +/- 1.5 and 7.3 +/- 3.8 mmHg, respectively, during bilateral CJV clipping (all p = 0.008). The IVP increment and MAP decrement were greater during the Q-test than during bilateral CJV clipping (p = 0.008 and p = 0.038). Although the Q-test and bilateral CJV clipping showed similar effects, the response with the Q-test was greater. Thus, the Q-test appears to obstruct other collateral cerebral veins in addition to bilateral CJV flows. Since this model revealed significant differences between the manual Q-test and bilateral CJV clipping, the finding should be taken into account in future studies on the Q-test in SD rats.	[Chou, Chi-Hsiang] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Chou, Chi-Hsiang] Taipei Vet Gen Hosp, Dept Neurol, Su Ao & Yuanshan Branch, Yi Lan, Taiwan; [Chou, Chi-Hsiang] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei 112, Taiwan; [Doong, Ming-Luen] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Natl Yang Ming Univ, Sch Med, Dept Neurol, Inst Brain Sci, Taipei 112, Taiwan; [Fuh, Jong-Ling; Wang, Shuu-Jiun] Natl Yang Ming Univ, Sch Med, Brain Res Ctr, Taipei 112, Taiwan; [Wu, Jaw-Ching] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Wu, Jaw-Ching] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	Taichung Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Doong, ML (corresponding author), Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan.	doong@ym.edu.tw; sjwang@vghtpe.gov.tw		zhou, qi xiang/0000-0001-6829-2538; Fuh, Jong-Ling/0000-0001-9135-3351; Wang, Shuu-Jiun/0000-0001-5179-5358	Taipei Veterans General Hospital Su-Ao and Yuanshan Branch, Taiwan National Science Council [98-2314-B-010-019-MY2]; Taipei Veterans General Hospital [VGHUST100-G7-1-1, V100C-087]; NSC support for Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 99-2911-I-008-100]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	Taipei Veterans General Hospital Su-Ao and Yuanshan Branch, Taiwan National Science Council; Taipei Veterans General Hospital(Taipei Veterans General Hospital); NSC support for Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported in part by grants from Taipei Veterans General Hospital Su-Ao and Yuanshan Branch, Taiwan National Science Council (98-2314-B-010-019-MY2), Taipei Veterans General Hospital (VGHUST100-G7-1-1, V100C-087), NSC support for Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 99-2911-I-008-100) and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayling John, 2002, Emerg Med Serv, V31, P42; Chou CH, 2009, CEPHALALGIA, V29, P373, DOI 10.1111/j.1468-2982.2008.01746.x; Chou CH, 2004, CEPHALALGIA, V24, P973, DOI 10.1111/j.1468-2982.2004.00781.x; Chou CH, 2011, ULTRASOUND MED BIOL, V37, P23, DOI 10.1016/j.ultrasmedbio.2010.10.018; Doepp F, 2003, HEADACHE, V43, P96, DOI 10.1046/j.1526-4610.2003.03024.x; Goldman J, 2007, AM J PHYSIOL-HEART C, V292, pH928, DOI 10.1152/ajpheart.00821.2006; Haerer AF, 1992, DEJONGS NEUROLOGIC E, P763; KOSTER M., 1961, ACTA PSYCHIAT ET NEUROL SCAND, V36, P347, DOI 10.1111/j.1600-0447.1961.tb01050.x; MILLER J D, 1987, Neurological Research, V9, P198; MILLER J D, 1987, Neurological Research, V9, P193; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pearce JMS, 2006, J NEUROL NEUROSUR PS, V77, P728, DOI 10.1136/jnnp.2005.083618; Queckenstedt, 1916, DEUTSCH Z NERVENHEIL, V55, P325, DOI [10.1007/BF01733057, DOI 10.1007/BF01733057]; Schreiber SJ, 2003, J APPL PHYSIOL, V94, P1802, DOI 10.1152/japplphysiol.00782.2002; Su DS, 2005, ACTA ANAESTH SCAND, V49, P1172, DOI 10.1111/j.1399-6576.2005.00747.x; SZABO K, 1995, ANN ANAT, V177, P313, DOI 10.1016/S0940-9602(11)80371-7	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e59409	10.1371/journal.pone.0059409	http://dx.doi.org/10.1371/journal.pone.0059409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516633	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200147
J	Deng, JY; Su, SC; Lin, XD; Hassett, DJ; Lu, LJ				Deng, Jingyuan; Su, Shengchang; Lin, Xiaodong; Hassett, Daniel J.; Lu, Long Jason			A Statistical Framework for Improving Genomic Annotations of Prokaryotic Essential Genes	PLOS ONE			English	Article							PREDICTING ESSENTIAL GENES; TRANSPOSON MUTANT LIBRARY; FLUX-BALANCE ANALYSIS; PSEUDOMONAS-AERUGINOSA; IDENTIFICATION; MUTAGENESIS; DELETION; RECONSTRUCTION; VIRULENCE; INSERTION	Large-scale systematic analysis of gene essentiality is an important step closer toward unraveling the complex relationship between genotypes and phenotypes. Such analysis cannot be accomplished without unbiased and accurate annotations of essential genes. In current genomic databases, most of the essential gene annotations are derived from whole-genome transposon mutagenesis (TM), the most frequently used experimental approach for determining essential genes in microorganisms under defined conditions. However, there are substantial systematic biases associated with TM experiments. In this study, we developed a novel Poisson model-based statistical framework to simulate the TM insertion process and subsequently correct the experimental biases. We first quantitatively assessed the effects of major factors that potentially influence the accuracy of TM and subsequently incorporated relevant factors into the framework. Through iteratively optimizing parameters, we inferred the actual insertion events occurred and described each gene's essentiality on probability measure. Evaluated by the definite mapping of essential gene profile in Escherichia coli, our model significantly improved the accuracy of original TM datasets, resulting in more accurate annotations of essential genes. Our method also showed encouraging results in improving subsaturation level TM datasets. To test our model's broad applicability to other bacteria, we applied it to Pseudomonas aeruginosa PAO1 and Francisella tularensis novicida TM datasets. We validated our predictions by literature as well as allelic exchange experiments in PAO1. Our model was correct on six of the seven tested genes. Remarkably, among all three cases that our predictions contradicted the TM assignments, experimental validations supported our predictions. In summary, our method will be a promising tool in improving genomic annotations of essential genes and enabling large-scale explorations of gene essentiality. Our contribution is timely considering the rapidly increasing essential gene sets. A Webserver has been set up to provide convenient access to this tool. All results and source codes are available for download upon publication at http://research.cchmc.org/essentialgene/.	[Deng, Jingyuan; Lu, Long Jason] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH USA; [Deng, Jingyuan; Lu, Long Jason] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Su, Shengchang; Hassett, Daniel J.] Univ Cincinnati, Dept Biochem & Mol Genet, Cincinnati, OH USA; [Lu, Long Jason] Univ Cincinnati, Dept Comp Sci, Cincinnati, OH 45221 USA; [Lin, Xiaodong] Rutgers State Univ, Dept Management Sci & Informat Syst, Piscataway, NJ USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Rutgers State University New Brunswick	Lu, LJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH USA.	long.lu@cchmc.org	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022		CCHMC Trustee Award; Cystic Fibrosis Foundation [HASSETT07G0, R457-CR01]	CCHMC Trustee Award; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by the CCHMC Trustee Award to LJL; and Cystic Fibrosis Foundation grants HASSETT07G0 and R457-CR01 to DJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Balakrishnan N, 2000, ADV STOCHASTIC SIMUL, Vxxvi; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Berg DE, 1989, MOBILE DNA, Vxii; Blades NJ, 2002, MS0220 J HOPK U DEP; Bruccoleri RE, 1998, NUCLEIC ACIDS RES, V26, P4482, DOI 10.1093/nar/26.19.4482; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Chen Y, 2005, BIOINFORMATICS, V21, P575, DOI 10.1093/bioinformatics/bti058; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Deng JY, 2012, BIOMOLECULES, V2, P1, DOI 10.3390/biom2010001; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; GOOD IJ, 1986, STAT SCI, V1, P157, DOI 10.1214/ss/1177013690; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hamer L, 2001, CURR OPIN CHEM BIOL, V5, P67, DOI 10.1016/S1367-5931(00)00162-9; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Imam S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-116; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Joyce Andrew R., 2008, V416, P433, DOI 10.1007/978-1-59745-321-9_30; Judson N, 2000, TRENDS MICROBIOL, V8, P521, DOI 10.1016/S0966-842X(00)01865-5; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lamichhane G, 2011, MBIO, V2, DOI 10.1128/mBio.00301-10; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lehmann EL, 1998, THEORY POINT ESTIMAT, Vxxvi; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mendum TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r127; Molina-Henares MA, 2010, ENVIRON MICROBIOL; Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08; Mushegian A, 1999, CURR OPIN GENET DEV, V9, P709, DOI 10.1016/S0959-437X(99)00023-4; Perumal D, 2011, J DRUG TARGET, V19, P1, DOI 10.3109/10611861003649753; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Ross SM, 1996, STOCHASTIC PROCESSES, Vxv; Saha S, 2006, GENET MOL RES, V5, P224; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Soemphol W, 2011, BIOSCI BIOTECH BIOCH, V75, P1921, DOI 10.1271/bbb.110310; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Stahl M, 2011, FUNCT INTEGR GENOMIC, V11, P241, DOI 10.1007/s10142-011-0214-7; Sundin C, 2004, MICROB PATHOGENESIS, V37, P313, DOI 10.1016/j.micpath.2004.10.005; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zolman J., 1993, BIOSTATISTICS EXPT D	54	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58178	10.1371/journal.pone.0058178	http://dx.doi.org/10.1371/journal.pone.0058178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520492	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900051
J	Gao, Y; Li, LP; Chan, EYY; Lau, J; Griffiths, SM				Gao, Yang; Li, Liping; Chan, Emily Y. Y.; Lau, Joseph; Griffiths, Sian M.			Parental Migration, Self-Efficacy and Cigarette Smoking among Rural Adolescents in South China	PLOS ONE			English	Article							BEHAVIOR; FAMILY; TOBACCO	Objectives: Millions of children and adolescents in rural China are left behind as their parents move away for work. Little is known about the impact of parental migration on their smoking and self-efficacy. This study explores the associations among parental migration, self-efficacy and smoking. Methods: A cross-sectional study was conducted among middle school students in Liangying Township, Guangdong, China. Socio-demographic and parental migration characteristics, as well as adolescent past 30-day smoking and self-efficacy level were collected using a self-administered questionnaire. Univariate and multivariate analyses were performed to estimate the risk of parental migration features for smoking and self-efficacy. Hierarchical regression was fitted to examine the relationship among parental migration, self-efficacy and smoking. Results: 2609 students (93.4%) participated into the study, 44% of who were with parents who had ever been or were currently migrating. Smoking prevalence was 9.7% in boys and 0.9% in girls. Paternal migration was protective for adolescent smoking, whilst maternal migration increased the risk. Both paternal and maternal migration had adverse effects on self-efficacy, a strong influencing factor for smoking. No significant relationship was found between other migration features and smoking and self-efficacy. The smoking risk of maternal migration was partly mediated by self-efficacy. There were no differences between boys and girls. Conclusions: Our findings suggest that adolescents whose mothers migrate from home to work elsewhere are at elevated risk for smoking. Improving self-efficacy may be an effective means to keep adolescents away from smoking, especially for those with maternal migration.	[Gao, Yang; Chan, Emily Y. Y.; Lau, Joseph; Griffiths, Sian M.] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Li, Liping] Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou, Peoples R China	Chinese University of Hong Kong; Shantou University	Griffiths, SM (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	siangriffiths@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017	Chan, Emily Ying Yang/0000-0002-8854-5093; Gao, Yang (Gemma)/0000-0003-0439-4804	Oxford University Li Ka Shing Foundation [BXRMXT0-004]	Oxford University Li Ka Shing Foundation	This work was supported by the Oxford University Li Ka Shing Foundation [BXRMXT0-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2009, J ADOLESCENT HEALTH, V45, P402, DOI 10.1016/j.jadohealth.2009.02.004; Avenevoli S, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1360-0443.98.s1.2.x; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bricker JB, 2010, PSYCHOL ADDICT BEHAV, V24, P436, DOI 10.1037/a0019800; Bureau of Statistics of Liangying Township, 2011, LIANG STAT 2010; Buttross LS, 2003, AM J MED SCI, V326, P235, DOI 10.1097/00000441-200310000-00016; Duan C., 2005, POPUL RES, V25, P29, DOI DOI 10.3969/J.ISSN.1000-6087.2005.01.004; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Gao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-56; Gilman SE, 2009, PEDIATRICS, V123, pE274, DOI 10.1542/peds.2008-2251; Grenard JL, 2006, NICOTINE TOB RES, V8, P245, DOI 10.1080/14622200600576610; Griesbach D, 2003, SOC SCI MED, V56, P41, DOI 10.1016/S0277-9536(02)00014-X; Guo Q, 2010, ADDICT BEHAV, V35, P95, DOI 10.1016/j.addbeh.2009.09.008; Harakeh Z, 2004, PREV MED, V39, P951, DOI 10.1016/j.ypmed.2004.03.036; Huang HE, 2006, S CHINA J PREV MED, V32, P51; Leung DYP, 2008, NICOTINE TOB RES, V10, P1311, DOI 10.1080/14622200802238928; Lin D, 2011, CHIN J SPEC ED, V131, P74; Meis TM, 2002, JCMC, V7; National Bureau of Statistics of China, 2010, CHIN STAT YB 2010; Otten R, 2007, J BEHAV MED, V30, P143, DOI 10.1007/s10865-006-9090-3; Turbin MS, 2006, HEALTH PSYCHOL, V25, P445, DOI 10.1037/0278-6133.25.4.445; Villanti A, 2011, ADDICT BEHAV, V36, P133, DOI 10.1016/j.addbeh.2010.08.018; Weiss JW, 2006, AM J HEALTH PROMOT, V20, P171, DOI 10.4278/0890-1171-20.3.171; Wen XZ, 2007, PREV MED, V45, P189, DOI 10.1016/j.ypmed.2007.02.009; Wen YB, 1999, GUANGDONG J HLTH EPI, V25, P1; World Health Organization, 2019, WHO REPORT GLOBAL TO; Yang GH, 2004, INT J EPIDEMIOL, V33, P1103, DOI 10.1093/ije/dyh225; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Zeng S, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P134	29	15	15	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57569	10.1371/journal.pone.0057569	http://dx.doi.org/10.1371/journal.pone.0057569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520474	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900033
J	Jhas, B; Sriskanthadevan, S; Skrtic, M; Sukhai, MA; Voisin, V; Jitkova, Y; Gronda, M; Hurren, R; Laister, RC; Bader, GD; Minden, MD; Schimmer, AD				Jhas, Bozhena; Sriskanthadevan, Shrivani; Skrtic, Marko; Sukhai, Mahadeo A.; Voisin, Veronique; Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Laister, Rob C.; Bader, Gary D.; Minden, Mark D.; Schimmer, Aaron D.			Metabolic Adaptation to Chronic Inhibition of Mitochondrial Protein Synthesis in Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CYTOTOXICITY ASSAY; ANTICANCER-DRUG; LACTIC-ACIDOSIS; COMPLEX-III; FACTOR-I; DNA; TRANSLATION; TISSUES; MECHANISM	Recently, we demonstrated that the anti-bacterial agent tigecycline preferentially induces death in leukemia cells through the inhibition of mitochondrial protein synthesis. Here, we sought to understand mechanisms of resistance to tigecycline by establishing a leukemia cell line resistant to the drug. TEX leukemia cells were treated with increasing concentrations of tigecycline over 4 months and a population of cells resistant to tigecycline (RTEX+TIG) was selected. Compared to wild type cells, RTEX+TIG cells had undetectable levels of mitochondrially translated proteins Cox-1 and Cox-2, reduced oxygen consumption and increased rates of glycolysis. Moreover, RTEX+TIG cells were more sensitive to inhibitors of glycolysis and more resistant to hypoxia. By electron microscopy, RTEX+TIG cells had abnormally swollen mitochondria with irregular cristae structures. RNA sequencing demonstrated a significant over-representation of genes with binding sites for the HIF1 alpha:HIF1 beta transcription factor complex in their promoters. Upregulation of HIF1a mRNA and protein in RTEX+TIG cells was confirmed by Q-RTPCR and immunoblotting. Strikingly, upon removal of tigecycline from RTEX+TIG cells, the cells reestablished aerobic metabolism. Levels of Cox-1 and Cox-2, oxygen consumption, glycolysis, mitochondrial mass and mitochondrial membrane potential returned to wild type levels, but HIF1a remained elevated. However, upon re-treatment with tigecycline for 72 hours, the glycolytic phenotype was re-established. Thus, we have generated cells with a reversible metabolic phenotype by chronic treatment with an inhibitor of mitochondrial protein synthesis. These cells will provide insight into cellular adaptations used to cope with metabolic stress.	[Jhas, Bozhena; Sriskanthadevan, Shrivani; Skrtic, Marko; Sukhai, Mahadeo A.; Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Laister, Rob C.; Minden, Mark D.; Schimmer, Aaron D.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Jhas, Bozhena; Sriskanthadevan, Shrivani; Skrtic, Marko; Sukhai, Mahadeo A.; Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Laister, Rob C.; Minden, Mark D.; Schimmer, Aaron D.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Voisin, Veronique; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Schimmer, AD (corresponding author), Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada.	aaron.schimmer@utoronto.ca	Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861; Schimmer, Aaron/0000-0003-4023-3899; Pirahas, Shrivani/0000-0002-6361-4769	Canadian Stem Cell Network; Leukemia and Lymphoma Society; National Institutes of Health [NCI 1R01CA157456]; Ontario Ministry of Research and Innovation; Princess Margaret Hospital Foundation; Ministry of Long Term Health; U.S. National Institutes of Health [U.S. National Institutes of Health grant GM103504]; Ontario Graduate Scholarship; Canadian Institutes of Health Research Post-Doctoral Fellow; Leukemia and Lymphoma Society Scholar in clinical research; NATIONAL CANCER INSTITUTE [R01CA157456, R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	Canadian Stem Cell Network; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Princess Margaret Hospital Foundation; Ministry of Long Term Health; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research Post-Doctoral Fellow; Leukemia and Lymphoma Society Scholar in clinical research(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Stem Cell Network, the Leukemia and Lymphoma Society, the National Institutes of Health (NCI 1R01CA157456), the Ontario Institute of Cancer Research with funding provided by the Ontario Ministry of Research and Innovation, the Princess Margaret Hospital Foundation, and the Ministry of Long Term Health and Planning in the Province of Ontario and U.S. National Institutes of Health grant GM103504 (GDB). B.J. is supported by Ontario Graduate Scholarship. M.A.S. is a Canadian Institutes of Health Research Post-Doctoral Fellow. A.D.S. is a Leukemia and Lymphoma Society Scholar in clinical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BIRCHMACHIN MA, 1989, PEDIATR RES, V25, P553, DOI 10.1203/00006450-198905000-00025; Chen R, 2011, ONCOGENE, V30, P2570, DOI 10.1038/onc.2010.623; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jung C, 2000, ANAL BIOCHEM, V286, P214, DOI 10.1006/abio.2000.4813; Kaplan NO, 1955, METHODS ENZYMOOGY; Kim HM, 1996, J PHARMACOL TOXICOL, V36, P163; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KRAHENBUHL S, 1994, CLIN CHIM ACTA, V230, P177, DOI 10.1016/0009-8981(94)90270-4; Lo S, 2005, INT J ONCOL, V27, P337; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Olson MW, 2006, ANTIMICROB AGENTS CH, V50, P2156, DOI 10.1128/AAC.01499-05; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Rorbach J, 2007, BIOCHEM SOC T, V35, P1290, DOI 10.1042/BST0351290; Schimmer AD, 2006, CANCER RES, V66, P2367, DOI 10.1158/0008-5472.CAN-05-1061; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; ZHENG X, 1989, NEUROLOGY, V39, P1203, DOI 10.1212/WNL.39.9.1203	37	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58367	10.1371/journal.pone.0058367	http://dx.doi.org/10.1371/journal.pone.0058367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520503	gold, Green Submitted, Green Published			2022-12-27	WOS:000318679900062
J	Miyauchi, C; Kitazawa, D; Ando, I; Hayashi, D; Inoue, YH				Miyauchi, Chie; Kitazawa, Daishi; Ando, Itaru; Hayashi, Daisuke; Inoue, Yoshihiro H.			Orbit/CLASP Is Required for Germline Cyst Formation through Its Developmental Control of Fusomes and Ring Canals in Drosophila Males	PLOS ONE			English	Article							ASYMMETRIC STEM-CELL; OOCYTE DIFFERENTIATION; MICROTUBULE NETWORK; MITOTIC SPINDLES; CONTRACTILE RING; PROTEINS; ORIENTATION; DIVISIONS; SPECTRIN; SPECIFICATION	Orbit, a Drosophila ortholog of microtubule plus-end enriched protein CLASP, plays an important role in many developmental processes involved in microtubule dynamics. Previous studies have shown that Orbit is required for asymmetric stem cell division and cystocyte divisions in germline cysts and for the development of microtubule networks that interconnect oocyte and nurse cells during oogenesis. Here, we examined the cellular localization of Orbit and its role in cyst formation during spermatogenesis. In male germline stem cells, distinct localization of Orbit was first observed on the spectrosome, which is a spherical precursor of the germline-specific cytoskeleton known as the fusome. In dividing stem cells and spermatogonia, Orbit was localized around centrosomes and on kinetochores and spindle microtubules. After cytokinesis, Orbit remained localized on ring canals, which are cytoplasmic bridges between the cells. Thereafter, it was found along fusomes, extending through the ring canal toward all spermatogonia in a cyst. Fusome localization of Orbit was not affected by microtubule depolymerization. Instead, our fluorescence resonance energy transfer experiments suggested that Orbit is closely associated with F-actin, which is abundantly found in fusomes. Surprisingly, F-actin depolymerization influenced neither fusome organization nor Orbit localization on the germline-specific cytoskeleton. We revealed that two conserved regions of Orbit are required for fusome localization. Using orbit hypomorphic mutants, we showed that the protein is required for ring canal formation and for fusome elongation mediated by the interaction of newly generated fusome plugs with the pre-existing fusome. The orbit mutation also disrupted ring canal clustering, which is essential for folding of the spermatogonia after cytokinesis. Orbit accumulates around centrosomes at the onset of spermatogonial mitosis and is required for the capture of one of the duplicated centrosomes onto the fusome. Moreover, Orbit is involved in the proper orientation of spindles towards fusomes during synchronous mitosis of spermatogonial cysts.	[Miyauchi, Chie; Kitazawa, Daishi; Ando, Itaru; Hayashi, Daisuke; Inoue, Yoshihiro H.] Kyoto Inst Technol, Grad Sch Sci & Technol, Insect Biomed Res Ctr, Kyoto 606, Japan	Kyoto Institute of Technology	Inoue, YH (corresponding author), Kyoto Inst Technol, Grad Sch Sci & Technol, Insect Biomed Res Ctr, Kyoto 606, Japan.	yhinoue@kit.ac.jp			 [2301301501];  [2357000400]	; 	This work was supported by Grants-in-Aid for Scientific Research on Priority Area in Japan to YHI (2301301501) and for Scientific Research (C) to YHI (2357000400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Aonuma M, 2005, CELL STRUCT FUNCT, V30, P7, DOI 10.1247/csf.30.7; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; deCuevas M, 1996, DEVELOPMENT, V122, P3959; DENG HY, 1995, J CELL BIOL, V128, P71, DOI 10.1083/jcb.128.1.71; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fuller Margaret T., 1993, P71; Giansanti MG, 1998, GENE DEV, V12, P396, DOI 10.1101/gad.12.3.396; Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Hime GR, 1996, J CELL SCI, V109, P2779; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Inoue YH, 2004, J CELL BIOL, V166, P49, DOI 10.1083/jcb.200402052; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Inoue YH, 2012, INTECH; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kitazawa D, 2012, J CELL SCI, V125, P3649, DOI 10.1242/jcs.103317; Lee KS, 2010, INSECT MOL BIOL, V19, P131, DOI 10.1111/j.1365-2583.2009.00955.x; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Li MG, 1999, J CELL BIOL, V146, P1061, DOI 10.1083/jcb.146.5.1061; Lighthouse DV, 2008, DEV BIOL, V317, P59, DOI 10.1016/j.ydbio.2008.02.009; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu Z, 1999, DEVELOPMENT, V126, P4477; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Mathe E, 2003, DEVELOPMENT, V130, P901, DOI 10.1242/dev.00315; McGrail M, 1997, DEVELOPMENT, V124, P2409; Montembault E, 2010, J CELL BIOL, V191, P1351, DOI 10.1083/jcb.201007060; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; Roper K, 2004, CURR BIOL, V14, P99, DOI 10.1016/j.cub.2003.12.056; Roper K, 2007, J CELL SCI, V120, P1081, DOI 10.1242/jcs.03407; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Spradling Allan C., 1993, P1; Tates AD, 1971, THESIS RIJKSUNIVERSI; Tilney LG, 1996, J CELL BIOL, V133, P61, DOI 10.1083/jcb.133.1.61; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Wilson PG, 1999, CURR BIOL, V9, P923, DOI 10.1016/S0960-9822(99)80400-X; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313; Yuan HB, 2012, DEV BIOL, V361, P57, DOI 10.1016/j.ydbio.2011.10.010; YUE L, 1992, GENE DEV, V6, P2443, DOI 10.1101/gad.6.12b.2443	53	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58220	10.1371/journal.pone.0058220	http://dx.doi.org/10.1371/journal.pone.0058220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520495	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900054
J	Lagopoulos, J; Hermens, DF; Hatton, SN; Tobias-Webb, J; Griffiths, K; Naismith, SL; Scott, EM; Hickie, IB				Lagopoulos, Jim; Hermens, Daniel F.; Hatton, Sean N.; Tobias-Webb, Juliette; Griffiths, Kristi; Naismith, Sharon L.; Scott, Elizabeth M.; Hickie, Ian B.			Microstructural White Matter Changes in the Corpus Callosum of Young People with Bipolar Disorder: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; MULTIPLE-SCLEROSIS; RATING-SCALE; SPINAL-CORD; SCHIZOPHRENIA; ABNORMALITIES; INTEGRITY; DEPRESSION; MANIA; RISK	To date, most studies of white matter changes in Bipolar Disorder (BD) have been conducted in older subjects and with well-established disorders. Studies of young people who are closer to their illness onset may help to identify core neurobiological characteristics and separate these from consequences of repeated illness episodes or prolonged treatment. Diffusion tensor imaging (DTI) was used to examine white matter microstructural changes in 58 young patients with BD (mean age 23 years; range 16-30 years) and 40 controls. Whole brain voxelwise measures of fractional anisotropy (FA), parallel diffusivity (lambda//) and radial diffusivity (lambda perpendicular to) were calculated for all subjects. White matter microstructure differences (decreased FA corrected p<.05) were found between the patients with BD and controls in the genu, body and splenium of the corpus callosum as well as the superior and anterior corona radiata. In addition, significantly increased radial diffusivity (p<.01) was found in the BD group. Neuroimaging studies of young patients with BD may help to clarify neurodevelopmental aspects of the illness and for identifying biomarkers of disease onset and progression. Our findings provide evidence of microstructural white matter changes early in the course of illness within the corpus callosum and the nature of these changes suggest they are associated with abnormalities in the myelination of axons.	[Lagopoulos, Jim; Hermens, Daniel F.; Hatton, Sean N.; Tobias-Webb, Juliette; Griffiths, Kristi; Naismith, Sharon L.; Scott, Elizabeth M.; Hickie, Ian B.] Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Camperdown, NSW, Australia	University of Sydney	Lagopoulos, J (corresponding author), Univ Sydney, Brain & Mind Res Inst, Clin Res Unit, Camperdown, NSW, Australia.	jim.lagopoulos@sydney.edu.au	Hickie, Ian B/K-8975-2015; Hatton, Sean/ABF-2549-2020; Hatton, Sean/U-5993-2019	Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Naismith, Sharon/0000-0001-9076-2778; Hatton, Sean/0000-0002-9149-8726	NHMRC [350241]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by NHMRC Program Grant (No. 350241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2006, AM J PSYCHIAT, V163, P322, DOI 10.1176/appi.ajp.163.2.322; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Angst J, 2007, BRIT J PSYCHIAT, V190, P189, DOI 10.1192/bjp.bp.106.030957; Barnea-Goraly N, 2009, BIOL PSYCHIAT, V66, P238, DOI 10.1016/j.biopsych.2009.02.025; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Benedetti F, 2011, BIOL PSYCHIAT, V69, P309, DOI 10.1016/j.biopsych.2010.07.028; Berrettini Wade, 2003, World Psychiatry, V2, P68; Brambilla P, 2003, BIOL PSYCHIAT, V54, P1294, DOI 10.1016/S0006-3223(03)00070-2; Chen CI, 2011, PEDIATR NEUROL, V44, P389, DOI 10.1016/j.pediatrneurol.2010.12.007; COFFMAN JA, 1990, BIOL PSYCHIAT, V27, P1188, DOI 10.1016/0006-3223(90)90416-Y; Cui LQ, 2011, PSYCHIAT RES-NEUROIM, V194, P347, DOI 10.1016/j.pscychresns.2011.03.010; Frazier JA, 2007, BIPOLAR DISORD, V9, P799, DOI 10.1111/j.1399-5618.2007.00482.x; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Hafeman DM, 2012, BIPOLAR DISORD, V14, P375, DOI 10.1111/j.1399-5618.2012.01023.x; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hermens DF, 2010, EARLY INTERV PSYCHIA, V4, P227, DOI 10.1111/j.1751-7893.2010.00194.x; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; James A, 2011, SCHIZOPHR RES, V128, P91, DOI 10.1016/j.schres.2011.02.014; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Klawiter EC, 2012, MULT SCLER J, V18, P1259, DOI 10.1177/1352458512436593; Macritchie KAN, 2010, BRIT J PSYCHIAT, V196, P52, DOI 10.1192/bjp.bp.108.058586; Malhi GS, 2008, BIPOLAR DISORD, V10, P943, DOI 10.1111/j.1399-5618.2008.00643.x; Merikangas KR, 2012, ARCH GEN PS IN PRESS; Moller HJ, 2003, J CLIN PSYCHIAT, V64, P23; Naismith RT, 2010, NEUROLOGY, V74, P1694, DOI 10.1212/WNL.0b013e3181e042c4; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Olley A, 2005, J NERV MENT DIS, V193, P323, DOI 10.1097/01.nmd.0000161684.35904.f4; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003; Pettigrew JD, 1998, P ROY SOC B-BIOL SCI, V265, P2141, DOI 10.1098/rspb.1998.0551; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Scott E, 2011, MED J AUSTR IN PRESS; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2013, J AFFECT DISORDERS, V144, P208, DOI 10.1016/j.jad.2012.06.031; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sprooten E, 2011, BIOL PSYCHIAT, V70, P350, DOI 10.1016/j.biopsych.2011.01.021; Starr M.A., 1903, ORGANIC NERVOUS DIS; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Uranova NA, 2004, SCHIZOPHR RES, V67, P269, DOI 10.1016/S0920-9964(03)00181-6; Vederine FE, 2011, PROG NEURO-PSYCHOPH, V35, P1820, DOI 10.1016/j.pnpbp.2011.05.009; Versace A, 2010, J AM ACAD CHILD PSY, V49, P1249, DOI 10.1016/j.jaac.2010.09.007; Wang F, 2008, BIOL PSYCHIAT, V64, P730, DOI 10.1016/j.biopsych.2008.06.001; Wang F, 2008, BRIT J PSYCHIAT, V193, P126, DOI 10.1192/bjp.bp.107.048793; Wechsler D, 2002, WECHSLER TEST ADULT; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yurgelun-Todd DA, 2007, BIPOLAR DISORD, V9, P504, DOI 10.1111/j.1399-5618.2007.00395.x; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	59	51	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59108	10.1371/journal.pone.0059108	http://dx.doi.org/10.1371/journal.pone.0059108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	125SR	23527101	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100077
J	Neumann, H; Gunther, C; Vieth, M; Grauer, M; Wittkopf, N; Mudter, J; Becker, C; Schoerner, C; Atreya, R; Neurath, MF				Neumann, Helmut; Guenther, Claudia; Vieth, Michael; Grauer, Martin; Wittkopf, Nadine; Mudter, Jonas; Becker, Christoph; Schoerner, Christoph; Atreya, Raja; Neurath, Markus F.			Confocal Laser Endomicroscopy for In Vivo Diagnosis of Clostridium difficile Associated Colitis - A Pilot Study	PLOS ONE			English	Article							EPITHELIAL GAPS; IDENTIFICATION; CLASSIFICATION	Background: Clostridium difficile infection (CDI) is one of the most dreaded causes of hospital-acquired diarrhea. Main objective was to investigate whether confocal laser endomicroscopy (CLE) has the capability for in vivo diagnosis of C. difficile associated histological changes. Second objective was to prove the presence of intramucosal bacteria using CLE. Methods: 80 patients were prospectively included, 10 patients were diagnosed with CDI based on toxigenic culture. To validate the presence of intramucosal bacteria ex vivo, CLE was performed in pure C. difficile culture; additionally fluorescence in situ hybridization (FISH) was performed. Finally, CLE with fluorescence labelled oligonucleotide probe specific for C. difficile was performed ex vivo in order to prove the presence of bacteria. Results: CLE identified CDI-associated histological changes in vivo (sensitivity and accuracy of 88.9% and 96.3%). In addition, intramucosal bacteria were visualized. The presence of these bacteria could be proven by CLE with labeled, specific molecular C. difficile probe and FISH-technique. Based on comparison between CLE and FISH analyses, sensitivity and specificity for the presence of intramucosal bacteria were 100%. Conclusion: CLE has the potential for in vivo diagnosis of CDI associated colitis. In addition, CLE allowed the detection of intramucosal bacteria in vivo.	[Neumann, Helmut; Guenther, Claudia; Grauer, Martin; Wittkopf, Nadine; Mudter, Jonas; Becker, Christoph; Atreya, Raja; Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany; [Vieth, Michael] Klinikum Bayreuth, Inst Pathol, Bayreuth, Germany; [Schoerner, Christoph] Univ Erlangen Nurnberg, Inst Microbiol Immunol & Hyg, Erlangen, Germany	University of Erlangen Nuremberg; Klinikum Bayreuth; University of Erlangen Nuremberg	Neumann, H (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany.	helmut.neumann@uk-erlangen.de	Becker, Christoph/L-2996-2016; Becker, Christoph/A-6694-2008	Becker, Christoph/0000-0002-1388-1041				AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bloedt K, 2009, J MED MICROBIOL, V58, P874, DOI 10.1099/jmm.0.009811-0; Buchner AM, 2010, GASTROENTEROLOGY, V138, pS95, DOI 10.1053/j.gastro.2009.10.053; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Gunther U, 2008, GUT, V57, P1331; Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kiesslich R, 2005, GASTROENTEROLOGY, V128, P2119, DOI 10.1053/j.gastro.2004.12.035; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Kiesslich R, 2007, GASTROENTEROLOGY, V133, P1769, DOI 10.1053/j.gastro.2007.09.011; Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leong RWL, 2008, GASTROENTEROLOGY, V135, P1870, DOI 10.1053/j.gastro.2008.08.054; Liu JJ, 2011, GASTROINTEST ENDOSC, V73, P1174, DOI 10.1016/j.gie.2011.01.018; Monkemuller K, 2006, ENDOSCOPY, V38, P546, DOI 10.1055/s-2006-925343; Monaghan T, 2008, GUT, V57, P850, DOI 10.1136/gut.2007.128157; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Moussata D, 2011, GUT, V60, P26, DOI 10.1136/gut.2010.213264; Neumann H, 2013, GUT, V62, P333, DOI 10.1136/gutjnl-2012-303121; Neumann H, 2012, INFLAMM BOWEL DIS, V18, P2261, DOI 10.1002/ibd.22907; Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029; Wallace M, 2011, ENDOSCOPY, V43, P882, DOI 10.1055/s-0030-1256632	26	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58753	10.1371/journal.pone.0058753	http://dx.doi.org/10.1371/journal.pone.0058753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527018	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562100039
J	Chang, AJ; Sohn, R; Lu, ZH; Arbeit, JM; Lapi, SE				Chang, Albert J.; Sohn, Rebecca; Lu, Zhi Hong; Arbeit, Jeffrey M.; Lapi, Suzanne E.			Detection of Rapalog-Mediated Therapeutic Response in Renal Cancer Xenografts Using Cu-64-bevacizumab ImmunoPET	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; MTOR INHIBITOR EVEROLIMUS; MAMMALIAN TARGET; CELL CARCINOMA; RAPAMYCIN; VEGF; PET; ANGIOGENESIS; METABOLISM	The importance of neovascularization for primary and metastatic tumor growth fostered numerous clinical trials of angiogenesis inhibitors either alone or in combination with conventional antineoplastic therapies. One challenge with the use of molecularly targeted agents has been the disconnection between size reduction and tumor biologic behavior, either when the drug is efficacious or when tumor resistance emerges. Here, we report the synthesis and characterization of Cu-64-NOTA-bevacizumab as a PET imaging agent for imaging intratumoral VEGF content in vivo. Cu-64-NOTA-bevacizumab avidly accumulated in 786-O renal carcinoma xenografts with lower levels in host organs. RAD001 (everolimus) markedly attenuated Cu-64-NOTA-bevacizumab accumulation within 786-O renal carcinoma xenografts. Tumor tissue and cellular molecular analysis validated PET imaging, demonstrating decreases in total and secreted VEGF content and VEGFR2 activation. Notably, Cu-64-NOTA-bevacizumab PET imaging was concordant with the growth arrest of RAD001 tumors. These data suggest that immunoPET targeting of angiogenic factors such as VEGF could be a new class of surrogate markers complementing the RECIST criteria in patients receiving molecularly targeted therapies.	[Chang, Albert J.] Washington Univ, Dept Radiat Oncol, St Louis, MO USA; [Chang, Albert J.; Lapi, Suzanne E.] Washington Univ, Dept Radiol, St Louis, MO USA; [Sohn, Rebecca; Lu, Zhi Hong; Arbeit, Jeffrey M.] Washington Univ, Dept Surg, Div Urol, St Louis, MO 63130 USA; [Arbeit, Jeffrey M.; Lapi, Suzanne E.] Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center	Arbeit, JM (corresponding author), Washington Univ, Dept Surg, Div Urol, St Louis, MO 63130 USA.	arbeitj@wustl.edu; lapis@mir.wustl.edu	Arbeit, Jeffrey/K-6920-2019	Lapi, Suzanne/0000-0003-0090-0191	NCI [R01CA159959]; Beatrice Roe Urology Research Fund; Mallinckrodt Department of Radiology; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA159959] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Beatrice Roe Urology Research Fund; Mallinckrodt Department of Radiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI R01CA159959, the Beatrice Roe Urology Research Fund, and Mallinckrodt Department of Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Mohand S, 2011, BIOCONJUGATE CHEM, V22, P1729, DOI 10.1021/bc2002665; Amato RJ, 2009, CANCER-AM CANCER SOC, V115, P2438, DOI 10.1002/cncr.24280; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Barlow AD, 2012, DIABETOLOGIA; Barwick T, 2009, NUCL MED COMMUN, V30, P908, DOI 10.1097/MNM.0b013e32832ee93b; Carew JS, 2011, TARGET ONCOL, V6, P17, DOI 10.1007/s11523-011-0167-8; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chowdhury S, 2011, HEMATOL ONCOL CLIN N, V25, P853, DOI 10.1016/j.hoc.2011.05.003; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Honer M, 2010, TRANSL ONCOL, V3, P264, DOI 10.1593/tlo.10127; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Huo YL, 2011, BIOCHEM SOC T, V39, P446, DOI 10.1042/BST0390446; Ikotun OF, 2011, FUTURE MED CHEM, V3, P599, DOI [10.4155/fmc.11.14, 10.4155/FMC.11.14]; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jain RK, 2008, NAT REV CANCER, V8, P309, DOI 10.1038/nrc2346; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Lowery A, 2012, FRONT BIOSCI, V17, P1996; Majhail NS, 2003, J CLIN ONCOL, V21, P3995, DOI 10.1200/JCO.2003.04.073; McCabe KE, 2010, CANCER BIOTHER RADIO, V25, P253, DOI 10.1089/cbr.2010.0776; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; McCubrey JA, 2011, J CELL PHYSIOL, V226, P2762, DOI 10.1002/jcp.22647; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Nagengast WB, 2011, CANCER RES, V71, P143, DOI 10.1158/0008-5472.CAN-10-1088; Nayak TK, 2011, INT J CANCER, V128, P920, DOI 10.1002/ijc.25409; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; O'Reilly T, 2010, TRANSL ONCOL, V3, P65, DOI 10.1593/tlo.09277; Oladipupo S, 2011, P NATL ACAD SCI USA, V108, P13264, DOI 10.1073/pnas.1101321108; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paudyal B, 2011, CANCER SCI, V102, P117, DOI 10.1111/j.1349-7006.2010.01763.x; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ratain MJ, 2004, J CLIN ONCOL, V22, P4442, DOI 10.1200/JCO.2004.07.960; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sadri K, 2011, NUCL MED COMMUN, V32, P563, DOI 10.1097/MNM.0b013e3283419523; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; van der Veldt AAM, 2010, TARGET ONCOL, V5, P95, DOI 10.1007/s11523-010-0146-5; Vercellino L, 2009, CANCER BIOTHER RADIO, V24, P137, DOI 10.1089/cbr.2008.0527; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Xouri G, 2010, SEMIN CELL DEV BIOL, V21, P40, DOI 10.1016/j.semcdb.2009.11.017; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zhang Y, 2012, AM J NUCL MED MOLEC, V2, P1	50	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58949	10.1371/journal.pone.0058949	http://dx.doi.org/10.1371/journal.pone.0058949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516584	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400081
J	Kanninen, KM; Grubman, A; Meyerowitz, J; Duncan, C; Tan, JL; Parker, SJ; Crouch, PJ; Paterson, BM; Hickey, JL; Donnelly, PS; Volitakis, I; Tammen, I; Palmer, DN; White, AR				Kanninen, Katja M.; Grubman, Alexandra; Meyerowitz, Jodi; Duncan, Clare; Tan, Jiang-Li; Parker, Sarah J.; Crouch, Peter J.; Paterson, Brett M.; Hickey, James L.; Donnelly, Paul S.; Volitakis, Irene; Tammen, Imke; Palmer, David N.; White, Anthony R.			Increased Zinc and Manganese in Parallel with Neurodegeneration, Synaptic Protein Changes and Activation of Akt/GSK3 Signaling in Ovine CLN6 Neuronal Ceroid Lipofuscinosis	PLOS ONE			English	Article							MITOCHONDRIAL ATP SYNTHASE; SOUTH HAMPSHIRE SHEEP; OXIDATIVE STRESS; BATTENS DISEASE; SUBUNIT-C; BRAIN; PARKINSONISM; ATP13A2; METALLOTHIONEIN; MUTATIONS	Mutations in the CLN6 gene cause a variant late infantile form of neuronal ceroid lipofuscinosis (NCL; Batten disease). CLN6 loss leads to disease clinically characterized by vision impairment, motor and cognitive dysfunction, and seizures. Accumulating evidence suggests that alterations in metal homeostasis and cellular signaling pathways are implicated in several neurodegenerative and developmental disorders, yet little is known about their role in the NCLs. To explore the disease mechanisms of CLN6 NCL, metal concentrations and expression of proteins implicated in cellular signaling pathways were assessed in brain tissue from South Hampshire and Merino CLN6 sheep. Analyses revealed increased zinc and manganese concentrations in affected sheep brain in those regions where neuroinflammation and neurodegeneration first occur. Synaptic proteins, the metal-binding protein metallothionein, and the Akt/GSK3 and ERK/MAPK cellular signaling pathways were also altered. These results demonstrate that altered metal concentrations, synaptic protein changes, and aberrant modulation of cellular signaling pathways are characteristic features in the CLN6 ovine form of NCL.	[Kanninen, Katja M.; Grubman, Alexandra; Meyerowitz, Jodi; Duncan, Clare; Tan, Jiang-Li; Parker, Sarah J.; Crouch, Peter J.; White, Anthony R.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Paterson, Brett M.; Hickey, James L.; Donnelly, Paul S.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Paterson, Brett M.; Hickey, James L.; Donnelly, Paul S.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Volitakis, Irene] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Tammen, Imke] Univ Sydney, Fac Vet Sci, ReproGen, Camden, NSW, Australia; [Palmer, David N.] Lincoln Univ, Fac Agr & Life Sci, Canterbury, New Zealand	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; Lincoln University - New Zealand	Kanninen, KM (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia.	katja.kanninen@uef.fi	Tammen, Imke/AFF-7998-2022; Grubman, Alexandra/AAD-3109-2019; Paterson, Brett M/A-2402-2016; White, Anthony/P-5596-2016	Tammen, Imke/0000-0002-5520-6597; Grubman, Alexandra/0000-0003-4408-4499; Paterson, Brett M/0000-0002-7768-811X; Volitakis, Irene/0000-0003-0766-817X; White, Anthony/0000-0003-1802-9891; Crouch, Peter/0000-0002-7777-4747	Sigrid Juselius Foundation; Academy of Finland; Paulo Foundation; Maud Kuistila Memorial Foundation; Australian Research Council ARC Future Fellowship; National Health and Medical Research Council of Australia; Neurological Foundation of New Zealand; Batten Disease Support and Research Association	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Paulo Foundation; Maud Kuistila Memorial Foundation; Australian Research Council ARC Future Fellowship(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Neurological Foundation of New Zealand; Batten Disease Support and Research Association	KMK was supported by the Sigrid Juselius Foundation, the Academy of Finland, the Paulo Foundation and the Maud Kuistila Memorial Foundation. ARW was supported by an Australian Research Council ARC Future Fellowship. This work was supported by funding from the National Health and Medical Research Council of Australia. The work at Lincoln University was supported in part by the Neurological Foundation of New Zealand and the Batten Disease Support and Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Bakirdere S, 2011, BIOL TRACE ELEM RES, V142, P492, DOI 10.1007/s12011-010-8804-0; Benedict JW, 2009, J NEUROSCI RES, V87, P2157, DOI 10.1002/jnr.22032; Bolognin S, 2009, NEUROMOL MED, V11, P223, DOI 10.1007/s12017-009-8102-1; Bowman AB, 2011, J TRACE ELEM MED BIO, V25, P191, DOI 10.1016/j.jtemb.2011.08.144; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; Dimri U, 2010, VET PARASITOL, V168, P318, DOI 10.1016/j.vetpar.2009.11.013; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009; Frugier T, 2008, NEUROBIOL DIS, V29, P306, DOI 10.1016/j.nbd.2007.09.006; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Heine C, 2003, BIOCHEM J, V376, P369, DOI 10.1042/BJ20030598; Heiskala H, 1988, Am J Med Genet Suppl, V5, P193; Hesketh S, 2007, J ANIM SCI, V85, P1596, DOI 10.2527/jas.2006-714; Himeno S, 2009, BIOCHIMIE, V91, P1218, DOI 10.1016/j.biochi.2009.04.002; Iguchi K, 2002, J ANDROL, V23, P819; JOHANSSON E, 1990, J TRACE ELEM ELECT H, V4, P139; JOLLY RD, 1989, NEUROPATH APPL NEURO, V15, P371, DOI 10.1111/j.1365-2990.1989.tb01236.x; Kay GW, 2006, BRAIN PATHOL, V16, P110, DOI 10.1111/j.1750-3639.2006.00002.x; Kay GW, 2011, NEUROBIOL DIS, V41, P614, DOI 10.1016/j.nbd.2010.11.008; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Kurian MA, 2011, DEV MED CHILD NEUROL, V53, P394, DOI 10.1111/j.1469-8749.2011.03955.x; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Lei Peng, 2011, Int J Alzheimers Dis, V2011, P189246, DOI 10.4061/2011/189246; Lin CL, 2011, CELL DEATH DIFFER, V18, P1651, DOI 10.1038/cdd.2011.80; MAYHEW IG, 1985, NEUROPATH APPL NEURO, V11, P273, DOI 10.1111/j.1365-2990.1985.tb00025.x; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Mole S., 2011, NEURONAL CEROID LIPO, DOI DOI 10.1093/MED/9780199590018.003.0018; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Mole SE, 2011, NEURONAL CEROID LIOP; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Nuttall JR, 2012, NEUROTOX RES, V21, P128, DOI 10.1007/s12640-011-9291-6; Obrenovich ME, 2011, BIOL TRACE ELEM RES, V144, P475, DOI 10.1007/s12011-011-9146-2; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Oppermann B, 2001, INVEST OPHTH VIS SCI, V42, P188; Oswald MJ, 2008, NEUROBIOL DIS, V32, P50, DOI 10.1016/j.nbd.2008.06.004; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Palmer D N, 1988, Am J Med Genet Suppl, V5, P141, DOI 10.1002/ajmg.1320310618; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Podhajska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039942; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Rider J A, 1988, Am J Med Genet Suppl, V5, P21; SAMUELSON DA, 1990, NEUROBIOL AGING, V11, P663, DOI 10.1016/0197-4580(90)90034-W; Santavuori P, 1988, Am J Med Genet Suppl, V5, P265; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; TEMPLETON DM, 1984, BIOCHEM J, V221, P569, DOI 10.1042/bj2210569; Toth K, 2011, ANNU REV NUTR, V31, P139, DOI 10.1146/annurev-nutr-072610-145218; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Velinov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029729; Wang X, 2012, J PHYSIOL BIOCHEM, V68, P563, DOI 10.1007/s13105-012-0174-y; Wohlke A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002304; Zangger K, 2001, BIOCHEM J, V359, P353, DOI 10.1042/0264-6021:3590353	63	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58644	10.1371/journal.pone.0058644	http://dx.doi.org/10.1371/journal.pone.0058644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516525	Green Published, gold			2022-12-27	WOS:000316407400044
J	Dixit, SS; Wang, TN; Manzano, EJQ; Yoo, S; Lee, J; Chiang, DY; Ryan, N; Respress, JL; Yechoor, VK; Wehrens, XHT				Dixit, Sayali S.; Wang, Tiannan; Manzano, Eiffel John Q.; Yoo, Shin; Lee, Jeongkyung; Chiang, David Y.; Ryan, Nicole; Respress, Jonathan L.; Yechoor, Vijay K.; Wehrens, Xander H. T.			Effects of CaMKII-Mediated Phosphorylation of Ryanodine Receptor Type 2 on Islet Calcium Handling, Insulin Secretion, and Glucose Tolerance	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM STRESS; PROTEIN-KINASE-II; INTRACELLULAR CA2+ STORES; HEART-FAILURE; MOUSE ISLETS; APOPTOSIS; CHANNELS; RESISTANCE; EXPRESSION	Altered insulin secretion contributes to the pathogenesis of type 2 diabetes. This alteration is correlated with altered intracellular Ca2+-handling in pancreatic beta cells. Insulin secretion is triggered by elevation in cytoplasmic Ca2+ concentration ([Ca2+](cyt)) of beta cells. This elevation in [Ca2+](cyt) leads to activation of Ca2+/calmodulin-dependent protein kinase II (CAMKII), which, in turn, controls multiple aspects of insulin secretion. CaMKII is known to phosphorylate ryanodine receptor 2 (RyR2), an intracellular Ca2+-release channel implicated in Ca2+-dependent steps of insulin secretion. Our data show that RyR2 is CaMKII phosphorylated in a pancreatic beta-cell line in a glucose-sensitive manner. However, it is not clear whether any change in CaMKII-mediated phosphorylation underlies abnormal RyR2 function in beta cells and whether such a change contributes to alterations in insulin secretion. Therefore, knock-in mice with a mutation in RyR2 that mimics its constitutive CaMKII phosphorylation, RyR2-S2814D, were studied. This mutation led to a gain-of-function defect in RyR2 indicated by increased basal RyR2-mediated Ca2+ leak in islets of these mice. This chronic in vivo defect in RyR2 resulted in basal hyperinsulinemia. In addition, S2814D mice also developed glucose intolerance, impaired glucose-stimulated insulin secretion and lowered [Ca2+](cyt) transients, which are hallmarks of pre-diabetes. The glucose-sensitive Ca2+ pool in islets from S2814D mice was also reduced. These observations were supported by immunohistochemical analyses of islets in diabetic human and mouse pancreata that revealed significantly enhanced CaMKII phosphorylation of RyR2 in type 2 diabetes. Together, these studies implicate that the chronic gain-of-function defect in RyR2 due to CaMKII hyperphosphorylation is a novel mechanism that contributes to pathogenesis of type 2 diabetes.	[Dixit, Sayali S.; Wang, Tiannan; Manzano, Eiffel John Q.; Yoo, Shin; Chiang, David Y.; Ryan, Nicole; Respress, Jonathan L.; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Lee, Jeongkyung; Yechoor, Vijay K.] Baylor Coll Med, Diabet & Endocrinol Res Ctr, Houston, TX 77030 USA; [Lee, Jeongkyung; Yechoor, Vijay K.] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Wehrens, Xander H. T.] Baylor Coll Med, Dept Med, Div Cardiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wehrens, XHT (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	wehrens@bcm.edu	Wehrens, Xander/AAQ-9574-2020; Yechoor, Vijay/AAX-3244-2021	Wehrens, Xander/0000-0001-5044-672X; Chiang, David/0000-0002-5883-6383	Muscular Dystrophy Association; National Institutes of Health (NIH) [HL089598, HL091947]; Diabetes and Endocrinology Research Center grant at Baylor College of Medicine [P30-079638]; Ruth L. Kirschstein National Research Service Award (NRSA); NIH grant [T32-HL07676-20]; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089598, R01HL117641, T32HL007676, R01HL091947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Endocrinology Research Center grant at Baylor College of Medicine; Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	XHTW is a W. M. Keck Foundation Distinguished Young Scholar in Medical Research, Established Investigator of the American Heart Association (AHA), and is supported by the Muscular Dystrophy Association and National Institutes of Health (NIH) grants HL089598 and HL091947. This work was supported in part by the Diabetes and Endocrinology Research Center grant (P30-079638) at Baylor College of Medicine. SSD was a recipient of the Ruth L. Kirschstein National Research Service Award (NRSA) supported by NIH grant T32-HL07676-20. DYC is supported by AHA predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BERGMAN RN, 1989, DIABETES, V38, P1512, DOI 10.2337/diabetes.38.12.1512; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Chen Z, 2010, FASEB J, V24, P357, DOI 10.1096/fj.09-138446; Chen-Izu Y, 2007, AM J PHYSIOL-HEART C, V293, pH2409, DOI 10.1152/ajpheart.00562.2007; Denda S, 2012, J INVEST DERMATOL, V132, P69, DOI 10.1038/jid.2011.256; Dror V, 2008, J BIOL CHEM, V283, P9909, DOI 10.1074/jbc.M710601200; Dukes ID, 1996, DIABETES, V45, P845, DOI 10.2337/diabetes.45.7.845; Dyachok O, 2001, J CELL SCI, V114, P2179; Easom RA, 1997, ENDOCRINOLOGY, V138, P2359, DOI 10.1210/en.138.6.2359; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Garcia-Perez C, 2008, J BIOL CHEM, V283, P32771, DOI 10.1074/jbc.M803385200; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Huang W, 2011, EXP EYE RES, V93, P700, DOI 10.1016/j.exer.2011.09.001; Islam MS, 2010, ADV EXP MED BIOL, V654, P235, DOI 10.1007/978-90-481-3271-3_11; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Jahanshahi P, 2009, ENDOCRINOLOGY, V150, P607, DOI 10.1210/en.2008-0773; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; Kato I, 2008, DIABETES-METAB RES, V24, P486, DOI 10.1002/dmrr.864; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Miura Y, 1997, J PHYSIOL-LONDON, V503, P387, DOI 10.1111/j.1469-7793.1997.387bh.x; Noguchi N, 2008, BIOCHEM BIOPH RES CO, V371, P735, DOI 10.1016/j.bbrc.2008.04.142; Okamoto H, 2002, DIABETES, V51, pS462, DOI 10.2337/diabetes.51.2007.S462; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; POLONSKY KS, 1995, DIABETES, V44, P705, DOI 10.2337/diabetes.44.6.705; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; ROE MW, 1994, J BIOL CHEM, V269, P18279; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Takasawa S, 2010, BIOCHEM BIOPH RES CO, V397, P140, DOI 10.1016/j.bbrc.2010.05.051; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Wehrens XHT, 2011, HEART RHYTHM, V8, P323, DOI 10.1016/j.hrthm.2010.09.079; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Wehrens XHT, 2004, NAT REV DRUG DISCOV, V3, P565, DOI 10.1038/nrd1440; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Weyer C, 2000, DIABETES, V49, P2094, DOI 10.2337/diabetes.49.12.2094; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245	60	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58655	10.1371/journal.pone.0058655	http://dx.doi.org/10.1371/journal.pone.0058655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516528	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200102
J	Basco, D; Blaauw, B; Pisani, F; Sparaneo, A; Nicchia, GP; Mola, MG; Reggiani, C; Svelto, M; Frigeri, A				Basco, Davide; Blaauw, Bert; Pisani, Francesco; Sparaneo, Angelo; Nicchia, Grazia Paola; Mola, Maria Grazia; Reggiani, Carlo; Svelto, Maria; Frigeri, Antonio			AQP4-Dependent Water Transport Plays a Functional Role in Exercise-Induced Skeletal Muscle Adaptations	PLOS ONE			English	Article							AQUAPORIN-4 EXPRESSION; MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; LOADING CONTROL; BRAIN; VOLUME; ORGANIZATION; ISOFORMS; ACTIN	In this study we assess the functional role of Aquaporin-4 (AQP4) in the skeletal muscle by analyzing whether physical activity modulates AQP4 expression and whether the absence of AQP4 has an effect on osmotic behavior, muscle contractile properties, and physical activity. To this purpose, rats and mice were trained on the treadmill for 10 (D10) and 30 (D30) days and tested with exercise to exhaustion, and muscles were used for immunoblotting, RT-PCR, and fiber-type distribution analysis. Taking advantage of the AQP4 KO murine model, functional analysis of AQP4 was performed on dissected muscle fibers and sarcolemma vesicles. Moreover, WT and AQP4 KO mice were subjected to both voluntary and forced activity. Rat fast-twitch muscles showed a twofold increase in AQP4 protein in D10 and D30 rats compared to sedentary rats. Such increase positively correlated with the animal performance, since highest level of AQP4 protein was found in high runner rats. Interestingly, no shift in muscle fiber composition nor an increase in AQP4-positive fibers was found. Furthermore, no changes in AQP4 mRNA after exercise were detected, suggesting that post-translational events are likely to be responsible for AQP4 modulation. Experiments performed on AQP4 KO mice revealed a strong impairment in osmotic responses as well as in forced and voluntary activities compared to WT mice, even though force development amplitude and contractile properties were unvaried. Our findings definitively demonstrate the physiological role of AQP4 in supporting muscle contractile activity and metabolic changes that occur in fast-twitch skeletal muscle during prolonged exercise.	[Basco, Davide; Pisani, Francesco; Sparaneo, Angelo; Nicchia, Grazia Paola; Mola, Maria Grazia; Svelto, Maria; Frigeri, Antonio] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Basco, Davide; Pisani, Francesco; Sparaneo, Angelo; Nicchia, Grazia Paola; Mola, Maria Grazia; Svelto, Maria; Frigeri, Antonio] Univ Bari, Ctr Excellence Comparat Genom CEGBA, Bari, Italy; [Blaauw, Bert] Venetian Inst Mol Med, Padua, Italy; [Blaauw, Bert; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Reggiani, Carlo] CNR, Inst Neurosci, Padua, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Veneto Institute Molecular Medicine; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Frigeri, A (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.	a.frigeri@biologia.uniba.it	Mola, Maria Grazia/I-3507-2019; PISANI, Francesco/AAC-1749-2019; frigeri, Antonio/AAC-6336-2022; Sparaneo, Angelo/B-4689-2017; blaauw, bert/A-7614-2014; Svelto, Maria/P-6186-2014	Mola, Maria Grazia/0000-0002-4421-9237; PISANI, Francesco/0000-0001-8511-117X; blaauw, bert/0000-0002-3893-1463; BLAAUW, BERT/0000-0002-4167-5106; Svelto, Maria/0000-0002-5584-9541; Basco, Davide/0000-0002-7984-5676; Frigeri, Antonio/0000-0002-5284-2934; Sparaneo, Angelo/0000-0002-3211-3072	Association Francaise Contre les Myopathies [14336]; FIRB - Rete Nazionale di Proteomica [RBRN07BMCT_009]	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); FIRB - Rete Nazionale di Proteomica	Funding was provided by the Association Francaise Contre les Myopathies (project no. 14336 to AF) and FIRB - Rete Nazionale di Proteomica (RBRN07BMCT_009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Assereto S, 2008, CELL CYCLE, V7, P2199, DOI 10.4161/cc.7.14.6272; Basco D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019225; Basco D, 2010, EUR J APPL PHYSIOL, V110, P1215, DOI 10.1007/s00421-010-1592-6; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; CRENSHAW AG, 1994, ACTA PHYSIOL SCAND, V152, P265, DOI 10.1111/j.1748-1716.1994.tb09806.x; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Fan Y, 2005, J NEUROSCI RES, V82, P458, DOI 10.1002/jnr.20664; Fathi R, 2010, REGUL PEPTIDES, V165, P133, DOI 10.1016/j.regpep.2010.05.013; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Frigeri A, 2004, FASEB J, V18, P905, DOI 10.1096/fj.03-0987fje; Frigeri A, 1998, J CLIN INVEST, V102, P695, DOI 10.1172/JCI2545; Frigeri A, 2002, FASEB J, V16, P1120, DOI 10.1096/fj.01-0797fje; FRIGERI A, 1995, J CELL SCI, V108, P2993; Frigeri A, 2001, FASEB J, V15, P90, DOI 10.1096/fj.00-0260com; Frigeri A, 2001, FASEB J, V15, P1282, DOI 10.1096/fj.00-0525fje; GREENLEAF JE, 1979, AM J PHYSIOL, V236, pR206, DOI 10.1152/ajpregu.1979.236.3.R206; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kaakinen M, 2007, CELL TISSUE RES, V329, P529, DOI 10.1007/s00441-007-0442-2; LINDINGER MI, 1994, AM J PHYSIOL, V266, pR1896, DOI 10.1152/ajpregu.1994.266.6.R1896; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Nicchia GP, 2010, NEUROSCIENCE, V168, P903, DOI 10.1016/j.neuroscience.2010.02.008; Pisani F, 2011, GLIA, V59, P1923, DOI 10.1002/glia.21234; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SCHOTLAND DL, 1981, ACTA NEUROPATHOL, V54, P189, DOI 10.1007/BF00687741; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Usher-Smith JA, 2009, BIOL REV, V84, P143, DOI 10.1111/j.1469-185X.2008.00066.x; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wakayama Y, 2002, ARCH NEUROL-CHICAGO, V59, P431, DOI 10.1001/archneur.59.3.431; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Yang BX, 2000, AM J PHYSIOL-CELL PH, V278, pC1108, DOI 10.1152/ajpcell.2000.278.6.C1108	37	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58712	10.1371/journal.pone.0058712	http://dx.doi.org/10.1371/journal.pone.0058712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520529	gold, Green Submitted, Green Published			2022-12-27	WOS:000318679900089
J	Luo, Q; Hamer, R; Reinert, G; Deane, CM				Luo, Qiang; Hamer, Rebecca; Reinert, Gesine; Deane, Charlotte M.			Local Network Patterns in Protein-Protein Interfaces	PLOS ONE			English	Article							STRUCTURALLY CONSERVED RESIDUES; HOT-SPOTS; BINDING; PREDICTION; MOTIFS; SITES; PRINCIPLES; MODEL	Protein-protein interfaces hold the key to understanding protein-protein interactions. In this paper we investigated local interaction network patterns beyond pair-wise contact sites by considering interfaces as contact networks among residues. A contact site was defined as any residue on the surface of one protein which was in contact with a residue on the surface of another protein. We labeled the sub-graphs of these contact networks by their amino acid types. The observed distributions of these labeled sub-graphs were compared with the corresponding background distributions and the results suggested that there were preferred chemical patterns of closely packed residues at the interface. These preferred patterns point to biological constraints on physical proximity between those residues on one protein which were involved in binding to residues which were close on the interacting partner. Interaction interfaces were far from random and contain information beyond pairs and triangles. To illustrate the possible application of the local network patterns observed, we introduced a signature method, called iScore, based on these local patterns to assess interface predictions. On our data sets iScore achieved 83.6% specificity with 82% sensitivity.	[Luo, Qiang] Natl Univ Def Technol, Coll Informat Syst & Management, Dept Management, Changsha, Hunan, Peoples R China; [Hamer, Rebecca; Reinert, Gesine; Deane, Charlotte M.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Hamer, Rebecca; Reinert, Gesine; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	National University of Defense Technology - China; University of Oxford; University of Oxford	Luo, Q (corresponding author), Natl Univ Def Technol, Coll Informat Syst & Management, Dept Management, Changsha, Hunan, Peoples R China.	mrqiangluo@gmail.com	Luo, Qiang/ADI-7405-2022	Luo, Qiang/0000-0002-0426-6039; Reinert, Gesine/0000-0002-0363-9470; Deane, Charlotte/0000-0003-1388-2252	BBSRC; EPSRC through OCISB; National Natural Sciences Foundation of China [11101429]; Research Fund for the Doctoral Program of Higher Education of China [20114307120019]; EPSRC [EP/K032402/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K032402/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC through OCISB(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported in part by BBSRC (www.bbsrc.ac.uk) and EPSRC (www.epsrc.ac.uk) through OCISB (www.sysbio.ox.ac.uk). QL is partially supported by National Natural Sciences Foundation of China (Grant No. 11101429) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20114307120019). Part of this work was completed while GR was visiting the Institute for Mathematical Sciences in Singapore, and the support is gratefully acknowledged. Part of this work was completed while QL was visiting the Centre for Computational Systems Biology in Fudan University, and the support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; BUCKLAND M, 1994, J AM SOC INFORM SCI, V45, P12, DOI 10.1002/(SICI)1097-4571(199401)45:1<12::AID-ASI2>3.0.CO;2-L; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Eisenhaber F, 1996, PROTEIN ENG, V9, P1121, DOI 10.1093/protein/9.12.1121; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Halperin I, 2004, STRUCTURE, V12, P1027, DOI 10.1016/j.str.2004.04.009; Hamer R, 2010, PROTEINS, V78, P2781, DOI 10.1002/prot.22792; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Liu SY, 2008, BIOINFORMATICS, V24, P2634, DOI 10.1093/bioinformatics/btn497; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Madaoui H, 2008, P NATL ACAD SCI USA, V105, P7708, DOI 10.1073/pnas.0707032105; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nussinov R, 2005, PHYS BIOL, V2; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Rahat O, 2008, PROTEINS, V71, P621, DOI 10.1002/prot.21749; Rahat O, 2009, BIOINFORMATICS, V25, P2921, DOI 10.1093/bioinformatics/btp541; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Snedecor G.W., 1989, AMES IOWA STATE U PR; Torrance JW, 2007, J MOL BIOL, V369, P1140, DOI 10.1016/j.jmb.2007.03.055; Tsai CJ, 1997, PROTEIN SCI, V6, P1793, DOI 10.1002/pro.5560060901; Tuncbag N, 2009, BRIEF BIOINFORM, V10, P217, DOI 10.1093/bib/bbp001; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105	32	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57031	10.1371/journal.pone.0057031	http://dx.doi.org/10.1371/journal.pone.0057031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520460	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900019
J	Sanjuan-Jimenez, R; Colmenero, JD; Bermudez, P; Alonso, A; Morata, P				Sanjuan-Jimenez, Rocio; Colmenero, Juan D.; Bermudez, Pilar; Alonso, Antonio; Morata, Pilar			Amplicon DNA Melting Analysis for the Simultaneous Detection of Brucella spp and Mycobacterium tuberculosis Complex. Potential Use in Rapid Differential Diagnosis between Extrapulmonary Tuberculosis and Focal Complications of Brucellosis	PLOS ONE			English	Article							TIME MULTIPLEX PCR; SYBR-GREEN-I; ASSAY; ABORTUS; IDENTIFICATION	Some sites of extrapulmonary tuberculosis and focal complications of brucellosis are very difficult to differentiate clinically, radiologically, and even histopathologically. Conventional microbiological methods for the diagnosis of extrapulmonary tuberculosis and complicated brucellosis not only lack adequate sensitivity, they are also time consuming, which could lead to an unfavourable prognosis. The aim of this work was to develop a multiplex real-time PCR assay based on SYBR Green I to simultaneously detect Brucella spp and Mycobacterium tuberculosis complex and evaluate the efficacy of the technique with different candidate genes. The IS711, bcsp31 and omp2a genes were used for the identification of Brucella spp and the IS6110, senX3-regX3 and cfp31 genes were targeted for the detection of the M. tuberculosis complex. As a result of the different combinations of primers, nine different reactions were evaluated. A test was defined as positive only when the gene combinations were capable of co-amplifying both pathogens in a single reaction tube and showed distinguishable melting temperatures for each microorganism. According to the melting analysis, only three combinations of amplicons (senX3-regX3+bcsp31, senX3-regX3+IS711 and IS6110+IS711) were visible. Detection limits of senX3-regX3+bcsp31 and senX3-regX3+IS711 were of 2 and 3 genome equivalents for M. tuberculosis complex and Brucella while for IS6110+IS711 they were of 200 and 300 genome equivalents, respectively. The three assays correctly identified all the samples, showing negative results for the control patients. The presence of multicopy elements and GC content were the components most influencing the efficiency of the test; this should be taken into account when designing a multiplex-based SYBR Green I assay. In conclusion, multiplex real time PCR assays based on the targets senX3-regX3+bcsp31 and senX3-regX3+IS711 using SYBR Green I are highly sensitive and reproducible. This may therefore be a practical approach for the rapid differential diagnosis between extrapulmonary tuberculosis and complicated brucellosis.	[Sanjuan-Jimenez, Rocio; Alonso, Antonio; Morata, Pilar] Univ Malaga, Fac Med, Biochem Mol Biol & Immunol Dept, E-29071 Malaga, Spain; [Colmenero, Juan D.] Carlos Haya Univ Hosp, Infect Dis Serv, Malaga, Spain; [Bermudez, Pilar] Carlos Haya Univ Hosp, Microbiol Serv, Malaga, Spain	Universidad de Malaga; Hospital Carlos Haya; Hospital Carlos Haya	Morata, P (corresponding author), Univ Malaga, Fac Med, Biochem Mol Biol & Immunol Dept, E-29071 Malaga, Spain.	morata@uma.es		Morata Losa, Maria Pilar/0000-0002-2423-6347; Sanjuan-Jimenez, Rocio/0000-0002-6591-0289	Consejeria de Innovacion Ciencia y Empresa of the Junta de Andalucia (Spain) [CTS-276, P-08-CTS-3969]	Consejeria de Innovacion Ciencia y Empresa of the Junta de Andalucia (Spain)(Junta de Andalucia)	This work received financial support from the Consejeria de Innovacion Ciencia y Empresa (grant CTS-276 and P-08-CTS-3969) both of the Junta de Andalucia (Spain). Rocio Sanjuan-Jimenez is a fellow attached to the project P-08-CTS-3969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bogdanovich T, 2004, J CLIN MICROBIOL, V42, P2261, DOI 10.1128/JCM.42.5.2261-2263.2004; Broccolo F, 2003, J CLIN MICROBIOL, V41, P4565, DOI 10.1128/JCM.41.10.4565-4572.2003; Colmenero JD, 2010, SPINE, V35, pE1392, DOI 10.1097/BRS.0b013e3181e8eeaf; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Queipo-Ortuno MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004526; Liu J, 2012, J CLIN MICROBIOL, V50, P98, DOI 10.1128/JCM.05416-11; Markoulatos P, 2000, J VIROL METHODS, V84, P161, DOI 10.1016/S0166-0934(99)00141-X; Morata P, 1998, J CLIN MICROBIOL, V36, P2443, DOI 10.1128/JCM.36.9.2443-2446.1998; Nakajima C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-118; Newby DT, 2003, APPL ENVIRON MICROB, V69, P4753, DOI 10.1128/AEM.69.8.4753-4759.2003; Pappas G, 2006, LANCET INFECT DIS, V3, P213; Probert WS, 2004, J CLIN MICROBIOL, V42, P1290, DOI 10.1128/JCM.42.3.1290-1293.2004; Queipo-Ortuno MI, 2005, CLIN MICROBIOL INFEC, V11, P713, DOI 10.1111/j.1469-0691.2005.01202.x; Redkar R, 2001, MOL CELL PROBE, V15, P43, DOI 10.1006/mcpr.2000.0338; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Smith K, 2004, J MED MICROBIOL, V53, P115, DOI 10.1099/jmm.0.05416-0; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853	20	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58353	10.1371/journal.pone.0058353	http://dx.doi.org/10.1371/journal.pone.0058353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520501	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900060
J	Wang, SH; An, TT; Duan, JC; Zhang, LJ; Wu, MN; Zhou, QH; Chen, JF; Zhuo, ML; Yang, L; Wang, YY; Bai, H; Wang, J				Wang, Shuhang; An, Tongtong; Duan, Jianchun; Zhang, Lijian; Wu, Meina; Zhou, Qinghua; Chen, Jinfeng; Zhuo, Minglei; Yang, Lu; Wang, Yuyan; Bai, Hua; Wang, Jie			Alterations in EGFR and Related Genes following Neo-Adjuvant Chemotherapy in Chinese Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; MET AMPLIFICATION; GEFITINIB; SENSITIVITY; RESISTANCE; ERLOTINIB; TUMORS	Introduction: Genetic aberrancies within epidermal growth factor receptor (EGFR) pathway are associated with therapeutic outcomes of EGFR-tyrosine kinase inhibitors (TKIs) in advanced non-small cell lung cancer (NSCLC). However, the impact of chemotherapy on EGFR-related genes alterations has not been defined in NSCLC. Our study aims to investigate the impact of neoadjuvant chemotherapy (Neoadj-Chemo) on EGFR activating mutations and associated EGFR-TKIs resistance-related genes. Patients and Methods: Matched tumor samples were obtained retrospectively from 66 NSCLC patients (stages IIb-IIIb) corresponding to pre-and post-Neoadj-Chemo. EGFR mutations were detected by denaturing high performance liquid chromatography (DHPLC) and confirmed by Amplification Refractory Mutation System technology (ARMS), KRAS mutations, T790M mutation and c-MET amplification were identified using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP), ARMS, and real-time PCR, respectively. Results: Before Neoadj-Chemo, EGFR mutations were identified in 33.3% (22/66) of NSCLC patients. Only 18.2% (12/66) of patients carried EGFR mutations after Neoadj-Chemo (p = 0.013). The median peak value of EGFR 19 exon mutations decreased non-significantly after Neoadj-Chemo. KRAS mutation rate decreased from 4.6% (3/66) to 3.0% (2/66) with Neoadj-Chemo. Although the overall percentage of patients exhibiting c-MET amplifications (6.1% [4/66]) did not change with Neoadj-Chemo, two patients transitioned from negative to positive c-MET amplification, and two patients reversed these changes post-Neoadj-Chemo. T790M mutations were absent from all samples. Conclusion: Neoadjuvant chemotherapy tends to decrease the mutation frequency of EGFR mutation and downstream genes, which suggests that real-time samples analysis for genetic aberrancies within EGFR pathways have important value to delineate specific patient populations and facilitate individualized treatment.	[Wang, Shuhang; An, Tongtong; Duan, Jianchun; Wu, Meina; Zhuo, Minglei; Yang, Lu; Wang, Yuyan; Bai, Hua; Wang, Jie] Peking Univ, Sch Oncol, Dept Thorac Med Oncol,Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Zhang, Lijian; Chen, Jinfeng] Peking Univ, Sch Oncol, Dept Thorac Surg,Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Zhou, Qinghua] Tianjin Med Univ Gen Hosp, Dept Thorac Surg, Tianjin, Peoples R China	Peking University; Peking University; Tianjin Medical University	Bai, H (corresponding author), Peking Univ, Sch Oncol, Dept Thorac Med Oncol,Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	baihuahb@sina.com; wangjie_cc@yahoo.com	Duan, Jianchun/AAM-5765-2020	zhuo, minglei/0000-0003-2489-7791	National Natural Sciences Foundation Distinguished Young Scholars [81025012]; National Natural Sciences Foundation General Program [81172235]; Capital Development Foundation [2007-1023]; Beijing Health Systems Academic Leader [2011-2-22]; Science and Technology Project of Beijing [Z090507017709015]; National Natural Sciences Foundation China Youth Science Foundation [81101726]	National Natural Sciences Foundation Distinguished Young Scholars; National Natural Sciences Foundation General Program; Capital Development Foundation; Beijing Health Systems Academic Leader; Science and Technology Project of Beijing; National Natural Sciences Foundation China Youth Science Foundation	Supported by grants from National Natural Sciences Foundation Distinguished Young Scholars (81025012), National Natural Sciences Foundation General Program (81172235), the Capital Development Foundation (2007-1023), Beijing Health Systems Academic Leader (2011-2-22) and Science and Technology Project of Beijing (Z090507017709015), National Natural Sciences Foundation China Youth Science Foundation (81101726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Chin TM, 2008, CLIN CANCER RES, V14, P6867, DOI 10.1158/1078-0432.CCR-08-0093; Dong Qiang-gang, 2006, Zhonghua Zhongliu Zazhi, V28, P686; Duan Jian-chun, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P323; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Lee JS, 2009, J THORAC ONCOL, V4, pS283; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mu XL, 2005, CLIN CANCER RES, V11, P4289, DOI 10.1158/1078-0432.CCR-04-2506; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wang SH, 2010, CLIN CANCER RES, V16, P1324, DOI 10.1158/1078-0432.CCR-09-2672; Yatabe Y, 2008, CANCER RES, V68, P2106, DOI 10.1158/0008-5472.CAN-07-5211; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757	34	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e51021	10.1371/journal.pone.0051021	http://dx.doi.org/10.1371/journal.pone.0051021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520442	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900001
J	Rangel, FA; Maal, TJJ; Bronkhorst, EM; Breuning, KH; Schols, JGJH; Berge, SJ; Kuijpers-Jagtman, AM				Rangel, Frits A.; Maal, Thomas J. J.; Bronkhorst, Ewald M.; Breuning, K. Hero; Schols, Jan G. J. H.; Berge, Stefaan J.; Kuijpers-Jagtman, Anne Marie			Accuracy and Reliability of a Novel Method for Fusion of Digital Dental Casts and Cone Beam Computed Tomography Scans	PLOS ONE			English	Article							ORTHOGNATHIC SURGERY; SIMULATION; ARTIFACT; MODEL; CT	Several methods have been proposed to integrate digital models into Cone Beam Computed Tomography scans. Since all these methods have some drawbacks such as radiation exposure, soft tissue deformation and time-consuming digital handling processes, we propose a new method to integrate digital dental casts into Cone Beam Computed Tomography scans. Plaster casts of 10 patients were randomly selected and 5 titanium markers were glued to the upper and lower plaster cast. The plaster models were scanned, impressions were taken from the plaster models and the impressions were also scanned. Linear measurements were performed on all three models, to assess accuracy and reproducibility. Besides that, matching of the scanned plaster models and scanned impressions was done, to assess the accuracy of the matching procedure. Results show that all measurement errors are smaller than 0.2 mm, and that 81% is smaller than 0.1 mm. Matching of the scanned plaster casts and scanned impressions show a mean error between the two surfaces of the upper arch of 0.14 mm and for the lower arch of 0.18 mm. The time needed for reconstructing the CBCT scans to a digital patient, where the impressions are integrated into the CBCT scan of the patient takes about 15 minutes, with little variance between patients. In conclusion, we can state that this new method is a reliable method to integrate digital dental casts into CBCT scans. As far as radiation exposure, soft tissue deformation and digital handling processes are concerned, it is a significant improvement compared to the previously published methods.	[Rangel, Frits A.; Breuning, K. Hero; Schols, Jan G. J. H.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands; [Rangel, Frits A.; Maal, Thomas J. J.; Breuning, K. Hero; Schols, Jan G. J. H.; Berge, Stefaan J.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Facial Imaging Res Grp Nijmegen Bruges 3D, NL-6525 ED Nijmegen, Netherlands; [Maal, Thomas J. J.; Berge, Stefaan J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Craniomaxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Bronkhorst, Ewald M.] Radboud Univ Nijmegen, Med Ctr, Dept Prevent & Restorat Dent, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Kuijpers-Jagtman, AM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.	orthodontics@dent.umcn.nl	Bronkhorst, Ewald/L-4230-2015; Schols, Jan G.J.H./AAD-9418-2022; Maal, Thomas JJ/L-4497-2015; Breuning, K.H./L-4228-2015; Kuijpers-Jagtman, Anne Marie/A-9413-2008; Berge, Stefaan/AAP-3708-2020; Bronkhorst, Ewald/AAR-2250-2020; Bergé, S.J./H-8011-2014; Schols, J.G.J.H./L-4635-2015; Rangel, Frits/B-1239-2016	Maal, Thomas JJ/0000-0002-1702-4733; Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Bronkhorst, Ewald/0000-0003-0953-8053; Schols, J.G.J.H./0000-0002-4452-4389; Rangel, Frits/0000-0003-4565-3016	Dutch Technology Foundation [STW 10315]	Dutch Technology Foundation(Technologiestichting STW)	This work was supported by a grant from the Dutch Technology Foundation (STW 10315), http://www.stw.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cascarini L, 2007, EMERG MED J, V24, P228, DOI 10.1136/emj.2006.036392; Choi JY, 2009, INT J ORAL MAX SURG, V38, P1306, DOI 10.1016/j.ijom.2009.06.009; Eggers G, 2008, BRIT J ORAL MAX SURG, V46, P639, DOI 10.1016/j.bjoms.2008.03.019; Faria Adriana Cláudia Lapria, 2008, Braz. oral res., V22, P293, DOI 10.1590/S1806-83242008000400002; Fleming PS, 2011, ORTHOD CRANIOFAC RES, V14, P1, DOI 10.1111/j.1601-6343.2010.01503.x; Gateno J, 2007, J ORAL MAXIL SURG, V65, P728, DOI 10.1016/j.joms.2006.04.001; Golub GH., 2013, MATRIX COMPUTATIONS; Greenhill GA, 2009, BRIT J ORAL MAX SURG, V47, P290, DOI 10.1016/j.bjoms.2009.01.011; Inal Samet, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe14, DOI 10.1016/j.tripleo.2006.05.001; Katsumata A, 2006, ORAL SURG ORAL MED O, V101, P652, DOI 10.1016/j.tripleo.2005.07.027; Kovacs M, 2009, ORAL SURG ORAL MED O, V108, P591, DOI 10.1016/j.tripleo.2009.06.009; Liang X, 2010, EUR J RADIOL, V75, P270, DOI 10.1016/j.ejrad.2009.04.016; Loubele M, 2008, THESIS KATHOLIEKE U; Loubele M, 2006, ORAL SURG ORAL MED O, V102, P225, DOI 10.1016/j.tripleo.2005.10.039; Nkenke E, 2004, DENTOMAXILLOFAC RAD, V33, P226, DOI 10.1259/dmfr/27071199; Rangel FA, 2012, ISRN DENT IN PRESS; Schulze RKW, 2010, CLIN ORAL IMPLAN RES, V21, P100, DOI 10.1111/j.1600-0501.2009.01817.x; Swennen GRJ, 2007, INT J ORAL MAX SURG, V36, P146, DOI 10.1016/j.ijom.2006.09.019; Swennen GRJ, 2009, J CRANIOFAC SURG, V20, P297, DOI 10.1097/SCS.0b013e3181996803; Uechi J, 2006, AM J ORTHOD DENTOFAC, V130, P786, DOI 10.1016/j.ajodo.2006.03.025	20	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59130	10.1371/journal.pone.0059130	http://dx.doi.org/10.1371/journal.pone.0059130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527111	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600058
J	Zhang, X; Li, L; Xu, ZB; Liang, ZL; Su, JY; Huang, JR; Li, B				Zhang, Xia; Li, Lin; Xu, Zhenbo; Liang, Zhili; Su, Jianyu; Huang, Jianrong; Li, Bing			Investigation of the Interaction of Naringin Palmitate with Bovine Serum Albumin: Spectroscopic Analysis and Molecular Docking	PLOS ONE			English	Article							FLUORESCENCE SPECTROSCOPY; INFRARED-SPECTROSCOPY; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; PROTEIN BINDING; ACID; WARFARIN; LIPASE; CONFORMATION; FLAVONOIDS	Background: Bovine serum albumin (BSA) contains high affinity binding sites for several endogenous and exogenous compounds and has been used to replace human serum albumin (HSA), as these two compounds share a similar structure. Naringin palmitate is a modified product of naringin that is produced by an acylation reaction with palmitic acid, which is considered to be an effective substance for enhancing naringin lipophilicity. In this study, the interaction of naringin palmitate with BSA was characterised by spectroscopic and molecular docking techniques. Methodology/ Principal Findings: The goal of this study was to investigate the interactions between naringin palmitate and BSA under physiological conditions, and differences in naringin and naringin palmitate affinities for BSA were further compared and analysed. The formation of naringin palmitate-BSA was revealed by fluorescence quenching, and the Stern-Volmer quenching constant (K-SV) was found to decrease with increasing temperature, suggesting that a static quenching mechanism was involved. The changes in enthalpy (Delta H) and entropy (Delta S) for the interaction were detected at -4.11 +/- 0.18 kJ.mol(-1) and -76.59 +/- 0.32 J.mol(-1).K-1, respectively, which indicated that the naringin palmitate-BSA interaction occurred mainly through van der Waals forces and hydrogen bond formation. The negative free energy change (Delta G) values of naringin palmitate at different temperatures suggested a spontaneous interaction. Circular dichroism studies revealed that the alpha-helical content of BSA decreased after interacting with naringin palmitate. Displacement studies suggested that naringin palmitate was partially bound to site I (subdomain IIA) of the BSA, which was also substantiated by the molecular docking studies. Conclusions/ Significance: In conclusion, naringin palmitate was transported by BSA and was easily removed afterwards. As a consequence, an extension of naringin applications for use in food, cosmetic and medicinal preparations may be clinically and practically significant, especially in the design of new naringin palmitate-inspired drugs.	[Zhang, Xia; Li, Lin; Xu, Zhenbo; Liang, Zhili; Su, Jianyu; Li, Bing] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Li, Lin; Su, Jianyu; Li, Bing] S China Univ Technol, Guangdong Prov Key Lab Green Proc Nat Prod & Prod, Guangzhou, Guangdong, Peoples R China; [Xu, Zhenbo] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Huang, Jianrong] Guangdong Pharmaceut Univ, Sch Food Sci, Zhongshan, Peoples R China	South China University of Technology; South China University of Technology; University System of Maryland; University of Maryland Baltimore; Guangdong Pharmaceutical University	Huang, JR (corresponding author), Guangdong Pharmaceut Univ, Sch Food Sci, Zhongshan, Peoples R China.	joanjr@126.com; bli@scut.edu.cn	li, bing/GWQ-9617-2022	Su, Jianyu/0000-0002-1662-0461	State Key Program of National Natural Science of China [31130042, 20976061]; National Key Technology RD Program [2012BAD37B01]; Fundamental Research Funds for the Central Universities, SCUT [2011ZZ0084];  [NCET-10-0395]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities); 	This work is supported by the State Key Program of National Natural Science of China (No. 31130042 and No. 20976061, www.nsfc.gov.cn), the National Key Technology R&D Program (No. 2012BAD37B01,kjzc.jhgl.org), NCET-10-0395 (www.dost.moe.edu.cn) and the Fundamental Research Funds for the Central Universities, SCUT (No. 2011ZZ0084, www.scut.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Ahmad E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038372; Ahmad E, 2011, CELL BIOCHEM BIOPHYS, V61, P313, DOI 10.1007/s12013-011-9214-4; Banerjee A, 2008, J PHOTOCH PHOTOBIO B, V90, P33, DOI 10.1016/j.jphotobiol.2007.10.005; Baroni S, 2001, EUR J BIOCHEM, V268, P6214, DOI 10.1046/j.0014-2956.2001.02569.x; Bian QQ, 2004, INT J BIOL MACROMOL, V34, P333, DOI 10.1016/j.ijbiomac.2004.09.005; Bujacz A, 2012, ACTA CRYSTALLOGR D, V68, P1278, DOI 10.1107/S0907444912027047; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chen G., 1990, METHOD FLUORESCENT A, P2; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; CONGDON RW, 1993, ANAL BIOCHEM, V213, P407, DOI 10.1006/abio.1993.1439; Danieli B, 1997, J MOL CATAL B-ENZYM, V3, P193, DOI 10.1016/S1381-1177(96)00055-0; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Ferguson PJ, 2004, J NUTR, V134, P1529, DOI 10.1093/jn/134.6.1529; Gayot S, 2003, J BIOTECHNOL, V101, P29, DOI 10.1016/S0168-1656(02)00286-9; Ghosh KS, 2008, CHEM PHYS LETT, V452, P193, DOI 10.1016/j.cplett.2007.12.018; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; Guo XJ, 2009, J MOL STRUCT, V931, P55, DOI 10.1016/j.molstruc.2007.06.035; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HELLER DP, 1994, BIOPHYS CHEM, V50, P305, DOI 10.1016/0301-4622(93)E0101-A; Hu YJ, 2004, J PHARMACEUT BIOMED, V36, P915, DOI 10.1016/j.jpba.2004.08.021; Kaldas MI, 2005, J AGR FOOD CHEM, V53, P4194, DOI 10.1021/jf050061m; Kandagal PB, 2008, J PHARMACEUT BIOMED, V47, P260, DOI 10.1016/j.jpba.2008.01.027; Khairullina VR, 2010, KINET CATAL+, V51, P219, DOI 10.1134/S0023158410020084; Klajnert B, 2002, BIOELECTROCHEMISTRY, V55, P33, DOI 10.1016/S1567-5394(01)00170-0; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; LAKOWICZ JR, 1980, BIOPHYS J, V32, P591, DOI 10.1016/S0006-3495(80)84992-7; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4171, DOI 10.1021/bi00745a021; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li Y, 2005, J MOL STRUCT, V743, P79, DOI 10.1016/j.molstruc.2005.02.032; Liang L, 2008, BIOMACROMOLECULES, V9, P50, DOI 10.1021/bm700728k; Liu Y, 2003, SPECTROCHIM ACTA A, V59, P2747, DOI 10.1016/S1386-1425(03)00055-6; Maidul H, 2011, PLOS ONE, V6; Maiti TK, 2008, J PHOTOCH PHOTOBIO A, V194, P297, DOI 10.1016/j.jphotochem.2007.08.028; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MILLER JN, 1984, ANALYST, V109, P191, DOI 10.1039/an9840900191; Nafisi S, 2009, J PHOTOCH PHOTOBIO B, V94, P1, DOI 10.1016/j.jphotobiol.2008.08.001; Naik PN, 2009, SPECTROCHIM ACTA A, V73, P841, DOI 10.1016/j.saa.2009.04.018; Ni Y, 2006, ANAL CHIM ACTA, V580, P206, DOI 10.1016/j.aca.2006.07.059; Olson RE, 1996, ANNU REP MED CHEM, V31, P327, DOI 10.1016/S0065-7743(08)60472-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Papadopoulou A, 2005, J AGR FOOD CHEM, V53, P158, DOI 10.1021/jf048693g; Pari L, 2011, EUR J PHARMACOL, V650, P364, DOI 10.1016/j.ejphar.2010.09.068; Perry JL, 2006, PHOTOCHEM PHOTOBIOL, V82, P1365, DOI 10.1562/2006-02-23-RA-811; Rahmelow K, 1996, ANAL BIOCHEM, V241, P5, DOI 10.1006/abio.1996.0369; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Roy A.S., 2010, J BIOPHYS CHEM, V01, P141, DOI [DOI 10.4236/JBPC.2010.13017, 10.4236/jbpc.2010.13017]; Sahoo BK, 2009, BIOPOLYMERS, V91, P108, DOI 10.1002/bip.21092; Salas MP, 2011, FOOD CHEM, V124, P1411, DOI 10.1016/j.foodchem.2010.07.100; Shaikh SMT, 2007, DYES PIGMENTS, V74, P665, DOI 10.1016/j.dyepig.2006.04.010; Sheng LJ, 2010, J MOL STRUCT, V979, P152, DOI 10.1016/j.molstruc.2010.06.018; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; SUSI H, 1986, METHOD ENZYMOL, V130, P290; T Forster, 1965, MODERN QUANTUM CHEMI, VIII, P93; Tanaya C, 2012, PLOS ONE, V7; Tang JH, 2006, BIOORGAN MED CHEM, V14, P3210, DOI 10.1016/j.bmc.2005.12.034; Tian JN, 2004, BIOMACROMOLECULES, V5, P1956, DOI 10.1021/bm049668m; Tsai SH, 1999, BRIT J PHARMACOL, V126, P673, DOI 10.1038/sj.bjp.0702357; Valeur B., 2001, NEW TRENDS FLUORESCE, VThird; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YQ, 2007, J LUMIN, V126, P211, DOI 10.1016/j.jlumin.2006.06.013; Wang YQ, 2007, J MOL STRUCT, V830, P40, DOI 10.1016/j.molstruc.2006.06.031; Wei XL, 2010, SPECTROCHIM ACTA A, V75, P299, DOI 10.1016/j.saa.2009.10.027; Yang CY, 2005, J PHARMACEUT BIOMED, V39, P263, DOI 10.1016/j.jpba.2005.02.028; Youn SH, 2007, J MOL CATAL B-ENZYM, V46, P26, DOI 10.1016/j.molcatb.2007.02.002; Zhang X, 2012, ADV MATER RES-SWITZ, V554-556, P1350, DOI 10.4028/www.scientific.net/AMR.554-556.1350; Zhang Y, 2008, J MOL STRUCT, V875, P1, DOI 10.1016/j.molstruc.2007.03.063	71	55	58	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59106	10.1371/journal.pone.0059106	http://dx.doi.org/10.1371/journal.pone.0059106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527100	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562600055
J	Distefano, G; Ferrari, RJ; Weiss, C; Deasy, BM; Boninger, ML; Fitzgerald, GK; Huard, J; Ambrosio, F				Distefano, Giovanna; Ferrari, Ricardo Jose; Weiss, Christopher; Deasy, Bridget M.; Boninger, Michael L.; Fitzgerald, G. Kelley; Huard, Johnny; Ambrosio, Fabrisia			Neuromuscular Electrical Stimulation as a Method to Maximize the Beneficial Effects of Muscle Stem Cells Transplanted into Dystrophic Skeletal Muscle	PLOS ONE			English	Article							MDX MICE; MYOBLAST TRANSPLANTATION; REPAIR; ADULT; REGENERATION; EXPRESSION; IMPROVES	Cellular therapy is a potential approach to improve the regenerative capacity of damaged or diseased skeletal muscle. However, its clinical use has often been limited by impaired donor cell survival, proliferation and differentiation following transplantation. Additionally, functional improvements after transplantation are all-too-often negligible. Because the host microenvironment plays an important role in the fate of transplanted cells, methods to modulate the microenvironment and guide donor cell behavior are warranted. The purpose of this study was to investigate whether the use of neuromuscular electrical stimulation (NMES) for 1 or 4 weeks following muscle-derived stem cell (MDSC) transplantation into dystrophic skeletal muscle can modulate the fate of donor cells and enhance their contribution to muscle regeneration and functional improvements. Animals submitted to 4 weeks of NMES after transplantation demonstrated a 2-fold increase in the number of dystrophin+ myofibers as compared to control transplanted muscles. These findings were concomitant with an increased vascularity in the MDSC+NMES group when compared to non-stimulated counterparts. Additionally, animals subjected to NMES (with or without MDSC transplantation) presented an increased maximal specific tetanic force when compared to controls. Although cell transplantation and/or the use of NMES resulted in no changes in fatigue resistance, the combination of both MDSC transplantation and NMES resulted in a faster recovery from fatigue, when compared to non-injected and non-stimulated counterparts. We conclude that NMES is a viable method to improve MDSC engraftment, enhance dystrophic muscle strength, and, in combination with MDSC transplantation, improve recovery from fatigue. These findings suggest that NMES may be a clinically-relevant adjunct approach for cell transplantation into skeletal muscle.	[Distefano, Giovanna; Ferrari, Ricardo Jose; Weiss, Christopher; Boninger, Michael L.; Ambrosio, Fabrisia] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Distefano, Giovanna; Ferrari, Ricardo Jose; Fitzgerald, G. Kelley; Ambrosio, Fabrisia] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA; [Huard, Johnny; Ambrosio, Fabrisia] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Huard, Johnny; Ambrosio, Fabrisia] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Deasy, Bridget M.; Boninger, Michael L.; Huard, Johnny; Ambrosio, Fabrisia] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ambrosio, F (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	ambrosiof@upmc.edu	Distefano, Giovanna/AAB-9914-2022	Distefano, Giovanna/0000-0003-1208-5008; Boninger, Michael/0000-0001-6966-919X; Weiss, Christopher/0000-0003-4704-9533; Fitzgerald, G Kelley/0000-0001-6293-3103	Foundation for Physical Therapy; NIH K12 for Physical and Occupational Therapists-Comprehensive Opportunities in Rehabilitation Research Training [K12 HD055931]; Competitive Medical Research Fund of the University of Pittsburgh; Department of Physical Medicine & Rehabilitation at the University of Pittsburgh; Cook MyoSite Incorporated; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, K01AG039477] Funding Source: NIH RePORTER	Foundation for Physical Therapy; NIH K12 for Physical and Occupational Therapists-Comprehensive Opportunities in Rehabilitation Research Training; Competitive Medical Research Fund of the University of Pittsburgh(University of Pittsburgh); Department of Physical Medicine & Rehabilitation at the University of Pittsburgh; Cook MyoSite Incorporated; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding Source: - Foundation for Physical Therapy (http://foundation4pt.org/) - NIH K12 for Physical and Occupational Therapists-Comprehensive Opportunities in Rehabilitation Research Training (K12 HD055931, FA) (http://www.corrt.pitt.edu/) - Competitive Medical Research Fund of the University of Pittsburgh (http://www.oorhs.pitt.edu/funding/cmrf.aspx) Department of Physical Medicine & Rehabilitation at the University of Pittsburgh (http://www.rehabmedicine.pitt.edu/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: One of the co-authors, Johnny Huard, has a potential financial conflict of interest because he has received remuneration as a consultant with Cook MyoSite Incorporated during the performance period of this project. None of the other authors has a financial or other relationship that might lead to conflict of interest concerning the publication of this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ambrosio F, 2010, TISSUE ENG PT A, V16, P839, DOI [10.1089/ten.tea.2009.0113, 10.1089/ten.TEA.2009.0113]; Ambrosio F, 2012, JOVE-J VIS EXP, DOI 10.3791/3914; Ambrosio F, 2009, ARCH PHYS MED REHAB, V90, P66, DOI 10.1016/j.apmr.2008.06.035; Annex BH, 1998, AM J PHYSIOL-HEART C, V274, pH860, DOI 10.1152/ajpheart.1998.274.3.H860; Auda-Boucher G, 2007, EXP CELL RES, V313, P997, DOI 10.1016/j.yexcr.2006.12.021; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bouchentouf M, 2006, NEUROMUSCULAR DISORD, V16, P518, DOI 10.1016/j.nmd.2006.06.003; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Brutsaert Tom D, 2002, BMC Physiol, V2, P8, DOI 10.1186/1472-6793-2-8; de Juan-Pardo EM, 2006, INT J NANOMED, V1, P203, DOI 10.2147/nano.2006.1.2.203; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Goudemant JF, 1998, NEUROMUSCULAR DISORD, V8, P371, DOI 10.1016/S0960-8966(98)00049-2; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; HANG J, 1995, AM J PHYSIOL-HEART C, V269, pH1827, DOI 10.1152/ajpheart.1995.269.5.H1827; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li Y, 2002, AM J PATHOL, V161, P895, DOI 10.1016/S0002-9440(10)64250-2; Mueller GM, 2002, HUM GENE THER, V13, P1081, DOI 10.1089/104303402753812485; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Payne TR, 2007, J AM COLL CARDIOL, V50, P1677, DOI 10.1016/j.jacc.2007.04.100; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404	25	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e54922	10.1371/journal.pone.0054922	http://dx.doi.org/10.1371/journal.pone.0054922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526927	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000317562100003
J	Martinho, O; Pinto, F; Granja, S; Miranda-Goncalves, V; Moreira, MAR; Ribeiro, LFJ; di Loreto, C; Rosner, MR; Longatto, A; Reis, RM				Martinho, Olga; Pinto, Filipe; Granja, Sara; Miranda-Goncalves, Vera; Moreira, Marise A. R.; Ribeiro, Luis F. J.; di Loreto, Celso; Rosner, Marsha R.; Longatto-Filho, Adhemar; Reis, Rui Manuel			RKIP Inhibition in Cervical Cancer Is Associated with Higher Tumor Aggressive Behavior and Resistance to Cisplatin Therapy	PLOS ONE			English	Article							RAF KINASE INHIBITOR; PROTEIN EXPRESSION; NASOPHARYNGEAL CARCINOMA; COLORECTAL-CANCER; DOWN-REGULATION; METASTASIS; PROSTATE; CELLS; SUPPRESSION; PROGRESSION	Cervical cancer is one of the most common cancers in women worldwide, being high-risk group the HPV infected, the leading etiological factor. The raf kinase inhibitory protein (RKIP) has been associated with tumor progression and metastasis in several human neoplasms, however its role on cervical cancer is unclear. In the present study, 259 uterine cervix tissues, including cervicitis, cervical intraepithelial lesions and carcinomas, were analyzed for RKIP expression by immunohistochemistry. We found that RKIP expression was significantly decreased during malignant progression, being highly expressed in non-neoplastic tissues (54% of the samples; 73/135), and expressed at low levels in the cervix invasive carcinomas (similar to 15% (19/124). Following in vitro downregulation of RKIP, we observed a viability and proliferative advantage of RKIP-inhibited cells over time, which was associated with an altered cell cycle distribution and higher colony number in a colony formation assay. An in vitro wound healing assay showed that RKIP abrogation is associated with increased migratory capability. RKIP downregulation was also associated with an increased vascularization of the tumors in vivo using a CAM assay. Furthermore, RKIP inhibition induced cervical cancer cells apoptotic resistance to cisplatin treatment. In conclusion, we described that RKIP protein is significantly depleted during the malignant progression of cervical tumors. Despite the lack of association with patient clinical outcome, we demonstrate, in vitro and in vivo, that loss of RKIP expression can be one of the factors that are behind the aggressiveness, malignant progression and chemotherapy resistance of cervical cancer.	[Martinho, Olga; Pinto, Filipe; Granja, Sara; Miranda-Goncalves, Vera; Longatto-Filho, Adhemar; Reis, Rui Manuel] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Martinho, Olga; Pinto, Filipe; Granja, Sara; Miranda-Goncalves, Vera; Longatto-Filho, Adhemar; Reis, Rui Manuel] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Martinho, Olga; Longatto-Filho, Adhemar; Reis, Rui Manuel] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Moreira, Marise A. R.] Univ Fed Goias, Sch Med, Dept Pathol, Goiania, Go, Brazil; [Ribeiro, Luis F. J.] Hosp Araujo Jorge, Goiania, Go, Brazil; [di Loreto, Celso] Adolfo Lutz Inst Sao Paulo, Div Pathol, Sao Paulo, Brazil; [Rosner, Marsha R.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Longatto-Filho, Adhemar] Univ Sao Paulo, Fac Med, Lab Med Invest LIM 14, Sao Paulo, Brazil	Universidade do Minho; Hospital de Cancer de Barretos; Universidade Federal de Goias; University of Chicago; Universidade de Sao Paulo	Reis, RM (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	rreis@ecsaude.uminho.pt	Reis, Rui M/C-2859-2009; Reis, Rui Manuel/B-1744-2018; Longatto-Filho, Adhemar/N-3397-2019; Granja, Sara/AAE-7136-2021; Reis, Rui Manuel/AAD-6470-2020; Pinto, Filipe/AAC-8234-2021; Filho, Adhemar Longatto/A-2889-2016; Sara, Granja C/T-6442-2018; longatto-filho, adhemar/D-7039-2013; Martinho, Olga/B-9695-2009	Reis, Rui M/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940; Longatto-Filho, Adhemar/0000-0002-5779-9752; Granja, Sara/0000-0001-8717-6751; Reis, Rui Manuel/0000-0002-9639-7940; Pinto, Filipe/0000-0003-2330-9863; Sara, Granja C/0000-0001-8717-6751; longatto-filho, adhemar/0000-0002-5779-9752; Martinho, Olga/0000-0002-3221-0403; Miranda-Goncalves, Vera/0000-0002-4231-5532	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/SAU-TOX/114549/2009]; FCT, Portugal [SFRH/BD/36463/2007, SFRH/BD/51062/2010, UMINHO/BI/016/2011, SFRH/BI/33503/2008]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by the Portuguese Fundacao para a Ciencia e Tecnologia (grant PTDC/SAU-TOX/114549/2009). Olga Martinho and Sara Granja were recipients of PhD fellowships (SFRH/BD/36463/2007 and SFRH/BD/51062/2010, respectively), and Filipe Pinto and Vera Miranda-Goncalves were recipients of research fellowships (UMINHO/BI/016/2011 and SFRH/BI/33503/2008, respectively), both from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akaishi J, 2006, ANTICANCER RES, V26, P4437; Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; al-Mulla F, 2011, MOL BIOSYST, V7, P928, DOI 10.1039/c0mb00208a; Al-Mulla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029532; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214; Bement WM, 2005, CHEM BIOL, V12, P953, DOI 10.1016/j.chembiol.2005.08.012; Biewenga P, 2008, GYNECOL ONCOL, V108, P520, DOI 10.1016/j.ygyno.2007.11.024; Bonavida B, 2008, NITRIC OXIDE-BIOL CH, V19, P152, DOI 10.1016/j.niox.2008.04.018; Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chatterjee D, 2008, CLIN CANCER RES, V14, P2994, DOI 10.1158/1078-0432.CCR-07-4496; Chen Y, 2008, J PROTEOME RES, V7, P5254, DOI 10.1021/pr800602c; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Cardeal LBD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033585; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Davey DD, 2003, CANCER J, V9, P327, DOI 10.1097/00130404-200309000-00002; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hellmann J, 2010, DEV NEUROSCI-BASEL, V32, P33, DOI 10.1159/000236595; Houben R, 2006, J INVEST DERMATOL, V126, P1135, DOI 10.1038/sj.jid.5700170; Hu CJ, 2011, J INT MED RES, V39, P229, DOI 10.1177/147323001103900125; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Keller ET, 2004, BIOCHEM PHARMACOL, V68, P1049, DOI 10.1016/j.bcp.2004.04.024; Kim HS, 2010, PATHOLOGY, V42, P655, DOI 10.3109/00313025.2010.522172; Kim HS, 2010, ENDOCR PATHOL, V21, P253, DOI 10.1007/s12022-010-9131-x; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; Li HZ, 2008, MOL CANCER RES, V6, P917, DOI 10.1158/1541-7786.MCR-08-0093; Li HZ, 2009, MOL CANCER RES, V7, P832, DOI 10.1158/1541-7786.MCR-08-0403; Logarinho E, 2012, NAT CELL BIOL, V14, P295, DOI 10.1038/ncb2423; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Maresch J, 2011, CANCER-AM CANCER SOC, V117, P2499, DOI 10.1002/cncr.25799; Martin AG, 2007, CLIN TRANSL ONCOL, V9, P347, DOI 10.1007/s12094-007-0066-8; Martinho O, 2013, ONCOL REP, V29, P690, DOI 10.3892/or.2012.2179; Martinho O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030769; Martinho O, 2012, J CLIN PATHOL, V65, P122, DOI 10.1136/jclinpath-2011-200358; Martinho O, 2009, VIRCHOWS ARCH, V455, P277, DOI 10.1007/s00428-009-0821-z; Minoo P, 2007, AM J CLIN PATHOL, V127, P820, DOI 10.1309/5D7MM22DAVGDT1R8; Moniz S, 2013, HUM MOL GENET, V22, P84, DOI 10.1093/hmg/dds405; Poomtavorn Y, 2011, ASIAN PAC J CANCER P, V12, P235; Ruan L, 2010, J CELL BIOCHEM, V110, P975, DOI 10.1002/jcb.22611; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; Shemon AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006028; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Woods KM, 2008, INT J RADIAT ONCOL, V72, P153, DOI 10.1016/j.ijrobp.2008.04.072; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Xu YF, 2010, J HEPATOL, V53, P872, DOI 10.1016/j.jhep.2010.05.019; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zaravinos A, 2011, PATHOL ONCOL RES, V17, P181, DOI 10.1007/s12253-010-9295-1; Zaravinos A, 2009, CELL CYCLE, V8, P1402, DOI 10.4161/cc.8.9.8308; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013; Zhu ST, 2005, CHEM BIOL, V12, P981, DOI 10.1016/j.chembiol.2005.07.007; Zlobec I, 2008, CLIN CANCER RES, V14, P143, DOI 10.1158/1078-0432.CCR-07-1380; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	61	39	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59104	10.1371/journal.pone.0059104	http://dx.doi.org/10.1371/journal.pone.0059104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527098	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562100076
J	Ning, JL; Mo, LW; Zhao, HZ; Lu, KZ; Lai, XN; Luo, XH; Zhao, HL; Ma, DQ				Ning, Jiaolin; Mo, Liwen; Zhao, Hongzhi; Lu, Kaizhi; Lai, Xinan; Luo, Xianghong; Zhao, Hailin; Ma, Daqing			Sodium Hydrosulphide Alleviates Remote Lung Injury Following Limb Traumatic Injury in Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HYDROGEN-SULFIDE PROTECTS; OXIDATIVE STRESS; ACUTE-PANCREATITIS; MICE; INHIBITION; PERMEABILITY; INFLAMMATION; MODULATION; REGULATOR	Hydrogen sulphide (H2S) was found to attenuate ventilator or oleic acid induced lung injury. The aim of this study was to explore the effects of exogenous H2S donor, sodium Hydrosulphide (NaHS), on lung injury following blast limb trauma and the underlying mechanisms. For in vitro experiments, pulmonary micro-vessel endothelial cells (PMVECs) were cultured and treated with NaHS or vehicle in the presence of TNF-alpha. For in vivo, blast limb traumatic rats, induced by using chartaceous electricity detonators, were randomly treated with NaHS, cystathionine gamma-lyase inhibitor (PAG) or vehicle. In vitro, NaHS (100 mu M) treatment increased PMVECs viability and decreased LDH release into culture media after tumor necrosis factor (TNF) alpha challenge. In addition, NaHS treatment prevented the increase of nitric oxide, Intercellular Adhesion Molecule 1(ICAM-1) and interleukin (IL)-6 production and inducible nitric oxide synthase activation induced by TNF-alpha. Knock-down of NF-E2-Related Factor 2 (Nrf2) partially abolished the protective effect of NaHS. In vivo, NaHS treatment significantly alleviated lung injury following blast limb trauma, demonstrated by a decreased histopathological score and lung water content. Furthermore, NaHS treatment reversed the decrease of H2S concentration in plasma, prevented the increase of TNF-alpha, IL-6, malondialdehyde and myeloperoxidase, increased the Nrf2 downstream effector glutathione in both plasma and lungs, and reversed the decrease of superoxide dismutase in both plasma and lungs induced by blast limb trauma. Our data indicated that NaHS protects against lung injury following blast limb trauma which is likely associated with suppression of the inflammatory and oxidative response and activation of Nrf2 cellular signal.	[Ning, Jiaolin; Lu, Kaizhi] Third Mil Med Univ, Southwest Hosp, Dept Anesthesiol, Chongqing, Peoples R China; [Mo, Liwen] Peoples Liberat Army Chengdu Mil Area Command Gen, Dept Nephrol, Chengdu, Sichuan, Peoples R China; [Zhao, Hongzhi] Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Lai, Xinan] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma & Burns, Surg Res Inst,Dept Traumat Surg, Chongqing, Peoples R China; [Luo, Xianghong; Zhao, Hailin; Ma, Daqing] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Fac Med, Dept Surg & Canc, London, England	Army Medical University; Army Medical University; Army Medical University; Imperial College London	Lu, KZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Anesthesiol, Chongqing, Peoples R China.	Lukaizhi@163.net; laixinan@163.com	Mo, Liwen/GRS-6594-2022; Ma, Daqing/GLT-2735-2022	Ma, Daqing/0000-0003-1235-0537; Ma, Daqing/0000-0002-0688-2097	PLA Army, China [06Z034]; National Natural Science Foundation of China [81100055]	PLA Army, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grant (06Z034) from the eleventh five-year planning scheme, PLA Army, China and National Natural Science Foundation of China (Grant No. 81100055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; ASCHERIO A, 1995, LANCET, V346, P721, DOI 10.1016/S0140-6736(95)91501-X; Aslami H, 2010, INTENS CARE MED, V36, P1946, DOI 10.1007/s00134-010-2022-2; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Bhatia M, 2000, GUT, V47, P838, DOI 10.1136/gut.47.6.838; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chignard M, 2000, AM J PHYSIOL-LUNG C, V279, pL1083, DOI 10.1152/ajplung.2000.279.6.L1083; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Dombkowski RA, 2004, AM J PHYSIOL-REG I, V286, pR678, DOI 10.1152/ajpregu.00419.2003; DONNELLY SC, 1994, LANCET, V344, P215, DOI 10.1016/S0140-6736(94)92995-5; EIERMANN GJ, 1983, AM REV RESPIR DIS, V128, P845; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Folch E, 1999, ANN SURG, V230, P792, DOI 10.1097/00000658-199912000-00008; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Hesse AK, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-11; Hinder F, 1999, AM J RESP CRIT CARE, V159, P252, DOI 10.1164/ajrccm.159.1.9806024; KHAN AA, 1990, TOXICOL APPL PHARM, V103, P482, DOI 10.1016/0041-008X(90)90321-K; Kimura H, 2012, ANTIOXID REDOX SIGNA; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Knight KR, 1997, EUR J PHARMACOL, V332, P273, DOI 10.1016/S0014-2999(97)01101-1; Korver AJH, 1996, INJURY, V27, P477, DOI 10.1016/0020-1383(96)00066-6; Kubo A, 2007, TOXICOLOGY, V241, P92, DOI 10.1016/j.tox.2007.08.087; Kubo S, 2007, TOXICOLOGY, V232, P138, DOI 10.1016/j.tox.2006.12.023; Lange M, 2012, SHOCK, V37, P468, DOI 10.1097/SHK.0b013e31824b1793; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Mikami Y, 2011, J BIOL CHEM, V286, P39379, DOI 10.1074/jbc.M111.298208; Nathens AB, 1998, J IMMUNOL, V160, P2959; Ning JL, 2012, J TRAUMA ACUTE CARE, V73, P1537, DOI 10.1097/TA.0b013e318266013a; Owens JG, 2010, FOOT ANKLE CLIN, V15, P175, DOI 10.1016/j.fcl.2009.10.005; Pan LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019766; Papaiahgari S, 2007, AM J RESP CRIT CARE, V176, P1222, DOI 10.1164/rccm.200701-060OC; Peng XQ, 2005, AM J RESP CRIT CARE, V172, P470, DOI 10.1164/rccm.200411-1547OC; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; STEPHENS KE, 1988, AM REV RESPIR DIS, V137, P1364, DOI 10.1164/ajrccm/137.6.1364; Su CF, 2007, CLIN EXP PHARMACOL P, V34, P339, DOI 10.1111/j.1440-1681.2007.04553.x; Tamizhselvi R, 2008, PANCREAS, V36, pE24, DOI 10.1097/MPA.0b013e31816857bb; Tokuda K, 2012, ANTIOXID REDOX SIGN, V17, P11, DOI 10.1089/ars.2011.4363; van Buul JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011336; Vega VL, 1999, SHOCK, V11, P403; Wagner CA, 2009, J NEPHROL, V22, P173; Wang C, 2011, CHINESE MED J-PEKING, V124, P3476, DOI 10.3760/cma.j.issn.0366-6999.2011.21.007; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Wintner EA, 2010, BRIT J PHARMACOL, V160, P941, DOI 10.1111/j.1476-5381.2010.00704.x; Yang YL, 2008, J BIOMED SCI, V15, P499, DOI 10.1007/s11373-008-9238-y; Yong QC, 2008, AM J PHYSIOL-HEART C, V295, pH1330, DOI 10.1152/ajpheart.00244.2008	48	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59100	10.1371/journal.pone.0059100	http://dx.doi.org/10.1371/journal.pone.0059100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527096	Green Submitted, gold, Green Published			2022-12-27	WOS:000317562100074
J	Zhao, XD; He, YY; Gao, J; Fan, LF; Li, ZH; Yang, GF; Chen, HL				Zhao, Xianda; He, Yuyu; Gao, Jun; Fan, Lifang; Li, Zonghuan; Yang, Guifang; Chen, Honglei			Caveolin-1 Expression Level in Cancer Associated Fibroblasts Predicts Outcome in Gastric Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; BREAST-CANCER; QUANTUM DOTS; STROMAL CAVEOLIN-1; PROGNOSTIC-SIGNIFICANCE; TUMOR MICROENVIRONMENT; ABSENCE; CLASSIFICATION; PROGRESSION	Aims: Altered expression of epithelial or stromal caveolin-1 (Cav-1) is observed in various types of human cancers. However, the clinical significance of Cav-1 expression in gastric cancer (GC) remains largely unknown. The present study aims to explore the clinicopathological significance and prognostic value of both tumor cells and cancer associated fibroblasts (CAFs) Cav-1 in GC. Methods and Results: Quantum dots immunofluorescence histochemistry was performed to examine the expression of Cav-1 in 20 cases of gastritis without intestinal metaplasia (IM), 20 cases of gastritis with IM and 286 cases of GC. Positive rates of epithelial Cav-1 in gastritis without IM, gastritis with IM and GC showed a decreasing trend (P = 0.012). Low expression of Cav-1 in CAFs but not in tumor cells was an independent predictor of poor prognosis in GC patients (P = 0.034 and 0.005 respectively in disease free survival and overall survival). Cav-1 level in tumor cells and CAFs showed no significant correlation with classic clinicopathological features. Conclusions: Loss of epithelial Cav-1 may promote malignant progression and low CAFs Cav-1 level herald worse outcome of GC patient, suggesting CAFs Cav-1 may be a candidate therapeutic target and a useful prognostic marker of GC.	[Zhao, Xianda; He, Yuyu; Fan, Lifang; Li, Zonghuan; Chen, Honglei] Wuhan Univ, Dept Pathol, Sch Basic Med Sci, Wuhan 430072, Peoples R China; [Gao, Jun] Wuhan Nano Tumor Diag Engn Res Ctr, Dept Mol Pathol, Wuhan, Peoples R China; [Yang, Guifang] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan 430072, Peoples R China; [Chen, Honglei] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA	Wuhan University; Wuhan University; Rush University	Chen, HL (corresponding author), Wuhan Univ, Dept Pathol, Sch Basic Med Sci, Wuhan 430072, Peoples R China.	hl-chen@whu.edu.cn	Zhao, Xianda/AAD-2482-2020; Chen, Honglei/ABG-8632-2021	Zhao, Xianda/0000-0002-7926-4900; 	National Undergraduate Innovation Project of China [111048670]; National Natural Sciences Foundation of China [30900652]	National Undergraduate Innovation Project of China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Undergraduate Innovation Project of China (NO. 111048670) and the National Natural Sciences Foundation of China (NO. 30900652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Adegboyega PA, 2010, HUM PATHOL, V41, P1128, DOI 10.1016/j.humpath.2009.12.014; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Barresi V, 2008, VIRCHOWS ARCH, V453, P571, DOI 10.1007/s00428-008-0681-y; Barresi V, 2006, ACTA NEUROPATHOL, V112, P617, DOI 10.1007/s00401-006-0097-1; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Burgermeister E, 2007, CANCER RES, V67, P8519, DOI 10.1158/0008-5472.CAN-07-1125; Chen C, 2011, BIOMATERIALS, V32, P7592, DOI 10.1016/j.biomaterials.2011.06.029; Chen C, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/9/095101; Chen C, 2009, BIOMATERIALS, V30, P2912, DOI 10.1016/j.biomaterials.2009.02.010; Chen HL, 2009, J MOL HISTOL, V40, P261, DOI 10.1007/s10735-009-9237-y; Di Vizio D, 2009, CELL CYCLE, V8, P2420, DOI 10.4161/cc.8.15.9116; Du ZM, 2009, INT J CANCER, V125, P1832, DOI 10.1002/ijc.24531; Dvorak HF, 2011, J SURG ONCOL, V103, P468, DOI 10.1002/jso.21709; Engelman JA, 1998, FEBS LETT, V429, P330, DOI 10.1016/S0014-5793(98)00619-X; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kunze E, 2006, INT J MOL MED, V17, P3; Li MX, 2012, CLIN EXP METASTAS, V29, P865, DOI 10.1007/s10585-012-9465-5; Li MH, 2010, TUMORI, V96, P734, DOI 10.1177/030089161009600516; Li ZH, 2011, J NANOSCI NANOTECHNO, V11, P7521, DOI 10.1166/jnn.2011.5122; Liu XL, 2011, BIOCHEM BIOPH RES CO, V409, P577, DOI 10.1016/j.bbrc.2011.05.052; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Qian N, 2011, CANCER SCI, V102, P1590, DOI 10.1111/j.1349-7006.2011.01985.x; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Sun GY, 2012, CHINESE J CANCER RES, V24, P23, DOI 10.1007/s11670-012-0023-0; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Witkiewicz AK, 2009, CELL CYCLE, V8, P1654, DOI 10.4161/cc.8.11.8544; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Xue J, 2010, EUR J HISTOCHEM, V54, P99, DOI 10.4081/ejh.2010.e20; Zhang H, 2008, BRIT J CANCER, V99, P1684, DOI 10.1038/sj.bjc.6604735	38	50	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59102	10.1371/journal.pone.0059102	http://dx.doi.org/10.1371/journal.pone.0059102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23527097	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100075
J	Yang, LQ; Lin, FC; Zhou, Y; Xu, JR; Yu, CS; Pan, WJ; Lei, H				Yang, Liqin; Lin, Fuchun; Zhou, Yan; Xu, Jianrong; Yu, Chunshui; Pan, Wen-Ju; Lei, Hao			Iterative Cross-Correlation Analysis of Resting State Functional Magnetic Resonance Imaging Data	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; HUMAN BRAIN; MAJOR DEPRESSION; BLIND SEPARATION; CONNECTIVITY; CORTEX; MRI	Seed-based cross-correlation analysis (sCCA) and independent component analysis have been widely employed to extract functional networks from the resting state functional magnetic resonance imaging data. However, the results of sCCA, in terms of both connectivity strength and network topology, can be sensitive to seed selection variations. ICA avoids the potential problems due to seed selection, but choosing which component(s) to represent the network of interest could be subjective and problematic. In this study, we proposed a seed-based iterative cross-correlation analysis (siCCA) method for resting state brain network analysis. The method was applied to extract default mode network (DMN) and stable task control network (STCN) in two independent datasets acquired from normal adults. Compared with the networks obtained by traditional sCCA and ICA, the resting state networks produced by siCCA were found to be highly stable and independent on seed selection. siCCA was used to analyze DMN in first-episode major depressive disorder (MDD) patients. It was found that, in the MDD patients, the volume of DMN negatively correlated with the patients' social disability screening schedule scores.	[Yang, Liqin; Lin, Fuchun; Pan, Wen-Ju; Lei, Hao] Chinese Acad Sci, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Zhou, Yan; Xu, Jianrong] Jiao Tong Univ, Sch Med, RenJi Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yu, Chunshui] Capital Med Univ, XuanWu Hosp, Dept Radiol, Beijing, Peoples R China; [Yang, Liqin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Shanghai Jiao Tong University; Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pan, WJ (corresponding author), Chinese Acad Sci, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Wuhan, Peoples R China.	wpan5@emory.edu; leihao@wipm.ac.cn	, 雷皓/H-8147-2019; Lei, Hao/A-7004-2008; Lin, Fuchun/M-2789-2019; Lin, Fuchun/D-2371-2012	, 雷皓/0000-0003-3412-1241; Lei, Hao/0000-0003-3412-1241; Lin, Fuchun/0000-0002-2282-6474; Lin, Fuchun/0000-0002-2282-6474; Yu, Chunshui/0000-0001-5648-5199; Yang, Liqin/0000-0003-1823-4756	973 program of the Ministry of Science and Technology of China [2011CB707802]; National Natural Science Foundation of China [81171302, 20921004, 81171325, 30970901]; Shanghai Science and Technology Committee Medical Guide Project [114119a0900]; Shanghai Leading Academic Discipline Project [S30203]	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Medical Guide Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 973 program of the Ministry of Science and Technology of China (2011CB707802), National Natural Science Foundation of China (No. 81171302, 20921004, 81171325 and 30970901), Shanghai Science and Technology Committee Medical Guide Project (No. 114119a0900), and Shanghai Leading Academic Discipline Project (No. S30203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franco AR, 2009, HUM BRAIN MAPP, V30, P2293, DOI 10.1002/hbm.20668; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Press W. H., 1992, ART SCI COMPUTING; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Shen YW, 1985, HDB EPIDEMIOLOGICAL; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; STERIADE M, 1994, TRENDS NEUROSCI, V17, P199; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293	31	3	3	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58653	10.1371/journal.pone.0058653	http://dx.doi.org/10.1371/journal.pone.0058653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527002	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600009
J	Blasche, S; Mortl, M; Steuber, H; Siszler, G; Nisa, S; Schwarz, F; Lavrik, I; Gronewold, TMA; Maskos, K; Donnenberg, MS; Ullmann, D; Uetz, P; Koegl, M				Blasche, Sonja; Moertl, Mario; Steuber, Holger; Siszler, Gabriella; Nisa, Shahista; Schwarz, Frank; Lavrik, Inna; Gronewold, Thomas M. A.; Maskos, Klaus; Donnenberg, Michael S.; Ullmann, Dirk; Uetz, Peter; Koegl, Manfred			The E. coli Effector Protein NleF Is a Caspase Inhibitor	PLOS ONE			English	Article							BLOCK APOPTOSIS; ACTIVATION; SPECIFICITY; SELECTION; INTERACT; SYSTEM; GENES; ESPF	Enterohemorrhagic and enteropathogenic E. coli (EHEC and EPEC) can cause severe and potentially life-threatening infections. Their pathogenicity is mediated by at least 40 effector proteins which they inject into their host cells by a type-III secretion system leading to the subversion of several cellular pathways. However, the molecular function of several effectors remains unknown, even though they contribute to virulence. Here we show that one of them, NleF, binds to caspase-4, -8, and -9 in yeast two-hybrid, LUMIER, and direct interaction assays. NleF inhibits the catalytic activity of the caspases in vitro and in cell lysate and prevents apoptosis in HeLa and Caco-2 cells. We have solved the crystal structure of the caspase-9/NleF complex which shows that NleF uses a novel mode of caspase inhibition, involving the insertion of the carboxy-terminus of NleF into the active site of the protease. In conformance with our structural model, mutagenized NleF with truncated or elongated carboxy-termini revealed a complete loss in caspase binding and apoptosis inhibition. Evasion of apoptosis helps pathogenic E. coli and other pathogens to take over the host cell by counteracting the cell's ability to self-destruct upon infection. Recently, two other effector proteins, namely NleD and NleH, were shown to interfere with apoptosis. Even though NleF is not the only effector protein capable of apoptosis inhibition, direct inhibition of caspases by bacterial effectors has not been reported to date. Also unique so far is its mode of inhibition that resembles the one obtained for synthetic peptide-type inhibitors and as such deviates substantially from previously reported caspase-9 inhibitors such as the BIR3 domain of XIAP.	[Blasche, Sonja; Siszler, Gabriella; Schwarz, Frank; Koegl, Manfred] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany; [Moertl, Mario; Steuber, Holger; Maskos, Klaus; Ullmann, Dirk] Proteros Biostruct GmbH, Martinsried, Germany; [Nisa, Shahista; Donnenberg, Michael S.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Lavrik, Inna] German Canc Res Ctr, Div Immunogenet, Heidelberg, Germany; [Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [Gronewold, Thomas M. A.] SAW Instruments GmbH, Bonn, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University System of Maryland; University of Maryland Baltimore; Helmholtz Association; German Cancer Research Center (DKFZ); Virginia Commonwealth University	Uetz, P (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA.	uetz@vcu.edu	Lavrik, Inna N/C-1700-2009; Uetz, Peter/A-7119-2012; Schwarz, Frank/AGV-7773-2022	Lavrik, Inna N/0000-0002-9324-309X; Uetz, Peter/0000-0001-6194-4927; Donnenberg, Michael/0000-0002-8818-3184	European Union (EU) [HEALTH-F3-2009-223101]; National Institute of Allergy and Infectious Diseases [1U19AI090873]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090873] Funding Source: NIH RePORTER	European Union (EU)(CGIAREuropean Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Seventh Research Framework Programme of the European Union (AntiPathoGN; EU grant HEALTH-F3-2009-223101). SN and MSD were supported by award number 1U19AI090873 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Milh M, 2001, INFECT IMMUN, V69, P7356, DOI 10.1128/IAI.69.12.7356-7364.2001; Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Brune W, 2011, VIRUS RES, V157, P144, DOI 10.1016/j.virusres.2010.10.012; Bustamante VH, 1998, J BACTERIOL, V180, P3013, DOI 10.1128/JB.180.11.3013-3016.1998; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1045; Charatan F, 2006, BRIT MED J, V333, P673, DOI 10.1136/bmj.333.7570.673-c; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Echtenkamp F, 2008, FEMS MICROBIOL LETT, V281, P98, DOI 10.1111/j.1574-6968.2008.01088.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foster DB, 2000, INFECT IMMUN, V68, P3108, DOI 10.1128/IAI.68.6.3108-3115.2000; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Heczko U, 2001, INFECT IMMUN, V69, P4580, DOI 10.1128/IAI.69.7.4580-4589.2001; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LEVINE MM, 1978, LANCET, V1, P1119; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nougayrede JP, 2007, CELL MICROBIOL, V9, P680, DOI 10.1111/j.1462-5822.2006.00820.x; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Ozoren N, 2002, NEOPLASIA, V4, P551, DOI 10.1038/sj.neo.7900270; Papatheodorou P, 2006, CELL MICROBIOL, V8, P677, DOI 10.1111/j.1462-5822.2005.00660.x; Perpeet M, 2006, ANAL LETT, V39, P1747, DOI 10.1080/000327106006714063; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sollberger G, 2012, J IMMUNOL, V188, P1992, DOI 10.4049/jimmunol.1101620; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; Tahoun A, 2011, INFECT IMMUN; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Xu GZ, 2003, J BIOL CHEM, V278, P5455, DOI 10.1074/jbc.M211607200; Yamada T, 2011, INT J PARASITOL, V41, P595, DOI 10.1016/j.ijpara.2010.11.012; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	46	72	79	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58937	10.1371/journal.pone.0058937	http://dx.doi.org/10.1371/journal.pone.0058937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516580	gold, Green Submitted, Green Published			2022-12-27	WOS:000316407400079
J	Chakraborty, S				Chakraborty, Sandeep			A Quantitative Measure of Electrostatic Perturbation in Holo and Apo Enzymes Induced by Structural Changes	PLOS ONE			English	Article							TOXIN REPRESSOR DTXR; ULTRAHIGH-RESOLUTION STRUCTURE; ZN SUPEROXIDE-DISMUTASE; FREE-ENERGY COUPLINGS; BETA-LACTAMASE; PK(A) VALUES; ENZYMATIC-REACTIONS; CRYSTAL-STRUCTURES; TRANSITION-STATE; LIGAND-BINDING	Biological pathways are subject to subtle manipulations that achieve a wide range of functional variation in differing physiological niches. In many instances, changes in the structure of an enzyme on ligand binding germinate electrostatic perturbations that form the basis of its changed catalytic or transcriptional efficiency. Computational methods that seek to gain insights into the electrostatic changes in enzymes require expertise to setup and computing prowess. In the current work, we present a fast, easy and reliable methodology to compute electrostatic perturbations induced by ligand binding (MEPP). The theoretical foundation of MEPP is the conserved electrostatic potential difference (EPD) in cognate pairs of active site residues in proteins with the same functionality. Previously, this invariance has been used to unravel promiscuous serine protease and metallo-b-lactamase scaffolds in alkaline phosphatases. Given that a similarity in EPD is significant, we expect differences in the EPD to be significant too. MEPP identifies residues or domains that undergo significant electrostatic perturbations, and also enumerates residue pairs that undergo significant polarity change. The gain in a certain polarity of a residue with respect to neighboring residues, or the reversal of polarity between two residues might indicate a change in the preferred ligand. The methodology of MEPP has been demonstrated on several enzymes that employ varying mechanisms to perform their roles. For example, we have attributed the change in polarity in residue pairs to be responsible for the loss of metal ion binding in fructose 1,6-bisphosphatases, and corroborated the pre-organized state of the active site of the enzyme with respect to functionally relevant changes in electric fields in ketosteroid isomerases.	Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sanchak@gmail.com			Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology (JC Bose Award Grant)	Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology (JC Bose Award Grant)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy) and the Department of Science and Technology (JC Bose Award Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexov E, 2011, PROTEINS, V79, P3260, DOI 10.1002/prot.23189; Atkins P., 2006, PHYS CHEM; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bate P, 2004, J MOL BIOL, V340, P263, DOI 10.1016/j.jmb.2004.04.070; Chakraborty S, 2012, FEBS LETT, V586, P3710, DOI 10.1016/j.febslet.2012.08.030; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039577; Chakraborty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028470; Chen P, 2004, J AM CHEM SOC, V126, P4991, DOI 10.1021/ja031564g; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eisberg R. M., 1985, QUANTUM PHYS ATOMS M; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Fafarman AT, 2012, P NATL ACAD SCI USA, V109, pE299, DOI 10.1073/pnas.1111566109; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Fuhrmann CN, 2006, J AM CHEM SOC, V128, P9086, DOI 10.1021/ja057721o; Gao JL, 2006, CHEM REV, V106, P3188, DOI 10.1021/cr050293k; Grochowski P, 2008, BIOPOLYMERS, V89, P93, DOI 10.1002/bip.20877; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jha SK, 2011, P NATL ACAD SCI USA, V108, P16612, DOI 10.1073/pnas.1113874108; JOHNSON ML, 1986, BIOCHEMISTRY-US, V25, P791, DOI 10.1021/bi00352a009; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Kamerlin SCL, 2010, P NATL ACAD SCI USA, V107, P4075, DOI 10.1073/pnas.0914579107; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; Khare SD, 2003, J MOL BIOL, V334, P515, DOI 10.1016/j.jmb.2003.09.069; Kraut DA, 2006, PLOS BIOL, V4, P501, DOI 10.1371/journal.pbio.0040099; KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385; Love JF, 2004, P NATL ACAD SCI USA, V101, P2506, DOI 10.1073/pnas.0303794101; Love JF, 2003, J BACTERIOL, V185, P2251, DOI 10.1128/JB.185.7.2251-2258.2003; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Pohl E, 1998, J BIOL CHEM, V273, P22420, DOI 10.1074/jbc.273.35.22420; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Ren Z, 2012, P NATL ACAD SCI USA, V109, P107, DOI 10.1073/pnas.1109213108; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROYER WE, 1994, J MOL BIOL, V235, P657, DOI 10.1006/jmbi.1994.1019; Schmidlin T, 2009, BIOPHYS J, V97, P1709, DOI 10.1016/j.bpj.2009.06.043; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Suarez RK, 1997, P NATL ACAD SCI USA, V94, P7065, DOI 10.1073/pnas.94.13.7065; Tomanicek SJ, 2011, FEBS LETT, V585, P364, DOI 10.1016/j.febslet.2010.12.017; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tuzmen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016474; van Gunsteren W. F., 1987, GRONINGEN MOL SIMULA; Vonderach M, 2011, PHYS CHEM CHEM PHYS, V13, P15554, DOI 10.1039/c1cp21528k; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; WARSHEL A, 1981, ACCOUNTS CHEM RES, V14, P284, DOI 10.1021/ar00069a004; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1981, BIOCHEMISTRY-US, V20, P3167, DOI 10.1021/bi00514a028; Warshel A, 1981, Ann N Y Acad Sci, V367, P370, DOI 10.1111/j.1749-6632.1981.tb50579.x; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; Warshel A, 2007, BIOCHEMISTRY-US, V46, P1466, DOI 10.1021/bi061752u; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; WEBER G, 1987, BIOCHEMISTRY-US, V26, P331, DOI 10.1021/bi00375a046; Wei Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-119; White A, 1998, NATURE, V394, P502, DOI 10.1038/28893; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	63	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59352	10.1371/journal.pone.0059352	http://dx.doi.org/10.1371/journal.pone.0059352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516628	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400107
J	Koizumi, A; Kitagawa, N; Kondo, HM; Kitamura, MS; Sato, T; Kashino, M				Koizumi, Ai; Kitagawa, Norimichi; Kondo, Hirohito M.; Kitamura, Miho S.; Sato, Takao; Kashino, Makio			Serotonin Transporter Gene-Linked Polymorphism Affects Detection of Facial Expressions	PLOS ONE			English	Article							REGION 5-HTTLPR POLYMORPHISM; REGULATORY REGION; AMYGDALA ACTIVITY; DEPRESSION; STIMULI; ANXIETY; RECOGNITION; ASSOCIATION; INTENSITY; ATTENTION	Previous studies have demonstrated that the serotonin transporter gene-linked polymorphic region (5-HTTLPR) affects the recognition of facial expressions and attention to them. However, the relationship between 5-HTTLPR and the perceptual detection of others' facial expressions, the process which takes place prior to emotional labeling (i.e., recognition), is not clear. To examine whether the perceptual detection of emotional facial expressions is influenced by the allelic variation (short/long) of 5-HTTLPR, happy and sad facial expressions were presented at weak and mid intensities (25% and 50%). Ninety-eight participants, genotyped for 5-HTTLPR, judged whether emotion in images of faces was present. Participants with short alleles showed higher sensitivity (d') to happy than to sad expressions, while participants with long allele(s) showed no such positivity advantage. This effect of 5-HTTLPR was found at different facial expression intensities among males and females. The results suggest that at the perceptual stage, a short allele enhances the processing of positive facial expressions rather than that of negative facial expressions.	[Kitagawa, Norimichi; Kondo, Hirohito M.; Kitamura, Miho S.; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Kanagawa, Japan; [Koizumi, Ai; Sato, Takao] Univ Tokyo, Dept Psychol, Tokyo, Japan; [Koizumi, Ai; Kashino, Makio] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kanagawa, Japan; [Kitamura, Miho S.] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [Kashino, Makio] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; Tokyo Institute of Technology	Koizumi, A (corresponding author), NTT Corp, NTT Commun Sci Labs, Kanagawa, Japan.	bellkoizumi@gmail.com	Kitamura, Miho/Q-2405-2019; Kondo, Hirohito/H-3646-2011	Kondo, Hirohito/0000-0002-7444-4996	Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists [20-11352, 18-4848]; Grants-in-Aid for Scientific Research [24650130] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AK and MSK were supported by the Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists (20-11352 and 18-4848; http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antypa N, 2011, NEUROSCIENCE, V172, P303, DOI 10.1016/j.neuroscience.2010.10.042; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Becker DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026551; Beevers CG, 2011, J ABNORM PSYCHOL, V120, P187, DOI 10.1037/a0022125; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Ekman P., 2002, FACIAL ACTION CODING; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Friedel E, 2009, PSYCHOPHARMACOLOGY, V205, P261, DOI 10.1007/s00213-009-1536-1; Gelernter J, 1997, HUM GENET, V101, P243, DOI 10.1007/s004390050624; Gorea A, 2000, P NATL ACAD SCI USA, V97, P12380, DOI 10.1073/pnas.97.22.12380; Green DM, 1966, SIGNAL DETECTION THE; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Koizumi A, 2010, NEUROREPORT, V21, P422, DOI 10.1097/WNR.0b013e32833833f0; Lee BT, 2008, GENES BRAIN BEHAV, V7, P899, DOI 10.1111/j.1601-183X.2008.00429.x; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036513; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Macmillan N. A., 1993, HDB DATA ANAL BEHAV, P21; Murakami F, 1999, J HUM GENET, V44, P15, DOI 10.1007/s100380050098; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Thomason ME, 2010, BIOL PSYCHOL, V85, P38, DOI 10.1016/j.biopsycho.2010.04.009; Yoon KL, 2009, J ABNORM PSYCHOL, V118, P223, DOI 10.1037/a0014658	35	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e59074	10.1371/journal.pone.0059074	http://dx.doi.org/10.1371/journal.pone.0059074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516600	gold, Green Submitted, Green Published			2022-12-27	WOS:000316407400090
J	Kouskoura, T; Kozlova, A; Alexiou, M; Blumer, S; Zouvelou, V; Katsaros, C; Chiquet, M; Mitsiadis, TA; Graf, D				Kouskoura, Thaleia; Kozlova, Anastasiia; Alexiou, Maria; Blumer, Susanne; Zouvelou, Vasiliki; Katsaros, Christos; Chiquet, Matthias; Mitsiadis, Thimios A.; Graf, Daniel			The Etiology of Cleft Palate Formation in BMP7-Deficient Mice	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; MOUSE SECONDARY PALATE; MUTANT MICE; EPITHELIAL DIFFERENTIATION; MATRIX METALLOPROTEINASES; CRANIOFACIAL DEVELOPMENT; NEURAL CREST; BMP; PALATOGENESIS; EXPRESSION	Palatogenesis is a complex process implying growth, elevation and fusion of the two lateral palatal shelves during embryogenesis. This process is tightly controlled by genetic and mechanistic cues that also coordinate the growth of other orofacial structures. Failure at any of these steps can result in cleft palate, which is a frequent craniofacial malformation in humans. To understand the etiology of cleft palate linked to the BMP signaling pathway, we studied palatogenesis in Bmp7-deficient mouse embryos. Bmp7 expression was found in several orofacial structures including the edges of the palatal shelves prior and during their fusion. Bmp7 deletion resulted in a general alteration of oral cavity morphology, unpaired palatal shelf elevation, delayed shelf approximation, and subsequent lack of fusion. Cell proliferation and expression of specific genes involved in palatogenesis were not altered in Bmp7-deficient embryos. Conditional ablation of Bmp7 with Keratin14-Cre or Wnt1-Cre revealed that neither epithelial nor neural crest-specific loss of Bmp7 alone could recapitulate the cleft palate phenotype. Palatal shelves from mutant embryos were able to fuse when cultured in vitro as isolated shelves in proximity, but not when cultured as whole upper jaw explants. Thus, deformations in the oral cavity of Bmp7-deficient embryos such as the shorter and wider mandible were not solely responsible for cleft palate formation. These findings indicate a requirement for Bmp7 for the coordination of both developmental and mechanistic aspects of palatogenesis.	[Kouskoura, Thaleia; Kozlova, Anastasiia; Alexiou, Maria; Mitsiadis, Thimios A.; Graf, Daniel] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland; [Kouskoura, Thaleia; Blumer, Susanne; Katsaros, Christos; Chiquet, Matthias] Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Zouvelou, Vasiliki] Univ Athens, Sch Med, Dept Histol & Embryol, Athens 11528, Greece	University of Zurich; University of Bern; Athens Medical School; National & Kapodistrian University of Athens	Graf, D (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	daniel.graf@zzm.uzh.ch	Mitsiadis, Thimios/B-5564-2016	Mitsiadis, Thimios/0000-0002-9812-9982; Graf, Daniel/0000-0003-1163-8117; Katsaros, Christos/0000-0001-5545-6740; Chiquet, Matthias/0000-0001-7812-4853	University of Zurich; Swiss National Science Foundation (SNSF) [31003A-135530]; Swiss Dental Association (SSO) [234-07, 255/10]	University of Zurich; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Dental Association (SSO)	This work was supported by funds from the University of Zurich, the Swiss National Science Foundation (SNSF) (grant 31003A-135530 to D.G.and T.A.M.), and the Swiss Dental Association (SSO) for the Projects 234-07 (T.A.M.) and 255/10 (T.K.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Barlow AJ, 1997, DEVELOPMENT, V124, P391; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Bloch-Zupan A, 2011, AM J HUM GENET, V89, P773, DOI 10.1016/j.ajhg.2011.11.002; Bonilla-Claudio M, 2012, DEVELOPMENT, V139, P709, DOI 10.1242/dev.073197; BRINKLEY LL, 1987, DEVELOPMENT, V100, P629; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chou MJ, 2004, ANAT EMBRYOL, V208, P19, DOI 10.1007/s00429-004-0379-0; d'Amaro R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00377; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DIEWERT VM, 1981, TERATOLOGY, V24, P43, DOI 10.1002/tera.1420240106; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Gkantidis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047762; Godin RE, 1998, DEVELOPMENT, V125, P3473; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Jin JZ, 2008, CELL TISSUE RES, V333, P29, DOI 10.1007/s00441-008-0612-x; Jin JZ, 2010, DEV DYNAM, V239, P2110, DOI 10.1002/dvdy.22339; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kouskoura Thaleia, 2011, Schweiz Monatsschr Zahnmed, V121, P636; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lavrin IO, 2001, ARCH ORAL BIOL, V46, P865, DOI 10.1016/S0003-9969(01)00044-9; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Li IWS, 1996, J CELL PHYSIOL, V169, P115, DOI 10.1002/(SICI)1097-4652(199610)169:1<115::AID-JCP12>3.0.CO;2-C; Li L, 2011, DEV BIOL, V349, P451, DOI 10.1016/j.ydbio.2010.10.023; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Lu HB, 2000, ARCH ORAL BIOL, V45, P133, DOI 10.1016/S0003-9969(99)00118-1; Maddox BK, 1998, J CRAN GENET DEV BIO, V18, P195; Martinez-Sanz E, 2008, DIFFERENTIATION, V76, P417, DOI 10.1111/j.1432-0436.2007.00226.x; Meng L, 2009, J DENT RES, V88, P22, DOI 10.1177/0022034508327868; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Morris-Wiman J, 1999, J CRAN GENET DEV BIO, V19, P201; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Prows C A, 1999, Neonatal Netw, V18, P13; Ricks JE, 2002, TERATOLOGY, V65, P116, DOI 10.1002/tera.10022; Sani FV, 2010, EUR J ORAL SCI, V118, P221, DOI 10.1111/j.1600-0722.2010.00732.x; SEEGMILLER RE, 1977, J EMBRYOL EXP MORPH, V38, P227; SHIOTA K, 1990, ACTA ANAT, V137, P59; SHULER CF, 1995, CRIT REV ORAL BIOL M, V6, P202, DOI 10.1177/10454411950060030301; Snead MP, 1999, J MED GENET, V36, P353; Tsunekawa N, 2005, EUR J NEUROSCI, V21, P173, DOI 10.1111/j.1460-9568.2004.03860.x; Vieira AR, 2008, J DENT RES, V87, P119, DOI 10.1177/154405910808700202; Wang YH, 1999, DEV DYNAM, V216, P320, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<320::AID-DVDY2>3.0.CO;2-H; Wyatt AW, 2010, HUM MUTAT, V31, P781, DOI 10.1002/humu.21280; Yu K, 2011, DEV DYNAM, V240, P1737, DOI 10.1002/dvdy.22670; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz; Zouvelou V, 2009, J EXP ZOOL PART B, V312B, P361, DOI 10.1002/jez.b.21262	61	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							0059463	10.1371/journal.pone.0059463	http://dx.doi.org/10.1371/journal.pone.0059463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516636	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400112
J	Liu, J; Liu, FY; Tong, ZQ; Li, ZH; Chen, W; Luo, WH; Li, H; Luo, HJ; Tang, Y; Tang, JM; Cai, J; Liao, FF; Wan, Y				Liu, Jia; Liu, Feng-Yu; Tong, Zhi-Qian; Li, Zhi-Hua; Chen, Wen; Luo, Wen-Hong; Li, Hui; Luo, Hong-Jun; Tang, Yan; Tang, Jun-Min; Cai, Jie; Liao, Fei-Fei; Wan, You			Lysine-Specific Demethylase 1 in Breast Cancer Cells Contributes to the Production of Endogenous Formaldehyde in the Metastatic Bone Cancer Pain Model of Rats	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE ALDH; DYNAMIC-RANGE NEURONS; ROOT GANGLION NEURONS; SPINAL DORSAL-HORN; SERINE HYDROXYMETHYLTRANSFERASE; DIMETHYLGLYCINE DEHYDROGENASE; INFLAMMATORY NOCICEPTION; DIFFERENT INTENSITIES; ECTOPIC DISCHARGES; NEUROPATHIC PAIN	Background: Bone cancer pain seriously affects the quality of life of cancer patients. Our previous study found that endogenous formaldehyde was produced by cancer cells metastasized into bone marrows and played an important role in bone cancer pain. However, the mechanism of production of this endogenous formaldehyde by metastatic cancer cells was unknown in bone cancer pain rats. Lysine-specific demethylase 1 (LSD1) is one of the major enzymes catalyzing the production of formaldehyde. The expression of LSD1 and the concentration of formaldehyde were up-regulated in many high-risk tumors. Objective: This study aimed to investigate whether LSD1 in metastasized MRMT-1 breast cancer cells in bone marrows participated in the production of endogenous formaldehyde in bone cancer pain rats. Methodology/Principal Findings: Concentration of the endogenous formaldehyde was measured by high performance liquid chromatography (HPLC). Endogenous formaldehyde dramatically increased in cultured MRMT-1 breast cancer cells in vitro, in bone marrows and sera of bone cancer pain rats, in tumor tissues and sera of MRMT-1 subcutaneous vaccination model rats in vivo. Formaldehyde at a concentration as low as the above measured (3 mM) induced pain behaviors in normal rats. The expression of LSD1 which mainly located in nuclei of cancer cells significantly increased in bone marrows of bone cancer pain rats from 14 d to 21 d after inoculation. Furthermore, inhibition of LSD1 decreased the production of formaldehyde in MRMT-1 cells in vitro. Intraperitoneal injection of LSD1 inhibitor pargyline from 3 d to 14 d after inoculation of MRMT-1 cancer cells reduced bone cancer pain behaviors. Conclusion: Our data in the present study, combing our previous report, suggested that in the endogenous formaldehyde-induced pain in bone cancer pain rats, LSD1 in metastasized cancer cells contributed to the production of the endogenous formaldehyde.	[Liu, Jia; Liu, Feng-Yu; Tong, Zhi-Qian; Li, Zhi-Hua; Chen, Wen; Cai, Jie; Liao, Fei-Fei; Wan, You] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Liu, Jia; Liu, Feng-Yu; Tong, Zhi-Qian; Li, Zhi-Hua; Chen, Wen; Cai, Jie; Liao, Fei-Fei; Wan, You] Peking Univ, Dept Neurobiol, Beijing 100871, Peoples R China; [Tong, Zhi-Qian] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Li, Zhi-Hua] Zhengzhou Univ, Basic Med Coll, Dept Anat, Zhengzhou, Peoples R China; [Luo, Wen-Hong; Li, Hui; Luo, Hong-Jun] Shantou Univ, Coll Med, Cent Lab, Shantou, Peoples R China; [Tang, Yan; Tang, Jun-Min] Peking Univ, Sch Basic Med Sci, Dept Anat & Histol, Beijing 100871, Peoples R China; [Wan, You] Minist Hlth, Minist Educ, Key Lab Neurosci, Beijing, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Zhengzhou University; Shantou University; Peking University	Wan, Y (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China.	ywan@hsc.pku.edu.cn	cai, jie/HHS-0606-2022; Wan, You/M-5279-2019	Wan, You/0000-0001-6110-7192	National Natural Science Foundation of China [81171042, 81070893]; Specialized Research Fund for Doctoral Program of Higher Education [20110001110058]; Key Project of Chinese Ministry of Education [109003]; Beijing Municipal Commission of Education "Special Grants for Outstanding Ph.D. Program Tutors"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Beijing Municipal Commission of Education "Special Grants for Outstanding Ph.D. Program Tutors"	This research was supported by grants from the National Natural Science Foundation of China (81171042, 81070893), Specialized Research Fund for Doctoral Program of Higher Education (20110001110058), the Key Project of Chinese Ministry of Education (109003) and Beijing Municipal Commission of Education "Special Grants for Outstanding Ph.D. Program Tutors". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J MOL MICROB BIOTECH, V6, P67, DOI 10.1159/000076737; ALOISI AM, 1995, BRAIN RES, V699, P242, DOI 10.1016/0006-8993(95)00912-A; ALOISI AM, 1995, PHYSIOL BEHAV, V58, P603, DOI 10.1016/0031-9384(95)00099-5; Binzak BA, 2001, AM J HUM GENET, V68, P839, DOI 10.1086/319520; Chi YN, 2012, NEUROSCI BULL, V28, P715, DOI 10.1007/s12264-012-1284-9; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Ebeler SE, 1997, J CHROMATOGR B, V702, P211, DOI 10.1016/S0378-4347(97)00369-1; Grant S, 2009, CLIN CANCER RES, V15, P7111, DOI 10.1158/1078-0432.CCR-09-2399; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Han Y, 2012, NEUROSCI BULL, V28, P165, DOI 10.1007/s12264-012-1211-0; HARADA Y, 1976, CANCER RES, V36, P18; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Ho YC, 2007, J BIOMED MATER RES B, V83B, P340, DOI 10.1002/jbm.b.30801; Huang Y, 2012, BREAST CANCER RES TR, V131, P777, DOI 10.1007/s10549-011-1480-8; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V88, P1; Jelski W, 2008, CLIN CHIM ACTA, V395, P1, DOI 10.1016/j.cca.2008.05.001; Jelski W, 2006, J CLIN LAB ANAL, V20, P105, DOI 10.1002/jcla.20109; Jiang YQ, 2008, PAIN, V137, P495, DOI 10.1016/j.pain.2007.10.011; Kalasz H, 2003, MINI-REV MED CHEM, V3, P175, DOI 10.2174/1389557033488187; Kauffman EC, 2011, MOL CARCINOGEN, V50, P931, DOI 10.1002/mc.20758; Liu FY, 2007, J PHARMACOL EXP THER, V321, P1046, DOI 10.1124/jpet.106.115204; Liu FY, 2012, BRAIN RES, V1427, P65, DOI 10.1016/j.brainres.2011.10.016; Liu FY, 2011, NEUROSCI BULL, V27, P1, DOI 10.1007/s12264-011-1039-z; Liu FY, 2010, BRAIN RES, V1330, P45, DOI 10.1016/j.brainres.2010.03.010; Lu Y, 2008, BRAIN RES, V1200, P19, DOI 10.1016/j.brainres.2008.01.012; Luo WH, 2001, J CHROMATOGR B, V753, P253, DOI 10.1016/S0378-4347(00)00552-1; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; Lyles GA, 1996, INT J BIOCHEM CELL B, V28, P259, DOI 10.1016/1357-2725(95)00130-1; MacAllister SL, 2011, CHEM-BIOL INTERACT, V191, P308, DOI 10.1016/j.cbi.2011.01.017; MACKENZIE CG, 1956, J BIOL CHEM, V222, P145; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; Mercadante S, 1997, PAIN, V69, P1, DOI 10.1016/S0304-3959(96)03267-8; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nagae M, 2007, J BONE MINER METAB, V25, P99, DOI 10.1007/s00774-006-0734-8; Peters CM, 2004, NEUROSCIENCE, V126, P1043, DOI 10.1016/j.neuroscience.2004.04.027; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Pradhan AAA, 2010, EUR J PAIN, V14, P503, DOI 10.1016/j.ejpain.2009.08.010; QUADRI SK, 1973, P SOC EXP BIOL MED, V142, P22; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Sabino M. C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P561; SCHIRCH V, 1986, EUR J BIOCHEM, V161, P45, DOI 10.1111/j.1432-1033.1986.tb10122.x; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Sevcik MA, 2005, PAIN, V115, P128, DOI 10.1016/j.pain.2005.02.022; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P1354, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1354::AID-RCM641>3.0.CO;2-J; Su YL, 2010, NEUROSCI BULL, V26, P429, DOI 10.1007/s12264-010-0932-1; Sun Q, 2005, BRAIN RES, V1032, P63, DOI 10.1016/j.brainres.2004.10.033; Sun Q, 2005, EXP NEUROL, V191, P128, DOI 10.1016/j.expneurol.2004.09.008; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Terry MB, 2006, CARCINOGENESIS, V27, P840, DOI 10.1093/carcin/bgi285; THORNDIKE J, 1977, CANCER RES, V37, P1125; Tong ZQ, 2013, AGE, V35, P583, DOI 10.1007/s11357-012-9388-8; Tong ZQ, 2011, NEUROBIOL AGING, V32, P31, DOI 10.1016/j.neurobiolaging.2009.07.013; Tong ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010234; Wang JW, 2012, NEUROCHEM RES, V37, P2125, DOI 10.1007/s11064-012-0834-x; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Willmann D, 2012, INT J CANCER, V131, P2704, DOI 10.1002/ijc.27555; Xing GG, 2007, EXP NEUROL, V208, P323, DOI 10.1016/j.expneurol.2007.09.004; Yi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-61; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	64	23	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58957	10.1371/journal.pone.0058957	http://dx.doi.org/10.1371/journal.pone.0058957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516587	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400084
J	Shin, JR; Lim, KJ; Kim, DJ; Cho, JH; Kim, SC				Shin, Ju Ri; Lim, Ki Jung; Kim, Da Jung; Cho, Ju Hyun; Kim, Sun Chang			Display of Multimeric Antimicrobial Peptides on the Escherichia coli Cell Surface and Its Application as Whole-Cell Antibiotics	PLOS ONE			English	Article							RESISTANCE; GROWTH; HISTORY; AGENTS	Concerns over the increasing emergence of antibiotic-resistant pathogenic microorganisms due to the overuse of antibiotics and the lack of effective antibiotics for livestock have prompted efforts to develop alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) with a broad-spectrum activity and rapid killing, along with little opportunity for the development of resistance, represent one of the promising novel alternatives. Their high production cost and cytotoxicity, however, limit the use of AMPs as effective antibiotic agents to livestock. To overcome these problems, we developed potent antimicrobial Escherichia coli displaying multimeric AMPs on the cell surface so that the AMP multimers can be converted into active AMP monomers by the pepsin in the stomach of livestock. Buf IIIb, a strong AMP without cytotoxicity, was expressed on the surface of E. coli as Lpp-OmpA-fused tandem multimers with a pepsin substrate residue, leucine, at the C-terminus of each monomer. The AMP multimers were successfully converted into active AMPs upon pepsin cleavage, and the liberated Buf IIIb-L monomers inhibited the growth of two major oral infectious pathogens of livestock, Salmonella enteritidis and Listeria monocytogenes. Live antimicrobial microorganisms developed in this study may represent the most effective means of providing potent AMPs to livestock, and have a great impact on controlling over pathogenic microorganisms in the livestock production.	[Shin, Ju Ri; Lim, Ki Jung; Kim, Da Jung; Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Cho, Ju Hyun] Gyeongsang Natl Univ, Dept Biol, Life Sci Res Inst, Jinju, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Gyeongsang National University	Cho, JH (corresponding author), Gyeongsang Natl Univ, Dept Biol, Life Sci Res Inst, Jinju, South Korea.	juhyun.cho@gnu.ac.kr; sunkim@kaist.ac.kr	Kim, Sun Chang/C-2026-2011; Kim, Sun/GSN-4867-2022		Next-Generation BioGreen 21 Program (SSAC) [PJ008110]; Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology [2011-0031955]	Next-Generation BioGreen 21 Program (SSAC)(Rural Development Administration (RDA), Republic of Korea); Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Next-Generation BioGreen 21 Program (SSAC; PJ008110), the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106; Burdock GA, 2004, TOXICOL LETT, V150, P3, DOI 10.1016/j.toxlet.2003.07.004; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Conly J, 2002, CAN MED ASSOC J, V167, P885; FRANCISCO JA, 1992, P NATL ACAD SCI USA, V89, P2713, DOI 10.1073/pnas.89.7.2713; Funk JA, 2006, MICROB DRUG RESIST, V12, P210, DOI 10.1089/mdr.2006.12.210; Ingham AB, 2007, BIOTECHNOL APPL BIOC, V47, P1, DOI 10.1043/BA20060207; Inglis GD, 2005, APPL ENVIRON MICROB, V71, P3872, DOI 10.1128/AEM.71.7.3872-3881.2005; Jang SA, 2012, PEPTIDES, V34, P283, DOI 10.1016/j.peptides.2012.01.015; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129; Kim JM, 2008, APPL MICROBIOL BIOT, V78, P123, DOI 10.1007/s00253-007-1273-5; Lee SH, 2004, APPL ENVIRON MICROB, V70, P5074, DOI 10.1128/AEM.70.9.5074-5080.2004; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Lloyd DH, 2012, VET DERMATOL, V23, P299, DOI 10.1111/j.1365-3164.2012.01042.x; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Melton-Witt JA, 2012, INFECT IMMUN, V80, P720, DOI 10.1128/IAI.05958-11; Merrell DS, 2002, CURR OPIN MICROBIOL, V5, P51, DOI 10.1016/S1369-5274(02)00285-0; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; MOORE PR, 1946, J BIOL CHEM, V165, P437; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Park IY, 2004, J BIOL CHEM, V279, P13896, DOI 10.1074/jbc.M311418200; Sambrook J., 2001, MOL CLONING LAB MANU; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Sivula CP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-182; Stathopoulos C, 1996, APPL MICROBIOL BIOT, V45, P112, DOI 10.1007/s002530050657; Strandberg KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049588; Wang AJA, 2002, APPL ENVIRON MICROB, V68, P1684, DOI 10.1128/AEM.68.4.1684-1689.2002; Yan F, 2004, CURR OPIN GASTROEN, V20, P565, DOI 10.1097/00001574-200411000-00011	30	14	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58997	10.1371/journal.pone.0058997	http://dx.doi.org/10.1371/journal.pone.0058997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516591	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400087
J	Amran, MY; Fujii, J; Suzuki, SO; Kolling, GL; Villanueva, SYAM; Kainuma, M; Kobayashi, H; Kameyama, H; Yoshida, S				Amran, Muhammad Yunus; Fujii, Jun; Suzuki, Satoshi O.; Kolling, Glynis L.; Villanueva, Sharon Y. A. M.; Kainuma, Mosaburo; Kobayashi, Hideyuki; Kameyama, Hideko; Yoshida, Shin-ichi			Investigation of Encephalopathy Caused by Shiga Toxin 2c-Producing Escherichia coli Infection in Mice	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; CENTRAL-NERVOUS-SYSTEM; GB3/CD77 SYNTHASE GENE; CELLS IN-VITRO; ENDOTHELIAL-CELLS; O104/H4 OUTBREAK; BRAIN; MODEL; AQUAPORIN-4; SCLEROSIS	A large outbreak of Shiga toxin (Stx)-producing enteroaggregative Escherichia coli (EAEC) O104:H4 occurred in northern Germany. From this outbreak, at least 900 patients developed hemolytic uremic syndrome (HUS), resulting in more than 50 deaths. Thirty percent of the HUS patients showed encephalopathy. We previously established a mouse model with encephalopathy associated with blood brain barrier (BBB) damage after oral infection with the Shiga toxin (Stx) 2c-producing Escherichia coli O157:H- strain E32511 (E32511). In this model, we detected high expression of the Stx receptor synthase enzyme, glycosphingolipid globotriaosylceramide (Gb3) synthase, in endothelial cells (ECs) and neurons in the reticular formation of the medulla oblongata by in situ hybridization. Caspase-3 was activated in neurons in the reticular formation of the medulla oblongata and the anterior horn of the spinal cord. Astrocytes (ASTs) were activated in the medulla oblongata and spinal cord, and a decrease in aquaporin 4 around the ECs suggested that BBB integrity was compromised directly by Stx2c or through the activation of ASTs. We also report the effectiveness of azithromycin (AZM) in our model. Moreover, AZM strongly inhibited the release of Stx2c from E32511 in vitro.	[Amran, Muhammad Yunus; Fujii, Jun; Villanueva, Sharon Y. A. M.; Kameyama, Hideko; Yoshida, Shin-ichi] Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Fukuoka 812, Japan; [Suzuki, Satoshi O.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka 812, Japan; [Kolling, Glynis L.] Univ Virginia, Ctr Global Hlth, Charlottesville, VA USA; [Kainuma, Mosaburo] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka 812, Japan; [Kobayashi, Hideyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Chem, Kitakyushu, Fukuoka 807, Japan; [Amran, Muhammad Yunus] Hasanuddin Univ, Fac Med, Hasanuddin Univ Hosp, Dept Neurol, Makassar, South Sulawesi, Indonesia	Kyushu University; Kyushu University; University of Virginia; Kyushu University; University of Occupational & Environmental Health - Japan; Universitas Hasanuddin	Amran, MY (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Bacteriol, Fukuoka 812, Japan.	yunus09@bact.med.kyushu-u.ac.jp	Suzuki, Satoshi O/H-8367-2019	Suzuki, Satoshi O/0000-0002-0742-5680; Villanueva, Sharon Yvette Angelina/0000-0001-6958-4110	Health and Labor Sciences Research Grants for Research on global health issues from the Ministry of Health, Labor and Welfare, Japan [851114300001]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23500479, 22590256]	Health and Labor Sciences Research Grants for Research on global health issues from the Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by funds from the 851114300001 Health and Labor Sciences Research Grants for Research on global health issues from the Ministry of Health, Labor and Welfare, Japan and grant 23500479 and 22590256 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR FE, 1987, DEV BRAIN RES, V36, P155, DOI 10.1016/0165-3806(87)90075-7; Bauwens A, 2011, THROMB HAEMOSTASIS, V105, P515, DOI 10.1160/TH10-02-0140; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; FORSYTH KD, 1989, LANCET, V2, P411; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Fujii J, 2003, INFECT IMMUN, V71, P2724, DOI 10.1128/IAI.71.5.2724-2735.2003; FUJII J, 1994, INFECT IMMUN, V62, P3447, DOI 10.1128/IAI.62.8.3447-3453.1994; Fujii J, 1996, INFECT IMMUN, V64, P5053, DOI 10.1128/IAI.64.12.5053-5060.1996; Fujii J, 2008, INFECT IMMUN, V76, P3679, DOI 10.1128/IAI.01581-07; Fujii J, 2009, MICROB PATHOGENESIS, V46, P179, DOI 10.1016/j.micpath.2009.01.005; Furukawa K, 2002, J BIOL CHEM, V277, P11247, DOI 10.1074/jbc.M109519200; Goldstein J, 2007, BRAIN RES, V1161, P106, DOI 10.1016/j.brainres.2007.05.067; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Hamm S, 2004, CELL TISSUE RES, V315, P157, DOI 10.1007/s00441-003-0825-y; Ikeda K, 1999, CLIN NEPHROL, V52, P357; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Landoni VI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002632; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; LOUISE CB, 1992, INFECT IMMUN, V60, P1536, DOI 10.1128/IAI.60.4.1536-1543.1992; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Matano S, 2012, J INFECT CHEMOTHER, V18, P558, DOI 10.1007/s10156-011-0336-9; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Nitschke M, 2012, JAMA-J AM MED ASSOC, V307, P1046, DOI 10.1001/jama.2012.264; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; Ohara T, 2002, ANTIMICROB AGENTS CH, V46, P3478, DOI 10.1128/AAC.46.11.3478-3483.2002; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rooney J C, 1971, Aust Paediatr J, V7, P28; Siegler RL, 1995, PEDIATR CLIN N AM, V42, P1505; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Smith M C, 1993, MLO Med Lab Obs, V25, P67; Lucero MS, 2012, MICROB PATHOGENESIS, V53, P87, DOI 10.1016/j.micpath.2012.05.005; Steinborn M, 2004, PEDIATR RADIOL, V34, P805, DOI 10.1007/s00247-004-1289-2; STROCKBINE NA, 1988, J BACTERIOL, V170, P1116, DOI 10.1128/jb.170.3.1116-1122.1988; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; UPADHYAYA K, 1980, PEDIATRICS, V65, P115; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; WIELS J, 1981, P NATL ACAD SCI-BIOL, V78, P6485, DOI 10.1073/pnas.78.10.6485; Wong CS, 2012, CLIN INFECT DIS, V55, P33, DOI 10.1093/cid/cis299; Yamada Y, 1999, ANN NEUROL, V45, P716; Yoshimura K, 1999, FEMS IMMUNOL MED MIC, V26, P101, DOI 10.1016/S0928-8244(99)00119-4; Zhang QS, 2009, J INFECT DIS, V199, P486, DOI 10.1086/596509	49	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58959	10.1371/journal.pone.0058959	http://dx.doi.org/10.1371/journal.pone.0058959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516588	Green Published, gold			2022-12-27	WOS:000316849200125
J	Artamonov, M; Momotani, K; Utepbergenov, D; Franke, A; Khromov, A; Derewenda, ZS; Somlyo, AV				Artamonov, Mykhaylo; Momotani, Ko; Utepbergenov, Darkhan; Franke, Aaron; Khromov, Alexander; Derewenda, Zygmunt S.; Somlyo, Avril V.			The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; PROTEIN PHOSPHATASE; CA2+ SENSITIZATION; SMALL-SUBUNIT; MAP KINASES; PHOSPHORYLATION; ACTIVATION; GROWTH; CELLS; DIPHOSPHORYLATION	In the canonical model of smooth muscle (SM) contraction, the contractile force is generated by phosphorylation of the myosin regulatory light chain (RLC20) by the myosin light chain kinase (MLCK). Moreover, phosphorylation of the myosin targeting subunit (MYPT1) of the RLC20 phosphatase (MLCP) by the RhoA-dependent ROCK kinase, inhibits the phosphatase activity and consequently inhibits dephosphorylation of RLC20 with concomitant increase in contractile force, at constant intracellular [Ca2+]. This pathway is referred to as Ca2+-sensitization. There is, however, emerging evidence suggesting that additional Ser/Thr kinases may contribute to the regulatory pathways in SM. Here, we report data implicating the p90 ribosomal S6 kinase (RSK) in SM contractility. During both Ca2+- and agonist (U46619) induced SM contraction, RSK inhibition by the highly selective compound BI-D1870 (which has no effect on MLCK or ROCK) resulted in significant suppression of contractile force. Furthermore, phosphorylation levels of RLC20 and MYPT1 were both significantly decreased. Experiments involving the irreversible MLCP inhibitor microcystin-LR, in the absence of Ca2+, revealed that the decrease in phosphorylation levels of RLC20 upon RSK inhibition are not due solely to the increase in the phosphatase activity, but reflect direct or indirect phosphorylation of RLC20 by RSK. Finally, we show that agonist (U46619) stimulation of SM leads to activation of extracellular signal-regulated kinases ERK1/2 and PDK1, consistent with a canonical activation cascade for RSK. Thus, we demonstrate a novel and important physiological function of the p90 ribosomal S6 kinase, which to date has been typically associated with the regulation of gene expression.	[Artamonov, Mykhaylo; Momotani, Ko; Utepbergenov, Darkhan; Franke, Aaron; Khromov, Alexander; Derewenda, Zygmunt S.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA	University of Virginia	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA.	avs5u@virginia.edu	Utepbergenov, Darkhan/N-9881-2014; Utepbergenov, Darkhan/AAA-1249-2021; Artamonov, Mykhaylo/AAD-3488-2021	Utepbergenov, Darkhan/0000-0002-9005-4103; Utepbergenov, Darkhan/0000-0002-9005-4103; Artamonov, Mykhaylo/0000-0002-0848-2054	University of Virginia Cancer Center through the NCI Cancer Center Support Grant [P30CA44579]; National Institutes of Health [R01GM86457, R01DK088905]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086457] Funding Source: NIH RePORTER	University of Virginia Cancer Center through the NCI Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the University of Virginia Cancer Center through the NCI Cancer Center Support Grant (P30CA44579) and in part by the National Institutes of Health (R01GM86457 to ZSD and AVS, and R01DK088905 to AVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Chao A, 2012, J PROTEOMICS, V75, P3342, DOI 10.1016/j.jprot.2012.03.043; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081, DOI 10.1152/ajpcell.1998.275.4.C1081; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; HAYSTEAD CMM, 1993, EUR J BIOCHEM, V214, P459, DOI 10.1111/j.1432-1033.1993.tb17942.x; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; HORIUTI K, 1988, J PHYSIOL-LONDON, V398, P131, DOI 10.1113/jphysiol.1988.sp017034; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Kawai M, 2007, J MUSCLE RES CELL M, V28, P371, DOI 10.1007/s10974-008-9131-3; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; Kuemmerle JF, 2003, AM J PHYSIOL-GASTR L, V284, pG411, DOI 10.1152/ajpgi.00310.2002; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Miggin SM, 2001, BBA-MOL CELL RES, V1539, P147, DOI 10.1016/S0167-4889(01)00103-3; Moffat LD, 2011, J BIOL CHEM, V286, P36978, DOI 10.1074/jbc.M111.257949; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Morrison DL, 1996, BIOCHEM CELL BIOL, V74, P549, DOI 10.1139/o96-459; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rocic P, 2001, AM J PHYSIOL-CELL PH, V280, pC90, DOI 10.1152/ajpcell.2001.280.1.C90; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith JA, 2005, CANCER RES, V65, P1027; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; SOMLYO AV, 1988, J GEN PHYSIOL, V91, P165, DOI 10.1085/jgp.91.2.165; Suizu F, 2000, J BIOCHEM-TOKYO, V128, P435, DOI 10.1093/oxfordjournals.jbchem.a022771; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Takizawa N, 2003, AM J PHYSIOL-CELL PH, V284, pC250, DOI 10.1152/ajpcell.00153.2002; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Xiao DL, 2002, AM J PHYSIOL-HEART C, V282, pH292, DOI 10.1152/ajpheart.2002.282.1.H292; Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905; Zhou YB, 1999, BIOCHEM BIOPH RES CO, V254, P158, DOI 10.1006/bbrc.1998.9915	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58703	10.1371/journal.pone.0058703	http://dx.doi.org/10.1371/journal.pone.0058703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516539	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200107
J	Baez, S; Herrera, E; Villarin, L; Theil, D; Gonzalez-Gadea, ML; Gomez, P; Mosquera, M; Huepe, D; Strejilevich, S; Vigliecca, NS; Matthaus, F; Decety, J; Manes, F; Ibanes, AM				Baez, Sandra; Herrera, Eduar; Villarin, Lilian; Theil, Donna; Luz Gonzalez-Gadea, Maria; Gomez, Pedro; Mosquera, Marcela; Huepe, David; Strejilevich, Sergio; Silvana Vigliecca, Nora; Matthaeus, Franziska; Decety, Jean; Manes, Facundo; Ibanes, Agustin M.			Contextual Social Cognition Impairments in Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							FACIAL AFFECT RECOGNITION; FRONTAL SCREENING IFS; CLINICAL HIGH-RISK; EMOTION RECOGNITION; EMPATHIC ABILITIES; BEHAVIORAL VARIANT; VISUAL CONTEXT; PERCEPTION; DEFICITS; EXPRESSIONS	Background: The ability to integrate contextual information with social cues to generate social meaning is a key aspect of social cognition. It is widely accepted that patients with schizophrenia and bipolar disorders have deficits in social cognition; however, previous studies on these disorders did not use tasks that replicate everyday situations. Methodology/Principal Findings: This study evaluates the performance of patients with schizophrenia and bipolar disorders on social cognition tasks (emotional processing, empathy, and social norms knowledge) that incorporate different levels of contextual dependence and involvement of real-life scenarios. Furthermore, we explored the association between social cognition measures, clinical symptoms and executive functions. Using a logistic regression analysis, we explored whether the involvement of more basic skills in emotional processing predicted performance on empathy tasks. The results showed that both patient groups exhibited deficits in social cognition tasks with greater context sensitivity and involvement of real-life scenarios. These deficits were more severe in schizophrenic than in bipolar patients. Patients did not differ from controls in tasks involving explicit knowledge. Moreover, schizophrenic patients' depression levels were negatively correlated with performance on empathy tasks. Conclusions/Significance: Overall performance on emotion recognition predicted performance on intentionality attribution during the more ambiguous situations of the empathy task. These results suggest that social cognition deficits could be related to a general impairment in the capacity to implicitly integrate contextual cues. Important implications for the assessment and treatment of individuals with schizophrenia and bipolar disorders, as well as for neurocognitive models of these pathologies are discussed.	[Baez, Sandra; Luz Gonzalez-Gadea, Maria; Strejilevich, Sergio; Manes, Facundo; Ibanes, Agustin M.] Favaloro Univ, Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina; [Baez, Sandra; Luz Gonzalez-Gadea, Maria; Strejilevich, Sergio; Manes, Facundo; Ibanes, Agustin M.] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina; [Baez, Sandra; Luz Gonzalez-Gadea, Maria; Silvana Vigliecca, Nora; Ibanes, Agustin M.] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, RA-1033 Buenos Aires, DF, Argentina; [Herrera, Eduar] Univ Autonoma Caribe, Barranquilla, Colombia; [Baez, Sandra] Pontif Catholic Univ Argentina, Buenos Aires, DF, Argentina; [Huepe, David; Ibanes, Agustin M.] Univ Diego Port, Lab Cognit & Social Neurosci, Santiago, Chile; [Villarin, Lilian; Matthaeus, Franziska] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany; [Decety, Jean] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Decety, Jean] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; [Decety, Jean] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA; [Gomez, Pedro] CARI Univ Hosp, Barranquilla, Colombia; [Mosquera, Marcela] Resurgir Psychiat Clin, Barranquilla, Colombia; [Theil, Donna] Univ Cologne, D-50931 Cologne, Germany; [Silvana Vigliecca, Nora] Univ Nacl Cordoba, Fac Filosofia & Humanidades, Inst Humanidades IDH, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Diego Portales; Ruprecht Karls University Heidelberg; University of Chicago; University of Chicago; University of Chicago; University of Cologne; National University of Cordoba	Ibanes, AM (corresponding author), Favaloro Univ, Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina.	aibanez@ineco.org.ar	Ibanez, Agustin/H-7976-2015; Matthäus, Franziska/AAE-5523-2022	Ibanez, Agustin/0000-0001-6758-5101; Matthäus, Franziska/0000-0001-6042-1366; Baez, Sandra/0000-0003-0875-1709; Huepe, David/0000-0001-8351-5314; Vigliecca, Nora Silvana/0000-0003-3545-0610; Strejilevich, Sergio Adrian/0000-0001-8410-7187; Herrera, Eduar/0000-0001-9409-245X	CONICET; FONDECYT [1130920]; INECO Foundation	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); INECO Foundation	This research was partially supported by CONICET, FONDECYT (1130920) and INECO Foundation grants to AI. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of those grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 1998, SCHIZOPHR RES, V32, P171, DOI 10.1016/S0920-9964(98)00042-5; Addington J, 2008, BRIT J PSYCHIAT, V192, P67, DOI 10.1192/bjp.bp.107.039784; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amoruso L, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00191; Baez S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00302; Bearden CE, 2001, BIPOLAR DISORD, V3, P106, DOI 10.1034/j.1399-5618.2001.030302.x; Berrettini W, 2003, AM J MED GENET C, V123C, P59, DOI 10.1002/ajmg.c.20014; Bigelow NO, 2006, SCHIZOPHR RES, V83, P257, DOI 10.1016/j.schres.2005.12.856; Bora E, 2008, PSYCHIAT RES, V160, P23, DOI 10.1016/j.psychres.2007.05.017; Bozikas VP, 2006, J AFFECT DISORDERS, V91, P53, DOI 10.1016/j.jad.2005.11.013; Brambilla P, 2007, BIPOLAR DISORD, V9, P230, DOI 10.1111/j.1399-5618.2007.00398.x; Bramon E, 2001, Curr Psychiatry Rep, V3, P332; Burdick KE, 2009, PSYCHIAT RES, V166, P192, DOI 10.1016/j.psychres.2008.03.006; Burgess PW, 2009, RESTOR NEUROL NEUROS, V27, P493, DOI 10.3233/RNN-2009-0511; Chen CH, 2006, BIOL PSYCHIAT, V59, P31, DOI 10.1016/j.biopsych.2005.06.008; Chung YS, 2011, SCHIZOPHR RES, V131, P235, DOI 10.1016/j.schres.2011.05.028; Chung YS, 2011, SCHIZOPHRENIA BULL, V37, P1048, DOI 10.1093/schbul/sbq012; Corcoran CM, 2011, PSYCHOL MED, V41, P251, DOI 10.1017/S0033291710000802; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; Cusi A, 2010, PSYCHIAT RES, V178, P354, DOI 10.1016/j.psychres.2009.07.009; CUTTING J, 1990, BRIT J PSYCHIAT, V157, P355, DOI 10.1192/bjp.157.3.355; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; Dawson-Saunders B., 1994, BASIC CLIN BIOSTATIS; Decety J, 2012, CEREB CORTEX, V22, P209, DOI 10.1093/cercor/bhr111; Depp CA, 2010, BIPOLAR DISORD, V12, P843, DOI 10.1111/j.1399-5618.2010.00880.x; Derntl B, 2009, SCHIZOPHR RES, V108, P197, DOI 10.1016/j.schres.2008.11.009; Ekman P., 1976, PICTURES FACIAL AFFE; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Frangou S, 2006, BIPOLAR DISORD, V8, P47, DOI 10.1111/j.1399-5618.2006.00274.x; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Getz GE, 2003, J INT NEUROPSYCH SOC, V9, P623, DOI 10.1017/S1355617703940021; Gleichgerrcht E, 2011, J CLIN EXP NEUROPSYC, V33, P997, DOI 10.1080/13803395.2011.589375; Goldstein TR, 2006, BIPOLAR DISORD, V8, P350, DOI 10.1111/j.1399-5618.2006.00321.x; Habel U, 2010, SCHIZOPHR RES, V122, P113, DOI 10.1016/j.schres.2010.06.009; Hair J., 2010, MULTIVARIATE DATA AN, V7; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2002, BRAIN, V125, P1428, DOI 10.1093/brain/awf149; Huang J, 2009, AUST NZ J PSYCHIAT, V43, P438, DOI 10.1080/00048670902817646; Ibanez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037306; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ibanez A, 2012, PSYCHIAT RES, V195, P18, DOI 10.1016/j.psychres.2011.07.027; Inoue Y, 2006, EUR ARCH PSY CLIN N, V256, P326, DOI 10.1007/s00406-006-0608-z; Martino DJ, 2011, PSYCHIAT RES, V189, P379, DOI 10.1016/j.psychres.2011.04.033; Jin H, 2001, J CLIN PSYCHIAT, V62, P797, DOI 10.4088/JCP.v62n1008; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Kohler CG, 2008, SCHIZOPHR RES, V105, P30, DOI 10.1016/j.schres.2008.05.030; Kohler CG, 2008, SCHIZOPHR RES, V105, P49, DOI 10.1016/j.schres.2008.05.010; Kohler CG, 2011, PSYCHIAT RES, V188, P303, DOI 10.1016/j.psychres.2011.04.019; Lee J, 2012, SCHIZOPHR B; Linden SC, 2010, NEUROPSYCHOLOGIA, V48, P997, DOI 10.1016/j.neuropsychologia.2009.11.023; Martino DJ, 2008, J AFFECT DISORDERS, V105, P291, DOI 10.1016/j.jad.2007.05.014; Marwick K, 2008, BRIT MED BULL, V88, P43, DOI 10.1093/bmb/ldn035; Mazza M, 2007, EUR ARCH PSY CLIN N, V257, P12, DOI 10.1007/s00406-006-0676-0; McCormick LM, 2012, PSYCHIAT RES-NEUROIM, V201, P233, DOI 10.1016/j.pscychresns.2012.01.004; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Mendoza R, 2011, PSYCHIAT RES, V185, P44, DOI 10.1016/j.psychres.2009.10.006; Monkul ES, 2007, SCHIZOPHR RES, V94, P245, DOI 10.1016/j.schres.2007.03.023; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Norman GR., 2000, BIOSTATISTICS BARE E, V2nd; Olsson SK, 2012, BIPOLAR DISORD, V14, P719, DOI 10.1111/bdi.12009; Paradiso S, 2003, AM J PSYCHIAT, V160, P1775, DOI 10.1176/appi.ajp.160.10.1775; Pearlson GD, 1997, BIOL PSYCHIAT, V41, P1, DOI 10.1016/S0006-3223(96)00373-3; Penn DL, 2002, PSYCHIAT RES, V109, P149, DOI 10.1016/S0165-1781(02)00004-5; Pinkham AE, 2006, PSYCHIAT RES, V143, P167, DOI 10.1016/j.psychres.2005.09.005; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Raven J.C., 1960, GUIDE STANDARD PROGR; Riveros R, 2010, SCHIZOPHR RES, V116, P297, DOI 10.1016/j.schres.2009.10.017; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Roca M, 2010, COGN BEHAV NEUROL, V23, P152, DOI 10.1097/WNN.0b013e3181e078de; Russell TA, 2007, NEUROPSYCHOLOGIA, V45, P107, DOI 10.1016/j.neuropsychologia.2006.04.026; Samame C, 2012, ACTA PSYCHIAT SCAND, V125, P266, DOI 10.1111/j.1600-0447.2011.01808.x; Schaefer KL, 2010, J PSYCHIATR RES, V44, P1229, DOI 10.1016/j.jpsychires.2010.04.024; Schenkel LS, 2005, J PSYCHIATR RES, V39, P499, DOI 10.1016/j.jpsychires.2005.01.001; Seidel EM, 2012, J PSYCHIATR RES, V46, P382, DOI 10.1016/j.jpsychires.2011.11.006; Shamay-Tsoory S, 2009, J NEUROPSYCH CLIN N, V21, P59, DOI 10.1176/appi.neuropsych.21.1.59; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; Taylor SF, 2012, SCHIZOPHRENIA BULL, V38, P73, DOI 10.1093/schbul/sbr105; Tighe SK, 2012, BIPOLAR DISORD, V14, P888, DOI 10.1111/bdi.12019; Torralva T, 2012, BIPOLAR DISORD, V14, P118, DOI 10.1111/j.1399-5618.2012.00987.x; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Turetsky BI, 2007, SCHIZOPHR RES, V94, P253, DOI 10.1016/j.schres.2007.05.001; Uhlhaas PJ, 2004, SCHIZOPHR RES, V68, P249, DOI 10.1016/s0920-9964(03)00184-1; van der Werf-Eldering MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013032; Villatte M, 2010, J BEHAV THER EXP PSY, V41, P125, DOI 10.1016/j.jbtep.2009.11.004; Vuilleumier P, 1998, NEUROPSY NEUROPSY BE, V11, P40; Walshaw PD, 2010, NEUROPSYCHOL REV, V20, P103, DOI 10.1007/s11065-009-9126-x; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wong AHC, 2003, NEUROSCI BIOBEHAV R, V27, P269, DOI 10.1016/S0149-7634(03)00035-6; Wynn JK, 2012, PSYCHOL MED, P1; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	97	80	85	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57664	10.1371/journal.pone.0057664	http://dx.doi.org/10.1371/journal.pone.0057664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520477	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900036
J	Brenner, AV; Neta, G; Sturgis, EM; Pfeiffer, RM; Hutchinson, A; Yeager, M; Xu, L; Zhou, C; Wheeler, W; Tucker, MA; Chanock, SJ; Sigurdson, AJ				Brenner, Alina V.; Neta, Gila; Sturgis, Erich M.; Pfeiffer, Ruth M.; Hutchinson, Amy; Yeager, Meredith; Xu, Li; Zhou, Cindy; Wheeler, William; Tucker, Margaret A.; Chanock, Stephen J.; Sigurdson, Alice J.			Common Single Nucleotide Polymorphisms in Genes Related to Immune Function and Risk of Papillary Thyroid Cancer	PLOS ONE			English	Article							PROTEIN-C INHIBITOR; US RADIOLOGIC TECHNOLOGISTS; LINKAGE DISEQUILIBRIUM; AUTOIMMUNE-DISEASE; FAMILY-HISTORY; UNITED-STATES; CARCINOMA; INFLAMMATION; ASSOCIATION; RADIATION	Accumulating evidence suggests that alterations in immune function may be important in the etiology of papillary thyroid cancer (PTC). To identify genetic markers in immune-related pathways, we evaluated 3,985 tag single nucleotide polymorphisms (SNPs) in 230 candidate gene regions (adhesion-extravasation-migration, arachidonic acid metabolism/eicosanoid signaling, complement and coagulation cascade, cytokine signaling, innate pathogen detection and antimicrobials, leukocyte signaling, TNF/NF-kappa B pathway or other) in a case-control study of 344 PTC cases and 452 controls. We used logistic regression models to estimate odds ratios (OR) and calculate one degree of freedom P values of linear trend (PSNP-trend) for the association between genotype (common homozygous, heterozygous, variant homozygous) and risk of PTC. To correct for multiple comparisons, we applied the false discovery rate method (FDR). Gene region-and pathway-level associations (P-Region and P-Pathway) were assessed by combining individual PSNP-trend values using the adaptive rank truncated product method. Two SNPs (rs6115, rs6112) in the SERPINA5 gene were significantly associated with risk of PTC (PSNP-FDR/PSNP-trend = 0.02/6x10(-6) and PSNP-FDR/PSNP-trend = 0.04/2x10(-5), respectively). These associations were independent of a history of autoimmune thyroiditis (OR = 6.4; 95% confidence interval: 3.0-13.4). At the gene region level, SERPINA5 was suggestively associated with risk of PTC (PRegion-FDR/P-Region = 0.07/0.0003). Overall, the complement and coagulation cascade pathway was the most significant pathway (PPathway = 0.02) associated with PTC risk largely due to the strong effect of SERPINA5. Our results require replication but suggest that the SERPINA5 gene, which codes for the protein C inhibitor involved in many biological processes including inflammation, may be a new susceptibility locus for PTC.	[Brenner, Alina V.; Neta, Gila; Sigurdson, Alice J.] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD USA; [Sturgis, Erich M.; Xu, Li] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD USA; [Hutchinson, Amy; Yeager, Meredith] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA; [Zhou, Cindy] George Washington Univ, Dept Epidemiol & Biostat, Washington, DC USA; [Wheeler, William] Informat Management Syst, Silver Spring, MD USA; [Tucker, Margaret A.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD USA; [Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brenner, AV (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD USA.	brennera@mail.nih.gov	Zhou, Cindy/H-2165-2015; Xu, Li/B-9535-2012; Yeager, Meredith/AAA-5322-2020; Tucker, Margaret A/B-4297-2015	Zhou, Cindy/0000-0003-4814-4305; 	Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; federal funds from the National Cancer Institute, National Institutes of Health [HHSN261200800001E]; American Thyroid Association; NATIONAL CANCER INSTITUTE [ZIACP010133] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Thyroid Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, by federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E, and by a grant from the American Thyroid Association (PI: E. M. Sturgis). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijsmans ITGW, 2011, MODERN PATHOL, V24, P463, DOI 10.1038/modpathol.2010.214; Borgmann S, 2001, CLIN IMMUNOL, V98, P244, DOI 10.1006/clim.2000.4962; Bozec A, 2010, CURR MED CHEM, V17, P3449, DOI 10.2174/092986710792927804; Brindel P, 2010, THYROID, V20, P393, DOI 10.1089/thy.2009.0350; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Castanet M, 2010, HORM RES PAEDIAT, V73, P423, DOI 10.1159/000281438; Cooper JD, 2012, HUM MOL GENET; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Espana F, 2007, SEMIN THROMB HEMOST, V33, P41, DOI 10.1055/s-2006-958460; Guarino V, 2010, MOL CELL ENDOCRINOL, V321, P94, DOI 10.1016/j.mce.2009.10.003; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Ho T, 2009, THYROID, V19, P129, DOI 10.1089/thy.2008.0153; Kivity S, 2010, EXPERT REV CLIN IMMU, V6, P691, DOI [10.1586/eci.10.60, 10.1586/ECI.10.60]; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Lonn S, 2007, CANCER EPIDEM BIOMAR, V16, P174, DOI 10.1158/1055-9965.EPI-06-0665; Loza MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001035; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; Meijers JCM, 2011, SEMIN THROMB HEMOST, V37, P349, DOI 10.1055/s-0031-1276583; Mona B, 2010, FERTIL STERIL, V93, P277, DOI 10.1016/j.fertnstert.2009.07.984; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Muzza M, 2010, CLIN ENDOCRINOL, V72, P702, DOI 10.1111/j.1365-2265.2009.03699.x; Prasad ML, 2004, HISTOPATHOLOGY, V45, P39, DOI 10.1111/j.1365-2559.2004.01876.x; Rahbari R, 2010, FUTURE ONCOL, V6, P1771, DOI 10.2217/FON.10.127; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Sigurdson AJ, 2003, CANCER-AM CANCER SOC, V97, P3080, DOI 10.1002/cncr.11444; Sinnott B, 2010, ENDOCR REV, V31, P756, DOI 10.1210/er.2010-0003; Sipos JA, 2010, CLIN ONCOL-UK, V22, P395, DOI 10.1016/j.clon.2010.05.004; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Suzuki K, 2008, J THROMB HAEMOST, V6, P2017, DOI 10.1111/j.1538-7836.2008.03181.x; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; TARONE RE, 1990, BIOMETRICS, V46, P515, DOI 10.2307/2531456; Vandenbroeck K, 2012, J INTERF CYTOK RES, V32, P139, DOI 10.1089/jir.2011.0103; Vierlinger K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-30; Weng MY, 2012, ANN RHEUM DIS, V71, P524, DOI 10.1136/annrheumdis-2011-200402; Xu L, 2012, CANCER-AM CANCER SOC, V118, P1228, DOI 10.1002/cncr.26398; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	42	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57243	10.1371/journal.pone.0057243	http://dx.doi.org/10.1371/journal.pone.0057243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520464	Green Published, Green Submitted, gold			2022-12-27	WOS:000318679900023
J	Brittain, PJ; Lobo, SEM; Rucker, J; Amarasinghe, M; Anilkumar, APP; Baggaley, M; Banerjee, P; Bearn, J; Broadbent, M; Butler, M; Campbell, CD; Cleare, AJ; Dratcu, L; Frangou, S; Gaughran, F; Goldin, M; Henke, A; Kern, N; Krayem, A; Mufti, F; McIvor, R; Needham-Bennett, H; Newman, S; Olajide, D; O'Flynn, D; Rao, R; Rehman, IU; Seneviratne, G; Stahl, D; Suleman, S; Treasure, J; Tully, J; Veale, D; Stewart, R; McGuffin, P; Lovestone, S; Hotopf, M; Schumann, G				Brittain, Philip James; Lobo, Sarah Elizabeth Margaret; Rucker, James; Amarasinghe, Myanthi; Anilkumar, Anantha Padmanabha Pillai; Baggaley, Martin; Banerjee, Pallavi; Bearn, Jenny; Broadbent, Matthew; Butler, Matthew; Campbell, Colin Donald; Cleare, Anthony James; Dratcu, Luiz; Frangou, Sophia; Gaughran, Fiona; Goldin, Matthew; Henke, Annika; Kern, Nikola; Krayem, Abdallah; Mufti, Faiza; McIvor, Ronan; Needham-Bennett, Humphrey; Newman, Stuart; Olajide, Dele; O'Flynn, David; Rao, Ranga; Rehman, Ijaz Ur; Seneviratne, Gertrude; Stahl, Daniel; Suleman, Sajid; Treasure, Janet; Tully, John; Veale, David; Stewart, Robert; McGuffin, Peter; Lovestone, Simon; Hotopf, Matthew; Schumann, Gunter			Harnessing Clinical Psychiatric Data with an Electronic Assessment Tool (OPCRIT plus ): The Utility of Symptom Dimensions	PLOS ONE			English	Article							MAJOR PSYCHOSES; FUNCTIONAL PSYCHOSES; SCHIZOPHRENIA; POPULATION; DISORDERS; DIAGNOSIS; SYSTEM; HEALTH	Progress in personalised psychiatry is dependent on researchers having access to systematic and accurately acquired symptom data across clinical diagnoses. We have developed a structured psychiatric assessment tool, OPCRIT+, that is being introduced into the electronic medical records system of the South London and Maudsley NHS Foundation Trust which can help to achieve this. In this report we examine the utility of the symptom data being collected with the tool. Cross-sectional mental state data from a mixed-diagnostic cohort of 876 inpatients was subjected to a principal components analysis (PCA). Six components, explaining 46% of the variance in recorded symptoms, were extracted. The components represented dimensions of mania, depression, positive symptoms, anxiety, negative symptoms and disorganization. As indicated by component scores, different clinical diagnoses demonstrated distinct symptom profiles characterized by wide-ranging levels of severity. When comparing the predictive value of symptoms against diagnosis for a variety of clinical outcome measures (e.g. 'Overactive, aggressive behaviour'), symptoms proved superior in five instances (R-2 range: 0.06-0.28) whereas diagnosis was best just once (R-2:0.25). This report demonstrates that symptom data being routinely gathered in an NHS trust, when documented on the appropriate tool, have considerable potential for onward use in a variety of clinical and research applications via representation as dimensions of psychopathology.	[Brittain, Philip James; Lobo, Sarah Elizabeth Margaret; Rucker, James; Amarasinghe, Myanthi; Broadbent, Matthew; Cleare, Anthony James; Frangou, Sophia; Henke, Annika; Treasure, Janet; Veale, David; Stewart, Robert; McGuffin, Peter; Lovestone, Simon; Hotopf, Matthew; Schumann, Gunter] Kings Coll London, Natl Inst Hlth Res Specialist, Biomed Res Ctr Mental Hlth, South London & Maudsley Natl Hlth Serv Fdn Trust, London WC2R 2LS, England; [Brittain, Philip James; Lobo, Sarah Elizabeth Margaret; Rucker, James; Amarasinghe, Myanthi; Broadbent, Matthew; Cleare, Anthony James; Frangou, Sophia; Henke, Annika; Stahl, Daniel; Treasure, Janet; Veale, David; Stewart, Robert; McGuffin, Peter; Lovestone, Simon; Hotopf, Matthew; Schumann, Gunter] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Newman, Stuart] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Campbell, Colin Donald] Kings Coll London, Inst Psychiat, Dept Forens & Dev Neurosci, London WC2R 2LS, England; [Gaughran, Fiona] Bethlem Royal & Maudsley Hosp, South London & Maudsley Natl Hlth Serv Fdn Trust, Natl Psychosis Serv, London, England; [Anilkumar, Anantha Padmanabha Pillai; Baggaley, Martin; Banerjee, Pallavi; Bearn, Jenny; Butler, Matthew; Dratcu, Luiz; Goldin, Matthew; Kern, Nikola; Krayem, Abdallah; Mufti, Faiza; McIvor, Ronan; Needham-Bennett, Humphrey; Olajide, Dele; O'Flynn, David; Rao, Ranga; Rehman, Ijaz Ur; Seneviratne, Gertrude; Suleman, Sajid; Tully, John] Bethlem Royal & Maudsley Hosp, South London & Maudsley Natl Hlth Serv Fdn Trust, London, England	South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; South London & Maudsley NHS Trust	Brittain, PJ (corresponding author), Kings Coll London, Natl Inst Hlth Res Specialist, Biomed Res Ctr Mental Hlth, South London & Maudsley Natl Hlth Serv Fdn Trust, London WC2R 2LS, England.	Philip.Brittain@kcl.ac.uk	Gaughran, Fiona/AAC-7160-2019; Stewart, Robert/B-1667-2010; Gaughran, Fiona/H-5495-2011; Tully, John/H-5936-2019; Stahl, Daniel/B-9713-2011; McGuffin, Peter/A-1565-2012; Cleare, Anthony/AAN-5418-2021; Veale, David M/F-5670-2010; Schumann, Gunter/H-1013-2013; Hotopf, Matthew/E-4971-2010; Rucker, James/H-6374-2019; Seneviratne, Gertrude/GXV-5444-2022	Stewart, Robert/0000-0002-4435-6397; Gaughran, Fiona/0000-0001-7414-5569; Tully, John/0000-0002-5858-3419; Stahl, Daniel/0000-0001-7987-6619; McGuffin, Peter/0000-0002-9888-2907; Veale, David M/0000-0002-1717-4766; Rucker, James/0000-0003-4647-8088; Hotopf, Matthew/0000-0002-3980-4466; Treasure, Janet/0000-0003-0871-4596; Lovestone, Simon/0000-0003-0473-4565; Frangou, Sophia/0000-0002-3210-6470	National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; Medical Research Council [G9817803B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10053] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Philip Brittain, Sarah Lobo, Myanthi Amarasinghe, Matthew Broadbent, Tony Cleare, Sophia Frangou, Janet Treasure, David Veale, Rob Stewart, Peter McGuffin, Simon Lovestone, Matthew Hotopf and Gunter Schumann are part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allardyce J, 2007, SOC PSYCH PSYCH EPID, V42, P429, DOI 10.1007/s00127-007-0179-y; Anderson R.D., 1956, P 3 S MATH STAT PROB, V5, P111; Brittain PJ, 2012, INT J METHO IN PRESS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cardno AG, 1996, SCHIZOPHR RES, V22, P233, DOI 10.1016/S0920-9964(96)00060-6; Cardno AG, 1997, SCHIZOPHR RES, V23, P231, DOI 10.1016/S0920-9964(96)00093-X; Cardno AG, 1999, SCHIZOPHRENIA BULL, V25, P841, DOI 10.1093/oxfordjournals.schbul.a033423; Cardno AG, 2001, BRIT J PSYCHIAT, V179, P39, DOI 10.1192/bjp.179.1.39; Carroll J.B., 1960, IBM 704 PROGRA UNPUB; Dikeos DG, 2006, BRIT J PSYCHIAT, V189, P346, DOI 10.1192/bjp.bp.105.017251; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Harman H. H., 1976, MODERN FACTOR ANAL; Kim T, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-44; Maciukiewicz M, 2012, SCHIZOPHR RES, V138, P223, DOI 10.1016/j.schres.2012.03.032; Matsuura M, 2004, SCHIZOPHR RES, V69, P189, DOI 10.1016/S0920-9964(02)00492-9; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; McIntosh AM, 2001, PSYCHOL MED, V31, P159, DOI 10.1017/S0033291799003177; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Rosenman S, 2000, AUST NZ J PSYCHIAT, V34, P792, DOI 10.1080/j.1440-1614.2000.00824.x; Rosenman S, 2003, ACTA PSYCHIAT SCAND, V107, P378, DOI 10.1034/j.1600-0447.2003.00059.x; Rucker J, 2011, BRIT J PSYCHIAT, V199, P151, DOI 10.1192/bjp.bp.110.082925; Serretti A, 2004, PSYCHIAT RES, V127, P101, DOI 10.1016/j.psychres.2003.07.005; Serretti A, 1996, AM J MED GENET, V67, P393, DOI 10.1002/(SICI)1096-8628(19960726)67:4<393::AID-AJMG13>3.0.CO;2-E; Serretti A, 2001, EUR ARCH PSY CLIN N, V251, P193, DOI 10.1007/s004060170040; Serretti A, 1999, COMPR PSYCHIAT, V40, P143, DOI 10.1016/S0010-440X(99)90118-9; Serretti A, 1998, Depress Anxiety, V8, P80; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Van Os J, 1999, PSYCHOL MED, V29, P595, DOI 10.1017/S0033291798008162; VanOs J, 1996, PSYCHOL MED, V26, P161, DOI 10.1017/S0033291700033808; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58790	10.1371/journal.pone.0058790	http://dx.doi.org/10.1371/journal.pone.0058790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	140TZ	23520532	Green Submitted, gold, Green Published			2022-12-27	WOS:000318679900092
J	Schwartz, C; Hampton, M; Andrews, MT				Schwartz, Christine; Hampton, Marshall; Andrews, Matthew T.			Seasonal and Regional Differences in Gene Expression in the Brain of a Hibernating Mammal	PLOS ONE			English	Article							GROUND-SQUIRRELS; PROTEIN RBM3; AROUSAL; RECEPTOR; HAMSTERS; SURVIVAL; TEMPERATURE; METABOLISM; ACTIVATION; PLASTICITY	Mammalian hibernation presents a unique opportunity to study naturally occurring neuroprotection. Hibernating ground squirrels undergo rapid and extreme physiological changes in body temperature, oxygen consumption, and heart rate without suffering neurological damage from ischemia and reperfusion injury. Different brain regions show markedly different activity during the torpor/arousal cycle: the cerebral cortex shows activity only during the periodic returns to normothermia, while the hypothalamus is active over the entire temperature range. Therefore, region-specific neuroprotective strategies must exist to permit this compartmentalized spectrum of activity. In this study, we use the Illumina HiSeq platform to compare the transcriptomes of these two brain regions at four collection points across the hibernation season: April Active, October Active, Torpor, and IBA. In the cerebral cortex, 1,085 genes were found to be differentially expressed across collection points, while 1,063 genes were differentially expressed in the hypothalamus. Comparison of these transcripts indicates that the cerebral cortex and hypothalamus implement very different strategies during hibernation, showing less than 20% of these differentially expressed genes in common. The cerebral cortex transcriptome shows evidence of remodeling and plasticity during hibernation, including transcripts for the presynaptic cytomatrix proteins bassoon and piccolo, and extracellular matrix components, including laminins and collagens. Conversely, the hypothalamic transcriptome displays upregulation of transcripts involved in damage response signaling and protein turnover during hibernation, including the DNA damage repair gene RAD50 and ubiquitin E3 ligases UBR1 and UBR5. Additionally, the hypothalamus transcriptome also provides evidence of potential mechanisms underlying the hibernation phenotype, including feeding and satiety signaling, seasonal timing mechanisms, and fuel utilization. This study provides insight into potential neuroprotective strategies and hibernation control mechanisms, and also specifically shows that the hibernator brain exhibits both seasonal and regional differences in mRNA expression.	[Schwartz, Christine; Andrews, Matthew T.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Hampton, Marshall] Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth	Andrews, MT (corresponding author), Univ Minnesota, Dept Biol, Duluth, MN 55812 USA.	mandrews@d.umn.edu		Hampton, Marshall/0000-0002-9725-3316	National Institutes of Health [1RC2HL101625-01, 1F32NS077643-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health (1RC2HL101625-01 to M. T. A). C. S. was supported by NIH fellowship 1F32NS077643-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bratincsak A, 2007, J COMP NEUROL, V505, P443, DOI 10.1002/cne.21507; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Chiu Kin, 2007, J Vis Exp, P269, DOI 10.3791/269; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; DAAN S, 1991, NEUROSCI LETT, V128, P265, DOI 10.1016/0304-3940(91)90276-Y; DAVIS DE, 1976, Q REV BIOL, V51, P477, DOI 10.1086/409594; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Drew KL, 2002, COMP BIOCHEM PHYS C, V133, P483, DOI 10.1016/S1532-0456(02)00118-7; Epperson LE, 2010, J COMP PHYSIOL B, V180, P599, DOI 10.1007/s00360-009-0422-9; Franklin K., 2007, MOUSE BRAIN STEREOTA; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gundelfinger ED, 2010, EUR J NEUROSCI, V31, P2156, DOI 10.1111/j.1460-9568.2010.07253.x; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Han S, 2010, J NEUROSCI, V30, P15102, DOI 10.1523/JNEUROSCI.3128-10.2010; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; HELLER HC, 1979, ANNU REV PHYSIOL, V41, P305, DOI 10.1146/annurev.ph.41.030179.001513; HELLER HC, 1972, COMP BIOCHEM PHYSIOL, V41, P349, DOI 10.1016/0300-9629(72)90066-7; HERMES MLHJ, 1993, BRAIN RES, V631, P313, DOI 10.1016/0006-8993(93)91550-C; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jethwa PH, 2008, NEUROENDOCRINOLOGY, V88, P80, DOI 10.1159/000127319; Jinka TR, 2011, J NEUROSCI, V31, P10752, DOI 10.1523/JNEUROSCI.1240-11.2011; Kasukawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023228; KILDUFF TS, 1990, J NEUROSCI, V10, P2463; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Martens K, 2010, FEBS LETT, V584, P1054, DOI 10.1016/j.febslet.2010.01.061; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McCroskery S, 2009, NEUROSCIENCE, V163, P168, DOI 10.1016/j.neuroscience.2009.06.012; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Morawski M, 2012, INT J BIOCHEM CELL B, V44, P690, DOI 10.1016/j.biocel.2012.01.010; MROSOVSK.N, 1974, PHYSIOL BEHAV, V12, P265, DOI 10.1016/0031-9384(74)90181-4; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Novak U, 2004, J CLIN NEUROSCI, V11, P227, DOI 10.1016/j.jocn.2003.10.006; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okamoto I, 2006, COMP BIOCHEM PHYS C, V144, P47, DOI 10.1016/j.cbpc.2006.05.003; Osborne PG, 2006, BEHAV BRAIN RES, V168, P208, DOI 10.1016/j.bbr.2005.11.007; Otaki JM, 2010, DEV NEUROBIOL, V70, P424, DOI 10.1002/dneu.20786; PENGELLEY E, 1961, CAN J ZOOLOG, V39, P105, DOI 10.1139/z61-013; Revel FG, 2007, P NATL ACAD SCI USA, V104, P13816, DOI 10.1073/pnas.0704699104; Ruby NF, 1996, P NATL ACAD SCI USA, V93, P9864, DOI 10.1073/pnas.93.18.9864; Russell RL, 2010, J COMP PHYSIOL B, V180, P1165, DOI 10.1007/s00360-010-0484-8; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; STANTON TL, 1982, REGUL PEPTIDES, V3, P135, DOI 10.1016/0167-0115(82)90090-8; TORKE KG, 1977, J MAMMAL, V58, P385, DOI 10.2307/1379337; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; van Breukelen F, 2002, J COMP PHYSIOL B, V172, P355, DOI 10.1007/s00360-002-0256-1; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; von der Ohe CG, 2006, J NEUROSCI, V26, P10590, DOI 10.1523/JNEUROSCI.2874-06.2006; Wardman JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028152; Wei SW, 2004, J ENDOCRINOL, V180, P357, DOI 10.1677/joe.0.1800357; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200; Yan J, 2006, PHYSIOL GENOMICS, V25, P346, DOI 10.1152/physiolgenomics.00260.2005; Yan J, 2008, PHYSIOL GENOMICS, V32, P170, DOI 10.1152/physiolgenomics.00075.2007; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	74	77	79	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58427	10.1371/journal.pone.0058427	http://dx.doi.org/10.1371/journal.pone.0058427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526982	Green Submitted, Green Published, gold			2022-12-27	WOS:000317562600021
J	Bao, DP; Gong, M; Zheng, HJ; Chen, MJ; Zhang, L; Wang, H; Jiang, JP; Wu, L; Zhu, YQ; Zhu, G; Zhou, Y; Li, CH; Wang, SY; Zhao, Y; Zhao, GP; Tan, Q				Bao, Dapeng; Gong, Ming; Zheng, Huajun; Chen, Mingjie; Zhang, Liang; Wang, Hong; Jiang, Jianping; Wu, Lin; Zhu, Yongqiang; Zhu, Gang; Zhou, Yan; Li, Chuanhua; Wang, Shengyue; Zhao, Yan; Zhao, Guoping; Tan, Qi			Sequencing and Comparative Analysis of the Straw Mushroom (Volvariella volvacea) Genome	PLOS ONE			English	Article							AFLATOXIN BIOSYNTHESIS; COPRINOPSIS-CINEREA; GENE IDENTIFICATION; NUCLEAR BEHAVIOR; MATING-TYPE; ENZYMES; FAMILY; BASIDIOMYCETE; EXPRESSION; LACCASE	Volvariella volvacea, the edible straw mushroom, is a highly nutritious food source that is widely cultivated on a commercial scale in many parts of Asia using agricultural wastes (rice straw, cotton wastes) as growth substrates. However, developments in V. volvacea cultivation have been limited due to a low biological efficiency (i.e. conversion of growth substrate to mushroom fruit bodies), sensitivity to low temperatures, and an unclear sexuality pattern that has restricted the breeding of improved strains. We have now sequenced the genome of V. volvacea and assembled it into 62 scaffolds with a total genome size of 35.7 megabases (Mb), containing 11,084 predicted gene models. Comparative analyses were performed with the model species in basidiomycete on mating type system, carbohydrate active enzymes, and fungal oxidative lignin enzymes. We also studied transcriptional regulation of the response to low temperature (4 degrees C). We found that the genome of V. volvacea has many genes that code for enzymes, which are involved in the degradation of cellulose, hemicellulose, and pectin. The molecular genetics of the mating type system in V. volvacea was also found to be similar to the bipolar system in basidiomycetes, suggesting that it is secondary homothallism. Sensitivity to low temperatures could be due to the lack of the initiation of the biosynthesis of unsaturated fatty acids, trehalose and glycogen biosyntheses in this mushroom. Genome sequencing of V. volvacea has improved our understanding of the biological characteristics related to the degradation of the cultivating compost consisting of agricultural waste, the sexual reproduction mechanism, and the sensitivity to low temperatures at the molecular level which in turn will enable us to increase the industrial production of this mushroom.	[Bao, Dapeng; Gong, Ming; Chen, Mingjie; Wang, Hong; Wu, Lin; Zhu, Gang; Li, Chuanhua; Zhao, Yan; Tan, Qi] Minist Sci & Technol MOST, Natl Engn Res Ctr Edible Fungi, Shanghai, Peoples R China; [Bao, Dapeng; Gong, Ming; Chen, Mingjie; Wang, Hong; Wu, Lin; Zhu, Gang; Li, Chuanhua; Zhao, Yan; Tan, Qi] Minist Agr, Key Lab Edible Fungi Resources & Utilizat South, Shanghai, Peoples R China; [Bao, Dapeng; Gong, Ming; Chen, Mingjie; Wang, Hong; Wu, Lin; Zhu, Gang; Li, Chuanhua; Zhao, Yan; Tan, Qi] Shanghai Acad Agr Sci, Inst Edible Fungi, Shanghai, Peoples R China; [Zheng, Huajun; Zhang, Liang; Jiang, Jianping; Zhu, Yongqiang; Zhou, Yan; Wang, Shengyue; Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Academy of Agricultural Sciences	Bao, DP (corresponding author), Minist Sci & Technol MOST, Natl Engn Res Ctr Edible Fungi, Shanghai, Peoples R China.	baodp@hotmail.com; syj0@saas.sh.cn		Zhao, Guo-Ping/0000-0002-7621-6620	Shanghai Committee of Science and Technology, P. R. China [10dz2212400]	Shanghai Committee of Science and Technology, P. R. China	This work was supported by the Shanghai Committee of Science and Technology, P. R. China (Grant No. 10dz2212400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; Aimi T, 2005, CURR GENET, V48, P184, DOI 10.1007/s00294-005-0012-7; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhatnagar D, 2003, APPL MICROBIOL BIOT, V61, P83, DOI 10.1007/s00253-002-1199-x; Briza P, 1996, EUR J BIOCHEM, V239, P124, DOI 10.1111/j.1432-1033.1996.0124u.x; BRIZA P, 1994, P NATL ACAD SCI USA, V91, P4524, DOI 10.1073/pnas.91.10.4524; Brown AJ, 2001, TRENDS GENET, V17, P393, DOI 10.1016/S0168-9525(01)02343-5; Buswell JA, 1996, WORLD J MICROB BIOT, V12, P537, DOI 10.1007/BF00419469; CAI YJ, 1994, MYCOL RES, V98, P1019, DOI 10.1016/S0953-7562(09)80428-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang S.-T., 1974, Mushroom Journal, P350; Chang S.T., 1978, BIOL CULTIVATION EDI, P573, DOI DOI 10.1016/B978-0-12-168050-3.50033-5; CHANG SC, 1982, APPL ENVIRON MICROB, V43, P440, DOI 10.1128/AEM.43.2.440-446.1982; CHANG ST, 1971, AM J BOT, V58, P552, DOI 10.2307/2441038; CHANG ST, 1966, NATURE, V212, P528, DOI 10.1038/212528b0; CHANG ST, 1977, ECON BOT, V31, P374, DOI 10.1007/BF02866890; CHANG ST, 1969, CYTOLOGIA, V34, P293, DOI 10.1508/cytologia.34.293; CHANG ST, 1969, BOT MAG TOKYO, V82, P102; CHANG ST, 1970, AM J BOT, V57, P165, DOI 10.2307/2440509; Chang ST, 1996, WORLD J MICROB BIOT, V12, P473, DOI 10.1007/BF00419460; Chang ST, 1965, CHUNG CHI J, V5, P91; Chang ST, 1996, MUSHROOM BIOL MUSHRO, V2, P1; Chang ST, 1980, MUSHROOM NEWSLETTER, V1, P5; Chen SC, 2004, FEMS MICROBIOL LETT, V230, P171, DOI 10.1016/S0378-1097(03)00878-4; Chen SC, 2003, FEMS MICROBIOL LETT, V218, P143, DOI 10.1111/j.1574-6968.2003.tb11510.x; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Dunaevskii IaE, 2008, RUSSIAN J BIOORGANIC, V34, P317; Ehrlich KC, 2004, APPL ENVIRON MICROB, V70, P6518, DOI 10.1128/AEM.70.11.6518-6524.2004; Elliot TJ, 1982, TROPICAL MUSHROOMS B, P11; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hibbett DS, 2001, SYST BIOL, V50, P215, DOI 10.1080/10635150151125879; Iwahashi H, 1998, APPL ENVIRON MICROB, V64, P4614; James TY, 2006, GENETICS, V172, P1877, DOI 10.1534/genetics.105.051128; Joh JH, 2004, FEMS MICROBIOL LETT, V239, P57, DOI 10.1016/j.femsle.2004.08.020; Kandror O, 2004, MOL CELL, V13, P771, DOI 10.1016/S1097-2765(04)00148-0; Kerrigan R. W., 2011, Mushroom biology and mushroom products. Proceedings of the 7th International Conference on Mushroom Biology and Mushroom Products, Arcachon, France, 4-7 October, 2011. Volume 1. Oral presentations, P1; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Kitazume T, 2002, EUR J BIOCHEM, V269, P2075, DOI 10.1046/j.1432-1033.2002.02855.x; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kudryavtseva OA, 2008, MICROBIOLOGY+, V77, P643, DOI 10.1134/S0026261708060015; Kues U, 2011, MYCOTA, V14, P97; LI Y, 1992, WORLD J MICROB BIOT, V8, P621, DOI 10.1007/BF01238801; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Melo NR, 2008, CYP56 DIT2P CANDIDA; Ming-Hua S, 2007, J MICROBIOL BIOTECHN, V17, P1271; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murata Y, 2006, EXTREMOPHILES, V10, P117, DOI 10.1007/s00792-005-0480-1; Nakayama N, 1996, J BIOCHEM-TOKYO, V119, P435; Natarajan K, 2007, PLOS BIOL, V5, pe17; Nelson David R., 2009, Human Genomics, V4, P59; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pacheco A, 2009, MICROBIOL-SGM, V155, P2021, DOI 10.1099/mic.0.025981-0; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Ramirez L, 2011, INT MICROBIOL, V14, P111, DOI 10.2436/20.1501.01.141; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; ROYSE DJ, 1987, EXP MYCOL, V11, P11, DOI 10.1016/0147-5975(87)90031-4; Saier Jr MH, 2006, TCDB TRANSPORTER CLA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Santiago CM, 1983, PHILIPPINES J SCI, V114, P53; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Sweeney MD, 2012, CATALYSTS, V2, P244, DOI 10.3390/catal2020244; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wen Y, 2005, APPL ENVIRON MICROB, V71, P3192, DOI 10.1128/AEM.71.6.3192-3198.2005; Xie B. G., 2010, ANN M MYC SOC CHIN, P2; Ya R, 2009, MYCOL RES, V113, P240, DOI 10.1016/j.mycres.2008.11.002; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; [张红 ZHANG Hong], 2006, [上海大学学报. 自然科学版, Journal of Shanghai University. Natural Science], V12, P547; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	90	110	154	5	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58294	10.1371/journal.pone.0058294	http://dx.doi.org/10.1371/journal.pone.0058294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23526973	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100021
J	Ibanez, LI; Roose, K; De Filette, M; Schotsaert, M; De Sloovere, J; Roels, S; Pollard, C; Schepens, B; Grooten, J; Fiers, W; Saelens, X				Ibanez, Lorena Itati; Roose, Kenny; De Filette, Marina; Schotsaert, Michael; De Sloovere, Jessica; Roels, Stefan; Pollard, Charlotte; Schepens, Bert; Grooten, Johan; Fiers, Walter; Saelens, Xavier			M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CORE PARTICLES; EXTRACELLULAR DOMAIN; ANTIBODY-RESPONSE; VACCINE; PROTEIN; M2; PROTECTION; IMMUNOGENICITY; MICE	The ectodomain of influenza A matrix protein 2 (M2e) is a candidate for a universal influenza A vaccine. We used recombinant Hepatitis B core antigen to produce virus-like particles presenting M2e (M2e-VLPs). We produced the VLPs with and without entrapped nucleic acids and compared their immunogenicity and protective efficacy. Immunization of BALB/c mice with M2e-VLPs containing nucleic acids induced a stronger, Th1-biased antibody response compared to particles lacking nucleic acids. The former also induced a stronger M2e-specific CD4(+) T cell response, as determined by ELISPOT. Mice vaccinated with alum-adjuvanted M2e-VLPs containing the nucleic acid-binding domain were better protected against influenza A virus challenge than mice vaccinated with similar particles lacking this domain, as deduced from the loss in body weight following challenge with X47 (H3N2) or PR/8 virus. Challenge of mice that had been immunized with M2e-VLPs with or without nucleic acids displayed significantly lower mortality, morbidity and lung virus titers than control-immunized groups. We conclude that nucleic acids present in M2e-VLPs correlate with improved immune protection.	[Ibanez, Lorena Itati; Roose, Kenny; De Filette, Marina; Schotsaert, Michael; Schepens, Bert; Fiers, Walter; Saelens, Xavier] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Ibanez, Lorena Itati; Roose, Kenny; De Filette, Marina; Schotsaert, Michael; Pollard, Charlotte; Schepens, Bert; Grooten, Johan; Fiers, Walter; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [De Sloovere, Jessica; Roels, Stefan] Vet & Agrochem Res Ctr CODA CERVA, Operat Direct Interact & Surveillance, Unit Surveillance Orientat & Vet Support, Brussels, Belgium; [Pollard, Charlotte] Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Institute of Tropical Medicine (ITM)	Saelens, X (corresponding author), VIB, Dept Mol Biomed Res, Ghent, Belgium.	xavier.saelens@dmbr.vib-ugent.be	Saelens, Xavier/N-5728-2015; Schotsaert, Michael/AAA-9960-2020	Schotsaert, Michael/0000-0003-3156-3132; , Xavier/0000-0002-3861-6965	Ghent University IOF-grant Stepstone [IOF08/STEP/001]; Ghent University Special Research Grant [BOF12/GOA/014]; Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie (IWT); Ghent University; FWO-Vlaanderen project [G.0375.10N]; Sanofi Pasteur	Ghent University IOF-grant Stepstone(Ghent University); Ghent University Special Research Grant; Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Ghent University(Ghent University); FWO-Vlaanderen project(FWO); Sanofi Pasteur	L.I.I. was a beneficiary of the Belgian Federal Sciences Administration (Federale Wetenschapsbeleid, BELSPO) and was supported by Ghent University IOF-grant Stepstone IOF08/STEP/001 and Ghent University Special Research Grant BOF12/GOA/014. K. R. was supported by a predoctoral fellowship from Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie (IWT). M. S. was a beneficiary of a "Bijzonder Onderzoeksfonds'' research grant from Ghent University and B. S. is postdoctoral fellow with FWO-Vlaanderen. Research related to M2e-based influenza vaccines in the group of X. S. is supported by FWO-Vlaanderen project G.0375.10N, Ghent University IOF-grant Stepstone IOF08/STEP/001, and a research collaboration with Sanofi Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Walter Fiers and Marina De Filette hold patent rights on the use of M2e as a vaccine antigen. Part of the research on M2e in the Saelens group (Ghent University and VIB) is supported by a research collaboration with Sanofi Pasteur. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; Dawood F., 2012, LANCET INFECT DIS; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; FERRARI C, 1991, J CLIN INVEST, V88, P214, DOI 10.1172/JCI115280; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Giles BM, 2012, J INFECT DIS, V205, P1562, DOI 10.1093/infdis/jis232; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; LAMB RA, 1981, P NATL ACAD SCI-BIOL, V78, P4170, DOI 10.1073/pnas.78.7.4170; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; MILICH DR, 1988, J IMMUNOL, V141, P3617; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Roose K, 2009, DRUG NEWS PERSPECT, V22, P80, DOI 10.1358/dnp.2009.22.2.1334451; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Sakaguchi T, 1997, P NATL ACAD SCI USA, V94, P5000, DOI 10.1073/pnas.94.10.5000; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schotsaert M, 2012, MUCOSAL IMMUNOLOGY; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Tate MD, 2011, VIRAL IMMUNOL, V24, P77, DOI 10.1089/vim.2010.0118; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wolf AI, 2012, PLOS ONE, V6; Wood JM, 2007, INFLUENZA OTHER RESP, V1, P5, DOI 10.1111/j.1750-2659.2006.00003.x; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988	53	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59081	10.1371/journal.pone.0059081	http://dx.doi.org/10.1371/journal.pone.0059081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527091	Green Published, gold, Green Submitted			2022-12-27	WOS:000316411600034
J	Ikezaki, K; Komori, T; Yanagida, T				Ikezaki, Keigo; Komori, Tomotaka; Yanagida, Toshio			Spontaneous Detachment of the Leading Head Contributes to Myosin VI Backward Steps	PLOS ONE			English	Article							HAND-OVER-HAND; LEVER ARM; MECHANISM	Myosin VI is an ATP driven molecular motor that normally takes forward and processive steps on actin filaments, but also on occasion stochastic backward steps. While a number of models have attempted to explain the backwards steps, none offer an acceptable mechanism for their existence. We therefore performed single molecule imaging of myosin VI and calculated the stepping rates of forward and backward steps at the single molecule level. The forward stepping rate was proportional to the ATP concentration, whereas the backward stepping rate was independent. Using these data, we proposed that spontaneous detachment of the leading head is uncoupled from ATP binding and is responsible for the backward steps of myosin VI.	[Ikezaki, Keigo; Komori, Tomotaka; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Ikezaki, Keigo; Komori, Tomotaka; Yanagida, Toshio] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Yanagida, Toshio] Ctr Informat & Neural Networks CiNet, Suita, Osaka, Japan; [Yanagida, Toshio] Osaka Univ, Immunol Frontier Res Ctr IFReC, Suita, Osaka, Japan	Osaka University; RIKEN; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Komori, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	komotomo@fbs.osaka-u.ac.jp; yanagida@fbs.osaka-u.ac.jp			MEXT, Japan [24-2619]; RIKEN QBiC, Japan; MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN QBiC, Japan; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for JSPS Fellows 24-2619 (to KI) from MEXT, Japan and funding from RIKEN QBiC, Japan and the Global COE program 'System Dynamics of Biological Function' also from MEXT, Japan. The funders had no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Dunn AR, 2010, P NATL ACAD SCI USA, V107, P7746, DOI 10.1073/pnas.1002430107; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Ikezaki K, 2012, SMALL, V8, P3035, DOI 10.1002/smll.201200765; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; Peiying C, 2011, J MOL BIOL, V405, P105; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Shiroguchi K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001031; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	20	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58912	10.1371/journal.pone.0058912	http://dx.doi.org/10.1371/journal.pone.0058912			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527046	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600016
J	Oliveira, AS; Silva, PB; Lund, ME; Gizzi, L; Farina, D; Kersting, UG				Oliveira, Anderson Souza; Silva, Priscila Brito; Lund, Morten Enemark; Gizzi, Leonardo; Farina, Dario; Kersting, Uwe Gustav			Effects of Perturbations to Balance on Neuromechanics of Fast Changes in Direction during Locomotion	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; MUSCLE SYNERGIES; ACTIVATION PATTERNS; MOTOR PATTERNS; HUMAN WALKING; KNEE; COORDINATION; STRATEGIES; STABILITY; JOINT	This study investigated whether the modular control of changes in direction while running is influenced by perturbations to balance. Twenty-two healthy men performed 90 degrees side-step unperturbed cutting manoeuvres while running (UPT) as well as manoeuvres perturbed at initial contact (PTB, 10 cm translation of a moveable force platform). Surface EMG activity from 16 muscles of the supporting limb and trunk, kinematics, and ground reaction forces were recorded. Motor modules composed by muscle weightings and their respective activation signals were extracted from the EMG signals by non-negative matrix factorization. Knee joint moments, co-contraction ratios and co-contraction indexes (hamstrings/quadriceps) and motor modules were compared between UPT and PTB. Five motor modules were enough to reconstruct UPT and PTB EMG activity (variance accounted for UPT = 92 +/- 5%, PTB = 90 +/- 6%). Moreover, higher similarities between muscle weightings from UPT and PTB (similarity = 0.83 +/- 0.08) were observed in comparison to the similarities between the activation signals that drive the temporal properties of the motor modules (similarity = 0.71 +/- 0.18). In addition, the reconstruction of PTB EMG from fixed muscle weightings from UPT resulted in higher reconstruction quality (82 +/- 6%) when compared to reconstruction of PTB EMG from fixed activation signals from UPT (59 +/- 11%). Perturbations at initial contact reduced knee abduction moments (7%), as well as co-contraction ratio (11%) and co-contraction index (12%) shortly after the perturbation onset. These changes in co-contraction ratio and co-contraction index were caused by a reduced activation of hamstrings that was also verified in the activation signals of the specific motor module related to initial contact. Our results suggested that perturbations to balance influence modular control of cutting manoeuvres, especially the temporal properties of muscle recruitment, due to altered afferent inputs to the motor patterns. Furthermore, reduced knee stability during perturbed events may be related to overall control of lower limb muscles.	[Oliveira, Anderson Souza; Silva, Priscila Brito; Kersting, Uwe Gustav] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Aalborg, Denmark; [Oliveira, Anderson Souza] Brazilian Educ Minist, CAPES Fdn, Brasilia, DF, Brazil; [Lund, Morten Enemark] Aalborg Univ, Dept Mech & Mfg Engn, Aalborg, Denmark; [Gizzi, Leonardo] Univ Hosp Gottingen, Pain Clin Ctr Anesthesiol Emergency & Intens Care, Gottingen, Germany; [Farina, Dario] Univ Gottingen, Univ Med Ctr Gottingen, Bernstein Ctr Computat Neurosci, Dept Neurorehabil Engn, D-37073 Gottingen, Germany	Aalborg University; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Aalborg University; University of Gottingen; University of Gottingen	Kersting, UG (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Aalborg, Denmark.	uwek@hst.aau.dk	Kersting, Uwe/AAS-6693-2021; Oliveira, Anderson/AAJ-1068-2020; Farina, Dario/AAB-2648-2019; Gizzi, Leonardo/B-5691-2013	Oliveira, Anderson/0000-0003-2186-8100; Gizzi, Leonardo/0000-0003-3009-6261; Kersting, Uwe G/0000-0001-9373-2080; de Brito Silva, Priscila/0000-0002-5879-3600	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Aalborg University [0293-09-1]; EU [600698]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Aalborg University; EU(European Commission)	The authors would like to thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for financial support to Anderson S. C. Oliveira for his PhD studies at Aalborg University (process 0293-09-1). The work was partly sponsored by the EU project "Integrative approach for the emergence of human-like robot locomotion" (H2R, contract number 600698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P859, DOI 10.1007/s00167-009-0823-z; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Andersen MS, 2010, COMPUT METHOD BIOMEC, V13, P171, DOI 10.1080/10255840903067080; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Besier TF, 2003, MED SCI SPORT EXER, V35, P119, DOI 10.1097/00005768-200301000-00019; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Cappellini G, 2010, J NEUROPHYSIOL, V103, P746, DOI 10.1152/jn.00499.2009; Oliveira ADC, 2009, J ELECTROMYOGR KINES, V19, P1079, DOI 10.1016/j.jelekin.2008.10.005; Oliveira ASC, 2012, J NEUROPHYSIOL, V108, P1895, DOI 10.1152/jn.00217.2012; Chvatal SA, 2012, J NEUROSCI, V32, P12237, DOI 10.1523/JNEUROSCI.6344-11.2012; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Dauty M., 2003, Annales de Readaptation et de Medecine Physique, V46, P601, DOI 10.1016/j.annrmp.2003.04.001; Dietz V, 2002, BRAIN, V125, P2626, DOI 10.1093/brain/awf273; Drakos MC, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000118; Duysens J, 2008, NEUROPHYSIOL CLIN, V38, P399, DOI 10.1016/j.neucli.2008.09.010; Gibson ASC, 2000, J ORTHOP SPORT PHYS, V30, P418, DOI 10.2519/jospt.2000.30.7.418; Gizzi L, 2011, J NEUROPHYSIOL, V106, P202, DOI 10.1152/jn.00727.2010; Hennig EM, 2011, RES SPORTS MED, V19, P186, DOI 10.1080/15438627.2011.582823; Hermens HJ, 2002, SENIAM PROJECT SURFA; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hewett Timothy E, 2010, N Am J Sports Phys Ther, V5, P234; Hug F, 2011, J NEUROPHYSIOL, V106, P91, DOI 10.1152/jn.01096.2010; Hug F, 2010, J APPL PHYSIOL, V108, P1727, DOI 10.1152/japplphysiol.01305.2009; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Ivanenko YP, 2006, NEUROSCIENTIST, V12, P339, DOI 10.1177/1073858406287987; Lacquaniti F, 2012, J PHYSIOL-LONDON, V590, P2189, DOI 10.1113/jphysiol.2011.215137; Landry Scott C, 2009, J Electromyogr Kinesiol, V19, pe370, DOI 10.1016/j.jelekin.2008.08.004; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lloyd DG, 1996, J BIOMECH ENG-T ASME, V118, P367, DOI 10.1115/1.2796019; Marigold DS, 2002, J NEUROPHYSIOL, V88, P339, DOI 10.1152/jn.00691.2001; McDonagh MJN, 2002, J PHYSIOL-LONDON, V544, P985, DOI 10.1113/jphysiol.2002.024844; Muceli S, 2010, J NEUROPHYSIOL, V103, P1532, DOI 10.1152/jn.00559.2009; Neptune RR, 1999, MED SCI SPORT EXER, V31, P294, DOI 10.1097/00005768-199902000-00014; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; Oh YK, 2012, AM J SPORT MED, V40, P574, DOI 10.1177/0363546511432544; Oliveira AS, 2013, NEUROSCIENCE, V228, P283, DOI 10.1016/j.neuroscience.2012.10.027; Oliveira AS, 2011, IFMBE PROC, V34, P271; Reynolds RF, 2003, EXP BRAIN RES, V151, P301, DOI 10.1007/s00221-003-1444-2; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Safavynia SA, 2012, J NEUROPHYSIOL, V107, P159, DOI 10.1152/jn.00653.2011; Schillings AM, 2000, J NEUROPHYSIOL, V83, P2093, DOI 10.1152/jn.2000.83.4.2093; Shin CS, 2011, MED SCI SPORT EXER, V43, P1484, DOI 10.1249/MSS.0b013e31820f8395; Tang PF, 1998, EXP BRAIN RES, V119, P141, DOI 10.1007/s002210050327; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Torres-Oviedo G, 2010, J NEUROPHYSIOL, V103, P3084, DOI 10.1152/jn.00960.2009; Tsuda E, 2001, AM J SPORT MED, V29, P83, DOI 10.1177/03635465010290011801; Turpin NA, 2011, J ELECTROMYOGR KINES, V21, P1030, DOI 10.1016/j.jelekin.2011.07.013; van der Linden MH, 2007, J NEUROPHYSIOL, V97, P3639, DOI 10.1152/jn.01272.2006; van Doornik J, 2007, IEEE T BIO-MED ENG, V54, P1696, DOI 10.1109/TBME.2007.894949; Wikstrom EA, 2006, SPORTS MED, V36, P393, DOI 10.2165/00007256-200636050-00003; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zebis MK, 2009, AM J SPORT MED, V37, P1967, DOI 10.1177/0363546509335000	56	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59029	10.1371/journal.pone.0059029	http://dx.doi.org/10.1371/journal.pone.0059029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527079	Green Published, gold			2022-12-27	WOS:000316411600029
J	Zhang, J; Xu, AQ; Ma, JX; Shi, XM; Guo, XL; Engelgau, M; Yan, LX; Li, Y; Li, YC; Wang, HC; Lu, ZL; Zhang, JY; Liang, XF				Zhang, Juan; Xu, Ai-qiang; Ma, Ji-xiang; Shi, Xiao-ming; Guo, Xiao-lei; Engelgau, Michael; Yan, Liu-xia; Li, Yuan; Li, Yi-chong; Wang, Hui-cheng; Lu, Zi-long; Zhang, Ji-yu; Liang, Xiao-feng			Dietary Sodium Intake: Knowledge, Attitudes and Practices in Shandong Province, China, 2011	PLOS ONE			English	Article							SALT; HYPERTENSION; PREVALENCE; REDUCTION; AWARENESS; DISEASE	Objective: To investigate the knowledge, attitudes and practices (KAP) for dietary sodium intake among adult residents of Shandong Province, China Methods: In 2011, we conducted a cross sectional survey among a representative sample of 15,350 adults aged 18 to 69 years using a standardized questionnaire to assess their KAP for sodium. Variation in the KAPs by gender, and residence location were compared using the Chi-square tests. Predictors for the 'intention to' and 'currently taking action to' reduce sodium intake were determined by multivariate logistic regression with adjustment for confounding factors. Results: KAPs for dietary sodium intake among urban residents was generally more favorable than among rural residents. Women were likely to have more favorable KAPs than men. About four fifth of subjects reported that they favored a low sodium diets. However, 31% reported that consumption of less sodium results in less physical strength. Overall, 70% indicated their intention to reduce sodium intake, although only 39 % reported that they had taken action to reduce sodium. Multiple logistic regression analyses indicated that favorable actions to dietary sodium reduction were more likely to occur among those who were aware of the link between sodium and hypertension, and less likely among those who had unfavorable attitudes towards dietary sodium reduction. Conclusion: Increasing knowledge levels about the benefits of sodium reduction will be a key success factor for effective sodium reduction initiatives and is linked to favorable behavioral change. Emphasis should be placed on the rural area.	[Zhang, Juan; Shi, Xiao-ming; Li, Yuan] Chinese Ctr Dis Control & Prevent, Div Noncommunicable Dis Control & Community Hlth, Beijing, Peoples R China; [Xu, Ai-qiang] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Ma, Ji-xiang; Yan, Liu-xia; Li, Yi-chong; Wang, Hui-cheng] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Guo, Xiao-lei; Lu, Zi-long; Zhang, Ji-yu] Shandong Ctr Dis Control & Prevent, Inst NCD Control & Prevent, Jinan, Peoples R China; [Engelgau, Michael] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Liang, Xiao-feng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA; Chinese Center for Disease Control & Prevention	Liang, XF (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.	liangxf@hotmail.com	zhang, jiyu/W-9297-2018; Shi, Xiaoming/V-2119-2018	zhang, jiyu/0000-0001-6236-8781; Shi, Xiaoming/0000-0002-7071-571X	Chinese Center for Disease Control and Prevention; Shandong Center for Disease Control and Prevention	Chinese Center for Disease Control and Prevention; Shandong Center for Disease Control and Prevention	The Chinese Center for Disease Control and Prevention, and Shandong Center for Disease Control and Prevention provided funding for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2011, CHIN NCD REP 2011; Appel LJ, 2012, ANN EPIDEMIOL, V22, P417, DOI 10.1016/j.annepidem.2012.04.003; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Chan WG, SALT REDUCTION INITI; China CDC & China News, 2011, CHINA CDC CHINA NEWS; Chinese Nutrition Society, 2007, CHIN NUTR GUID; EVERS SE, 1987, PREV MED, V16, P213, DOI 10.1016/0091-7435(87)90085-5; GLANZ K, 1997, HLTH BEHAV HLTH ED T; Gunn Janelle P., 2012, Morbidity and Mortality Weekly Report, V61, P89; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Institute of Medicine-IOM, 2008, DIETARY REFERENCE IN; Karanja N, 2007, J AM DIET ASSOC, V107, P1530, DOI 10.1016/j.jada.2007.06.013; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Ministry of Health, 2010, ANN REP HLTH STAT; Puska P, 2002, PUBLIC HEALTH NUTR, V5, P234; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966; Yan Li, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1188; Yang J, 2007, CHINESE PUBLIC HLTH, V23, P542	22	41	51	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e58973	10.1371/journal.pone.0058973	http://dx.doi.org/10.1371/journal.pone.0058973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527061	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600021
J	Archetti, M; Richardson, AD; O'Keefe, J; Delpierre, N				Archetti, Marco; Richardson, Andrew D.; O'Keefe, John; Delpierre, Nicolas			Predicting Climate Change Impacts on the Amount and Duration of Autumn Colors in a New England Forest	PLOS ONE			English	Article							GROWING-SEASON; PHENOLOGICAL TRANSITIONS; DECIDUOUS FOREST; FLOWERING TIMES; PRODUCTIVITY; TEMPERATURE; EARLIER	Climate change affects the phenology of many species. As temperature and precipitation are thought to control autumn color change in temperate deciduous trees, it is possible that climate change might also affect the phenology of autumn colors. Using long-term data for eight tree species in a New England hardwood forest, we show that the timing and cumulative amount of autumn color are correlated with variation in temperature and precipitation at specific times of the year. A phenological model driven by accumulated cold degree-days and photoperiod reproduces most of the interspecific and interannual variability in the timing of autumn colors. We use this process-oriented model to predict changes in the phenology of autumn colors to 2099, showing that, while responses vary among species, climate change under standard IPCC projections will lead to an overall increase in the amount of autumn colors for most species.	[Archetti, Marco; Richardson, Andrew D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [O'Keefe, John] Harvard Forest, Petersham, MA USA; [Delpierre, Nicolas] Univ Paris Sud, Lab Ecol Systemat & Evolut, Orsay, France	Harvard University; Harvard University; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Archetti, M (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	m.archetti@uea.ac.uk	Richardson, Andrew/F-5691-2011	Richardson, Andrew/0000-0002-0148-6714; Delpierre, Nicolas/0000-0003-0906-9402	National Foundation's (NSF) LTER program [DEB-0080592]; National Science Foundation [EF-1065029]; Northeastern States Research Cooperative; United States of America National Phenology Network; USGS [G10AP00129]; United States National Park Service Inventory and Monitoring Program; Direct For Biological Sciences [1237491] Funding Source: National Science Foundation; Emerging Frontiers [1065029, 1065734, 1065074] Funding Source: National Science Foundation	National Foundation's (NSF) LTER program; National Science Foundation(National Science Foundation (NSF)); Northeastern States Research Cooperative; United States of America National Phenology Network; USGS(United States Geological Survey); United States National Park Service Inventory and Monitoring Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research at Harvard Forest is partially supported by the National Foundation's (NSF) LTER program (award number DEB-0080592). ADR acknowledges support from the National Science Foundation through the Macrosystems Biology program (award EF-1065029), and the Northeastern States Research Cooperative, in addition to the United States Geological Survey Status (USGS) and Trends Program, the United States National Park Service Inventory and Monitoring Program, and the United States of America National Phenology Network, through grant number G10AP00129 from the USGS. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of either USGS or NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2009, TRENDS ECOL EVOL, V24, P166, DOI 10.1016/j.tree.2008.10.006; Archetti M, 2009, ANN BOT-LONDON, V103, P703, DOI 10.1093/aob/mcn259; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Delpierre N, 2009, AGR FOREST METEOROL, V149, P938, DOI 10.1016/j.agrformet.2008.11.014; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dragoni D, 2011, GLOBAL CHANGE BIOL, V17, P886, DOI 10.1111/j.1365-2486.2010.02281.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Estrella N, 2006, CLIM RES, V32, P253, DOI 10.3354/cr032253; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; FITTER AH, 1995, FUNCT ECOL, V9, P55, DOI 10.2307/2390090; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Fridley JD, 2012, NATURE, V485, P359, DOI 10.1038/nature11056; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Frumhoff PC, 2007, CONFRONTING CLIMATE; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hagen SC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006154; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Jolly WM, 2004, TREE PHYSIOL, V24, P1069, DOI 10.1093/treephys/24.9.1069; Kozlowski TT., 1997, GROWTH CONTROL WOODY; Lebourgeois F, 2010, INT J BIOMETEOROL, V54, P563, DOI 10.1007/s00484-010-0305-5; Matsumoto K, 2003, GLOBAL CHANGE BIOL, V9, P1634, DOI 10.1046/j.1365-2486.2003.00688.x; MAYER DG, 1993, ECOL MODEL, V68, P21, DOI 10.1016/0304-3800(93)90105-2; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Migliavacca M., 2012, BIOGEOSCI DISCUSS, V9, P879, DOI DOI 10.5194/BGD-9-879-2012; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Press W., 1992, NUMERICAL RECIPES FO; Primack D, 2004, AM J BOT, V91, P1260, DOI 10.3732/ajb.91.8.1260; Richardson AD, 2006, GLOBAL CHANGE BIOL, V12, P1174, DOI 10.1111/j.1365-2486.2006.01164.x; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Richardson Andrew D., 2009, P87, DOI 10.1007/978-1-4419-0026-5_4; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Sparks TH, 2011, INT J BIOMETEOROL, V55, P447, DOI 10.1007/s00484-010-0355-8; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021	42	78	80	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57373	10.1371/journal.pone.0057373	http://dx.doi.org/10.1371/journal.pone.0057373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520468	gold, Green Submitted, Green Published			2022-12-27	WOS:000318679900027
J	Kierdorf, K; Katzmarski, N; Haas, CA; Prinz, M				Kierdorf, Katrin; Katzmarski, Natalie; Haas, Carola A.; Prinz, Marco			Bone Marrow Cell Recruitment to the Brain in the Absence of Irradiation or Parabiosis Bias	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HEMATOPOIETIC-CELLS; ALZHEIMERS-DISEASE; AMYLOID DEPOSITION; MYELOID CELLS; STEM-CELLS; MICROGLIA; BLOOD; BARRIER; CNS	The engraftment of bone marrow-derived cells has been described not only during diseases of the central nervous system (CNS) but also under healthy conditions. However, previous studies pointing to an ample bone marrow cell engraftment used irradiation-induced bone marrow chimeras that evoked severe alterations of the CNS micromilieu including disturbances of the blood brain barrier (BBB), damage of endothelial cells and local induction of proinflammatory cytokines. On the other hand, parabiosis experiments using temporarily joined circulatory systems generally yielded low levels of myeloid cell chimerism thereby potentially underestimating bone marrow cell turnover with the CNS. To avoid these drawbacks we established a protocol using the alkylating agent busulfan prior to allogenic bone marrow transplantation from CX(3)CR1(GFP/+) donors. This regimen resulted in a stable and high peripheral myeloid chimerism, significantly reduced cytokine induction and preserved BBB integrity. Importantly, bone marrow cell recruitment to the CNS was strongly diminished under these conditions and only weakly enhanced during local neurodegeneration induced by facial nerve axotomy. These results underscore the requirement of local CNS conditioning for efficient recruitment of bone marrow cells, establish busulfan as an alternative treatment for studying bone marrow chimeras and suggest a critical re-evaluation of earlier chimeric studies involving irradiation or parabiosis regimens.	[Kierdorf, Katrin; Katzmarski, Natalie; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Kierdorf, Katrin; Katzmarski, Natalie] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Haas, Carola A.] Univ Freiburg, Dept Neurosurg, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Kierdorf, Katrin/AAO-6288-2021	Kierdorf, Katrin/0000-0002-9272-4780	Deutsche Forschungsgemeinschaft (DFG) research unit (FOR) "From monocytes to brain macrophagesconditions influencing the fate of myeloid cells in the brain" [1336]; BMBF; DFG [SFB 620, PR 577/8-2]; competence network of neurodegenerative disorders (DZNE); centre of chronic immunodeficiency (CCI)	Deutsche Forschungsgemeinschaft (DFG) research unit (FOR) "From monocytes to brain macrophagesconditions influencing the fate of myeloid cells in the brain"(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); competence network of neurodegenerative disorders (DZNE); centre of chronic immunodeficiency (CCI)	MP is supported by the Deutsche Forschungsgemeinschaft (DFG) funded research unit (FOR) 1336 "From monocytes to brain macrophagesconditions influencing the fate of myeloid cells in the brain". MP is further granted by the BMBF-funded competence network of multiple sclerosis (KKNMS), the competence network of neurodegenerative disorders (DZNE), the centre of chronic immunodeficiency (CCI), and the DFG (SFB 620, PR 577/8-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Algotsson A, 2007, ACTA NEUROL SCAND, V115, P403, DOI 10.1111/j.1600-0404.2007.00823.x; Bowman GL, 2007, NEUROLOGY, V68, P1809, DOI 10.1212/01.wnl.0000262031.18018.1a; Cartier N, 2010, BRAIN PATHOL, V20, P857, DOI 10.1111/j.1750-3639.2010.00394.x; CHAMPLIN RE, 1985, BLOOD, V65, P1039; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; HADDOW A, 1953, LANCET, V264, P207; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Koistinaho M, 2005, BRAIN RES REV, V48, P240, DOI 10.1016/j.brainresrev.2004.12.014; Lampron A, 2011, CELL TRANSPLANT; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; PUGIN J, 1995, J INFLAMM, V45, P49; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; VASSAL G, 1990, CANCER RES, V50, P6203; Yuan H, 2003, BRAIN RES, V969, P59, DOI 10.1016/S0006-8993(03)02278-9	38	111	111	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58544	10.1371/journal.pone.0058544	http://dx.doi.org/10.1371/journal.pone.0058544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23526995	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900080
J	Lizunov, VA; Stenkula, K; Troy, A; Cushman, SW; Zimmerberg, J				Lizunov, Vladimir A.; Stenkula, Karin; Troy, Aaron; Cushman, Samuel W.; Zimmerberg, Joshua			Insulin Regulates Glut4 Confinement in Plasma Membrane Clusters in Adipose Cells	PLOS ONE			English	Article							GLUCOSE-TRANSPORT; ANCHORED PROTEINS; LIPID RAFTS; TRANSLOCATION; VESICLES; FUSION; RAT; TRAFFICKING; MICROSCOPY; DIFFUSION	Insulin-stimulated delivery of glucose transporter-4 (GLUT4) to the plasma membrane (PM) is the hallmark of glucose metabolism. In this study we examined insulin's effects on GLUT4 organization in PM of adipose cells by direct microscopic observation of single monomers tagged with photoswitchable fluorescent protein. In the basal state, after exocytotic delivery only a fraction of GLUT4 is dispersed into the PM as monomers, while most of the GLUT4 stays at the site of fusion and forms elongated clusters (60-240 nm). GLUT4 monomers outside clusters diffuse freely and do not aggregate with other monomers. In contrast, GLUT4 molecule collision with an existing cluster can lead to immediate confinement and association with that cluster. Insulin has three effects: it shifts the fraction of dispersed GLUT4 upon delivery, it augments the dissociation of GLUT4 monomers from clusters similar to 3-fold and it decreases the rate of endocytic uptake. All together these three effects of insulin shift most of the PM GLUT4 from clustered to dispersed states. GLUT4 confinement in clusters represents a novel kinetic mechanism for insulin regulation of glucose homeostasis.	[Lizunov, Vladimir A.; Troy, Aaron; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Stenkula, Karin; Cushman, Samuel W.] NIDDKD, Expt Diabet Metab & Nutr Sect, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	joshz@mail.nih.gov		Stenkula, Karin/0000-0002-0739-1150; Troy, Aaron/0000-0001-9844-5718	Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055118] Funding Source: NIH RePORTER	Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011919; Al-Hasani H, 1999, FEBS LETT, V460, P338, DOI 10.1016/S0014-5793(99)01369-1; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Deutsch E, 2012, MOL BIOL CELL; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hagiwara A, 2011, CYTOSKELETON, V68, P512, DOI 10.1002/cm.20528; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Kenkre VM, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051907; KONO T, 1977, J BIOL CHEM, V252, P2226; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lizunov VA, 2012, AM J PHYSIOL-ENDOC M, V302, pE950, DOI 10.1152/ajpendo.00466.2011; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806; Malide D, 2000, J CELL SCI, V113, P4203; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078	44	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e57559	10.1371/journal.pone.0057559	http://dx.doi.org/10.1371/journal.pone.0057559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520472	Green Submitted, Green Published, gold			2022-12-27	WOS:000318679900031
J	Qin, SP; Hu, CS; Oenema, O				Qin, Shuping; Hu, Chunsheng; Oenema, Oene			Differentiating Intracellular from Extracellular Alkaline Phosphatase Activity in Soil by Sonication	PLOS ONE			English	Article							ENZYME-ACTIVITIES; ACID-PHOSPHATASE; ORGANIC-MATTER; FUMIGATION; PHOSPHORUS; EXTRACTION; ULTRASOUND; DYNAMICS; ENERGY	Differentiating intracellular from extracellular enzyme activity is important in soil enzymology, but not easy. Here, we report on an adjusted sonication method for the separation of intracellular from extracellular phosphatase activity in soil. Under optimal sonication conditions [soil:water ratio = 1/8 (w/v) and power density = 15 watt ml(-1)], the activity of alkaline phosphomonoesterase (phosphatase) in a Haplic Cambisol soil increased with sonication time in two distinct steps. A first plateau of enzyme activity was reached between 60 and 100 s, and a second higher plateau after 300 s. We also found that sonication for 100 s under optimal conditions activated most (about 80%) of the alkaline phosphatase that was added to an autoclaved soil, while total bacteria number was not affected. Sonication for 300 s reduced the total bacteria number by three orders of magnitude but had no further effects on enzyme activity. Our results indicate that the first plateau of alkaline phosphatase activity was derived from extracellular enzymes attached to soil particles, and the second plateau to the combination of extracellular and intracellular enzymes after cell lysis. We conclude that our adjusted sonication method may be an alternative to the currently used physiological and chloroform-fumigation methods for differentiating intracellular from extracellular phosphatase activity in soil. Further testing is needed to find out whether this holds for other soil types.	[Qin, Shuping; Hu, Chunsheng] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Hebei, Peoples R China; [Oenema, Oene] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Oenema, Oene] Alterra, Res, Wageningen, Netherlands	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Wageningen University & Research; Wageningen University & Research	Hu, CS (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Hebei, Peoples R China.	cshu@sjziam.ac.cn	Qin, Shuping/B-4451-2010		National Natural Science Foundation of China [31270554, 30970534]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31270554) and 30970534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd S. A., 1990, Soil biochemistry. Volume 6., P1; De Cesare F, 2000, SOIL BIOL BIOCHEM, V32, P825, DOI 10.1016/S0038-0717(99)00212-6; Dilly O, 1998, Z PFLANZ BODENKUNDE, V161, P243, DOI 10.1002/jpln.1998.3581610310; Gianfreda L, 2006, SOIL BIOL, V8, P257; Grierson PF, 2000, SOIL BIOL BIOCHEM, V32, P1817, DOI 10.1016/S0038-0717(00)00155-3; Guenon R, 2013, SOIL BIOL BIOCHEM, V57, P663, DOI 10.1016/j.soilbio.2012.07.006; Klose S, 1999, BIOL FERT SOILS, V29, P46, DOI 10.1007/s003740050523; Klose S, 2002, J PLANT NUTR SOIL SC, V165, P429, DOI 10.1002/1522-2624(200208)165:4<429::AID-JPLN429>3.0.CO;2-S; Kong CH, 2008, SOIL BIOL BIOCHEM, V40, P1862, DOI 10.1016/j.soilbio.2008.03.009; Kramer S, 2000, SOIL BIOL BIOCHEM, V32, P179, DOI 10.1016/S0038-0717(99)00140-6; MAMBA S, 1995, INT J ENVIRON AN CH, V60, P295, DOI 10.1080/03067319508042885; Margon A, 2008, SOIL BIOL BIOCHEM, V40, P2178, DOI 10.1016/j.soilbio.2008.02.006; Murage EW, 2007, SOIL SCI SOC AM J, V71, P1363, DOI 10.2136/sssaj2006.0196; NAKAS JP, 1987, SOIL BIOL BIOCHEM, V19, P13, DOI 10.1016/0038-0717(87)90118-0; Nannipieri P, 2012, BIOL FERT SOILS, V48, P743, DOI 10.1007/s00374-012-0723-0; Nannipieri P, 2011, SOIL BIOL, V26, P215, DOI 10.1007/978-3-642-15271-9_9; Nannipieri P, 2002, BOOK SOIL P, P1; Nannipieri P, 1996, SOIL BIOL BIOCHEM, V28, P107, DOI 10.1016/0038-0717(95)00108-5; Ormeci B, 2005, ENVIRON ENG SCI, V22, P459, DOI 10.1089/ees.2005.22.459; RAMSAY AJ, 1984, SOIL BIOL BIOCHEM, V16, P475, DOI 10.1016/0038-0717(84)90055-5; Renella G, 2002, SOIL BIOL BIOCHEM, V34, P51, DOI 10.1016/S0038-0717(01)00152-3; Saha S, 2008, EUR J SOIL BIOL, V44, P309, DOI 10.1016/j.ejsobi.2008.02.004; Speir T, 1978, SOIL ENZYMES, V203; Stemmer M, 1998, SOIL BIOL BIOCHEM, V30, P9, DOI 10.1016/S0038-0717(97)00093-X; STEVENSON I. L., 1958, Plant and Soil, V10, P1, DOI 10.1007/BF01343733; TARAFDAR JC, 1988, BIOL FERT SOILS, V5, P308, DOI 10.1007/BF00262137; Udawatta RP, 2009, AGR ECOSYST ENVIRON, V131, P98, DOI 10.1016/j.agee.2008.06.001; Vargas LHM, 2004, WORLD J MICROB BIOT, V20, P137, DOI 10.1023/B:WIBI.0000021726.69233.12; Wang JB, 2011, PLANT SOIL ENVIRON, V57, P251, DOI 10.17221/437/2010-PSE; Yachmenev VG, 2004, ULTRASONICS, V42, P87, DOI 10.1016/j.ultras.2004.01.011; Yeates C, 1998, Biol Proced Online, V1, P40, DOI 10.1251/bpo6	31	4	6	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58691	10.1371/journal.pone.0058691	http://dx.doi.org/10.1371/journal.pone.0058691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23527006	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500114
J	Li, SH; Zhang, XJ; Sun, Z; Li, FH; Xiang, JH				Li, Shihao; Zhang, Xiaojun; Sun, Zheng; Li, Fuhua; Xiang, Jianhai			Transcriptome Analysis on Chinese Shrimp Fenneropenaeus chinensis during WSSV Acute Infection	PLOS ONE			English	Article							SPOT-SYNDROME-VIRUS; BLACK TIGER SHRIMP; DIFFERENTIALLY EXPRESSED GENES; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; PROPHENOLOXIDASE-ACTIVATING SYSTEM; ANTILIPOPOLYSACCHARIDE FACTOR ALF; RNA INTERFERENCE PATHWAY; PENAEUS-MONODON; MOLECULAR-CLONING; ANTIMICROBIAL ACTIVITY	Previous studies have discovered a lot of immune-related genes responding to white spot syndrome virus (WSSV) infection in crustacean. However, little information is available in relation to underlying mechanisms of host responses during the WSSV acute infection stage in naturally infected shrimp. In this study, we employed next-generation sequencing and bioinformatic techniques to observe the transcriptome differences of the shrimp between latent infection stage and acute infection stage. A total of 64,188,426 Illumina reads, including 31,685,758 reads from the latent infection group and 32,502,668 reads from the acute infection group, were generated and assembled into 46,676 unigenes (mean length: 676 bp; range: 200-15,094 bp). Approximately 24,000 peptides were predicted and classified based on homology searches, gene ontology, clusters of orthologous groups of proteins, and biological pathway mapping. Among which, 805 differentially expressed genes were identified and categorized into 11 groups based on their possible function. Genes in the Toll and IMD pathways, the Ras-activated endocytosis process, the RNA interference pathway, anti-lipopolysaccharide factors and many other genes, were found to be activated in shrimp from latent infection stage to acute infection stage. The anti-bacterially proPO-activating cascade was firstly uncovered to be probably participated in antiviral process. These genes contain not only members playing function in host defense against WSSV, but also genes utilized by WSSV for its rapid proliferation. In addition, the transcriptome data provides detail information for identifying novel genes in absence of the genome database of shrimp.	[Li, Shihao; Zhang, Xiaojun; Sun, Zheng; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, FH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	fhli@ms.qdio.ac.cn; jhxiang@ms.qdio.ac.cn	zhang, jin/GXV-9154-2022; xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787; Sun, Zheng/0000-0002-8537-8576; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046	Major State Basic Research Development Program [2012CB114403]; National High Tech Research and Development Program [2012AA10A404, 2012AA092205]; National Natural Science Foundation Program [31072203]; China Agriculture Research System-47 [CARS-47]; Special Fund for Agro-scientific Research in the Public Interest [201103034]	Major State Basic Research Development Program(National Basic Research Program of China); National High Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation Program(National Natural Science Foundation of China (NSFC)); China Agriculture Research System-47; Special Fund for Agro-scientific Research in the Public Interest	This work was financially supported by the Major State Basic Research Development Program (2012CB114403), National High Tech Research and Development Program (2012AA10A404, 2012AA092205), National Natural Science Foundation Program (31072203), China Agriculture Research System-47 (CARS-47), and Special Fund for Agro-scientific Research in the Public Interest (201103034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Assavalapsakul W, 2009, DIS AQUAT ORGAN, V84, P167, DOI 10.3354/dao02044; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Beale KM, 2008, COMP BIOCHEM PHYS D, V3, P263, DOI 10.1016/j.cbd.2008.07.001; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Chen LL, 2000, DIS AQUAT ORGAN, V40, P157, DOI 10.3354/dao040157; Chen P, 2010, FISH SHELLFISH IMMUN, V28, P106, DOI 10.1016/j.fsi.2009.10.002; Chen WY, 2008, DEV COMP IMMUNOL, V32, P1142, DOI 10.1016/j.dci.2008.03.003; Chen YH, 2012, FISH SHELLFISH IMMUN, V32, P373, DOI 10.1016/j.fsi.2011.11.032; Codran A, 2006, J GEN VIROL, V87, P2583, DOI 10.1099/vir.0.81710-0; Dechklar M, 2008, BIOCHEM BIOPH RES CO, V367, P768, DOI 10.1016/j.bbrc.2008.01.031; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Flegel T.W., 2008, DIS ASIAN AQUACULTUR, V6, P355; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Gai YC, 2008, FISH SHELLFISH IMMUN, V24, P156, DOI 10.1016/j.fsi.2007.08.006; Gao HW, 2009, MOL BIOL REP, V36, P1159, DOI 10.1007/s11033-008-9292-6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han F, 2012, GENE, V495, P65, DOI 10.1016/j.gene.2011.11.048; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; HOESS A, 1993, EMBO J, V12, P3351, DOI 10.1002/j.1460-2075.1993.tb06008.x; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hossain MS, 2004, VIROLOGY, V325, P106, DOI 10.1016/j.virol.2004.05.005; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Imjongjirak C, 2007, MOL IMMUNOL, V44, P3195, DOI 10.1016/j.molimm.2007.01.028; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jimenez-Vega F, 2007, J SHELLFISH RES, V26, P1169, DOI 10.2983/0730-8000(2007)26[1169:IOLVAA]2.0.CO;2; Jiravanichpaisal P, 2006, FISH SHELLFISH IMMUN, V20, P718, DOI 10.1016/j.fsi.2005.09.002; Jiravanichpaisal P, 2004, FISH SHELLFISH IMMUN, V17, P265, DOI 10.1016/j.fsi.2004.03.010; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Khadijah S, 2003, J VIROL, V77, P10162, DOI 10.1128/JVI.77.18.10162-10167.2003; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Ko CF, 2007, DEV COMP IMMUNOL, V31, P12, DOI 10.1016/j.dci.2006.05.002; Krishnan P, 2009, DIS AQUAT ORGAN, V86, P263, DOI 10.3354/dao02126; Lai CY, 2005, FISH SHELLFISH IMMUN, V18, P417, DOI 10.1016/j.fsi.2004.10.004; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Li CH, 2008, DEV COMP IMMUNOL, V32, P784, DOI 10.1016/j.dci.2007.11.008; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Li FH, 2009, DEV COMP IMMUNOL, V33, P1093, DOI 10.1016/j.dci.2009.06.001; Liu B, 2006, AQUACULTURE, V253, P163, DOI 10.1016/j.aquaculture.2005.08.022; Liu CH, 2006, FISH SHELLFISH IMMUN, V21, P60, DOI 10.1016/j.fsi.2005.10.004; Liu FS, 2005, MAR BIOTECHNOL, V7, P600, DOI 10.1007/s10126-005-5006-4; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Magbanua FO, 2000, DIS AQUAT ORGAN, V42, P77, DOI 10.3354/dao042077; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; Masuda T, 2012, FISH SHELLFISH IMMUN, V32, P61, DOI 10.1016/j.fsi.2011.10.020; Mekata T, 2011, MOL CELL PROBE, V25, P94, DOI 10.1016/j.mcp.2011.02.001; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ren Q, 2009, FISH SHELLFISH IMMUN, V26, P787, DOI 10.1016/j.fsi.2009.03.004; Robalino J, 2005, J VIROL, V79, P13561, DOI 10.1128/JVI.79.21.13561-13571.2005; Roux MM, 2002, J VIROL, V76, P8978, DOI 10.1128/JVI.76.17.8978.2002; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Saksmerprome V, 2009, J VIROL METHODS, V162, P213, DOI 10.1016/j.jviromet.2009.08.010; Sarathi M, 2008, MAR BIOTECHNOL, V10, P198, DOI 10.1007/s10126-007-9052-y; Shekhar MS, 2009, MAR BIOTECHNOL, V11, P1, DOI 10.1007/s10126-008-9155-0; Shi XZ, 2009, FISH SHELLFISH IMMUN, V27, P610, DOI 10.1016/j.fsi.2009.07.005; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Sritunyalucksana K, 1999, DEV COMP IMMUNOL, V23, P179, DOI 10.1016/S0145-305X(99)00005-1; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Su JS, 2008, FISH SHELLFISH IMMUN, V24, P223, DOI 10.1016/j.fsi.2007.11.006; Sun C, 2011, MOL BIOL REP, V38, P5313, DOI 10.1007/s11033-011-0681-x; Sun YM, 2013, AQUACULTURE, V376, P124, DOI 10.1016/j.aquaculture.2012.11.014; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Swift ML, 1997, J CHEM INF COMP SCI, V37, P411, DOI 10.1021/ci960402j; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LT, 2001, J FISH DIS, V24, P315, DOI 10.1046/j.1365-2761.2001.00286.x; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thakur PC, 2002, DIS AQUAT ORGAN, V49, P235, DOI 10.3354/dao049235; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Tirasophon W, 2005, BIOCHEM BIOPH RES CO, V334, P102, DOI 10.1016/j.bbrc.2005.06.063; Tirasophon W, 2007, ANTIVIR RES, V74, P150, DOI 10.1016/j.antiviral.2006.11.002; Tsai MF, 1999, DIS AQUAT ORGAN, V38, P107, DOI 10.3354/dao038107; Unajak S, 2006, COMP BIOCHEM PHYS B, V145, P179, DOI 10.1016/j.cbpb.2006.07.002; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Wang DD, 2012, CHIN J OCEANOL LIMN, V30, P611, DOI 10.1007/s00343-012-1195-7; Wang LL, 2011, AFR J BIOTECHNOL, V10, P17678, DOI 10.5897/AJB11.2017; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Westenberg M, 2005, VIRUS RES, V114, P133, DOI 10.1016/j.virusres.2005.06.006; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Wu Y, 2007, AQUACULTURE, V271, P21, DOI 10.1016/j.aquaculture.2007.06.029; Xu JY, 2007, ANTIVIR RES, V73, P126, DOI 10.1016/j.antiviral.2006.08.007; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; You XX, 2010, AQUACULTURE, V305, P133, DOI 10.1016/j.aquaculture.2010.04.024; Zeng Y, 2009, FISH SHELLFISH IMMUN, V26, P646, DOI 10.1016/j.fsi.2008.11.005; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhao PC, 2011, INSECT BIOCHEM MOLEC, V41, P645, DOI 10.1016/j.ibmb.2011.04.006; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003; Zhu F, 2012, MAR BIOTECHNOL, V14, P63, DOI 10.1007/s10126-011-9387-2; Zong RR, 2008, FISH SHELLFISH IMMUN, V25, P258, DOI 10.1016/j.fsi.2008.05.006	119	131	138	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58627	10.1371/journal.pone.0058627	http://dx.doi.org/10.1371/journal.pone.0058627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	24098432	Green Published, gold, Green Submitted			2022-12-27	WOS:000317562100033
J	Duan, JB; Zhang, JG; Deng, HW; Wang, YP				Duan, Junbo; Zhang, Ji-Gang; Deng, Hong-Wen; Wang, Yu-Ping			Comparative Studies of Copy Number Variation Detection Methods for Next-Generation Sequencing Technologies	PLOS ONE			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; CANCER; IDENTIFICATION; ALGORITHMS; DISEASE; SEQ	Copy number variation (CNV) has played an important role in studies of susceptibility or resistance to complex diseases. Traditional methods such as fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH) suffer from low resolution of genomic regions. Following the emergence of next generation sequencing (NGS) technologies, CNV detection methods based on the short read data have recently been developed. However, due to the relatively young age of the procedures, their performance is not fully understood. To help investigators choose suitable methods to detect CNVs, comparative studies are needed. We compared six publicly available CNV detection methods: CNV-seq, FREEC, readDepth, CNVnator, SegSeq and event-wise testing (EWT). They are evaluated both on simulated and real data with different experiment settings. The receiver operating characteristic (ROC) curve is employed to demonstrate the detection performance in terms of sensitivity and specificity, box plot is employed to compare their performances in terms of breakpoint and copy number estimation, Venn diagram is employed to show the consistency among these methods, and F-score is employed to show the overlapping quality of detected CNVs. The computational demands are also studied. The results of our work provide a comprehensive evaluation on the performances of the selected CNV detection methods, which will help biological investigators choose the best possible method.	[Duan, Junbo; Deng, Hong-Wen; Wang, Yu-Ping] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Zhang, Ji-Gang; Deng, Hong-Wen; Wang, Yu-Ping] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Duan, Junbo; Zhang, Ji-Gang; Deng, Hong-Wen; Wang, Yu-Ping] Tulane Univ, Ctr Bioinformat & Genom, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University	Wang, YP (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	wyp@tulane.edu	DUAN, Junbo/A-8795-2010	Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health; National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049, R01AR059781, R01AR050496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work is supported by the National Institutes of Health and National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Duan JB, 2011, IEEE INT C BIO BIO W, P3, DOI 10.1109/BIBMW.2011.6112348; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gusnanto A, 2012, BIOINFORMATICS, V28, P40, DOI 10.1093/bioinformatics/btr593; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ivakhno S, 2010, BIOINFORMATICS, V26, P3051, DOI 10.1093/bioinformatics/btq587; Kim TM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-432; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr068; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simpson JT, 2010, BIOINFORMATICS, V26, P565, DOI 10.1093/bioinformatics/btp693; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang CH, 2008, ANN STAT, V36, P1509	33	190	200	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59128	10.1371/journal.pone.0059128	http://dx.doi.org/10.1371/journal.pone.0059128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527109	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600057
J	Zhang, JX; Guo, LY; Feng, L; Jiang, WD; Kuang, SY; Liu, Y; Hu, K; Jiang, J; Li, SH; Tang, L; Zhou, XQ				Zhang, Jin-Xiu; Guo, Lin-Ying; Feng, Lin; Jiang, Wei-Dan; Kuang, Sheng-Yao; Liu, Yang; Hu, Kai; Jiang, Jun; Li, Shu-Hong; Tang, Ling; Zhou, Xiao-Qiu			Soybean beta-Conglycinin Induces Inflammation and Oxidation and Causes Dysfunction of Intestinal Digestion and Absorption in Fish	PLOS ONE			English	Article							SALMON SALMO-SALAR; TROUT ONCORHYNCHUS-MYKISS; MORHUA FED STANDARD; FED GRADED-LEVELS; JUVENILE JIAN; ENZYME-ACTIVITIES; ATLANTIC SALMON; BODY-COMPOSITION; RAINBOW-TROUT; GLUTAMINE SUPPLEMENTATION	beta-conglycinin has been identified as one of the major feed allergens. However, studies of beta-conglycinin on fish are scarce. This study investigated the effects of b-conglycinin on the growth, digestive and absorptive ability, inflammatory response, oxidative status and gene expression of juvenile Jian carp (Cyprinus carpio var. Jian) in vivo and their enterocytes in vitro. The results indicated that the specific growth rate (SGR), feed intake, and feed efficiency were reduced by beta-conglycinin. In addition, activities of trypsin, chymotrypsin, lipase, creatine kinase, Na+, K+-ATPase and alkaline phosphatase in the intestine showed similar tendencies. The protein content of the hepatopancreas and intestines, and the weight and length of the intestines were all reduced by beta-conglycinin. beta-conglycinin increased lipid and protein oxidation in the detected tissues and cells. However, beta-conglycinin decreased superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione peroxidase (GPx) and glutathione reductase (GR) activities and glutathione (GSH) content in the intestine and enterocytes. Similar antioxidant activity in the hepatopancreas was observed, except for GST. The expression of target of rapamycin (TOR) gene was reduced by beta-conglycinin. Furthermore, mRNA levels of interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor-beta (TGF-beta) genes were increased by beta-conglycinin. However, beta-conglycinin increased CuZnSOD, MnSOD, CAT, and GPx1b gene expression. In conclusion, this study indicates that beta-conglycinin induces inflammation and oxidation, and causes dysfunction of intestinal digestion and absorption in fish, and finally reduces fish growth. The results of this study provide some information to the mechanism of beta-conglycinin-induced negative effects.	[Zhang, Jin-Xiu; Guo, Lin-Ying; Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Li, Shu-Hong; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Zhou, Xiao-Qiu] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Jiang, Wei-Dan; Liu, Yang; Hu, Kai; Jiang, Jun; Zhou, Xiao-Qiu] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zhou, XQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	xqzhouqq@tom.com	jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022		National Science Foundation of China [3087192]; National Department Public Benefit Research Foundation (Agriculture) of China [2010003020]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-08-0905]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation (Agriculture) of China; Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This study was financially supported by the National Science Foundation of China (3087192), National Department Public Benefit Research Foundation (Agriculture) of China (2010003020) and Project supported by the Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-08-0905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHUSSAINI AH, 1949, Q J MICROSC SCI, V90, P323; Bakke-McKellep AM, 2007, J FISH DIS, V30, P65, DOI 10.1111/j.1365-2761.2007.00782.x; Baltacioglu E, 2008, ARCH ORAL BIOL, V53, P716, DOI 10.1016/j.archoralbio.2008.02.002; Baudry N, 1996, FEBS LETT, V396, P223, DOI 10.1016/0014-5793(96)01107-6; Bhor VM, 2004, INT J BIOCHEM CELL B, V36, P89, DOI 10.1016/S1357-2725(03)00142-0; Bicho A, 1999, J EXP BIOL, V202, P39; Bohne VJB, 2007, FOOD CHEM TOXICOL, V45, P733, DOI 10.1016/j.fct.2006.10.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buttle LG, 2001, VET IMMUNOL IMMUNOP, V80, P237, DOI 10.1016/S0165-2427(01)00269-0; Cao YH, 1998, JPEN-PARENTER ENTER, V22, P224, DOI 10.1177/0148607198022004224; Chen F, 2011, J ANIM SCI, V89, P743, DOI 10.2527/jas.2010-3146; Chen GF, 2012, BRIT J NUTR, V108, P195, DOI 10.1017/S0007114511005459; Chen J, 2009, AQUACULTURE, V288, P285, DOI 10.1016/j.aquaculture.2008.10.053; DALY JG, 1995, FISH SHELLFISH IMMUN, V5, P265, DOI 10.1006/fsim.1995.0026; Feng L, 2009, THESIS SICHUAN AGR U; Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246; Furne M, 2005, AQUACULTURE, V250, P391, DOI 10.1016/j.aquaculture.2005.05.017; Gamboa-Delgado J, 2009, AQUACULTURE, V291, P115, DOI 10.1016/j.aquaculture.2009.03.012; Guillaume J., 2001, NUTR FEEDING FISH CR, P35; Guo PF, 2008, INT ARCH ALLERGY IMM, V145, P102, DOI 10.1159/000108135; Han PF, 2010, ARCH ANIM NUTR, V64, P254, DOI 10.1080/17450391003625003; Hao Y, 2009, ARCH ANIM NUTR, V63, P188, DOI 10.1080/17450390902860026; He W, 2009, AQUACULT NUTR, V15, P402, DOI 10.1111/j.1365-2095.2008.00604.x; Hegazi MM, 2010, AQUAT TOXICOL, V99, P118, DOI 10.1016/j.aquatox.2010.04.007; Huang HH, 2011, AQUACULT NUTR, V17, pE233, DOI 10.1111/j.1365-2095.2010.00756.x; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; ILENCHUK TT, 1982, INSECT BIOCHEM, V12, P675, DOI 10.1016/0020-1790(82)90056-7; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang J., 2005, THESIS SICHUAN AGR U; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Jiang WD, 2009, AQUAC RES, V40, P955, DOI 10.1111/j.1365-2109.2009.02191.x; Johnson AT, 2003, J SURG RES, V115, P242, DOI 10.1016/j.jss.2003.07.003; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; LI DF, 1990, J ANIM SCI, V68, P1790; Li W, 2010, AQUACULT NUTR, V16, P137, DOI 10.1111/j.1365-2095.2008.00645.x; Lilleeng E, 2007, AQUACULTURE, V267, P269, DOI 10.1016/j.aquaculture.2007.01.048; Lilleeng E, 2009, FISH SHELLFISH IMMUN, V27, P65, DOI 10.1016/j.fsi.2009.04.007; Lin SM, 2011, ANIM FEED SCI TECH, V168, P80, DOI 10.1016/j.anifeedsci.2011.03.012; Lin Y, 2006, AQUACULTURE, V256, P389, DOI 10.1016/j.aquaculture.2006.02.011; Ling J, 2010, AQUACULT NUTR, V16, P616, DOI 10.1111/j.1365-2095.2009.00699.x; Liu ZQ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1105, DOI 10.1152/ajpendo.00337.2002; Lushchak V I, 2001, Am J Physiol Regul Integr Comp Physiol, V280, pR100; Moellering D, 1999, FEBS LETT, V448, P292, DOI 10.1016/S0014-5793(99)00371-3; Mulier B, 1998, EUR RESPIR J, V11, P384, DOI 10.1183/09031936.98.11020384; National Research Council, 1993, NUTR REQ FISH; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nishi T, 2003, J NUTR, V133, P352, DOI 10.1093/jn/133.2.352; Ostaszewska T, 2005, AQUACULTURE, V245, P273, DOI 10.1016/j.aquaculture.2004.12.005; Refstie S, 2006, AQUACULTURE, V261, P269, DOI 10.1016/j.aquaculture.2006.07.011; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Salze G, 2010, AQUACULTURE, V298, P294, DOI 10.1016/j.aquaculture.2009.11.003; Satoh J, 2003, J GASTROEN HEPATOL, V18, P719, DOI 10.1046/j.1440-1746.2003.03042.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sun P, 2008, J NUTR BIOCHEM, V19, P627, DOI 10.1016/j.jnutbio.2007.08.007; Tan LN, 2011, AQUACULT NUTR, V17, P338, DOI 10.1111/j.1365-2095.2010.00793.x; Tang L, 2009, AQUACULT NUTR, V15, P477, DOI 10.1111/j.1365-2095.2008.00613.x; Turan A, 2007, DIGEST DIS SCI, V52, P1840, DOI 10.1007/s10620-006-9633-z; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; Utsumi S., 1997, FOOD PROTEINS THEIR, P257; Vardi N, 2008, FOOD CHEM TOXICOL, V46, P3015, DOI 10.1016/j.fct.2008.05.039; Wasa M, 2005, J SURG RES, V123, P75, DOI 10.1016/j.jss.2004.07.018; Wen ZP, 2009, AQUACULT NUTR, V15, P470, DOI 10.1111/j.1365-2095.2008.00612.x; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; WINDMUELLER HG, 1982, ADV ENZYMOL RAMB, V53, P201; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; Xiao WW, 2011, AQUACULT NUTR, V17, P408, DOI 10.1111/j.1365-2095.2010.00818.x; Xu J, 2010, J ANIM PLANT SCI, V20, P170; Zhang J-X, 2007, AQUACULT SCI, V2, P315; Zhang J-X, 2003, THESIS SICHUAN AGR U; Zhang XD, 2008, AQUACULTURE, V280, P136, DOI 10.1016/j.aquaculture.2008.05.010; Zhao Y, 2010, FOOD AGR IMMUNOL, V21, P209, DOI 10.1080/09540101003596644; Zhou XQ, 2008, AQUACULT NUTR, V14, P381, DOI 10.1111/j.1365-2095.2007.00535.x; Zhu Q, 2012, J APPL ICHTHYOL, DOI [10.1111/j.1439-0426.2011.011676.x, DOI 10.1111/J.1439-0426.2011.011676.X]	76	265	280	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e58115	10.1371/journal.pone.0058115	http://dx.doi.org/10.1371/journal.pone.0058115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	24124552	gold, Green Published, Green Submitted			2022-12-27	WOS:000318679900047
J	Zhang, XL; Ge, XH; Shao, YJ; Sun, GL; Li, ZY				Zhang, Xueli; Ge, Xianhong; Shao, Yujiao; Sun, Genlou; Li, Zaiyun			Genomic Change, Retrotransposon Mobilization and Extensive Cytosine Methylation Alteration in Brassica napus Introgressions from Two Intertribal Hybridizations	PLOS ONE			English	Article							PARTIAL HYBRIDS; CHROMOSOME ELIMINATION; INTERGENERIC HYBRIDS; DNA METHYLATION; TRANSCRIPTIONAL ACTIVATION; HOMEOLOGOUS RECOMBINATION; ORYCHOPHRAGMUS-VIOLACEUS; HELIANTHUS-ANNUUS; GENE-EXPRESSION; MAJOR ROLE	Hybridization and introgression represent important means for the transfer and/or de novo origination of traits and play an important role in facilitating speciation and plant breeding. Two sets of introgression lines in Brassica napus L. were previously established by its intertribal hybridizations with two wild species and long-term selection. In this study, the methods of amplified fragment length polymorphisms (AFLP), sequence-specific amplification polymorphism (SSAP) and methylation-sensitive amplified polymorphism (MSAP) were used to determine their genomic change, retrotransposon mobilization and cytosine methylation alteration in these lines. The genomic change revealed by the loss or gain of AFLP bands occurred for similar to 10% of the total bands amplified in the two sets of introgressions, while no bands specific for wild species were detected. The new and absent SSAP bands appeared for 9 out of 11 retrotransposons analyzed, with low frequency of new bands and their total percentage of about 5% in both sets. MSAP analysis indicated that methylation changes were common in these lines (33.4-39.8%) and the hypermethylation was more frequent than hypomethylation. Our results suggested that certain extents of genetic and epigenetic alterations were induced by hybridization and alien DNA introgression. The cryptic mechanism of these changes and potential application of these lines in breeding were also discussed.	[Zhang, Xueli; Ge, Xianhong; Li, Zaiyun] Huazhong Agr Univ, Natl Ctr Oil Crop Improvement Wuhan, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China; [Shao, Yujiao] Hubei Univ Educ, Coll Chem & Life Sci, Wuhan, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Huazhong Agricultural University; Hubei University Education; Saint Marys University - Canada	Ge, XH (corresponding author), Huazhong Agr Univ, Natl Ctr Oil Crop Improvement Wuhan, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement,Natl Ctr Crop, Wuhan, Peoples R China.	gexianhong@gmail.com; lizaiyun@mail.hzau.edu.cn	; Zeng, Qingdong/H-7208-2014	Wu, Jianhui/0000-0001-8154-1199; Zeng, Qingdong/0000-0002-7856-2340; Kang, Zhensheng/0000-0001-5575-0122	Agricultural Ministry of China [201103016]	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs)	The work was supported by the grant from Agricultural Ministry of China (201103016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; ANDERSON E., 1949, Introgressive hybridization.; Arnold ML, 2004, PLANT CELL, V16, P562, DOI 10.1105/tpc.160370; Beaulieu J, 2009, MOL GENET GENOMICS, V281, P421, DOI 10.1007/s00438-008-0421-7; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen HF, 2007, PLANT CELL REP, V26, P1791, DOI 10.1007/s00299-007-0392-x; Cheng BF, 2002, GENOME, V45, P110, DOI 10.1139/g01-131; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Du XZ, 2008, PLANT CELL REP, V27, P261, DOI 10.1007/s00299-007-0452-2; Faure N, 2002, THEOR APPL GENET, V104, P652, DOI 10.1007/s001220100746; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hua YW, 2006, ANN BOT-LONDON, V97, P993, DOI 10.1093/aob/mcl073; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kashkush K, 2007, GENETICS, V177, P1975, DOI 10.1534/genetics.107.080234; Kidwell Kimberlee K., 1992, P1; Kraitshtein Z, 2010, GENETICS, V186, P801, DOI 10.1534/genetics.110.120790; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Lashermes P, 2000, THEOR APPL GENET, V100, P139, DOI 10.1007/s001220050019; Leflon M, 2006, THEOR APPL GENET, V113, P1467, DOI 10.1007/s00122-006-0393-0; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; Li ZY, 2007, PLANT CELL REP, V26, P701, DOI 10.1007/s00299-006-0290-7; Liu B., 1999, Journal of Genetics and Breeding, V53, P279; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Liu H.L., 2000, GENETICS BREEDING RA; Liu M, 2007, GENOME, V50, P985, DOI 10.1139/G07-071; LUO P, 1994, PLANT BREEDING, V113, P83, DOI 10.1111/j.1439-0523.1994.tb00707.x; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Ma N, 2007, EUPHYTICA, V157, P231, DOI 10.1007/s10681-007-9416-4; Ma N, 2006, PLANT CELL REP, V25, P1089, DOI 10.1007/s00299-006-0171-0; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Melayah D, 2001, PLANT J, V28, P159, DOI 10.1046/j.1365-313X.2001.01141.x; Nicolas SD, 2007, GENETICS, V175, P487, DOI 10.1534/genetics.106.062968; Okamoto H, 2001, TRENDS PLANT SCI, V6, P527, DOI 10.1016/S1360-1385(01)02105-7; Osborn TC, 2003, GENETICS, V165, P1569; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Tate Jennifer A., 2005, P371, DOI 10.1016/B978-012301463-4/50009-7; Tu YQ, 2009, ANN BOT-LONDON, V103, P1039, DOI 10.1093/aob/mcp045; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang NN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-190; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu YH, 2009, PLANTA, V229, P471, DOI 10.1007/s00425-008-0844-8; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhao N, 2011, GENETICS, V188, P499, DOI 10.1534/genetics.111.127688; Zhao ZG, 2007, GENOME, V50, P226, DOI 10.1139/G06-146; Zou J, 2011, PLANT J, V68, P212, DOI 10.1111/j.1365-313X.2011.04679.x	74	38	46	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56346	10.1371/journal.pone.0056346	http://dx.doi.org/10.1371/journal.pone.0056346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23526955	Green Submitted, Green Published, gold			2022-12-27	WOS:000315524900023
J	Stappert, L; Borghese, L; Roese-Koerner, B; Weinhold, S; Koch, P; Terstegge, S; Uhrberg, M; Wernet, P; Brustle, O				Stappert, Laura; Borghese, Lodovica; Roese-Koerner, Beate; Weinhold, Sandra; Koch, Philipp; Terstegge, Stefanie; Uhrberg, Markus; Wernet, Peter; Bruestle, Oliver			MicroRNA-Based Promotion of Human Neuronal Differentiation and Subtype Specification	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; POSTTRANSCRIPTIONAL REGULATION; DOPAMINE NEURONS; IN-VITRO; HUMAN ES; FUNCTIONAL-NEURONS; HUMAN FIBROBLASTS; MAMMALIAN BRAIN; EXPRESSION; MOUSE	MicroRNAs are key regulators of neural cell proliferation, differentiation and fate choice. Due to the limited access to human primary neural tissue, the role of microRNAs in human neuronal differentiation remains largely unknown. Here, we use a population of long-term self-renewing neuroepithelial-like stem cells (lt-NES cells) derived from human embryonic stem cells to study the expression and function of microRNAs at early stages of human neural stem cell differentiation and neuronal lineage decision. Based on microRNA expression profiling followed by gain- and loss-of-function analyses in lt-NES cells and their neuronal progeny, we demonstrate that miR-153, miR-324-5p/3p and miR-181a/a* contribute to the shift of lt-NES cells from self-renewal to neuronal differentiation. We further show that miR-125b and miR-181a specifically promote the generation of neurons of dopaminergic fate, whereas miR-181a* inhibits the development of this neurotransmitter subtype. Our data demonstrate that time-controlled modulation of specific microRNA activities not only regulates human neural stem cell self-renewal and differentiation but also contributes to the development of defined neuronal subtypes.	[Stappert, Laura; Borghese, Lodovica; Roese-Koerner, Beate; Koch, Philipp; Terstegge, Stefanie; Bruestle, Oliver] Univ Bonn, LIFE & BRAIN Ctr, Inst Reconstruct Neurobiol, Bonn, Germany; [Stappert, Laura; Borghese, Lodovica; Roese-Koerner, Beate; Koch, Philipp; Terstegge, Stefanie; Bruestle, Oliver] Hertie Fdn, Bonn, Germany; [Weinhold, Sandra; Uhrberg, Markus; Wernet, Peter] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany	University of Bonn; Heinrich Heine University Dusseldorf	Borghese, L (corresponding author), Univ Bonn, LIFE & BRAIN Ctr, Inst Reconstruct Neurobiol, Bonn, Germany.	borghese@uni-bonn.de; brustle@uni-bonn.de	Koch, Philipp/M-1186-2016; Koch, Philipp/AAZ-3751-2020	Koch, Philipp/0000-0003-3713-8786	European Union [FP7-HEALTH-2007-B-22943-NeuroStemcell]; Federal Ministry of Education and Research [01GN0902, 01GN1008A, 01GN1008C, 0315799]; German Research Foundation [SFB-TR3]; Medical Research Council [G0700089, MC_PC_15004] Funding Source: researchfish; MRC [MC_PC_15004, G0700089] Funding Source: UKRI	European Union(European Commission); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Union grant number FP7-HEALTH-2007-B-22943-NeuroStemcell], the Federal Ministry of Education and Research [grant numbers 01GN0902, 01GN1008A, 01GN1008C and 0315799 (BIODISC)], the German Research Foundation [grant number SFB-TR3, D2], BIO. NRW [roject StemCellFactory], BONFOR and the Hertie Foundation. The microRNA profiling was performed as part of the Interdisciplinary Transregional Research Project of the Stem Cell Network North Rhine Westphalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2002, J ANAT, V200, P225, DOI 10.1046/j.1469-7580.2002.00032.x; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Chandrasekar V, 2011, NEUROPSYCHOPHARMACOL, V36, P1149, DOI 10.1038/npp.2010.250; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delay C, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-70; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Guibinga GH, 2012, HUM MOL GENET, V21, P609, DOI 10.1093/hmg/ddr495; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Heyer MP, 2012, J NEUROSCI, V32, P10887, DOI 10.1523/JNEUROSCI.1732-12.2012; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jaeger I, 2011, DEVELOPMENT, V138, P4363, DOI 10.1242/dev.066746; Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Koch P, 2012, AM J PATHOL, V180, P2404, DOI 10.1016/j.ajpath.2012.02.012; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuchenbauer F, 2011, BLOOD, V118, P3350, DOI 10.1182/blood-2010-10-312454; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lao Kaiqin, 2007, Biotechnology Journal, V2, P33, DOI 10.1002/biot.200600119; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Roese-Koerner B, 2013, CURR MOL ME IN PRESS; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saba R, 2012, MOL CELL BIOL, V32, P619, DOI 10.1128/MCB.05896-11; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152; Xu JZ, 2011, INT J CANCER, V129, P2527, DOI 10.1002/ijc.25917; Xu JZ, 2010, INT J CANCER, V126, P1029, DOI 10.1002/ijc.24823; Xu XL, 2011, J NEUROSCI, V31, P13705, DOI 10.1523/JNEUROSCI.2827-11.2011; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang SC, 2008, PHILOS T R SOC B, V363, P87, DOI 10.1098/rstb.2006.2014	68	60	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2013	8	3							e59011	10.1371/journal.pone.0059011	http://dx.doi.org/10.1371/journal.pone.0059011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZS	23527072	Green Published, Green Submitted, gold			2022-12-27	WOS:000316411600025
J	Rayhan, RU; Stevens, BW; Timbol, CR; Adewuyi, O; Walitt, B; VanMeter, JW; Baraniuk, JN				Rayhan, Rakib U.; Stevens, Benson W.; Timbol, Christian R.; Adewuyi, Oluwatoyin; Walitt, Brian; VanMeter, John W.; Baraniuk, James N.			Increased Brain White Matter Axial Diffusivity Associated with Fatigue, Pain and Hyperalgesia in Gulf War Illness	PLOS ONE			English	Article							ATTENTION; VETERANS; MOTION; VALIDATION; MECHANISMS; DISTORTION; MIGRAINE; STIMULI; NETWORK; DORSAL	Background: Gulf War exposures in 1990 and 1991 have caused 25% to 30% of deployed personnel to develop a syndrome of chronic fatigue, pain, hyperalgesia, cognitive and affective dysfunction. Methods: Gulf War veterans (n=31) and sedentary veteran and civilian controls (n=20) completed fMRI scans for diffusion tensor imaging. A combination of dolorimetry, subjective reports of pain and fatigue were correlated to white matter diffusivity properties to identify tracts associated with symptom constructs. Results: Gulf War Illness subjects had significantly correlated fatigue, pain, hyperalgesia, and increased axial diffusivity in the right inferior fronto-occipital fasciculus. ROC generated thresholds and subsequent binary regression analysis predicted CMI classification based upon axial diffusivity in the right inferior fronto-occipital fasciculus. These correlates were absent for controls in dichotomous regression analysis. Conclusion: The right inferior fronto-occipital fasciculus may be a potential biomarker for Gulf War Illness. This tract links cortical regions involved in fatigue, pain, emotional and reward processing, and the right ventral attention network in cognition. The axonal neuropathological mechanism(s) explaining increased axial diffusivity may account for the most prominent symptoms of Gulf War Illness.	[Rayhan, Rakib U.; Timbol, Christian R.; Adewuyi, Oluwatoyin; Baraniuk, James N.] Georgetown Univ, Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA; [Stevens, Benson W.; VanMeter, John W.] Georgetown Univ, Med Ctr, Dept Neurol, Ctr Funct & Mol Imaging, Washington, DC 20007 USA; [Walitt, Brian] Washington Hosp Ctr, Div Rheumatol, Washington, DC 20010 USA	Georgetown University; Georgetown University; MedStar Washington Hospital Center	Rayhan, RU (corresponding author), Georgetown Univ, Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA.	rur@georgetown.edu	VanMeter, John W/D-2589-2018	VanMeter, John W/0000-0002-7012-5197; Baraniuk, James Nicholas/0000-0002-1866-4177	Department of Defense Congressionally Directed Medical Research Program (CDMRP) award [W81-XWH-09-1-0526]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA) [UL1TR000101, UL1RR031975]	Department of Defense Congressionally Directed Medical Research Program (CDMRP) award; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Sources of funding were provided by the Department of Defense Congressionally Directed Medical Research Program (CDMRP) award W81-XWH-09-1-0526. Research support for the Clinical Research Unit at Georgetown University Medical Center was funded in whole or in part with federal funds (Grant #UL1TR000101, previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Baraniuk JN, 2013, AM J TRANSL RES, V5, P53; Baraniuk JN, 1998, ANN ALLERG ASTHMA IM, V81, P359, DOI 10.1016/S1081-1206(10)63129-8; Barnden LR, 2011, NMR BIOMED, V24, P1302, DOI 10.1002/nbm.1692; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodersen KH, 2012, NEUROIMAGE, V63, P1162, DOI 10.1016/j.neuroimage.2012.08.035; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Burdach K., 1822, BAUE LEBEN GEHIRNS Z, VSecond; Camara E, 2010, J NEUROSCI, V30, P11398, DOI 10.1523/JNEUROSCI.0111-10.2010; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Cook DB, 2004, J RHEUMATOL, V31, P364; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Eisen SA, 2005, ANN INTERN MED, V142, P881, DOI 10.7326/0003-4819-142-11-200506070-00005; Farmer MA, 2012, NEUROSCI LETT, V520, P197, DOI 10.1016/j.neulet.2012.05.001; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Forkel J, 2012, CORTEX; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Gu L, 2012, J TRAUMA AC IN PRESS; Harrison DM, 2013, J NEUROL, V260, P397, DOI 10.1007/s00415-012-6638-8; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kumar R, 2011, J NEUROL SCI, V307, P106, DOI 10.1016/j.jns.2011.04.028; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lima D, 2008, SCI PAIN, V5, P477; Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagae LM, 2012, AM J NEURORADIOL, V33, P1720, DOI 10.3174/ajnr.A3037; Naranch K, 2002, OTOLARYNG HEAD NECK, V127, P387, DOI 10.1067/mhn.2002.129038; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Petrides M., 2002, PRINCIPLES FRONTAL L; Pierpaoli C, 2010, STOCKH SWED ISMRM 18; Ravindran MK, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-30; Research Advisory Committee on Gulf War Veterans' Illness (RAC-GWVI), 2008, GULF WAR ILLN HLTH G; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Senapati AK, 2005, BRAIN RES, V1036, P173, DOI 10.1016/j.brainres.2004.12.043; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; Tillman GD, 2012, NEUROTOXICOLOGY; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wallin MT, 2009, COGN BEHAV NEUROL, V22, P155, DOI 10.1097/WNN.0b013e3181b278e8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserfallen JB, 1997, J ALLERGY CLIN IMMUN, V100, P16, DOI 10.1016/S0091-6749(97)70189-1; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39	75	119	119	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58493	10.1371/journal.pone.0058493	http://dx.doi.org/10.1371/journal.pone.0058493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23798990	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600025
J	Zhang, Y; Tan, XJ; Cui, AL; Mao, NY; Xu, ST; Zhu, Z; Zhou, JH; Shi, J; Zhao, YP; Wang, XJ; Huang, XY; Zhu, SL; Zhang, Y; Tang, W; Ling, H; Xu, WB				Zhang, Yan; Tan, Xiaojuan; Cui, Aili; Mao, Naiying; Xu, Songtao; Zhu, Zhen; Zhou, Jianhui; Shi, Jing; Zhao, Yueping; Wang, Xianjun; Huang, Xueyong; Zhu, Shuangli; Zhang, Yong; Tang, Wei; Ling, Hua; Xu, Wenbo			Complete Genome Analysis of the C4 Subgenotype Strains of Enterovirus 71: Predominant Recombination C4 Viruses Persistently Circulating in China for 14 Years	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; HAND; FOOT; COXSACKIEVIRUS; EMERGENCE; EVOLUTION; INFECTION; OUTBREAK; SINGAPORE	Genetic recombination is a well-known phenomenon for enteroviruses. To investigate the genetic characterization and the potential recombination of enterovirus 71 (EV71) circulating in China, we determined the 16 complete genome sequences of EV71 isolated from Hand Foot Mouth Disease (HFMD) patients during the large scale outbreak and non-outbreak years since 1998 in China. The full length genome sequences of 16 Chinese EV71 in present study were aligned with 186 genome sequences of EV71 available from GenBank, including 104 China mainland and 82 international sequences, covering the time period of 1970-2011. The oldest strains of each subgenotype of EV71 and prototype strains of HEV-A were included to do the phylogenetic and Simplot analysis. Phylogenetic analysis indicated that all Chinese strains were clustered into C4 subgenotype of EV71, except for HuB/CHN/2009 clustered into A and Xiamen/CHN/2009 clustered into B5 subgenotype. Most of C4 EV71 were clustered into 2 predominant evolutionary branches: C4b and C4a evolutionary brunches. Our comprehensive recombination analysis showed the evidence of genome recombination of subgenotype C4 (including C4a and C4b) sequences between structural genes from genotype C EV71 and non-structural genes from the prototype strains of CAV16, 14 and 4, but the evidence of intratypic recombination between C4 strains and B subgenotype was not enough strong. This intertypic recombination C4 viruses were first seen in 1998 and became the predominant endemic viruses circulating in China mainland for at least 14 years. A shift between C4a and C4b evolutionary brunches of C4 recombination viruses were observed, and C4a viruses have been associated with large scale nationwide HFMD outbreak with higher morbidity and mortality since 2007.	[Zhang, Yan; Tan, Xiaojuan; Cui, Aili; Mao, Naiying; Xu, Songtao; Zhu, Zhen; Shi, Jing; Zhu, Shuangli; Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhou, Jianhui] Jilin Prov Ctr Dis Control & Prevent, Changchun, Peoples R China; [Shi, Jing] Capital Univ Med Sci, Beijing Children Hosp, Beijing, Peoples R China; [Zhao, Yueping] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Wang, Xianjun] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Huang, Xueyong] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Tang, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Ling, Hua] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Shanghai Center for Disease Control & Prevention	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	National Basic Research Program of China (973 Program) [2011CB504902]; National Natural Science Foundation of China [30901259]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003]; Science and Technology Development Plan of Shandong Province [2009GG10002055]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of National Ministry of Science; Science and Technology Development Plan of Shandong Province	This study was supported by National Basic Research Program of China (973 Program): (Grant No. 2011CB504902); Projects of the National Natural Science Foundation of China (Grant No. 30901259); Key Technologies R&D Program of National Ministry of Science (Grant No. 2013ZX10004-202; 2012ZX10004201-003); and Science and Technology Development Plan of Shandong Province (2009GG10002055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; CHRISTODOULOU C, 1990, J VIROL, V64, P4922, DOI 10.1128/JVI.64.10.4922-4929.1990; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; Melnick J.L., 1996, FIELDS VIROLOGY, Vthird, P655; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yamayoshi S, 2012, J VIROL, V86, P5686, DOI 10.1128/JVI.00020-12; Yang F, 2001, SCI CHINA SER C, V44, P178, DOI 10.1007/BF02879323; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034401; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	38	67	107	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56341	10.1371/journal.pone.0056341	http://dx.doi.org/10.1371/journal.pone.0056341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23516601	Green Published, Green Submitted, gold			2022-12-27	WOS:000315159200036
J	Li, RM; Xie, W; Wang, SL; Wu, QJ; Yang, NN; Yang, X; Pan, HP; Zhou, XM; Bai, LY; Xu, BY; Zhou, XG; Zhang, YJ				Li, Rumei; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Yang, Nina; Yang, Xin; Pan, Huipeng; Zhou, Xiaomao; Bai, Lianyang; Xu, Baoyun; Zhou, Xuguo; Zhang, Youjun			Reference Gene Selection for qRT-PCR Analysis in the Sweetpotato Whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae)	PLOS ONE			English	Article							REAL-TIME PCR; RT-PCR; HOUSEKEEPING GENES; QUANTITATIVE PCR; Q-BIOTYPE; EXPRESSION; RNA; NORMALIZATION; QUANTIFICATION; SUSCEPTIBILITY	Background: Accurate evaluation of gene expression requires normalization relative to the expression of reliable reference genes. Expression levels of "classical" reference genes can differ, however, across experimental conditions. Although quantitative real-time PCR (qRT-PCR) has been used extensively to decipher gene function in the sweetpotato whitefly Bemisia tabaci, a world-wide pest in many agricultural systems, the stability of its reference genes has rarely been validated. Results: In this study, 15 candidate reference genes from B. tabaci were evaluated using two Excel-based algorithms geNorm and Normfinder under a diverse set of biotic and abiotic conditions. At least two reference genes were selected to normalize gene expressions in B. tabaci under experimental conditions. Specifically, for biotic conditions including host plant, acquisition of a plant virus, developmental stage, tissue (body region of the adult), and whitefly biotype, ribosomal protein L29 was the most stable reference gene. In contrast, the expression of elongation factor 1 alpha, peptidylprolyl isomerase A, NADH dehydrogenase, succinate dehydrogenase complex subunit A and heat shock protein 40 were consistently stable across various abiotic conditions including photoperiod, temperature, and insecticide susceptibility. Conclusion: Our finding is the first step toward establishing a standardized quantitative real-time PCR procedure following the MIQE (Minimum Information for publication of Quantitative real time PCR Experiments) guideline in an agriculturally important insect pest, and provides a solid foundation for future RNA interference based functional study in B. tabaci.	[Li, Rumei; Zhou, Xiaomao; Bai, Lianyang] Hunan Agr Univ, Inst Pesticide, Changsha, Hunan, Peoples R China; [Li, Rumei; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Yang, Nina; Yang, Xin; Pan, Huipeng; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Pan, Huipeng; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; zhangyj@mail.caas.net.cn	Zhang, Youjun/AAY-7948-2020; Yang, Xin/AAG-5375-2020	Zhang, Youjun/0000-0003-3508-6695; 	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2013CB127602]; National Natural Science Foundation of China [30900153]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2013CB127602), and the National Natural Science Foundation of China (No. 30900153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; de Boer ME, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-54; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kylee J, 2011, PLOS ONE, V6; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mahadav A, 2009, INSECT BIOCHEM MOLEC, V39, P668, DOI 10.1016/j.ibmb.2009.08.002; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tunbridge EM, 2011, BIOL PSYCHIAT, V69, P173, DOI 10.1016/j.biopsych.2010.05.023; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Wu JB, 2006, PLANT DIS, V90, P1359, DOI 10.1094/PD-90-1359C; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Xie W, 2011, PEST MANAG SCI, V67, P87, DOI 10.1002/ps.2037; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002	53	156	166	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53006	10.1371/journal.pone.0053006	http://dx.doi.org/10.1371/journal.pone.0053006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23308130	Green Published, Green Submitted, gold			2022-12-27	WOS:000313429800024
J	Manrique-Poyato, MI; Lopez-Leon, MD; Gomez, R; Perfectti, F; Camacho, JPM				Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Gomez, Ricardo; Perfectti, Francisco; Martinez Camacho, Juan Pedro			Population Genetic Structure of the Grasshopper Eyprepocnemis plorans in the South and East of the Iberian Peninsula	PLOS ONE			English	Article							SEQUENCE REPEAT POLYMORPHISMS; B-CHROMOSOME; ALLELIC DROPOUT; FEMALE FITNESS; RAPD MARKERS; ISSR-PCR; DIVERSITY; IDENTIFICATION; DYNAMICS; GENOME	The grasshopper Eyprepocnemis plorans subsp. plorans harbors a very widespread polymorphism for supernumerary (B) chromosomes which appear to have arisen recently. These chromosomes behave as genomic parasites because they are harmful for the individuals carrying them and show meiotic drive in the initial stages of population invasion. The rapid increase in B chromosome frequency at intrapopulation level is thus granted by meiotic drive, but its spread among populations most likely depends on interpopulation gene flow. We analyze here the population genetic structure in 10 natural populations from two regions (in the south and east) of the Iberian Peninsula. The southern populations were coastal whereas the eastern ones were inland populations located at 260-655 m altitude. The analysis of 97 ISSR markers revealed significant genetic differentiation among populations (average G(ST) = 0.129), and the Structure software and AMOVA indicated a significant genetic differentiation between southern and eastern populations. There was also significant isolation by distance (IBD) between populations. Remarkably, these results were roughly similar to those found when only the markers showing low or no dropout were included, suggesting that allelic dropout had negligible effects on population genetic analysis. We conclude that high gene flow helped this parasitic B chromosome to spread through most of the geographical range of the subspecies E. plorans plorans.	[Inmaculada Manrique-Poyato, Maria; Dolores Lopez-Leon, Maria; Perfectti, Francisco; Martinez Camacho, Juan Pedro] Univ Granada, Dept Genet, Granada, Spain; [Inmaculada Manrique-Poyato, Maria] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Celulas Troncales, Seville, Spain; [Gomez, Ricardo] Univ Castilla La Mancha, Dept Ciencia & Tecnol Agroforestal, Albacete, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Universidad de Castilla-La Mancha	Camacho, JPM (corresponding author), Univ Granada, Dept Genet, Granada, Spain.	jpmcamac@ugr.es	Perfectti, Francisco/C-5087-2008; López-León, María Dolores/L-9026-2014; Camacho, Juan Pedro M/L-6869-2014; Cabrero, Josefa/L-8899-2014	Perfectti, Francisco/0000-0002-5551-213X; López-León, María Dolores/0000-0003-2337-7313; Camacho, Juan Pedro M/0000-0002-2507-9814; Cabrero, Josefa/0000-0002-5848-6985; Gomez Ladron de Guevara, Ricardo/0000-0003-3430-0346	Spanish Ministerio de Ciencia e Innovacion [CGL2009-11917]; Spanish Ministerio de Ciencia e Innovacion; FEDER funds	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER funds(European Commission)	This study was supported by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2009-11917), and was partially performed by FEDER funds. MIMP was supported by a fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J, 2004, MOL MARKERS NATURAL; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Cabrero J, 1999, HEREDITY, V83, P435, DOI 10.1038/sj.hdy.6885960; Cabrero J, 1997, CHROMOSOME RES, V5, P194, DOI 10.1023/A:1018499015091; Camacho JPM, 1997, AM NAT, V149, P1030, DOI 10.1086/286037; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Cano J, 2005, J DERMATOL SCI, V39, P17, DOI 10.1016/j.jdermsci.2005.01.016; Datwyler SL, 2004, SYST BOT, V29, P165, DOI 10.1600/036364404772974077; de Leon JH, 2005, J INSECT SCI, V5; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dirsh V. M., 1958, Proceedings of the Royal Entomological Society of London (B), V27, P33; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez ME, 2002, THEOR APPL GENET, V104, P845, DOI 10.1007/s00122-001-0848-2; Hernandez F., 1984, Boletin del Servicio de Defensa contra Plagas e Inspeccion Fitopatologica, V10, P245; Herrera JA, 1996, HEREDITY, V76, P633, DOI 10.1038/hdy.1996.90; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Hundsdoerfer AK, 2005, ORG DIVERS EVOL, V5, P173, DOI 10.1016/j.ode.2004.11.012; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; JONES RN, 1991, AM NAT, V137, P430, DOI 10.1086/285175; KANTETY RV, 1995, MOL BREEDING, V1, P365, DOI 10.1007/BF01248414; Kar PK, 2005, GENETICA, V125, P173, DOI 10.1007/s10709-005-7002-z; Kojima T, 1998, THEOR APPL GENET, V96, P37, DOI 10.1007/s001220050706; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lu ZX, 2006, PLANT SCI, V170, P407, DOI 10.1016/j.plantsci.2005.09.009; Munoz E, 1998, P ROY SOC B-BIOL SCI, V265, P1903, DOI 10.1098/rspb.1998.0518; Nagaoka T, 1997, THEOR APPL GENET, V94, P597, DOI 10.1007/s001220050456; PARDO MC, 1995, HEREDITY, V74, P654, DOI 10.1038/hdy.1995.89; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P376, DOI 10.1159/000079315; Phillips CB, 2002, NEW ZEAL J AGR RES, V45, P295, DOI 10.1080/00288233.2002.9513519; Pinedo-Cancino V, 2006, AM J TROP MED HYG, V75, P238, DOI 10.4269/ajtmh.2006.75.238; Pradeep Appukuttan R., 2005, Journal of Applied Genetics, V46, P291; Ratnaparkhe MB, 1998, THEOR APPL GENET, V97, P515, DOI 10.1007/s001220050925; Ren ZM, 2008, GENETICA, V132, P103, DOI 10.1007/s10709-007-9153-6; Roux O, 2007, MOL PHYLOGENET EVOL, V43, P240, DOI 10.1016/j.ympev.2006.09.017; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Sesarini C, 2008, GENETICA, V133, P295, DOI 10.1007/s10709-007-9213-y; Slatkin Montgomery, 1994, P3; Soulsbury CD, 2007, CONSERV GENET, V8, P733, DOI 10.1007/s10592-006-9194-x; Spiegelhalter DJ, 2002, J R STAT SOC B, V17, P37; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tester DJ, 2006, HEART RHYTHM, V3, P815, DOI 10.1016/j.hrthm.2006.03.016; Tsumura Y, 1996, THEOR APPL GENET, V92, P40, DOI 10.1007/BF00222949; Vandergast AG, 2009, J INSECT CONSERV, V13, P329, DOI 10.1007/s10841-008-9176-z; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vijayan K, 2006, J INSECT SCI, V6, DOI 10.1673/2006_6_30.1; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu W, 2005, BIOCHEM SYST ECOL, V33, P1141, DOI 10.1016/j.bse.2005.02.010; Zhang XP, 2006, BIOCHEM SYST ECOL, V34, P38, DOI 10.1016/j.bse.2005.05.007; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	54	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2013	8	3							e59041	10.1371/journal.pone.0059041	http://dx.doi.org/10.1371/journal.pone.0059041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140TZ	23520552	Green Published, gold, Green Submitted			2022-12-27	WOS:000318679900112
J	Yu, H; Jin, HW; Sun, LD; Zhang, LR; Sun, G; Wang, ZL; Yu, YC				Yu, Hui; Jin, Hongwei; Sun, Lidan; Zhang, Liangren; Sun, Gang; Wang, Zhanli; Yu, Yongchun			Toll-Like Receptor 7 Agonists: Chemical Feature Based Pharmacophore Identification and Molecular Docking Studies	PLOS ONE			English	Article							TLR7; RECOGNITION; INFECTION; PATTERNS; LIGANDS	Chemical feature based pharmacophore models were generated for Toll-like receptors 7 (TLR7) agonists using HypoGen algorithm, which is implemented in the Discovery Studio software. Several methods tools used in validation of pharmacophore model were presented. The first hypothesis Hypo1 was considered to be the best pharmacophore model, which consists of four features: one hydrogen bond acceptor, one hydrogen bond donor, and two hydrophobic features. In addition, homology modeling and molecular docking studies were employed to probe the intermolecular interactions between TLR7 and its agonists. The results further confirmed the reliability of the pharmacophore model. The obtained pharmacophore model (Hypo1) was then employed as a query to screen the Traditional Chinese Medicine Database (TCMD) for other potential lead compounds. One hit was identified as a potent TLR7 agonist, which has antiviral activity against hepatitis virus in vitro. Therefore, our current work provides confidence for the utility of the selected chemical feature based pharmacophore model to design novel TLR7 agonists with desired biological activity.	[Yu, Hui; Yu, Yongchun] Tongji Univ, Affiliated Peoples Hosp 10, Dept Lab Ctr, Shanghai 200092, Peoples R China; [Jin, Hongwei; Sun, Lidan; Zhang, Liangren] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Yu, Hui; Sun, Gang] Second Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China; [Wang, Zhanli] First Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China	Tongji University; Peking University; Baotou Medical College; Baotou Medical College	Wang, ZL (corresponding author), First Affiliated Hosp, Baotou Med Coll, Baotou, Peoples R China.	wang.zhanli@hotmail.com; yyc@tongji.edu.cn	Zhang, Liang/GWM-6088-2022; Patel, Hemal/C-7325-2019	Westenbrink, B. Daan/0000-0002-1362-7019; Patel, Hemal/0000-0001-6722-9625; van Gilst, Wiek/0000-0003-2968-8585	National Natural Science Foundation of China [20902068]; Ministry of Education of China [20090001120049]; Natural Science Foundation of Inner Mongolia Autonomous Region, China [2011BS1201]; State Key Laboratory of Natural and Biomimetic Drugs [K20110103]; Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Inner Mongolia Autonomous Region, China; State Key Laboratory of Natural and Biomimetic Drugs; Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China	This work was supported in part by grants from the National Natural Science Foundation of China (No. 20902068), Doctoral Fund of Ministry of Education of China (No. 20090001120049), Natural Science Foundation of Inner Mongolia Autonomous Region, China (No. 2011BS1201), Project of State Key Laboratory of Natural and Biomimetic Drugs (No. K20110103), and Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2005, TRAD CHIN MED DAT TC; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; CHONG L, 2008, Patent No. 200805555; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; COOK A, 2008, Patent No. 2008004948; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Gong J, 2010, J MOL MODEL, V16, P1283, DOI 10.1007/s00894-009-0640-9; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Iavarone C, 2011, J IMMUNOL, V186, P4213, DOI 10.4049/jimmunol.1003585; JONES P, 2006, Patent No. 2006117670; JONES P, 2007, Patent No. 200709301; Jones P, 2011, BIOORG MED CHEM LETT, V21, P5939, DOI 10.1016/j.bmcl.2011.07.076; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kurimoto A, 2010, J MED CHEM, V53, P2964, DOI 10.1021/jm100070n; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Li H, 2000, IUL BIOTECH, V2, P171; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Pryde DC, 2011, MEDCHEMCOMM, V2, P185, DOI 10.1039/c0md00197j; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TD, 2011, BIOORG MED CHEM LETT, V21, P2389, DOI 10.1016/j.bmcl.2011.02.092; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186; Yu H, 2012, CURR MED CHEM, V19, P1365, DOI 10.2174/092986712799462603	34	69	88	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e56514	10.1371/journal.pone.0056514	http://dx.doi.org/10.1371/journal.pone.0056514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23526932	gold, Green Submitted, Green Published			2022-12-27	WOS:000317562600005
J	Yang, DY; Baumgartner, RN; Slattery, ML; Wang, CX; Giuliano, AR; Murtaugh, MA; Risendal, BC; Byers, T; Baumgartner, KB				Yang, Dongyan; Baumgartner, Richard N.; Slattery, Martha L.; Wang, Chenxi; Giuliano, Anna R.; Murtaugh, Maureen A.; Risendal, Betsy C.; Byers, Tim; Baumgartner, Kathy B.			Dietary Intake of Folate, B-Vitamins and Methionine and Breast Cancer Risk among Hispanic and Non-Hispanic White Women	PLOS ONE			English	Article							ONE-CARBON METABOLISM; SOUTHWESTERN UNITED-STATES; ESTROGEN-RECEPTOR STATUS; MTHFR POLYMORPHISMS; BODY-SIZE; POSTMENOPAUSAL WOMEN; GENE POLYMORPHISMS; COLON-CANCER; ALCOHOL; NUTRIENTS	Background: Low dietary folate intake is associated with several neoplasias, but reports are inconsistent for breast cancer. Additionally, the association of folate with breast cancer estrogen receptor (ER) status is not well established. Objective: To determine if dietary intakes of folate, B-vitamins (B-2, B-6, B-12) and methionine are associated with breast cancer risk and ER status in Hispanic, and non-Hispanic White women in the southwestern US. Materials and Methods: Primary breast cancer cases (n = 2,325) in the 4-Corners region (Arizona, Colorado, New Mexico and Utah), diagnosed between October 1999 and May 2004, were identified through state cancer registries. Controls (n = 2,525) were frequency-matched by ethnicity and age (+/- 5 years). Dietary intake, physical activity and other exposures were assessed using in-person interviews. Risk was assessed through multivariable and multinomial logistic regression with adjustment for relevant covariates. Result: While there was no overall association with breast cancer, the highest quartile of folate intake was marginally inversely associated with ER- breast cancer (Odds Ratio (OR) = 0.50, 95% CI 0.25-1.00, p for trend = 0.07). Vitamin B-12 intake was inversely associated with breast cancer also (OR = 0.73, 95% CI 0.53-1.00, p for trend = 0.06), particularly for the highest quartile of ER+ breast cancer (OR = 0.67, 95% CI 0.46-0.99, p for trend = 0.06), among NHW women (OR = 0.49, 95% CI 0.29-0.81, p for trend = 0.01) and invasive breast cancer (OR = 0.63; 95% CI: 0.42, 0.93, P-trend = 0.01). Methionine intake was also inversely associated with ER+ breast cancer (OR for 4th quartile = 0.83, 95% CI 0.66-1.03, p for trend = 0.04), primarily among Hispanic women (OR = 0.71, 95% CI 0.47-1.06, and P for trend = 0.02). Conclusion: Higher intake of folate is marginally associated with a lower risk for ER- breast cancer, and higher intakes of vitamin B-12 and methionine are marginally associated with a lower risk of ER+ breast cancer.	[Yang, Dongyan; Baumgartner, Richard N.; Wang, Chenxi; Baumgartner, Kathy B.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA; [Slattery, Martha L.; Murtaugh, Maureen A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Risendal, Betsy C.; Byers, Tim] Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA	University of Louisville; Utah System of Higher Education; University of Utah; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Yang, DY (corresponding author), Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA.	d0yang01@louisville.edu	Lv, Yuanjie/AER-0767-2022; Murtaugh, Maureen/AAN-6225-2020; Wang, Wei Eric/AAE-9504-2022; peng, yu/GXW-2071-2022; Wang, Wei Eric/AFE-0795-2022	Murtaugh, Maureen/0000-0001-5281-0302; 	National Cancer Institute [CA 078682, CA 078762, CA078552, CA078802, N01-PC-67000]; Utah Cancer Registry; State of Utah Department of Health	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Utah Cancer Registry; State of Utah Department of Health	This research was supported by the grants from the National Cancer Institute (CA 078682, CA 078762, CA078552, and CA078802). This research also was supported by the Utah Cancer Registry, which is funded by Contract #N01-PC-67000 from the National Cancer Institute, and with additional support from the State of Utah Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Baumgartner Kathy B., 2002, Ethnicity & Disease, V12, P460; Buechley RW, 1976, GEN USEFUL ETHNIC SE; Chen J, 2005, CANCER RES, V65, P1606, DOI 10.1158/0008-5472.CAN-04-2630; Cho EY, 2007, CANCER EPIDEM BIOMAR, V16, P2787, DOI 10.1158/1055-9965.EPI-07-0683; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; DuBose Katrina D, 2007, J Phys Act Health, V4, P343; Durnitrescu RG, 2005, ALCOHOL, V35, P213, DOI 10.1016/j.alcohol.2005.04.005; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Hines LM, 2008, CANCER EPIDEM BIOMAR, V17, P2700, DOI 10.1158/1055-9965.EPI-08-0504; HOWARD CA, 1983, AM J EPIDEMIOL, V117, P27, DOI 10.1093/oxfordjournals.aje.a113512; Institute of Medicine, 1998, DIET REF INT THIAM R, P1; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 2006, NUTR REV, V64, P468, DOI 10.1301/nr.2006.oct.468-475; Koutros S, 2008, AM J EPIDEMIOL, V167, P287, DOI 10.1093/aje/kwm307; Lajous M, 2006, CANCER EPIDEM BIOMAR, V15, P443, DOI 10.1158/1055-9965.EPI-05-0532; Lajous M, 2006, CANCER CAUSE CONTROL, V17, P1209, DOI 10.1007/s10552-006-0053-3; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Levi F, 2001, INT J CANCER, V91, P260, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1041&gt;3.3.CO;2-R; Lewis SJ, 2006, JNCI-J NATL CANCER I, V98, P1607, DOI 10.1093/jnci/djj440; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Mason JB, 2005, ALCOHOL, V35, P235, DOI 10.1016/j.alcohol.2005.03.012; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; Murtaugh MA, 2008, AM J CLIN NUTR, V87, P978, DOI 10.1093/ajcn/87.4.978; Murtaugh MA, 2007, J AM DIET ASSOC, V107, P1311, DOI 10.1016/j.jada.2007.05.008; Murtaugh MA, 2007, CANCER CAUSE CONTROL, V18, P153, DOI 10.1007/s10552-006-0099-2; Negri E, 2000, J NATL CANCER I, V92, P1270, DOI 10.1093/jnci/92.15.1270-a; Osborne CK, 1991, BREAST DIS, P301; Prinz-Langenohl R, 2001, EUR J NUTR, V40, P98, DOI 10.1007/PL00007387; Risendal B, 2008, CANC CAUSES CONTROL; Rogers A, 2004, AM J EPIDEMIOL, V160, P85, DOI 10.1093/aje/kwh176; Rohan TE, 2000, J NATL CANCER I, V92, P266, DOI 10.1093/jnci/92.3.266; Rollison DE, 2008, AM J EPIDEMIOL, V167, P447, DOI 10.1093/aje/kwm322; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sellers TA, 2002, CANCER EPIDEM BIOMAR, V11, P1104; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shrubsole MJ, 2011, AM J EPIDEMIOL, V173, P1171, DOI 10.1093/aje/kwq491; Shrubsole MJ, 2004, CANCER EPIDEM BIOMAR, V13, P190, DOI 10.1158/1055-9965.EPI-03-0273; Shrubsole MJ, 2001, CANCER RES, V61, P7136; Slattery ML, 2007, BREAST CANCER RES TR, V104, P197, DOI 10.1007/s10549-006-9403-9; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; Slattery ML, 2008, OBESITY, V16, P339, DOI 10.1038/oby.2007.44; Slattery ML, 2007, BREAST CANCER RES TR, V105, P327, DOI 10.1007/s10549-006-9453-z; Slattery ML, 2007, ANN EPIDEMIOL, V17, P342, DOI 10.1016/j.annepidem.2006.10.017; Slattery ML, 2007, CANCER EPIDEM BIOMAR, V16, P747, DOI 10.1158/1055-9965.EPI-06-0667; Slattery ML, 2007, BREAST CANCER RES TR, V102, P85, DOI 10.1007/s10549-006-9292-y; SLATTERY ML, 1994, J AM DIET ASSOC, V94, P761, DOI 10.1016/0002-8223(94)91944-5; Slattery ML, 2005, CANCER CAUSE CONTROL, V16, P1147, DOI 10.1007/s10552-005-0318-2; STANFORD JL, 1989, AM J PUBLIC HEALTH, V79, P71, DOI 10.2105/AJPH.79.1.71; Steffen AD, 2008, CANCER EPIDEM BIOMAR, V17, P447, DOI 10.1158/1055-9965.EPI-07-2576; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Suitor CW, 2000, J AM DIET ASSOC, V100, P88, DOI 10.1016/S0002-8223(00)00027-4; Suzuki T, 2008, CARCINOGENESIS, V29, P356, DOI 10.1093/carcin/bgm295; Sweeney C, 2008, CANCER CAUSE CONTROL, V19, P391, DOI 10.1007/s10552-007-9098-1; Sweeney C, 2007, AM J EPIDEMIOL, V166, P1210, DOI 10.1093/aje/kwm192; Sweeney C, 2007, CANCER EPIDEM BIOMAR, V16, P142, DOI 10.1158/1055-9965.EPI-06-0706; Ulrich CM, 2006, NUTRIENT-GENE INTERACTIONS IN CANCER, P75, DOI 10.1201/9781420004847.ch5; Ulrich CM, 2007, AM J CLIN NUTR, V86, P271, DOI 10.1093/ajcn/86.2.271; Wang C, 2008, BREAST CANC RES TREA; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett W., 2012, NUTR EPIDEMIOLOGY; Word DL, 1996, 13 US BUR CENS POP D, P1; Zhang SM, 2005, CANCER EPIDEM BIOMAR, V14, P2004, DOI 10.1158/1055-9965.EPI-05-0083; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632; Zhu KM, 1998, CANCER CAUSE CONTROL, V9, P615, DOI 10.1023/A:1008819210777	78	222	229	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e54495	10.1371/journal.pone.0054495	http://dx.doi.org/10.1371/journal.pone.0054495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23667467	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000006
J	Yang, DZ; Wang, W; Li, LP; Peng, YL; Chen, P; Huang, HY; Guo, YL; Xia, XW; Wang, YY; Wang, HY; Wang, WE; Zeng, CY				Yang, Dezhong; Wang, Wei; Li, Liangpeng; Peng, Yulan; Chen, Peng; Huang, Haiyun; Guo, Yanli; Xia, Xuewei; Wang, Yuanyuan; Wang, Hongyong; Wang, Wei Eric; Zeng, Chunyu			The Relative Contribution of Paracine Effect versus Direct Differentiation on Adipose-Derived Stem Cell Transplantation Mediated Cardiac Repair	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FUNCTIONAL IMPROVEMENT; REGENERATIVE MEDICINE; PARACRINE MECHANISMS; CONDITIONED MEDIUM; STROMAL CELLS; IN-VITRO; HEART; THERAPY; DISEASE	Background: Recent studies have demonstrated that transplantation of adipose-derived stem cell (ADSC) can improve cardiac function in animal models of myocardial infarction (MI). However, the mechanisms underlying the beneficial effect are not fully understood. In this study, we characterized the paracrine effect of transplanted ADSC and investigated its relative importance versus direct differentiation in ADSC transplantation mediated cardiac repair. Methodology/Principal Findings: MI was experimentally induced in mice by ligation of the left anterior descending coronary artery. Either human ADSC, conditioned medium (CM) collected from the same amount of ADSC or control medium was injected into the peri-infarct region immediately after MI. Compared with the control group, both ADSC and ADSC-CM significantly reduced myocardial infarct size and improved cardiac function. The therapeutic efficacy of ADSC was moderately superior to ADSC-CM. ADSC-CM significantly reduced cardiomyocyte apoptosis in the infarct border zone, to a similar degree with ADSC treatment. ADSC enhanced angiogenesis in the infarct border zone, but to a stronger degree than that seen in the ADSC-CM treatment. ADSC was able to differentiate to endothelial cell and smooth muscle cell in post-MI heart; these ADSC-derived vascular cells amount to about 9% of the enhanced angiogenesis. No cardiomyocyte differentiated from ADSC was found. Conclusions: ADSC-CM is sufficient to improve cardiac function of infarcted hearts. The therapeutic function of ADSC transplantation is mainly induced by paracrine-mediated cardioprotection and angiogenesis, while ADSC differentiation contributes a minor benefit by being involved in angiogenesis. Highlights 1 ADSC-CM is sufficient to exert a therapeutic potential. 2. ADSC was able to differentiate to vascular cells but not cardiomyocyte. 3. ADSC derived vascular cells amount to about 9% of the enhanced angiogenesis. 4. Paracrine effect is the major mechanism of ADSC therapeutic function for MI.	[Yang, Dezhong; Wang, Wei; Li, Liangpeng; Peng, Yulan; Chen, Peng; Xia, Xuewei; Wang, Hongyong; Wang, Wei Eric; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Huang, Haiyun; Guo, Yanli] Third Mil Med Univ, Southwest Hosp, Dept Ultrasonog, Chongqing, Peoples R China; [Wang, Yuanyuan] Third Mil Med Univ, Daping Hosp, Dept Plast Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Wang, WE (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	wangw28@gmail.com; cyzeng1@hotmail.com	Lv, Yuanjie/AER-0767-2022; Murtaugh, Maureen/AAN-6225-2020; Wang, Wei Eric/AAE-9504-2022; peng, yu/GXW-2071-2022; Wang, Wei Eric/AFE-0795-2022	Murtaugh, Maureen/0000-0001-5281-0302; 	National Natural Science Foundation of China [31130029, 81100111, 30925018]; Natural Science Foundation Project of CQ CSTC (CSTC) [2009BA5044]; National Basic Research Program of China (973 Program) [2008CB517308, 2012CB517801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC (CSTC)(Natural Science Foundation Project of CQ CSTC); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the grants from the National Natural Science Foundation of China (31130029, 81100111, 30925018), Natural Science Foundation Project of CQ CSTC (CSTC, 2009BA5044), and National Basic Research Program of China (973 Program, 2008CB517308, 2012CB517801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Christoffels V, 2011, NATURE, V474, P585, DOI 10.1038/474585a; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Deveza L, 2013, STEM CELLS DEV, V22, P483, DOI 10.1089/scd.2012.0201; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li XH, 2007, J MOL CELL CARDIOL, V42, P295, DOI 10.1016/j.yjmcc.2006.07.002; Li YX, 2011, CIRCULATION, V123, P866, DOI 10.1161/CIRCULATIONAHA.110.947531; Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Ramkisoensing AA, 2012, STEM CELLS, V30, P1236, DOI 10.1002/stem.1086; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sanchez PL, 2010, EUR HEART J, V31, P394, DOI 10.1093/eurheartj/ehp403; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xiong DZ, 2010, J MOL CELL CARDIOL, V48, P211, DOI 10.1016/j.yjmcc.2009.07.003; Yang JJ, 2012, TOHOKU J EXP MED, V226, P231, DOI 10.1620/tjem.226.231; Zhang HY, 2010, CIRC RES, V107, P800, DOI 10.1161/CIRCRESAHA.110.219220	40	222	229	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e59020	10.1371/journal.pone.0059020	http://dx.doi.org/10.1371/journal.pone.0059020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	23667467	gold, Green Published, Green Submitted			2022-12-27	WOS:000317562100066
J	Li, M; Zhang, YM; Zhang, ZY; Ji, XH; Zhang, R; Liu, DL; Gao, LP; Zhang, J; Wang, BA; Wu, YS; Wu, SJ; Chen, XL; Feng, SQ; Chen, XS				Li, Min; Zhang, Yanmin; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wang, Biao; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen			Hypersensitive Ethylene Signaling and ZMdPG1 Expression Lead to Fruit Softening and Dehiscence	PLOS ONE			English	Article							DNA-BINDING PROTEINS; GOLDEN-DELICIOUS APPLES; GCC-BOX; TOMATO FRUIT; ARABIDOPSIS-THALIANA; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; GENE-EXPRESSION; MESSENGER-RNA; CIS-ELEMENTS	Taishanzaoxia' fruit rapid softening and dehiscence during ripening stage and this process is very sensitive to endogenous ethylene. In this study, we cloned five ethylene signal transcription factors (ZMdEIL1, ZMdEIL2, ZMdEIL3, ZMdERF1 and ZMdERF2) and one functional gene, ZMdPG1, encoding polygalacturonase that could loose the cell connection which associated with fruit firmness decrease and fruit dehiscence to illustrate the reasons for this specific fruit phenotypic and physiological changes. Expression analysis showed that ZMdERF1 and ZMdEIL2 transcription were more abundant in 'Taishanzaoxia' softening fruit and dehiscent fruit and their expression was inhibited by an ethylene inhibitor 1-methylcyclopropene. Therefore, ZMdERF1 and ZMdEIL2 expression were responses to endogenous ethylene and associated with fruit softening and dehiscence. ZMdPG1 expression was induced when fruit softening and dehiscence but this induction can be blocked by 1-MCP, indicating that ZMdPG1 was essential for fruit softening and dehiscence and its expression was mediated by the endogenously occurred ethylene. ZMdPG1 overexpression in Arabidopsis led to silique early dehiscence while suppressing ZMdPG1 expression by antisense ZMdPG1 prevented silique naturally opening. The result also suggested that ZMdPG1 related with the connection between cells that contributed to fruit softening and dehiscence. ZMdERF1 was more closely related with ethylene signaling but it was not directly regulated the ZMdPG1, which might be regulated by the synergic pattern of ethylene transcription factors because of both the ZMdERF1 and ZMdERF2 could interact with ZMdEIL2.	[Li, Min; Zhang, Zongying; Ji, Xiaohao; Zhang, Rui; Liu, Daliang; Gao, Liping; Zhang, Jing; Wu, Yusen; Wu, Shujing; Chen, Xiaoliu; Feng, Shouqian; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Yanmin] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Wang, Biao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Key Basic Research Program of China [2011CB100606]; National Natural Science Foundation of China [31171932, 31272132]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2011CB100606 and the National Natural Science Foundation of China (31171932 and 31272132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Atkinson R.G., 2008, New Zealand Patent, Patent No. [NZ570886, 570886]; ATKINSON RG, 1994, PLANT PHYSIOL, V105, P1437, DOI 10.1104/pp.105.4.1437; Atkinson RG, 2002, PLANT PHYSIOL, V129, P122, DOI 10.1104/pp.010986; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Camps C, 2005, J TEXTURE STUD, V36, P387, DOI 10.1111/j.1745-4603.2005.00023.x; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELLAPENNA D, 1986, P NATL ACAD SCI USA, V83, P6420, DOI 10.1073/pnas.83.17.6420; DELLAPENNA D, 1989, PLANT PHYSIOL, V90, P1372, DOI 10.1104/pp.90.4.1372; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Huang SZ, 2010, PLANT SCI, V178, P251, DOI 10.1016/j.plantsci.2010.01.005; Jiang CZ, 2008, J EXP BOT, V59, P973, DOI 10.1093/jxb/ern023; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liu ChaoChao, 2011, Acta Horticulturae Sinica, V38, P133; Liu MeiYan, 2012, Acta Horticulturae Sinica, V39, P845; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Mir NA, 2001, J AM SOC HORTIC SCI, V126, P618, DOI 10.21273/JASHS.126.5.618; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Pirrello J, 2006, PLANT CELL PHYSIOL, V47, P1195, DOI 10.1093/pcp/pcj084; Rieu I, 2003, J EXP BOT, V54, P2239, DOI 10.1093/jxb/erg240; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Saftner RA, 2003, J AM SOC HORTIC SCI, V128, P120, DOI 10.21273/JASHS.128.1.0120; Sawada K, 2000, J NEUROCHEM, V74, P1731, DOI 10.1046/j.1471-4159.2000.0741731.x; Schupp JR, 2004, HORTSCIENCE, V39, P1030, DOI 10.21273/HORTSCI.39.5.1030; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; SPEIRS J, 1990, J PLANT PHYSIOL, V135, P576, DOI 10.1016/S0176-1617(11)80639-5; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Toivonen PMA, 2005, J HORTIC SCI BIOTECH, V80, P439, DOI 10.1080/14620316.2005.11511957; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Wakasa Y, 2006, POSTHARVEST BIOL TEC, V39, P193, DOI 10.1016/j.postharvbio.2005.10.005; Wang AD, 2009, POSTHARVEST BIOL TEC, V52, P38, DOI 10.1016/j.postharvbio.2008.09.001; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang ZY, 2000, PLANT MOL BIOL, V42, P317, DOI 10.1023/A:1006309529922; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Weinthal D, 2009, TRENDS PLANT SCI, V14, P59, DOI 10.1016/j.tplants.2008.11.002; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081; Yin XueRen, 2009, Acta Horticulturae Sinica, V36, P133; Yokotani N, 2003, J EXP BOT, V54, P2775, DOI 10.1093/jxb/erg308; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101	57	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58745	10.1371/journal.pone.0058745	http://dx.doi.org/10.1371/journal.pone.0058745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527016	Green Published, Green Submitted, gold			2022-12-27	WOS:000317562600038
J	Li, M; Zhang, QP; Liu, LN; Lu, WP; Wei, H; Li, RW; Lu, S				Li, Mei; Zhang, Qiuping; Liu, Lina; Lu, Weipeng; Wei, Hong; Li, Rachel W.; Lu, Shen			Expression of the Mismatch Repair Gene hMLH1 Is Enhanced in Non-Small Cell Lung Cancer with EGFR Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CLINICAL-SIGNIFICANCE; ACQUIRED-RESISTANCE; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; CARCINOMAS; PROTEINS; HMSH2	Mismatch repair (MMR) plays a pivotal role in keeping the genome stable. MMR dysfunction can lead to carcinogenesis by gene mutation accumulation. HMSH2 and hMLH1 are two key components of MMR. High or low expression of them often mark the status of MMR function. Mutations (EGFR, KRAS, etc) are common in non-small cell lung cancer (NSCLC). However, it is not clear what role MMR plays in NSCLC gene mutations. The expression of MMR proteins hMSH2 and hMLH1, and the proliferation markers PCNA and Ki67 were measured by immunohistochemistry in 181 NSCLCs. EGFR and KRAS mutations were identified by high resolution melting analysis. Stronger hMLH1 expression correlated to a higher frequency of EGFR mutations in exon 19 and 21 (p<0.0005). Overexpression of hMLH1 and the adenocarcinoma subtype were both independent factors that related to EGFR mutations in NSCLCs (p=0.013 and p<0.0005). The expression of hMLH1, hMSH2 and PCNA increased, while Ki67 expression significantly decreased (p=0.030) in NSCLCs with EGFR mutations. Overexpression of hMLH1 could be a new molecular marker to predict the response to EGFR-TKIs in NSCLCs. Furthermore, EGFR mutations might be an early event of NSCLC that occur before MMR dysfunction.	[Li, Mei; Lu, Weipeng; Wei, Hong; Lu, Shen] Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China; [Zhang, Qiuping] Dalian Med Univ, Hosp 1, Dept Pathol, Dalian, Peoples R China; [Liu, Lina] Dalian Med Univ, Hosp 1, Dept Internal Med, Dalian, Peoples R China; [Li, Rachel W.] Australian Med Univ, Sch Med, Canberra, ACT, Australia	Dalian Medical University; Dalian Medical University; Dalian Medical University	Lu, S (corresponding author), Dalian Med Univ, Hosp 2, Cent Lab, Dalian, Peoples R China.	lvshen1956@126.com	Li, Rachel Wei/T-2261-2019; zhang, qiu/GXG-5600-2022; Wang, Shaolin/M-2282-2013	Li, Rachel Wei/0000-0001-7053-7928; Wang, Shaolin/0000-0003-0866-4584; Li, Min/0000-0002-6059-7756	National Nature Science Funds in China [81071805]; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	National Nature Science Funds in China; Dalian Merricon Gene Diagnosis Technology Co., Ltd.	This work was supported by the National Nature Science Funds in China (Fund No. 81071805; URL: http://isisn.nsfc.gov.cn/egrantweb/), and Dalian Merricon Gene Diagnosis Technology Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Betz BL, 2011, AM J CLIN PATHOL, V136, P564, DOI 10.1309/AJCP84TUTQOSUONG; Bischoff J, 2012, CLIN EXP METASTAS, V29, P889, DOI 10.1007/s10585-012-9478-0; Chung H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003463; Donehower LA, 2013, J PATHOL, V229, P99, DOI 10.1002/path.4087; Kawaguchi M, 2009, INT J ONCOL, V34, P1541, DOI 10.3892/ijo_00000283; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; Lee SY, 2010, J THORAC ONCOL, V5, P1734, DOI 10.1097/JTO.0b013e3181f0beca; Li M, 2011, NEOPLASMA, V58, P74, DOI 10.4149/neo_2011_01_74; Li M, 2008, ONCOL REP, V19, P401; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Luchtenborg M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-160; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Romeo F, 2011, INT J BIOCHEM CELL B, V43, P1754, DOI 10.1016/j.biocel.2011.08.011; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saletta F, 2007, CANCER RES, V67, P7088, DOI 10.1158/0008-5472.CAN-06-4420; Sasaki H, 2006, LUNG CANCER, V54, P103, DOI 10.1016/j.lungcan.2006.06.003; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Sholl LM, 2010, AM J CLIN PATHOL, V133, P922, DOI 10.1309/AJCPST1CTHZS3PSZ; Stoehr C, 2012, PATHOBIOLOGY, V79, P162, DOI 10.1159/000335642; Stubbert LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-207; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takahashi Y, 2005, MOL CARCINOGEN, V42, P150, DOI 10.1002/mc.20073; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Vageli D, 2009, LUNG CANCER, V64, P282, DOI 10.1016/j.lungcan.2008.09.018; Vageli DP, 2012, INT J BIOL MARKER, V27, pE400, DOI 10.5301/JBM.2012.9420; van Puijenbroek M, 2008, FAM CANCER, V7, P319, DOI 10.1007/s10689-008-9194-8; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang Y, 2000, GENE DEV, V14, P927; Wang YC, 2003, J CLIN INVEST, V111, P887, DOI 10.1172/JCI200315475; Wu CC, 2008, CANCER, V113, P3199, DOI 10.1002/cncr.23925; Xinarianos G, 2000, CANCER RES, V60, P4216; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014	47	68	78	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78500	10.1371/journal.pone.0078500	http://dx.doi.org/10.1371/journal.pone.0078500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	23527016	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300065
